data_1f3y_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1f3y _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 8.7 mtm . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.863 0.363 . . . . 0.0 110.771 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.707 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 5.6 t70 . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.465 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.461 ' HD3' ' CH2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.089 0 CA-C-O 121.096 0.474 . . . . 0.0 110.892 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.667 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 2.2 m-80 -132.88 175.01 9.73 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.414 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.516 HG21 ' CA ' ' A' ' 57' ' ' ALA . 4.2 m -142.62 164.96 16.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.252 0.549 . . . . 0.0 111.638 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.555 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -134.09 156.71 22.5 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.534 HG13 ' HB2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -128.98 122.24 56.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.321 0.581 . . . . 0.0 112.198 -179.156 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.2 t -101.17 110.7 22.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.296 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.418 HD22 HG13 ' A' ' 67' ' ' VAL . 61.7 tp -107.4 124.69 50.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.045 0.45 . . . . 0.0 111.727 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.567 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -117.77 142.91 46.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.876 -179.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.484 ' OD1' ' CH2' ' A' ' 136' ' ' TRP . 4.7 m-20 -96.85 -175.74 3.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.532 0.682 . . . . 0.0 111.34 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -56.06 -5.74 0.2 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.688 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.502 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 1.2 m-20 -103.47 -0.77 29.46 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 40.3 mmtt 71.7 24.82 3.38 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.602 ' HB3' ' O ' ' A' ' 137' ' ' VAL . 71.9 mttt -94.49 -177.55 4.27 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.923 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.543 HG13 ' HA ' ' A' ' 139' ' ' PRO . 1.8 mm -122.85 141.53 42.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.939 0.399 . . . . 0.0 111.39 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.489 ' CE1' HD13 ' A' ' 119' ' ' ILE . 17.9 t80 -67.63 106.77 2.3 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.065 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -103.77 138.47 40.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.021 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.436 ' HB3' ' CG ' ' A' ' 131' ' ' PHE . . . -138.06 138.73 39.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.277 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 47.9 p -100.6 148.13 25.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.021 0.438 . . . . 0.0 111.933 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.661 ' O ' ' N ' ' A' ' 35' ' ' ASP . 11.1 mtp85 -70.66 129.09 38.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.868 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.696 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.3 OUTLIER -55.49 56.44 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.381 0.425 . . . . 0.0 111.992 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.661 ' N ' ' O ' ' A' ' 33' ' ' ARG . 11.5 p-10 -177.35 -37.63 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.251 0.548 . . . . 0.0 109.815 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.515 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 18.8 mt -113.05 108.5 53.11 Favored Pre-proline 0 N--CA 1.454 -0.268 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.574 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.09 -18.26 21.34 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.485 2.123 . . . . 0.0 113.145 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -95.41 -9.49 32.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.748 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.53 91.71 7.72 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.897 0.379 . . . . 0.0 111.416 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.646 ' O ' ' HA ' ' A' ' 146' ' ' THR . 75.9 m95 -94.13 147.17 23.42 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.023 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.22 163.28 20.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.156 0.503 . . . . 0.0 111.452 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.427 ' HE3' ' CZ3' ' A' ' 107' ' ' TRP . 1.0 OUTLIER -100.6 156.05 35.65 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.517 178.477 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.418 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 8.3 Cg_endo -49.97 152.73 7.06 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.441 2.094 . . . . 0.0 112.355 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.424 ' HA ' HD11 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -177.8 148.28 0.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.262 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.54 -160.66 10.09 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.654 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.656 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -120.2 142.44 16.03 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.602 -0.808 . . . . 0.0 113.243 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.432 HG13 HG13 ' A' ' 17' ' ' VAL . 30.2 mt -69.64 144.32 14.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.722 0.296 . . . . 0.0 111.168 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.17 -174.88 0.68 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.578 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -48.54 -59.85 3.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.13 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -132.64 59.79 0.68 Allowed Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.384 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 52' ' ' ASP . 4.9 tp10 -118.26 155.64 30.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.825 0.345 . . . . 0.0 110.784 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.412 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -72.71 154.13 91.34 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.506 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.441 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 12.2 Cg_exo -70.86 -49.22 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.597 2.198 . . . . 0.0 111.427 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.495 ' HG2' ' CD2' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -53.21 -45.36 68.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.326 179.58 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -67.91 -44.11 77.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.193 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.46 93.04 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.516 ' CA ' HG21 ' A' ' 17' ' ' VAL . . . -58.01 -54.95 41.11 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.768 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.419 HD13 ' CZ ' ' A' ' 54' ' ' ARG . 14.1 mt -56.6 -53.01 46.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.185 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 59' ' ' ARG . 16.2 mtt-85 -60.85 -59.41 5.43 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.638 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -46.87 -44.7 19.8 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 121.3 0.572 . . . . 0.0 109.768 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.534 ' HB2' HG13 ' A' ' 19' ' ' ILE . 7.2 tt -51.01 -46.51 61.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.482 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.435 ' O ' ' N ' ' A' ' 66' ' ' GLY . 10.2 ttt180 -65.04 -64.52 0.84 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.869 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -48.28 -20.46 0.39 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -97.29 -36.26 10.47 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.402 HG21 ' CE2' ' A' ' 131' ' ' PHE . 17.3 p -129.09 -8.16 4.85 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 82.38 -13.4 40.46 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.36 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.502 ' HB ' HD21 ' A' ' 61' ' ' LEU . 54.9 t -59.25 114.1 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-O 121.233 0.54 . . . . 0.0 111.207 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 70' ' ' ALA . 1.0 OUTLIER -121.98 -38.77 2.68 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.915 179.028 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.449 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 10.4 m -61.55 74.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.614 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.636 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -157.47 156.09 31.49 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.086 0.47 . . . . 0.0 111.835 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -129.58 150.91 50.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.44 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.492 HG21 ' CE2' ' A' ' 110' ' ' PHE . 8.0 t -74.46 126.38 35.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.146 0.498 . . . . 0.0 111.363 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.504 HD13 ' HB2' ' A' ' 111' ' ' LYS . 1.0 OUTLIER -107.0 -20.38 6.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.054 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.452 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.75 175.78 4.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.009 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -155.11 146.65 23.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.523 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.582 ' HA ' HG13 ' A' ' 160' ' ' VAL . 69.9 t -71.08 135.58 84.95 Favored Pre-proline 0 N--CA 1.453 -0.31 0 CA-C-O 121.002 0.43 . . . . 0.0 110.349 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.44 ' HD3' HG11 ' A' ' 160' ' ' VAL . 29.5 Cg_endo -63.69 -54.39 0.99 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.951 2.434 . . . . 0.0 112.586 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.707 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.8 OUTLIER -100.48 -179.23 4.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.695 -179.128 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.503 ' O ' ' CD2' ' A' ' 80' ' ' LEU . 44.9 m95 -92.62 -155.94 0.45 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.069 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.503 ' CD2' ' O ' ' A' ' 79' ' ' TRP . 80.6 mt . . . . . 0 N--CA 1.465 0.294 0 CA-C-O 120.818 0.342 . . . . 0.0 110.259 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.375 0 CA-C-O 121.051 0.453 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.667 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 3.7 mt-30 -125.42 129.71 50.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.406 -178.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.465 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 3.4 ttpt -104.35 135.55 45.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.375 178.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.555 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 53.9 m95 -103.04 161.87 13.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.318 0.58 . . . . 0.0 112.348 -178.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.495 ' CD2' ' HG2' ' A' ' 54' ' ' ARG . 96.3 m-85 -140.89 153.99 45.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.527 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.446 ' HB2' ' CE1' ' A' ' 161' ' ' PHE . 10.5 tp -101.18 141.01 34.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.852 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.495 ' HE1' ' HB2' ' A' ' 108' ' ' PHE . 90.6 m-85 -143.16 145.57 32.94 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.636 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 56.4 tttt -103.4 124.83 49.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.94 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.451 ' CD1' HG13 ' A' ' 67' ' ' VAL . 41.1 t80 -78.87 96.04 5.57 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.743 0.306 . . . . 0.0 111.288 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 15.8 p -98.39 52.67 1.03 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.545 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.449 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -152.59 -146.35 4.34 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.526 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.16 147.41 46.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.131 0.491 . . . . 0.0 111.318 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.43 ' C ' ' H ' ' A' ' 118' ' ' GLU . 63.0 m-20 -61.19 -27.72 68.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.163 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -56.7 -4.31 0.15 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.283 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.43 ' H ' ' C ' ' A' ' 116' ' ' ASP . 7.5 tp10 -90.8 -16.97 27.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.889 0.376 . . . . 0.0 110.931 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.565 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 5.5 mt -84.13 98.41 5.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.171 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 47.8 p-10 -104.0 -8.51 19.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.015 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 46.8 mt . . . . . 0 N--CA 1.466 0.368 0 CA-C-O 120.609 0.243 . . . . 0.0 111.545 -178.89 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.766 0.317 . . . . 0.0 111.535 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.436 ' CG ' ' HB3' ' A' ' 31' ' ' ALA . 3.4 m-85 -105.37 146.45 29.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.086 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.696 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -92.62 -34.3 7.04 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.874 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -148.83 144.17 26.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.661 0.267 . . . . 0.0 110.98 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.565 ' CZ2' HD11 ' A' ' 119' ' ' ILE . 47.2 p-90 -132.61 166.82 21.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.915 0.388 . . . . 0.0 111.546 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.6 t -160.73 178.7 9.2 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.894 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.484 ' CH2' ' OD1' ' A' ' 23' ' ' ASN . 86.2 m95 -114.41 100.99 8.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.723 178.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.602 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 19.9 m -118.67 164.89 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.052 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.515 ' OG1' ' HB2' ' A' ' 141' ' ' GLN . 23.2 p -72.3 166.32 42.66 Favored Pre-proline 0 C--N 1.328 -0.35 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.544 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.543 ' HA ' HG13 ' A' ' 28' ' ' ILE . 25.6 Cg_exo -58.2 -55.46 2.21 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.072 1.848 . . . . 0.0 110.668 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -63.58 -27.86 69.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.291 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.515 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.8 OUTLIER -72.73 -46.24 54.59 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.354 179.496 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 tp -58.32 -39.38 79.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.763 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.538 ' O ' HG23 ' A' ' 146' ' ' THR . 12.7 mm -62.57 -31.84 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.048 0.452 . . . . 0.0 110.417 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.62 -53.5 11.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.71 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.441 HD23 ' CD1' ' A' ' 40' ' ' TRP . 0.9 OUTLIER -72.81 -19.14 61.39 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.803 -179.051 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.646 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 14.2 t -73.87 175.32 7.41 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.424 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.453 ' CG1' ' CB ' ' A' ' 39' ' ' ALA . 34.3 m -85.05 144.28 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.649 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.441 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 2.7 mt-10 -48.13 -46.65 34.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.942 0.401 . . . . 0.0 111.351 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -52.7 -11.37 0.21 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.459 ' HB3' ' CE1' ' A' ' 154' ' ' TYR . 31.9 mttm -132.57 -3.27 3.35 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -63.33 -55.46 35.72 Favored Pre-proline 0 C--N 1.326 -0.439 0 O-C-N 122.431 -0.168 . . . . 0.0 111.203 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 29.8 Cg_endo -64.96 -29.25 57.7 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.067 1.845 . . . . 0.0 111.719 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 29.3 t -69.26 -51.54 42.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.459 ' CE1' ' HB3' ' A' ' 150' ' ' LYS . 7.4 m-30 -64.84 -37.19 86.78 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.84 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -56.22 -45.87 79.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.672 179.244 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -67.68 -30.6 70.17 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.463 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 90.8 t -68.57 -41.16 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.511 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.432 ' CD2' ' HB3' ' A' ' 139' ' ' PRO . 67.9 mt -64.56 -47.23 79.51 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.453 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 17.4 p -50.22 -42.48 51.72 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.582 HG13 ' HA ' ' A' ' 76' ' ' VAL . 98.7 t -65.43 -41.34 90.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.526 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 21.5 m-30 -81.82 5.75 17.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.933 -1.031 . . . . 0.0 112.933 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.61 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.88 -51.78 79.46 Favored Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.649 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.1 Cg_endo -60.05 -11.73 16.61 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.123 1.882 . . . . 0.0 111.996 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.452 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 95.7 m-70 -108.46 -19.19 13.54 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.366 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 96.8 mt . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.868 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.4 ' O ' ' HB2' ' A' ' 79' ' ' TRP . 8.4 mtm . . . . . 0 CA--C 1.524 -0.05 0 CA-C-O 120.665 0.269 . . . . 0.0 111.032 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.758 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 3.9 p-10 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.642 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.714 ' HG2' HD12 ' A' ' 47' ' ' ILE . 4.3 ttp180 . . . . . 0 CA--C 1.532 0.27 0 CA-C-O 121.02 0.438 . . . . 0.0 111.453 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.642 ' OD1' ' HG2' ' A' ' 105' ' ' GLN . 0.2 OUTLIER -134.89 173.39 11.76 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.993 179.241 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.847 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 33.6 m -132.12 160.33 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 CA-C-O 120.986 0.422 . . . . 0.0 111.917 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.609 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -127.08 148.22 17.27 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.26 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.845 ' HB ' ' HB2' ' A' ' 43' ' ' PRO . 2.8 mp -122.5 117.11 51.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.486 ' CB ' ' HE2' ' A' ' 161' ' ' PHE . 43.9 t -101.04 99.7 10.19 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.721 HD22 ' HD2' ' A' ' 112' ' ' PHE . 21.2 tp -101.26 117.03 34.17 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.005 -177.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.708 ' HE2' HD13 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -119.98 160.1 23.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.795 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.613 ' ND2' ' HB2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -97.3 174.24 6.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.19 0.519 . . . . 0.0 110.416 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -57.59 -5.63 0.39 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.245 177.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.559 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.5 OUTLIER -99.39 3.5 45.91 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.709 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.559 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 5.8 mmtp 73.75 18.77 3.35 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.349 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.613 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 2.9 mttt -96.27 142.05 28.88 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.486 ' N ' ' O ' ' A' ' 137' ' ' VAL . 2.5 mp -100.79 144.48 12.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.574 0.702 . . . . 0.0 112.063 -178.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.671 ' CE1' HD13 ' A' ' 119' ' ' ILE . 92.1 t80 -75.39 140.2 42.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.007 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.604 ' HB1' HD13 ' A' ' 142' ' ' LEU . . . -137.76 151.6 48.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.615 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.585 ' HB1' ' CG ' ' A' ' 131' ' ' PHE . . . -139.83 135.91 33.47 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.319 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.691 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 96.6 p -98.08 140.66 32.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.913 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.425 ' NH2' ' HG2' ' A' ' 41' ' ' GLN . 1.7 mtt-85 -67.65 127.84 34.24 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.849 0.357 . . . . 0.0 110.767 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.697 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.6 OUTLIER -45.88 -34.88 4.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.295 0.569 . . . . 0.0 110.458 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -71.47 -38.3 71.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.139 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.517 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 31.3 mm -125.41 108.94 26.53 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.98 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.3 -18.51 23.24 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.578 2.185 . . . . 0.0 112.862 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -92.2 -12.24 33.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.664 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.691 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.48 104.98 17.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.759 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.544 ' O ' ' HA ' ' A' ' 146' ' ' THR . 75.6 m95 -96.82 152.49 18.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.632 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.511 ' HG3' ' C ' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -158.18 160.99 37.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.475 0.655 . . . . 0.0 111.927 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.457 ' HB2' ' HE2' ' A' ' 42' ' ' MET . 13.4 mtm -98.87 155.04 37.07 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.092 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.845 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 51.4 Cg_exo -50.74 144.94 24.81 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.23 1.954 . . . . 0.0 112.087 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.847 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -170.57 141.62 1.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.079 -179.503 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 16' ' ' ASN . . . -148.71 -173.41 19.46 Favored Glycine 0 C--O 1.224 -0.471 0 N-CA-C 111.446 -0.661 . . . . 0.0 111.446 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.56 ' HA2' ' CB ' ' A' ' 16' ' ' ASN . . . -95.82 -154.32 30.46 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.508 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.714 HD12 ' HG2' ' A' ' 15' ' ' ARG . 1.7 mt -163.12 125.53 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 122.535 0.334 . . . . 0.0 110.736 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.27 172.41 12.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.995 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.469 ' HG3' ' H ' ' A' ' 50' ' ' GLY . 1.8 pt-20 -46.92 -76.66 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.61 -179.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.469 ' H ' ' HG3' ' A' ' 49' ' ' GLU . . . -85.17 34.49 3.24 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.963 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.556 ' OE2' ' HB1' ' A' ' 56' ' ' ALA . 4.8 tm-20 -113.19 123.94 51.37 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.526 ' HB2' ' OD1' ' A' ' 55' ' ' ASN . 1.8 m-20 -70.59 158.69 87.25 Favored Pre-proline 0 C--N 1.326 -0.439 0 C-N-CA 120.62 -0.432 . . . . 0.0 109.857 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.578 ' HB3' HG12 ' A' ' 17' ' ' VAL . 6.8 Cg_exo -74.19 -50.11 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.874 2.383 . . . . 0.0 113.463 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.581 ' HD3' HG23 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -49.52 -45.2 47.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.267 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.526 ' OD1' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -67.67 -44.79 76.98 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.053 0.454 . . . . 0.0 110.321 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.556 ' HB1' ' OE2' ' A' ' 51' ' ' GLU . . . -58.72 -41.73 87.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.686 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.645 ' CA ' HG21 ' A' ' 17' ' ' VAL . . . -57.64 -56.77 17.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.2 0.524 . . . . 0.0 109.639 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.593 HG12 ' HE2' ' A' ' 110' ' ' PHE . 26.9 mt -54.38 -53.78 27.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.26 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.518 ' HA ' HH11 ' A' ' 59' ' ' ARG . 0.0 OUTLIER -62.11 -60.06 4.15 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.82 -179.246 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.429 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 16.6 mm-40 -46.21 -49.85 16.54 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.7 tp -49.74 -44.56 48.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.34 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.479 ' HD2' ' HA2' ' A' ' 66' ' ' GLY . 21.9 tpt85 -63.85 -65.44 0.68 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.491 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -49.22 -22.62 1.06 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -97.21 -32.71 11.79 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 119' ' ' ILE . 5.6 p -127.65 -6.28 5.74 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.479 ' HA2' ' HD2' ' A' ' 62' ' ' ARG . . . 79.36 -14.36 16.81 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.08 -1.057 . . . . 0.0 111.561 -178.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.5 HG11 ' CD2' ' A' ' 21' ' ' LEU . 78.7 t -58.55 117.25 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 121.11 0.481 . . . . 0.0 111.682 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.435 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -128.26 -38.96 1.74 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.457 178.003 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.1 m -62.41 73.44 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.941 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.16 155.31 22.7 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.866 0.365 . . . . 0.0 111.957 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.423 ' HG3' HG22 ' A' ' 113' ' ' THR . 1.7 mt-10 -128.62 151.34 49.6 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.573 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.661 HG22 ' CE2' ' A' ' 110' ' ' PHE . 12.2 t -75.07 126.71 36.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.405 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.708 HD13 ' HE2' ' A' ' 22' ' ' MET . 1.4 mt -106.71 -19.32 6.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.31 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.505 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -171.05 175.73 4.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.606 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.9 OUTLIER -153.17 143.73 22.62 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.256 179.4 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.752 HG12 ' O ' ' A' ' 78' ' ' TYR . 38.6 t -70.52 131.97 87.79 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 120.937 0.399 . . . . 0.0 111.087 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.511 ' HD2' HG11 ' A' ' 76' ' ' VAL . 34.4 Cg_endo -65.13 -50.74 1.9 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.057 2.505 . . . . 0.0 112.987 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.758 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 3.1 p90 -100.07 177.43 5.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.983 0.421 . . . . 0.0 111.931 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.606 ' CH2' ' HG3' ' A' ' 15' ' ' ARG . 58.7 m95 -94.2 -163.44 1.05 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.727 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.46 ' HG ' ' C ' ' A' ' 79' ' ' TRP . 15.9 mt . . . . . 0 N--CA 1.463 0.196 0 CA-C-O 121.055 0.455 . . . . 0.0 110.626 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.454 ' O ' ' ND2' ' A' ' 16' ' ' ASN . . . . . . . . 0 CA--C 1.515 -0.402 0 CA-C-O 121.247 0.546 . . . . 0.0 110.642 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.642 ' HG2' ' OD1' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -125.43 119.4 28.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.432 -177.412 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.6 ' HE2' ' CE2' ' A' ' 79' ' ' TRP . 2.0 ttmm -104.17 134.4 47.48 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.609 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 16.0 m95 -101.68 164.67 11.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.279 0.561 . . . . 0.0 112.303 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.543 ' HB2' ' HE1' ' A' ' 110' ' ' PHE . 95.9 m-85 -140.05 153.18 46.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.09 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.589 ' HG ' HD11 ' A' ' 73' ' ' ILE . 16.5 tp -101.24 141.04 34.69 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.844 0.354 . . . . 0.0 110.983 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.709 ' CD1' HG23 ' A' ' 19' ' ' ILE . 45.7 m-85 -142.43 145.77 34.13 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.594 0.712 . . . . 0.0 112.759 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 8.6 tttt -104.88 122.82 46.58 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.065 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.721 ' HD2' HD22 ' A' ' 21' ' ' LEU . 36.5 t80 -77.23 95.81 4.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.99 0.424 . . . . 0.0 110.709 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.423 HG22 ' HG3' ' A' ' 71' ' ' GLU . 28.5 p -95.77 55.27 1.61 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.917 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -159.64 -140.99 3.02 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.678 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.527 ' HG3' ' CG ' ' A' ' 117' ' ' GLN . 0.7 OUTLIER -125.81 147.61 49.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.785 0.326 . . . . 0.0 110.948 179.627 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.509 ' HB3' ' CH2' ' A' ' 134' ' ' TRP . 85.7 m-20 -62.1 -28.18 69.45 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.527 ' CG ' ' HG3' ' A' ' 115' ' ' GLN . 0.2 OUTLIER -57.65 -5.09 0.33 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.218 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 116' ' ' ASP . 25.2 tp10 -88.0 -17.66 30.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.017 0.436 . . . . 0.0 110.602 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.671 HD13 ' CE1' ' A' ' 29' ' ' PHE . 9.1 mt -81.09 105.26 10.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.393 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 23.9 t30 -104.27 -26.26 12.56 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.695 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.454 ' HA ' HD22 ' A' ' 121' ' ' LEU . 63.5 mt . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.12 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.954 0.407 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.585 ' CG ' ' HB1' ' A' ' 31' ' ' ALA . 2.7 m-85 -104.8 142.74 34.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.144 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.697 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -83.72 -36.25 14.27 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.709 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -151.31 154.18 36.24 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.22 -0.49 . . . . 0.0 110.6 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.545 ' CZ2' HD11 ' A' ' 119' ' ' ILE . 23.8 p-90 -135.25 166.79 22.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.825 0.345 . . . . 0.0 111.116 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.445 ' N ' ' HZ3' ' A' ' 40' ' ' TRP . 29.9 t -161.24 163.22 31.17 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.346 0.593 . . . . 0.0 111.657 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.549 ' CZ3' ' HB2' ' A' ' 29' ' ' PHE . 77.2 m95 -110.46 108.32 18.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.054 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 28' ' ' ILE . 34.0 m -123.31 173.72 8.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.861 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.513 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 15.2 p -72.97 172.47 7.84 Favored Pre-proline 0 C--N 1.323 -0.571 0 C-N-CA 120.449 -0.501 . . . . 0.0 109.885 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.565 ' O ' HG12 ' A' ' 143' ' ' ILE . 13.4 Cg_exo -61.75 -55.25 1.18 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.427 1.418 . . . . 0.0 110.314 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.1 -30.81 71.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.066 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -69.86 -48.55 58.41 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.87 0.367 . . . . 0.0 110.153 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.604 HD13 ' HB1' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -54.43 -41.17 69.07 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.429 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.771 HG23 ' HD3' ' A' ' 155' ' ' LYS . 28.3 mm -60.13 -36.87 70.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.936 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.56 -52.28 22.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.41 0.624 . . . . 0.0 111.037 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.4 mp -70.85 -24.88 62.6 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.849 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.544 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 5.2 t -71.8 169.5 15.6 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.539 0.685 . . . . 0.0 111.825 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.498 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 33.8 m -74.3 154.69 6.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.846 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.473 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 0.4 OUTLIER -60.91 -54.59 43.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.071 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.498 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 39.9 p90 -57.07 0.63 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.413 ' H ' ' C ' ' A' ' 148' ' ' GLU . 13.6 mmtt -133.77 -7.7 2.79 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 122.032 -0.417 . . . . 0.0 111.873 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.466 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 0.4 OUTLIER -62.03 -59.24 13.69 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.276 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.473 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 19.2 Cg_endo -59.5 -28.54 87.73 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.347 2.031 . . . . 0.0 111.337 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 24.4 t -68.81 -50.69 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.422 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 7.6 m-30 -66.0 -38.01 87.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.875 178.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.771 ' HD3' HG23 ' A' ' 143' ' ' ILE . 4.8 tptp -56.3 -43.36 78.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.393 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.432 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.3 tp10 -68.17 -34.4 76.24 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.592 HG13 ' CE2' ' A' ' 161' ' ' PHE . 58.5 t -66.01 -41.0 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.615 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.458 ' CD2' ' HB3' ' A' ' 139' ' ' PRO . 38.3 mt -63.8 -45.33 90.15 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.621 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.512 ' O ' ' HB3' ' A' ' 162' ' ' ALA . 28.4 t -53.96 -40.0 66.45 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.724 HG12 ' HA ' ' A' ' 76' ' ' VAL . 62.0 t -67.73 -41.44 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-O 121.491 0.662 . . . . 0.0 109.309 178.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.592 ' CE2' HG13 ' A' ' 157' ' ' VAL . 21.9 m-30 -80.74 4.72 18.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.354 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.611 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.44 -52.45 74.52 Favored Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.604 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.4 Cg_endo -58.48 -13.05 15.55 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.177 1.918 . . . . 0.0 111.603 178.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.505 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 94.5 m-70 -107.85 -19.33 13.56 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.125 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 98.0 mt . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.624 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.9 mmt . . . . . 0 C--O 1.232 0.175 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.0 t70 . . . . . 0 C--N 1.323 -0.544 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.501 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.445 ' HG3' ' CZ3' ' A' ' 79' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.947 ' HB2' ' HG2' ' A' ' 105' ' ' GLN . 0.7 OUTLIER -134.05 -178.83 5.21 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.553 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.678 HG21 ' CA ' ' A' ' 57' ' ' ALA . 23.8 m -140.59 166.63 18.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.348 0.594 . . . . 0.0 111.768 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.567 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -131.33 161.38 23.6 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 178.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.557 HG12 ' O ' ' A' ' 57' ' ' ALA . 3.6 mp -128.64 119.19 49.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.008 0.432 . . . . 0.0 112.04 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.406 ' CB ' ' HE2' ' A' ' 161' ' ' PHE . 10.2 t -104.25 105.0 15.0 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.824 HD23 ' HD2' ' A' ' 112' ' ' PHE . 13.1 tp -108.28 122.28 46.64 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.789 -178.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.654 ' CE ' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -119.37 163.31 17.38 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.818 179.455 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.779 ' ND2' ' HB2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -99.85 168.67 9.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.435 179.818 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.644 ' HA ' ' HE2' ' A' ' 111' ' ' LYS . 71.2 m-20 -56.33 -4.88 0.16 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.021 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.513 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 1.2 m-20 -100.06 2.61 43.45 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.795 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.623 ' HZ3' ' HA ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER 73.91 21.64 2.61 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.173 -178.376 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.779 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -93.86 145.62 24.48 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.045 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.784 HG13 ' HA ' ' A' ' 139' ' ' PRO . 1.5 mm -100.51 139.11 22.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.465 0.65 . . . . 0.0 111.994 -178.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.651 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 82.2 t80 -79.21 140.27 37.73 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.109 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.843 ' HB1' HD12 ' A' ' 142' ' ' LEU . . . -143.71 157.97 44.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.046 0.451 . . . . 0.0 111.033 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.557 ' HB2' ' CB ' ' A' ' 131' ' ' PHE . . . -146.51 138.93 25.08 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.996 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.62 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 60.7 p -99.8 147.99 24.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.297 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.653 ' O ' ' N ' ' A' ' 35' ' ' ASP . 18.2 mtp180 -69.75 129.01 38.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.403 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.786 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.3 OUTLIER -54.96 55.31 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.653 ' N ' ' O ' ' A' ' 33' ' ' ARG . 23.0 t70 -177.4 -28.42 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.87 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.515 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 25.5 mm -119.21 110.65 37.56 Favored Pre-proline 0 N--CA 1.455 -0.181 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.606 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -75.67 -20.28 15.72 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.633 2.222 . . . . 0.0 112.905 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.36 -8.49 32.37 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.8 104.09 16.38 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 120.616 0.246 . . . . 0.0 110.881 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.698 ' O ' ' HA ' ' A' ' 146' ' ' THR . 65.9 m95 -105.89 144.6 32.39 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.909 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.571 ' HG3' ' C ' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -156.92 161.62 39.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.487 0.66 . . . . 0.0 111.622 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.532 ' HB3' ' CZ3' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -96.82 152.87 38.71 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.36 179.062 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.524 ' HG2' ' HB ' ' A' ' 19' ' ' ILE . 5.1 Cg_endo -48.61 158.74 1.02 Allowed 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.197 2.598 . . . . 0.0 111.976 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.82 -179.67 0.63 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.453 0.168 . . . . 0.0 111.084 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.592 ' HA3' ' HG2' ' A' ' 60' ' ' GLU . . . 164.4 155.79 8.56 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.696 -0.764 . . . . 0.0 113.11 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.68 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -76.66 132.09 12.09 Favored Glycine 0 C--N 1.334 0.431 0 N-CA-C 114.702 0.641 . . . . 0.0 114.702 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.661 HG12 ' HA ' ' A' ' 53' ' ' PRO . 2.9 mt -68.93 145.83 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.406 -0.397 . . . . 0.0 110.464 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.455 ' N ' HG22 ' A' ' 47' ' ' ILE . 11.4 m-20 -67.51 -173.12 0.28 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.171 0.51 . . . . 0.0 111.144 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.47 ' HG2' ' H ' ' A' ' 50' ' ' GLY . 1.4 pm0 -50.16 -82.45 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.282 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.47 ' H ' ' HG2' ' A' ' 49' ' ' GLU . . . -109.76 54.6 0.54 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.083 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -115.16 154.61 28.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.096 0.474 . . . . 0.0 110.363 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.457 ' HB2' ' ND2' ' A' ' 55' ' ' ASN . 0.6 OUTLIER -70.44 156.39 91.97 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.805 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.661 ' HA ' HG12 ' A' ' 47' ' ' ILE . 2.7 Cg_exo -74.88 -53.22 0.1 Allowed 'Trans proline' 0 CA--C 1.507 -0.843 0 C-N-CA 122.702 2.268 . . . . 0.0 112.217 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.608 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -48.18 -52.98 18.48 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.925 179.309 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.531 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 1.2 m-20 -53.75 -46.49 70.91 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.002 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 60' ' ' GLU . . . -60.01 -42.34 94.07 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.678 ' CA ' HG21 ' A' ' 17' ' ' VAL . . . -59.07 -61.91 2.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.494 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.608 ' CD1' ' O ' ' A' ' 54' ' ' ARG . 3.3 mp -55.88 -46.51 80.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.497 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.531 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 0.7 OUTLIER -63.14 -63.1 1.29 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.44 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.592 ' HG2' ' HA3' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -42.8 -46.35 5.17 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 120.944 0.402 . . . . 0.0 110.045 179.38 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.527 HD13 ' HB ' ' A' ' 67' ' ' VAL . 12.0 tp -50.05 -47.75 53.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.153 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.467 ' O ' ' N ' ' A' ' 66' ' ' GLY . 40.0 ttp180 -64.77 -62.25 1.68 Allowed 'General case' 0 CA--C 1.523 -0.091 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.415 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -51.61 -20.41 1.98 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.806 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -100.62 -36.85 9.01 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.664 ' O ' ' HA ' ' A' ' 119' ' ' ILE . 2.3 p -127.23 1.97 6.41 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 70.15 -11.82 1.94 Allowed Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.375 -178.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.665 HG11 HD23 ' A' ' 21' ' ' LEU . 75.2 t -58.14 109.72 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-O 121.198 0.523 . . . . 0.0 111.422 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -121.75 -41.3 2.47 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.898 178.495 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.425 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 7.4 m -60.75 74.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.692 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.43 153.36 19.5 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.992 0.425 . . . . 0.0 112.097 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.554 ' HG3' HG21 ' A' ' 113' ' ' THR . 1.5 mt-10 -124.4 148.23 47.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.237 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.543 ' HA ' ' HD1' ' A' ' 110' ' ' PHE . 20.3 t -76.04 126.59 36.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.956 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.654 HD11 ' CE ' ' A' ' 22' ' ' MET . 0.6 OUTLIER -109.25 -19.08 7.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.276 179.074 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.506 ' HB3' ' NE2' ' A' ' 164' ' ' HIS . . . -169.78 176.73 4.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.214 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.9 OUTLIER -162.74 149.24 12.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.885 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.52 ' HA ' HG12 ' A' ' 160' ' ' VAL . 41.5 t -71.64 140.59 84.33 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.293 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.448 ' HD3' HG13 ' A' ' 160' ' ' VAL . 32.6 Cg_endo -64.91 -72.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.931 2.421 . . . . 0.0 113.424 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.428 ' HE1' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -85.18 176.34 8.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.197 0.522 . . . . 0.0 111.74 -178.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.455 ' CD1' ' HD3' ' A' ' 106' ' ' LYS . 29.8 m95 -93.27 109.28 20.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.652 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.428 HD22 ' HE1' ' A' ' 78' ' ' TYR . 39.4 mt . . . . . 0 C--N 1.326 -0.456 0 CA-C-O 120.808 0.337 . . . . 0.0 111.329 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.254 0 CA-C-O 121.004 0.43 . . . . 0.0 110.723 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.947 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 70.0 mt-30 -122.48 130.61 53.24 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.455 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 1.1 ttpp -105.5 131.02 53.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.915 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.567 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 20.5 m95 -102.23 163.07 12.44 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.528 ' CE2' ' HG3' ' A' ' 54' ' ' ARG . 92.6 m-85 -140.69 148.5 40.89 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.235 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.506 ' HB2' ' CZ ' ' A' ' 161' ' ' PHE . 18.8 tp -102.4 128.68 48.89 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.922 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.543 ' HD1' ' HA ' ' A' ' 72' ' ' VAL . 7.7 m-85 -134.54 148.25 50.45 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 121.314 0.578 . . . . 0.0 112.156 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.644 ' HE2' ' HA ' ' A' ' 24' ' ' ASN . 2.1 tttt -98.75 126.12 44.28 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.933 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.824 ' HD2' HD23 ' A' ' 21' ' ' LEU . 33.8 t80 -78.12 96.43 5.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.14 0.495 . . . . 0.0 110.512 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.554 HG21 ' HG3' ' A' ' 71' ' ' GLU . 82.4 p -96.65 50.01 1.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.672 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.425 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -155.37 -144.13 3.84 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.553 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.407 ' N ' ' HE1' ' A' ' 112' ' ' PHE . 8.0 pt20 -123.85 151.42 43.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.115 0.483 . . . . 0.0 111.564 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -62.36 -25.01 67.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.299 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -59.92 -4.97 0.83 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.946 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -91.16 -17.8 25.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.98 0.419 . . . . 0.0 110.613 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.664 ' HA ' ' O ' ' A' ' 65' ' ' THR . 8.8 mt -81.05 104.2 9.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.937 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.456 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 2.3 t30 -102.18 -26.52 13.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.055 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.535 ' CD2' HG22 ' A' ' 65' ' ' THR . 61.7 mt . . . . . 0 N--CA 1.466 0.369 0 CA-C-O 120.842 0.353 . . . . 0.0 111.667 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.197 0 CA-C-O 120.584 0.231 . . . . 0.0 111.439 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.764 ' C ' HD11 ' A' ' 34' ' ' LEU . 4.2 m-85 -114.7 140.72 48.63 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.312 0.577 . . . . 0.0 111.473 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.786 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -80.81 -35.85 23.88 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.754 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -153.75 153.78 32.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.963 0.411 . . . . 0.0 110.66 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.543 ' HA ' ' CZ3' ' A' ' 40' ' ' TRP . 32.6 p-90 -135.18 166.04 24.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.093 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.421 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 13.2 t -161.45 166.95 26.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.097 0.475 . . . . 0.0 111.847 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.651 ' CZ3' ' HB2' ' A' ' 29' ' ' PHE . 53.7 m95 -109.31 103.57 12.54 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.344 178.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.579 ' O ' ' N ' ' A' ' 28' ' ' ILE . 28.5 m -117.56 168.96 8.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.5 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.551 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 11.3 p -71.43 170.63 11.15 Favored Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.965 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.784 ' HA ' HG13 ' A' ' 28' ' ' ILE . 24.4 Cg_exo -57.7 -58.89 0.67 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 121.957 1.772 . . . . 0.0 109.841 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.8 -29.86 69.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.624 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.503 ' HG3' ' HG1' ' A' ' 138' ' ' THR . 6.7 mt-30 -70.73 -48.4 54.71 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 120.934 0.397 . . . . 0.0 110.656 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.843 HD12 ' HB1' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -54.6 -41.97 70.55 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.728 ' CG2' ' HG3' ' A' ' 151' ' ' LYS . 24.3 mm -61.73 -33.92 59.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.255 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.78 -51.54 16.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.377 0.608 . . . . 0.0 110.321 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.42 -21.23 62.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.696 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.698 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 14.7 t -73.45 175.36 7.06 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.717 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.686 ' CG2' ' HD2' ' A' ' 150' ' ' LYS . 34.0 m -86.05 148.26 4.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.655 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.508 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 2.1 mt-10 -48.31 -50.32 30.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.467 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.3 -4.24 0.08 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.686 ' HD2' ' CG2' ' A' ' 147' ' ' VAL . 18.7 mttt -136.51 -7.14 1.96 Allowed 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.728 ' HG3' ' CG2' ' A' ' 143' ' ' ILE . 2.7 ttpp -62.99 -54.34 47.41 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.35 0.119 . . . . 0.0 110.816 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 38.0 Cg_endo -66.38 -29.44 45.71 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.435 2.09 . . . . 0.0 110.989 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 9.3 t -68.1 -55.91 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.55 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 4.6 m-30 -63.09 -37.4 87.05 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.581 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.579 ' HG2' HG23 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -55.78 -45.34 78.17 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.441 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.504 ' O ' HG21 ' A' ' 160' ' ' VAL . 12.8 tm-20 -67.49 -34.58 77.43 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.657 HG13 ' CE2' ' A' ' 161' ' ' PHE . 47.9 t -63.35 -42.1 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.546 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.564 HD13 ' CG1' ' A' ' 143' ' ' ILE . 36.0 mt -63.91 -43.92 94.5 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.883 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.553 ' O ' ' HB1' ' A' ' 162' ' ' ALA . 1.9 m -56.85 -39.31 74.05 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.52 HG12 ' HA ' ' A' ' 76' ' ' VAL . 76.1 t -67.54 -42.4 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.657 ' CE2' HG13 ' A' ' 157' ' ' VAL . 18.8 m-30 -81.24 7.13 12.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.089 -0.959 . . . . 0.0 112.006 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.553 ' HB1' ' O ' ' A' ' 159' ' ' SER . . . -58.97 -54.9 51.9 Favored Pre-proline 0 C--N 1.332 -0.169 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.178 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 15.9 Cg_endo -57.58 -12.94 12.4 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 121.825 1.683 . . . . 0.0 111.768 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.506 ' NE2' ' HB3' ' A' ' 74' ' ' ALA . 78.4 m-70 -107.46 -17.25 14.17 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.237 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.623 ' HA ' ' HZ3' ' A' ' 26' ' ' LYS . 98.2 mt . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.586 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 5.1 mpp? . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.827 0.346 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.634 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 1.5 p30 . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.983 0.42 . . . . 0.0 110.353 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.462 ' HD2' ' CH2' ' A' ' 79' ' ' TRP . 4.7 ttp180 . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 121.103 0.478 . . . . 0.0 111.967 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.728 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 2.1 m-80 -131.66 176.39 8.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.395 -0.82 . . . . 0.0 108.96 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.603 HG21 ' CA ' ' A' ' 57' ' ' ALA . 6.2 m -144.1 166.15 13.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.794 0.33 . . . . 0.0 111.389 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.475 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -136.4 160.24 24.68 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.144 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.628 ' HB ' ' HB2' ' A' ' 43' ' ' PRO . 3.6 mp -129.23 119.36 48.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.043 0.449 . . . . 0.0 111.536 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.0 t -98.29 92.73 5.85 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.182 -0.674 . . . . 0.0 109.182 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.507 ' HA ' ' O ' ' A' ' 110' ' ' PHE . 39.2 tp -91.01 123.32 34.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.741 -178.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.665 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -117.46 152.57 34.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.126 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.61 ' OD1' ' CE3' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -97.66 174.9 6.4 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.507 -179.321 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -56.76 -6.11 0.29 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.769 177.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -101.25 -1.7 33.03 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.631 0.253 . . . . 0.0 111.43 -179.151 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 6.1 mmpt? 75.6 21.72 1.69 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.106 -178.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.665 ' O ' ' HA ' ' A' ' 22' ' ' MET . 6.0 mttt -91.59 175.65 6.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.585 HG13 ' HA ' ' A' ' 139' ' ' PRO . 1.8 mm -118.77 138.12 50.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.131 0.491 . . . . 0.0 111.756 -178.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.406 ' CE1' HD11 ' A' ' 119' ' ' ILE . 9.9 t80 -63.72 101.62 0.37 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.181 178.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.653 ' HA ' ' O ' ' A' ' 41' ' ' GLN . . . -97.86 137.37 36.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.935 0.398 . . . . 0.0 111.315 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.492 ' HB2' ' CG ' ' A' ' 131' ' ' PHE . . . -137.64 139.86 40.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.331 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 60.1 p -104.47 150.59 24.43 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.619 ' O ' ' N ' ' A' ' 35' ' ' ASP . 4.9 mtp180 -74.55 129.93 38.64 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.309 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.701 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -56.89 52.71 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.883 0.473 . . . . 0.0 112.211 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.619 ' N ' ' O ' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -174.97 -37.03 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.054 0.454 . . . . 0.0 110.18 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.452 ' HB ' ' CB ' ' A' ' 39' ' ' ALA . 3.8 mm -112.09 106.23 56.24 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.739 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.53 -60.14 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.07 2.513 . . . . 0.0 113.895 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -67.9 2.87 1.76 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.602 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.85 93.24 8.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.749 0.309 . . . . 0.0 111.454 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.535 ' O ' ' HA ' ' A' ' 146' ' ' THR . 76.4 m95 -98.68 155.04 17.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.089 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.653 ' O ' ' HA ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -162.72 -139.35 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.976 -0.289 . . . . 0.0 111.002 -178.564 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.581 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 4.9 ptt? -176.91 163.36 1.56 Allowed Pre-proline 0 N--CA 1.446 -0.671 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.628 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 2.9 Cg_endo -38.22 130.24 1.0 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.276 2.651 . . . . 0.0 113.342 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.575 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 1.7 tm0? -174.23 141.65 0.75 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.118 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -161.49 -156.45 8.33 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.472 -0.871 . . . . 0.0 112.387 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.669 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -118.24 138.94 14.24 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.03 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.421 ' CG1' HG11 ' A' ' 17' ' ' VAL . 46.2 mt -69.49 145.03 13.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.864 0.364 . . . . 0.0 111.63 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -69.15 -174.34 0.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.817 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -48.58 -75.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.127 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -116.33 56.24 0.53 Allowed Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.276 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -115.16 147.68 39.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.808 0.337 . . . . 0.0 110.773 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -71.12 160.16 83.33 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.606 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.38 -49.07 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.672 2.248 . . . . 0.0 111.653 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.455 ' O ' HG13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -52.21 -45.78 65.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.689 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -64.53 -45.3 87.79 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.857 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.532 ' HA ' ' HD3' ' A' ' 59' ' ' ARG . . . -62.51 -45.62 92.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.688 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.603 ' CA ' HG21 ' A' ' 17' ' ' VAL . . . -57.29 -55.15 38.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.317 0.579 . . . . 0.0 109.832 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 54' ' ' ARG . 27.1 mt -56.43 -51.06 69.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.4 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.532 ' HD3' ' HA ' ' A' ' 56' ' ' ALA . 2.8 ptm180 -65.17 -54.18 33.56 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.557 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.4 OUTLIER -46.25 -44.62 16.51 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.295 0.569 . . . . 0.0 109.884 179.374 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.598 HD12 ' HB3' ' A' ' 43' ' ' PRO . 8.4 tp -51.48 -51.62 53.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.489 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.463 ' O ' ' N ' ' A' ' 66' ' ' GLY . 15.1 ttm180 -64.87 -61.6 2.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.473 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -51.33 -23.47 3.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.111 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -97.13 -38.18 9.83 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.464 HG23 ' CD2' ' A' ' 121' ' ' LEU . 1.1 p -131.26 -3.33 3.89 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 78.75 -9.44 36.98 Favored Glycine 0 CA--C 1.517 0.205 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.135 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.539 ' HB ' ' CD1' ' A' ' 61' ' ' LEU . 69.6 t -58.49 111.76 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.209 0.528 . . . . 0.0 111.444 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -121.63 -39.38 2.65 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.429 178.493 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.408 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 14.2 m -62.7 70.37 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.93 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.37 152.89 19.01 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.216 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.667 ' O ' HD12 ' A' ' 73' ' ' ILE . 0.3 OUTLIER -129.06 157.81 40.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.297 179.443 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.495 HG22 ' CE2' ' A' ' 110' ' ' PHE . 16.5 t -78.62 131.08 35.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.261 0.553 . . . . 0.0 112.033 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.667 HD12 ' O ' ' A' ' 71' ' ' GLU . 0.8 OUTLIER -104.7 -22.5 4.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.176 178.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.435 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -171.83 178.26 3.08 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.703 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.27 145.02 30.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.011 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.708 ' HA ' HG13 ' A' ' 160' ' ' VAL . 53.5 t -70.98 136.94 84.9 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.858 0.361 . . . . 0.0 110.533 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.432 ' CD ' HG11 ' A' ' 76' ' ' VAL . 12.2 Cg_endo -53.11 -68.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.943 2.429 . . . . 0.0 111.831 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.634 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -96.65 -173.36 2.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.692 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.509 ' CD1' ' HD3' ' A' ' 106' ' ' LYS . 31.9 m95 -89.3 -157.18 0.44 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.628 ' HB2' ' O ' ' A' ' 105' ' ' GLN . 72.1 mt . . . . . 0 C--N 1.326 -0.425 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.526 0 CA-C-O 121.204 0.526 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.728 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 3.2 mt-30 -126.0 123.75 39.18 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.434 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.509 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 9.3 ttpt -102.93 138.63 39.57 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 177.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.487 ' CZ2' ' CE1' ' A' ' 154' ' ' TYR . 31.3 m95 -103.36 162.68 12.8 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -177.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -139.74 155.55 47.27 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.881 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.519 ' CD2' ' HB ' ' A' ' 73' ' ' ILE . 39.4 tp -100.99 138.14 38.43 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.961 -0.295 . . . . 0.0 110.272 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.507 ' O ' ' HA ' ' A' ' 21' ' ' LEU . 23.8 m-85 -139.25 137.21 35.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.203 0.525 . . . . 0.0 112.155 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 10.2 ttmt -102.12 126.16 49.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.392 177.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.475 ' CD1' HG12 ' A' ' 67' ' ' VAL . 34.0 t80 -78.57 98.27 6.07 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.769 0.318 . . . . 0.0 110.999 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 8.0 p -97.86 50.4 1.03 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.408 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -152.64 -147.39 4.59 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.339 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -118.94 150.84 39.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.939 0.4 . . . . 0.0 110.885 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.404 ' C ' ' H ' ' A' ' 118' ' ' GLU . 21.0 m-20 -59.77 -35.1 73.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.728 -179.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -6.39 0.21 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.083 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 116' ' ' ASP . 1.0 OUTLIER -89.84 -14.52 34.19 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.743 0.306 . . . . 0.0 111.023 179.521 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.517 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 19.2 mt -78.98 100.37 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.029 0.442 . . . . 0.0 111.999 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 65' ' ' THR . 2.2 t30 -104.16 98.73 8.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.752 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.464 ' CD2' HG23 ' A' ' 65' ' ' THR . 35.8 mt . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.953 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 . . . . . 0 CA--C 1.521 -0.14 0 CA-C-O 121.044 0.449 . . . . 0.0 110.361 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.492 ' CG ' ' HB2' ' A' ' 31' ' ' ALA . 4.8 m-85 -103.45 143.82 32.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.108 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.701 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -85.92 -36.16 10.52 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.388 -0.911 . . . . 0.0 111.985 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -151.37 141.42 22.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.965 0.412 . . . . 0.0 110.925 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.517 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 42.7 p-90 -128.94 166.68 18.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.073 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.43 ' N ' ' HZ3' ' A' ' 40' ' ' TRP . 27.3 t -161.02 179.11 8.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.769 -178.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.61 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 75.8 m95 -114.01 103.73 11.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.59 178.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.3 m -119.22 168.44 11.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.776 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.473 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 17.6 p -74.01 169.89 16.99 Favored Pre-proline 0 CA--C 1.516 -0.358 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.491 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.585 ' HA ' HG13 ' A' ' 28' ' ' ILE . 16.6 Cg_exo -61.57 -53.53 2.23 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.781 1.654 . . . . 0.0 110.512 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.59 -27.72 69.14 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.782 178.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.444 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.2 OUTLIER -73.37 -44.29 58.93 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.486 179.743 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 41' ' ' GLN . 5.4 tp -58.94 -38.35 78.81 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.628 HG22 ' HG2' ' A' ' 155' ' ' LYS . 12.2 mm -63.74 -37.09 78.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.53 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.53 -49.66 52.4 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.297 0.57 . . . . 0.0 110.201 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.479 HD22 ' CD1' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -73.92 -20.15 60.47 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.752 -179.286 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.621 HG21 ' O ' ' A' ' 143' ' ' ILE . 12.7 t -76.2 173.11 11.77 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.514 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.491 ' CG1' ' HB3' ' A' ' 39' ' ' ALA . 35.5 m -80.43 147.24 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.248 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.599 ' HA ' ' HE2' ' A' ' 151' ' ' LYS . 5.3 mt-10 -52.21 -47.65 65.52 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.249 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -52.08 -10.91 0.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.459 ' HB3' ' CE1' ' A' ' 154' ' ' TYR . 21.1 mttt -135.72 -5.52 2.21 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.599 ' HE2' ' HA ' ' A' ' 148' ' ' GLU . 7.2 mtmm -58.28 -61.32 7.77 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 121.278 -0.169 . . . . 0.0 111.154 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.513 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 35.3 Cg_endo -64.83 -26.36 59.85 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.608 2.205 . . . . 0.0 111.738 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 26.3 t -68.25 -50.78 54.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.487 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 7.5 m-30 -66.46 -38.33 87.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.734 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.628 ' HG2' HG22 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -58.13 -42.1 85.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.073 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.26 -32.9 70.94 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.423 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 84.0 t -67.13 -41.09 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.728 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.472 HD23 ' HB3' ' A' ' 139' ' ' PRO . 44.8 mt -64.15 -39.26 93.63 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.93 0.395 . . . . 0.0 110.22 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 162' ' ' ALA . 16.9 m -55.81 -41.1 73.69 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.708 HG13 ' HA ' ' A' ' 76' ' ' VAL . 95.5 t -66.81 -44.84 88.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.175 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.558 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 21.7 m-30 -80.79 5.09 16.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.575 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.621 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.17 -51.86 78.7 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.745 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 18.1 Cg_endo -58.71 -12.18 13.81 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.231 1.954 . . . . 0.0 111.961 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.435 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 89.2 m-70 -110.32 -20.95 12.45 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.252 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 89.3 mt . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.938 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 12.6 mtm . . . . . 0 CA--C 1.53 0.189 0 CA-C-O 120.526 0.203 . . . . 0.0 110.49 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.552 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 29.7 t0 . . . . . 0 C--N 1.332 -0.184 0 CA-C-O 120.945 0.403 . . . . 0.0 110.728 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.57 ' HG3' ' CZ3' ' A' ' 79' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.8 0.333 . . . . 0.0 110.553 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.724 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 8.6 m120 -131.05 170.64 14.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.165 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.642 HG22 ' CA ' ' A' ' 57' ' ' ALA . 13.2 m -141.06 162.61 22.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.462 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.629 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -134.31 159.17 23.72 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.613 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.488 HG22 ' CD1' ' A' ' 110' ' ' PHE . 3.8 mp -128.41 119.02 49.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -97.85 89.42 4.59 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.624 HD21 ' HD1' ' A' ' 112' ' ' PHE . 27.1 tp -90.4 115.6 27.7 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.448 -178.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.464 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 1.7 ptt? -118.28 166.1 13.03 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.058 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.589 ' OD1' ' CE3' ' A' ' 136' ' ' TRP . 0.0 OUTLIER -101.36 167.85 9.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.298 179.492 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -55.89 -4.06 0.1 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.578 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.592 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 1.7 m-20 -100.67 2.63 41.73 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.592 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER 76.38 20.13 1.57 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.941 -178.374 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.588 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 2.1 mmtt -92.69 147.88 22.51 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.573 HG13 ' HA ' ' A' ' 139' ' ' PRO . 0.8 OUTLIER -101.0 138.82 23.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.164 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.452 ' N ' ' O ' ' A' ' 21' ' ' LEU . 12.1 t80 -78.46 134.37 37.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.831 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 134' ' ' TRP . . . -140.2 151.81 45.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.05 0.452 . . . . 0.0 111.224 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -143.28 133.43 24.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.637 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.508 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 3.4 m -97.25 156.5 16.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.165 0.507 . . . . 0.0 112.002 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.577 ' O ' ' N ' ' A' ' 35' ' ' ASP . 32.8 mtp85 -74.47 129.92 38.65 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.742 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.726 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 1.2 mp -57.3 54.9 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.221 0.608 . . . . 0.0 112.289 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.577 ' N ' ' O ' ' A' ' 33' ' ' ARG . 9.9 p-10 -175.89 -33.72 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.062 0.458 . . . . 0.0 109.919 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.668 ' HB ' ' HB1' ' A' ' 39' ' ' ALA . 4.5 mt -117.51 103.05 51.53 Favored Pre-proline 0 N--CA 1.448 -0.549 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.475 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -61.27 -47.34 12.34 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.014 2.476 . . . . 0.0 113.344 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.83 -2.08 22.14 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.668 ' HB1' ' HB ' ' A' ' 36' ' ' ILE . . . -95.55 95.63 8.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.852 0.358 . . . . 0.0 111.428 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.609 ' O ' ' HA ' ' A' ' 146' ' ' THR . 66.6 m95 -100.59 150.94 22.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.893 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.85 165.03 37.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.319 0.581 . . . . 0.0 111.52 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.444 ' HE1' ' HB2' ' A' ' 42' ' ' MET . 27.0 mtm -100.56 150.51 37.04 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.111 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -50.07 150.79 9.75 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.236 1.957 . . . . 0.0 111.89 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -175.58 177.56 1.74 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.606 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.09 158.84 20.09 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.136 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.724 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -87.54 134.88 12.76 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.164 -1.017 . . . . 0.0 113.39 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.451 HD12 ' CG1' ' A' ' 17' ' ' VAL . 50.1 mt -68.25 148.23 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.058 0.456 . . . . 0.0 111.908 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.435 ' N ' HG22 ' A' ' 47' ' ' ILE . 28.1 m-20 -69.98 -172.74 0.57 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.203 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.46 -77.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.141 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -112.51 56.22 0.48 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.58 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.451 ' O ' HG23 ' A' ' 47' ' ' ILE . 3.3 tp10 -114.25 149.31 36.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.75 0.31 . . . . 0.0 110.711 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.404 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 12.6 m-20 -71.14 155.1 93.58 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.321 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.447 ' HA ' HG13 ' A' ' 17' ' ' VAL . 4.7 Cg_exo -74.92 -50.84 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.758 2.305 . . . . 0.0 112.277 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.477 ' HD3' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -51.31 -46.56 62.59 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.731 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -68.09 -40.33 82.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.104 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.59 -43.14 99.4 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.642 ' CA ' HG22 ' A' ' 17' ' ' VAL . . . -57.02 -51.35 69.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.072 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 54' ' ' ARG . 12.3 mt -56.38 -54.82 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.983 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.53 -63.62 1.21 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.289 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -42.32 -46.56 4.62 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.039 0.447 . . . . 0.0 110.223 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.436 HD12 ' HB ' ' A' ' 67' ' ' VAL . 8.2 tp -52.34 -46.76 66.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.487 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.478 ' O ' ' N ' ' A' ' 66' ' ' GLY . 23.0 ttm180 -64.22 -63.06 1.25 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.171 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -49.78 -20.09 0.78 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -95.95 -40.52 9.24 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.476 HG21 ' CD2' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -126.34 -5.31 6.6 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.074 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 81.59 -11.71 44.44 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.214 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.502 HG22 HG12 ' A' ' 119' ' ' ILE . 71.7 t -57.81 114.73 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.155 0.503 . . . . 0.0 111.5 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -123.38 -39.06 2.49 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.33 178.126 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.406 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 5.9 m -62.67 73.32 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.214 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.523 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -162.64 155.3 19.29 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.942 0.401 . . . . 0.0 111.75 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.515 ' O ' HD12 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -130.96 153.99 48.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.452 179.112 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.514 HG23 ' CE2' ' A' ' 110' ' ' PHE . 43.4 t -76.55 131.78 34.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.336 0.588 . . . . 0.0 112.378 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.729 HD11 ' HB2' ' A' ' 111' ' ' LYS . 1.2 mm -103.91 -21.43 5.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.176 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.403 ' HB2' ' NE2' ' A' ' 164' ' ' HIS . . . -169.94 178.62 3.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.182 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -146.3 140.59 26.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.037 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.61 ' HA ' HG13 ' A' ' 160' ' ' VAL . 48.3 t -70.37 138.33 86.57 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.978 0.418 . . . . 0.0 110.535 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.445 ' N ' HG11 ' A' ' 76' ' ' VAL . 19.1 Cg_endo -58.92 -68.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.993 2.462 . . . . 0.0 112.477 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -96.67 -173.38 2.72 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.829 -179.405 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.57 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 44.0 m95 -93.72 -159.03 0.66 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.536 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.522 ' HB2' ' HG2' ' A' ' 105' ' ' GLN . 41.0 mt . . . . . 0 C--N 1.331 -0.222 0 CA-C-O 121.366 0.603 . . . . 0.0 111.131 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.276 0 CA-C-O 120.871 0.367 . . . . 0.0 110.835 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.617 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -133.66 128.53 35.25 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.845 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.463 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 5.3 ttpp -102.32 132.39 48.32 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.629 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 19.5 m95 -104.93 160.86 14.68 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.459 ' CE1' ' HG2' ' A' ' 54' ' ' ARG . 91.4 m-85 -137.99 154.37 49.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.667 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.517 ' HG ' HG12 ' A' ' 73' ' ' ILE . 32.5 tp -97.65 141.69 30.36 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.514 ' CE2' HG23 ' A' ' 72' ' ' VAL . 23.3 m-85 -139.15 138.21 36.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.292 0.567 . . . . 0.0 112.116 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.729 ' HB2' HD11 ' A' ' 73' ' ' ILE . 1.4 ttpt -103.59 128.31 50.88 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.437 177.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.624 ' HD1' HD21 ' A' ' 21' ' ' LEU . 36.9 t80 -78.1 102.82 7.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.818 0.342 . . . . 0.0 111.008 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 49.2 p -100.47 47.65 0.93 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.009 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.406 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -152.73 -146.08 4.28 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.485 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -117.89 146.77 43.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.885 0.374 . . . . 0.0 110.814 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -59.51 -32.36 70.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.705 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -59.29 -4.48 0.56 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.907 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.15 -15.63 31.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.619 0.247 . . . . 0.0 110.951 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.537 HD13 ' CZ2' ' A' ' 134' ' ' TRP . 17.6 mt -76.11 99.67 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.912 0.386 . . . . 0.0 111.541 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 65' ' ' THR . 1.5 m120 -106.16 95.95 6.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.687 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.476 ' CD2' HG21 ' A' ' 65' ' ' THR . 11.2 mt . . . . . 0 CA--C 1.532 0.277 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.838 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.461 0.095 0 CA-C-O 120.714 0.292 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.425 ' CB ' ' HB1' ' A' ' 31' ' ' ALA . 3.4 m-85 -120.02 138.63 53.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.217 0.532 . . . . 0.0 109.898 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.726 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -83.26 -36.45 14.68 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.026 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -149.03 144.43 26.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.948 0.404 . . . . 0.0 110.615 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.537 ' CZ2' HD13 ' A' ' 119' ' ' ILE . 33.4 p-90 -129.63 163.73 25.42 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.455 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.41 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 34.9 t -163.38 176.59 9.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.914 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.589 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 28.5 m95 -111.76 103.42 11.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.317 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 28' ' ' ILE . 24.2 m -118.39 166.26 12.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.511 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 14.5 p -71.82 171.49 9.15 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.216 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.573 ' HA ' HG13 ' A' ' 28' ' ' ILE . 13.4 Cg_exo -63.14 -54.18 1.21 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 121.83 1.687 . . . . 0.0 109.87 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -64.29 -28.35 69.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.911 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.436 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.4 OUTLIER -73.14 -45.75 54.93 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.393 179.745 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.459 HD13 ' HB1' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -58.44 -39.45 79.88 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.566 ' O ' HG22 ' A' ' 146' ' ' THR . 27.3 mm -61.99 -33.76 59.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.132 0.491 . . . . 0.0 110.032 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.03 -53.17 11.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.379 0.609 . . . . 0.0 110.818 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.426 HD22 ' CD1' ' A' ' 40' ' ' TRP . 1.1 mp -72.56 -19.38 61.51 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.72 -179.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 11.7 t -74.19 177.72 5.59 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.4 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.548 HG23 ' HB2' ' A' ' 150' ' ' LYS . 20.9 m -84.46 151.03 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.767 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.426 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 10.6 mt-10 -55.26 -54.75 39.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.486 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.495 ' CE1' HG22 ' A' ' 147' ' ' VAL . 44.3 p90 -55.93 -2.1 0.05 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.548 ' HB2' HG23 ' A' ' 147' ' ' VAL . 29.6 mttm -133.42 -8.06 2.91 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.493 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 0.4 OUTLIER -61.35 -56.45 33.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 121.49 -0.084 . . . . 0.0 111.196 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.493 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 22.7 Cg_endo -62.48 -28.94 78.23 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.163 1.909 . . . . 0.0 111.591 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 31.2 t -67.16 -51.63 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.563 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.472 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 6.9 m-30 -66.19 -39.37 89.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.965 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -56.29 -42.43 77.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.684 179.731 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.07 -33.32 73.37 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.544 HG12 ' CE2' ' A' ' 161' ' ' PHE . 48.8 t -67.5 -40.61 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.43 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 36.9 mt -63.44 -47.1 83.26 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.247 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.496 ' O ' ' HB1' ' A' ' 162' ' ' ALA . 1.8 t -50.72 -42.86 57.68 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.536 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.61 HG13 ' HA ' ' A' ' 76' ' ' VAL . 79.5 t -65.74 -41.65 90.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.544 ' CE2' HG12 ' A' ' 157' ' ' VAL . 18.3 m-30 -80.84 5.19 16.76 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.597 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.598 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.63 -52.77 71.66 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.6 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.0 Cg_endo -58.18 -12.4 12.88 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.112 1.874 . . . . 0.0 111.876 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.403 ' NE2' ' HB2' ' A' ' 74' ' ' ALA . 95.0 m-70 -108.5 -20.23 13.18 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.333 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 95.4 mt . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.105 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.8 mtm . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 120.674 0.273 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.664 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 9.2 t0 . . . . . 0 C--N 1.333 -0.139 0 CA-C-O 121.004 0.43 . . . . 0.0 110.812 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.766 ' HG2' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 121.275 0.56 . . . . 0.0 110.322 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.67 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 3.4 m120 -132.6 173.99 10.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.405 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.561 HG22 ' HB1' ' A' ' 57' ' ' ALA . 2.1 m -140.63 166.73 18.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.409 0.623 . . . . 0.0 111.831 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.652 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -133.33 155.08 21.52 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.252 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.539 HD11 ' HB2' ' A' ' 43' ' ' PRO . 3.4 mp -126.88 119.17 52.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.986 0.422 . . . . 0.0 111.956 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.449 ' O ' ' N ' ' A' ' 110' ' ' PHE . 45.4 t -101.79 102.41 13.03 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.589 HD22 ' CD1' ' A' ' 112' ' ' PHE . 15.5 tp -105.39 118.87 37.65 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.108 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.556 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 1.2 ptm -119.75 161.61 20.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.83 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.498 ' OD1' ' CE3' ' A' ' 136' ' ' TRP . 0.2 OUTLIER -95.77 169.96 9.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.962 0.411 . . . . 0.0 110.155 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -56.62 -5.0 0.18 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.054 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.548 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 4.7 m-20 -98.87 2.93 47.1 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER 75.76 19.45 1.98 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.942 -178.538 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 22' ' ' MET . 1.1 mmtt -94.46 140.8 29.35 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.495 HD12 ' CG ' ' A' ' 139' ' ' PRO . 3.0 mp -102.4 145.57 11.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.681 0.753 . . . . 0.0 112.218 -178.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.63 ' CE1' HD12 ' A' ' 119' ' ' ILE . 83.8 t80 -76.89 137.31 39.06 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.914 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.655 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -140.45 148.64 41.47 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.145 -0.316 . . . . 0.0 110.145 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -138.58 136.82 36.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.841 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.732 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 91.5 p -97.15 143.33 28.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.946 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.511 ' HD3' ' HB2' ' A' ' 39' ' ' ALA . 21.9 mtp85 -68.95 127.48 33.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.738 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.713 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.7 OUTLIER -43.78 -35.31 1.84 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.304 0.573 . . . . 0.0 110.835 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -72.71 -40.09 66.44 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.007 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.57 HG23 ' HB3' ' A' ' 39' ' ' ALA . 8.7 mt -125.31 104.76 28.48 Favored Pre-proline 0 N--CA 1.455 -0.175 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.738 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.75 -20.2 52.64 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.738 2.292 . . . . 0.0 112.871 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.48 -6.59 54.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.706 0.288 . . . . 0.0 111.496 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.732 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.56 93.27 8.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.123 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.65 ' O ' ' HA ' ' A' ' 146' ' ' THR . 78.1 m95 -90.89 144.93 25.18 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.543 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.418 ' HA ' ' HE2' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -158.73 162.6 37.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.184 0.516 . . . . 0.0 111.232 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.573 ' HE3' ' CZ3' ' A' ' 107' ' ' TRP . 1.8 mtm -98.08 152.05 37.84 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.892 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.539 ' HB2' HD11 ' A' ' 19' ' ' ILE . 1.5 Cg_endo -46.96 144.86 7.8 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.239 1.96 . . . . 0.0 111.873 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -172.68 146.4 1.65 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.578 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.44 ' HA3' ' HG3' ' A' ' 60' ' ' GLU . . . -157.32 -167.02 17.79 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.9 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.67 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -117.85 137.68 13.37 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.133 -1.032 . . . . 0.0 113.655 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.766 HD12 ' HG2' ' A' ' 15' ' ' ARG . 3.3 mt -70.52 148.78 10.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.356 -0.422 . . . . 0.0 111.735 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.493 ' N ' HG23 ' A' ' 47' ' ' ILE . 4.5 m-20 -68.61 -173.8 0.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.372 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -49.11 -78.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.178 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -111.93 57.13 0.44 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.601 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.459 ' O ' HG21 ' A' ' 47' ' ' ILE . 7.4 tp10 -117.4 153.86 32.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.946 0.403 . . . . 0.0 110.871 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.86 161.61 77.79 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.486 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.531 ' HA ' HG12 ' A' ' 47' ' ' ILE . 7.3 Cg_exo -74.21 -47.87 0.23 Allowed 'Trans proline' 0 CA--C 1.514 -0.517 0 C-N-CA 122.857 2.371 . . . . 0.0 111.226 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.743 HH11 HG13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -51.98 -44.03 63.86 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.213 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -68.09 -42.13 80.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.946 0.403 . . . . 0.0 110.402 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.431 ' HA ' ' HG2' ' A' ' 59' ' ' ARG . . . -60.49 -44.46 95.93 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.561 ' HB1' HG22 ' A' ' 17' ' ' VAL . . . -57.96 -53.7 55.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.388 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.743 HG13 HH11 ' A' ' 54' ' ' ARG . 57.4 mt -53.27 -52.82 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.526 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.438 ' HG3' ' N ' ' A' ' 60' ' ' GLU . 9.2 ptm180 -63.43 -56.57 15.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.824 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.44 ' HG3' ' HA3' ' A' ' 45' ' ' GLY . 29.2 mm-40 -50.99 -48.45 61.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.063 0.459 . . . . 0.0 110.054 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.1 tp -51.01 -48.5 61.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.393 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.473 ' HD2' ' HA2' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -66.77 -63.29 1.1 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.328 0.585 . . . . 0.0 110.721 179.304 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.67 -22.36 2.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.088 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -99.74 -38.06 8.84 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.426 HG23 ' CD2' ' A' ' 121' ' ' LEU . 0.8 OUTLIER -127.22 -13.6 5.56 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.858 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.473 ' HA2' ' HD2' ' A' ' 62' ' ' ARG . . . 85.4 -13.42 55.38 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.254 -0.974 . . . . 0.0 111.76 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.528 HG22 HG12 ' A' ' 119' ' ' ILE . 27.3 t -57.31 106.02 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 121.236 0.541 . . . . 0.0 111.135 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.456 ' CG2' ' HG2' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -121.18 -39.86 2.65 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.219 178.605 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.0 m -62.68 73.43 0.02 OUTLIER 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.064 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -164.0 159.1 20.33 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.674 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.45 152.18 49.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.873 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.463 HG21 ' CZ ' ' A' ' 110' ' ' PHE . 19.9 t -75.14 127.7 36.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.056 0.455 . . . . 0.0 111.076 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.538 HD13 ' CA ' ' A' ' 111' ' ' LYS . 2.3 mt -108.1 -19.12 6.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.902 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.473 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.09 176.24 4.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.204 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.1 pm0 -154.39 145.26 22.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.453 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.775 ' HA ' HG11 ' A' ' 160' ' ' VAL . 53.5 t -71.25 138.32 84.28 Favored Pre-proline 0 C--N 1.329 -0.286 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.927 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.521 ' HD2' HG13 ' A' ' 76' ' ' VAL . 21.3 Cg_endo -61.82 -55.34 1.13 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.814 2.342 . . . . 0.0 112.696 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.664 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 1.2 p90 -102.17 -178.64 3.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.491 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.545 ' CD1' ' HD3' ' A' ' 106' ' ' LYS . 39.3 m95 -93.54 -157.56 0.55 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.392 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.424 ' CD2' ' O ' ' A' ' 79' ' ' TRP . 55.7 mt . . . . . 0 CA--C 1.516 -0.349 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.176 0 CA-C-O 120.874 0.369 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.621 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 23.9 mt-30 -136.45 124.06 22.31 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.545 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 14.4 ttpp -104.76 140.36 38.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.165 178.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.652 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 19.4 m95 -110.11 160.23 16.65 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.684 ' HB2' HH21 ' A' ' 54' ' ' ARG . 19.0 m-85 -139.07 160.12 40.53 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.125 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.48 ' HG ' HD12 ' A' ' 73' ' ' ILE . 11.7 tp -98.44 142.52 29.96 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.622 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.532 ' HZ ' ' NH1' ' A' ' 54' ' ' ARG . 5.7 m-85 -135.36 145.71 47.65 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.538 ' CA ' HD13 ' A' ' 73' ' ' ILE . 1.8 tttt -106.31 117.16 33.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.854 177.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.589 ' CD1' HD22 ' A' ' 21' ' ' LEU . 55.1 t80 -78.03 101.29 6.86 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.661 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 14.1 p -97.58 40.43 1.16 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.406 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.402 ' C ' ' CE2' ' A' ' 112' ' ' PHE . . . -140.64 -148.36 5.11 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.805 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -123.64 152.03 42.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.702 0.287 . . . . 0.0 111.129 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.42 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 11.6 p-10 -58.31 -39.16 78.63 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.418 0.627 . . . . 0.0 111.204 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -58.2 -3.72 0.28 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.335 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.406 ' H ' ' C ' ' A' ' 116' ' ' ASP . 3.0 tt0 -89.29 -17.34 29.15 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.092 0.473 . . . . 0.0 110.432 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.63 HD12 ' CE1' ' A' ' 29' ' ' PHE . 9.4 mt -88.74 106.84 17.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.462 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 27.3 t30 -100.09 -20.31 16.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.167 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 120' ' ' ASN . 66.8 mt . . . . . 0 N--CA 1.463 0.217 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.089 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.872 0.368 . . . . 0.0 110.363 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -109.74 140.71 43.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.987 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.713 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -89.98 -32.12 10.25 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.12 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.95 152.25 34.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.885 0.374 . . . . 0.0 110.363 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.53 ' CZ2' HD13 ' A' ' 119' ' ' ILE . 37.3 p-90 -137.76 167.62 21.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.009 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.459 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 30.5 t -162.42 175.58 11.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.481 0.657 . . . . 0.0 112.168 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.498 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 35.6 m95 -111.25 105.65 14.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.105 178.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 25.2 m -120.93 170.1 11.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.545 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 18.4 p -73.01 172.0 9.01 Favored Pre-proline 0 CA--C 1.518 -0.284 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.971 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.666 ' HB3' HD21 ' A' ' 158' ' ' LEU . 11.4 Cg_exo -62.81 -55.85 0.74 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.579 1.519 . . . . 0.0 110.286 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -64.23 -25.14 67.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.351 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.439 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 1.8 mm-40 -72.96 -47.63 43.7 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.483 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.655 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -57.79 -39.38 77.4 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.848 -179.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.626 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 6.2 mm -62.82 -37.74 79.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.316 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.51 -48.99 58.78 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.312 0.577 . . . . 0.0 110.488 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.3 mp -75.0 -20.19 59.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.137 -0.938 . . . . 0.0 113.115 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.65 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 14.1 t -74.92 178.58 5.46 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.787 -178.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.637 HG23 ' HB2' ' A' ' 150' ' ' LYS . 27.7 m -82.89 148.62 5.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.115 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.472 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 45.4 mt-10 -55.1 -53.06 60.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.441 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.551 ' CZ ' HG22 ' A' ' 147' ' ' VAL . 51.1 p90 -56.66 -2.22 0.07 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.637 ' HB2' HG23 ' A' ' 147' ' ' VAL . 21.5 mttt -134.76 -7.6 2.43 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.626 ' HG2' ' O ' ' A' ' 143' ' ' ILE . 7.6 mtmm -58.88 -60.02 11.86 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.56 0.219 . . . . 0.0 111.095 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.472 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 31.8 Cg_endo -62.89 -26.78 74.51 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.397 2.064 . . . . 0.0 111.631 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.522 HG21 ' HA ' ' A' ' 150' ' ' LYS . 26.0 t -68.85 -50.99 49.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.418 ' HE2' ' HA ' ' A' ' 41' ' ' GLN . 12.6 m-30 -65.76 -37.3 85.97 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.532 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.602 ' HE2' ' HA ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -57.68 -40.69 80.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.986 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.11 -32.55 72.93 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.605 HG11 ' CE2' ' A' ' 161' ' ' PHE . 48.6 t -66.64 -42.07 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.007 178.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.666 HD21 ' HB3' ' A' ' 139' ' ' PRO . 34.7 mt -64.36 -47.56 78.83 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.58 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.458 ' O ' ' HB3' ' A' ' 162' ' ' ALA . 2.9 p -50.01 -40.63 45.13 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.775 HG11 ' HA ' ' A' ' 76' ' ' VAL . 57.7 t -68.1 -41.37 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.35 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.605 ' CE2' HG11 ' A' ' 157' ' ' VAL . 21.0 m-30 -80.87 4.26 19.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.402 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.608 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.48 -51.5 81.35 Favored Pre-proline 0 C--N 1.331 -0.22 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.776 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.8 Cg_endo -58.63 -12.67 14.93 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.064 1.843 . . . . 0.0 111.818 178.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.473 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 89.4 m-70 -108.76 -18.51 13.69 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.253 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 85.8 mt . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.331 -0.842 . . . . 0.0 110.678 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 9.2 mtm . . . . . 0 N--CA 1.463 0.195 0 CA-C-O 120.853 0.359 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.75 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 17.3 t0 . . . . . 0 N--CA 1.464 0.237 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.416 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.671 ' HG2' HD13 ' A' ' 47' ' ' ILE . 1.5 ttt180 . . . . . 0 N--CA 1.451 -0.393 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.635 ' HA ' ' H ' ' A' ' 47' ' ' ILE . 1.5 m120 -129.84 173.19 10.9 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.707 HG23 ' N ' ' A' ' 57' ' ' ALA . 30.2 m -134.33 165.53 31.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.736 0.779 . . . . 0.0 111.683 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.816 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -131.42 158.2 22.65 Favored Glycine 0 N--CA 1.433 -1.539 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.502 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.463 HD11 ' C ' ' A' ' 43' ' ' PRO . 3.4 mp -123.27 117.95 53.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.496 0.665 . . . . 0.0 111.976 -178.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.444 ' HB3' HD13 ' A' ' 109' ' ' LEU . 37.6 t -104.43 103.74 13.5 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.603 HD22 HG13 ' A' ' 67' ' ' VAL . 30.8 tp -104.47 122.96 46.62 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.893 -177.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.728 ' HB3' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -113.64 137.58 51.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.714 179.845 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.443 ' OD1' ' CZ3' ' A' ' 136' ' ' TRP . 5.6 m-20 -98.11 -172.25 2.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.475 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -52.38 -7.59 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.187 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.491 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 3.7 m-20 -99.73 -7.21 25.87 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.996 0.427 . . . . 0.0 111.045 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.745 ' HE2' ' HA ' ' A' ' 165' ' ' LEU . 0.0 OUTLIER 73.38 20.42 3.22 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 121.652 0.739 . . . . 0.0 109.291 -179.379 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.728 ' O ' ' HB3' ' A' ' 22' ' ' MET . 7.1 mttp -91.72 -161.03 0.78 Allowed 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.767 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 2.5 mp -135.61 145.73 31.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.42 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.658 ' CE1' HD13 ' A' ' 119' ' ' ILE . 81.0 t80 -65.77 110.99 3.02 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.326 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 41' ' ' GLN . . . -100.21 137.56 38.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.842 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.435 ' HB1' ' CG ' ' A' ' 131' ' ' PHE . . . -135.75 132.94 37.45 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.809 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.825 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 48.6 p -98.81 141.39 31.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.221 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.1 mtp-105 -68.67 127.1 31.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.193 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.776 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.3 OUTLIER -45.9 -34.12 3.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.294 0.568 . . . . 0.0 110.73 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.39 -39.78 67.71 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.519 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.634 ' HB ' ' HB2' ' A' ' 39' ' ' ALA . 27.9 mt -123.63 106.64 32.13 Favored Pre-proline 0 N--CA 1.455 -0.214 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.084 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -68.37 -19.88 42.99 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.714 2.276 . . . . 0.0 112.628 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -91.39 -7.46 50.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.514 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.825 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -90.71 96.46 10.65 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.04 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.607 ' O ' ' HA ' ' A' ' 146' ' ' THR . 75.8 m95 -94.76 146.61 24.06 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.116 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.554 ' O ' ' HA ' ' A' ' 30' ' ' ALA . 0.5 OUTLIER -157.79 -124.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.56 -179.29 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.572 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 9.8 ptt? 179.98 163.29 0.86 Allowed Pre-proline 0 N--CA 1.452 -0.345 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.572 ' HD2' ' HB2' ' A' ' 42' ' ' MET . 10.2 Cg_endo -50.99 147.05 20.18 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.114 2.542 . . . . 0.0 112.577 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.456 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 10.6 pt20 -174.22 146.61 1.13 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.809 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.462 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . -160.52 154.38 25.4 Favored Glycine 0 C--O 1.228 -0.273 0 C-N-CA 120.146 -1.026 . . . . 0.0 112.789 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.604 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -78.31 136.95 19.02 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.611 -0.804 . . . . 0.0 114.034 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.671 HD13 ' HG2' ' A' ' 15' ' ' ARG . 3.7 mt -69.62 141.93 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.13 -0.535 . . . . 0.0 110.469 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -68.45 -172.95 0.38 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.738 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -48.22 -73.33 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.208 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -118.42 57.17 0.55 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.483 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HG3' ' N ' ' A' ' 52' ' ' ASP . 2.1 tp10 -114.34 147.43 39.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.66 0.266 . . . . 0.0 110.456 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 26.9 m-20 -70.9 139.83 85.81 Favored Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.159 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.619 ' HB2' ' HZ ' ' A' ' 108' ' ' PHE . 38.6 Cg_exo -58.27 -47.7 18.72 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.354 2.036 . . . . 0.0 112.016 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.584 ' HD3' HG22 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -52.93 -46.17 67.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.904 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -68.0 -40.97 82.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.242 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 60' ' ' GLU . . . -61.71 -44.49 96.83 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.765 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.707 ' N ' HG23 ' A' ' 17' ' ' VAL . . . -56.41 -54.49 45.07 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.812 178.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.489 HG12 ' HE2' ' A' ' 110' ' ' PHE . 10.1 mt -55.25 -55.31 17.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.173 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -60.47 -61.66 2.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.945 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.462 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 4.4 mm-40 -46.89 -43.74 19.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.179 0.514 . . . . 0.0 109.777 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.689 HD11 ' HB ' ' A' ' 67' ' ' VAL . 9.0 tp -51.17 -48.27 61.96 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.923 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.454 ' O ' ' N ' ' A' ' 66' ' ' GLY . 17.9 ttm180 -64.66 -62.91 1.29 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.164 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -49.7 -22.97 1.53 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.268 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -96.02 -37.73 10.52 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.499 HG22 ' CD2' ' A' ' 121' ' ' LEU . 1.3 p -124.34 -35.69 2.75 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.638 -0.425 . . . . 0.0 112.027 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 107.16 -13.53 40.47 Favored Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -178.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.689 ' HB ' HD11 ' A' ' 61' ' ' LEU . 78.1 t -56.24 109.75 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 120.889 0.376 . . . . 0.0 110.49 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 70' ' ' ALA . 3.9 p -120.86 -41.06 2.58 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.315 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.6 m -60.89 72.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.234 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -160.79 157.95 27.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.196 0.522 . . . . 0.0 112.213 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.16 149.63 50.88 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.131 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.788 HG21 ' CE2' ' A' ' 110' ' ' PHE . 12.8 t -74.0 128.14 36.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.172 0.51 . . . . 0.0 111.923 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.546 HD11 ' N ' ' A' ' 111' ' ' LYS . 0.9 OUTLIER -108.83 -18.25 7.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.363 178.668 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.527 ' HB2' ' NE2' ' A' ' 164' ' ' HIS . . . -168.54 179.69 4.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.399 0.619 . . . . 0.0 112.325 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -160.09 147.22 16.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.568 179.764 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.809 ' HA ' HG12 ' A' ' 160' ' ' VAL . 42.7 t -71.2 140.12 85.19 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-O 120.959 0.409 . . . . 0.0 111.533 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.646 ' HD3' HG13 ' A' ' 160' ' ' VAL . 32.2 Cg_endo -64.89 -69.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.094 2.53 . . . . 0.0 112.931 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.75 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -87.4 172.41 9.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.689 -178.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.548 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 54.3 m95 -92.93 102.72 15.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.846 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.47 HD21 ' CD1' ' A' ' 78' ' ' TYR . 65.3 mt . . . . . 0 C--N 1.328 -0.357 0 CA-C-O 120.916 0.388 . . . . 0.0 110.79 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.596 ' O ' ' HA ' ' A' ' 15' ' ' ARG . . . . . . . . 0 C--O 1.225 -0.216 0 CA-C-O 120.799 0.333 . . . . 0.0 110.667 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.549 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 36.7 mt-30 -132.32 126.19 32.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.296 0.569 . . . . 0.0 112.354 -178.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 3.3 ttmt -104.55 135.14 46.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.897 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.816 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 38.8 m95 -101.81 165.58 11.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.198 0.523 . . . . 0.0 112.082 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.619 ' HZ ' ' HB2' ' A' ' 53' ' ' PRO . 97.6 m-85 -141.01 152.69 45.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.892 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.553 ' O ' HG12 ' A' ' 72' ' ' VAL . 10.0 tp -101.2 140.04 36.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.744 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.788 ' CE2' HG21 ' A' ' 72' ' ' VAL . 50.6 m-85 -141.49 143.58 33.91 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 26.5 tttt -100.83 124.59 46.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.247 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.513 ' CD1' HD23 ' A' ' 21' ' ' LEU . 30.8 t80 -78.71 101.36 7.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.728 0.299 . . . . 0.0 110.64 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 18.3 p -98.26 40.54 1.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.501 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.43 -145.41 4.34 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.777 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -121.63 149.07 43.71 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.965 0.412 . . . . 0.0 111.449 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.428 ' C ' ' H ' ' A' ' 118' ' ' GLU . 11.3 p-10 -60.47 -36.32 77.98 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.501 0.667 . . . . 0.0 111.081 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -57.01 -2.87 0.09 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.405 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.428 ' H ' ' C ' ' A' ' 116' ' ' ASP . 3.4 tt0 -89.66 -17.71 27.86 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.163 0.506 . . . . 0.0 110.149 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.658 HD13 ' CE1' ' A' ' 29' ' ' PHE . 9.6 mt -83.36 100.65 7.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.373 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -94.86 -0.46 54.03 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.499 ' CD2' HG22 ' A' ' 65' ' ' THR . 53.5 mt . . . . . 0 N--CA 1.468 0.436 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.521 ' HG3' ' CE1' ' A' ' 131' ' ' PHE . 2.5 tp10 . . . . . 0 N--CA 1.463 0.209 0 CA-C-O 120.731 0.3 . . . . 0.0 110.693 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.614 ' C ' HD13 ' A' ' 34' ' ' LEU . 1.6 m-85 -126.93 140.11 52.57 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.987 0.422 . . . . 0.0 110.378 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.776 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -84.44 -33.44 19.66 Favored Glycine 0 CA--C 1.507 -0.43 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.211 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.59 151.83 29.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.506 -0.347 . . . . 0.0 110.254 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.537 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 37.0 p-90 -138.48 169.56 17.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.591 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.508 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 45.9 t -162.06 177.47 9.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.287 0.565 . . . . 0.0 111.364 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.473 ' CE2' ' CZ3' ' A' ' 134' ' ' TRP . 79.7 m95 -109.47 95.65 5.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.95 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.682 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 25.4 m -116.4 162.82 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.772 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.547 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 12.7 p -72.27 174.13 4.65 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.915 0.388 . . . . 0.0 110.567 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.641 ' O ' HG12 ' A' ' 143' ' ' ILE . 9.4 Cg_exo -63.46 -57.08 0.41 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.526 1.484 . . . . 0.0 110.291 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -60.66 -32.33 71.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.277 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.423 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.9 OUTLIER -70.66 -47.63 58.97 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.566 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.534 HD11 ' CB ' ' A' ' 30' ' ' ALA . 38.7 tp -57.04 -38.42 73.16 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.733 HG22 ' HD3' ' A' ' 155' ' ' LYS . 19.9 mm -60.77 -35.66 65.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.286 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -50.12 35.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.213 0.53 . . . . 0.0 110.867 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.538 HD21 ' CD1' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -73.85 -21.13 60.22 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.132 -179.525 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.613 HG23 ' O ' ' A' ' 143' ' ' ILE . 14.9 t -74.52 171.52 13.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.996 0.427 . . . . 0.0 111.383 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.637 ' CG1' ' HB3' ' A' ' 39' ' ' ALA . 27.7 m -73.67 157.27 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.248 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.45 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 15.4 pt-20 -62.19 -54.17 44.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.12 0.486 . . . . 0.0 110.749 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.484 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 41.5 p90 -57.77 -1.15 0.09 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.409 ' HB2' ' CG2' ' A' ' 147' ' ' VAL . 75.0 mttt -132.57 -8.07 3.24 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.162 0.437 . . . . 0.0 111.878 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.546 ' HG3' HG23 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -61.7 -55.98 37.03 Favored Pre-proline 0 N--CA 1.463 0.192 0 CA-C-O 120.422 0.153 . . . . 0.0 110.744 179.308 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.536 ' HD3' ' HD2' ' A' ' 151' ' ' LYS . 29.9 Cg_endo -64.21 -28.51 64.41 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.083 1.855 . . . . 0.0 111.239 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 21.6 t -68.04 -52.92 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.499 ' HE1' ' CZ2' ' A' ' 107' ' ' TRP . 16.0 m-30 -63.42 -39.66 95.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.79 178.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.733 ' HD3' HG22 ' A' ' 143' ' ' ILE . 0.1 OUTLIER -53.79 -45.4 70.72 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.083 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.46 ' O ' HG23 ' A' ' 160' ' ' VAL . 3.0 tt0 -67.74 -33.88 75.74 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.711 HG13 ' CE2' ' A' ' 161' ' ' PHE . 47.3 t -64.77 -42.36 94.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.392 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.572 HD22 ' HB3' ' A' ' 139' ' ' PRO . 52.1 mt -63.84 -44.14 94.07 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.362 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.528 ' O ' ' HB1' ' A' ' 162' ' ' ALA . 40.0 t -52.09 -39.78 60.27 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.809 HG12 ' HA ' ' A' ' 76' ' ' VAL . 57.7 t -66.77 -41.15 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.105 177.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.711 ' CE2' HG13 ' A' ' 157' ' ' VAL . 23.1 m-30 -80.44 5.9 13.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.694 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.528 ' HB1' ' O ' ' A' ' 159' ' ' SER . . . -62.88 -50.99 74.62 Favored Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.828 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.607 ' HD2' ' O ' ' A' ' 160' ' ' VAL . 31.2 Cg_exo -57.67 -15.43 20.74 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 121.896 1.731 . . . . 0.0 111.209 178.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.527 ' NE2' ' HB2' ' A' ' 74' ' ' ALA . 83.6 m-70 -107.56 -25.76 11.21 Favored 'General case' 0 N--CA 1.458 -0.065 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.012 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.745 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 50.1 mt . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.543 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 5.7 mtm . . . . . 0 N--CA 1.461 0.076 0 CA-C-O 120.85 0.357 . . . . 0.0 110.681 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.7 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 9.7 t70 . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.043 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.528 0.1 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.7 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 3.4 m-80 -132.91 172.9 11.99 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.503 HG21 ' CA ' ' A' ' 57' ' ' ALA . 11.1 m -137.26 170.86 17.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 120.963 0.411 . . . . 0.0 111.221 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.545 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -137.1 158.82 24.46 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.814 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.5 mp -131.99 122.76 49.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 51.6 t -103.34 92.39 4.48 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.518 HD22 ' CD1' ' A' ' 112' ' ' PHE . 8.5 tp -98.3 122.06 40.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.647 -178.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.551 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -122.94 160.55 25.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.757 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.488 ' ND2' ' HB3' ' A' ' 112' ' ' PHE . 1.6 m120 -97.34 -178.12 4.06 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.526 0.679 . . . . 0.0 111.034 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -60.54 -7.41 2.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.747 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.529 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 1.3 m-20 -99.71 3.1 44.85 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.529 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER 72.51 22.05 3.46 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.073 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -96.41 140.74 30.62 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.471 ' N ' ' CD1' ' A' ' 28' ' ' ILE . 2.1 mp -97.2 144.03 11.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.658 0.742 . . . . 0.0 112.094 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.408 ' CZ ' HG23 ' A' ' 119' ' ' ILE . 5.5 t80 -70.74 106.62 3.62 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.462 -1.245 . . . . 0.0 111.014 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.506 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -104.0 142.87 33.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.72 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.541 ' HB2' ' CG ' ' A' ' 131' ' ' PHE . . . -141.3 137.0 32.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.728 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.586 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 10.0 p -101.88 151.41 22.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.645 ' O ' ' N ' ' A' ' 35' ' ' ASP . 7.7 mtp180 -73.4 129.27 37.65 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.367 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.719 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -56.08 53.96 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.72 0.408 . . . . 0.0 112.083 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.645 ' N ' ' O ' ' A' ' 33' ' ' ARG . 4.7 t0 -175.78 -35.31 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.082 0.468 . . . . 0.0 110.098 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.566 ' HB ' ' HB2' ' A' ' 39' ' ' ALA . 6.7 mm -112.97 106.05 55.35 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.559 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.81 -62.08 0.18 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.122 2.548 . . . . 0.0 113.98 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -67.2 0.7 2.54 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.586 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.74 96.88 10.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.776 0.322 . . . . 0.0 111.059 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.613 ' O ' ' HA ' ' A' ' 146' ' ' THR . 69.7 m95 -100.93 148.51 24.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.783 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.456 ' NE2' ' CD ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -156.19 163.64 39.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.636 0.731 . . . . 0.0 112.466 -179.102 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.438 ' HE3' ' CD2' ' A' ' 154' ' ' TYR . 12.2 mtm -97.93 150.93 37.27 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.481 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -50.18 146.35 18.15 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.186 1.924 . . . . 0.0 111.966 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -173.07 150.96 2.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.642 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.43 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . -160.14 160.67 31.86 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.387 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.7 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -81.13 139.67 20.69 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.479 -179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.424 ' CG1' HG13 ' A' ' 17' ' ' VAL . 40.5 mt -69.82 138.94 21.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.639 -0.281 . . . . 0.0 111.385 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -69.04 -173.54 0.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.974 0.416 . . . . 0.0 110.914 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -46.09 -82.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.148 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -112.07 55.97 0.49 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.994 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -112.4 147.67 35.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.952 0.406 . . . . 0.0 110.852 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.467 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 29.1 m-20 -68.73 164.33 46.88 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.132 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 3.6 Cg_exo -78.91 -51.41 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.689 2.259 . . . . 0.0 111.401 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.532 ' HD3' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -51.94 -46.04 64.56 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.331 179.41 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -67.11 -41.8 85.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.108 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.467 ' HB1' ' O ' ' A' ' 52' ' ' ASP . . . -61.07 -44.22 97.71 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.503 ' CA ' HG21 ' A' ' 17' ' ' VAL . . . -56.49 -52.27 65.36 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.747 178.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 54' ' ' ARG . 9.7 mt -56.32 -55.8 16.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.261 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.73 -63.89 1.14 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.011 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.43 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 0.2 OUTLIER -43.52 -46.12 6.84 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-O 121.248 0.547 . . . . 0.0 110.039 179.583 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.451 HD13 ' HB ' ' A' ' 67' ' ' VAL . 10.0 tp -52.84 -47.11 67.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.156 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.494 ' O ' ' N ' ' A' ' 66' ' ' GLY . 19.7 ttm180 -64.48 -64.97 0.74 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.33 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.12 -21.79 0.82 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.324 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -96.57 -35.17 11.17 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.491 HG21 ' CD2' ' A' ' 121' ' ' LEU . 0.6 OUTLIER -129.91 -4.69 4.55 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -178.594 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 80.35 -11.13 39.41 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.448 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.5 HG23 HG12 ' A' ' 119' ' ' ILE . 85.4 t -58.0 112.62 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-O 121.079 0.466 . . . . 0.0 111.625 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.472 ' CG2' ' HG3' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -123.86 -39.86 2.36 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.646 178.172 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.6 m -62.24 75.62 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.955 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.63 157.84 25.24 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.157 0.503 . . . . 0.0 112.305 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.453 ' HG3' HG22 ' A' ' 113' ' ' THR . 2.6 mt-10 -131.29 150.17 52.26 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.442 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.532 HG21 ' HD3' ' A' ' 54' ' ' ARG . 6.4 t -75.51 127.09 36.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.21 0.529 . . . . 0.0 111.414 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.541 HD12 ' HB2' ' A' ' 111' ' ' LYS . 0.7 OUTLIER -109.13 -19.65 6.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.559 179.466 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.455 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -168.92 177.47 4.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.755 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -157.46 147.78 20.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.664 179.851 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.734 ' HA ' HG13 ' A' ' 160' ' ' VAL . 50.2 t -71.51 139.17 83.74 Favored Pre-proline 0 C--N 1.332 -0.152 0 CA-C-O 121.084 0.469 . . . . 0.0 110.827 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.413 ' HD3' HG11 ' A' ' 160' ' ' VAL . 36.4 Cg_endo -66.21 -52.88 0.75 Allowed 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.805 2.337 . . . . 0.0 112.916 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.7 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -101.21 174.12 6.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.314 0.578 . . . . 0.0 112.13 -178.763 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -92.61 95.86 9.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.487 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.459 ' CD1' HG23 ' A' ' 157' ' ' VAL . 62.4 mt . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 120.776 0.322 . . . . 0.0 110.823 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.267 0 CA-C-O 121.196 0.522 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.696 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 40.7 mt-30 -126.12 133.07 51.74 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -105.72 130.66 53.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.34 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.545 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 14.3 m95 -99.34 161.47 13.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.055 0.455 . . . . 0.0 111.735 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.482 ' CE1' ' HG2' ' A' ' 54' ' ' ARG . 98.1 m-85 -139.9 152.13 46.16 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.292 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.416 ' CD2' ' CB ' ' A' ' 164' ' ' HIS . 17.3 tp -99.01 134.81 41.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.458 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.484 ' CE2' HG23 ' A' ' 72' ' ' VAL . 27.2 m-85 -136.46 144.67 44.51 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 15.2 tttt -103.94 119.95 40.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.216 177.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.518 ' CD1' HD22 ' A' ' 21' ' ' LEU . 43.0 t80 -78.37 100.46 6.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.794 0.331 . . . . 0.0 110.667 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.453 HG22 ' HG3' ' A' ' 71' ' ' GLU . 18.6 p -97.13 45.16 1.04 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.85 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.68 -147.93 4.75 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.058 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -119.34 149.72 41.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 0.0 111.056 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.424 ' C ' ' H ' ' A' ' 118' ' ' GLU . 14.7 p-10 -60.38 -38.68 84.69 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.512 0.672 . . . . 0.0 111.243 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -55.98 -3.03 0.07 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.598 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' A' ' 116' ' ' ASP . 1.1 tt0 -89.71 -18.88 25.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.943 0.401 . . . . 0.0 110.556 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.547 HD13 ' CH2' ' A' ' 134' ' ' TRP . 20.1 mt -85.0 106.21 14.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.849 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 38.3 t30 -100.54 -25.41 14.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.327 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.491 ' CD2' HG21 ' A' ' 65' ' ' THR . 46.5 mt . . . . . 0 N--CA 1.465 0.322 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.206 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.441 ' C ' HD12 ' A' ' 34' ' ' LEU . 3.1 mm-40 . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.991 0.424 . . . . 0.0 111.358 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.541 ' CG ' ' HB2' ' A' ' 31' ' ' ALA . 1.9 m-85 -104.41 142.42 34.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.673 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.719 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -85.03 -37.46 10.02 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.043 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -146.24 145.39 30.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.76 0.314 . . . . 0.0 110.483 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.547 ' CH2' HD13 ' A' ' 119' ' ' ILE . 36.2 p-90 -135.71 170.95 15.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.27 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.5 t -167.68 178.48 5.3 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.491 0.662 . . . . 0.0 112.719 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.468 ' CD2' ' OD1' ' A' ' 23' ' ' ASN . 81.2 m95 -113.12 102.99 10.91 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.588 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 25.4 m -120.83 170.44 10.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.536 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 11.1 p -75.41 173.05 7.65 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.889 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.565 ' O ' HG12 ' A' ' 143' ' ' ILE . 12.3 Cg_exo -62.61 -54.01 1.49 Allowed 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.731 1.621 . . . . 0.0 110.381 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -63.93 -30.69 71.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.356 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.76 -43.77 65.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.474 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.506 HD13 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -59.8 -39.27 84.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.313 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.606 ' O ' HG22 ' A' ' 146' ' ' THR . 34.1 mm -63.04 -37.21 78.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.19 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.94 -50.81 38.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.35 0.595 . . . . 0.0 110.528 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.448 HD23 ' CD1' ' A' ' 40' ' ' TRP . 1.3 mp -73.49 -19.82 60.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.179 -0.918 . . . . 0.0 112.709 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.613 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 12.4 t -75.81 172.06 13.33 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.111 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 26.9 m -82.77 145.17 8.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.378 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.51 ' HG3' ' HE3' ' A' ' 151' ' ' LYS . 6.7 mt-10 -47.46 -50.32 23.27 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.602 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -50.2 -12.27 0.08 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -135.37 -3.91 2.38 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.547 ' HG2' ' CG2' ' A' ' 146' ' ' THR . 8.1 mttt -58.69 -60.71 9.5 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.379 0.133 . . . . 0.0 111.178 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.468 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 32.3 Cg_endo -64.44 -27.57 62.53 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.641 2.227 . . . . 0.0 111.754 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 40.3 t -67.88 -50.41 59.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.501 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 8.9 m-30 -66.59 -38.54 87.23 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.021 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.485 ' N ' HD13 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -57.24 -41.18 79.09 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.812 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -70.09 -31.48 69.08 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.478 HG11 ' CE2' ' A' ' 161' ' ' PHE . 51.0 t -66.9 -42.2 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.797 178.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.56 HD22 ' HB3' ' A' ' 139' ' ' PRO . 74.0 mt -63.89 -40.23 96.04 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.238 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 64.2 m -56.41 -41.79 76.93 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.734 HG13 ' HA ' ' A' ' 76' ' ' VAL . 89.3 t -66.74 -43.72 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 115.525 -0.761 . . . . 0.0 108.983 177.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.478 ' CE2' HG11 ' A' ' 157' ' ' VAL . 21.9 m-30 -81.12 7.46 11.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.436 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.455 ' N ' ' CD ' ' A' ' 163' ' ' PRO . . . -59.22 -50.45 87.56 Favored Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.755 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.5 ' HD2' ' O ' ' A' ' 160' ' ' VAL . 34.0 Cg_exo -59.41 -13.05 18.87 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.425 2.083 . . . . 0.0 111.58 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.455 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 86.7 m-70 -109.02 -20.75 12.92 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.294 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 83.8 mt . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.942 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.43 ' O ' ' HB2' ' A' ' 79' ' ' TRP . 1.9 mpp? . . . . . 0 CA--C 1.523 -0.076 0 CA-C-O 120.641 0.258 . . . . 0.0 110.847 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.677 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 12.4 p-10 . . . . . 0 C--N 1.331 -0.197 0 CA-C-O 121.015 0.436 . . . . 0.0 110.759 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.658 ' HG2' HD11 ' A' ' 47' ' ' ILE . 23.2 ttt180 . . . . . 0 N--CA 1.45 -0.457 0 CA-C-O 121.212 0.53 . . . . 0.0 109.751 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.558 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 23.7 m-80 -130.9 171.68 12.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.981 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.684 HG11 ' CD1' ' A' ' 47' ' ' ILE . 22.4 m -134.26 163.34 37.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.14 0.495 . . . . 0.0 111.199 178.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.602 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -138.66 157.87 24.82 Favored Glycine 0 N--CA 1.442 -0.955 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.301 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.597 HG22 ' CD1' ' A' ' 110' ' ' PHE . 2.1 mp -128.56 118.22 46.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.3 t -96.82 98.34 10.05 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.61 HD21 ' HD1' ' A' ' 112' ' ' PHE . 32.0 tp -99.29 116.18 30.87 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.106 -177.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.672 ' HE2' HD12 ' A' ' 73' ' ' ILE . 1.6 ptt? -119.66 161.77 20.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.027 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.52 ' N ' ' OD1' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -94.45 171.32 8.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.092 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -57.34 -5.53 0.32 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.703 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.565 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.6 OUTLIER -99.37 3.04 45.79 Favored 'General case' 0 CA--C 1.521 -0.136 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 11.0 mmtp 73.71 21.88 2.68 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.986 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.605 ' O ' ' HA ' ' A' ' 22' ' ' MET . 2.3 mmtt -92.66 143.17 26.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.674 HG13 ' HA ' ' A' ' 139' ' ' PRO . 1.4 mm -98.96 138.0 24.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.17 0.51 . . . . 0.0 112.283 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.643 ' CE1' HD12 ' A' ' 119' ' ' ILE . 78.1 t80 -75.05 136.67 41.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.398 177.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 134' ' ' TRP . . . -140.33 151.48 45.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.679 0.275 . . . . 0.0 111.102 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -141.34 138.14 32.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.33 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.673 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 43.9 p -95.69 144.87 25.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.66 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 -69.68 136.15 50.71 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.213 0.53 . . . . 0.0 111.318 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.616 ' H ' ' CD2' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -42.11 -48.9 4.82 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.583 -178.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -71.69 -33.25 68.64 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.95 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.559 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 2.8 mt -122.45 110.46 32.24 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.758 0.313 . . . . 0.0 111.531 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.6 -18.77 15.15 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.449 2.099 . . . . 0.0 112.382 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -91.73 -10.45 40.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.352 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.673 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.2 96.47 10.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.564 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.668 ' O ' ' HA ' ' A' ' 146' ' ' THR . 76.0 m95 -90.86 147.59 23.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.682 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -154.84 169.73 23.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.471 0.653 . . . . 0.0 111.667 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.497 ' HE3' ' CZ3' ' A' ' 107' ' ' TRP . 19.3 mtm -107.3 147.2 34.78 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.176 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -48.8 136.88 27.91 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.459 2.106 . . . . 0.0 111.525 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.463 ' CB ' ' HA2' ' A' ' 18' ' ' GLY . 3.1 pp0? -173.08 155.01 2.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.996 0.427 . . . . 0.0 111.269 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 16' ' ' ASN . . . -156.04 -165.1 14.04 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.571 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -95.71 -148.72 24.64 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.209 -0.996 . . . . 0.0 113.243 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.684 ' CD1' HG11 ' A' ' 17' ' ' VAL . 3.0 mt -163.04 125.92 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.545 -0.328 . . . . 0.0 110.488 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.29 169.51 16.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.083 0.468 . . . . 0.0 111.122 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -46.25 -62.22 1.44 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.696 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -99.88 42.35 1.99 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.775 -0.726 . . . . 0.0 113.089 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -119.64 128.81 54.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.553 0.216 . . . . 0.0 110.571 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -69.13 164.61 46.59 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.501 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 3.4 Cg_exo -76.81 -48.05 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.65 2.233 . . . . 0.0 111.912 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.706 ' HE ' HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -55.84 -43.87 77.43 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.21 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -66.92 -45.13 78.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.293 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 60' ' ' GLU . . . -62.29 -43.79 98.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.672 ' CA ' HG23 ' A' ' 17' ' ' VAL . . . -57.37 -61.14 2.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.902 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.519 HG12 ' CE2' ' A' ' 110' ' ' PHE . 25.4 mt -54.61 -48.65 70.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.393 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -64.96 -62.24 1.67 Allowed 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 121.066 -0.254 . . . . 0.0 111.078 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.416 ' HG3' ' HA3' ' A' ' 45' ' ' GLY . 44.8 mm-40 -42.53 -48.68 5.35 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-O 120.908 0.385 . . . . 0.0 110.101 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.477 HD22 ' O ' ' A' ' 67' ' ' VAL . 0.4 OUTLIER -51.25 -47.84 62.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.267 178.761 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.472 ' HG3' ' CG2' ' A' ' 68' ' ' THR . 9.0 ttm180 -63.94 -65.28 0.7 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.124 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -48.62 -19.94 0.4 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -98.82 -35.37 10.14 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.68 -6.93 7.4 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 120.326 -0.549 . . . . 0.0 112.319 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 79.56 -12.35 28.09 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.488 -178.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.477 ' O ' HD22 ' A' ' 61' ' ' LEU . 78.9 t -57.43 121.8 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 121.164 0.506 . . . . 0.0 111.306 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -131.78 -38.22 1.14 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.808 178.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 113' ' ' THR . 5.8 m -61.24 71.75 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.894 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -159.81 153.34 22.52 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.097 0.475 . . . . 0.0 112.212 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.544 ' HG3' HG21 ' A' ' 113' ' ' THR . 1.4 mt-10 -128.19 151.73 48.9 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.845 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.706 HG13 ' HE ' ' A' ' 54' ' ' ARG . 10.8 t -75.43 132.66 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 121.313 0.577 . . . . 0.0 111.575 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.672 HD12 ' HE2' ' A' ' 22' ' ' MET . 1.7 mt -109.85 -18.79 7.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.932 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.489 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.22 176.03 4.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.604 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -152.71 145.58 24.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.452 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.674 ' HA ' HG13 ' A' ' 160' ' ' VAL . 52.9 t -71.94 134.67 83.27 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.142 0.496 . . . . 0.0 111.208 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.42 ' HD3' HG11 ' A' ' 160' ' ' VAL . 33.0 Cg_endo -67.39 -56.87 0.2 Allowed 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.912 2.408 . . . . 0.0 113.01 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.677 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 1.3 p90 -97.29 178.28 5.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.813 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.495 ' C ' ' HG ' ' A' ' 80' ' ' LEU . 56.1 m95 -94.83 -158.58 0.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.47 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.821 ' HB2' ' HG2' ' A' ' 105' ' ' GLN . 13.1 mt . . . . . 0 N--CA 1.463 0.22 0 CA-C-O 121.127 0.489 . . . . 0.0 110.359 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 80' ' ' LEU . . . . . . . . 0 CA--C 1.522 -0.126 0 CA-C-O 121.018 0.437 . . . . 0.0 111.791 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.821 ' HG2' ' HB2' ' A' ' 80' ' ' LEU . 0.9 OUTLIER -129.2 118.82 23.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.875 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 16.3 ttpp -102.91 129.07 49.5 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.939 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.602 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 22.7 m95 -102.38 165.18 11.26 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -177.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.501 ' CZ ' ' HB2' ' A' ' 53' ' ' PRO . 96.5 m-85 -137.53 153.94 49.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.546 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.623 ' O ' HG11 ' A' ' 72' ' ' VAL . 16.8 tp -101.08 139.46 36.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.402 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.597 ' CD1' HG22 ' A' ' 19' ' ' ILE . 34.0 m-85 -141.88 145.97 35.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.555 0.693 . . . . 0.0 112.828 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 18.7 tttt -104.69 123.3 47.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.917 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.61 ' HD1' HD21 ' A' ' 21' ' ' LEU . 46.5 t80 -78.6 95.32 5.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.868 0.366 . . . . 0.0 110.663 179.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.544 HG21 ' HG3' ' A' ' 71' ' ' GLU . 65.7 p -94.16 50.89 1.43 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.876 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -151.99 -143.43 3.7 Favored Glycine 0 N--CA 1.453 -0.217 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.055 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -124.97 150.0 47.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.368 . . . . 0.0 111.244 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.45 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 20.3 p-10 -57.07 -39.03 74.16 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.519 0.676 . . . . 0.0 111.143 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -58.21 -4.58 0.37 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.101 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 116' ' ' ASP . 1.3 tt0 -89.62 -17.02 29.24 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.079 0.466 . . . . 0.0 110.128 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.643 HD12 ' CE1' ' A' ' 29' ' ' PHE . 7.6 mt -78.77 99.88 3.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.33 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.98 91.08 3.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.529 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 120.73 0.3 . . . . 0.0 110.631 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.45 ' O ' HD22 ' A' ' 34' ' ' LEU . 0.8 OUTLIER . . . . . 0 CA--C 1.52 -0.204 0 CA-C-O 121.298 0.57 . . . . 0.0 109.74 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.505 ' N ' HD21 ' A' ' 34' ' ' LEU . 4.9 m-85 -133.78 139.18 46.16 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.582 ' N ' HD23 ' A' ' 34' ' ' LEU . . . -77.58 -35.79 35.52 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.848 -178.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -156.13 152.01 27.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.872 0.368 . . . . 0.0 111.083 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.568 ' CZ2' HD13 ' A' ' 119' ' ' ILE . 27.5 p-90 -133.15 163.99 28.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.197 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.483 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 13.4 t -158.95 167.33 29.66 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.157 0.503 . . . . 0.0 112.072 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.473 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 37.3 m95 -103.44 102.84 12.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.4 177.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 28' ' ' ILE . 26.4 m -118.21 164.91 14.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.539 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 26.8 p -71.64 168.98 17.52 Favored Pre-proline 0 C--N 1.325 -0.474 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.408 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.674 ' HA ' HG13 ' A' ' 28' ' ' ILE . 16.2 Cg_exo -58.91 -58.82 0.57 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 121.72 1.613 . . . . 0.0 110.826 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.28 -27.16 68.83 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.794 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.528 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 29.1 mt-30 -71.69 -47.47 53.85 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.205 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.479 HD12 ' HB3' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -56.24 -41.28 75.48 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.571 ' O ' HG22 ' A' ' 146' ' ' THR . 19.1 mm -61.44 -34.57 61.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.219 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.39 -50.92 23.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.262 0.553 . . . . 0.0 110.858 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.2 mp -73.49 -21.47 60.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.311 -0.858 . . . . 0.0 112.281 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.668 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 12.1 t -73.61 174.81 7.78 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.918 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 33.0 m -80.02 160.2 4.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.688 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.435 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 2.4 mt-10 -60.59 -51.9 67.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.07 0.462 . . . . 0.0 110.915 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.24 -7.65 0.15 Allowed 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.494 ' HA ' HG21 ' A' ' 153' ' ' VAL . 0.8 OUTLIER -131.43 -6.38 3.75 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.571 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -61.74 -53.57 59.55 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 110.543 -0.169 . . . . 0.0 110.543 179.499 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 39.5 Cg_endo -67.97 -28.88 35.03 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.259 1.973 . . . . 0.0 111.347 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.494 HG21 ' HA ' ' A' ' 150' ' ' LYS . 17.3 t -68.47 -52.83 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.469 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 6.1 m-30 -65.75 -37.1 85.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.784 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.571 ' HB2' ' O ' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -57.46 -41.61 80.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.591 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.35 -34.32 75.88 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.529 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 53.8 t -64.9 -41.17 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.347 178.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.457 HD21 ' HB3' ' A' ' 139' ' ' PRO . 56.7 mt -63.65 -48.91 75.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.666 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.482 ' O ' ' HB3' ' A' ' 162' ' ' ALA . 0.9 OUTLIER -49.2 -40.1 32.16 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.188 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.674 HG13 ' HA ' ' A' ' 76' ' ' VAL . 58.5 t -67.63 -42.91 87.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.328 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.582 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 21.9 m-30 -80.71 5.15 16.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.38 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.593 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.85 -53.36 67.22 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.628 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.7 Cg_endo -58.77 -13.2 17.09 Favored 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 122.17 1.914 . . . . 0.0 111.729 178.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.489 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 95.1 m-70 -107.06 -19.08 13.73 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.205 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 96.5 mt . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.807 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 4.1 mtm . . . . . 0 N--CA 1.456 -0.142 0 CA-C-O 120.59 0.233 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.519 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 12.2 t70 . . . . . 0 C--N 1.33 -0.263 0 CA-C-O 120.916 0.389 . . . . 0.0 110.54 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.594 ' HG3' ' CZ3' ' A' ' 79' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.064 0.459 . . . . 0.0 111.214 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.61 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 2.0 m-80 -131.59 173.74 10.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.46 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.618 HG23 ' CA ' ' A' ' 57' ' ' ALA . 6.6 m -139.55 165.32 22.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.174 0.511 . . . . 0.0 111.84 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.527 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -135.38 155.31 22.08 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 178.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.776 HG13 ' HB2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -129.67 124.51 59.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.069 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.521 ' CB ' ' HE2' ' A' ' 161' ' ' PHE . 0.5 OUTLIER -106.6 108.69 20.32 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.953 177.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.533 HD21 ' CG1' ' A' ' 67' ' ' VAL . 11.0 tp -104.19 124.3 48.87 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.582 -178.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.701 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -124.34 155.18 39.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.95 179.342 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.506 ' OD1' ' CE3' ' A' ' 136' ' ' TRP . 0.2 OUTLIER -92.85 176.04 6.58 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.05 0.452 . . . . 0.0 110.134 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.434 ' HA ' ' HE3' ' A' ' 111' ' ' LYS . 1.1 m-80 -57.24 -6.94 0.46 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.064 177.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.593 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 5.5 m-20 -100.46 -0.15 38.56 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.593 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 14.7 mmtm 76.97 19.86 1.33 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.291 -178.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.701 ' O ' ' HA ' ' A' ' 22' ' ' MET . 3.8 mmtt -93.57 141.58 28.31 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.438 ' N ' ' CD1' ' A' ' 28' ' ' ILE . 2.2 mp -101.5 143.51 14.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.669 0.747 . . . . 0.0 112.358 -178.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.492 ' CE1' HD12 ' A' ' 119' ' ' ILE . 11.3 t80 -69.85 108.05 3.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.196 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 134' ' ' TRP . . . -106.92 145.89 31.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.948 0.404 . . . . 0.0 110.924 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.469 ' HB3' ' CG ' ' A' ' 131' ' ' PHE . . . -139.5 137.52 35.57 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.236 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.788 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 25.0 p -99.19 141.75 31.55 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.998 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.583 ' HD2' ' HB3' ' A' ' 39' ' ' ALA . 1.7 mtt85 -69.59 128.34 36.14 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.712 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.5 OUTLIER -46.4 -35.73 5.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.318 0.58 . . . . 0.0 110.891 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.67 -33.97 71.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.665 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.665 ' HB ' ' HB1' ' A' ' 39' ' ' ALA . 20.4 mm -131.05 104.75 15.16 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.914 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.55 -20.37 60.4 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.765 2.31 . . . . 0.0 112.676 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.01 -4.0 53.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.412 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.788 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.97 91.83 8.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.112 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.544 ' O ' ' HA ' ' A' ' 146' ' ' THR . 77.3 m95 -91.83 164.38 13.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.357 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.579 ' HG2' ' NH1' ' A' ' 33' ' ' ARG . 0.0 OUTLIER 174.24 175.13 0.16 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.81 0.814 . . . . 0.0 112.264 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.577 ' HG3' ' CZ3' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -108.19 156.7 37.95 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.29 177.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.443 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 10.1 Cg_endo -50.7 157.35 3.64 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.498 2.132 . . . . 0.0 112.665 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.523 ' HA ' HD11 ' A' ' 19' ' ' ILE . 4.5 pt20 177.99 150.62 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.6 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -160.9 -157.27 8.64 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.447 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -122.22 143.01 15.33 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.91 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.422 HD11 ' HB3' ' A' ' 53' ' ' PRO . 48.5 mt -70.01 146.71 12.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.916 0.389 . . . . 0.0 111.532 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -69.49 -175.08 0.77 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.72 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.51 -61.33 2.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.339 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.85 57.35 0.73 Allowed Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.689 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.415 ' O ' HG21 ' A' ' 47' ' ' ILE . 47.7 tp10 -117.17 155.7 28.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.693 0.283 . . . . 0.0 110.469 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -72.02 161.56 78.19 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.496 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 5.6 Cg_exo -78.3 -49.17 0.09 OUTLIER 'Trans proline' 0 CA--C 1.515 -0.441 0 C-N-CA 122.635 2.223 . . . . 0.0 111.73 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.574 ' HG2' ' CD2' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -52.26 -46.92 65.99 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.47 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -67.71 -41.85 82.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.376 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.22 -42.26 98.29 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.618 ' CA ' HG23 ' A' ' 17' ' ' VAL . . . -57.47 -54.27 48.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.855 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.512 HD13 ' HD2' ' A' ' 54' ' ' ARG . 21.3 mt -56.39 -53.0 45.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.854 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -61.21 -57.71 11.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.652 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 15.1 mm-40 -46.5 -46.03 18.83 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.553 0.692 . . . . 0.0 109.709 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.776 ' HB2' HG13 ' A' ' 19' ' ' ILE . 10.1 tt -52.81 -46.69 67.81 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.959 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.535 ' NE ' ' HA2' ' A' ' 66' ' ' GLY . 0.7 OUTLIER -62.77 -63.43 1.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.995 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -50.42 -22.54 1.92 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.357 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 8.6 mt-10 -96.74 -34.76 11.22 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -177.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.454 HG22 ' CE1' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -130.29 -15.44 3.67 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.465 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.535 ' HA2' ' NE ' ' A' ' 62' ' ' ARG . . . 93.07 -16.32 60.79 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.656 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.678 ' HB ' HD23 ' A' ' 61' ' ' LEU . 74.8 t -58.15 113.86 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.262 0.553 . . . . 0.0 111.937 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.475 HG22 ' HD3' ' A' ' 62' ' ' ARG . 0.2 OUTLIER -125.87 -36.78 2.35 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.716 178.075 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.9 m -63.6 73.83 0.03 OUTLIER 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.698 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.546 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -159.28 157.06 29.85 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.898 0.38 . . . . 0.0 111.981 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.578 ' HG3' HG21 ' A' ' 113' ' ' THR . 0.8 OUTLIER -127.8 149.08 50.42 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.101 179.019 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.512 HG23 ' CE2' ' A' ' 110' ' ' PHE . 19.1 t -74.21 126.3 34.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.077 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.565 HD12 ' HB2' ' A' ' 111' ' ' LYS . 1.4 mt -105.52 -17.6 7.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.236 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.496 ' HB2' ' NE2' ' A' ' 164' ' ' HIS . . . -171.09 175.71 4.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.484 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.0 OUTLIER -154.06 138.65 16.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.109 179.492 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.571 ' HA ' HG12 ' A' ' 160' ' ' VAL . 52.3 t -71.33 135.27 84.43 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-O 121.178 0.513 . . . . 0.0 111.16 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.405 ' N ' HG11 ' A' ' 76' ' ' VAL . 27.3 Cg_endo -66.16 -70.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.867 2.378 . . . . 0.0 112.027 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 6.4 p90 -78.33 170.67 16.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.095 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.594 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 48.2 m95 -93.64 -155.14 0.43 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.467 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.495 HD11 ' HD1' ' A' ' 107' ' ' TRP . 20.8 mt . . . . . 0 C--N 1.326 -0.426 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.119 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.565 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 5.2 mt-30 -128.99 127.33 41.43 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.527 ' HB2' ' CD2' ' A' ' 79' ' ' TRP . 2.0 ttpt -105.67 141.38 37.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.718 178.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.577 ' CZ3' ' HG3' ' A' ' 42' ' ' MET . 54.9 m95 -105.98 163.74 12.52 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.574 ' CD2' ' HG2' ' A' ' 54' ' ' ARG . 96.0 m-85 -141.07 152.47 44.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.895 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.527 ' HG ' HD11 ' A' ' 73' ' ' ILE . 17.8 tp -101.87 143.29 31.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.13 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.553 ' HE1' ' HB2' ' A' ' 108' ' ' PHE . 54.8 m-85 -144.51 145.08 31.66 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.637 0.732 . . . . 0.0 112.965 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.565 ' HB2' HD12 ' A' ' 73' ' ' ILE . 4.4 tttt -104.23 126.06 51.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.737 178.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.486 ' CD1' HG11 ' A' ' 67' ' ' VAL . 34.9 t80 -78.99 100.74 7.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.741 0.305 . . . . 0.0 110.868 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.578 HG21 ' HG3' ' A' ' 71' ' ' GLU . 72.7 p -100.83 50.06 0.88 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.993 0.425 . . . . 0.0 110.952 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -154.1 -145.58 4.19 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.294 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -121.5 150.89 40.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.017 0.437 . . . . 0.0 110.973 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.488 ' HB3' ' HH2' ' A' ' 134' ' ' TRP . 44.7 m-20 -59.11 -34.72 72.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.032 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -58.96 -2.62 0.26 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.191 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.417 ' H ' ' C ' ' A' ' 116' ' ' ASP . 0.8 OUTLIER -89.57 -15.23 33.31 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.805 0.336 . . . . 0.0 111.037 179.787 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.588 HG12 HG21 ' A' ' 67' ' ' VAL . 11.3 mt -78.54 100.3 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.828 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -102.42 92.34 4.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.099 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 38.0 mt . . . . . 0 C--N 1.331 -0.215 0 CA-C-O 121.159 0.504 . . . . 0.0 110.036 179.206 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.462 ' HB3' ' CD1' ' A' ' 131' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.995 0.426 . . . . 0.0 110.673 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.531 ' C ' HD13 ' A' ' 34' ' ' LEU . 2.6 m-85 -106.67 142.6 36.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.497 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.712 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -80.77 -36.01 23.58 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.478 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.51 155.54 36.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.261 -0.47 . . . . 0.0 110.274 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.55 ' CZ2' HD13 ' A' ' 119' ' ' ILE . 25.0 p-90 -140.45 167.53 21.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.159 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.534 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 26.6 t -163.01 176.13 10.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.286 0.565 . . . . 0.0 111.533 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.506 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 64.5 m95 -111.75 103.73 12.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.48 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.451 HG22 ' HB2' ' A' ' 142' ' ' LEU . 26.0 m -121.67 171.54 10.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.375 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.597 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 10.9 p -74.15 177.03 2.34 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.827 ' HB2' HD23 ' A' ' 158' ' ' LEU . 13.9 Cg_endo -74.27 -47.37 0.25 Allowed 'Trans proline' 0 N--CA 1.443 -1.481 0 C-N-CA 121.242 1.294 . . . . 0.0 109.964 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.4 -32.89 73.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.9 177.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.61 -47.97 57.46 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.021 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.503 HD22 ' SD ' ' A' ' 42' ' ' MET . 23.9 tp -60.75 -37.61 82.38 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.67 ' HA ' HG21 ' A' ' 146' ' ' THR . 31.1 mm -59.19 -40.09 80.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 121.373 0.606 . . . . 0.0 109.468 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.29 -51.67 34.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.127 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.517 HD22 ' CD1' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -72.76 -17.94 61.55 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.67 HG21 ' HA ' ' A' ' 143' ' ' ILE . 14.2 t -74.64 -175.94 2.62 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.063 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.719 ' CG1' ' HB2' ' A' ' 39' ' ' ALA . 28.7 m -87.74 151.41 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.06 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.732 ' HG2' ' H ' ' A' ' 149' ' ' PHE . 0.6 OUTLIER -58.76 -53.41 58.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.938 0.399 . . . . 0.0 111.368 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.732 ' H ' ' HG2' ' A' ' 148' ' ' GLU . 48.0 p90 -56.18 -3.35 0.09 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.435 ' HE2' ' CE2' ' A' ' 149' ' ' PHE . 0.7 OUTLIER -133.14 -4.84 3.06 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.757 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' A' ' 143' ' ' ILE . 9.1 mttt -62.37 -59.99 11.31 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 13.6 Cg_endo -56.57 -26.07 62.39 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.25 1.966 . . . . 0.0 111.635 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 12.1 t -68.69 -54.16 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.532 ' O ' ' HB ' ' A' ' 157' ' ' VAL . 4.9 m-30 -65.3 -37.05 85.96 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.807 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -40.46 77.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.264 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.442 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.9 OUTLIER -66.68 -29.39 69.39 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.075 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.544 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 88.9 t -64.67 -39.23 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.216 179.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.827 HD23 ' HB2' ' A' ' 139' ' ' PRO . 0.2 OUTLIER -61.33 -50.1 74.3 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.074 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.4 m -51.95 -43.05 63.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.932 0.396 . . . . 0.0 110.028 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.571 HG12 ' HA ' ' A' ' 76' ' ' VAL . 50.0 t -68.15 -42.2 84.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.346 0.593 . . . . 0.0 109.433 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.544 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 13.2 m-30 -81.28 5.14 18.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.739 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.603 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.44 -52.14 76.38 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.692 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 17.8 Cg_endo -59.72 -12.06 16.71 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.263 1.975 . . . . 0.0 112.045 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.517 ' O ' ' HE3' ' A' ' 26' ' ' LYS . 92.3 m-70 -109.17 -20.77 12.87 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.337 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 94.0 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.974 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.479 ' N ' ' HE3' ' A' ' 6' ' ' MET . 0.7 OUTLIER . . . . . 0 CA--C 1.522 -0.111 0 CA-C-O 120.711 0.291 . . . . 0.0 110.49 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.662 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 1.8 t0 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.319 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.684 ' HG2' HD11 ' A' ' 47' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 121.274 0.559 . . . . 0.0 110.218 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.916 ' HB2' ' HG2' ' A' ' 105' ' ' GLN . 3.0 m120 -135.48 172.86 12.4 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.978 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.733 HG23 ' CA ' ' A' ' 57' ' ' ALA . 5.3 m -136.98 168.7 21.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.572 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -140.45 154.6 24.23 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.388 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.852 HD12 ' HA ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -129.05 125.33 62.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.158 0.504 . . . . 0.0 111.98 -178.851 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.424 ' HB3' ' CE2' ' A' ' 161' ' ' PHE . 43.4 t -104.57 102.85 12.46 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 178.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.84 HD23 ' HD2' ' A' ' 112' ' ' PHE . 24.7 tp -104.14 119.2 38.42 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.366 0.603 . . . . 0.0 111.659 -178.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.626 ' CE ' HD12 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -119.86 158.92 25.63 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.786 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.63 ' ND2' ' HB3' ' A' ' 112' ' ' PHE . 6.9 m120 -98.02 179.1 4.89 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.806 0.812 . . . . 0.0 111.819 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -58.44 -6.55 0.7 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.354 -1.293 . . . . 0.0 111.464 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.6 OUTLIER -101.21 3.39 40.92 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.726 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.535 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 3.1 mmpp? 72.08 22.53 3.67 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -178.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.548 ' O ' ' HA ' ' A' ' 22' ' ' MET . 10.3 mttt -95.02 149.97 20.67 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.728 HG13 ' HA ' ' A' ' 139' ' ' PRO . 1.9 mm -100.98 138.51 24.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.3 0.571 . . . . 0.0 111.519 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.611 ' CE1' HD13 ' A' ' 119' ' ' ILE . 72.6 t80 -73.63 133.62 43.49 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.358 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.675 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -133.53 152.68 51.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.82 0.343 . . . . 0.0 111.175 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.55 ' HB1' ' CB ' ' A' ' 131' ' ' PHE . . . -145.4 136.19 24.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.939 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.62 ' HA ' ' NH2' ' A' ' 33' ' ' ARG . 39.3 p -99.41 147.73 24.95 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.99 0.424 . . . . 0.0 111.829 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.62 ' NH2' ' HA ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -69.9 131.38 44.35 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.933 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.765 HD11 ' C ' ' A' ' 131' ' ' PHE . 0.5 OUTLIER -57.13 51.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 179.694 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.619 ' N ' ' O ' ' A' ' 33' ' ' ARG . 0.6 OUTLIER -175.31 -26.69 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.666 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.771 HG21 ' HB1' ' A' ' 39' ' ' ALA . 5.3 mm -119.92 106.54 41.27 Favored Pre-proline 0 CA--C 1.53 0.189 0 CA-C-O 120.968 0.413 . . . . 0.0 110.649 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.22 -63.76 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.447 2.765 . . . . 0.0 114.019 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -64.91 0.47 1.19 Allowed 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.771 ' HB1' HG21 ' A' ' 36' ' ' ILE . . . -90.56 110.91 22.04 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 120.528 0.204 . . . . 0.0 110.838 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.695 ' O ' ' HA ' ' A' ' 146' ' ' THR . 74.4 m95 -118.78 150.57 39.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.746 0.308 . . . . 0.0 110.611 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.648 ' HB3' ' HH ' ' A' ' 154' ' ' TYR . 67.0 mt-30 -157.96 173.4 16.82 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.385 0.612 . . . . 0.0 111.687 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.611 ' HE2' HD23 ' A' ' 142' ' ' LEU . 3.3 mtm -106.63 152.77 40.84 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.958 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.533 ' O ' HG12 ' A' ' 19' ' ' ILE . 12.5 Cg_endo -55.68 144.22 76.5 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.124 1.883 . . . . 0.0 111.499 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.852 ' HA ' HD12 ' A' ' 19' ' ' ILE . 3.9 pt20 -175.94 157.14 1.86 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.819 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 16' ' ' ASN . . . -161.89 -159.42 10.16 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.469 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.587 ' C ' HG13 ' A' ' 47' ' ' ILE . . . -99.4 -148.72 23.43 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.595 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.684 HD11 ' HG2' ' A' ' 15' ' ' ARG . 7.5 mt -158.68 141.03 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 122.803 0.441 . . . . 0.0 110.077 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -67.84 -173.45 0.35 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.336 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.54 -81.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.41 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -107.49 54.88 0.54 Allowed Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.06 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -112.07 136.78 51.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.773 0.32 . . . . 0.0 110.928 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.468 ' HB2' ' ND2' ' A' ' 55' ' ' ASN . 13.5 m-20 -66.52 147.46 98.96 Favored Pre-proline 0 N--CA 1.453 -0.285 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.34 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.725 ' HB3' HG11 ' A' ' 17' ' ' VAL . 23.1 Cg_exo -64.37 -48.51 4.5 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 123.077 2.518 . . . . 0.0 113.393 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.593 ' O ' HG13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -45.72 -50.83 13.34 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.603 -179.428 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.468 ' ND2' ' HB2' ' A' ' 52' ' ' ASP . 22.2 p30 -65.7 -42.07 91.6 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.7 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.446 ' N ' ' OD1' ' A' ' 55' ' ' ASN . . . -60.29 -41.9 94.34 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.733 ' CA ' HG23 ' A' ' 17' ' ' VAL . . . -57.78 -53.37 58.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.247 178.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.748 HG12 ' CE2' ' A' ' 110' ' ' PHE . 33.0 mt -60.26 -52.32 62.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.932 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.68 -56.66 17.33 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.353 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.412 ' OE1' ' HA3' ' A' ' 45' ' ' GLY . 47.4 mm-40 -47.78 -47.31 30.86 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.753 HD23 ' HB ' ' A' ' 67' ' ' VAL . 10.2 tt -50.68 -50.46 54.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.873 178.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' A' ' 66' ' ' GLY . 32.9 ttt180 -61.55 -63.24 1.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.492 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -49.85 -19.36 0.65 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.25 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -101.28 -35.38 9.28 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 119' ' ' ILE . 1.3 p -126.08 -1.23 7.12 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 73.74 -13.12 4.3 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.027 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.753 ' HB ' HD23 ' A' ' 61' ' ' LEU . 71.1 t -58.52 111.57 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-O 121.106 0.479 . . . . 0.0 111.273 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.48 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -121.6 -41.44 2.48 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.921 178.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 113' ' ' THR . 20.3 m -59.95 74.14 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.33 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.578 ' HB3' ' HA ' ' A' ' 112' ' ' PHE . . . -161.76 156.72 23.22 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.51 ' HG3' HG21 ' A' ' 113' ' ' THR . 0.4 OUTLIER -130.33 151.64 50.61 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.478 179.183 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.859 HG22 ' CE2' ' A' ' 110' ' ' PHE . 6.5 t -75.95 127.61 37.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.527 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.626 HD12 ' CE ' ' A' ' 22' ' ' MET . 1.2 mt -106.68 -19.72 6.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.799 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.504 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.54 176.68 4.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.955 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -154.76 146.16 23.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.422 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.792 ' HA ' HG12 ' A' ' 160' ' ' VAL . 54.3 t -70.71 136.82 85.57 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.624 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.457 ' CD ' HG13 ' A' ' 160' ' ' VAL . 17.5 Cg_endo -55.48 -62.44 0.27 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.901 2.401 . . . . 0.0 112.568 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.662 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -100.47 -175.87 3.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.371 -179.186 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.626 ' CD1' ' HD3' ' A' ' 106' ' ' LYS . 40.4 m95 -90.05 -160.09 0.66 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.007 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 79' ' ' TRP . 36.2 mt . . . . . 0 N--CA 1.465 0.282 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 -0.087 0 CA-C-O 120.862 0.363 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.916 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 45.8 mt-30 -130.33 124.66 32.81 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -178.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.626 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 16.3 ttpp -103.41 138.1 40.61 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.98 178.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.572 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 14.3 m95 -104.76 165.21 11.22 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.346 0.593 . . . . 0.0 112.428 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.656 ' HB2' ' HE1' ' A' ' 110' ' ' PHE . 96.1 m-85 -142.17 152.49 43.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.0 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.61 ' HG ' HD13 ' A' ' 73' ' ' ILE . 18.1 tp -98.83 137.68 37.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.86 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.859 ' CE2' HG22 ' A' ' 72' ' ' VAL . 49.2 m-85 -139.03 145.46 39.64 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.58 ' N ' HD11 ' A' ' 73' ' ' ILE . 14.6 tttm -104.0 124.04 48.3 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.771 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.84 ' HD2' HD23 ' A' ' 21' ' ' LEU . 36.7 t80 -78.23 96.46 5.23 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.889 0.376 . . . . 0.0 110.568 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.51 HG21 ' HG3' ' A' ' 71' ' ' GLU . 71.0 p -95.33 57.44 1.98 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.362 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -163.06 -143.81 3.82 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.546 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.482 ' N ' ' HE1' ' A' ' 112' ' ' PHE . 7.4 mm100 -123.82 146.66 48.2 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.019 0.438 . . . . 0.0 111.463 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.421 ' HB3' ' CH2' ' A' ' 134' ' ' TRP . 90.3 m-20 -62.05 -23.57 66.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.834 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -3.92 0.45 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.971 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.408 ' H ' ' C ' ' A' ' 116' ' ' ASP . 27.0 tp10 -90.27 -18.05 26.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.065 0.46 . . . . 0.0 110.544 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.614 HG12 HG22 ' A' ' 67' ' ' VAL . 8.4 mt -82.33 104.41 10.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.834 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -102.61 -26.41 13.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.032 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.405 ' CD1' ' HD1' ' A' ' 134' ' ' TRP . 68.0 mt . . . . . 0 N--CA 1.469 0.479 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.244 0 CA-C-O 120.685 0.278 . . . . 0.0 111.35 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.765 ' C ' HD11 ' A' ' 34' ' ' LEU . 3.2 m-85 -130.76 140.84 50.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.092 0.472 . . . . 0.0 110.911 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.737 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -78.44 -35.77 32.12 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.785 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -155.75 152.46 28.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.369 -0.416 . . . . 0.0 110.74 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.545 ' HA ' ' HZ3' ' A' ' 40' ' ' TRP . 29.0 p-90 -132.2 164.61 25.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.118 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.422 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 23.4 t -159.46 165.74 32.45 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.325 0.583 . . . . 0.0 112.048 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.564 ' CD2' ' OD1' ' A' ' 23' ' ' ASN . 91.6 m95 -108.39 102.09 11.23 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.481 178.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' ' 28' ' ' ILE . 28.9 m -117.47 171.29 6.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.837 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.529 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 27.8 p -71.99 167.1 34.54 Favored Pre-proline 0 CA--C 1.513 -0.465 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.889 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.728 ' HA ' HG13 ' A' ' 28' ' ' ILE . 21.7 Cg_exo -57.7 -58.83 0.69 Allowed 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.428 1.418 . . . . 0.0 109.889 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.11 -27.17 68.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.035 178.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.483 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 2.0 mm-40 -71.91 -48.36 46.04 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.1 0.476 . . . . 0.0 110.259 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.675 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -55.37 -40.74 71.69 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.22 179.711 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.733 ' CG2' ' HG3' ' A' ' 151' ' ' LYS . 27.3 mm -61.83 -31.84 52.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.329 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.73 -53.42 10.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.354 0.597 . . . . 0.0 110.33 179.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.08 -18.62 61.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.835 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.695 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 14.8 t -73.77 174.69 8.07 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.395 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.551 ' CG1' ' HB2' ' A' ' 39' ' ' ALA . 18.7 m -86.41 149.56 4.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.589 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.578 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 19.9 mt-10 -47.33 -52.3 16.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.95 0.405 . . . . 0.0 111.334 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -55.26 -3.71 0.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . 10.2 mmtm -136.08 -8.2 2.06 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -178.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.733 ' HG3' ' CG2' ' A' ' 143' ' ' ILE . 2.6 ttpp -64.53 -57.77 15.87 Favored Pre-proline 0 C--N 1.322 -0.589 0 C-N-CA 121.145 -0.222 . . . . 0.0 110.66 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.578 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 36.7 Cg_endo -66.06 -30.95 46.88 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.566 2.177 . . . . 0.0 111.469 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 23.4 t -68.07 -51.71 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.648 ' HH ' ' HB3' ' A' ' 41' ' ' GLN . 15.4 m-30 -65.36 -39.17 91.98 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.591 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.633 ' HG2' HG23 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -54.41 -45.26 72.9 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.934 -179.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.94 -35.46 80.03 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.544 HG13 ' CE2' ' A' ' 161' ' ' PHE . 46.4 t -65.16 -41.63 92.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.721 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.672 HD21 ' HB3' ' A' ' 139' ' ' PRO . 30.1 mt -63.41 -43.03 98.7 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.164 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.526 ' O ' ' HB3' ' A' ' 162' ' ' ALA . 0.3 OUTLIER -55.88 -38.45 70.18 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.306 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.792 HG12 ' HA ' ' A' ' 76' ' ' VAL . 85.0 t -68.79 -43.08 83.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.594 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 22.2 m-30 -80.77 5.19 16.57 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.964 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.576 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.32 -52.89 71.21 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.07 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.4 Cg_endo -57.75 -13.41 14.35 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 121.664 1.576 . . . . 0.0 111.741 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.504 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 86.9 m-70 -108.06 -21.91 12.61 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.09 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 85.9 mt . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.397 -0.811 . . . . 0.0 110.569 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.2 mtm . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.804 0.335 . . . . 0.0 110.395 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.713 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 4.2 p30 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.85 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.579 ' HB2' ' HZ3' ' A' ' 79' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.239 0.542 . . . . 0.0 111.862 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.633 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 2.1 m-80 -131.18 174.95 9.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.742 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.751 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 16.0 m -143.82 157.81 16.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.95 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.587 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -127.96 167.24 20.3 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.22 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.501 HD12 ' CG ' ' A' ' 60' ' ' GLU . 5.3 mp -126.91 123.2 62.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.24 0.543 . . . . 0.0 112.461 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.405 ' HB3' HD11 ' A' ' 109' ' ' LEU . 1.4 t -107.49 96.12 6.18 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.438 -0.801 . . . . 0.0 108.9 178.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.501 HD21 ' CG1' ' A' ' 67' ' ' VAL . 26.5 tp -99.61 122.97 43.42 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.917 -178.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.495 ' CB ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -119.64 151.53 38.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.399 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.711 ' OD1' ' CE3' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -96.24 175.44 6.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.313 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -58.31 -3.68 0.29 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.352 177.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.583 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.7 OUTLIER -99.1 -1.26 39.96 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 120.605 0.24 . . . . 0.0 111.376 -179.251 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.583 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 1.4 mmtm 75.12 20.98 2.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.961 -178.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.495 ' O ' ' CB ' ' A' ' 22' ' ' MET . 4.8 mttt -93.41 -178.64 4.8 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.503 HD12 ' CA ' ' A' ' 139' ' ' PRO . 2.8 mp -135.67 144.93 32.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.585 0.707 . . . . 0.0 111.886 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.563 ' HE1' ' CD2' ' A' ' 134' ' ' TRP . 33.2 t80 -66.17 108.33 2.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.985 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 41' ' ' GLN . . . -102.99 140.19 37.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.163 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.422 ' HB1' ' CG ' ' A' ' 131' ' ' PHE . . . -139.07 134.16 32.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.747 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.576 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 55.6 p -100.12 149.21 23.75 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.075 0.464 . . . . 0.0 111.785 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.622 ' O ' ' N ' ' A' ' 35' ' ' ASP . 26.3 mtp85 -72.42 129.95 39.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.489 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.701 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -55.72 56.22 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.995 0.518 . . . . 0.0 112.346 179.799 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.622 ' N ' ' O ' ' A' ' 33' ' ' ARG . 3.0 p-10 -177.08 -33.03 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.157 0.503 . . . . 0.0 109.866 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.479 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 21.1 mt -116.66 105.72 49.46 Favored Pre-proline 0 N--CA 1.452 -0.366 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.482 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.52 -19.62 21.54 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.442 2.095 . . . . 0.0 112.88 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -92.38 -9.74 40.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.551 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.576 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -94.19 106.44 18.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.805 0.336 . . . . 0.0 111.278 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.579 ' O ' ' HA ' ' A' ' 146' ' ' THR . 68.9 m95 -105.71 144.61 32.22 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.75 178.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.517 ' O ' ' HA ' ' A' ' 30' ' ' ALA . 0.8 OUTLIER -153.73 -125.73 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.095 -179.742 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.538 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 0.0 OUTLIER 177.62 160.81 0.56 Allowed Pre-proline 0 N--CA 1.453 -0.32 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.538 ' HD2' ' HB2' ' A' ' 42' ' ' MET . 1.6 Cg_endo -40.69 142.29 0.74 Allowed 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 123.546 2.831 . . . . 0.0 113.03 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.751 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -172.62 146.4 1.68 Allowed 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.884 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -160.62 -162.63 12.71 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.332 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.633 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -120.05 139.93 14.21 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.887 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.438 ' CG1' HG13 ' A' ' 17' ' ' VAL . 28.7 mt -69.37 142.03 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.838 0.352 . . . . 0.0 111.131 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -69.01 -174.12 0.57 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.93 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -49.66 -79.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.049 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -110.1 50.32 0.78 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.285 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -111.57 149.59 31.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.822 0.344 . . . . 0.0 110.576 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.409 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 2.2 m-20 -70.41 162.38 70.57 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.159 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 1.2 Cg_endo -82.96 -51.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.974 2.45 . . . . 0.0 112.021 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.659 ' HD3' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -49.98 -47.33 52.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.623 179.594 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -69.25 -38.26 78.37 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.046 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 52' ' ' ASP . . . -61.82 -45.02 95.63 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.635 ' CA ' HG22 ' A' ' 17' ' ' VAL . . . -58.05 -55.48 34.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.405 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.409 ' O ' ' HB3' ' A' ' 61' ' ' LEU . 47.2 mt -57.55 -46.53 86.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.183 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.08 -66.08 0.59 Allowed 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.278 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.501 ' CG ' HD12 ' A' ' 19' ' ' ILE . 23.6 pt-20 -43.06 -40.45 3.12 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.114 0.483 . . . . 0.0 110.199 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.49 ' CD1' ' HB ' ' A' ' 67' ' ' VAL . 4.9 tp -52.23 -47.42 65.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.376 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 66' ' ' GLY . 1.6 tmm_? -63.51 -63.91 1.05 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.957 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -51.13 -21.17 1.8 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.17 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -97.53 -38.41 9.58 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.437 HG21 ' CD2' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -128.88 -15.15 4.37 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -178.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 91.54 -14.23 64.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.193 -1.004 . . . . 0.0 112.835 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.553 HG22 HG12 ' A' ' 119' ' ' ILE . 55.7 t -56.26 110.57 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.104 0.478 . . . . 0.0 111.321 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.41 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -122.34 -39.8 2.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.466 178.203 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 9.4 m -62.37 74.39 0.02 OUTLIER 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.456 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -162.85 154.86 18.33 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.922 0.391 . . . . 0.0 111.795 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.448 ' HG3' HG22 ' A' ' 113' ' ' THR . 1.0 OUTLIER -127.22 146.63 50.35 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.209 179.454 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.659 HG21 ' HD3' ' A' ' 54' ' ' ARG . 8.5 t -76.73 129.96 36.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.202 0.525 . . . . 0.0 112.224 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.648 HD13 ' HB2' ' A' ' 111' ' ' LYS . 0.7 OUTLIER -113.3 -18.12 7.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.947 179.43 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.464 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -169.04 178.63 4.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.147 0.499 . . . . 0.0 112.013 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.4 pm0 -157.66 152.71 25.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.882 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.827 ' HA ' HG12 ' A' ' 160' ' ' VAL . 33.7 t -72.93 136.61 79.78 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.265 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.455 ' HD3' ' CG1' ' A' ' 160' ' ' VAL . 20.7 Cg_endo -59.45 -76.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.943 2.428 . . . . 0.0 112.564 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.713 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -80.65 171.68 14.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.698 -179.179 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.579 ' HZ3' ' HB2' ' A' ' 15' ' ' ARG . 27.9 m95 -94.33 97.53 10.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.608 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.43 HD22 ' CD1' ' A' ' 78' ' ' TYR . 51.1 mt . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.8 0.333 . . . . 0.0 110.89 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 15' ' ' ARG . . . . . . . . 0 C--O 1.224 -0.274 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.538 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 2.9 mt-30 -123.19 123.75 41.48 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.418 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 1.0 OUTLIER -104.25 132.66 50.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.435 178.364 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.587 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 51.6 m95 -101.74 166.53 10.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.241 0.543 . . . . 0.0 112.448 -178.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.564 ' CD1' ' HG2' ' A' ' 54' ' ' ARG . 98.0 m-85 -141.47 151.63 43.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.955 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.444 ' HB2' ' CE1' ' A' ' 161' ' ' PHE . 29.5 tp -107.68 126.73 52.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.968 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.498 ' CE1' ' HB3' ' A' ' 108' ' ' PHE . 4.1 m-85 -132.8 145.54 51.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.315 0.578 . . . . 0.0 111.918 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.648 ' HB2' HD13 ' A' ' 73' ' ' ILE . 47.8 tttt -95.27 127.69 41.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.602 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.451 ' CD1' HD22 ' A' ' 21' ' ' LEU . 38.2 t80 -78.33 101.33 7.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.898 0.38 . . . . 0.0 110.853 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.448 HG22 ' HG3' ' A' ' 71' ' ' GLU . 41.6 p -100.53 53.07 0.87 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.702 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -158.04 -146.49 4.53 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.409 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -121.85 152.1 39.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.995 0.426 . . . . 0.0 111.26 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.435 ' HB3' ' HH2' ' A' ' 134' ' ' TRP . 61.4 m-20 -60.12 -35.1 74.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.874 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -58.18 -2.05 0.16 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.116 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.434 ' H ' ' C ' ' A' ' 116' ' ' ASP . 0.7 OUTLIER -90.41 -15.8 30.26 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.942 0.401 . . . . 0.0 110.853 179.543 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.562 HD11 ' CE1' ' A' ' 29' ' ' PHE . 14.3 mt -81.05 100.6 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.223 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 65' ' ' THR . 6.5 p-10 -103.78 93.68 5.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.339 178.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.437 ' CD2' HG21 ' A' ' 65' ' ' THR . 39.0 mt . . . . . 0 C--N 1.331 -0.226 0 CA-C-O 121.076 0.465 . . . . 0.0 110.1 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.461 0.084 0 CA-C-O 120.796 0.331 . . . . 0.0 111.371 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.56 ' C ' HD12 ' A' ' 34' ' ' LEU . 2.2 m-85 -102.23 139.71 37.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.136 0.493 . . . . 0.0 110.573 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.701 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -82.34 -36.89 16.01 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.013 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -151.57 149.33 29.05 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.86 0.362 . . . . 0.0 110.53 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.563 ' CD2' ' HE1' ' A' ' 29' ' ' PHE . 31.9 p-90 -136.53 166.41 23.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.063 0.458 . . . . 0.0 111.236 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.47 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 29.5 t -162.56 178.48 8.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.381 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.711 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 64.8 m95 -114.21 99.66 7.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.742 178.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 22.2 m -113.89 169.05 5.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.347 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.516 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 20.9 p -74.71 171.91 10.29 Favored Pre-proline 0 C--N 1.324 -0.536 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.881 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.558 ' O ' HG12 ' A' ' 143' ' ' ILE . 13.1 Cg_exo -62.47 -54.36 1.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.488 1.459 . . . . 0.0 110.279 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.67 -29.1 70.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.995 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.449 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 33.3 mt-30 -71.69 -47.33 54.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.328 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.513 HD12 ' CB ' ' A' ' 30' ' ' ALA . 64.2 tp -57.95 -38.92 76.86 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.691 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 27.7 mm -61.27 -38.8 80.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.517 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.92 -50.48 49.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.223 0.535 . . . . 0.0 110.565 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.486 HD21 ' CD1' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -74.54 -19.16 60.45 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.718 -179.154 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.745 HG21 ' HG3' ' A' ' 151' ' ' LYS . 14.7 t -74.88 174.03 9.82 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.487 -179.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.534 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 24.1 m -78.08 154.73 5.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.46 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.743 ' HA ' ' HD3' ' A' ' 151' ' ' LYS . 13.5 mt-10 -60.89 -54.85 39.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.079 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.534 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 35.7 p90 -55.52 -1.48 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.438 ' H ' ' C ' ' A' ' 148' ' ' GLU . 58.1 mttt -135.27 -6.82 2.29 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.745 ' HG3' HG21 ' A' ' 146' ' ' THR . 14.0 mtpp -60.71 -62.19 6.47 Favored Pre-proline 0 CA--C 1.531 0.237 0 O-C-N 122.317 -0.239 . . . . 0.0 111.335 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.47 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 18.6 Cg_endo -59.92 -27.13 84.24 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.239 1.959 . . . . 0.0 111.334 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.429 HG21 ' HA ' ' A' ' 150' ' ' LYS . 26.3 t -68.8 -50.85 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.467 ' HE1' ' CZ2' ' A' ' 107' ' ' TRP . 14.3 m-30 -65.78 -39.56 91.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.672 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.534 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.5 OUTLIER -56.09 -40.65 73.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.332 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.57 -31.41 68.43 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.484 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 90.3 t -66.28 -41.31 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.593 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.454 ' CD2' ' HB3' ' A' ' 139' ' ' PRO . 58.7 mt -63.78 -41.97 97.86 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.468 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 14.5 m -54.54 -41.02 69.25 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.827 HG12 ' HA ' ' A' ' 76' ' ' VAL . 98.4 t -66.57 -44.07 90.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.553 178.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.609 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 22.4 m-30 -81.21 5.09 18.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.384 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.46 ' N ' ' CD ' ' A' ' 163' ' ' PRO . . . -59.4 -50.45 87.29 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.015 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 160' ' ' VAL . 36.8 Cg_exo -59.22 -11.86 14.42 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.528 2.152 . . . . 0.0 112.051 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.464 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 73.8 m-70 -113.13 -17.52 12.37 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.437 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 97.9 mt . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.791 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 N--CA 1.461 0.098 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.597 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 30.1 t70 . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.822 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 . . . . . 0 N--CA 1.461 0.108 0 CA-C-O 120.964 0.412 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.738 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 0.9 OUTLIER -134.48 167.35 20.93 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.387 179.091 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.546 HG22 ' CA ' ' A' ' 57' ' ' ALA . 12.5 m -136.05 166.33 27.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.976 0.417 . . . . 0.0 111.289 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.533 ' HA3' ' CE3' ' A' ' 107' ' ' TRP . . . -134.02 154.77 21.51 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.546 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.469 HD13 ' HB2' ' A' ' 61' ' ' LEU . 3.7 mp -125.45 121.5 60.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.074 0.464 . . . . 0.0 111.862 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.424 ' HB2' ' HE2' ' A' ' 161' ' ' PHE . 0.4 OUTLIER -101.1 92.24 4.91 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.742 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.406 HD22 ' CG1' ' A' ' 67' ' ' VAL . 22.7 tp -96.57 113.38 24.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.534 -178.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.413 ' CB ' ' O ' ' A' ' 27' ' ' LYS . 1.3 ptt? -116.14 167.24 11.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.707 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.636 ' OD1' ' CE3' ' A' ' 136' ' ' TRP . 0.0 OUTLIER -102.09 168.99 9.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.384 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -56.79 -3.55 0.12 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.418 177.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.565 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 1.8 m-20 -99.55 3.03 45.28 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 3.7 mmtm 74.46 20.4 2.52 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.114 -178.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.56 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 1.2 mmtt -94.85 145.35 24.96 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.72 HG13 ' HA ' ' A' ' 139' ' ' PRO . 1.1 mm -99.32 140.95 17.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.995 0.426 . . . . 0.0 112.082 -177.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.522 ' CE1' HD11 ' A' ' 119' ' ' ILE . 73.1 t80 -78.15 135.23 37.62 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.463 178.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.483 ' CB ' HD13 ' A' ' 142' ' ' LEU . . . -141.3 153.83 45.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.776 0.322 . . . . 0.0 110.79 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.595 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -142.55 145.13 33.29 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.64 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.615 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 17.6 p -94.31 148.18 22.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.543 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.4 mtp180 -69.35 133.6 48.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.084 0.469 . . . . 0.0 111.006 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.651 ' H ' ' CD2' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -38.47 -48.78 1.42 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.612 -178.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.17 -34.9 61.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.171 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.471 ' HB ' ' HB1' ' A' ' 39' ' ' ALA . 29.2 mm -123.31 104.41 34.73 Favored Pre-proline 0 C--O 1.233 0.184 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.01 -16.89 45.89 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.862 2.375 . . . . 0.0 112.377 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -89.89 -10.15 46.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.425 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.615 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.78 88.64 6.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.935 0.398 . . . . 0.0 110.338 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.605 ' O ' ' HA ' ' A' ' 146' ' ' THR . 75.8 m95 -85.57 146.53 26.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.365 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.473 ' HB3' ' OH ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -165.41 162.16 19.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.921 -179.871 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.3 156.93 35.25 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.079 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.414 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 1.9 Cg_endo -44.34 155.07 0.26 Allowed 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.048 2.499 . . . . 0.0 113.08 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.439 ' HA ' HD11 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -176.17 171.36 2.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.207 -179.576 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.477 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . 176.9 152.55 9.92 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.677 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.738 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -77.75 135.97 17.35 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.602 -0.809 . . . . 0.0 113.358 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.9 mt -69.46 145.6 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.734 0.302 . . . . 0.0 111.007 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.57 -175.66 0.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.028 0.442 . . . . 0.0 111.257 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.422 ' HG3' ' H ' ' A' ' 50' ' ' GLY . 0.2 OUTLIER -52.22 -47.5 65.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.856 179.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.422 ' H ' ' HG3' ' A' ' 49' ' ' GLU . . . -143.34 52.79 0.62 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.286 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -112.9 150.22 32.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.772 0.32 . . . . 0.0 110.446 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.408 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 0.4 OUTLIER -68.1 156.26 90.21 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.903 179.659 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.453 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 3.0 Cg_exo -73.93 -49.35 0.2 Allowed 'Trans proline' 0 CA--C 1.515 -0.442 0 C-N-CA 122.41 2.074 . . . . 0.0 111.113 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.547 ' HD3' HG22 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -53.13 -46.57 68.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.307 179.293 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -67.7 -40.11 84.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.135 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 52' ' ' ASP . . . -62.04 -44.7 96.13 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.546 ' CA ' HG22 ' A' ' 17' ' ' VAL . . . -56.07 -52.21 65.07 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.931 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 54' ' ' ARG . 22.4 mt -56.43 -56.45 13.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.548 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -60.05 4.42 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.672 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.477 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -45.87 -47.53 16.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.155 0.503 . . . . 0.0 109.744 179.081 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.469 ' HB2' HD13 ' A' ' 19' ' ' ILE . 4.2 tp -50.25 -46.64 55.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.324 178.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 66' ' ' GLY . 18.7 ttm180 -64.98 -63.51 1.09 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.357 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -49.78 -22.66 1.5 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.436 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.411 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 31.3 mt-10 -97.01 -36.58 10.47 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -177.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.432 HG22 ' CD2' ' A' ' 121' ' ' LEU . 0.6 OUTLIER -124.26 -13.77 7.13 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 86.04 -16.24 43.93 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.232 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.507 HG21 HG12 ' A' ' 119' ' ' ILE . 52.3 t -58.13 117.26 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-O 121.254 0.549 . . . . 0.0 111.42 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.424 ' CG2' ' HG3' ' A' ' 62' ' ' ARG . 0.9 OUTLIER -122.64 -38.13 2.68 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.652 178.568 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.8 m -62.31 73.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.581 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.595 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -160.74 157.69 27.35 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.019 0.438 . . . . 0.0 112.126 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -131.53 152.19 50.96 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.95 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.547 HG22 ' HD3' ' A' ' 54' ' ' ARG . 4.2 t -75.24 127.15 36.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.148 0.499 . . . . 0.0 111.428 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.556 HD12 ' HG ' ' A' ' 109' ' ' LEU . 1.6 mt -107.95 -19.67 6.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.596 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.454 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -169.56 176.78 4.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.0 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.3 OUTLIER -154.89 146.44 23.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.752 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.665 ' HA ' HG11 ' A' ' 160' ' ' VAL . 50.7 t -72.58 140.58 81.82 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.106 0.479 . . . . 0.0 111.203 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.493 ' HD3' HG12 ' A' ' 160' ' ' VAL . 26.8 Cg_endo -62.08 -62.67 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.27 2.647 . . . . 0.0 113.138 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.597 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -96.53 177.05 5.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.049 -178.514 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.48 ' CE3' ' HB2' ' A' ' 106' ' ' LYS . 49.9 m95 -93.38 97.45 10.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.174 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.519 HD22 ' CD1' ' A' ' 78' ' ' TYR . 38.3 mt . . . . . 0 C--N 1.326 -0.419 0 CA-C-O 120.885 0.374 . . . . 0.0 111.087 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.396 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.726 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 10.6 mt-30 -122.21 126.47 48.32 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.48 ' HB2' ' CE3' ' A' ' 79' ' ' TRP . 2.4 ttmt -102.69 131.96 49.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.245 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.533 ' CE3' ' HA3' ' A' ' 18' ' ' GLY . 74.6 m95 -101.99 161.35 13.74 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -177.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.492 ' CE1' ' HG2' ' A' ' 54' ' ' ARG . 99.5 m-85 -142.64 150.53 40.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.784 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.556 ' HG ' HD12 ' A' ' 73' ' ' ILE . 15.0 tp -98.56 139.72 33.87 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.255 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.494 ' CE2' HG21 ' A' ' 72' ' ' VAL . 32.0 m-85 -138.81 142.72 38.71 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -178.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.595 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 1.1 tttt -102.28 120.18 40.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.679 178.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.433 ' CD1' HG13 ' A' ' 67' ' ' VAL . 65.4 t80 -78.23 98.72 5.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.796 0.332 . . . . 0.0 110.596 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.4 p -95.25 39.64 1.11 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.601 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.402 ' C ' ' CE2' ' A' ' 112' ' ' PHE . . . -135.64 -148.22 5.58 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.268 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.432 ' HB2' ' HG2' ' A' ' 117' ' ' GLN . 0.1 OUTLIER -125.45 150.32 47.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.857 0.36 . . . . 0.0 111.137 179.474 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.426 ' C ' ' H ' ' A' ' 118' ' ' GLU . 9.6 p-10 -58.43 -39.7 80.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.483 0.658 . . . . 0.0 110.662 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.432 ' HG2' ' HB2' ' A' ' 115' ' ' GLN . 14.8 pt20 -58.61 -3.5 0.31 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.913 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.426 ' H ' ' C ' ' A' ' 116' ' ' ASP . 2.0 tt0 -89.03 -22.14 23.11 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.238 0.542 . . . . 0.0 110.234 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.536 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 10.5 mt -83.05 100.11 6.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.19 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.428 ' O ' ' C ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -97.51 9.38 42.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.021 -179.546 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 121' ' ' LEU . 71.7 mt . . . . . 0 N--CA 1.467 0.399 0 CA-C-O 121.22 0.533 . . . . 0.0 111.56 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.517 ' O ' HD21 ' A' ' 34' ' ' LEU . 3.9 tp10 . . . . . 0 N--CA 1.454 -0.247 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.573 ' N ' HD23 ' A' ' 34' ' ' LEU . 2.1 m-85 -131.91 139.0 48.6 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 178.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.57 ' N ' HD22 ' A' ' 34' ' ' LEU . . . -85.92 -33.13 16.09 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.688 -178.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 31' ' ' ALA . 1.9 tt0 -150.78 153.87 36.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.338 0.113 . . . . 0.0 110.947 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.595 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 43.3 p-90 -135.36 168.28 19.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.057 0.456 . . . . 0.0 111.691 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.429 ' N ' ' HZ3' ' A' ' 40' ' ' TRP . 15.9 t -162.74 167.26 23.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.526 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.636 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 53.7 m95 -103.95 102.91 12.69 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.6 ' O ' ' N ' ' A' ' 28' ' ' ILE . 21.7 m -119.66 165.08 15.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.497 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 19.0 p -72.01 170.98 10.48 Favored Pre-proline 0 C--N 1.327 -0.413 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.027 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.72 ' HA ' HG13 ' A' ' 28' ' ' ILE . 13.7 Cg_exo -62.88 -54.58 1.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.031 1.821 . . . . 0.0 110.41 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -64.94 -26.75 68.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.584 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.489 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.8 OUTLIER -72.04 -46.56 56.56 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.502 179.582 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.483 HD13 ' CB ' ' A' ' 30' ' ' ALA . 0.6 OUTLIER -57.35 -38.38 74.05 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.832 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.638 HG22 ' HG2' ' A' ' 155' ' ' LYS . 7.1 mm -60.88 -35.95 68.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.215 0.531 . . . . 0.0 110.219 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.68 -51.69 26.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.202 0.525 . . . . 0.0 110.769 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.437 HD21 ' CD1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER -73.75 -19.97 60.64 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.415 -0.812 . . . . 0.0 112.712 -179.034 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.605 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 7.3 t -73.78 177.76 5.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.976 0.417 . . . . 0.0 111.487 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.468 ' HB ' ' CE2' ' A' ' 149' ' ' PHE . 16.2 m -82.24 149.5 4.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.334 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.487 ' HA ' ' HE3' ' A' ' 151' ' ' LYS . 42.6 mt-10 -60.29 -55.21 36.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.049 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.468 ' CE2' ' HB ' ' A' ' 147' ' ' VAL . 55.1 p90 -54.24 -4.34 0.05 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.462 ' HG2' ' CZ ' ' A' ' 154' ' ' TYR . 0.1 OUTLIER -132.73 -6.54 3.2 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.435 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.487 ' HE3' ' HA ' ' A' ' 148' ' ' GLU . 11.6 mttt -59.79 -59.49 13.67 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.475 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 11.8 Cg_endo -55.73 -27.66 62.64 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.312 2.008 . . . . 0.0 111.651 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.456 ' O ' HG23 ' A' ' 157' ' ' VAL . 39.5 t -69.27 -53.9 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.473 ' OH ' ' HB3' ' A' ' 41' ' ' GLN . 9.1 m-30 -63.51 -36.86 85.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.855 178.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.638 ' HG2' HG22 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -57.73 -43.5 85.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.085 179.782 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -69.11 -28.49 66.52 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.558 HG11 ' CE2' ' A' ' 161' ' ' PHE . 48.6 t -68.48 -42.25 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.973 178.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.433 HD12 ' HE2' ' A' ' 155' ' ' LYS . 47.8 mt -63.68 -43.5 96.5 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.561 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.465 ' O ' ' HB1' ' A' ' 162' ' ' ALA . 1.8 t -53.76 -41.3 67.01 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.665 HG11 ' HA ' ' A' ' 76' ' ' VAL . 88.2 t -66.75 -42.59 89.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.378 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.59 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 22.1 m-30 -80.15 4.08 18.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.552 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.592 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.58 -53.1 69.59 Favored Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 120.531 -0.467 . . . . 0.0 110.644 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 18.9 Cg_endo -58.89 -12.21 14.41 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.141 1.894 . . . . 0.0 111.921 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.454 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 92.9 m-70 -109.19 -17.98 13.73 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.28 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 95.6 mt . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.854 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.6 mpp? . . . . . 0 N--CA 1.454 -0.265 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.6 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 33.1 t70 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.368 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.414 ' HG2' HD12 ' A' ' 47' ' ' ILE . 5.4 ttp180 . . . . . 0 N--CA 1.464 0.245 0 CA-C-O 120.973 0.416 . . . . 0.0 111.475 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.681 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 3.2 m120 -135.34 -178.76 5.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.127 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.488 HG22 ' CA ' ' A' ' 57' ' ' ALA . 14.9 m -142.65 167.57 14.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.39 0.614 . . . . 0.0 111.967 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.451 ' HA3' ' CE3' ' A' ' 107' ' ' TRP . . . -138.18 155.41 23.37 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.891 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.573 HG13 ' HB2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.31 129.23 62.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.063 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.4 t -108.77 106.11 15.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.898 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.477 HD23 HG11 ' A' ' 67' ' ' VAL . 7.4 tp -105.98 123.59 48.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.845 -178.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.511 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -124.22 165.98 16.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.113 179.444 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.527 ' N ' ' OD1' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -97.45 171.96 8.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.004 0.431 . . . . 0.0 110.406 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -58.48 -5.35 0.52 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.585 177.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.532 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -99.8 2.6 44.18 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.782 0.325 . . . . 0.0 111.771 -179.137 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.532 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 17.1 mmtp 73.61 22.29 2.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.953 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 22' ' ' MET . 2.2 mmtt -93.0 143.87 25.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.637 HG13 ' HA ' ' A' ' 139' ' ' PRO . 0.9 OUTLIER -98.07 138.02 23.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.286 0.565 . . . . 0.0 112.457 -177.913 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.426 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 17.1 t80 -80.22 135.1 36.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.726 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.439 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -142.58 151.77 41.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.945 0.403 . . . . 0.0 111.281 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -143.14 136.77 28.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.309 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.643 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 3.5 p -97.19 152.65 18.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.847 0.356 . . . . 0.0 111.45 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.659 ' O ' ' N ' ' A' ' 35' ' ' ASP . 15.3 mtp180 -68.54 130.43 42.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.731 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.674 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.3 OUTLIER -53.32 52.42 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.145 0.578 . . . . 0.0 112.491 -179.722 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.659 ' N ' ' O ' ' A' ' 33' ' ' ARG . 0.5 OUTLIER -177.68 -36.06 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.895 0.379 . . . . 0.0 110.347 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.476 HG23 ' CB ' ' A' ' 39' ' ' ALA . 4.0 mp -112.61 103.01 55.34 Favored Pre-proline 0 N--CA 1.454 -0.25 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.58 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -62.99 -46.04 11.42 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.167 2.578 . . . . 0.0 113.45 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -72.32 -4.44 29.81 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.643 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -94.75 93.03 7.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.798 0.332 . . . . 0.0 111.083 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.642 ' O ' ' HA ' ' A' ' 146' ' ' THR . 63.7 m95 -100.15 145.93 27.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.438 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.96 158.1 21.88 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.403 0.621 . . . . 0.0 111.593 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.451 ' HG3' ' HZ3' ' A' ' 107' ' ' TRP . 3.4 ptp -94.28 158.46 35.82 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.198 178.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.435 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 9.4 Cg_endo -49.31 154.47 3.87 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.423 2.082 . . . . 0.0 112.223 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.464 ' HA ' HD12 ' A' ' 19' ' ' ILE . 0.2 OUTLIER -178.56 140.9 0.2 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.142 -179.664 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.4 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . -157.63 164.82 33.27 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.757 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.587 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -88.25 142.19 17.28 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.894 -0.669 . . . . 0.0 113.54 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.463 HG23 ' N ' ' A' ' 48' ' ' ASP . 3.9 mt -70.44 146.73 11.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 122.66 0.384 . . . . 0.0 111.283 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.463 ' N ' HG23 ' A' ' 47' ' ' ILE . 23.8 m-20 -67.54 -174.55 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.406 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.88 -60.78 2.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.163 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.97 61.97 0.65 Allowed Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.465 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 52' ' ' ASP . 3.9 tp10 -119.94 155.86 31.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.731 0.3 . . . . 0.0 110.818 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.435 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -71.99 158.84 86.94 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.352 179.63 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 2.9 Cg_exo -76.12 -50.37 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.605 2.203 . . . . 0.0 111.67 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.512 ' HD3' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -53.07 -44.95 67.9 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.508 179.798 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -67.81 -42.13 82.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.012 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.404 ' O ' ' HG2' ' A' ' 60' ' ' GLU . . . -62.2 -42.6 99.44 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.488 ' CA ' HG22 ' A' ' 17' ' ' VAL . . . -56.55 -53.72 54.32 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.808 178.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.463 HG12 ' CE2' ' A' ' 110' ' ' PHE . 17.7 mt -57.56 -53.51 43.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.065 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -60.06 -58.69 7.44 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.923 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 56' ' ' ALA . 26.0 mm-40 -47.34 -45.84 25.03 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.226 0.536 . . . . 0.0 109.634 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.573 ' HB2' HG13 ' A' ' 19' ' ' ILE . 7.5 tt -51.83 -49.69 62.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.257 178.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.43 ' O ' ' N ' ' A' ' 66' ' ' GLY . 47.7 ttt180 -63.06 -62.83 1.44 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.167 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -51.35 -19.16 1.2 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.32 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -98.91 -32.54 11.26 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.78 -11.61 3.42 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.609 -178.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 87.14 -15.16 55.17 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.464 -0.874 . . . . 0.0 111.967 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.493 HG22 HG12 ' A' ' 119' ' ' ILE . 77.7 t -58.3 113.72 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 121.248 0.546 . . . . 0.0 111.358 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -121.47 -39.96 2.61 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.481 178.637 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.419 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 6.1 m -62.5 74.6 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.14 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.568 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -158.88 154.94 26.84 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.667 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.16 151.46 49.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.432 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.528 HG23 ' CE2' ' A' ' 110' ' ' PHE . 2.8 t -74.9 127.8 36.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.725 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.531 HD12 ' HB2' ' A' ' 111' ' ' LYS . 1.0 OUTLIER -109.11 -17.87 7.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.332 178.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.464 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -169.04 173.73 6.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.569 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -153.09 136.06 15.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.648 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.547 ' HA ' HG12 ' A' ' 160' ' ' VAL . 41.8 t -73.48 137.48 77.79 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.03 0.443 . . . . 0.0 111.081 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.421 ' N ' HG13 ' A' ' 76' ' ' VAL . 41.6 Cg_endo -72.09 -73.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.723 2.282 . . . . 0.0 112.54 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 2.2 p90 -67.57 157.81 33.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.097 0.475 . . . . 0.0 111.543 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.513 ' CE2' ' HD3' ' A' ' 106' ' ' LYS . 49.7 m95 -94.75 109.4 21.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.187 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.508 HD13 HG22 ' A' ' 157' ' ' VAL . 15.0 mt . . . . . 0 C--N 1.329 -0.284 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.404 0 CA-C-O 121.101 0.477 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.681 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 6.3 mt-30 -124.51 123.08 39.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.534 -177.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.513 ' HD3' ' CE2' ' A' ' 79' ' ' TRP . 14.2 ttpp -101.69 135.28 43.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.482 178.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.496 ' CD1' HD12 ' A' ' 80' ' ' LEU . 73.6 m95 -101.78 163.44 12.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.263 0.554 . . . . 0.0 112.445 -178.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.508 ' CE1' ' HG2' ' A' ' 54' ' ' ARG . 98.1 m-85 -143.18 150.63 39.65 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.839 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 20.1 tp -99.26 138.77 35.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.311 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.528 ' CE2' HG23 ' A' ' 72' ' ' VAL . 62.0 m-85 -139.76 140.28 36.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.642 0.734 . . . . 0.0 112.888 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 1.7 tttt -101.27 123.63 45.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.754 178.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.426 ' CD1' HD21 ' A' ' 21' ' ' LEU . 39.4 t80 -78.34 96.61 5.35 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.809 0.337 . . . . 0.0 111.166 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 17.3 p -97.7 49.68 1.03 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.039 0.447 . . . . 0.0 110.596 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.419 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -150.01 -148.57 4.8 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.296 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.407 ' HB2' ' HG2' ' A' ' 117' ' ' GLN . 28.7 mt-30 -121.84 151.46 40.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.823 0.344 . . . . 0.0 110.936 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 118' ' ' GLU . 16.2 m-20 -61.11 -28.8 69.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.8 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . 0.407 ' HG2' ' HB2' ' A' ' 115' ' ' GLN . 2.1 pt20 -59.0 -3.2 0.32 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.137 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.41 ' H ' ' C ' ' A' ' 116' ' ' ASP . 8.7 tp10 -90.7 -17.68 26.34 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.903 0.382 . . . . 0.0 110.895 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.569 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 15.9 mt -81.76 95.89 3.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.615 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -96.72 3.8 52.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.951 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 29.5 mt . . . . . 0 N--CA 1.466 0.363 0 CA-C-O 120.975 0.417 . . . . 0.0 111.449 -179.436 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 . . . . . 0 N--CA 1.455 -0.19 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.526 ' HA ' ' O ' ' A' ' 32' ' ' SER . 3.2 m-85 -127.62 140.91 51.8 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.114 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.674 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -96.25 -29.28 8.52 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.498 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -145.18 146.75 31.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.725 0.298 . . . . 0.0 110.339 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.569 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 40.8 p-90 -135.89 165.77 24.86 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.939 0.399 . . . . 0.0 111.548 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.449 ' N ' ' HZ3' ' A' ' 40' ' ' TRP . 36.6 t -164.61 177.5 8.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.335 0.588 . . . . 0.0 112.164 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.533 ' NE1' ' HZ3' ' A' ' 134' ' ' TRP . 35.2 m95 -113.24 104.58 12.48 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.338 178.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.584 ' O ' ' N ' ' A' ' 28' ' ' ILE . 16.3 m -120.05 168.71 12.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.279 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.504 ' OG1' ' HB2' ' A' ' 141' ' ' GLN . 23.3 p -73.09 168.86 20.86 Favored Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.24 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.637 ' HA ' HG13 ' A' ' 28' ' ' ILE . 16.5 Cg_exo -61.88 -53.27 2.23 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 121.866 1.71 . . . . 0.0 110.471 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.7 -27.79 68.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.654 178.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.504 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 37.2 mt-30 -72.42 -46.28 55.86 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.045 0.45 . . . . 0.0 110.154 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.439 HD13 ' HB2' ' A' ' 30' ' ' ALA . 0.5 OUTLIER -56.26 -40.76 74.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.826 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.547 ' O ' HG21 ' A' ' 146' ' ' THR . 14.9 mm -62.15 -34.0 61.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.234 0.54 . . . . 0.0 110.158 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.89 -51.51 25.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.21 0.528 . . . . 0.0 110.714 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.419 HD21 ' CD1' ' A' ' 40' ' ' TRP . 1.6 mp -73.86 -20.99 60.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.877 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 11.7 t -73.77 175.81 6.88 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.504 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 23.0 m -86.44 149.72 4.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.996 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 151' ' ' LYS . 3.0 tt0 -50.81 -50.85 55.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.643 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -51.13 -11.4 0.1 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -131.8 -3.06 3.68 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.536 ' HG3' ' CG2' ' A' ' 146' ' ' THR . 0.6 OUTLIER -60.66 -63.43 4.31 Favored Pre-proline 0 C--N 1.325 -0.458 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.143 179.799 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.43 ' CD ' ' CB ' ' A' ' 151' ' ' LYS . 17.3 Cg_endo -58.33 -30.27 90.62 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.429 2.086 . . . . 0.0 111.962 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.467 ' O ' HG22 ' A' ' 157' ' ' VAL . 19.0 t -68.9 -51.41 44.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.485 ' CE1' ' CH2' ' A' ' 107' ' ' TRP . 7.7 m-30 -63.4 -36.41 83.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.919 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.458 ' HD3' HG22 ' A' ' 143' ' ' ILE . 0.5 OUTLIER -57.86 -46.31 85.01 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.112 179.608 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.03 -31.94 72.82 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.508 HG22 HD13 ' A' ' 80' ' ' LEU . 92.4 t -66.76 -41.48 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.415 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.434 HD22 ' HB3' ' A' ' 139' ' ' PRO . 62.8 mt -64.03 -44.51 92.32 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.4 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.7 t -53.49 -42.84 67.71 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 76' ' ' VAL . 92.3 t -66.48 -42.18 89.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.172 178.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.541 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 21.9 m-30 -81.79 5.9 17.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.624 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.438 ' N ' ' CD ' ' A' ' 163' ' ' PRO . . . -59.09 -50.86 85.59 Favored Pre-proline 0 C--N 1.327 -0.382 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.004 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.454 ' HD2' ' O ' ' A' ' 160' ' ' VAL . 30.6 Cg_exo -60.12 -10.84 13.74 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.346 2.031 . . . . 0.0 112.085 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.464 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 87.6 m-70 -111.23 -18.24 13.0 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.44 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 96.7 mt . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.868 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.537 ' C ' ' HB2' ' A' ' 78' ' ' TYR . 0.4 OUTLIER . . . . . 0 CA--C 1.523 -0.074 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.581 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 2.8 p30 . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 120.682 0.277 . . . . 0.0 111.004 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.589 ' HG3' ' CZ3' ' A' ' 79' ' ' TRP . 6.7 ttp180 . . . . . 0 N--CA 1.451 -0.396 0 CA-C-O 121.35 0.595 . . . . 0.0 110.103 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.658 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 2.2 m-80 -128.81 175.29 8.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.844 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 106' ' ' LYS . 25.7 m -134.64 159.5 41.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.177 0.513 . . . . 0.0 110.872 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.605 ' HA3' ' CE3' ' A' ' 107' ' ' TRP . . . -131.64 155.3 21.32 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.564 HD13 ' HB2' ' A' ' 61' ' ' LEU . 1.6 mp -125.37 117.08 48.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.419 ' CB ' ' HE2' ' A' ' 161' ' ' PHE . 6.1 t -101.39 99.23 9.55 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.534 HD23 ' CD1' ' A' ' 112' ' ' PHE . 41.5 tp -100.83 119.09 38.15 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.727 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.622 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -119.75 159.77 23.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.926 179.656 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.5 ' N ' ' OD1' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -94.6 171.87 8.53 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.024 0.44 . . . . 0.0 110.232 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -58.23 -4.77 0.39 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.675 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.6 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.5 OUTLIER -101.02 2.58 40.68 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.03 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.6 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 2.1 mmtm 75.12 20.86 2.03 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.186 -178.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.622 ' O ' ' HA ' ' A' ' 22' ' ' MET . 3.8 mmtt -92.2 143.87 25.99 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.743 HG13 ' HA ' ' A' ' 139' ' ' PRO . 1.6 mm -97.26 136.93 26.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.092 0.472 . . . . 0.0 112.009 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.566 ' CE1' HD11 ' A' ' 119' ' ' ILE . 33.8 t80 -74.13 105.53 5.38 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.41 178.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.425 ' CB ' ' CD1' ' A' ' 142' ' ' LEU . . . -103.88 144.37 31.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.799 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.478 ' HB2' ' CG ' ' A' ' 131' ' ' PHE . . . -142.25 131.37 23.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.388 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.775 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 6.6 p -97.9 147.29 24.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.069 0.461 . . . . 0.0 111.747 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.516 ' HD3' ' HB2' ' A' ' 39' ' ' ALA . 4.7 mtp180 -68.36 128.95 38.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.389 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.682 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -45.14 -35.86 3.41 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.277 0.56 . . . . 0.0 110.883 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.53 -38.01 68.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.038 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.651 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 23.9 mt -122.81 105.92 34.84 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.214 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.11 -21.17 36.89 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.825 2.35 . . . . 0.0 112.967 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -92.06 -6.97 50.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.709 0.29 . . . . 0.0 111.568 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.775 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.34 95.45 10.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.691 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.643 ' O ' ' HA ' ' A' ' 146' ' ' THR . 72.3 m95 -93.65 136.73 33.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.912 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.496 ' HG3' ' C ' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -161.59 158.41 26.22 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.105 0.479 . . . . 0.0 110.699 179.755 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.55 ' HG3' ' HZ3' ' A' ' 107' ' ' TRP . 0.1 OUTLIER -94.34 157.8 36.83 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.55 178.844 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.518 ' HB2' HD13 ' A' ' 19' ' ' ILE . 2.8 Cg_endo -44.08 151.79 0.46 Allowed 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 123.119 2.546 . . . . 0.0 112.891 -179.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -171.39 143.06 1.77 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.201 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.658 ' O ' ' HB3' ' A' ' 16' ' ' ASN . . . -140.48 -178.38 17.0 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.623 ' HA2' ' CB ' ' A' ' 16' ' ' ASN . . . -112.18 23.58 15.97 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.016 -1.088 . . . . 0.0 114.736 -178.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 46' ' ' GLY . 29.9 mt 60.13 130.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 117.543 0.672 . . . . 0.0 111.064 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.3 -176.15 0.71 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.825 0.345 . . . . 0.0 110.88 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.69 -81.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.212 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.39 55.91 0.49 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.359 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -116.21 153.01 32.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.873 0.368 . . . . 0.0 111.002 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.538 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 1.4 m-20 -69.61 173.54 3.93 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 8.9 Cg_endo -85.53 -54.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.378 2.052 . . . . 0.0 111.678 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.643 ' HD3' HG23 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -54.36 -43.34 71.23 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.315 179.012 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -69.44 -40.81 76.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.308 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.538 ' HB1' ' O ' ' A' ' 52' ' ' ASP . . . -60.78 -45.73 93.24 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.536 ' CA ' HG21 ' A' ' 17' ' ' VAL . . . -54.29 -49.37 69.77 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.014 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.607 ' O ' ' HB3' ' A' ' 61' ' ' LEU . 18.0 mt -58.97 -55.47 23.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.246 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.67 -63.67 1.22 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.187 -179.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.528 ' OE2' ' N ' ' A' ' 45' ' ' GLY . 0.3 OUTLIER -47.2 -37.43 10.26 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.407 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.607 ' HB3' ' O ' ' A' ' 58' ' ' ILE . 9.8 tp -53.24 -48.43 68.21 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.868 178.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.506 ' O ' ' N ' ' A' ' 66' ' ' GLY . 16.7 ttp180 -64.17 -64.23 0.94 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.489 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -48.98 -22.1 0.8 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.272 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -96.99 -37.45 10.17 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -178.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.51 HG22 ' CD2' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -127.66 -5.04 5.84 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.571 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 78.16 -13.88 13.4 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.252 -0.975 . . . . 0.0 111.872 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.523 HG21 HG12 ' A' ' 119' ' ' ILE . 75.3 t -58.62 112.71 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-O 121.194 0.521 . . . . 0.0 111.291 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.425 ' CG2' ' HG3' ' A' ' 62' ' ' ARG . 0.8 OUTLIER -121.59 -40.43 2.56 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.414 178.653 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.409 ' HB2' ' HA3' ' A' ' 114' ' ' GLY . 11.8 m -62.09 74.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.38 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.569 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.62 156.45 23.21 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.478 ' HG3' HG22 ' A' ' 113' ' ' THR . 1.0 OUTLIER -130.84 152.03 50.62 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.758 179.703 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.643 HG23 ' HD3' ' A' ' 54' ' ' ARG . 3.3 t -75.0 126.75 36.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.95 0.405 . . . . 0.0 111.186 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.58 HD12 ' HE2' ' A' ' 22' ' ' MET . 1.0 OUTLIER -107.47 -19.66 6.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.266 179.218 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.463 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.88 176.39 4.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.582 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -154.46 148.37 25.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.422 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.582 ' HA ' HG13 ' A' ' 160' ' ' VAL . 55.3 t -70.65 139.29 86.14 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.983 0.42 . . . . 0.0 110.894 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.622 ' HD3' HG11 ' A' ' 160' ' ' VAL . 18.7 Cg_endo -59.04 -62.9 0.15 Allowed 'Trans proline' 0 CA--C 1.519 -0.271 0 C-N-CA 123.233 2.622 . . . . 0.0 112.499 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -103.46 -172.47 2.12 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.426 -178.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.589 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 64.5 m95 -91.8 -158.29 0.57 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.974 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 79' ' ' TRP . 26.6 mt . . . . . 0 C--N 1.328 -0.358 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 -0.094 0 CA-C-O 120.7 0.286 . . . . 0.0 110.61 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.472 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 15.7 mt-30 -126.31 123.97 39.24 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 0.7 OUTLIER -104.46 139.19 39.74 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.134 178.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.605 ' CE3' ' HA3' ' A' ' 18' ' ' GLY . 77.8 m95 -106.82 162.91 13.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.371 0.605 . . . . 0.0 112.576 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.601 ' CD1' ' HG2' ' A' ' 54' ' ' ARG . 96.5 m-85 -140.0 152.98 46.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.205 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.559 ' HG ' HD13 ' A' ' 73' ' ' ILE . 11.8 tp -99.99 136.93 39.15 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.557 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.576 ' CE2' HG12 ' A' ' 58' ' ' ILE . 29.6 m-85 -140.03 144.54 36.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.504 0.669 . . . . 0.0 112.631 -178.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -104.39 123.17 46.96 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.977 178.397 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.534 ' CD1' HD23 ' A' ' 21' ' ' LEU . 56.6 t80 -79.13 99.42 6.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.912 0.387 . . . . 0.0 110.552 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.478 HG22 ' HG3' ' A' ' 71' ' ' GLU . 30.3 p -95.78 41.71 1.1 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.324 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.409 ' HA3' ' HB2' ' A' ' 69' ' ' SER . . . -141.81 -148.33 5.01 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.651 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -122.7 149.84 43.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.951 0.405 . . . . 0.0 111.359 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.411 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 18.1 p-10 -58.99 -37.0 75.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.386 0.612 . . . . 0.0 111.231 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -57.43 -3.5 0.17 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.46 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.41 ' H ' ' C ' ' A' ' 116' ' ' ASP . 1.1 tp10 -90.49 -20.54 22.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.146 0.498 . . . . 0.0 110.303 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.566 HD11 ' CE1' ' A' ' 29' ' ' PHE . 9.7 mt -88.35 107.07 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.215 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.415 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 58.1 t30 -102.23 -26.07 13.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.191 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.51 ' CD2' HG22 ' A' ' 65' ' ' THR . 56.9 mt . . . . . 0 N--CA 1.464 0.233 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.178 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.441 ' HB2' ' CE1' ' A' ' 131' ' ' PHE . 61.0 mm-40 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.986 0.422 . . . . 0.0 110.539 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.532 ' C ' HD13 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -134.02 143.87 48.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.104 -179.872 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.682 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -89.73 -33.69 8.96 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.054 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.35 142.9 28.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.836 0.35 . . . . 0.0 110.543 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.52 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 34.5 p-90 -135.29 170.33 16.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.137 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.45 ' N ' ' CE3' ' A' ' 134' ' ' TRP . 22.6 t -168.33 176.66 5.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.315 0.579 . . . . 0.0 111.758 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.507 ' CE2' ' CZ3' ' A' ' 134' ' ' TRP . 48.0 m95 -110.69 102.84 11.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.479 178.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 28' ' ' ILE . 29.6 m -118.19 167.6 11.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.5 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 18.3 p -72.51 169.53 16.63 Favored Pre-proline 0 C--N 1.326 -0.429 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.211 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.743 ' HA ' HG13 ' A' ' 28' ' ' ILE . 17.1 Cg_exo -60.2 -56.51 1.08 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.723 1.615 . . . . 0.0 110.379 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -62.76 -27.76 69.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.73 178.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.447 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 10.8 mt-30 -71.35 -48.81 47.92 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.544 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.444 ' O ' ' HB ' ' A' ' 146' ' ' THR . 5.2 tp -57.41 -38.48 74.39 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.642 ' O ' HG21 ' A' ' 146' ' ' THR . 16.4 mm -60.13 -36.71 69.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.538 179.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.98 -53.04 14.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.247 0.546 . . . . 0.0 110.954 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.468 HD22 ' CD1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER -71.78 -19.0 62.07 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.174 -179.189 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 13.1 t -73.57 177.33 5.42 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.112 0.482 . . . . 0.0 111.302 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.559 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 36.0 m -81.03 149.53 4.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.748 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.45 ' C ' ' H ' ' A' ' 150' ' ' LYS . 2.7 mt-10 -57.83 -53.47 57.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.813 0.34 . . . . 0.0 110.988 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.495 ' CE1' ' HB ' ' A' ' 147' ' ' VAL . 39.4 p90 -57.08 2.38 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.486 ' HG3' ' CD2' ' A' ' 149' ' ' PHE . 6.4 mtpp -139.12 -5.95 1.43 Allowed 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 0.2 OUTLIER -63.09 -52.39 63.0 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.849 -0.159 . . . . 0.0 110.686 179.681 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 151' ' ' LYS . 15.1 Cg_exo -65.28 -29.3 54.96 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.296 1.997 . . . . 0.0 111.393 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.493 ' O ' HG23 ' A' ' 157' ' ' VAL . 37.2 t -67.92 -53.55 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.524 ' CD2' ' HE3' ' A' ' 42' ' ' MET . 4.0 m-30 -63.31 -39.49 94.69 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.578 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.606 ' HE2' ' HA ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -56.22 -38.18 70.71 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.247 179.527 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.412 ' O ' HG23 ' A' ' 160' ' ' VAL . 4.7 tm-20 -68.48 -36.53 79.09 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.606 HG11 ' CE2' ' A' ' 161' ' ' PHE . 40.0 t -64.51 -41.02 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.863 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.502 HD11 ' CB ' ' A' ' 139' ' ' PRO . 43.4 mt -65.4 -46.94 78.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.939 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.542 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 0.4 OUTLIER -52.15 -40.34 61.27 Favored 'General case' 0 CA--C 1.522 -0.127 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.052 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.622 HG11 ' HD3' ' A' ' 77' ' ' PRO . 98.4 t -67.33 -42.43 87.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.606 ' CE2' HG11 ' A' ' 157' ' ' VAL . 17.3 m-30 -80.09 5.49 14.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.034 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.578 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.1 -53.72 63.06 Favored Pre-proline 0 C--N 1.331 -0.229 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.528 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 18.2 Cg_endo -58.41 -13.26 16.13 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 121.989 1.793 . . . . 0.0 111.56 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.463 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 93.8 m-70 -107.25 -17.71 14.07 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.986 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 92.3 mt . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.026 -0.987 . . . . 0.0 110.368 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.458 -0.051 0 CA-C-O 120.678 0.275 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.419 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 6.3 p-10 . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.892 0.377 . . . . 0.0 110.211 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.596 ' HG2' HD11 ' A' ' 47' ' ' ILE . 1.7 ttp180 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 121.278 0.561 . . . . 0.0 110.786 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.799 ' HB2' ' HG2' ' A' ' 105' ' ' GLN . 2.8 m-80 -132.26 173.73 10.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.338 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.602 HG23 ' CA ' ' A' ' 57' ' ' ALA . 11.5 m -140.49 169.6 15.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.18 0.514 . . . . 0.0 111.281 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.604 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -136.25 153.95 21.76 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.253 178.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.681 ' HB ' ' HB2' ' A' ' 43' ' ' PRO . 2.4 mp -126.34 122.16 60.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.465 ' CB ' ' HE2' ' A' ' 161' ' ' PHE . 40.9 t -104.88 107.62 18.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.083 177.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.591 HD21 HG13 ' A' ' 67' ' ' VAL . 17.3 tp -106.08 126.66 52.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.726 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.599 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -118.82 141.04 49.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.057 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.451 ' OD1' ' CH2' ' A' ' 136' ' ' TRP . 5.6 m-20 -95.22 -175.98 3.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.191 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -55.5 -6.25 0.17 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.472 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 4.5 m-20 -100.71 -0.13 37.9 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 30.0 mmtt 68.68 23.57 7.07 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.599 ' O ' ' HA ' ' A' ' 22' ' ' MET . 72.2 mttt -95.13 176.78 6.1 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.915 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.598 ' CG1' ' HA ' ' A' ' 139' ' ' PRO . 2.0 mm -116.94 142.14 32.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.344 0.592 . . . . 0.0 111.249 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.549 ' CE1' HD13 ' A' ' 119' ' ' ILE . 6.6 t80 -66.88 103.48 1.14 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.108 179.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.651 ' HA ' ' O ' ' A' ' 41' ' ' GLN . . . -97.58 137.87 35.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.986 0.422 . . . . 0.0 111.253 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.476 ' HB3' ' CG ' ' A' ' 131' ' ' PHE . . . -139.25 132.69 30.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.477 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.65 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 77.0 p -101.32 146.9 26.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.919 0.39 . . . . 0.0 111.38 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 33' ' ' ARG . 5.5 mtp85 -69.55 128.98 38.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.37 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.698 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.6 OUTLIER -44.69 -37.04 3.43 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.37 0.605 . . . . 0.0 111.034 -179.863 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.86 -36.47 70.13 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.752 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.493 ' HB ' ' HB1' ' A' ' 39' ' ' ALA . 23.7 mm -122.99 110.57 31.23 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.12 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.23 -19.74 13.25 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.397 2.064 . . . . 0.0 112.644 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -91.06 -10.1 43.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.471 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.65 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.24 95.01 9.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.691 0.282 . . . . 0.0 111.075 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.64 ' O ' ' HA ' ' A' ' 146' ' ' THR . 78.7 m95 -87.99 158.41 18.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.126 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.651 ' O ' ' HA ' ' A' ' 30' ' ' ALA . 1.6 mt-30 -166.95 -138.25 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.629 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.538 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 8.5 ptt? -175.82 162.23 2.03 Favored Pre-proline 0 N--CA 1.453 -0.319 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.681 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 1.5 Cg_endo -40.9 134.19 2.51 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 123.257 2.638 . . . . 0.0 113.088 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -173.73 143.51 1.0 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.875 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.428 ' HA3' ' HG2' ' A' ' 60' ' ' GLU . . . -159.6 -158.64 9.26 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.783 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.681 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -117.31 141.8 16.85 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.742 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.596 HD11 ' HG2' ' A' ' 15' ' ' ARG . 13.9 mt -71.69 143.0 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 122.496 0.319 . . . . 0.0 110.88 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -69.23 -176.19 0.89 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.919 0.39 . . . . 0.0 110.587 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -49.13 -81.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.225 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -108.05 53.22 0.61 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.251 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -118.35 153.73 33.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.915 0.388 . . . . 0.0 111.048 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.53 163.29 64.6 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.426 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.48 ' HA ' HG12 ' A' ' 47' ' ' ILE . 5.8 Cg_exo -78.5 -52.58 0.06 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 122.952 2.435 . . . . 0.0 112.486 -179.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.628 ' O ' HD12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -48.89 -51.85 27.68 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.762 179.659 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -57.26 -42.68 82.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.175 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 60' ' ' GLU . . . -61.59 -43.52 98.7 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.602 ' CA ' HG23 ' A' ' 17' ' ' VAL . . . -57.57 -57.77 11.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.344 177.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.628 HD12 ' O ' ' A' ' 54' ' ' ARG . 1.9 mp -55.23 -48.99 75.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.577 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.7 mtt180 -65.01 -62.55 1.48 Allowed 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.304 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -42.3 -47.26 4.79 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.118 0.485 . . . . 0.0 110.119 179.581 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.484 HD13 HG23 ' A' ' 19' ' ' ILE . 0.1 OUTLIER -50.8 -49.37 58.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.083 178.715 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.453 ' O ' ' N ' ' A' ' 66' ' ' GLY . 13.9 ttp180 -63.73 -65.54 0.67 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.493 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -49.02 -20.4 0.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -98.1 -35.48 10.4 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -178.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.593 ' O ' ' HA ' ' A' ' 119' ' ' ILE . 0.8 OUTLIER -133.03 7.99 4.03 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -178.38 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 69.87 -9.73 2.68 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.974 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.591 HG13 HD21 ' A' ' 21' ' ' LEU . 77.1 t -56.76 108.66 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-O 121.153 0.501 . . . . 0.0 111.393 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.452 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -124.58 -39.71 2.28 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.593 178.26 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.0 m -63.77 70.91 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.991 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -156.96 156.91 33.8 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.037 0.446 . . . . 0.0 111.932 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.426 ' HG3' HG21 ' A' ' 113' ' ' THR . 0.9 OUTLIER -129.39 149.1 51.31 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.435 179.108 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.469 HG22 ' CE2' ' A' ' 110' ' ' PHE . 12.3 t -74.71 125.0 33.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.503 HD11 ' HB2' ' A' ' 111' ' ' LYS . 0.9 OUTLIER -105.5 -21.62 5.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.12 179.302 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.477 ' HB2' ' NE2' ' A' ' 164' ' ' HIS . . . -170.42 177.02 4.21 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.554 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -155.36 152.05 28.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.757 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.657 HG13 ' O ' ' A' ' 78' ' ' TYR . 54.1 t -70.48 132.57 87.49 Favored Pre-proline 0 C--N 1.327 -0.387 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.814 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.456 ' HD3' HG13 ' A' ' 160' ' ' VAL . 18.6 Cg_endo -57.97 -55.12 2.51 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.125 2.55 . . . . 0.0 112.681 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.657 ' O ' HG13 ' A' ' 76' ' ' VAL . 0.6 OUTLIER -101.88 -174.36 2.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.65 -179.518 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.461 ' O ' ' HG ' ' A' ' 80' ' ' LEU . 33.9 m95 -94.65 -154.67 0.43 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.602 ' HB2' ' O ' ' A' ' 105' ' ' GLN . 95.5 mt . . . . . 0 CA--C 1.515 -0.392 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.198 0 CA-C-O 121.095 0.474 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.799 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 71.1 mt-30 -132.51 122.65 25.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.291 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.439 ' HD3' ' CD2' ' A' ' 79' ' ' TRP . 14.8 ttpp -105.2 138.26 41.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.482 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.604 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 28.4 m95 -103.96 162.75 12.87 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.542 ' HB2' ' HE1' ' A' ' 110' ' ' PHE . 51.3 m-85 -140.34 154.07 46.63 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.479 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 161' ' ' PHE . 12.0 tp -103.22 140.97 36.67 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.323 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.623 ' CD1' HG22 ' A' ' 19' ' ' ILE . 63.1 m-85 -143.69 150.0 38.03 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 16.5 tttt -106.69 124.21 49.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.533 178.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.465 ' HE1' ' N ' ' A' ' 115' ' ' GLN . 16.0 t80 -78.92 100.88 7.43 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.012 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.426 HG21 ' HG3' ' A' ' 71' ' ' GLU . 60.1 p -95.9 39.98 1.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.115 0.483 . . . . 0.0 110.845 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -145.64 -144.12 4.06 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.078 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.756 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 50.6 mt-30 -123.11 160.8 25.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.898 0.38 . . . . 0.0 111.207 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -60.14 -27.67 67.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.665 0.745 . . . . 0.0 111.309 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -52.82 -5.78 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.321 -1.309 . . . . 0.0 113.741 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.756 ' HG2' ' O ' ' A' ' 115' ' ' GLN . 0.1 OUTLIER -90.96 -24.48 20.12 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.085 178.785 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.593 ' HA ' ' O ' ' A' ' 65' ' ' THR . 7.0 mt -84.53 101.39 8.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.619 -0.718 . . . . 0.0 112.442 -178.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -107.04 -32.0 8.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.403 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.496 ' CD2' HG22 ' A' ' 65' ' ' THR . 9.9 mt . . . . . 0 C--N 1.331 -0.206 0 CA-C-O 121.035 0.445 . . . . 0.0 110.519 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 . . . . . 0 N--CA 1.463 0.182 0 CA-C-O 121.015 0.436 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.547 ' C ' HD12 ' A' ' 34' ' ' LEU . 1.6 m-85 -130.68 143.3 50.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.05 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.698 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -87.46 -35.96 9.09 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.639 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -148.34 144.76 27.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.944 0.402 . . . . 0.0 110.741 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.519 ' CZ2' HD11 ' A' ' 119' ' ' ILE . 39.0 p-90 -135.88 169.34 17.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.94 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.421 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 33.6 t -162.75 176.3 10.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.315 0.578 . . . . 0.0 112.03 -178.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.451 ' CH2' ' OD1' ' A' ' 23' ' ' ASN . 83.4 m95 -110.71 103.03 11.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.314 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.443 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 30.1 m -120.55 167.83 13.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.911 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.484 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 24.3 p -72.2 167.26 33.7 Favored Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.066 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.598 ' HA ' ' CG1' ' A' ' 28' ' ' ILE . 20.2 Cg_exo -59.62 -55.65 1.64 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.731 1.621 . . . . 0.0 110.296 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -62.7 -26.93 68.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.265 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.459 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 11.7 mm100 -72.51 -46.84 52.76 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.625 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.523 HD11 ' O ' ' A' ' 41' ' ' GLN . 1.5 tp -58.21 -38.52 76.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.858 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.64 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 28.9 mm -62.31 -38.89 82.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.252 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.27 -50.16 55.63 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.307 0.575 . . . . 0.0 110.729 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.495 HD22 ' CD1' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -74.58 -20.22 60.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.967 -179.053 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.64 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 13.2 t -74.89 176.37 7.18 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.141 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.446 ' O ' ' HG3' ' A' ' 151' ' ' LYS . 35.3 m -81.63 142.79 13.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.818 0.342 . . . . 0.0 111.53 -179.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.491 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 55.2 mt-10 -50.27 -51.15 47.29 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.278 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.15 -10.91 0.09 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -135.25 -4.02 2.4 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.64 ' HG2' ' O ' ' A' ' 143' ' ' ILE . 9.7 mttt -59.47 -57.98 22.9 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 120.36 0.124 . . . . 0.0 111.164 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 20.8 Cg_endo -60.78 -27.55 84.99 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.427 2.085 . . . . 0.0 111.658 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 39.0 t -68.97 -52.89 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.547 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 5.0 m-30 -64.31 -40.65 96.34 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.505 178.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.472 ' N ' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -55.85 -41.34 74.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.258 179.521 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -68.31 -33.46 74.35 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.602 HG12 ' CE2' ' A' ' 161' ' ' PHE . 44.6 t -66.42 -40.77 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.944 178.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.402 HD11 HG13 ' A' ' 143' ' ' ILE . 52.2 mt -63.46 -45.83 89.01 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.644 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 0.2 OUTLIER -50.15 -40.14 45.52 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.119 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.608 HG12 ' HA ' ' A' ' 76' ' ' VAL . 88.8 t -66.99 -42.69 88.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.944 177.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.602 ' CE2' HG12 ' A' ' 157' ' ' VAL . 14.1 m-30 -81.03 5.58 16.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.685 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.621 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.42 -51.89 78.55 Favored Pre-proline 0 C--N 1.331 -0.237 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.428 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 18.1 Cg_endo -59.08 -12.39 15.54 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.021 1.814 . . . . 0.0 111.716 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.477 ' NE2' ' HB2' ' A' ' 74' ' ' ALA . 94.9 m-70 -107.69 -20.14 13.32 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.464 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 96.8 mt . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.761 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.417 ' HE2' ' HB2' ' A' ' 6' ' ' MET . 3.9 mpp? . . . . . 0 N--CA 1.462 0.141 0 CA-C-O 120.745 0.307 . . . . 0.0 110.534 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.72 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 63.8 t0 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.952 0.406 . . . . 0.0 110.489 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.435 ' HG3' ' CZ3' ' A' ' 79' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.166 0 CA-C-O 121.031 0.443 . . . . 0.0 110.144 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.601 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 4.2 m-80 -133.19 172.67 12.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.132 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.519 HG22 ' CA ' ' A' ' 57' ' ' ALA . 16.6 m -135.84 164.98 30.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.224 0.535 . . . . 0.0 111.443 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.708 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -138.67 155.88 23.89 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.97 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.507 HG21 ' CD1' ' A' ' 110' ' ' PHE . 2.5 mp -131.11 123.91 54.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.6 t -102.33 101.22 11.45 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.539 HD22 ' HD1' ' A' ' 112' ' ' PHE . 20.7 tp -99.58 117.52 34.15 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.359 -178.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.661 ' HE1' HD11 ' A' ' 73' ' ' ILE . 1.4 ptt? -118.08 166.74 12.19 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.729 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.578 ' ND2' ' HB2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -101.21 169.67 8.76 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.28 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -56.37 -4.5 0.14 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.52 178.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.502 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 2.7 m-20 -99.06 2.96 46.61 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 3.3 mmtp 74.18 20.47 2.69 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.014 -178.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.578 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 1.1 mmtt -94.17 145.55 24.62 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.72 HG13 ' HA ' ' A' ' 139' ' ' PRO . 1.1 mm -97.93 139.94 19.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.294 0.568 . . . . 0.0 112.473 -177.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.408 ' N ' ' O ' ' A' ' 21' ' ' LEU . 18.6 t80 -75.99 122.54 24.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.809 178.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.611 ' HA ' ' O ' ' A' ' 41' ' ' GLN . . . -122.68 146.68 47.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.967 0.413 . . . . 0.0 111.124 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.455 ' HB3' ' CG ' ' A' ' 131' ' ' PHE . . . -137.65 136.5 37.52 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.407 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.557 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 97.0 p -100.73 144.52 29.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.909 0.385 . . . . 0.0 111.049 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.2 mtp-105 -69.83 126.71 30.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.487 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.687 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.3 OUTLIER -45.43 -33.37 2.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.296 0.57 . . . . 0.0 110.781 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.01 -38.23 64.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.008 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.549 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 56.1 mt -124.67 104.56 30.65 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.09 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.24 -18.1 50.4 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.727 2.285 . . . . 0.0 112.774 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -94.22 -11.0 31.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.554 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.557 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.42 96.77 10.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.778 0.323 . . . . 0.0 111.196 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.542 ' O ' ' HA ' ' A' ' 146' ' ' THR . 77.1 m95 -89.53 161.89 15.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.341 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.611 ' O ' ' HA ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -169.26 -139.47 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.932 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.472 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 10.2 ptt? -175.07 161.93 2.34 Favored Pre-proline 0 C--N 1.327 -0.386 0 O-C-N 122.196 -0.315 . . . . 0.0 110.368 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' A' ' 42' ' ' MET . 1.9 Cg_endo -40.8 131.91 2.72 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.015 2.477 . . . . 0.0 112.946 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.44 144.66 0.3 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.652 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.645 ' HA3' ' HG2' ' A' ' 60' ' ' GLU . . . -161.26 -163.12 13.63 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.059 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.601 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -109.3 145.94 16.73 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.723 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.427 ' H ' ' HA ' ' A' ' 16' ' ' ASN . 19.8 mt -72.49 143.64 13.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 122.354 0.262 . . . . 0.0 110.973 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -69.54 -174.85 0.75 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.836 0.35 . . . . 0.0 110.458 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -48.48 -71.13 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.147 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -120.9 54.23 0.67 Allowed Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.384 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -113.47 150.66 32.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.803 0.335 . . . . 0.0 110.875 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -69.66 158.89 85.89 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.053 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.423 ' HB3' HG11 ' A' ' 17' ' ' VAL . 4.0 Cg_exo -76.4 -50.37 0.11 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.595 2.197 . . . . 0.0 111.426 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.542 ' C ' ' HD2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -52.49 -46.81 66.77 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.297 179.325 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -66.9 -41.81 86.53 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.056 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' A' ' 60' ' ' GLU . . . -61.13 -44.43 97.35 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.519 ' CA ' HG22 ' A' ' 17' ' ' VAL . . . -55.43 -53.98 49.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.094 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.516 HG12 ' CE2' ' A' ' 110' ' ' PHE . 34.6 mt -55.02 -53.73 31.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.098 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 -62.29 -60.76 3.11 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.976 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.645 ' HG2' ' HA3' ' A' ' 45' ' ' GLY . 0.6 OUTLIER -44.1 -48.25 8.99 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.105 0.479 . . . . 0.0 110.121 179.269 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.468 HD22 ' O ' ' A' ' 67' ' ' VAL . 0.8 OUTLIER -52.73 -46.23 67.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.565 179.046 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.489 ' O ' ' N ' ' A' ' 66' ' ' GLY . 42.9 ttp180 -64.87 -62.75 1.37 Allowed 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 121.343 0.592 . . . . 0.0 111.015 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -50.09 -21.69 1.37 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.359 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -96.11 -36.6 10.93 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.44 HG21 ' CE2' ' A' ' 131' ' ' PHE . 3.6 p -127.27 -4.62 6.12 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 80.3 -12.07 34.23 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.362 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.496 ' CG2' HG12 ' A' ' 119' ' ' ILE . 64.3 t -58.2 118.98 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 121.33 0.586 . . . . 0.0 111.587 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.415 ' CG2' ' HG3' ' A' ' 62' ' ' ARG . 1.1 p -127.2 -40.01 1.86 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.402 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.8 m -62.54 76.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.512 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.584 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -162.92 156.7 20.24 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.401 ' HG3' HG21 ' A' ' 113' ' ' THR . 2.3 mt-10 -129.82 150.17 51.24 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.858 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.63 HG23 ' CE2' ' A' ' 110' ' ' PHE . 21.3 t -74.0 129.41 36.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.265 0.555 . . . . 0.0 111.753 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.661 HD11 ' HE1' ' A' ' 22' ' ' MET . 1.3 mt -110.56 -18.36 7.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.452 179.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.452 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -171.3 175.93 4.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.405 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -154.6 150.01 27.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.603 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.662 ' HA ' HG11 ' A' ' 160' ' ' VAL . 11.2 t -72.03 136.85 82.08 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.846 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.519 ' HD3' HG12 ' A' ' 160' ' ' VAL . 35.1 Cg_endo -67.56 -60.25 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.9 2.4 . . . . 0.0 113.306 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.72 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -94.27 172.98 7.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.08 -178.478 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.435 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 57.1 m95 -91.71 100.69 13.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.281 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.577 HD23 ' HG2' ' A' ' 156' ' ' GLU . 88.8 mt . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 121.054 0.454 . . . . 0.0 110.783 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.149 0 CA-C-O 121.165 0.507 . . . . 0.0 111.262 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.466 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 35.6 mt-30 -126.15 125.18 42.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.943 -178.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.475 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 3.5 ttmm -104.95 136.83 43.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.554 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.708 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 23.8 m95 -103.14 170.39 7.99 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.401 ' CZ ' ' HB2' ' A' ' 53' ' ' PRO . 96.2 m-85 -141.8 154.14 45.01 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.913 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.521 ' HG ' HD12 ' A' ' 73' ' ' ILE . 15.6 tp -101.76 138.56 38.58 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.67 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.63 ' CE2' HG23 ' A' ' 72' ' ' VAL . 31.0 m-85 -141.68 144.07 33.9 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.584 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 3.2 tttm -102.21 124.91 48.62 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.962 178.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.539 ' HD1' HD22 ' A' ' 21' ' ' LEU . 49.9 t80 -78.38 99.88 6.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.811 0.339 . . . . 0.0 110.56 178.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.401 HG21 ' HG3' ' A' ' 71' ' ' GLU . 35.1 p -99.37 51.29 0.94 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.027 0.442 . . . . 0.0 110.501 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -153.81 -146.93 4.51 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.504 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.434 ' O ' ' HZ ' ' A' ' 112' ' ' PHE . 2.7 mm-40 -120.93 146.61 46.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.028 0.442 . . . . 0.0 110.714 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -57.15 -33.08 67.05 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.873 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -58.23 -5.64 0.51 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.862 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -90.73 -15.19 30.68 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.64 0.257 . . . . 0.0 111.026 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.561 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 19.2 mt -77.9 100.24 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.901 0.381 . . . . 0.0 111.883 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -105.8 97.34 7.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.498 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.421 ' CD2' HG22 ' A' ' 65' ' ' THR . 27.2 mt . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.11 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 . . . . . 0 C--O 1.233 0.201 0 CA-C-O 120.907 0.384 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.455 ' CG ' ' HB3' ' A' ' 31' ' ' ALA . 2.0 m-85 -104.18 144.15 31.97 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.401 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.687 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -88.72 -35.54 8.37 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.558 -0.83 . . . . 0.0 111.713 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.6 148.4 28.59 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.854 0.359 . . . . 0.0 110.719 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.561 ' CZ2' HD11 ' A' ' 119' ' ' ILE . 37.6 p-90 -135.4 165.31 25.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.264 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.417 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 22.6 t -160.13 176.95 11.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.392 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.57 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 41.9 m95 -113.75 105.02 12.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.224 178.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.634 ' O ' ' N ' ' A' ' 28' ' ' ILE . 24.4 m -119.39 170.3 9.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.269 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.497 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 24.4 p -72.86 169.32 17.94 Favored Pre-proline 0 C--N 1.324 -0.529 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.504 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.72 ' HA ' HG13 ' A' ' 28' ' ' ILE . 17.3 Cg_exo -60.52 -51.83 4.66 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.082 1.855 . . . . 0.0 110.401 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -67.41 -28.81 68.23 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.847 178.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.461 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 2.3 mt-30 -71.35 -47.05 58.78 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.614 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.474 HD12 ' HB2' ' A' ' 30' ' ' ALA . 3.5 tp -55.67 -39.24 70.68 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.513 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 24.2 mm -62.82 -38.37 81.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.233 0.54 . . . . 0.0 110.514 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.73 -49.86 55.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.187 0.517 . . . . 0.0 110.627 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.483 HD23 ' CD1' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -74.63 -21.65 59.33 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.02 -179.196 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 6.2 t -73.49 -178.92 3.24 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.68 -178.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.565 HG22 ' CZ ' ' A' ' 149' ' ' PHE . 30.7 m -86.39 151.1 3.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.822 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.588 ' HG3' ' H ' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -58.93 -53.69 55.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.683 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.588 ' H ' ' HG3' ' A' ' 148' ' ' GLU . 39.3 p90 -55.38 -3.44 0.06 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.551 ' HB2' HG23 ' A' ' 147' ' ' VAL . 28.4 mttm -133.15 -7.4 3.02 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 143' ' ' ILE . 8.1 mttt -60.37 -61.7 7.42 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.629 0.252 . . . . 0.0 111.192 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.555 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 10.7 Cg_endo -53.92 -31.28 62.29 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.742 2.295 . . . . 0.0 112.011 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.481 ' O ' HG22 ' A' ' 157' ' ' VAL . 38.9 t -67.18 -52.05 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.476 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 4.0 m-30 -63.77 -37.93 89.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.651 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.422 ' CD ' HG13 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -55.93 -46.74 78.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.822 179.504 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.577 ' HG2' HD23 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -67.26 -28.92 68.44 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.416 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.56 HG11 ' CE2' ' A' ' 161' ' ' PHE . 47.4 t -68.89 -42.24 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.717 178.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.611 HD23 ' HB3' ' A' ' 139' ' ' PRO . 49.4 mt -63.91 -46.43 84.86 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.551 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 40.5 t -50.33 -42.19 52.53 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.662 HG11 ' HA ' ' A' ' 76' ' ' VAL . 94.6 t -65.92 -42.03 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.282 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.593 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 16.8 m-30 -81.07 4.9 18.23 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.534 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.489 ' HB2' ' HD3' ' A' ' 163' ' ' PRO . . . -58.86 -50.18 89.37 Favored Pre-proline 0 C--N 1.329 -0.294 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.653 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.549 ' HD2' ' O ' ' A' ' 160' ' ' VAL . 24.2 Cg_exo -61.55 -11.93 22.3 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.389 2.059 . . . . 0.0 111.602 178.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.452 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 84.1 m-70 -109.69 -17.8 13.61 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.341 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 86.3 mt . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.725 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 12.4 mtm . . . . . 0 N--CA 1.46 0.058 0 CA-C-O 120.762 0.315 . . . . 0.0 110.653 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.706 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 11.3 p-10 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.607 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.535 ' HG3' ' CZ3' ' A' ' 79' ' ' TRP . 3.9 ttp180 . . . . . 0 CA--C 1.532 0.252 0 CA-C-O 120.905 0.383 . . . . 0.0 111.579 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.699 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 66.0 m-20 -133.47 176.54 8.45 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.218 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.626 HG23 ' CA ' ' A' ' 57' ' ' ALA . 13.1 m -139.25 166.29 21.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.365 0.602 . . . . 0.0 112.079 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.573 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -133.83 162.2 24.41 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.365 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.501 ' HB ' ' HB2' ' A' ' 43' ' ' PRO . 3.4 mp -129.49 117.47 42.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.496 ' HB2' ' HE2' ' A' ' 161' ' ' PHE . 0.5 OUTLIER -103.86 99.76 9.54 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.609 HD21 ' CD1' ' A' ' 112' ' ' PHE . 12.4 tp -102.26 126.87 49.38 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.847 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.503 ' CB ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -124.49 153.84 41.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.239 -179.724 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.559 ' ND2' ' HB3' ' A' ' 112' ' ' PHE . 2.2 m120 -99.39 -178.61 3.96 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.684 0.754 . . . . 0.0 111.094 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -58.73 -6.17 0.7 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.041 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.508 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 2.7 m-20 -99.55 0.19 41.8 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -178.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 2.0 mmtm 72.7 21.92 3.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.921 -178.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 22' ' ' MET . 15.3 mttt -95.77 169.19 10.18 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.487 ' N ' ' CD1' ' A' ' 28' ' ' ILE . 1.5 mp -117.67 143.24 28.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.475 0.655 . . . . 0.0 111.566 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.493 ' CE2' ' HD3' ' A' ' 43' ' ' PRO . 6.5 t80 -64.48 99.65 0.32 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.724 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.741 ' HA ' ' O ' ' A' ' 41' ' ' GLN . . . -96.46 138.73 33.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.193 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.46 ' HB3' ' CD2' ' A' ' 131' ' ' PHE . . . -136.23 135.98 39.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.578 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.719 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 70.0 p -102.15 141.95 34.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.852 0.358 . . . . 0.0 111.473 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.543 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -70.9 128.11 34.88 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.515 179.501 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.693 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.3 OUTLIER -44.24 -37.82 3.45 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.181 0.515 . . . . 0.0 111.04 -179.859 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -71.59 -35.24 70.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.508 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 39' ' ' ALA . 16.3 mt -126.4 106.72 24.06 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 120.728 0.299 . . . . 0.0 111.068 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.7 -43.84 12.03 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.86 2.374 . . . . 0.0 113.276 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -75.29 -3.55 33.99 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.719 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.34 96.13 10.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.751 0.31 . . . . 0.0 110.671 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.591 ' CD1' ' HB3' ' A' ' 145' ' ' LEU . 74.1 m95 -94.46 163.0 13.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.57 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.741 ' O ' ' HA ' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -174.31 -135.3 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.341 -178.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.621 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 6.4 ptt? -177.03 165.32 1.45 Allowed Pre-proline 0 N--CA 1.453 -0.307 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.646 ' HB3' HD12 ' A' ' 61' ' ' LEU . 4.1 Cg_endo -45.05 144.47 3.84 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.736 2.291 . . . . 0.0 113.246 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -174.26 141.94 0.76 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.323 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.543 ' HA3' ' HG3' ' A' ' 60' ' ' GLU . . . -142.65 -173.21 14.29 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.991 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.671 ' HA2' ' CB ' ' A' ' 16' ' ' ASN . . . -116.68 22.07 11.04 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 119.984 -1.103 . . . . 0.0 114.445 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.496 ' CD1' HG12 ' A' ' 17' ' ' VAL . 43.1 mt 61.28 131.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 117.234 0.517 . . . . 0.0 111.346 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -68.02 -176.18 0.67 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.724 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -47.67 -69.74 0.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.315 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -119.13 57.1 0.56 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.504 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -117.95 150.72 38.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.888 0.375 . . . . 0.0 110.945 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.84 173.09 4.53 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.748 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.47 ' HA ' HG11 ' A' ' 17' ' ' VAL . 2.0 Cg_endo -80.74 -52.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.541 2.16 . . . . 0.0 111.58 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.597 ' HG2' ' CD1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -54.01 -44.22 70.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.515 179.153 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -68.52 -45.09 73.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.372 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.485 ' HB2' ' HA ' ' A' ' 47' ' ' ILE . . . -60.51 -42.47 96.45 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.626 ' CA ' HG23 ' A' ' 17' ' ' VAL . . . -56.66 -60.16 3.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.319 0.58 . . . . 0.0 109.723 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.408 HD11 ' CD ' ' A' ' 54' ' ' ARG . 47.2 mt -53.92 -51.33 46.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.207 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -61.02 -62.68 1.68 Allowed 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.85 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.543 ' HG3' ' HA3' ' A' ' 45' ' ' GLY . 8.8 mm-40 -43.71 -44.03 6.3 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.261 0.553 . . . . 0.0 109.908 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.646 HD12 ' HB3' ' A' ' 43' ' ' PRO . 0.6 OUTLIER -51.87 -47.96 64.28 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.968 178.59 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.476 ' O ' ' N ' ' A' ' 66' ' ' GLY . 38.5 ttt180 -63.23 -65.58 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.214 0.531 . . . . 0.0 111.095 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -47.75 -25.27 1.18 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.317 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -93.38 -35.58 12.95 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.577 ' HB ' HG23 ' A' ' 119' ' ' ILE . 1.4 p -127.68 -37.14 1.99 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.752 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 111.48 -10.56 28.34 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.184 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.633 ' HB ' ' CD1' ' A' ' 61' ' ' LEU . 68.6 t -56.86 111.97 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.197 0.523 . . . . 0.0 111.633 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 70' ' ' ALA . 6.9 p -123.66 -39.15 2.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.651 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.4 m -62.48 74.43 0.02 OUTLIER 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.018 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -160.88 157.11 26.04 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.447 ' HG3' HG22 ' A' ' 113' ' ' THR . 0.4 OUTLIER -128.01 144.85 51.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.095 179.1 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.538 HG21 ' HD3' ' A' ' 54' ' ' ARG . 21.6 t -73.98 125.79 33.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.129 0.49 . . . . 0.0 111.319 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.478 HD12 ' HB2' ' A' ' 111' ' ' LYS . 1.0 OUTLIER -107.36 -20.06 6.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.683 179.728 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.505 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -169.73 177.46 4.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.818 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.443 ' HB3' ' HD1' ' A' ' 108' ' ' PHE . 3.7 pm0 -157.73 150.59 23.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.563 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.772 ' HA ' HG13 ' A' ' 160' ' ' VAL . 53.4 t -71.91 134.44 83.48 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.135 0.493 . . . . 0.0 111.354 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.44 ' HD3' HG11 ' A' ' 160' ' ' VAL . 29.7 Cg_endo -63.77 -54.06 1.09 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.099 2.533 . . . . 0.0 112.657 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.706 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 2.4 p90 -99.11 178.79 4.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.235 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.535 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 43.5 m95 -94.56 -158.0 0.6 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.623 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 105' ' ' GLN . 70.6 mt . . . . . 0 N--CA 1.464 0.256 0 CA-C-O 121.023 0.439 . . . . 0.0 110.197 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.348 0 CA-C-O 121.278 0.561 . . . . 0.0 109.595 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.699 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 13.1 mt-30 -121.98 123.32 41.39 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.662 -177.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 78' ' ' TYR . 5.1 ttpt -104.62 135.47 45.95 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 177.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.573 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 19.5 m95 -101.2 162.74 12.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.205 0.526 . . . . 0.0 112.3 -178.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.597 ' CD1' ' HG2' ' A' ' 54' ' ' ARG . 97.6 m-85 -137.38 149.37 46.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.643 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.415 ' HB2' ' CE1' ' A' ' 161' ' ' PHE . 19.0 tp -102.62 125.63 49.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.31 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.467 ' CE2' HG23 ' A' ' 19' ' ' ILE . 11.9 m-85 -128.87 144.84 51.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.296 0.569 . . . . 0.0 111.507 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.573 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -96.35 118.56 33.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.397 179.137 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.609 ' CD1' HD21 ' A' ' 21' ' ' LEU . 50.6 t80 -79.06 94.61 5.35 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.319 179.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.447 HG22 ' HG3' ' A' ' 71' ' ' GLU . 19.5 p -94.67 45.46 1.12 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.378 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.34 -146.2 4.6 Favored Glycine 0 C--N 1.331 0.298 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.263 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -121.02 146.89 46.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.963 0.411 . . . . 0.0 111.401 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.488 ' HB2' ' CZ2' ' A' ' 134' ' ' TRP . 11.2 p-10 -58.3 -39.88 80.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.19 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -57.52 -4.4 0.25 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.278 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 116' ' ' ASP . 3.5 tt0 -88.85 -16.35 32.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.014 0.435 . . . . 0.0 110.562 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.577 HG23 ' HB ' ' A' ' 65' ' ' THR . 11.0 mt -82.35 102.83 8.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.951 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -101.2 98.86 9.22 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.285 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.49 HD21 HG23 ' A' ' 65' ' ' THR . 50.8 mt . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.637 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 . . . . . 0 C--O 1.23 0.076 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.511 ' CE1' HG22 ' A' ' 65' ' ' THR . 0.5 OUTLIER -102.16 142.26 33.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.492 178.894 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.693 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -82.53 -35.39 19.98 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.145 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.93 147.88 27.1 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.751 0.31 . . . . 0.0 110.735 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.522 ' HA ' ' CZ3' ' A' ' 40' ' ' TRP . 39.1 p-90 -137.4 173.47 11.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.045 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.446 ' N ' ' HZ3' ' A' ' 40' ' ' TRP . 22.0 t -168.57 -179.46 3.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.462 0.649 . . . . 0.0 112.003 -178.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.527 ' CD2' ' OD1' ' A' ' 23' ' ' ASN . 88.8 m95 -113.25 100.72 8.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.907 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.456 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 32.6 m -118.3 169.78 8.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.283 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.521 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 12.3 p -74.04 172.32 8.84 Favored Pre-proline 0 C--N 1.329 -0.317 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.161 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.613 ' HB3' HD22 ' A' ' 158' ' ' LEU . 16.4 Cg_exo -61.87 -56.96 0.6 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.845 1.697 . . . . 0.0 110.337 179.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.38 -27.93 69.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.563 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.409 ' HG3' ' OG1' ' A' ' 138' ' ' THR . 1.0 OUTLIER -70.98 -49.31 46.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.503 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.413 ' CD1' ' CB ' ' A' ' 30' ' ' ALA . 12.8 tp -57.74 -37.39 73.52 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.686 ' O ' HG22 ' A' ' 146' ' ' THR . 13.2 mm -62.47 -39.3 83.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.14 0.495 . . . . 0.0 110.698 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.32 -48.91 63.64 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.325 0.583 . . . . 0.0 110.437 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.591 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -75.53 -18.78 59.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.742 -179.149 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.686 HG22 ' O ' ' A' ' 143' ' ' ILE . 15.2 t -76.31 178.02 6.82 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.364 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.531 ' CG2' ' HD3' ' A' ' 150' ' ' LYS . 19.2 m -87.34 147.49 5.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.987 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.467 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 52.4 mt-10 -50.87 -49.79 58.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.927 0.394 . . . . 0.0 111.599 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.403 ' C ' ' HD2' ' A' ' 150' ' ' LYS . 1.2 m-85 -52.14 -7.13 0.05 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.531 ' HD3' ' CG2' ' A' ' 147' ' ' VAL . 7.7 mptt -137.09 -2.38 2.07 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' A' ' 143' ' ' ILE . 14.7 mttt -63.79 -62.9 4.56 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 111.533 0.197 . . . . 0.0 111.533 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.467 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 19.3 Cg_endo -60.41 -29.04 87.92 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.266 1.978 . . . . 0.0 111.422 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 157' ' ' VAL . 21.2 t -68.23 -51.37 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.543 ' OH ' ' HG2' ' A' ' 41' ' ' GLN . 7.6 m-30 -63.95 -36.96 85.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.729 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.678 ' HD3' HG21 ' A' ' 143' ' ' ILE . 0.2 OUTLIER -57.93 -42.83 85.69 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.597 179.289 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.408 ' HG3' ' OH ' ' A' ' 78' ' ' TYR . 1.2 tp10 -68.35 -35.23 77.45 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.511 HG12 ' CE2' ' A' ' 161' ' ' PHE . 59.2 t -66.21 -41.86 89.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.551 178.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.613 HD22 ' HB3' ' A' ' 139' ' ' PRO . 40.8 mt -64.87 -41.73 95.43 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.901 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.458 ' O ' ' HB1' ' A' ' 162' ' ' ALA . 0.8 OUTLIER -55.75 -38.74 70.21 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.109 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.772 HG13 ' HA ' ' A' ' 76' ' ' VAL . 98.7 t -69.06 -44.55 81.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.194 177.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.574 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 22.1 m-30 -80.05 4.98 15.43 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.392 -179.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.612 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.97 -52.44 74.81 Favored Pre-proline 0 C--N 1.329 -0.316 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.757 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 17.4 Cg_endo -57.77 -12.37 11.63 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.226 1.951 . . . . 0.0 112.088 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.505 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 85.0 m-70 -110.46 -19.98 12.75 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.342 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 93.4 mt . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.163 -0.923 . . . . 0.0 110.733 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.8 mtm . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.759 0.314 . . . . 0.0 110.606 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 10.8 p-10 . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.549 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.605 ' HG3' ' CZ3' ' A' ' 79' ' ' TRP . 2.0 ttp180 . . . . . 0 C--O 1.234 0.265 0 CA-C-O 121.042 0.449 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.676 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 2.2 m-80 -132.72 174.6 10.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.901 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.577 HG22 ' CA ' ' A' ' 57' ' ' ALA . 14.4 m -141.8 167.22 16.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.969 0.414 . . . . 0.0 110.796 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.625 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -136.05 159.38 24.29 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.562 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.748 HG13 ' HB2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -130.7 120.91 49.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.29 0.567 . . . . 0.0 112.321 -178.586 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.41 ' CB ' ' CE2' ' A' ' 161' ' ' PHE . 53.0 t -104.3 100.09 9.81 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.073 178.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.501 HD21 ' CD1' ' A' ' 112' ' ' PHE . 12.0 tp -99.84 119.81 38.77 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.178 -178.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.679 ' HE2' HD12 ' A' ' 73' ' ' ILE . 0.6 OUTLIER -121.4 157.89 29.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.808 179.801 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.544 ' OD1' ' CE3' ' A' ' 136' ' ' TRP . 0.0 OUTLIER -97.16 172.48 7.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.45 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -57.06 -4.14 0.17 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.479 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.592 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.7 OUTLIER -100.25 0.72 40.86 Favored 'General case' 0 C--N 1.34 0.17 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -178.88 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.592 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 3.8 mmtm 76.45 19.17 1.68 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.222 -178.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 22' ' ' MET . 2.8 mttt -95.73 143.97 26.52 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.482 HD11 ' CG ' ' A' ' 139' ' ' PRO . 3.1 mp -102.75 145.48 12.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.54 0.686 . . . . 0.0 112.23 -178.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.574 ' CE1' HD13 ' A' ' 119' ' ' ILE . 90.8 t80 -74.98 138.68 42.43 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.643 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.632 ' HB1' HD13 ' A' ' 142' ' ' LEU . . . -137.51 148.65 46.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.972 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -141.11 134.48 29.71 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.911 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.657 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 2.1 m -95.09 151.14 19.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.924 0.392 . . . . 0.0 111.122 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.0 mtp-105 -69.61 132.29 45.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.425 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.678 ' H ' ' CD2' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -39.18 -46.52 1.49 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.961 -178.924 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.24 -34.76 68.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.181 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.61 ' HB ' ' HB2' ' A' ' 39' ' ' ALA . 19.5 mt -119.05 114.44 35.15 Favored Pre-proline 0 CA--C 1.529 0.17 0 C-N-CA 120.954 -0.299 . . . . 0.0 111.297 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -78.27 -20.42 11.22 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.171 1.914 . . . . 0.0 112.279 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -91.57 -10.08 41.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.922 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.657 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -90.51 92.86 9.05 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.483 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.65 ' O ' ' HA ' ' A' ' 146' ' ' THR . 76.8 m95 -88.32 148.88 24.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.657 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.551 ' HB3' ' HH ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -159.3 158.02 31.61 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.346 0.593 . . . . 0.0 111.567 -179.255 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.476 ' HE3' ' CZ3' ' A' ' 107' ' ' TRP . 28.3 mtm -90.41 148.51 39.09 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.991 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.462 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 11.3 Cg_endo -53.88 151.5 26.32 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.729 1.619 . . . . 0.0 111.319 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.506 ' HA ' HD12 ' A' ' 19' ' ' ILE . 4.1 pt20 -174.74 154.23 1.91 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.419 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.431 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . -159.9 159.94 31.11 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.298 -0.953 . . . . 0.0 112.151 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.663 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -86.79 137.34 14.74 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.693 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.45 HD11 ' CG1' ' A' ' 17' ' ' VAL . 45.2 mt -68.36 146.51 12.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.616 0.246 . . . . 0.0 111.289 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -68.66 -174.64 0.58 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.017 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.05 -61.36 2.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.472 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.59 58.62 0.7 Allowed Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.764 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -117.44 154.06 32.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.68 0.276 . . . . 0.0 110.623 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.72 159.78 84.07 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 6.1 Cg_exo -78.54 -49.85 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.528 2.152 . . . . 0.0 111.686 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.519 ' HG2' ' CD2' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -51.49 -46.64 63.23 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.305 179.563 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -67.38 -44.61 78.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.351 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.68 -39.9 90.12 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.577 ' CA ' HG22 ' A' ' 17' ' ' VAL . . . -58.6 -56.12 26.27 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.442 0.639 . . . . 0.0 109.565 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.508 HD11 ' HD2' ' A' ' 54' ' ' ARG . 23.6 mt -55.86 -52.71 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.854 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -62.1 -58.19 8.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.826 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.431 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 70.6 mm-40 -46.21 -45.63 17.03 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.382 0.61 . . . . 0.0 109.848 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.748 ' HB2' HG13 ' A' ' 19' ' ' ILE . 9.9 tt -52.45 -45.91 66.23 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.865 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.68 ' HD2' ' HA2' ' A' ' 66' ' ' GLY . 19.9 tpt85 -62.81 -65.6 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.377 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -50.11 -23.91 2.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.076 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . 0.503 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 6.3 mt-10 -91.87 -35.29 14.14 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -177.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.458 HG21 ' CD2' ' A' ' 131' ' ' PHE . 1.7 p -123.76 -43.79 2.11 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 120.505 -0.478 . . . . 0.0 112.141 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.68 ' HA2' ' HD2' ' A' ' 62' ' ' ARG . . . 119.89 -17.58 10.0 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.275 -178.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.588 HG23 HG12 ' A' ' 119' ' ' ILE . 76.5 t -58.73 115.22 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-O 121.443 0.64 . . . . 0.0 111.842 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.5 OUTLIER -124.55 -37.04 2.55 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.5 178.223 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.4 m -62.35 73.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.102 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -159.63 156.08 27.3 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.444 ' HG3' HG21 ' A' ' 113' ' ' THR . 1.3 mt-10 -128.65 148.57 50.81 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.328 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.476 HG21 ' CD2' ' A' ' 110' ' ' PHE . 26.2 t -75.25 127.92 36.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.108 0.48 . . . . 0.0 111.341 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.679 HD12 ' HE2' ' A' ' 22' ' ' MET . 1.7 mt -107.84 -18.58 7.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.482 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.467 ' HB2' ' NE2' ' A' ' 164' ' ' HIS . . . -170.91 175.48 4.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.219 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -151.52 149.68 29.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.469 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.788 ' HA ' HG12 ' A' ' 160' ' ' VAL . 39.7 t -72.92 134.94 80.77 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.99 0.424 . . . . 0.0 111.144 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.57 ' HD2' HG12 ' A' ' 76' ' ' VAL . 17.8 Cg_endo -57.0 -68.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.201 2.601 . . . . 0.0 112.707 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.685 ' O ' HG13 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -95.5 -174.86 3.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.76 -178.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.605 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 47.2 m95 -90.9 -158.05 0.53 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.037 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 79' ' ' TRP . 50.7 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.947 0.404 . . . . 0.0 110.552 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.22 0 CA-C-O 120.676 0.274 . . . . 0.0 110.299 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.676 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.8 OUTLIER -130.53 130.46 44.17 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -178.575 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.492 ' HE2' ' CE2' ' A' ' 79' ' ' TRP . 1.9 ttmt -104.04 135.87 44.75 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.625 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 18.7 m95 -105.68 164.01 12.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -177.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.519 ' CD2' ' HG2' ' A' ' 54' ' ' ARG . 96.3 m-85 -139.44 153.59 47.61 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.528 -179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.502 ' HB2' ' CE1' ' A' ' 161' ' ' PHE . 13.8 tp -100.91 142.61 32.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.429 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.714 ' CE1' HG21 ' A' ' 19' ' ' ILE . 10.1 m-85 -144.54 146.13 32.2 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.578 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 22.8 tttt -101.56 124.57 47.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.474 178.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.501 ' CD1' HD21 ' A' ' 21' ' ' LEU . 49.4 t80 -77.91 97.37 5.28 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.549 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.444 HG21 ' HG3' ' A' ' 71' ' ' GLU . 59.3 p -96.72 53.91 1.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.035 0.445 . . . . 0.0 110.588 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -157.96 -147.24 4.75 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.492 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -122.31 149.15 44.13 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.996 0.427 . . . . 0.0 110.826 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.462 ' HB3' ' CH2' ' A' ' 134' ' ' TRP . 76.6 m-20 -58.61 -32.26 68.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.291 -179.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -59.31 -5.45 0.75 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.464 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.65 -16.11 33.22 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.944 0.402 . . . . 0.0 111.005 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.588 HG12 HG23 ' A' ' 67' ' ' VAL . 6.1 mt -79.04 101.84 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.901 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -101.21 92.85 5.16 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.767 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.408 ' CG ' ' HD1' ' A' ' 134' ' ' TRP . 87.5 mt . . . . . 0 C--N 1.333 -0.144 0 CA-C-O 120.896 0.379 . . . . 0.0 110.626 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.432 ' O ' HD23 ' A' ' 34' ' ' LEU . 6.5 mm-40 . . . . . 0 N--CA 1.454 -0.231 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.558 ' N ' HD22 ' A' ' 34' ' ' LEU . 8.4 m-85 -132.24 142.84 49.55 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.609 ' N ' HD21 ' A' ' 34' ' ' LEU . . . -86.9 -32.16 15.61 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.397 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 31' ' ' ALA . 1.9 tt0 -154.52 154.47 33.17 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.725 0.297 . . . . 0.0 111.337 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.534 ' CZ2' HD11 ' A' ' 119' ' ' ILE . 22.1 p-90 -134.6 164.94 26.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.217 0.532 . . . . 0.0 112.162 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.421 ' N ' ' HZ3' ' A' ' 40' ' ' TRP . 12.2 t -159.24 162.93 36.24 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.277 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.544 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 51.7 m95 -107.1 105.67 15.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.018 178.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.427 ' O ' ' N ' ' A' ' 28' ' ' ILE . 30.1 m -121.34 170.96 10.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.882 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.549 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 17.2 p -72.38 173.32 5.79 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.549 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 7.0 Cg_exo -64.68 -52.8 1.19 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 121.623 1.548 . . . . 0.0 109.896 178.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -64.44 -31.65 72.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.654 178.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.467 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.9 OUTLIER -70.11 -45.92 65.89 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.051 179.645 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.632 HD13 ' HB1' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -56.92 -39.91 75.34 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.682 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.641 HG21 ' HD3' ' A' ' 155' ' ' LYS . 33.4 mm -62.47 -33.89 61.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.087 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.46 -53.45 13.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.239 0.542 . . . . 0.0 110.54 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.4 mp -71.62 -21.19 61.87 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.649 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.65 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 7.4 t -74.99 169.38 18.11 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.586 -178.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.518 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 25.4 m -72.86 162.49 4.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.615 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.713 ' HG2' ' N ' ' A' ' 149' ' ' PHE . 0.3 OUTLIER -67.87 -50.98 53.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.19 0.519 . . . . 0.0 110.88 179.762 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.713 ' N ' ' HG2' ' A' ' 148' ' ' GLU . 40.2 p90 -58.52 -2.58 0.22 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.938 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.5 ' HG3' ' CD2' ' A' ' 149' ' ' PHE . 23.6 mttt -132.15 -7.49 3.43 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.51 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 0.3 OUTLIER -63.23 -56.13 30.33 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 121.307 -0.157 . . . . 0.0 110.63 179.286 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 20.0 Cg_endo -61.87 -28.21 81.08 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.214 1.942 . . . . 0.0 111.636 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.417 HG21 ' HA ' ' A' ' 150' ' ' LYS . 15.0 t -68.83 -48.5 70.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.551 ' HH ' ' HB3' ' A' ' 41' ' ' GLN . 7.5 m-30 -68.83 -37.65 79.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.765 178.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.641 ' HD3' HG21 ' A' ' 143' ' ' ILE . 2.0 tptp -55.34 -44.83 76.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.521 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -67.57 -34.25 76.66 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.63 HG12 ' CE2' ' A' ' 161' ' ' PHE . 47.7 t -67.79 -41.0 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.847 178.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 38.7 mt -62.77 -44.91 94.95 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.385 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 62.5 m -51.54 -40.29 59.39 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.788 HG12 ' HA ' ' A' ' 76' ' ' VAL . 81.9 t -67.28 -42.23 87.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.142 178.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.67 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 22.3 m-30 -80.12 2.8 22.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.496 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.589 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.98 -52.81 72.18 Favored Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.053 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.6 Cg_endo -58.11 -12.09 11.9 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.153 1.902 . . . . 0.0 112.136 179.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.467 ' NE2' ' HB2' ' A' ' 74' ' ' ALA . 87.1 m-70 -110.72 -16.12 13.68 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.492 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 93.7 mt . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.912 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.435 ' HB2' ' HE1' ' A' ' 6' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.089 0 N-CA-C 110.383 -0.229 . . . . 0.0 110.383 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.756 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 9.0 t0 . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.944 0.402 . . . . 0.0 110.062 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.463 ' HG2' HD13 ' A' ' 47' ' ' ILE . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.128 0 CA-C-O 121.115 0.483 . . . . 0.0 110.173 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.678 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 3.4 m120 -132.3 173.1 11.62 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.899 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.594 HG22 ' N ' ' A' ' 57' ' ' ALA . 21.2 m -143.71 162.41 15.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.318 0.58 . . . . 0.0 112.425 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.536 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -133.95 158.98 23.58 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 177.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.677 HG13 ' HB2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -134.14 126.34 49.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.8 t -102.82 100.64 10.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.237 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.44 HD23 ' CD1' ' A' ' 112' ' ' PHE . 11.4 tp -99.73 118.91 37.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.435 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.567 ' CE ' HD12 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -120.48 166.54 13.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.633 179.622 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.559 ' OD1' ' CE3' ' A' ' 136' ' ' TRP . 0.0 OUTLIER -101.04 171.9 7.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.573 -179.695 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -56.82 -5.32 0.22 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.525 178.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.531 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 1.4 m-20 -98.53 1.95 47.07 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.66 0.267 . . . . 0.0 111.687 -178.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.1 OUTLIER 76.07 18.31 2.0 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.102 -178.508 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.499 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 0.2 OUTLIER -94.68 142.17 27.76 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.836 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.473 HD12 ' CG ' ' A' ' 139' ' ' PRO . 3.7 mp -99.33 146.47 8.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.761 0.791 . . . . 0.0 112.612 -178.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.6 ' CE1' HD11 ' A' ' 119' ' ' ILE . 87.2 t80 -78.15 136.97 37.94 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.239 -1.346 . . . . 0.0 110.035 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 41' ' ' GLN . . . -137.88 146.77 43.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.893 0.378 . . . . 0.0 110.336 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.45 ' HB3' ' CG ' ' A' ' 131' ' ' PHE . . . -138.69 132.33 30.67 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.138 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.584 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 28.5 m -99.15 148.36 24.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.233 -179.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 36' ' ' ILE . 4.8 mtp180 -69.13 127.9 34.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.649 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.722 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 1.7 mp -43.69 -37.51 2.67 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.175 0.512 . . . . 0.0 111.035 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.08 -36.77 72.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.851 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' A' ' 39' ' ' ALA . 23.1 mt -121.63 112.9 32.19 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.076 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.96 -18.76 11.29 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.258 1.972 . . . . 0.0 112.843 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -92.88 -11.26 33.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.511 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.584 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.05 99.55 12.36 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 120.817 0.341 . . . . 0.0 110.715 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.614 ' O ' ' HA ' ' A' ' 146' ' ' THR . 72.4 m95 -94.39 157.33 16.07 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.98 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.6 ' HG3' ' O ' ' A' ' 40' ' ' TRP . 22.9 mt-30 -159.89 -131.69 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 121.111 -0.235 . . . . 0.0 110.399 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.517 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 3.0 ptt? -179.14 161.67 1.0 Allowed Pre-proline 0 N--CA 1.453 -0.31 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.517 ' HD2' ' HB2' ' A' ' 42' ' ' MET . 9.8 Cg_endo -49.86 140.91 29.8 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.119 1.879 . . . . 0.0 112.242 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.555 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER 179.77 144.17 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.73 -179.173 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.467 ' HA3' ' HG2' ' A' ' 60' ' ' GLU . . . -160.47 -156.62 8.27 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.14 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.678 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -117.84 138.55 14.07 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.132 -1.032 . . . . 0.0 113.539 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.552 ' CD1' HG12 ' A' ' 17' ' ' VAL . 4.2 mt -69.54 148.44 11.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.488 -0.356 . . . . 0.0 111.006 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.483 ' N ' HG21 ' A' ' 47' ' ' ILE . 22.3 m-20 -68.92 -174.25 0.57 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.849 0.357 . . . . 0.0 110.686 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -47.96 -62.26 1.55 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.464 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.82 60.67 0.68 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.559 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -117.04 153.28 32.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.765 0.317 . . . . 0.0 110.669 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -70.13 147.08 95.43 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.451 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 16.7 Cg_exo -67.09 -46.51 3.04 Favored 'Trans proline' 0 CA--C 1.513 -0.529 0 C-N-CA 122.138 1.892 . . . . 0.0 111.395 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.605 ' C ' ' HD2' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -52.21 -49.02 64.75 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.097 179.153 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -63.77 -44.31 93.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.512 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 60' ' ' GLU . . . -60.58 -42.28 96.38 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.594 ' N ' HG22 ' A' ' 17' ' ' VAL . . . -56.07 -52.93 62.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.978 178.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.517 HG12 ' CE2' ' A' ' 110' ' ' PHE . 17.3 mt -57.49 -54.37 31.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.881 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -61.39 -58.68 7.24 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.729 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.467 ' HG2' ' HA3' ' A' ' 45' ' ' GLY . 0.7 OUTLIER -45.38 -45.41 12.6 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.536 0.684 . . . . 0.0 109.511 179.318 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.677 ' HB2' HG13 ' A' ' 19' ' ' ILE . 7.6 tt -52.55 -51.14 61.15 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.731 178.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' A' ' 66' ' ' GLY . 7.3 ttm105 -62.44 -62.46 1.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.195 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -51.38 -20.48 1.77 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.43 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -100.57 -35.58 9.47 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 119' ' ' ILE . 0.8 OUTLIER -124.1 -11.3 7.56 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.027 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 84.54 -14.5 46.25 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.868 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.639 HG11 HD22 ' A' ' 61' ' ' LEU . 39.8 t -57.99 115.2 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.434 0.635 . . . . 0.0 111.316 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.451 ' CG2' ' HG3' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -123.54 -39.94 2.39 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.813 178.93 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.416 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 7.2 m -63.0 74.98 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.643 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.555 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -160.27 155.91 25.57 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -128.48 151.39 49.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.399 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.683 HG23 ' CE2' ' A' ' 110' ' ' PHE . 20.2 t -75.64 130.72 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-O 121.292 0.567 . . . . 0.0 112.066 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.581 HD11 ' HB2' ' A' ' 111' ' ' LYS . 1.0 OUTLIER -111.04 -19.11 7.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.37 179.045 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.48 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -170.94 176.54 4.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.812 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.4 OUTLIER -157.05 145.21 19.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.123 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.648 ' HA ' HG13 ' A' ' 160' ' ' VAL . 25.6 t -72.1 138.03 81.9 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-O 121.006 0.431 . . . . 0.0 110.838 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.87 -45.09 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.9 2.4 . . . . 0.0 113.49 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.756 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 1.1 p90 -99.41 161.84 13.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.147 0.499 . . . . 0.0 112.242 -178.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.442 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 73.2 m95 -95.14 109.95 21.96 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.851 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 17.3 mt . . . . . 0 C--N 1.328 -0.343 0 C-N-CA 121.128 -0.229 . . . . 0.0 110.527 179.51 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.444 0 CA-C-O 121.175 0.512 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.667 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 53.6 mt-30 -128.8 123.51 33.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.986 -178.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.434 ' HB2' ' CE3' ' A' ' 79' ' ' TRP . 0.8 OUTLIER -103.25 134.85 45.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.816 178.604 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.536 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 73.0 m95 -102.29 159.01 15.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.306 0.574 . . . . 0.0 112.268 -178.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.451 ' CZ ' ' HB2' ' A' ' 53' ' ' PRO . 93.9 m-85 -139.26 151.15 46.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.485 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.55 ' HG ' HD13 ' A' ' 73' ' ' ILE . 24.0 tp -100.33 139.36 36.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.7 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.683 ' CE2' HG23 ' A' ' 72' ' ' VAL . 40.5 m-85 -140.95 144.92 35.41 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.581 ' HB2' HD11 ' A' ' 73' ' ' ILE . 29.9 tttt -103.37 124.28 48.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.804 177.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.44 ' CD1' HD23 ' A' ' 21' ' ' LEU . 44.4 t80 -78.47 101.85 7.53 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.848 0.356 . . . . 0.0 110.857 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 21.3 p -100.77 46.43 0.95 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.548 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.416 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -150.84 -145.13 4.06 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.24 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.416 ' O ' ' HZ ' ' A' ' 112' ' ' PHE . 1.4 pt20 -124.86 149.06 47.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.182 0.515 . . . . 0.0 111.429 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -58.86 -26.54 64.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.944 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -57.42 -7.25 0.56 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.41 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -89.75 -16.45 30.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.099 0.476 . . . . 0.0 110.566 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.6 HD11 ' CE1' ' A' ' 29' ' ' PHE . 3.7 mt -88.64 108.21 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.696 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -109.07 -31.39 7.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.168 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 38.3 mt . . . . . 0 N--CA 1.464 0.231 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.64 -179.207 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 121.163 0.506 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.45 ' CG ' ' HB3' ' A' ' 31' ' ' ALA . 4.9 m-85 -133.66 145.62 50.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.014 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.722 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -90.68 -33.77 8.25 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.817 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.16 146.55 27.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.884 0.373 . . . . 0.0 110.761 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.487 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 39.6 p-90 -134.76 167.12 21.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.187 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.447 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 13.0 t -164.98 168.85 17.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.426 0.632 . . . . 0.0 112.243 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.559 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 36.4 m95 -106.01 106.89 17.61 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.085 178.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.432 ' O ' ' N ' ' A' ' 28' ' ' ILE . 29.8 m -122.43 171.02 11.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.126 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.544 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 11.6 p -72.4 173.45 5.62 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.544 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 5.3 Cg_exo -65.01 -53.59 0.84 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 121.564 1.509 . . . . 0.0 110.374 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.22 -25.8 68.23 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.599 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -73.04 -49.03 31.06 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.611 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.465 HD12 ' CB ' ' A' ' 30' ' ' ALA . 4.2 tp -56.07 -38.62 70.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.909 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.781 HG21 ' HD3' ' A' ' 155' ' ' LYS . 14.0 mm -62.66 -40.74 89.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.137 0.494 . . . . 0.0 110.636 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.85 -47.98 70.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.261 0.553 . . . . 0.0 110.556 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.527 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -76.32 -22.32 55.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.695 -179.181 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.614 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 10.0 t -75.46 179.44 5.25 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.113 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.45 ' CG1' ' CB ' ' A' ' 39' ' ' ALA . 21.0 m -86.28 158.36 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.196 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.565 ' HA ' ' HD3' ' A' ' 151' ' ' LYS . 8.9 mt-10 -60.64 -49.52 77.2 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.147 0.499 . . . . 0.0 110.799 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -54.09 -8.49 0.19 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.352 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -135.21 -6.02 2.33 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.565 ' HD3' ' HA ' ' A' ' 148' ' ' GLU . 1.2 mtpp -58.62 -62.26 6.05 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.717 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.458 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 18.1 Cg_endo -60.6 -27.29 84.58 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.308 2.005 . . . . 0.0 111.505 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.56 ' O ' HG23 ' A' ' 157' ' ' VAL . 22.1 t -67.51 -53.35 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.479 ' HE2' ' HA ' ' A' ' 41' ' ' GLN . 6.4 m-30 -63.18 -38.22 90.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.101 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.781 ' HD3' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -56.88 -45.39 82.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.071 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.428 ' O ' HG22 ' A' ' 160' ' ' VAL . 1.5 tt0 -67.31 -33.42 75.24 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 153' ' ' VAL . 81.3 t -66.71 -41.75 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.613 178.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 162' ' ' ALA . 54.6 mt -62.88 -44.84 95.02 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.404 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 162' ' ' ALA . 0.6 OUTLIER -52.98 -40.67 63.92 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.219 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.648 HG13 ' HA ' ' A' ' 76' ' ' VAL . 60.8 t -67.51 -43.41 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.242 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.59 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 21.6 m-30 -80.94 4.89 17.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.495 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.59 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.63 -52.69 72.22 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.798 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 17.9 Cg_endo -58.08 -11.91 11.36 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.067 1.845 . . . . 0.0 112.058 179.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.48 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 83.3 m-70 -110.26 -19.02 13.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.502 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 96.9 mt . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.661 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 5.4 mtm . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.715 0.293 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.714 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 7.0 p-10 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.227 -179.366 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.437 ' HG2' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 121.261 0.553 . . . . 0.0 109.953 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.642 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 3.6 m-80 -129.83 172.18 11.94 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.039 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.67 HG23 ' N ' ' A' ' 57' ' ' ALA . 21.1 m -138.89 167.31 20.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.495 0.664 . . . . 0.0 111.727 179.196 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.705 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -134.83 161.08 24.48 Favored Glycine 0 N--CA 1.438 -1.191 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.521 178.726 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.687 HG13 ' HB2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -129.21 119.92 50.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.09 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.412 ' CB ' ' HE2' ' A' ' 161' ' ' PHE . 37.4 t -101.66 111.08 23.21 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.02 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.453 HD23 HG13 ' A' ' 67' ' ' VAL . 59.9 tp -105.9 124.34 49.41 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.925 -178.37 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.677 ' HB3' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -116.51 137.58 52.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.8 -179.954 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.482 ' OD1' ' CH2' ' A' ' 136' ' ' TRP . 6.7 m-20 -96.8 -173.8 2.82 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.307 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -54.81 -5.03 0.08 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.128 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 3.0 m-20 -101.76 -1.54 32.18 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 122.173 -0.329 . . . . 0.0 111.787 -178.819 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 11.4 mmtm 69.5 23.3 6.05 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -177.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.677 ' O ' ' HB3' ' A' ' 22' ' ' MET . 84.2 mttt -95.59 -167.4 1.6 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.876 179.267 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.451 HD12 ' CG ' ' A' ' 139' ' ' PRO . 2.1 mp -136.0 146.27 29.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.968 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.623 ' CE1' HD12 ' A' ' 119' ' ' ILE . 90.3 t80 -70.55 138.73 51.19 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.514 179.512 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.591 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -140.22 149.1 42.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.099 179.593 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.57 ' HB3' ' HB3' ' A' ' 131' ' ' PHE . . . -143.55 145.0 32.19 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.045 -179.701 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.644 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 28.4 p -98.97 145.74 26.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.09 0.471 . . . . 0.0 111.466 -179.512 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.641 ' O ' ' N ' ' A' ' 35' ' ' ASP . 25.3 mtp180 -69.34 129.82 40.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.783 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.635 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.5 OUTLIER -56.85 55.49 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.862 -179.98 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.641 ' N ' ' O ' ' A' ' 33' ' ' ARG . 0.9 OUTLIER -177.23 -34.82 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.157 0.504 . . . . 0.0 110.223 -179.688 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.599 ' HB ' ' HB2' ' A' ' 39' ' ' ALA . 7.1 mm -117.18 106.02 47.93 Favored Pre-proline 0 N--CA 1.451 -0.411 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.135 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -58.53 -60.51 0.35 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.396 2.731 . . . . 0.0 114.443 -178.134 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.92 1.48 3.37 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.285 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.644 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.4 94.35 9.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.631 0.253 . . . . 0.0 110.991 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.648 ' O ' ' HA ' ' A' ' 146' ' ' THR . 71.1 m95 -99.24 141.82 31.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.343 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.513 ' NE2' ' HD2' ' A' ' 33' ' ' ARG . 12.5 mt-30 -146.54 174.08 11.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.954 0.883 . . . . 0.0 112.378 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.518 ' HB3' ' CH2' ' A' ' 107' ' ' TRP . 2.6 ttp -108.62 140.28 21.65 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 113.932 -1.486 . . . . 0.0 109.121 178.82 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.419 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 9.4 Cg_endo -52.09 146.56 29.9 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.097 1.865 . . . . 0.0 111.817 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.654 ' HA ' HD12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -174.84 157.12 2.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.325 179.944 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 16' ' ' ASN . . . -158.39 -172.12 25.13 Favored Glycine 0 C--O 1.226 -0.383 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.662 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -107.97 139.95 15.27 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.242 -0.98 . . . . 0.0 113.614 -179.593 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.54 ' CD1' HG12 ' A' ' 17' ' ' VAL . 6.5 mt -71.52 146.5 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.694 0.283 . . . . 0.0 110.824 179.504 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.401 ' N ' HG21 ' A' ' 47' ' ' ILE . 5.2 m-20 -68.95 -175.17 0.68 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.848 0.356 . . . . 0.0 111.081 179.744 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -48.75 -51.45 28.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.304 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -142.52 62.79 0.51 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.351 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -117.87 150.92 38.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.676 0.274 . . . . 0.0 110.332 179.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.87 141.16 92.03 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.346 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 33.5 Cg_exo -61.55 -45.34 18.19 Favored 'Trans proline' 0 CA--C 1.513 -0.563 0 C-N-CA 122.2 1.933 . . . . 0.0 111.513 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.568 ' HD2' HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -51.57 -48.22 63.22 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.042 179.39 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -65.77 -43.99 87.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.638 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.88 -41.19 91.04 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.67 ' N ' HG23 ' A' ' 17' ' ' VAL . . . -58.63 -54.11 50.74 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.903 178.746 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.568 HD11 ' HD2' ' A' ' 54' ' ' ARG . 10.6 mt -56.37 -51.73 60.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.056 179.023 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -61.31 -56.7 17.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.49 -179.247 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.424 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 74.9 mm-40 -50.47 -42.63 54.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.019 0.437 . . . . 0.0 110.015 179.366 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.687 ' HB2' HG13 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -52.08 -49.34 63.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.419 178.732 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.467 ' HD2' ' C ' ' A' ' 62' ' ' ARG . 4.2 tmm_? -64.13 -65.97 0.61 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.626 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -48.27 -22.53 0.69 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -100.32 -34.16 10.1 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -178.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 49.5 p -123.12 -8.81 8.22 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.31 -0.556 . . . . 0.0 112.365 -178.536 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 80.53 -18.03 9.47 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.385 -178.592 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.512 HG12 HD21 ' A' ' 61' ' ' LEU . 97.8 t -57.15 121.05 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.263 0.554 . . . . 0.0 111.413 179.257 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.419 ' CG2' ' CG ' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -129.14 -39.37 1.55 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.89 178.731 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.3 m -62.79 75.06 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.483 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -158.93 156.23 29.1 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.575 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.402 ' HG3' HG21 ' A' ' 113' ' ' THR . 0.5 OUTLIER -128.54 151.45 49.43 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.236 179.389 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.675 HG23 ' CE2' ' A' ' 110' ' ' PHE . 7.8 t -75.59 130.77 35.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.318 0.58 . . . . 0.0 112.166 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.58 HD13 ' HB2' ' A' ' 111' ' ' LYS . 0.9 OUTLIER -111.75 -19.2 7.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.555 178.805 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.542 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -169.81 178.38 4.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.626 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -156.23 149.23 24.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.833 179.63 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.708 ' HA ' HG11 ' A' ' 160' ' ' VAL . 52.6 t -73.08 137.86 79.1 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-O 121.186 0.517 . . . . 0.0 111.574 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.534 ' HD3' HG12 ' A' ' 160' ' ' VAL . 20.4 Cg_endo -62.52 -70.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.397 2.732 . . . . 0.0 112.794 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.714 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -87.45 173.55 9.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.063 -178.723 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.431 ' CH2' ' HG3' ' A' ' 53' ' ' PRO . 48.9 m95 -93.97 100.09 12.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.964 179.738 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.448 ' CD1' HG22 ' A' ' 157' ' ' VAL . 52.1 mt . . . . . 0 C--N 1.327 -0.385 0 CA-C-O 120.922 0.391 . . . . 0.0 110.893 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 15' ' ' ARG . . . . . . . . 0 CA--C 1.514 -0.412 0 CA-C-O 121.016 0.436 . . . . 0.0 109.833 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.607 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 9.4 mt-30 -128.96 122.42 30.11 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.362 -178.068 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.03 135.33 44.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.509 179.693 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.705 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 42.7 m95 -103.66 166.25 10.54 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.063 0.458 . . . . 0.0 111.636 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 53' ' ' PRO . 91.1 m-85 -141.53 155.33 45.81 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.836 -179.471 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.488 ' O ' HG13 ' A' ' 72' ' ' VAL . 8.4 tp -101.14 141.96 33.27 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.459 179.126 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.675 ' CE2' HG23 ' A' ' 72' ' ' VAL . 49.4 m-85 -144.83 144.34 31.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.49 0.662 . . . . 0.0 112.502 -178.598 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.592 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 9.5 tttt -103.65 125.98 50.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.731 177.874 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.433 ' HA ' ' HB2' ' A' ' 70' ' ' ALA . 51.0 t80 -78.85 97.37 5.95 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.032 0.444 . . . . 0.0 110.939 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.402 HG21 ' HG3' ' A' ' 71' ' ' GLU . 39.1 p -97.1 51.03 1.1 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.536 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -153.17 -146.77 4.45 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.422 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.405 ' O ' ' HZ ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -122.4 145.12 48.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.177 0.513 . . . . 0.0 111.069 179.786 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -59.12 -26.15 64.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.05 -179.137 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -58.37 -5.07 0.45 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.209 -179.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -90.88 -18.23 25.15 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.996 0.427 . . . . 0.0 110.977 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.623 HD12 ' CE1' ' A' ' 29' ' ' PHE . 5.5 mt -83.85 103.53 11.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.709 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -101.68 -12.53 18.32 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.243 -179.419 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.626 ' HG ' ' HD1' ' A' ' 134' ' ' TRP . 16.6 mt . . . . . 0 N--CA 1.473 0.693 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.057 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 . . . . . 0 N--CA 1.463 0.188 0 CA-C-O 121.13 0.49 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.57 ' HB3' ' HB3' ' A' ' 31' ' ' ALA . 6.5 m-85 -105.3 147.03 28.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.696 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.635 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -86.2 -34.95 11.47 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.953 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.37 154.79 33.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.626 0.251 . . . . 0.0 111.2 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.626 ' HD1' ' HG ' ' A' ' 121' ' ' LEU . 36.4 p-90 -133.31 164.48 27.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.059 0.457 . . . . 0.0 111.875 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.5 t -157.99 165.61 34.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.685 -179.419 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.482 ' CH2' ' OD1' ' A' ' 23' ' ' ASN . 89.6 m95 -106.75 97.53 7.31 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.936 178.305 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.615 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 21.0 m -113.37 163.11 10.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.338 179.611 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.506 ' HG1' ' H ' ' A' ' 141' ' ' GLN . 10.5 p -70.92 174.32 3.77 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.199 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.58 ' HB3' HD23 ' A' ' 158' ' ' LEU . 12.2 Cg_exo -63.25 -53.35 1.53 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.543 1.495 . . . . 0.0 111.279 179.698 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -27.11 68.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.074 0.464 . . . . 0.0 111.067 179.332 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.506 ' H ' ' HG1' ' A' ' 138' ' ' THR . 21.7 mt-30 -72.23 -47.3 51.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.882 179.767 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.591 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.3 OUTLIER -55.34 -41.41 72.44 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.482 179.498 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.722 HG21 ' HG2' ' A' ' 155' ' ' LYS . 28.9 mm -61.12 -34.24 59.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.553 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.57 -52.08 17.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.861 179.115 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.3 mp -72.97 -21.78 60.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.228 -179.309 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.648 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 8.2 t -73.21 173.87 8.83 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.99 0.424 . . . . 0.0 111.675 -178.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.467 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 16.3 m -79.83 154.03 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.984 -179.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.46 ' C ' ' H ' ' A' ' 150' ' ' LYS . 4.0 mt-10 -58.41 -54.82 42.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.849 0.357 . . . . 0.0 110.73 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.467 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 51.7 p90 -56.93 2.47 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.561 ' HG2' ' CZ ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -137.53 -6.41 1.75 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.581 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.519 ' HG3' ' CG2' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -64.44 -56.35 23.53 Favored Pre-proline 0 N--CA 1.464 0.262 0 N-CA-C 111.326 0.121 . . . . 0.0 111.326 -179.979 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 29.4 Cg_endo -63.66 -28.5 69.19 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.278 1.985 . . . . 0.0 111.834 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 25.9 t -68.66 -51.09 49.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.561 ' CZ ' ' HG2' ' A' ' 150' ' ' LYS . 16.5 m-30 -64.93 -40.74 95.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.678 178.449 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.722 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -53.9 -43.62 69.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.401 -179.675 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -69.38 -32.44 71.48 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.218 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.594 HG13 ' CE2' ' A' ' 161' ' ' PHE . 46.9 t -65.0 -41.81 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.683 178.709 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.58 HD23 ' HB3' ' A' ' 139' ' ' PRO . 37.3 mt -62.54 -46.71 87.13 Favored 'General case' 0 CA--C 1.524 -0.038 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.366 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.441 ' O ' ' HB1' ' A' ' 162' ' ' ALA . 0.1 OUTLIER -49.43 -38.54 29.66 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.884 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.708 HG11 ' HA ' ' A' ' 76' ' ' VAL . 80.1 t -68.85 -44.21 81.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.354 177.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.641 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 22.4 m-30 -79.6 4.18 16.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.284 -179.287 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.596 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.38 -53.64 64.0 Favored Pre-proline 0 C--N 1.327 -0.378 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.71 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 16.9 Cg_endo -57.91 -12.77 13.0 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.44 2.093 . . . . 0.0 111.907 178.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.542 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 91.3 m-70 -109.4 -16.95 13.9 Favored 'General case' 0 N--CA 1.46 0.027 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.457 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 95.5 mt . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.165 -0.921 . . . . 0.0 110.803 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.41 ' N ' ' SD ' ' A' ' 6' ' ' MET . 2.2 mpp? . . . . . 0 N--CA 1.455 -0.175 0 CA-C-O 120.567 0.222 . . . . 0.0 110.442 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 16.1 t70 . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 110.35 -179.854 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.472 ' HG2' HD13 ' A' ' 47' ' ' ILE . 2.5 ttt180 . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 121.042 0.449 . . . . 0.0 110.408 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.664 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 59.1 m-20 -133.08 176.85 8.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.163 179.072 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.675 HG22 ' N ' ' A' ' 57' ' ' ALA . 27.2 m -142.2 164.58 17.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.252 0.549 . . . . 0.0 111.703 179.109 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.585 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -130.33 155.71 21.21 Favored Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.847 178.65 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 57' ' ' ALA . 3.7 mp -122.06 119.42 58.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.154 0.502 . . . . 0.0 112.021 -178.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.451 ' CB ' ' HE2' ' A' ' 161' ' ' PHE . 50.0 t -103.79 101.69 11.51 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.133 178.602 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.565 HD21 ' CD1' ' A' ' 112' ' ' PHE . 31.3 tp -102.68 121.52 42.6 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.898 -178.452 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.607 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -116.23 142.69 46.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.849 179.602 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.503 ' OD1' ' CZ3' ' A' ' 136' ' ' TRP . 7.8 m-20 -95.94 -177.72 4.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.465 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -56.14 -4.85 0.14 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.521 179.501 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.536 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.7 OUTLIER -103.13 -0.61 30.36 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.79 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 1.8 mmtp 72.61 23.82 2.95 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -178.249 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.625 ' HB3' ' O ' ' A' ' 137' ' ' VAL . 25.9 mttt -94.77 175.24 6.73 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.217 179.285 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.522 ' CG1' ' HA ' ' A' ' 139' ' ' PRO . 1.8 mm -120.01 141.16 41.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.976 0.417 . . . . 0.0 111.064 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.668 ' CE1' HD12 ' A' ' 119' ' ' ILE . 58.3 t80 -66.8 107.07 2.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.278 179.23 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' A' ' 134' ' ' TRP . . . -101.51 139.09 37.65 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.823 0.344 . . . . 0.0 110.929 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.442 ' HB2' ' CG ' ' A' ' 131' ' ' PHE . . . -138.14 132.0 31.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.281 179.816 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.667 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 53.4 p -99.0 146.29 26.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.839 0.352 . . . . 0.0 111.584 -179.341 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.555 ' HD3' ' HB2' ' A' ' 39' ' ' ALA . 17.5 mtp180 -69.34 128.13 35.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.432 179.601 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.732 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -45.18 -35.4 3.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.356 0.598 . . . . 0.0 110.984 -179.884 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -72.4 -36.15 68.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.765 179.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.606 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 17.6 mm -124.47 111.45 28.02 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.764 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -75.24 -20.75 16.11 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.432 2.088 . . . . 0.0 113.023 -179.273 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -92.63 -7.52 46.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.387 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.667 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.8 93.06 8.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.807 0.337 . . . . 0.0 111.047 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.616 ' O ' ' HA ' ' A' ' 146' ' ' THR . 81.6 m95 -88.0 144.03 26.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.015 179.142 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.412 ' NE2' ' HD2' ' A' ' 33' ' ' ARG . 11.5 mt-30 -153.76 174.38 14.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.54 0.686 . . . . 0.0 111.878 -179.2 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.56 ' HB3' ' CZ3' ' A' ' 107' ' ' TRP . 2.0 mtm -108.36 146.17 33.04 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.98 179.596 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -50.75 156.23 4.76 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.465 2.11 . . . . 0.0 111.995 179.783 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -176.41 174.02 2.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.946 -179.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.456 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . 178.96 154.81 13.41 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.306 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.664 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -82.56 135.68 14.42 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.205 -179.382 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.506 ' CD1' HG13 ' A' ' 17' ' ' VAL . 2.8 mt -70.07 144.66 13.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.736 0.303 . . . . 0.0 111.141 179.801 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.413 ' N ' HG23 ' A' ' 47' ' ' ILE . 0.9 OUTLIER -66.77 -174.76 0.34 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.243 179.345 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -48.52 -77.06 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.04 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -113.27 57.35 0.45 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.689 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.408 ' O ' HG21 ' A' ' 47' ' ' ILE . 9.2 tp10 -115.77 148.35 39.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.795 0.331 . . . . 0.0 110.896 179.731 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -72.16 142.58 85.03 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.536 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.49 ' HA ' HG12 ' A' ' 47' ' ' ILE . 56.7 Cg_exo -54.42 -45.43 41.02 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.714 2.276 . . . . 0.0 112.579 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.457 ' HD3' ' HA ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -52.14 -44.49 64.58 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.29 -179.616 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -65.71 -47.43 75.39 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.461 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.02 -43.19 99.36 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.412 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.675 ' N ' HG22 ' A' ' 17' ' ' VAL . . . -58.13 -58.57 7.86 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.617 178.796 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.475 HG12 ' CE2' ' A' ' 110' ' ' PHE . 20.8 mt -56.17 -51.23 64.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.377 179.368 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -63.13 -64.89 0.78 Allowed 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.452 -179.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.456 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 56.2 mm-40 -42.29 -44.98 4.06 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.004 0.43 . . . . 0.0 110.43 179.932 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.495 HD11 ' HB ' ' A' ' 67' ' ' VAL . 14.4 tp -51.58 -46.76 63.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.975 178.562 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.48 ' O ' ' N ' ' A' ' 66' ' ' GLY . 21.1 ttm180 -65.12 -65.76 0.63 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.25 179.429 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -49.39 -21.59 0.93 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.372 -179.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -97.87 -36.5 10.16 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.2 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.95 -3.1 5.18 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 77.4 -12.19 15.02 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.415 -179.5 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.512 HG22 HG12 ' A' ' 119' ' ' ILE . 50.2 t -57.85 110.99 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-O 121.235 0.54 . . . . 0.0 111.503 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.457 ' CG2' ' HG3' ' A' ' 62' ' ' ARG . 0.6 OUTLIER -123.08 -40.33 2.41 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.668 178.629 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.7 m -62.17 73.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.396 179.485 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -160.66 158.22 28.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.023 0.439 . . . . 0.0 112.174 -179.631 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -129.66 149.42 51.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.655 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.596 HG22 ' CE2' ' A' ' 110' ' ' PHE . 3.3 t -73.73 127.26 35.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.069 0.461 . . . . 0.0 110.962 179.227 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.523 HD12 ' HB2' ' A' ' 111' ' ' LYS . 1.0 OUTLIER -106.61 -19.81 6.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.181 179.32 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.46 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.91 176.57 4.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.182 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.38 145.76 24.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.414 179.635 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.574 ' HA ' HG11 ' A' ' 160' ' ' VAL . 52.8 t -71.5 137.17 83.48 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.0 0.429 . . . . 0.0 110.859 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.482 ' HD3' HG12 ' A' ' 160' ' ' VAL . 17.7 Cg_endo -59.1 -66.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.198 2.599 . . . . 0.0 112.715 -179.575 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.428 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -96.65 -176.38 3.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.207 -178.965 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.524 ' O ' ' HG ' ' A' ' 80' ' ' LEU . 37.3 m95 -89.49 -154.43 0.31 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.815 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 79' ' ' TRP . 81.6 mt . . . . . 0 C--N 1.33 -0.255 0 CA-C-O 121.103 0.478 . . . . 0.0 110.725 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 -0.112 0 CA-C-O 120.959 0.409 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.583 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 24.1 mt-30 -129.0 123.37 32.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.167 -178.473 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 4.4 ttpt -103.83 140.93 36.98 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.659 179.429 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.585 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 24.8 m95 -105.19 167.46 9.71 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.399 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 53' ' ' PRO . 78.3 m-85 -143.39 156.1 44.59 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.09 -179.496 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.49 ' O ' HG11 ' A' ' 72' ' ' VAL . 8.0 tp -103.59 138.66 39.95 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.769 179.007 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.596 ' CE2' HG22 ' A' ' 72' ' ' VAL . 55.7 m-85 -142.92 144.45 32.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.397 0.618 . . . . 0.0 112.634 -178.896 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 22.4 tttt -104.11 123.59 47.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.522 177.734 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.565 ' CD1' HD21 ' A' ' 21' ' ' LEU . 55.3 t80 -79.31 99.62 7.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.875 0.369 . . . . 0.0 110.629 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 30.2 p -96.96 41.64 1.11 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.405 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -140.29 -148.33 5.14 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.54 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -121.21 148.4 44.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.955 0.407 . . . . 0.0 111.151 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.426 ' C ' ' H ' ' A' ' 118' ' ' GLU . 9.5 p-10 -58.6 -38.24 77.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.37 0.605 . . . . 0.0 111.181 -179.558 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -56.57 -3.8 0.12 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.286 -179.402 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.426 ' H ' ' C ' ' A' ' 116' ' ' ASP . 1.3 tt0 -90.05 -21.01 22.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.121 0.486 . . . . 0.0 110.326 179.371 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.668 HD12 ' CE1' ' A' ' 29' ' ' PHE . 14.3 mt -85.89 105.17 14.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.124 179.646 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.425 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 18.0 p-10 -102.82 -26.18 13.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.087 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 120' ' ' ASN . 56.3 mt . . . . . 0 N--CA 1.464 0.236 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.025 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.408 ' C ' HD11 ' A' ' 34' ' ' LEU . 5.1 mp0 . . . . . 0 N--CA 1.462 0.159 0 CA-C-O 120.789 0.328 . . . . 0.0 111.326 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.442 ' CG ' ' HB2' ' A' ' 31' ' ' ALA . 3.1 m-85 -104.75 143.05 33.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.069 0.461 . . . . 0.0 110.64 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.732 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -90.14 -35.63 7.5 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.705 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -150.28 148.21 28.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.96 0.41 . . . . 0.0 110.619 179.626 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.527 ' CD2' ' HE1' ' A' ' 29' ' ' PHE . 38.1 p-90 -137.14 167.98 20.49 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.607 179.465 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.458 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 42.9 t -160.27 174.64 13.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.318 0.58 . . . . 0.0 112.314 -178.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.503 ' CZ3' ' OD1' ' A' ' 23' ' ' ASN . 78.7 m95 -109.23 100.71 9.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.551 178.384 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.625 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 28.9 m -119.03 165.61 14.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.5 ' OG1' ' HB2' ' A' ' 141' ' ' GLN . 26.8 p -71.63 167.24 32.36 Favored Pre-proline 0 C--N 1.327 -0.411 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.11 179.351 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.522 ' HA ' ' CG1' ' A' ' 28' ' ' ILE . 21.6 Cg_exo -59.43 -54.59 2.41 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.818 1.678 . . . . 0.0 110.435 179.554 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.3 -28.86 70.0 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.391 178.237 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.5 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 40.0 mt-30 -71.55 -46.4 59.61 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.248 179.707 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.502 HD12 ' CB ' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -57.65 -39.05 76.14 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.72 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.715 ' HA ' HG22 ' A' ' 146' ' ' THR . 27.5 mm -60.3 -36.24 67.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.639 179.268 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.84 -53.3 15.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.242 0.544 . . . . 0.0 110.881 179.559 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.72 -19.52 62.04 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.448 -179.14 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.715 HG22 ' HA ' ' A' ' 143' ' ' ILE . 7.6 t -73.02 179.64 3.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.056 0.455 . . . . 0.0 111.523 -179.115 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.512 HG23 ' CZ ' ' A' ' 149' ' ' PHE . 21.9 m -85.28 151.25 3.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.439 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.439 ' C ' ' H ' ' A' ' 150' ' ' LYS . 48.4 mt-10 -58.48 -53.86 53.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.801 0.334 . . . . 0.0 111.227 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.512 ' CZ ' HG23 ' A' ' 147' ' ' VAL . 53.1 p90 -56.28 0.81 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -179.721 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.499 ' HG2' ' CE1' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -136.83 -7.99 1.86 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.482 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.608 ' HG3' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -62.53 -52.79 62.86 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.895 -0.138 . . . . 0.0 111.072 179.562 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 28.6 Cg_endo -63.47 -28.58 70.89 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.121 1.88 . . . . 0.0 111.895 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 23.3 t -68.42 -49.33 66.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.499 ' CE1' ' HG2' ' A' ' 150' ' ' LYS . 5.4 m-30 -66.58 -40.59 89.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.806 178.87 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.531 ' HD3' HG23 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -53.2 -44.82 68.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.518 179.449 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.32 -33.34 74.13 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.133 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.537 HG12 ' CE2' ' A' ' 161' ' ' PHE . 64.2 t -66.07 -41.31 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.695 178.688 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.433 HD22 ' HB3' ' A' ' 139' ' ' PRO . 64.8 mt -64.88 -45.01 87.77 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.55 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 162' ' ' ALA . 0.2 OUTLIER -52.35 -41.41 63.03 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.235 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.574 HG11 ' HA ' ' A' ' 76' ' ' VAL . 94.0 t -66.11 -42.33 91.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.033 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.537 ' CE2' HG12 ' A' ' 157' ' ' VAL . 19.7 m-30 -81.05 6.35 13.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.554 -179.192 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.586 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.46 -53.64 64.04 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.55 179.592 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 18.1 Cg_endo -59.56 -12.14 16.45 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.021 1.814 . . . . 0.0 111.86 178.712 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.46 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 96.5 m-70 -107.37 -18.55 13.84 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.292 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 78.3 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.794 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.413 ' C ' ' HB2' ' A' ' 78' ' ' TYR . 0.3 OUTLIER . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.527 0.203 . . . . 0.0 110.597 . . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.734 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 17.9 t70 . . . . . 0 N--CA 1.462 0.167 0 CA-C-O 120.713 0.292 . . . . 0.0 111.358 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.655 ' HB2' ' CZ3' ' A' ' 79' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.417 0 CA-C-O 121.33 0.586 . . . . 0.0 111.184 . . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.64 ' CB ' ' HA2' ' A' ' 46' ' ' GLY . 75.1 m-20 -131.61 176.57 8.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.235 -179.767 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.649 HG23 ' N ' ' A' ' 57' ' ' ALA . 18.4 m -141.97 157.37 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 120.221 -0.592 . . . . 0.0 112.377 179.626 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.463 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -126.28 168.43 18.42 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.209 178.39 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.612 HG12 ' HB2' ' A' ' 61' ' ' LEU . 5.1 mp -128.73 116.62 41.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -178.745 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.425 ' CB ' ' HE2' ' A' ' 161' ' ' PHE . 8.3 t -103.87 98.23 8.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.617 178.28 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.654 HD21 HG13 ' A' ' 67' ' ' VAL . 13.6 tp -99.25 127.2 45.22 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.792 -178.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.706 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -121.62 151.63 40.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.821 179.496 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.547 ' N ' ' OD1' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -94.61 173.84 7.41 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.859 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.418 ' HA ' ' HE3' ' A' ' 111' ' ' LYS . 20.6 p30 -57.91 -5.68 0.45 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.653 176.819 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.562 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 4.9 m-20 -102.55 0.38 33.4 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.081 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 24.3 mmtp 75.18 22.73 1.7 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.262 -178.464 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.706 ' O ' ' HA ' ' A' ' 22' ' ' MET . 5.6 mmtt -93.37 143.81 25.92 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.803 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.728 HG13 ' HA ' ' A' ' 139' ' ' PRO . 1.8 mm -97.43 136.18 29.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.206 0.527 . . . . 0.0 111.762 -178.819 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.439 ' CE1' HD11 ' A' ' 119' ' ' ILE . 4.4 t80 -65.78 100.71 0.57 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.51 178.49 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 134' ' ' TRP . . . -96.11 141.01 30.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.793 0.33 . . . . 0.0 111.058 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.42 ' HB3' ' CG ' ' A' ' 131' ' ' PHE . . . -138.12 131.6 30.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.487 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.75 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 53.8 p -99.3 144.48 28.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.887 0.375 . . . . 0.0 111.593 -179.358 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.443 ' HD3' ' HB2' ' A' ' 39' ' ' ALA . 3.8 mtp180 -71.97 128.0 34.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.807 179.62 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.686 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -44.02 -38.38 3.5 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.251 0.548 . . . . 0.0 111.141 179.918 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -71.77 -34.04 69.13 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.215 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.709 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 18.8 mt -124.85 105.38 29.63 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.73 0.3 . . . . 0.0 111.006 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -69.73 -20.16 35.33 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.687 2.258 . . . . 0.0 112.748 -179.673 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -93.84 -7.59 42.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.651 -179.599 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.75 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.52 100.49 13.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.615 0.245 . . . . 0.0 111.032 -179.851 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.631 ' O ' ' HA ' ' A' ' 146' ' ' THR . 76.2 m95 -96.25 146.82 24.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.098 179.167 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.541 ' HG3' ' OG1' ' A' ' 146' ' ' THR . 0.2 OUTLIER -162.48 -128.75 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.668 -179.184 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.464 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 2.1 ptt? 178.96 163.13 0.7 Allowed Pre-proline 0 N--CA 1.448 -0.571 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.843 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.644 ' HB3' ' HA ' ' A' ' 61' ' ' LEU . 82.0 Cg_exo -45.07 148.85 1.48 Allowed 'Trans proline' 0 CA--C 1.529 0.241 0 C-N-CA 122.454 2.103 . . . . 0.0 113.047 -179.229 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.519 ' HG3' ' O ' ' A' ' 17' ' ' VAL . 51.9 tt0 -173.79 145.79 1.19 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.465 -179.452 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.754 ' HA3' ' HG2' ' A' ' 60' ' ' GLU . . . -145.81 -168.71 13.4 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.293 179.739 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.64 ' HA2' ' CB ' ' A' ' 16' ' ' ASN . . . -117.47 17.2 12.43 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 119.997 -1.097 . . . . 0.0 115.382 -178.595 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.525 ' CD1' HG13 ' A' ' 17' ' ' VAL . 11.3 mt 62.01 136.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 117.796 0.798 . . . . 0.0 111.444 179.122 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.504 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 3.3 m-20 -69.68 -175.97 0.96 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.857 179.366 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.414 ' CG ' ' H ' ' A' ' 50' ' ' GLY . 1.9 pt-20 -47.89 -81.08 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.428 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.414 ' H ' ' CG ' ' A' ' 49' ' ' GLU . . . -108.12 55.48 0.51 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.814 179.567 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.504 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 4.0 tp10 -116.66 142.95 46.23 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.892 0.377 . . . . 0.0 111.159 -179.356 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.452 ' HB2' ' ND2' ' A' ' 55' ' ' ASN . 7.6 m-20 -64.8 168.89 6.12 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.102 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 4.2 Cg_exo -77.25 -53.75 0.07 OUTLIER 'Trans proline' 0 CA--C 1.515 -0.468 0 C-N-CA 122.742 2.295 . . . . 0.0 113.472 -178.747 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.619 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -49.17 -51.78 30.44 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.065 -179.255 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 56' ' ' ALA . 18.2 p30 -62.31 -37.91 87.38 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 119.816 -0.754 . . . . 0.0 110.501 -179.301 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.504 ' N ' ' OD1' ' A' ' 55' ' ' ASN . . . -64.39 -44.77 90.27 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.735 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.649 ' N ' HG23 ' A' ' 17' ' ' VAL . . . -60.02 -61.54 2.53 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.904 178.271 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.619 ' CD1' ' O ' ' A' ' 54' ' ' ARG . 2.6 mp -53.41 -46.9 59.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.626 179.454 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 5.4 mmt180 -64.18 -62.52 1.57 Allowed 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.739 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.754 ' HG2' ' HA3' ' A' ' 45' ' ' GLY . 0.2 OUTLIER -42.56 -43.09 3.61 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.185 0.517 . . . . 0.0 110.171 179.667 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.644 ' HA ' ' HB3' ' A' ' 43' ' ' PRO . 1.9 tp -50.0 -47.92 52.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.998 178.851 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.477 ' HD2' ' HA2' ' A' ' 66' ' ' GLY . 1.9 tmm_? -67.07 -65.94 0.62 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.079 178.885 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -49.26 -24.3 1.74 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.373 -179.106 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -93.95 -36.94 11.94 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.39 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.495 HG21 ' CE1' ' A' ' 131' ' ' PHE . 1.4 p -127.81 -31.24 2.44 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.402 -0.519 . . . . 0.0 112.395 -178.941 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.477 ' HA2' ' HD2' ' A' ' 62' ' ' ARG . . . 106.92 -13.75 41.27 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.654 -178.896 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.654 HG13 HD21 ' A' ' 21' ' ' LEU . 73.6 t -55.77 107.18 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-O 121.167 0.508 . . . . 0.0 111.022 179.523 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -121.47 -39.41 2.66 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.577 178.716 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.7 m -61.55 74.22 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.863 178.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -162.56 157.19 21.79 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.113 0.482 . . . . 0.0 112.029 -179.309 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.412 ' HG3' HG23 ' A' ' 113' ' ' THR . 1.3 mt-10 -126.72 148.76 49.85 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.055 179.154 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.477 ' HA ' ' HD1' ' A' ' 110' ' ' PHE . 24.8 t -76.06 126.28 36.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.12 0.485 . . . . 0.0 111.627 179.615 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.548 HD11 ' HB2' ' A' ' 111' ' ' LYS . 0.7 OUTLIER -107.5 -21.49 5.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.421 179.289 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.466 ' HB3' ' CE1' ' A' ' 164' ' ' HIS . . . -169.49 177.43 4.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.81 -179.192 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.53 152.16 21.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.527 179.689 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.698 ' HA ' HG11 ' A' ' 160' ' ' VAL . 43.1 t -71.9 135.87 82.82 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.974 0.416 . . . . 0.0 111.055 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.533 ' HD3' HG12 ' A' ' 160' ' ' VAL . 18.1 Cg_endo -60.13 -62.21 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.075 2.516 . . . . 0.0 112.612 -179.452 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.734 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -98.01 -177.3 3.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.154 -179.186 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.655 ' CZ3' ' HB2' ' A' ' 15' ' ' ARG . 28.8 m95 -94.27 -152.73 0.35 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.557 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 79' ' ' TRP . 24.2 mt . . . . . 0 C--N 1.328 -0.338 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.564 ' O ' ' HA ' ' A' ' 15' ' ' ARG . . . . . . . . 0 C--O 1.223 -0.331 0 CA-C-O 120.59 0.233 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.64 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 18.7 mt-30 -113.87 123.29 49.42 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.044 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.473 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 2.2 ttpt -106.03 133.44 50.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.3 177.807 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.504 ' CZ2' ' CE1' ' A' ' 154' ' ' TYR . 41.8 m95 -102.72 160.48 14.55 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.023 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.481 ' HB3' ' CE1' ' A' ' 110' ' ' PHE . 90.8 m-85 -133.91 154.12 51.29 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.705 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.464 ' HB2' ' CE1' ' A' ' 161' ' ' PHE . 11.5 tp -109.83 128.24 55.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.149 179.648 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.481 ' CE1' ' HB3' ' A' ' 108' ' ' PHE . 5.4 m-85 -133.9 147.75 51.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.279 0.561 . . . . 0.0 111.8 179.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.559 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 21.8 tttt -99.47 124.52 44.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.572 178.542 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.564 ' HD1' HD21 ' A' ' 21' ' ' LEU . 34.8 t80 -78.54 101.03 7.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.882 0.373 . . . . 0.0 110.952 179.599 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.412 HG23 ' HG3' ' A' ' 71' ' ' GLU . 15.9 p -98.99 40.77 1.18 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.74 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.27 -146.66 4.68 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.364 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -120.82 153.7 36.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.887 0.375 . . . . 0.0 111.216 179.786 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.46 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 4.4 p30 -59.7 -39.2 83.82 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.487 0.66 . . . . 0.0 111.164 -179.611 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -59.31 -1.74 0.24 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.86 -1.063 . . . . 0.0 112.161 -179.325 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' A' ' 116' ' ' ASP . 2.0 tt0 -89.93 -17.91 27.09 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.864 0.364 . . . . 0.0 110.701 179.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.56 HG12 HG23 ' A' ' 67' ' ' VAL . 13.6 mt -80.81 102.66 6.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.588 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -102.0 94.3 5.71 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.899 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.461 ' CD2' HG22 ' A' ' 65' ' ' THR . 44.9 mt . . . . . 0 C--N 1.33 -0.256 0 CA-C-O 121.028 0.442 . . . . 0.0 110.613 179.745 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.889 0.376 . . . . 0.0 110.781 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.495 ' CE1' HG21 ' A' ' 65' ' ' THR . 0.8 OUTLIER -103.8 141.88 35.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.434 179.902 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.686 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -83.86 -34.82 17.51 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.005 -179.642 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.06 149.77 29.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.855 0.36 . . . . 0.0 110.46 179.787 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.548 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 32.7 p-90 -137.89 170.12 16.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.066 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.452 ' N ' ' CE3' ' A' ' 134' ' ' TRP . 22.8 t -165.71 177.53 7.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.513 0.673 . . . . 0.0 111.918 -178.681 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.487 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 73.6 m95 -111.42 103.49 11.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.422 178.437 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.7 m -119.26 171.68 7.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.503 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 22.3 p -74.0 167.29 36.85 Favored Pre-proline 0 C--N 1.326 -0.431 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.955 179.143 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.728 ' HA ' HG13 ' A' ' 28' ' ' ILE . 21.7 Cg_exo -59.11 -55.85 1.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.772 1.648 . . . . 0.0 110.347 178.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.37 -25.41 68.28 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.855 178.494 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.416 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 9.1 mm-40 -72.84 -47.16 48.59 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.73 -179.74 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.431 HD12 ' CB ' ' A' ' 30' ' ' ALA . 20.3 tp -59.64 -37.73 79.47 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.635 ' O ' HG22 ' A' ' 146' ' ' THR . 12.7 mm -63.03 -36.15 74.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.555 178.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.27 -52.99 15.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.333 0.587 . . . . 0.0 110.367 179.607 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.516 HD23 ' CD1' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -72.2 -16.77 61.96 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.575 -179.239 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.635 HG22 ' O ' ' A' ' 143' ' ' ILE . 12.7 t -76.45 176.0 8.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.019 0.438 . . . . 0.0 111.46 -179.652 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.537 ' HB ' ' CE1' ' A' ' 149' ' ' PHE . 17.6 m -74.9 150.88 6.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.674 179.432 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.426 ' C ' ' H ' ' A' ' 150' ' ' LYS . 50.6 mt-10 -58.32 -53.28 60.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.869 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.537 ' CE1' ' HB ' ' A' ' 147' ' ' VAL . 38.2 p90 -57.47 0.91 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -179.577 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.426 ' H ' ' C ' ' A' ' 148' ' ' GLU . 53.1 mttt -134.41 -9.17 2.54 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.99 -0.444 . . . . 0.0 111.967 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.513 ' CG ' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -60.58 -54.64 52.82 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.919 -0.128 . . . . 0.0 110.823 179.781 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 38.8 Cg_endo -67.5 -28.18 38.71 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.196 1.931 . . . . 0.0 111.61 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.457 ' O ' HG21 ' A' ' 157' ' ' VAL . 37.8 t -68.74 -50.96 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.369 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.504 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 5.8 m-30 -66.68 -38.49 86.91 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.669 178.449 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -56.09 -39.99 72.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.595 179.837 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.07 -31.98 71.12 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.02 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.592 HG13 ' CE2' ' A' ' 161' ' ' PHE . 42.2 t -64.77 -42.11 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.69 178.699 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.544 HD21 ' HB3' ' A' ' 139' ' ' PRO . 64.9 mt -64.49 -44.22 91.66 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.661 179.625 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.5 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 38.5 t -52.63 -40.32 62.65 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.142 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.698 HG11 ' HA ' ' A' ' 76' ' ' VAL . 91.2 t -67.43 -42.48 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.518 -0.765 . . . . 0.0 108.984 177.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.592 ' CE2' HG13 ' A' ' 157' ' ' VAL . 21.1 m-30 -80.72 6.47 12.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.188 -179.527 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.589 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.46 -53.41 66.43 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.684 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 18.0 Cg_endo -57.67 -12.87 12.49 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.143 1.896 . . . . 0.0 111.869 178.811 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.466 ' CE1' ' HB3' ' A' ' 74' ' ' ALA . 90.5 m-70 -108.68 -19.36 13.45 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.263 -179.925 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 97.7 mt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.606 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.446 ' C ' ' HB2' ' A' ' 78' ' ' TYR . 16.0 mtm . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.67 0.271 . . . . 0.0 110.416 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.634 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 4.1 p-10 . . . . . 0 C--N 1.331 -0.204 0 CA-C-O 120.748 0.309 . . . . 0.0 111.498 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.614 ' HG3' ' CZ3' ' A' ' 79' ' ' TRP . 1.2 ttp180 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.743 0.306 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.67 ' HB2' ' HG2' ' A' ' 105' ' ' GLN . 0.5 OUTLIER -133.0 -177.5 4.54 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.14 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.655 HG21 ' CA ' ' A' ' 57' ' ' ALA . 35.3 m -140.71 168.06 17.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.289 179.303 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.67 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -134.16 154.45 21.4 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.329 179.077 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.789 ' HB ' ' HB2' ' A' ' 43' ' ' PRO . 3.1 mp -126.66 117.32 47.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.005 0.431 . . . . 0.0 111.871 -179.379 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.417 ' CB ' ' HE2' ' A' ' 161' ' ' PHE . 42.1 t -98.48 99.43 10.59 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.592 HD21 HG11 ' A' ' 67' ' ' VAL . 24.3 tp -98.31 115.18 27.88 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.522 -178.407 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.822 ' HE2' HD11 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -115.6 163.0 16.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.44 179.253 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.696 ' ND2' ' HB2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -98.5 168.11 10.39 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.169 179.958 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -55.71 -4.43 0.11 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.195 177.83 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.557 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -100.63 2.92 42.12 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.934 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 5.6 mmtp 74.44 21.55 2.31 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.01 -178.352 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.696 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 1.9 mmtt -92.33 150.03 21.08 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.839 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.616 HG13 ' HA ' ' A' ' 139' ' ' PRO . 1.5 mm -102.92 137.2 31.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.597 ' CE1' HD11 ' A' ' 119' ' ' ILE . 88.4 t80 -76.55 138.35 40.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.534 177.932 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.502 ' O ' ' HB2' ' A' ' 134' ' ' TRP . . . -143.5 153.05 42.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.943 0.402 . . . . 0.0 110.877 -179.708 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.532 ' HB3' ' CB ' ' A' ' 131' ' ' PHE . . . -145.8 132.39 19.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.523 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 4.1 m -97.38 153.26 18.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.127 0.489 . . . . 0.0 111.76 -179.016 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.603 ' O ' ' N ' ' A' ' 35' ' ' ASP . 6.7 mtp180 -68.83 131.64 45.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.966 -179.254 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.729 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -55.37 55.3 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.218 0.607 . . . . 0.0 112.191 179.979 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.603 ' N ' ' O ' ' A' ' 33' ' ' ARG . 1.3 t0 -178.31 -29.67 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.07 0.462 . . . . 0.0 109.977 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.509 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 24.0 mt -118.82 107.4 42.4 Favored Pre-proline 0 N--CA 1.451 -0.376 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.62 179.522 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.04 -18.26 21.46 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.514 2.143 . . . . 0.0 112.852 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -94.53 -13.04 26.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.666 -179.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.554 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.38 101.38 13.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.71 0.291 . . . . 0.0 110.816 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.627 ' O ' ' HA ' ' A' ' 146' ' ' THR . 68.1 m95 -102.81 147.6 26.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.135 179.527 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.427 ' HG2' ' C ' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -152.2 160.27 43.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.269 0.557 . . . . 0.0 111.751 -179.984 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.629 ' HE2' ' CZ3' ' A' ' 107' ' ' TRP . 6.4 mtm -98.64 154.02 37.66 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.055 179.227 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.789 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 52.9 Cg_exo -49.08 154.19 3.62 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.574 2.183 . . . . 0.0 112.152 -179.77 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.647 ' HA ' HD12 ' A' ' 19' ' ' ILE . 13.7 pt20 -177.4 178.15 1.1 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.882 -178.759 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . 0.495 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . 170.91 150.11 6.83 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.426 -0.893 . . . . 0.0 112.578 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.65 ' HA2' ' CB ' ' A' ' 16' ' ' ASN . . . -74.47 135.03 18.89 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.688 -179.475 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.629 ' H ' ' HA ' ' A' ' 16' ' ' ASN . 11.7 mt -70.64 141.73 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -68.39 -171.02 0.23 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.843 0.354 . . . . 0.0 110.993 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.561 ' HG3' ' H ' ' A' ' 50' ' ' GLY . 2.3 pt-20 -49.06 -67.32 0.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.525 -179.476 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.561 ' H ' ' HG3' ' A' ' 49' ' ' GLU . . . -127.67 54.39 0.78 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.742 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -108.99 148.15 31.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.746 0.308 . . . . 0.0 110.504 -179.692 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.404 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 7.7 m-20 -68.84 140.67 91.71 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.253 179.843 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.577 ' HB3' HG12 ' A' ' 17' ' ' VAL . 35.3 Cg_exo -60.23 -47.14 15.54 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.325 2.017 . . . . 0.0 111.682 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.466 ' HD2' HD13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -53.04 -45.98 68.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.564 179.404 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -67.31 -43.85 80.64 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.431 179.63 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.24 -42.05 94.43 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.655 ' CA ' HG21 ' A' ' 17' ' ' VAL . . . -57.78 -55.53 33.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.94 178.604 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.555 HG12 ' HE2' ' A' ' 110' ' ' PHE . 14.4 mt -55.15 -54.08 28.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.257 179.284 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -61.28 -63.67 1.21 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.811 -179.538 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . 0.495 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 46.4 mm-40 -43.94 -47.29 8.46 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.164 0.507 . . . . 0.0 110.017 179.181 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.463 ' HB2' HD11 ' A' ' 19' ' ' ILE . 0.2 OUTLIER -50.12 -46.72 53.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.066 178.336 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.466 ' O ' ' N ' ' A' ' 66' ' ' GLY . 24.6 ttm180 -63.15 -64.67 0.84 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.48 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -48.32 -20.16 0.37 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.532 0.568 . . . . 0.0 112.532 -179.194 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -98.4 -38.52 9.19 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -178.173 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -125.29 -5.6 7.2 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.704 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 79.02 -11.69 27.56 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.349 -0.929 . . . . 0.0 111.904 -178.74 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.592 HG11 HD21 ' A' ' 21' ' ' LEU . 58.8 t -57.91 114.19 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 121.033 0.445 . . . . 0.0 111.185 179.509 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -124.36 -41.33 2.18 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.187 178.285 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.402 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 14.9 m -61.37 73.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.302 179.307 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.62 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.16 152.34 18.75 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.359 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . 0.488 ' HG3' HG23 ' A' ' 113' ' ' THR . 0.9 OUTLIER -126.2 150.63 48.21 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.232 179.291 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.754 HG22 ' CE2' ' A' ' 110' ' ' PHE . 21.3 t -74.79 127.93 36.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.146 0.498 . . . . 0.0 111.766 179.683 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.822 HD11 ' HE2' ' A' ' 22' ' ' MET . 1.6 mt -105.73 -18.96 6.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.146 179.325 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.498 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.94 176.56 4.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.54 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -155.04 146.76 23.3 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.37 179.43 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.7 t -70.64 140.19 86.71 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 120.918 0.39 . . . . 0.0 111.068 -179.602 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.739 ' HD3' HG11 ' A' ' 160' ' ' VAL . 29.9 Cg_endo -63.55 -59.44 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.138 2.558 . . . . 0.0 112.288 -179.787 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.634 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -102.31 -174.63 2.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.433 -179.202 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.614 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 34.1 m95 -89.26 -158.96 0.54 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.665 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.574 ' HB2' ' O ' ' A' ' 105' ' ' GLN . 65.8 mt . . . . . 0 N--CA 1.464 0.269 0 CA-C-O 121.248 0.547 . . . . 0.0 110.87 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.174 0 CA-C-O 120.912 0.387 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.67 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 28.7 mt-30 -132.03 126.7 34.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.488 -178.663 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 13.3 ttmt -102.7 134.88 45.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.283 179.46 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.67 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 17.2 m95 -101.82 163.64 12.15 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.483 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.582 ' HB2' ' HE1' ' A' ' 110' ' ' PHE . 96.4 m-85 -141.36 153.12 44.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.207 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.617 ' HG ' HD12 ' A' ' 73' ' ' ILE . 15.7 tp -99.7 139.03 35.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.942 179.628 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.785 ' CD1' HG21 ' A' ' 19' ' ' ILE . 41.6 m-85 -140.97 145.36 35.88 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.355 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 14.1 tttt -102.93 123.74 47.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.848 178.545 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.524 ' CD1' HD22 ' A' ' 21' ' ' LEU . 54.8 t80 -78.3 98.11 5.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.958 0.408 . . . . 0.0 110.454 179.124 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' THR . . . . . 0.488 HG23 ' HG3' ' A' ' 71' ' ' GLU . 43.7 p -95.9 41.62 1.1 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.622 -179.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.402 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -143.67 -146.86 4.61 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.143 -179.68 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . 0.412 ' O ' ' HZ ' ' A' ' 112' ' ' PHE . 3.7 mm100 -124.02 149.02 46.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.987 0.422 . . . . 0.0 111.219 -179.626 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -58.47 -30.65 67.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.536 -179.494 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -59.65 -4.79 0.72 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.099 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -90.69 -20.28 22.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.023 0.44 . . . . 0.0 110.482 179.712 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.597 HD11 ' CE1' ' A' ' 29' ' ' PHE . 11.8 mt -83.97 106.56 14.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.426 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 2.7 t30 -102.19 -25.29 13.75 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.954 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.468 ' HA ' HD22 ' A' ' 121' ' ' LEU . 74.0 mt . . . . . 0 N--CA 1.467 0.415 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.363 179.719 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.461 0.113 0 CA-C-O 120.706 0.288 . . . . 0.0 111.002 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.533 ' C ' HD11 ' A' ' 34' ' ' LEU . 3.1 m-85 -102.25 140.71 36.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.171 0.51 . . . . 0.0 110.359 179.606 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.729 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -85.74 -35.79 11.17 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.922 -179.404 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.23 145.92 27.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.971 0.415 . . . . 0.0 110.439 179.823 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 36.4 p-90 -132.0 163.75 27.71 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.919 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.43 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 32.0 t -160.93 175.69 12.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.337 0.589 . . . . 0.0 111.987 -179.476 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.587 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 31.2 m95 -110.42 101.07 9.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.509 178.461 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 28' ' ' ILE . 28.4 m -116.43 164.8 12.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.899 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.545 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 17.4 p -71.33 170.22 12.51 Favored Pre-proline 0 C--N 1.324 -0.52 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.447 179.776 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.616 ' HA ' HG13 ' A' ' 28' ' ' ILE . 15.7 Cg_exo -59.86 -58.92 0.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.805 1.67 . . . . 0.0 110.335 179.149 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.9 -29.07 69.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.995 178.716 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.488 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.7 OUTLIER -72.47 -46.59 54.15 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.275 179.796 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.565 HD22 ' HE3' ' A' ' 42' ' ' MET . 0.5 OUTLIER -57.47 -40.51 78.71 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.341 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.599 HG12 ' O ' ' A' ' 139' ' ' PRO . 36.3 mm -60.6 -37.21 74.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.913 179.375 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.21 -49.79 39.79 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.232 0.539 . . . . 0.0 111.02 179.498 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.467 HD21 ' CD1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER -74.23 -21.07 59.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.433 -179.086 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.627 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 10.7 t -74.19 174.83 8.19 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.24 -179.481 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 33.3 m -85.01 146.01 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.461 -179.254 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.515 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 41.7 mt-10 -49.97 -50.89 45.33 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.364 -179.783 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -52.84 -7.17 0.07 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.482 ' HD2' ' HH ' ' A' ' 154' ' ' TYR . 5.1 mttm -137.18 -4.44 1.9 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.64 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.574 ' HG2' ' O ' ' A' ' 143' ' ' ILE . 11.3 mttt -61.17 -59.11 14.77 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 121.279 -0.169 . . . . 0.0 110.972 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.515 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 22.4 Cg_endo -60.96 -28.83 86.9 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.407 2.072 . . . . 0.0 111.653 179.588 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.51 ' O ' HG22 ' A' ' 157' ' ' VAL . 30.5 t -68.61 -55.03 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.277 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.531 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 7.4 m-30 -61.65 -39.73 92.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.864 178.494 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -56.32 -43.79 79.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.922 -179.946 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.472 ' O ' HG21 ' A' ' 160' ' ' VAL . 2.7 tt0 -67.63 -31.69 71.88 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.568 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.585 HG11 ' CE2' ' A' ' 161' ' ' PHE . 47.1 t -65.83 -41.34 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.651 178.729 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.458 ' CD2' ' HB3' ' A' ' 139' ' ' PRO . 64.0 mt -62.31 -47.01 86.15 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.023 -179.891 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.508 ' O ' ' HB1' ' A' ' 162' ' ' ALA . 4.8 m -51.9 -38.75 57.43 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.739 HG11 ' HD3' ' A' ' 77' ' ' PRO . 92.6 t -68.21 -44.22 84.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.273 177.892 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.634 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 21.2 m-30 -79.67 4.3 16.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.901 -179.381 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.556 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.38 -54.96 50.97 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.649 179.692 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 17.4 Cg_endo -57.92 -12.74 12.97 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.024 1.816 . . . . 0.0 111.666 178.807 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.498 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 89.6 m-70 -108.25 -16.25 14.29 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.437 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 77.6 mt . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.712 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' MET . . . . . 0.549 ' O ' ' HB2' ' A' ' 78' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.121 0 CA-C-O 120.582 0.23 . . . . 0.0 110.501 . . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.47 ' HA ' ' CB ' ' A' ' 78' ' ' TYR . 3.3 t0 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.051 -179.454 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' ARG . . . . . 0.461 ' HG3' ' CZ3' ' A' ' 79' ' ' TRP . 1.6 ttp180 . . . . . 0 CA--C 1.529 0.161 0 CA-C-O 120.896 0.379 . . . . 0.0 111.962 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ASN . . . . . 0.789 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 3.1 m-80 -133.35 176.91 8.1 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.117 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.59 HG21 ' CA ' ' A' ' 57' ' ' ALA . 12.5 m -140.91 169.24 15.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.784 0.326 . . . . 0.0 111.299 179.494 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.558 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -134.84 162.85 24.76 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.779 -0.725 . . . . 0.0 112.264 179.423 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ILE . . . . . 0.497 HG22 ' CE2' ' A' ' 110' ' ' PHE . 3.9 mp -128.62 120.59 52.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -178.963 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.6 t -107.01 98.02 7.73 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.47 HD22 ' CD1' ' A' ' 112' ' ' PHE . 4.7 tp -104.69 126.13 51.46 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.946 -178.488 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' MET . . . . . 0.481 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -124.51 162.8 23.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.786 179.009 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.635 ' OD1' ' CE3' ' A' ' 136' ' ' TRP . 0.0 OUTLIER -98.89 171.25 8.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.205 179.78 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -56.7 -5.12 0.2 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.512 177.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' ASP . . . . . 0.508 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -98.21 3.7 48.93 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 120.781 0.324 . . . . 0.0 111.687 -179.111 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 15.1 mmtp 73.22 19.45 3.55 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.182 -178.611 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.492 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -96.81 142.19 29.11 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.923 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.456 HD12 ' CG ' ' A' ' 139' ' ' PRO . 2.7 mp -102.22 145.83 11.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.804 0.811 . . . . 0.0 112.648 -177.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . 0.628 ' CE1' HD11 ' A' ' 119' ' ' ILE . 86.2 t80 -74.65 138.7 43.06 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.779 179.665 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.553 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -140.54 147.19 39.12 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.712 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.457 ' HB3' ' CB ' ' A' ' 131' ' ' PHE . . . -137.87 137.97 38.63 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.909 0.385 . . . . 0.0 111.039 -179.542 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.733 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 91.5 p -100.15 144.8 28.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.39 -179.665 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.463 ' HD3' ' CB ' ' A' ' 39' ' ' ALA . 5.2 mtp180 -70.06 126.48 29.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.74 179.579 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.702 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.7 OUTLIER -43.36 -34.81 1.34 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.361 0.6 . . . . 0.0 110.596 179.756 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -72.83 -41.5 64.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.858 179.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.4 mt -120.78 104.54 41.92 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.054 179.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -66.79 -21.62 50.76 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.728 2.285 . . . . 0.0 112.661 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -92.19 -4.96 53.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.464 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.733 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.52 92.26 7.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.605 0.241 . . . . 0.0 111.338 -179.734 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.618 ' O ' ' HA ' ' A' ' 146' ' ' THR . 81.5 m95 -89.07 144.65 25.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.325 179.194 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.07 162.38 36.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.259 0.552 . . . . 0.0 111.314 -179.486 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' MET . . . . . 0.517 ' HB3' ' CZ3' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -97.95 149.46 35.74 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.595 179.79 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' PRO . . . . . 0.412 ' HG2' ' HB ' ' A' ' 19' ' ' ILE . 5.1 Cg_endo -48.41 156.67 1.63 Allowed 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.533 2.155 . . . . 0.0 112.022 179.684 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 11.7 pt20 -176.4 -179.95 1.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.601 -179.657 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 170.49 157.3 12.39 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.191 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.698 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -82.84 137.23 16.33 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.339 -179.435 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.4 ' CG1' HG13 ' A' ' 17' ' ' VAL . 43.5 mt -69.58 142.35 16.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.827 0.346 . . . . 0.0 110.965 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -68.98 -174.27 0.58 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.662 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -48.5 -81.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.14 179.727 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.74 54.75 0.53 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.399 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -115.5 147.1 41.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.918 0.39 . . . . 0.0 110.963 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.09 164.36 53.22 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.469 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.432 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 5.9 Cg_exo -74.85 -46.61 0.24 Allowed 'Trans proline' 0 CA--C 1.516 -0.405 0 C-N-CA 122.762 2.308 . . . . 0.0 111.584 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.457 ' HD3' ' HA ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -51.68 -46.02 63.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.807 179.851 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 3.7 m120 -65.14 -48.04 74.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.309 179.688 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.12 -43.2 99.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.861 179.472 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.59 ' CA ' HG21 ' A' ' 17' ' ' VAL . . . -59.15 -58.31 9.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.897 178.537 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.433 ' CD1' ' HG3' ' A' ' 54' ' ' ARG . 26.0 mt -56.93 -49.64 78.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.425 179.38 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 6.1 ttp180 -64.18 -63.63 1.1 Allowed 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.354 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -42.18 -43.62 3.42 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.957 0.408 . . . . 0.0 110.277 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.536 HD11 ' HB ' ' A' ' 67' ' ' VAL . 13.6 tp -51.77 -50.11 61.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.053 178.557 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 66' ' ' GLY . 1.1 ttt180 -63.01 -64.96 0.76 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.987 179.456 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -48.82 -25.37 1.84 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.768 -179.553 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -92.72 -40.19 10.84 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -178.522 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' THR . . . . . 0.544 HG23 ' CD2' ' A' ' 121' ' ' LEU . 0.8 OUTLIER -121.44 -34.45 3.44 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.59 -179.233 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 106.42 -11.7 43.26 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.409 -178.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.588 HG23 HG12 ' A' ' 119' ' ' ILE . 32.4 t -57.22 111.44 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-O 121.111 0.481 . . . . 0.0 111.58 179.534 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' THR . . . . . 0.464 ' CG2' ' HG3' ' A' ' 62' ' ' ARG . 0.8 OUTLIER -122.71 -39.15 2.56 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.79 178.505 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.0 m -61.97 74.76 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.077 179.104 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -162.14 155.81 21.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.026 0.441 . . . . 0.0 111.963 -179.435 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -126.72 147.94 49.92 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.363 179.447 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.481 ' HA ' ' HD1' ' A' ' 110' ' ' PHE . 6.6 t -75.58 126.81 36.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.222 0.534 . . . . 0.0 111.425 179.334 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.583 HD13 ' HB2' ' A' ' 111' ' ' LYS . 0.8 OUTLIER -106.97 -20.77 5.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.28 179.537 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.483 ' HB2' ' NE2' ' A' ' 164' ' ' HIS . . . -169.81 177.92 4.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.647 -179.702 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -155.08 150.16 26.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.502 179.817 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.736 ' HA ' HG13 ' A' ' 160' ' ' VAL . 44.0 t -71.71 136.18 83.19 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.894 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.477 ' HD2' HG13 ' A' ' 76' ' ' VAL . 16.6 Cg_endo -55.06 -69.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.041 2.494 . . . . 0.0 112.138 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . 0.638 ' O ' HG11 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -94.07 -172.45 2.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.666 -179.759 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' TRP . . . . . 0.461 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 29.2 m95 -90.06 -158.47 0.53 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 178.816 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 79' ' ' TRP . 57.8 mt . . . . . 0 C--N 1.328 -0.327 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -179.772 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.371 0 CA-C-O 121.102 0.477 . . . . 0.0 109.948 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.789 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 43.1 mt-30 -128.14 128.32 44.62 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -177.518 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.457 ' HE2' ' NE1' ' A' ' 79' ' ' TRP . 19.8 ttmt -104.9 134.89 47.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.539 178.044 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' TRP . . . . . 0.558 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 32.6 m95 -102.91 162.8 12.63 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.073 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' PHE . . . . . 0.448 ' HB3' ' CE1' ' A' ' 110' ' ' PHE . 98.2 m-85 -138.44 153.0 48.85 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.866 -179.875 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' LEU . . . . . 0.475 ' HB2' ' CE1' ' A' ' 161' ' ' PHE . 19.2 tp -108.78 122.45 47.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.876 179.528 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.497 ' CE2' HG22 ' A' ' 19' ' ' ILE . 8.8 m-85 -127.47 148.4 50.31 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.243 0.544 . . . . 0.0 111.689 179.912 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' LYS . . . . . 0.583 ' HB2' HD13 ' A' ' 73' ' ' ILE . 33.2 tttt -98.59 124.81 43.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.428 178.343 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' PHE . . . . . 0.47 ' CD1' HD22 ' A' ' 21' ' ' LEU . 46.6 t80 -78.43 102.01 7.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.85 0.357 . . . . 0.0 110.901 179.702 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.8 p -99.33 42.0 1.12 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.288 179.573 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.92 -149.13 5.14 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.727 -179.803 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.46 150.06 42.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.989 0.423 . . . . 0.0 111.243 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.435 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 4.1 p30 -58.05 -38.92 77.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.376 0.608 . . . . 0.0 111.272 -179.667 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.63 -3.07 0.16 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.981 -1.008 . . . . 0.0 112.381 -179.6 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.428 ' H ' ' C ' ' A' ' 116' ' ' ASP . 2.6 tt0 -89.18 -18.63 26.74 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.051 0.453 . . . . 0.0 110.435 179.469 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.628 HD11 ' CE1' ' A' ' 29' ' ' PHE . 7.5 mt -86.81 107.24 16.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.962 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.544 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 7.9 p-10 -96.98 -22.67 16.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.222 -179.567 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.544 ' HB2' ' O ' ' A' ' 120' ' ' ASN . 47.6 mt . . . . . 0 N--CA 1.466 0.331 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.743 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.668 0.27 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' PHE . . . . . 0.457 ' CB ' ' HB3' ' A' ' 31' ' ' ALA . 1.5 m-85 -108.88 141.6 40.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.874 0.369 . . . . 0.0 110.348 179.683 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.702 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -91.31 -30.84 10.27 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.387 -179.703 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.51 150.52 32.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.731 0.3 . . . . 0.0 110.598 179.501 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' TRP . . . . . 0.56 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 40.3 p-90 -137.78 168.74 19.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.089 179.532 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.441 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 27.2 t -163.5 174.32 11.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.392 0.615 . . . . 0.0 112.54 -178.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' TRP . . . . . 0.635 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 36.8 m95 -110.12 107.08 16.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.849 177.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 28' ' ' ILE . 26.4 m -121.71 172.64 8.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.678 -179.711 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.516 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 25.3 p -74.08 171.36 11.29 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.812 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.581 ' O ' HG12 ' A' ' 143' ' ' ILE . 9.2 Cg_exo -63.19 -54.55 1.04 Allowed 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 121.331 1.354 . . . . 0.0 109.851 178.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.68 -29.02 70.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.965 178.717 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.501 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 2.9 mt-30 -71.27 -46.46 60.88 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.933 0.397 . . . . 0.0 110.259 179.408 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 142' ' ' LEU . . . . . 0.553 HD13 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -57.5 -39.86 77.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.651 179.59 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 143' ' ' ILE . . . . . 0.581 HG12 ' O ' ' A' ' 139' ' ' PRO . 26.1 mm -62.31 -38.34 80.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.298 179.279 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.98 -51.44 32.51 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.349 0.595 . . . . 0.0 110.781 179.639 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.36 -21.24 61.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.713 -179.093 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 146' ' ' THR . . . . . 0.618 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 8.3 t -73.7 173.91 9.13 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.502 -179.108 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 147' ' ' VAL . . . . . 0.576 HG23 ' HB2' ' A' ' 150' ' ' LYS . 29.9 m -77.13 155.67 5.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.689 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.451 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 72.2 mt-10 -58.44 -55.74 31.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.151 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.505 ' CE1' HG22 ' A' ' 147' ' ' VAL . 29.5 p90 -56.01 -0.64 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -179.594 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.576 ' HB2' HG23 ' A' ' 147' ' ' VAL . 48.9 mttt -135.04 -7.85 2.33 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.83 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.524 ' HG2' ' HD3' ' A' ' 152' ' ' PRO . 0.1 OUTLIER -62.57 -56.72 27.25 Favored Pre-proline 0 C--N 1.328 -0.358 0 O-C-N 122.43 -0.169 . . . . 0.0 110.975 179.762 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.524 ' HD3' ' HG2' ' A' ' 151' ' ' LYS . 30.6 Cg_endo -64.56 -25.8 62.27 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.061 1.841 . . . . 0.0 111.149 179.197 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.478 HG22 ' HA ' ' A' ' 150' ' ' LYS . 20.6 t -68.55 -50.9 51.87 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.456 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.458 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 9.0 m-30 -67.89 -36.67 80.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.975 178.664 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.444 ' N ' HD13 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -58.53 -40.89 84.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.543 179.532 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.0 -35.7 74.58 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.91 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 157' ' ' VAL . . . . . 0.472 HG13 ' CE2' ' A' ' 161' ' ' PHE . 61.5 t -66.53 -39.85 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.695 178.821 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.451 HD22 ' CD1' ' A' ' 165' ' ' LEU . 27.7 mt -63.14 -42.4 99.46 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.556 179.741 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 159' ' ' SER . . . . . 0.401 ' O ' ' HB1' ' A' ' 162' ' ' ALA . 67.3 m -54.38 -39.89 67.63 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.37 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . 0.736 HG13 ' HA ' ' A' ' 76' ' ' VAL . 95.1 t -67.71 -45.16 85.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.178 177.788 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 161' ' ' PHE . . . . . 0.603 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 22.0 m-30 -80.45 5.01 16.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.724 -178.748 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . 0.611 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.23 -52.02 77.45 Favored Pre-proline 0 C--N 1.328 -0.353 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.815 179.617 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.2 Cg_endo -58.36 -11.75 11.69 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.328 2.019 . . . . 0.0 112.296 179.172 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 164' ' ' HIS . . . . . 0.483 ' NE2' ' HB2' ' A' ' 74' ' ' ALA . 81.8 m-70 -111.78 -18.21 12.78 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.4 -179.698 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 91.7 mt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.811 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 112.538 -0.225 . . . . 0.0 112.538 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.41 174.25 13.13 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.699 2.266 . . . . 0.0 112.515 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.88 -172.0 2.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.729 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.409 ' O ' ' OG ' ' A' ' 5' ' ' SER . . . -117.21 -27.12 2.75 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.455 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.75 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 68.6 p 56.32 -87.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.755 0.312 . . . . 0.0 111.784 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.425 ' HE3' ' CG2' ' A' ' 81' ' ' THR . 8.7 mtm 64.59 127.39 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.771 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.707 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 5.6 t70 -67.69 -9.84 47.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.465 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -136.72 118.86 11.53 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.213 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.414 ' HD3' ' NE1' ' A' ' 79' ' ' TRP . 11.7 Cg_endo -55.33 119.87 7.26 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.406 2.071 . . . . 0.0 112.356 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.457 ' HD2' ' CD2' ' A' ' 13' ' ' TYR . 9.1 Cg_exo -71.82 172.35 14.7 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.017 2.478 . . . . 0.0 112.743 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.14 133.51 39.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.925 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' A' ' 99' ' ' ASP . . . 56.17 91.04 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.717 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.471 ' CE1' ' HG2' ' A' ' 101' ' ' LYS . 5.0 m-85 -161.17 136.37 7.64 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.421 ' HB3' ' CG ' ' A' ' 103' ' ' GLN . 24.0 ttt85 -70.53 85.56 0.62 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.847 0.355 . . . . 0.0 111.838 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.461 ' HD3' ' CH2' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -51.78 106.44 0.14 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.096 0.474 . . . . 0.0 110.892 179.251 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.667 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 2.2 m-80 -132.88 175.01 9.73 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.414 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.516 HG21 ' CA ' ' A' ' 57' ' ' ALA . 4.2 m -142.62 164.96 16.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.252 0.549 . . . . 0.0 111.638 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.555 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -134.09 156.71 22.5 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.534 HG13 ' HB2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -128.98 122.24 56.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.321 0.581 . . . . 0.0 112.198 -179.156 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.2 t -101.17 110.7 22.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.296 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.418 HD22 HG13 ' A' ' 67' ' ' VAL . 61.7 tp -107.4 124.69 50.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.045 0.45 . . . . 0.0 111.727 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.567 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -117.77 142.91 46.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.876 -179.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.484 ' OD1' ' CH2' ' A' ' 136' ' ' TRP . 4.7 m-20 -96.85 -175.74 3.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.532 0.682 . . . . 0.0 111.34 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -56.06 -5.74 0.2 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.688 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.502 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 1.2 m-20 -103.47 -0.77 29.46 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 40.3 mmtt 71.7 24.82 3.38 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.602 ' HB3' ' O ' ' A' ' 137' ' ' VAL . 71.9 mttt -94.49 -177.55 4.27 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.923 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.543 HG13 ' HA ' ' A' ' 139' ' ' PRO . 1.8 mm -122.85 141.53 42.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.939 0.399 . . . . 0.0 111.39 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.489 ' CE1' HD13 ' A' ' 119' ' ' ILE . 17.9 t80 -67.63 106.77 2.3 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.065 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -103.77 138.47 40.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.021 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.436 ' HB3' ' CG ' ' A' ' 131' ' ' PHE . . . -138.06 138.73 39.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.277 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.533 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 47.9 p -100.6 148.13 25.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.021 0.438 . . . . 0.0 111.933 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.661 ' O ' ' N ' ' A' ' 35' ' ' ASP . 11.1 mtp85 -70.66 129.09 38.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.868 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.696 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.3 OUTLIER -55.49 56.44 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.381 0.425 . . . . 0.0 111.992 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.661 ' N ' ' O ' ' A' ' 33' ' ' ARG . 11.5 p-10 -177.35 -37.63 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.251 0.548 . . . . 0.0 109.815 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.515 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 18.8 mt -113.05 108.5 53.11 Favored Pre-proline 0 N--CA 1.454 -0.268 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.574 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.09 -18.26 21.34 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.485 2.123 . . . . 0.0 113.145 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -95.41 -9.49 32.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.748 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.533 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.53 91.71 7.72 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.897 0.379 . . . . 0.0 111.416 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.646 ' O ' ' HA ' ' A' ' 146' ' ' THR . 75.9 m95 -94.13 147.17 23.42 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.023 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.22 163.28 20.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.156 0.503 . . . . 0.0 111.452 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.427 ' HE3' ' CZ3' ' A' ' 107' ' ' TRP . 1.0 OUTLIER -100.6 156.05 35.65 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.517 178.477 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.418 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 8.3 Cg_endo -49.97 152.73 7.06 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.441 2.094 . . . . 0.0 112.355 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.424 ' HA ' HD11 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -177.8 148.28 0.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.262 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.54 -160.66 10.09 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.654 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.656 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -120.2 142.44 16.03 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.602 -0.808 . . . . 0.0 113.243 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.432 HG13 HG13 ' A' ' 17' ' ' VAL . 30.2 mt -69.64 144.32 14.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.722 0.296 . . . . 0.0 111.168 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.17 -174.88 0.68 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.578 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -48.54 -59.85 3.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.13 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -132.64 59.79 0.68 Allowed Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.384 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 52' ' ' ASP . 4.9 tp10 -118.26 155.64 30.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.825 0.345 . . . . 0.0 110.784 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.412 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -72.71 154.13 91.34 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.506 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.441 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 12.2 Cg_exo -70.86 -49.22 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.597 2.198 . . . . 0.0 111.427 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.495 ' HG2' ' CD2' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -53.21 -45.36 68.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.326 179.58 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.9 m-20 -67.91 -44.11 77.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.193 179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.46 93.04 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.516 ' CA ' HG21 ' A' ' 17' ' ' VAL . . . -58.01 -54.95 41.11 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.768 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.419 HD13 ' CZ ' ' A' ' 54' ' ' ARG . 14.1 mt -56.6 -53.01 46.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.185 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 59' ' ' ARG . 16.2 mtt-85 -60.85 -59.41 5.43 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.638 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -46.87 -44.7 19.8 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 121.3 0.572 . . . . 0.0 109.768 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.534 ' HB2' HG13 ' A' ' 19' ' ' ILE . 7.2 tt -51.01 -46.51 61.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.482 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.435 ' O ' ' N ' ' A' ' 66' ' ' GLY . 10.2 ttt180 -65.04 -64.52 0.84 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.869 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -48.28 -20.46 0.39 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -97.29 -36.26 10.47 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.402 HG21 ' CE2' ' A' ' 131' ' ' PHE . 17.3 p -129.09 -8.16 4.85 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 82.38 -13.4 40.46 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.36 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.502 ' HB ' HD21 ' A' ' 61' ' ' LEU . 54.9 t -59.25 114.1 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-O 121.233 0.54 . . . . 0.0 111.207 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.436 ' O ' ' N ' ' A' ' 70' ' ' ALA . 1.0 OUTLIER -121.98 -38.77 2.68 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.915 179.028 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.449 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 10.4 m -61.55 74.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.614 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.636 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -157.47 156.09 31.49 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.086 0.47 . . . . 0.0 111.835 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -129.58 150.91 50.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.44 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.492 HG21 ' CE2' ' A' ' 110' ' ' PHE . 8.0 t -74.46 126.38 35.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.146 0.498 . . . . 0.0 111.363 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.504 HD13 ' HB2' ' A' ' 111' ' ' LYS . 1.0 OUTLIER -107.0 -20.38 6.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.054 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.452 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.75 175.78 4.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.009 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -155.11 146.65 23.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.523 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.582 ' HA ' HG13 ' A' ' 160' ' ' VAL . 69.9 t -71.08 135.58 84.95 Favored Pre-proline 0 N--CA 1.453 -0.31 0 CA-C-O 121.002 0.43 . . . . 0.0 110.349 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.44 ' HD3' HG11 ' A' ' 160' ' ' VAL . 29.5 Cg_endo -63.69 -54.39 0.99 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.951 2.434 . . . . 0.0 112.586 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.707 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.8 OUTLIER -100.48 -179.23 4.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.695 -179.128 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.503 ' O ' ' CD2' ' A' ' 80' ' ' LEU . 44.9 m95 -92.62 -155.94 0.45 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.069 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.75 ' HA ' ' HA ' ' A' ' 5' ' ' SER . 80.6 mt -162.9 105.31 1.04 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.818 0.342 . . . . 0.0 110.259 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.566 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 66.6 p -104.06 95.32 5.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.288 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.86 89.02 4.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.751 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -72.99 154.74 40.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.001 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.584 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 4.9 m-85 -103.78 158.0 32.77 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.902 0.382 . . . . 0.0 111.431 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.463 ' HB3' ' HD2' ' A' ' 86' ' ' PRO . 32.0 Cg_exo -57.94 177.59 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.737 2.291 . . . . 0.0 111.893 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 85' ' ' PRO . 23.5 Cg_endo -62.02 -28.38 80.41 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.312 2.008 . . . . 0.0 112.132 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.25 -58.05 3.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.627 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.584 ' HB ' ' HB3' ' A' ' 84' ' ' PHE . 57.3 t -68.34 -25.56 31.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.057 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.592 ' HD2' ' CB ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -54.94 -51.96 64.48 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.87 0.366 . . . . 0.0 110.763 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.425 ' HA ' HD13 ' A' ' 94' ' ' ILE . 34.2 mt-10 -62.63 -23.56 67.14 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.148 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.9 mttm -93.61 -16.09 24.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.267 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.435 ' HG ' ' CE1' ' A' ' 84' ' ' PHE . 1.9 tm? -120.29 -64.74 1.22 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.835 0.35 . . . . 0.0 111.137 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.592 ' CB ' ' HD2' ' A' ' 89' ' ' ARG . 14.7 t-20 -49.44 -61.16 2.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.37 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.448 HD11 ' N ' ' A' ' 94' ' ' ILE . 2.4 mp -71.71 -8.04 10.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.234 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -72.83 -6.76 47.07 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.518 0.199 . . . . 0.0 111.506 179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.501 ' HB2' ' HB2' ' A' ' 100' ' ' TRP . 43.3 m95 -104.83 -19.35 13.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.662 0.268 . . . . 0.0 111.233 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 133.72 -83.95 0.29 Allowed Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.742 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -171.85 28.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.351 0.595 . . . . 0.0 111.612 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.455 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 68.0 m-20 -129.4 -44.69 1.24 Allowed 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.145 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.585 ' O ' ' HB3' ' A' ' 101' ' ' LYS . 11.7 m95 -67.14 -164.88 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.212 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.585 ' HB3' ' O ' ' A' ' 100' ' ' TRP . 0.0 OUTLIER 165.45 0.9 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.651 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 175.47 -144.29 7.13 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 119.838 -1.172 . . . . 0.0 112.778 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.566 ' O ' ' HA ' ' A' ' 81' ' ' THR . 2.0 mt-30 -146.43 110.03 4.85 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.681 -0.118 . . . . 0.0 110.681 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.498 ' CB ' HG21 ' A' ' 81' ' ' THR . . . -91.68 111.92 23.63 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.051 0.453 . . . . 0.0 110.246 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.667 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 3.7 mt-30 -125.42 129.71 50.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.406 -178.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.465 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 3.4 ttpt -104.35 135.55 45.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.375 178.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.555 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 53.9 m95 -103.04 161.87 13.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.318 0.58 . . . . 0.0 112.348 -178.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.495 ' CD2' ' HG2' ' A' ' 54' ' ' ARG . 96.3 m-85 -140.89 153.99 45.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.527 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.446 ' HB2' ' CE1' ' A' ' 161' ' ' PHE . 10.5 tp -101.18 141.01 34.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.852 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.495 ' HE1' ' HB2' ' A' ' 108' ' ' PHE . 90.6 m-85 -143.16 145.57 32.94 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.636 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 56.4 tttt -103.4 124.83 49.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.94 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.451 ' CD1' HG13 ' A' ' 67' ' ' VAL . 41.1 t80 -78.87 96.04 5.57 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.743 0.306 . . . . 0.0 111.288 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 15.8 p -98.39 52.67 1.03 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.545 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.449 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -152.59 -146.35 4.34 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.526 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.16 147.41 46.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.131 0.491 . . . . 0.0 111.318 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.43 ' C ' ' H ' ' A' ' 118' ' ' GLU . 63.0 m-20 -61.19 -27.72 68.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.163 -179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -56.7 -4.31 0.15 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.283 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.43 ' H ' ' C ' ' A' ' 116' ' ' ASP . 7.5 tp10 -90.8 -16.97 27.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.889 0.376 . . . . 0.0 110.931 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.565 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 5.5 mt -84.13 98.41 5.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.171 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 47.8 p-10 -104.0 -8.51 19.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.015 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 46.8 mt 42.91 26.82 0.08 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.609 0.243 . . . . 0.0 111.545 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.416 ' HA ' ' HB3' ' A' ' 129' ' ' PRO . 11.2 mt -106.23 -173.39 2.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.006 0.431 . . . . 0.0 111.642 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 173.49 127.29 0.97 Allowed Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.689 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.56 87.13 6.25 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.016 0.436 . . . . 0.0 111.067 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.403 ' O ' ' CB ' ' A' ' 126' ' ' SER . . . -129.47 1.19 6.03 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.934 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 125' ' ' GLY . 3.9 p 80.86 -13.93 0.88 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -91.51 -77.32 0.43 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.683 0.278 . . . . 0.0 111.146 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.519 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 0.1 OUTLIER -179.98 160.08 0.85 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.612 179.503 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.519 ' HD2' ' HB2' ' A' ' 128' ' ' LYS . 11.9 Cg_endo -65.87 -179.93 1.54 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.217 1.945 . . . . 0.0 111.872 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -95.06 -67.45 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.535 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.436 ' CG ' ' HB3' ' A' ' 31' ' ' ALA . 3.4 m-85 -105.37 146.45 29.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.086 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.696 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -92.62 -34.3 7.04 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.874 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -148.83 144.17 26.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.661 0.267 . . . . 0.0 110.98 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.565 ' CZ2' HD11 ' A' ' 119' ' ' ILE . 47.2 p-90 -132.61 166.82 21.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.915 0.388 . . . . 0.0 111.546 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.6 t -160.73 178.7 9.2 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.894 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.484 ' CH2' ' OD1' ' A' ' 23' ' ' ASN . 86.2 m95 -114.41 100.99 8.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.723 178.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.602 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 19.9 m -118.67 164.89 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.052 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.515 ' OG1' ' HB2' ' A' ' 141' ' ' GLN . 23.2 p -72.3 166.32 42.66 Favored Pre-proline 0 C--N 1.328 -0.35 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.544 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.543 ' HA ' HG13 ' A' ' 28' ' ' ILE . 25.6 Cg_exo -58.2 -55.46 2.21 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.072 1.848 . . . . 0.0 110.668 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -63.58 -27.86 69.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.291 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.515 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.8 OUTLIER -72.73 -46.24 54.59 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.354 179.496 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . . . . . . . . . 2.8 tp -58.32 -39.38 79.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.763 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.538 ' O ' HG23 ' A' ' 146' ' ' THR . 12.7 mm -62.57 -31.84 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.048 0.452 . . . . 0.0 110.417 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.62 -53.5 11.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.71 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.441 HD23 ' CD1' ' A' ' 40' ' ' TRP . 0.9 OUTLIER -72.81 -19.14 61.39 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.803 -179.051 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.646 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 14.2 t -73.87 175.32 7.41 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.424 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.453 ' CG1' ' CB ' ' A' ' 39' ' ' ALA . 34.3 m -85.05 144.28 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.649 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.441 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 2.7 mt-10 -48.13 -46.65 34.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.942 0.401 . . . . 0.0 111.351 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -52.7 -11.37 0.21 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.459 ' HB3' ' CE1' ' A' ' 154' ' ' TYR . 31.9 mttm -132.57 -3.27 3.35 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -63.33 -55.46 35.72 Favored Pre-proline 0 C--N 1.326 -0.439 0 O-C-N 122.431 -0.168 . . . . 0.0 111.203 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.478 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 29.8 Cg_endo -64.96 -29.25 57.7 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.067 1.845 . . . . 0.0 111.719 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 29.3 t -69.26 -51.54 42.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.459 ' CE1' ' HB3' ' A' ' 150' ' ' LYS . 7.4 m-30 -64.84 -37.19 86.78 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.84 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.501 ' HB2' ' O ' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -56.22 -45.87 79.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.672 179.244 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -67.68 -30.6 70.17 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.463 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 90.8 t -68.57 -41.16 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.511 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.432 ' CD2' ' HB3' ' A' ' 139' ' ' PRO . 67.9 mt -64.56 -47.23 79.51 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.453 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.441 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 17.4 p -50.22 -42.48 51.72 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.582 HG13 ' HA ' ' A' ' 76' ' ' VAL . 98.7 t -65.43 -41.34 90.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.526 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 21.5 m-30 -81.82 5.75 17.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.933 -1.031 . . . . 0.0 112.933 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.61 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.88 -51.78 79.46 Favored Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.649 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.1 Cg_endo -60.05 -11.73 16.61 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.123 1.882 . . . . 0.0 111.996 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.452 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 95.7 m-70 -108.46 -19.19 13.54 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.366 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 96.8 mt . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.868 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 CA-C-O 120.276 -0.18 . . . . 0.0 112.945 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.2 156.28 35.71 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.495 2.13 . . . . 0.0 112.909 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -139.79 106.47 5.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.212 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.14 -41.33 85.69 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.806 -0.711 . . . . 0.0 113.113 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.804 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 0.7 OUTLIER 70.08 -98.13 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 122.171 0.188 . . . . 0.0 111.16 -179.5 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.51 ' HE3' HG21 ' A' ' 81' ' ' THR . 8.4 mtm 65.58 132.38 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.665 0.269 . . . . 0.0 111.032 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.758 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 3.9 p-10 -71.66 -22.67 61.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.642 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m -101.44 140.99 21.71 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.684 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.483 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 68.1 Cg_endo -74.89 128.17 11.35 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.133 1.889 . . . . 0.0 111.351 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.543 ' HB2' ' CE1' ' A' ' 13' ' ' TYR . 1.1 Cg_endo -82.88 167.07 14.69 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.966 2.444 . . . . 0.0 112.773 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -49.14 124.41 8.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.031 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.469 ' HA3' ' HA ' ' A' ' 100' ' ' TRP . . . 51.58 98.11 0.01 OUTLIER Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.751 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.543 ' CE1' ' HB2' ' A' ' 10' ' ' PRO . 11.0 m-85 -153.84 136.11 14.89 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.696 0.284 . . . . 0.0 110.694 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.427 ' HD3' ' NE2' ' A' ' 103' ' ' GLN . 1.7 ttt180 -70.86 75.32 0.62 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.083 0.468 . . . . 0.0 111.689 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.714 ' HG2' HD12 ' A' ' 47' ' ' ILE . 4.3 ttp180 -47.87 113.7 0.77 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.453 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.642 ' OD1' ' HG2' ' A' ' 105' ' ' GLN . 0.2 OUTLIER -134.89 173.39 11.76 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.993 179.241 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.847 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 33.6 m -132.12 160.33 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 CA-C-O 120.986 0.422 . . . . 0.0 111.917 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.609 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -127.08 148.22 17.27 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.26 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.845 ' HB ' ' HB2' ' A' ' 43' ' ' PRO . 2.8 mp -122.5 117.11 51.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.486 ' CB ' ' HE2' ' A' ' 161' ' ' PHE . 43.9 t -101.04 99.7 10.19 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.721 HD22 ' HD2' ' A' ' 112' ' ' PHE . 21.2 tp -101.26 117.03 34.17 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.005 -177.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.708 ' HE2' HD13 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -119.98 160.1 23.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.795 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.613 ' ND2' ' HB2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -97.3 174.24 6.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.19 0.519 . . . . 0.0 110.416 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -57.59 -5.63 0.39 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.245 177.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.559 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.5 OUTLIER -99.39 3.5 45.91 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.709 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.559 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 5.8 mmtp 73.75 18.77 3.35 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.349 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.613 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 2.9 mttt -96.27 142.05 28.88 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.486 ' N ' ' O ' ' A' ' 137' ' ' VAL . 2.5 mp -100.79 144.48 12.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.574 0.702 . . . . 0.0 112.063 -178.419 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.671 ' CE1' HD13 ' A' ' 119' ' ' ILE . 92.1 t80 -75.39 140.2 42.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.007 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.604 ' HB1' HD13 ' A' ' 142' ' ' LEU . . . -137.76 151.6 48.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.615 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.585 ' HB1' ' CG ' ' A' ' 131' ' ' PHE . . . -139.83 135.91 33.47 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.319 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.691 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 96.6 p -98.08 140.66 32.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.913 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.425 ' NH2' ' HG2' ' A' ' 41' ' ' GLN . 1.7 mtt-85 -67.65 127.84 34.24 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.849 0.357 . . . . 0.0 110.767 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.712 HD22 ' HG2' ' A' ' 129' ' ' PRO . 0.6 OUTLIER -45.88 -34.88 4.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.295 0.569 . . . . 0.0 110.458 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -71.47 -38.3 71.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.139 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.517 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 31.3 mm -125.41 108.94 26.53 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.98 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.3 -18.51 23.24 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.578 2.185 . . . . 0.0 112.862 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -92.2 -12.24 33.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.664 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.691 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.48 104.98 17.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.759 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.544 ' O ' ' HA ' ' A' ' 146' ' ' THR . 75.6 m95 -96.82 152.49 18.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.632 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.511 ' HG3' ' C ' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -158.18 160.99 37.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.475 0.655 . . . . 0.0 111.927 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.457 ' HB2' ' HE2' ' A' ' 42' ' ' MET . 13.4 mtm -98.87 155.04 37.07 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.092 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.845 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 51.4 Cg_exo -50.74 144.94 24.81 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.23 1.954 . . . . 0.0 112.087 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.847 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -170.57 141.62 1.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.079 -179.503 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' A' ' 16' ' ' ASN . . . -148.71 -173.41 19.46 Favored Glycine 0 C--O 1.224 -0.471 0 N-CA-C 111.446 -0.661 . . . . 0.0 111.446 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.56 ' HA2' ' CB ' ' A' ' 16' ' ' ASN . . . -95.82 -154.32 30.46 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.508 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.714 HD12 ' HG2' ' A' ' 15' ' ' ARG . 1.7 mt -163.12 125.53 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 122.535 0.334 . . . . 0.0 110.736 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.27 172.41 12.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.995 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.469 ' HG3' ' H ' ' A' ' 50' ' ' GLY . 1.8 pt-20 -46.92 -76.66 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.61 -179.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.469 ' H ' ' HG3' ' A' ' 49' ' ' GLU . . . -85.17 34.49 3.24 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.963 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.556 ' OE2' ' HB1' ' A' ' 56' ' ' ALA . 4.8 tm-20 -113.19 123.94 51.37 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.526 ' HB2' ' OD1' ' A' ' 55' ' ' ASN . 1.8 m-20 -70.59 158.69 87.25 Favored Pre-proline 0 C--N 1.326 -0.439 0 C-N-CA 120.62 -0.432 . . . . 0.0 109.857 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.578 ' HB3' HG12 ' A' ' 17' ' ' VAL . 6.8 Cg_exo -74.19 -50.11 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.874 2.383 . . . . 0.0 113.463 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.581 ' HD3' HG23 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -49.52 -45.2 47.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.267 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.526 ' OD1' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -67.67 -44.79 76.98 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.053 0.454 . . . . 0.0 110.321 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.556 ' HB1' ' OE2' ' A' ' 51' ' ' GLU . . . -58.72 -41.73 87.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.686 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.645 ' CA ' HG21 ' A' ' 17' ' ' VAL . . . -57.64 -56.77 17.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.2 0.524 . . . . 0.0 109.639 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.593 HG12 ' HE2' ' A' ' 110' ' ' PHE . 26.9 mt -54.38 -53.78 27.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.26 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.518 ' HA ' HH11 ' A' ' 59' ' ' ARG . 0.0 OUTLIER -62.11 -60.06 4.15 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.82 -179.246 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.429 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 16.6 mm-40 -46.21 -49.85 16.54 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.56 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 9.7 tp -49.74 -44.56 48.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.34 178.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.479 ' HD2' ' HA2' ' A' ' 66' ' ' GLY . 21.9 tpt85 -63.85 -65.44 0.68 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.491 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -49.22 -22.62 1.06 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -179.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -97.21 -32.71 11.79 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -177.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 119' ' ' ILE . 5.6 p -127.65 -6.28 5.74 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.479 ' HA2' ' HD2' ' A' ' 62' ' ' ARG . . . 79.36 -14.36 16.81 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.08 -1.057 . . . . 0.0 111.561 -178.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.5 HG11 ' CD2' ' A' ' 21' ' ' LEU . 78.7 t -58.55 117.25 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 121.11 0.481 . . . . 0.0 111.682 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.435 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.3 OUTLIER -128.26 -38.96 1.74 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.457 178.003 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.1 m -62.41 73.44 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.941 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.16 155.31 22.7 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.866 0.365 . . . . 0.0 111.957 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.423 ' HG3' HG22 ' A' ' 113' ' ' THR . 1.7 mt-10 -128.62 151.34 49.6 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.573 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.661 HG22 ' CE2' ' A' ' 110' ' ' PHE . 12.2 t -75.07 126.71 36.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.405 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.708 HD13 ' HE2' ' A' ' 22' ' ' MET . 1.4 mt -106.71 -19.32 6.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.31 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.505 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -171.05 175.73 4.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.606 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.43 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.9 OUTLIER -153.17 143.73 22.62 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.256 179.4 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.752 HG12 ' O ' ' A' ' 78' ' ' TYR . 38.6 t -70.52 131.97 87.79 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 120.937 0.399 . . . . 0.0 111.087 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.511 ' HD2' HG11 ' A' ' 76' ' ' VAL . 34.4 Cg_endo -65.13 -50.74 1.9 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.057 2.505 . . . . 0.0 112.987 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.758 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 3.1 p90 -100.07 177.43 5.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.983 0.421 . . . . 0.0 111.931 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.606 ' CH2' ' HG3' ' A' ' 15' ' ' ARG . 58.7 m95 -94.2 -163.44 1.05 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.727 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.804 ' HA ' ' HA ' ' A' ' 5' ' ' SER . 15.9 mt -159.94 104.15 1.52 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.055 0.455 . . . . 0.0 110.626 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.798 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 5.4 p -109.8 101.73 10.57 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.765 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.432 ' O ' ' C ' ' A' ' 83' ' ' ASP . 4.5 t80 -78.88 37.07 0.29 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.092 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 82' ' ' TYR . 5.7 p-10 25.3 -110.03 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.112 0.565 . . . . 0.0 112.413 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.615 ' CB ' HD22 ' A' ' 93' ' ' ASN . 0.1 OUTLIER 174.63 -178.58 0.11 Allowed Pre-proline 0 C--N 1.332 -0.187 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -179.315 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.773 ' HG2' HG22 ' A' ' 88' ' ' VAL . 78.4 Cg_exo -55.21 177.3 0.11 Allowed 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.21 1.94 . . . . 0.0 112.082 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.456 ' HD2' ' HB3' ' A' ' 85' ' ' PRO . 52.4 Cg_endo -71.24 -54.39 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.676 2.251 . . . . 0.0 113.659 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.66 -35.04 34.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.856 0.36 . . . . 0.0 111.216 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.773 HG22 ' HG2' ' A' ' 85' ' ' PRO . 12.9 t -61.3 -14.03 9.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.046 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.645 ' HA ' ' ND2' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -58.84 -76.73 0.04 OUTLIER 'General case' 0 CA--C 1.527 0.087 0 CA-C-O 121.001 0.429 . . . . 0.0 110.966 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.445 ' HA ' HD11 ' A' ' 94' ' ' ILE . 0.9 OUTLIER -65.17 -12.07 47.17 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.89 -33.77 15.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.6 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.606 ' HB3' HG11 ' A' ' 88' ' ' VAL . 2.6 tm? -121.88 -51.37 2.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.907 0.384 . . . . 0.0 112.031 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.645 ' ND2' ' HA ' ' A' ' 89' ' ' ARG . 2.6 m-80 -52.02 -57.61 8.99 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.52 -178.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.694 HG13 ' HD3' ' A' ' 101' ' ' LYS . 4.1 mp -74.94 -7.74 10.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.322 0.582 . . . . 0.0 109.675 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -79.16 -100.81 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.892 179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.625 ' CD1' ' CD1' ' A' ' 100' ' ' TRP . 80.9 m95 40.9 29.84 0.08 Allowed 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 122.593 0.357 . . . . 0.0 111.64 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.67 -55.75 4.72 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.466 -0.874 . . . . 0.0 112.518 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 40.0 t -175.38 145.0 0.73 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.955 0.407 . . . . 0.0 111.27 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 58.15 84.4 0.1 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.792 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.625 ' CD1' ' CD1' ' A' ' 96' ' ' TRP . 0.4 OUTLIER -171.04 175.31 4.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.842 0.353 . . . . 0.0 111.102 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.694 ' HD3' HG13 ' A' ' 94' ' ' ILE . 4.3 ttpt 167.51 6.83 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.348 -178.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.496 ' HA3' ' CE2' ' A' ' 13' ' ' TYR . . . 169.25 -157.06 28.74 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.969 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.798 ' O ' ' HA ' ' A' ' 81' ' ' THR . 48.3 tt0 -147.2 117.0 7.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.792 0.296 . . . . 0.0 110.697 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.549 ' HA ' HG22 ' A' ' 81' ' ' THR . . . -94.2 123.95 37.91 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.247 0.546 . . . . 0.0 110.642 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.642 ' HG2' ' OD1' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -125.43 119.4 28.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.432 -177.412 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.6 ' HE2' ' CE2' ' A' ' 79' ' ' TRP . 2.0 ttmm -104.17 134.4 47.48 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.609 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 16.0 m95 -101.68 164.67 11.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.279 0.561 . . . . 0.0 112.303 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.543 ' HB2' ' HE1' ' A' ' 110' ' ' PHE . 95.9 m-85 -140.05 153.18 46.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.09 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.589 ' HG ' HD11 ' A' ' 73' ' ' ILE . 16.5 tp -101.24 141.04 34.69 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.844 0.354 . . . . 0.0 110.983 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.709 ' CD1' HG23 ' A' ' 19' ' ' ILE . 45.7 m-85 -142.43 145.77 34.13 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.594 0.712 . . . . 0.0 112.759 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 8.6 tttt -104.88 122.82 46.58 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.065 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.721 ' HD2' HD22 ' A' ' 21' ' ' LEU . 36.5 t80 -77.23 95.81 4.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.99 0.424 . . . . 0.0 110.709 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.423 HG22 ' HG3' ' A' ' 71' ' ' GLU . 28.5 p -95.77 55.27 1.61 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.917 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -159.64 -140.99 3.02 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.678 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.527 ' HG3' ' CG ' ' A' ' 117' ' ' GLN . 0.7 OUTLIER -125.81 147.61 49.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.785 0.326 . . . . 0.0 110.948 179.627 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.509 ' HB3' ' CH2' ' A' ' 134' ' ' TRP . 85.7 m-20 -62.1 -28.18 69.45 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.527 ' CG ' ' HG3' ' A' ' 115' ' ' GLN . 0.2 OUTLIER -57.65 -5.09 0.33 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.218 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 116' ' ' ASP . 25.2 tp10 -88.0 -17.66 30.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.017 0.436 . . . . 0.0 110.602 179.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.671 HD13 ' CE1' ' A' ' 29' ' ' PHE . 9.1 mt -81.09 105.26 10.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.393 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.488 ' C ' ' H ' ' A' ' 122' ' ' LEU . 23.9 t30 -104.27 -26.26 12.56 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.695 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.454 ' HA ' HD22 ' A' ' 121' ' ' LEU . 63.5 mt 73.11 -34.23 0.29 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.12 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.755 HD23 ' HB3' ' A' ' 129' ' ' PRO . 60.7 mt -74.57 161.46 29.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.967 0.413 . . . . 0.0 110.797 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.06 -6.41 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 CA-C-N 115.702 -0.681 . . . . 0.0 113.091 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -140.32 70.36 1.36 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.819 0.343 . . . . 0.0 110.215 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -76.73 42.29 1.77 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.777 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.01 -28.37 12.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.926 0.393 . . . . 0.0 110.408 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.91 -47.98 0.18 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.919 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 23.3 pttt -178.93 153.61 0.76 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.075 0.464 . . . . 0.0 111.083 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.755 ' HB3' HD23 ' A' ' 122' ' ' LEU . 11.7 Cg_endo -74.6 -174.27 1.8 Allowed 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.629 2.219 . . . . 0.0 113.049 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -88.89 -72.77 0.53 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.854 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.585 ' CG ' ' HB1' ' A' ' 31' ' ' ALA . 2.7 m-85 -104.8 142.74 34.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.144 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.697 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -83.72 -36.25 14.27 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.709 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -151.31 154.18 36.24 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.22 -0.49 . . . . 0.0 110.6 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.545 ' CZ2' HD11 ' A' ' 119' ' ' ILE . 23.8 p-90 -135.25 166.79 22.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.825 0.345 . . . . 0.0 111.116 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.445 ' N ' ' HZ3' ' A' ' 40' ' ' TRP . 29.9 t -161.24 163.22 31.17 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.346 0.593 . . . . 0.0 111.657 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.549 ' CZ3' ' HB2' ' A' ' 29' ' ' PHE . 77.2 m95 -110.46 108.32 18.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.054 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 28' ' ' ILE . 34.0 m -123.31 173.72 8.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.861 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.513 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 15.2 p -72.97 172.47 7.84 Favored Pre-proline 0 C--N 1.323 -0.571 0 C-N-CA 120.449 -0.501 . . . . 0.0 109.885 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.565 ' O ' HG12 ' A' ' 143' ' ' ILE . 13.4 Cg_exo -61.75 -55.25 1.18 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.427 1.418 . . . . 0.0 110.314 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.1 -30.81 71.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.066 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -69.86 -48.55 58.41 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.87 0.367 . . . . 0.0 110.153 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.604 HD13 ' HB1' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -54.43 -41.17 69.07 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.429 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.771 HG23 ' HD3' ' A' ' 155' ' ' LYS . 28.3 mm -60.13 -36.87 70.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.936 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.56 -52.28 22.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.41 0.624 . . . . 0.0 111.037 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.4 mp -70.85 -24.88 62.6 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.849 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.544 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 5.2 t -71.8 169.5 15.6 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.539 0.685 . . . . 0.0 111.825 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.498 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 33.8 m -74.3 154.69 6.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.846 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.473 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 0.4 OUTLIER -60.91 -54.59 43.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.071 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.498 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 39.9 p90 -57.07 0.63 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.413 ' HB2' HG22 ' A' ' 147' ' ' VAL . 13.6 mmtt -133.77 -7.7 2.79 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 122.032 -0.417 . . . . 0.0 111.873 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.466 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 0.4 OUTLIER -62.03 -59.24 13.69 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.276 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.473 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 19.2 Cg_endo -59.5 -28.54 87.73 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.347 2.031 . . . . 0.0 111.337 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 24.4 t -68.81 -50.69 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.422 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 7.6 m-30 -66.0 -38.01 87.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.875 178.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.771 ' HD3' HG23 ' A' ' 143' ' ' ILE . 4.8 tptp -56.3 -43.36 78.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.393 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.432 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.3 tp10 -68.17 -34.4 76.24 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.592 HG13 ' CE2' ' A' ' 161' ' ' PHE . 58.5 t -66.01 -41.0 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.615 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.458 ' CD2' ' HB3' ' A' ' 139' ' ' PRO . 38.3 mt -63.8 -45.33 90.15 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.621 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.512 ' O ' ' HB3' ' A' ' 162' ' ' ALA . 28.4 t -53.96 -40.0 66.45 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.724 HG12 ' HA ' ' A' ' 76' ' ' VAL . 62.0 t -67.73 -41.44 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-O 121.491 0.662 . . . . 0.0 109.309 178.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.592 ' CE2' HG13 ' A' ' 157' ' ' VAL . 21.9 m-30 -80.74 4.72 18.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.354 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.611 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.44 -52.45 74.52 Favored Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.604 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.4 Cg_endo -58.48 -13.05 15.55 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.177 1.918 . . . . 0.0 111.603 178.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.505 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 94.5 m-70 -107.85 -19.33 13.56 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.125 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.553 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 98.0 mt . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.624 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 112.612 -0.195 . . . . 0.0 112.612 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.37 133.92 55.04 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.656 2.237 . . . . 0.0 111.845 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.593 ' CD1' HG22 ' A' ' 153' ' ' VAL . 0.4 OUTLIER 63.52 120.91 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.952 0.406 . . . . 0.0 110.48 -179.666 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -80.7 -54.67 3.6 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.182 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.686 ' HB3' ' HA ' ' A' ' 80' ' ' LEU . 50.9 p 51.85 98.34 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.64 ' HE1' ' N ' ' A' ' 5' ' ' SER . 1.9 mmt -94.22 157.57 16.0 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -65.31 -52.95 50.64 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 89.2 p -98.71 148.97 35.28 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.928 178.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.418 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 56.8 Cg_endo -71.76 118.47 5.66 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.17 1.913 . . . . 0.0 112.505 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.571 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 1.1 Cg_endo -79.81 171.55 15.35 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 123.133 2.555 . . . . 0.0 113.185 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -52.28 129.2 27.5 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.504 ' CA ' ' HA ' ' A' ' 100' ' ' TRP . . . 53.24 25.83 27.0 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.56 178.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.571 ' CD1' ' HB2' ' A' ' 10' ' ' PRO . 10.5 m-85 -98.55 48.06 0.98 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.76 0.314 . . . . 0.0 110.761 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.665 ' HG2' ' OD1' ' A' ' 16' ' ' ASN . 0.0 OUTLIER 34.89 -154.53 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.4 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.472 ' H ' ' CG ' ' A' ' 14' ' ' ARG . 0.3 OUTLIER 177.13 91.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.233 -179.262 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.947 ' HB2' ' HG2' ' A' ' 105' ' ' GLN . 0.7 OUTLIER -134.05 -178.83 5.21 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.553 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.678 HG21 ' CA ' ' A' ' 57' ' ' ALA . 23.8 m -140.59 166.63 18.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.348 0.594 . . . . 0.0 111.768 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.567 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -131.33 161.38 23.6 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 178.597 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.557 HG12 ' O ' ' A' ' 57' ' ' ALA . 3.6 mp -128.64 119.19 49.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.008 0.432 . . . . 0.0 112.04 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.406 ' CB ' ' HE2' ' A' ' 161' ' ' PHE . 10.2 t -104.25 105.0 15.0 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.824 HD23 ' HD2' ' A' ' 112' ' ' PHE . 13.1 tp -108.28 122.28 46.64 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.789 -178.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.654 ' CE ' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -119.37 163.31 17.38 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.818 179.455 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.779 ' ND2' ' HB2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -99.85 168.67 9.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.435 179.818 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.644 ' HA ' ' HE2' ' A' ' 111' ' ' LYS . 71.2 m-20 -56.33 -4.88 0.16 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.021 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.513 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 1.2 m-20 -100.06 2.61 43.45 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.795 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.623 ' HZ3' ' HA ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER 73.91 21.64 2.61 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.173 -178.376 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.779 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -93.86 145.62 24.48 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.045 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.784 HG13 ' HA ' ' A' ' 139' ' ' PRO . 1.5 mm -100.51 139.11 22.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.465 0.65 . . . . 0.0 111.994 -178.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.651 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 82.2 t80 -79.21 140.27 37.73 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.109 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.843 ' HB1' HD12 ' A' ' 142' ' ' LEU . . . -143.71 157.97 44.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.046 0.451 . . . . 0.0 111.033 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.557 ' HB2' ' CB ' ' A' ' 131' ' ' PHE . . . -146.51 138.93 25.08 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.996 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.62 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 60.7 p -99.8 147.99 24.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.297 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.653 ' O ' ' N ' ' A' ' 35' ' ' ASP . 18.2 mtp180 -69.75 129.01 38.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.403 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.786 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.3 OUTLIER -54.96 55.31 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.653 ' N ' ' O ' ' A' ' 33' ' ' ARG . 23.0 t70 -177.4 -28.42 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.87 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.515 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 25.5 mm -119.21 110.65 37.56 Favored Pre-proline 0 N--CA 1.455 -0.181 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.606 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -75.67 -20.28 15.72 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.633 2.222 . . . . 0.0 112.905 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.36 -8.49 32.37 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.8 104.09 16.38 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 120.616 0.246 . . . . 0.0 110.881 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.698 ' O ' ' HA ' ' A' ' 146' ' ' THR . 65.9 m95 -105.89 144.6 32.39 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.909 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.571 ' HG3' ' C ' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -156.92 161.62 39.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.487 0.66 . . . . 0.0 111.622 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.532 ' HB3' ' CZ3' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -96.82 152.87 38.71 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.36 179.062 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.524 ' HG2' ' HB ' ' A' ' 19' ' ' ILE . 5.1 Cg_endo -48.61 158.74 1.02 Allowed 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.197 2.598 . . . . 0.0 111.976 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.82 -179.67 0.63 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.453 0.168 . . . . 0.0 111.084 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.592 ' HA3' ' HG2' ' A' ' 60' ' ' GLU . . . 164.4 155.79 8.56 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.696 -0.764 . . . . 0.0 113.11 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.68 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -76.66 132.09 12.09 Favored Glycine 0 C--N 1.334 0.431 0 N-CA-C 114.702 0.641 . . . . 0.0 114.702 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.661 HG12 ' HA ' ' A' ' 53' ' ' PRO . 2.9 mt -68.93 145.83 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.406 -0.397 . . . . 0.0 110.464 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.455 ' N ' HG22 ' A' ' 47' ' ' ILE . 11.4 m-20 -67.51 -173.12 0.28 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.171 0.51 . . . . 0.0 111.144 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.47 ' HG2' ' H ' ' A' ' 50' ' ' GLY . 1.4 pm0 -50.16 -82.45 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.282 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.47 ' H ' ' HG2' ' A' ' 49' ' ' GLU . . . -109.76 54.6 0.54 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.083 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -115.16 154.61 28.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.096 0.474 . . . . 0.0 110.363 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.457 ' HB2' ' ND2' ' A' ' 55' ' ' ASN . 0.6 OUTLIER -70.44 156.39 91.97 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.805 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.661 ' HA ' HG12 ' A' ' 47' ' ' ILE . 2.7 Cg_exo -74.88 -53.22 0.1 Allowed 'Trans proline' 0 CA--C 1.507 -0.843 0 C-N-CA 122.702 2.268 . . . . 0.0 112.217 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.608 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -48.18 -52.98 18.48 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.925 179.309 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.531 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 1.2 m-20 -53.75 -46.49 70.91 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.002 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.442 ' O ' ' HB2' ' A' ' 60' ' ' GLU . . . -60.01 -42.34 94.07 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.678 ' CA ' HG21 ' A' ' 17' ' ' VAL . . . -59.07 -61.91 2.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.494 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.608 ' CD1' ' O ' ' A' ' 54' ' ' ARG . 3.3 mp -55.88 -46.51 80.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.497 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.531 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 0.7 OUTLIER -63.14 -63.1 1.29 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.44 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.592 ' HG2' ' HA3' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -42.8 -46.35 5.17 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 120.944 0.402 . . . . 0.0 110.045 179.38 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.527 HD13 ' HB ' ' A' ' 67' ' ' VAL . 12.0 tp -50.05 -47.75 53.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.153 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.467 ' O ' ' N ' ' A' ' 66' ' ' GLY . 40.0 ttp180 -64.77 -62.25 1.68 Allowed 'General case' 0 CA--C 1.523 -0.091 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.415 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -51.61 -20.41 1.98 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.806 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -100.62 -36.85 9.01 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.664 ' O ' ' HA ' ' A' ' 119' ' ' ILE . 2.3 p -127.23 1.97 6.41 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 70.15 -11.82 1.94 Allowed Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.375 -178.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.665 HG11 HD23 ' A' ' 21' ' ' LEU . 75.2 t -58.14 109.72 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-O 121.198 0.523 . . . . 0.0 111.422 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.449 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -121.75 -41.3 2.47 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.898 178.495 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.425 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 7.4 m -60.75 74.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.692 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.43 153.36 19.5 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.992 0.425 . . . . 0.0 112.097 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.554 ' HG3' HG21 ' A' ' 113' ' ' THR . 1.5 mt-10 -124.4 148.23 47.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.237 178.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.543 ' HA ' ' HD1' ' A' ' 110' ' ' PHE . 20.3 t -76.04 126.59 36.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.956 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.654 HD11 ' CE ' ' A' ' 22' ' ' MET . 0.6 OUTLIER -109.25 -19.08 7.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.276 179.074 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.506 ' HB3' ' NE2' ' A' ' 164' ' ' HIS . . . -169.78 176.73 4.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.214 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.9 OUTLIER -162.74 149.24 12.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.885 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.52 ' HA ' HG12 ' A' ' 160' ' ' VAL . 41.5 t -71.64 140.59 84.33 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.293 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.448 ' HD3' HG13 ' A' ' 160' ' ' VAL . 32.6 Cg_endo -64.91 -72.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.931 2.421 . . . . 0.0 113.424 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.428 ' HE1' HD22 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -85.18 176.34 8.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.197 0.522 . . . . 0.0 111.74 -178.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.493 ' O ' ' HA ' ' A' ' 5' ' ' SER . 29.8 m95 -93.27 109.28 20.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.652 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.686 ' HA ' ' HB3' ' A' ' 5' ' ' SER . 39.4 mt -64.44 110.83 2.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.808 0.337 . . . . 0.0 111.329 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.687 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 8.0 p -115.02 -169.84 1.63 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.318 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.443 ' CE1' ' HB2' ' A' ' 103' ' ' GLN . 4.9 p90 -172.81 78.67 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.655 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -70.67 157.18 38.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.696 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.533 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 1.6 m-85 -100.56 163.63 17.79 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-O 120.934 0.397 . . . . 0.0 111.206 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.624 ' HB2' ' HD2' ' A' ' 86' ' ' PRO . 98.4 Cg_endo -84.12 -178.86 3.67 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.475 2.783 . . . . 0.0 112.776 -179.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.624 ' HD2' ' HB2' ' A' ' 85' ' ' PRO . 10.9 Cg_endo -52.11 151.86 15.81 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 122.451 2.101 . . . . 0.0 112.255 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.603 ' O ' ' HB2' ' A' ' 91' ' ' LYS . 0.0 OUTLIER 72.88 -41.97 0.52 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.963 -179.579 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.428 ' H ' ' C ' ' A' ' 86' ' ' PRO . 18.0 t -79.14 -31.42 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-O 120.786 0.327 . . . . 0.0 110.865 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.612 ' O ' ' HB2' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -60.9 -67.2 0.42 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.896 179.601 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.615 ' HA ' HD12 ' A' ' 94' ' ' ILE . 1.0 OUTLIER -61.63 -13.08 19.18 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 179.776 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.603 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -91.18 -35.34 14.59 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.811 0.338 . . . . 0.0 111.64 -179.61 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.473 ' C ' HD13 ' A' ' 92' ' ' LEU . 1.4 tm? -119.38 -52.71 2.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.118 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.949 ' HB3' ' HA ' ' A' ' 101' ' ' LYS . 5.0 m120 -51.56 -34.4 36.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.961 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.615 HD12 ' HA ' ' A' ' 90' ' ' GLU . 1.5 mp -94.81 -12.83 8.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.03 0.443 . . . . 0.0 110.133 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.76 -2.69 12.69 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.093 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.574 ' HB2' ' CD1' ' A' ' 100' ' ' TRP . 44.4 m95 -84.2 16.06 3.19 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.632 0.253 . . . . 0.0 111.195 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.725 ' O ' ' HB2' ' A' ' 98' ' ' SER . . . 67.88 113.28 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.302 -0.952 . . . . 0.0 111.322 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.725 ' HB2' ' O ' ' A' ' 97' ' ' GLY . 2.9 m 87.08 -167.97 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 122.824 0.45 . . . . 0.0 110.331 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.415 ' CG ' ' H ' ' A' ' 100' ' ' TRP . 2.5 p-10 -44.44 -91.98 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.481 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.648 ' CZ3' ' HA ' ' A' ' 14' ' ' ARG . 6.5 m95 54.65 170.58 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 120.757 0.313 . . . . 0.0 110.995 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.949 ' HA ' ' HB3' ' A' ' 93' ' ' ASN . 0.7 OUTLIER 169.75 28.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.765 179.145 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.429 ' HA2' ' ND2' ' A' ' 93' ' ' ASN . . . 154.91 -161.63 30.42 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.907 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.687 ' O ' ' HA ' ' A' ' 81' ' ' THR . 1.3 mt-30 -147.59 120.15 8.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 117.133 0.467 . . . . 0.0 111.805 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.524 ' HA ' ' CG2' ' A' ' 81' ' ' THR . . . -107.78 111.16 23.19 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.004 0.43 . . . . 0.0 110.723 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.947 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 70.0 mt-30 -122.48 130.61 53.24 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.455 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 1.1 ttpp -105.5 131.02 53.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.915 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.567 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 20.5 m95 -102.23 163.07 12.44 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.528 ' CE2' ' HG3' ' A' ' 54' ' ' ARG . 92.6 m-85 -140.69 148.5 40.89 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.235 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.506 ' HB2' ' CZ ' ' A' ' 161' ' ' PHE . 18.8 tp -102.4 128.68 48.89 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.922 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.543 ' HD1' ' HA ' ' A' ' 72' ' ' VAL . 7.7 m-85 -134.54 148.25 50.45 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 121.314 0.578 . . . . 0.0 112.156 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.644 ' HE2' ' HA ' ' A' ' 24' ' ' ASN . 2.1 tttt -98.75 126.12 44.28 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.933 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.824 ' HD2' HD23 ' A' ' 21' ' ' LEU . 33.8 t80 -78.12 96.43 5.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.14 0.495 . . . . 0.0 110.512 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.554 HG21 ' HG3' ' A' ' 71' ' ' GLU . 82.4 p -96.65 50.01 1.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.672 -179.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.425 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -155.37 -144.13 3.84 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.553 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.407 ' N ' ' HE1' ' A' ' 112' ' ' PHE . 8.0 pt20 -123.85 151.42 43.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.115 0.483 . . . . 0.0 111.564 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -62.36 -25.01 67.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.299 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -59.92 -4.97 0.83 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.946 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -91.16 -17.8 25.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.98 0.419 . . . . 0.0 110.613 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.664 ' HA ' ' O ' ' A' ' 65' ' ' THR . 8.8 mt -81.05 104.2 9.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.937 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.456 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 2.3 t30 -102.18 -26.52 13.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.055 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.535 ' CD2' HG22 ' A' ' 65' ' ' THR . 61.7 mt 74.23 -36.62 0.34 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.842 0.353 . . . . 0.0 111.667 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.685 ' CD2' ' HB3' ' A' ' 129' ' ' PRO . 90.8 mt -71.62 164.94 24.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.244 0.545 . . . . 0.0 111.185 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -130.08 4.37 6.01 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.371 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 61.35 56.1 2.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.143 0.497 . . . . 0.0 110.814 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -124.91 145.3 15.66 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.037 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.6 -4.05 14.03 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.983 -0.128 . . . . 0.0 111.119 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.572 ' O ' ' HG3' ' A' ' 128' ' ' LYS . 0.2 OUTLIER -88.06 -79.09 0.3 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.251 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.572 ' HG3' ' O ' ' A' ' 127' ' ' GLU . 29.1 mttm -177.0 163.09 1.54 Allowed Pre-proline 0 N--CA 1.451 -0.383 0 CA-C-O 121.545 0.688 . . . . 0.0 111.117 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.685 ' HB3' ' CD2' ' A' ' 122' ' ' LEU . 33.6 Cg_endo -74.97 -176.72 3.01 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 123.514 2.809 . . . . 0.0 113.282 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.14 -62.26 1.3 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.439 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.764 ' C ' HD11 ' A' ' 34' ' ' LEU . 4.2 m-85 -114.7 140.72 48.63 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.312 0.577 . . . . 0.0 111.473 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.786 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -80.81 -35.85 23.88 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.754 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -153.75 153.78 32.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.963 0.411 . . . . 0.0 110.66 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.543 ' HA ' ' CZ3' ' A' ' 40' ' ' TRP . 32.6 p-90 -135.18 166.04 24.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.093 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.421 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 13.2 t -161.45 166.95 26.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.097 0.475 . . . . 0.0 111.847 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.651 ' CZ3' ' HB2' ' A' ' 29' ' ' PHE . 53.7 m95 -109.31 103.57 12.54 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.344 178.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.579 ' O ' ' N ' ' A' ' 28' ' ' ILE . 28.5 m -117.56 168.96 8.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.5 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.551 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 11.3 p -71.43 170.63 11.15 Favored Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.965 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.784 ' HA ' HG13 ' A' ' 28' ' ' ILE . 24.4 Cg_exo -57.7 -58.89 0.67 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 121.957 1.772 . . . . 0.0 109.841 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.8 -29.86 69.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.624 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.503 ' HG3' ' HG1' ' A' ' 138' ' ' THR . 6.7 mt-30 -70.73 -48.4 54.71 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 120.934 0.397 . . . . 0.0 110.656 179.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.843 HD12 ' HB1' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -54.6 -41.97 70.55 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.728 ' CG2' ' HG3' ' A' ' 151' ' ' LYS . 24.3 mm -61.73 -33.92 59.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.255 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.78 -51.54 16.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.377 0.608 . . . . 0.0 110.321 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.42 -21.23 62.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.696 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.698 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 14.7 t -73.45 175.36 7.06 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.717 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.686 ' CG2' ' HD2' ' A' ' 150' ' ' LYS . 34.0 m -86.05 148.26 4.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.655 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.508 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 2.1 mt-10 -48.31 -50.32 30.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.467 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.3 -4.24 0.08 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.686 ' HD2' ' CG2' ' A' ' 147' ' ' VAL . 18.7 mttt -136.51 -7.14 1.96 Allowed 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.728 ' HG3' ' CG2' ' A' ' 143' ' ' ILE . 2.7 ttpp -62.99 -54.34 47.41 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.35 0.119 . . . . 0.0 110.816 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.523 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 38.0 Cg_endo -66.38 -29.44 45.71 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.435 2.09 . . . . 0.0 110.989 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.593 HG22 ' CD1' ' A' ' 3' ' ' LEU . 9.3 t -68.1 -55.91 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.55 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 4.6 m-30 -63.09 -37.4 87.05 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.581 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.579 ' HG2' HG23 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -55.78 -45.34 78.17 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.441 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.504 ' O ' HG21 ' A' ' 160' ' ' VAL . 12.8 tm-20 -67.49 -34.58 77.43 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.657 HG13 ' CE2' ' A' ' 161' ' ' PHE . 47.9 t -63.35 -42.1 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.546 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.564 HD13 ' CG1' ' A' ' 143' ' ' ILE . 36.0 mt -63.91 -43.92 94.5 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.883 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.553 ' O ' ' HB1' ' A' ' 162' ' ' ALA . 1.9 m -56.85 -39.31 74.05 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.52 HG12 ' HA ' ' A' ' 76' ' ' VAL . 76.1 t -67.54 -42.4 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.657 ' CE2' HG13 ' A' ' 157' ' ' VAL . 18.8 m-30 -81.24 7.13 12.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.089 -0.959 . . . . 0.0 112.006 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.553 ' HB1' ' O ' ' A' ' 159' ' ' SER . . . -58.97 -54.9 51.9 Favored Pre-proline 0 C--N 1.332 -0.169 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.178 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 15.9 Cg_endo -57.58 -12.94 12.4 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 121.825 1.683 . . . . 0.0 111.768 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.506 ' NE2' ' HB3' ' A' ' 74' ' ' ALA . 78.4 m-70 -107.46 -17.25 14.17 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.237 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.623 ' HA ' ' HZ3' ' A' ' 26' ' ' LYS . 98.2 mt . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.586 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 CA-C-O 120.309 -0.162 . . . . 0.0 112.713 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.445 ' C ' ' HG ' ' A' ' 3' ' ' LEU . 53.1 Cg_exo -53.09 -178.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.512 2.141 . . . . 0.0 112.046 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.583 ' HA ' ' HA ' ' A' ' 82' ' ' TYR . 1.3 pp 32.15 94.18 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.349 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.08 138.9 21.3 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.127 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.483 ' HB3' ' CD1' ' A' ' 78' ' ' TYR . 1.3 m -82.28 -74.5 0.34 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.066 0.46 . . . . 0.0 111.386 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 5.1 mpp? 63.46 129.25 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.72 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.634 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 1.5 p30 -66.79 -33.23 75.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.983 0.42 . . . . 0.0 110.353 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.422 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 0.4 OUTLIER -103.83 146.36 32.37 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.231 179.211 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.486 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 61.0 Cg_endo -71.78 105.2 1.75 Allowed 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.364 2.043 . . . . 0.0 111.854 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.592 ' HB2' ' CE2' ' A' ' 13' ' ' TYR . 10.3 Cg_endo -51.57 164.49 0.9 Allowed 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 123.46 2.773 . . . . 0.0 113.135 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -53.78 134.15 42.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.783 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.63 88.4 0.01 OUTLIER Glycine 0 C--N 1.331 0.27 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.0 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.592 ' CE2' ' HB2' ' A' ' 10' ' ' PRO . 12.3 m-85 -151.9 130.48 12.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.854 0.359 . . . . 0.0 110.97 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.662 ' HA ' ' CZ3' ' A' ' 100' ' ' TRP . 6.5 ttt180 -66.48 81.34 0.1 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.272 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.462 ' HD2' ' CH2' ' A' ' 79' ' ' TRP . 4.7 ttp180 -49.07 109.89 0.3 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.967 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.728 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 2.1 m-80 -131.66 176.39 8.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.395 -0.82 . . . . 0.0 108.96 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.603 HG21 ' CA ' ' A' ' 57' ' ' ALA . 6.2 m -144.1 166.15 13.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.794 0.33 . . . . 0.0 111.389 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.475 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -136.4 160.24 24.68 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.144 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.628 ' HB ' ' HB2' ' A' ' 43' ' ' PRO . 3.6 mp -129.23 119.36 48.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.043 0.449 . . . . 0.0 111.536 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 3.0 t -98.29 92.73 5.85 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.182 -0.674 . . . . 0.0 109.182 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.507 ' HA ' ' O ' ' A' ' 110' ' ' PHE . 39.2 tp -91.01 123.32 34.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.741 -178.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.665 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -117.46 152.57 34.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.126 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.61 ' OD1' ' CE3' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -97.66 174.9 6.4 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.507 -179.321 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -56.76 -6.11 0.29 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.769 177.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.525 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -101.25 -1.7 33.03 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.631 0.253 . . . . 0.0 111.43 -179.151 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 6.1 mmpt? 75.6 21.72 1.69 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.106 -178.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.665 ' O ' ' HA ' ' A' ' 22' ' ' MET . 6.0 mttt -91.59 175.65 6.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.585 HG13 ' HA ' ' A' ' 139' ' ' PRO . 1.8 mm -118.77 138.12 50.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.131 0.491 . . . . 0.0 111.756 -178.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.406 ' CE1' HD11 ' A' ' 119' ' ' ILE . 9.9 t80 -63.72 101.62 0.37 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.181 178.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.653 ' HA ' ' O ' ' A' ' 41' ' ' GLN . . . -97.86 137.37 36.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.935 0.398 . . . . 0.0 111.315 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.492 ' HB2' ' CG ' ' A' ' 131' ' ' PHE . . . -137.64 139.86 40.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.331 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.602 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 60.1 p -104.47 150.59 24.43 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.619 ' O ' ' N ' ' A' ' 35' ' ' ASP . 4.9 mtp180 -74.55 129.93 38.64 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.309 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.701 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -56.89 52.71 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.883 0.473 . . . . 0.0 112.211 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.619 ' N ' ' O ' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -174.97 -37.03 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.054 0.454 . . . . 0.0 110.18 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.452 ' HB ' ' CB ' ' A' ' 39' ' ' ALA . 3.8 mm -112.09 106.23 56.24 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.739 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.53 -60.14 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.07 2.513 . . . . 0.0 113.895 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -67.9 2.87 1.76 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.602 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.85 93.24 8.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.749 0.309 . . . . 0.0 111.454 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.535 ' O ' ' HA ' ' A' ' 146' ' ' THR . 76.4 m95 -98.68 155.04 17.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.089 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.653 ' O ' ' HA ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -162.72 -139.35 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.976 -0.289 . . . . 0.0 111.002 -178.564 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.581 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 4.9 ptt? -176.91 163.36 1.56 Allowed Pre-proline 0 N--CA 1.446 -0.671 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.628 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 2.9 Cg_endo -38.22 130.24 1.0 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.276 2.651 . . . . 0.0 113.342 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.575 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 1.7 tm0? -174.23 141.65 0.75 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.118 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -161.49 -156.45 8.33 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.472 -0.871 . . . . 0.0 112.387 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.669 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -118.24 138.94 14.24 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.03 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.421 ' CG1' HG11 ' A' ' 17' ' ' VAL . 46.2 mt -69.49 145.03 13.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.864 0.364 . . . . 0.0 111.63 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -69.15 -174.34 0.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.817 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -48.58 -75.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.127 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -116.33 56.24 0.53 Allowed Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.276 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -115.16 147.68 39.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.808 0.337 . . . . 0.0 110.773 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -71.12 160.16 83.33 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.606 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -69.38 -49.07 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.672 2.248 . . . . 0.0 111.653 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.455 ' O ' HG13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -52.21 -45.78 65.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.689 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -64.53 -45.3 87.79 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.857 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.532 ' HA ' ' HD3' ' A' ' 59' ' ' ARG . . . -62.51 -45.62 92.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.688 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.603 ' CA ' HG21 ' A' ' 17' ' ' VAL . . . -57.29 -55.15 38.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.317 0.579 . . . . 0.0 109.832 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.455 HG13 ' O ' ' A' ' 54' ' ' ARG . 27.1 mt -56.43 -51.06 69.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.4 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.532 ' HD3' ' HA ' ' A' ' 56' ' ' ALA . 2.8 ptm180 -65.17 -54.18 33.56 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.557 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.4 OUTLIER -46.25 -44.62 16.51 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.295 0.569 . . . . 0.0 109.884 179.374 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.598 HD12 ' HB3' ' A' ' 43' ' ' PRO . 8.4 tp -51.48 -51.62 53.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.489 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.463 ' O ' ' N ' ' A' ' 66' ' ' GLY . 15.1 ttm180 -64.87 -61.6 2.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.473 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -51.33 -23.47 3.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.111 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -97.13 -38.18 9.83 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.464 HG23 ' CD2' ' A' ' 121' ' ' LEU . 1.1 p -131.26 -3.33 3.89 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 78.75 -9.44 36.98 Favored Glycine 0 CA--C 1.517 0.205 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.135 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.539 ' HB ' ' CD1' ' A' ' 61' ' ' LEU . 69.6 t -58.49 111.76 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.209 0.528 . . . . 0.0 111.444 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.485 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -121.63 -39.38 2.65 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.429 178.493 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.408 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 14.2 m -62.7 70.37 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.93 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.537 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.37 152.89 19.01 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.216 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.667 ' O ' HD12 ' A' ' 73' ' ' ILE . 0.3 OUTLIER -129.06 157.81 40.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.297 179.443 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.495 HG22 ' CE2' ' A' ' 110' ' ' PHE . 16.5 t -78.62 131.08 35.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.261 0.553 . . . . 0.0 112.033 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.667 HD12 ' O ' ' A' ' 71' ' ' GLU . 0.8 OUTLIER -104.7 -22.5 4.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.176 178.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.435 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -171.83 178.26 3.08 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.703 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.27 145.02 30.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.011 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.708 ' HA ' HG13 ' A' ' 160' ' ' VAL . 53.5 t -70.98 136.94 84.9 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.858 0.361 . . . . 0.0 110.533 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.432 ' CD ' HG11 ' A' ' 76' ' ' VAL . 12.2 Cg_endo -53.11 -68.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.943 2.429 . . . . 0.0 111.831 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.634 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -96.65 -173.36 2.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.692 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.509 ' CD1' ' HD3' ' A' ' 106' ' ' LYS . 31.9 m95 -89.3 -157.18 0.44 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.628 ' HB2' ' O ' ' A' ' 105' ' ' GLN . 72.1 mt -162.7 101.49 1.03 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.615 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 5.4 p -104.24 -165.0 1.1 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.234 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.583 ' HA ' ' HA ' ' A' ' 3' ' ' LEU . 0.2 OUTLIER -168.33 70.66 0.09 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.564 179.583 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.503 ' HB3' ' OH ' ' A' ' 13' ' ' TYR . 1.0 OUTLIER -66.28 175.58 2.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.813 -179.236 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.561 ' CE1' ' CD1' ' A' ' 92' ' ' LEU . 0.3 OUTLIER -122.93 159.27 54.54 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.214 -179.073 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.462 ' HD2' HG21 ' A' ' 88' ' ' VAL . 63.3 Cg_exo -50.22 176.61 0.03 OUTLIER 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.577 2.184 . . . . 0.0 111.205 178.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -70.08 -44.83 1.65 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 121.977 1.784 . . . . 0.0 112.968 -179.466 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.92 -29.11 63.96 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.462 HG21 ' HD2' ' A' ' 85' ' ' PRO . 61.8 t -67.78 -6.98 5.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.54 ' O ' ' HB3' ' A' ' 93' ' ' ASN . 3.4 mmm180 -64.09 0.62 0.88 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -119.43 -16.75 8.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.903 0.382 . . . . 0.0 110.607 178.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.89 -26.69 16.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.036 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.561 ' CD1' ' CE1' ' A' ' 84' ' ' PHE . 1.8 tm? -117.2 -53.09 2.48 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.715 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.54 ' HB3' ' O ' ' A' ' 89' ' ' ARG . 14.6 t-20 -55.96 -51.26 68.32 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.858 0.361 . . . . 0.0 110.511 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.518 ' N ' HD12 ' A' ' 94' ' ' ILE . 1.7 mp -66.9 -14.27 17.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.436 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.466 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 8.2 tp-100 -70.2 -13.27 62.11 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.943 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.518 ' HE1' HD13 ' A' ' 92' ' ' LEU . 42.3 m95 -106.05 0.12 25.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.205 179.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 73.25 -75.64 0.96 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.119 -1.039 . . . . 0.0 110.974 -178.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.66 -165.27 0.11 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 178.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -94.74 107.83 19.84 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.93 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.662 ' CZ3' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -114.87 -20.29 10.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.51 179.813 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.505 ' HA ' ' HZ ' ' A' ' 84' ' ' PHE . 0.7 OUTLIER 16.38 54.35 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -178.851 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 100' ' ' TRP . . . 109.81 -174.3 17.65 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.488 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.633 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 12.7 tt0 -144.89 107.61 4.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.557 -0.322 . . . . 0.0 110.207 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.484 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -90.42 116.95 28.75 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.204 0.526 . . . . 0.0 110.99 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.728 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 3.2 mt-30 -126.0 123.75 39.18 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.434 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.509 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 9.3 ttpt -102.93 138.63 39.57 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 177.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.487 ' CZ2' ' CE1' ' A' ' 154' ' ' TYR . 31.3 m95 -103.36 162.68 12.8 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -177.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -139.74 155.55 47.27 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.881 179.753 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.519 ' CD2' ' HB ' ' A' ' 73' ' ' ILE . 39.4 tp -100.99 138.14 38.43 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.961 -0.295 . . . . 0.0 110.272 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.507 ' O ' ' HA ' ' A' ' 21' ' ' LEU . 23.8 m-85 -139.25 137.21 35.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.203 0.525 . . . . 0.0 112.155 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.537 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 10.2 ttmt -102.12 126.16 49.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.392 177.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.475 ' CD1' HG12 ' A' ' 67' ' ' VAL . 34.0 t80 -78.57 98.27 6.07 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.769 0.318 . . . . 0.0 110.999 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 8.0 p -97.86 50.4 1.03 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.408 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -152.64 -147.39 4.59 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.339 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -118.94 150.84 39.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.939 0.4 . . . . 0.0 110.885 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.404 ' C ' ' H ' ' A' ' 118' ' ' GLU . 21.0 m-20 -59.77 -35.1 73.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.728 -179.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -6.39 0.21 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.083 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.404 ' H ' ' C ' ' A' ' 116' ' ' ASP . 1.0 OUTLIER -89.84 -14.52 34.19 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.743 0.306 . . . . 0.0 111.023 179.521 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.517 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 19.2 mt -78.98 100.37 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.029 0.442 . . . . 0.0 111.999 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 65' ' ' THR . 2.2 t30 -104.16 98.73 8.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.752 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.464 ' CD2' HG23 ' A' ' 65' ' ' THR . 35.8 mt -69.84 -10.6 59.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.953 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.481 HD21 ' HB3' ' A' ' 129' ' ' PRO . 3.3 mm? -98.3 -174.01 2.72 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.875 0.369 . . . . 0.0 111.039 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 128.0 -7.61 6.81 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.726 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -101.83 73.67 1.43 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.937 0.399 . . . . 0.0 110.818 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -65.17 153.54 50.61 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.587 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 64.35 15.33 9.4 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -149.03 -96.5 0.07 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 121.228 -0.189 . . . . 0.0 111.029 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.2 pttt -179.46 155.41 0.77 Allowed Pre-proline 0 C--O 1.232 0.157 0 CA-C-O 120.993 0.425 . . . . 0.0 111.069 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.548 ' HG2' HD13 ' A' ' 34' ' ' LEU . 9.6 Cg_endo -70.98 -174.34 1.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.639 2.226 . . . . 0.0 112.212 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 15.7 mm-40 -97.05 -66.71 0.88 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.361 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.492 ' CG ' ' HB2' ' A' ' 31' ' ' ALA . 4.8 m-85 -103.45 143.82 32.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.108 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.701 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -85.92 -36.16 10.52 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.388 -0.911 . . . . 0.0 111.985 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -151.37 141.42 22.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.965 0.412 . . . . 0.0 110.925 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.517 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 42.7 p-90 -128.94 166.68 18.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.073 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.43 ' N ' ' HZ3' ' A' ' 40' ' ' TRP . 27.3 t -161.02 179.11 8.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.769 -178.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.61 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 75.8 m95 -114.01 103.73 11.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.59 178.443 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.3 m -119.22 168.44 11.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.776 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.473 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 17.6 p -74.01 169.89 16.99 Favored Pre-proline 0 CA--C 1.516 -0.358 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.491 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.585 ' HA ' HG13 ' A' ' 28' ' ' ILE . 16.6 Cg_exo -61.57 -53.53 2.23 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.781 1.654 . . . . 0.0 110.512 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.59 -27.72 69.14 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.782 178.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.444 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.2 OUTLIER -73.37 -44.29 58.93 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.486 179.743 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.422 HD12 ' O ' ' A' ' 41' ' ' GLN . 5.4 tp -58.94 -38.35 78.81 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.628 HG22 ' HG2' ' A' ' 155' ' ' LYS . 12.2 mm -63.74 -37.09 78.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.53 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.53 -49.66 52.4 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.297 0.57 . . . . 0.0 110.201 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.479 HD22 ' CD1' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -73.92 -20.15 60.47 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.752 -179.286 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.621 HG21 ' O ' ' A' ' 143' ' ' ILE . 12.7 t -76.2 173.11 11.77 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.514 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.491 ' CG1' ' HB3' ' A' ' 39' ' ' ALA . 35.5 m -80.43 147.24 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.248 -179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.599 ' HA ' ' HE2' ' A' ' 151' ' ' LYS . 5.3 mt-10 -52.21 -47.65 65.52 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.249 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -52.08 -10.91 0.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.459 ' HB3' ' CE1' ' A' ' 154' ' ' TYR . 21.1 mttt -135.72 -5.52 2.21 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.599 ' HE2' ' HA ' ' A' ' 148' ' ' GLU . 7.2 mtmm -58.28 -61.32 7.77 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 121.278 -0.169 . . . . 0.0 111.154 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.513 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 35.3 Cg_endo -64.83 -26.36 59.85 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.608 2.205 . . . . 0.0 111.738 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 26.3 t -68.25 -50.78 54.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.487 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 7.5 m-30 -66.46 -38.33 87.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.734 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.628 ' HG2' HG22 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -58.13 -42.1 85.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.073 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.26 -32.9 70.94 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.423 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 84.0 t -67.13 -41.09 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.728 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.472 HD23 ' HB3' ' A' ' 139' ' ' PRO . 44.8 mt -64.15 -39.26 93.63 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.93 0.395 . . . . 0.0 110.22 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.407 ' O ' ' HB3' ' A' ' 162' ' ' ALA . 16.9 m -55.81 -41.1 73.69 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.708 HG13 ' HA ' ' A' ' 76' ' ' VAL . 95.5 t -66.81 -44.84 88.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.175 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.558 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 21.7 m-30 -80.79 5.09 16.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.575 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.621 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.17 -51.86 78.7 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.745 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 18.1 Cg_endo -58.71 -12.18 13.81 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.231 1.954 . . . . 0.0 111.961 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.435 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 89.2 m-70 -110.32 -20.95 12.45 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.252 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.558 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 89.3 mt . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.938 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 CA-C-O 120.217 -0.213 . . . . 0.0 112.654 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.498 ' O ' ' HB3' ' A' ' 82' ' ' TYR . 50.3 Cg_exo -54.05 168.6 0.83 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.68 2.253 . . . . 0.0 112.744 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.564 HD21 ' HB2' ' A' ' 152' ' ' PRO . 4.5 mm? -120.27 95.34 4.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.394 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.87 -43.76 8.1 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.197 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.747 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 1.4 m 62.82 -96.64 0.06 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 12.6 mtm 64.22 135.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.526 0.203 . . . . 0.0 110.49 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.552 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 29.7 t0 -64.45 -42.65 95.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.945 0.403 . . . . 0.0 110.728 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.463 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 4.8 p -102.55 110.09 62.22 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.947 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.54 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 70.1 Cg_endo -76.21 103.7 1.79 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.441 2.094 . . . . 0.0 112.688 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.571 ' HG2' ' CD2' ' A' ' 13' ' ' TYR . 6.6 Cg_endo -50.85 161.29 1.45 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 123.547 2.831 . . . . 0.0 113.778 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.21 161.55 3.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.236 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.744 ' O ' ' HA ' ' A' ' 100' ' ' TRP . . . 81.6 -20.63 7.27 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.241 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.571 ' CD2' ' HG2' ' A' ' 10' ' ' PRO . 11.7 m-85 -87.27 130.76 34.47 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 122.431 -0.452 . . . . 0.0 110.505 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.656 ' HB3' ' HG2' ' A' ' 103' ' ' GLN . 3.7 tpt180 -69.86 95.52 0.92 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.804 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.57 ' HG3' ' CZ3' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -51.08 113.05 0.83 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.553 178.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.724 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 8.6 m120 -131.05 170.64 14.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.165 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.642 HG22 ' CA ' ' A' ' 57' ' ' ALA . 13.2 m -141.06 162.61 22.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.462 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.629 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -134.31 159.17 23.72 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.613 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.488 HG22 ' CD1' ' A' ' 110' ' ' PHE . 3.8 mp -128.41 119.02 49.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 41.9 t -97.85 89.42 4.59 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.624 HD21 ' HD1' ' A' ' 112' ' ' PHE . 27.1 tp -90.4 115.6 27.7 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.448 -178.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.464 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 1.7 ptt? -118.28 166.1 13.03 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.058 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.589 ' OD1' ' CE3' ' A' ' 136' ' ' TRP . 0.0 OUTLIER -101.36 167.85 9.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.298 179.492 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -55.89 -4.06 0.1 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.578 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.592 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 1.7 m-20 -100.67 2.63 41.73 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.592 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER 76.38 20.13 1.57 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.941 -178.374 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.588 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 2.1 mmtt -92.69 147.88 22.51 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.573 HG13 ' HA ' ' A' ' 139' ' ' PRO . 0.8 OUTLIER -101.0 138.82 23.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.164 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.452 ' N ' ' O ' ' A' ' 21' ' ' LEU . 12.1 t80 -78.46 134.37 37.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.831 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 134' ' ' TRP . . . -140.2 151.81 45.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.05 0.452 . . . . 0.0 111.224 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.453 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -143.28 133.43 24.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.637 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.508 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 3.4 m -97.25 156.5 16.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.165 0.507 . . . . 0.0 112.002 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.577 ' O ' ' N ' ' A' ' 35' ' ' ASP . 32.8 mtp85 -74.47 129.92 38.65 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.742 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.726 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 1.2 mp -57.3 54.9 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.221 0.608 . . . . 0.0 112.289 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.577 ' N ' ' O ' ' A' ' 33' ' ' ARG . 9.9 p-10 -175.89 -33.72 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.062 0.458 . . . . 0.0 109.919 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.668 ' HB ' ' HB1' ' A' ' 39' ' ' ALA . 4.5 mt -117.51 103.05 51.53 Favored Pre-proline 0 N--CA 1.448 -0.549 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.475 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -61.27 -47.34 12.34 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.014 2.476 . . . . 0.0 113.344 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.83 -2.08 22.14 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.668 ' HB1' ' HB ' ' A' ' 36' ' ' ILE . . . -95.55 95.63 8.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.852 0.358 . . . . 0.0 111.428 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.609 ' O ' ' HA ' ' A' ' 146' ' ' THR . 66.6 m95 -100.59 150.94 22.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.893 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.85 165.03 37.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.319 0.581 . . . . 0.0 111.52 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.444 ' HE1' ' HB2' ' A' ' 42' ' ' MET . 27.0 mtm -100.56 150.51 37.04 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.111 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -50.07 150.79 9.75 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.236 1.957 . . . . 0.0 111.89 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 18.2 pt20 -175.58 177.56 1.74 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.606 -179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 175.09 158.84 20.09 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.136 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.724 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -87.54 134.88 12.76 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.164 -1.017 . . . . 0.0 113.39 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.451 HD12 ' CG1' ' A' ' 17' ' ' VAL . 50.1 mt -68.25 148.23 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.058 0.456 . . . . 0.0 111.908 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.435 ' N ' HG22 ' A' ' 47' ' ' ILE . 28.1 m-20 -69.98 -172.74 0.57 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.203 178.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.46 -77.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.141 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -112.51 56.22 0.48 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.58 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.451 ' O ' HG23 ' A' ' 47' ' ' ILE . 3.3 tp10 -114.25 149.31 36.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.75 0.31 . . . . 0.0 110.711 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.404 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 12.6 m-20 -71.14 155.1 93.58 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.321 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.447 ' HA ' HG13 ' A' ' 17' ' ' VAL . 4.7 Cg_exo -74.92 -50.84 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.758 2.305 . . . . 0.0 112.277 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.477 ' HD3' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -51.31 -46.56 62.59 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.731 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 52.5 m-80 -68.09 -40.33 82.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.104 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.59 -43.14 99.4 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.642 ' CA ' HG22 ' A' ' 17' ' ' VAL . . . -57.02 -51.35 69.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.072 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.447 HG13 ' O ' ' A' ' 54' ' ' ARG . 12.3 mt -56.38 -54.82 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.983 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.53 -63.62 1.21 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.289 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -42.32 -46.56 4.62 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.039 0.447 . . . . 0.0 110.223 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.436 HD12 ' HB ' ' A' ' 67' ' ' VAL . 8.2 tp -52.34 -46.76 66.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.487 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.478 ' O ' ' N ' ' A' ' 66' ' ' GLY . 23.0 ttm180 -64.22 -63.06 1.25 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.171 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -49.78 -20.09 0.78 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -95.95 -40.52 9.24 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.476 HG21 ' CD2' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -126.34 -5.31 6.6 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.074 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 81.59 -11.71 44.44 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.214 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.502 HG22 HG12 ' A' ' 119' ' ' ILE . 71.7 t -57.81 114.73 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.155 0.503 . . . . 0.0 111.5 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -123.38 -39.06 2.49 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.33 178.126 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.406 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 5.9 m -62.67 73.32 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.214 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.523 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -162.64 155.3 19.29 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.942 0.401 . . . . 0.0 111.75 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.515 ' O ' HD12 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -130.96 153.99 48.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.452 179.112 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.514 HG23 ' CE2' ' A' ' 110' ' ' PHE . 43.4 t -76.55 131.78 34.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.336 0.588 . . . . 0.0 112.378 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.729 HD11 ' HB2' ' A' ' 111' ' ' LYS . 1.2 mm -103.91 -21.43 5.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.176 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.403 ' HB2' ' NE2' ' A' ' 164' ' ' HIS . . . -169.94 178.62 3.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.182 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -146.3 140.59 26.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.037 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.61 ' HA ' HG13 ' A' ' 160' ' ' VAL . 48.3 t -70.37 138.33 86.57 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.978 0.418 . . . . 0.0 110.535 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.445 ' N ' HG11 ' A' ' 76' ' ' VAL . 19.1 Cg_endo -58.92 -68.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.993 2.462 . . . . 0.0 112.477 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.552 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -96.67 -173.38 2.72 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.829 -179.405 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.57 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 44.0 m95 -93.72 -159.03 0.66 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.536 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.747 ' HA ' ' HA ' ' A' ' 5' ' ' SER . 41.0 mt -160.12 102.73 1.45 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.366 0.603 . . . . 0.0 111.131 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.605 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 24.4 p -107.17 -178.36 3.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.368 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.515 ' CE1' ' HB2' ' A' ' 103' ' ' GLN . 1.6 p90 -170.11 71.71 0.06 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.192 178.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -67.18 139.97 57.46 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.629 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 2.4 m-85 -103.58 162.03 21.24 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.421 ' CB ' ' HD2' ' A' ' 86' ' ' PRO . 26.7 Cg_exo -62.97 175.77 2.24 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.138 2.559 . . . . 0.0 112.119 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.421 ' HD2' ' CB ' ' A' ' 85' ' ' PRO . 18.5 Cg_endo -59.71 -22.81 69.19 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.502 2.135 . . . . 0.0 112.907 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -76.02 -47.78 23.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.915 0.388 . . . . 0.0 110.535 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.629 ' HB ' ' HB3' ' A' ' 84' ' ' PHE . 47.5 t -84.08 -17.83 10.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.038 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.638 ' HG3' ' CB ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -66.0 -1.07 2.73 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.146 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.616 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 0.3 OUTLIER -96.75 -44.81 6.92 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 121.891 -0.506 . . . . 0.0 110.674 179.111 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.9 mmtm -83.61 -0.63 51.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.673 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.559 ' HG ' ' CE1' ' A' ' 84' ' ' PHE . 1.2 tm? -121.38 -65.85 1.1 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.669 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.638 ' CB ' ' HG3' ' A' ' 89' ' ' ARG . 5.3 t-20 -61.45 -54.3 45.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.013 0.435 . . . . 0.0 111.18 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.616 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 1.7 mp -57.7 -14.17 2.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.235 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 49.0 mm-40 -74.25 -15.73 60.98 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.855 0.36 . . . . 0.0 110.669 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.531 ' HB2' ' CG ' ' A' ' 100' ' ' TRP . 6.2 m95 -103.43 -92.97 0.34 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.403 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.451 ' C ' ' HD1' ' A' ' 100' ' ' TRP . . . 171.13 -127.81 1.51 Allowed Glycine 0 C--N 1.339 0.703 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.629 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.466 ' O ' ' CD1' ' A' ' 100' ' ' TRP . 2.9 p -75.05 148.44 39.8 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 69.03 -39.92 0.44 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 178.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.744 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 78.9 m95 -44.72 172.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.616 ' HB3' ' O ' ' A' ' 100' ' ' TRP . 1.4 pttt 163.0 0.53 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.82 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 177.82 -159.37 25.12 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.912 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.656 ' HG2' ' HB3' ' A' ' 14' ' ' ARG . 35.1 mt-30 -147.08 111.03 5.04 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.892 0.346 . . . . 0.0 111.397 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.508 ' CB ' HG21 ' A' ' 81' ' ' THR . . . -92.26 125.42 36.92 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.871 0.367 . . . . 0.0 110.835 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.617 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -133.66 128.53 35.25 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.845 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.463 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 5.3 ttpp -102.32 132.39 48.32 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.629 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 19.5 m95 -104.93 160.86 14.68 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.459 ' CE1' ' HG2' ' A' ' 54' ' ' ARG . 91.4 m-85 -137.99 154.37 49.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.667 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.517 ' HG ' HG12 ' A' ' 73' ' ' ILE . 32.5 tp -97.65 141.69 30.36 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.514 ' CE2' HG23 ' A' ' 72' ' ' VAL . 23.3 m-85 -139.15 138.21 36.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.292 0.567 . . . . 0.0 112.116 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.729 ' HB2' HD11 ' A' ' 73' ' ' ILE . 1.4 ttpt -103.59 128.31 50.88 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.437 177.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.624 ' HD1' HD21 ' A' ' 21' ' ' LEU . 36.9 t80 -78.1 102.82 7.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.818 0.342 . . . . 0.0 111.008 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 49.2 p -100.47 47.65 0.93 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.009 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.406 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -152.73 -146.08 4.28 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.485 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -117.89 146.77 43.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.885 0.374 . . . . 0.0 110.814 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -59.51 -32.36 70.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.705 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -59.29 -4.48 0.56 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.907 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.15 -15.63 31.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.619 0.247 . . . . 0.0 110.951 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.537 HD13 ' CZ2' ' A' ' 134' ' ' TRP . 17.6 mt -76.11 99.67 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.912 0.386 . . . . 0.0 111.541 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 65' ' ' THR . 1.5 m120 -106.16 95.95 6.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.687 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.476 ' CD2' HG21 ' A' ' 65' ' ' THR . 11.2 mt -70.47 -5.44 28.67 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.838 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.455 ' CD2' ' HG3' ' A' ' 129' ' ' PRO . 1.9 mt -128.46 12.42 6.44 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.286 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.26 -120.19 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.19 -0.529 . . . . 0.0 113.226 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -95.17 138.39 32.95 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.911 0.386 . . . . 0.0 111.28 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -176.75 -116.43 0.47 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.173 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.76 -68.67 0.89 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.923 0.392 . . . . 0.0 110.336 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -147.51 -82.26 0.13 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.064 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 12.7 pttm -78.91 155.9 77.5 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.187 0.517 . . . . 0.0 110.931 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.664 ' HG2' HD12 ' A' ' 34' ' ' LEU . 61.1 Cg_endo -76.47 179.25 6.59 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 123.028 2.486 . . . . 0.0 112.594 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.98 -39.89 5.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.425 ' CB ' ' HB1' ' A' ' 31' ' ' ALA . 3.4 m-85 -120.02 138.63 53.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.217 0.532 . . . . 0.0 109.898 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.726 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -83.26 -36.45 14.68 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.026 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -149.03 144.43 26.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.948 0.404 . . . . 0.0 110.615 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.537 ' CZ2' HD13 ' A' ' 119' ' ' ILE . 33.4 p-90 -129.63 163.73 25.42 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.455 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.41 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 34.9 t -163.38 176.59 9.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.914 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.589 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 28.5 m95 -111.76 103.42 11.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.317 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 28' ' ' ILE . 24.2 m -118.39 166.26 12.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.511 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 14.5 p -71.82 171.49 9.15 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.216 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.573 ' HA ' HG13 ' A' ' 28' ' ' ILE . 13.4 Cg_exo -63.14 -54.18 1.21 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 121.83 1.687 . . . . 0.0 109.87 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -64.29 -28.35 69.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.911 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.436 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.4 OUTLIER -73.14 -45.75 54.93 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.393 179.745 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.459 HD13 ' HB1' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -58.44 -39.45 79.88 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.566 ' O ' HG22 ' A' ' 146' ' ' THR . 27.3 mm -61.99 -33.76 59.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.132 0.491 . . . . 0.0 110.032 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.03 -53.17 11.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.379 0.609 . . . . 0.0 110.818 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.426 HD22 ' CD1' ' A' ' 40' ' ' TRP . 1.1 mp -72.56 -19.38 61.51 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.72 -179.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.609 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 11.7 t -74.19 177.72 5.59 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.4 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.548 HG23 ' HB2' ' A' ' 150' ' ' LYS . 20.9 m -84.46 151.03 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.767 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.426 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 10.6 mt-10 -55.26 -54.75 39.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.486 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.495 ' CE1' HG22 ' A' ' 147' ' ' VAL . 44.3 p90 -55.93 -2.1 0.05 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.548 ' HB2' HG23 ' A' ' 147' ' ' VAL . 29.6 mttm -133.42 -8.06 2.91 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.493 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 0.4 OUTLIER -61.35 -56.45 33.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 121.49 -0.084 . . . . 0.0 111.196 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.564 ' HB2' HD21 ' A' ' 3' ' ' LEU . 22.7 Cg_endo -62.48 -28.94 78.23 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.163 1.909 . . . . 0.0 111.591 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.403 ' HA ' HD13 ' A' ' 3' ' ' LEU . 31.2 t -67.16 -51.63 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.472 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 6.9 m-30 -66.19 -39.37 89.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.965 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -56.29 -42.43 77.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.684 179.731 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.07 -33.32 73.37 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.544 HG12 ' CE2' ' A' ' 161' ' ' PHE . 48.8 t -67.5 -40.61 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.43 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 36.9 mt -63.44 -47.1 83.26 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.247 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.496 ' O ' ' HB1' ' A' ' 162' ' ' ALA . 1.8 t -50.72 -42.86 57.68 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.536 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.61 HG13 ' HA ' ' A' ' 76' ' ' VAL . 79.5 t -65.74 -41.65 90.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.544 ' CE2' HG12 ' A' ' 157' ' ' VAL . 18.3 m-30 -80.84 5.19 16.76 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.597 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.598 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.63 -52.77 71.66 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.6 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.0 Cg_endo -58.18 -12.4 12.88 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.112 1.874 . . . . 0.0 111.876 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.403 ' NE2' ' HB2' ' A' ' 74' ' ' ALA . 95.0 m-70 -108.5 -20.23 13.18 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.333 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 95.4 mt . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.105 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 112.343 -0.303 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.484 ' HG2' ' CB ' ' A' ' 152' ' ' PRO . 73.5 Cg_exo -50.31 134.19 37.63 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.556 2.171 . . . . 0.0 111.996 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.455 HD21 ' CD2' ' A' ' 82' ' ' TYR . 0.3 OUTLIER 57.99 -172.18 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.253 -179.052 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.442 ' HA3' ' HE1' ' A' ' 6' ' ' MET . . . -134.1 -4.28 2.98 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.17 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.866 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 88.5 p 55.99 -92.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.459 ' HE2' ' OG1' ' A' ' 81' ' ' THR . 2.8 mtm 70.09 128.54 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.674 0.273 . . . . 0.0 110.605 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.664 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 9.2 t0 -67.0 -31.74 72.5 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.004 0.43 . . . . 0.0 110.812 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 m -102.22 145.24 30.15 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.242 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.439 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 57.5 Cg_endo -71.02 106.3 1.86 Allowed 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.116 1.877 . . . . 0.0 111.556 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.575 ' HG2' ' CD2' ' A' ' 13' ' ' TYR . 6.9 Cg_endo -48.58 166.07 0.15 Allowed 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 123.025 2.483 . . . . 0.0 112.392 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -50.7 121.36 5.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.71 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.555 ' HA3' ' HA ' ' A' ' 100' ' ' TRP . . . 50.95 103.51 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.676 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.584 ' CD1' ' HB ' ' A' ' 81' ' ' THR . 9.5 m-85 -158.24 142.21 15.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.48 0.181 . . . . 0.0 110.84 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.513 ' HD2' ' CH2' ' A' ' 96' ' ' TRP . 17.5 ttt-85 -70.91 86.76 0.71 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.802 0.334 . . . . 0.0 111.604 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.766 ' HG2' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -50.49 109.44 0.31 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.275 0.56 . . . . 0.0 110.322 179.035 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.67 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 3.4 m120 -132.6 173.99 10.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.405 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.561 HG22 ' HB1' ' A' ' 57' ' ' ALA . 2.1 m -140.63 166.73 18.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.409 0.623 . . . . 0.0 111.831 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.652 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -133.33 155.08 21.52 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.252 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.539 HD11 ' HB2' ' A' ' 43' ' ' PRO . 3.4 mp -126.88 119.17 52.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.986 0.422 . . . . 0.0 111.956 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.449 ' O ' ' N ' ' A' ' 110' ' ' PHE . 45.4 t -101.79 102.41 13.03 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.589 HD22 ' CD1' ' A' ' 112' ' ' PHE . 15.5 tp -105.39 118.87 37.65 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.108 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.556 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 1.2 ptm -119.75 161.61 20.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.83 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.498 ' OD1' ' CE3' ' A' ' 136' ' ' TRP . 0.2 OUTLIER -95.77 169.96 9.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.962 0.411 . . . . 0.0 110.155 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -56.62 -5.0 0.18 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.054 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.548 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 4.7 m-20 -98.87 2.93 47.1 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER 75.76 19.45 1.98 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.942 -178.538 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 22' ' ' MET . 1.1 mmtt -94.46 140.8 29.35 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.495 HD12 ' CG ' ' A' ' 139' ' ' PRO . 3.0 mp -102.4 145.57 11.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.681 0.753 . . . . 0.0 112.218 -178.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.63 ' CE1' HD12 ' A' ' 119' ' ' ILE . 83.8 t80 -76.89 137.31 39.06 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.914 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.655 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -140.45 148.64 41.47 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.145 -0.316 . . . . 0.0 110.145 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.475 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -138.58 136.82 36.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.841 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.732 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 91.5 p -97.15 143.33 28.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.946 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.511 ' HD3' ' HB2' ' A' ' 39' ' ' ALA . 21.9 mtp85 -68.95 127.48 33.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.738 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.713 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.7 OUTLIER -43.78 -35.31 1.84 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.304 0.573 . . . . 0.0 110.835 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -72.71 -40.09 66.44 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.007 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.57 HG23 ' HB3' ' A' ' 39' ' ' ALA . 8.7 mt -125.31 104.76 28.48 Favored Pre-proline 0 N--CA 1.455 -0.175 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.738 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.75 -20.2 52.64 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.738 2.292 . . . . 0.0 112.871 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.48 -6.59 54.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.706 0.288 . . . . 0.0 111.496 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.732 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.56 93.27 8.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.123 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.65 ' O ' ' HA ' ' A' ' 146' ' ' THR . 78.1 m95 -90.89 144.93 25.18 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.543 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.418 ' HA ' ' HE2' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -158.73 162.6 37.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.184 0.516 . . . . 0.0 111.232 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.573 ' HE3' ' CZ3' ' A' ' 107' ' ' TRP . 1.8 mtm -98.08 152.05 37.84 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.892 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.539 ' HB2' HD11 ' A' ' 19' ' ' ILE . 1.5 Cg_endo -46.96 144.86 7.8 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.239 1.96 . . . . 0.0 111.873 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 12.5 tt0 -172.68 146.4 1.65 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.578 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.44 ' HA3' ' HG3' ' A' ' 60' ' ' GLU . . . -157.32 -167.02 17.79 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.9 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.67 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -117.85 137.68 13.37 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.133 -1.032 . . . . 0.0 113.655 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.766 HD12 ' HG2' ' A' ' 15' ' ' ARG . 3.3 mt -70.52 148.78 10.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.356 -0.422 . . . . 0.0 111.735 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.493 ' N ' HG23 ' A' ' 47' ' ' ILE . 4.5 m-20 -68.61 -173.8 0.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.372 178.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -49.11 -78.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.178 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -111.93 57.13 0.44 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.601 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.459 ' O ' HG21 ' A' ' 47' ' ' ILE . 7.4 tp10 -117.4 153.86 32.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.946 0.403 . . . . 0.0 110.871 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.86 161.61 77.79 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.486 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.531 ' HA ' HG12 ' A' ' 47' ' ' ILE . 7.3 Cg_exo -74.21 -47.87 0.23 Allowed 'Trans proline' 0 CA--C 1.514 -0.517 0 C-N-CA 122.857 2.371 . . . . 0.0 111.226 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.743 HH11 HG13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -51.98 -44.03 63.86 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.213 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -68.09 -42.13 80.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.946 0.403 . . . . 0.0 110.402 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.431 ' HA ' ' HG2' ' A' ' 59' ' ' ARG . . . -60.49 -44.46 95.93 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.561 ' HB1' HG22 ' A' ' 17' ' ' VAL . . . -57.96 -53.7 55.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.388 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.743 HG13 HH11 ' A' ' 54' ' ' ARG . 57.4 mt -53.27 -52.82 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.526 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.438 ' HG3' ' N ' ' A' ' 60' ' ' GLU . 9.2 ptm180 -63.43 -56.57 15.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.824 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.44 ' HG3' ' HA3' ' A' ' 45' ' ' GLY . 29.2 mm-40 -50.99 -48.45 61.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.063 0.459 . . . . 0.0 110.054 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . . . . . . . . . 14.1 tp -51.01 -48.5 61.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.393 179.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.473 ' HD2' ' HA2' ' A' ' 66' ' ' GLY . 1.0 OUTLIER -66.77 -63.29 1.1 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.328 0.585 . . . . 0.0 110.721 179.304 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.67 -22.36 2.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.088 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -99.74 -38.06 8.84 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.426 HG23 ' CD2' ' A' ' 121' ' ' LEU . 0.8 OUTLIER -127.22 -13.6 5.56 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.858 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.473 ' HA2' ' HD2' ' A' ' 62' ' ' ARG . . . 85.4 -13.42 55.38 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.254 -0.974 . . . . 0.0 111.76 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.528 HG22 HG12 ' A' ' 119' ' ' ILE . 27.3 t -57.31 106.02 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 121.236 0.541 . . . . 0.0 111.135 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.456 ' CG2' ' HG2' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -121.18 -39.86 2.65 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.219 178.605 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.0 m -62.68 73.43 0.02 OUTLIER 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.064 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.51 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -164.0 159.1 20.33 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.674 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.45 152.18 49.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.873 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.463 HG21 ' CZ ' ' A' ' 110' ' ' PHE . 19.9 t -75.14 127.7 36.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.056 0.455 . . . . 0.0 111.076 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.538 HD13 ' CA ' ' A' ' 111' ' ' LYS . 2.3 mt -108.1 -19.12 6.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.902 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.473 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.09 176.24 4.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.204 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.576 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.1 pm0 -154.39 145.26 22.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.453 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.775 ' HA ' HG11 ' A' ' 160' ' ' VAL . 53.5 t -71.25 138.32 84.28 Favored Pre-proline 0 C--N 1.329 -0.286 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.927 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.521 ' HD2' HG13 ' A' ' 76' ' ' VAL . 21.3 Cg_endo -61.82 -55.34 1.13 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.814 2.342 . . . . 0.0 112.696 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.664 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 1.2 p90 -102.17 -178.64 3.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.491 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.545 ' CD1' ' HD3' ' A' ' 106' ' ' LYS . 39.3 m95 -93.54 -157.56 0.55 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.392 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.866 ' HA ' ' HA ' ' A' ' 5' ' ' SER . 55.7 mt -161.7 100.84 1.16 Allowed 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.734 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 0.8 OUTLIER -106.82 122.92 47.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.157 -177.666 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.455 ' CD2' HD21 ' A' ' 3' ' ' LEU . 20.9 m-85 -78.75 -166.49 0.89 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.942 178.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -176.39 145.23 0.57 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.676 0.274 . . . . 0.0 110.549 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.456 ' CZ ' ' HG ' ' A' ' 92' ' ' LEU . 4.1 m-85 -96.64 166.72 13.51 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.762 0.315 . . . . 0.0 111.366 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.413 ' HD2' ' HB ' ' A' ' 88' ' ' VAL . 19.9 Cg_exo -65.6 177.07 2.99 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.631 2.221 . . . . 0.0 111.95 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.405 ' HD2' ' CB ' ' A' ' 85' ' ' PRO . 56.4 Cg_endo -70.04 -23.27 29.71 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.351 2.034 . . . . 0.0 112.312 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -84.64 -61.5 1.77 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.247 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.424 ' C ' ' H ' ' A' ' 90' ' ' GLU . 11.3 t -63.9 -12.53 11.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.766 0.317 . . . . 0.0 111.35 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.584 ' HD2' ' CB ' ' A' ' 93' ' ' ASN . 0.1 OUTLIER -59.66 -2.62 0.38 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.458 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' A' ' 88' ' ' VAL . 1.4 mm-40 -106.76 -21.74 12.94 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.652 0.263 . . . . 0.0 111.03 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.55 -15.14 17.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.876 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.476 HD23 ' NE1' ' A' ' 96' ' ' TRP . 0.3 OUTLIER -116.0 -56.12 2.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.312 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.672 ' OD1' ' HA ' ' A' ' 101' ' ' LYS . 0.9 OUTLIER -59.88 -54.18 49.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.355 0.598 . . . . 0.0 110.863 179.42 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.574 ' N ' HD12 ' A' ' 94' ' ' ILE . 1.7 mp -68.43 -12.85 16.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.321 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.45 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 0.5 OUTLIER -69.8 -14.83 62.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.334 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.575 ' HB2' ' HB2' ' A' ' 100' ' ' TRP . 28.8 m95 -95.95 20.16 10.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.634 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.07 -71.75 2.91 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.114 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.421 ' O ' ' CG ' ' A' ' 99' ' ' ASP . 53.0 p -176.98 159.88 1.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.813 -0.227 . . . . 0.0 110.579 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.421 ' CG ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER 80.62 -39.18 0.16 Allowed 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.365 0.416 . . . . 0.0 111.729 179.639 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.575 ' HB2' ' HB2' ' A' ' 96' ' ' TRP . 14.8 m95 -58.4 -171.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.306 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.672 ' HA ' ' OD1' ' A' ' 93' ' ' ASN . 0.6 OUTLIER 166.59 12.57 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.771 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.447 ' HA3' ' CE1' ' A' ' 13' ' ' TYR . . . 161.37 -148.82 17.01 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.822 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.734 ' O ' ' HA ' ' A' ' 81' ' ' THR . 72.7 mt-30 -146.17 117.69 8.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 117.021 0.41 . . . . 0.0 111.516 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.451 ' HB2' ' CG2' ' A' ' 81' ' ' THR . . . -91.49 126.95 36.74 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 120.874 0.369 . . . . 0.0 110.177 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.621 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 23.9 mt-30 -136.45 124.06 22.31 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.545 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 14.4 ttpp -104.76 140.36 38.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.165 178.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.652 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 19.4 m95 -110.11 160.23 16.65 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.684 ' HB2' HH21 ' A' ' 54' ' ' ARG . 19.0 m-85 -139.07 160.12 40.53 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.125 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.48 ' HG ' HD12 ' A' ' 73' ' ' ILE . 11.7 tp -98.44 142.52 29.96 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.622 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.532 ' HZ ' ' NH1' ' A' ' 54' ' ' ARG . 5.7 m-85 -135.36 145.71 47.65 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.538 ' CA ' HD13 ' A' ' 73' ' ' ILE . 1.8 tttt -106.31 117.16 33.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.854 177.004 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.589 ' CD1' HD22 ' A' ' 21' ' ' LEU . 55.1 t80 -78.03 101.29 6.86 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.661 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 14.1 p -97.58 40.43 1.16 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.406 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.402 ' C ' ' CE2' ' A' ' 112' ' ' PHE . . . -140.64 -148.36 5.11 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.805 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -123.64 152.03 42.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.702 0.287 . . . . 0.0 111.129 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.42 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 11.6 p-10 -58.31 -39.16 78.63 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.418 0.627 . . . . 0.0 111.204 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -58.2 -3.72 0.28 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.335 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.406 ' H ' ' C ' ' A' ' 116' ' ' ASP . 3.0 tt0 -89.29 -17.34 29.15 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.092 0.473 . . . . 0.0 110.432 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.63 HD12 ' CE1' ' A' ' 29' ' ' PHE . 9.4 mt -88.74 106.84 17.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.462 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.466 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 27.3 t30 -100.09 -20.31 16.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.167 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.466 ' HB2' ' O ' ' A' ' 120' ' ' ASN . 66.8 mt 75.95 -31.14 0.19 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.089 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.5 HD13 ' HD3' ' A' ' 129' ' ' PRO . 4.3 mm? -76.78 177.28 7.74 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.83 0.348 . . . . 0.0 111.156 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 117.99 125.68 3.57 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.736 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 46.89 96.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.838 0.351 . . . . 0.0 111.46 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -150.84 155.5 26.19 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.555 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 61.3 m -90.91 -21.44 21.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.55 0.214 . . . . 0.0 111.091 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.494 ' C ' ' HG3' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -149.63 -50.07 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.398 -179.552 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.753 ' HB3' ' HD2' ' A' ' 129' ' ' PRO . 25.0 mtpt -157.92 165.96 17.55 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-O 121.183 0.516 . . . . 0.0 111.246 -178.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.753 ' HD2' ' HB3' ' A' ' 128' ' ' LYS . 6.2 Cg_endo -53.02 -174.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.195 2.597 . . . . 0.0 112.758 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.06 -48.44 3.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.363 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . . . . . . . . . 1.4 m-85 -109.74 140.71 43.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.987 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.713 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -89.98 -32.12 10.25 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.12 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.95 152.25 34.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.885 0.374 . . . . 0.0 110.363 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.53 ' CZ2' HD13 ' A' ' 119' ' ' ILE . 37.3 p-90 -137.76 167.62 21.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.009 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.459 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 30.5 t -162.42 175.58 11.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.481 0.657 . . . . 0.0 112.168 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.498 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 35.6 m95 -111.25 105.65 14.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.105 178.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 25.2 m -120.93 170.1 11.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.545 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 18.4 p -73.01 172.0 9.01 Favored Pre-proline 0 CA--C 1.518 -0.284 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.971 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.666 ' HB3' HD21 ' A' ' 158' ' ' LEU . 11.4 Cg_exo -62.81 -55.85 0.74 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.579 1.519 . . . . 0.0 110.286 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -64.23 -25.14 67.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.351 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.439 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 1.8 mm-40 -72.96 -47.63 43.7 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.483 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.655 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -57.79 -39.38 77.4 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.848 -179.812 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.626 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 6.2 mm -62.82 -37.74 79.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.316 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.51 -48.99 58.78 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.312 0.577 . . . . 0.0 110.488 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.3 mp -75.0 -20.19 59.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.137 -0.938 . . . . 0.0 113.115 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.65 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 14.1 t -74.92 178.58 5.46 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.787 -178.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.637 HG23 ' HB2' ' A' ' 150' ' ' LYS . 27.7 m -82.89 148.62 5.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.115 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.472 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 45.4 mt-10 -55.1 -53.06 60.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.441 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.551 ' CZ ' HG22 ' A' ' 147' ' ' VAL . 51.1 p90 -56.66 -2.22 0.07 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.637 ' HB2' HG23 ' A' ' 147' ' ' VAL . 21.5 mttt -134.76 -7.6 2.43 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.626 ' HG2' ' O ' ' A' ' 143' ' ' ILE . 7.6 mtmm -58.88 -60.02 11.86 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.56 0.219 . . . . 0.0 111.095 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.484 ' CB ' ' HG2' ' A' ' 2' ' ' PRO . 31.8 Cg_endo -62.89 -26.78 74.51 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.397 2.064 . . . . 0.0 111.631 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.522 HG21 ' HA ' ' A' ' 150' ' ' LYS . 26.0 t -68.85 -50.99 49.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.418 ' HE2' ' HA ' ' A' ' 41' ' ' GLN . 12.6 m-30 -65.76 -37.3 85.97 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.532 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.602 ' HE2' ' HA ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -57.68 -40.69 80.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.986 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -68.11 -32.55 72.93 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.605 HG11 ' CE2' ' A' ' 161' ' ' PHE . 48.6 t -66.64 -42.07 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.007 178.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.666 HD21 ' HB3' ' A' ' 139' ' ' PRO . 34.7 mt -64.36 -47.56 78.83 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.58 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.458 ' O ' ' HB3' ' A' ' 162' ' ' ALA . 2.9 p -50.01 -40.63 45.13 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.775 HG11 ' HA ' ' A' ' 76' ' ' VAL . 57.7 t -68.1 -41.37 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.35 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.605 ' CE2' HG11 ' A' ' 157' ' ' VAL . 21.0 m-30 -80.87 4.26 19.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.402 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.608 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.48 -51.5 81.35 Favored Pre-proline 0 C--N 1.331 -0.22 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.776 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.8 Cg_endo -58.63 -12.67 14.93 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.064 1.843 . . . . 0.0 111.818 178.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.473 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 89.4 m-70 -108.76 -18.51 13.69 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.253 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 85.8 mt . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.331 -0.842 . . . . 0.0 110.678 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 CA-C-O 120.192 -0.227 . . . . 0.0 112.648 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.16 166.63 1.54 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.603 2.202 . . . . 0.0 112.827 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.503 ' HB3' ' O ' ' A' ' 81' ' ' THR . 0.2 OUTLIER -80.01 134.88 36.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.081 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.431 ' O ' ' OG ' ' A' ' 5' ' ' SER . . . -94.68 -15.63 45.56 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.415 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.578 ' HA ' ' O ' ' A' ' 79' ' ' TRP . 3.6 p 58.43 -87.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.496 ' H ' ' HG ' ' A' ' 5' ' ' SER . 9.2 mtm 67.53 137.84 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.853 0.359 . . . . 0.0 111.116 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.75 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 17.3 t0 -66.97 -39.85 87.31 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.416 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.8 m -98.11 138.82 20.95 Favored Pre-proline 0 C--N 1.325 -0.486 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.35 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.429 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 74.4 Cg_endo -75.46 107.5 2.49 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.156 1.904 . . . . 0.0 112.236 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.524 ' HG2' ' CD1' ' A' ' 13' ' ' TYR . 4.9 Cg_endo -48.27 165.21 0.16 Allowed 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 123.315 2.677 . . . . 0.0 112.794 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -51.1 129.7 24.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.412 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.31 85.99 0.02 OUTLIER Glycine 0 CA--C 1.517 0.192 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.797 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.524 ' CD1' ' HG2' ' A' ' 10' ' ' PRO . 9.8 m-85 -152.34 152.28 31.9 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.977 0.417 . . . . 0.0 111.588 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.817 ' HG3' ' H ' ' A' ' 15' ' ' ARG . 9.7 tpt180 -63.93 -154.58 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.697 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.817 ' H ' ' HG3' ' A' ' 14' ' ' ARG . 1.5 ttt180 176.64 96.38 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 122.881 0.472 . . . . 0.0 109.863 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.635 ' HA ' ' H ' ' A' ' 47' ' ' ILE . 1.5 m120 -129.84 173.19 10.9 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.707 HG23 ' N ' ' A' ' 57' ' ' ALA . 30.2 m -134.33 165.53 31.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.736 0.779 . . . . 0.0 111.683 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.816 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -131.42 158.2 22.65 Favored Glycine 0 N--CA 1.433 -1.539 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.502 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.463 HD11 ' C ' ' A' ' 43' ' ' PRO . 3.4 mp -123.27 117.95 53.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.496 0.665 . . . . 0.0 111.976 -178.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.444 ' HB3' HD13 ' A' ' 109' ' ' LEU . 37.6 t -104.43 103.74 13.5 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.603 HD22 HG13 ' A' ' 67' ' ' VAL . 30.8 tp -104.47 122.96 46.62 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.893 -177.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.728 ' HB3' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -113.64 137.58 51.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.714 179.845 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.443 ' OD1' ' CZ3' ' A' ' 136' ' ' TRP . 5.6 m-20 -98.11 -172.25 2.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.475 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -52.38 -7.59 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.187 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.491 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 3.7 m-20 -99.73 -7.21 25.87 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.996 0.427 . . . . 0.0 111.045 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.745 ' HE2' ' HA ' ' A' ' 165' ' ' LEU . 0.0 OUTLIER 73.38 20.42 3.22 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 121.652 0.739 . . . . 0.0 109.291 -179.379 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.728 ' O ' ' HB3' ' A' ' 22' ' ' MET . 7.1 mttp -91.72 -161.03 0.78 Allowed 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.767 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 21' ' ' LEU . 2.5 mp -135.61 145.73 31.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.42 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.658 ' CE1' HD13 ' A' ' 119' ' ' ILE . 81.0 t80 -65.77 110.99 3.02 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.326 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 41' ' ' GLN . . . -100.21 137.56 38.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.842 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.435 ' HB1' ' CG ' ' A' ' 131' ' ' PHE . . . -135.75 132.94 37.45 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.809 179.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.825 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 48.6 p -98.81 141.39 31.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.221 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.1 mtp-105 -68.67 127.1 31.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.193 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.776 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.3 OUTLIER -45.9 -34.12 3.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.294 0.568 . . . . 0.0 110.73 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.39 -39.78 67.71 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.519 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.634 ' HB ' ' HB2' ' A' ' 39' ' ' ALA . 27.9 mt -123.63 106.64 32.13 Favored Pre-proline 0 N--CA 1.455 -0.214 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.084 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -68.37 -19.88 42.99 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.714 2.276 . . . . 0.0 112.628 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -91.39 -7.46 50.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.514 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.825 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -90.71 96.46 10.65 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.04 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.607 ' O ' ' HA ' ' A' ' 146' ' ' THR . 75.8 m95 -94.76 146.61 24.06 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.116 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.554 ' O ' ' HA ' ' A' ' 30' ' ' ALA . 0.5 OUTLIER -157.79 -124.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.56 -179.29 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.572 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 9.8 ptt? 179.98 163.29 0.86 Allowed Pre-proline 0 N--CA 1.452 -0.345 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.572 ' HD2' ' HB2' ' A' ' 42' ' ' MET . 10.2 Cg_endo -50.99 147.05 20.18 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.114 2.542 . . . . 0.0 112.577 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.456 ' HA ' ' HA2' ' A' ' 18' ' ' GLY . 10.6 pt20 -174.22 146.61 1.13 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.809 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.462 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . -160.52 154.38 25.4 Favored Glycine 0 C--O 1.228 -0.273 0 C-N-CA 120.146 -1.026 . . . . 0.0 112.789 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.604 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -78.31 136.95 19.02 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.611 -0.804 . . . . 0.0 114.034 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.671 HD13 ' HG2' ' A' ' 15' ' ' ARG . 3.7 mt -69.62 141.93 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.13 -0.535 . . . . 0.0 110.469 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -68.45 -172.95 0.38 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.738 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -48.22 -73.33 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.208 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -118.42 57.17 0.55 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.483 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.404 ' HG3' ' N ' ' A' ' 52' ' ' ASP . 2.1 tp10 -114.34 147.43 39.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.66 0.266 . . . . 0.0 110.456 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.41 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 26.9 m-20 -70.9 139.83 85.81 Favored Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.159 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.619 ' HB2' ' HZ ' ' A' ' 108' ' ' PHE . 38.6 Cg_exo -58.27 -47.7 18.72 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.354 2.036 . . . . 0.0 112.016 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.584 ' HD3' HG22 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -52.93 -46.17 67.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.904 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -68.0 -40.97 82.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.242 179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 60' ' ' GLU . . . -61.71 -44.49 96.83 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.765 179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.707 ' N ' HG23 ' A' ' 17' ' ' VAL . . . -56.41 -54.49 45.07 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.812 178.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.489 HG12 ' HE2' ' A' ' 110' ' ' PHE . 10.1 mt -55.25 -55.31 17.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.173 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -60.47 -61.66 2.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.945 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.462 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 4.4 mm-40 -46.89 -43.74 19.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.179 0.514 . . . . 0.0 109.777 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.689 HD11 ' HB ' ' A' ' 67' ' ' VAL . 9.0 tp -51.17 -48.27 61.96 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.923 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.454 ' O ' ' N ' ' A' ' 66' ' ' GLY . 17.9 ttm180 -64.66 -62.91 1.29 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.164 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -49.7 -22.97 1.53 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.268 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -96.02 -37.73 10.52 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.499 HG22 ' CD2' ' A' ' 121' ' ' LEU . 1.3 p -124.34 -35.69 2.75 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.638 -0.425 . . . . 0.0 112.027 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 107.16 -13.53 40.47 Favored Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -178.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.689 ' HB ' HD11 ' A' ' 61' ' ' LEU . 78.1 t -56.24 109.75 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 120.889 0.376 . . . . 0.0 110.49 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.483 ' O ' ' N ' ' A' ' 70' ' ' ALA . 3.9 p -120.86 -41.06 2.58 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.315 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.6 m -60.89 72.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.234 179.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -160.79 157.95 27.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.196 0.522 . . . . 0.0 112.213 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.16 149.63 50.88 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.131 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.788 HG21 ' CE2' ' A' ' 110' ' ' PHE . 12.8 t -74.0 128.14 36.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.172 0.51 . . . . 0.0 111.923 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.546 HD11 ' N ' ' A' ' 111' ' ' LYS . 0.9 OUTLIER -108.83 -18.25 7.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.363 178.668 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.527 ' HB2' ' NE2' ' A' ' 164' ' ' HIS . . . -168.54 179.69 4.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.399 0.619 . . . . 0.0 112.325 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -160.09 147.22 16.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.568 179.764 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.809 ' HA ' HG12 ' A' ' 160' ' ' VAL . 42.7 t -71.2 140.12 85.19 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-O 120.959 0.409 . . . . 0.0 111.533 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.646 ' HD3' HG13 ' A' ' 160' ' ' VAL . 32.2 Cg_endo -64.89 -69.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.094 2.53 . . . . 0.0 112.931 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.75 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -87.4 172.41 9.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.689 -178.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.578 ' O ' ' HA ' ' A' ' 5' ' ' SER . 54.3 m95 -92.93 102.72 15.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.846 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.47 HD21 ' CD1' ' A' ' 78' ' ' TYR . 65.3 mt -63.02 109.67 1.55 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.916 0.388 . . . . 0.0 110.79 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.577 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 21.4 p -100.38 -160.32 0.79 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.886 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.408 ' HD1' HD23 ' A' ' 3' ' ' LEU . 1.2 t80 -175.12 60.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.536 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.08 148.96 46.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.666 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.667 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 39.0 m-85 -99.56 161.07 25.73 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.215 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.512 ' HB3' ' HD2' ' A' ' 86' ' ' PRO . 38.4 Cg_exo -56.76 -178.32 0.08 OUTLIER 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 123.06 2.507 . . . . 0.0 112.062 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.512 ' HD2' ' HB3' ' A' ' 85' ' ' PRO . 33.7 Cg_endo -64.5 -22.08 65.57 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.447 2.098 . . . . 0.0 112.681 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -77.11 -62.46 1.64 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.992 0.425 . . . . 0.0 110.464 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.667 ' HB ' ' HB3' ' A' ' 84' ' ' PHE . 37.5 t -64.6 -17.38 21.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.026 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.647 ' HG3' ' HB2' ' A' ' 93' ' ' ASN . 2.9 ttp180 -55.04 -62.63 1.54 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.093 0.473 . . . . 0.0 110.636 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.485 ' HA ' ' CD1' ' A' ' 94' ' ' ILE . 2.2 mm-40 -62.93 -13.29 32.69 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.792 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.09 -33.61 15.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.718 0.294 . . . . 0.0 111.784 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.485 ' C ' HD11 ' A' ' 92' ' ' LEU . 1.8 tm? -120.48 -54.48 2.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.264 0.554 . . . . 0.0 111.504 -178.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.854 ' HB3' ' HA ' ' A' ' 101' ' ' LYS . 1.7 m-20 -52.56 -57.5 9.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.943 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.485 ' CD1' ' HA ' ' A' ' 90' ' ' GLU . 4.3 mp -75.29 -6.42 8.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.709 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -76.14 -1.11 24.58 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.858 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.615 ' CZ3' ' HD3' ' A' ' 14' ' ' ARG . 77.8 m95 -92.71 30.15 1.62 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.715 0.293 . . . . 0.0 110.822 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.408 ' O ' ' CB ' ' A' ' 98' ' ' SER . . . 68.05 19.49 71.94 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.663 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.453 ' O ' ' HD1' ' A' ' 100' ' ' TRP . 5.3 m 82.5 160.62 0.14 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 122.372 0.269 . . . . 0.0 111.037 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.3 t70 77.23 25.93 0.74 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.631 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.667 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 30.3 m95 -139.36 -164.67 1.71 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.997 -178.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.854 ' HA ' ' HB3' ' A' ' 93' ' ' ASN . 12.2 ttpp 163.64 12.08 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.441 0.463 . . . . 0.0 111.998 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 161.92 -163.57 34.85 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 120.314 -0.946 . . . . 0.0 111.987 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.577 ' O ' ' HA ' ' A' ' 81' ' ' THR . 36.3 mt-30 -144.98 123.58 12.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.886 0.343 . . . . 0.0 111.48 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.596 ' O ' ' HA ' ' A' ' 15' ' ' ARG . . . -100.35 125.47 46.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.667 179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.549 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 36.7 mt-30 -132.32 126.19 32.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.296 0.569 . . . . 0.0 112.354 -178.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 3.3 ttmt -104.55 135.14 46.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.897 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.816 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 38.8 m95 -101.81 165.58 11.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.198 0.523 . . . . 0.0 112.082 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.619 ' HZ ' ' HB2' ' A' ' 53' ' ' PRO . 97.6 m-85 -141.01 152.69 45.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.892 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.553 ' O ' HG12 ' A' ' 72' ' ' VAL . 10.0 tp -101.2 140.04 36.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.744 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.788 ' CE2' HG21 ' A' ' 72' ' ' VAL . 50.6 m-85 -141.49 143.58 33.91 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 26.5 tttt -100.83 124.59 46.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.247 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.513 ' CD1' HD23 ' A' ' 21' ' ' LEU . 30.8 t80 -78.71 101.36 7.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.728 0.299 . . . . 0.0 110.64 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 18.3 p -98.26 40.54 1.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.501 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.43 -145.41 4.34 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.777 -179.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -121.63 149.07 43.71 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.965 0.412 . . . . 0.0 111.449 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.428 ' C ' ' H ' ' A' ' 118' ' ' GLU . 11.3 p-10 -60.47 -36.32 77.98 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.501 0.667 . . . . 0.0 111.081 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -57.01 -2.87 0.09 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.405 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.428 ' H ' ' C ' ' A' ' 116' ' ' ASP . 3.4 tt0 -89.66 -17.71 27.86 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.163 0.506 . . . . 0.0 110.149 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.658 HD13 ' CE1' ' A' ' 29' ' ' PHE . 9.6 mt -83.36 100.65 7.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.373 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -94.86 -0.46 54.03 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.613 ' O ' ' HG ' ' A' ' 122' ' ' LEU . 53.5 mt 40.55 27.06 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.613 ' HG ' ' O ' ' A' ' 121' ' ' LEU . 0.4 OUTLIER -171.25 -173.99 1.37 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.945 0.402 . . . . 0.0 111.182 -179.413 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 112.84 128.99 5.05 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.573 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 12.7 t0 58.74 75.51 0.39 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.816 0.341 . . . . 0.0 111.021 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -178.84 89.4 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.356 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.17 -4.81 15.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.65 0.262 . . . . 0.0 111.202 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.569 ' O ' ' HG3' ' A' ' 128' ' ' LYS . 12.0 mt-10 -88.5 -75.13 0.44 Allowed 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.506 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.569 ' HG3' ' O ' ' A' ' 127' ' ' GLU . 12.7 mttt -175.34 164.16 2.15 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.694 0.759 . . . . 0.0 111.576 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.605 ' HB3' HD21 ' A' ' 122' ' ' LEU . 22.5 Cg_endo -72.78 -173.69 1.28 Allowed 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 123.681 2.921 . . . . 0.0 113.261 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.521 ' HG3' ' CE1' ' A' ' 131' ' ' PHE . 2.5 tp10 -114.51 -46.48 2.96 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.693 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.614 ' C ' HD13 ' A' ' 34' ' ' LEU . 1.6 m-85 -126.93 140.11 52.57 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.987 0.422 . . . . 0.0 110.378 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.776 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -84.44 -33.44 19.66 Favored Glycine 0 CA--C 1.507 -0.43 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.211 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.59 151.83 29.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.506 -0.347 . . . . 0.0 110.254 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.537 ' HB2' ' O ' ' A' ' 30' ' ' ALA . 37.0 p-90 -138.48 169.56 17.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.591 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.508 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 45.9 t -162.06 177.47 9.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.287 0.565 . . . . 0.0 111.364 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.473 ' CE2' ' CZ3' ' A' ' 134' ' ' TRP . 79.7 m95 -109.47 95.65 5.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.95 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.682 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 25.4 m -116.4 162.82 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.772 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.547 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 12.7 p -72.27 174.13 4.65 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.915 0.388 . . . . 0.0 110.567 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.641 ' O ' HG12 ' A' ' 143' ' ' ILE . 9.4 Cg_exo -63.46 -57.08 0.41 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.526 1.484 . . . . 0.0 110.291 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -60.66 -32.33 71.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.277 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.423 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.9 OUTLIER -70.66 -47.63 58.97 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.566 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.534 HD11 ' CB ' ' A' ' 30' ' ' ALA . 38.7 tp -57.04 -38.42 73.16 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.733 HG22 ' HD3' ' A' ' 155' ' ' LYS . 19.9 mm -60.77 -35.66 65.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.286 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -50.12 35.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.213 0.53 . . . . 0.0 110.867 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.538 HD21 ' CD1' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -73.85 -21.13 60.22 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.132 -179.525 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.613 HG23 ' O ' ' A' ' 143' ' ' ILE . 14.9 t -74.52 171.52 13.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.996 0.427 . . . . 0.0 111.383 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.637 ' CG1' ' HB3' ' A' ' 39' ' ' ALA . 27.7 m -73.67 157.27 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.248 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.45 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 15.4 pt-20 -62.19 -54.17 44.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.12 0.486 . . . . 0.0 110.749 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.484 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 41.5 p90 -57.77 -1.15 0.09 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.409 ' HB2' ' CG2' ' A' ' 147' ' ' VAL . 75.0 mttt -132.57 -8.07 3.24 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.162 0.437 . . . . 0.0 111.878 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.546 ' HG3' HG23 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -61.7 -55.98 37.03 Favored Pre-proline 0 N--CA 1.463 0.192 0 CA-C-O 120.422 0.153 . . . . 0.0 110.744 179.308 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.536 ' HD3' ' HD2' ' A' ' 151' ' ' LYS . 29.9 Cg_endo -64.21 -28.51 64.41 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.083 1.855 . . . . 0.0 111.239 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 21.6 t -68.04 -52.92 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.499 ' HE1' ' CZ2' ' A' ' 107' ' ' TRP . 16.0 m-30 -63.42 -39.66 95.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.79 178.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.733 ' HD3' HG22 ' A' ' 143' ' ' ILE . 0.1 OUTLIER -53.79 -45.4 70.72 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.083 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.46 ' O ' HG23 ' A' ' 160' ' ' VAL . 3.0 tt0 -67.74 -33.88 75.74 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.711 HG13 ' CE2' ' A' ' 161' ' ' PHE . 47.3 t -64.77 -42.36 94.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.392 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.572 HD22 ' HB3' ' A' ' 139' ' ' PRO . 52.1 mt -63.84 -44.14 94.07 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.362 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.528 ' O ' ' HB1' ' A' ' 162' ' ' ALA . 40.0 t -52.09 -39.78 60.27 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.809 HG12 ' HA ' ' A' ' 76' ' ' VAL . 57.7 t -66.77 -41.15 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.105 177.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.711 ' CE2' HG13 ' A' ' 157' ' ' VAL . 23.1 m-30 -80.44 5.9 13.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.694 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.528 ' HB1' ' O ' ' A' ' 159' ' ' SER . . . -62.88 -50.99 74.62 Favored Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.828 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.607 ' HD2' ' O ' ' A' ' 160' ' ' VAL . 31.2 Cg_exo -57.67 -15.43 20.74 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 121.896 1.731 . . . . 0.0 111.209 178.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.527 ' NE2' ' HB2' ' A' ' 74' ' ' ALA . 83.6 m-70 -107.56 -25.76 11.21 Favored 'General case' 0 N--CA 1.458 -0.065 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.012 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.745 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 50.1 mt . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.543 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.424 ' HA2' ' CZ ' ' A' ' 82' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 112.404 -0.278 . . . . 0.0 112.404 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.37 136.14 68.11 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.575 2.183 . . . . 0.0 112.132 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.18 121.81 41.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.664 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.71 -19.06 45.6 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.562 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.589 ' HA ' ' O ' ' A' ' 79' ' ' TRP . 0.8 OUTLIER 64.95 -78.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.067 0.46 . . . . 0.0 111.401 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.403 ' HE3' ' N ' ' A' ' 5' ' ' SER . 5.7 mtm 68.51 130.63 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.681 -179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.7 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 9.7 t70 -66.19 -35.64 80.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.043 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.7 m -93.95 140.4 22.94 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.261 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.404 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 69.0 Cg_endo -74.64 106.4 2.25 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.378 2.052 . . . . 0.0 112.601 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.472 ' O ' ' O ' ' A' ' 11' ' ' GLU . 12.2 Cg_endo -54.42 -166.98 0.01 OUTLIER 'Trans proline' 0 CA--C 1.518 -0.313 0 C-N-CA 123.342 2.695 . . . . 0.0 112.659 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.5 ' O ' ' C ' ' A' ' 12' ' ' GLY . 0.1 OUTLIER -50.74 -165.78 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.163 179.617 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.5 ' C ' ' O ' ' A' ' 11' ' ' GLU . . . -24.53 -84.59 0.01 OUTLIER Glycine 0 C--N 1.335 0.488 0 CA-C-N 116.258 -0.428 . . . . 0.0 113.151 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.531 ' HA ' ' O ' ' A' ' 100' ' ' TRP . 11.0 m-85 59.25 137.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.616 0.246 . . . . 0.0 110.987 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.724 ' HA ' ' CZ3' ' A' ' 100' ' ' TRP . 8.8 ttt180 -66.71 74.66 0.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.34 0.591 . . . . 0.0 110.598 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 13' ' ' TYR . 0.7 OUTLIER -48.16 101.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.22 -179.656 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.7 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 3.4 m-80 -132.91 172.9 11.99 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.503 HG21 ' CA ' ' A' ' 57' ' ' ALA . 11.1 m -137.26 170.86 17.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 120.963 0.411 . . . . 0.0 111.221 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.545 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -137.1 158.82 24.46 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.814 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 3.5 mp -131.99 122.76 49.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 51.6 t -103.34 92.39 4.48 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.518 HD22 ' CD1' ' A' ' 112' ' ' PHE . 8.5 tp -98.3 122.06 40.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.647 -178.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.551 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -122.94 160.55 25.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.757 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.488 ' ND2' ' HB3' ' A' ' 112' ' ' PHE . 1.6 m120 -97.34 -178.12 4.06 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.526 0.679 . . . . 0.0 111.034 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -60.54 -7.41 2.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.747 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.529 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 1.3 m-20 -99.71 3.1 44.85 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.529 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER 72.51 22.05 3.46 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.073 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -96.41 140.74 30.62 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.471 ' N ' ' CD1' ' A' ' 28' ' ' ILE . 2.1 mp -97.2 144.03 11.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.658 0.742 . . . . 0.0 112.094 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.408 ' CZ ' HG23 ' A' ' 119' ' ' ILE . 5.5 t80 -70.74 106.62 3.62 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.462 -1.245 . . . . 0.0 111.014 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.506 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -104.0 142.87 33.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.72 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.541 ' HB2' ' CG ' ' A' ' 131' ' ' PHE . . . -141.3 137.0 32.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.728 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.586 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 10.0 p -101.88 151.41 22.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.645 ' O ' ' N ' ' A' ' 35' ' ' ASP . 7.7 mtp180 -73.4 129.27 37.65 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.367 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.719 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -56.08 53.96 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.72 0.408 . . . . 0.0 112.083 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.645 ' N ' ' O ' ' A' ' 33' ' ' ARG . 4.7 t0 -175.78 -35.31 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.082 0.468 . . . . 0.0 110.098 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.566 ' HB ' ' HB2' ' A' ' 39' ' ' ALA . 6.7 mm -112.97 106.05 55.35 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.559 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.81 -62.08 0.18 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.122 2.548 . . . . 0.0 113.98 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -67.2 0.7 2.54 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.586 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.74 96.88 10.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.776 0.322 . . . . 0.0 111.059 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.613 ' O ' ' HA ' ' A' ' 146' ' ' THR . 69.7 m95 -100.93 148.51 24.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.783 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.456 ' NE2' ' CD ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -156.19 163.64 39.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.636 0.731 . . . . 0.0 112.466 -179.102 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.438 ' HE3' ' CD2' ' A' ' 154' ' ' TYR . 12.2 mtm -97.93 150.93 37.27 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.481 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -50.18 146.35 18.15 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.186 1.924 . . . . 0.0 111.966 -179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -173.07 150.96 2.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.642 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.43 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . -160.14 160.67 31.86 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.387 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.7 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -81.13 139.67 20.69 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.479 -179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.424 ' CG1' HG13 ' A' ' 17' ' ' VAL . 40.5 mt -69.82 138.94 21.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.639 -0.281 . . . . 0.0 111.385 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -69.04 -173.54 0.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.974 0.416 . . . . 0.0 110.914 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -46.09 -82.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.148 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -112.07 55.97 0.49 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.994 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -112.4 147.67 35.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.952 0.406 . . . . 0.0 110.852 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.467 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 29.1 m-20 -68.73 164.33 46.88 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.132 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.426 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 3.6 Cg_exo -78.91 -51.41 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.689 2.259 . . . . 0.0 111.401 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.532 ' HD3' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -51.94 -46.04 64.56 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.331 179.41 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -67.11 -41.8 85.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.108 179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.467 ' HB1' ' O ' ' A' ' 52' ' ' ASP . . . -61.07 -44.22 97.71 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.503 ' CA ' HG21 ' A' ' 17' ' ' VAL . . . -56.49 -52.27 65.36 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.747 178.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.464 HG13 ' O ' ' A' ' 54' ' ' ARG . 9.7 mt -56.32 -55.8 16.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.261 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.73 -63.89 1.14 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.011 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.43 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 0.2 OUTLIER -43.52 -46.12 6.84 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-O 121.248 0.547 . . . . 0.0 110.039 179.583 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.451 HD13 ' HB ' ' A' ' 67' ' ' VAL . 10.0 tp -52.84 -47.11 67.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.156 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.494 ' O ' ' N ' ' A' ' 66' ' ' GLY . 19.7 ttm180 -64.48 -64.97 0.74 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.33 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.12 -21.79 0.82 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.324 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -96.57 -35.17 11.17 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.491 HG21 ' CD2' ' A' ' 121' ' ' LEU . 0.6 OUTLIER -129.91 -4.69 4.55 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -178.594 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.494 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 80.35 -11.13 39.41 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.448 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.5 HG23 HG12 ' A' ' 119' ' ' ILE . 85.4 t -58.0 112.62 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-O 121.079 0.466 . . . . 0.0 111.625 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.472 ' CG2' ' HG3' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -123.86 -39.86 2.36 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.646 178.172 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.6 m -62.24 75.62 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.955 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.63 157.84 25.24 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.157 0.503 . . . . 0.0 112.305 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.453 ' HG3' HG22 ' A' ' 113' ' ' THR . 2.6 mt-10 -131.29 150.17 52.26 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.442 179.643 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.532 HG21 ' HD3' ' A' ' 54' ' ' ARG . 6.4 t -75.51 127.09 36.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.21 0.529 . . . . 0.0 111.414 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.541 HD12 ' HB2' ' A' ' 111' ' ' LYS . 0.7 OUTLIER -109.13 -19.65 6.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.559 179.466 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.455 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -168.92 177.47 4.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.755 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.455 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -157.46 147.78 20.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.664 179.851 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.734 ' HA ' HG13 ' A' ' 160' ' ' VAL . 50.2 t -71.51 139.17 83.74 Favored Pre-proline 0 C--N 1.332 -0.152 0 CA-C-O 121.084 0.469 . . . . 0.0 110.827 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.413 ' HD3' HG11 ' A' ' 160' ' ' VAL . 36.4 Cg_endo -66.21 -52.88 0.75 Allowed 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.805 2.337 . . . . 0.0 112.916 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.7 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -101.21 174.12 6.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.314 0.578 . . . . 0.0 112.13 -178.763 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.589 ' O ' ' HA ' ' A' ' 5' ' ' SER . 46.9 m95 -92.61 95.86 9.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.487 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.459 ' CD1' HG23 ' A' ' 157' ' ' VAL . 62.4 mt -57.5 110.56 0.89 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.776 0.322 . . . . 0.0 110.823 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.606 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 3.7 p -107.21 -158.46 0.65 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.229 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.424 ' CZ ' ' HA2' ' A' ' 1' ' ' GLY . 7.2 t80 -169.26 40.05 0.03 OUTLIER 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.732 0.301 . . . . 0.0 111.239 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -73.19 162.65 29.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.869 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.538 ' HD2' HD11 ' A' ' 92' ' ' LEU . 1.1 m-85 -99.66 160.82 26.38 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.413 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.508 ' CB ' ' HD2' ' A' ' 86' ' ' PRO . 31.4 Cg_exo -58.78 -174.98 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.657 2.238 . . . . 0.0 111.528 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.508 ' HD2' ' CB ' ' A' ' 85' ' ' PRO . 54.0 Cg_endo -70.43 -9.08 25.11 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.105 1.87 . . . . 0.0 113.361 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.402 ' HG3' ' H ' ' A' ' 88' ' ' VAL . 0.2 OUTLIER -99.25 -53.05 3.34 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.2 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.458 ' HB ' ' HB3' ' A' ' 84' ' ' PHE . 21.1 t -72.42 -8.52 11.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.737 0.303 . . . . 0.0 111.118 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.575 ' O ' ' HB3' ' A' ' 93' ' ' ASN . 0.7 OUTLIER -68.2 -2.41 8.03 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.587 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.3 -22.61 10.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.746 0.308 . . . . 0.0 110.951 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.58 -23.26 19.1 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.262 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.538 HD11 ' HD2' ' A' ' 84' ' ' PHE . 1.3 tm? -120.1 -56.21 2.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.885 0.374 . . . . 0.0 111.186 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.713 ' OD1' ' HA ' ' A' ' 101' ' ' LYS . 1.4 t-20 -51.13 -58.33 6.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.61 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.518 HD11 ' N ' ' A' ' 94' ' ' ILE . 1.7 mp -67.18 -12.93 15.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.22 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 1.2 mm-40 -76.38 -5.85 49.05 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.734 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.667 ' HB3' ' HD1' ' A' ' 100' ' ' TRP . 70.5 m95 -87.95 16.78 5.51 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.073 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.487 ' O ' ' CB ' ' A' ' 98' ' ' SER . . . 79.66 0.85 85.73 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.562 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.487 ' CB ' ' O ' ' A' ' 97' ' ' GLY . 2.2 p 89.29 161.2 0.06 Allowed 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 122.75 0.42 . . . . 0.0 111.572 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 65.42 19.61 11.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.11 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.724 ' CZ3' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -116.32 -30.61 5.87 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.478 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.713 ' HA ' ' OD1' ' A' ' 93' ' ' ASN . 0.9 OUTLIER 17.21 54.92 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -178.716 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 100.43 -163.78 18.93 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.896 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.606 ' O ' ' HA ' ' A' ' 81' ' ' THR . 5.5 tt0 -145.01 101.33 3.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.47 -0.365 . . . . 0.0 110.373 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -90.6 112.39 24.08 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.196 0.522 . . . . 0.0 110.397 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.696 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 40.7 mt-30 -126.12 133.07 51.74 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -105.72 130.66 53.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.34 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.545 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 14.3 m95 -99.34 161.47 13.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.055 0.455 . . . . 0.0 111.735 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.482 ' CE1' ' HG2' ' A' ' 54' ' ' ARG . 98.1 m-85 -139.9 152.13 46.16 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.292 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.416 ' CD2' ' CB ' ' A' ' 164' ' ' HIS . 17.3 tp -99.01 134.81 41.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.458 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.484 ' CE2' HG23 ' A' ' 72' ' ' VAL . 27.2 m-85 -136.46 144.67 44.51 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 15.2 tttt -103.94 119.95 40.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.216 177.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.518 ' CD1' HD22 ' A' ' 21' ' ' LEU . 43.0 t80 -78.37 100.46 6.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.794 0.331 . . . . 0.0 110.667 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.453 HG22 ' HG3' ' A' ' 71' ' ' GLU . 18.6 p -97.13 45.16 1.04 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.85 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.68 -147.93 4.75 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.058 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -119.34 149.72 41.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 0.0 111.056 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.424 ' C ' ' H ' ' A' ' 118' ' ' GLU . 14.7 p-10 -60.38 -38.68 84.69 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.512 0.672 . . . . 0.0 111.243 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -55.98 -3.03 0.07 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.598 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' A' ' 116' ' ' ASP . 1.1 tt0 -89.71 -18.88 25.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.943 0.401 . . . . 0.0 110.556 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.547 HD13 ' CH2' ' A' ' 134' ' ' TRP . 20.1 mt -85.0 106.21 14.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.849 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 38.3 t30 -100.54 -25.41 14.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.327 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.491 ' CD2' HG21 ' A' ' 65' ' ' THR . 46.5 mt 78.91 -34.41 0.16 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.206 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.505 ' HA ' ' HB3' ' A' ' 129' ' ' PRO . 66.9 mt -62.92 167.64 4.57 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.996 0.426 . . . . 0.0 111.22 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -152.26 2.9 0.36 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.273 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.1 p30 49.74 39.8 18.67 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.992 0.425 . . . . 0.0 111.042 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -74.13 1.49 48.4 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.331 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 65.64 24.85 11.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.94 0.37 . . . . 0.0 110.733 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.92 -59.34 0.28 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.543 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? -178.39 155.42 0.94 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.976 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.575 ' HG2' HD13 ' A' ' 34' ' ' LEU . 13.9 Cg_endo -72.61 -175.22 1.74 Allowed 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.5 2.133 . . . . 0.0 112.179 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.441 ' C ' HD12 ' A' ' 34' ' ' LEU . 3.1 mm-40 -92.7 -71.21 0.66 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.358 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.541 ' CG ' ' HB2' ' A' ' 31' ' ' ALA . 1.9 m-85 -104.41 142.42 34.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.673 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.719 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -85.03 -37.46 10.02 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.043 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -146.24 145.39 30.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.76 0.314 . . . . 0.0 110.483 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.547 ' CH2' HD13 ' A' ' 119' ' ' ILE . 36.2 p-90 -135.71 170.95 15.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.27 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.5 t -167.68 178.48 5.3 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.491 0.662 . . . . 0.0 112.719 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.468 ' CD2' ' OD1' ' A' ' 23' ' ' ASN . 81.2 m95 -113.12 102.99 10.91 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.588 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 25.4 m -120.83 170.44 10.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.536 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 11.1 p -75.41 173.05 7.65 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.889 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.565 ' O ' HG12 ' A' ' 143' ' ' ILE . 12.3 Cg_exo -62.61 -54.01 1.49 Allowed 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.731 1.621 . . . . 0.0 110.381 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -63.93 -30.69 71.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.356 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.76 -43.77 65.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.474 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.506 HD13 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -59.8 -39.27 84.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.313 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.606 ' O ' HG22 ' A' ' 146' ' ' THR . 34.1 mm -63.04 -37.21 78.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.19 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.94 -50.81 38.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.35 0.595 . . . . 0.0 110.528 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.448 HD23 ' CD1' ' A' ' 40' ' ' TRP . 1.3 mp -73.49 -19.82 60.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.179 -0.918 . . . . 0.0 112.709 -179.193 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.613 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 12.4 t -75.81 172.06 13.33 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.111 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 26.9 m -82.77 145.17 8.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.378 -179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.51 ' HG3' ' HE3' ' A' ' 151' ' ' LYS . 6.7 mt-10 -47.46 -50.32 23.27 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.602 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -50.2 -12.27 0.08 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -135.37 -3.91 2.38 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.547 ' HG2' ' CG2' ' A' ' 146' ' ' THR . 8.1 mttt -58.69 -60.71 9.5 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.379 0.133 . . . . 0.0 111.178 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.468 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 32.3 Cg_endo -64.44 -27.57 62.53 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.641 2.227 . . . . 0.0 111.754 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 40.3 t -67.88 -50.41 59.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.516 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.501 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 8.9 m-30 -66.59 -38.54 87.23 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.021 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.485 ' N ' HD13 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -57.24 -41.18 79.09 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.812 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -70.09 -31.48 69.08 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.478 HG11 ' CE2' ' A' ' 161' ' ' PHE . 51.0 t -66.9 -42.2 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.797 178.625 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.56 HD22 ' HB3' ' A' ' 139' ' ' PRO . 74.0 mt -63.89 -40.23 96.04 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.238 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 64.2 m -56.41 -41.79 76.93 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.734 HG13 ' HA ' ' A' ' 76' ' ' VAL . 89.3 t -66.74 -43.72 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 115.525 -0.761 . . . . 0.0 108.983 177.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.478 ' CE2' HG11 ' A' ' 157' ' ' VAL . 21.9 m-30 -81.12 7.46 11.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.436 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.455 ' N ' ' CD ' ' A' ' 163' ' ' PRO . . . -59.22 -50.45 87.56 Favored Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.755 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.5 ' HD2' ' O ' ' A' ' 160' ' ' VAL . 34.0 Cg_exo -59.41 -13.05 18.87 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.425 2.083 . . . . 0.0 111.58 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.455 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 86.7 m-70 -109.02 -20.75 12.92 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.294 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.469 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 83.8 mt . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.942 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.953 0 N-CA-C 112.194 -0.362 . . . . 0.0 112.194 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.37 132.72 49.87 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.567 2.178 . . . . 0.0 111.75 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 82' ' ' TYR . 0.3 OUTLIER -92.39 141.48 28.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.072 0.463 . . . . 0.0 111.161 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -96.97 12.53 65.63 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.661 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.937 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 97.5 p 55.45 -89.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.452 ' HB2' ' O ' ' A' ' 5' ' ' SER . 1.9 mpp? 67.39 122.37 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.847 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.677 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 12.4 p-10 -69.37 -32.46 71.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.015 0.436 . . . . 0.0 110.759 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.436 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 29.8 m -103.07 134.23 19.9 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.203 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.41 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 68.7 Cg_endo -74.79 104.41 1.88 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.26 1.974 . . . . 0.0 112.317 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.582 ' HG2' ' CD2' ' A' ' 13' ' ' TYR . 6.2 Cg_endo -49.62 163.6 0.45 Allowed 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 123.107 2.538 . . . . 0.0 112.665 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -51.01 130.41 25.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.651 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.84 87.89 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.504 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.631 ' CZ ' ' HG3' ' A' ' 101' ' ' LYS . 8.2 m-85 -154.21 153.72 32.26 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.574 ' HA ' ' CZ3' ' A' ' 100' ' ' TRP . 0.2 OUTLIER -65.23 -158.18 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.543 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.658 ' HG2' HD11 ' A' ' 47' ' ' ILE . 23.2 ttt180 179.98 101.34 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.212 0.53 . . . . 0.0 109.751 -178.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.558 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 23.7 m-80 -130.9 171.68 12.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.981 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.684 HG11 ' CD1' ' A' ' 47' ' ' ILE . 22.4 m -134.26 163.34 37.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.14 0.495 . . . . 0.0 111.199 178.172 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.602 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -138.66 157.87 24.82 Favored Glycine 0 N--CA 1.442 -0.955 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.301 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.597 HG22 ' CD1' ' A' ' 110' ' ' PHE . 2.1 mp -128.56 118.22 46.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 50.3 t -96.82 98.34 10.05 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 177.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.61 HD21 ' HD1' ' A' ' 112' ' ' PHE . 32.0 tp -99.29 116.18 30.87 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.106 -177.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.672 ' HE2' HD12 ' A' ' 73' ' ' ILE . 1.6 ptt? -119.66 161.77 20.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.027 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -94.45 171.32 8.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.092 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -57.34 -5.53 0.32 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.703 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.565 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.6 OUTLIER -99.37 3.04 45.79 Favored 'General case' 0 CA--C 1.521 -0.136 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 11.0 mmtp 73.71 21.88 2.68 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.986 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.605 ' O ' ' HA ' ' A' ' 22' ' ' MET . 2.3 mmtt -92.66 143.17 26.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.674 HG13 ' HA ' ' A' ' 139' ' ' PRO . 1.4 mm -98.96 138.0 24.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.17 0.51 . . . . 0.0 112.283 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.643 ' CE1' HD12 ' A' ' 119' ' ' ILE . 78.1 t80 -75.05 136.67 41.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.398 177.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 134' ' ' TRP . . . -140.33 151.48 45.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.679 0.275 . . . . 0.0 111.102 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.5 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -141.34 138.14 32.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.33 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.673 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 43.9 p -95.69 144.87 25.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.66 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 35.1 mtp180 -69.68 136.15 50.71 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.213 0.53 . . . . 0.0 111.318 -179.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.616 ' H ' ' CD2' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -42.11 -48.9 4.82 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.583 -178.947 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -71.69 -33.25 68.64 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.95 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.559 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 2.8 mt -122.45 110.46 32.24 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.758 0.313 . . . . 0.0 111.531 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.6 -18.77 15.15 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.449 2.099 . . . . 0.0 112.382 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -91.73 -10.45 40.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.352 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.673 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.2 96.47 10.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.564 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.668 ' O ' ' HA ' ' A' ' 146' ' ' THR . 76.0 m95 -90.86 147.59 23.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.682 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -154.84 169.73 23.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.471 0.653 . . . . 0.0 111.667 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.497 ' HE3' ' CZ3' ' A' ' 107' ' ' TRP . 19.3 mtm -107.3 147.2 34.78 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.176 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_endo -48.8 136.88 27.91 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.459 2.106 . . . . 0.0 111.525 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.463 ' CB ' ' HA2' ' A' ' 18' ' ' GLY . 3.1 pp0? -173.08 155.01 2.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.996 0.427 . . . . 0.0 111.269 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 16' ' ' ASN . . . -156.04 -165.1 14.04 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.571 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -95.71 -148.72 24.64 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.209 -0.996 . . . . 0.0 113.243 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.684 ' CD1' HG11 ' A' ' 17' ' ' VAL . 3.0 mt -163.04 125.92 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.545 -0.328 . . . . 0.0 110.488 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.29 169.51 16.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.083 0.468 . . . . 0.0 111.122 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -46.25 -62.22 1.44 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.696 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -99.88 42.35 1.99 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.775 -0.726 . . . . 0.0 113.089 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -119.64 128.81 54.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.553 0.216 . . . . 0.0 110.571 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -69.13 164.61 46.59 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.501 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 3.4 Cg_exo -76.81 -48.05 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.65 2.233 . . . . 0.0 111.912 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.706 ' HE ' HG13 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -55.84 -43.87 77.43 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.21 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -66.92 -45.13 78.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.293 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 60' ' ' GLU . . . -62.29 -43.79 98.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.672 ' CA ' HG23 ' A' ' 17' ' ' VAL . . . -57.37 -61.14 2.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.902 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.519 HG12 ' CE2' ' A' ' 110' ' ' PHE . 25.4 mt -54.61 -48.65 70.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.393 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 13.5 ttt180 -64.96 -62.24 1.67 Allowed 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 121.066 -0.254 . . . . 0.0 111.078 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.416 ' HG3' ' HA3' ' A' ' 45' ' ' GLY . 44.8 mm-40 -42.53 -48.68 5.35 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-O 120.908 0.385 . . . . 0.0 110.101 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.477 HD22 ' O ' ' A' ' 67' ' ' VAL . 0.4 OUTLIER -51.25 -47.84 62.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.267 178.761 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.472 ' HG3' ' CG2' ' A' ' 68' ' ' THR . 9.0 ttm180 -63.94 -65.28 0.7 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.124 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -48.62 -19.94 0.4 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -98.82 -35.37 10.14 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -124.68 -6.93 7.4 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 120.326 -0.549 . . . . 0.0 112.319 -178.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.471 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 79.56 -12.35 28.09 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.488 -178.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.477 ' O ' HD22 ' A' ' 61' ' ' LEU . 78.9 t -57.43 121.8 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 121.164 0.506 . . . . 0.0 111.306 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.49 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -131.78 -38.22 1.14 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.808 178.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 113' ' ' THR . 5.8 m -61.24 71.75 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.894 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.562 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -159.81 153.34 22.52 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.097 0.475 . . . . 0.0 112.212 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.544 ' HG3' HG21 ' A' ' 113' ' ' THR . 1.4 mt-10 -128.19 151.73 48.9 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.845 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.706 HG13 ' HE ' ' A' ' 54' ' ' ARG . 10.8 t -75.43 132.66 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 121.313 0.577 . . . . 0.0 111.575 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.672 HD12 ' HE2' ' A' ' 22' ' ' MET . 1.7 mt -109.85 -18.79 7.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.932 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.489 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.22 176.03 4.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.604 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -152.71 145.58 24.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.452 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.674 ' HA ' HG13 ' A' ' 160' ' ' VAL . 52.9 t -71.94 134.67 83.27 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.142 0.496 . . . . 0.0 111.208 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.42 ' HD3' HG11 ' A' ' 160' ' ' VAL . 33.0 Cg_endo -67.39 -56.87 0.2 Allowed 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.912 2.408 . . . . 0.0 113.01 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.677 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 1.3 p90 -97.29 178.28 5.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.813 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.495 ' C ' ' HG ' ' A' ' 80' ' ' LEU . 56.1 m95 -94.83 -158.58 0.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.47 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.937 ' HA ' ' HA ' ' A' ' 5' ' ' SER . 13.1 mt -159.87 103.24 1.5 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.127 0.489 . . . . 0.0 110.359 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.876 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 7.2 p -115.02 100.66 8.35 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.35 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.546 ' CE1' ' HB2' ' A' ' 103' ' ' GLN . 0.1 OUTLIER -83.03 91.93 7.28 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.135 178.606 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -69.53 -136.88 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.568 ' HD1' ' HD2' ' A' ' 85' ' ' PRO . 0.6 OUTLIER -176.96 156.03 1.26 Allowed Pre-proline 0 N--CA 1.466 0.369 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.574 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 41.6 Cg_exo -58.35 -176.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.429 2.086 . . . . 0.0 111.043 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.511 ' HD2' ' CB ' ' A' ' 85' ' ' PRO . 39.2 Cg_endo -66.6 -11.23 30.91 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.341 2.027 . . . . 0.0 113.188 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -86.18 -62.8 1.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.631 0.253 . . . . 0.0 111.194 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.552 ' HB ' ' CG ' ' A' ' 84' ' ' PHE . 3.2 t -70.57 -20.73 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.291 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.574 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -48.42 -27.03 2.38 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.896 0.379 . . . . 0.0 110.408 179.54 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.44 ' HA ' HD12 ' A' ' 94' ' ' ILE . 7.1 mt-10 -68.24 -64.04 0.94 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.051 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.461 ' O ' ' HG2' ' A' ' 95' ' ' GLN . 13.5 mttt -66.2 -6.46 13.69 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.763 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.678 ' C ' HD23 ' A' ' 92' ' ' LEU . 0.1 OUTLIER -99.35 -63.69 1.1 Allowed 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.17 179.089 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.529 ' ND2' ' HB3' ' A' ' 101' ' ' LYS . 59.7 t-20 -81.41 -50.38 9.52 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.625 ' H ' HD13 ' A' ' 94' ' ' ILE . 3.0 mp -68.52 -8.36 9.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.723 -178.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -80.7 -3.13 49.59 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.574 0.226 . . . . 0.0 111.056 178.526 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.524 ' CD1' ' O ' ' A' ' 92' ' ' LEU . 81.5 m95 -108.17 -55.38 2.38 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.826 0.346 . . . . 0.0 111.55 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 171.57 -81.39 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.36 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -170.01 25.98 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.343 0.592 . . . . 0.0 111.755 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -131.25 -54.22 1.03 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.941 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.574 ' CZ3' ' HA ' ' A' ' 14' ' ' ARG . 43.2 m95 -54.62 -175.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.079 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.631 ' HG3' ' CZ ' ' A' ' 13' ' ' TYR . 4.2 ptpt 164.6 9.26 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.515 ' HA2' HD21 ' A' ' 92' ' ' LEU . . . 175.23 -161.7 31.01 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.347 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.876 ' O ' ' HA ' ' A' ' 81' ' ' THR . 7.1 mt-30 -146.36 117.66 7.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.199 0.499 . . . . 0.0 111.427 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.426 ' HA ' HG22 ' A' ' 81' ' ' THR . . . -94.02 122.75 36.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.018 0.437 . . . . 0.0 111.791 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.821 ' HG2' ' HB2' ' A' ' 80' ' ' LEU . 0.9 OUTLIER -129.2 118.82 23.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.875 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 16.3 ttpp -102.91 129.07 49.5 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.939 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.602 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 22.7 m95 -102.38 165.18 11.26 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -177.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.501 ' CZ ' ' HB2' ' A' ' 53' ' ' PRO . 96.5 m-85 -137.53 153.94 49.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.546 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.623 ' O ' HG11 ' A' ' 72' ' ' VAL . 16.8 tp -101.08 139.46 36.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.402 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.597 ' CD1' HG22 ' A' ' 19' ' ' ILE . 34.0 m-85 -141.88 145.97 35.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.555 0.693 . . . . 0.0 112.828 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.562 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 18.7 tttt -104.69 123.3 47.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.917 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.61 ' HD1' HD21 ' A' ' 21' ' ' LEU . 46.5 t80 -78.6 95.32 5.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.868 0.366 . . . . 0.0 110.663 179.115 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.544 HG21 ' HG3' ' A' ' 71' ' ' GLU . 65.7 p -94.16 50.89 1.43 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.876 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -151.99 -143.43 3.7 Favored Glycine 0 N--CA 1.453 -0.217 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.055 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -124.97 150.0 47.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.368 . . . . 0.0 111.244 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.45 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 20.3 p-10 -57.07 -39.03 74.16 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.519 0.676 . . . . 0.0 111.143 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -58.21 -4.58 0.37 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.101 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 116' ' ' ASP . 1.3 tt0 -89.62 -17.02 29.24 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.079 0.466 . . . . 0.0 110.128 179.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.643 HD12 ' CE1' ' A' ' 29' ' ' PHE . 7.6 mt -78.77 99.88 3.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.33 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.98 91.08 3.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.529 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -69.93 -14.27 62.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.73 0.3 . . . . 0.0 110.631 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.483 ' CD2' ' HG3' ' A' ' 129' ' ' PRO . 2.9 mt -106.72 -165.69 1.1 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.886 -179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 121.14 128.09 3.5 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.472 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 57.56 -179.07 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.82 0.343 . . . . 0.0 110.906 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -65.51 -84.27 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.207 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.474 ' C ' ' H ' ' A' ' 128' ' ' LYS . 0.1 OUTLIER 59.21 15.04 3.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.462 0.172 . . . . 0.0 111.289 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.404 ' HB3' ' HZ3' ' A' ' 128' ' ' LYS . 0.0 OUTLIER 70.09 -41.64 0.49 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.614 0.245 . . . . 0.0 111.475 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.474 ' H ' ' C ' ' A' ' 126' ' ' SER . 0.0 OUTLIER -178.0 157.84 1.15 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.935 0.398 . . . . 0.0 110.654 179.396 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.486 ' HG2' ' CD1' ' A' ' 34' ' ' LEU . 2.3 Cg_endo -65.95 -174.08 0.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.948 1.766 . . . . 0.0 111.587 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.45 ' O ' HD22 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -99.73 -34.84 10.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.298 0.57 . . . . 0.0 109.74 179.408 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.505 ' N ' HD21 ' A' ' 34' ' ' LEU . 4.9 m-85 -133.78 139.18 46.16 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.582 ' N ' HD23 ' A' ' 34' ' ' LEU . . . -77.58 -35.79 35.52 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.848 -178.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -156.13 152.01 27.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.872 0.368 . . . . 0.0 111.083 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.568 ' CZ2' HD13 ' A' ' 119' ' ' ILE . 27.5 p-90 -133.15 163.99 28.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.197 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.483 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 13.4 t -158.95 167.33 29.66 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.157 0.503 . . . . 0.0 112.072 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.473 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 37.3 m95 -103.44 102.84 12.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.4 177.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 28' ' ' ILE . 26.4 m -118.21 164.91 14.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.539 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 26.8 p -71.64 168.98 17.52 Favored Pre-proline 0 C--N 1.325 -0.474 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.408 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.674 ' HA ' HG13 ' A' ' 28' ' ' ILE . 16.2 Cg_exo -58.91 -58.82 0.57 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 121.72 1.613 . . . . 0.0 110.826 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.28 -27.16 68.83 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.794 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.528 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 29.1 mt-30 -71.69 -47.47 53.85 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.205 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.479 HD12 ' HB3' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -56.24 -41.28 75.48 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.571 ' O ' HG22 ' A' ' 146' ' ' THR . 19.1 mm -61.44 -34.57 61.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.219 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.39 -50.92 23.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.262 0.553 . . . . 0.0 110.858 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.2 mp -73.49 -21.47 60.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.311 -0.858 . . . . 0.0 112.281 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.668 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 12.1 t -73.61 174.81 7.78 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.918 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 33.0 m -80.02 160.2 4.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.688 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.435 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 2.4 mt-10 -60.59 -51.9 67.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.07 0.462 . . . . 0.0 110.915 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.24 -7.65 0.15 Allowed 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.494 ' HA ' HG21 ' A' ' 153' ' ' VAL . 0.8 OUTLIER -131.43 -6.38 3.75 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.571 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -61.74 -53.57 59.55 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 110.543 -0.169 . . . . 0.0 110.543 179.499 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 39.5 Cg_endo -67.97 -28.88 35.03 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.259 1.973 . . . . 0.0 111.347 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.494 HG21 ' HA ' ' A' ' 150' ' ' LYS . 17.3 t -68.47 -52.83 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.469 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 6.1 m-30 -65.75 -37.1 85.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.784 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.571 ' HB2' ' O ' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -57.46 -41.61 80.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.591 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -68.35 -34.32 75.88 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.529 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 53.8 t -64.9 -41.17 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.347 178.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.457 HD21 ' HB3' ' A' ' 139' ' ' PRO . 56.7 mt -63.65 -48.91 75.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.666 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.482 ' O ' ' HB3' ' A' ' 162' ' ' ALA . 0.9 OUTLIER -49.2 -40.1 32.16 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.188 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.674 HG13 ' HA ' ' A' ' 76' ' ' VAL . 58.5 t -67.63 -42.91 87.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.328 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.582 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 21.9 m-30 -80.71 5.15 16.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.38 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.593 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.85 -53.36 67.22 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.628 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.7 Cg_endo -58.77 -13.2 17.09 Favored 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 122.17 1.914 . . . . 0.0 111.729 178.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.489 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 95.1 m-70 -107.06 -19.08 13.73 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.205 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 96.5 mt . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.807 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 112.566 -0.213 . . . . 0.0 112.566 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.54 -179.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.551 2.168 . . . . 0.0 111.673 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.418 HD13 ' O ' ' A' ' 3' ' ' LEU . 0.3 OUTLIER -91.17 165.42 13.49 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.028 0.442 . . . . 0.0 111.377 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -115.08 -29.31 2.6 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.615 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.494 ' HB3' ' CD2' ' A' ' 80' ' ' LEU . 0.3 OUTLIER 63.16 138.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.2 0.524 . . . . 0.0 111.577 179.574 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 4.1 mtm -144.58 155.94 43.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.383 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.519 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 12.2 t70 -64.55 -47.59 78.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.916 0.389 . . . . 0.0 110.54 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.404 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 0.8 OUTLIER -100.18 148.96 35.58 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.107 179.087 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.493 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 57.7 Cg_endo -71.86 105.33 1.78 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.259 1.973 . . . . 0.0 112.06 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.531 ' HB2' ' CE2' ' A' ' 13' ' ' TYR . 6.2 Cg_endo -49.43 166.53 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 123.122 2.548 . . . . 0.0 113.043 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -53.45 130.91 37.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.057 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.481 ' CA ' ' HA ' ' A' ' 100' ' ' TRP . . . 56.25 81.89 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.293 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.662 ' CE1' ' HB ' ' A' ' 81' ' ' THR . 35.4 m-85 -154.16 119.7 5.18 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.723 ' HB3' ' HG3' ' A' ' 103' ' ' GLN . 8.3 ttt180 -66.56 91.28 0.18 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.054 0.454 . . . . 0.0 111.526 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.594 ' HG3' ' CZ3' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -48.0 112.94 0.64 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.214 179.324 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.61 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 2.0 m-80 -131.59 173.74 10.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.46 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.618 HG23 ' CA ' ' A' ' 57' ' ' ALA . 6.6 m -139.55 165.32 22.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.174 0.511 . . . . 0.0 111.84 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.527 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -135.38 155.31 22.08 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 178.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.776 HG13 ' HB2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -129.67 124.51 59.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.069 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.521 ' CB ' ' HE2' ' A' ' 161' ' ' PHE . 0.5 OUTLIER -106.6 108.69 20.32 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.953 177.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.533 HD21 ' CG1' ' A' ' 67' ' ' VAL . 11.0 tp -104.19 124.3 48.87 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.582 -178.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.701 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -124.34 155.18 39.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.95 179.342 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.506 ' OD1' ' CE3' ' A' ' 136' ' ' TRP . 0.2 OUTLIER -92.85 176.04 6.58 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.05 0.452 . . . . 0.0 110.134 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.434 ' HA ' ' HE3' ' A' ' 111' ' ' LYS . 1.1 m-80 -57.24 -6.94 0.46 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.064 177.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.593 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 5.5 m-20 -100.46 -0.15 38.56 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.593 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 14.7 mmtm 76.97 19.86 1.33 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.291 -178.545 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.701 ' O ' ' HA ' ' A' ' 22' ' ' MET . 3.8 mmtt -93.57 141.58 28.31 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.438 ' N ' ' CD1' ' A' ' 28' ' ' ILE . 2.2 mp -101.5 143.51 14.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.669 0.747 . . . . 0.0 112.358 -178.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.492 ' CE1' HD12 ' A' ' 119' ' ' ILE . 11.3 t80 -69.85 108.05 3.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.196 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 134' ' ' TRP . . . -106.92 145.89 31.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.948 0.404 . . . . 0.0 110.924 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.469 ' HB3' ' CG ' ' A' ' 131' ' ' PHE . . . -139.5 137.52 35.57 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.236 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.788 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 25.0 p -99.19 141.75 31.55 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.998 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.583 ' HD2' ' HB3' ' A' ' 39' ' ' ALA . 1.7 mtt85 -69.59 128.34 36.14 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.796 HD11 ' HG2' ' A' ' 129' ' ' PRO . 0.5 OUTLIER -46.4 -35.73 5.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.318 0.58 . . . . 0.0 110.891 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -70.67 -33.97 71.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.665 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.665 ' HB ' ' HB1' ' A' ' 39' ' ' ALA . 20.4 mm -131.05 104.75 15.16 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.914 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.55 -20.37 60.4 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.765 2.31 . . . . 0.0 112.676 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.01 -4.0 53.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.412 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.788 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.97 91.83 8.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.112 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.544 ' O ' ' HA ' ' A' ' 146' ' ' THR . 77.3 m95 -91.83 164.38 13.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.357 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.579 ' HG2' ' NH1' ' A' ' 33' ' ' ARG . 0.0 OUTLIER 174.24 175.13 0.16 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.81 0.814 . . . . 0.0 112.264 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.577 ' HG3' ' CZ3' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -108.19 156.7 37.95 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.29 177.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.443 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 10.1 Cg_endo -50.7 157.35 3.64 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.498 2.132 . . . . 0.0 112.665 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.523 ' HA ' HD11 ' A' ' 19' ' ' ILE . 4.5 pt20 177.99 150.62 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.6 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -160.9 -157.27 8.64 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.447 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -122.22 143.01 15.33 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.91 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.422 HD11 ' HB3' ' A' ' 53' ' ' PRO . 48.5 mt -70.01 146.71 12.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.916 0.389 . . . . 0.0 111.532 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -69.49 -175.08 0.77 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.72 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.51 -61.33 2.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.339 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.85 57.35 0.73 Allowed Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.689 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.415 ' O ' HG21 ' A' ' 47' ' ' ILE . 47.7 tp10 -117.17 155.7 28.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.693 0.283 . . . . 0.0 110.469 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -72.02 161.56 78.19 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.496 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 5.6 Cg_exo -78.3 -49.17 0.09 OUTLIER 'Trans proline' 0 CA--C 1.515 -0.441 0 C-N-CA 122.635 2.223 . . . . 0.0 111.73 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.574 ' HG2' ' CD2' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -52.26 -46.92 65.99 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.47 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 70.3 m-20 -67.71 -41.85 82.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.376 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.22 -42.26 98.29 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.618 ' CA ' HG23 ' A' ' 17' ' ' VAL . . . -57.47 -54.27 48.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.855 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.512 HD13 ' HD2' ' A' ' 54' ' ' ARG . 21.3 mt -56.39 -53.0 45.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.854 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 24.1 mtt180 -61.21 -57.71 11.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.652 -178.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.406 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 15.1 mm-40 -46.5 -46.03 18.83 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.553 0.692 . . . . 0.0 109.709 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.776 ' HB2' HG13 ' A' ' 19' ' ' ILE . 10.1 tt -52.81 -46.69 67.81 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.959 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.535 ' NE ' ' HA2' ' A' ' 66' ' ' GLY . 0.7 OUTLIER -62.77 -63.43 1.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.995 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -50.42 -22.54 1.92 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.357 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 8.6 mt-10 -96.74 -34.76 11.22 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -177.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.454 HG22 ' CE1' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -130.29 -15.44 3.67 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.465 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.535 ' HA2' ' NE ' ' A' ' 62' ' ' ARG . . . 93.07 -16.32 60.79 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.656 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.678 ' HB ' HD23 ' A' ' 61' ' ' LEU . 74.8 t -58.15 113.86 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.262 0.553 . . . . 0.0 111.937 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.475 HG22 ' HD3' ' A' ' 62' ' ' ARG . 0.2 OUTLIER -125.87 -36.78 2.35 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.716 178.075 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.9 m -63.6 73.83 0.03 OUTLIER 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.698 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.546 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -159.28 157.06 29.85 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.898 0.38 . . . . 0.0 111.981 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.578 ' HG3' HG21 ' A' ' 113' ' ' THR . 0.8 OUTLIER -127.8 149.08 50.42 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.101 179.019 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.512 HG23 ' CE2' ' A' ' 110' ' ' PHE . 19.1 t -74.21 126.3 34.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.077 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.565 HD12 ' HB2' ' A' ' 111' ' ' LYS . 1.4 mt -105.52 -17.6 7.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.236 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.496 ' HB2' ' NE2' ' A' ' 164' ' ' HIS . . . -171.09 175.71 4.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.484 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.0 OUTLIER -154.06 138.65 16.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.109 179.492 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.571 ' HA ' HG12 ' A' ' 160' ' ' VAL . 52.3 t -71.33 135.27 84.43 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-O 121.178 0.513 . . . . 0.0 111.16 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.405 ' N ' HG11 ' A' ' 76' ' ' VAL . 27.3 Cg_endo -66.16 -70.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.867 2.378 . . . . 0.0 112.027 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.519 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 6.4 p90 -78.33 170.67 16.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.095 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.594 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 48.2 m95 -93.64 -155.14 0.43 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.467 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.495 HD11 ' HD1' ' A' ' 107' ' ' TRP . 20.8 mt -161.35 106.32 1.33 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.667 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 20.0 p -100.79 100.62 11.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.705 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.401 ' HD1' HD22 ' A' ' 3' ' ' LEU . 6.0 t80 -77.63 58.94 1.88 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.833 0.349 . . . . 0.0 110.531 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.471 ' HB2' ' NE ' ' A' ' 89' ' ' ARG . 5.7 p30 -68.47 170.06 9.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.27 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.526 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 2.3 m-85 -104.77 172.22 4.29 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.664 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.526 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 52.1 Cg_exo -56.27 170.88 1.02 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.408 2.072 . . . . 0.0 112.296 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 85' ' ' PRO . 26.9 Cg_endo -61.7 -16.44 48.58 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.676 2.251 . . . . 0.0 112.71 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.22 -56.59 3.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.791 0.329 . . . . 0.0 110.547 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.436 ' HB ' ' HB3' ' A' ' 84' ' ' PHE . 14.0 t -69.06 -15.36 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.041 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.801 ' HA ' HD21 ' A' ' 93' ' ' ASN . 12.0 tpp85 -68.44 -2.65 9.08 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.83 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.913 ' HA ' HG12 ' A' ' 94' ' ' ILE . 0.6 OUTLIER -111.43 -49.34 3.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.781 0.324 . . . . 0.0 111.66 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 56.0 mttt -65.46 -23.0 66.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.655 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.547 HD13 ' N ' ' A' ' 93' ' ' ASN . 1.4 tm? -120.96 -59.67 1.72 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.801 HD21 ' HA ' ' A' ' 89' ' ' ARG . 27.3 m-80 -57.24 -51.68 68.39 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -177.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.913 HG12 ' HA ' ' A' ' 90' ' ' GLU . 8.5 mm -65.89 -3.1 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.854 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.634 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.3 OUTLIER -99.96 -103.06 0.23 Allowed 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.564 ' HE1' ' HA ' ' A' ' 93' ' ' ASN . 65.8 m95 56.86 -60.01 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.128 0.49 . . . . 0.0 111.193 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 95' ' ' GLN . . . 168.28 -95.46 0.11 Allowed Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.3 -166.63 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.458 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 0.5 OUTLIER -67.16 79.09 0.14 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.557 0.217 . . . . 0.0 110.522 179.659 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.572 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 88.4 m95 -105.29 -167.92 1.4 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.608 ' HG2' ' HD2' ' A' ' 89' ' ' ARG . 0.0 OUTLIER 168.16 15.72 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.778 -179.416 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.571 ' HA2' ' OD1' ' A' ' 93' ' ' ASN . . . 154.55 -158.27 28.13 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.723 ' HG3' ' HB3' ' A' ' 14' ' ' ARG . 6.4 tt0 -144.93 113.34 6.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.894 0.347 . . . . 0.0 111.443 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -93.13 122.12 35.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.133 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.565 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 5.2 mt-30 -128.99 127.33 41.43 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.527 ' HB2' ' CD2' ' A' ' 79' ' ' TRP . 2.0 ttpt -105.67 141.38 37.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.718 178.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.577 ' CZ3' ' HG3' ' A' ' 42' ' ' MET . 54.9 m95 -105.98 163.74 12.52 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.266 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.574 ' CD2' ' HG2' ' A' ' 54' ' ' ARG . 96.0 m-85 -141.07 152.47 44.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.895 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.527 ' HG ' HD11 ' A' ' 73' ' ' ILE . 17.8 tp -101.87 143.29 31.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.13 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.553 ' HE1' ' HB2' ' A' ' 108' ' ' PHE . 54.8 m-85 -144.51 145.08 31.66 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.637 0.732 . . . . 0.0 112.965 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.565 ' HB2' HD12 ' A' ' 73' ' ' ILE . 4.4 tttt -104.23 126.06 51.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.737 178.253 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.486 ' CD1' HG11 ' A' ' 67' ' ' VAL . 34.9 t80 -78.99 100.74 7.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.741 0.305 . . . . 0.0 110.868 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.578 HG21 ' HG3' ' A' ' 71' ' ' GLU . 72.7 p -100.83 50.06 0.88 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.993 0.425 . . . . 0.0 110.952 -179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -154.1 -145.58 4.19 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.294 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -121.5 150.89 40.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.017 0.437 . . . . 0.0 110.973 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.488 ' HB3' ' HH2' ' A' ' 134' ' ' TRP . 44.7 m-20 -59.11 -34.72 72.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.032 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -58.96 -2.62 0.26 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.191 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.417 ' H ' ' C ' ' A' ' 116' ' ' ASP . 0.8 OUTLIER -89.57 -15.23 33.31 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.805 0.336 . . . . 0.0 111.037 179.787 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.588 HG12 HG21 ' A' ' 67' ' ' VAL . 11.3 mt -78.54 100.3 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.828 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -102.42 92.34 4.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.099 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 38.0 mt -67.48 -57.62 6.2 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.159 0.504 . . . . 0.0 110.036 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.574 HD12 ' HG3' ' A' ' 129' ' ' PRO . 2.4 mm? -71.46 -176.02 1.43 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.356 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 111.94 -3.09 27.2 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.003 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.82 81.41 3.14 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.786 0.327 . . . . 0.0 111.044 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -77.0 59.25 3.53 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.337 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 98.5 p -120.31 -55.01 2.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.14 0.495 . . . . 0.0 110.771 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -146.91 -46.72 0.18 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.476 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.508 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 0.1 OUTLIER -178.05 156.89 1.09 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 121.27 0.557 . . . . 0.0 111.343 178.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.796 ' HG2' HD11 ' A' ' 34' ' ' LEU . 28.6 Cg_endo -69.72 -179.9 3.22 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 123.104 2.536 . . . . 0.0 112.808 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.462 ' HB3' ' CD1' ' A' ' 131' ' ' PHE . 0.8 OUTLIER -89.76 -70.67 0.65 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.673 179.713 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.531 ' C ' HD13 ' A' ' 34' ' ' LEU . 2.6 m-85 -106.67 142.6 36.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.497 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.712 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -80.77 -36.01 23.58 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.478 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.51 155.54 36.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.261 -0.47 . . . . 0.0 110.274 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.55 ' CZ2' HD13 ' A' ' 119' ' ' ILE . 25.0 p-90 -140.45 167.53 21.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.159 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.534 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 26.6 t -163.01 176.13 10.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.286 0.565 . . . . 0.0 111.533 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.506 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 64.5 m95 -111.75 103.73 12.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.48 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.451 HG22 ' HB2' ' A' ' 142' ' ' LEU . 26.0 m -121.67 171.54 10.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.375 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.597 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 10.9 p -74.15 177.03 2.34 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.827 ' HB2' HD23 ' A' ' 158' ' ' LEU . 13.9 Cg_endo -74.27 -47.37 0.25 Allowed 'Trans proline' 0 N--CA 1.443 -1.481 0 C-N-CA 121.242 1.294 . . . . 0.0 109.964 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.4 -32.89 73.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.9 177.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.61 -47.97 57.46 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.021 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.503 HD22 ' SD ' ' A' ' 42' ' ' MET . 23.9 tp -60.75 -37.61 82.38 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.67 ' HA ' HG21 ' A' ' 146' ' ' THR . 31.1 mm -59.19 -40.09 80.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 121.373 0.606 . . . . 0.0 109.468 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.29 -51.67 34.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.127 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.517 HD22 ' CD1' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -72.76 -17.94 61.55 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.97 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.67 HG21 ' HA ' ' A' ' 143' ' ' ILE . 14.2 t -74.64 -175.94 2.62 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.063 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.719 ' CG1' ' HB2' ' A' ' 39' ' ' ALA . 28.7 m -87.74 151.41 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.06 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.732 ' HG2' ' H ' ' A' ' 149' ' ' PHE . 0.6 OUTLIER -58.76 -53.41 58.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.938 0.399 . . . . 0.0 111.368 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.732 ' H ' ' HG2' ' A' ' 148' ' ' GLU . 48.0 p90 -56.18 -3.35 0.09 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.435 ' HE2' ' CE2' ' A' ' 149' ' ' PHE . 0.7 OUTLIER -133.14 -4.84 3.06 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.757 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.639 ' HG2' ' O ' ' A' ' 143' ' ' ILE . 9.1 mttt -62.37 -59.99 11.31 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.452 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 13.6 Cg_endo -56.57 -26.07 62.39 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.25 1.966 . . . . 0.0 111.635 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 12.1 t -68.69 -54.16 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.532 ' O ' ' HB ' ' A' ' 157' ' ' VAL . 4.9 m-30 -65.3 -37.05 85.96 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.807 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.31 -40.46 77.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.264 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.442 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.9 OUTLIER -66.68 -29.39 69.39 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.075 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.544 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 88.9 t -64.67 -39.23 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.216 179.133 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.827 HD23 ' HB2' ' A' ' 139' ' ' PRO . 0.2 OUTLIER -61.33 -50.1 74.3 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.074 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.4 m -51.95 -43.05 63.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.932 0.396 . . . . 0.0 110.028 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.571 HG12 ' HA ' ' A' ' 76' ' ' VAL . 50.0 t -68.15 -42.2 84.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.346 0.593 . . . . 0.0 109.433 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.544 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 13.2 m-30 -81.28 5.14 18.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.739 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.603 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.44 -52.14 76.38 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.692 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 17.8 Cg_endo -59.72 -12.06 16.71 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.263 1.975 . . . . 0.0 112.045 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.517 ' O ' ' HE3' ' A' ' 26' ' ' LYS . 92.3 m-70 -109.17 -20.77 12.87 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.337 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 94.0 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.974 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.148 0 N-CA-C 112.172 -0.371 . . . . 0.0 112.172 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -52.32 149.59 22.33 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.553 2.168 . . . . 0.0 112.077 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.544 ' N ' HD21 ' A' ' 3' ' ' LEU . 0.0 OUTLIER 48.38 -175.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.093 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -124.35 -53.46 0.19 Allowed Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.991 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.546 ' HB3' ' CD2' ' A' ' 80' ' ' LEU . 0.3 OUTLIER 65.23 129.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.791 0.329 . . . . 0.0 111.345 179.486 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.795 ' HE2' HG21 ' A' ' 81' ' ' THR . 0.7 OUTLIER -145.89 149.28 33.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.49 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.662 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 1.8 t0 -65.46 -6.47 10.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.319 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.434 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 0.7 OUTLIER -145.16 128.93 8.63 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.391 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.443 ' HG3' ' HD2' ' A' ' 15' ' ' ARG . 56.7 Cg_endo -69.74 104.53 1.33 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.674 2.249 . . . . 0.0 112.563 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.571 ' HG2' ' CE2' ' A' ' 13' ' ' TYR . 6.2 Cg_endo -49.94 165.49 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.282 2.655 . . . . 0.0 112.801 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.65 132.95 31.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.126 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.693 ' CA ' ' HA ' ' A' ' 100' ' ' TRP . . . 71.02 67.38 1.9 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.733 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.571 ' CE2' ' HG2' ' A' ' 10' ' ' PRO . 10.3 m-85 -153.33 119.5 5.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.526 0.203 . . . . 0.0 110.673 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.569 ' HA ' ' HZ3' ' A' ' 100' ' ' TRP . 7.4 tpt180 -66.36 94.7 0.28 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.51 0.671 . . . . 0.0 111.886 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.684 ' HG2' HD11 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -52.74 112.83 0.91 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.218 178.493 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.916 ' HB2' ' HG2' ' A' ' 105' ' ' GLN . 3.0 m120 -135.48 172.86 12.4 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.978 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.733 HG23 ' CA ' ' A' ' 57' ' ' ALA . 5.3 m -136.98 168.7 21.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.572 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -140.45 154.6 24.23 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.388 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.852 HD12 ' HA ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -129.05 125.33 62.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.158 0.504 . . . . 0.0 111.98 -178.851 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.424 ' HB3' ' CE2' ' A' ' 161' ' ' PHE . 43.4 t -104.57 102.85 12.46 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 178.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.84 HD23 ' HD2' ' A' ' 112' ' ' PHE . 24.7 tp -104.14 119.2 38.42 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.366 0.603 . . . . 0.0 111.659 -178.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.626 ' CE ' HD12 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -119.86 158.92 25.63 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.786 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.63 ' ND2' ' HB3' ' A' ' 112' ' ' PHE . 6.9 m120 -98.02 179.1 4.89 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.806 0.812 . . . . 0.0 111.819 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -58.44 -6.55 0.7 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.354 -1.293 . . . . 0.0 111.464 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.535 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.6 OUTLIER -101.21 3.39 40.92 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.726 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.535 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 3.1 mmpp? 72.08 22.53 3.67 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -178.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.548 ' O ' ' HA ' ' A' ' 22' ' ' MET . 10.3 mttt -95.02 149.97 20.67 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.728 HG13 ' HA ' ' A' ' 139' ' ' PRO . 1.9 mm -100.98 138.51 24.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.3 0.571 . . . . 0.0 111.519 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.611 ' CE1' HD13 ' A' ' 119' ' ' ILE . 72.6 t80 -73.63 133.62 43.49 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.358 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.675 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -133.53 152.68 51.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.82 0.343 . . . . 0.0 111.175 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.55 ' HB1' ' CB ' ' A' ' 131' ' ' PHE . . . -145.4 136.19 24.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.939 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.62 ' HA ' ' NH2' ' A' ' 33' ' ' ARG . 39.3 p -99.41 147.73 24.95 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.99 0.424 . . . . 0.0 111.829 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.62 ' NH2' ' HA ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -69.9 131.38 44.35 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.933 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.881 HD12 ' HG2' ' A' ' 129' ' ' PRO . 0.5 OUTLIER -57.13 51.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 179.694 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.619 ' N ' ' O ' ' A' ' 33' ' ' ARG . 0.6 OUTLIER -175.31 -26.69 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.666 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.771 HG21 ' HB1' ' A' ' 39' ' ' ALA . 5.3 mm -119.92 106.54 41.27 Favored Pre-proline 0 CA--C 1.53 0.189 0 CA-C-O 120.968 0.413 . . . . 0.0 110.649 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.22 -63.76 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.447 2.765 . . . . 0.0 114.019 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -64.91 0.47 1.19 Allowed 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.771 ' HB1' HG21 ' A' ' 36' ' ' ILE . . . -90.56 110.91 22.04 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 120.528 0.204 . . . . 0.0 110.838 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.695 ' O ' ' HA ' ' A' ' 146' ' ' THR . 74.4 m95 -118.78 150.57 39.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.746 0.308 . . . . 0.0 110.611 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.648 ' HB3' ' HH ' ' A' ' 154' ' ' TYR . 67.0 mt-30 -157.96 173.4 16.82 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.385 0.612 . . . . 0.0 111.687 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.611 ' HE2' HD23 ' A' ' 142' ' ' LEU . 3.3 mtm -106.63 152.77 40.84 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.958 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.533 ' O ' HG12 ' A' ' 19' ' ' ILE . 12.5 Cg_endo -55.68 144.22 76.5 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.124 1.883 . . . . 0.0 111.499 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.852 ' HA ' HD12 ' A' ' 19' ' ' ILE . 3.9 pt20 -175.94 157.14 1.86 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.819 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 16' ' ' ASN . . . -161.89 -159.42 10.16 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.469 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.587 ' C ' HG13 ' A' ' 47' ' ' ILE . . . -99.4 -148.72 23.43 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.595 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.684 HD11 ' HG2' ' A' ' 15' ' ' ARG . 7.5 mt -158.68 141.03 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 122.803 0.441 . . . . 0.0 110.077 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -67.84 -173.45 0.35 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.336 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.54 -81.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.41 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -107.49 54.88 0.54 Allowed Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.06 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -112.07 136.78 51.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.773 0.32 . . . . 0.0 110.928 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.468 ' HB2' ' ND2' ' A' ' 55' ' ' ASN . 13.5 m-20 -66.52 147.46 98.96 Favored Pre-proline 0 N--CA 1.453 -0.285 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.34 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.725 ' HB3' HG11 ' A' ' 17' ' ' VAL . 23.1 Cg_exo -64.37 -48.51 4.5 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 123.077 2.518 . . . . 0.0 113.393 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.593 ' O ' HG13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -45.72 -50.83 13.34 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.603 -179.428 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.468 ' ND2' ' HB2' ' A' ' 52' ' ' ASP . 22.2 p30 -65.7 -42.07 91.6 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.7 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.446 ' N ' ' OD1' ' A' ' 55' ' ' ASN . . . -60.29 -41.9 94.34 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.733 ' CA ' HG23 ' A' ' 17' ' ' VAL . . . -57.78 -53.37 58.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.247 178.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.748 HG12 ' CE2' ' A' ' 110' ' ' PHE . 33.0 mt -60.26 -52.32 62.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.932 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.68 -56.66 17.33 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.353 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.412 ' OE1' ' HA3' ' A' ' 45' ' ' GLY . 47.4 mm-40 -47.78 -47.31 30.86 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.753 HD23 ' HB ' ' A' ' 67' ' ' VAL . 10.2 tt -50.68 -50.46 54.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.873 178.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.451 ' O ' ' N ' ' A' ' 66' ' ' GLY . 32.9 ttt180 -61.55 -63.24 1.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.492 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -49.85 -19.36 0.65 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.25 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -101.28 -35.38 9.28 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.479 ' O ' ' HA ' ' A' ' 119' ' ' ILE . 1.3 p -126.08 -1.23 7.12 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 73.74 -13.12 4.3 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.027 -178.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.753 ' HB ' HD23 ' A' ' 61' ' ' LEU . 71.1 t -58.52 111.57 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-O 121.106 0.479 . . . . 0.0 111.273 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.48 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.8 OUTLIER -121.6 -41.44 2.48 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.921 178.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 113' ' ' THR . 20.3 m -59.95 74.14 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.33 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.578 ' HB3' ' HA ' ' A' ' 112' ' ' PHE . . . -161.76 156.72 23.22 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.51 ' HG3' HG21 ' A' ' 113' ' ' THR . 0.4 OUTLIER -130.33 151.64 50.61 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.478 179.183 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.859 HG22 ' CE2' ' A' ' 110' ' ' PHE . 6.5 t -75.95 127.61 37.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.527 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.626 HD12 ' CE ' ' A' ' 22' ' ' MET . 1.2 mt -106.68 -19.72 6.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.799 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.504 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.54 176.68 4.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.955 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -154.76 146.16 23.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.422 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.792 ' HA ' HG12 ' A' ' 160' ' ' VAL . 54.3 t -70.71 136.82 85.57 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.624 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.457 ' CD ' HG13 ' A' ' 160' ' ' VAL . 17.5 Cg_endo -55.48 -62.44 0.27 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.901 2.401 . . . . 0.0 112.568 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.662 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -100.47 -175.87 3.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.371 -179.186 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.626 ' CD1' ' HD3' ' A' ' 106' ' ' LYS . 40.4 m95 -90.05 -160.09 0.66 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.007 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.546 ' CD2' ' HB3' ' A' ' 5' ' ' SER . 36.2 mt -162.18 106.92 1.2 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.795 HG21 ' HE2' ' A' ' 6' ' ' MET . 9.7 p -103.47 -174.35 2.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.192 0.52 . . . . 0.0 111.704 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.514 ' CE2' HD22 ' A' ' 3' ' ' LEU . 0.2 OUTLIER -171.39 69.11 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.012 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -71.92 160.24 32.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.527 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.537 ' CE1' HD11 ' A' ' 92' ' ' LEU . 27.5 m-85 -97.61 171.52 5.86 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.113 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.513 ' HB3' ' HD2' ' A' ' 86' ' ' PRO . 43.7 Cg_exo -56.92 -178.03 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.759 2.306 . . . . 0.0 111.828 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 85' ' ' PRO . 35.3 Cg_endo -65.04 -24.49 59.8 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.368 2.046 . . . . 0.0 112.566 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.21 -62.68 1.47 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.285 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.486 ' HB ' ' CB ' ' A' ' 84' ' ' PHE . 22.0 t -66.26 -18.06 23.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.45 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.651 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -57.35 -24.51 55.62 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.733 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.572 ' HA ' ' CD1' ' A' ' 94' ' ' ILE . 0.9 OUTLIER -104.44 -11.29 17.15 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.664 -179.453 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.632 ' O ' ' HB2' ' A' ' 95' ' ' GLN . 0.1 OUTLIER -86.86 -47.83 8.7 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.369 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.667 HD13 ' N ' ' A' ' 93' ' ' ASN . 1.1 tm? -102.66 -55.86 2.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.149 0.499 . . . . 0.0 111.16 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.72 ' O ' ' HB2' ' A' ' 100' ' ' TRP . 94.1 m-20 -52.35 -34.35 47.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.685 -177.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.651 HD13 ' O ' ' A' ' 89' ' ' ARG . 1.1 mp -93.3 -12.97 8.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.632 ' HB2' ' O ' ' A' ' 91' ' ' LYS . 2.4 tp60 -64.44 -4.56 4.06 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.131 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.758 ' HB2' ' CD1' ' A' ' 100' ' ' TRP . 63.5 m95 -84.9 10.18 12.39 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.625 0.232 . . . . 0.0 111.625 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 55.6 41.86 83.0 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.297 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.531 ' HB2' ' HE1' ' A' ' 100' ' ' TRP . 0.4 OUTLIER -175.13 27.96 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.327 0.584 . . . . 0.0 111.474 179.757 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.477 ' O ' ' HA ' ' A' ' 94' ' ' ILE . 2.7 t70 74.98 -69.71 0.17 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.255 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.758 ' CD1' ' HB2' ' A' ' 96' ' ' TRP . 58.6 m95 50.75 -150.81 0.24 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.471 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.649 ' HA ' ' HB3' ' A' ' 93' ' ' ASN . 11.9 ttmt 170.64 11.98 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.602 0.361 . . . . 0.0 111.968 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.533 ' HA2' ' OD1' ' A' ' 93' ' ' ASN . . . 148.66 -162.23 28.83 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.211 -179.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.525 ' HA ' ' N ' ' A' ' 14' ' ' ARG . 0.4 OUTLIER -142.18 126.07 17.16 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 117.455 0.628 . . . . 0.0 111.413 179.773 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.497 ' HA ' HG22 ' A' ' 81' ' ' THR . . . -97.22 127.77 43.49 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.869 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.916 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 45.8 mt-30 -130.33 124.66 32.81 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -178.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.626 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 16.3 ttpp -103.41 138.1 40.61 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.98 178.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.572 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 14.3 m95 -104.76 165.21 11.22 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.346 0.593 . . . . 0.0 112.428 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.656 ' HB2' ' HE1' ' A' ' 110' ' ' PHE . 96.1 m-85 -142.17 152.49 43.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.0 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.61 ' HG ' HD13 ' A' ' 73' ' ' ILE . 18.1 tp -98.83 137.68 37.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.86 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.859 ' CE2' HG22 ' A' ' 72' ' ' VAL . 49.2 m-85 -139.03 145.46 39.64 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.58 ' N ' HD11 ' A' ' 73' ' ' ILE . 14.6 tttm -104.0 124.04 48.3 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.771 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.84 ' HD2' HD23 ' A' ' 21' ' ' LEU . 36.7 t80 -78.23 96.46 5.23 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.889 0.376 . . . . 0.0 110.568 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.51 HG21 ' HG3' ' A' ' 71' ' ' GLU . 71.0 p -95.33 57.44 1.98 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.362 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -163.06 -143.81 3.82 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.546 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.482 ' N ' ' HE1' ' A' ' 112' ' ' PHE . 7.4 mm100 -123.82 146.66 48.2 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.019 0.438 . . . . 0.0 111.463 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.421 ' HB3' ' CH2' ' A' ' 134' ' ' TRP . 90.3 m-20 -62.05 -23.57 66.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.834 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -3.92 0.45 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.971 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.408 ' H ' ' C ' ' A' ' 116' ' ' ASP . 27.0 tp10 -90.27 -18.05 26.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.065 0.46 . . . . 0.0 110.544 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.614 HG12 HG22 ' A' ' 67' ' ' VAL . 8.4 mt -82.33 104.41 10.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.834 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.528 ' C ' ' H ' ' A' ' 122' ' ' LEU . 2.6 p-10 -102.61 -26.41 13.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.032 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.405 ' CD1' ' HD1' ' A' ' 134' ' ' TRP . 68.0 mt 68.69 -30.15 0.18 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.575 ' HA ' ' HB3' ' A' ' 129' ' ' PRO . 95.6 mt -78.49 6.34 8.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.66 0.267 . . . . 0.0 111.385 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -67.92 75.97 0.23 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.554 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.69 -106.45 0.16 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.833 -0.684 . . . . 0.0 111.09 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -169.55 -151.02 7.09 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.634 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 92.3 p -71.23 -5.38 31.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.616 0.246 . . . . 0.0 111.537 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.584 ' O ' ' HG2' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -85.61 -77.5 0.29 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.585 0.231 . . . . 0.0 111.254 -179.498 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.626 ' HD2' ' CD ' ' A' ' 129' ' ' PRO . 4.1 mmtt -176.87 163.66 1.57 Allowed Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 121.373 0.606 . . . . 0.0 110.58 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.881 ' HG2' HD12 ' A' ' 34' ' ' LEU . 29.3 Cg_endo -74.2 -172.67 1.21 Allowed 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 123.738 2.959 . . . . 0.0 112.644 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.83 -42.48 4.7 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.35 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.765 ' C ' HD11 ' A' ' 34' ' ' LEU . 3.2 m-85 -130.76 140.84 50.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.092 0.472 . . . . 0.0 110.911 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.737 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -78.44 -35.77 32.12 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.785 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -155.75 152.46 28.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.369 -0.416 . . . . 0.0 110.74 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.545 ' HA ' ' HZ3' ' A' ' 40' ' ' TRP . 29.0 p-90 -132.2 164.61 25.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.118 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.422 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 23.4 t -159.46 165.74 32.45 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.325 0.583 . . . . 0.0 112.048 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.564 ' CD2' ' OD1' ' A' ' 23' ' ' ASN . 91.6 m95 -108.39 102.09 11.23 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.481 178.329 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' ' 28' ' ' ILE . 28.9 m -117.47 171.29 6.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.837 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.529 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 27.8 p -71.99 167.1 34.54 Favored Pre-proline 0 CA--C 1.513 -0.465 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.889 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.728 ' HA ' HG13 ' A' ' 28' ' ' ILE . 21.7 Cg_exo -57.7 -58.83 0.69 Allowed 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.428 1.418 . . . . 0.0 109.889 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.11 -27.17 68.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.035 178.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.483 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 2.0 mm-40 -71.91 -48.36 46.04 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.1 0.476 . . . . 0.0 110.259 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.675 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -55.37 -40.74 71.69 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.22 179.711 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.733 ' CG2' ' HG3' ' A' ' 151' ' ' LYS . 27.3 mm -61.83 -31.84 52.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.329 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.73 -53.42 10.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.354 0.597 . . . . 0.0 110.33 179.1 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.08 -18.62 61.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.835 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.695 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 14.8 t -73.77 174.69 8.07 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.395 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.551 ' CG1' ' HB2' ' A' ' 39' ' ' ALA . 18.7 m -86.41 149.56 4.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.589 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.578 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 19.9 mt-10 -47.33 -52.3 16.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.95 0.405 . . . . 0.0 111.334 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -55.26 -3.71 0.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . 10.2 mmtm -136.08 -8.2 2.06 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -178.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.733 ' HG3' ' CG2' ' A' ' 143' ' ' ILE . 2.6 ttpp -64.53 -57.77 15.87 Favored Pre-proline 0 C--N 1.322 -0.589 0 C-N-CA 121.145 -0.222 . . . . 0.0 110.66 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.578 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 36.7 Cg_endo -66.06 -30.95 46.88 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.566 2.177 . . . . 0.0 111.469 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.438 ' HA ' HD13 ' A' ' 3' ' ' LEU . 23.4 t -68.07 -51.71 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.648 ' HH ' ' HB3' ' A' ' 41' ' ' GLN . 15.4 m-30 -65.36 -39.17 91.98 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.591 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.633 ' HG2' HG23 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -54.41 -45.26 72.9 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.934 -179.951 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.94 -35.46 80.03 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.544 HG13 ' CE2' ' A' ' 161' ' ' PHE . 46.4 t -65.16 -41.63 92.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.721 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.672 HD21 ' HB3' ' A' ' 139' ' ' PRO . 30.1 mt -63.41 -43.03 98.7 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.164 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.526 ' O ' ' HB3' ' A' ' 162' ' ' ALA . 0.3 OUTLIER -55.88 -38.45 70.18 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.306 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.792 HG12 ' HA ' ' A' ' 76' ' ' VAL . 85.0 t -68.79 -43.08 83.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.571 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.594 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 22.2 m-30 -80.77 5.19 16.57 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.964 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.576 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.32 -52.89 71.21 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.07 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.4 Cg_endo -57.75 -13.41 14.35 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 121.664 1.576 . . . . 0.0 111.741 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.504 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 86.9 m-70 -108.06 -21.91 12.61 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.09 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 85.9 mt . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.397 -0.811 . . . . 0.0 110.569 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.114 0 N-CA-C 112.427 -0.269 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.434 ' O ' ' HG ' ' A' ' 3' ' ' LEU . 38.2 Cg_endo -66.78 -174.99 0.51 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.34 2.027 . . . . 0.0 112.39 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 2' ' ' PRO . 0.4 OUTLIER 37.88 98.63 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.313 -179.654 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.54 -14.66 75.53 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.295 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.601 ' HA ' ' O ' ' A' ' 79' ' ' TRP . 0.7 OUTLIER 64.18 -81.68 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.929 0.395 . . . . 0.0 111.617 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.2 mtm 65.47 138.86 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.395 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.713 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 4.2 p30 -66.63 -5.49 11.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.85 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.27 130.86 13.9 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.472 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 40.9 Cg_endo -66.83 107.96 1.38 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.333 2.022 . . . . 0.0 112.249 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.497 ' HG2' ' CE1' ' A' ' 13' ' ' TYR . 2.0 Cg_endo -43.49 168.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 123.357 2.705 . . . . 0.0 112.855 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -51.05 128.58 21.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.905 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.572 ' CA ' ' HA ' ' A' ' 100' ' ' TRP . . . 61.64 75.66 0.29 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.778 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.507 ' CE2' ' HA3' ' A' ' 102' ' ' GLY . 11.7 m-85 -151.13 109.62 3.8 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.401 ' HA ' ' CZ3' ' A' ' 100' ' ' TRP . 1.5 tpt180 -70.07 95.55 0.97 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.878 0.37 . . . . 0.0 111.069 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.579 ' HB2' ' HZ3' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -51.98 131.84 31.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.239 0.542 . . . . 0.0 111.862 -179.788 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.633 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 2.1 m-80 -131.18 174.95 9.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.742 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.751 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 16.0 m -143.82 157.81 16.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.95 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.587 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -127.96 167.24 20.3 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.22 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.501 HD12 ' CG ' ' A' ' 60' ' ' GLU . 5.3 mp -126.91 123.2 62.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.24 0.543 . . . . 0.0 112.461 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.405 ' HB3' HD11 ' A' ' 109' ' ' LEU . 1.4 t -107.49 96.12 6.18 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.438 -0.801 . . . . 0.0 108.9 178.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.501 HD21 ' CG1' ' A' ' 67' ' ' VAL . 26.5 tp -99.61 122.97 43.42 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.917 -178.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.495 ' CB ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -119.64 151.53 38.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.399 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.711 ' OD1' ' CE3' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -96.24 175.44 6.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.313 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -58.31 -3.68 0.29 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.352 177.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.583 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.7 OUTLIER -99.1 -1.26 39.96 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 120.605 0.24 . . . . 0.0 111.376 -179.251 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.583 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 1.4 mmtm 75.12 20.98 2.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.961 -178.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.495 ' O ' ' CB ' ' A' ' 22' ' ' MET . 4.8 mttt -93.41 -178.64 4.8 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.503 HD12 ' CA ' ' A' ' 139' ' ' PRO . 2.8 mp -135.67 144.93 32.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.585 0.707 . . . . 0.0 111.886 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.563 ' HE1' ' CD2' ' A' ' 134' ' ' TRP . 33.2 t80 -66.17 108.33 2.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.985 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.517 ' HA ' ' O ' ' A' ' 41' ' ' GLN . . . -102.99 140.19 37.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.163 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.422 ' HB1' ' CG ' ' A' ' 131' ' ' PHE . . . -139.07 134.16 32.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.747 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.576 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 55.6 p -100.12 149.21 23.75 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.075 0.464 . . . . 0.0 111.785 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.622 ' O ' ' N ' ' A' ' 35' ' ' ASP . 26.3 mtp85 -72.42 129.95 39.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.489 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.701 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -55.72 56.22 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.995 0.518 . . . . 0.0 112.346 179.799 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.622 ' N ' ' O ' ' A' ' 33' ' ' ARG . 3.0 p-10 -177.08 -33.03 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.157 0.503 . . . . 0.0 109.866 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.479 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 21.1 mt -116.66 105.72 49.46 Favored Pre-proline 0 N--CA 1.452 -0.366 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.482 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.52 -19.62 21.54 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.442 2.095 . . . . 0.0 112.88 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -92.38 -9.74 40.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.551 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.576 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -94.19 106.44 18.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.805 0.336 . . . . 0.0 111.278 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.579 ' O ' ' HA ' ' A' ' 146' ' ' THR . 68.9 m95 -105.71 144.61 32.22 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.75 178.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.517 ' O ' ' HA ' ' A' ' 30' ' ' ALA . 0.8 OUTLIER -153.73 -125.73 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.095 -179.742 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.538 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 0.0 OUTLIER 177.62 160.81 0.56 Allowed Pre-proline 0 N--CA 1.453 -0.32 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.538 ' HD2' ' HB2' ' A' ' 42' ' ' MET . 1.6 Cg_endo -40.69 142.29 0.74 Allowed 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 123.546 2.831 . . . . 0.0 113.03 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.751 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -172.62 146.4 1.68 Allowed 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.884 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -160.62 -162.63 12.71 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.332 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.633 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -120.05 139.93 14.21 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.887 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.438 ' CG1' HG13 ' A' ' 17' ' ' VAL . 28.7 mt -69.37 142.03 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.838 0.352 . . . . 0.0 111.131 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -69.01 -174.12 0.57 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.93 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -49.66 -79.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.049 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -110.1 50.32 0.78 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.285 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -111.57 149.59 31.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.822 0.344 . . . . 0.0 110.576 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.409 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 2.2 m-20 -70.41 162.38 70.57 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.159 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.462 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 1.2 Cg_endo -82.96 -51.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.974 2.45 . . . . 0.0 112.021 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.659 ' HD3' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -49.98 -47.33 52.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.623 179.594 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -69.25 -38.26 78.37 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.046 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.409 ' HB3' ' O ' ' A' ' 52' ' ' ASP . . . -61.82 -45.02 95.63 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.635 ' CA ' HG22 ' A' ' 17' ' ' VAL . . . -58.05 -55.48 34.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.405 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.409 ' O ' ' HB3' ' A' ' 61' ' ' LEU . 47.2 mt -57.55 -46.53 86.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.183 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.08 -66.08 0.59 Allowed 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.278 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.501 ' CG ' HD12 ' A' ' 19' ' ' ILE . 23.6 pt-20 -43.06 -40.45 3.12 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.114 0.483 . . . . 0.0 110.199 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.49 ' CD1' ' HB ' ' A' ' 67' ' ' VAL . 4.9 tp -52.23 -47.42 65.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.376 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 66' ' ' GLY . 1.6 tmm_? -63.51 -63.91 1.05 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.957 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -51.13 -21.17 1.8 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.17 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -97.53 -38.41 9.58 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.437 HG21 ' CD2' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -128.88 -15.15 4.37 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -178.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 91.54 -14.23 64.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.193 -1.004 . . . . 0.0 112.835 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.553 HG22 HG12 ' A' ' 119' ' ' ILE . 55.7 t -56.26 110.57 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.104 0.478 . . . . 0.0 111.321 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.41 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -122.34 -39.8 2.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.466 178.203 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 9.4 m -62.37 74.39 0.02 OUTLIER 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.456 179.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -162.85 154.86 18.33 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.922 0.391 . . . . 0.0 111.795 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.448 ' HG3' HG22 ' A' ' 113' ' ' THR . 1.0 OUTLIER -127.22 146.63 50.35 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.209 179.454 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.659 HG21 ' HD3' ' A' ' 54' ' ' ARG . 8.5 t -76.73 129.96 36.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.202 0.525 . . . . 0.0 112.224 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.648 HD13 ' HB2' ' A' ' 111' ' ' LYS . 0.7 OUTLIER -113.3 -18.12 7.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.947 179.43 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.464 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -169.04 178.63 4.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.147 0.499 . . . . 0.0 112.013 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.4 pm0 -157.66 152.71 25.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.882 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.827 ' HA ' HG12 ' A' ' 160' ' ' VAL . 33.7 t -72.93 136.61 79.78 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.265 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.455 ' HD3' ' CG1' ' A' ' 160' ' ' VAL . 20.7 Cg_endo -59.45 -76.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.943 2.428 . . . . 0.0 112.564 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.713 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -80.65 171.68 14.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.698 -179.179 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.601 ' O ' ' HA ' ' A' ' 5' ' ' SER . 27.9 m95 -94.33 97.53 10.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.608 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.43 HD22 ' CD1' ' A' ' 78' ' ' TYR . 51.1 mt -58.97 109.39 0.82 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.8 0.333 . . . . 0.0 110.89 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.46 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 5.1 p -100.01 -167.56 1.47 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.007 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.402 ' HD1' ' HB3' ' A' ' 3' ' ' LEU . 2.5 t80 -170.64 80.17 0.09 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.662 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -70.22 158.3 36.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.441 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.473 ' CE2' ' HG ' ' A' ' 92' ' ' LEU . 6.1 m-85 -102.87 166.42 11.94 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.948 0.404 . . . . 0.0 112.007 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.533 ' HB2' ' HD2' ' A' ' 86' ' ' PRO . 85.8 Cg_endo -92.1 177.26 1.73 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.332 2.688 . . . . 0.0 112.549 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.533 ' HD2' ' HB2' ' A' ' 85' ' ' PRO . 10.9 Cg_endo -53.07 159.65 5.2 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.392 2.061 . . . . 0.0 112.026 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 2.6 tptt 70.86 -58.41 0.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.126 -179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.402 ' CG1' ' HD2' ' A' ' 84' ' ' PHE . 11.2 t -65.07 -37.38 80.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.988 0.423 . . . . 0.0 110.64 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.508 ' HD2' HD21 ' A' ' 93' ' ' ASN . 0.0 OUTLIER -48.78 -38.49 22.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.93 -179.712 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.515 ' HA ' HD11 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -70.41 -24.41 62.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.79 0.329 . . . . 0.0 110.791 179.509 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.506 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -98.5 -7.82 27.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.803 179.478 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.473 ' HG ' ' CE2' ' A' ' 84' ' ' PHE . 0.8 OUTLIER -122.09 -59.29 1.67 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.329 -179.602 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.617 ' CG ' ' HA ' ' A' ' 101' ' ' LYS . 31.9 t-20 -61.86 -64.28 0.99 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.207 0.527 . . . . 0.0 111.924 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.52 ' H ' HD12 ' A' ' 94' ' ' ILE . 3.9 mp -63.03 -9.89 5.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.376 -178.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.506 ' HG3' ' O ' ' A' ' 91' ' ' LYS . 6.2 mm100 -78.19 -1.82 34.61 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.247 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.632 ' HB3' ' CD1' ' A' ' 100' ' ' TRP . 86.6 m95 -91.47 -3.11 56.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.544 0.212 . . . . 0.0 111.566 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.62 -77.37 0.63 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.755 -0.736 . . . . 0.0 113.377 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.11 -168.56 0.05 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.892 0.377 . . . . 0.0 111.433 -179.267 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.33 104.88 4.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.785 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.632 ' CD1' ' HB3' ' A' ' 96' ' ' TRP . 71.7 m95 -141.57 -164.59 1.81 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.838 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.617 ' HA ' ' CG ' ' A' ' 93' ' ' ASN . 0.7 OUTLIER 164.56 24.21 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 O-C-N 123.226 0.329 . . . . 0.0 111.589 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.507 ' HA3' ' CE2' ' A' ' 13' ' ' TYR . . . 154.3 -160.44 29.5 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.492 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' A' ' 81' ' ' THR . 2.0 tt0 -149.27 122.26 8.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.827 0.314 . . . . 0.0 111.34 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.503 ' O ' ' HA ' ' A' ' 15' ' ' ARG . . . -97.96 121.18 39.56 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.538 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 2.9 mt-30 -123.19 123.75 41.48 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.418 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 1.0 OUTLIER -104.25 132.66 50.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.435 178.364 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.587 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 51.6 m95 -101.74 166.53 10.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.241 0.543 . . . . 0.0 112.448 -178.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.564 ' CD1' ' HG2' ' A' ' 54' ' ' ARG . 98.0 m-85 -141.47 151.63 43.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.955 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.444 ' HB2' ' CE1' ' A' ' 161' ' ' PHE . 29.5 tp -107.68 126.73 52.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.968 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.498 ' CE1' ' HB3' ' A' ' 108' ' ' PHE . 4.1 m-85 -132.8 145.54 51.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.315 0.578 . . . . 0.0 111.918 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.648 ' HB2' HD13 ' A' ' 73' ' ' ILE . 47.8 tttt -95.27 127.69 41.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.602 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.451 ' CD1' HD22 ' A' ' 21' ' ' LEU . 38.2 t80 -78.33 101.33 7.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.898 0.38 . . . . 0.0 110.853 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.448 HG22 ' HG3' ' A' ' 71' ' ' GLU . 41.6 p -100.53 53.07 0.87 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.702 179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -158.04 -146.49 4.53 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.409 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -121.85 152.1 39.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.995 0.426 . . . . 0.0 111.26 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.435 ' HB3' ' HH2' ' A' ' 134' ' ' TRP . 61.4 m-20 -60.12 -35.1 74.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.874 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -58.18 -2.05 0.16 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.116 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.434 ' H ' ' C ' ' A' ' 116' ' ' ASP . 0.7 OUTLIER -90.41 -15.8 30.26 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.942 0.401 . . . . 0.0 110.853 179.543 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.562 HD11 ' CE1' ' A' ' 29' ' ' PHE . 14.3 mt -81.05 100.6 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.223 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 65' ' ' THR . 6.5 p-10 -103.78 93.68 5.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.339 178.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.437 ' CD2' HG21 ' A' ' 65' ' ' THR . 39.0 mt -65.81 -48.92 70.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.076 0.465 . . . . 0.0 110.1 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.46 ' CD2' ' HG3' ' A' ' 129' ' ' PRO . 61.1 mt -77.25 164.89 25.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.807 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 140.8 -8.91 2.8 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.371 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.14 79.71 3.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.811 0.339 . . . . 0.0 110.237 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -83.07 33.32 2.91 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.703 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.4 t -106.78 -37.11 6.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.833 0.349 . . . . 0.0 110.653 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -146.99 -59.2 0.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.888 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 27.6 pttt -178.3 156.02 0.99 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 121.132 0.492 . . . . 0.0 111.336 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.665 ' HG2' HD13 ' A' ' 34' ' ' LEU . 14.6 Cg_endo -71.49 -176.88 2.14 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.709 2.273 . . . . 0.0 112.432 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -97.22 -69.89 0.74 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.371 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.56 ' C ' HD12 ' A' ' 34' ' ' LEU . 2.2 m-85 -102.23 139.71 37.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.136 0.493 . . . . 0.0 110.573 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.701 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -82.34 -36.89 16.01 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.013 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -151.57 149.33 29.05 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.86 0.362 . . . . 0.0 110.53 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.563 ' CD2' ' HE1' ' A' ' 29' ' ' PHE . 31.9 p-90 -136.53 166.41 23.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.063 0.458 . . . . 0.0 111.236 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.47 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 29.5 t -162.56 178.48 8.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.381 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.711 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 64.8 m95 -114.21 99.66 7.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.742 178.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 22.2 m -113.89 169.05 5.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.347 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.516 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 20.9 p -74.71 171.91 10.29 Favored Pre-proline 0 C--N 1.324 -0.536 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.881 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.558 ' O ' HG12 ' A' ' 143' ' ' ILE . 13.1 Cg_exo -62.47 -54.36 1.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.488 1.459 . . . . 0.0 110.279 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.67 -29.1 70.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.995 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.449 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 33.3 mt-30 -71.69 -47.33 54.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.328 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.513 HD12 ' CB ' ' A' ' 30' ' ' ALA . 64.2 tp -57.95 -38.92 76.86 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.691 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 27.7 mm -61.27 -38.8 80.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.517 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.92 -50.48 49.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.223 0.535 . . . . 0.0 110.565 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.486 HD21 ' CD1' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -74.54 -19.16 60.45 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.718 -179.154 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.745 HG21 ' HG3' ' A' ' 151' ' ' LYS . 14.7 t -74.88 174.03 9.82 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.487 -179.429 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.534 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 24.1 m -78.08 154.73 5.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.46 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.743 ' HA ' ' HD3' ' A' ' 151' ' ' LYS . 13.5 mt-10 -60.89 -54.85 39.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.079 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.534 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 35.7 p90 -55.52 -1.48 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.438 ' H ' ' C ' ' A' ' 148' ' ' GLU . 58.1 mttt -135.27 -6.82 2.29 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.745 ' HG3' HG21 ' A' ' 146' ' ' THR . 14.0 mtpp -60.71 -62.19 6.47 Favored Pre-proline 0 CA--C 1.531 0.237 0 O-C-N 122.317 -0.239 . . . . 0.0 111.335 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.47 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 18.6 Cg_endo -59.92 -27.13 84.24 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.239 1.959 . . . . 0.0 111.334 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.429 HG21 ' HA ' ' A' ' 150' ' ' LYS . 26.3 t -68.8 -50.85 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.467 ' HE1' ' CZ2' ' A' ' 107' ' ' TRP . 14.3 m-30 -65.78 -39.56 91.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.672 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.534 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.5 OUTLIER -56.09 -40.65 73.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.332 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.57 -31.41 68.43 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.987 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.484 ' CG1' ' CE2' ' A' ' 161' ' ' PHE . 90.3 t -66.28 -41.31 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.593 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.454 ' CD2' ' HB3' ' A' ' 139' ' ' PRO . 58.7 mt -63.78 -41.97 97.86 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.468 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 14.5 m -54.54 -41.02 69.25 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.222 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.827 HG12 ' HA ' ' A' ' 76' ' ' VAL . 98.4 t -66.57 -44.07 90.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.553 178.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.609 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 22.4 m-30 -81.21 5.09 18.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.384 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.46 ' N ' ' CD ' ' A' ' 163' ' ' PRO . . . -59.4 -50.45 87.29 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.015 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.506 ' HD2' ' O ' ' A' ' 160' ' ' VAL . 36.8 Cg_exo -59.22 -11.86 14.42 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.528 2.152 . . . . 0.0 112.051 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.464 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 73.8 m-70 -113.13 -17.52 12.37 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.437 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 97.9 mt . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.791 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.603 -0.199 . . . . 0.0 112.603 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -53.93 155.99 13.51 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.535 2.157 . . . . 0.0 112.277 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 2.3 tp 60.18 108.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.315 179.641 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.07 -47.61 12.98 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.518 -0.848 . . . . 0.0 111.552 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.639 ' HA ' ' O ' ' A' ' 79' ' ' TRP . 0.7 OUTLIER 71.69 -75.43 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.089 0.471 . . . . 0.0 112.023 179.269 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.462 ' HB2' ' O ' ' A' ' 5' ' ' SER . 4.0 mpp? 67.79 131.37 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.039 -178.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.597 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 30.1 t70 -66.04 -35.65 81.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.822 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.98 152.15 40.28 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.508 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.451 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 59.1 Cg_endo -72.11 106.98 2.14 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.465 2.11 . . . . 0.0 112.199 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.583 ' HB2' ' CE1' ' A' ' 13' ' ' TYR . 11.6 Cg_endo -54.17 -174.07 0.02 OUTLIER 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 123.205 2.604 . . . . 0.0 112.707 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 13' ' ' TYR . 1.5 pt-20 -52.48 -157.66 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.859 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.567 ' O ' ' HA ' ' A' ' 100' ' ' TRP . . . -58.69 65.89 0.01 OUTLIER Glycine 0 C--N 1.33 0.23 0 CA-C-N 116.004 -0.543 . . . . 0.0 113.98 -178.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.583 ' CE1' ' HB2' ' A' ' 10' ' ' PRO . 16.5 m-85 -93.12 148.11 22.29 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.718 ' HA ' ' HZ3' ' A' ' 100' ' ' TRP . 1.0 OUTLIER -65.16 82.95 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.143 0.497 . . . . 0.0 111.021 179.497 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.1 ttp180 -50.89 102.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.181 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.738 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 0.9 OUTLIER -134.48 167.35 20.93 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.387 179.091 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.546 HG22 ' CA ' ' A' ' 57' ' ' ALA . 12.5 m -136.05 166.33 27.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.976 0.417 . . . . 0.0 111.289 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.533 ' HA3' ' CE3' ' A' ' 107' ' ' TRP . . . -134.02 154.77 21.51 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.546 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.469 HD13 ' HB2' ' A' ' 61' ' ' LEU . 3.7 mp -125.45 121.5 60.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.074 0.464 . . . . 0.0 111.862 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.424 ' HB2' ' HE2' ' A' ' 161' ' ' PHE . 0.4 OUTLIER -101.1 92.24 4.91 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.742 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.406 HD22 ' CG1' ' A' ' 67' ' ' VAL . 22.7 tp -96.57 113.38 24.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.534 -178.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.413 ' CB ' ' O ' ' A' ' 27' ' ' LYS . 1.3 ptt? -116.14 167.24 11.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.707 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.636 ' OD1' ' CE3' ' A' ' 136' ' ' TRP . 0.0 OUTLIER -102.09 168.99 9.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.384 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -56.79 -3.55 0.12 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.418 177.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.565 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 1.8 m-20 -99.55 3.03 45.28 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.565 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 3.7 mmtm 74.46 20.4 2.52 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.114 -178.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.56 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 1.2 mmtt -94.85 145.35 24.96 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.72 HG13 ' HA ' ' A' ' 139' ' ' PRO . 1.1 mm -99.32 140.95 17.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.995 0.426 . . . . 0.0 112.082 -177.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.522 ' CE1' HD11 ' A' ' 119' ' ' ILE . 73.1 t80 -78.15 135.23 37.62 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.463 178.228 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.483 ' CB ' HD13 ' A' ' 142' ' ' LEU . . . -141.3 153.83 45.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.776 0.322 . . . . 0.0 110.79 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.595 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -142.55 145.13 33.29 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.64 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.615 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 17.6 p -94.31 148.18 22.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.543 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.4 mtp180 -69.35 133.6 48.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.084 0.469 . . . . 0.0 111.006 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.651 ' H ' ' CD2' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -38.47 -48.78 1.42 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.612 -178.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.17 -34.9 61.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.171 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.471 ' HB ' ' HB1' ' A' ' 39' ' ' ALA . 29.2 mm -123.31 104.41 34.73 Favored Pre-proline 0 C--O 1.233 0.184 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.01 -16.89 45.89 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.862 2.375 . . . . 0.0 112.377 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -89.89 -10.15 46.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.425 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.615 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.78 88.64 6.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.935 0.398 . . . . 0.0 110.338 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.605 ' O ' ' HA ' ' A' ' 146' ' ' THR . 75.8 m95 -85.57 146.53 26.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.365 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.473 ' HB3' ' OH ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -165.41 162.16 19.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.921 -179.871 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -98.3 156.93 35.25 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.079 179.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.414 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 1.9 Cg_endo -44.34 155.07 0.26 Allowed 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.048 2.499 . . . . 0.0 113.08 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.439 ' HA ' HD11 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -176.17 171.36 2.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.207 -179.576 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.477 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . 176.9 152.55 9.92 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.677 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.738 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -77.75 135.97 17.35 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.602 -0.809 . . . . 0.0 113.358 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 16.9 mt -69.46 145.6 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.734 0.302 . . . . 0.0 111.007 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.57 -175.66 0.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.028 0.442 . . . . 0.0 111.257 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.422 ' HG3' ' H ' ' A' ' 50' ' ' GLY . 0.2 OUTLIER -52.22 -47.5 65.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.856 179.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.422 ' H ' ' HG3' ' A' ' 49' ' ' GLU . . . -143.34 52.79 0.62 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.286 -179.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -112.9 150.22 32.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.772 0.32 . . . . 0.0 110.446 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.408 ' O ' ' HB3' ' A' ' 56' ' ' ALA . 0.4 OUTLIER -68.1 156.26 90.21 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.903 179.659 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.453 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 3.0 Cg_exo -73.93 -49.35 0.2 Allowed 'Trans proline' 0 CA--C 1.515 -0.442 0 C-N-CA 122.41 2.074 . . . . 0.0 111.113 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.547 ' HD3' HG22 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -53.13 -46.57 68.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.307 179.293 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 -67.7 -40.11 84.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.135 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 52' ' ' ASP . . . -62.04 -44.7 96.13 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.546 ' CA ' HG22 ' A' ' 17' ' ' VAL . . . -56.07 -52.21 65.07 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.931 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.471 HG13 ' O ' ' A' ' 54' ' ' ARG . 22.4 mt -56.43 -56.45 13.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.548 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -60.05 4.42 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.672 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.477 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -45.87 -47.53 16.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.155 0.503 . . . . 0.0 109.744 179.081 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.469 ' HB2' HD13 ' A' ' 19' ' ' ILE . 4.2 tp -50.25 -46.64 55.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.324 178.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 66' ' ' GLY . 18.7 ttm180 -64.98 -63.51 1.09 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.357 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -49.78 -22.66 1.5 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.436 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.411 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 31.3 mt-10 -97.01 -36.58 10.47 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -177.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.432 HG22 ' CD2' ' A' ' 121' ' ' LEU . 0.6 OUTLIER -124.26 -13.77 7.13 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.979 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 86.04 -16.24 43.93 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.232 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.507 HG21 HG12 ' A' ' 119' ' ' ILE . 52.3 t -58.13 117.26 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-O 121.254 0.549 . . . . 0.0 111.42 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.424 ' CG2' ' HG3' ' A' ' 62' ' ' ARG . 0.9 OUTLIER -122.64 -38.13 2.68 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.652 178.568 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.8 m -62.31 73.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.581 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.595 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -160.74 157.69 27.35 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.019 0.438 . . . . 0.0 112.126 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -131.53 152.19 50.96 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.95 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.547 HG22 ' HD3' ' A' ' 54' ' ' ARG . 4.2 t -75.24 127.15 36.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.148 0.499 . . . . 0.0 111.428 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.556 HD12 ' HG ' ' A' ' 109' ' ' LEU . 1.6 mt -107.95 -19.67 6.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.596 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.454 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -169.56 176.78 4.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.0 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.3 OUTLIER -154.89 146.44 23.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.752 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.665 ' HA ' HG11 ' A' ' 160' ' ' VAL . 50.7 t -72.58 140.58 81.82 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.106 0.479 . . . . 0.0 111.203 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.493 ' HD3' HG12 ' A' ' 160' ' ' VAL . 26.8 Cg_endo -62.08 -62.67 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.27 2.647 . . . . 0.0 113.138 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.597 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -96.53 177.05 5.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.049 -178.514 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.639 ' O ' ' HA ' ' A' ' 5' ' ' SER . 49.9 m95 -93.38 97.45 10.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.174 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.519 HD22 ' CD1' ' A' ' 78' ' ' TYR . 38.3 mt -57.27 110.57 0.87 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.885 0.374 . . . . 0.0 111.087 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.573 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 1.8 p -112.78 -165.3 0.98 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.804 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -170.58 72.8 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.767 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -70.99 164.77 24.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.459 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.619 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 3.9 m-85 -104.63 160.43 26.03 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.229 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.502 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 30.4 Cg_exo -60.82 178.44 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.662 2.241 . . . . 0.0 111.285 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.459 ' HD2' ' CB ' ' A' ' 85' ' ' PRO . 17.9 Cg_endo -60.08 -16.09 37.48 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.181 1.92 . . . . 0.0 112.98 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.47 -62.05 1.54 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.769 0.319 . . . . 0.0 111.341 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.619 ' HB ' ' HB3' ' A' ' 84' ' ' PHE . 31.0 t -66.07 -6.52 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.704 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.523 ' O ' ' HB2' ' A' ' 93' ' ' ASN . 0.5 OUTLIER -67.66 -0.33 3.88 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -120.14 -22.48 6.62 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.715 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.544 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -91.12 -13.69 32.58 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.095 179.477 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.541 ' O ' ' HG2' ' A' ' 95' ' ' GLN . 1.2 tm? -121.45 -64.16 1.25 Allowed 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.39 0.614 . . . . 0.0 110.443 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.8 ' HB3' ' HA ' ' A' ' 101' ' ' LYS . 4.7 m120 -51.75 -23.2 4.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.615 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.458 ' CG2' ' O ' ' A' ' 94' ' ' ILE . 2.0 mp -112.54 -6.93 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.36 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.544 ' HB3' ' O ' ' A' ' 91' ' ' LYS . 1.3 pt20 -61.4 -11.4 10.15 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.543 ' HB2' ' CD1' ' A' ' 100' ' ' TRP . 11.9 m95 -93.37 35.69 1.09 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.499 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 54.5 84.58 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.883 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.3 p 58.17 162.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.82 0.343 . . . . 0.0 111.185 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.45 ' O ' ' HB2' ' A' ' 100' ' ' TRP . 2.0 t0 56.26 -160.25 0.21 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.66 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.718 ' HZ3' ' HA ' ' A' ' 14' ' ' ARG . 91.8 m95 65.81 173.25 0.23 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.297 179.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.8 ' HA ' ' HB3' ' A' ' 93' ' ' ASN . 0.0 OUTLIER 167.06 67.49 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 179.699 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.84 -165.45 12.58 Favored Glycine 0 C--N 1.339 0.716 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.652 177.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.573 ' O ' ' HA ' ' A' ' 81' ' ' THR . 36.8 mt-30 -141.29 117.63 10.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.708 0.29 . . . . 0.0 110.634 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.425 ' N ' ' HB3' ' A' ' 13' ' ' TYR . . . -101.75 112.94 25.7 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.717 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.726 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 10.6 mt-30 -122.21 126.47 48.32 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.48 ' HB2' ' CE3' ' A' ' 79' ' ' TRP . 2.4 ttmt -102.69 131.96 49.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.245 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.533 ' CE3' ' HA3' ' A' ' 18' ' ' GLY . 74.6 m95 -101.99 161.35 13.74 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -177.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.492 ' CE1' ' HG2' ' A' ' 54' ' ' ARG . 99.5 m-85 -142.64 150.53 40.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.784 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.556 ' HG ' HD12 ' A' ' 73' ' ' ILE . 15.0 tp -98.56 139.72 33.87 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.255 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.494 ' CE2' HG21 ' A' ' 72' ' ' VAL . 32.0 m-85 -138.81 142.72 38.71 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -178.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.595 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 1.1 tttt -102.28 120.18 40.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.679 178.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.433 ' CD1' HG13 ' A' ' 67' ' ' VAL . 65.4 t80 -78.23 98.72 5.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.796 0.332 . . . . 0.0 110.596 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.4 p -95.25 39.64 1.11 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.601 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.402 ' C ' ' CE2' ' A' ' 112' ' ' PHE . . . -135.64 -148.22 5.58 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.268 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.432 ' HB2' ' HG2' ' A' ' 117' ' ' GLN . 0.1 OUTLIER -125.45 150.32 47.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.857 0.36 . . . . 0.0 111.137 179.474 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.426 ' C ' ' H ' ' A' ' 118' ' ' GLU . 9.6 p-10 -58.43 -39.7 80.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.483 0.658 . . . . 0.0 110.662 -179.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.432 ' HG2' ' HB2' ' A' ' 115' ' ' GLN . 14.8 pt20 -58.61 -3.5 0.31 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.913 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.426 ' H ' ' C ' ' A' ' 116' ' ' ASP . 2.0 tt0 -89.03 -22.14 23.11 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.238 0.542 . . . . 0.0 110.234 179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.536 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 10.5 mt -83.05 100.11 6.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.19 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.428 ' O ' ' C ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -97.51 9.38 42.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.021 -179.546 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 121' ' ' LEU . 71.7 mt 31.49 56.51 0.28 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.22 0.533 . . . . 0.0 111.56 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.673 HD21 ' HB3' ' A' ' 129' ' ' PRO . 0.5 OUTLIER 58.49 165.44 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.264 179.756 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -162.24 -131.34 1.21 Allowed Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 51.02 -162.24 0.07 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.882 0.373 . . . . 0.0 111.172 179.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.82 60.3 0.55 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.077 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.1 m -97.38 -63.22 1.15 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.766 0.317 . . . . 0.0 111.31 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 128' ' ' LYS . 5.0 tt0 -145.6 -74.61 0.22 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.138 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 129' ' ' PRO . 12.6 pttp -179.31 148.26 0.52 Allowed Pre-proline 0 C--N 1.332 -0.171 0 CA-C-O 121.137 0.494 . . . . 0.0 111.81 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.673 ' HB3' HD21 ' A' ' 122' ' ' LEU . 5.9 Cg_exo -69.55 -165.41 0.15 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 123.011 2.474 . . . . 0.0 112.829 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.517 ' O ' HD21 ' A' ' 34' ' ' LEU . 3.9 tp10 -109.25 -32.83 7.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.872 178.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.573 ' N ' HD23 ' A' ' 34' ' ' LEU . 2.1 m-85 -131.91 139.0 48.6 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 178.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.57 ' N ' HD22 ' A' ' 34' ' ' LEU . . . -85.92 -33.13 16.09 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.688 -178.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.478 ' O ' ' HA ' ' A' ' 31' ' ' ALA . 1.9 tt0 -150.78 153.87 36.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.338 0.113 . . . . 0.0 110.947 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.595 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 43.3 p-90 -135.36 168.28 19.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.057 0.456 . . . . 0.0 111.691 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.429 ' N ' ' HZ3' ' A' ' 40' ' ' TRP . 15.9 t -162.74 167.26 23.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.526 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.636 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 53.7 m95 -103.95 102.91 12.69 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.6 ' O ' ' N ' ' A' ' 28' ' ' ILE . 21.7 m -119.66 165.08 15.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.497 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 19.0 p -72.01 170.98 10.48 Favored Pre-proline 0 C--N 1.327 -0.413 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.027 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.72 ' HA ' HG13 ' A' ' 28' ' ' ILE . 13.7 Cg_exo -62.88 -54.58 1.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.031 1.821 . . . . 0.0 110.41 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -64.94 -26.75 68.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.584 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.489 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.8 OUTLIER -72.04 -46.56 56.56 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.502 179.582 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.483 HD13 ' CB ' ' A' ' 30' ' ' ALA . 0.6 OUTLIER -57.35 -38.38 74.05 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.832 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.638 HG22 ' HG2' ' A' ' 155' ' ' LYS . 7.1 mm -60.88 -35.95 68.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.215 0.531 . . . . 0.0 110.219 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.68 -51.69 26.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.202 0.525 . . . . 0.0 110.769 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.437 HD21 ' CD1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER -73.75 -19.97 60.64 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.415 -0.812 . . . . 0.0 112.712 -179.034 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.605 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 7.3 t -73.78 177.76 5.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.976 0.417 . . . . 0.0 111.487 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.468 ' HB ' ' CE2' ' A' ' 149' ' ' PHE . 16.2 m -82.24 149.5 4.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.334 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.487 ' HA ' ' HE3' ' A' ' 151' ' ' LYS . 42.6 mt-10 -60.29 -55.21 36.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.049 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.468 ' CE2' ' HB ' ' A' ' 147' ' ' VAL . 55.1 p90 -54.24 -4.34 0.05 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.462 ' HG2' ' CZ ' ' A' ' 154' ' ' TYR . 0.1 OUTLIER -132.73 -6.54 3.2 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.435 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.487 ' HE3' ' HA ' ' A' ' 148' ' ' GLU . 11.6 mttt -59.79 -59.49 13.67 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.475 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 11.8 Cg_endo -55.73 -27.66 62.64 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.312 2.008 . . . . 0.0 111.651 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.456 ' O ' HG23 ' A' ' 157' ' ' VAL . 39.5 t -69.27 -53.9 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.473 ' OH ' ' HB3' ' A' ' 41' ' ' GLN . 9.1 m-30 -63.51 -36.86 85.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.855 178.554 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.638 ' HG2' HG22 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -57.73 -43.5 85.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.085 179.782 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -69.11 -28.49 66.52 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.558 HG11 ' CE2' ' A' ' 161' ' ' PHE . 48.6 t -68.48 -42.25 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.973 178.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.433 HD12 ' HE2' ' A' ' 155' ' ' LYS . 47.8 mt -63.68 -43.5 96.5 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.561 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.465 ' O ' ' HB1' ' A' ' 162' ' ' ALA . 1.8 t -53.76 -41.3 67.01 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.665 HG11 ' HA ' ' A' ' 76' ' ' VAL . 88.2 t -66.75 -42.59 89.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.378 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.59 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 22.1 m-30 -80.15 4.08 18.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.552 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.592 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.58 -53.1 69.59 Favored Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 120.531 -0.467 . . . . 0.0 110.644 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 18.9 Cg_endo -58.89 -12.21 14.41 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.141 1.894 . . . . 0.0 111.921 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.454 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 92.9 m-70 -109.19 -17.98 13.73 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.28 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 95.6 mt . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.854 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.132 0 N-CA-C 112.393 -0.283 . . . . 0.0 112.393 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.49 146.44 33.37 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.523 2.149 . . . . 0.0 112.129 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.483 HD13 ' HA ' ' A' ' 153' ' ' VAL . 8.2 mt 62.21 -173.31 0.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.109 0.481 . . . . 0.0 110.873 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.43 -43.23 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.577 ' HA ' ' O ' ' A' ' 79' ' ' TRP . 0.3 OUTLIER 52.0 105.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 179.281 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.6 mpp? -103.63 140.72 37.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.054 178.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.6 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 33.1 t70 -66.92 -8.66 31.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.368 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.01 114.08 6.98 Favored Pre-proline 0 CA--C 1.531 0.242 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.477 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 22.7 Cg_endo -61.45 118.61 5.49 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.378 2.052 . . . . 0.0 112.456 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.477 ' HD3' ' HA ' ' A' ' 9' ' ' PRO . 4.0 Cg_exo -81.8 167.42 16.57 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.197 2.598 . . . . 0.0 112.761 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.36 153.47 7.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.403 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 69.02 1.81 27.91 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 121.054 -0.593 . . . . 0.0 114.194 178.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.467 ' HB2' ' O ' ' A' ' 10' ' ' PRO . 21.7 m-85 -92.38 124.48 36.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.476 0.638 . . . . 0.0 110.708 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.451 ' HA ' ' CZ2' ' A' ' 100' ' ' TRP . 0.8 OUTLIER -68.98 82.84 0.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.919 0.39 . . . . 0.0 110.891 179.393 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.414 ' HG2' HD12 ' A' ' 47' ' ' ILE . 5.4 ttp180 -50.21 111.75 0.57 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.475 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.681 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 3.2 m120 -135.34 -178.76 5.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.127 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.488 HG22 ' CA ' ' A' ' 57' ' ' ALA . 14.9 m -142.65 167.57 14.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.39 0.614 . . . . 0.0 111.967 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.451 ' HA3' ' CE3' ' A' ' 107' ' ' TRP . . . -138.18 155.41 23.37 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.891 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.573 HG13 ' HB2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -131.31 129.23 62.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.063 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.4 t -108.77 106.11 15.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.898 178.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.477 HD23 HG11 ' A' ' 67' ' ' VAL . 7.4 tp -105.98 123.59 48.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.845 -178.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.511 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -124.22 165.98 16.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.113 179.444 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.527 ' N ' ' OD1' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -97.45 171.96 8.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.004 0.431 . . . . 0.0 110.406 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -58.48 -5.35 0.52 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.585 177.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.532 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -99.8 2.6 44.18 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.782 0.325 . . . . 0.0 111.771 -179.137 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.532 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 17.1 mmtp 73.61 22.29 2.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.953 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.511 ' O ' ' HA ' ' A' ' 22' ' ' MET . 2.2 mmtt -93.0 143.87 25.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.637 HG13 ' HA ' ' A' ' 139' ' ' PRO . 0.9 OUTLIER -98.07 138.02 23.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.286 0.565 . . . . 0.0 112.457 -177.913 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.426 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 17.1 t80 -80.22 135.1 36.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.726 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.439 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -142.58 151.77 41.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.945 0.403 . . . . 0.0 111.281 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -143.14 136.77 28.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.309 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.643 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 3.5 p -97.19 152.65 18.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.847 0.356 . . . . 0.0 111.45 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.659 ' O ' ' N ' ' A' ' 35' ' ' ASP . 15.3 mtp180 -68.54 130.43 42.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.731 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.674 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.3 OUTLIER -53.32 52.42 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.145 0.578 . . . . 0.0 112.491 -179.722 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.659 ' N ' ' O ' ' A' ' 33' ' ' ARG . 0.5 OUTLIER -177.68 -36.06 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.895 0.379 . . . . 0.0 110.347 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.476 HG23 ' CB ' ' A' ' 39' ' ' ALA . 4.0 mp -112.61 103.01 55.34 Favored Pre-proline 0 N--CA 1.454 -0.25 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.58 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -62.99 -46.04 11.42 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.167 2.578 . . . . 0.0 113.45 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -72.32 -4.44 29.81 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.643 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -94.75 93.03 7.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.798 0.332 . . . . 0.0 111.083 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.642 ' O ' ' HA ' ' A' ' 146' ' ' THR . 63.7 m95 -100.15 145.93 27.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.438 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.96 158.1 21.88 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.403 0.621 . . . . 0.0 111.593 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.451 ' HG3' ' HZ3' ' A' ' 107' ' ' TRP . 3.4 ptp -94.28 158.46 35.82 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.198 178.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.435 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 9.4 Cg_endo -49.31 154.47 3.87 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.423 2.082 . . . . 0.0 112.223 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.464 ' HA ' HD12 ' A' ' 19' ' ' ILE . 0.2 OUTLIER -178.56 140.9 0.2 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.142 -179.664 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.4 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . -157.63 164.82 33.27 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.757 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.587 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -88.25 142.19 17.28 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.894 -0.669 . . . . 0.0 113.54 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.463 HG23 ' N ' ' A' ' 48' ' ' ASP . 3.9 mt -70.44 146.73 11.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 122.66 0.384 . . . . 0.0 111.283 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.463 ' N ' HG23 ' A' ' 47' ' ' ILE . 23.8 m-20 -67.54 -174.55 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.406 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.88 -60.78 2.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.163 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.97 61.97 0.65 Allowed Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.465 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.435 ' HG3' ' N ' ' A' ' 52' ' ' ASP . 3.9 tp10 -119.94 155.86 31.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.731 0.3 . . . . 0.0 110.818 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.435 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -71.99 158.84 86.94 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.352 179.63 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 2.9 Cg_exo -76.12 -50.37 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.605 2.203 . . . . 0.0 111.67 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.512 ' HD3' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -53.07 -44.95 67.9 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.508 179.798 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -67.81 -42.13 82.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.012 179.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.404 ' O ' ' HG2' ' A' ' 60' ' ' GLU . . . -62.2 -42.6 99.44 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.488 ' CA ' HG22 ' A' ' 17' ' ' VAL . . . -56.55 -53.72 54.32 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.808 178.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.463 HG12 ' CE2' ' A' ' 110' ' ' PHE . 17.7 mt -57.56 -53.51 43.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.065 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -60.06 -58.69 7.44 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.923 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 56' ' ' ALA . 26.0 mm-40 -47.34 -45.84 25.03 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.226 0.536 . . . . 0.0 109.634 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.573 ' HB2' HG13 ' A' ' 19' ' ' ILE . 7.5 tt -51.83 -49.69 62.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.257 178.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.43 ' O ' ' N ' ' A' ' 66' ' ' GLY . 47.7 ttt180 -63.06 -62.83 1.44 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.167 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.44 ' O ' ' CD1' ' A' ' 122' ' ' LEU . 6.2 mm-40 -51.35 -19.16 1.2 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.32 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.44 ' O ' HD23 ' A' ' 122' ' ' LEU . 13.5 mm-40 -98.91 -32.54 11.26 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -178.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -131.78 -11.61 3.42 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.609 -178.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 87.14 -15.16 55.17 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.464 -0.874 . . . . 0.0 111.967 -179.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.493 HG22 HG12 ' A' ' 119' ' ' ILE . 77.7 t -58.3 113.72 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 121.248 0.546 . . . . 0.0 111.358 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.427 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.7 OUTLIER -121.47 -39.96 2.61 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.481 178.637 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.419 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 6.1 m -62.5 74.6 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.14 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.568 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -158.88 154.94 26.84 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.667 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.16 151.46 49.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.432 179.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.528 HG23 ' CE2' ' A' ' 110' ' ' PHE . 2.8 t -74.9 127.8 36.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.725 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.531 HD12 ' HB2' ' A' ' 111' ' ' LYS . 1.0 OUTLIER -109.11 -17.87 7.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.332 178.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.464 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -169.04 173.73 6.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.569 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -153.09 136.06 15.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.648 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.547 ' HA ' HG12 ' A' ' 160' ' ' VAL . 41.8 t -73.48 137.48 77.79 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.03 0.443 . . . . 0.0 111.081 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.421 ' N ' HG13 ' A' ' 76' ' ' VAL . 41.6 Cg_endo -72.09 -73.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.723 2.282 . . . . 0.0 112.54 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.6 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 2.2 p90 -67.57 157.81 33.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.097 0.475 . . . . 0.0 111.543 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.577 ' O ' ' HA ' ' A' ' 5' ' ' SER . 49.7 m95 -94.75 109.4 21.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.187 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.508 HD13 HG22 ' A' ' 157' ' ' VAL . 15.0 mt -61.94 115.66 4.24 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.622 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 11.4 p -117.92 126.25 52.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.124 0.488 . . . . 0.0 112.272 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 82' ' ' TYR . 0.5 OUTLIER -80.02 39.32 0.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.971 179.303 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -73.07 134.24 44.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.759 0.314 . . . . 0.0 111.054 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.47 ' CE1' ' HG ' ' A' ' 92' ' ' LEU . 7.2 m-85 -103.75 156.91 34.94 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.976 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.456 ' CB ' ' HD2' ' A' ' 86' ' ' PRO . 15.6 Cg_exo -68.99 176.94 5.54 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.827 2.352 . . . . 0.0 111.589 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.456 ' HD2' ' CB ' ' A' ' 85' ' ' PRO . 6.3 Cg_endo -48.59 160.17 0.68 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.335 2.023 . . . . 0.0 111.793 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.4 ' CB ' ' O ' ' A' ' 86' ' ' PRO . 0.3 OUTLIER 79.4 -53.94 0.42 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.678 -179.405 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.9 t -63.6 -31.48 53.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.95 0.405 . . . . 0.0 110.57 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 93' ' ' ASN . 4.8 mmt85 -59.68 -51.81 68.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.109 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.435 ' HA ' HD11 ' A' ' 94' ' ' ILE . 1.8 mp0 -56.38 -23.74 39.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.065 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 47.8 mttt -98.59 -20.66 16.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.152 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.47 ' HG ' ' CE1' ' A' ' 84' ' ' PHE . 2.0 tm? -119.83 -61.81 1.56 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.714 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 89' ' ' ARG . 52.1 t-20 -47.49 -59.69 3.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.872 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.435 HD11 ' HA ' ' A' ' 90' ' ' GLU . 3.3 mp -75.17 -6.9 9.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.071 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.68 -0.09 25.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.579 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -94.08 27.14 2.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.688 0.28 . . . . 0.0 111.478 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 52.69 24.26 17.75 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 121.026 -0.607 . . . . 0.0 113.263 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -174.72 -174.48 0.82 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.694 0.283 . . . . 0.0 110.904 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.48 -89.01 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.459 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.499 ' O ' ' HB3' ' A' ' 101' ' ' LYS . 0.0 OUTLIER 57.84 -176.31 0.07 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.88 0.371 . . . . 0.0 111.39 179.058 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.499 ' HB3' ' O ' ' A' ' 100' ' ' TRP . 0.1 OUTLIER 163.17 52.66 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.649 179.27 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.85 -170.69 13.77 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.505 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.622 ' O ' ' HA ' ' A' ' 81' ' ' THR . 18.4 mt-30 -146.98 120.41 9.03 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.401 ' HA ' ' CG2' ' A' ' 81' ' ' THR . . . -91.04 116.97 29.21 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.101 0.477 . . . . 0.0 109.884 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.681 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 6.3 mt-30 -124.51 123.08 39.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.534 -177.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.513 ' HD3' ' CE2' ' A' ' 79' ' ' TRP . 14.2 ttpp -101.69 135.28 43.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.482 178.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.496 ' CD1' HD12 ' A' ' 80' ' ' LEU . 73.6 m95 -101.78 163.44 12.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.263 0.554 . . . . 0.0 112.445 -178.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.508 ' CE1' ' HG2' ' A' ' 54' ' ' ARG . 98.1 m-85 -143.18 150.63 39.65 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.839 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . . . . . . . . . 20.1 tp -99.26 138.77 35.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.311 179.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.528 ' CE2' HG23 ' A' ' 72' ' ' VAL . 62.0 m-85 -139.76 140.28 36.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.642 0.734 . . . . 0.0 112.888 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.568 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 1.7 tttt -101.27 123.63 45.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.754 178.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.426 ' CD1' HD21 ' A' ' 21' ' ' LEU . 39.4 t80 -78.34 96.61 5.35 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.809 0.337 . . . . 0.0 111.166 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 17.3 p -97.7 49.68 1.03 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.039 0.447 . . . . 0.0 110.596 179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.419 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -150.01 -148.57 4.8 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.296 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.407 ' HB2' ' HG2' ' A' ' 117' ' ' GLN . 28.7 mt-30 -121.84 151.46 40.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.823 0.344 . . . . 0.0 110.936 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 118' ' ' GLU . 16.2 m-20 -61.11 -28.8 69.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.8 -179.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . 0.407 ' HG2' ' HB2' ' A' ' 115' ' ' GLN . 2.1 pt20 -59.0 -3.2 0.32 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.137 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.41 ' H ' ' C ' ' A' ' 116' ' ' ASP . 8.7 tp10 -90.7 -17.68 26.34 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.903 0.382 . . . . 0.0 110.895 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.569 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 15.9 mt -81.76 95.89 3.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.615 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -96.72 3.8 52.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.951 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 29.5 mt 38.29 63.35 0.86 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.975 0.417 . . . . 0.0 111.449 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.644 HD22 ' HB3' ' A' ' 129' ' ' PRO . 1.8 mm? 64.79 -172.34 0.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.334 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -171.33 -1.59 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.742 -0.663 . . . . 0.0 113.495 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -143.67 -164.72 1.93 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.796 0.331 . . . . 0.0 110.861 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 124.48 167.69 12.71 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.65 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.77 -10.8 59.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.701 0.286 . . . . 0.0 111.319 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -146.06 -67.88 0.28 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.833 0.349 . . . . 0.0 110.618 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.482 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 4.9 pttt -168.99 159.79 7.92 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.05 0.452 . . . . 0.0 111.224 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.66 ' HB2' ' CD1' ' A' ' 34' ' ' LEU . 51.7 Cg_exo -48.17 -167.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 123.459 2.773 . . . . 0.0 113.771 -178.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -96.12 -33.88 11.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.834 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.526 ' HA ' ' O ' ' A' ' 32' ' ' SER . 3.2 m-85 -127.62 140.91 51.8 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.114 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.674 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -96.25 -29.28 8.52 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.498 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -145.18 146.75 31.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.725 0.298 . . . . 0.0 110.339 179.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.569 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 40.8 p-90 -135.89 165.77 24.86 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.939 0.399 . . . . 0.0 111.548 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.449 ' N ' ' HZ3' ' A' ' 40' ' ' TRP . 36.6 t -164.61 177.5 8.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.335 0.588 . . . . 0.0 112.164 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.533 ' NE1' ' HZ3' ' A' ' 134' ' ' TRP . 35.2 m95 -113.24 104.58 12.48 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.338 178.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.584 ' O ' ' N ' ' A' ' 28' ' ' ILE . 16.3 m -120.05 168.71 12.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.279 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.504 ' OG1' ' HB2' ' A' ' 141' ' ' GLN . 23.3 p -73.09 168.86 20.86 Favored Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.24 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.637 ' HA ' HG13 ' A' ' 28' ' ' ILE . 16.5 Cg_exo -61.88 -53.27 2.23 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 121.866 1.71 . . . . 0.0 110.471 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.7 -27.79 68.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.654 178.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.504 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 37.2 mt-30 -72.42 -46.28 55.86 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.045 0.45 . . . . 0.0 110.154 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.439 HD13 ' HB2' ' A' ' 30' ' ' ALA . 0.5 OUTLIER -56.26 -40.76 74.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.826 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.547 ' O ' HG21 ' A' ' 146' ' ' THR . 14.9 mm -62.15 -34.0 61.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.234 0.54 . . . . 0.0 110.158 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.89 -51.51 25.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.21 0.528 . . . . 0.0 110.714 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.419 HD21 ' CD1' ' A' ' 40' ' ' TRP . 1.6 mp -73.86 -20.99 60.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.877 -179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.642 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 11.7 t -73.77 175.81 6.88 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.504 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 23.0 m -86.44 149.72 4.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.996 -179.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 151' ' ' LYS . 3.0 tt0 -50.81 -50.85 55.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.643 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -51.13 -11.4 0.1 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -131.8 -3.06 3.68 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.536 ' HG3' ' CG2' ' A' ' 146' ' ' THR . 0.6 OUTLIER -60.66 -63.43 4.31 Favored Pre-proline 0 C--N 1.325 -0.458 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.143 179.799 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.43 ' CD ' ' CB ' ' A' ' 151' ' ' LYS . 17.3 Cg_endo -58.33 -30.27 90.62 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.429 2.086 . . . . 0.0 111.962 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.483 ' HA ' HD13 ' A' ' 3' ' ' LEU . 19.0 t -68.9 -51.41 44.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.485 ' CE1' ' CH2' ' A' ' 107' ' ' TRP . 7.7 m-30 -63.4 -36.41 83.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.919 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.458 ' HD3' HG22 ' A' ' 143' ' ' ILE . 0.5 OUTLIER -57.86 -46.31 85.01 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.112 179.608 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.03 -31.94 72.82 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.508 HG22 HD13 ' A' ' 80' ' ' LEU . 92.4 t -66.76 -41.48 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.415 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.434 HD22 ' HB3' ' A' ' 139' ' ' PRO . 62.8 mt -64.03 -44.51 92.32 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.4 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.7 t -53.49 -42.84 67.71 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 76' ' ' VAL . 92.3 t -66.48 -42.18 89.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.172 178.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.541 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 21.9 m-30 -81.79 5.9 17.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.624 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.438 ' N ' ' CD ' ' A' ' 163' ' ' PRO . . . -59.09 -50.86 85.59 Favored Pre-proline 0 C--N 1.327 -0.382 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.004 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.454 ' HD2' ' O ' ' A' ' 160' ' ' VAL . 30.6 Cg_exo -60.12 -10.84 13.74 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.346 2.031 . . . . 0.0 112.085 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.464 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 87.6 m-70 -111.23 -18.24 13.0 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.44 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 96.7 mt . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.868 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.19 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.06 137.44 76.46 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.57 2.18 . . . . 0.0 112.33 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER 61.75 -174.69 0.13 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.049 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.07 -47.7 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.02 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.604 ' HB3' ' O ' ' A' ' 79' ' ' TRP . 0.9 OUTLIER 62.95 137.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.047 0.451 . . . . 0.0 111.813 179.409 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.537 ' C ' ' HB2' ' A' ' 78' ' ' TYR . 0.4 OUTLIER -143.81 138.24 28.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.283 179.714 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.581 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 2.8 p30 -63.12 -9.29 10.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.682 0.277 . . . . 0.0 111.004 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.0 p -146.49 140.44 15.29 Favored Pre-proline 0 CA--C 1.53 0.21 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.438 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 45.9 Cg_endo -67.46 107.91 1.5 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.298 1.999 . . . . 0.0 112.193 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.459 ' HG3' ' SD ' ' A' ' 6' ' ' MET . 4.6 Cg_endo -49.27 165.05 0.24 Allowed 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.233 2.622 . . . . 0.0 113.091 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -51.42 128.38 22.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.395 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 53.42 78.91 0.1 OUTLIER Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.741 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -151.98 155.96 39.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.578 0.228 . . . . 0.0 110.743 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.732 ' HA ' ' HZ3' ' A' ' 100' ' ' TRP . 0.1 OUTLIER -66.33 -159.74 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.093 -179.201 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.589 ' HG3' ' CZ3' ' A' ' 79' ' ' TRP . 6.7 ttp180 179.52 102.26 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.35 0.595 . . . . 0.0 110.103 -178.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.658 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 2.2 m-80 -128.81 175.29 8.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.844 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.579 ' HA ' ' O ' ' A' ' 106' ' ' LYS . 25.7 m -134.64 159.5 41.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.177 0.513 . . . . 0.0 110.872 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.605 ' HA3' ' CE3' ' A' ' 107' ' ' TRP . . . -131.64 155.3 21.32 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.564 HD13 ' HB2' ' A' ' 61' ' ' LEU . 1.6 mp -125.37 117.08 48.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.419 ' CB ' ' HE2' ' A' ' 161' ' ' PHE . 6.1 t -101.39 99.23 9.55 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.534 HD23 ' CD1' ' A' ' 112' ' ' PHE . 41.5 tp -100.83 119.09 38.15 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.727 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.622 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -119.75 159.77 23.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.926 179.656 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -94.6 171.87 8.53 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.024 0.44 . . . . 0.0 110.232 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -58.23 -4.77 0.39 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.675 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.6 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.5 OUTLIER -101.02 2.58 40.68 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.03 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.6 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 2.1 mmtm 75.12 20.86 2.03 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.186 -178.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.622 ' O ' ' HA ' ' A' ' 22' ' ' MET . 3.8 mmtt -92.2 143.87 25.99 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.743 HG13 ' HA ' ' A' ' 139' ' ' PRO . 1.6 mm -97.26 136.93 26.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.092 0.472 . . . . 0.0 112.009 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.566 ' CE1' HD11 ' A' ' 119' ' ' ILE . 33.8 t80 -74.13 105.53 5.38 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.41 178.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.425 ' CB ' ' CD1' ' A' ' 142' ' ' LEU . . . -103.88 144.37 31.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.799 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.478 ' HB2' ' CG ' ' A' ' 131' ' ' PHE . . . -142.25 131.37 23.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.388 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.775 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 6.6 p -97.9 147.29 24.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.069 0.461 . . . . 0.0 111.747 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.516 ' HD3' ' HB2' ' A' ' 39' ' ' ALA . 4.7 mtp180 -68.36 128.95 38.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.389 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.694 HD11 ' HG2' ' A' ' 129' ' ' PRO . 0.4 OUTLIER -45.14 -35.86 3.41 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.277 0.56 . . . . 0.0 110.883 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.53 -38.01 68.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.038 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.651 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 23.9 mt -122.81 105.92 34.84 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.214 -179.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.11 -21.17 36.89 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.825 2.35 . . . . 0.0 112.967 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -92.06 -6.97 50.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.709 0.29 . . . . 0.0 111.568 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.775 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.34 95.45 10.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.691 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.643 ' O ' ' HA ' ' A' ' 146' ' ' THR . 72.3 m95 -93.65 136.73 33.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.912 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.496 ' HG3' ' C ' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -161.59 158.41 26.22 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.105 0.479 . . . . 0.0 110.699 179.755 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.55 ' HG3' ' HZ3' ' A' ' 107' ' ' TRP . 0.1 OUTLIER -94.34 157.8 36.83 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.55 178.844 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.518 ' HB2' HD13 ' A' ' 19' ' ' ILE . 2.8 Cg_endo -44.08 151.79 0.46 Allowed 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 123.119 2.546 . . . . 0.0 112.891 -179.126 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -171.39 143.06 1.77 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.201 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.658 ' O ' ' HB3' ' A' ' 16' ' ' ASN . . . -140.48 -178.38 17.0 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.623 ' HA2' ' CB ' ' A' ' 16' ' ' ASN . . . -112.18 23.58 15.97 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.016 -1.088 . . . . 0.0 114.736 -178.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.421 ' O ' ' O ' ' A' ' 46' ' ' GLY . 29.9 mt 60.13 130.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 117.543 0.672 . . . . 0.0 111.064 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.3 -176.15 0.71 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.825 0.345 . . . . 0.0 110.88 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.69 -81.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.212 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.39 55.91 0.49 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.359 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -116.21 153.01 32.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.873 0.368 . . . . 0.0 111.002 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.538 ' O ' ' HB1' ' A' ' 56' ' ' ALA . 1.4 m-20 -69.61 173.54 3.93 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.446 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 8.9 Cg_endo -85.53 -54.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.378 2.052 . . . . 0.0 111.678 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.643 ' HD3' HG23 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -54.36 -43.34 71.23 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.315 179.012 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -69.44 -40.81 76.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.308 179.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.538 ' HB1' ' O ' ' A' ' 52' ' ' ASP . . . -60.78 -45.73 93.24 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.536 ' CA ' HG21 ' A' ' 17' ' ' VAL . . . -54.29 -49.37 69.77 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.014 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.607 ' O ' ' HB3' ' A' ' 61' ' ' LEU . 18.0 mt -58.97 -55.47 23.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.246 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.67 -63.67 1.22 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.187 -179.174 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.528 ' OE2' ' N ' ' A' ' 45' ' ' GLY . 0.3 OUTLIER -47.2 -37.43 10.26 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.407 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.607 ' HB3' ' O ' ' A' ' 58' ' ' ILE . 9.8 tp -53.24 -48.43 68.21 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.868 178.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.506 ' O ' ' N ' ' A' ' 66' ' ' GLY . 16.7 ttp180 -64.17 -64.23 0.94 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.489 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -48.98 -22.1 0.8 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.272 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -96.99 -37.45 10.17 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -178.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.51 HG22 ' CD2' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -127.66 -5.04 5.84 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.571 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 78.16 -13.88 13.4 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.252 -0.975 . . . . 0.0 111.872 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.523 HG21 HG12 ' A' ' 119' ' ' ILE . 75.3 t -58.62 112.71 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-O 121.194 0.521 . . . . 0.0 111.291 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.425 ' CG2' ' HG3' ' A' ' 62' ' ' ARG . 0.8 OUTLIER -121.59 -40.43 2.56 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.414 178.653 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.409 ' HB2' ' HA3' ' A' ' 114' ' ' GLY . 11.8 m -62.09 74.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.38 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.569 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.62 156.45 23.21 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.478 ' HG3' HG22 ' A' ' 113' ' ' THR . 1.0 OUTLIER -130.84 152.03 50.62 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.758 179.703 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.643 HG23 ' HD3' ' A' ' 54' ' ' ARG . 3.3 t -75.0 126.75 36.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.95 0.405 . . . . 0.0 111.186 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.58 HD12 ' HE2' ' A' ' 22' ' ' MET . 1.0 OUTLIER -107.47 -19.66 6.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.266 179.218 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.463 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.88 176.39 4.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.582 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -154.46 148.37 25.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.422 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.582 ' HA ' HG13 ' A' ' 160' ' ' VAL . 55.3 t -70.65 139.29 86.14 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.983 0.42 . . . . 0.0 110.894 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.622 ' HD3' HG11 ' A' ' 160' ' ' VAL . 18.7 Cg_endo -59.04 -62.9 0.15 Allowed 'Trans proline' 0 CA--C 1.519 -0.271 0 C-N-CA 123.233 2.622 . . . . 0.0 112.499 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.581 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -103.46 -172.47 2.12 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.426 -178.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.604 ' O ' ' HB3' ' A' ' 5' ' ' SER . 64.5 m95 -91.8 -158.29 0.57 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.974 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 79' ' ' TRP . 26.6 mt -164.44 105.4 0.86 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.731 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 23.9 p -104.62 -172.92 2.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.206 0.527 . . . . 0.0 111.289 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -169.6 70.98 0.07 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.834 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -70.39 163.4 26.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.137 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.452 ' CZ ' ' HG ' ' A' ' 92' ' ' LEU . 6.4 m-85 -97.86 168.61 9.74 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.304 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.492 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 16.8 Cg_exo -67.29 177.09 4.07 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.566 2.177 . . . . 0.0 111.132 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.25 8.18 0.94 Allowed 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.397 2.065 . . . . 0.0 113.27 179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.475 ' HG3' ' H ' ' A' ' 88' ' ' VAL . 0.9 OUTLIER -109.38 -45.92 3.64 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.703 0.287 . . . . 0.0 111.152 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.475 ' H ' ' HG3' ' A' ' 87' ' ' LYS . 13.9 t -87.76 -20.82 7.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.601 179.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.506 ' O ' ' HB2' ' A' ' 93' ' ' ASN . 1.4 tmm_? -37.85 -70.67 0.09 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.556 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.638 ' HA ' HD13 ' A' ' 94' ' ' ILE . 0.5 OUTLIER -63.46 -12.34 30.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.544 179.828 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.635 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -88.33 -29.85 20.01 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.312 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.635 ' C ' HD22 ' A' ' 92' ' ' LEU . 0.0 OUTLIER -122.92 -36.19 2.91 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -179.199 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.794 ' HB3' ' HA ' ' A' ' 101' ' ' LYS . 68.0 m-20 -73.37 -57.98 3.63 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -177.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.679 HG22 ' O ' ' A' ' 94' ' ' ILE . 3.1 mp -74.28 -4.58 5.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.353 0.596 . . . . 0.0 110.083 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.635 ' HG3' ' O ' ' A' ' 91' ' ' LYS . 0.9 OUTLIER -78.54 -2.06 36.95 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.678 179.2 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.454 ' HB2' ' CB ' ' A' ' 100' ' ' TRP . 62.2 m95 -82.84 -76.97 0.25 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.635 0.255 . . . . 0.0 110.795 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 162.98 64.07 0.02 OUTLIER Glycine 0 CA--C 1.521 0.429 0 C-N-CA 120.346 -0.931 . . . . 0.0 113.67 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 69.2 m 65.1 145.64 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.935 0.397 . . . . 0.0 111.773 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.35 1.75 2.16 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.551 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.732 ' HZ3' ' HA ' ' A' ' 14' ' ' ARG . 92.1 m95 -103.44 163.76 12.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.038 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.794 ' HA ' ' HB3' ' A' ' 93' ' ' ASN . 15.1 ttmt 167.76 29.51 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.379 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 150.84 -160.01 28.42 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.722 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.731 ' O ' ' HA ' ' A' ' 81' ' ' THR . 2.7 mt-30 -147.2 113.25 5.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.103 0.451 . . . . 0.0 112.085 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.46 ' HB2' HG22 ' A' ' 81' ' ' THR . . . -96.13 119.42 34.59 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.61 179.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.472 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 15.7 mt-30 -126.31 123.97 39.24 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.579 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 0.7 OUTLIER -104.46 139.19 39.74 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.134 178.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.605 ' CE3' ' HA3' ' A' ' 18' ' ' GLY . 77.8 m95 -106.82 162.91 13.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.371 0.605 . . . . 0.0 112.576 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.601 ' CD1' ' HG2' ' A' ' 54' ' ' ARG . 96.5 m-85 -140.0 152.98 46.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.205 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.559 ' HG ' HD13 ' A' ' 73' ' ' ILE . 11.8 tp -99.99 136.93 39.15 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.557 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.576 ' CE2' HG12 ' A' ' 58' ' ' ILE . 29.6 m-85 -140.03 144.54 36.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.504 0.669 . . . . 0.0 112.631 -178.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.569 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -104.39 123.17 46.96 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.977 178.397 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.534 ' CD1' HD23 ' A' ' 21' ' ' LEU . 56.6 t80 -79.13 99.42 6.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.912 0.387 . . . . 0.0 110.552 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.478 HG22 ' HG3' ' A' ' 71' ' ' GLU . 30.3 p -95.78 41.71 1.1 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.324 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.409 ' HA3' ' HB2' ' A' ' 69' ' ' SER . . . -141.81 -148.33 5.01 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.651 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -122.7 149.84 43.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.951 0.405 . . . . 0.0 111.359 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.411 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 18.1 p-10 -58.99 -37.0 75.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.386 0.612 . . . . 0.0 111.231 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -57.43 -3.5 0.17 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.46 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.41 ' H ' ' C ' ' A' ' 116' ' ' ASP . 1.1 tp10 -90.49 -20.54 22.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.146 0.498 . . . . 0.0 110.303 179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.566 HD11 ' CE1' ' A' ' 29' ' ' PHE . 9.7 mt -88.35 107.07 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.215 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.5 ' C ' ' H ' ' A' ' 122' ' ' LEU . 58.1 t30 -102.23 -26.07 13.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.191 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.51 ' CD2' HG22 ' A' ' 65' ' ' THR . 56.9 mt 71.02 -37.48 0.39 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.178 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.695 ' HA ' ' HB3' ' A' ' 129' ' ' PRO . 18.8 mt -91.14 9.41 31.16 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.154 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.1 -124.69 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.126 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 40.8 t0 57.11 -106.82 0.35 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.735 -0.232 . . . . 0.0 110.912 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 116.84 44.74 0.57 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.731 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 51.6 p -120.24 -53.53 2.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.974 0.416 . . . . 0.0 111.126 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -147.38 -42.73 0.17 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.169 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.654 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 4.4 pttm -177.43 161.83 1.42 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.174 0.511 . . . . 0.0 111.494 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.695 ' HB3' ' HA ' ' A' ' 122' ' ' LEU . 11.0 Cg_endo -60.01 179.15 0.31 Allowed 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 123.157 2.571 . . . . 0.0 112.754 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.441 ' HB2' ' CE1' ' A' ' 131' ' ' PHE . 61.0 mm-40 -111.28 -34.7 6.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.539 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.532 ' C ' HD13 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -134.02 143.87 48.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.104 -179.872 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.682 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -89.73 -33.69 8.96 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.054 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.35 142.9 28.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.836 0.35 . . . . 0.0 110.543 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.52 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 34.5 p-90 -135.29 170.33 16.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.137 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.45 ' N ' ' CE3' ' A' ' 134' ' ' TRP . 22.6 t -168.33 176.66 5.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.315 0.579 . . . . 0.0 111.758 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.507 ' CE2' ' CZ3' ' A' ' 134' ' ' TRP . 48.0 m95 -110.69 102.84 11.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.479 178.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 28' ' ' ILE . 29.6 m -118.19 167.6 11.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.5 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 18.3 p -72.51 169.53 16.63 Favored Pre-proline 0 C--N 1.326 -0.429 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.211 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.743 ' HA ' HG13 ' A' ' 28' ' ' ILE . 17.1 Cg_exo -60.2 -56.51 1.08 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.723 1.615 . . . . 0.0 110.379 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -62.76 -27.76 69.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.73 178.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.447 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 10.8 mt-30 -71.35 -48.81 47.92 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.544 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.444 ' O ' ' HB ' ' A' ' 146' ' ' THR . 5.2 tp -57.41 -38.48 74.39 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.642 ' O ' HG21 ' A' ' 146' ' ' THR . 16.4 mm -60.13 -36.71 69.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.538 179.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.98 -53.04 14.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.247 0.546 . . . . 0.0 110.954 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.468 HD22 ' CD1' ' A' ' 40' ' ' TRP . 0.8 OUTLIER -71.78 -19.0 62.07 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.174 -179.189 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.643 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 13.1 t -73.57 177.33 5.42 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.112 0.482 . . . . 0.0 111.302 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.559 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 36.0 m -81.03 149.53 4.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.748 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.45 ' C ' ' H ' ' A' ' 150' ' ' LYS . 2.7 mt-10 -57.83 -53.47 57.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.813 0.34 . . . . 0.0 110.988 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.495 ' CE1' ' HB ' ' A' ' 147' ' ' VAL . 39.4 p90 -57.08 2.38 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.486 ' HG3' ' CD2' ' A' ' 149' ' ' PHE . 6.4 mtpp -139.12 -5.95 1.43 Allowed 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.504 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 0.2 OUTLIER -63.09 -52.39 63.0 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.849 -0.159 . . . . 0.0 110.686 179.681 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 151' ' ' LYS . 15.1 Cg_exo -65.28 -29.3 54.96 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.296 1.997 . . . . 0.0 111.393 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.493 ' O ' HG23 ' A' ' 157' ' ' VAL . 37.2 t -67.92 -53.55 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.524 ' CD2' ' HE3' ' A' ' 42' ' ' MET . 4.0 m-30 -63.31 -39.49 94.69 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.578 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.606 ' HE2' ' HA ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -56.22 -38.18 70.71 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.247 179.527 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.412 ' O ' HG23 ' A' ' 160' ' ' VAL . 4.7 tm-20 -68.48 -36.53 79.09 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.606 HG11 ' CE2' ' A' ' 161' ' ' PHE . 40.0 t -64.51 -41.02 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.863 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.502 HD11 ' CB ' ' A' ' 139' ' ' PRO . 43.4 mt -65.4 -46.94 78.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.939 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.542 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 0.4 OUTLIER -52.15 -40.34 61.27 Favored 'General case' 0 CA--C 1.522 -0.127 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.052 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.622 HG11 ' HD3' ' A' ' 77' ' ' PRO . 98.4 t -67.33 -42.43 87.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.606 ' CE2' HG11 ' A' ' 157' ' ' VAL . 17.3 m-30 -80.09 5.49 14.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.034 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.578 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.1 -53.72 63.06 Favored Pre-proline 0 C--N 1.331 -0.229 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.528 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 18.2 Cg_endo -58.41 -13.26 16.13 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 121.989 1.793 . . . . 0.0 111.56 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.463 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 93.8 m-70 -107.25 -17.71 14.07 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.986 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 92.3 mt . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.026 -0.987 . . . . 0.0 110.368 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.191 0 N-CA-C 112.372 -0.291 . . . . 0.0 112.372 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.56 135.24 55.14 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.518 2.145 . . . . 0.0 112.142 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 62.31 115.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.886 -179.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.56 -46.17 15.7 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.321 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.75 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 0.7 OUTLIER 72.67 -65.01 0.37 Allowed 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.953 0.406 . . . . 0.0 111.375 -179.894 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.401 ' HB2' ' O ' ' A' ' 5' ' ' SER . 3.6 mpp? 63.87 125.2 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.642 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.419 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 6.3 p-10 -65.12 -47.56 76.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.892 0.377 . . . . 0.0 110.211 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.42 153.27 41.43 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.128 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.466 ' HB3' ' CZ2' ' A' ' 79' ' ' TRP . 61.0 Cg_endo -74.46 106.35 2.22 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.513 2.142 . . . . 0.0 112.635 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 11' ' ' GLU . 14.2 Cg_endo -55.7 -171.49 0.03 OUTLIER 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.025 2.483 . . . . 0.0 112.625 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.458 ' CB ' ' HE2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -50.34 -165.4 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.913 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 11' ' ' GLU . . . -28.42 -86.93 0.01 OUTLIER Glycine 0 C--N 1.339 0.738 0 CA-C-N 115.943 -0.571 . . . . 0.0 113.172 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.611 ' HE1' ' HB3' ' A' ' 83' ' ' ASP . 9.9 m-85 60.39 153.58 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.875 0.369 . . . . 0.0 111.729 179.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.544 ' HB2' ' HZ3' ' A' ' 100' ' ' TRP . 0.0 OUTLIER -69.64 67.9 0.24 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.774 178.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.596 ' HG2' HD11 ' A' ' 47' ' ' ILE . 1.7 ttp180 -46.5 98.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.278 0.561 . . . . 0.0 110.786 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.799 ' HB2' ' HG2' ' A' ' 105' ' ' GLN . 2.8 m-80 -132.26 173.73 10.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.338 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.602 HG23 ' CA ' ' A' ' 57' ' ' ALA . 11.5 m -140.49 169.6 15.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.18 0.514 . . . . 0.0 111.281 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.604 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -136.25 153.95 21.76 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.253 178.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.681 ' HB ' ' HB2' ' A' ' 43' ' ' PRO . 2.4 mp -126.34 122.16 60.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.465 ' CB ' ' HE2' ' A' ' 161' ' ' PHE . 40.9 t -104.88 107.62 18.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.083 177.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.591 HD21 HG13 ' A' ' 67' ' ' VAL . 17.3 tp -106.08 126.66 52.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.726 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.599 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -118.82 141.04 49.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.057 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.451 ' OD1' ' CH2' ' A' ' 136' ' ' TRP . 5.6 m-20 -95.22 -175.98 3.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.191 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -55.5 -6.25 0.17 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.472 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.444 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 4.5 m-20 -100.71 -0.13 37.9 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.444 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 30.0 mmtt 68.68 23.57 7.07 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.599 ' O ' ' HA ' ' A' ' 22' ' ' MET . 72.2 mttt -95.13 176.78 6.1 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.915 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.598 ' CG1' ' HA ' ' A' ' 139' ' ' PRO . 2.0 mm -116.94 142.14 32.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.344 0.592 . . . . 0.0 111.249 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.549 ' CE1' HD13 ' A' ' 119' ' ' ILE . 6.6 t80 -66.88 103.48 1.14 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.108 179.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.651 ' HA ' ' O ' ' A' ' 41' ' ' GLN . . . -97.58 137.87 35.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.986 0.422 . . . . 0.0 111.253 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.476 ' HB3' ' CG ' ' A' ' 131' ' ' PHE . . . -139.25 132.69 30.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.477 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.65 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 77.0 p -101.32 146.9 26.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.919 0.39 . . . . 0.0 111.38 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 33' ' ' ARG . 5.5 mtp85 -69.55 128.98 38.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.37 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.698 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.6 OUTLIER -44.69 -37.04 3.43 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.37 0.605 . . . . 0.0 111.034 -179.863 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.86 -36.47 70.13 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.752 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.493 ' HB ' ' HB1' ' A' ' 39' ' ' ALA . 23.7 mm -122.99 110.57 31.23 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.12 -179.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.23 -19.74 13.25 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.397 2.064 . . . . 0.0 112.644 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -91.06 -10.1 43.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.471 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.65 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.24 95.01 9.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.691 0.282 . . . . 0.0 111.075 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.64 ' O ' ' HA ' ' A' ' 146' ' ' THR . 78.7 m95 -87.99 158.41 18.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.126 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.651 ' O ' ' HA ' ' A' ' 30' ' ' ALA . 1.6 mt-30 -166.95 -138.25 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.629 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.538 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 8.5 ptt? -175.82 162.23 2.03 Favored Pre-proline 0 N--CA 1.453 -0.319 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.681 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 1.5 Cg_endo -40.9 134.19 2.51 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 123.257 2.638 . . . . 0.0 113.088 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.405 ' HG2' ' O ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -173.73 143.51 1.0 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.875 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.428 ' HA3' ' HG2' ' A' ' 60' ' ' GLU . . . -159.6 -158.64 9.26 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.783 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.681 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -117.31 141.8 16.85 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.742 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.596 HD11 ' HG2' ' A' ' 15' ' ' ARG . 13.9 mt -71.69 143.0 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 122.496 0.319 . . . . 0.0 110.88 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -69.23 -176.19 0.89 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.919 0.39 . . . . 0.0 110.587 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -49.13 -81.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.225 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -108.05 53.22 0.61 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.251 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -118.35 153.73 33.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.915 0.388 . . . . 0.0 111.048 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.53 163.29 64.6 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.426 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.48 ' HA ' HG12 ' A' ' 47' ' ' ILE . 5.8 Cg_exo -78.5 -52.58 0.06 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 122.952 2.435 . . . . 0.0 112.486 -179.389 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.628 ' O ' HD12 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -48.89 -51.85 27.68 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.762 179.659 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -57.26 -42.68 82.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.175 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 60' ' ' GLU . . . -61.59 -43.52 98.7 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.602 ' CA ' HG23 ' A' ' 17' ' ' VAL . . . -57.57 -57.77 11.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.344 177.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.628 HD12 ' O ' ' A' ' 54' ' ' ARG . 1.9 mp -55.23 -48.99 75.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.577 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.7 mtt180 -65.01 -62.55 1.48 Allowed 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.304 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.446 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -42.3 -47.26 4.79 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.118 0.485 . . . . 0.0 110.119 179.581 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.484 HD13 HG23 ' A' ' 19' ' ' ILE . 0.1 OUTLIER -50.8 -49.37 58.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.083 178.715 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.453 ' O ' ' N ' ' A' ' 66' ' ' GLY . 13.9 ttp180 -63.73 -65.54 0.67 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.493 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -49.02 -20.4 0.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -98.1 -35.48 10.4 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -178.378 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.593 ' O ' ' HA ' ' A' ' 119' ' ' ILE . 0.8 OUTLIER -133.03 7.99 4.03 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -178.38 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 69.87 -9.73 2.68 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.974 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.591 HG13 HD21 ' A' ' 21' ' ' LEU . 77.1 t -56.76 108.66 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-O 121.153 0.501 . . . . 0.0 111.393 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.452 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -124.58 -39.71 2.28 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.593 178.26 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.0 m -63.77 70.91 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.991 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -156.96 156.91 33.8 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.037 0.446 . . . . 0.0 111.932 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.426 ' HG3' HG21 ' A' ' 113' ' ' THR . 0.9 OUTLIER -129.39 149.1 51.31 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.435 179.108 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.469 HG22 ' CE2' ' A' ' 110' ' ' PHE . 12.3 t -74.71 125.0 33.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.503 HD11 ' HB2' ' A' ' 111' ' ' LYS . 0.9 OUTLIER -105.5 -21.62 5.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.12 179.302 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.477 ' HB2' ' NE2' ' A' ' 164' ' ' HIS . . . -170.42 177.02 4.21 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.554 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -155.36 152.05 28.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.757 179.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.657 HG13 ' O ' ' A' ' 78' ' ' TYR . 54.1 t -70.48 132.57 87.49 Favored Pre-proline 0 C--N 1.327 -0.387 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.814 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.456 ' HD3' HG13 ' A' ' 160' ' ' VAL . 18.6 Cg_endo -57.97 -55.12 2.51 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.125 2.55 . . . . 0.0 112.681 -179.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.657 ' O ' HG13 ' A' ' 76' ' ' VAL . 0.6 OUTLIER -101.88 -174.36 2.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.65 -179.518 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.488 ' HB2' ' O ' ' A' ' 5' ' ' SER . 33.9 m95 -94.65 -154.67 0.43 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.75 ' HA ' ' HA ' ' A' ' 5' ' ' SER . 95.5 mt -163.47 105.26 0.97 Allowed 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.673 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 4.5 p -125.09 100.26 6.48 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.283 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -78.42 52.46 1.15 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.611 ' HB3' ' HE1' ' A' ' 13' ' ' TYR . 3.3 p30 -71.32 -156.42 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.935 -178.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.692 ' CE1' ' HG2' ' A' ' 89' ' ' ARG . 49.6 p90 -101.39 145.39 30.36 Favored Pre-proline 0 N--CA 1.452 -0.369 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.648 -179.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.589 ' CB ' ' HD2' ' A' ' 86' ' ' PRO . 47.0 Cg_exo -53.22 -170.54 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.52 2.147 . . . . 0.0 110.787 178.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.589 ' HD2' ' CB ' ' A' ' 85' ' ' PRO . 18.7 Cg_endo -59.54 -76.6 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 121.712 1.608 . . . . 0.0 113.837 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -76.51 43.85 0.33 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.544 HG23 ' HD2' ' A' ' 85' ' ' PRO . 58.5 t -121.47 -0.18 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.692 ' HG2' ' CE1' ' A' ' 84' ' ' PHE . 5.2 mmm180 -40.63 -66.08 0.35 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.127 0.489 . . . . 0.0 111.373 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.784 ' HA ' HD12 ' A' ' 94' ' ' ILE . 7.9 tt0 -65.18 -15.15 62.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.918 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.655 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -86.95 -35.9 18.63 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.488 -179.512 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.63 ' O ' ' HB2' ' A' ' 95' ' ' GLN . 2.1 tm? -123.11 -46.03 2.09 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.498 ' HB2' ' CE2' ' A' ' 84' ' ' PHE . 35.5 t-20 -53.01 -61.76 2.09 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.96 0.409 . . . . 0.0 111.919 -178.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.784 HD12 ' HA ' ' A' ' 90' ' ' GLU . 2.6 mp -63.7 -8.51 4.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.172 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.655 ' HG3' ' O ' ' A' ' 91' ' ' LYS . 3.6 mm-40 -76.48 -6.14 50.49 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.619 0.247 . . . . 0.0 111.46 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.45 ' HE1' ' CD1' ' A' ' 92' ' ' LEU . 93.1 m95 -97.84 24.81 6.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.904 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.47 ' O ' ' CB ' ' A' ' 98' ' ' SER . . . 93.5 18.67 37.68 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.314 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 97' ' ' GLY . 0.9 OUTLIER 88.48 125.12 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.86 0.362 . . . . 0.0 110.842 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.3 t0 57.02 112.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.41 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.877 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -162.32 -82.88 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.374 179.799 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.877 ' HB2' ' O ' ' A' ' 100' ' ' TRP . 6.7 mptt 128.77 -45.34 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.983 0.913 . . . . 0.0 111.521 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 159.72 -128.5 2.01 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.23 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.673 ' O ' ' HA ' ' A' ' 81' ' ' THR . 9.6 mt-30 -145.87 106.88 4.14 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 122.992 -0.122 . . . . 0.0 110.733 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.506 ' HB3' ' HB3' ' A' ' 13' ' ' TYR . . . -97.86 118.69 34.97 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.095 0.474 . . . . 0.0 111.276 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.799 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 71.1 mt-30 -132.51 122.65 25.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.291 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.439 ' HD3' ' CD2' ' A' ' 79' ' ' TRP . 14.8 ttpp -105.2 138.26 41.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.482 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.604 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 28.4 m95 -103.96 162.75 12.87 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.542 ' HB2' ' HE1' ' A' ' 110' ' ' PHE . 51.3 m-85 -140.34 154.07 46.63 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.479 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 161' ' ' PHE . 12.0 tp -103.22 140.97 36.67 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.323 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.623 ' CD1' HG22 ' A' ' 19' ' ' ILE . 63.1 m-85 -143.69 150.0 38.03 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 16.5 tttt -106.69 124.21 49.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.533 178.3 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.465 ' HE1' ' N ' ' A' ' 115' ' ' GLN . 16.0 t80 -78.92 100.88 7.43 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.012 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.426 HG21 ' HG3' ' A' ' 71' ' ' GLU . 60.1 p -95.9 39.98 1.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.115 0.483 . . . . 0.0 110.845 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -145.64 -144.12 4.06 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.078 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.756 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 50.6 mt-30 -123.11 160.8 25.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.898 0.38 . . . . 0.0 111.207 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -60.14 -27.67 67.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.665 0.745 . . . . 0.0 111.309 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -52.82 -5.78 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.321 -1.309 . . . . 0.0 113.741 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.756 ' HG2' ' O ' ' A' ' 115' ' ' GLN . 0.1 OUTLIER -90.96 -24.48 20.12 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.085 178.785 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.593 ' HA ' ' O ' ' A' ' 65' ' ' THR . 7.0 mt -84.53 101.39 8.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.619 -0.718 . . . . 0.0 112.442 -178.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.485 ' C ' ' H ' ' A' ' 122' ' ' LEU . 12.4 t30 -107.04 -32.0 8.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.403 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.496 ' CD2' HG22 ' A' ' 65' ' ' THR . 9.9 mt 74.04 -40.3 0.45 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.035 0.445 . . . . 0.0 110.519 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.757 ' HA ' ' HB3' ' A' ' 129' ' ' PRO . 34.6 mt -78.27 175.33 10.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.911 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 155.2 123.04 0.82 Allowed Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.051 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -96.22 129.77 43.45 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.756 0.312 . . . . 0.0 110.988 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 157.89 -21.51 0.38 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.504 -0.855 . . . . 0.0 113.103 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 55.0 p -115.58 -81.01 0.61 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.955 0.377 . . . . 0.0 111.283 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.82 -42.08 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.191 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.747 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 0.5 OUTLIER -177.47 163.61 1.4 Allowed Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 121.276 0.56 . . . . 0.0 111.589 179.576 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.757 ' HB3' ' HA ' ' A' ' 122' ' ' LEU . 17.3 Cg_endo -57.95 -176.91 0.08 OUTLIER 'Trans proline' 0 CA--C 1.528 0.18 0 C-N-CA 123.184 2.589 . . . . 0.0 112.313 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -110.59 -42.65 4.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.596 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.547 ' C ' HD12 ' A' ' 34' ' ' LEU . 1.6 m-85 -130.68 143.3 50.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.05 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.698 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -87.46 -35.96 9.09 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.639 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -148.34 144.76 27.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.944 0.402 . . . . 0.0 110.741 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.519 ' CZ2' HD11 ' A' ' 119' ' ' ILE . 39.0 p-90 -135.88 169.34 17.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.94 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.421 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 33.6 t -162.75 176.3 10.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.315 0.578 . . . . 0.0 112.03 -178.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.451 ' CH2' ' OD1' ' A' ' 23' ' ' ASN . 83.4 m95 -110.71 103.03 11.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.314 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.443 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 30.1 m -120.55 167.83 13.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.911 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.484 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 24.3 p -72.2 167.26 33.7 Favored Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.066 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.598 ' HA ' ' CG1' ' A' ' 28' ' ' ILE . 20.2 Cg_exo -59.62 -55.65 1.64 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.731 1.621 . . . . 0.0 110.296 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -62.7 -26.93 68.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.265 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.459 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 11.7 mm100 -72.51 -46.84 52.76 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.625 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.523 HD11 ' O ' ' A' ' 41' ' ' GLN . 1.5 tp -58.21 -38.52 76.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.858 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.64 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 28.9 mm -62.31 -38.89 82.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.252 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.27 -50.16 55.63 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.307 0.575 . . . . 0.0 110.729 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.495 HD22 ' CD1' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -74.58 -20.22 60.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.967 -179.053 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.64 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 13.2 t -74.89 176.37 7.18 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.141 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.446 ' O ' ' HG3' ' A' ' 151' ' ' LYS . 35.3 m -81.63 142.79 13.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.818 0.342 . . . . 0.0 111.53 -179.231 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.491 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 55.2 mt-10 -50.27 -51.15 47.29 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.278 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.15 -10.91 0.09 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -135.25 -4.02 2.4 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.64 ' HG2' ' O ' ' A' ' 143' ' ' ILE . 9.7 mttt -59.47 -57.98 22.9 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 120.36 0.124 . . . . 0.0 111.164 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 20.8 Cg_endo -60.78 -27.55 84.99 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.427 2.085 . . . . 0.0 111.658 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 39.0 t -68.97 -52.89 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.547 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 5.0 m-30 -64.31 -40.65 96.34 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.505 178.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.472 ' N ' HD12 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -55.85 -41.34 74.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.258 179.521 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -68.31 -33.46 74.35 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.602 HG12 ' CE2' ' A' ' 161' ' ' PHE . 44.6 t -66.42 -40.77 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.944 178.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.402 HD11 HG13 ' A' ' 143' ' ' ILE . 52.2 mt -63.46 -45.83 89.01 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.644 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 0.2 OUTLIER -50.15 -40.14 45.52 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.119 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.608 HG12 ' HA ' ' A' ' 76' ' ' VAL . 88.8 t -66.99 -42.69 88.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.944 177.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.602 ' CE2' HG12 ' A' ' 157' ' ' VAL . 14.1 m-30 -81.03 5.58 16.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.685 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.621 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.42 -51.89 78.55 Favored Pre-proline 0 C--N 1.331 -0.237 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.428 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 18.1 Cg_endo -59.08 -12.39 15.54 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.021 1.814 . . . . 0.0 111.716 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.477 ' NE2' ' HB2' ' A' ' 74' ' ' ALA . 94.9 m-70 -107.69 -20.14 13.32 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.464 -179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 96.8 mt . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.761 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -56.08 171.81 0.73 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.598 2.199 . . . . 0.0 112.029 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.694 ' HG ' ' HB2' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -103.81 105.92 16.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.93 0.395 . . . . 0.0 111.158 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -88.78 172.5 40.66 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.883 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 79' ' ' TRP . 71.3 p -151.81 -79.24 0.11 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.979 0.419 . . . . 0.0 111.853 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.463 ' HB2' ' O ' ' A' ' 5' ' ' SER . 3.9 mpp? 68.23 133.56 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.534 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.72 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 63.8 t0 -65.45 -32.55 74.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.952 0.406 . . . . 0.0 110.489 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.15 125.85 36.71 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.902 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.454 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 73.5 Cg_endo -75.02 105.66 2.13 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.196 1.931 . . . . 0.0 112.126 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.505 ' HG2' ' CG ' ' A' ' 13' ' ' TYR . 1.9 Cg_endo -46.02 177.34 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 123.132 2.555 . . . . 0.0 112.28 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.589 ' HB3' ' HB3' ' A' ' 99' ' ' ASP . 6.1 mm-40 -40.29 115.55 0.57 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.283 0.564 . . . . 0.0 111.994 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.524 ' HA3' ' HA ' ' A' ' 100' ' ' TRP . . . 61.19 -80.21 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.372 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.505 ' CG ' ' HG2' ' A' ' 10' ' ' PRO . 8.6 m-85 38.52 56.84 1.81 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.635 ' HA ' ' CH2' ' A' ' 100' ' ' TRP . 0.0 OUTLIER 32.61 -152.93 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.792 179.346 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.452 ' H ' ' CG ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER 176.64 96.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.031 0.443 . . . . 0.0 110.144 -179.498 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.601 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 4.2 m-80 -133.19 172.67 12.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.132 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.519 HG22 ' CA ' ' A' ' 57' ' ' ALA . 16.6 m -135.84 164.98 30.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.224 0.535 . . . . 0.0 111.443 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.708 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -138.67 155.88 23.89 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.97 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.507 HG21 ' CD1' ' A' ' 110' ' ' PHE . 2.5 mp -131.11 123.91 54.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 8.6 t -102.33 101.22 11.45 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.539 HD22 ' HD1' ' A' ' 112' ' ' PHE . 20.7 tp -99.58 117.52 34.15 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.359 -178.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.661 ' HE1' HD11 ' A' ' 73' ' ' ILE . 1.4 ptt? -118.08 166.74 12.19 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.729 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.578 ' ND2' ' HB2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -101.21 169.67 8.76 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.28 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -56.37 -4.5 0.14 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.52 178.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.502 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 2.7 m-20 -99.06 2.96 46.61 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 3.3 mmtp 74.18 20.47 2.69 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.014 -178.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.578 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 1.1 mmtt -94.17 145.55 24.62 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.72 HG13 ' HA ' ' A' ' 139' ' ' PRO . 1.1 mm -97.93 139.94 19.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.294 0.568 . . . . 0.0 112.473 -177.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.408 ' N ' ' O ' ' A' ' 21' ' ' LEU . 18.6 t80 -75.99 122.54 24.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.809 178.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.611 ' HA ' ' O ' ' A' ' 41' ' ' GLN . . . -122.68 146.68 47.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.967 0.413 . . . . 0.0 111.124 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.455 ' HB3' ' CG ' ' A' ' 131' ' ' PHE . . . -137.65 136.5 37.52 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.407 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.557 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 97.0 p -100.73 144.52 29.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.909 0.385 . . . . 0.0 111.049 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.2 mtp-105 -69.83 126.71 30.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.487 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.687 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.3 OUTLIER -45.43 -33.37 2.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.296 0.57 . . . . 0.0 110.781 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.01 -38.23 64.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.008 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.549 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 56.1 mt -124.67 104.56 30.65 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.09 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.24 -18.1 50.4 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.727 2.285 . . . . 0.0 112.774 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -94.22 -11.0 31.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.554 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.557 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.42 96.77 10.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.778 0.323 . . . . 0.0 111.196 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.542 ' O ' ' HA ' ' A' ' 146' ' ' THR . 77.1 m95 -89.53 161.89 15.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.341 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.611 ' O ' ' HA ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -169.26 -139.47 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.932 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.472 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 10.2 ptt? -175.07 161.93 2.34 Favored Pre-proline 0 C--N 1.327 -0.386 0 O-C-N 122.196 -0.315 . . . . 0.0 110.368 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.472 ' HD2' ' HB2' ' A' ' 42' ' ' MET . 1.9 Cg_endo -40.8 131.91 2.72 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.015 2.477 . . . . 0.0 112.946 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -178.44 144.66 0.3 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.652 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.645 ' HA3' ' HG2' ' A' ' 60' ' ' GLU . . . -161.26 -163.12 13.63 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.059 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.601 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -109.3 145.94 16.73 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.723 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.427 ' H ' ' HA ' ' A' ' 16' ' ' ASN . 19.8 mt -72.49 143.64 13.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 122.354 0.262 . . . . 0.0 110.973 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -69.54 -174.85 0.75 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.836 0.35 . . . . 0.0 110.458 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -48.48 -71.13 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.147 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -120.9 54.23 0.67 Allowed Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.384 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -113.47 150.66 32.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.803 0.335 . . . . 0.0 110.875 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -69.66 158.89 85.89 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.053 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.423 ' HB3' HG11 ' A' ' 17' ' ' VAL . 4.0 Cg_exo -76.4 -50.37 0.11 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.595 2.197 . . . . 0.0 111.426 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.542 ' HD2' ' C ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -52.49 -46.81 66.77 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.297 179.325 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -66.9 -41.81 86.53 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.056 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.552 ' O ' ' HB2' ' A' ' 60' ' ' GLU . . . -61.13 -44.43 97.35 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.519 ' CA ' HG22 ' A' ' 17' ' ' VAL . . . -55.43 -53.98 49.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.094 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.516 HG12 ' CE2' ' A' ' 110' ' ' PHE . 34.6 mt -55.02 -53.73 31.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.098 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 -62.29 -60.76 3.11 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.976 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.645 ' HG2' ' HA3' ' A' ' 45' ' ' GLY . 0.6 OUTLIER -44.1 -48.25 8.99 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.105 0.479 . . . . 0.0 110.121 179.269 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.468 HD22 ' O ' ' A' ' 67' ' ' VAL . 0.8 OUTLIER -52.73 -46.23 67.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.565 179.046 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.489 ' O ' ' N ' ' A' ' 66' ' ' GLY . 42.9 ttp180 -64.87 -62.75 1.37 Allowed 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 121.343 0.592 . . . . 0.0 111.015 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -50.09 -21.69 1.37 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.359 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -96.11 -36.6 10.93 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.44 HG21 ' CE2' ' A' ' 131' ' ' PHE . 3.6 p -127.27 -4.62 6.12 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.819 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 80.3 -12.07 34.23 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.362 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.496 ' CG2' HG12 ' A' ' 119' ' ' ILE . 64.3 t -58.2 118.98 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 121.33 0.586 . . . . 0.0 111.587 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.415 ' CG2' ' HG3' ' A' ' 62' ' ' ARG . 1.1 p -127.2 -40.01 1.86 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.402 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.8 m -62.54 76.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.512 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.584 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -162.92 156.7 20.24 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.401 ' HG3' HG21 ' A' ' 113' ' ' THR . 2.3 mt-10 -129.82 150.17 51.24 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.858 179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.63 HG23 ' CE2' ' A' ' 110' ' ' PHE . 21.3 t -74.0 129.41 36.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.265 0.555 . . . . 0.0 111.753 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.661 HD11 ' HE1' ' A' ' 22' ' ' MET . 1.3 mt -110.56 -18.36 7.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.452 179.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.452 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -171.3 175.93 4.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.405 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -154.6 150.01 27.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.603 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.662 ' HA ' HG11 ' A' ' 160' ' ' VAL . 11.2 t -72.03 136.85 82.08 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.846 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.519 ' HD3' HG12 ' A' ' 160' ' ' VAL . 35.1 Cg_endo -67.56 -60.25 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.9 2.4 . . . . 0.0 113.306 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.72 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -94.27 172.98 7.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.08 -178.478 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.548 ' O ' ' HA ' ' A' ' 5' ' ' SER . 57.1 m95 -91.71 100.69 13.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.281 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.577 HD23 ' HG2' ' A' ' 156' ' ' GLU . 88.8 mt -60.02 112.97 2.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.054 0.454 . . . . 0.0 110.783 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.509 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 4.3 p -114.22 -172.19 2.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.899 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -171.89 67.4 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.212 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -67.04 169.54 8.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.206 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.628 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 28.9 m-85 -97.08 174.98 2.85 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.692 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 52.2 Cg_exo -55.35 -178.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 121.946 1.764 . . . . 0.0 111.529 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.455 ' HD2' ' HB3' ' A' ' 85' ' ' PRO . 46.8 Cg_endo -69.82 -1.62 8.84 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.218 1.946 . . . . 0.0 112.929 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.9 -61.84 1.56 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.804 0.335 . . . . 0.0 110.701 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.628 ' HB ' ' HB3' ' A' ' 84' ' ' PHE . 59.3 t -58.75 -41.5 82.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.067 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.653 ' O ' ' HB2' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -78.35 -1.23 32.32 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.246 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.79 ' HA ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -110.4 -14.93 14.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.922 0.392 . . . . 0.0 111.209 179.376 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.8 -22.29 12.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.548 179.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.421 HD11 ' N ' ' A' ' 93' ' ' ASN . 1.3 tm? -120.83 -48.19 2.27 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.508 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.653 ' HB2' ' O ' ' A' ' 89' ' ' ARG . 2.1 m-80 -67.73 -30.35 69.81 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.561 -179.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.79 HD13 ' HA ' ' A' ' 90' ' ' GLU . 1.1 mp -68.9 -9.73 12.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.879 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.586 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -101.54 -103.04 0.26 Allowed 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.636 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.588 ' NE1' ' HA ' ' A' ' 93' ' ' ASN . 66.6 m95 57.2 -65.24 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.948 0.499 . . . . 0.0 111.697 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 95' ' ' GLN . . . -171.5 -125.08 0.8 Allowed Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.095 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.37 101.58 0.76 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.992 0.425 . . . . 0.0 110.95 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.589 ' HB3' ' HB3' ' A' ' 11' ' ' GLU . 0.2 OUTLIER 65.89 -81.66 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.315 -179.463 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.635 ' CH2' ' HA ' ' A' ' 14' ' ' ARG . 27.9 m95 55.16 169.98 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.907 178.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.598 ' HD2' HD12 ' A' ' 94' ' ' ILE . 0.0 OUTLIER 166.69 29.96 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.576 -179.723 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.613 ' HA2' ' OD1' ' A' ' 93' ' ' ASN . . . 149.48 -153.32 25.08 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.037 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.509 ' O ' ' HA ' ' A' ' 81' ' ' THR . 40.7 mt-30 -144.6 117.54 8.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.724 0.262 . . . . 0.0 110.805 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.439 ' HA ' HG23 ' A' ' 81' ' ' THR . . . -105.14 116.44 31.95 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.165 0.507 . . . . 0.0 111.262 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.466 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 35.6 mt-30 -126.15 125.18 42.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.943 -178.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.475 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 3.5 ttmm -104.95 136.83 43.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.554 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.708 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 23.8 m95 -103.14 170.39 7.99 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.401 ' CZ ' ' HB2' ' A' ' 53' ' ' PRO . 96.2 m-85 -141.8 154.14 45.01 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.913 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.521 ' HG ' HD12 ' A' ' 73' ' ' ILE . 15.6 tp -101.76 138.56 38.58 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.67 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.63 ' CE2' HG23 ' A' ' 72' ' ' VAL . 31.0 m-85 -141.68 144.07 33.9 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.584 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 3.2 tttm -102.21 124.91 48.62 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.962 178.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.539 ' HD1' HD22 ' A' ' 21' ' ' LEU . 49.9 t80 -78.38 99.88 6.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.811 0.339 . . . . 0.0 110.56 178.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.401 HG21 ' HG3' ' A' ' 71' ' ' GLU . 35.1 p -99.37 51.29 0.94 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.027 0.442 . . . . 0.0 110.501 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -153.81 -146.93 4.51 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.504 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.434 ' O ' ' HZ ' ' A' ' 112' ' ' PHE . 2.7 mm-40 -120.93 146.61 46.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.028 0.442 . . . . 0.0 110.714 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -57.15 -33.08 67.05 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.873 -178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -58.23 -5.64 0.51 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.862 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -90.73 -15.19 30.68 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.64 0.257 . . . . 0.0 111.026 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.561 HD11 ' CZ2' ' A' ' 134' ' ' TRP . 19.2 mt -77.9 100.24 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.901 0.381 . . . . 0.0 111.883 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -105.8 97.34 7.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.498 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.421 ' CD2' HG22 ' A' ' 65' ' ' THR . 27.2 mt -69.78 -11.11 60.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.11 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 22.2 mt -86.29 172.18 10.66 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.979 0.419 . . . . 0.0 111.327 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -154.91 -125.81 0.98 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.075 -0.584 . . . . 0.0 112.161 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.02 123.51 38.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.763 0.316 . . . . 0.0 110.76 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -65.11 75.57 0.08 OUTLIER Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.44 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -119.18 -35.06 3.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.658 0.266 . . . . 0.0 111.089 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -146.37 -59.55 0.3 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.182 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -179.96 156.01 0.74 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.02 0.438 . . . . 0.0 110.792 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.558 ' HG2' HD13 ' A' ' 34' ' ' LEU . 11.7 Cg_endo -71.96 -174.66 1.4 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.43 2.087 . . . . 0.0 112.287 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -92.5 -70.99 0.67 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.014 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.455 ' CG ' ' HB3' ' A' ' 31' ' ' ALA . 2.0 m-85 -104.18 144.15 31.97 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.401 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.687 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -88.72 -35.54 8.37 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.558 -0.83 . . . . 0.0 111.713 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.6 148.4 28.59 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.854 0.359 . . . . 0.0 110.719 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.561 ' CZ2' HD11 ' A' ' 119' ' ' ILE . 37.6 p-90 -135.4 165.31 25.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.264 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.417 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 22.6 t -160.13 176.95 11.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.392 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.57 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 41.9 m95 -113.75 105.02 12.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.224 178.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.634 ' O ' ' N ' ' A' ' 28' ' ' ILE . 24.4 m -119.39 170.3 9.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.269 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.497 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 24.4 p -72.86 169.32 17.94 Favored Pre-proline 0 C--N 1.324 -0.529 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.504 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.72 ' HA ' HG13 ' A' ' 28' ' ' ILE . 17.3 Cg_exo -60.52 -51.83 4.66 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.082 1.855 . . . . 0.0 110.401 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -67.41 -28.81 68.23 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.847 178.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.461 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 2.3 mt-30 -71.35 -47.05 58.78 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.614 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.474 HD12 ' HB2' ' A' ' 30' ' ' ALA . 3.5 tp -55.67 -39.24 70.68 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.513 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 24.2 mm -62.82 -38.37 81.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.233 0.54 . . . . 0.0 110.514 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.73 -49.86 55.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.187 0.517 . . . . 0.0 110.627 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.483 HD23 ' CD1' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -74.63 -21.65 59.33 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.02 -179.196 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 6.2 t -73.49 -178.92 3.24 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.68 -178.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.565 HG22 ' CZ ' ' A' ' 149' ' ' PHE . 30.7 m -86.39 151.1 3.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.822 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.588 ' HG3' ' H ' ' A' ' 149' ' ' PHE . 0.1 OUTLIER -58.93 -53.69 55.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.683 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.588 ' H ' ' HG3' ' A' ' 148' ' ' GLU . 39.3 p90 -55.38 -3.44 0.06 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.551 ' HB2' HG23 ' A' ' 147' ' ' VAL . 28.4 mttm -133.15 -7.4 3.02 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 179.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 143' ' ' ILE . 8.1 mttt -60.37 -61.7 7.42 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.629 0.252 . . . . 0.0 111.192 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.694 ' HB2' ' HG ' ' A' ' 3' ' ' LEU . 10.7 Cg_endo -53.92 -31.28 62.29 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.742 2.295 . . . . 0.0 112.011 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.481 ' O ' HG22 ' A' ' 157' ' ' VAL . 38.9 t -67.18 -52.05 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.476 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 4.0 m-30 -63.77 -37.93 89.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.651 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.422 ' CD ' HG13 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -55.93 -46.74 78.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.822 179.504 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.577 ' HG2' HD23 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -67.26 -28.92 68.44 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.416 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.56 HG11 ' CE2' ' A' ' 161' ' ' PHE . 47.4 t -68.89 -42.24 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.717 178.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.611 HD23 ' HB3' ' A' ' 139' ' ' PRO . 49.4 mt -63.91 -46.43 84.86 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.551 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 40.5 t -50.33 -42.19 52.53 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.662 HG11 ' HA ' ' A' ' 76' ' ' VAL . 94.6 t -65.92 -42.03 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.282 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.593 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 16.8 m-30 -81.07 4.9 18.23 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.534 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.489 ' HB2' ' HD3' ' A' ' 163' ' ' PRO . . . -58.86 -50.18 89.37 Favored Pre-proline 0 C--N 1.329 -0.294 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.653 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.549 ' HD2' ' O ' ' A' ' 160' ' ' VAL . 24.2 Cg_exo -61.55 -11.93 22.3 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.389 2.059 . . . . 0.0 111.602 178.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.452 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 84.1 m-70 -109.69 -17.8 13.61 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.341 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 86.3 mt . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.725 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.411 ' HA2' ' HG3' ' A' ' 85' ' ' PRO . . . . . . . . 0 N--CA 1.488 2.146 0 N-CA-C 112.57 -0.212 . . . . 0.0 112.57 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.98 -179.18 4.39 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.466 2.11 . . . . 0.0 112.107 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -94.7 148.6 22.11 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.497 ' O ' ' OG ' ' A' ' 5' ' ' SER . . . -104.67 -17.13 15.55 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.424 -0.894 . . . . 0.0 113.752 -178.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.901 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 15.4 p 60.23 -104.66 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.405 ' HE2' HG22 ' A' ' 81' ' ' THR . 12.4 mtm 68.12 130.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.762 0.315 . . . . 0.0 110.653 -179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.706 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 11.3 p-10 -69.07 -23.63 64.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.607 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.37 122.75 42.83 Favored Pre-proline 0 C--N 1.325 -0.471 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.686 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.56 115.0 4.09 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.116 1.878 . . . . 0.0 112.076 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.472 ' HD2' ' CD2' ' A' ' 13' ' ' TYR . 4.3 Cg_exo -79.81 175.42 10.53 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.227 2.618 . . . . 0.0 112.76 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -55.92 152.8 9.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.118 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.528 ' HA2' ' HA ' ' A' ' 100' ' ' TRP . . . 51.08 69.28 1.17 Allowed Glycine 0 C--N 1.329 0.179 0 C-N-CA 121.171 -0.537 . . . . 0.0 113.579 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.564 ' CE1' ' O ' ' A' ' 101' ' ' LYS . 30.2 m-85 -152.94 114.0 4.16 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.535 ' HG2' ' CZ3' ' A' ' 96' ' ' TRP . 0.7 OUTLIER -67.2 89.1 0.19 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.262 0.553 . . . . 0.0 111.705 -179.14 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.535 ' HG3' ' CZ3' ' A' ' 79' ' ' TRP . 3.9 ttp180 -53.29 113.97 1.32 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.579 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.699 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 66.0 m-20 -133.47 176.54 8.45 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.218 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.626 HG23 ' CA ' ' A' ' 57' ' ' ALA . 13.1 m -139.25 166.29 21.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.365 0.602 . . . . 0.0 112.079 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.573 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -133.83 162.2 24.41 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.365 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.501 ' HB ' ' HB2' ' A' ' 43' ' ' PRO . 3.4 mp -129.49 117.47 42.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.496 ' HB2' ' HE2' ' A' ' 161' ' ' PHE . 0.5 OUTLIER -103.86 99.76 9.54 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.992 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.609 HD21 ' CD1' ' A' ' 112' ' ' PHE . 12.4 tp -102.26 126.87 49.38 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.847 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.503 ' CB ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -124.49 153.84 41.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.239 -179.724 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.559 ' ND2' ' HB3' ' A' ' 112' ' ' PHE . 2.2 m120 -99.39 -178.61 3.96 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.684 0.754 . . . . 0.0 111.094 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -58.73 -6.17 0.7 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.041 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.508 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 2.7 m-20 -99.55 0.19 41.8 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -178.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 2.0 mmtm 72.7 21.92 3.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.921 -178.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.503 ' O ' ' CB ' ' A' ' 22' ' ' MET . 15.3 mttt -95.77 169.19 10.18 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.487 ' N ' ' CD1' ' A' ' 28' ' ' ILE . 1.5 mp -117.67 143.24 28.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.475 0.655 . . . . 0.0 111.566 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.493 ' CE2' ' HD3' ' A' ' 43' ' ' PRO . 6.5 t80 -64.48 99.65 0.32 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.724 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.741 ' HA ' ' O ' ' A' ' 41' ' ' GLN . . . -96.46 138.73 33.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.193 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.46 ' HB3' ' CD2' ' A' ' 131' ' ' PHE . . . -136.23 135.98 39.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.578 179.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.719 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 70.0 p -102.15 141.95 34.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.852 0.358 . . . . 0.0 111.473 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.543 ' HD2' ' HB1' ' A' ' 39' ' ' ALA . 0.3 OUTLIER -70.9 128.11 34.88 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.515 179.501 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.725 HD22 ' HG2' ' A' ' 129' ' ' PRO . 0.3 OUTLIER -44.24 -37.82 3.45 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.181 0.515 . . . . 0.0 111.04 -179.859 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -71.59 -35.24 70.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.508 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.565 ' HB ' ' HB2' ' A' ' 39' ' ' ALA . 16.3 mt -126.4 106.72 24.06 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 120.728 0.299 . . . . 0.0 111.068 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.7 -43.84 12.03 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.86 2.374 . . . . 0.0 113.276 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -75.29 -3.55 33.99 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.719 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.34 96.13 10.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.751 0.31 . . . . 0.0 110.671 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.591 ' CD1' ' HB3' ' A' ' 145' ' ' LEU . 74.1 m95 -94.46 163.0 13.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.57 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.741 ' O ' ' HA ' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -174.31 -135.3 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.341 -178.945 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.621 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 6.4 ptt? -177.03 165.32 1.45 Allowed Pre-proline 0 N--CA 1.453 -0.307 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.646 ' HB3' HD12 ' A' ' 61' ' ' LEU . 4.1 Cg_endo -45.05 144.47 3.84 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.736 2.291 . . . . 0.0 113.246 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -174.26 141.94 0.76 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.323 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.543 ' HA3' ' HG3' ' A' ' 60' ' ' GLU . . . -142.65 -173.21 14.29 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.991 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.671 ' HA2' ' CB ' ' A' ' 16' ' ' ASN . . . -116.68 22.07 11.04 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 119.984 -1.103 . . . . 0.0 114.445 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.496 HD13 ' HG2' ' A' ' 15' ' ' ARG . 43.1 mt 61.28 131.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 117.234 0.517 . . . . 0.0 111.346 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -68.02 -176.18 0.67 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.724 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -47.67 -69.74 0.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.315 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -119.13 57.1 0.56 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.504 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -117.95 150.72 38.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.888 0.375 . . . . 0.0 110.945 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.84 173.09 4.53 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.748 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.47 ' HA ' HG11 ' A' ' 17' ' ' VAL . 2.0 Cg_endo -80.74 -52.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.541 2.16 . . . . 0.0 111.58 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.597 ' HG2' ' CD1' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -54.01 -44.22 70.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.515 179.153 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -68.52 -45.09 73.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.372 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.485 ' HB2' ' HA ' ' A' ' 47' ' ' ILE . . . -60.51 -42.47 96.45 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.626 ' CA ' HG23 ' A' ' 17' ' ' VAL . . . -56.66 -60.16 3.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.319 0.58 . . . . 0.0 109.723 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.408 HD11 ' CD ' ' A' ' 54' ' ' ARG . 47.2 mt -53.92 -51.33 46.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.207 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -61.02 -62.68 1.68 Allowed 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.85 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.543 ' HG3' ' HA3' ' A' ' 45' ' ' GLY . 8.8 mm-40 -43.71 -44.03 6.3 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.261 0.553 . . . . 0.0 109.908 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.646 HD12 ' HB3' ' A' ' 43' ' ' PRO . 0.6 OUTLIER -51.87 -47.96 64.28 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.968 178.59 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.476 ' O ' ' N ' ' A' ' 66' ' ' GLY . 38.5 ttt180 -63.23 -65.58 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.214 0.531 . . . . 0.0 111.095 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -47.75 -25.27 1.18 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.317 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -93.38 -35.58 12.95 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.577 ' HB ' HG23 ' A' ' 119' ' ' ILE . 1.4 p -127.68 -37.14 1.99 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.752 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 111.48 -10.56 28.34 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.184 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.633 ' HB ' ' CD1' ' A' ' 61' ' ' LEU . 68.6 t -56.86 111.97 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.197 0.523 . . . . 0.0 111.633 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.43 ' O ' ' N ' ' A' ' 70' ' ' ALA . 6.9 p -123.66 -39.15 2.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.651 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.4 m -62.48 74.43 0.02 OUTLIER 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.018 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.573 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -160.88 157.11 26.04 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.447 ' HG3' HG22 ' A' ' 113' ' ' THR . 0.4 OUTLIER -128.01 144.85 51.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.095 179.1 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.538 HG21 ' HD3' ' A' ' 54' ' ' ARG . 21.6 t -73.98 125.79 33.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.129 0.49 . . . . 0.0 111.319 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.478 HD12 ' HB2' ' A' ' 111' ' ' LYS . 1.0 OUTLIER -107.36 -20.06 6.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.683 179.728 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.505 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -169.73 177.46 4.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.818 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.443 ' HB3' ' HD1' ' A' ' 108' ' ' PHE . 3.7 pm0 -157.73 150.59 23.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.563 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.772 ' HA ' HG13 ' A' ' 160' ' ' VAL . 53.4 t -71.91 134.44 83.48 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.135 0.493 . . . . 0.0 111.354 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.44 ' HD3' HG11 ' A' ' 160' ' ' VAL . 29.7 Cg_endo -63.77 -54.06 1.09 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.099 2.533 . . . . 0.0 112.657 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.706 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 2.4 p90 -99.11 178.79 4.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.235 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.535 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 43.5 m95 -94.56 -158.0 0.6 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.623 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.901 ' HA ' ' HA ' ' A' ' 5' ' ' SER . 70.6 mt -160.31 101.69 1.39 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.023 0.439 . . . . 0.0 110.197 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.727 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 77.8 p -89.69 115.38 27.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.016 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.451 ' HE1' ' O ' ' A' ' 149' ' ' PHE . 12.9 m-85 -78.33 61.43 2.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.624 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.63 127.11 31.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.71 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.641 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 57.1 m-85 -102.36 159.51 29.15 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.759 0.314 . . . . 0.0 110.961 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.456 ' CB ' ' HD2' ' A' ' 86' ' ' PRO . 33.9 Cg_exo -56.54 178.39 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.452 2.102 . . . . 0.0 111.761 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.456 ' HD2' ' CB ' ' A' ' 85' ' ' PRO . 33.0 Cg_endo -63.91 -30.71 67.59 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.374 2.049 . . . . 0.0 112.352 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -70.93 -50.88 29.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.649 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.641 ' HB ' ' HB3' ' A' ' 84' ' ' PHE . 30.6 t -73.9 -21.74 18.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.913 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.697 ' HG3' ' HB3' ' A' ' 93' ' ' ASN . 2.1 tpp180 -57.59 -47.68 81.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.909 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.428 ' HA ' HD12 ' A' ' 94' ' ' ILE . 3.6 mt-10 -71.31 -17.91 62.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.717 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.27 -22.37 17.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.856 0.36 . . . . 0.0 110.743 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.646 HD12 ' HE1' ' A' ' 96' ' ' TRP . 1.5 tm? -120.93 -62.36 1.45 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.664 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.704 ' OD1' ' HA ' ' A' ' 101' ' ' LYS . 0.2 OUTLIER -47.45 -61.51 1.88 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.31 0.576 . . . . 0.0 112.171 -179.613 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.479 HG22 ' O ' ' A' ' 94' ' ' ILE . 3.9 mp -68.98 -5.11 4.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.79 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.28 -4.38 58.37 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.646 ' HE1' HD12 ' A' ' 92' ' ' LEU . 65.9 m95 -95.76 -0.06 51.8 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 98' ' ' SER . . . 66.21 119.6 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.158 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.504 ' HB2' ' O ' ' A' ' 97' ' ' GLY . 0.1 OUTLIER 89.97 -166.3 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 122.877 0.471 . . . . 0.0 110.704 -179.567 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.21 -85.74 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.769 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.655 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 29.8 m95 56.75 178.57 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.799 -0.182 . . . . 0.0 110.868 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.704 ' HA ' ' OD1' ' A' ' 93' ' ' ASN . 1.6 ttpp 161.78 64.15 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 122.643 0.377 . . . . 0.0 111.098 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.03 -172.12 20.42 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.524 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.727 ' O ' ' HA ' ' A' ' 81' ' ' THR . 1.0 OUTLIER -144.04 118.86 9.9 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 120.536 0.208 . . . . 0.0 110.935 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -86.88 115.93 24.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.278 0.561 . . . . 0.0 109.595 179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.699 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 13.1 mt-30 -121.98 123.32 41.39 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.662 -177.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 78' ' ' TYR . 5.1 ttpt -104.62 135.47 45.95 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 177.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.573 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 19.5 m95 -101.2 162.74 12.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.205 0.526 . . . . 0.0 112.3 -178.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.597 ' CD1' ' HG2' ' A' ' 54' ' ' ARG . 97.6 m-85 -137.38 149.37 46.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.643 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.415 ' HB2' ' CE1' ' A' ' 161' ' ' PHE . 19.0 tp -102.62 125.63 49.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.31 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.467 ' CE2' HG23 ' A' ' 19' ' ' ILE . 11.9 m-85 -128.87 144.84 51.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.296 0.569 . . . . 0.0 111.507 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.573 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 0.0 OUTLIER -96.35 118.56 33.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.397 179.137 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.609 ' CD1' HD21 ' A' ' 21' ' ' LEU . 50.6 t80 -79.06 94.61 5.35 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.319 179.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.447 HG22 ' HG3' ' A' ' 71' ' ' GLU . 19.5 p -94.67 45.46 1.12 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.378 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.34 -146.2 4.6 Favored Glycine 0 C--N 1.331 0.298 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.263 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -121.02 146.89 46.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.963 0.411 . . . . 0.0 111.401 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.488 ' HB2' ' CZ2' ' A' ' 134' ' ' TRP . 11.2 p-10 -58.3 -39.88 80.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.19 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -57.52 -4.4 0.25 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.278 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 116' ' ' ASP . 3.5 tt0 -88.85 -16.35 32.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.014 0.435 . . . . 0.0 110.562 179.479 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.577 HG23 ' HB ' ' A' ' 65' ' ' THR . 11.0 mt -82.35 102.83 8.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.951 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -101.2 98.86 9.22 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.285 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.49 HD21 HG23 ' A' ' 65' ' ' THR . 50.8 mt -68.74 -1.65 7.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.637 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.829 ' HA ' ' HB3' ' A' ' 129' ' ' PRO . 12.1 mt -73.05 -149.35 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 121.285 -0.166 . . . . 0.0 110.761 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . 0.441 ' H ' ' HB3' ' A' ' 122' ' ' LEU . . . 156.83 136.89 2.2 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -88.07 86.82 7.17 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.127 0.489 . . . . 0.0 110.631 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 161.69 134.56 1.66 Allowed Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.645 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.8 p 69.96 0.1 2.94 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.721 0.296 . . . . 0.0 111.677 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 71.32 -47.33 0.66 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.392 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 129' ' ' PRO . 30.4 pttt -78.05 145.54 69.71 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.017 0.437 . . . . 0.0 111.107 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.829 ' HB3' ' HA ' ' A' ' 122' ' ' LEU . 13.4 Cg_endo -82.99 -171.43 1.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.085 2.523 . . . . 0.0 112.826 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -87.29 -74.03 0.45 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.759 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.511 ' CE1' HG22 ' A' ' 65' ' ' THR . 0.5 OUTLIER -102.16 142.26 33.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.492 178.894 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.693 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -82.53 -35.39 19.98 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.145 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.93 147.88 27.1 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.751 0.31 . . . . 0.0 110.735 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.522 ' CH2' HD12 ' A' ' 119' ' ' ILE . 39.1 p-90 -137.4 173.47 11.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.045 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.446 ' N ' ' HZ3' ' A' ' 40' ' ' TRP . 22.0 t -168.57 -179.46 3.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.462 0.649 . . . . 0.0 112.003 -178.254 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.527 ' CD2' ' OD1' ' A' ' 23' ' ' ASN . 88.8 m95 -113.25 100.72 8.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.907 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.456 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 32.6 m -118.3 169.78 8.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.283 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.521 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 12.3 p -74.04 172.32 8.84 Favored Pre-proline 0 C--N 1.329 -0.317 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.161 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.613 ' HB3' HD22 ' A' ' 158' ' ' LEU . 16.4 Cg_exo -61.87 -56.96 0.6 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.845 1.697 . . . . 0.0 110.337 179.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.38 -27.93 69.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.563 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.409 ' HG3' ' OG1' ' A' ' 138' ' ' THR . 1.0 OUTLIER -70.98 -49.31 46.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.503 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.413 ' CD1' ' CB ' ' A' ' 30' ' ' ALA . 12.8 tp -57.74 -37.39 73.52 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.686 ' O ' HG22 ' A' ' 146' ' ' THR . 13.2 mm -62.47 -39.3 83.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.14 0.495 . . . . 0.0 110.698 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.32 -48.91 63.64 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.325 0.583 . . . . 0.0 110.437 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.591 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -75.53 -18.78 59.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.742 -179.149 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.686 HG22 ' O ' ' A' ' 143' ' ' ILE . 15.2 t -76.31 178.02 6.82 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.364 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.531 ' CG2' ' HD3' ' A' ' 150' ' ' LYS . 19.2 m -87.34 147.49 5.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.987 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.467 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 52.4 mt-10 -50.87 -49.79 58.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.927 0.394 . . . . 0.0 111.599 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.451 ' O ' ' HE1' ' A' ' 82' ' ' TYR . 1.2 m-85 -52.14 -7.13 0.05 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.531 ' HD3' ' CG2' ' A' ' 147' ' ' VAL . 7.7 mptt -137.09 -2.38 2.07 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' A' ' 143' ' ' ILE . 14.7 mttt -63.79 -62.9 4.56 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 111.533 0.197 . . . . 0.0 111.533 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.467 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 19.3 Cg_endo -60.41 -29.04 87.92 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.266 1.978 . . . . 0.0 111.422 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 157' ' ' VAL . 21.2 t -68.23 -51.37 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.543 ' OH ' ' HG2' ' A' ' 41' ' ' GLN . 7.6 m-30 -63.95 -36.96 85.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.729 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.678 ' HD3' HG21 ' A' ' 143' ' ' ILE . 0.2 OUTLIER -57.93 -42.83 85.69 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.597 179.289 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.408 ' HG3' ' OH ' ' A' ' 78' ' ' TYR . 1.2 tp10 -68.35 -35.23 77.45 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.511 HG12 ' CE2' ' A' ' 161' ' ' PHE . 59.2 t -66.21 -41.86 89.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.551 178.339 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.613 HD22 ' HB3' ' A' ' 139' ' ' PRO . 40.8 mt -64.87 -41.73 95.43 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.901 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.458 ' O ' ' HB1' ' A' ' 162' ' ' ALA . 0.8 OUTLIER -55.75 -38.74 70.21 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.109 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.772 HG13 ' HA ' ' A' ' 76' ' ' VAL . 98.7 t -69.06 -44.55 81.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.194 177.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.574 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 22.1 m-30 -80.05 4.98 15.43 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.392 -179.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.612 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.97 -52.44 74.81 Favored Pre-proline 0 C--N 1.329 -0.316 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.757 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 17.4 Cg_endo -57.77 -12.37 11.63 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.226 1.951 . . . . 0.0 112.088 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.505 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 85.0 m-70 -110.46 -19.98 12.75 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.342 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 93.4 mt . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.163 -0.923 . . . . 0.0 110.733 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.132 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -52.05 149.65 20.67 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.544 2.163 . . . . 0.0 112.259 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.483 HD13 ' CG2' ' A' ' 153' ' ' VAL . 2.5 mt -145.22 -167.73 2.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.113 0.483 . . . . 0.0 110.848 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.539 ' O ' ' HA ' ' A' ' 80' ' ' LEU . . . -159.53 144.2 9.93 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.63 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.587 ' N ' ' HE3' ' A' ' 6' ' ' MET . 0.7 OUTLIER -120.47 -76.16 0.58 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.117 0.458 . . . . 0.0 111.804 -179.652 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.587 ' HE3' ' N ' ' A' ' 5' ' ' SER . 3.8 mtm 65.68 132.05 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.606 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 10.8 p-10 -64.19 -44.94 90.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.549 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.7 p -97.43 155.09 37.71 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.42 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.439 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 57.5 Cg_endo -71.1 106.38 1.89 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.274 1.983 . . . . 0.0 111.683 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.559 ' HG2' ' CD2' ' A' ' 13' ' ' TYR . 8.1 Cg_endo -48.8 165.74 0.17 Allowed 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 123.157 2.571 . . . . 0.0 113.112 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -51.75 127.61 21.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.257 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.478 ' O ' ' CG ' ' A' ' 101' ' ' LYS . . . 41.89 95.1 0.01 OUTLIER Glycine 0 C--O 1.226 -0.381 0 CA-C-N 115.673 -0.694 . . . . 0.0 113.855 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.559 ' CD2' ' HG2' ' A' ' 10' ' ' PRO . 9.2 m-85 -153.95 147.34 24.93 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.82 0.343 . . . . 0.0 110.466 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.627 ' HA ' ' CZ2' ' A' ' 100' ' ' TRP . 28.1 ttt180 -71.17 83.58 0.73 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.243 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.605 ' HG3' ' CZ3' ' A' ' 79' ' ' TRP . 2.0 ttp180 -50.71 111.35 0.53 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.676 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 2.2 m-80 -132.72 174.6 10.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.901 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.577 HG22 ' CA ' ' A' ' 57' ' ' ALA . 14.4 m -141.8 167.22 16.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.969 0.414 . . . . 0.0 110.796 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.625 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -136.05 159.38 24.29 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.562 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.748 HG13 ' HB2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -130.7 120.91 49.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.29 0.567 . . . . 0.0 112.321 -178.586 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.41 ' CB ' ' CE2' ' A' ' 161' ' ' PHE . 53.0 t -104.3 100.09 9.81 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.073 178.457 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.501 HD21 ' CD1' ' A' ' 112' ' ' PHE . 12.0 tp -99.84 119.81 38.77 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.178 -178.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.679 ' HE2' HD12 ' A' ' 73' ' ' ILE . 0.6 OUTLIER -121.4 157.89 29.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.808 179.801 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.544 ' OD1' ' CE3' ' A' ' 136' ' ' TRP . 0.0 OUTLIER -97.16 172.48 7.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.45 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -57.06 -4.14 0.17 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.479 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.592 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.7 OUTLIER -100.25 0.72 40.86 Favored 'General case' 0 C--N 1.34 0.17 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -178.88 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.592 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 3.8 mmtm 76.45 19.17 1.68 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.222 -178.47 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.538 ' O ' ' HA ' ' A' ' 22' ' ' MET . 2.8 mttt -95.73 143.97 26.52 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.482 HD11 ' CG ' ' A' ' 139' ' ' PRO . 3.1 mp -102.75 145.48 12.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.54 0.686 . . . . 0.0 112.23 -178.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.574 ' CE1' HD13 ' A' ' 119' ' ' ILE . 90.8 t80 -74.98 138.68 42.43 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.643 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.632 ' HB1' HD13 ' A' ' 142' ' ' LEU . . . -137.51 148.65 46.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.972 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.456 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -141.11 134.48 29.71 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.911 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.657 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 2.1 m -95.09 151.14 19.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.924 0.392 . . . . 0.0 111.122 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.0 mtp-105 -69.61 132.29 45.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.425 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.678 ' H ' ' CD2' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -39.18 -46.52 1.49 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.961 -178.924 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.24 -34.76 68.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.181 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.61 ' HB ' ' HB2' ' A' ' 39' ' ' ALA . 19.5 mt -119.05 114.44 35.15 Favored Pre-proline 0 CA--C 1.529 0.17 0 C-N-CA 120.954 -0.299 . . . . 0.0 111.297 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -78.27 -20.42 11.22 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.171 1.914 . . . . 0.0 112.279 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -91.57 -10.08 41.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.922 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.657 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -90.51 92.86 9.05 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.483 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.65 ' O ' ' HA ' ' A' ' 146' ' ' THR . 76.8 m95 -88.32 148.88 24.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.657 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.551 ' HB3' ' HH ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -159.3 158.02 31.61 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.346 0.593 . . . . 0.0 111.567 -179.255 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.476 ' HE3' ' CZ3' ' A' ' 107' ' ' TRP . 28.3 mtm -90.41 148.51 39.09 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.991 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.462 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 11.3 Cg_endo -53.88 151.5 26.32 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.729 1.619 . . . . 0.0 111.319 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.506 ' HA ' HD12 ' A' ' 19' ' ' ILE . 4.1 pt20 -174.74 154.23 1.91 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.419 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.431 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . -159.9 159.94 31.11 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.298 -0.953 . . . . 0.0 112.151 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.663 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -86.79 137.34 14.74 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.693 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.45 HD11 ' CG1' ' A' ' 17' ' ' VAL . 45.2 mt -68.36 146.51 12.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.616 0.246 . . . . 0.0 111.289 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -68.66 -174.64 0.58 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.017 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.05 -61.36 2.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.472 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.59 58.62 0.7 Allowed Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.764 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -117.44 154.06 32.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.68 0.276 . . . . 0.0 110.623 179.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.72 159.78 84.07 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 6.1 Cg_exo -78.54 -49.85 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.528 2.152 . . . . 0.0 111.686 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.519 ' HG2' ' CD2' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -51.49 -46.64 63.23 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.305 179.563 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -67.38 -44.61 78.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.351 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.68 -39.9 90.12 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.577 ' CA ' HG22 ' A' ' 17' ' ' VAL . . . -58.6 -56.12 26.27 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.442 0.639 . . . . 0.0 109.565 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.508 HD11 ' HD2' ' A' ' 54' ' ' ARG . 23.6 mt -55.86 -52.71 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.854 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -62.1 -58.19 8.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.826 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.431 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 70.6 mm-40 -46.21 -45.63 17.03 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.382 0.61 . . . . 0.0 109.848 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.748 ' HB2' HG13 ' A' ' 19' ' ' ILE . 9.9 tt -52.45 -45.91 66.23 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.865 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.68 ' HD2' ' HA2' ' A' ' 66' ' ' GLY . 19.9 tpt85 -62.81 -65.6 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.377 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -50.11 -23.91 2.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.076 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.503 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 6.3 mt-10 -91.87 -35.29 14.14 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -177.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.458 HG21 ' CD2' ' A' ' 131' ' ' PHE . 1.7 p -123.76 -43.79 2.11 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 120.505 -0.478 . . . . 0.0 112.141 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.68 ' HA2' ' HD2' ' A' ' 62' ' ' ARG . . . 119.89 -17.58 10.0 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.275 -178.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.588 HG23 HG12 ' A' ' 119' ' ' ILE . 76.5 t -58.73 115.22 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-O 121.443 0.64 . . . . 0.0 111.842 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.5 OUTLIER -124.55 -37.04 2.55 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.5 178.223 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.4 m -62.35 73.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.102 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -159.63 156.08 27.3 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.444 ' HG3' HG21 ' A' ' 113' ' ' THR . 1.3 mt-10 -128.65 148.57 50.81 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.328 179.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.476 HG21 ' CD2' ' A' ' 110' ' ' PHE . 26.2 t -75.25 127.92 36.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.108 0.48 . . . . 0.0 111.341 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.679 HD12 ' HE2' ' A' ' 22' ' ' MET . 1.7 mt -107.84 -18.58 7.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.482 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.467 ' HB2' ' NE2' ' A' ' 164' ' ' HIS . . . -170.91 175.48 4.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.219 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -151.52 149.68 29.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.469 179.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.788 ' HA ' HG12 ' A' ' 160' ' ' VAL . 39.7 t -72.92 134.94 80.77 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.99 0.424 . . . . 0.0 111.144 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.57 ' HD2' HG12 ' A' ' 76' ' ' VAL . 17.8 Cg_endo -57.0 -68.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.201 2.601 . . . . 0.0 112.707 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.685 ' O ' HG13 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -95.5 -174.86 3.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.76 -178.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.605 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 47.2 m95 -90.9 -158.05 0.53 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.037 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.539 ' HA ' ' O ' ' A' ' 4' ' ' GLY . 50.7 mt -162.31 103.14 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.947 0.404 . . . . 0.0 110.552 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.598 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 66.5 p -90.11 -175.23 4.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.696 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -169.78 64.7 0.05 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.185 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.421 ' HA ' HD22 ' A' ' 93' ' ' ASN . 9.9 p-10 -74.11 172.62 11.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.853 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.484 ' HB2' ' OD1' ' A' ' 93' ' ' ASN . 4.8 m-85 -95.63 175.29 2.85 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.825 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.571 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 49.6 Cg_exo -55.17 166.52 2.25 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.29 1.993 . . . . 0.0 112.05 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.51 -7.19 6.62 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.605 2.204 . . . . 0.0 113.522 -179.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.83 -36.37 5.71 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.614 0.245 . . . . 0.0 111.501 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.561 ' HB ' ' HD2' ' A' ' 85' ' ' PRO . 12.4 t -87.15 -27.59 5.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.391 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.839 ' O ' ' HB2' ' A' ' 93' ' ' ASN . 2.6 tmm_? -59.62 -19.58 50.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.865 0.364 . . . . 0.0 111.251 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -97.58 -21.3 17.15 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.47 -179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -96.14 -17.58 20.75 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.266 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.454 HD12 ' N ' ' A' ' 93' ' ' ASN . 1.5 tm? -119.57 -57.17 2.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.778 0.323 . . . . 0.0 111.119 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.839 ' HB2' ' O ' ' A' ' 89' ' ' ARG . 4.1 m120 -60.38 -46.72 88.96 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.54 ' N ' HD12 ' A' ' 94' ' ' ILE . 1.4 mp -63.89 -8.71 4.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.445 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.7 OUTLIER -98.41 -103.06 0.21 Allowed 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.108 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.596 ' HE1' ' HA ' ' A' ' 93' ' ' ASN . 59.8 m95 59.8 -65.0 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.16 0.584 . . . . 0.0 111.577 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 95' ' ' GLN . . . -173.57 -54.91 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.991 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 43.5 t -174.92 139.08 0.48 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.25 0.547 . . . . 0.0 111.436 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 52.41 19.0 1.03 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.29 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.627 ' CZ2' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -96.68 175.6 6.31 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.86 0.362 . . . . 0.0 111.329 -179.519 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.543 ' HA ' ' HB3' ' A' ' 93' ' ' ASN . 1.0 OUTLIER 167.89 31.12 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.633 179.534 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.494 ' HA3' ' HE1' ' A' ' 13' ' ' TYR . . . 143.07 -157.38 26.86 Favored Glycine 0 C--N 1.332 0.36 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.604 ' HG2' ' HB3' ' A' ' 14' ' ' ARG . 17.0 mt-30 -146.47 108.19 4.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.129 0.465 . . . . 0.0 111.373 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.473 ' HB2' HG22 ' A' ' 81' ' ' THR . . . -94.1 118.31 31.34 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.299 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.676 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.8 OUTLIER -130.53 130.46 44.17 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -178.575 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.492 ' HE2' ' CE2' ' A' ' 79' ' ' TRP . 1.9 ttmt -104.04 135.87 44.75 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.625 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 18.7 m95 -105.68 164.01 12.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -177.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.519 ' CD2' ' HG2' ' A' ' 54' ' ' ARG . 96.3 m-85 -139.44 153.59 47.61 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.528 -179.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.502 ' HB2' ' CE1' ' A' ' 161' ' ' PHE . 13.8 tp -100.91 142.61 32.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.429 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.714 ' CE1' HG21 ' A' ' 19' ' ' ILE . 10.1 m-85 -144.54 146.13 32.2 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.578 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 22.8 tttt -101.56 124.57 47.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.474 178.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.501 ' CD1' HD21 ' A' ' 21' ' ' LEU . 49.4 t80 -77.91 97.37 5.28 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.549 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.444 HG21 ' HG3' ' A' ' 71' ' ' GLU . 59.3 p -96.72 53.91 1.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.035 0.445 . . . . 0.0 110.588 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -157.96 -147.24 4.75 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.492 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -122.31 149.15 44.13 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.996 0.427 . . . . 0.0 110.826 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.462 ' HB3' ' CH2' ' A' ' 134' ' ' TRP . 76.6 m-20 -58.61 -32.26 68.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.291 -179.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -59.31 -5.45 0.75 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.464 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.65 -16.11 33.22 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.944 0.402 . . . . 0.0 111.005 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.588 HG12 HG23 ' A' ' 67' ' ' VAL . 6.1 mt -79.04 101.84 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.901 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.49 ' C ' ' H ' ' A' ' 122' ' ' LEU . 3.8 t30 -101.21 92.85 5.16 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.767 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.447 ' C ' ' CD2' ' A' ' 122' ' ' LEU . 87.5 mt -72.42 41.49 0.09 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.896 0.379 . . . . 0.0 110.626 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.822 HD21 ' HB3' ' A' ' 129' ' ' PRO . 0.4 OUTLIER 57.64 153.57 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.4 0.619 . . . . 0.0 111.805 179.665 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -162.43 -1.25 0.06 OUTLIER Glycine 0 CA--C 1.518 0.26 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.576 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.401 ' O ' ' O ' ' A' ' 125' ' ' GLY . 0.9 OUTLIER -100.86 -161.4 0.86 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 122.64 0.376 . . . . 0.0 110.412 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 124' ' ' ASP . . . -56.56 -115.08 0.01 OUTLIER Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.951 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 59.15 15.57 4.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.606 0.241 . . . . 0.0 111.203 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 70.94 -48.44 0.67 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.327 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.553 ' HE3' ' HG ' ' A' ' 34' ' ' LEU . 8.7 ptmt -179.83 148.13 0.48 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.119 0.485 . . . . 0.0 111.573 178.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.822 ' HB3' HD21 ' A' ' 122' ' ' LEU . 6.3 Cg_exo -65.22 -161.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 123.055 2.503 . . . . 0.0 112.533 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.432 ' O ' HD23 ' A' ' 34' ' ' LEU . 6.5 mm-40 -110.86 -36.47 5.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.679 178.498 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.558 ' N ' HD22 ' A' ' 34' ' ' LEU . 8.4 m-85 -132.24 142.84 49.55 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.609 ' N ' HD21 ' A' ' 34' ' ' LEU . . . -86.9 -32.16 15.61 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.397 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 31' ' ' ALA . 1.9 tt0 -154.52 154.47 33.17 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.725 0.297 . . . . 0.0 111.337 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.534 ' CZ2' HD11 ' A' ' 119' ' ' ILE . 22.1 p-90 -134.6 164.94 26.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.217 0.532 . . . . 0.0 112.162 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.421 ' N ' ' HZ3' ' A' ' 40' ' ' TRP . 12.2 t -159.24 162.93 36.24 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.277 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.544 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 51.7 m95 -107.1 105.67 15.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.018 178.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.427 ' O ' ' N ' ' A' ' 28' ' ' ILE . 30.1 m -121.34 170.96 10.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.882 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.549 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 17.2 p -72.38 173.32 5.79 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.549 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 7.0 Cg_exo -64.68 -52.8 1.19 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 121.623 1.548 . . . . 0.0 109.896 178.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -64.44 -31.65 72.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.654 178.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.467 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.9 OUTLIER -70.11 -45.92 65.89 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.051 179.645 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.632 HD13 ' HB1' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -56.92 -39.91 75.34 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.682 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.641 HG21 ' HD3' ' A' ' 155' ' ' LYS . 33.4 mm -62.47 -33.89 61.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.087 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.46 -53.45 13.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.239 0.542 . . . . 0.0 110.54 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.4 mp -71.62 -21.19 61.87 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.649 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.65 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 7.4 t -74.99 169.38 18.11 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.586 -178.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.518 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 25.4 m -72.86 162.49 4.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.615 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.713 ' HG2' ' N ' ' A' ' 149' ' ' PHE . 0.3 OUTLIER -67.87 -50.98 53.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.19 0.519 . . . . 0.0 110.88 179.762 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.713 ' N ' ' HG2' ' A' ' 148' ' ' GLU . 40.2 p90 -58.52 -2.58 0.22 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.938 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.5 ' HG3' ' CD2' ' A' ' 149' ' ' PHE . 23.6 mttt -132.15 -7.49 3.43 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.51 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 0.3 OUTLIER -63.23 -56.13 30.33 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 121.307 -0.157 . . . . 0.0 110.63 179.286 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 20.0 Cg_endo -61.87 -28.21 81.08 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.214 1.942 . . . . 0.0 111.636 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.483 ' CG2' HD13 ' A' ' 3' ' ' LEU . 15.0 t -68.83 -48.5 70.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.551 ' HH ' ' HB3' ' A' ' 41' ' ' GLN . 7.5 m-30 -68.83 -37.65 79.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.765 178.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.641 ' HD3' HG21 ' A' ' 143' ' ' ILE . 2.0 tptp -55.34 -44.83 76.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.521 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -67.57 -34.25 76.66 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.63 HG12 ' CE2' ' A' ' 161' ' ' PHE . 47.7 t -67.79 -41.0 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.847 178.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 38.7 mt -62.77 -44.91 94.95 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.385 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 62.5 m -51.54 -40.29 59.39 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.788 HG12 ' HA ' ' A' ' 76' ' ' VAL . 81.9 t -67.28 -42.23 87.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.142 178.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.67 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 22.3 m-30 -80.12 2.8 22.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.496 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.589 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.98 -52.81 72.18 Favored Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.053 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.6 Cg_endo -58.11 -12.09 11.9 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.153 1.902 . . . . 0.0 112.136 179.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.467 ' NE2' ' HB2' ' A' ' 74' ' ' ALA . 87.1 m-70 -110.72 -16.12 13.68 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.492 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.67 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 93.7 mt . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.912 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.456 ' C ' ' H ' ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.408 ' HD3' ' HA3' ' A' ' 1' ' ' GLY . 27.5 Cg_exo -63.18 4.56 0.4 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.879 2.386 . . . . 0.0 113.551 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.486 ' CD2' ' HB2' ' A' ' 152' ' ' PRO . 2.8 mm? -94.32 76.11 3.94 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.301 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.476 ' O ' ' HE2' ' A' ' 6' ' ' MET . . . -95.62 64.28 1.29 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.085 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.427 ' O ' ' HG3' ' A' ' 6' ' ' MET . 99.7 p -59.52 155.48 15.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.979 0.418 . . . . 0.0 111.774 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.645 ' HE3' HG22 ' A' ' 81' ' ' THR . 0.0 OUTLIER -145.23 132.4 20.46 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.383 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.756 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 9.0 t0 -61.36 -36.07 79.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.944 0.402 . . . . 0.0 110.062 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.519 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 61.9 p -100.62 121.38 53.11 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.572 178.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.467 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 46.3 Cg_endo -69.1 102.54 0.93 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.175 1.916 . . . . 0.0 113.624 -178.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.803 ' O ' ' O ' ' A' ' 11' ' ' GLU . 5.9 Cg_endo -50.78 169.47 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 123.236 2.624 . . . . 0.0 112.122 178.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . 0.803 ' O ' ' O ' ' A' ' 10' ' ' PRO . 68.9 mm-40 6.06 -146.95 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 O-C-N 124.144 0.903 . . . . 0.0 112.971 178.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 99' ' ' ASP . . . -57.39 -81.26 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.765 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.592 ' H ' ' HA ' ' A' ' 100' ' ' TRP . 9.6 m-85 61.85 130.89 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.881 0.372 . . . . 0.0 110.618 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.478 ' HB3' ' HG2' ' A' ' 103' ' ' GLN . 2.1 ttt180 -72.19 86.23 1.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.435 -179.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.463 ' HG2' HD13 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -49.05 108.89 0.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.115 0.483 . . . . 0.0 110.173 179.008 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.678 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 3.4 m120 -132.3 173.1 11.62 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.899 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.594 HG22 ' N ' ' A' ' 57' ' ' ALA . 21.2 m -143.71 162.41 15.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.318 0.58 . . . . 0.0 112.425 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.536 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -133.95 158.98 23.58 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 177.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.677 HG13 ' HB2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -134.14 126.34 49.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 35.8 t -102.82 100.64 10.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.237 178.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.44 HD23 ' CD1' ' A' ' 112' ' ' PHE . 11.4 tp -99.73 118.91 37.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.435 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.567 ' CE ' HD12 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -120.48 166.54 13.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.633 179.622 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.559 ' OD1' ' CE3' ' A' ' 136' ' ' TRP . 0.0 OUTLIER -101.04 171.9 7.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.573 -179.695 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -56.82 -5.32 0.22 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.525 178.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.531 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 1.4 m-20 -98.53 1.95 47.07 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.66 0.267 . . . . 0.0 111.687 -178.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.531 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.1 OUTLIER 76.07 18.31 2.0 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.102 -178.508 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.499 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 0.2 OUTLIER -94.68 142.17 27.76 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.836 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.473 HD12 ' CG ' ' A' ' 139' ' ' PRO . 3.7 mp -99.33 146.47 8.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.761 0.791 . . . . 0.0 112.612 -178.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.6 ' CE1' HD11 ' A' ' 119' ' ' ILE . 87.2 t80 -78.15 136.97 37.94 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.239 -1.346 . . . . 0.0 110.035 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.488 ' HA ' ' O ' ' A' ' 41' ' ' GLN . . . -137.88 146.77 43.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.893 0.378 . . . . 0.0 110.336 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.45 ' HB3' ' CG ' ' A' ' 131' ' ' PHE . . . -138.69 132.33 30.67 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.138 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.584 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 28.5 m -99.15 148.36 24.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.233 -179.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 36' ' ' ILE . 4.8 mtp180 -69.13 127.9 34.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.649 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.722 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 1.7 mp -43.69 -37.51 2.67 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.175 0.512 . . . . 0.0 111.035 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.08 -36.77 72.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.851 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' A' ' 39' ' ' ALA . 23.1 mt -121.63 112.9 32.19 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.076 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.96 -18.76 11.29 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.258 1.972 . . . . 0.0 112.843 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -92.88 -11.26 33.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.511 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.584 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.05 99.55 12.36 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 120.817 0.341 . . . . 0.0 110.715 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.614 ' O ' ' HA ' ' A' ' 146' ' ' THR . 72.4 m95 -94.39 157.33 16.07 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.98 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.6 ' HG3' ' O ' ' A' ' 40' ' ' TRP . 22.9 mt-30 -159.89 -131.69 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 121.111 -0.235 . . . . 0.0 110.399 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.517 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 3.0 ptt? -179.14 161.67 1.0 Allowed Pre-proline 0 N--CA 1.453 -0.31 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.517 ' HD2' ' HB2' ' A' ' 42' ' ' MET . 9.8 Cg_endo -49.86 140.91 29.8 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.119 1.879 . . . . 0.0 112.242 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.555 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER 179.77 144.17 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.73 -179.173 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.467 ' HA3' ' HG2' ' A' ' 60' ' ' GLU . . . -160.47 -156.62 8.27 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.14 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.678 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -117.84 138.55 14.07 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.132 -1.032 . . . . 0.0 113.539 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.552 ' CD1' HG12 ' A' ' 17' ' ' VAL . 4.2 mt -69.54 148.44 11.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.488 -0.356 . . . . 0.0 111.006 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.483 ' N ' HG21 ' A' ' 47' ' ' ILE . 22.3 m-20 -68.92 -174.25 0.57 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.849 0.357 . . . . 0.0 110.686 179.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -47.96 -62.26 1.55 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.464 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.82 60.67 0.68 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.559 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -117.04 153.28 32.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.765 0.317 . . . . 0.0 110.669 179.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -70.13 147.08 95.43 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.451 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 16.7 Cg_exo -67.09 -46.51 3.04 Favored 'Trans proline' 0 CA--C 1.513 -0.529 0 C-N-CA 122.138 1.892 . . . . 0.0 111.395 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.605 ' HD2' ' C ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -52.21 -49.02 64.75 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.097 179.153 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -63.77 -44.31 93.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.512 179.812 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 60' ' ' GLU . . . -60.58 -42.28 96.38 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.594 ' N ' HG22 ' A' ' 17' ' ' VAL . . . -56.07 -52.93 62.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.978 178.776 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.517 HG12 ' CE2' ' A' ' 110' ' ' PHE . 17.3 mt -57.49 -54.37 31.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.881 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -61.39 -58.68 7.24 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.729 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.467 ' HG2' ' HA3' ' A' ' 45' ' ' GLY . 0.7 OUTLIER -45.38 -45.41 12.6 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.536 0.684 . . . . 0.0 109.511 179.318 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.677 ' HB2' HG13 ' A' ' 19' ' ' ILE . 7.6 tt -52.55 -51.14 61.15 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.731 178.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.525 ' O ' ' N ' ' A' ' 66' ' ' GLY . 7.3 ttm105 -62.44 -62.46 1.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.195 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -51.38 -20.48 1.77 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.43 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -100.57 -35.58 9.47 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 119' ' ' ILE . 0.8 OUTLIER -124.1 -11.3 7.56 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.027 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 84.54 -14.5 46.25 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.868 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.639 HG11 HD22 ' A' ' 61' ' ' LEU . 39.8 t -57.99 115.2 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.434 0.635 . . . . 0.0 111.316 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.451 ' CG2' ' HG3' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -123.54 -39.94 2.39 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.813 178.93 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.416 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 7.2 m -63.0 74.98 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.643 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.555 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -160.27 155.91 25.57 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -128.48 151.39 49.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.399 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.683 HG23 ' CE2' ' A' ' 110' ' ' PHE . 20.2 t -75.64 130.72 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-O 121.292 0.567 . . . . 0.0 112.066 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.581 HD11 ' HB2' ' A' ' 111' ' ' LYS . 1.0 OUTLIER -111.04 -19.11 7.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.37 179.045 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.48 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -170.94 176.54 4.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.812 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.4 OUTLIER -157.05 145.21 19.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.123 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.648 ' HA ' HG13 ' A' ' 160' ' ' VAL . 25.6 t -72.1 138.03 81.9 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-O 121.006 0.431 . . . . 0.0 110.838 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -76.87 -45.09 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.9 2.4 . . . . 0.0 113.49 -179.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.756 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 1.1 p90 -99.41 161.84 13.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.147 0.499 . . . . 0.0 112.242 -178.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.442 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 73.2 m95 -95.14 109.95 21.96 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.851 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 17.3 mt -68.02 125.67 27.06 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.128 -0.229 . . . . 0.0 110.527 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.658 ' CG2' ' HA ' ' A' ' 104' ' ' ALA . 21.1 p -139.81 92.13 2.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.86 0.362 . . . . 0.0 111.806 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.468 ' O ' ' C ' ' A' ' 83' ' ' ASP . 0.2 OUTLIER -79.86 38.08 0.38 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.487 179.179 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.468 ' C ' ' O ' ' A' ' 82' ' ' TYR . 3.6 p30 27.66 -132.59 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.387 0.275 . . . . 0.0 111.501 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.48 ' CD2' ' HG ' ' A' ' 92' ' ' LEU . 0.5 OUTLIER -141.79 178.66 1.44 Allowed Pre-proline 0 C--O 1.231 0.098 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.163 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.571 ' HG2' HG23 ' A' ' 88' ' ' VAL . 74.9 Cg_exo -52.59 156.08 9.24 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 121.816 1.677 . . . . 0.0 111.452 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.36 -10.43 26.01 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.659 2.239 . . . . 0.0 113.413 -178.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.0 -20.37 11.56 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.571 HG23 ' HG2' ' A' ' 85' ' ' PRO . 10.6 t -91.49 -28.49 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.699 ' HD2' ' HB2' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -30.83 -77.51 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.134 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.548 ' O ' HG21 ' A' ' 94' ' ' ILE . 41.6 mt-10 -62.05 -10.34 9.76 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.997 0.427 . . . . 0.0 111.369 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 88' ' ' VAL . 0.8 OUTLIER -84.73 -36.21 21.95 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.948 0.404 . . . . 0.0 109.992 179.426 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.908 ' CD1' ' H ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -121.36 -74.23 0.62 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.559 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.908 ' H ' ' CD1' ' A' ' 92' ' ' LEU . 6.8 m120 -24.1 -62.19 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.221 1.008 . . . . 0.0 112.879 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.548 HG21 ' O ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -55.39 -48.28 77.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 114.361 -1.29 . . . . 0.0 113.127 -178.463 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.459 ' H ' HG22 ' A' ' 94' ' ' ILE . 0.6 OUTLIER -62.82 -102.1 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -177.213 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.757 ' HE1' HD22 ' A' ' 92' ' ' LEU . 77.7 m95 49.12 26.0 1.31 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 98' ' ' SER . . . 67.26 39.1 92.13 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.155 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 97' ' ' GLY . 1.4 m 84.97 154.83 0.09 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.771 0.32 . . . . 0.0 111.042 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.492 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 1.3 m-20 51.52 89.98 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.718 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.592 ' HA ' ' H ' ' A' ' 13' ' ' TYR . 0.9 OUTLIER 174.06 173.7 0.17 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.67 -179.561 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.571 ' HA ' ' HB3' ' A' ' 93' ' ' ASN . 0.0 OUTLIER 169.46 19.86 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.961 -179.682 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.67 ' HA2' ' ND2' ' A' ' 93' ' ' ASN . . . 154.95 -144.17 10.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 119.919 -1.134 . . . . 0.0 112.827 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.478 ' HG2' ' HB3' ' A' ' 14' ' ' ARG . 15.3 mt-30 -143.77 116.71 8.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.446 0.165 . . . . 0.0 110.616 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.658 ' HA ' ' CG2' ' A' ' 81' ' ' THR . . . -98.81 120.92 40.06 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.175 0.512 . . . . 0.0 110.646 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.667 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 53.6 mt-30 -128.8 123.51 33.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.986 -178.55 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.434 ' HB2' ' CE3' ' A' ' 79' ' ' TRP . 0.8 OUTLIER -103.25 134.85 45.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.816 178.604 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.536 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 73.0 m95 -102.29 159.01 15.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.306 0.574 . . . . 0.0 112.268 -178.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.451 ' CZ ' ' HB2' ' A' ' 53' ' ' PRO . 93.9 m-85 -139.26 151.15 46.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.485 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.55 ' HG ' HD13 ' A' ' 73' ' ' ILE . 24.0 tp -100.33 139.36 36.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.7 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.683 ' CE2' HG23 ' A' ' 72' ' ' VAL . 40.5 m-85 -140.95 144.92 35.41 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.581 ' HB2' HD11 ' A' ' 73' ' ' ILE . 29.9 tttt -103.37 124.28 48.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.804 177.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.44 ' CD1' HD23 ' A' ' 21' ' ' LEU . 44.4 t80 -78.47 101.85 7.53 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.848 0.356 . . . . 0.0 110.857 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 21.3 p -100.77 46.43 0.95 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.548 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.416 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -150.84 -145.13 4.06 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.24 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.416 ' O ' ' HZ ' ' A' ' 112' ' ' PHE . 1.4 pt20 -124.86 149.06 47.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.182 0.515 . . . . 0.0 111.429 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -58.86 -26.54 64.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.944 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -57.42 -7.25 0.56 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.41 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -89.75 -16.45 30.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.099 0.476 . . . . 0.0 110.566 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.6 HD11 ' CE1' ' A' ' 29' ' ' PHE . 3.7 mt -88.64 108.21 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.696 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.454 ' C ' ' H ' ' A' ' 122' ' ' LEU . 14.1 p-10 -109.07 -31.39 7.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.168 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 38.3 mt 75.04 -39.74 0.42 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.64 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.716 ' HA ' ' HB3' ' A' ' 129' ' ' PRO . 78.2 mt -67.2 171.12 6.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.574 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.33 111.24 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.976 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -144.61 -9.74 0.63 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.333 -0.434 . . . . 0.0 111.417 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 135.76 40.95 0.14 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.213 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 67.96 7.81 6.04 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.577 0.227 . . . . 0.0 111.328 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -97.54 -72.29 0.65 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.913 0.387 . . . . 0.0 110.856 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.62 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 7.7 ptpp? -178.97 160.3 1.01 Allowed Pre-proline 0 C--N 1.332 -0.159 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.247 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.716 ' HB3' ' HA ' ' A' ' 122' ' ' LEU . 15.2 Cg_endo -62.65 -177.84 0.34 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 123.053 2.502 . . . . 0.0 112.602 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -109.88 -35.05 6.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.072 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.45 ' CG ' ' HB3' ' A' ' 31' ' ' ALA . 4.9 m-85 -133.66 145.62 50.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.014 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.722 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -90.68 -33.77 8.25 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.817 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.16 146.55 27.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.884 0.373 . . . . 0.0 110.761 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.487 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 39.6 p-90 -134.76 167.12 21.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.187 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.447 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 13.0 t -164.98 168.85 17.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.426 0.632 . . . . 0.0 112.243 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.559 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 36.4 m95 -106.01 106.89 17.61 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.085 178.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.432 ' O ' ' N ' ' A' ' 28' ' ' ILE . 29.8 m -122.43 171.02 11.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.126 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.544 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 11.6 p -72.4 173.45 5.62 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.544 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 5.3 Cg_exo -65.01 -53.59 0.84 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 121.564 1.509 . . . . 0.0 110.374 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.22 -25.8 68.23 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.599 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -73.04 -49.03 31.06 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.611 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.465 HD12 ' CB ' ' A' ' 30' ' ' ALA . 4.2 tp -56.07 -38.62 70.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.909 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.781 HG21 ' HD3' ' A' ' 155' ' ' LYS . 14.0 mm -62.66 -40.74 89.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.137 0.494 . . . . 0.0 110.636 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.85 -47.98 70.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.261 0.553 . . . . 0.0 110.556 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.527 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -76.32 -22.32 55.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.695 -179.181 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.614 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 10.0 t -75.46 179.44 5.25 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.113 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.45 ' CG1' ' CB ' ' A' ' 39' ' ' ALA . 21.0 m -86.28 158.36 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.196 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.565 ' HA ' ' HD3' ' A' ' 151' ' ' LYS . 8.9 mt-10 -60.64 -49.52 77.2 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.147 0.499 . . . . 0.0 110.799 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -54.09 -8.49 0.19 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.352 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -135.21 -6.02 2.33 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.565 ' HD3' ' HA ' ' A' ' 148' ' ' GLU . 1.2 mtpp -58.62 -62.26 6.05 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.717 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.486 ' HB2' ' CD2' ' A' ' 3' ' ' LEU . 18.1 Cg_endo -60.6 -27.29 84.58 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.308 2.005 . . . . 0.0 111.505 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.56 ' O ' HG23 ' A' ' 157' ' ' VAL . 22.1 t -67.51 -53.35 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.479 ' HE2' ' HA ' ' A' ' 41' ' ' GLN . 6.4 m-30 -63.18 -38.22 90.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.101 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.781 ' HD3' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -56.88 -45.39 82.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.071 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.428 ' O ' HG22 ' A' ' 160' ' ' VAL . 1.5 tt0 -67.31 -33.42 75.24 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.56 HG23 ' O ' ' A' ' 153' ' ' VAL . 81.3 t -66.71 -41.75 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.613 178.198 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.412 ' O ' ' N ' ' A' ' 162' ' ' ALA . 54.6 mt -62.88 -44.84 95.02 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.404 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 162' ' ' ALA . 0.6 OUTLIER -52.98 -40.67 63.92 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.219 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.648 HG13 ' HA ' ' A' ' 76' ' ' VAL . 60.8 t -67.51 -43.41 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.242 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.59 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 21.6 m-30 -80.94 4.89 17.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.495 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.59 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.63 -52.69 72.22 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.798 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 17.9 Cg_endo -58.08 -11.91 11.36 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.067 1.845 . . . . 0.0 112.058 179.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.48 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 83.3 m-70 -110.26 -19.02 13.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.502 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 96.9 mt . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.661 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 CA-C-O 120.126 -0.263 . . . . 0.0 112.581 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.36 173.71 9.27 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.574 2.182 . . . . 0.0 112.239 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -103.95 123.68 47.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.014 -179.968 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.07 -22.75 37.25 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.696 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.585 ' HA ' ' O ' ' A' ' 79' ' ' TRP . 1.1 m 65.76 -82.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.971 0.415 . . . . 0.0 111.042 -179.735 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.417 ' HE2' ' N ' ' A' ' 5' ' ' SER . 5.4 mtm 67.03 137.61 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.757 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.714 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 7.0 p-10 -67.64 -40.18 84.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.227 -179.366 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.9 142.4 24.54 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 121.154 -0.218 . . . . 0.0 110.707 179.592 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.78 106.92 2.35 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.467 2.111 . . . . 0.0 112.058 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.515 ' HB2' ' CE1' ' A' ' 13' ' ' TYR . 3.2 Cg_endo -47.86 165.23 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.096 2.531 . . . . 0.0 113.01 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -52.22 129.64 28.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.19 179.57 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 53.16 84.96 0.02 OUTLIER Glycine 0 CA--C 1.517 0.214 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.778 179.812 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.515 ' CE1' ' HB2' ' A' ' 10' ' ' PRO . 9.5 m-85 -149.93 152.0 34.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.824 0.345 . . . . 0.0 111.42 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.548 ' HG3' ' H ' ' A' ' 15' ' ' ARG . 0.7 OUTLIER -64.01 -152.77 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.923 -179.427 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.548 ' H ' ' HG3' ' A' ' 14' ' ' ARG . 0.0 OUTLIER 177.94 95.61 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.261 0.553 . . . . 0.0 109.953 -178.772 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.642 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 3.6 m-80 -129.83 172.18 11.94 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.039 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.67 HG23 ' N ' ' A' ' 57' ' ' ALA . 21.1 m -138.89 167.31 20.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.495 0.664 . . . . 0.0 111.727 179.196 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.705 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -134.83 161.08 24.48 Favored Glycine 0 N--CA 1.438 -1.191 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.521 178.726 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.687 HG13 ' HB2' ' A' ' 61' ' ' LEU . 0.0 OUTLIER -129.21 119.92 50.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.09 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.412 ' CB ' ' HE2' ' A' ' 161' ' ' PHE . 37.4 t -101.66 111.08 23.21 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.02 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.453 HD23 HG13 ' A' ' 67' ' ' VAL . 59.9 tp -105.9 124.34 49.41 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.925 -178.37 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.677 ' HB3' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -116.51 137.58 52.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.8 -179.954 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.482 ' OD1' ' CH2' ' A' ' 136' ' ' TRP . 6.7 m-20 -96.8 -173.8 2.82 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.307 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -54.81 -5.03 0.08 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.128 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.47 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 3.0 m-20 -101.76 -1.54 32.18 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 122.173 -0.329 . . . . 0.0 111.787 -178.819 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 11.4 mmtm 69.5 23.3 6.05 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -177.924 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.677 ' O ' ' HB3' ' A' ' 22' ' ' MET . 84.2 mttt -95.59 -167.4 1.6 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.876 179.267 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.451 HD12 ' CG ' ' A' ' 139' ' ' PRO . 2.1 mp -136.0 146.27 29.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.968 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.623 ' CE1' HD12 ' A' ' 119' ' ' ILE . 90.3 t80 -70.55 138.73 51.19 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.514 179.512 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.591 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -140.22 149.1 42.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.099 179.593 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.57 ' HB3' ' HB3' ' A' ' 131' ' ' PHE . . . -143.55 145.0 32.19 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.045 -179.701 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.644 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 28.4 p -98.97 145.74 26.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.09 0.471 . . . . 0.0 111.466 -179.512 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.641 ' O ' ' N ' ' A' ' 35' ' ' ASP . 25.3 mtp180 -69.34 129.82 40.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.783 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.685 HD12 ' HG2' ' A' ' 129' ' ' PRO . 0.5 OUTLIER -56.85 55.49 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.862 -179.98 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.641 ' N ' ' O ' ' A' ' 33' ' ' ARG . 0.9 OUTLIER -177.23 -34.82 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.157 0.504 . . . . 0.0 110.223 -179.688 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.599 ' HB ' ' HB2' ' A' ' 39' ' ' ALA . 7.1 mm -117.18 106.02 47.93 Favored Pre-proline 0 N--CA 1.451 -0.411 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.135 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -58.53 -60.51 0.35 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.396 2.731 . . . . 0.0 114.443 -178.134 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.92 1.48 3.37 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.285 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.644 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.4 94.35 9.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.631 0.253 . . . . 0.0 110.991 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.648 ' O ' ' HA ' ' A' ' 146' ' ' THR . 71.1 m95 -99.24 141.82 31.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.343 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.513 ' NE2' ' HD2' ' A' ' 33' ' ' ARG . 12.5 mt-30 -146.54 174.08 11.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.954 0.883 . . . . 0.0 112.378 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.518 ' HB3' ' CH2' ' A' ' 107' ' ' TRP . 2.6 ttp -108.62 140.28 21.65 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 113.932 -1.486 . . . . 0.0 109.121 178.82 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.419 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 9.4 Cg_endo -52.09 146.56 29.9 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.097 1.865 . . . . 0.0 111.817 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.654 ' HA ' HD12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -174.84 157.12 2.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.325 179.944 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.452 ' O ' ' HB3' ' A' ' 16' ' ' ASN . . . -158.39 -172.12 25.13 Favored Glycine 0 C--O 1.226 -0.383 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.662 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.642 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -107.97 139.95 15.27 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.242 -0.98 . . . . 0.0 113.614 -179.593 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.54 ' CD1' HG12 ' A' ' 17' ' ' VAL . 6.5 mt -71.52 146.5 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.694 0.283 . . . . 0.0 110.824 179.504 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.401 ' N ' HG21 ' A' ' 47' ' ' ILE . 5.2 m-20 -68.95 -175.17 0.68 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.848 0.356 . . . . 0.0 111.081 179.744 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -48.75 -51.45 28.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.304 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -142.52 62.79 0.51 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.351 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -117.87 150.92 38.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.676 0.274 . . . . 0.0 110.332 179.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.87 141.16 92.03 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.346 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 33.5 Cg_exo -61.55 -45.34 18.19 Favored 'Trans proline' 0 CA--C 1.513 -0.563 0 C-N-CA 122.2 1.933 . . . . 0.0 111.513 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.568 ' HD2' HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -51.57 -48.22 63.22 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.042 179.39 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -65.77 -43.99 87.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.638 179.705 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.88 -41.19 91.04 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.67 ' N ' HG23 ' A' ' 17' ' ' VAL . . . -58.63 -54.11 50.74 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.903 178.746 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.568 HD11 ' HD2' ' A' ' 54' ' ' ARG . 10.6 mt -56.37 -51.73 60.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.056 179.023 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -61.31 -56.7 17.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.49 -179.247 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.424 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 74.9 mm-40 -50.47 -42.63 54.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.019 0.437 . . . . 0.0 110.015 179.366 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.687 ' HB2' HG13 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -52.08 -49.34 63.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.419 178.732 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.467 ' HD2' ' C ' ' A' ' 62' ' ' ARG . 4.2 tmm_? -64.13 -65.97 0.61 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.626 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -48.27 -22.53 0.69 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -100.32 -34.16 10.1 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -178.246 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 49.5 p -123.12 -8.81 8.22 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.31 -0.556 . . . . 0.0 112.365 -178.536 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.464 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 80.53 -18.03 9.47 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.385 -178.592 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.512 HG12 HD21 ' A' ' 61' ' ' LEU . 97.8 t -57.15 121.05 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.263 0.554 . . . . 0.0 111.413 179.257 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.419 ' CG2' ' CG ' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -129.14 -39.37 1.55 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.89 178.731 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.3 m -62.79 75.06 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.483 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.592 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -158.93 156.23 29.1 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.575 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.402 ' HG3' HG21 ' A' ' 113' ' ' THR . 0.5 OUTLIER -128.54 151.45 49.43 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.236 179.389 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.675 HG23 ' CE2' ' A' ' 110' ' ' PHE . 7.8 t -75.59 130.77 35.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.318 0.58 . . . . 0.0 112.166 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.58 HD13 ' HB2' ' A' ' 111' ' ' LYS . 0.9 OUTLIER -111.75 -19.2 7.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.555 178.805 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.542 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -169.81 178.38 4.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.626 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -156.23 149.23 24.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.833 179.63 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.708 ' HA ' HG11 ' A' ' 160' ' ' VAL . 52.6 t -73.08 137.86 79.1 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-O 121.186 0.517 . . . . 0.0 111.574 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.534 ' HD3' HG12 ' A' ' 160' ' ' VAL . 20.4 Cg_endo -62.52 -70.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.397 2.732 . . . . 0.0 112.794 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.714 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -87.45 173.55 9.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.063 -178.723 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.585 ' O ' ' HA ' ' A' ' 5' ' ' SER . 48.9 m95 -93.97 100.09 12.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.964 179.738 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.448 ' CD1' HG22 ' A' ' 157' ' ' VAL . 52.1 mt -58.45 112.91 1.74 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.922 0.391 . . . . 0.0 110.893 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 15.7 p -105.88 -165.23 1.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.944 -179.589 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -169.64 47.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.495 179.703 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -72.39 146.61 46.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.518 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.53 ' CB ' ' HB ' ' A' ' 88' ' ' VAL . 38.4 m-85 -98.92 173.07 4.11 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.263 -179.464 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.497 ' CD ' ' HB3' ' A' ' 84' ' ' PHE . 33.6 Cg_exo -61.77 -173.85 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.618 2.212 . . . . 0.0 111.369 179.439 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 85' ' ' PRO . 71.3 Cg_endo -75.56 17.16 0.68 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.346 2.031 . . . . 0.0 113.53 -179.714 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.59 -59.76 1.96 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.889 0.376 . . . . 0.0 110.821 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.53 ' HB ' ' CB ' ' A' ' 84' ' ' PHE . 44.9 t -56.09 -20.9 10.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.352 179.659 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -47.58 -42.54 24.0 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.084 0.469 . . . . 0.0 111.272 -179.668 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.534 ' HA ' HD11 ' A' ' 94' ' ' ILE . 3.7 tt0 -65.17 -17.45 64.49 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.007 -179.819 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -102.78 -22.18 13.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.965 179.479 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.457 HD11 ' HA2' ' A' ' 102' ' ' GLY . 1.2 tm? -121.5 -58.23 1.78 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.326 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.468 ' HB3' ' O ' ' A' ' 89' ' ' ARG . 25.9 t-20 -50.99 -63.93 0.97 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.949 0.404 . . . . 0.0 111.512 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.534 HD11 ' HA ' ' A' ' 90' ' ' GLU . 3.9 mp -71.7 -4.82 5.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.275 -179.288 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.437 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 34.3 tt0 -72.03 -6.66 43.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.355 178.913 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.496 ' HB2' ' CG ' ' A' ' 100' ' ' TRP . 71.6 m95 -100.3 -6.35 26.03 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.753 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.55 39.52 97.96 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.082 179.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.59 -163.53 0.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.713 0.292 . . . . 0.0 110.895 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.76 82.66 4.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.267 179.252 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.621 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 48.6 m95 -124.56 -164.99 1.32 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.657 -179.544 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.621 ' HB2' ' O ' ' A' ' 100' ' ' TRP . 19.7 ttpt 166.41 -13.36 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.256 0.347 . . . . 0.0 111.712 -179.701 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.457 ' HA2' HD11 ' A' ' 92' ' ' LEU . . . -175.6 -162.98 27.68 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.192 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.512 ' O ' ' HA ' ' A' ' 81' ' ' THR . 31.4 mt-30 -143.2 124.94 15.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.777 0.322 . . . . 0.0 110.6 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.403 ' O ' ' HA ' ' A' ' 15' ' ' ARG . . . -97.58 121.99 40.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.833 179.29 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.607 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 9.4 mt-30 -128.96 122.42 30.11 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.362 -178.068 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.03 135.33 44.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.509 179.693 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.705 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 42.7 m95 -103.66 166.25 10.54 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.063 0.458 . . . . 0.0 111.636 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.46 ' CZ ' ' HB2' ' A' ' 53' ' ' PRO . 91.1 m-85 -141.53 155.33 45.81 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.836 -179.471 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.488 ' O ' HG13 ' A' ' 72' ' ' VAL . 8.4 tp -101.14 141.96 33.27 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.459 179.126 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.675 ' CE2' HG23 ' A' ' 72' ' ' VAL . 49.4 m-85 -144.83 144.34 31.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.49 0.662 . . . . 0.0 112.502 -178.598 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.592 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 9.5 tttt -103.65 125.98 50.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.731 177.874 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.433 ' HA ' ' HB2' ' A' ' 70' ' ' ALA . 51.0 t80 -78.85 97.37 5.95 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.032 0.444 . . . . 0.0 110.939 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.402 HG21 ' HG3' ' A' ' 71' ' ' GLU . 39.1 p -97.1 51.03 1.1 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.536 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -153.17 -146.77 4.45 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.422 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.405 ' O ' ' HZ ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -122.4 145.12 48.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.177 0.513 . . . . 0.0 111.069 179.786 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -59.12 -26.15 64.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.05 -179.137 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -58.37 -5.07 0.45 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.209 -179.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -90.88 -18.23 25.15 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.996 0.427 . . . . 0.0 110.977 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.623 HD12 ' CE1' ' A' ' 29' ' ' PHE . 5.5 mt -83.85 103.53 11.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.709 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' A' ' 122' ' ' LEU . 0.5 OUTLIER -101.68 -12.53 18.32 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.243 -179.419 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.626 ' HG ' ' HD1' ' A' ' 134' ' ' TRP . 16.6 mt 37.07 28.57 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.057 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.831 ' HA ' ' HB3' ' A' ' 129' ' ' PRO . 10.7 mt -105.0 4.46 31.69 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.827 -179.511 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.56 130.36 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.497 -0.859 . . . . 0.0 111.96 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.35 69.55 7.0 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.343 0.592 . . . . 0.0 110.424 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -161.66 172.86 37.94 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.107 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.2 8.99 33.04 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.614 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -91.47 -75.04 0.49 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.841 0.353 . . . . 0.0 111.246 -179.756 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.579 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 1.7 pttm -178.68 163.73 1.1 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.735 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.831 ' HB3' ' HA ' ' A' ' 122' ' ' LEU . 27.7 Cg_endo -66.41 166.35 21.9 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.904 2.403 . . . . 0.0 112.815 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -97.72 -61.04 1.45 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.253 179.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.57 ' HB3' ' HB3' ' A' ' 31' ' ' ALA . 6.5 m-85 -105.3 147.03 28.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.696 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.635 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -86.2 -34.95 11.47 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.953 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -154.37 154.79 33.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.626 0.251 . . . . 0.0 111.2 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.626 ' HD1' ' HG ' ' A' ' 121' ' ' LEU . 36.4 p-90 -133.31 164.48 27.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.059 0.457 . . . . 0.0 111.875 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.5 t -157.99 165.61 34.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.685 -179.419 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.482 ' CH2' ' OD1' ' A' ' 23' ' ' ASN . 89.6 m95 -106.75 97.53 7.31 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.936 178.305 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.615 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 21.0 m -113.37 163.11 10.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.338 179.611 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.506 ' HG1' ' H ' ' A' ' 141' ' ' GLN . 10.5 p -70.92 174.32 3.77 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.199 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.58 ' HB3' HD23 ' A' ' 158' ' ' LEU . 12.2 Cg_exo -63.25 -53.35 1.53 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.543 1.495 . . . . 0.0 111.279 179.698 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -27.11 68.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.074 0.464 . . . . 0.0 111.067 179.332 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.506 ' H ' ' HG1' ' A' ' 138' ' ' THR . 21.7 mt-30 -72.23 -47.3 51.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.882 179.767 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.591 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.3 OUTLIER -55.34 -41.41 72.44 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.482 179.498 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.722 HG21 ' HG2' ' A' ' 155' ' ' LYS . 28.9 mm -61.12 -34.24 59.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.553 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.57 -52.08 17.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.861 179.115 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.3 mp -72.97 -21.78 60.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.228 -179.309 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.648 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 8.2 t -73.21 173.87 8.83 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.99 0.424 . . . . 0.0 111.675 -178.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.467 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 16.3 m -79.83 154.03 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.984 -179.743 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.46 ' C ' ' H ' ' A' ' 150' ' ' LYS . 4.0 mt-10 -58.41 -54.82 42.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.849 0.357 . . . . 0.0 110.73 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.467 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 51.7 p90 -56.93 2.47 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.561 ' HG2' ' CZ ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -137.53 -6.41 1.75 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.581 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.519 ' HG3' ' CG2' ' A' ' 143' ' ' ILE . 0.0 OUTLIER -64.44 -56.35 23.53 Favored Pre-proline 0 N--CA 1.464 0.262 0 N-CA-C 111.326 0.121 . . . . 0.0 111.326 -179.979 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.486 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 29.4 Cg_endo -63.66 -28.5 69.19 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.278 1.985 . . . . 0.0 111.834 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 25.9 t -68.66 -51.09 49.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.561 ' CZ ' ' HG2' ' A' ' 150' ' ' LYS . 16.5 m-30 -64.93 -40.74 95.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.678 178.449 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.722 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -53.9 -43.62 69.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.401 -179.675 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -69.38 -32.44 71.48 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.218 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.594 HG13 ' CE2' ' A' ' 161' ' ' PHE . 46.9 t -65.0 -41.81 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.683 178.709 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.58 HD23 ' HB3' ' A' ' 139' ' ' PRO . 37.3 mt -62.54 -46.71 87.13 Favored 'General case' 0 CA--C 1.524 -0.038 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.366 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.441 ' O ' ' HB1' ' A' ' 162' ' ' ALA . 0.1 OUTLIER -49.43 -38.54 29.66 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.884 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.708 HG11 ' HA ' ' A' ' 76' ' ' VAL . 80.1 t -68.85 -44.21 81.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.354 177.727 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.641 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 22.4 m-30 -79.6 4.18 16.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.284 -179.287 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.596 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.38 -53.64 64.0 Favored Pre-proline 0 C--N 1.327 -0.378 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.71 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 16.9 Cg_endo -57.91 -12.77 13.0 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.44 2.093 . . . . 0.0 111.907 178.827 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.542 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 91.3 m-70 -109.4 -16.95 13.9 Favored 'General case' 0 N--CA 1.46 0.027 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.457 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 95.5 mt . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.165 -0.921 . . . . 0.0 110.803 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 112.615 -0.194 . . . . 0.0 112.615 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.605 ' HG2' ' HB3' ' A' ' 152' ' ' PRO . 74.1 Cg_exo -50.38 177.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.668 2.245 . . . . 0.0 112.545 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.519 ' HG ' ' C ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER 44.64 -172.05 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.278 0.561 . . . . 0.0 111.656 -179.489 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -126.4 128.32 6.32 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.535 179.411 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.526 ' HB2' ' CD1' ' A' ' 78' ' ' TYR . 93.8 p -121.27 104.08 9.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.943 0.402 . . . . 0.0 111.217 -179.409 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.41 ' N ' ' SD ' ' A' ' 6' ' ' MET . 2.2 mpp? -96.92 149.66 21.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.442 179.789 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.428 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 16.1 t70 -63.83 -54.71 30.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 110.35 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.439 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 0.9 OUTLIER -98.24 145.35 29.69 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.83 178.655 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.424 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 41.9 Cg_endo -67.28 105.15 0.98 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.255 1.97 . . . . 0.0 111.989 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.444 ' HG2' ' CG ' ' A' ' 13' ' ' TYR . 9.2 Cg_endo -52.21 165.34 0.96 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 123.086 2.524 . . . . 0.0 112.193 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -50.82 122.25 7.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.244 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.546 ' HA3' ' HA ' ' A' ' 100' ' ' TRP . . . 52.55 80.13 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.538 179.36 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.444 ' CG ' ' HG2' ' A' ' 10' ' ' PRO . 8.9 m-85 -149.51 62.34 1.02 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.822 0.344 . . . . 0.0 110.499 179.317 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.664 ' HA ' ' CZ3' ' A' ' 100' ' ' TRP . 2.0 ttt-85 31.05 -152.43 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.82 179.571 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.472 ' HG2' HD13 ' A' ' 47' ' ' ILE . 2.5 ttt180 176.32 95.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.042 0.449 . . . . 0.0 110.408 -179.422 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.664 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 59.1 m-20 -133.08 176.85 8.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.163 179.072 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.675 HG22 ' N ' ' A' ' 57' ' ' ALA . 27.2 m -142.2 164.58 17.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.252 0.549 . . . . 0.0 111.703 179.109 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.585 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -130.33 155.71 21.21 Favored Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.847 178.65 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.468 HG12 ' O ' ' A' ' 57' ' ' ALA . 3.7 mp -122.06 119.42 58.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.154 0.502 . . . . 0.0 112.021 -178.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.451 ' CB ' ' HE2' ' A' ' 161' ' ' PHE . 50.0 t -103.79 101.69 11.51 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.133 178.602 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.565 HD21 ' CD1' ' A' ' 112' ' ' PHE . 31.3 tp -102.68 121.52 42.6 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.898 -178.452 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.607 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -116.23 142.69 46.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.849 179.602 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.503 ' OD1' ' CZ3' ' A' ' 136' ' ' TRP . 7.8 m-20 -95.94 -177.72 4.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.465 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -56.14 -4.85 0.14 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.521 179.501 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.536 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.7 OUTLIER -103.13 -0.61 30.36 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.79 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.536 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 1.8 mmtp 72.61 23.82 2.95 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -178.249 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.625 ' HB3' ' O ' ' A' ' 137' ' ' VAL . 25.9 mttt -94.77 175.24 6.73 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.217 179.285 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.522 ' CG1' ' HA ' ' A' ' 139' ' ' PRO . 1.8 mm -120.01 141.16 41.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.976 0.417 . . . . 0.0 111.064 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.668 ' CE1' HD12 ' A' ' 119' ' ' ILE . 58.3 t80 -66.8 107.07 2.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.278 179.23 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' A' ' 134' ' ' TRP . . . -101.51 139.09 37.65 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.823 0.344 . . . . 0.0 110.929 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.442 ' HB2' ' CG ' ' A' ' 131' ' ' PHE . . . -138.14 132.0 31.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.281 179.816 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.667 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 53.4 p -99.0 146.29 26.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.839 0.352 . . . . 0.0 111.584 -179.341 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.555 ' HD3' ' HB2' ' A' ' 39' ' ' ALA . 17.5 mtp180 -69.34 128.13 35.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.432 179.601 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.732 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -45.18 -35.4 3.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.356 0.598 . . . . 0.0 110.984 -179.884 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -72.4 -36.15 68.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.765 179.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.606 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 17.6 mm -124.47 111.45 28.02 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.764 -179.948 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -75.24 -20.75 16.11 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.432 2.088 . . . . 0.0 113.023 -179.273 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -92.63 -7.52 46.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.387 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.667 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.8 93.06 8.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.807 0.337 . . . . 0.0 111.047 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.616 ' O ' ' HA ' ' A' ' 146' ' ' THR . 81.6 m95 -88.0 144.03 26.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.015 179.142 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.412 ' NE2' ' HD2' ' A' ' 33' ' ' ARG . 11.5 mt-30 -153.76 174.38 14.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.54 0.686 . . . . 0.0 111.878 -179.2 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.56 ' HB3' ' CZ3' ' A' ' 107' ' ' TRP . 2.0 mtm -108.36 146.17 33.04 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.98 179.596 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -50.75 156.23 4.76 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.465 2.11 . . . . 0.0 111.995 179.783 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 pt20 -176.41 174.02 2.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.946 -179.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.456 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . 178.96 154.81 13.41 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.306 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.664 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -82.56 135.68 14.42 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.205 -179.382 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.506 ' CD1' HG13 ' A' ' 17' ' ' VAL . 2.8 mt -70.07 144.66 13.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.736 0.303 . . . . 0.0 111.141 179.801 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.413 ' N ' HG23 ' A' ' 47' ' ' ILE . 0.9 OUTLIER -66.77 -174.76 0.34 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.243 179.345 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -48.52 -77.06 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.04 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -113.27 57.35 0.45 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.689 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.408 ' O ' HG21 ' A' ' 47' ' ' ILE . 9.2 tp10 -115.77 148.35 39.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.795 0.331 . . . . 0.0 110.896 179.731 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 78.8 m-20 -72.16 142.58 85.03 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.536 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.49 ' HA ' HG12 ' A' ' 47' ' ' ILE . 56.7 Cg_exo -54.42 -45.43 41.02 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.714 2.276 . . . . 0.0 112.579 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.457 ' HD3' ' HA ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -52.14 -44.49 64.58 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.29 -179.616 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -65.71 -47.43 75.39 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.461 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.02 -43.19 99.36 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.412 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.675 ' N ' HG22 ' A' ' 17' ' ' VAL . . . -58.13 -58.57 7.86 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.617 178.796 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.475 HG12 ' CE2' ' A' ' 110' ' ' PHE . 20.8 mt -56.17 -51.23 64.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.377 179.368 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -63.13 -64.89 0.78 Allowed 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.452 -179.511 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.456 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 56.2 mm-40 -42.29 -44.98 4.06 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.004 0.43 . . . . 0.0 110.43 179.932 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.495 HD11 ' HB ' ' A' ' 67' ' ' VAL . 14.4 tp -51.58 -46.76 63.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.975 178.562 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.48 ' O ' ' N ' ' A' ' 66' ' ' GLY . 21.1 ttm180 -65.12 -65.76 0.63 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.25 179.429 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -49.39 -21.59 0.93 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.372 -179.266 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -97.87 -36.5 10.16 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.2 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -128.95 -3.1 5.18 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.717 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 77.4 -12.19 15.02 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.415 -179.5 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.512 HG22 HG12 ' A' ' 119' ' ' ILE . 50.2 t -57.85 110.99 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-O 121.235 0.54 . . . . 0.0 111.503 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.457 ' CG2' ' HG3' ' A' ' 62' ' ' ARG . 0.6 OUTLIER -123.08 -40.33 2.41 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.668 178.629 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.7 m -62.17 73.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.396 179.485 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -160.66 158.22 28.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.023 0.439 . . . . 0.0 112.174 -179.631 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -129.66 149.42 51.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.655 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.596 HG22 ' CE2' ' A' ' 110' ' ' PHE . 3.3 t -73.73 127.26 35.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.069 0.461 . . . . 0.0 110.962 179.227 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.523 HD12 ' HB2' ' A' ' 111' ' ' LYS . 1.0 OUTLIER -106.61 -19.81 6.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.181 179.32 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.46 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.91 176.57 4.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.182 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.38 145.76 24.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.414 179.635 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.574 ' HA ' HG11 ' A' ' 160' ' ' VAL . 52.8 t -71.5 137.17 83.48 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.0 0.429 . . . . 0.0 110.859 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.482 ' HD3' HG12 ' A' ' 160' ' ' VAL . 17.7 Cg_endo -59.1 -66.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.198 2.599 . . . . 0.0 112.715 -179.575 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.526 ' CD1' ' HB2' ' A' ' 5' ' ' SER . 0.1 OUTLIER -96.65 -176.38 3.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.207 -178.965 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.524 ' O ' ' HG ' ' A' ' 80' ' ' LEU . 37.3 m95 -89.49 -154.43 0.31 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.815 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 79' ' ' TRP . 81.6 mt -162.16 105.51 1.16 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.103 0.478 . . . . 0.0 110.725 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.474 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 16.9 p -114.37 174.16 6.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.023 -179.836 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.505 ' O ' ' O ' ' A' ' 83' ' ' ASP . 39.7 p90 -172.63 37.95 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.213 179.297 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 82' ' ' TYR . 2.9 p30 38.09 -171.69 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 179.296 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.49 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 3.1 m-85 -112.36 176.41 1.5 Allowed Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.211 179.708 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.679 ' HG2' HG21 ' A' ' 88' ' ' VAL . 88.5 Cg_exo -50.22 -176.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.62 2.213 . . . . 0.0 112.255 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.577 ' HD2' ' HB3' ' A' ' 85' ' ' PRO . 31.0 Cg_endo -66.09 -62.03 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.111 1.874 . . . . 0.0 113.03 -179.193 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.68 -28.54 40.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.751 0.31 . . . . 0.0 111.259 -179.616 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.679 HG21 ' HG2' ' A' ' 85' ' ' PRO . 41.7 t -66.82 -17.14 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.213 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.649 ' HD2' ' ND2' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -67.95 0.48 3.45 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.805 -179.742 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.777 ' HA ' HG12 ' A' ' 94' ' ' ILE . 7.2 mt-10 -121.72 -66.25 1.06 Allowed 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.991 0.424 . . . . 0.0 111.659 179.629 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.4 ' O ' ' HB2' ' A' ' 95' ' ' GLN . 0.1 OUTLIER -53.26 -41.09 65.16 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -179.051 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.739 HD11 ' N ' ' A' ' 93' ' ' ASN . 0.6 OUTLIER -104.33 -56.2 2.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.952 0.406 . . . . 0.0 111.851 -178.769 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.739 ' N ' HD11 ' A' ' 92' ' ' LEU . 9.7 t30 -55.43 -49.49 72.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.157 -178.335 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.777 HG12 ' HA ' ' A' ' 90' ' ' GLU . 32.8 mm -75.8 -8.35 11.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.038 0.447 . . . . 0.0 110.464 179.29 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.432 ' HB3' ' H ' ' A' ' 96' ' ' TRP . 1.1 tt0 -80.81 -100.57 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.675 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.585 ' CE3' ' CZ3' ' A' ' 100' ' ' TRP . 89.1 m95 41.36 31.03 0.15 Allowed 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.658 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.463 ' O ' ' CB ' ' A' ' 98' ' ' SER . . . 64.63 54.98 25.44 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.929 179.592 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 97' ' ' GLY . 6.5 t 87.2 162.33 0.08 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.513 0.325 . . . . 0.0 111.127 179.65 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.446 ' O ' ' HB2' ' A' ' 100' ' ' TRP . 6.9 p-10 39.51 -140.93 0.05 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.565 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.664 ' CZ3' ' HA ' ' A' ' 14' ' ' ARG . 35.9 m95 67.9 174.84 0.27 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 110.608 -0.145 . . . . 0.0 110.608 -179.419 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.678 ' HA ' ' ND2' ' A' ' 93' ' ' ASN . 16.9 ptpt 165.31 31.46 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.568 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 151.83 -158.94 28.05 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.235 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.489 ' HA ' ' CB ' ' A' ' 14' ' ' ARG . 77.8 mt-30 -147.13 126.84 13.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.962 0.381 . . . . 0.0 111.94 -179.77 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.442 ' HA ' ' CG2' ' A' ' 81' ' ' THR . . . -108.12 123.31 48.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.874 179.224 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.583 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 24.1 mt-30 -129.0 123.37 32.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.167 -178.473 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.563 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 4.4 ttpt -103.83 140.93 36.98 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.659 179.429 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.585 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 24.8 m95 -105.19 167.46 9.71 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.399 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 53' ' ' PRO . 78.3 m-85 -143.39 156.1 44.59 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.09 -179.496 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.49 ' O ' HG11 ' A' ' 72' ' ' VAL . 8.0 tp -103.59 138.66 39.95 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.769 179.007 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.596 ' CE2' HG22 ' A' ' 72' ' ' VAL . 55.7 m-85 -142.92 144.45 32.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.397 0.618 . . . . 0.0 112.634 -178.896 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 22.4 tttt -104.11 123.59 47.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.522 177.734 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.565 ' CD1' HD21 ' A' ' 21' ' ' LEU . 55.3 t80 -79.31 99.62 7.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.875 0.369 . . . . 0.0 110.629 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 30.2 p -96.96 41.64 1.11 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.405 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -140.29 -148.33 5.14 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.54 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -121.21 148.4 44.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.955 0.407 . . . . 0.0 111.151 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.426 ' C ' ' H ' ' A' ' 118' ' ' GLU . 9.5 p-10 -58.6 -38.24 77.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.37 0.605 . . . . 0.0 111.181 -179.558 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -56.57 -3.8 0.12 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.286 -179.402 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.426 ' H ' ' C ' ' A' ' 116' ' ' ASP . 1.3 tt0 -90.05 -21.01 22.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.121 0.486 . . . . 0.0 110.326 179.371 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.668 HD12 ' CE1' ' A' ' 29' ' ' PHE . 14.3 mt -85.89 105.17 14.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.124 179.646 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.438 ' C ' ' H ' ' A' ' 122' ' ' LEU . 18.0 p-10 -102.82 -26.18 13.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.087 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 120' ' ' ASN . 56.3 mt 76.62 -36.05 0.25 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.025 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.438 ' H ' ' C ' ' A' ' 120' ' ' ASN . 96.3 mt -66.95 -169.44 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.999 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 118.01 -5.87 15.68 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.252 -179.454 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 128' ' ' LYS . 0.6 OUTLIER -102.68 63.13 0.84 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.466 -0.367 . . . . 0.0 110.457 179.767 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -77.71 45.33 2.42 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.672 -179.828 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.6 t -120.65 -40.66 2.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.907 0.384 . . . . 0.0 110.745 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -146.61 -45.3 0.19 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.107 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.409 ' O ' ' HB3' ' A' ' 124' ' ' ASP . 48.4 pttt -178.4 155.49 0.95 Allowed Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.95 0.405 . . . . 0.0 111.053 179.044 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.497 ' HG2' HD12 ' A' ' 34' ' ' LEU . 18.1 Cg_endo -71.41 -175.78 1.69 Allowed 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.709 2.272 . . . . 0.0 112.401 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.408 ' C ' HD11 ' A' ' 34' ' ' LEU . 5.1 mp0 -95.51 -69.46 0.75 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.326 -179.612 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.442 ' CG ' ' HB2' ' A' ' 31' ' ' ALA . 3.1 m-85 -104.75 143.05 33.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.069 0.461 . . . . 0.0 110.64 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.732 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -90.14 -35.63 7.5 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.705 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -150.28 148.21 28.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.96 0.41 . . . . 0.0 110.619 179.626 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.527 ' CD2' ' HE1' ' A' ' 29' ' ' PHE . 38.1 p-90 -137.14 167.98 20.49 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.607 179.465 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.458 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 42.9 t -160.27 174.64 13.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.318 0.58 . . . . 0.0 112.314 -178.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.503 ' CZ3' ' OD1' ' A' ' 23' ' ' ASN . 78.7 m95 -109.23 100.71 9.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.551 178.384 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.625 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 28.9 m -119.03 165.61 14.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.5 ' OG1' ' HB2' ' A' ' 141' ' ' GLN . 26.8 p -71.63 167.24 32.36 Favored Pre-proline 0 C--N 1.327 -0.411 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.11 179.351 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.522 ' HA ' ' CG1' ' A' ' 28' ' ' ILE . 21.6 Cg_exo -59.43 -54.59 2.41 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.818 1.678 . . . . 0.0 110.435 179.554 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.3 -28.86 70.0 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.391 178.237 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.5 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 40.0 mt-30 -71.55 -46.4 59.61 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.248 179.707 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.502 HD12 ' CB ' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -57.65 -39.05 76.14 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.72 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.715 ' HA ' HG22 ' A' ' 146' ' ' THR . 27.5 mm -60.3 -36.24 67.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.639 179.268 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.84 -53.3 15.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.242 0.544 . . . . 0.0 110.881 179.559 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.72 -19.52 62.04 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.448 -179.14 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.715 HG22 ' HA ' ' A' ' 143' ' ' ILE . 7.6 t -73.02 179.64 3.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.056 0.455 . . . . 0.0 111.523 -179.115 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.512 HG23 ' CZ ' ' A' ' 149' ' ' PHE . 21.9 m -85.28 151.25 3.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.439 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.439 ' C ' ' H ' ' A' ' 150' ' ' LYS . 48.4 mt-10 -58.48 -53.86 53.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.801 0.334 . . . . 0.0 111.227 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.512 ' CZ ' HG23 ' A' ' 147' ' ' VAL . 53.1 p90 -56.28 0.81 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -179.721 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.499 ' HG2' ' CE1' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -136.83 -7.99 1.86 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.482 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.608 ' HG3' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -62.53 -52.79 62.86 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.895 -0.138 . . . . 0.0 111.072 179.562 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.605 ' HB3' ' HG2' ' A' ' 2' ' ' PRO . 28.6 Cg_endo -63.47 -28.58 70.89 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.121 1.88 . . . . 0.0 111.895 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 23.3 t -68.42 -49.33 66.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.499 ' CE1' ' HG2' ' A' ' 150' ' ' LYS . 5.4 m-30 -66.58 -40.59 89.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.806 178.87 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.531 ' HD3' HG23 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -53.2 -44.82 68.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.518 179.449 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -68.32 -33.34 74.13 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.133 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.537 HG12 ' CE2' ' A' ' 161' ' ' PHE . 64.2 t -66.07 -41.31 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.695 178.688 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.433 HD22 ' HB3' ' A' ' 139' ' ' PRO . 64.8 mt -64.88 -45.01 87.77 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.55 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 162' ' ' ALA . 0.2 OUTLIER -52.35 -41.41 63.03 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.235 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.574 HG11 ' HA ' ' A' ' 76' ' ' VAL . 94.0 t -66.11 -42.33 91.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.033 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.537 ' CE2' HG12 ' A' ' 157' ' ' VAL . 19.7 m-30 -81.05 6.35 13.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.554 -179.192 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.586 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.46 -53.64 64.04 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.55 179.592 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 18.1 Cg_endo -59.56 -12.14 16.45 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.021 1.814 . . . . 0.0 111.86 178.712 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.46 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 96.5 m-70 -107.37 -18.55 13.84 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.292 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 78.3 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.794 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.54 -0.224 . . . . 0.0 112.54 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.77 -177.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.652 2.234 . . . . 0.0 112.209 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.98 132.44 44.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.909 179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.08 132.48 11.01 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.973 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.61 ' HB3' ' O ' ' A' ' 79' ' ' TRP . 0.8 OUTLIER -120.37 139.97 52.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.881 0.372 . . . . 0.0 111.321 -179.829 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.433 ' HE1' ' OG1' ' A' ' 81' ' ' THR . 0.3 OUTLIER -143.78 147.31 33.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.597 -179.949 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.734 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 17.9 t70 -65.02 -10.29 28.52 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.713 0.292 . . . . 0.0 111.358 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' SER . . . . . 0.418 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -143.18 117.39 6.21 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.608 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.6 ' HB3' ' CB ' ' A' ' 104' ' ' ALA . 57.6 Cg_endo -68.71 105.37 1.29 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.533 2.155 . . . . 0.0 112.853 -179.391 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.614 ' HG2' ' CD2' ' A' ' 13' ' ' TYR . 8.6 Cg_endo -52.04 161.3 2.51 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.941 2.427 . . . . 0.0 112.577 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -55.49 129.67 39.75 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.546 179.501 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.889 ' HA2' ' HA ' ' A' ' 100' ' ' TRP . . . 108.76 -25.04 20.38 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.415 -0.898 . . . . 0.0 114.272 178.141 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.614 ' CD2' ' HG2' ' A' ' 10' ' ' PRO . 87.3 m-85 -87.44 121.19 29.55 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.909 0.355 . . . . 0.0 110.47 -179.604 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.663 ' HA ' ' HZ3' ' A' ' 100' ' ' TRP . 0.0 OUTLIER -71.48 85.34 0.84 Allowed 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.018 0.437 . . . . 0.0 110.825 179.91 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.655 ' HB2' ' CZ3' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -49.01 123.72 7.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.184 -179.932 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.64 ' CB ' ' HA2' ' A' ' 46' ' ' GLY . 75.1 m-20 -131.61 176.57 8.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.235 -179.767 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.649 HG23 ' N ' ' A' ' 57' ' ' ALA . 18.4 m -141.97 157.37 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 120.221 -0.592 . . . . 0.0 112.377 179.626 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.463 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -126.28 168.43 18.42 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.209 178.39 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.612 HG12 ' HB2' ' A' ' 61' ' ' LEU . 5.1 mp -128.73 116.62 41.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -178.745 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.425 ' CB ' ' HE2' ' A' ' 161' ' ' PHE . 8.3 t -103.87 98.23 8.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.617 178.28 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.654 HD21 HG13 ' A' ' 67' ' ' VAL . 13.6 tp -99.25 127.2 45.22 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.792 -178.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.706 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -121.62 151.63 40.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.821 179.496 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.547 ' OD1' ' N ' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -94.61 173.84 7.41 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.859 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.418 ' HA ' ' HE3' ' A' ' 111' ' ' LYS . 20.6 p30 -57.91 -5.68 0.45 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.653 176.819 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.562 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 4.9 m-20 -102.55 0.38 33.4 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.081 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.562 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 24.3 mmtp 75.18 22.73 1.7 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.262 -178.464 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.706 ' O ' ' HA ' ' A' ' 22' ' ' MET . 5.6 mmtt -93.37 143.81 25.92 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.803 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.728 HG13 ' HA ' ' A' ' 139' ' ' PRO . 1.8 mm -97.43 136.18 29.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.206 0.527 . . . . 0.0 111.762 -178.819 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.439 ' CE1' HD11 ' A' ' 119' ' ' ILE . 4.4 t80 -65.78 100.71 0.57 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.51 178.49 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 134' ' ' TRP . . . -96.11 141.01 30.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.793 0.33 . . . . 0.0 111.058 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.42 ' HB3' ' CG ' ' A' ' 131' ' ' PHE . . . -138.12 131.6 30.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.487 179.809 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.75 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 53.8 p -99.3 144.48 28.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.887 0.375 . . . . 0.0 111.593 -179.358 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.443 ' HD3' ' HB2' ' A' ' 39' ' ' ALA . 3.8 mtp180 -71.97 128.0 34.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.807 179.62 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.686 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -44.02 -38.38 3.5 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.251 0.548 . . . . 0.0 111.141 179.918 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -71.77 -34.04 69.13 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.215 -179.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.709 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 18.8 mt -124.85 105.38 29.63 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.73 0.3 . . . . 0.0 111.006 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -69.73 -20.16 35.33 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.687 2.258 . . . . 0.0 112.748 -179.673 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -93.84 -7.59 42.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.651 -179.599 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.75 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.52 100.49 13.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.615 0.245 . . . . 0.0 111.032 -179.851 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.631 ' O ' ' HA ' ' A' ' 146' ' ' THR . 76.2 m95 -96.25 146.82 24.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.098 179.167 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.541 ' HG3' ' OG1' ' A' ' 146' ' ' THR . 0.2 OUTLIER -162.48 -128.75 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.668 -179.184 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.464 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 2.1 ptt? 178.96 163.13 0.7 Allowed Pre-proline 0 N--CA 1.448 -0.571 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.843 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.644 ' HB3' ' HA ' ' A' ' 61' ' ' LEU . 82.0 Cg_exo -45.07 148.85 1.48 Allowed 'Trans proline' 0 CA--C 1.529 0.241 0 C-N-CA 122.454 2.103 . . . . 0.0 113.047 -179.229 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.519 ' HG3' ' O ' ' A' ' 17' ' ' VAL . 51.9 tt0 -173.79 145.79 1.19 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.465 -179.452 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.754 ' HA3' ' HG2' ' A' ' 60' ' ' GLU . . . -145.81 -168.71 13.4 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.293 179.739 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.64 ' HA2' ' CB ' ' A' ' 16' ' ' ASN . . . -117.47 17.2 12.43 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 119.997 -1.097 . . . . 0.0 115.382 -178.595 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.525 ' CD1' HG13 ' A' ' 17' ' ' VAL . 11.3 mt 62.01 136.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 117.796 0.798 . . . . 0.0 111.444 179.122 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.504 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 3.3 m-20 -69.68 -175.97 0.96 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.857 179.366 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.414 ' CG ' ' H ' ' A' ' 50' ' ' GLY . 1.9 pt-20 -47.89 -81.08 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.428 -179.947 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.414 ' H ' ' CG ' ' A' ' 49' ' ' GLU . . . -108.12 55.48 0.51 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.814 179.567 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.504 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 4.0 tp10 -116.66 142.95 46.23 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.892 0.377 . . . . 0.0 111.159 -179.356 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.452 ' HB2' ' ND2' ' A' ' 55' ' ' ASN . 7.6 m-20 -64.8 168.89 6.12 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.102 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 4.2 Cg_exo -77.25 -53.75 0.07 OUTLIER 'Trans proline' 0 CA--C 1.515 -0.468 0 C-N-CA 122.742 2.295 . . . . 0.0 113.472 -178.747 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.619 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -49.17 -51.78 30.44 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.065 -179.255 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 56' ' ' ALA . 18.2 p30 -62.31 -37.91 87.38 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 119.816 -0.754 . . . . 0.0 110.501 -179.301 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.504 ' N ' ' OD1' ' A' ' 55' ' ' ASN . . . -64.39 -44.77 90.27 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.735 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.649 ' N ' HG23 ' A' ' 17' ' ' VAL . . . -60.02 -61.54 2.53 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.904 178.271 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.619 ' CD1' ' O ' ' A' ' 54' ' ' ARG . 2.6 mp -53.41 -46.9 59.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.626 179.454 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 5.4 mmt180 -64.18 -62.52 1.57 Allowed 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.739 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.754 ' HG2' ' HA3' ' A' ' 45' ' ' GLY . 0.2 OUTLIER -42.56 -43.09 3.61 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.185 0.517 . . . . 0.0 110.171 179.667 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.644 ' HA ' ' HB3' ' A' ' 43' ' ' PRO . 1.9 tp -50.0 -47.92 52.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.998 178.851 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.477 ' HD2' ' HA2' ' A' ' 66' ' ' GLY . 1.9 tmm_? -67.07 -65.94 0.62 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.079 178.885 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -49.26 -24.3 1.74 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.373 -179.106 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -93.95 -36.94 11.94 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.39 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.495 HG21 ' CE1' ' A' ' 131' ' ' PHE . 1.4 p -127.81 -31.24 2.44 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.402 -0.519 . . . . 0.0 112.395 -178.941 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.477 ' HA2' ' HD2' ' A' ' 62' ' ' ARG . . . 106.92 -13.75 41.27 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.654 -178.896 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.654 HG13 HD21 ' A' ' 21' ' ' LEU . 73.6 t -55.77 107.18 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-O 121.167 0.508 . . . . 0.0 111.022 179.523 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.461 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.6 OUTLIER -121.47 -39.41 2.66 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.577 178.716 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.7 m -61.55 74.22 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.863 178.859 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -162.56 157.19 21.79 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.113 0.482 . . . . 0.0 112.029 -179.309 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.412 ' HG3' HG23 ' A' ' 113' ' ' THR . 1.3 mt-10 -126.72 148.76 49.85 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.055 179.154 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.477 ' HA ' ' HD1' ' A' ' 110' ' ' PHE . 24.8 t -76.06 126.28 36.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.12 0.485 . . . . 0.0 111.627 179.615 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.548 HD11 ' HB2' ' A' ' 111' ' ' LYS . 0.7 OUTLIER -107.5 -21.49 5.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.421 179.289 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.466 ' HB3' ' CE1' ' A' ' 164' ' ' HIS . . . -169.49 177.43 4.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.81 -179.192 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.53 152.16 21.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.527 179.689 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.698 ' HA ' HG11 ' A' ' 160' ' ' VAL . 43.1 t -71.9 135.87 82.82 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.974 0.416 . . . . 0.0 111.055 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.533 ' HD3' HG12 ' A' ' 160' ' ' VAL . 18.1 Cg_endo -60.13 -62.21 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.075 2.516 . . . . 0.0 112.612 -179.452 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.734 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -98.01 -177.3 3.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.154 -179.186 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.655 ' CZ3' ' HB2' ' A' ' 15' ' ' ARG . 28.8 m95 -94.27 -152.73 0.35 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.557 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.481 ' HG ' ' O ' ' A' ' 79' ' ' TRP . 24.2 mt -164.39 101.97 0.83 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.754 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.659 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 77.7 p -92.89 92.88 8.1 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.898 0.38 . . . . 0.0 111.878 -178.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.429 ' HH ' ' HA ' ' A' ' 149' ' ' PHE . 7.7 t80 -78.48 87.55 4.47 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.865 178.832 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -72.01 161.65 30.61 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.594 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.783 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 46.7 m-85 -102.7 143.77 27.27 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.234 -179.319 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.497 ' HB3' ' HD2' ' A' ' 86' ' ' PRO . 37.6 Cg_exo -58.26 -178.6 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.62 2.213 . . . . 0.0 111.821 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.497 ' HD2' ' HB3' ' A' ' 85' ' ' PRO . 35.0 Cg_endo -65.49 -11.65 31.36 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.139 1.893 . . . . 0.0 112.488 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.61 -43.48 10.15 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.843 0.354 . . . . 0.0 110.856 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.783 ' HB ' ' HB3' ' A' ' 84' ' ' PHE . 17.1 t -90.76 -24.85 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.325 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.577 ' O ' ' HG3' ' A' ' 89' ' ' ARG . 7.1 tpp85 -68.94 -4.44 16.64 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.969 0.414 . . . . 0.0 110.491 178.984 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.414 ' HA ' ' CD1' ' A' ' 94' ' ' ILE . 2.0 mt-10 -114.08 -15.31 12.28 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.719 0.295 . . . . 0.0 111.464 179.643 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.77 -27.7 14.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.867 0.365 . . . . 0.0 110.969 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.489 HD12 ' CE2' ' A' ' 84' ' ' PHE . 0.9 OUTLIER -120.13 -52.89 2.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.979 -179.662 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.559 ' HB2' ' O ' ' A' ' 89' ' ' ARG . 7.2 m120 -62.26 -23.14 66.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.865 -179.017 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.414 ' CD1' ' HA ' ' A' ' 90' ' ' GLU . 0.7 OUTLIER -74.14 -14.73 16.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.298 179.308 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.436 ' HB3' ' H ' ' A' ' 96' ' ' TRP . 0.4 OUTLIER -81.82 -102.3 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.208 179.469 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.822 ' HB3' ' CD1' ' A' ' 100' ' ' TRP . 93.4 m95 33.53 97.41 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 178.511 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -41.1 -70.08 0.45 Allowed Glycine 0 CA--C 1.522 0.498 0 CA-C-N 115.709 -0.678 . . . . 0.0 113.132 179.524 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.24 -164.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.865 0.364 . . . . 0.0 110.753 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.547 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 0.6 OUTLIER -87.04 88.13 7.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.061 179.698 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.889 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 52.7 m95 -107.14 -165.63 1.08 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.108 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.66 ' HB2' ' O ' ' A' ' 100' ' ' TRP . 0.1 OUTLIER 159.23 62.96 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.516 0.726 . . . . 0.0 109.74 -179.268 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.8 -169.86 14.88 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.459 -0.876 . . . . 0.0 112.708 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.659 ' O ' ' HA ' ' A' ' 81' ' ' THR . 40.9 mt-30 -148.32 127.09 12.58 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.758 0.313 . . . . 0.0 111.466 -179.56 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.6 ' CB ' ' HB3' ' A' ' 9' ' ' PRO . . . -92.49 116.27 28.84 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.941 179.859 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.64 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 18.7 mt-30 -113.87 123.29 49.42 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.044 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.473 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 2.2 ttpt -106.03 133.44 50.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.3 177.807 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.504 ' CZ2' ' CE1' ' A' ' 154' ' ' TYR . 41.8 m95 -102.72 160.48 14.55 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.023 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.481 ' HB3' ' CE1' ' A' ' 110' ' ' PHE . 90.8 m-85 -133.91 154.12 51.29 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.705 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.464 ' HB2' ' CE1' ' A' ' 161' ' ' PHE . 11.5 tp -109.83 128.24 55.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.149 179.648 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.481 ' CE1' ' HB3' ' A' ' 108' ' ' PHE . 5.4 m-85 -133.9 147.75 51.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.279 0.561 . . . . 0.0 111.8 179.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.559 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 21.8 tttt -99.47 124.52 44.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.572 178.542 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.564 ' HD1' HD21 ' A' ' 21' ' ' LEU . 34.8 t80 -78.54 101.03 7.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.882 0.373 . . . . 0.0 110.952 179.599 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.412 HG23 ' HG3' ' A' ' 71' ' ' GLU . 15.9 p -98.99 40.77 1.18 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.74 -179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.27 -146.66 4.68 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.364 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -120.82 153.7 36.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.887 0.375 . . . . 0.0 111.216 179.786 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.46 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 4.4 p30 -59.7 -39.2 83.82 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.487 0.66 . . . . 0.0 111.164 -179.611 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -59.31 -1.74 0.24 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.86 -1.063 . . . . 0.0 112.161 -179.325 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' A' ' 116' ' ' ASP . 2.0 tt0 -89.93 -17.91 27.09 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.864 0.364 . . . . 0.0 110.701 179.701 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.56 HG12 HG23 ' A' ' 67' ' ' VAL . 13.6 mt -80.81 102.66 6.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.588 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -102.0 94.3 5.71 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.899 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.461 ' CD2' HG22 ' A' ' 65' ' ' THR . 44.9 mt -67.72 -41.26 83.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.028 0.442 . . . . 0.0 110.613 179.745 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.556 HD21 ' CB ' ' A' ' 129' ' ' PRO . 6.0 mt -97.34 143.96 27.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.189 -179.522 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -154.01 -129.21 1.3 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.195 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.02 102.83 14.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.704 0.287 . . . . 0.0 110.888 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -164.29 119.32 0.87 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.547 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.61 -10.44 59.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.606 0.241 . . . . 0.0 111.219 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.402 ' O ' ' HB3' ' A' ' 128' ' ' LYS . 6.5 tt0 -90.74 -72.99 0.55 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.694 0.283 . . . . 0.0 110.752 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.402 ' HB3' ' O ' ' A' ' 127' ' ' GLU . 0.1 OUTLIER 179.79 153.56 0.62 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.688 178.988 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.648 ' HG2' HD21 ' A' ' 34' ' ' LEU . 10.5 Cg_endo -73.4 -173.41 1.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.552 2.168 . . . . 0.0 112.393 179.645 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -89.79 -74.28 0.49 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.781 179.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.495 ' CE1' HG21 ' A' ' 65' ' ' THR . 0.8 OUTLIER -103.8 141.88 35.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.434 179.902 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.686 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -83.86 -34.82 17.51 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.005 -179.642 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.06 149.77 29.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.855 0.36 . . . . 0.0 110.46 179.787 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.548 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 32.7 p-90 -137.89 170.12 16.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.066 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.452 ' N ' ' CE3' ' A' ' 134' ' ' TRP . 22.8 t -165.71 177.53 7.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.513 0.673 . . . . 0.0 111.918 -178.681 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.487 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 73.6 m95 -111.42 103.49 11.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.422 178.437 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.7 m -119.26 171.68 7.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.503 HG23 ' HE2' ' A' ' 27' ' ' LYS . 22.3 p -74.0 167.29 36.85 Favored Pre-proline 0 C--N 1.326 -0.431 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.955 179.143 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.728 ' HA ' HG13 ' A' ' 28' ' ' ILE . 21.7 Cg_exo -59.11 -55.85 1.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.772 1.648 . . . . 0.0 110.347 178.979 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.37 -25.41 68.28 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.855 178.494 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.416 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 9.1 mm-40 -72.84 -47.16 48.59 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.73 -179.74 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.431 HD12 ' CB ' ' A' ' 30' ' ' ALA . 20.3 tp -59.64 -37.73 79.47 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.635 ' O ' HG22 ' A' ' 146' ' ' THR . 12.7 mm -63.03 -36.15 74.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.555 178.94 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.27 -52.99 15.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.333 0.587 . . . . 0.0 110.367 179.607 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.516 HD23 ' CD1' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -72.2 -16.77 61.96 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.575 -179.239 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.635 HG22 ' O ' ' A' ' 143' ' ' ILE . 12.7 t -76.45 176.0 8.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.019 0.438 . . . . 0.0 111.46 -179.652 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.537 ' HB ' ' CE1' ' A' ' 149' ' ' PHE . 17.6 m -74.9 150.88 6.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.674 179.432 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.426 ' C ' ' H ' ' A' ' 150' ' ' LYS . 50.6 mt-10 -58.32 -53.28 60.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.869 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.537 ' CE1' ' HB ' ' A' ' 147' ' ' VAL . 38.2 p90 -57.47 0.91 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -179.577 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.426 ' H ' ' C ' ' A' ' 148' ' ' GLU . 53.1 mttt -134.41 -9.17 2.54 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.99 -0.444 . . . . 0.0 111.967 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.513 ' CG ' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -60.58 -54.64 52.82 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.919 -0.128 . . . . 0.0 110.823 179.781 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 38.8 Cg_endo -67.5 -28.18 38.71 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.196 1.931 . . . . 0.0 111.61 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.457 ' O ' HG21 ' A' ' 157' ' ' VAL . 37.8 t -68.74 -50.96 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.369 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.504 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 5.8 m-30 -66.68 -38.49 86.91 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.669 178.449 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -56.09 -39.99 72.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.595 179.837 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.07 -31.98 71.12 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.02 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.592 HG13 ' CE2' ' A' ' 161' ' ' PHE . 42.2 t -64.77 -42.11 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.69 178.699 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.544 HD21 ' HB3' ' A' ' 139' ' ' PRO . 64.9 mt -64.49 -44.22 91.66 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.661 179.625 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.5 ' O ' ' HB2' ' A' ' 162' ' ' ALA . 38.5 t -52.63 -40.32 62.65 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.142 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.698 HG11 ' HA ' ' A' ' 76' ' ' VAL . 91.2 t -67.43 -42.48 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.518 -0.765 . . . . 0.0 108.984 177.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.592 ' CE2' HG13 ' A' ' 157' ' ' VAL . 21.1 m-30 -80.72 6.47 12.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.188 -179.527 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.589 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.46 -53.41 66.43 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.684 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 18.0 Cg_endo -57.67 -12.87 12.49 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.143 1.896 . . . . 0.0 111.869 178.811 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.466 ' CE1' ' HB3' ' A' ' 74' ' ' ALA . 90.5 m-70 -108.68 -19.36 13.45 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.263 -179.925 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 97.7 mt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.606 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.564 -0.214 . . . . 0.0 112.564 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -72.95 -167.28 0.34 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.477 2.118 . . . . 0.0 111.927 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.497 HD12 ' HA ' ' A' ' 153' ' ' VAL . 4.4 mm? 60.55 110.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.81 0.338 . . . . 0.0 110.601 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.472 ' O ' ' HG3' ' A' ' 6' ' ' MET . . . -96.29 -39.53 4.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.826 -179.754 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.844 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 11.5 p 57.89 -103.54 0.18 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.438 0.295 . . . . 0.0 111.741 -179.366 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.472 ' HG3' ' O ' ' A' ' 4' ' ' GLY . 16.0 mtm 64.45 128.28 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.67 0.271 . . . . 0.0 110.416 -179.141 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.634 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 4.1 p-10 -67.05 -6.4 17.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.748 0.309 . . . . 0.0 111.498 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 79.3 p -142.26 107.43 5.68 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.586 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.514 ' HB3' ' CB ' ' A' ' 104' ' ' ALA . 57.3 Cg_endo -70.45 107.78 2.07 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.423 2.082 . . . . 0.0 112.823 -179.242 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.47 ' HG2' ' CD2' ' A' ' 13' ' ' TYR . 2.7 Cg_endo -47.4 167.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.177 2.585 . . . . 0.0 112.668 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -49.3 137.1 14.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.077 179.758 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 99' ' ' ASP . . . 62.5 64.31 3.97 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.839 179.658 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.47 ' CD2' ' HG2' ' A' ' 10' ' ' PRO . 11.5 m-85 -149.65 55.2 0.96 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.062 0.458 . . . . 0.0 110.857 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.865 ' HG2' HD22 ' A' ' 16' ' ' ASN . 0.2 OUTLIER 32.23 -157.54 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.578 179.185 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.614 ' HG3' ' CZ3' ' A' ' 79' ' ' TRP . 1.2 ttp180 176.57 93.09 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.743 0.306 . . . . 0.0 111.142 -178.552 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.865 HD22 ' HG2' ' A' ' 14' ' ' ARG . 0.5 OUTLIER -133.0 -177.5 4.54 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.14 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.655 HG21 ' CA ' ' A' ' 57' ' ' ALA . 35.3 m -140.71 168.06 17.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.289 179.303 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.67 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -134.16 154.45 21.4 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.329 179.077 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.789 ' HB ' ' HB2' ' A' ' 43' ' ' PRO . 3.1 mp -126.66 117.32 47.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.005 0.431 . . . . 0.0 111.871 -179.379 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.417 ' CB ' ' HE2' ' A' ' 161' ' ' PHE . 42.1 t -98.48 99.43 10.59 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.928 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.592 HD21 HG11 ' A' ' 67' ' ' VAL . 24.3 tp -98.31 115.18 27.88 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.522 -178.407 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.822 ' HE2' HD11 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -115.6 163.0 16.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.44 179.253 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.696 ' ND2' ' HB2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -98.5 168.11 10.39 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.169 179.958 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -55.71 -4.43 0.11 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.195 177.83 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.557 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -100.63 2.92 42.12 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.934 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 5.6 mmtp 74.44 21.55 2.31 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.01 -178.352 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.696 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 1.9 mmtt -92.33 150.03 21.08 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.839 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.616 HG13 ' HA ' ' A' ' 139' ' ' PRO . 1.5 mm -102.92 137.2 31.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.997 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.597 ' CE1' HD11 ' A' ' 119' ' ' ILE . 88.4 t80 -76.55 138.35 40.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.534 177.932 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.502 ' O ' ' HB2' ' A' ' 134' ' ' TRP . . . -143.5 153.05 42.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.943 0.402 . . . . 0.0 110.877 -179.708 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.532 ' HB3' ' CB ' ' A' ' 131' ' ' PHE . . . -145.8 132.39 19.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.523 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 4.1 m -97.38 153.26 18.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.127 0.489 . . . . 0.0 111.76 -179.016 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.603 ' O ' ' N ' ' A' ' 35' ' ' ASP . 6.7 mtp180 -68.83 131.64 45.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.966 -179.254 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.729 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -55.37 55.3 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.218 0.607 . . . . 0.0 112.191 179.979 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.603 ' N ' ' O ' ' A' ' 33' ' ' ARG . 1.3 t0 -178.31 -29.67 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.07 0.462 . . . . 0.0 109.977 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.509 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 24.0 mt -118.82 107.4 42.4 Favored Pre-proline 0 N--CA 1.451 -0.376 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.62 179.522 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.04 -18.26 21.46 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.514 2.143 . . . . 0.0 112.852 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -94.53 -13.04 26.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.666 -179.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.554 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.38 101.38 13.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.71 0.291 . . . . 0.0 110.816 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.627 ' O ' ' HA ' ' A' ' 146' ' ' THR . 68.1 m95 -102.81 147.6 26.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.135 179.527 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.427 ' HG2' ' C ' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -152.2 160.27 43.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.269 0.557 . . . . 0.0 111.751 -179.984 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.629 ' HE2' ' CZ3' ' A' ' 107' ' ' TRP . 6.4 mtm -98.64 154.02 37.66 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.055 179.227 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.789 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 52.9 Cg_exo -49.08 154.19 3.62 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.574 2.183 . . . . 0.0 112.152 -179.77 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.647 ' HA ' HD12 ' A' ' 19' ' ' ILE . 13.7 pt20 -177.4 178.15 1.1 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.882 -178.759 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.495 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . 170.91 150.11 6.83 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.426 -0.893 . . . . 0.0 112.578 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.65 ' HA2' ' CB ' ' A' ' 16' ' ' ASN . . . -74.47 135.03 18.89 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.688 -179.475 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.629 ' H ' ' HA ' ' A' ' 16' ' ' ASN . 11.7 mt -70.64 141.73 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -68.39 -171.02 0.23 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.843 0.354 . . . . 0.0 110.993 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.561 ' HG3' ' H ' ' A' ' 50' ' ' GLY . 2.3 pt-20 -49.06 -67.32 0.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.525 -179.476 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.561 ' H ' ' HG3' ' A' ' 49' ' ' GLU . . . -127.67 54.39 0.78 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.742 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -108.99 148.15 31.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.746 0.308 . . . . 0.0 110.504 -179.692 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.404 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 7.7 m-20 -68.84 140.67 91.71 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.253 179.843 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.577 ' HB3' HG12 ' A' ' 17' ' ' VAL . 35.3 Cg_exo -60.23 -47.14 15.54 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.325 2.017 . . . . 0.0 111.682 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.466 ' HD2' HD13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -53.04 -45.98 68.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.564 179.404 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -67.31 -43.85 80.64 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.431 179.63 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.24 -42.05 94.43 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.646 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.655 ' CA ' HG21 ' A' ' 17' ' ' VAL . . . -57.78 -55.53 33.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.94 178.604 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.555 HG12 ' HE2' ' A' ' 110' ' ' PHE . 14.4 mt -55.15 -54.08 28.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.257 179.284 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -61.28 -63.67 1.21 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.811 -179.538 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.495 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 46.4 mm-40 -43.94 -47.29 8.46 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.164 0.507 . . . . 0.0 110.017 179.181 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.463 ' HB2' HD11 ' A' ' 19' ' ' ILE . 0.2 OUTLIER -50.12 -46.72 53.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.066 178.336 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.466 ' O ' ' N ' ' A' ' 66' ' ' GLY . 24.6 ttm180 -63.15 -64.67 0.84 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.48 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -48.32 -20.16 0.37 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.532 0.568 . . . . 0.0 112.532 -179.194 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -98.4 -38.52 9.19 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -178.173 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -125.29 -5.6 7.2 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.704 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 79.02 -11.69 27.56 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.349 -0.929 . . . . 0.0 111.904 -178.74 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.592 HG11 HD21 ' A' ' 21' ' ' LEU . 58.8 t -57.91 114.19 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 121.033 0.445 . . . . 0.0 111.185 179.509 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 70' ' ' ALA . 0.9 OUTLIER -124.36 -41.33 2.18 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.187 178.285 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.402 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 14.9 m -61.37 73.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.302 179.307 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.62 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.16 152.34 18.75 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.359 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.488 ' HG3' HG23 ' A' ' 113' ' ' THR . 0.9 OUTLIER -126.2 150.63 48.21 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.232 179.291 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.754 HG22 ' CE2' ' A' ' 110' ' ' PHE . 21.3 t -74.79 127.93 36.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.146 0.498 . . . . 0.0 111.766 179.683 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.822 HD11 ' HE2' ' A' ' 22' ' ' MET . 1.6 mt -105.73 -18.96 6.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.146 179.325 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.498 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.94 176.56 4.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.54 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -155.04 146.76 23.3 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.37 179.43 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 54.7 t -70.64 140.19 86.71 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 120.918 0.39 . . . . 0.0 111.068 -179.602 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.739 ' HD3' HG11 ' A' ' 160' ' ' VAL . 29.9 Cg_endo -63.55 -59.44 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.138 2.558 . . . . 0.0 112.288 -179.787 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.634 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -102.31 -174.63 2.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.433 -179.202 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.614 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 34.1 m95 -89.26 -158.96 0.54 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.665 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.844 ' HA ' ' HA ' ' A' ' 5' ' ' SER . 65.8 mt -161.37 101.42 1.21 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.248 0.547 . . . . 0.0 110.87 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.815 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 70.8 p -96.59 -173.75 2.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.28 -179.681 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -171.0 58.23 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.742 179.627 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.9 p30 -70.58 173.28 7.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.598 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.598 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 4.2 m-85 -101.05 166.49 12.32 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.165 -179.815 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.503 ' CB ' ' HD2' ' A' ' 86' ' ' PRO . 26.2 Cg_exo -61.69 -177.23 0.22 Allowed 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.68 2.253 . . . . 0.0 111.23 179.514 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 85' ' ' PRO . 36.0 Cg_endo -66.23 -3.23 8.31 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.191 1.927 . . . . 0.0 112.982 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.63 -67.1 0.91 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.993 0.425 . . . . 0.0 111.021 -179.806 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.598 ' HB ' ' HB3' ' A' ' 84' ' ' PHE . 13.0 t -61.32 -14.68 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.961 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.584 HH11 ' HB3' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -50.15 -76.49 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.933 0.397 . . . . 0.0 111.275 179.552 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.476 ' HA ' ' CD1' ' A' ' 94' ' ' ILE . 3.7 mm-40 -55.27 -17.13 4.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.678 -179.59 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.511 ' O ' ' HB2' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -81.84 -49.46 10.34 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.046 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.52 HD11 ' HE1' ' A' ' 96' ' ' TRP . 1.5 tm? -111.03 -46.46 3.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.809 0.337 . . . . 0.0 111.366 -179.015 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.636 ' HB3' ' HA ' ' A' ' 101' ' ' LYS . 10.8 m120 -54.88 -38.82 68.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.653 -179.414 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.478 HD13 ' NH1' ' A' ' 89' ' ' ARG . 1.7 mp -92.88 -10.25 9.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.004 0.431 . . . . 0.0 110.231 179.18 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.511 ' HB2' ' O ' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -67.68 -4.65 12.73 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.939 179.887 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.758 ' HB2' ' HB2' ' A' ' 100' ' ' TRP . 60.7 m95 -84.58 32.87 0.51 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.668 0.27 . . . . 0.0 111.077 179.765 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.605 ' O ' ' HB2' ' A' ' 98' ' ' SER . . . 73.87 23.06 77.32 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.661 -179.917 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.605 ' HB2' ' O ' ' A' ' 97' ' ' GLY . 15.5 m 78.3 170.57 0.2 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.383 0.273 . . . . 0.0 110.901 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.562 ' HB2' ' O ' ' A' ' 98' ' ' SER . 1.1 m-20 75.79 -45.79 0.54 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.523 -179.69 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.758 ' HB2' ' HB2' ' A' ' 96' ' ' TRP . 29.3 m95 -72.4 -166.19 0.24 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.496 -179.694 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.636 ' HA ' ' HB3' ' A' ' 93' ' ' ASN . 0.0 OUTLIER 167.65 9.33 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.758 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 165.73 -156.4 28.31 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.934 -179.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.815 ' O ' ' HA ' ' A' ' 81' ' ' THR . 62.2 tt0 -148.68 113.83 5.51 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.748 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.524 ' CB ' HG23 ' A' ' 81' ' ' THR . . . -98.48 121.21 40.14 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.126 179.522 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.67 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 28.7 mt-30 -132.03 126.7 34.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.488 -178.663 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 13.3 ttmt -102.7 134.88 45.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.283 179.46 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.67 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 17.2 m95 -101.82 163.64 12.15 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.483 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.582 ' HB2' ' HE1' ' A' ' 110' ' ' PHE . 96.4 m-85 -141.36 153.12 44.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.207 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.617 ' HG ' HD12 ' A' ' 73' ' ' ILE . 15.7 tp -99.7 139.03 35.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.942 179.628 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.785 ' CD1' HG21 ' A' ' 19' ' ' ILE . 41.6 m-85 -140.97 145.36 35.88 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.355 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.62 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 14.1 tttt -102.93 123.74 47.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.848 178.545 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.524 ' CD1' HD22 ' A' ' 21' ' ' LEU . 54.8 t80 -78.3 98.11 5.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.958 0.408 . . . . 0.0 110.454 179.124 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' THR . . . . . 0.488 HG23 ' HG3' ' A' ' 71' ' ' GLU . 43.7 p -95.9 41.62 1.1 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.622 -179.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.402 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -143.67 -146.86 4.61 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.143 -179.68 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . 0.412 ' O ' ' HZ ' ' A' ' 112' ' ' PHE . 3.7 mm100 -124.02 149.02 46.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.987 0.422 . . . . 0.0 111.219 -179.626 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -58.47 -30.65 67.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.536 -179.494 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -59.65 -4.79 0.72 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.099 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -90.69 -20.28 22.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.023 0.44 . . . . 0.0 110.482 179.712 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.597 HD11 ' CE1' ' A' ' 29' ' ' PHE . 11.8 mt -83.97 106.56 14.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.426 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 2.7 t30 -102.19 -25.29 13.75 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.954 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.468 HD22 ' HA ' ' A' ' 121' ' ' LEU . 74.0 mt 74.62 -38.01 0.37 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.363 179.719 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.46 ' CD2' ' HG3' ' A' ' 129' ' ' PRO . 8.7 mt -76.96 168.42 20.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.92 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -111.28 -129.02 5.39 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.131 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -98.78 22.54 9.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.788 0.328 . . . . 0.0 111.082 179.827 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 57.29 81.02 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.547 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.85 -46.9 2.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.906 0.384 . . . . 0.0 110.878 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -147.36 -47.17 0.17 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.698 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.5 pttt -178.03 155.15 1.0 Allowed Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.053 179.031 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.72 ' HG2' HD12 ' A' ' 34' ' ' LEU . 27.8 Cg_endo -74.69 -178.41 4.05 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.899 2.399 . . . . 0.0 112.774 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -96.53 -65.17 0.98 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.002 -179.575 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.533 ' C ' HD11 ' A' ' 34' ' ' LEU . 3.1 m-85 -102.25 140.71 36.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.171 0.51 . . . . 0.0 110.359 179.606 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.729 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -85.74 -35.79 11.17 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.922 -179.404 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.23 145.92 27.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.971 0.415 . . . . 0.0 110.439 179.823 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.518 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 36.4 p-90 -132.0 163.75 27.71 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.919 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.43 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 32.0 t -160.93 175.69 12.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.337 0.589 . . . . 0.0 111.987 -179.476 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.587 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 31.2 m95 -110.42 101.07 9.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.509 178.461 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 28' ' ' ILE . 28.4 m -116.43 164.8 12.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.899 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.545 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 17.4 p -71.33 170.22 12.51 Favored Pre-proline 0 C--N 1.324 -0.52 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.447 179.776 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.616 ' HA ' HG13 ' A' ' 28' ' ' ILE . 15.7 Cg_exo -59.86 -58.92 0.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.805 1.67 . . . . 0.0 110.335 179.149 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.9 -29.07 69.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.995 178.716 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.488 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.7 OUTLIER -72.47 -46.59 54.15 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.275 179.796 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.565 HD22 ' HE3' ' A' ' 42' ' ' MET . 0.5 OUTLIER -57.47 -40.51 78.71 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.341 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.599 HG12 ' O ' ' A' ' 139' ' ' PRO . 36.3 mm -60.6 -37.21 74.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.913 179.375 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.21 -49.79 39.79 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.232 0.539 . . . . 0.0 111.02 179.498 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.467 HD21 ' CD1' ' A' ' 40' ' ' TRP . 0.7 OUTLIER -74.23 -21.07 59.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.433 -179.086 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.627 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 10.7 t -74.19 174.83 8.19 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.24 -179.481 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 33.3 m -85.01 146.01 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.461 -179.254 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.515 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 41.7 mt-10 -49.97 -50.89 45.33 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.364 -179.783 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -52.84 -7.17 0.07 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.482 ' HD2' ' HH ' ' A' ' 154' ' ' TYR . 5.1 mttm -137.18 -4.44 1.9 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.64 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.574 ' HG2' ' O ' ' A' ' 143' ' ' ILE . 11.3 mttt -61.17 -59.11 14.77 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 121.279 -0.169 . . . . 0.0 110.972 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.515 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 22.4 Cg_endo -60.96 -28.83 86.9 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.407 2.072 . . . . 0.0 111.653 179.588 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.51 ' O ' HG22 ' A' ' 157' ' ' VAL . 30.5 t -68.61 -55.03 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.277 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.531 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 7.4 m-30 -61.65 -39.73 92.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.864 178.494 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 151' ' ' LYS . 0.0 OUTLIER -56.32 -43.79 79.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.922 -179.946 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.472 ' O ' HG21 ' A' ' 160' ' ' VAL . 2.7 tt0 -67.63 -31.69 71.88 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.568 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.585 HG11 ' CE2' ' A' ' 161' ' ' PHE . 47.1 t -65.83 -41.34 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.651 178.729 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.458 ' CD2' ' HB3' ' A' ' 139' ' ' PRO . 64.0 mt -62.31 -47.01 86.15 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.023 -179.891 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.508 ' O ' ' HB1' ' A' ' 162' ' ' ALA . 4.8 m -51.9 -38.75 57.43 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.966 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.739 HG11 ' HD3' ' A' ' 77' ' ' PRO . 92.6 t -68.21 -44.22 84.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.273 177.892 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.634 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 21.2 m-30 -79.67 4.3 16.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.901 -179.381 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.556 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.38 -54.96 50.97 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.649 179.692 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 17.4 Cg_endo -57.92 -12.74 12.97 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.024 1.816 . . . . 0.0 111.666 178.807 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.498 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 89.6 m-70 -108.25 -16.25 14.29 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.437 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 77.6 mt . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.712 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 112.348 -0.301 . . . . 0.0 112.348 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.06 165.96 1.12 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.389 2.059 . . . . 0.0 111.931 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.522 ' CD1' ' HA ' ' A' ' 153' ' ' VAL . 27.6 mt 61.46 -172.31 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.022 0.439 . . . . 0.0 111.192 179.941 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.462 ' O ' ' HE1' ' A' ' 6' ' ' MET . . . -154.28 49.11 0.5 Allowed Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.819 179.443 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -52.79 148.74 7.03 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.153 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' MET . . . . . 0.832 ' HE2' HG21 ' A' ' 81' ' ' THR . 0.0 OUTLIER -144.83 155.7 43.63 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.501 179.601 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.47 ' HA ' ' CB ' ' A' ' 78' ' ' TYR . 3.3 t0 -61.45 -55.45 31.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.051 -179.454 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.5 m -97.28 154.35 38.11 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.48 179.463 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.455 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 55.8 Cg_endo -70.26 106.6 1.78 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.279 1.986 . . . . 0.0 112.102 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.576 ' HG2' ' CD2' ' A' ' 13' ' ' TYR . 9.7 Cg_endo -52.74 163.33 1.98 Allowed 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 123.256 2.638 . . . . 0.0 113.177 -179.687 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -54.06 134.46 43.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.322 -0.853 . . . . 0.0 111.451 179.574 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.429 ' O ' ' HB3' ' A' ' 101' ' ' LYS . . . 51.2 88.13 0.01 OUTLIER Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.909 179.401 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.576 ' CD2' ' HG2' ' A' ' 10' ' ' PRO . 12.5 m-85 -154.63 125.52 7.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.674 0.273 . . . . 0.0 110.628 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ARG . . . . . 0.552 ' HA ' ' CZ3' ' A' ' 100' ' ' TRP . 17.2 ttt-85 -63.09 89.77 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.025 0.441 . . . . 0.0 110.499 179.743 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' ARG . . . . . 0.461 ' HG3' ' CZ3' ' A' ' 79' ' ' TRP . 1.6 ttp180 -55.47 106.91 0.27 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.962 -179.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . 0.789 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 3.1 m-80 -133.35 176.91 8.1 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.117 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.59 HG21 ' CA ' ' A' ' 57' ' ' ALA . 12.5 m -140.91 169.24 15.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.784 0.326 . . . . 0.0 111.299 179.494 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.558 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -134.84 162.85 24.76 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.779 -0.725 . . . . 0.0 112.264 179.423 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . 0.497 HG22 ' CE2' ' A' ' 110' ' ' PHE . 3.9 mp -128.62 120.59 52.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -178.963 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 29.6 t -107.01 98.02 7.73 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.47 HD22 ' CD1' ' A' ' 112' ' ' PHE . 4.7 tp -104.69 126.13 51.46 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.946 -178.488 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' MET . . . . . 0.481 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -124.51 162.8 23.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.786 179.009 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.635 ' OD1' ' CE3' ' A' ' 136' ' ' TRP . 0.0 OUTLIER -98.89 171.25 8.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.205 179.78 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -56.7 -5.12 0.2 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.512 177.865 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' ASP . . . . . 0.508 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -98.21 3.7 48.93 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 120.781 0.324 . . . . 0.0 111.687 -179.111 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 15.1 mmtp 73.22 19.45 3.55 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.182 -178.611 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.492 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -96.81 142.19 29.11 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.923 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.456 HD12 ' CG ' ' A' ' 139' ' ' PRO . 2.7 mp -102.22 145.83 11.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.804 0.811 . . . . 0.0 112.648 -177.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . 0.628 ' CE1' HD11 ' A' ' 119' ' ' ILE . 86.2 t80 -74.65 138.7 43.06 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.779 179.665 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.553 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -140.54 147.19 39.12 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.712 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.457 ' HB3' ' CB ' ' A' ' 131' ' ' PHE . . . -137.87 137.97 38.63 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.909 0.385 . . . . 0.0 111.039 -179.542 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.733 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 91.5 p -100.15 144.8 28.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.39 -179.665 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.463 ' HD3' ' CB ' ' A' ' 39' ' ' ALA . 5.2 mtp180 -70.06 126.48 29.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.74 179.579 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.702 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.7 OUTLIER -43.36 -34.81 1.34 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.361 0.6 . . . . 0.0 110.596 179.756 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -72.83 -41.5 64.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.858 179.614 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.4 mt -120.78 104.54 41.92 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.054 179.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -66.79 -21.62 50.76 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.728 2.285 . . . . 0.0 112.661 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -92.19 -4.96 53.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.464 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.733 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.52 92.26 7.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.605 0.241 . . . . 0.0 111.338 -179.734 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.618 ' O ' ' HA ' ' A' ' 146' ' ' THR . 81.5 m95 -89.07 144.65 25.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.325 179.194 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.07 162.38 36.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.259 0.552 . . . . 0.0 111.314 -179.486 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.517 ' HB3' ' CZ3' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -97.95 149.46 35.74 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.595 179.79 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' PRO . . . . . 0.412 ' HG2' ' HB ' ' A' ' 19' ' ' ILE . 5.1 Cg_endo -48.41 156.67 1.63 Allowed 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.533 2.155 . . . . 0.0 112.022 179.684 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.473 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 11.7 pt20 -176.4 -179.95 1.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.601 -179.657 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 170.49 157.3 12.39 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.191 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.698 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -82.84 137.23 16.33 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.339 -179.435 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.4 ' CG1' HG13 ' A' ' 17' ' ' VAL . 43.5 mt -69.58 142.35 16.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.827 0.346 . . . . 0.0 110.965 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -68.98 -174.27 0.58 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.662 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -48.5 -81.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.14 179.727 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.74 54.75 0.53 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.399 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -115.5 147.1 41.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.918 0.39 . . . . 0.0 110.963 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.09 164.36 53.22 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.469 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.432 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 5.9 Cg_exo -74.85 -46.61 0.24 Allowed 'Trans proline' 0 CA--C 1.516 -0.405 0 C-N-CA 122.762 2.308 . . . . 0.0 111.584 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.457 ' HD3' ' HA ' ' A' ' 54' ' ' ARG . 0.0 OUTLIER -51.68 -46.02 63.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.807 179.851 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.409 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 3.7 m120 -65.14 -48.04 74.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.309 179.688 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.12 -43.2 99.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.861 179.472 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.59 ' CA ' HG21 ' A' ' 17' ' ' VAL . . . -59.15 -58.31 9.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.897 178.537 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.433 ' CD1' ' HG3' ' A' ' 54' ' ' ARG . 26.0 mt -56.93 -49.64 78.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.425 179.38 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.409 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 6.1 ttp180 -64.18 -63.63 1.1 Allowed 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.354 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -42.18 -43.62 3.42 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.957 0.408 . . . . 0.0 110.277 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.536 HD11 ' HB ' ' A' ' 67' ' ' VAL . 13.6 tp -51.77 -50.11 61.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.053 178.557 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.526 ' O ' ' N ' ' A' ' 66' ' ' GLY . 1.1 ttt180 -63.01 -64.96 0.76 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.987 179.456 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -48.82 -25.37 1.84 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.768 -179.553 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -92.72 -40.19 10.84 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -178.522 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' THR . . . . . 0.544 HG23 ' CD2' ' A' ' 121' ' ' LEU . 0.8 OUTLIER -121.44 -34.45 3.44 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.59 -179.233 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 106.42 -11.7 43.26 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.409 -178.874 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.588 HG23 HG12 ' A' ' 119' ' ' ILE . 32.4 t -57.22 111.44 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-O 121.111 0.481 . . . . 0.0 111.58 179.534 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.464 ' CG2' ' HG3' ' A' ' 62' ' ' ARG . 0.8 OUTLIER -122.71 -39.15 2.56 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.79 178.505 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.0 m -61.97 74.76 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.077 179.104 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -162.14 155.81 21.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.026 0.441 . . . . 0.0 111.963 -179.435 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -126.72 147.94 49.92 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.363 179.447 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.481 ' HA ' ' HD1' ' A' ' 110' ' ' PHE . 6.6 t -75.58 126.81 36.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.222 0.534 . . . . 0.0 111.425 179.334 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.583 HD13 ' HB2' ' A' ' 111' ' ' LYS . 0.8 OUTLIER -106.97 -20.77 5.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.28 179.537 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.483 ' HB2' ' NE2' ' A' ' 164' ' ' HIS . . . -169.81 177.92 4.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.647 -179.702 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -155.08 150.16 26.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.502 179.817 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.736 ' HA ' HG13 ' A' ' 160' ' ' VAL . 44.0 t -71.71 136.18 83.19 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.894 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.477 ' HD2' HG13 ' A' ' 76' ' ' VAL . 16.6 Cg_endo -55.06 -69.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.041 2.494 . . . . 0.0 112.138 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.638 ' O ' HG11 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -94.07 -172.45 2.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.666 -179.759 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' TRP . . . . . 0.461 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 29.2 m95 -90.06 -158.47 0.53 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 178.816 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.434 ' HG ' ' O ' ' A' ' 79' ' ' TRP . 57.8 mt -162.21 111.5 1.47 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -179.772 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' THR . . . . . 0.832 HG21 ' HE2' ' A' ' 6' ' ' MET . 29.8 p -109.05 -166.43 1.11 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.557 -179.239 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -168.08 43.32 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.434 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.451 ' HB2' ' CE1' ' A' ' 13' ' ' TYR . 33.1 t70 -71.59 152.82 42.59 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.189 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' PHE . . . . . 0.576 ' CE1' ' HG ' ' A' ' 92' ' ' LEU . 3.3 m-85 -104.77 165.32 13.47 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 120.957 0.408 . . . . 0.0 111.878 -178.806 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.596 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 33.2 Cg_exo -61.57 174.17 2.34 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.971 2.447 . . . . 0.0 111.623 179.542 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . 0.428 ' HD2' ' HB3' ' A' ' 85' ' ' PRO . 10.9 Cg_endo -52.95 -37.83 78.64 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.657 2.238 . . . . 0.0 112.749 -179.774 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.18 -61.27 2.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.879 0.371 . . . . 0.0 110.586 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' A' ' 84' ' ' PHE . 52.5 t -68.13 -27.2 36.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.833 179.628 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' ARG . . . . . 0.7 ' HG3' ' CB ' ' A' ' 93' ' ' ASN . 3.1 tpp85 -50.59 -39.93 51.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.179 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.567 ' HA ' HD12 ' A' ' 94' ' ' ILE . 20.1 mt-10 -72.0 -20.31 61.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.237 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -98.89 -13.08 20.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.969 179.778 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.576 ' HG ' ' CE1' ' A' ' 84' ' ' PHE . 1.1 tm? -121.21 -61.81 1.5 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.737 0.304 . . . . 0.0 111.584 -179.572 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.7 ' CB ' ' HG3' ' A' ' 89' ' ' ARG . 37.4 t-20 -55.91 -56.84 15.89 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.186 0.517 . . . . 0.0 111.303 -179.595 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' ILE . . . . . 0.567 HD12 ' HA ' ' A' ' 90' ' ' GLU . 2.9 mp -72.31 -10.07 13.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.514 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' GLN . . . . . 0.471 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 51.7 tt0 -66.33 -17.57 64.84 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.969 179.203 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' TRP . . . . . 0.463 ' NE1' HD21 ' A' ' 92' ' ' LEU . 2.4 m95 -105.11 20.81 18.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.1 179.479 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 68.62 -75.95 0.29 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.344 -0.931 . . . . 0.0 111.707 -179.043 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 25.3 p -68.38 -170.18 0.18 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.158 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . 0.42 ' C ' ' H ' ' A' ' 101' ' ' LYS . 0.6 OUTLIER -64.98 -85.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.003 -179.959 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.702 ' HA ' ' CE3' ' A' ' 100' ' ' TRP . 0.0 OUTLIER 73.82 -31.07 0.21 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.512 0.325 . . . . 0.0 111.761 -179.779 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 100' ' ' TRP . 0.6 OUTLIER 14.06 55.8 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -179.292 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 100' ' ' TRP . . . 101.01 -163.29 18.27 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.646 -0.787 . . . . 0.0 113.711 177.919 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.662 ' O ' ' HA ' ' A' ' 81' ' ' THR . 6.7 mt-30 -144.41 118.25 9.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.679 -0.261 . . . . 0.0 110.575 -179.742 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.468 ' HA ' ' CG2' ' A' ' 81' ' ' THR . . . -90.33 117.86 29.39 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.102 0.477 . . . . 0.0 109.948 179.52 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.789 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 43.1 mt-30 -128.14 128.32 44.62 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -177.518 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.457 ' HE2' ' NE1' ' A' ' 79' ' ' TRP . 19.8 ttmt -104.9 134.89 47.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.539 178.044 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' TRP . . . . . 0.558 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 32.6 m95 -102.91 162.8 12.63 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.073 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' PHE . . . . . 0.448 ' HB3' ' CE1' ' A' ' 110' ' ' PHE . 98.2 m-85 -138.44 153.0 48.85 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.866 -179.875 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' LEU . . . . . 0.475 ' HB2' ' CE1' ' A' ' 161' ' ' PHE . 19.2 tp -108.78 122.45 47.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.876 179.528 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.497 ' CE2' HG22 ' A' ' 19' ' ' ILE . 8.8 m-85 -127.47 148.4 50.31 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.243 0.544 . . . . 0.0 111.689 179.912 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.583 ' HB2' HD13 ' A' ' 73' ' ' ILE . 33.2 tttt -98.59 124.81 43.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.428 178.343 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.47 ' CD1' HD22 ' A' ' 21' ' ' LEU . 46.6 t80 -78.43 102.01 7.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.85 0.357 . . . . 0.0 110.901 179.702 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.8 p -99.33 42.0 1.12 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.288 179.573 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.92 -149.13 5.14 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.727 -179.803 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.46 150.06 42.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.989 0.423 . . . . 0.0 111.243 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.435 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 4.1 p30 -58.05 -38.92 77.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.376 0.608 . . . . 0.0 111.272 -179.667 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.63 -3.07 0.16 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.981 -1.008 . . . . 0.0 112.381 -179.6 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.428 ' H ' ' C ' ' A' ' 116' ' ' ASP . 2.6 tt0 -89.18 -18.63 26.74 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.051 0.453 . . . . 0.0 110.435 179.469 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.628 HD11 ' CE1' ' A' ' 29' ' ' PHE . 7.5 mt -86.81 107.24 16.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.962 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.544 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 7.9 p-10 -96.98 -22.67 16.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.222 -179.567 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.544 ' HB2' ' O ' ' A' ' 120' ' ' ASN . 47.6 mt 76.76 -34.75 0.22 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.743 179.618 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.473 ' CD2' ' HG3' ' A' ' 129' ' ' PRO . 78.3 mt -63.54 162.84 12.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.191 0.52 . . . . 0.0 111.585 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -169.47 3.51 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.187 0 CA-C-N 115.512 -0.767 . . . . 0.0 113.197 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.0 90.74 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.918 0.389 . . . . 0.0 111.027 -179.847 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -103.98 -133.35 7.83 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.463 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.9 t -94.85 -23.76 17.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.68 0.276 . . . . 0.0 111.252 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.426 ' O ' ' CG ' ' A' ' 128' ' ' LYS . 1.0 OUTLIER -146.91 -42.43 0.18 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.264 -179.867 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.819 ' HB3' ' HD2' ' A' ' 129' ' ' PRO . 55.8 mttt -162.4 167.01 13.02 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-O 121.189 0.519 . . . . 0.0 111.309 -178.679 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.819 ' HD2' ' HB3' ' A' ' 128' ' ' LYS . 6.3 Cg_endo -48.63 -172.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.616 2.877 . . . . 0.0 112.739 -179.827 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -101.33 -53.91 2.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.854 -179.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' PHE . . . . . 0.457 ' CB ' ' HB3' ' A' ' 31' ' ' ALA . 1.5 m-85 -108.88 141.6 40.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.874 0.369 . . . . 0.0 110.348 179.683 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.702 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -91.31 -30.84 10.27 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.387 -179.703 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.51 150.52 32.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.731 0.3 . . . . 0.0 110.598 179.501 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' TRP . . . . . 0.56 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 40.3 p-90 -137.78 168.74 19.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.089 179.532 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.441 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 27.2 t -163.5 174.32 11.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.392 0.615 . . . . 0.0 112.54 -178.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' TRP . . . . . 0.635 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 36.8 m95 -110.12 107.08 16.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.849 177.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.44 ' O ' ' N ' ' A' ' 28' ' ' ILE . 26.4 m -121.71 172.64 8.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.678 -179.711 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.516 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 25.3 p -74.08 171.36 11.29 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.812 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.581 ' O ' HG12 ' A' ' 143' ' ' ILE . 9.2 Cg_exo -63.19 -54.55 1.04 Allowed 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 121.331 1.354 . . . . 0.0 109.851 178.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.68 -29.02 70.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.965 178.717 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.501 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 2.9 mt-30 -71.27 -46.46 60.88 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.933 0.397 . . . . 0.0 110.259 179.408 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 142' ' ' LEU . . . . . 0.553 HD13 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -57.5 -39.86 77.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.651 179.59 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.581 HG12 ' O ' ' A' ' 139' ' ' PRO . 26.1 mm -62.31 -38.34 80.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.298 179.279 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.98 -51.44 32.51 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.349 0.595 . . . . 0.0 110.781 179.639 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.36 -21.24 61.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.713 -179.093 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 146' ' ' THR . . . . . 0.618 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 8.3 t -73.7 173.91 9.13 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.502 -179.108 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 147' ' ' VAL . . . . . 0.576 HG23 ' HB2' ' A' ' 150' ' ' LYS . 29.9 m -77.13 155.67 5.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.689 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.451 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 72.2 mt-10 -58.44 -55.74 31.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.151 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.505 ' CE1' HG22 ' A' ' 147' ' ' VAL . 29.5 p90 -56.01 -0.64 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -179.594 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.576 ' HB2' HG23 ' A' ' 147' ' ' VAL . 48.9 mttt -135.04 -7.85 2.33 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.83 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.524 ' HG2' ' HD3' ' A' ' 152' ' ' PRO . 0.1 OUTLIER -62.57 -56.72 27.25 Favored Pre-proline 0 C--N 1.328 -0.358 0 O-C-N 122.43 -0.169 . . . . 0.0 110.975 179.762 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.524 ' HD3' ' HG2' ' A' ' 151' ' ' LYS . 30.6 Cg_endo -64.56 -25.8 62.27 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.061 1.841 . . . . 0.0 111.149 179.197 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.522 ' HA ' ' CD1' ' A' ' 3' ' ' LEU . 20.6 t -68.55 -50.9 51.87 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.456 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.458 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 9.0 m-30 -67.89 -36.67 80.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.975 178.664 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.444 ' N ' HD13 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -58.53 -40.89 84.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.543 179.532 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.0 -35.7 74.58 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.91 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 157' ' ' VAL . . . . . 0.472 HG13 ' CE2' ' A' ' 161' ' ' PHE . 61.5 t -66.53 -39.85 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.695 178.821 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.451 HD22 ' CD1' ' A' ' 165' ' ' LEU . 27.7 mt -63.14 -42.4 99.46 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.556 179.741 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 159' ' ' SER . . . . . 0.401 ' O ' ' HB1' ' A' ' 162' ' ' ALA . 67.3 m -54.38 -39.89 67.63 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.37 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . 0.736 HG13 ' HA ' ' A' ' 76' ' ' VAL . 95.1 t -67.71 -45.16 85.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.178 177.788 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 161' ' ' PHE . . . . . 0.603 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 22.0 m-30 -80.45 5.01 16.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.724 -178.748 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . 0.611 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.23 -52.02 77.45 Favored Pre-proline 0 C--N 1.328 -0.353 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.815 179.617 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.2 Cg_endo -58.36 -11.75 11.69 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.328 2.019 . . . . 0.0 112.296 179.172 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 164' ' ' HIS . . . . . 0.483 ' NE2' ' HB2' ' A' ' 74' ' ' ALA . 81.8 m-70 -111.78 -18.21 12.78 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.4 -179.698 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.603 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 91.7 mt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.811 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 8.7 mtm . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.863 0.363 . . . . 0.0 110.771 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.718 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 5.6 t70 . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.465 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.597 ' CG ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.089 0 CA-C-O 121.096 0.474 . . . . 0.0 110.892 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.689 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 2.2 m-80 -132.88 175.01 9.73 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.414 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.597 HG13 ' CG1' ' A' ' 47' ' ' ILE . 4.2 m -142.62 164.96 16.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.252 0.549 . . . . 0.0 111.638 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.557 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -134.09 156.71 22.5 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.0 HG23 ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -128.98 122.24 56.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.321 0.581 . . . . 0.0 112.198 -179.156 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.2 t -101.17 110.7 22.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.296 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.802 HD21 ' HD1' ' A' ' 112' ' ' PHE . 61.7 tp -107.4 124.69 50.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.045 0.45 . . . . 0.0 111.727 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.665 ' SD ' HD11 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -117.77 142.91 46.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.876 -179.756 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.484 ' OD1' ' CH2' ' A' ' 136' ' ' TRP . 4.7 m-20 -96.85 -175.74 3.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.532 0.682 . . . . 0.0 111.34 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -56.06 -5.74 0.2 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.688 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.508 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 1.2 m-20 -103.47 -0.77 29.46 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 40.3 mmtt 71.7 24.82 3.38 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.608 ' HB3' ' O ' ' A' ' 137' ' ' VAL . 71.9 mttt -94.49 -177.55 4.27 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.923 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.847 HD11 ' HG3' ' A' ' 139' ' ' PRO . 1.8 mm -122.85 141.53 42.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.939 0.399 . . . . 0.0 111.39 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.734 ' HE2' HG21 ' A' ' 65' ' ' THR . 17.9 t80 -67.63 106.77 2.3 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.065 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.542 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . . . -103.77 138.47 40.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.021 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.52 ' HB1' ' CG ' ' A' ' 131' ' ' PHE . . . -138.06 138.73 39.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.277 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.542 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 47.9 p -100.6 148.13 25.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.021 0.438 . . . . 0.0 111.933 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.664 ' NE ' HD12 ' A' ' 36' ' ' ILE . 11.1 mtp85 -70.66 129.09 38.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.868 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.711 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.3 OUTLIER -55.49 56.44 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.381 0.425 . . . . 0.0 111.992 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.661 ' N ' ' O ' ' A' ' 33' ' ' ARG . 11.5 p-10 -177.35 -37.63 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.251 0.548 . . . . 0.0 109.815 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.664 HD12 ' NE ' ' A' ' 33' ' ' ARG . 18.8 mt -113.05 108.5 53.11 Favored Pre-proline 0 N--CA 1.454 -0.268 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.574 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.09 -18.26 21.34 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.485 2.123 . . . . 0.0 113.145 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -95.41 -9.49 32.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.748 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.59 ' HB1' ' CG1' ' A' ' 147' ' ' VAL . . . -92.53 91.71 7.72 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.897 0.379 . . . . 0.0 111.416 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.657 ' O ' ' HA ' ' A' ' 146' ' ' THR . 75.9 m95 -94.13 147.17 23.42 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.023 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.22 163.28 20.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.156 0.503 . . . . 0.0 111.452 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.41 ' HG3' ' CH2' ' A' ' 107' ' ' TRP . 1.0 OUTLIER -100.6 156.05 35.65 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.517 178.477 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.419 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 8.3 Cg_endo -49.97 152.73 7.06 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.441 2.094 . . . . 0.0 112.355 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -177.8 148.28 0.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.262 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.54 -160.66 10.09 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.654 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.689 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -120.2 142.44 16.03 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.602 -0.808 . . . . 0.0 113.243 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.597 ' CG1' HG13 ' A' ' 17' ' ' VAL . 30.2 mt -69.64 144.32 14.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.722 0.296 . . . . 0.0 111.168 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.17 -174.88 0.68 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.578 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -48.54 -59.85 3.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.13 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -132.64 59.79 0.68 Allowed Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.384 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' A' ' 52' ' ' ASP . 4.9 tp10 -118.26 155.64 30.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.825 0.345 . . . . 0.0 110.784 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.403 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -72.71 154.13 91.34 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.506 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.537 ' HA ' HG11 ' A' ' 17' ' ' VAL . 12.2 Cg_exo -70.86 -49.22 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.597 2.198 . . . . 0.0 111.427 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.668 ' HE ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -53.21 -45.36 68.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.326 179.58 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.528 ' HA ' HD12 ' A' ' 58' ' ' ILE . 2.9 m-20 -67.91 -44.11 77.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.193 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.46 93.04 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.0 ' HB1' HG23 ' A' ' 19' ' ' ILE . . . -58.01 -54.95 41.11 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.768 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.553 HD11 ' CZ ' ' A' ' 54' ' ' ARG . 14.1 mt -56.6 -53.01 46.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.185 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 59' ' ' ARG . 16.2 mtt-85 -60.85 -59.41 5.43 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.638 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -46.87 -44.7 19.8 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 121.3 0.572 . . . . 0.0 109.768 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.908 HD12 ' HB ' ' A' ' 19' ' ' ILE . 7.2 tt -51.01 -46.51 61.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.482 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.737 ' HG3' HG23 ' A' ' 68' ' ' THR . 10.2 ttt180 -65.04 -64.52 0.84 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.869 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -48.28 -20.46 0.39 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -97.29 -36.26 10.47 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.761 HG22 ' CD2' ' A' ' 121' ' ' LEU . 17.3 p -129.09 -8.16 4.85 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.38 -13.4 40.46 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.36 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.698 HG11 HD22 ' A' ' 21' ' ' LEU . 54.9 t -59.25 114.1 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-O 121.233 0.54 . . . . 0.0 111.207 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.737 HG23 ' HG3' ' A' ' 62' ' ' ARG . 1.0 OUTLIER -121.98 -38.77 2.68 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.915 179.028 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.464 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 10.4 m -61.55 74.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.614 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.64 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -157.47 156.09 31.49 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.086 0.47 . . . . 0.0 111.835 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -129.58 150.91 50.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.44 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.957 HG22 ' CE2' ' A' ' 110' ' ' PHE . 8.0 t -74.46 126.38 35.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.146 0.498 . . . . 0.0 111.363 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.564 HD11 ' N ' ' A' ' 111' ' ' LYS . 1.0 OUTLIER -107.0 -20.38 6.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.054 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.452 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.75 175.78 4.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.009 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -155.11 146.65 23.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.523 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.721 ' HA ' HG11 ' A' ' 160' ' ' VAL . 69.9 t -71.08 135.58 84.95 Favored Pre-proline 0 N--CA 1.453 -0.31 0 CA-C-O 121.002 0.43 . . . . 0.0 110.349 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.522 ' HD2' HG13 ' A' ' 76' ' ' VAL . 29.5 Cg_endo -63.69 -54.39 0.99 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.951 2.434 . . . . 0.0 112.586 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.718 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.8 OUTLIER -100.48 -179.23 4.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.695 -179.128 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.638 ' O ' HD23 ' A' ' 80' ' ' LEU . 44.9 m95 -92.62 -155.94 0.45 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.069 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.638 HD23 ' O ' ' A' ' 79' ' ' TRP . 80.6 mt . . . . . 0 N--CA 1.465 0.294 0 CA-C-O 120.818 0.342 . . . . 0.0 110.259 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.375 0 CA-C-O 121.051 0.453 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.679 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 3.7 mt-30 -125.42 129.71 50.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.406 -178.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.486 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 3.4 ttpt -104.35 135.55 45.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.375 178.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.557 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 53.9 m95 -103.04 161.87 13.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.318 0.58 . . . . 0.0 112.348 -178.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.531 ' HB2' ' HE1' ' A' ' 110' ' ' PHE . 96.3 m-85 -140.89 153.99 45.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.527 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.665 HD11 ' SD ' ' A' ' 22' ' ' MET . 10.5 tp -101.18 141.01 34.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.852 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.957 ' CE2' HG22 ' A' ' 72' ' ' VAL . 90.6 m-85 -143.16 145.57 32.94 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.64 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 56.4 tttt -103.4 124.83 49.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.94 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.802 ' HD1' HD21 ' A' ' 21' ' ' LEU . 41.1 t80 -78.87 96.04 5.57 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.743 0.306 . . . . 0.0 111.288 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 15.8 p -98.39 52.67 1.03 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.545 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -152.59 -146.35 4.34 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.526 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.16 147.41 46.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.131 0.491 . . . . 0.0 111.318 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -61.19 -27.72 68.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.163 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -56.7 -4.31 0.15 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.283 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -90.8 -16.97 27.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.889 0.376 . . . . 0.0 110.931 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.647 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 5.5 mt -84.13 98.41 5.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.171 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 47.8 p-10 -104.0 -8.51 19.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.015 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.761 ' CD2' HG22 ' A' ' 65' ' ' THR . 46.8 mt . . . . . 0 N--CA 1.466 0.368 0 CA-C-O 120.609 0.243 . . . . 0.0 111.545 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.766 0.317 . . . . 0.0 111.535 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.729 ' HB2' HD13 ' A' ' 121' ' ' LEU . 3.4 m-85 -105.37 146.45 29.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.086 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.711 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -92.62 -34.3 7.04 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.874 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -148.83 144.17 26.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.661 0.267 . . . . 0.0 110.98 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.647 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 47.2 p-90 -132.61 166.82 21.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.915 0.388 . . . . 0.0 111.546 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.6 t -160.73 178.7 9.2 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.894 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.484 ' CH2' ' OD1' ' A' ' 23' ' ' ASN . 86.2 m95 -114.41 100.99 8.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.723 178.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.608 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 19.9 m -118.67 164.89 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.052 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.537 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 23.2 p -72.3 166.32 42.66 Favored Pre-proline 0 C--N 1.328 -0.35 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.544 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.847 ' HG3' HD11 ' A' ' 28' ' ' ILE . 25.6 Cg_exo -58.2 -55.46 2.21 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.072 1.848 . . . . 0.0 110.668 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -63.58 -27.86 69.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.291 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.508 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.8 OUTLIER -72.73 -46.24 54.59 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.354 179.496 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.542 ' CD1' ' HB2' ' A' ' 30' ' ' ALA . 2.8 tp -58.32 -39.38 79.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.763 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 1.082 HG21 ' HD3' ' A' ' 155' ' ' LYS . 12.7 mm -62.57 -31.84 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.048 0.452 . . . . 0.0 110.417 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.62 -53.5 11.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.71 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.81 -19.14 61.39 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.803 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.657 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 14.2 t -73.87 175.32 7.41 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.424 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.59 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 34.3 m -85.05 144.28 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.649 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.473 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 2.7 mt-10 -48.13 -46.65 34.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.942 0.401 . . . . 0.0 111.351 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -52.7 -11.37 0.21 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 154' ' ' TYR . 31.9 mttm -132.57 -3.27 3.35 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -63.33 -55.46 35.72 Favored Pre-proline 0 C--N 1.326 -0.439 0 O-C-N 122.431 -0.168 . . . . 0.0 111.203 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 29.8 Cg_endo -64.96 -29.25 57.7 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.067 1.845 . . . . 0.0 111.719 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.61 ' O ' HG23 ' A' ' 157' ' ' VAL . 29.3 t -69.26 -51.54 42.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.495 ' HB2' ' CD1' ' A' ' 143' ' ' ILE . 7.4 m-30 -64.84 -37.19 86.78 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.84 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 1.082 ' HD3' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -56.22 -45.87 79.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.672 179.244 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.458 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.3 tt0 -67.68 -30.6 70.17 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 153' ' ' VAL . 90.8 t -68.57 -41.16 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.511 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.711 HD22 ' HB3' ' A' ' 139' ' ' PRO . 67.9 mt -64.56 -47.23 79.51 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.453 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.4 p -50.22 -42.48 51.72 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.721 HG11 ' HA ' ' A' ' 76' ' ' VAL . 98.7 t -65.43 -41.34 90.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.58 ' CD2' HD13 ' A' ' 109' ' ' LEU . 21.5 m-30 -81.82 5.75 17.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.933 -1.031 . . . . 0.0 112.933 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.621 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.88 -51.78 79.46 Favored Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.649 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.1 Cg_endo -60.05 -11.73 16.61 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.123 1.882 . . . . 0.0 111.996 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.452 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 95.7 m-70 -108.46 -19.19 13.54 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.366 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 96.8 mt . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.868 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.4 ' O ' ' HB2' ' A' ' 79' ' ' TRP . 8.4 mtm . . . . . 0 CA--C 1.524 -0.05 0 CA-C-O 120.665 0.269 . . . . 0.0 111.032 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.772 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 3.9 p-10 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.642 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.837 ' HG2' HD12 ' A' ' 47' ' ' ILE . 4.3 ttp180 . . . . . 0 CA--C 1.532 0.27 0 CA-C-O 121.02 0.438 . . . . 0.0 111.453 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.643 ' OD1' ' HG2' ' A' ' 105' ' ' GLN . 0.2 OUTLIER -134.89 173.39 11.76 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.993 179.241 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.861 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 33.6 m -132.12 160.33 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 CA-C-O 120.986 0.422 . . . . 0.0 111.917 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.621 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -127.08 148.22 17.27 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.26 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.908 HG21 HD22 ' A' ' 61' ' ' LEU . 2.8 mp -122.5 117.11 51.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.642 ' O ' HD12 ' A' ' 109' ' ' LEU . 43.9 t -101.04 99.7 10.19 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.723 HD22 HG11 ' A' ' 67' ' ' VAL . 21.2 tp -101.26 117.03 34.17 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.005 -177.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.566 ' HE2' HD13 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -119.98 160.1 23.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.795 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.646 ' ND2' ' CE3' ' A' ' 136' ' ' TRP . 0.2 OUTLIER -97.3 174.24 6.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.19 0.519 . . . . 0.0 110.416 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -57.59 -5.63 0.39 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.245 177.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.572 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.5 OUTLIER -99.39 3.5 45.91 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.709 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 5.8 mmtp 73.75 18.77 3.35 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.349 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.558 ' O ' ' HA ' ' A' ' 22' ' ' MET . 2.9 mttt -96.27 142.05 28.88 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.686 HD12 ' N ' ' A' ' 28' ' ' ILE . 2.5 mp -100.79 144.48 12.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.574 0.702 . . . . 0.0 112.063 -178.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.689 ' CE1' HD13 ' A' ' 119' ' ' ILE . 92.1 t80 -75.39 140.2 42.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.007 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.971 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -137.76 151.6 48.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.615 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.54 ' HB1' ' CB ' ' A' ' 131' ' ' PHE . . . -139.83 135.91 33.47 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.319 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.71 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 96.6 p -98.08 140.66 32.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.913 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.46 ' HD2' ' HB3' ' A' ' 39' ' ' ALA . 1.7 mtt-85 -67.65 127.84 34.24 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.849 0.357 . . . . 0.0 110.767 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.711 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.6 OUTLIER -45.88 -34.88 4.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.295 0.569 . . . . 0.0 110.458 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -71.47 -38.3 71.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.139 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.408 ' N ' ' O ' ' A' ' 33' ' ' ARG . 31.3 mm -125.41 108.94 26.53 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.98 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.3 -18.51 23.24 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.578 2.185 . . . . 0.0 112.862 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -92.2 -12.24 33.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.664 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.909 ' HB1' ' CG1' ' A' ' 147' ' ' VAL . . . -91.48 104.98 17.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.759 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.549 ' O ' ' HA ' ' A' ' 146' ' ' THR . 75.6 m95 -96.82 152.49 18.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.632 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.53 ' HG3' ' C ' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -158.18 160.99 37.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.475 0.655 . . . . 0.0 111.927 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.633 ' HG3' HD11 ' A' ' 142' ' ' LEU . 13.4 mtm -98.87 155.04 37.07 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.092 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.874 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 51.4 Cg_exo -50.74 144.94 24.81 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.23 1.954 . . . . 0.0 112.087 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.861 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -170.57 141.62 1.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.079 -179.503 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.569 ' O ' ' HB2' ' A' ' 16' ' ' ASN . . . -148.71 -173.41 19.46 Favored Glycine 0 C--O 1.224 -0.471 0 N-CA-C 111.446 -0.661 . . . . 0.0 111.446 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.578 ' HA2' ' CB ' ' A' ' 16' ' ' ASN . . . -95.82 -154.32 30.46 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.508 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.837 HD12 ' HG2' ' A' ' 15' ' ' ARG . 1.7 mt -163.12 125.53 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 122.535 0.334 . . . . 0.0 110.736 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.27 172.41 12.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.995 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.455 ' HG3' ' H ' ' A' ' 50' ' ' GLY . 1.8 pt-20 -46.92 -76.66 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.61 -179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.455 ' H ' ' HG3' ' A' ' 49' ' ' GLU . . . -85.17 34.49 3.24 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.963 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.708 ' OE1' ' HB2' ' A' ' 56' ' ' ALA . 4.8 tm-20 -113.19 123.94 51.37 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.545 ' HB2' ' OD1' ' A' ' 55' ' ' ASN . 1.8 m-20 -70.59 158.69 87.25 Favored Pre-proline 0 C--N 1.326 -0.439 0 C-N-CA 120.62 -0.432 . . . . 0.0 109.857 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.557 ' CA ' HG11 ' A' ' 17' ' ' VAL . 6.8 Cg_exo -74.19 -50.11 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.874 2.383 . . . . 0.0 113.463 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.835 ' CZ ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -49.52 -45.2 47.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.267 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.545 ' OD1' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -67.67 -44.79 76.98 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.053 0.454 . . . . 0.0 110.321 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.708 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . . . -58.72 -41.73 87.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.686 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.774 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -57.64 -56.77 17.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.2 0.524 . . . . 0.0 109.639 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.631 HG12 ' HE2' ' A' ' 110' ' ' PHE . 26.9 mt -54.38 -53.78 27.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.26 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.559 ' HA ' HH11 ' A' ' 59' ' ' ARG . 0.0 OUTLIER -62.11 -60.06 4.15 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.82 -179.246 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.439 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 16.6 mm-40 -46.21 -49.85 16.54 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.56 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.908 HD22 HG21 ' A' ' 19' ' ' ILE . 9.7 tp -49.74 -44.56 48.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.34 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.843 ' HD3' HG23 ' A' ' 68' ' ' THR . 21.9 tpt85 -63.85 -65.44 0.68 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.491 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.4 ' OE2' ' HB3' ' A' ' 59' ' ' ARG . 0.8 OUTLIER -49.22 -22.62 1.06 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -179.15 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -97.21 -32.71 11.79 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -177.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 119' ' ' ILE . 5.6 p -127.65 -6.28 5.74 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.483 ' HA2' ' HD2' ' A' ' 62' ' ' ARG . . . 79.36 -14.36 16.81 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.08 -1.057 . . . . 0.0 111.561 -178.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.723 HG11 HD22 ' A' ' 21' ' ' LEU . 78.7 t -58.55 117.25 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 121.11 0.481 . . . . 0.0 111.682 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.843 HG23 ' HD3' ' A' ' 62' ' ' ARG . 0.3 OUTLIER -128.26 -38.96 1.74 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.457 178.003 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.1 m -62.41 73.44 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.941 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.16 155.31 22.7 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.866 0.365 . . . . 0.0 111.957 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.436 ' HG3' HG21 ' A' ' 113' ' ' THR . 1.7 mt-10 -128.62 151.34 49.6 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.573 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.835 HG21 ' CZ ' ' A' ' 54' ' ' ARG . 12.2 t -75.07 126.71 36.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.405 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.657 HD11 ' HB2' ' A' ' 111' ' ' LYS . 1.4 mt -106.71 -19.32 6.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.31 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.505 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -171.05 175.73 4.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.606 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.9 OUTLIER -153.17 143.73 22.62 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.256 179.4 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.786 ' HA ' HG11 ' A' ' 160' ' ' VAL . 38.6 t -70.52 131.97 87.79 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 120.937 0.399 . . . . 0.0 111.087 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.488 ' HD2' HG11 ' A' ' 160' ' ' VAL . 34.4 Cg_endo -65.13 -50.74 1.9 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.057 2.505 . . . . 0.0 112.987 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.772 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 3.1 p90 -100.07 177.43 5.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.983 0.421 . . . . 0.0 111.931 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.632 ' CH2' ' HG3' ' A' ' 15' ' ' ARG . 58.7 m95 -94.2 -163.44 1.05 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.727 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.596 HD23 ' O ' ' A' ' 79' ' ' TRP . 15.9 mt . . . . . 0 N--CA 1.463 0.196 0 CA-C-O 121.055 0.455 . . . . 0.0 110.626 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.454 ' O ' ' ND2' ' A' ' 16' ' ' ASN . . . . . . . . 0 CA--C 1.515 -0.402 0 CA-C-O 121.247 0.546 . . . . 0.0 110.642 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.643 ' HG2' ' OD1' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -125.43 119.4 28.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.432 -177.412 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.619 ' HE2' ' CE2' ' A' ' 79' ' ' TRP . 2.0 ttmm -104.17 134.4 47.48 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.621 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 16.0 m95 -101.68 164.67 11.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.279 0.561 . . . . 0.0 112.303 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.586 ' HB2' ' HE1' ' A' ' 110' ' ' PHE . 95.9 m-85 -140.05 153.18 46.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.09 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.642 HD12 ' O ' ' A' ' 20' ' ' CYS . 16.5 tp -101.24 141.04 34.69 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.844 0.354 . . . . 0.0 110.983 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.809 ' CE2' HG22 ' A' ' 72' ' ' VAL . 45.7 m-85 -142.43 145.77 34.13 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.594 0.712 . . . . 0.0 112.759 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.657 ' HB2' HD11 ' A' ' 73' ' ' ILE . 8.6 tttt -104.88 122.82 46.58 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.065 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.669 ' HD2' HD21 ' A' ' 21' ' ' LEU . 36.5 t80 -77.23 95.81 4.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.99 0.424 . . . . 0.0 110.709 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.436 HG21 ' HG3' ' A' ' 71' ' ' GLU . 28.5 p -95.77 55.27 1.61 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.917 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -159.64 -140.99 3.02 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.678 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.541 ' HG3' ' CG ' ' A' ' 117' ' ' GLN . 0.7 OUTLIER -125.81 147.61 49.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.785 0.326 . . . . 0.0 110.948 179.627 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.513 ' HB3' ' CH2' ' A' ' 134' ' ' TRP . 85.7 m-20 -62.1 -28.18 69.45 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.541 ' CG ' ' HG3' ' A' ' 115' ' ' GLN . 0.2 OUTLIER -57.65 -5.09 0.33 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.218 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -88.0 -17.66 30.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.017 0.436 . . . . 0.0 110.602 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.689 HD13 ' CE1' ' A' ' 29' ' ' PHE . 9.1 mt -81.09 105.26 10.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.393 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.423 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 23.9 t30 -104.27 -26.26 12.56 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.695 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.481 HD22 ' HD2' ' A' ' 131' ' ' PHE . 63.5 mt . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.12 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.512 ' O ' HD12 ' A' ' 34' ' ' LEU . 4.5 mp0 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.954 0.407 . . . . 0.0 110.854 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.54 ' CB ' ' HB1' ' A' ' 31' ' ' ALA . 2.7 m-85 -104.8 142.74 34.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.144 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.711 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -83.72 -36.25 14.27 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.709 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -151.31 154.18 36.24 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.22 -0.49 . . . . 0.0 110.6 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.553 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 23.8 p-90 -135.25 166.79 22.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.825 0.345 . . . . 0.0 111.116 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.449 ' N ' ' HZ3' ' A' ' 40' ' ' TRP . 29.9 t -161.24 163.22 31.17 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.346 0.593 . . . . 0.0 111.657 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.646 ' CE3' ' ND2' ' A' ' 23' ' ' ASN . 77.2 m95 -110.46 108.32 18.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.054 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' A' ' 28' ' ' ILE . 34.0 m -123.31 173.72 8.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.861 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.561 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 15.2 p -72.97 172.47 7.84 Favored Pre-proline 0 C--N 1.323 -0.571 0 C-N-CA 120.449 -0.501 . . . . 0.0 109.885 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.709 ' HB3' HD22 ' A' ' 158' ' ' LEU . 13.4 Cg_exo -61.75 -55.25 1.18 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.427 1.418 . . . . 0.0 110.314 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.1 -30.81 71.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.066 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -69.86 -48.55 58.41 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.87 0.367 . . . . 0.0 110.153 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.971 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -54.43 -41.17 69.07 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.429 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.596 HG21 ' HD3' ' A' ' 155' ' ' LYS . 28.3 mm -60.13 -36.87 70.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.936 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.56 -52.28 22.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.41 0.624 . . . . 0.0 111.037 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.4 mp -70.85 -24.88 62.6 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.849 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 5.2 t -71.8 169.5 15.6 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.539 0.685 . . . . 0.0 111.825 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.909 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 33.8 m -74.3 154.69 6.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.846 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.504 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 0.4 OUTLIER -60.91 -54.59 43.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.071 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.446 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 39.9 p90 -57.07 0.63 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.422 ' HE3' HH22 ' A' ' 33' ' ' ARG . 13.6 mmtt -133.77 -7.7 2.79 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 122.032 -0.417 . . . . 0.0 111.873 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.496 ' HG3' HG23 ' A' ' 143' ' ' ILE . 0.4 OUTLIER -62.03 -59.24 13.69 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.276 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.504 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 19.2 Cg_endo -59.5 -28.54 87.73 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.347 2.031 . . . . 0.0 111.337 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.791 ' O ' HG23 ' A' ' 157' ' ' VAL . 24.4 t -68.81 -50.69 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.422 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 7.6 m-30 -66.0 -38.01 87.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.875 178.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.596 ' HD3' HG21 ' A' ' 143' ' ' ILE . 4.8 tptp -56.3 -43.36 78.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.393 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.492 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.3 tp10 -68.17 -34.4 76.24 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 153' ' ' VAL . 58.5 t -66.01 -41.0 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.615 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.709 HD22 ' HB3' ' A' ' 139' ' ' PRO . 38.3 mt -63.8 -45.33 90.15 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.621 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 28.4 t -53.96 -40.0 66.45 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.786 HG11 ' HA ' ' A' ' 76' ' ' VAL . 62.0 t -67.73 -41.44 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-O 121.491 0.662 . . . . 0.0 109.309 178.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.605 ' CE2' HG12 ' A' ' 157' ' ' VAL . 21.9 m-30 -80.74 4.72 18.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.354 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.62 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.44 -52.45 74.52 Favored Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.604 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.4 Cg_endo -58.48 -13.05 15.55 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.177 1.918 . . . . 0.0 111.603 178.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.505 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 94.5 m-70 -107.85 -19.33 13.56 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.125 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 98.0 mt . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.624 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.9 mmt . . . . . 0 C--O 1.232 0.175 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.0 t70 . . . . . 0 C--N 1.323 -0.544 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.501 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.496 ' HG3' HD12 ' A' ' 47' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.986 ' HB2' ' HG2' ' A' ' 105' ' ' GLN . 0.7 OUTLIER -134.05 -178.83 5.21 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.553 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.657 HG21 ' N ' ' A' ' 57' ' ' ALA . 23.8 m -140.59 166.63 18.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.348 0.594 . . . . 0.0 111.768 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.572 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -131.33 161.38 23.6 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 178.597 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.023 HG21 HD22 ' A' ' 61' ' ' LEU . 3.6 mp -128.64 119.19 49.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.008 0.432 . . . . 0.0 112.04 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.455 ' O ' HD12 ' A' ' 109' ' ' LEU . 10.2 t -104.25 105.0 15.0 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.845 HD22 HG11 ' A' ' 67' ' ' VAL . 13.1 tp -108.28 122.28 46.64 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.789 -178.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.769 ' HE1' HD13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -119.37 163.31 17.38 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.818 179.455 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.673 ' ND2' ' CE3' ' A' ' 136' ' ' TRP . 0.3 OUTLIER -99.85 168.67 9.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.435 179.818 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.645 ' HA ' ' HE2' ' A' ' 111' ' ' LYS . 71.2 m-20 -56.33 -4.88 0.16 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.021 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.511 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 1.2 m-20 -100.06 2.61 43.45 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.795 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.586 ' NZ ' ' HA ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER 73.91 21.64 2.61 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.173 -178.376 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.651 ' HB2' ' OD1' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -93.86 145.62 24.48 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.045 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.778 HG13 ' HA ' ' A' ' 139' ' ' PRO . 1.5 mm -100.51 139.11 22.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.465 0.65 . . . . 0.0 111.994 -178.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.662 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 82.2 t80 -79.21 140.27 37.73 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.109 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 1.014 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -143.71 157.97 44.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.046 0.451 . . . . 0.0 111.033 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.566 ' HB1' ' CB ' ' A' ' 131' ' ' PHE . . . -146.51 138.93 25.08 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.996 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.635 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 60.7 p -99.8 147.99 24.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.297 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.653 ' O ' ' N ' ' A' ' 35' ' ' ASP . 18.2 mtp180 -69.75 129.01 38.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.403 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.805 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.3 OUTLIER -54.96 55.31 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.653 ' N ' ' O ' ' A' ' 33' ' ' ARG . 23.0 t70 -177.4 -28.42 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.87 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.479 HG13 ' CZ ' ' A' ' 33' ' ' ARG . 25.5 mm -119.21 110.65 37.56 Favored Pre-proline 0 N--CA 1.455 -0.181 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.606 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -75.67 -20.28 15.72 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.633 2.222 . . . . 0.0 112.905 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.36 -8.49 32.37 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.635 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.8 104.09 16.38 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 120.616 0.246 . . . . 0.0 110.881 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.714 ' O ' ' HA ' ' A' ' 146' ' ' THR . 65.9 m95 -105.89 144.6 32.39 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.909 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.591 ' HG3' ' C ' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -156.92 161.62 39.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.487 0.66 . . . . 0.0 111.622 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.555 ' HB3' ' CZ3' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -96.82 152.87 38.71 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.36 179.062 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.632 ' HG3' HD13 ' A' ' 61' ' ' LEU . 5.1 Cg_endo -48.61 158.74 1.02 Allowed 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.197 2.598 . . . . 0.0 111.976 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.604 ' HA ' HD12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -178.82 -179.67 0.63 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.453 0.168 . . . . 0.0 111.084 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.639 ' HA3' ' HG2' ' A' ' 60' ' ' GLU . . . 164.4 155.79 8.56 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.696 -0.764 . . . . 0.0 113.11 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.724 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -76.66 132.09 12.09 Favored Glycine 0 C--N 1.334 0.431 0 N-CA-C 114.702 0.641 . . . . 0.0 114.702 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.676 HG12 ' HA ' ' A' ' 53' ' ' PRO . 2.9 mt -68.93 145.83 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.406 -0.397 . . . . 0.0 110.464 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -67.51 -173.12 0.28 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.171 0.51 . . . . 0.0 111.144 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.465 ' HG2' ' H ' ' A' ' 50' ' ' GLY . 1.4 pm0 -50.16 -82.45 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.282 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.465 ' H ' ' HG2' ' A' ' 49' ' ' GLU . . . -109.76 54.6 0.54 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.083 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -115.16 154.61 28.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.096 0.474 . . . . 0.0 110.363 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.473 ' HB2' ' ND2' ' A' ' 55' ' ' ASN . 0.6 OUTLIER -70.44 156.39 91.97 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.805 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.676 ' HA ' HG12 ' A' ' 47' ' ' ILE . 2.7 Cg_exo -74.88 -53.22 0.1 Allowed 'Trans proline' 0 CA--C 1.507 -0.843 0 C-N-CA 122.702 2.268 . . . . 0.0 112.217 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.608 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -48.18 -52.98 18.48 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.925 179.309 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.535 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 1.2 m-20 -53.75 -46.49 70.91 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.002 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 60' ' ' GLU . . . -60.01 -42.34 94.07 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.657 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -59.07 -61.91 2.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.494 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.608 ' CD1' ' O ' ' A' ' 54' ' ' ARG . 3.3 mp -55.88 -46.51 80.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.497 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.535 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 0.7 OUTLIER -63.14 -63.1 1.29 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.44 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.639 ' HG2' ' HA3' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -42.8 -46.35 5.17 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 120.944 0.402 . . . . 0.0 110.045 179.38 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.023 HD22 HG21 ' A' ' 19' ' ' ILE . 12.0 tp -50.05 -47.75 53.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.153 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.867 ' HG3' HG23 ' A' ' 68' ' ' THR . 40.0 ttp180 -64.77 -62.25 1.68 Allowed 'General case' 0 CA--C 1.523 -0.091 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.415 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -51.61 -20.41 1.98 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.806 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -100.62 -36.85 9.01 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.668 ' O ' ' HA ' ' A' ' 119' ' ' ILE . 2.3 p -127.23 1.97 6.41 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 70.15 -11.82 1.94 Allowed Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.375 -178.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.845 HG11 HD22 ' A' ' 21' ' ' LEU . 75.2 t -58.14 109.72 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-O 121.198 0.523 . . . . 0.0 111.422 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.867 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.6 OUTLIER -121.75 -41.3 2.47 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.898 178.495 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.437 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 7.4 m -60.75 74.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.692 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.561 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.43 153.36 19.5 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.992 0.425 . . . . 0.0 112.097 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -124.4 148.23 47.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.237 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.773 HG22 ' CE1' ' A' ' 110' ' ' PHE . 20.3 t -76.04 126.59 36.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.956 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.769 HD13 ' HE1' ' A' ' 22' ' ' MET . 0.6 OUTLIER -109.25 -19.08 7.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.276 179.074 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.433 ' HB3' ' HB3' ' A' ' 109' ' ' LEU . . . -169.78 176.73 4.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.214 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.9 OUTLIER -162.74 149.24 12.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.885 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.746 ' HA ' HG11 ' A' ' 160' ' ' VAL . 41.5 t -71.64 140.59 84.33 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.293 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.618 ' HD2' HG13 ' A' ' 76' ' ' VAL . 32.6 Cg_endo -64.91 -72.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.931 2.421 . . . . 0.0 113.424 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.423 ' HE1' HD21 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -85.18 176.34 8.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.197 0.522 . . . . 0.0 111.74 -178.84 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.485 ' HH2' HD13 ' A' ' 47' ' ' ILE . 29.8 m95 -93.27 109.28 20.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.652 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.453 HD11 ' OE1' ' A' ' 156' ' ' GLU . 39.4 mt . . . . . 0 C--N 1.326 -0.456 0 CA-C-O 120.808 0.337 . . . . 0.0 111.329 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.254 0 CA-C-O 121.004 0.43 . . . . 0.0 110.723 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.986 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 70.0 mt-30 -122.48 130.61 53.24 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.476 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 1.1 ttpp -105.5 131.02 53.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.915 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.572 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 20.5 m95 -102.23 163.07 12.44 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.543 ' CE2' ' HG3' ' A' ' 54' ' ' ARG . 92.6 m-85 -140.69 148.5 40.89 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.235 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.632 HD22 ' HB3' ' A' ' 161' ' ' PHE . 18.8 tp -102.4 128.68 48.89 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.922 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.905 ' CE2' HG23 ' A' ' 19' ' ' ILE . 7.7 m-85 -134.54 148.25 50.45 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 121.314 0.578 . . . . 0.0 112.156 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.645 ' HE2' ' HA ' ' A' ' 24' ' ' ASN . 2.1 tttt -98.75 126.12 44.28 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.933 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.753 ' HD2' HD21 ' A' ' 21' ' ' LEU . 33.8 t80 -78.12 96.43 5.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.14 0.495 . . . . 0.0 110.512 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 82.4 p -96.65 50.01 1.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.672 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.437 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -155.37 -144.13 3.84 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.553 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.419 ' N ' ' HE1' ' A' ' 112' ' ' PHE . 8.0 pt20 -123.85 151.42 43.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.115 0.483 . . . . 0.0 111.564 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -62.36 -25.01 67.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.299 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -59.92 -4.97 0.83 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.946 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -91.16 -17.8 25.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.98 0.419 . . . . 0.0 110.613 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.668 ' HA ' ' O ' ' A' ' 65' ' ' THR . 8.8 mt -81.05 104.2 9.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.937 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 2.3 t30 -102.18 -26.52 13.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.055 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.641 HD23 HG22 ' A' ' 65' ' ' THR . 61.7 mt . . . . . 0 N--CA 1.466 0.369 0 CA-C-O 120.842 0.353 . . . . 0.0 111.667 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.197 0 CA-C-O 120.584 0.231 . . . . 0.0 111.439 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.566 ' CB ' ' HB1' ' A' ' 31' ' ' ALA . 4.2 m-85 -114.7 140.72 48.63 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.312 0.577 . . . . 0.0 111.473 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.805 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -80.81 -35.85 23.88 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.754 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -153.75 153.78 32.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.963 0.411 . . . . 0.0 110.66 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.571 ' HD1' HD11 ' A' ' 121' ' ' LEU . 32.6 p-90 -135.18 166.04 24.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.093 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.432 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 13.2 t -161.45 166.95 26.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.097 0.475 . . . . 0.0 111.847 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.673 ' CE3' ' ND2' ' A' ' 23' ' ' ASN . 53.7 m95 -109.31 103.57 12.54 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.344 178.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.484 ' O ' ' N ' ' A' ' 28' ' ' ILE . 28.5 m -117.56 168.96 8.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.5 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.597 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 11.3 p -71.43 170.63 11.15 Favored Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.965 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.778 ' HA ' HG13 ' A' ' 28' ' ' ILE . 24.4 Cg_exo -57.7 -58.89 0.67 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 121.957 1.772 . . . . 0.0 109.841 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.8 -29.86 69.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.624 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -70.73 -48.4 54.71 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 120.934 0.397 . . . . 0.0 110.656 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 1.014 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -54.6 -41.97 70.55 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.745 ' CG2' ' HG3' ' A' ' 151' ' ' LYS . 24.3 mm -61.73 -33.92 59.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.255 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.78 -51.54 16.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.377 0.608 . . . . 0.0 110.321 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.42 -21.23 62.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.696 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.714 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 14.7 t -73.45 175.36 7.06 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.717 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.713 ' CG2' ' HD2' ' A' ' 150' ' ' LYS . 34.0 m -86.05 148.26 4.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.655 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.541 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 2.1 mt-10 -48.31 -50.32 30.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.467 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.3 -4.24 0.08 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.713 ' HD2' ' CG2' ' A' ' 147' ' ' VAL . 18.7 mttt -136.51 -7.14 1.96 Allowed 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.745 ' HG3' ' CG2' ' A' ' 143' ' ' ILE . 2.7 ttpp -62.99 -54.34 47.41 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.35 0.119 . . . . 0.0 110.816 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.541 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 38.0 Cg_endo -66.38 -29.44 45.71 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.435 2.09 . . . . 0.0 110.989 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.801 ' O ' HG23 ' A' ' 157' ' ' VAL . 9.3 t -68.1 -55.91 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.55 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 4.6 m-30 -63.09 -37.4 87.05 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.581 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.741 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -55.78 -45.34 78.17 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.441 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.548 ' O ' HG23 ' A' ' 160' ' ' VAL . 12.8 tm-20 -67.49 -34.58 77.43 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 153' ' ' VAL . 47.9 t -63.35 -42.1 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.546 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.593 HD22 ' HB3' ' A' ' 139' ' ' PRO . 36.0 mt -63.91 -43.92 94.5 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.883 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.9 m -56.85 -39.31 74.05 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.746 HG11 ' HA ' ' A' ' 76' ' ' VAL . 76.1 t -67.54 -42.4 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.664 ' CE2' HG12 ' A' ' 157' ' ' VAL . 18.8 m-30 -81.24 7.13 12.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.089 -0.959 . . . . 0.0 112.006 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.553 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.97 -54.9 51.9 Favored Pre-proline 0 C--N 1.332 -0.169 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.178 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 15.9 Cg_endo -57.58 -12.94 12.4 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 121.825 1.683 . . . . 0.0 111.768 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.429 ' CE1' ' HB2' ' A' ' 74' ' ' ALA . 42.3 m80 -107.46 -17.25 14.17 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.237 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 98.2 mt . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.586 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 5.1 mpp? . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.827 0.346 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.651 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 1.5 p30 . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.983 0.42 . . . . 0.0 110.353 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.808 ' HG2' HD12 ' A' ' 47' ' ' ILE . 4.7 ttp180 . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 121.103 0.478 . . . . 0.0 111.967 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.737 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 2.1 m-80 -131.66 176.39 8.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.395 -0.82 . . . . 0.0 108.96 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.663 HG13 ' CG1' ' A' ' 47' ' ' ILE . 6.2 m -144.1 166.15 13.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.794 0.33 . . . . 0.0 111.389 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.487 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -136.4 160.24 24.68 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.144 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.679 HG13 ' HB1' ' A' ' 57' ' ' ALA . 3.6 mp -129.23 119.36 48.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.043 0.449 . . . . 0.0 111.536 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.69 ' O ' HD12 ' A' ' 109' ' ' LEU . 3.0 t -98.29 92.73 5.85 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.182 -0.674 . . . . 0.0 109.182 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.688 HD22 HG11 ' A' ' 67' ' ' VAL . 39.2 tp -91.01 123.32 34.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.741 -178.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.765 ' CG ' HD11 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -117.46 152.57 34.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.126 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.75 ' ND2' ' CE3' ' A' ' 136' ' ' TRP . 0.2 OUTLIER -97.66 174.9 6.4 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.507 -179.321 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -56.76 -6.11 0.29 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.769 177.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.526 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -101.25 -1.7 33.03 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.631 0.253 . . . . 0.0 111.43 -179.151 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 6.1 mmpt? 75.6 21.72 1.69 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.106 -178.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.674 ' O ' ' HA ' ' A' ' 22' ' ' MET . 6.0 mttt -91.59 175.65 6.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.693 HD11 ' HG3' ' A' ' 139' ' ' PRO . 1.8 mm -118.77 138.12 50.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.131 0.491 . . . . 0.0 111.756 -178.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.536 ' CZ ' HG21 ' A' ' 65' ' ' THR . 9.9 t80 -63.72 101.62 0.37 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.181 178.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.669 ' HA ' ' O ' ' A' ' 41' ' ' GLN . . . -97.86 137.37 36.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.935 0.398 . . . . 0.0 111.315 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.449 ' HB1' ' CG ' ' A' ' 131' ' ' PHE . . . -137.64 139.86 40.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.331 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.604 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 60.1 p -104.47 150.59 24.43 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.619 ' O ' ' N ' ' A' ' 35' ' ' ASP . 4.9 mtp180 -74.55 129.93 38.64 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.309 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.715 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -56.89 52.71 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.883 0.473 . . . . 0.0 112.211 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.619 ' N ' ' O ' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -174.97 -37.03 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.054 0.454 . . . . 0.0 110.18 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.576 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 3.8 mm -112.09 106.23 56.24 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.739 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.53 -60.14 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.07 2.513 . . . . 0.0 113.895 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -67.9 2.87 1.76 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.604 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.85 93.24 8.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.749 0.309 . . . . 0.0 111.454 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.55 ' O ' ' HA ' ' A' ' 146' ' ' THR . 76.4 m95 -98.68 155.04 17.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.089 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.669 ' O ' ' HA ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -162.72 -139.35 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.976 -0.289 . . . . 0.0 111.002 -178.564 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.583 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 4.9 ptt? -176.91 163.36 1.56 Allowed Pre-proline 0 N--CA 1.446 -0.671 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.871 ' HG3' HD13 ' A' ' 61' ' ' LEU . 2.9 Cg_endo -38.22 130.24 1.0 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.276 2.651 . . . . 0.0 113.342 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.599 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 1.7 tm0? -174.23 141.65 0.75 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.118 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -161.49 -156.45 8.33 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.472 -0.871 . . . . 0.0 112.387 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.71 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -118.24 138.94 14.24 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.03 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.808 HD12 ' HG2' ' A' ' 15' ' ' ARG . 46.2 mt -69.49 145.03 13.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.864 0.364 . . . . 0.0 111.63 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -69.15 -174.34 0.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.817 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -48.58 -75.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.127 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -116.33 56.24 0.53 Allowed Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.276 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -115.16 147.68 39.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.808 0.337 . . . . 0.0 110.773 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -71.12 160.16 83.33 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.606 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.537 ' HA ' HG11 ' A' ' 17' ' ' VAL . 15.8 Cg_exo -69.38 -49.07 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.672 2.248 . . . . 0.0 111.653 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.843 ' NH2' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -52.21 -45.78 65.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.689 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -64.53 -45.3 87.79 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.857 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.535 ' HA ' ' HD3' ' A' ' 59' ' ' ARG . . . -62.51 -45.62 92.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.688 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.679 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -57.29 -55.15 38.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.317 0.579 . . . . 0.0 109.832 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.531 HD11 ' HG3' ' A' ' 54' ' ' ARG . 27.1 mt -56.43 -51.06 69.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.4 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.535 ' HD3' ' HA ' ' A' ' 56' ' ' ALA . 2.8 ptm180 -65.17 -54.18 33.56 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.557 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.4 OUTLIER -46.25 -44.62 16.51 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.295 0.569 . . . . 0.0 109.884 179.374 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.871 HD13 ' HG3' ' A' ' 43' ' ' PRO . 8.4 tp -51.48 -51.62 53.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.489 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.841 ' HG3' HG23 ' A' ' 68' ' ' THR . 15.1 ttm180 -64.87 -61.6 2.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.473 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -51.33 -23.47 3.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.111 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -97.13 -38.18 9.83 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.689 HG22 ' CD2' ' A' ' 121' ' ' LEU . 1.1 p -131.26 -3.33 3.89 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 78.75 -9.44 36.98 Favored Glycine 0 CA--C 1.517 0.205 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.135 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.776 ' HB ' HD11 ' A' ' 61' ' ' LEU . 69.6 t -58.49 111.76 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.209 0.528 . . . . 0.0 111.444 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.841 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.8 OUTLIER -121.63 -39.38 2.65 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.429 178.493 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.419 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 14.2 m -62.7 70.37 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.93 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.37 152.89 19.01 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.216 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 0.3 OUTLIER -129.06 157.81 40.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.297 179.443 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.843 HG11 ' NH2' ' A' ' 54' ' ' ARG . 16.5 t -78.62 131.08 35.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.261 0.553 . . . . 0.0 112.033 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.84 ' N ' HD13 ' A' ' 73' ' ' ILE . 0.8 OUTLIER -104.7 -22.5 4.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.176 178.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.435 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -171.83 178.26 3.08 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.703 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.27 145.02 30.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.011 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.827 ' HA ' HG11 ' A' ' 160' ' ' VAL . 53.5 t -70.98 136.94 84.9 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.858 0.361 . . . . 0.0 110.533 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.43 ' HD2' HG13 ' A' ' 76' ' ' VAL . 12.2 Cg_endo -53.11 -68.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.943 2.429 . . . . 0.0 111.831 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.651 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -96.65 -173.36 2.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.692 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.52 ' CD1' ' HD3' ' A' ' 106' ' ' LYS . 31.9 m95 -89.3 -157.18 0.44 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.637 ' HB2' ' O ' ' A' ' 105' ' ' GLN . 72.1 mt . . . . . 0 C--N 1.326 -0.425 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.526 0 CA-C-O 121.204 0.526 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.737 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -126.0 123.75 39.18 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.434 -178.809 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.52 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 9.3 ttpt -102.93 138.63 39.57 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 177.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.487 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 31.3 m95 -103.36 162.68 12.8 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -177.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.402 ' CZ ' ' HB2' ' A' ' 53' ' ' PRO . 90.4 m-85 -139.74 155.55 47.27 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.881 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.765 HD11 ' CG ' ' A' ' 22' ' ' MET . 39.4 tp -100.99 138.14 38.43 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.961 -0.295 . . . . 0.0 110.272 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.7 ' CZ ' HG22 ' A' ' 72' ' ' VAL . 23.8 m-85 -139.25 137.21 35.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.203 0.525 . . . . 0.0 112.155 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 10.2 ttmt -102.12 126.16 49.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.392 177.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.669 ' CE1' HG13 ' A' ' 67' ' ' VAL . 34.0 t80 -78.57 98.27 6.07 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.769 0.318 . . . . 0.0 110.999 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 8.0 p -97.86 50.4 1.03 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.419 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -152.64 -147.39 4.59 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.339 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -118.94 150.84 39.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.939 0.4 . . . . 0.0 110.885 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -59.77 -35.1 73.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.728 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -6.39 0.21 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.083 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.84 -14.52 34.19 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.743 0.306 . . . . 0.0 111.023 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.71 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 19.2 mt -78.98 100.37 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.029 0.442 . . . . 0.0 111.999 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 65' ' ' THR . 2.2 t30 -104.16 98.73 8.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.752 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.689 ' CD2' HG22 ' A' ' 65' ' ' THR . 35.8 mt . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.953 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.448 ' C ' HD12 ' A' ' 34' ' ' LEU . 15.7 mm-40 . . . . . 0 CA--C 1.521 -0.14 0 CA-C-O 121.044 0.449 . . . . 0.0 110.361 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.643 ' CE2' HG23 ' A' ' 65' ' ' THR . 4.8 m-85 -103.45 143.82 32.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.108 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.715 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -85.92 -36.16 10.52 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.388 -0.911 . . . . 0.0 111.985 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -151.37 141.42 22.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.965 0.412 . . . . 0.0 110.925 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.71 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 42.7 p-90 -128.94 166.68 18.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.073 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.433 ' N ' ' HZ3' ' A' ' 40' ' ' TRP . 27.3 t -161.02 179.11 8.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.769 -178.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.75 ' CE3' ' ND2' ' A' ' 23' ' ' ASN . 75.8 m95 -114.01 103.73 11.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.59 178.443 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.3 m -119.22 168.44 11.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.776 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.513 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 17.6 p -74.01 169.89 16.99 Favored Pre-proline 0 CA--C 1.516 -0.358 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.491 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.693 ' HG3' HD11 ' A' ' 28' ' ' ILE . 16.6 Cg_exo -61.57 -53.53 2.23 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.781 1.654 . . . . 0.0 110.512 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.59 -27.72 69.14 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.782 178.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.434 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.2 OUTLIER -73.37 -44.29 58.93 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.486 179.743 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.476 HD11 ' O ' ' A' ' 41' ' ' GLN . 5.4 tp -58.94 -38.35 78.81 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.801 HG21 ' HG2' ' A' ' 155' ' ' LYS . 12.2 mm -63.74 -37.09 78.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.53 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.53 -49.66 52.4 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.297 0.57 . . . . 0.0 110.201 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.411 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -73.92 -20.15 60.47 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.752 -179.286 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.624 HG23 ' HG2' ' A' ' 151' ' ' LYS . 12.7 t -76.2 173.11 11.77 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.514 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.5 m -80.43 147.24 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.248 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.613 ' HA ' ' HE2' ' A' ' 151' ' ' LYS . 5.3 mt-10 -52.21 -47.65 65.52 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.249 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -52.08 -10.91 0.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.47 ' HB3' ' CE1' ' A' ' 154' ' ' TYR . 21.1 mttt -135.72 -5.52 2.21 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.624 ' HG2' HG23 ' A' ' 146' ' ' THR . 7.2 mtmm -58.28 -61.32 7.77 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 121.278 -0.169 . . . . 0.0 111.154 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.541 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 35.3 Cg_endo -64.83 -26.36 59.85 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.608 2.205 . . . . 0.0 111.738 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.726 ' O ' HG23 ' A' ' 157' ' ' VAL . 26.3 t -68.25 -50.78 54.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.487 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 7.5 m-30 -66.46 -38.33 87.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.734 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.801 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -58.13 -42.1 85.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.073 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.26 -32.9 70.94 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 153' ' ' VAL . 84.0 t -67.13 -41.09 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.728 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.566 HD22 ' HB3' ' A' ' 139' ' ' PRO . 44.8 mt -64.15 -39.26 93.63 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.93 0.395 . . . . 0.0 110.22 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 16.9 m -55.81 -41.1 73.69 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.827 HG11 ' HA ' ' A' ' 76' ' ' VAL . 95.5 t -66.81 -44.84 88.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.175 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.574 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 21.7 m-30 -80.79 5.09 16.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.575 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.636 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.17 -51.86 78.7 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.745 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 18.1 Cg_endo -58.71 -12.18 13.81 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.231 1.954 . . . . 0.0 111.961 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.435 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 89.2 m-70 -110.32 -20.95 12.45 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.252 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 89.3 mt . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.938 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 12.6 mtm . . . . . 0 CA--C 1.53 0.189 0 CA-C-O 120.526 0.203 . . . . 0.0 110.49 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 29.7 t0 . . . . . 0 C--N 1.332 -0.184 0 CA-C-O 120.945 0.403 . . . . 0.0 110.728 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.58 ' HG3' ' CZ3' ' A' ' 79' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.8 0.333 . . . . 0.0 110.553 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.745 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 40.9 m-20 -131.05 170.64 14.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.165 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.547 HG13 ' CG1' ' A' ' 47' ' ' ILE . 13.2 m -141.06 162.61 22.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.462 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.642 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -134.31 159.17 23.72 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.613 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.092 HG21 HD22 ' A' ' 61' ' ' LEU . 3.8 mp -128.41 119.02 49.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.776 ' O ' HD12 ' A' ' 109' ' ' LEU . 41.9 t -97.85 89.42 4.59 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.85 HD22 HG11 ' A' ' 67' ' ' VAL . 27.1 tp -90.4 115.6 27.7 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.448 -178.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.655 ' SD ' HD11 ' A' ' 109' ' ' LEU . 1.7 ptt? -118.28 166.1 13.03 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.058 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.739 ' ND2' ' CE3' ' A' ' 136' ' ' TRP . 0.3 OUTLIER -101.36 167.85 9.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.298 179.492 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -55.89 -4.06 0.1 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.578 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.594 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 1.7 m-20 -100.67 2.63 41.73 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.594 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER 76.38 20.13 1.57 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.941 -178.374 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 22' ' ' MET . 2.1 mmtt -92.69 147.88 22.51 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.867 HD11 ' HG3' ' A' ' 139' ' ' PRO . 0.8 OUTLIER -101.0 138.82 23.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.164 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.567 ' HZ ' HG21 ' A' ' 65' ' ' THR . 12.1 t80 -78.46 134.37 37.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.831 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.637 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -140.2 151.81 45.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.05 0.452 . . . . 0.0 111.224 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.712 ' HB1' ' CB ' ' A' ' 131' ' ' PHE . . . -143.28 133.43 24.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.637 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 3.4 m -97.25 156.5 16.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.165 0.507 . . . . 0.0 112.002 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.577 ' O ' ' N ' ' A' ' 35' ' ' ASP . 32.8 mtp85 -74.47 129.92 38.65 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.742 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.746 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 1.2 mp -57.3 54.9 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.221 0.608 . . . . 0.0 112.289 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.577 ' N ' ' O ' ' A' ' 33' ' ' ARG . 9.9 p-10 -175.89 -33.72 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.062 0.458 . . . . 0.0 109.919 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 4.5 mt -117.51 103.05 51.53 Favored Pre-proline 0 N--CA 1.448 -0.549 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.475 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -61.27 -47.34 12.34 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.014 2.476 . . . . 0.0 113.344 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.83 -2.08 22.14 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.506 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -95.55 95.63 8.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.852 0.358 . . . . 0.0 111.428 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.623 ' O ' ' HA ' ' A' ' 146' ' ' THR . 66.6 m95 -100.59 150.94 22.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.893 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.85 165.03 37.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.319 0.581 . . . . 0.0 111.52 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.438 ' HB2' ' HE2' ' A' ' 42' ' ' MET . 27.0 mtm -100.56 150.51 37.04 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.111 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.528 ' CB ' HD13 ' A' ' 61' ' ' LEU . 4.8 Cg_endo -50.07 150.79 9.75 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.236 1.957 . . . . 0.0 111.89 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.576 ' HA ' HD12 ' A' ' 19' ' ' ILE . 18.2 pt20 -175.58 177.56 1.74 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.606 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.401 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . 175.09 158.84 20.09 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.136 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.745 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -87.54 134.88 12.76 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.164 -1.017 . . . . 0.0 113.39 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.547 ' CG1' HG13 ' A' ' 17' ' ' VAL . 50.1 mt -68.25 148.23 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.058 0.456 . . . . 0.0 111.908 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -69.98 -172.74 0.57 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.203 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.46 -77.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.141 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -112.51 56.22 0.48 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.58 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.484 ' O ' HG21 ' A' ' 47' ' ' ILE . 3.3 tp10 -114.25 149.31 36.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.75 0.31 . . . . 0.0 110.711 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -71.14 155.1 93.58 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.321 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.519 ' HA ' HG11 ' A' ' 17' ' ' VAL . 4.7 Cg_exo -74.92 -50.84 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.758 2.305 . . . . 0.0 112.277 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.675 ' CZ ' HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -51.31 -46.56 62.59 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.731 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.773 ' HA ' HD12 ' A' ' 58' ' ' ILE . 52.5 m-80 -68.09 -40.33 82.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.104 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.59 -43.14 99.4 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.671 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -57.02 -51.35 69.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.072 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.773 HD12 ' HA ' ' A' ' 55' ' ' ASN . 12.3 mt -56.38 -54.82 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.983 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.53 -63.62 1.21 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.289 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.401 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 0.4 OUTLIER -42.32 -46.56 4.62 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.039 0.447 . . . . 0.0 110.223 179.686 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.092 HD22 HG21 ' A' ' 19' ' ' ILE . 8.2 tp -52.34 -46.76 66.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.487 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.914 ' HG3' HG23 ' A' ' 68' ' ' THR . 23.0 ttm180 -64.22 -63.06 1.25 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.171 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -49.78 -20.09 0.78 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -95.95 -40.52 9.24 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.817 HG22 HD23 ' A' ' 121' ' ' LEU . 0.7 OUTLIER -126.34 -5.31 6.6 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.074 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 81.59 -11.71 44.44 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.214 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.85 HG11 HD22 ' A' ' 21' ' ' LEU . 71.7 t -57.81 114.73 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.155 0.503 . . . . 0.0 111.5 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.914 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.6 OUTLIER -123.38 -39.06 2.49 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.33 178.126 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.418 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 5.9 m -62.67 73.32 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.214 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -162.64 155.3 19.29 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.942 0.401 . . . . 0.0 111.75 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.96 153.99 48.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.452 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.68 HG22 ' CZ ' ' A' ' 110' ' ' PHE . 43.4 t -76.55 131.78 34.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.336 0.588 . . . . 0.0 112.378 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.695 ' N ' HD13 ' A' ' 73' ' ' ILE . 1.2 mm -103.91 -21.43 5.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.176 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.468 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -169.94 178.62 3.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.182 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -146.3 140.59 26.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.037 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.726 ' HA ' HG11 ' A' ' 160' ' ' VAL . 48.3 t -70.37 138.33 86.57 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.978 0.418 . . . . 0.0 110.535 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.532 ' HD2' HG13 ' A' ' 76' ' ' VAL . 19.1 Cg_endo -58.92 -68.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.993 2.462 . . . . 0.0 112.477 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -96.67 -173.38 2.72 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.829 -179.405 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.58 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 44.0 m95 -93.72 -159.03 0.66 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.536 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.562 ' HB2' ' HG2' ' A' ' 105' ' ' GLN . 41.0 mt . . . . . 0 C--N 1.331 -0.222 0 CA-C-O 121.366 0.603 . . . . 0.0 111.131 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.403 ' HB3' HH21 ' A' ' 15' ' ' ARG . . . . . . . . 0 N--CA 1.465 0.276 0 CA-C-O 120.871 0.367 . . . . 0.0 110.835 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.633 ' HB3' ' HB2' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -133.66 128.53 35.25 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.845 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.478 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 5.3 ttpp -102.32 132.39 48.32 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.642 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 19.5 m95 -104.93 160.86 14.68 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.481 ' HB2' ' HE1' ' A' ' 110' ' ' PHE . 91.4 m-85 -137.99 154.37 49.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.667 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.776 HD12 ' O ' ' A' ' 20' ' ' CYS . 32.5 tp -97.65 141.69 30.36 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.708 ' CD1' HG23 ' A' ' 19' ' ' ILE . 23.3 m-85 -139.15 138.21 36.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.292 0.567 . . . . 0.0 112.116 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.563 ' HB2' HD11 ' A' ' 73' ' ' ILE . 1.4 ttpt -103.59 128.31 50.88 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.437 177.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.563 ' HD1' HD21 ' A' ' 21' ' ' LEU . 36.9 t80 -78.1 102.82 7.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.818 0.342 . . . . 0.0 111.008 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 49.2 p -100.47 47.65 0.93 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.009 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.418 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -152.73 -146.08 4.28 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.485 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -117.89 146.77 43.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.885 0.374 . . . . 0.0 110.814 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -59.51 -32.36 70.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.705 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -59.29 -4.48 0.56 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.907 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.15 -15.63 31.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.619 0.247 . . . . 0.0 110.951 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.747 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 17.6 mt -76.11 99.67 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.912 0.386 . . . . 0.0 111.541 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 65' ' ' THR . 1.5 m120 -106.16 95.95 6.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.687 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.817 HD23 HG22 ' A' ' 65' ' ' THR . 11.2 mt . . . . . 0 CA--C 1.532 0.277 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.838 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.461 0.095 0 CA-C-O 120.714 0.292 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.712 ' CB ' ' HB1' ' A' ' 31' ' ' ALA . 3.4 m-85 -120.02 138.63 53.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.217 0.532 . . . . 0.0 109.898 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.746 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -83.26 -36.45 14.68 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.026 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -149.03 144.43 26.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.948 0.404 . . . . 0.0 110.615 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.747 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 33.4 p-90 -129.63 163.73 25.42 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.455 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.417 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 34.9 t -163.38 176.59 9.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.914 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.739 ' CE3' ' ND2' ' A' ' 23' ' ' ASN . 28.5 m95 -111.76 103.42 11.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.317 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 28' ' ' ILE . 24.2 m -118.39 166.26 12.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.565 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 14.5 p -71.82 171.49 9.15 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.216 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.867 ' HG3' HD11 ' A' ' 28' ' ' ILE . 13.4 Cg_exo -63.14 -54.18 1.21 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 121.83 1.687 . . . . 0.0 109.87 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -64.29 -28.35 69.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.911 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.431 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.4 OUTLIER -73.14 -45.75 54.93 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.393 179.745 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.637 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -58.44 -39.45 79.88 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 139' ' ' PRO . 27.3 mm -61.99 -33.76 59.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.132 0.491 . . . . 0.0 110.032 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.03 -53.17 11.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.379 0.609 . . . . 0.0 110.818 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.1 mp -72.56 -19.38 61.51 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.72 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.623 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 11.7 t -74.19 177.72 5.59 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.4 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.752 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 20.9 m -84.46 151.03 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.767 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.458 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 10.6 mt-10 -55.26 -54.75 39.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.486 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.752 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 44.3 p90 -55.93 -2.1 0.05 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.422 ' HG3' ' CE2' ' A' ' 149' ' ' PHE . 29.6 mttm -133.42 -8.06 2.91 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.502 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 0.4 OUTLIER -61.35 -56.45 33.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 121.49 -0.084 . . . . 0.0 111.196 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 22.7 Cg_endo -62.48 -28.94 78.23 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.163 1.909 . . . . 0.0 111.591 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.804 ' O ' HG23 ' A' ' 157' ' ' VAL . 31.2 t -67.16 -51.63 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.472 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 6.9 m-30 -66.19 -39.37 89.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.965 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.544 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -56.29 -42.43 77.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.684 179.731 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.446 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.7 OUTLIER -69.07 -33.32 73.37 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.167 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 153' ' ' VAL . 48.8 t -67.5 -40.61 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.43 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.707 HD22 ' HB3' ' A' ' 139' ' ' PRO . 36.9 mt -63.44 -47.1 83.26 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.247 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.8 t -50.72 -42.86 57.68 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.536 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.726 HG11 ' HA ' ' A' ' 76' ' ' VAL . 79.5 t -65.74 -41.65 90.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.548 ' CE2' HG12 ' A' ' 157' ' ' VAL . 18.3 m-30 -80.84 5.19 16.76 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.597 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.616 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.63 -52.77 71.66 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.6 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.0 Cg_endo -58.18 -12.4 12.88 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.112 1.874 . . . . 0.0 111.876 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.468 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 95.0 m-70 -108.5 -20.23 13.18 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.333 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 95.4 mt . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.105 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.8 mtm . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 120.674 0.273 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.672 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 9.2 t0 . . . . . 0 C--N 1.333 -0.139 0 CA-C-O 121.004 0.43 . . . . 0.0 110.812 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.547 ' HG2' HD13 ' A' ' 47' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 121.275 0.56 . . . . 0.0 110.322 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.706 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 3.4 m120 -132.6 173.99 10.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.405 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.693 HG12 HD11 ' A' ' 47' ' ' ILE . 2.1 m -140.63 166.73 18.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.409 0.623 . . . . 0.0 111.831 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.672 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -133.33 155.08 21.52 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.252 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.691 HG13 ' HB1' ' A' ' 57' ' ' ALA . 3.4 mp -126.88 119.17 52.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.986 0.422 . . . . 0.0 111.956 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' A' ' 110' ' ' PHE . 45.4 t -101.79 102.41 13.03 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.963 HD22 HG11 ' A' ' 67' ' ' VAL . 15.5 tp -105.39 118.87 37.65 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.108 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.635 ' HE2' HD13 ' A' ' 73' ' ' ILE . 1.2 ptm -119.75 161.61 20.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.83 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.498 ' OD1' ' CE3' ' A' ' 136' ' ' TRP . 0.2 OUTLIER -95.77 169.96 9.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.962 0.411 . . . . 0.0 110.155 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -56.62 -5.0 0.18 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.054 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.552 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 4.7 m-20 -98.87 2.93 47.1 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.552 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER 75.76 19.45 1.98 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.942 -178.538 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 22' ' ' MET . 1.1 mmtt -94.46 140.8 29.35 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.672 HD13 ' N ' ' A' ' 139' ' ' PRO . 3.0 mp -102.4 145.57 11.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.681 0.753 . . . . 0.0 112.218 -178.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.576 ' CE1' HD13 ' A' ' 119' ' ' ILE . 83.8 t80 -76.89 137.31 39.06 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.914 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.984 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -140.45 148.64 41.47 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.145 -0.316 . . . . 0.0 110.145 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.543 ' HB1' ' CB ' ' A' ' 131' ' ' PHE . . . -138.58 136.82 36.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.841 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.751 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 91.5 p -97.15 143.33 28.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.946 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.774 ' HE ' HD12 ' A' ' 36' ' ' ILE . 21.9 mtp85 -68.95 127.48 33.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.738 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.73 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.7 OUTLIER -43.78 -35.31 1.84 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.304 0.573 . . . . 0.0 110.835 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -72.71 -40.09 66.44 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.007 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.774 HD12 ' HE ' ' A' ' 33' ' ' ARG . 8.7 mt -125.31 104.76 28.48 Favored Pre-proline 0 N--CA 1.455 -0.175 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.738 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.75 -20.2 52.64 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.738 2.292 . . . . 0.0 112.871 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.48 -6.59 54.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.706 0.288 . . . . 0.0 111.496 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.751 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.56 93.27 8.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.123 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.664 ' O ' ' HA ' ' A' ' 146' ' ' THR . 78.1 m95 -90.89 144.93 25.18 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.543 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.428 ' HA ' ' HE2' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -158.73 162.6 37.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.184 0.516 . . . . 0.0 111.232 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.508 ' HB2' ' HE2' ' A' ' 42' ' ' MET . 1.8 mtm -98.08 152.05 37.84 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.892 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.415 ' HG2' ' O ' ' A' ' 19' ' ' ILE . 1.5 Cg_endo -46.96 144.86 7.8 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.239 1.96 . . . . 0.0 111.873 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 17' ' ' VAL . 6.7 tt0 -172.68 146.4 1.65 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.578 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.416 ' HA3' ' HG3' ' A' ' 60' ' ' GLU . . . -157.32 -167.02 17.79 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.9 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.706 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -117.85 137.68 13.37 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.133 -1.032 . . . . 0.0 113.655 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.693 HD11 HG12 ' A' ' 17' ' ' VAL . 3.3 mt -70.52 148.78 10.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.356 -0.422 . . . . 0.0 111.735 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -68.61 -173.8 0.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.372 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -49.11 -78.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.178 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -111.93 57.13 0.44 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.601 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.485 ' O ' HG21 ' A' ' 47' ' ' ILE . 7.4 tp10 -117.4 153.86 32.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.946 0.403 . . . . 0.0 110.871 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.86 161.61 77.79 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.486 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.541 ' HA ' HG12 ' A' ' 47' ' ' ILE . 7.3 Cg_exo -74.21 -47.87 0.23 Allowed 'Trans proline' 0 CA--C 1.514 -0.517 0 C-N-CA 122.857 2.371 . . . . 0.0 111.226 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.777 HH11 HG13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -51.98 -44.03 63.86 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.213 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -68.09 -42.13 80.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.946 0.403 . . . . 0.0 110.402 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.434 ' HA ' ' HG2' ' A' ' 59' ' ' ARG . . . -60.49 -44.46 95.93 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.691 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -57.96 -53.7 55.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.388 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.777 HG13 HH11 ' A' ' 54' ' ' ARG . 57.4 mt -53.27 -52.82 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.526 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.455 ' HG3' ' N ' ' A' ' 60' ' ' GLU . 9.2 ptm180 -63.43 -56.57 15.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.824 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.455 ' N ' ' HG3' ' A' ' 59' ' ' ARG . 29.2 mm-40 -50.99 -48.45 61.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.063 0.459 . . . . 0.0 110.054 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.568 HD21 HG12 ' A' ' 67' ' ' VAL . 14.1 tp -51.01 -48.5 61.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.393 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.937 ' HG2' HG23 ' A' ' 68' ' ' THR . 1.0 OUTLIER -66.77 -63.29 1.1 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.328 0.585 . . . . 0.0 110.721 179.304 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.67 -22.36 2.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.088 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -99.74 -38.06 8.84 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.617 HG22 HD23 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -127.22 -13.6 5.56 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.858 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.501 ' HA2' ' HD2' ' A' ' 62' ' ' ARG . . . 85.4 -13.42 55.38 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.254 -0.974 . . . . 0.0 111.76 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.963 HG11 HD22 ' A' ' 21' ' ' LEU . 27.3 t -57.31 106.02 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 121.236 0.541 . . . . 0.0 111.135 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.937 HG23 ' HG2' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -121.18 -39.86 2.65 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.219 178.605 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.0 m -62.68 73.43 0.02 OUTLIER 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.064 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -164.0 159.1 20.33 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.674 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.45 152.18 49.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.873 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.509 HG22 ' CE1' ' A' ' 110' ' ' PHE . 19.9 t -75.14 127.7 36.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.056 0.455 . . . . 0.0 111.076 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.635 HD13 ' HE2' ' A' ' 22' ' ' MET . 2.3 mt -108.1 -19.12 6.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.902 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.473 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.09 176.24 4.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.204 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.595 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.1 pm0 -154.39 145.26 22.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.453 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.776 ' HA ' HG11 ' A' ' 160' ' ' VAL . 53.5 t -71.25 138.32 84.28 Favored Pre-proline 0 C--N 1.329 -0.286 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.927 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.622 ' HD2' HG13 ' A' ' 76' ' ' VAL . 21.3 Cg_endo -61.82 -55.34 1.13 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.814 2.342 . . . . 0.0 112.696 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.672 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 1.2 p90 -102.17 -178.64 3.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.491 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.56 ' CD1' ' HD3' ' A' ' 106' ' ' LYS . 39.3 m95 -93.54 -157.56 0.55 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.392 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.539 HD23 ' O ' ' A' ' 79' ' ' TRP . 55.7 mt . . . . . 0 CA--C 1.516 -0.349 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.176 0 CA-C-O 120.874 0.369 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.647 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 23.9 mt-30 -136.45 124.06 22.31 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.56 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 14.4 ttpp -104.76 140.36 38.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.165 178.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.672 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 19.4 m95 -110.11 160.23 16.65 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.701 ' HB2' HH21 ' A' ' 54' ' ' ARG . 19.0 m-85 -139.07 160.12 40.53 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.125 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.61 HD11 ' SD ' ' A' ' 22' ' ' MET . 11.7 tp -98.44 142.52 29.96 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.622 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.531 ' HZ ' ' NH1' ' A' ' 54' ' ' ARG . 5.7 m-85 -135.36 145.71 47.65 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.541 ' CA ' HD11 ' A' ' 73' ' ' ILE . 1.8 tttt -106.31 117.16 33.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.854 177.004 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.665 ' HB2' HD11 ' A' ' 21' ' ' LEU . 55.1 t80 -78.03 101.29 6.86 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.661 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 14.1 p -97.58 40.43 1.16 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.406 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.402 ' C ' ' CE2' ' A' ' 112' ' ' PHE . . . -140.64 -148.36 5.11 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.805 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -123.64 152.03 42.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.702 0.287 . . . . 0.0 111.129 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.444 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 11.6 p-10 -58.31 -39.16 78.63 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.418 0.627 . . . . 0.0 111.204 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -58.2 -3.72 0.28 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.335 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -89.29 -17.34 29.15 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.092 0.473 . . . . 0.0 110.432 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.587 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 9.4 mt -88.74 106.84 17.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.462 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 27.3 t30 -100.09 -20.31 16.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.167 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.617 HD23 HG22 ' A' ' 65' ' ' THR . 66.8 mt . . . . . 0 N--CA 1.463 0.217 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.089 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.872 0.368 . . . . 0.0 110.363 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.543 ' CB ' ' HB1' ' A' ' 31' ' ' ALA . 1.4 m-85 -109.74 140.71 43.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.987 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.73 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -89.98 -32.12 10.25 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.12 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.95 152.25 34.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.885 0.374 . . . . 0.0 110.363 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.587 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 37.3 p-90 -137.76 167.62 21.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.009 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.468 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 30.5 t -162.42 175.58 11.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.481 0.657 . . . . 0.0 112.168 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.498 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 35.6 m95 -111.25 105.65 14.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.105 178.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 25.2 m -120.93 170.1 11.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.6 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 18.4 p -73.01 172.0 9.01 Favored Pre-proline 0 CA--C 1.518 -0.284 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.971 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.672 ' N ' HD13 ' A' ' 28' ' ' ILE . 11.4 Cg_exo -62.81 -55.85 0.74 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.579 1.519 . . . . 0.0 110.286 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -64.23 -25.14 67.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.351 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.431 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 1.8 mm-40 -72.96 -47.63 43.7 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.483 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.984 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -57.79 -39.38 77.4 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.848 -179.812 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.636 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 6.2 mm -62.82 -37.74 79.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.316 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.51 -48.99 58.78 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.312 0.577 . . . . 0.0 110.488 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.3 mp -75.0 -20.19 59.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.137 -0.938 . . . . 0.0 113.115 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.664 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 14.1 t -74.92 178.58 5.46 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.787 -178.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.684 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 27.7 m -82.89 148.62 5.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.115 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.502 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 45.4 mt-10 -55.1 -53.06 60.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.441 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.684 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 51.1 p90 -56.66 -2.22 0.07 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.443 ' HG3' ' CE2' ' A' ' 149' ' ' PHE . 21.5 mttt -134.76 -7.6 2.43 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' A' ' 143' ' ' ILE . 7.6 mtmm -58.88 -60.02 11.86 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.56 0.219 . . . . 0.0 111.095 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.502 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 31.8 Cg_endo -62.89 -26.78 74.51 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.397 2.064 . . . . 0.0 111.631 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.644 ' O ' HG23 ' A' ' 157' ' ' VAL . 26.0 t -68.85 -50.99 49.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.428 ' HE2' ' HA ' ' A' ' 41' ' ' GLN . 12.6 m-30 -65.76 -37.3 85.97 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.532 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.621 ' HE2' ' HA ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -57.68 -40.69 80.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.986 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.549 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.3 OUTLIER -68.11 -32.55 72.93 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.83 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 153' ' ' VAL . 48.6 t -66.64 -42.07 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.007 178.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.584 HD12 ' HE2' ' A' ' 155' ' ' LYS . 34.7 mt -64.36 -47.56 78.83 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.58 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 2.9 p -50.01 -40.63 45.13 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.776 HG11 ' HA ' ' A' ' 76' ' ' VAL . 57.7 t -68.1 -41.37 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.35 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.601 ' CE2' HG12 ' A' ' 157' ' ' VAL . 21.0 m-30 -80.87 4.26 19.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.402 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.618 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.48 -51.5 81.35 Favored Pre-proline 0 C--N 1.331 -0.22 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.776 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.8 Cg_endo -58.63 -12.67 14.93 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.064 1.843 . . . . 0.0 111.818 178.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.473 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 89.4 m-70 -108.76 -18.51 13.69 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.253 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 85.8 mt . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.331 -0.842 . . . . 0.0 110.678 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 9.2 mtm . . . . . 0 N--CA 1.463 0.195 0 CA-C-O 120.853 0.359 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.765 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 17.3 t0 . . . . . 0 N--CA 1.464 0.237 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.416 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 104' ' ' ALA . 1.5 ttt180 . . . . . 0 N--CA 1.451 -0.393 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.646 ' HA ' ' H ' ' A' ' 47' ' ' ILE . 1.5 m120 -129.84 173.19 10.9 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.713 HG13 HD11 ' A' ' 47' ' ' ILE . 30.2 m -134.33 165.53 31.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.736 0.779 . . . . 0.0 111.683 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.825 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -131.42 158.2 22.65 Favored Glycine 0 N--CA 1.433 -1.539 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.502 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.992 HG21 HD22 ' A' ' 61' ' ' LEU . 3.4 mp -123.27 117.95 53.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.496 0.665 . . . . 0.0 111.976 -178.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.538 ' O ' HD12 ' A' ' 109' ' ' LEU . 37.6 t -104.43 103.74 13.5 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.879 HD22 HG11 ' A' ' 67' ' ' VAL . 30.8 tp -104.47 122.96 46.62 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.893 -177.765 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.739 ' HB3' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -113.64 137.58 51.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.714 179.845 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.443 ' OD1' ' CZ3' ' A' ' 136' ' ' TRP . 5.6 m-20 -98.11 -172.25 2.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.475 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -52.38 -7.59 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.187 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.522 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 3.7 m-20 -99.73 -7.21 25.87 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.996 0.427 . . . . 0.0 111.045 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.766 ' HE2' ' HA ' ' A' ' 165' ' ' LEU . 0.0 OUTLIER 73.38 20.42 3.22 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 121.652 0.739 . . . . 0.0 109.291 -179.379 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.801 ' C ' HD12 ' A' ' 28' ' ' ILE . 7.1 mttp -91.72 -161.03 0.78 Allowed 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.767 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.801 HD12 ' C ' ' A' ' 27' ' ' LYS . 2.5 mp -135.61 145.73 31.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.42 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.579 ' CE1' HD13 ' A' ' 119' ' ' ILE . 81.0 t80 -65.77 110.99 3.02 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.326 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.635 ' HB2' HG22 ' A' ' 137' ' ' VAL . . . -100.21 137.56 38.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.842 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.75 132.94 37.45 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.809 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.842 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 48.6 p -98.81 141.39 31.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.221 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.498 ' NH1' HD12 ' A' ' 36' ' ' ILE . 11.1 mtp-105 -68.67 127.1 31.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.193 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.791 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.3 OUTLIER -45.9 -34.12 3.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.294 0.568 . . . . 0.0 110.73 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.39 -39.78 67.71 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.519 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.498 HD12 ' NH1' ' A' ' 33' ' ' ARG . 27.9 mt -123.63 106.64 32.13 Favored Pre-proline 0 N--CA 1.455 -0.214 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.084 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -68.37 -19.88 42.99 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.714 2.276 . . . . 0.0 112.628 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -91.39 -7.46 50.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.514 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.842 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -90.71 96.46 10.65 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.04 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.618 ' O ' ' HA ' ' A' ' 146' ' ' THR . 75.8 m95 -94.76 146.61 24.06 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.116 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.569 ' O ' ' HA ' ' A' ' 30' ' ' ALA . 0.5 OUTLIER -157.79 -124.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.56 -179.29 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.579 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 9.8 ptt? 179.98 163.29 0.86 Allowed Pre-proline 0 N--CA 1.452 -0.345 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.579 ' HD2' ' HB2' ' A' ' 42' ' ' MET . 10.2 Cg_endo -50.99 147.05 20.18 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.114 2.542 . . . . 0.0 112.577 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.609 ' HA ' HD12 ' A' ' 19' ' ' ILE . 10.6 pt20 -174.22 146.61 1.13 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.809 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.463 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . -160.52 154.38 25.4 Favored Glycine 0 C--O 1.228 -0.273 0 C-N-CA 120.146 -1.026 . . . . 0.0 112.789 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.64 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -78.31 136.95 19.02 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.611 -0.804 . . . . 0.0 114.034 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.713 HD11 HG13 ' A' ' 17' ' ' VAL . 3.7 mt -69.62 141.93 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.13 -0.535 . . . . 0.0 110.469 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -68.45 -172.95 0.38 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.738 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -48.22 -73.33 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.208 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -118.42 57.17 0.55 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.483 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 52' ' ' ASP . 2.1 tp10 -114.34 147.43 39.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.66 0.266 . . . . 0.0 110.456 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 26.9 m-20 -70.9 139.83 85.81 Favored Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.159 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.642 ' HB2' ' HZ ' ' A' ' 108' ' ' PHE . 38.6 Cg_exo -58.27 -47.7 18.72 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.354 2.036 . . . . 0.0 112.016 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.845 ' HE ' HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -52.93 -46.17 67.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.904 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.666 ' HA ' HD12 ' A' ' 58' ' ' ILE . 86.7 m-20 -68.0 -40.97 82.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.242 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.71 -44.49 96.83 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.765 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.657 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -56.41 -54.49 45.07 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.812 178.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.845 HD11 ' HE ' ' A' ' 54' ' ' ARG . 10.1 mt -55.25 -55.31 17.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.173 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -60.47 -61.66 2.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.945 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.463 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 4.4 mm-40 -46.89 -43.74 19.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.179 0.514 . . . . 0.0 109.777 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.992 HD22 HG21 ' A' ' 19' ' ' ILE . 9.0 tp -51.17 -48.27 61.96 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.923 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.746 ' HG3' HG23 ' A' ' 68' ' ' THR . 17.9 ttm180 -64.66 -62.91 1.29 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.164 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -49.7 -22.97 1.53 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.268 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -96.02 -37.73 10.52 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.667 HG22 HD23 ' A' ' 121' ' ' LEU . 1.3 p -124.34 -35.69 2.75 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.638 -0.425 . . . . 0.0 112.027 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 107.16 -13.53 40.47 Favored Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -178.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.879 HG11 HD22 ' A' ' 21' ' ' LEU . 78.1 t -56.24 109.75 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 120.889 0.376 . . . . 0.0 110.49 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.746 HG23 ' HG3' ' A' ' 62' ' ' ARG . 3.9 p -120.86 -41.06 2.58 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.315 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.406 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 15.6 m -60.89 72.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.234 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -160.79 157.95 27.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.196 0.522 . . . . 0.0 112.213 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.16 149.63 50.88 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.131 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.809 HG22 ' CE2' ' A' ' 110' ' ' PHE . 12.8 t -74.0 128.14 36.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.172 0.51 . . . . 0.0 111.923 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.541 HD13 ' CE ' ' A' ' 22' ' ' MET . 0.9 OUTLIER -108.83 -18.25 7.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.363 178.668 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.464 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -168.54 179.69 4.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.399 0.619 . . . . 0.0 112.325 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -160.09 147.22 16.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.568 179.764 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.898 ' HA ' HG11 ' A' ' 160' ' ' VAL . 42.7 t -71.2 140.12 85.19 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-O 120.959 0.409 . . . . 0.0 111.533 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.632 ' HD2' HG13 ' A' ' 76' ' ' VAL . 32.2 Cg_endo -64.89 -69.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.094 2.53 . . . . 0.0 112.931 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.765 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -87.4 172.41 9.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.689 -178.909 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.569 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 54.3 m95 -92.93 102.72 15.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.846 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.56 ' CD1' HG22 ' A' ' 157' ' ' VAL . 65.3 mt . . . . . 0 C--N 1.328 -0.357 0 CA-C-O 120.916 0.388 . . . . 0.0 110.79 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.6 ' O ' ' HA ' ' A' ' 15' ' ' ARG . . . . . . . . 0 C--O 1.225 -0.216 0 CA-C-O 120.799 0.333 . . . . 0.0 110.667 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.541 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 36.7 mt-30 -132.32 126.19 32.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.296 0.569 . . . . 0.0 112.354 -178.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 3.3 ttmt -104.55 135.14 46.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.897 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.825 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 38.8 m95 -101.81 165.58 11.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.198 0.523 . . . . 0.0 112.082 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.642 ' HZ ' ' HB2' ' A' ' 53' ' ' PRO . 97.6 m-85 -141.01 152.69 45.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.892 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.668 HD11 ' SD ' ' A' ' 22' ' ' MET . 10.0 tp -101.2 140.04 36.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.744 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.809 ' CE2' HG22 ' A' ' 72' ' ' VAL . 50.6 m-85 -141.49 143.58 33.91 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 26.5 tttt -100.83 124.59 46.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.247 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.753 ' CE1' HG13 ' A' ' 67' ' ' VAL . 30.8 t80 -78.71 101.36 7.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.728 0.299 . . . . 0.0 110.64 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 18.3 p -98.26 40.54 1.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.501 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.406 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -144.43 -145.41 4.34 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.777 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -121.63 149.07 43.71 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.965 0.412 . . . . 0.0 111.449 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.424 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 11.3 p-10 -60.47 -36.32 77.98 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.501 0.667 . . . . 0.0 111.081 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -57.01 -2.87 0.09 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.405 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 116' ' ' ASP . 3.4 tt0 -89.66 -17.71 27.86 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.163 0.506 . . . . 0.0 110.149 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.579 HD13 ' CE1' ' A' ' 29' ' ' PHE . 9.6 mt -83.36 100.65 7.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.373 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -94.86 -0.46 54.03 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.68 HD11 ' HD1' ' A' ' 134' ' ' TRP . 53.5 mt . . . . . 0 N--CA 1.468 0.436 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.544 ' HG3' ' CE1' ' A' ' 131' ' ' PHE . 2.5 tp10 . . . . . 0 N--CA 1.463 0.209 0 CA-C-O 120.731 0.3 . . . . 0.0 110.693 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.553 ' HE2' HG23 ' A' ' 65' ' ' THR . 1.6 m-85 -126.93 140.11 52.57 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.987 0.422 . . . . 0.0 110.378 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.791 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -84.44 -33.44 19.66 Favored Glycine 0 CA--C 1.507 -0.43 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.211 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.59 151.83 29.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.506 -0.347 . . . . 0.0 110.254 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.68 ' HD1' HD11 ' A' ' 121' ' ' LEU . 37.0 p-90 -138.48 169.56 17.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.591 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.516 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 45.9 t -162.06 177.47 9.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.287 0.565 . . . . 0.0 111.364 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.473 ' CE2' ' CZ3' ' A' ' 134' ' ' TRP . 79.7 m95 -109.47 95.65 5.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.95 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.703 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 25.4 m -116.4 162.82 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.772 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.6 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 12.7 p -72.27 174.13 4.65 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.915 0.388 . . . . 0.0 110.567 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.712 ' HB3' HD22 ' A' ' 158' ' ' LEU . 9.4 Cg_exo -63.46 -57.08 0.41 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.526 1.484 . . . . 0.0 110.291 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -60.66 -32.33 71.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.277 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.413 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.9 OUTLIER -70.66 -47.63 58.97 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.566 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.547 HD13 ' CB ' ' A' ' 30' ' ' ALA . 38.7 tp -57.04 -38.42 73.16 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.668 HG12 ' O ' ' A' ' 139' ' ' PRO . 19.9 mm -60.77 -35.66 65.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.286 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -50.12 35.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.213 0.53 . . . . 0.0 110.867 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.505 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -73.85 -21.13 60.22 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.132 -179.525 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.618 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 14.9 t -74.52 171.52 13.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.996 0.427 . . . . 0.0 111.383 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.498 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 27.7 m -73.67 157.27 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.248 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.485 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 15.4 pt-20 -62.19 -54.17 44.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.12 0.486 . . . . 0.0 110.749 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.498 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 41.5 p90 -57.77 -1.15 0.09 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.418 ' HE3' ' HE2' ' A' ' 149' ' ' PHE . 75.0 mttt -132.57 -8.07 3.24 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.162 0.437 . . . . 0.0 111.878 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.536 ' HG3' HG22 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -61.7 -55.98 37.03 Favored Pre-proline 0 N--CA 1.463 0.192 0 CA-C-O 120.422 0.153 . . . . 0.0 110.744 179.308 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.519 ' HD3' ' HD2' ' A' ' 151' ' ' LYS . 29.9 Cg_endo -64.21 -28.51 64.41 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.083 1.855 . . . . 0.0 111.239 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.789 ' O ' HG23 ' A' ' 157' ' ' VAL . 21.6 t -68.04 -52.92 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.503 ' HE1' ' CZ2' ' A' ' 107' ' ' TRP . 16.0 m-30 -63.42 -39.66 95.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.79 178.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.621 ' HD3' HG21 ' A' ' 143' ' ' ILE . 0.1 OUTLIER -53.79 -45.4 70.72 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.083 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.499 ' O ' HG23 ' A' ' 160' ' ' VAL . 3.0 tt0 -67.74 -33.88 75.74 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 153' ' ' VAL . 47.3 t -64.77 -42.36 94.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.392 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.712 HD22 ' HB3' ' A' ' 139' ' ' PRO . 52.1 mt -63.84 -44.14 94.07 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.362 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 40.0 t -52.09 -39.78 60.27 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.898 HG11 ' HA ' ' A' ' 76' ' ' VAL . 57.7 t -66.77 -41.15 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.105 177.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.72 ' CE2' HG12 ' A' ' 157' ' ' VAL . 23.1 m-30 -80.44 5.9 13.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.694 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.7 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . . . -62.88 -50.99 74.62 Favored Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.828 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.7 ' HD3' ' HB3' ' A' ' 162' ' ' ALA . 31.2 Cg_exo -57.67 -15.43 20.74 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 121.896 1.731 . . . . 0.0 111.209 178.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.464 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 83.6 m-70 -107.56 -25.76 11.21 Favored 'General case' 0 N--CA 1.458 -0.065 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.012 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.766 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 50.1 mt . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.543 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 5.7 mtm . . . . . 0 N--CA 1.461 0.076 0 CA-C-O 120.85 0.357 . . . . 0.0 110.681 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.716 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 9.7 t70 . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.043 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.731 ' HG2' HD12 ' A' ' 47' ' ' ILE . 0.7 OUTLIER . . . . . 0 CA--C 1.528 0.1 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.739 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 3.4 m-80 -132.91 172.9 11.99 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.67 HG13 ' CG1' ' A' ' 47' ' ' ILE . 11.1 m -137.26 170.86 17.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 120.963 0.411 . . . . 0.0 111.221 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.562 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -137.1 158.82 24.46 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.814 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.967 HG21 HD22 ' A' ' 61' ' ' LEU . 3.5 mp -131.99 122.76 49.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.589 ' O ' HD12 ' A' ' 109' ' ' LEU . 51.6 t -103.34 92.39 4.48 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.877 HD22 HG11 ' A' ' 67' ' ' VAL . 8.5 tp -98.3 122.06 40.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.647 -178.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.693 ' HE1' HD13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -122.94 160.55 25.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.757 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.619 ' ND2' ' CD2' ' A' ' 136' ' ' TRP . 24.2 m-20 -97.34 -178.12 4.06 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.526 0.679 . . . . 0.0 111.034 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -60.54 -7.41 2.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.747 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 1.3 m-20 -99.71 3.1 44.85 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER 72.51 22.05 3.46 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.073 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -96.41 140.74 30.62 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.724 HD12 ' N ' ' A' ' 28' ' ' ILE . 2.1 mp -97.2 144.03 11.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.658 0.742 . . . . 0.0 112.094 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.61 ' CZ ' HG21 ' A' ' 65' ' ' THR . 5.5 t80 -70.74 106.62 3.62 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.462 -1.245 . . . . 0.0 111.014 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.665 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -104.0 142.87 33.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.72 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.518 ' HB1' ' CG ' ' A' ' 131' ' ' PHE . . . -141.3 137.0 32.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.728 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 10.0 p -101.88 151.41 22.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.645 ' O ' ' N ' ' A' ' 35' ' ' ASP . 7.7 mtp180 -73.4 129.27 37.65 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.367 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.733 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -56.08 53.96 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.72 0.408 . . . . 0.0 112.083 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.645 ' N ' ' O ' ' A' ' 33' ' ' ARG . 4.7 t0 -175.78 -35.31 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.082 0.468 . . . . 0.0 110.098 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.545 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 6.7 mm -112.97 106.05 55.35 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.559 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.81 -62.08 0.18 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.122 2.548 . . . . 0.0 113.98 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -67.2 0.7 2.54 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.74 96.88 10.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.776 0.322 . . . . 0.0 111.059 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.634 ' O ' ' HA ' ' A' ' 146' ' ' THR . 69.7 m95 -100.93 148.51 24.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.783 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.456 ' NE2' ' CD ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -156.19 163.64 39.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.636 0.731 . . . . 0.0 112.466 -179.102 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.707 ' SD ' HG21 ' A' ' 28' ' ' ILE . 12.2 mtm -97.93 150.93 37.27 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.481 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.498 ' CB ' HD13 ' A' ' 61' ' ' LEU . 4.7 Cg_endo -50.18 146.35 18.15 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.186 1.924 . . . . 0.0 111.966 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.582 ' HA ' HD12 ' A' ' 19' ' ' ILE . 1.1 pt20 -173.07 150.96 2.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.642 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.435 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . -160.14 160.67 31.86 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.387 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.739 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -81.13 139.67 20.69 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.479 -179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.731 HD12 ' HG2' ' A' ' 15' ' ' ARG . 40.5 mt -69.82 138.94 21.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.639 -0.281 . . . . 0.0 111.385 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -69.04 -173.54 0.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.974 0.416 . . . . 0.0 110.914 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -46.09 -82.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.148 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -112.07 55.97 0.49 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.994 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -112.4 147.67 35.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.952 0.406 . . . . 0.0 110.852 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -68.73 164.33 46.88 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.132 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 3.6 Cg_exo -78.91 -51.41 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.689 2.259 . . . . 0.0 111.401 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.908 ' CZ ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -51.94 -46.04 64.56 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.331 179.41 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.788 ' HA ' HD12 ' A' ' 58' ' ' ILE . 75.7 m-20 -67.11 -41.8 85.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.108 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.402 ' HB1' ' OE2' ' A' ' 60' ' ' GLU . . . -61.07 -44.22 97.71 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.776 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -56.49 -52.27 65.36 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.747 178.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.788 HD12 ' HA ' ' A' ' 55' ' ' ASN . 9.7 mt -56.32 -55.8 16.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.261 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.73 -63.89 1.14 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.011 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.435 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 0.2 OUTLIER -43.52 -46.12 6.84 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-O 121.248 0.547 . . . . 0.0 110.039 179.583 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.967 HD22 HG21 ' A' ' 19' ' ' ILE . 10.0 tp -52.84 -47.11 67.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.156 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.898 ' HG3' HG23 ' A' ' 68' ' ' THR . 19.7 ttm180 -64.48 -64.97 0.74 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.33 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.12 -21.79 0.82 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.324 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -96.57 -35.17 11.17 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.766 HG22 HD23 ' A' ' 121' ' ' LEU . 0.6 OUTLIER -129.91 -4.69 4.55 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -178.594 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 80.35 -11.13 39.41 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.448 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.877 HG11 HD22 ' A' ' 21' ' ' LEU . 85.4 t -58.0 112.62 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-O 121.079 0.466 . . . . 0.0 111.625 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.898 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -123.86 -39.86 2.36 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.646 178.172 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.6 m -62.24 75.62 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.955 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.63 157.84 25.24 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.157 0.503 . . . . 0.0 112.305 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -131.29 150.17 52.26 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.442 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.908 HG21 ' CZ ' ' A' ' 54' ' ' ARG . 6.4 t -75.51 127.09 36.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.21 0.529 . . . . 0.0 111.414 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.693 HD13 ' HE1' ' A' ' 22' ' ' MET . 0.7 OUTLIER -109.13 -19.65 6.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.559 179.466 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.523 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -168.92 177.47 4.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.755 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -157.46 147.78 20.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.664 179.851 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.784 ' HA ' HG11 ' A' ' 160' ' ' VAL . 50.2 t -71.51 139.17 83.74 Favored Pre-proline 0 C--N 1.332 -0.152 0 CA-C-O 121.084 0.469 . . . . 0.0 110.827 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HD2' HG13 ' A' ' 76' ' ' VAL . 36.4 Cg_endo -66.21 -52.88 0.75 Allowed 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.805 2.337 . . . . 0.0 112.916 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.716 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -101.21 174.12 6.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.314 0.578 . . . . 0.0 112.13 -178.763 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -92.61 95.86 9.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.487 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.651 ' CD1' HG22 ' A' ' 157' ' ' VAL . 62.4 mt . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 120.776 0.322 . . . . 0.0 110.823 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.267 0 CA-C-O 121.196 0.522 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.694 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 40.7 mt-30 -126.12 133.07 51.74 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -105.72 130.66 53.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.34 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.562 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 14.3 m95 -99.34 161.47 13.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.055 0.455 . . . . 0.0 111.735 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.495 ' CE1' ' HG2' ' A' ' 54' ' ' ARG . 98.1 m-85 -139.9 152.13 46.16 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.292 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.672 ' HG ' HD12 ' A' ' 73' ' ' ILE . 17.3 tp -99.01 134.81 41.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.458 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.577 ' CZ ' HG22 ' A' ' 72' ' ' VAL . 27.2 m-85 -136.46 144.67 44.51 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 15.2 tttt -103.94 119.95 40.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.216 177.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.702 ' CE1' HG13 ' A' ' 67' ' ' VAL . 43.0 t80 -78.37 100.46 6.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.794 0.331 . . . . 0.0 110.667 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 18.6 p -97.13 45.16 1.04 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.85 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.68 -147.93 4.75 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.058 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -119.34 149.72 41.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 0.0 111.056 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.446 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 14.7 p-10 -60.38 -38.68 84.69 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.512 0.672 . . . . 0.0 111.243 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -55.98 -3.03 0.07 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.598 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.401 ' H ' ' C ' ' A' ' 116' ' ' ASP . 1.1 tt0 -89.71 -18.88 25.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.943 0.401 . . . . 0.0 110.556 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.699 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 20.1 mt -85.0 106.21 14.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.849 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 38.3 t30 -100.54 -25.41 14.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.327 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.766 HD23 HG22 ' A' ' 65' ' ' THR . 46.5 mt . . . . . 0 N--CA 1.465 0.322 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.206 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.522 ' O ' HD12 ' A' ' 34' ' ' LEU . 3.1 mm-40 . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.991 0.424 . . . . 0.0 111.358 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.655 ' CE2' HG23 ' A' ' 65' ' ' THR . 1.9 m-85 -104.41 142.42 34.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.673 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.733 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -85.03 -37.46 10.02 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.043 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -146.24 145.39 30.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.76 0.314 . . . . 0.0 110.483 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.699 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 36.2 p-90 -135.71 170.95 15.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.27 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.5 t -167.68 178.48 5.3 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.491 0.662 . . . . 0.0 112.719 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.619 ' CD2' ' ND2' ' A' ' 23' ' ' ASN . 81.2 m95 -113.12 102.99 10.91 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.588 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 28' ' ' ILE . 25.4 m -120.83 170.44 10.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.586 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 11.1 p -75.41 173.05 7.65 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.889 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.675 ' HB3' HD22 ' A' ' 158' ' ' LEU . 12.3 Cg_exo -62.61 -54.01 1.49 Allowed 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.731 1.621 . . . . 0.0 110.381 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -63.93 -30.69 71.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.356 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.76 -43.77 65.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.474 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.665 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -59.8 -39.27 84.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.313 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.754 HG21 ' HG2' ' A' ' 155' ' ' LYS . 34.1 mm -63.04 -37.21 78.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.19 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.94 -50.81 38.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.35 0.595 . . . . 0.0 110.528 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.3 mp -73.49 -19.82 60.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.179 -0.918 . . . . 0.0 112.709 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 12.4 t -75.81 172.06 13.33 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.111 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.471 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 26.9 m -82.77 145.17 8.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.378 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.554 ' HG3' ' HE3' ' A' ' 151' ' ' LYS . 6.7 mt-10 -47.46 -50.32 23.27 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.602 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -50.2 -12.27 0.08 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -135.37 -3.91 2.38 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.62 ' HG2' HG23 ' A' ' 146' ' ' THR . 8.1 mttt -58.69 -60.71 9.5 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.379 0.133 . . . . 0.0 111.178 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.497 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 32.3 Cg_endo -64.44 -27.57 62.53 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.641 2.227 . . . . 0.0 111.754 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.797 ' O ' HG23 ' A' ' 157' ' ' VAL . 40.3 t -67.88 -50.41 59.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.501 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 8.9 m-30 -66.59 -38.54 87.23 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.021 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.754 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -57.24 -41.18 79.09 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.812 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.406 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.4 tt0 -70.09 -31.48 69.08 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 153' ' ' VAL . 51.0 t -66.9 -42.2 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.797 178.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.675 HD22 ' HB3' ' A' ' 139' ' ' PRO . 74.0 mt -63.89 -40.23 96.04 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.238 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 64.2 m -56.41 -41.79 76.93 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.784 HG11 ' HA ' ' A' ' 76' ' ' VAL . 89.3 t -66.74 -43.72 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 115.525 -0.761 . . . . 0.0 108.983 177.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.504 ' CE2' HG12 ' A' ' 157' ' ' VAL . 21.9 m-30 -81.12 7.46 11.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.436 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.692 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . . . -59.22 -50.45 87.56 Favored Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.755 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.692 ' HD3' ' HB3' ' A' ' 162' ' ' ALA . 34.0 Cg_exo -59.41 -13.05 18.87 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.425 2.083 . . . . 0.0 111.58 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.523 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 86.7 m-70 -109.02 -20.75 12.92 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.294 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.509 HD23 ' HZ1' ' A' ' 26' ' ' LYS . 83.8 mt . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.942 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.434 ' O ' ' HB2' ' A' ' 79' ' ' TRP . 1.9 mpp? . . . . . 0 CA--C 1.523 -0.076 0 CA-C-O 120.641 0.258 . . . . 0.0 110.847 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.697 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 12.4 p-10 . . . . . 0 C--N 1.331 -0.197 0 CA-C-O 121.015 0.436 . . . . 0.0 110.759 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.655 ' HG2' HD12 ' A' ' 47' ' ' ILE . 23.2 ttt180 . . . . . 0 N--CA 1.45 -0.457 0 CA-C-O 121.212 0.53 . . . . 0.0 109.751 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.569 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 23.7 m-80 -130.9 171.68 12.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.981 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.701 HG13 HD11 ' A' ' 47' ' ' ILE . 22.4 m -134.26 163.34 37.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.14 0.495 . . . . 0.0 111.199 178.172 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.615 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -138.66 157.87 24.82 Favored Glycine 0 N--CA 1.442 -0.955 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.301 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.659 HG21 HD13 ' A' ' 61' ' ' LEU . 2.1 mp -128.56 118.22 46.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.588 ' O ' HD12 ' A' ' 109' ' ' LEU . 50.3 t -96.82 98.34 10.05 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 177.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.629 HD21 ' HD1' ' A' ' 112' ' ' PHE . 32.0 tp -99.29 116.18 30.87 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.106 -177.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.891 ' HE2' HD13 ' A' ' 73' ' ' ILE . 1.6 ptt? -119.66 161.77 20.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.027 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.52 ' N ' ' OD1' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -94.45 171.32 8.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.092 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -57.34 -5.53 0.32 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.703 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.575 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.6 OUTLIER -99.37 3.04 45.79 Favored 'General case' 0 CA--C 1.521 -0.136 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.877 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 11.0 mmtp 73.71 21.88 2.68 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.986 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.613 ' O ' ' HA ' ' A' ' 22' ' ' MET . 2.3 mmtt -92.66 143.17 26.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.729 HD11 ' HG3' ' A' ' 139' ' ' PRO . 1.4 mm -98.96 138.0 24.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.17 0.51 . . . . 0.0 112.283 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.608 ' CE1' HD13 ' A' ' 119' ' ' ILE . 78.1 t80 -75.05 136.67 41.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.398 177.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.715 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -140.33 151.48 45.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.679 0.275 . . . . 0.0 111.102 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -141.34 138.14 32.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.33 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.69 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 43.9 p -95.69 144.87 25.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.66 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.457 ' NE ' HD12 ' A' ' 36' ' ' ILE . 35.1 mtp180 -69.68 136.15 50.71 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.213 0.53 . . . . 0.0 111.318 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.93 ' H ' HD23 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -42.11 -48.9 4.82 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.583 -178.947 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -71.69 -33.25 68.64 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.95 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.457 HD12 ' NE ' ' A' ' 33' ' ' ARG . 2.8 mt -122.45 110.46 32.24 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.758 0.313 . . . . 0.0 111.531 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.6 -18.77 15.15 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.449 2.099 . . . . 0.0 112.382 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -91.73 -10.45 40.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.352 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.693 ' HB1' ' CG1' ' A' ' 147' ' ' VAL . . . -91.2 96.47 10.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.564 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.69 ' O ' ' HA ' ' A' ' 146' ' ' THR . 76.0 m95 -90.86 147.59 23.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.682 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -154.84 169.73 23.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.471 0.653 . . . . 0.0 111.667 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.505 ' HB2' ' HE2' ' A' ' 42' ' ' MET . 19.3 mtm -107.3 147.2 34.78 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.176 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.484 ' CG ' HD12 ' A' ' 61' ' ' LEU . 5.3 Cg_endo -48.8 136.88 27.91 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.459 2.106 . . . . 0.0 111.525 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.504 ' HA ' HD12 ' A' ' 19' ' ' ILE . 3.1 pp0? -173.08 155.01 2.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.996 0.427 . . . . 0.0 111.269 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.484 ' O ' ' HB3' ' A' ' 16' ' ' ASN . . . -156.04 -165.1 14.04 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.571 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.569 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -95.71 -148.72 24.64 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.209 -0.996 . . . . 0.0 113.243 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.701 HD11 HG13 ' A' ' 17' ' ' VAL . 3.0 mt -163.04 125.92 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.545 -0.328 . . . . 0.0 110.488 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.29 169.51 16.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.083 0.468 . . . . 0.0 111.122 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -46.25 -62.22 1.44 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.696 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -99.88 42.35 1.99 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.775 -0.726 . . . . 0.0 113.089 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -119.64 128.81 54.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.553 0.216 . . . . 0.0 110.571 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -69.13 164.61 46.59 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.592 ' HA ' HG11 ' A' ' 17' ' ' VAL . 3.4 Cg_exo -76.81 -48.05 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.65 2.233 . . . . 0.0 111.912 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.755 HH21 HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -55.84 -43.87 77.43 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.21 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 73.9 m-20 -66.92 -45.13 78.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.293 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.29 -43.79 98.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.605 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -57.37 -61.14 2.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.902 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.546 HG12 ' CE2' ' A' ' 110' ' ' PHE . 25.4 mt -54.61 -48.65 70.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.393 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 13.5 ttt180 -64.96 -62.24 1.67 Allowed 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 121.066 -0.254 . . . . 0.0 111.078 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -42.53 -48.68 5.35 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-O 120.908 0.385 . . . . 0.0 110.101 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.659 HD13 HG21 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -51.25 -47.84 62.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.267 178.761 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.9 ' HG3' HG23 ' A' ' 68' ' ' THR . 9.0 ttm180 -63.94 -65.28 0.7 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.124 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -48.62 -19.94 0.4 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -98.82 -35.37 10.14 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.795 HG22 HD23 ' A' ' 121' ' ' LEU . 0.7 OUTLIER -124.68 -6.93 7.4 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 120.326 -0.549 . . . . 0.0 112.319 -178.932 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 79.56 -12.35 28.09 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.488 -178.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.717 HG22 HG12 ' A' ' 119' ' ' ILE . 78.9 t -57.43 121.8 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 121.164 0.506 . . . . 0.0 111.306 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.9 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.6 OUTLIER -131.78 -38.22 1.14 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.808 178.637 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 113' ' ' THR . 5.8 m -61.24 71.75 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.894 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -159.81 153.34 22.52 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.097 0.475 . . . . 0.0 112.212 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -128.19 151.73 48.9 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.845 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.799 HG22 ' CE2' ' A' ' 110' ' ' PHE . 10.8 t -75.43 132.66 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 121.313 0.577 . . . . 0.0 111.575 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.891 HD13 ' HE2' ' A' ' 22' ' ' MET . 1.7 mt -109.85 -18.79 7.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.932 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.489 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.22 176.03 4.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.604 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -152.71 145.58 24.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.452 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.735 ' HA ' HG11 ' A' ' 160' ' ' VAL . 52.9 t -71.94 134.67 83.27 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.142 0.496 . . . . 0.0 111.208 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.522 ' HD2' HG13 ' A' ' 76' ' ' VAL . 33.0 Cg_endo -67.39 -56.87 0.2 Allowed 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.912 2.408 . . . . 0.0 113.01 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.697 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 1.3 p90 -97.29 178.28 5.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.813 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.582 ' O ' HD23 ' A' ' 80' ' ' LEU . 56.1 m95 -94.83 -158.58 0.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.47 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.865 ' HB2' ' HG2' ' A' ' 105' ' ' GLN . 13.1 mt . . . . . 0 N--CA 1.463 0.22 0 CA-C-O 121.127 0.489 . . . . 0.0 110.359 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 80' ' ' LEU . . . . . . . . 0 CA--C 1.522 -0.126 0 CA-C-O 121.018 0.437 . . . . 0.0 111.791 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.865 ' HG2' ' HB2' ' A' ' 80' ' ' LEU . 1.0 OUTLIER -129.2 118.82 23.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.875 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 78' ' ' TYR . 16.3 ttpp -102.91 129.07 49.5 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.939 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.615 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 22.7 m95 -102.38 165.18 11.26 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -177.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.518 ' CZ ' ' HB2' ' A' ' 53' ' ' PRO . 96.5 m-85 -137.53 153.94 49.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.546 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.588 HD12 ' O ' ' A' ' 20' ' ' CYS . 16.8 tp -101.08 139.46 36.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.402 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.799 ' CE2' HG22 ' A' ' 72' ' ' VAL . 34.0 m-85 -141.88 145.97 35.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.555 0.693 . . . . 0.0 112.828 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.706 ' HB2' HD11 ' A' ' 73' ' ' ILE . 18.7 tttt -104.69 123.3 47.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.917 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.629 ' HD1' HD21 ' A' ' 21' ' ' LEU . 46.5 t80 -78.6 95.32 5.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.868 0.366 . . . . 0.0 110.663 179.115 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.419 ' N ' ' O ' ' A' ' 69' ' ' SER . 65.7 p -94.16 50.89 1.43 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.876 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -151.99 -143.43 3.7 Favored Glycine 0 N--CA 1.453 -0.217 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.055 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -124.97 150.0 47.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.368 . . . . 0.0 111.244 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.476 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 20.3 p-10 -57.07 -39.03 74.16 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.519 0.676 . . . . 0.0 111.143 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -58.21 -4.58 0.37 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.101 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -89.62 -17.02 29.24 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.079 0.466 . . . . 0.0 110.128 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.717 HG12 HG22 ' A' ' 67' ' ' VAL . 7.6 mt -78.77 99.88 3.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.33 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.98 91.08 3.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.529 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.795 HD23 HG22 ' A' ' 65' ' ' THR . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 120.73 0.3 . . . . 0.0 110.631 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.663 ' C ' HD21 ' A' ' 34' ' ' LEU . 0.8 OUTLIER . . . . . 0 CA--C 1.52 -0.204 0 CA-C-O 121.298 0.57 . . . . 0.0 109.74 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.648 ' N ' HD21 ' A' ' 34' ' ' LEU . 4.9 m-85 -133.78 139.18 46.16 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.758 ' N ' HD22 ' A' ' 34' ' ' LEU . . . -77.58 -35.79 35.52 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.848 -178.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -156.13 152.01 27.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.872 0.368 . . . . 0.0 111.083 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.64 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 27.5 p-90 -133.15 163.99 28.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.197 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.489 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 13.4 t -158.95 167.33 29.66 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.157 0.503 . . . . 0.0 112.072 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.473 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 37.3 m95 -103.44 102.84 12.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.4 177.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 28' ' ' ILE . 26.4 m -118.21 164.91 14.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.593 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 26.8 p -71.64 168.98 17.52 Favored Pre-proline 0 C--N 1.325 -0.474 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.408 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.729 ' HG3' HD11 ' A' ' 28' ' ' ILE . 16.2 Cg_exo -58.91 -58.82 0.57 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 121.72 1.613 . . . . 0.0 110.826 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.28 -27.16 68.83 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.794 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.526 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 12.2 mt-30 -71.69 -47.47 53.85 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.205 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.715 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -56.24 -41.28 75.48 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.637 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.816 HG21 ' HG2' ' A' ' 155' ' ' LYS . 19.1 mm -61.44 -34.57 61.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.219 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.39 -50.92 23.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.262 0.553 . . . . 0.0 110.858 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.2 mp -73.49 -21.47 60.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.311 -0.858 . . . . 0.0 112.281 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.69 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 12.1 t -73.61 174.81 7.78 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.918 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.693 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 33.0 m -80.02 160.2 4.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.688 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.47 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 2.4 mt-10 -60.59 -51.9 67.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.07 0.462 . . . . 0.0 110.915 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.24 -7.65 0.15 Allowed 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -131.43 -6.38 3.75 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.612 ' HG3' HG22 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -61.74 -53.57 59.55 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 110.543 -0.169 . . . . 0.0 110.543 179.499 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 39.5 Cg_endo -67.97 -28.88 35.03 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.259 1.973 . . . . 0.0 111.347 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.689 ' O ' HG23 ' A' ' 157' ' ' VAL . 17.3 t -68.47 -52.83 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.469 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 6.1 m-30 -65.75 -37.1 85.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.784 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.816 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -57.46 -41.61 80.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.591 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.481 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.6 OUTLIER -68.35 -34.32 75.88 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.465 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 153' ' ' VAL . 53.8 t -64.9 -41.17 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.347 178.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.606 HD22 ' HB3' ' A' ' 139' ' ' PRO . 56.7 mt -63.65 -48.91 75.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.666 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -49.2 -40.1 32.16 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.735 HG11 ' HA ' ' A' ' 76' ' ' VAL . 58.5 t -67.63 -42.91 87.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.328 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.63 ' CE2' HG12 ' A' ' 157' ' ' VAL . 21.9 m-30 -80.71 5.15 16.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.38 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.607 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.85 -53.36 67.22 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.628 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.7 Cg_endo -58.77 -13.2 17.09 Favored 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 122.17 1.914 . . . . 0.0 111.729 178.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.489 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 95.1 m-70 -107.06 -19.08 13.73 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.205 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 96.5 mt . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.807 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 4.1 mtm . . . . . 0 N--CA 1.456 -0.142 0 CA-C-O 120.59 0.233 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.526 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 12.2 t70 . . . . . 0 C--N 1.33 -0.263 0 CA-C-O 120.916 0.389 . . . . 0.0 110.54 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.865 ' HG2' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.064 0.459 . . . . 0.0 111.214 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.637 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 2.0 m-80 -131.59 173.74 10.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.46 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.615 HG13 HG13 ' A' ' 47' ' ' ILE . 6.6 m -139.55 165.32 22.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.174 0.511 . . . . 0.0 111.84 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.529 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -135.38 155.31 22.08 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 178.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.091 HG23 ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -129.67 124.51 59.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.069 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.533 ' CB ' ' HE2' ' A' ' 161' ' ' PHE . 0.5 OUTLIER -106.6 108.69 20.32 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.953 177.717 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.875 HD22 HG11 ' A' ' 67' ' ' VAL . 11.0 tp -104.19 124.3 48.87 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.582 -178.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.713 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -124.34 155.18 39.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.95 179.342 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.506 ' OD1' ' CE3' ' A' ' 136' ' ' TRP . 0.2 OUTLIER -92.85 176.04 6.58 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.05 0.452 . . . . 0.0 110.134 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.453 ' HA ' ' HE3' ' A' ' 111' ' ' LYS . 1.1 m-80 -57.24 -6.94 0.46 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.064 177.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.604 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 5.5 m-20 -100.46 -0.15 38.56 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.604 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 14.7 mmtm 76.97 19.86 1.33 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.291 -178.545 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.713 ' O ' ' HA ' ' A' ' 22' ' ' MET . 3.8 mmtt -93.57 141.58 28.31 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.69 HD12 ' N ' ' A' ' 28' ' ' ILE . 2.2 mp -101.5 143.51 14.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.669 0.747 . . . . 0.0 112.358 -178.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.657 ' CE2' HG21 ' A' ' 65' ' ' THR . 11.3 t80 -69.85 108.05 3.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.196 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.734 ' CB ' HD13 ' A' ' 142' ' ' LEU . . . -106.92 145.89 31.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.948 0.404 . . . . 0.0 110.924 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -139.5 137.52 35.57 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.236 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.808 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 25.0 p -99.19 141.75 31.55 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.998 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.581 ' NH1' ' HG2' ' A' ' 41' ' ' GLN . 1.7 mtt85 -69.59 128.34 36.14 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.728 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.5 OUTLIER -46.4 -35.73 5.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.318 0.58 . . . . 0.0 110.891 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.487 ' O ' HD13 ' A' ' 36' ' ' ILE . 4.0 m-20 -70.67 -33.97 71.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.665 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.487 HD13 ' O ' ' A' ' 35' ' ' ASP . 20.4 mm -131.05 104.75 15.16 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.914 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.55 -20.37 60.4 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.765 2.31 . . . . 0.0 112.676 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.01 -4.0 53.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.412 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.808 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.97 91.83 8.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.112 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.558 ' O ' ' HA ' ' A' ' 146' ' ' THR . 77.3 m95 -91.83 164.38 13.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.357 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.581 ' HG2' ' NH1' ' A' ' 33' ' ' ARG . 0.0 OUTLIER 174.24 175.13 0.16 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.81 0.814 . . . . 0.0 112.264 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.612 ' HG3' ' CZ3' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -108.19 156.7 37.95 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.29 177.904 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.439 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 10.1 Cg_endo -50.7 157.35 3.64 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.498 2.132 . . . . 0.0 112.665 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.99 150.62 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.6 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -160.9 -157.27 8.64 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.447 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.637 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -122.22 143.01 15.33 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.91 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.865 HD12 ' HG2' ' A' ' 15' ' ' ARG . 48.5 mt -70.01 146.71 12.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.916 0.389 . . . . 0.0 111.532 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -69.49 -175.08 0.77 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.72 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.51 -61.33 2.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.339 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.85 57.35 0.73 Allowed Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.689 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.426 ' O ' HG21 ' A' ' 47' ' ' ILE . 47.7 tp10 -117.17 155.7 28.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.693 0.283 . . . . 0.0 110.469 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -72.02 161.56 78.19 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 5.6 Cg_exo -78.3 -49.17 0.09 OUTLIER 'Trans proline' 0 CA--C 1.515 -0.441 0 C-N-CA 122.635 2.223 . . . . 0.0 111.73 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.814 ' HE ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -52.26 -46.92 65.99 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.47 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.454 ' HA ' HD12 ' A' ' 58' ' ' ILE . 20.2 m120 -67.71 -41.85 82.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.376 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.22 -42.26 98.29 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.091 ' HB1' HG23 ' A' ' 19' ' ' ILE . . . -57.47 -54.27 48.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.855 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.513 HD11 ' CZ ' ' A' ' 54' ' ' ARG . 21.3 mt -56.39 -53.0 45.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.854 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 59' ' ' ARG . 24.1 mtt180 -61.21 -57.71 11.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.652 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 15.1 mm-40 -46.5 -46.03 18.83 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.553 0.692 . . . . 0.0 109.709 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.955 HD21 ' HB ' ' A' ' 67' ' ' VAL . 10.1 tt -52.81 -46.69 67.81 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.959 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.827 ' HD3' HG23 ' A' ' 68' ' ' THR . 0.7 OUTLIER -62.77 -63.43 1.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.995 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -50.42 -22.54 1.92 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.357 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 8.6 mt-10 -96.74 -34.76 11.22 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -177.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.657 HG21 ' CE2' ' A' ' 29' ' ' PHE . 0.8 OUTLIER -130.29 -15.44 3.67 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.465 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.549 ' HA2' ' NE ' ' A' ' 62' ' ' ARG . . . 93.07 -16.32 60.79 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.656 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.955 ' HB ' HD21 ' A' ' 61' ' ' LEU . 74.8 t -58.15 113.86 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.262 0.553 . . . . 0.0 111.937 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.827 HG23 ' HD3' ' A' ' 62' ' ' ARG . 0.2 OUTLIER -125.87 -36.78 2.35 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.716 178.075 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.9 m -63.6 73.83 0.03 OUTLIER 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.698 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -159.28 157.06 29.85 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.898 0.38 . . . . 0.0 111.981 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.8 149.08 50.42 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.101 179.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.952 HG22 ' CE2' ' A' ' 110' ' ' PHE . 19.1 t -74.21 126.3 34.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.077 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.566 HD11 ' HB2' ' A' ' 111' ' ' LYS . 1.4 mt -105.52 -17.6 7.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.236 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.45 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -171.09 175.71 4.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.484 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.0 OUTLIER -154.06 138.65 16.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.109 179.492 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.632 ' HA ' HG11 ' A' ' 160' ' ' VAL . 52.3 t -71.33 135.27 84.43 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-O 121.178 0.513 . . . . 0.0 111.16 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.521 ' HD2' HG13 ' A' ' 76' ' ' VAL . 27.3 Cg_endo -66.16 -70.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.867 2.378 . . . . 0.0 112.027 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.53 ' O ' HG12 ' A' ' 76' ' ' VAL . 6.4 p90 -78.33 170.67 16.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.095 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.609 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 48.2 m95 -93.64 -155.14 0.43 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.467 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.532 HD12 ' HD1' ' A' ' 107' ' ' TRP . 20.8 mt . . . . . 0 C--N 1.326 -0.426 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.119 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.571 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 5.2 mt-30 -128.99 127.33 41.43 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.535 ' HB2' ' CD2' ' A' ' 79' ' ' TRP . 2.0 ttpt -105.67 141.38 37.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.718 178.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.612 ' CZ3' ' HG3' ' A' ' 42' ' ' MET . 54.9 m95 -105.98 163.74 12.52 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.266 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.595 ' HB2' ' HE1' ' A' ' 110' ' ' PHE . 96.0 m-85 -141.07 152.47 44.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.895 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.695 HD11 ' SD ' ' A' ' 22' ' ' MET . 17.8 tp -101.87 143.29 31.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.13 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.999 ' CE1' HG22 ' A' ' 19' ' ' ILE . 54.8 m-85 -144.51 145.08 31.66 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.637 0.732 . . . . 0.0 112.965 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.566 ' HB2' HD11 ' A' ' 73' ' ' ILE . 4.4 tttt -104.23 126.06 51.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.737 178.253 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.636 ' CD1' HD21 ' A' ' 21' ' ' LEU . 34.9 t80 -78.99 100.74 7.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.741 0.305 . . . . 0.0 110.868 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 72.7 p -100.83 50.06 0.88 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.993 0.425 . . . . 0.0 110.952 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -154.1 -145.58 4.19 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.294 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -121.5 150.89 40.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.017 0.437 . . . . 0.0 110.973 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.505 ' HB3' ' HH2' ' A' ' 134' ' ' TRP . 44.7 m-20 -59.11 -34.72 72.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.032 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -58.96 -2.62 0.26 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.191 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.57 -15.23 33.31 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.805 0.336 . . . . 0.0 111.037 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.745 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 11.3 mt -78.54 100.3 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.828 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -102.42 92.34 4.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.099 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.718 HD11 ' HD1' ' A' ' 134' ' ' TRP . 38.0 mt . . . . . 0 C--N 1.331 -0.215 0 CA-C-O 121.159 0.504 . . . . 0.0 110.036 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.571 ' O ' HD12 ' A' ' 34' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.995 0.426 . . . . 0.0 110.673 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.531 ' CE1' HG23 ' A' ' 65' ' ' THR . 2.6 m-85 -106.67 142.6 36.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.497 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.728 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -80.77 -36.01 23.58 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.478 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.51 155.54 36.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.261 -0.47 . . . . 0.0 110.274 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.745 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 25.0 p-90 -140.45 167.53 21.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.159 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.546 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 26.6 t -163.01 176.13 10.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.286 0.565 . . . . 0.0 111.533 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.506 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 64.5 m95 -111.75 103.73 12.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.48 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.415 HG23 ' HB2' ' A' ' 142' ' ' LEU . 26.0 m -121.67 171.54 10.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.375 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.634 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 10.9 p -74.15 177.03 2.34 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 1.003 ' HB2' HD21 ' A' ' 158' ' ' LEU . 13.9 Cg_endo -74.27 -47.37 0.25 Allowed 'Trans proline' 0 N--CA 1.443 -1.481 0 C-N-CA 121.242 1.294 . . . . 0.0 109.964 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.4 -32.89 73.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.9 177.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.61 -47.97 57.46 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.021 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.734 HD13 ' CB ' ' A' ' 30' ' ' ALA . 23.9 tp -60.75 -37.61 82.38 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.715 ' O ' HG22 ' A' ' 146' ' ' THR . 31.1 mm -59.19 -40.09 80.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 121.373 0.606 . . . . 0.0 109.468 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.29 -51.67 34.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.127 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.468 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -72.76 -17.94 61.55 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.97 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.715 HG22 ' O ' ' A' ' 143' ' ' ILE . 14.2 t -74.64 -175.94 2.62 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.063 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.694 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 28.7 m -87.74 151.41 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.06 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.702 ' HG2' ' N ' ' A' ' 149' ' ' PHE . 0.6 OUTLIER -58.76 -53.41 58.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.938 0.399 . . . . 0.0 111.368 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.702 ' N ' ' HG2' ' A' ' 148' ' ' GLU . 48.0 p90 -56.18 -3.35 0.09 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.452 ' HE2' ' CE2' ' A' ' 149' ' ' PHE . 0.7 OUTLIER -133.14 -4.84 3.06 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.757 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.655 ' HG2' ' O ' ' A' ' 143' ' ' ILE . 9.1 mttt -62.37 -59.99 11.31 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.48 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 13.6 Cg_endo -56.57 -26.07 62.39 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.25 1.966 . . . . 0.0 111.635 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 12.1 t -68.69 -54.16 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.545 ' O ' ' HB ' ' A' ' 157' ' ' VAL . 4.9 m-30 -65.3 -37.05 85.96 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.807 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.428 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -57.31 -40.46 77.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.264 179.585 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.411 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.9 OUTLIER -66.68 -29.39 69.39 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.075 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.545 ' HB ' ' O ' ' A' ' 154' ' ' TYR . 88.9 t -64.67 -39.23 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.216 179.133 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 1.003 HD21 ' HB2' ' A' ' 139' ' ' PRO . 0.2 OUTLIER -61.33 -50.1 74.3 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.074 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.4 m -51.95 -43.05 63.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.932 0.396 . . . . 0.0 110.028 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.632 HG11 ' HA ' ' A' ' 76' ' ' VAL . 50.0 t -68.15 -42.2 84.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.346 0.593 . . . . 0.0 109.433 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.544 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 13.2 m-30 -81.28 5.14 18.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.739 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.616 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.44 -52.14 76.38 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.692 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 17.8 Cg_endo -59.72 -12.06 16.71 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.263 1.975 . . . . 0.0 112.045 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.528 ' O ' ' HE3' ' A' ' 26' ' ' LYS . 92.3 m-70 -109.17 -20.77 12.87 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.337 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 94.0 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.974 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.479 ' C ' ' HB2' ' A' ' 78' ' ' TYR . 0.7 OUTLIER . . . . . 0 CA--C 1.522 -0.111 0 CA-C-O 120.711 0.291 . . . . 0.0 110.49 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.673 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 1.8 t0 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.319 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.626 ' HG3' ' CZ3' ' A' ' 79' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 121.274 0.559 . . . . 0.0 110.218 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.991 ' HB2' ' HG2' ' A' ' 105' ' ' GLN . 3.0 m120 -135.48 172.86 12.4 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.978 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.706 HG13 ' CG1' ' A' ' 47' ' ' ILE . 5.3 m -136.98 168.7 21.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.592 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -140.45 154.6 24.23 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.388 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.011 HG23 ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -129.05 125.33 62.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.158 0.504 . . . . 0.0 111.98 -178.851 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.526 ' O ' HD12 ' A' ' 109' ' ' LEU . 43.4 t -104.57 102.85 12.46 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 178.18 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.887 HD22 HG11 ' A' ' 67' ' ' VAL . 24.7 tp -104.14 119.2 38.42 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.366 0.603 . . . . 0.0 111.659 -178.216 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.689 ' HE3' HD13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -119.86 158.92 25.63 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.786 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.714 ' ND2' ' CD2' ' A' ' 136' ' ' TRP . 77.6 m-20 -98.02 179.1 4.89 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.806 0.812 . . . . 0.0 111.819 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -58.44 -6.55 0.7 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.354 -1.293 . . . . 0.0 111.464 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.546 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.6 OUTLIER -101.21 3.39 40.92 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.726 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 3.1 mmpp? 72.08 22.53 3.67 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -178.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 22' ' ' MET . 10.3 mttt -95.02 149.97 20.67 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.725 HG13 ' HA ' ' A' ' 139' ' ' PRO . 1.9 mm -100.98 138.51 24.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.3 0.571 . . . . 0.0 111.519 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.627 ' CE1' HD13 ' A' ' 119' ' ' ILE . 72.6 t80 -73.63 133.62 43.49 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.358 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.828 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -133.53 152.68 51.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.82 0.343 . . . . 0.0 111.175 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.556 ' HB1' ' CB ' ' A' ' 131' ' ' PHE . . . -145.4 136.19 24.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.939 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.644 ' HA ' ' NH2' ' A' ' 33' ' ' ARG . 39.3 p -99.41 147.73 24.95 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.99 0.424 . . . . 0.0 111.829 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.644 ' NH2' ' HA ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -69.9 131.38 44.35 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.933 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.758 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.5 OUTLIER -57.13 51.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 179.694 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.619 ' N ' ' O ' ' A' ' 33' ' ' ARG . 0.6 OUTLIER -175.31 -26.69 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.666 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.517 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 5.3 mm -119.92 106.54 41.27 Favored Pre-proline 0 CA--C 1.53 0.189 0 CA-C-O 120.968 0.413 . . . . 0.0 110.649 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.22 -63.76 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.447 2.765 . . . . 0.0 114.019 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -64.91 0.47 1.19 Allowed 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.54 ' HB1' ' HE ' ' A' ' 33' ' ' ARG . . . -90.56 110.91 22.04 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 120.528 0.204 . . . . 0.0 110.838 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.705 ' O ' ' HA ' ' A' ' 146' ' ' THR . 74.4 m95 -118.78 150.57 39.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.746 0.308 . . . . 0.0 110.611 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.581 ' HG3' ' NH2' ' A' ' 33' ' ' ARG . 67.0 mt-30 -157.96 173.4 16.82 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.385 0.612 . . . . 0.0 111.687 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.438 ' SD ' HG21 ' A' ' 28' ' ' ILE . 3.3 mtm -106.63 152.77 40.84 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.958 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.527 ' O ' HG12 ' A' ' 19' ' ' ILE . 12.5 Cg_endo -55.68 144.22 76.5 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.124 1.883 . . . . 0.0 111.499 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.433 ' CB ' ' HA2' ' A' ' 18' ' ' GLY . 3.9 pt20 -175.94 157.14 1.86 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.819 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.43 ' HA3' ' OE1' ' A' ' 60' ' ' GLU . . . -161.89 -159.42 10.16 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.469 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.61 ' C ' HG13 ' A' ' 47' ' ' ILE . . . -99.4 -148.72 23.43 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.595 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.706 ' CG1' HG13 ' A' ' 17' ' ' VAL . 7.5 mt -158.68 141.03 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 122.803 0.441 . . . . 0.0 110.077 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -67.84 -173.45 0.35 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.336 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.54 -81.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.41 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -107.49 54.88 0.54 Allowed Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.06 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -112.07 136.78 51.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.773 0.32 . . . . 0.0 110.928 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.479 ' HB2' ' ND2' ' A' ' 55' ' ' ASN . 13.5 m-20 -66.52 147.46 98.96 Favored Pre-proline 0 N--CA 1.453 -0.285 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.34 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.572 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 23.1 Cg_exo -64.37 -48.51 4.5 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 123.077 2.518 . . . . 0.0 113.393 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.887 ' HE ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -45.72 -50.83 13.34 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.603 -179.428 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.479 ' ND2' ' HB2' ' A' ' 52' ' ' ASP . 22.2 p30 -65.7 -42.07 91.6 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.7 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.446 ' N ' ' OD1' ' A' ' 55' ' ' ASN . . . -60.29 -41.9 94.34 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.011 ' HB1' HG23 ' A' ' 19' ' ' ILE . . . -57.78 -53.37 58.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.247 178.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.783 HD11 ' NE ' ' A' ' 54' ' ' ARG . 33.0 mt -60.26 -52.32 62.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.932 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.68 -56.66 17.33 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.353 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.43 ' OE1' ' HA3' ' A' ' 45' ' ' GLY . 47.4 mm-40 -47.78 -47.31 30.86 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.902 HD21 ' HB ' ' A' ' 67' ' ' VAL . 10.2 tt -50.68 -50.46 54.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.873 178.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.82 ' HG3' HG23 ' A' ' 68' ' ' THR . 32.9 ttt180 -61.55 -63.24 1.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.492 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -49.85 -19.36 0.65 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.25 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -101.28 -35.38 9.28 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.584 HG21 ' CE2' ' A' ' 29' ' ' PHE . 1.3 p -126.08 -1.23 7.12 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.74 -13.12 4.3 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.027 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.902 ' HB ' HD21 ' A' ' 61' ' ' LEU . 71.1 t -58.52 111.57 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-O 121.106 0.479 . . . . 0.0 111.273 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.82 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.8 OUTLIER -121.6 -41.44 2.48 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.921 178.973 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 113' ' ' THR . 20.3 m -59.95 74.14 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.33 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.522 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.76 156.72 23.22 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.33 151.64 50.61 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.478 179.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.967 HG22 ' CE2' ' A' ' 110' ' ' PHE . 6.5 t -75.95 127.61 37.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.527 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.689 HD13 ' HE3' ' A' ' 22' ' ' MET . 1.2 mt -106.68 -19.72 6.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.799 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.504 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.54 176.68 4.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.955 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -154.76 146.16 23.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.422 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.886 ' HA ' HG11 ' A' ' 160' ' ' VAL . 54.3 t -70.71 136.82 85.57 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.624 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.522 ' HD2' HG11 ' A' ' 160' ' ' VAL . 17.5 Cg_endo -55.48 -62.44 0.27 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.901 2.401 . . . . 0.0 112.568 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.673 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -100.47 -175.87 3.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.371 -179.186 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.643 ' CD1' ' HD3' ' A' ' 106' ' ' LYS . 40.4 m95 -90.05 -160.09 0.66 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.007 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.506 HD11 HG22 ' A' ' 157' ' ' VAL . 36.2 mt . . . . . 0 N--CA 1.465 0.282 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 -0.087 0 CA-C-O 120.862 0.363 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.991 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 45.8 mt-30 -130.33 124.66 32.81 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -178.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.643 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 16.3 ttpp -103.41 138.1 40.61 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.98 178.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.592 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 14.3 m95 -104.76 165.21 11.22 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.346 0.593 . . . . 0.0 112.428 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.695 ' HB2' ' HE1' ' A' ' 110' ' ' PHE . 96.1 m-85 -142.17 152.49 43.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.0 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.526 HD12 ' O ' ' A' ' 20' ' ' CYS . 18.1 tp -98.83 137.68 37.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.86 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.967 ' CE2' HG22 ' A' ' 72' ' ' VAL . 49.2 m-85 -139.03 145.46 39.64 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.575 ' HB2' HD11 ' A' ' 73' ' ' ILE . 14.6 tttm -104.0 124.04 48.3 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.771 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.864 ' HD2' HD21 ' A' ' 21' ' ' LEU . 36.7 t80 -78.23 96.46 5.23 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.889 0.376 . . . . 0.0 110.568 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.452 ' H ' ' HA ' ' A' ' 70' ' ' ALA . 71.0 p -95.33 57.44 1.98 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.362 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.404 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -163.06 -143.81 3.82 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.546 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.495 ' N ' ' HE1' ' A' ' 112' ' ' PHE . 7.4 mm100 -123.82 146.66 48.2 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.019 0.438 . . . . 0.0 111.463 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.424 ' HB3' ' CH2' ' A' ' 134' ' ' TRP . 90.3 m-20 -62.05 -23.57 66.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.834 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -3.92 0.45 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.971 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.0 tp10 -90.27 -18.05 26.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.065 0.46 . . . . 0.0 110.544 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.627 HD13 ' CE1' ' A' ' 29' ' ' PHE . 8.4 mt -82.33 104.41 10.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.834 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -102.61 -26.41 13.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.032 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.596 HD11 ' HD1' ' A' ' 134' ' ' TRP . 68.0 mt . . . . . 0 N--CA 1.469 0.479 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.244 0 CA-C-O 120.685 0.278 . . . . 0.0 111.35 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.556 ' CB ' ' HB1' ' A' ' 31' ' ' ALA . 3.2 m-85 -130.76 140.84 50.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.092 0.472 . . . . 0.0 110.911 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.758 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -78.44 -35.77 32.12 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.785 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -155.75 152.46 28.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.369 -0.416 . . . . 0.0 110.74 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.596 ' HD1' HD11 ' A' ' 121' ' ' LEU . 29.0 p-90 -132.2 164.61 25.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.118 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.428 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 23.4 t -159.46 165.74 32.45 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.325 0.583 . . . . 0.0 112.048 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.714 ' CD2' ' ND2' ' A' ' 23' ' ' ASN . 91.6 m95 -108.39 102.09 11.23 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.481 178.329 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' ' 28' ' ' ILE . 28.9 m -117.47 171.29 6.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.837 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.585 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 27.8 p -71.99 167.1 34.54 Favored Pre-proline 0 CA--C 1.513 -0.465 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.889 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.725 ' HA ' HG13 ' A' ' 28' ' ' ILE . 21.7 Cg_exo -57.7 -58.83 0.69 Allowed 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.428 1.418 . . . . 0.0 109.889 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.11 -27.17 68.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.035 178.594 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.474 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 2.0 mm-40 -71.91 -48.36 46.04 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.1 0.476 . . . . 0.0 110.259 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.828 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -55.37 -40.74 71.69 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.22 179.711 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.787 HG21 ' HG2' ' A' ' 155' ' ' LYS . 27.3 mm -61.83 -31.84 52.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.329 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.73 -53.42 10.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.354 0.597 . . . . 0.0 110.33 179.1 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.08 -18.62 61.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.835 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.705 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 14.8 t -73.77 174.69 8.07 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.395 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.402 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 18.7 m -86.41 149.56 4.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.589 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.605 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 19.9 mt-10 -47.33 -52.3 16.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.95 0.405 . . . . 0.0 111.334 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -55.26 -3.71 0.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . 10.2 mmtm -136.08 -8.2 2.06 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -178.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.746 ' HG3' ' CG2' ' A' ' 143' ' ' ILE . 2.6 ttpp -64.53 -57.77 15.87 Favored Pre-proline 0 C--N 1.322 -0.589 0 C-N-CA 121.145 -0.222 . . . . 0.0 110.66 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.605 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 36.7 Cg_endo -66.06 -30.95 46.88 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.566 2.177 . . . . 0.0 111.469 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.801 ' O ' HG23 ' A' ' 157' ' ' VAL . 23.4 t -68.07 -51.71 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.587 ' CZ ' ' HB3' ' A' ' 150' ' ' LYS . 15.4 m-30 -65.36 -39.17 91.98 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.591 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.787 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -54.41 -45.26 72.9 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.934 -179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.405 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.7 OUTLIER -66.94 -35.46 80.03 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.307 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 153' ' ' VAL . 46.4 t -65.16 -41.63 92.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.721 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.499 HD22 ' HB3' ' A' ' 139' ' ' PRO . 30.1 mt -63.41 -43.03 98.7 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.164 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.88 -38.45 70.18 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.886 HG11 ' HA ' ' A' ' 76' ' ' VAL . 85.0 t -68.79 -43.08 83.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.619 ' CE2' HG12 ' A' ' 157' ' ' VAL . 22.2 m-30 -80.77 5.19 16.57 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.964 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.593 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.32 -52.89 71.21 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.07 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.4 Cg_endo -57.75 -13.41 14.35 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 121.664 1.576 . . . . 0.0 111.741 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.504 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 86.9 m-70 -108.06 -21.91 12.61 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.09 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 85.9 mt . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.397 -0.811 . . . . 0.0 110.569 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.2 mtm . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.804 0.335 . . . . 0.0 110.395 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.728 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 4.2 p30 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.85 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.618 ' HB2' ' HZ3' ' A' ' 79' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.239 0.542 . . . . 0.0 111.862 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.678 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 2.1 m-80 -131.18 174.95 9.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.742 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.768 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 16.0 m -143.82 157.81 16.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.95 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.59 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -127.96 167.24 20.3 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.22 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.057 HG21 HD22 ' A' ' 61' ' ' LEU . 5.3 mp -126.91 123.2 62.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.24 0.543 . . . . 0.0 112.461 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.654 ' O ' HD12 ' A' ' 109' ' ' LEU . 1.4 t -107.49 96.12 6.18 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.438 -0.801 . . . . 0.0 108.9 178.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.817 HD22 HG11 ' A' ' 67' ' ' VAL . 26.5 tp -99.61 122.97 43.42 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.917 -178.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.612 ' HG2' HD11 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -119.64 151.53 38.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.399 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.847 ' ND2' ' CE3' ' A' ' 136' ' ' TRP . 0.3 OUTLIER -96.24 175.44 6.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.313 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -58.31 -3.68 0.29 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.352 177.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.595 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.7 OUTLIER -99.1 -1.26 39.96 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 120.605 0.24 . . . . 0.0 111.376 -179.251 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.595 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 1.4 mmtm 75.12 20.98 2.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.961 -178.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.721 ' C ' HD12 ' A' ' 28' ' ' ILE . 4.8 mttt -93.41 -178.64 4.8 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.721 HD12 ' C ' ' A' ' 27' ' ' LYS . 2.8 mp -135.67 144.93 32.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.585 0.707 . . . . 0.0 111.886 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.578 ' CE1' HD13 ' A' ' 119' ' ' ILE . 33.2 t80 -66.17 108.33 2.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.985 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.654 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -102.99 140.19 37.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.163 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.07 134.16 32.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.747 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.58 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 55.6 p -100.12 149.21 23.75 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.075 0.464 . . . . 0.0 111.785 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.622 ' O ' ' N ' ' A' ' 35' ' ' ASP . 26.3 mtp85 -72.42 129.95 39.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.489 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.716 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -55.72 56.22 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.995 0.518 . . . . 0.0 112.346 179.799 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.622 ' N ' ' O ' ' A' ' 33' ' ' ARG . 3.0 p-10 -177.08 -33.03 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.157 0.503 . . . . 0.0 109.866 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.459 HD12 ' HE ' ' A' ' 33' ' ' ARG . 21.1 mt -116.66 105.72 49.46 Favored Pre-proline 0 N--CA 1.452 -0.366 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.482 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.52 -19.62 21.54 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.442 2.095 . . . . 0.0 112.88 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -92.38 -9.74 40.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.551 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.636 ' HB1' HG13 ' A' ' 147' ' ' VAL . . . -94.19 106.44 18.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.805 0.336 . . . . 0.0 111.278 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.594 ' O ' ' HA ' ' A' ' 146' ' ' THR . 68.9 m95 -105.71 144.61 32.22 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.75 178.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.589 ' HG3' ' HG1' ' A' ' 146' ' ' THR . 0.8 OUTLIER -153.73 -125.73 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.095 -179.742 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.632 ' SD ' HD21 ' A' ' 142' ' ' LEU . 0.0 OUTLIER 177.62 160.81 0.56 Allowed Pre-proline 0 N--CA 1.453 -0.32 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.743 ' HG3' HD13 ' A' ' 61' ' ' LEU . 1.6 Cg_endo -40.69 142.29 0.74 Allowed 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 123.546 2.831 . . . . 0.0 113.03 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.768 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -172.62 146.4 1.68 Allowed 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.884 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -160.62 -162.63 12.71 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.332 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.678 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -120.05 139.93 14.21 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.887 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.629 ' CG1' HG13 ' A' ' 17' ' ' VAL . 28.7 mt -69.37 142.03 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.838 0.352 . . . . 0.0 111.131 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -69.01 -174.12 0.57 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.93 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -49.66 -79.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.049 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -110.1 50.32 0.78 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.285 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -111.57 149.59 31.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.822 0.344 . . . . 0.0 110.576 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.41 162.38 70.57 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.159 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.565 ' HB3' HD11 ' A' ' 47' ' ' ILE . 1.2 Cg_endo -82.96 -51.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.974 2.45 . . . . 0.0 112.021 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.737 ' CZ ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -49.98 -47.33 52.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.623 179.594 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -69.25 -38.26 78.37 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.046 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.82 -45.02 95.63 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.679 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -58.05 -55.48 34.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.405 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.573 HD11 ' CD ' ' A' ' 54' ' ' ARG . 47.2 mt -57.55 -46.53 86.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.183 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.08 -66.08 0.59 Allowed 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.278 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.551 ' CG ' HD11 ' A' ' 19' ' ' ILE . 23.6 pt-20 -43.06 -40.45 3.12 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.114 0.483 . . . . 0.0 110.199 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.057 HD22 HG21 ' A' ' 19' ' ' ILE . 4.9 tp -52.23 -47.42 65.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.376 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.86 ' HG2' HG23 ' A' ' 68' ' ' THR . 1.6 tmm_? -63.51 -63.91 1.05 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.957 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -51.13 -21.17 1.8 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.17 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -97.53 -38.41 9.58 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.722 HG22 ' CD2' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -128.88 -15.15 4.37 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -178.853 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 91.54 -14.23 64.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.193 -1.004 . . . . 0.0 112.835 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.817 HG11 HD22 ' A' ' 21' ' ' LEU . 55.7 t -56.26 110.57 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.104 0.478 . . . . 0.0 111.321 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.86 HG23 ' HG2' ' A' ' 62' ' ' ARG . 0.9 OUTLIER -122.34 -39.8 2.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.466 178.203 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.407 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 9.4 m -62.37 74.39 0.02 OUTLIER 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.456 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -162.85 154.86 18.33 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.922 0.391 . . . . 0.0 111.795 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.22 146.63 50.35 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.209 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.737 HG21 ' CZ ' ' A' ' 54' ' ' ARG . 8.5 t -76.73 129.96 36.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.202 0.525 . . . . 0.0 112.224 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.702 HD11 ' HB2' ' A' ' 111' ' ' LYS . 0.7 OUTLIER -113.3 -18.12 7.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.947 179.43 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.464 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -169.04 178.63 4.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.147 0.499 . . . . 0.0 112.013 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.465 ' HB3' ' HD1' ' A' ' 108' ' ' PHE . 1.4 pm0 -157.66 152.71 25.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.882 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.841 ' HA ' HG11 ' A' ' 160' ' ' VAL . 33.7 t -72.93 136.61 79.78 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.265 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.615 ' HD2' HG21 ' A' ' 160' ' ' VAL . 20.7 Cg_endo -59.45 -76.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.943 2.428 . . . . 0.0 112.564 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.728 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -80.65 171.68 14.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.698 -179.179 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.618 ' HZ3' ' HB2' ' A' ' 15' ' ' ARG . 27.9 m95 -94.33 97.53 10.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.608 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.512 ' CD1' HG22 ' A' ' 157' ' ' VAL . 51.1 mt . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.8 0.333 . . . . 0.0 110.89 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.506 ' O ' ' HA ' ' A' ' 15' ' ' ARG . . . . . . . . 0 C--O 1.224 -0.274 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.551 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 2.9 mt-30 -123.19 123.75 41.48 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.427 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 1.0 OUTLIER -104.25 132.66 50.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.435 178.364 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.59 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 51.6 m95 -101.74 166.53 10.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.241 0.543 . . . . 0.0 112.448 -178.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.575 ' CD1' ' HG2' ' A' ' 54' ' ' ARG . 98.0 m-85 -141.47 151.63 43.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.955 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.654 HD12 ' O ' ' A' ' 20' ' ' CYS . 29.5 tp -107.68 126.73 52.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.968 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.883 ' CE2' HG23 ' A' ' 19' ' ' ILE . 4.1 m-85 -132.8 145.54 51.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.315 0.578 . . . . 0.0 111.918 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.702 ' HB2' HD11 ' A' ' 73' ' ' ILE . 47.8 tttt -95.27 127.69 41.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.602 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.804 ' CD1' HD21 ' A' ' 21' ' ' LEU . 38.2 t80 -78.33 101.33 7.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.898 0.38 . . . . 0.0 110.853 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.6 p -100.53 53.07 0.87 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.702 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.407 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -158.04 -146.49 4.53 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.409 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -121.85 152.1 39.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.995 0.426 . . . . 0.0 111.26 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.449 ' HB3' ' HH2' ' A' ' 134' ' ' TRP . 61.4 m-20 -60.12 -35.1 74.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.874 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -58.18 -2.05 0.16 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.116 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 116' ' ' ASP . 0.7 OUTLIER -90.41 -15.8 30.26 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.942 0.401 . . . . 0.0 110.853 179.543 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.68 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 14.3 mt -81.05 100.6 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.223 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 65' ' ' THR . 6.5 p-10 -103.78 93.68 5.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.339 178.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.722 ' CD2' HG22 ' A' ' 65' ' ' THR . 39.0 mt . . . . . 0 C--N 1.331 -0.226 0 CA-C-O 121.076 0.465 . . . . 0.0 110.1 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.653 ' O ' HD12 ' A' ' 34' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.461 0.084 0 CA-C-O 120.796 0.331 . . . . 0.0 111.371 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.675 ' CE2' HG23 ' A' ' 65' ' ' THR . 2.2 m-85 -102.23 139.71 37.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.136 0.493 . . . . 0.0 110.573 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.716 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -82.34 -36.89 16.01 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.013 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -151.57 149.33 29.05 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.86 0.362 . . . . 0.0 110.53 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.707 ' HD1' HD11 ' A' ' 121' ' ' LEU . 31.9 p-90 -136.53 166.41 23.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.063 0.458 . . . . 0.0 111.236 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.483 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 29.5 t -162.56 178.48 8.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.381 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.847 ' CE3' ' ND2' ' A' ' 23' ' ' ASN . 64.8 m95 -114.21 99.66 7.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.742 178.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 22.2 m -113.89 169.05 5.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.347 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.572 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 20.9 p -74.71 171.91 10.29 Favored Pre-proline 0 C--N 1.324 -0.536 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.881 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.669 ' HB3' HD22 ' A' ' 158' ' ' LEU . 13.1 Cg_exo -62.47 -54.36 1.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.488 1.459 . . . . 0.0 110.279 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.67 -29.1 70.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.995 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.443 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 33.3 mt-30 -71.69 -47.33 54.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.328 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.654 HD13 ' HB2' ' A' ' 30' ' ' ALA . 64.2 tp -57.95 -38.92 76.86 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.714 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 27.7 mm -61.27 -38.8 80.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.517 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.92 -50.48 49.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.223 0.535 . . . . 0.0 110.565 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.429 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -74.54 -19.16 60.45 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.718 -179.154 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.949 HG23 ' HG3' ' A' ' 151' ' ' LYS . 14.7 t -74.88 174.03 9.82 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.487 -179.429 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.636 HG13 ' HB1' ' A' ' 39' ' ' ALA . 24.1 m -78.08 154.73 5.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.46 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.759 ' HA ' ' HD3' ' A' ' 151' ' ' LYS . 13.5 mt-10 -60.89 -54.85 39.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.079 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.517 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 35.7 p90 -55.52 -1.48 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.429 ' HG3' ' CD2' ' A' ' 149' ' ' PHE . 58.1 mttt -135.27 -6.82 2.29 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.949 ' HG3' HG23 ' A' ' 146' ' ' THR . 14.0 mtpp -60.71 -62.19 6.47 Favored Pre-proline 0 CA--C 1.531 0.237 0 O-C-N 122.317 -0.239 . . . . 0.0 111.335 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.495 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 18.6 Cg_endo -59.92 -27.13 84.24 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.239 1.959 . . . . 0.0 111.334 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.645 ' O ' HG23 ' A' ' 157' ' ' VAL . 26.3 t -68.8 -50.85 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.474 ' HE1' ' CZ2' ' A' ' 107' ' ' TRP . 14.3 m-30 -65.78 -39.56 91.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.672 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.655 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.5 OUTLIER -56.09 -40.65 73.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.332 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.439 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.6 OUTLIER -70.57 -31.41 68.43 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.987 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 153' ' ' VAL . 90.3 t -66.28 -41.31 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.593 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.669 HD22 ' HB3' ' A' ' 139' ' ' PRO . 58.7 mt -63.78 -41.97 97.86 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.468 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 14.5 m -54.54 -41.02 69.25 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.841 HG11 ' HA ' ' A' ' 76' ' ' VAL . 98.4 t -66.57 -44.07 90.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.553 178.049 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.625 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 22.4 m-30 -81.21 5.09 18.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.384 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.7 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . . . -59.4 -50.45 87.29 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.015 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.7 ' HD3' ' HB3' ' A' ' 162' ' ' ALA . 36.8 Cg_exo -59.22 -11.86 14.42 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.528 2.152 . . . . 0.0 112.051 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.464 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 73.8 m-70 -113.13 -17.52 12.37 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.437 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 97.9 mt . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.791 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 N--CA 1.461 0.098 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.607 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 30.1 t70 . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.822 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.556 ' HG2' HD12 ' A' ' 47' ' ' ILE . 1.1 ttp180 . . . . . 0 N--CA 1.461 0.108 0 CA-C-O 120.964 0.412 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.78 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 0.9 OUTLIER -134.48 167.35 20.93 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.387 179.091 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.644 HG13 ' CG1' ' A' ' 47' ' ' ILE . 12.5 m -136.05 166.33 27.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.976 0.417 . . . . 0.0 111.289 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.536 ' HA3' ' CE3' ' A' ' 107' ' ' TRP . . . -134.02 154.77 21.51 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.546 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.952 HG21 HD22 ' A' ' 61' ' ' LEU . 3.7 mp -125.45 121.5 60.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.074 0.464 . . . . 0.0 111.862 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.553 ' O ' HD12 ' A' ' 109' ' ' LEU . 0.4 OUTLIER -101.1 92.24 4.91 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.742 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.778 HD22 HG11 ' A' ' 67' ' ' VAL . 22.7 tp -96.57 113.38 24.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.534 -178.619 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.515 ' SD ' HD11 ' A' ' 109' ' ' LEU . 1.3 ptt? -116.14 167.24 11.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.707 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.786 ' ND2' ' CE3' ' A' ' 136' ' ' TRP . 0.3 OUTLIER -102.09 168.99 9.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.384 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -56.79 -3.55 0.12 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.418 177.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.573 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 1.8 m-20 -99.55 3.03 45.28 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.063 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 3.7 mmtm 74.46 20.4 2.52 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.114 -178.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HB2' ' OD1' ' A' ' 23' ' ' ASN . 1.2 mmtt -94.85 145.35 24.96 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.809 HD11 ' HG3' ' A' ' 139' ' ' PRO . 1.1 mm -99.32 140.95 17.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.995 0.426 . . . . 0.0 112.082 -177.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.495 ' CE1' HD13 ' A' ' 119' ' ' ILE . 73.1 t80 -78.15 135.23 37.62 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.463 178.228 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.621 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . . . -141.3 153.83 45.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.776 0.322 . . . . 0.0 110.79 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.636 ' HB1' ' HB3' ' A' ' 131' ' ' PHE . . . -142.55 145.13 33.29 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.64 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 17.6 p -94.31 148.18 22.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.543 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.4 mtp180 -69.35 133.6 48.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.084 0.469 . . . . 0.0 111.006 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.001 ' H ' HD23 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -38.47 -48.78 1.42 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.612 -178.881 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.426 ' O ' HD13 ' A' ' 36' ' ' ILE . 0.8 OUTLIER -75.17 -34.9 61.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.171 -179.569 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.426 HD13 ' O ' ' A' ' 35' ' ' ASP . 29.2 mm -123.31 104.41 34.73 Favored Pre-proline 0 C--O 1.233 0.184 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.01 -16.89 45.89 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.862 2.375 . . . . 0.0 112.377 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -89.89 -10.15 46.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.425 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.633 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.78 88.64 6.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.935 0.398 . . . . 0.0 110.338 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.621 ' O ' ' HA ' ' A' ' 146' ' ' THR . 75.8 m95 -85.57 146.53 26.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.365 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.494 ' HB3' ' OH ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -165.41 162.16 19.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.921 -179.871 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.751 ' SD ' HD21 ' A' ' 142' ' ' LEU . 0.0 OUTLIER -98.3 156.93 35.25 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.079 179.206 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.524 ' HG3' HD13 ' A' ' 61' ' ' LEU . 1.9 Cg_endo -44.34 155.07 0.26 Allowed 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.048 2.499 . . . . 0.0 113.08 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.587 ' HA ' HD12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -176.17 171.36 2.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.207 -179.576 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.484 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . 176.9 152.55 9.92 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.677 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.78 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -77.75 135.97 17.35 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.602 -0.809 . . . . 0.0 113.358 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.644 ' CG1' HG13 ' A' ' 17' ' ' VAL . 16.9 mt -69.46 145.6 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.734 0.302 . . . . 0.0 111.007 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.57 -175.66 0.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.028 0.442 . . . . 0.0 111.257 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.22 -47.5 65.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.856 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -143.34 52.79 0.62 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.286 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -112.9 150.22 32.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.772 0.32 . . . . 0.0 110.446 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.1 156.26 90.21 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.903 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 3.0 Cg_exo -73.93 -49.35 0.2 Allowed 'Trans proline' 0 CA--C 1.515 -0.442 0 C-N-CA 122.41 2.074 . . . . 0.0 111.113 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.923 ' CZ ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -53.13 -46.57 68.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.307 179.293 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.542 ' HA ' HD12 ' A' ' 58' ' ' ILE . 84.9 m-20 -67.7 -40.11 84.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.135 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.04 -44.7 96.13 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.808 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -56.07 -52.21 65.07 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.931 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.705 HD11 ' HE ' ' A' ' 54' ' ' ARG . 22.4 mt -56.43 -56.45 13.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.548 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -60.05 4.42 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.672 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.484 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -45.87 -47.53 16.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.155 0.503 . . . . 0.0 109.744 179.081 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.952 HD22 HG21 ' A' ' 19' ' ' ILE . 4.2 tp -50.25 -46.64 55.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.324 178.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.798 ' HG3' HG23 ' A' ' 68' ' ' THR . 18.7 ttm180 -64.98 -63.51 1.09 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.357 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -49.78 -22.66 1.5 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.436 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.428 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 31.3 mt-10 -97.01 -36.58 10.47 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -177.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.542 HG22 ' CD2' ' A' ' 121' ' ' LEU . 0.6 OUTLIER -124.26 -13.77 7.13 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.979 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 86.04 -16.24 43.93 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.232 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.778 HG11 HD22 ' A' ' 21' ' ' LEU . 52.3 t -58.13 117.26 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-O 121.254 0.549 . . . . 0.0 111.42 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.798 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.9 OUTLIER -122.64 -38.13 2.68 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.652 178.568 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.8 m -62.31 73.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.581 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.595 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -160.74 157.69 27.35 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.019 0.438 . . . . 0.0 112.126 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -131.53 152.19 50.96 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.95 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.923 HG21 ' CZ ' ' A' ' 54' ' ' ARG . 4.2 t -75.24 127.15 36.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.148 0.499 . . . . 0.0 111.428 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.569 HD11 ' HB2' ' A' ' 111' ' ' LYS . 1.6 mt -107.95 -19.67 6.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.596 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.454 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -169.56 176.78 4.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.0 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.3 OUTLIER -154.89 146.44 23.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.752 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.821 ' HA ' HG11 ' A' ' 160' ' ' VAL . 50.7 t -72.58 140.58 81.82 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.106 0.479 . . . . 0.0 111.203 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.635 ' HD2' HG13 ' A' ' 76' ' ' VAL . 26.8 Cg_endo -62.08 -62.67 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.27 2.647 . . . . 0.0 113.138 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -96.53 177.05 5.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.049 -178.514 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.49 ' CE3' ' HB2' ' A' ' 106' ' ' LYS . 49.9 m95 -93.38 97.45 10.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.174 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.923 HD12 ' CD1' ' A' ' 107' ' ' TRP . 38.3 mt . . . . . 0 C--N 1.326 -0.419 0 CA-C-O 120.885 0.374 . . . . 0.0 111.087 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.396 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.732 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 10.6 mt-30 -122.21 126.47 48.32 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.49 ' HB2' ' CE3' ' A' ' 79' ' ' TRP . 2.4 ttmt -102.69 131.96 49.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.245 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.923 ' CD1' HD12 ' A' ' 80' ' ' LEU . 74.6 m95 -101.99 161.35 13.74 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -177.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.505 ' CE1' ' HG2' ' A' ' 54' ' ' ARG . 99.5 m-85 -142.64 150.53 40.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.784 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.63 HD12 ' H ' ' A' ' 110' ' ' PHE . 15.0 tp -98.56 139.72 33.87 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.255 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.63 ' H ' HD12 ' A' ' 109' ' ' LEU . 32.0 m-85 -138.81 142.72 38.71 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -178.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.595 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 1.1 tttt -102.28 120.18 40.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.679 178.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.612 ' HB2' HD11 ' A' ' 21' ' ' LEU . 65.4 t80 -78.23 98.72 5.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.796 0.332 . . . . 0.0 110.596 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.4 p -95.25 39.64 1.11 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.601 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.402 ' C ' ' CE2' ' A' ' 112' ' ' PHE . . . -135.64 -148.22 5.58 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.268 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.444 ' HB2' ' HG2' ' A' ' 117' ' ' GLN . 0.1 OUTLIER -125.45 150.32 47.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.857 0.36 . . . . 0.0 111.137 179.474 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -58.43 -39.7 80.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.483 0.658 . . . . 0.0 110.662 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.444 ' HG2' ' HB2' ' A' ' 115' ' ' GLN . 14.8 pt20 -58.61 -3.5 0.31 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.913 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -89.03 -22.14 23.11 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.238 0.542 . . . . 0.0 110.234 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.589 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 10.5 mt -83.05 100.11 6.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.19 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.428 ' O ' ' C ' ' A' ' 121' ' ' LEU . 1.6 p-10 -97.51 9.38 42.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.021 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.542 ' CD2' HG22 ' A' ' 65' ' ' THR . 71.7 mt . . . . . 0 N--CA 1.467 0.399 0 CA-C-O 121.22 0.533 . . . . 0.0 111.56 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.692 ' C ' HD21 ' A' ' 34' ' ' LEU . 3.9 tp10 . . . . . 0 N--CA 1.454 -0.247 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.722 ' N ' HD21 ' A' ' 34' ' ' LEU . 2.1 m-85 -131.91 139.0 48.6 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 178.044 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.708 ' N ' HD22 ' A' ' 34' ' ' LEU . . . -85.92 -33.13 16.09 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.688 -178.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 31' ' ' ALA . 1.9 tt0 -150.78 153.87 36.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.338 0.113 . . . . 0.0 110.947 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.611 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 43.3 p-90 -135.36 168.28 19.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.057 0.456 . . . . 0.0 111.691 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.431 ' N ' ' HZ3' ' A' ' 40' ' ' TRP . 15.9 t -162.74 167.26 23.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.526 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.786 ' CE3' ' ND2' ' A' ' 23' ' ' ASN . 53.7 m95 -103.95 102.91 12.69 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.6 ' O ' ' N ' ' A' ' 28' ' ' ILE . 21.7 m -119.66 165.08 15.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.556 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 19.0 p -72.01 170.98 10.48 Favored Pre-proline 0 C--N 1.327 -0.413 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.027 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.809 ' HG3' HD11 ' A' ' 28' ' ' ILE . 13.7 Cg_exo -62.88 -54.58 1.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.031 1.821 . . . . 0.0 110.41 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -64.94 -26.75 68.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.584 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.483 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.8 OUTLIER -72.04 -46.56 56.56 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.502 179.582 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.751 HD21 ' SD ' ' A' ' 42' ' ' MET . 0.6 OUTLIER -57.35 -38.38 74.05 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.832 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.55 ' O ' HG22 ' A' ' 146' ' ' THR . 7.1 mm -60.88 -35.95 68.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.215 0.531 . . . . 0.0 110.219 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.68 -51.69 26.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.202 0.525 . . . . 0.0 110.769 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.75 -19.97 60.64 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.415 -0.812 . . . . 0.0 112.712 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.621 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 7.3 t -73.78 177.76 5.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.976 0.417 . . . . 0.0 111.487 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.597 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 16.2 m -82.24 149.5 4.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.334 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.508 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 42.6 mt-10 -60.29 -55.21 36.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.049 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.597 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 55.1 p90 -54.24 -4.34 0.05 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.49 ' HG2' ' CZ ' ' A' ' 154' ' ' TYR . 0.1 OUTLIER -132.73 -6.54 3.2 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.435 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.584 ' HG3' HG23 ' A' ' 146' ' ' THR . 11.6 mttt -59.79 -59.49 13.67 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.508 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 11.8 Cg_endo -55.73 -27.66 62.64 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.312 2.008 . . . . 0.0 111.651 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.754 ' O ' HG23 ' A' ' 157' ' ' VAL . 39.5 t -69.27 -53.9 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.494 ' OH ' ' HB3' ' A' ' 41' ' ' GLN . 9.1 m-30 -63.51 -36.86 85.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.855 178.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.563 ' HE2' ' HA ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -57.73 -43.5 85.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.085 179.782 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -69.11 -28.49 66.52 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 153' ' ' VAL . 48.6 t -68.48 -42.25 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.973 178.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.659 HD22 ' HB3' ' A' ' 139' ' ' PRO . 47.8 mt -63.68 -43.5 96.5 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.561 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.8 t -53.76 -41.3 67.01 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.821 HG11 ' HA ' ' A' ' 76' ' ' VAL . 88.2 t -66.75 -42.59 89.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.378 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.609 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 22.1 m-30 -80.15 4.08 18.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.552 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.606 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.58 -53.1 69.59 Favored Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 120.531 -0.467 . . . . 0.0 110.644 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 18.9 Cg_endo -58.89 -12.21 14.41 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.141 1.894 . . . . 0.0 111.921 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.454 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 92.9 m-70 -109.19 -17.98 13.73 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.28 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 95.6 mt . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.854 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.6 mpp? . . . . . 0 N--CA 1.454 -0.265 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.619 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 33.1 t70 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.368 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.457 ' CG ' HD12 ' A' ' 47' ' ' ILE . 5.4 ttp180 . . . . . 0 N--CA 1.464 0.245 0 CA-C-O 120.973 0.416 . . . . 0.0 111.475 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.696 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 3.2 m120 -135.34 -178.76 5.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.127 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.582 HG13 HG13 ' A' ' 47' ' ' ILE . 14.9 m -142.65 167.57 14.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.39 0.614 . . . . 0.0 111.967 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.572 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -138.18 155.41 23.37 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.891 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.022 HG23 ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -131.31 129.23 62.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.063 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.49 ' O ' HD12 ' A' ' 109' ' ' LEU . 35.4 t -108.77 106.11 15.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.898 178.262 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.778 HD22 HG11 ' A' ' 67' ' ' VAL . 7.4 tp -105.98 123.59 48.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.845 -178.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.624 ' CE ' HD13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -124.22 165.98 16.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.113 179.444 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.527 ' N ' ' OD1' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -97.45 171.96 8.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.004 0.431 . . . . 0.0 110.406 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -58.48 -5.35 0.52 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.585 177.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.534 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -99.8 2.6 44.18 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.782 0.325 . . . . 0.0 111.771 -179.137 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 17.1 mmtp 73.61 22.29 2.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.953 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 22' ' ' MET . 2.2 mmtt -93.0 143.87 25.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.876 HD11 ' HG3' ' A' ' 139' ' ' PRO . 0.9 OUTLIER -98.07 138.02 23.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.286 0.565 . . . . 0.0 112.457 -177.913 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.534 ' CZ ' HG21 ' A' ' 65' ' ' THR . 17.1 t80 -80.22 135.1 36.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.726 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.74 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -142.58 151.77 41.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.945 0.403 . . . . 0.0 111.281 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.651 ' HB1' ' CB ' ' A' ' 131' ' ' PHE . . . -143.14 136.77 28.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.309 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.656 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 3.5 p -97.19 152.65 18.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.847 0.356 . . . . 0.0 111.45 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.659 ' O ' ' N ' ' A' ' 35' ' ' ASP . 15.3 mtp180 -68.54 130.43 42.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.731 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.679 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.3 OUTLIER -53.32 52.42 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.145 0.578 . . . . 0.0 112.491 -179.722 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.659 ' N ' ' O ' ' A' ' 33' ' ' ARG . 0.5 OUTLIER -177.68 -36.06 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.895 0.379 . . . . 0.0 110.347 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.628 HD13 ' NE ' ' A' ' 33' ' ' ARG . 4.0 mp -112.61 103.01 55.34 Favored Pre-proline 0 N--CA 1.454 -0.25 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.58 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -62.99 -46.04 11.42 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.167 2.578 . . . . 0.0 113.45 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -72.32 -4.44 29.81 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.656 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -94.75 93.03 7.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.798 0.332 . . . . 0.0 111.083 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.656 ' O ' ' HA ' ' A' ' 146' ' ' THR . 63.7 m95 -100.15 145.93 27.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.438 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.96 158.1 21.88 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.403 0.621 . . . . 0.0 111.593 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.47 ' HG3' ' HZ3' ' A' ' 107' ' ' TRP . 3.4 ptp -94.28 158.46 35.82 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.198 178.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.439 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 9.4 Cg_endo -49.31 154.47 3.87 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.423 2.082 . . . . 0.0 112.223 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -178.56 140.9 0.2 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.142 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.423 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -157.63 164.82 33.27 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.757 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.621 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -88.25 142.19 17.28 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.894 -0.669 . . . . 0.0 113.54 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.582 HG13 HG13 ' A' ' 17' ' ' VAL . 3.9 mt -70.44 146.73 11.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 122.66 0.384 . . . . 0.0 111.283 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -67.54 -174.55 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.406 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.88 -60.78 2.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.163 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.97 61.97 0.65 Allowed Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.465 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.504 ' O ' HG21 ' A' ' 47' ' ' ILE . 3.9 tp10 -119.94 155.86 31.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.731 0.3 . . . . 0.0 110.818 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.426 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -71.99 158.84 86.94 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.352 179.63 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.458 ' HA ' HG11 ' A' ' 17' ' ' VAL . 2.9 Cg_exo -76.12 -50.37 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.605 2.203 . . . . 0.0 111.67 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.878 ' CZ ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -53.07 -44.95 67.9 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.508 179.798 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.46 ' HA ' HD12 ' A' ' 58' ' ' ILE . 12.7 m120 -67.81 -42.13 82.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.012 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.416 ' O ' ' HG2' ' A' ' 60' ' ' GLU . . . -62.2 -42.6 99.44 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.022 ' HB1' HG23 ' A' ' 19' ' ' ILE . . . -56.55 -53.72 54.32 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.808 178.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.622 HD11 ' NE ' ' A' ' 54' ' ' ARG . 17.7 mt -57.56 -53.51 43.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.065 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -60.06 -58.69 7.44 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.923 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 56' ' ' ALA . 26.0 mm-40 -47.34 -45.84 25.03 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.226 0.536 . . . . 0.0 109.634 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.84 HD12 ' HB ' ' A' ' 19' ' ' ILE . 7.5 tt -51.83 -49.69 62.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.257 178.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.779 ' HG3' HG23 ' A' ' 68' ' ' THR . 47.7 ttt180 -63.06 -62.83 1.44 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.167 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -51.35 -19.16 1.2 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.32 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -98.91 -32.54 11.26 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -178.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.573 HG22 ' CD2' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -131.78 -11.61 3.42 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.609 -178.684 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.14 -15.16 55.17 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.464 -0.874 . . . . 0.0 111.967 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.778 HG11 HD22 ' A' ' 21' ' ' LEU . 77.7 t -58.3 113.72 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 121.248 0.546 . . . . 0.0 111.358 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.779 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -121.47 -39.96 2.61 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.481 178.637 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.432 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 6.1 m -62.5 74.6 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.14 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -158.88 154.94 26.84 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.667 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.403 ' HG3' HG21 ' A' ' 113' ' ' THR . 0.9 OUTLIER -128.16 151.46 49.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.432 179.607 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.878 HG21 ' CZ ' ' A' ' 54' ' ' ARG . 2.8 t -74.9 127.8 36.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.725 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.694 HD12 ' HG ' ' A' ' 109' ' ' LEU . 1.0 OUTLIER -109.11 -17.87 7.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.332 178.922 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.552 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -169.04 173.73 6.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.569 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 2.6 pm0 -153.09 136.06 15.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.648 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.65 ' HA ' HG11 ' A' ' 160' ' ' VAL . 41.8 t -73.48 137.48 77.79 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.03 0.443 . . . . 0.0 111.081 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.594 ' HD2' HG13 ' A' ' 76' ' ' VAL . 41.6 Cg_endo -72.09 -73.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.723 2.282 . . . . 0.0 112.54 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.619 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 2.2 p90 -67.57 157.81 33.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.097 0.475 . . . . 0.0 111.543 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.518 ' CE2' ' HD3' ' A' ' 106' ' ' LYS . 49.7 m95 -94.75 109.4 21.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.187 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.496 HD12 ' CD1' ' A' ' 107' ' ' TRP . 15.0 mt . . . . . 0 C--N 1.329 -0.284 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.404 0 CA-C-O 121.101 0.477 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.696 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 6.3 mt-30 -124.51 123.08 39.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.534 -177.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.518 ' HD3' ' CE2' ' A' ' 79' ' ' TRP . 14.2 ttpp -101.69 135.28 43.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.482 178.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.496 ' CD1' HD12 ' A' ' 80' ' ' LEU . 73.6 m95 -101.78 163.44 12.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.263 0.554 . . . . 0.0 112.445 -178.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.525 ' CE1' ' HG2' ' A' ' 54' ' ' ARG . 98.1 m-85 -143.18 150.63 39.65 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.839 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.694 ' HG ' HD12 ' A' ' 73' ' ' ILE . 20.1 tp -99.26 138.77 35.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.311 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.806 ' CE2' HG22 ' A' ' 72' ' ' VAL . 62.0 m-85 -139.76 140.28 36.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.642 0.734 . . . . 0.0 112.888 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.591 ' N ' HD11 ' A' ' 73' ' ' ILE . 1.7 tttt -101.27 123.63 45.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.754 178.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.625 ' CE1' HG13 ' A' ' 67' ' ' VAL . 39.4 t80 -78.34 96.61 5.35 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.809 0.337 . . . . 0.0 111.166 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.403 HG21 ' HG3' ' A' ' 71' ' ' GLU . 17.3 p -97.7 49.68 1.03 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.039 0.447 . . . . 0.0 110.596 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.432 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -150.01 -148.57 4.8 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.296 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.45 ' HB2' ' HG2' ' A' ' 117' ' ' GLN . 28.7 mt-30 -121.84 151.46 40.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.823 0.344 . . . . 0.0 110.936 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -61.11 -28.8 69.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.8 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLN . . . . . 0.45 ' HG2' ' HB2' ' A' ' 115' ' ' GLN . 2.1 pt20 -59.0 -3.2 0.32 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.137 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -90.7 -17.68 26.34 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.903 0.382 . . . . 0.0 110.895 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.692 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 15.9 mt -81.76 95.89 3.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.615 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.6 p30 -96.72 3.8 52.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.951 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.573 ' CD2' HG22 ' A' ' 65' ' ' THR . 29.5 mt . . . . . 0 N--CA 1.466 0.363 0 CA-C-O 120.975 0.417 . . . . 0.0 111.449 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 . . . . . 0 N--CA 1.455 -0.19 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.651 ' CB ' ' HB1' ' A' ' 31' ' ' ALA . 3.2 m-85 -127.62 140.91 51.8 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.114 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.679 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -96.25 -29.28 8.52 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.498 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.403 ' HG2' ' OG ' ' A' ' 32' ' ' SER . 0.2 OUTLIER -145.18 146.75 31.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.725 0.298 . . . . 0.0 110.339 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.692 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 40.8 p-90 -135.89 165.77 24.86 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.939 0.399 . . . . 0.0 111.548 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.452 ' N ' ' HZ3' ' A' ' 40' ' ' TRP . 36.6 t -164.61 177.5 8.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.335 0.588 . . . . 0.0 112.164 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.537 ' NE1' ' HZ3' ' A' ' 134' ' ' TRP . 35.2 m95 -113.24 104.58 12.48 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.338 178.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.528 ' O ' ' N ' ' A' ' 28' ' ' ILE . 16.3 m -120.05 168.71 12.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.279 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.527 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 23.3 p -73.09 168.86 20.86 Favored Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.24 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.876 ' HG3' HD11 ' A' ' 28' ' ' ILE . 16.5 Cg_exo -61.88 -53.27 2.23 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 121.866 1.71 . . . . 0.0 110.471 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.7 -27.79 68.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.654 178.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.499 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 37.2 mt-30 -72.42 -46.28 55.86 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.045 0.45 . . . . 0.0 110.154 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.74 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.5 OUTLIER -56.26 -40.76 74.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.826 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.488 ' O ' HG22 ' A' ' 146' ' ' THR . 14.9 mm -62.15 -34.0 61.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.234 0.54 . . . . 0.0 110.158 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.89 -51.51 25.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.21 0.528 . . . . 0.0 110.714 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.6 mp -73.86 -20.99 60.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.877 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.656 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 11.7 t -73.77 175.81 6.88 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.504 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.533 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 23.0 m -86.44 149.72 4.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.996 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 151' ' ' LYS . 3.0 tt0 -50.81 -50.85 55.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.643 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -51.13 -11.4 0.1 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -131.8 -3.06 3.68 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.543 ' HG3' ' CG2' ' A' ' 146' ' ' THR . 0.6 OUTLIER -60.66 -63.43 4.31 Favored Pre-proline 0 C--N 1.325 -0.458 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.143 179.799 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.431 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 17.3 Cg_endo -58.33 -30.27 90.62 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.429 2.086 . . . . 0.0 111.962 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.711 ' O ' HG23 ' A' ' 157' ' ' VAL . 19.0 t -68.9 -51.41 44.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.485 ' CE1' ' CH2' ' A' ' 107' ' ' TRP . 7.7 m-30 -63.4 -36.41 83.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.919 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.46 ' HD3' HG13 ' A' ' 143' ' ' ILE . 0.5 OUTLIER -57.86 -46.31 85.01 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.112 179.608 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.463 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.7 OUTLIER -67.03 -31.94 72.82 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.57 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 153' ' ' VAL . 92.4 t -66.76 -41.48 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.415 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.724 HD22 ' HB3' ' A' ' 139' ' ' PRO . 62.8 mt -64.03 -44.51 92.32 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.4 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.7 t -53.49 -42.84 67.71 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.65 HG11 ' HA ' ' A' ' 76' ' ' VAL . 92.3 t -66.48 -42.18 89.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.172 178.183 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.555 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 21.9 m-30 -81.79 5.9 17.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.624 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.705 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . . . -59.09 -50.86 85.59 Favored Pre-proline 0 C--N 1.327 -0.382 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.004 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.705 ' HD3' ' HB3' ' A' ' 162' ' ' ALA . 30.6 Cg_exo -60.12 -10.84 13.74 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.346 2.031 . . . . 0.0 112.085 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.552 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 87.6 m-70 -111.23 -18.24 13.0 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.44 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 96.7 mt . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.868 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.573 ' C ' ' HB2' ' A' ' 78' ' ' TYR . 0.4 OUTLIER . . . . . 0 CA--C 1.523 -0.074 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.589 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 2.8 p30 . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 120.682 0.277 . . . . 0.0 111.004 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.601 ' HG2' HD12 ' A' ' 47' ' ' ILE . 6.7 ttp180 . . . . . 0 N--CA 1.451 -0.396 0 CA-C-O 121.35 0.595 . . . . 0.0 110.103 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.672 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 2.2 m-80 -128.81 175.29 8.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.844 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.761 HG13 ' CG1' ' A' ' 47' ' ' ILE . 25.7 m -134.64 159.5 41.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.177 0.513 . . . . 0.0 110.872 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.615 ' HA3' ' CE3' ' A' ' 107' ' ' TRP . . . -131.64 155.3 21.32 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.006 HG21 HD22 ' A' ' 61' ' ' LEU . 1.6 mp -125.37 117.08 48.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.476 ' O ' HD12 ' A' ' 109' ' ' LEU . 6.1 t -101.39 99.23 9.55 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.822 HD22 HG11 ' A' ' 67' ' ' VAL . 41.5 tp -100.83 119.09 38.15 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.727 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.801 ' HE2' HD13 ' A' ' 73' ' ' ILE . 0.4 OUTLIER -119.75 159.77 23.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.926 179.656 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.5 ' N ' ' OD1' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -94.6 171.87 8.53 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.024 0.44 . . . . 0.0 110.232 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -58.23 -4.77 0.39 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.675 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.612 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.5 OUTLIER -101.02 2.58 40.68 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.03 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.612 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 2.1 mmtm 75.12 20.86 2.03 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.186 -178.59 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.632 ' O ' ' HA ' ' A' ' 22' ' ' MET . 3.8 mmtt -92.2 143.87 25.99 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.756 HD11 ' HG3' ' A' ' 139' ' ' PRO . 1.6 mm -97.26 136.93 26.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.092 0.472 . . . . 0.0 112.009 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.567 ' CE1' HD13 ' A' ' 119' ' ' ILE . 33.8 t80 -74.13 105.53 5.38 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.41 178.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.603 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -103.88 144.37 31.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.799 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.405 ' HB1' ' CG ' ' A' ' 131' ' ' PHE . . . -142.25 131.37 23.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.388 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.785 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 6.6 p -97.9 147.29 24.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.069 0.461 . . . . 0.0 111.747 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 33' ' ' ARG . 4.7 mtp180 -68.36 128.95 38.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.389 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.697 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -45.14 -35.86 3.41 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.277 0.56 . . . . 0.0 110.883 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.53 -38.01 68.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.038 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.9 mt -122.81 105.92 34.84 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.214 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.11 -21.17 36.89 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.825 2.35 . . . . 0.0 112.967 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -92.06 -6.97 50.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.709 0.29 . . . . 0.0 111.568 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.785 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.34 95.45 10.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.691 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.658 ' O ' ' HA ' ' A' ' 146' ' ' THR . 72.3 m95 -93.65 136.73 33.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.912 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.513 ' HG3' ' C ' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -161.59 158.41 26.22 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.105 0.479 . . . . 0.0 110.699 179.755 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.597 ' HG3' ' HZ3' ' A' ' 107' ' ' TRP . 0.1 OUTLIER -94.34 157.8 36.83 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.55 178.844 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.508 ' CG ' HD13 ' A' ' 61' ' ' LEU . 2.8 Cg_endo -44.08 151.79 0.46 Allowed 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 123.119 2.546 . . . . 0.0 112.891 -179.126 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -171.39 143.06 1.77 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.201 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.672 ' O ' ' HB3' ' A' ' 16' ' ' ASN . . . -140.48 -178.38 17.0 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.65 ' HA2' ' CB ' ' A' ' 16' ' ' ASN . . . -112.18 23.58 15.97 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.016 -1.088 . . . . 0.0 114.736 -178.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.761 ' CG1' HG13 ' A' ' 17' ' ' VAL . 29.9 mt 60.13 130.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 117.543 0.672 . . . . 0.0 111.064 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.3 -176.15 0.71 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.825 0.345 . . . . 0.0 110.88 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.69 -81.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.212 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.39 55.91 0.49 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.359 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -116.21 153.01 32.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.873 0.368 . . . . 0.0 111.002 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.61 173.54 3.93 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.488 ' HA ' HG11 ' A' ' 17' ' ' VAL . 8.9 Cg_endo -85.53 -54.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.378 2.052 . . . . 0.0 111.678 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.806 ' HE ' HD11 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -54.36 -43.34 71.23 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.315 179.012 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.713 ' HA ' HD12 ' A' ' 58' ' ' ILE . 7.2 m-20 -69.44 -40.81 76.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.308 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.415 ' O ' ' CG ' ' A' ' 60' ' ' GLU . . . -60.78 -45.73 93.24 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.445 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -54.29 -49.37 69.77 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.014 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.806 HD11 ' HE ' ' A' ' 54' ' ' ARG . 18.0 mt -58.97 -55.47 23.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.246 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.67 -63.67 1.22 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.187 -179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.614 ' CD ' HD11 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -47.2 -37.43 10.26 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.407 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.006 HD22 HG21 ' A' ' 19' ' ' ILE . 9.8 tp -53.24 -48.43 68.21 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.868 178.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.901 ' HG3' HG23 ' A' ' 68' ' ' THR . 16.7 ttp180 -64.17 -64.23 0.94 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.489 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -48.98 -22.1 0.8 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.272 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -96.99 -37.45 10.17 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -178.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.562 HG22 ' CD2' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -127.66 -5.04 5.84 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.571 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 78.16 -13.88 13.4 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.252 -0.975 . . . . 0.0 111.872 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.822 HG11 HD22 ' A' ' 21' ' ' LEU . 75.3 t -58.62 112.71 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-O 121.194 0.521 . . . . 0.0 111.291 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.901 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.8 OUTLIER -121.59 -40.43 2.56 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.414 178.653 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.427 ' HB2' ' HA3' ' A' ' 114' ' ' GLY . 11.8 m -62.09 74.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.38 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.62 156.45 23.21 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.84 152.03 50.62 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.758 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.541 HG22 ' CE2' ' A' ' 110' ' ' PHE . 3.3 t -75.0 126.75 36.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.95 0.405 . . . . 0.0 111.186 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.801 HD13 ' HE2' ' A' ' 22' ' ' MET . 1.0 OUTLIER -107.47 -19.66 6.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.266 179.218 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.429 ' HB2' ' CE1' ' A' ' 164' ' ' HIS . . . -170.88 176.39 4.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.582 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -154.46 148.37 25.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.422 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.799 ' HA ' HG11 ' A' ' 160' ' ' VAL . 55.3 t -70.65 139.29 86.14 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.983 0.42 . . . . 0.0 110.894 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.57 ' HD2' HG13 ' A' ' 76' ' ' VAL . 18.7 Cg_endo -59.04 -62.9 0.15 Allowed 'Trans proline' 0 CA--C 1.519 -0.271 0 C-N-CA 123.233 2.622 . . . . 0.0 112.499 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.589 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -103.46 -172.47 2.12 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.426 -178.909 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.596 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 64.5 m95 -91.8 -158.29 0.57 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.974 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.69 HD11 ' OE1' ' A' ' 156' ' ' GLU . 26.6 mt . . . . . 0 C--N 1.328 -0.358 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 -0.094 0 CA-C-O 120.7 0.286 . . . . 0.0 110.61 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.463 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 15.7 mt-30 -126.31 123.97 39.24 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.571 ' HB2' ' CE3' ' A' ' 79' ' ' TRP . 0.7 OUTLIER -104.46 139.19 39.74 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.134 178.982 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.615 ' CE3' ' HA3' ' A' ' 18' ' ' GLY . 77.8 m95 -106.82 162.91 13.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.371 0.605 . . . . 0.0 112.576 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.616 ' CD1' ' HG2' ' A' ' 54' ' ' ARG . 96.5 m-85 -140.0 152.98 46.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.205 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.599 HD11 ' SD ' ' A' ' 22' ' ' MET . 11.8 tp -99.99 136.93 39.15 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.557 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.608 ' CE2' HG12 ' A' ' 58' ' ' ILE . 29.6 m-85 -140.03 144.54 36.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.504 0.669 . . . . 0.0 112.631 -178.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.569 ' HB2' HD11 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -104.39 123.17 46.96 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.977 178.397 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.624 ' CD1' HD21 ' A' ' 21' ' ' LEU . 56.6 t80 -79.13 99.42 6.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.912 0.387 . . . . 0.0 110.552 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 69' ' ' SER . 30.3 p -95.78 41.71 1.1 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.324 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 69' ' ' SER . . . -141.81 -148.33 5.01 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.651 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -122.7 149.84 43.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.951 0.405 . . . . 0.0 111.359 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.437 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 18.1 p-10 -58.99 -37.0 75.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.386 0.612 . . . . 0.0 111.231 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -57.43 -3.5 0.17 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.46 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -90.49 -20.54 22.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.146 0.498 . . . . 0.0 110.303 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.567 HD13 ' CE1' ' A' ' 29' ' ' PHE . 9.7 mt -88.35 107.07 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.215 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 58.1 t30 -102.23 -26.07 13.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.191 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.562 ' CD2' HG22 ' A' ' 65' ' ' THR . 56.9 mt . . . . . 0 N--CA 1.464 0.233 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.178 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.461 ' HB2' ' CE1' ' A' ' 131' ' ' PHE . 61.0 mm-40 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.986 0.422 . . . . 0.0 110.539 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.502 ' CE1' HG23 ' A' ' 65' ' ' THR . 0.7 OUTLIER -134.02 143.87 48.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.104 -179.872 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.697 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -89.73 -33.69 8.96 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.054 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.35 142.9 28.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.836 0.35 . . . . 0.0 110.543 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.534 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 34.5 p-90 -135.29 170.33 16.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.137 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.45 ' N ' ' CE3' ' A' ' 134' ' ' TRP . 22.6 t -168.33 176.66 5.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.315 0.579 . . . . 0.0 111.758 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.507 ' CE2' ' CZ3' ' A' ' 134' ' ' TRP . 48.0 m95 -110.69 102.84 11.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.479 178.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 28' ' ' ILE . 29.6 m -118.19 167.6 11.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.548 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 18.3 p -72.51 169.53 16.63 Favored Pre-proline 0 C--N 1.326 -0.429 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.211 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.756 ' HG3' HD11 ' A' ' 28' ' ' ILE . 17.1 Cg_exo -60.2 -56.51 1.08 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.723 1.615 . . . . 0.0 110.379 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -62.76 -27.76 69.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.73 178.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.44 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 10.8 mt-30 -71.35 -48.81 47.92 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.544 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.603 HD13 ' HB2' ' A' ' 30' ' ' ALA . 5.2 tp -57.41 -38.48 74.39 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.654 ' O ' HG22 ' A' ' 146' ' ' THR . 16.4 mm -60.13 -36.71 69.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.538 179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.98 -53.04 14.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.247 0.546 . . . . 0.0 110.954 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.78 -19.0 62.07 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.174 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.658 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 13.1 t -73.57 177.33 5.42 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.112 0.482 . . . . 0.0 111.302 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.515 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 36.0 m -81.03 149.53 4.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.748 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.415 ' C ' ' H ' ' A' ' 150' ' ' LYS . 2.7 mt-10 -57.83 -53.47 57.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.813 0.34 . . . . 0.0 110.988 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.5 ' CD2' ' HG3' ' A' ' 150' ' ' LYS . 39.4 p90 -57.08 2.38 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.501 ' HD2' HG21 ' A' ' 147' ' ' VAL . 6.4 mtpp -139.12 -5.95 1.43 Allowed 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 0.2 OUTLIER -63.09 -52.39 63.0 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.849 -0.159 . . . . 0.0 110.686 179.681 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 151' ' ' LYS . 15.1 Cg_exo -65.28 -29.3 54.96 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.296 1.997 . . . . 0.0 111.393 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.562 ' O ' HG23 ' A' ' 157' ' ' VAL . 37.2 t -67.92 -53.55 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.517 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 4.0 m-30 -63.31 -39.49 94.69 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.578 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.625 ' HE2' ' HA ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -56.22 -38.18 70.71 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.247 179.527 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.69 ' OE1' HD11 ' A' ' 80' ' ' LEU . 4.7 tm-20 -68.48 -36.53 79.09 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.62 HG12 ' CE2' ' A' ' 161' ' ' PHE . 40.0 t -64.51 -41.02 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.863 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.659 HD22 ' HB3' ' A' ' 139' ' ' PRO . 43.4 mt -65.4 -46.94 78.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.939 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -52.15 -40.34 61.27 Favored 'General case' 0 CA--C 1.522 -0.127 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.799 HG11 ' HA ' ' A' ' 76' ' ' VAL . 98.4 t -67.33 -42.43 87.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.62 ' CE2' HG12 ' A' ' 157' ' ' VAL . 17.3 m-30 -80.09 5.49 14.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.034 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.592 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.1 -53.72 63.06 Favored Pre-proline 0 C--N 1.331 -0.229 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.528 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 18.2 Cg_endo -58.41 -13.26 16.13 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 121.989 1.793 . . . . 0.0 111.56 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.429 ' CE1' ' HB2' ' A' ' 74' ' ' ALA . 40.5 m80 -107.25 -17.71 14.07 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.986 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 92.3 mt . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.026 -0.987 . . . . 0.0 110.368 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.458 -0.051 0 CA-C-O 120.678 0.275 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.446 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 6.3 p-10 . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.892 0.377 . . . . 0.0 110.211 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 121.278 0.561 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.837 ' HB2' ' HG2' ' A' ' 105' ' ' GLN . 2.8 m-80 -132.26 173.73 10.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.338 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.716 HG13 ' CG1' ' A' ' 47' ' ' ILE . 11.5 m -140.49 169.6 15.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.18 0.514 . . . . 0.0 111.281 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.615 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -136.25 153.95 21.76 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.253 178.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.832 HG23 ' CE1' ' A' ' 110' ' ' PHE . 2.4 mp -126.34 122.16 60.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.491 ' O ' HD12 ' A' ' 109' ' ' LEU . 40.9 t -104.88 107.62 18.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.083 177.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.793 HD21 ' CD2' ' A' ' 112' ' ' PHE . 17.3 tp -106.08 126.66 52.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.726 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.77 ' SD ' HD11 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -118.82 141.04 49.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.057 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.451 ' OD1' ' CH2' ' A' ' 136' ' ' TRP . 5.6 m-20 -95.22 -175.98 3.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.191 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -55.5 -6.25 0.17 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.472 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 4.5 m-20 -100.71 -0.13 37.9 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.465 ' NZ ' ' HE3' ' A' ' 22' ' ' MET . 30.0 mmtt 68.68 23.57 7.07 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 22' ' ' MET . 72.2 mttt -95.13 176.78 6.1 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.915 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.621 HD11 ' HG3' ' A' ' 139' ' ' PRO . 2.0 mm -116.94 142.14 32.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.344 0.592 . . . . 0.0 111.249 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.617 ' CZ ' HG21 ' A' ' 65' ' ' THR . 6.6 t80 -66.88 103.48 1.14 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.108 179.015 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' A' ' 41' ' ' GLN . . . -97.58 137.87 35.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.986 0.422 . . . . 0.0 111.253 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.426 ' HB1' ' CG ' ' A' ' 131' ' ' PHE . . . -139.25 132.69 30.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.477 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.662 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 77.0 p -101.32 146.9 26.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.919 0.39 . . . . 0.0 111.38 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 33' ' ' ARG . 5.5 mtp85 -69.55 128.98 38.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.37 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.715 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.6 OUTLIER -44.69 -37.04 3.43 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.37 0.605 . . . . 0.0 111.034 -179.863 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.86 -36.47 70.13 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.752 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.7 mm -122.99 110.57 31.23 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.12 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.23 -19.74 13.25 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.397 2.064 . . . . 0.0 112.644 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -91.06 -10.1 43.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.471 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.733 ' HB1' ' CG1' ' A' ' 147' ' ' VAL . . . -92.24 95.01 9.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.691 0.282 . . . . 0.0 111.075 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.661 ' O ' ' HA ' ' A' ' 146' ' ' THR . 78.7 m95 -87.99 158.41 18.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.126 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.664 ' O ' ' HA ' ' A' ' 30' ' ' ALA . 1.6 mt-30 -166.95 -138.25 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.629 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.531 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 8.5 ptt? -175.82 162.23 2.03 Favored Pre-proline 0 N--CA 1.453 -0.319 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.755 ' HG3' HD12 ' A' ' 61' ' ' LEU . 1.5 Cg_endo -40.9 134.19 2.51 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 123.257 2.638 . . . . 0.0 113.088 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -173.73 143.51 1.0 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.875 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.453 ' HA3' ' HG2' ' A' ' 60' ' ' GLU . . . -159.6 -158.64 9.26 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.783 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.715 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -117.31 141.8 16.85 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.742 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.716 ' CG1' HG13 ' A' ' 17' ' ' VAL . 13.9 mt -71.69 143.0 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 122.496 0.319 . . . . 0.0 110.88 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -69.23 -176.19 0.89 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.919 0.39 . . . . 0.0 110.587 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -49.13 -81.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.225 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -108.05 53.22 0.61 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.251 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -118.35 153.73 33.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.915 0.388 . . . . 0.0 111.048 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.53 163.29 64.6 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.426 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.467 ' HA ' HG12 ' A' ' 47' ' ' ILE . 5.8 Cg_exo -78.5 -52.58 0.06 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 122.952 2.435 . . . . 0.0 112.486 -179.389 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.653 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -48.89 -51.85 27.68 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.762 179.659 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -57.26 -42.68 82.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.175 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 60' ' ' GLU . . . -61.59 -43.52 98.7 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.603 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -57.57 -57.77 11.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.344 177.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.653 HD13 ' O ' ' A' ' 54' ' ' ARG . 1.9 mp -55.23 -48.99 75.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.577 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.7 mtt180 -65.01 -62.55 1.48 Allowed 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.304 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.453 ' HG2' ' HA3' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -42.3 -47.26 4.79 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.118 0.485 . . . . 0.0 110.119 179.581 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.755 HD12 ' HG3' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -50.8 -49.37 58.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.083 178.715 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.93 ' HG3' HG23 ' A' ' 68' ' ' THR . 13.9 ttp180 -63.73 -65.54 0.67 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.493 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -49.02 -20.4 0.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -98.1 -35.48 10.4 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -178.378 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.872 HG22 HD23 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -133.03 7.99 4.03 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -178.38 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.87 -9.73 2.68 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.974 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.734 HG13 ' CE2' ' A' ' 112' ' ' PHE . 77.1 t -56.76 108.66 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-O 121.153 0.501 . . . . 0.0 111.393 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.93 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.6 OUTLIER -124.58 -39.71 2.28 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.593 178.26 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.0 m -63.77 70.91 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.991 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -156.96 156.91 33.8 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.037 0.446 . . . . 0.0 111.932 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.427 ' HG3' HG21 ' A' ' 113' ' ' THR . 0.9 OUTLIER -129.39 149.1 51.31 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.435 179.108 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.967 HG22 ' CE2' ' A' ' 110' ' ' PHE . 12.3 t -74.71 125.0 33.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 111' ' ' LYS . 0.9 OUTLIER -105.5 -21.62 5.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.12 179.302 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -170.42 177.02 4.21 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.554 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 2.0 pm0 -155.36 152.05 28.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.757 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.725 ' HA ' HG11 ' A' ' 160' ' ' VAL . 54.1 t -70.48 132.57 87.49 Favored Pre-proline 0 C--N 1.327 -0.387 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.814 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -57.97 -55.12 2.51 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.125 2.55 . . . . 0.0 112.681 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.556 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.6 OUTLIER -101.88 -174.36 2.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.65 -179.518 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.472 ' O ' ' HG ' ' A' ' 80' ' ' LEU . 33.9 m95 -94.65 -154.67 0.43 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.612 ' HB2' ' O ' ' A' ' 105' ' ' GLN . 95.5 mt . . . . . 0 CA--C 1.515 -0.392 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.198 0 CA-C-O 121.095 0.474 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.837 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 71.1 mt-30 -132.51 122.65 25.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.291 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.455 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 14.8 ttpp -105.2 138.26 41.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.482 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.615 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 28.4 m95 -103.96 162.75 12.87 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.585 ' HB2' ' HE1' ' A' ' 110' ' ' PHE . 51.3 m-85 -140.34 154.07 46.63 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.479 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.77 HD11 ' SD ' ' A' ' 22' ' ' MET . 12.0 tp -103.22 140.97 36.67 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.323 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.967 ' CE2' HG22 ' A' ' 72' ' ' VAL . 63.1 m-85 -143.69 150.0 38.03 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 16.5 tttt -106.69 124.21 49.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.533 178.3 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.793 ' CD2' HD21 ' A' ' 21' ' ' LEU . 16.0 t80 -78.92 100.88 7.43 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.012 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.427 HG21 ' HG3' ' A' ' 71' ' ' GLU . 60.1 p -95.9 39.98 1.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.115 0.483 . . . . 0.0 110.845 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -145.64 -144.12 4.06 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.078 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.776 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 50.6 mt-30 -123.11 160.8 25.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.898 0.38 . . . . 0.0 111.207 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.409 ' HB2' ' CZ2' ' A' ' 134' ' ' TRP . 9.2 p-10 -60.14 -27.67 67.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.665 0.745 . . . . 0.0 111.309 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -52.82 -5.78 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.321 -1.309 . . . . 0.0 113.741 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.776 ' HG2' ' O ' ' A' ' 115' ' ' GLN . 0.1 OUTLIER -90.96 -24.48 20.12 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.085 178.785 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.608 ' HA ' ' O ' ' A' ' 65' ' ' THR . 7.0 mt -84.53 101.39 8.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.619 -0.718 . . . . 0.0 112.442 -178.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -107.04 -32.0 8.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.403 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.872 HD23 HG22 ' A' ' 65' ' ' THR . 9.9 mt . . . . . 0 C--N 1.331 -0.206 0 CA-C-O 121.035 0.445 . . . . 0.0 110.519 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 . . . . . 0 N--CA 1.463 0.182 0 CA-C-O 121.015 0.436 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.626 ' CE2' HG23 ' A' ' 65' ' ' THR . 1.6 m-85 -130.68 143.3 50.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.05 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.715 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -87.46 -35.96 9.09 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.639 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -148.34 144.76 27.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.944 0.402 . . . . 0.0 110.741 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.687 ' HD1' HD11 ' A' ' 121' ' ' LEU . 39.0 p-90 -135.88 169.34 17.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.94 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.428 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 33.6 t -162.75 176.3 10.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.315 0.578 . . . . 0.0 112.03 -178.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.451 ' CH2' ' OD1' ' A' ' 23' ' ' ASN . 83.4 m95 -110.71 103.03 11.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.314 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.44 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 30.1 m -120.55 167.83 13.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.911 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.542 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 24.3 p -72.2 167.26 33.7 Favored Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.066 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.621 ' HG3' HD11 ' A' ' 28' ' ' ILE . 20.2 Cg_exo -59.62 -55.65 1.64 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.731 1.621 . . . . 0.0 110.296 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -62.7 -26.93 68.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.265 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.45 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 11.7 mm100 -72.51 -46.84 52.76 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.625 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.635 HD11 ' O ' ' A' ' 41' ' ' GLN . 1.5 tp -58.21 -38.52 76.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.858 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.825 HG21 ' HG2' ' A' ' 155' ' ' LYS . 28.9 mm -62.31 -38.89 82.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.252 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.27 -50.16 55.63 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.307 0.575 . . . . 0.0 110.729 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.58 -20.22 60.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.967 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.661 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 13.2 t -74.89 176.37 7.18 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.141 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.733 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 35.3 m -81.63 142.79 13.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.818 0.342 . . . . 0.0 111.53 -179.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.523 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 55.2 mt-10 -50.27 -51.15 47.29 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.278 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.15 -10.91 0.09 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -135.25 -4.02 2.4 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.644 ' HG2' ' O ' ' A' ' 143' ' ' ILE . 9.7 mttt -59.47 -57.98 22.9 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 120.36 0.124 . . . . 0.0 111.164 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 20.8 Cg_endo -60.78 -27.55 84.99 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.427 2.085 . . . . 0.0 111.658 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.733 ' O ' HG23 ' A' ' 157' ' ' VAL . 39.0 t -68.97 -52.89 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.547 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 5.0 m-30 -64.31 -40.65 96.34 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.505 178.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.825 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -55.85 -41.34 74.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.258 179.521 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -68.31 -33.46 74.35 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 153' ' ' VAL . 44.6 t -66.42 -40.77 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.944 178.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.617 HD22 ' HB3' ' A' ' 139' ' ' PRO . 52.2 mt -63.46 -45.83 89.01 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.644 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.15 -40.14 45.52 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.725 HG11 ' HA ' ' A' ' 76' ' ' VAL . 88.8 t -66.99 -42.69 88.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.944 177.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.689 ' CE2' HG12 ' A' ' 157' ' ' VAL . 14.1 m-30 -81.03 5.58 16.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.685 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.631 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.42 -51.89 78.55 Favored Pre-proline 0 C--N 1.331 -0.237 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.428 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 18.1 Cg_endo -59.08 -12.39 15.54 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.021 1.814 . . . . 0.0 111.716 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -107.69 -20.14 13.32 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.464 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 96.8 mt . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.761 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.462 0.141 0 CA-C-O 120.745 0.307 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.735 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 63.8 t0 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.952 0.406 . . . . 0.0 110.489 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.536 ' HG2' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.166 0 CA-C-O 121.031 0.443 . . . . 0.0 110.144 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.62 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 4.2 m-80 -133.19 172.67 12.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.132 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.663 HG13 ' CG1' ' A' ' 47' ' ' ILE . 16.6 m -135.84 164.98 30.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.224 0.535 . . . . 0.0 111.443 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.719 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -138.67 155.88 23.89 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.97 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.814 HG13 ' HB1' ' A' ' 57' ' ' ALA . 2.5 mp -131.11 123.91 54.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.51 ' O ' HD12 ' A' ' 109' ' ' LEU . 8.6 t -102.33 101.22 11.45 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.871 HD22 HG11 ' A' ' 67' ' ' VAL . 20.7 tp -99.58 117.52 34.15 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.359 -178.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.491 ' SD ' HD11 ' A' ' 109' ' ' LEU . 1.4 ptt? -118.08 166.74 12.19 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.729 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.716 ' ND2' ' CE3' ' A' ' 136' ' ' TRP . 0.3 OUTLIER -101.21 169.67 8.76 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.28 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -56.37 -4.5 0.14 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.52 178.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.5 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 2.7 m-20 -99.06 2.96 46.61 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 3.3 mmtp 74.18 20.47 2.69 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.014 -178.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.462 ' HB2' ' OD1' ' A' ' 23' ' ' ASN . 1.1 mmtt -94.17 145.55 24.62 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.817 HD11 ' HG3' ' A' ' 139' ' ' PRO . 1.1 mm -97.93 139.94 19.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.294 0.568 . . . . 0.0 112.473 -177.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.408 ' HE1' ' CD2' ' A' ' 134' ' ' TRP . 18.6 t80 -75.99 122.54 24.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.809 178.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.62 ' HA ' ' O ' ' A' ' 41' ' ' GLN . . . -122.68 146.68 47.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.967 0.413 . . . . 0.0 111.124 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.446 ' O ' ' HG3' ' A' ' 41' ' ' GLN . . . -137.65 136.5 37.52 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.407 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.574 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 97.0 p -100.73 144.52 29.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.909 0.385 . . . . 0.0 111.049 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.2 mtp-105 -69.83 126.71 30.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.487 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.697 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.3 OUTLIER -45.43 -33.37 2.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.296 0.57 . . . . 0.0 110.781 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.01 -38.23 64.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.008 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.473 HG22 ' H ' ' A' ' 39' ' ' ALA . 56.1 mt -124.67 104.56 30.65 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.09 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.24 -18.1 50.4 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.727 2.285 . . . . 0.0 112.774 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -94.22 -11.0 31.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.554 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.8 ' HB1' ' CG1' ' A' ' 147' ' ' VAL . . . -91.42 96.77 10.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.778 0.323 . . . . 0.0 111.196 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.552 ' O ' ' HA ' ' A' ' 146' ' ' THR . 77.1 m95 -89.53 161.89 15.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.341 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.62 ' O ' ' HA ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -169.26 -139.47 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.932 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.487 ' H ' ' HB2' ' A' ' 41' ' ' GLN . 10.2 ptt? -175.07 161.93 2.34 Favored Pre-proline 0 C--N 1.327 -0.386 0 O-C-N 122.196 -0.315 . . . . 0.0 110.368 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 42' ' ' MET . 1.9 Cg_endo -40.8 131.91 2.72 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.015 2.477 . . . . 0.0 112.946 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.465 ' HA ' HD12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -178.44 144.66 0.3 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.652 179.755 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.675 ' HA3' ' HG2' ' A' ' 60' ' ' GLU . . . -161.26 -163.12 13.63 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.059 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.62 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -109.3 145.94 16.73 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.723 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.663 ' CG1' HG13 ' A' ' 17' ' ' VAL . 19.8 mt -72.49 143.64 13.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 122.354 0.262 . . . . 0.0 110.973 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -69.54 -174.85 0.75 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.836 0.35 . . . . 0.0 110.458 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -48.48 -71.13 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.147 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -120.9 54.23 0.67 Allowed Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.384 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -113.47 150.66 32.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.803 0.335 . . . . 0.0 110.875 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -69.66 158.89 85.89 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.053 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.555 ' HA ' HG11 ' A' ' 17' ' ' VAL . 4.0 Cg_exo -76.4 -50.37 0.11 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.595 2.197 . . . . 0.0 111.426 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.819 ' HE ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -52.49 -46.81 66.77 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.297 179.325 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -66.9 -41.81 86.53 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.056 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.562 ' O ' ' HB2' ' A' ' 60' ' ' GLU . . . -61.13 -44.43 97.35 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.814 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -55.43 -53.98 49.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.094 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.675 HD11 ' NE ' ' A' ' 54' ' ' ARG . 34.6 mt -55.02 -53.73 31.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.098 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 -62.29 -60.76 3.11 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.976 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.675 ' HG2' ' HA3' ' A' ' 45' ' ' GLY . 0.6 OUTLIER -44.1 -48.25 8.99 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.105 0.479 . . . . 0.0 110.121 179.269 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.688 HD13 HG21 ' A' ' 19' ' ' ILE . 0.8 OUTLIER -52.73 -46.23 67.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.565 179.046 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.805 ' HG3' HG23 ' A' ' 68' ' ' THR . 42.9 ttp180 -64.87 -62.75 1.37 Allowed 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 121.343 0.592 . . . . 0.0 111.015 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -50.09 -21.69 1.37 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.359 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -96.11 -36.6 10.93 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.575 HG23 ' CE2' ' A' ' 131' ' ' PHE . 3.6 p -127.27 -4.62 6.12 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.819 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 80.3 -12.07 34.23 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.362 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.871 HG11 HD22 ' A' ' 21' ' ' LEU . 64.3 t -58.2 118.98 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 121.33 0.586 . . . . 0.0 111.587 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.805 HG23 ' HG3' ' A' ' 62' ' ' ARG . 1.1 p -127.2 -40.01 1.86 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.402 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.8 m -62.54 76.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.512 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -162.92 156.7 20.24 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -129.82 150.17 51.24 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.858 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.819 HG21 ' HE ' ' A' ' 54' ' ' ARG . 21.3 t -74.0 129.41 36.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.265 0.555 . . . . 0.0 111.753 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.641 HD11 ' HB2' ' A' ' 111' ' ' LYS . 1.3 mt -110.56 -18.36 7.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.452 179.264 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.493 ' HB2' ' CG ' ' A' ' 164' ' ' HIS . . . -171.3 175.93 4.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.405 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -154.6 150.01 27.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.603 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.731 ' HA ' HG11 ' A' ' 160' ' ' VAL . 11.2 t -72.03 136.85 82.08 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.846 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.697 ' HD2' HG21 ' A' ' 160' ' ' VAL . 35.1 Cg_endo -67.56 -60.25 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.9 2.4 . . . . 0.0 113.306 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.735 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -94.27 172.98 7.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.08 -178.478 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.59 ' HB3' ' HB1' ' A' ' 104' ' ' ALA . 57.1 m95 -91.71 100.69 13.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.281 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.548 HD21 ' HG2' ' A' ' 156' ' ' GLU . 88.8 mt . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 121.054 0.454 . . . . 0.0 110.783 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.59 ' HB1' ' HB3' ' A' ' 79' ' ' TRP . . . . . . . . 0 CA--C 1.521 -0.149 0 CA-C-O 121.165 0.507 . . . . 0.0 111.262 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.454 ' CG ' ' HB2' ' A' ' 16' ' ' ASN . 35.6 mt-30 -126.15 125.18 42.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.943 -178.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.49 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 3.5 ttmm -104.95 136.83 43.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.554 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.719 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 23.8 m95 -103.14 170.39 7.99 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 53' ' ' PRO . 96.2 m-85 -141.8 154.14 45.01 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.913 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.524 HD12 ' H ' ' A' ' 110' ' ' PHE . 15.6 tp -101.76 138.56 38.58 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.67 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.747 ' CZ ' HG22 ' A' ' 72' ' ' VAL . 31.0 m-85 -141.68 144.07 33.9 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.641 ' HB2' HD11 ' A' ' 73' ' ' ILE . 3.2 tttm -102.21 124.91 48.62 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.962 178.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.597 ' HD1' HD21 ' A' ' 21' ' ' LEU . 49.9 t80 -78.38 99.88 6.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.811 0.339 . . . . 0.0 110.56 178.896 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 35.1 p -99.37 51.29 0.94 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.027 0.442 . . . . 0.0 110.501 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -153.81 -146.93 4.51 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.504 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.439 ' O ' ' HZ ' ' A' ' 112' ' ' PHE . 2.7 mm-40 -120.93 146.61 46.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.028 0.442 . . . . 0.0 110.714 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.4 ' HB3' ' CH2' ' A' ' 134' ' ' TRP . 18.1 m-20 -57.15 -33.08 67.05 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.873 -178.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -58.23 -5.64 0.51 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.862 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -90.73 -15.19 30.68 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.64 0.257 . . . . 0.0 111.026 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.653 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 19.2 mt -77.9 100.24 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.901 0.381 . . . . 0.0 111.883 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -105.8 97.34 7.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.498 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.756 HD13 ' HB2' ' A' ' 131' ' ' PHE . 27.2 mt . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.11 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 . . . . . 0 C--O 1.233 0.201 0 CA-C-O 120.907 0.384 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.756 ' HB2' HD13 ' A' ' 121' ' ' LEU . 2.0 m-85 -104.18 144.15 31.97 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.401 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.697 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -88.72 -35.54 8.37 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.558 -0.83 . . . . 0.0 111.713 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.6 148.4 28.59 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.854 0.359 . . . . 0.0 110.719 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.653 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 37.6 p-90 -135.4 165.31 25.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.264 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.426 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 22.6 t -160.13 176.95 11.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.392 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.716 ' CE3' ' ND2' ' A' ' 23' ' ' ASN . 41.9 m95 -113.75 105.02 12.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.224 178.099 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 28' ' ' ILE . 24.4 m -119.39 170.3 9.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.269 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.549 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 24.4 p -72.86 169.32 17.94 Favored Pre-proline 0 C--N 1.324 -0.529 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.504 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.817 ' HG3' HD11 ' A' ' 28' ' ' ILE . 17.3 Cg_exo -60.52 -51.83 4.66 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.082 1.855 . . . . 0.0 110.401 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -67.41 -28.81 68.23 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.847 178.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.455 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 2.3 mt-30 -71.35 -47.05 58.78 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.614 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.538 ' CD1' ' HB2' ' A' ' 30' ' ' ALA . 3.5 tp -55.67 -39.24 70.68 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.536 ' O ' HG22 ' A' ' 146' ' ' THR . 24.2 mm -62.82 -38.37 81.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.233 0.54 . . . . 0.0 110.514 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.73 -49.86 55.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.187 0.517 . . . . 0.0 110.627 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.437 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -74.63 -21.65 59.33 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.02 -179.196 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.687 HG23 ' HG3' ' A' ' 151' ' ' LYS . 6.2 t -73.49 -178.92 3.24 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.68 -178.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.8 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 30.7 m -86.39 151.1 3.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.822 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.58 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 0.1 OUTLIER -58.93 -53.69 55.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.683 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.56 ' H ' ' HG3' ' A' ' 148' ' ' GLU . 39.3 p90 -55.38 -3.44 0.06 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 28.4 mttm -133.15 -7.4 3.02 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.687 ' HG3' HG23 ' A' ' 146' ' ' THR . 8.1 mttt -60.37 -61.7 7.42 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.629 0.252 . . . . 0.0 111.192 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.58 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 10.7 Cg_endo -53.92 -31.28 62.29 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.742 2.295 . . . . 0.0 112.011 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.851 ' O ' HG23 ' A' ' 157' ' ' VAL . 38.9 t -67.18 -52.05 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.485 ' HE2' ' HA ' ' A' ' 41' ' ' GLN . 4.0 m-30 -63.77 -37.93 89.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.651 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.506 ' HD3' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -55.93 -46.74 78.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.822 179.504 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.548 ' HG2' HD21 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -67.26 -28.92 68.44 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.416 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 153' ' ' VAL . 47.4 t -68.89 -42.24 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.717 178.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.494 HD22 ' HB3' ' A' ' 139' ' ' PRO . 49.4 mt -63.91 -46.43 84.86 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.551 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 40.5 t -50.33 -42.19 52.53 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.731 HG11 ' HA ' ' A' ' 76' ' ' VAL . 94.6 t -65.92 -42.03 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.282 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.61 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 16.8 m-30 -81.07 4.9 18.23 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.534 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.702 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . . . -58.86 -50.18 89.37 Favored Pre-proline 0 C--N 1.329 -0.294 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.653 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.702 ' HD3' ' HB3' ' A' ' 162' ' ' ALA . 24.2 Cg_exo -61.55 -11.93 22.3 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.389 2.059 . . . . 0.0 111.602 178.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.493 ' CG ' ' HB2' ' A' ' 74' ' ' ALA . 54.6 m80 -109.69 -17.8 13.61 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.341 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 86.3 mt . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.725 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 12.4 mtm . . . . . 0 N--CA 1.46 0.058 0 CA-C-O 120.762 0.315 . . . . 0.0 110.653 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.721 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 11.3 p-10 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.607 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.598 ' HG2' HD12 ' A' ' 47' ' ' ILE . 3.9 ttp180 . . . . . 0 CA--C 1.532 0.252 0 CA-C-O 120.905 0.383 . . . . 0.0 111.579 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.712 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 66.0 m-20 -133.47 176.54 8.45 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.218 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.801 HG13 ' CG1' ' A' ' 47' ' ' ILE . 13.1 m -139.25 166.29 21.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.365 0.602 . . . . 0.0 112.079 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.59 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -133.83 162.2 24.41 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.365 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.869 HG21 HD22 ' A' ' 61' ' ' LEU . 3.4 mp -129.49 117.47 42.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.551 ' O ' HD12 ' A' ' 109' ' ' LEU . 0.5 OUTLIER -103.86 99.76 9.54 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.992 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.832 HD11 ' HB2' ' A' ' 112' ' ' PHE . 12.4 tp -102.26 126.87 49.38 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.847 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.59 ' HE3' HD13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -124.49 153.84 41.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.239 -179.724 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.675 ' ND2' ' CD2' ' A' ' 136' ' ' TRP . 47.2 m-20 -99.39 -178.61 3.96 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.684 0.754 . . . . 0.0 111.094 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -58.73 -6.17 0.7 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.041 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.523 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 2.7 m-20 -99.55 0.19 41.8 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -178.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 2.0 mmtm 72.7 21.92 3.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.921 -178.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.552 ' C ' HD12 ' A' ' 28' ' ' ILE . 15.3 mttt -95.77 169.19 10.18 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.735 HD12 ' N ' ' A' ' 28' ' ' ILE . 1.5 mp -117.67 143.24 28.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.475 0.655 . . . . 0.0 111.566 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.519 ' CE2' ' HD3' ' A' ' 43' ' ' PRO . 6.5 t80 -64.48 99.65 0.32 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.724 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.756 ' HA ' ' O ' ' A' ' 41' ' ' GLN . . . -96.46 138.73 33.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.193 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.23 135.98 39.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.578 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.733 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 70.0 p -102.15 141.95 34.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.852 0.358 . . . . 0.0 111.473 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.9 128.11 34.88 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.515 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.707 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.3 OUTLIER -44.24 -37.82 3.45 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.181 0.515 . . . . 0.0 111.04 -179.859 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -71.59 -35.24 70.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.508 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.403 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 16.3 mt -126.4 106.72 24.06 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 120.728 0.299 . . . . 0.0 111.068 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.7 -43.84 12.03 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.86 2.374 . . . . 0.0 113.276 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -75.29 -3.55 33.99 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.769 ' HB1' ' CG1' ' A' ' 147' ' ' VAL . . . -92.34 96.13 10.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.751 0.31 . . . . 0.0 110.671 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.603 ' CD1' ' HB3' ' A' ' 145' ' ' LEU . 74.1 m95 -94.46 163.0 13.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.57 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.756 ' O ' ' HA ' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -174.31 -135.3 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.341 -178.945 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.626 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 6.4 ptt? -177.03 165.32 1.45 Allowed Pre-proline 0 N--CA 1.453 -0.307 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.904 ' HG3' HD13 ' A' ' 61' ' ' LEU . 4.1 Cg_endo -45.05 144.47 3.84 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.736 2.291 . . . . 0.0 113.246 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.462 ' HA ' HD12 ' A' ' 19' ' ' ILE . 21.1 pt20 -174.26 141.94 0.76 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.323 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.538 ' HA3' ' HG3' ' A' ' 60' ' ' GLU . . . -142.65 -173.21 14.29 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.991 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.701 ' HA2' ' CB ' ' A' ' 16' ' ' ASN . . . -116.68 22.07 11.04 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 119.984 -1.103 . . . . 0.0 114.445 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.801 ' CG1' HG13 ' A' ' 17' ' ' VAL . 43.1 mt 61.28 131.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 117.234 0.517 . . . . 0.0 111.346 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -68.02 -176.18 0.67 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.724 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -47.67 -69.74 0.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.315 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -119.13 57.1 0.56 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.504 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -117.95 150.72 38.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.888 0.375 . . . . 0.0 110.945 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.84 173.09 4.53 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.748 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.639 ' HA ' HG11 ' A' ' 17' ' ' VAL . 2.0 Cg_endo -80.74 -52.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.541 2.16 . . . . 0.0 111.58 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.739 ' HE ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -54.01 -44.22 70.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.515 179.153 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -68.52 -45.09 73.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.372 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.428 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -60.51 -42.47 96.45 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.717 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -56.66 -60.16 3.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.319 0.58 . . . . 0.0 109.723 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.543 HD11 ' CD ' ' A' ' 54' ' ' ARG . 47.2 mt -53.92 -51.33 46.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.207 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -61.02 -62.68 1.68 Allowed 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.85 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.538 ' HG3' ' HA3' ' A' ' 45' ' ' GLY . 8.8 mm-40 -43.71 -44.03 6.3 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.261 0.553 . . . . 0.0 109.908 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.96 HD11 ' HB ' ' A' ' 67' ' ' VAL . 0.6 OUTLIER -51.87 -47.96 64.28 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.968 178.59 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.721 ' HG3' HG23 ' A' ' 68' ' ' THR . 38.5 ttt180 -63.23 -65.58 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.214 0.531 . . . . 0.0 111.095 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -47.75 -25.27 1.18 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.317 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -93.38 -35.58 12.95 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.605 ' HB ' HG23 ' A' ' 119' ' ' ILE . 1.4 p -127.68 -37.14 1.99 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.752 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 111.48 -10.56 28.34 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.184 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.96 ' HB ' HD11 ' A' ' 61' ' ' LEU . 68.6 t -56.86 111.97 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.197 0.523 . . . . 0.0 111.633 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.721 HG23 ' HG3' ' A' ' 62' ' ' ARG . 6.9 p -123.66 -39.15 2.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.651 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.4 m -62.48 74.43 0.02 OUTLIER 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.018 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -160.88 157.11 26.04 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -128.01 144.85 51.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.095 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.808 HG22 ' CE1' ' A' ' 110' ' ' PHE . 21.6 t -73.98 125.79 33.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.129 0.49 . . . . 0.0 111.319 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.619 HD11 ' HB2' ' A' ' 111' ' ' LYS . 1.0 OUTLIER -107.36 -20.06 6.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.683 179.728 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.468 ' CB ' ' CE1' ' A' ' 164' ' ' HIS . . . -169.73 177.46 4.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.818 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.478 ' HB3' ' HD1' ' A' ' 108' ' ' PHE . 3.7 pm0 -157.73 150.59 23.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.563 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.854 ' HA ' HG11 ' A' ' 160' ' ' VAL . 53.4 t -71.91 134.44 83.48 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.135 0.493 . . . . 0.0 111.354 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.46 ' HD2' HG13 ' A' ' 76' ' ' VAL . 29.7 Cg_endo -63.77 -54.06 1.09 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.099 2.533 . . . . 0.0 112.657 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.721 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 2.4 p90 -99.11 178.79 4.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.235 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.549 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 43.5 m95 -94.56 -158.0 0.6 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.623 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.528 HD23 ' O ' ' A' ' 79' ' ' TRP . 70.6 mt . . . . . 0 N--CA 1.464 0.256 0 CA-C-O 121.023 0.439 . . . . 0.0 110.197 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 15' ' ' ARG . . . . . . . . 0 CA--C 1.516 -0.348 0 CA-C-O 121.278 0.561 . . . . 0.0 109.595 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.712 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 13.1 mt-30 -121.98 123.32 41.39 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.662 -177.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 78' ' ' TYR . 5.1 ttpt -104.62 135.47 45.95 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 177.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.59 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 19.5 m95 -101.2 162.74 12.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.205 0.526 . . . . 0.0 112.3 -178.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.614 ' CD1' ' HG2' ' A' ' 54' ' ' ARG . 97.6 m-85 -137.38 149.37 46.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.643 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.551 HD12 ' O ' ' A' ' 20' ' ' CYS . 19.0 tp -102.62 125.63 49.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.31 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.808 ' CE1' HG22 ' A' ' 72' ' ' VAL . 11.9 m-85 -128.87 144.84 51.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.296 0.569 . . . . 0.0 111.507 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.619 ' HB2' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -96.35 118.56 33.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.397 179.137 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.832 ' HB2' HD11 ' A' ' 21' ' ' LEU . 50.6 t80 -79.06 94.61 5.35 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.319 179.044 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 19.5 p -94.67 45.46 1.12 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.378 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.34 -146.2 4.6 Favored Glycine 0 C--N 1.331 0.298 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.263 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -121.02 146.89 46.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.963 0.411 . . . . 0.0 111.401 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.504 ' HB2' ' CZ2' ' A' ' 134' ' ' TRP . 11.2 p-10 -58.3 -39.88 80.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.19 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -57.52 -4.4 0.25 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.278 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -88.85 -16.35 32.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.014 0.435 . . . . 0.0 110.562 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.627 HG12 HG22 ' A' ' 67' ' ' VAL . 11.0 mt -82.35 102.83 8.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.951 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -101.2 98.86 9.22 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.285 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.82 HD13 ' HB2' ' A' ' 131' ' ' PHE . 50.8 mt . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.637 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.625 ' O ' HD12 ' A' ' 34' ' ' LEU . 1.9 mp0 . . . . . 0 C--O 1.23 0.076 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.82 ' HB2' HD13 ' A' ' 121' ' ' LEU . 0.5 OUTLIER -102.16 142.26 33.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.492 178.894 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.707 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -82.53 -35.39 19.98 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.145 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.93 147.88 27.1 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.751 0.31 . . . . 0.0 110.735 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.6 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 39.1 p-90 -137.4 173.47 11.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.045 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.449 ' N ' ' HZ3' ' A' ' 40' ' ' TRP . 22.0 t -168.57 -179.46 3.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.462 0.649 . . . . 0.0 112.003 -178.254 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.675 ' CD2' ' ND2' ' A' ' 23' ' ' ASN . 88.8 m95 -113.25 100.72 8.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.907 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.467 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 32.6 m -118.3 169.78 8.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.283 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.579 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 12.3 p -74.04 172.32 8.84 Favored Pre-proline 0 C--N 1.329 -0.317 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.161 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.601 ' HB3' HD22 ' A' ' 158' ' ' LEU . 16.4 Cg_exo -61.87 -56.96 0.6 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.845 1.697 . . . . 0.0 110.337 179.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.38 -27.93 69.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.563 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.409 ' HG3' ' OG1' ' A' ' 138' ' ' THR . 1.0 OUTLIER -70.98 -49.31 46.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.503 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.717 HD13 ' HB2' ' A' ' 30' ' ' ALA . 12.8 tp -57.74 -37.39 73.52 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.61 ' O ' HG22 ' A' ' 146' ' ' THR . 13.2 mm -62.47 -39.3 83.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.14 0.495 . . . . 0.0 110.698 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.32 -48.91 63.64 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.325 0.583 . . . . 0.0 110.437 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.603 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -75.53 -18.78 59.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.742 -179.149 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.686 ' OG1' ' HG3' ' A' ' 41' ' ' GLN . 15.2 t -76.31 178.02 6.82 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.364 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.769 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 19.2 m -87.34 147.49 5.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.987 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.496 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 52.4 mt-10 -50.87 -49.79 58.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.927 0.394 . . . . 0.0 111.599 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.426 ' C ' ' HD2' ' A' ' 150' ' ' LYS . 1.2 m-85 -52.14 -7.13 0.05 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.547 ' HD3' ' CG2' ' A' ' 147' ' ' VAL . 7.7 mptt -137.09 -2.38 2.07 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.559 ' HG2' ' O ' ' A' ' 143' ' ' ILE . 14.7 mttt -63.79 -62.9 4.56 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 111.533 0.197 . . . . 0.0 111.533 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 19.3 Cg_endo -60.41 -29.04 87.92 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.266 1.978 . . . . 0.0 111.422 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.719 ' O ' HG23 ' A' ' 157' ' ' VAL . 21.2 t -68.23 -51.37 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.553 ' OH ' ' HG2' ' A' ' 41' ' ' GLN . 7.6 m-30 -63.95 -36.96 85.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.729 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.501 ' HD3' HG21 ' A' ' 143' ' ' ILE . 0.2 OUTLIER -57.93 -42.83 85.69 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.597 179.289 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.424 ' HG3' ' OH ' ' A' ' 78' ' ' TYR . 1.2 tp10 -68.35 -35.23 77.45 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 153' ' ' VAL . 59.2 t -66.21 -41.86 89.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.551 178.339 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.601 HD22 ' HB3' ' A' ' 139' ' ' PRO . 40.8 mt -64.87 -41.73 95.43 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.901 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.75 -38.74 70.21 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.854 HG11 ' HA ' ' A' ' 76' ' ' VAL . 98.7 t -69.06 -44.55 81.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.194 177.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.588 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 22.1 m-30 -80.05 4.98 15.43 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.392 -179.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.628 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.97 -52.44 74.81 Favored Pre-proline 0 C--N 1.329 -0.316 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.757 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 17.4 Cg_endo -57.77 -12.37 11.63 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.226 1.951 . . . . 0.0 112.088 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.468 ' CE1' ' CB ' ' A' ' 74' ' ' ALA . 32.5 m80 -110.46 -19.98 12.75 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.342 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 93.4 mt . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.163 -0.923 . . . . 0.0 110.733 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.405 ' O ' ' HB2' ' A' ' 78' ' ' TYR . 3.8 mtm . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.759 0.314 . . . . 0.0 110.606 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.508 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 10.8 p-10 . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.549 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.612 ' HG3' ' CZ3' ' A' ' 79' ' ' TRP . 2.0 ttp180 . . . . . 0 C--O 1.234 0.265 0 CA-C-O 121.042 0.449 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.684 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 2.2 m-80 -132.72 174.6 10.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.901 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.676 HG13 ' CG1' ' A' ' 47' ' ' ILE . 14.4 m -141.8 167.22 16.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.969 0.414 . . . . 0.0 110.796 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.64 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -136.05 159.38 24.29 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.562 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.012 HG22 ' CE1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -130.7 120.91 49.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.29 0.567 . . . . 0.0 112.321 -178.586 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.686 ' O ' HD12 ' A' ' 109' ' ' LEU . 53.0 t -104.3 100.09 9.81 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.073 178.457 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.868 HD22 HG11 ' A' ' 67' ' ' VAL . 12.0 tp -99.84 119.81 38.77 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.178 -178.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.597 ' SD ' HD11 ' A' ' 109' ' ' LEU . 0.6 OUTLIER -121.4 157.89 29.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.808 179.801 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.694 ' ND2' ' CE3' ' A' ' 136' ' ' TRP . 0.2 OUTLIER -97.16 172.48 7.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.45 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -57.06 -4.14 0.17 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.479 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.605 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.7 OUTLIER -100.25 0.72 40.86 Favored 'General case' 0 C--N 1.34 0.17 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -178.88 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 3.8 mmtm 76.45 19.17 1.68 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.222 -178.47 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 22' ' ' MET . 2.8 mttt -95.73 143.97 26.52 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.659 HD12 ' N ' ' A' ' 28' ' ' ILE . 3.1 mp -102.75 145.48 12.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.54 0.686 . . . . 0.0 112.23 -178.272 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.575 ' CE1' HD13 ' A' ' 119' ' ' ILE . 90.8 t80 -74.98 138.68 42.43 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.643 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.907 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -137.51 148.65 46.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.972 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -141.11 134.48 29.71 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.911 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.676 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 2.1 m -95.09 151.14 19.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.924 0.392 . . . . 0.0 111.122 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.0 mtp-105 -69.61 132.29 45.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.425 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.018 ' H ' HD23 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -39.18 -46.52 1.49 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.961 -178.924 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.24 -34.76 68.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.181 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.509 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 19.5 mt -119.05 114.44 35.15 Favored Pre-proline 0 CA--C 1.529 0.17 0 C-N-CA 120.954 -0.299 . . . . 0.0 111.297 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -78.27 -20.42 11.22 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.171 1.914 . . . . 0.0 112.279 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -91.57 -10.08 41.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.922 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.676 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -90.51 92.86 9.05 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.483 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.659 ' O ' ' HA ' ' A' ' 146' ' ' THR . 76.8 m95 -88.32 148.88 24.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.657 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.3 158.02 31.61 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.346 0.593 . . . . 0.0 111.567 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.543 ' HG3' HD11 ' A' ' 142' ' ' LEU . 28.3 mtm -90.41 148.51 39.09 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.991 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.464 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 11.3 Cg_endo -53.88 151.5 26.32 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.729 1.619 . . . . 0.0 111.319 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.416 ' HA ' ' CD1' ' A' ' 19' ' ' ILE . 4.1 pt20 -174.74 154.23 1.91 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.419 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.432 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . -159.9 159.94 31.11 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.298 -0.953 . . . . 0.0 112.151 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.684 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -86.79 137.34 14.74 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.693 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.676 ' CG1' HG13 ' A' ' 17' ' ' VAL . 45.2 mt -68.36 146.51 12.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.616 0.246 . . . . 0.0 111.289 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -68.66 -174.64 0.58 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.017 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.05 -61.36 2.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.472 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.59 58.62 0.7 Allowed Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.764 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.436 ' O ' HG21 ' A' ' 47' ' ' ILE . 2.3 tp10 -117.44 154.06 32.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.68 0.276 . . . . 0.0 110.623 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.72 159.78 84.07 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.53 ' HA ' HG11 ' A' ' 17' ' ' VAL . 6.1 Cg_exo -78.54 -49.85 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.528 2.152 . . . . 0.0 111.686 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.746 ' HE ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -51.49 -46.64 63.23 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.305 179.563 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -67.38 -44.61 78.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.351 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.68 -39.9 90.12 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.924 ' HB1' HG23 ' A' ' 19' ' ' ILE . . . -58.6 -56.12 26.27 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.442 0.639 . . . . 0.0 109.565 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.573 HD11 ' NE ' ' A' ' 54' ' ' ARG . 23.6 mt -55.86 -52.71 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.854 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -62.1 -58.19 8.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.826 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.432 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 70.6 mm-40 -46.21 -45.63 17.03 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.382 0.61 . . . . 0.0 109.848 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.89 HD21 ' HB ' ' A' ' 67' ' ' VAL . 9.9 tt -52.45 -45.91 66.23 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.865 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.706 ' HD2' ' HA2' ' A' ' 66' ' ' GLY . 19.9 tpt85 -62.81 -65.6 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.377 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -50.11 -23.91 2.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.076 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLU . . . . . 0.52 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 6.3 mt-10 -91.87 -35.29 14.14 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -177.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.525 HG21 ' CE2' ' A' ' 29' ' ' PHE . 1.7 p -123.76 -43.79 2.11 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 120.505 -0.478 . . . . 0.0 112.141 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.706 ' HA2' ' HD2' ' A' ' 62' ' ' ARG . . . 119.89 -17.58 10.0 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.275 -178.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.89 ' HB ' HD21 ' A' ' 61' ' ' LEU . 76.5 t -58.73 115.22 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-O 121.443 0.64 . . . . 0.0 111.842 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.646 HG23 ' HD3' ' A' ' 62' ' ' ARG . 0.5 OUTLIER -124.55 -37.04 2.55 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.5 178.223 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.4 m -62.35 73.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.102 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.572 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -159.63 156.08 27.3 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -128.65 148.57 50.81 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.328 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.837 HG22 ' CE2' ' A' ' 110' ' ' PHE . 26.2 t -75.25 127.92 36.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.108 0.48 . . . . 0.0 111.341 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.662 HD11 ' HB2' ' A' ' 111' ' ' LYS . 1.7 mt -107.84 -18.58 7.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.482 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.437 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.91 175.48 4.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.219 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.4 pt-20 -151.52 149.68 29.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.469 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.833 ' HA ' HG11 ' A' ' 160' ' ' VAL . 39.7 t -72.92 134.94 80.77 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.99 0.424 . . . . 0.0 111.144 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.48 ' HD2' HG11 ' A' ' 160' ' ' VAL . 17.8 Cg_endo -57.0 -68.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.201 2.601 . . . . 0.0 112.707 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.524 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -95.5 -174.86 3.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.76 -178.833 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.612 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 47.2 m95 -90.9 -158.05 0.53 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.037 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 79' ' ' TRP . 50.7 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.947 0.404 . . . . 0.0 110.552 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.22 0 CA-C-O 120.676 0.274 . . . . 0.0 110.299 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.677 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.8 OUTLIER -130.53 130.46 44.17 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -178.575 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.514 ' HE2' ' CE2' ' A' ' 79' ' ' TRP . 1.9 ttmt -104.04 135.87 44.75 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.64 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 18.7 m95 -105.68 164.01 12.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -177.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.53 ' CD2' ' HG2' ' A' ' 54' ' ' ARG . 96.3 m-85 -139.44 153.59 47.61 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.528 -179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.686 HD12 ' O ' ' A' ' 20' ' ' CYS . 13.8 tp -100.91 142.61 32.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.429 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 1.012 ' CE1' HG22 ' A' ' 19' ' ' ILE . 10.1 m-85 -144.54 146.13 32.2 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.662 ' HB2' HD11 ' A' ' 73' ' ' ILE . 22.8 tttt -101.56 124.57 47.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.474 178.053 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.701 ' CE1' HG13 ' A' ' 67' ' ' VAL . 49.4 t80 -77.91 97.37 5.28 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.549 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 59.3 p -96.72 53.91 1.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.035 0.445 . . . . 0.0 110.588 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -157.96 -147.24 4.75 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.492 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -122.31 149.15 44.13 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.996 0.427 . . . . 0.0 110.826 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.466 ' HB3' ' CH2' ' A' ' 134' ' ' TRP . 76.6 m-20 -58.61 -32.26 68.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.291 -179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -59.31 -5.45 0.75 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.464 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.65 -16.11 33.22 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.944 0.402 . . . . 0.0 111.005 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.734 HG12 HG22 ' A' ' 67' ' ' VAL . 6.1 mt -79.04 101.84 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.901 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -101.21 92.85 5.16 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.767 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.575 HD11 ' CD1' ' A' ' 134' ' ' TRP . 87.5 mt . . . . . 0 C--N 1.333 -0.144 0 CA-C-O 120.896 0.379 . . . . 0.0 110.626 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.695 ' C ' HD21 ' A' ' 34' ' ' LEU . 6.5 mm-40 . . . . . 0 N--CA 1.454 -0.231 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.647 ' N ' HD21 ' A' ' 34' ' ' LEU . 8.4 m-85 -132.24 142.84 49.55 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.721 ' N ' HD22 ' A' ' 34' ' ' LEU . . . -86.9 -32.16 15.61 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.397 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 31' ' ' ALA . 1.9 tt0 -154.52 154.47 33.17 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.725 0.297 . . . . 0.0 111.337 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.64 ' CE2' HD12 ' A' ' 119' ' ' ILE . 22.1 p-90 -134.6 164.94 26.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.217 0.532 . . . . 0.0 112.162 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.425 ' N ' ' HZ3' ' A' ' 40' ' ' TRP . 12.2 t -159.24 162.93 36.24 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.277 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.694 ' CE3' ' ND2' ' A' ' 23' ' ' ASN . 51.7 m95 -107.1 105.67 15.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.018 178.012 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 28' ' ' ILE . 30.1 m -121.34 170.96 10.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.882 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.598 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 17.2 p -72.38 173.32 5.79 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.68 ' HB3' HD22 ' A' ' 158' ' ' LEU . 7.0 Cg_exo -64.68 -52.8 1.19 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 121.623 1.548 . . . . 0.0 109.896 178.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -64.44 -31.65 72.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.654 178.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.463 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.9 OUTLIER -70.11 -45.92 65.89 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.051 179.645 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.907 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -56.92 -39.91 75.34 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.682 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.643 HG21 ' CE ' ' A' ' 155' ' ' LYS . 33.4 mm -62.47 -33.89 61.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.087 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.46 -53.45 13.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.239 0.542 . . . . 0.0 110.54 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.4 mp -71.62 -21.19 61.87 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.649 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.659 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 7.4 t -74.99 169.38 18.11 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.586 -178.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.572 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 25.4 m -72.86 162.49 4.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.615 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.731 ' HG2' ' N ' ' A' ' 149' ' ' PHE . 0.3 OUTLIER -67.87 -50.98 53.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.19 0.519 . . . . 0.0 110.88 179.762 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.731 ' N ' ' HG2' ' A' ' 148' ' ' GLU . 40.2 p90 -58.52 -2.58 0.22 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.938 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.526 ' HG3' ' CD2' ' A' ' 149' ' ' PHE . 23.6 mttt -132.15 -7.49 3.43 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.56 ' HG3' HG23 ' A' ' 143' ' ' ILE . 0.3 OUTLIER -63.23 -56.13 30.33 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 121.307 -0.157 . . . . 0.0 110.63 179.286 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 20.0 Cg_endo -61.87 -28.21 81.08 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.214 1.942 . . . . 0.0 111.636 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.815 ' O ' HG23 ' A' ' 157' ' ' VAL . 15.0 t -68.83 -48.5 70.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.528 ' CE1' ' CH2' ' A' ' 107' ' ' TRP . 7.5 m-30 -68.83 -37.65 79.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.765 178.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.643 ' CE ' HG21 ' A' ' 143' ' ' ILE . 2.0 tptp -55.34 -44.83 76.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.521 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.417 ' O ' HG23 ' A' ' 160' ' ' VAL . 4.7 tt0 -67.57 -34.25 76.66 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 153' ' ' VAL . 47.7 t -67.79 -41.0 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.847 178.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.68 HD22 ' HB3' ' A' ' 139' ' ' PRO . 38.7 mt -62.77 -44.91 94.95 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.385 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 62.5 m -51.54 -40.29 59.39 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.833 HG11 ' HA ' ' A' ' 76' ' ' VAL . 81.9 t -67.28 -42.23 87.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.142 178.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.687 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 22.3 m-30 -80.12 2.8 22.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.496 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.597 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.98 -52.81 72.18 Favored Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.053 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.6 Cg_endo -58.11 -12.09 11.9 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.153 1.902 . . . . 0.0 112.136 179.099 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.437 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 87.1 m-70 -110.72 -16.12 13.68 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.492 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.687 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 93.7 mt . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.912 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.46 ' HE3' ' HB2' ' A' ' 6' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.089 0 N-CA-C 110.383 -0.229 . . . . 0.0 110.383 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.78 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 9.0 t0 . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.944 0.402 . . . . 0.0 110.062 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.449 ' HG3' ' CZ3' ' A' ' 79' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.128 0 CA-C-O 121.115 0.483 . . . . 0.0 110.173 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.71 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 3.4 m120 -132.3 173.1 11.62 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.899 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.66 ' CG1' HD11 ' A' ' 47' ' ' ILE . 21.2 m -143.71 162.41 15.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.318 0.58 . . . . 0.0 112.425 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.649 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -133.95 158.98 23.58 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 177.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.016 HG23 ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -134.14 126.34 49.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.987 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.533 ' O ' HD12 ' A' ' 109' ' ' LEU . 35.8 t -102.82 100.64 10.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.237 178.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.9 HD22 HG11 ' A' ' 67' ' ' VAL . 11.4 tp -99.73 118.91 37.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.435 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.584 ' CE ' HD13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -120.48 166.54 13.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.633 179.622 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.707 ' ND2' ' CE3' ' A' ' 136' ' ' TRP . 0.3 OUTLIER -101.04 171.9 7.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.573 -179.695 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -56.82 -5.32 0.22 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.525 178.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.534 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 1.4 m-20 -98.53 1.95 47.07 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.66 0.267 . . . . 0.0 111.687 -178.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.1 OUTLIER 76.07 18.31 2.0 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.102 -178.508 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.2 OUTLIER -94.68 142.17 27.76 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.836 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.684 HD13 ' N ' ' A' ' 139' ' ' PRO . 3.7 mp -99.33 146.47 8.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.761 0.791 . . . . 0.0 112.612 -178.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.568 ' CE1' HD13 ' A' ' 119' ' ' ILE . 87.2 t80 -78.15 136.97 37.94 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.239 -1.346 . . . . 0.0 110.035 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.621 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -137.88 146.77 43.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.893 0.378 . . . . 0.0 110.336 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.453 ' HB1' ' CG ' ' A' ' 131' ' ' PHE . . . -138.69 132.33 30.67 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.138 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.596 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 28.5 m -99.15 148.36 24.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.233 -179.081 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 36' ' ' ILE . 4.8 mtp180 -69.13 127.9 34.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.649 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.739 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 1.7 mp -43.69 -37.51 2.67 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.175 0.512 . . . . 0.0 111.035 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.08 -36.77 72.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.851 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.4 ' N ' ' O ' ' A' ' 33' ' ' ARG . 23.1 mt -121.63 112.9 32.19 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.076 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.96 -18.76 11.29 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.258 1.972 . . . . 0.0 112.843 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -92.88 -11.26 33.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.511 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.778 ' HB1' ' CG1' ' A' ' 147' ' ' VAL . . . -92.05 99.55 12.36 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 120.817 0.341 . . . . 0.0 110.715 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.637 ' O ' ' HA ' ' A' ' 146' ' ' THR . 72.4 m95 -94.39 157.33 16.07 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.98 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.651 ' O ' HD11 ' A' ' 142' ' ' LEU . 22.9 mt-30 -159.89 -131.69 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 121.111 -0.235 . . . . 0.0 110.399 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.526 ' H ' ' HB3' ' A' ' 41' ' ' GLN . 3.0 ptt? -179.14 161.67 1.0 Allowed Pre-proline 0 N--CA 1.453 -0.31 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.523 ' HD2' ' HB2' ' A' ' 42' ' ' MET . 9.8 Cg_endo -49.86 140.91 29.8 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.119 1.879 . . . . 0.0 112.242 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.583 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER 179.77 144.17 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.73 -179.173 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.495 ' HA3' ' HG2' ' A' ' 60' ' ' GLU . . . -160.47 -156.62 8.27 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.14 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.71 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -117.84 138.55 14.07 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.132 -1.032 . . . . 0.0 113.539 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.66 HD11 ' CG1' ' A' ' 17' ' ' VAL . 4.2 mt -69.54 148.44 11.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.488 -0.356 . . . . 0.0 111.006 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -68.92 -174.25 0.57 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.849 0.357 . . . . 0.0 110.686 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -47.96 -62.26 1.55 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.464 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.82 60.67 0.68 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.559 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.476 ' O ' HG21 ' A' ' 47' ' ' ILE . 3.7 tp10 -117.04 153.28 32.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.765 0.317 . . . . 0.0 110.669 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 7.9 m-20 -70.13 147.08 95.43 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 16.7 Cg_exo -67.09 -46.51 3.04 Favored 'Trans proline' 0 CA--C 1.513 -0.529 0 C-N-CA 122.138 1.892 . . . . 0.0 111.395 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.79 ' NE ' HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -52.21 -49.02 64.75 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.097 179.153 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.532 ' HA ' HD12 ' A' ' 58' ' ' ILE . 2.4 m120 -63.77 -44.31 93.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.512 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 60' ' ' GLU . . . -60.58 -42.28 96.38 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 1.016 ' HB1' HG23 ' A' ' 19' ' ' ILE . . . -56.07 -52.93 62.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.978 178.776 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.79 HD11 ' NE ' ' A' ' 54' ' ' ARG . 17.3 mt -57.49 -54.37 31.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.881 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -61.39 -58.68 7.24 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.729 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.495 ' HG2' ' HA3' ' A' ' 45' ' ' GLY . 0.7 OUTLIER -45.38 -45.41 12.6 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.536 0.684 . . . . 0.0 109.511 179.318 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.789 HD12 ' HB ' ' A' ' 19' ' ' ILE . 7.6 tt -52.55 -51.14 61.15 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.731 178.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.847 ' HG3' HG23 ' A' ' 68' ' ' THR . 7.3 ttm105 -62.44 -62.46 1.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.195 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -51.38 -20.48 1.77 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.43 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -100.57 -35.58 9.47 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.558 HG22 ' CD2' ' A' ' 121' ' ' LEU . 0.8 OUTLIER -124.1 -11.3 7.56 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.027 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 84.54 -14.5 46.25 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.868 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.9 HG11 HD22 ' A' ' 21' ' ' LEU . 39.8 t -57.99 115.2 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.434 0.635 . . . . 0.0 111.316 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.847 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -123.54 -39.94 2.39 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.813 178.93 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.427 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 7.2 m -63.0 74.98 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.643 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -160.27 155.91 25.57 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLU . . . . . 0.413 ' HG3' HG21 ' A' ' 113' ' ' THR . 2.9 mt-10 -128.48 151.39 49.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.399 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.702 HG21 ' HE ' ' A' ' 54' ' ' ARG . 20.2 t -75.64 130.72 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-O 121.292 0.567 . . . . 0.0 112.066 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.589 HD12 ' HG ' ' A' ' 109' ' ' LEU . 1.0 OUTLIER -111.04 -19.11 7.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.37 179.045 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.504 ' HB2' ' CE1' ' A' ' 164' ' ' HIS . . . -170.94 176.54 4.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.812 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.4 OUTLIER -157.05 145.21 19.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.123 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.672 ' HA ' HG11 ' A' ' 160' ' ' VAL . 25.6 t -72.1 138.03 81.9 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-O 121.006 0.431 . . . . 0.0 110.838 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.598 ' HD2' HG13 ' A' ' 76' ' ' VAL . 73.7 Cg_endo -76.87 -45.09 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.9 2.4 . . . . 0.0 113.49 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.78 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 1.1 p90 -99.41 161.84 13.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.147 0.499 . . . . 0.0 112.242 -178.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.449 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 73.2 m95 -95.14 109.95 21.96 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.851 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.501 HD12 ' CD1' ' A' ' 107' ' ' TRP . 17.3 mt . . . . . 0 C--N 1.328 -0.343 0 C-N-CA 121.128 -0.229 . . . . 0.0 110.527 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.444 0 CA-C-O 121.175 0.512 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.706 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 53.6 mt-30 -128.8 123.51 33.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.986 -178.55 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.446 ' HB2' ' CE3' ' A' ' 79' ' ' TRP . 0.8 OUTLIER -103.25 134.85 45.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.816 178.604 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.543 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 73.0 m95 -102.29 159.01 15.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.306 0.574 . . . . 0.0 112.268 -178.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.458 ' CZ ' ' HB2' ' A' ' 53' ' ' PRO . 93.9 m-85 -139.26 151.15 46.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.485 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.589 ' HG ' HD12 ' A' ' 73' ' ' ILE . 24.0 tp -100.33 139.36 36.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.7 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.746 ' CE1' HG22 ' A' ' 19' ' ' ILE . 40.5 m-85 -140.95 144.92 35.41 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.579 ' HB2' HD11 ' A' ' 73' ' ' ILE . 29.9 tttt -103.37 124.28 48.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.804 177.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.468 ' HB2' HD11 ' A' ' 21' ' ' LEU . 44.4 t80 -78.47 101.85 7.53 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.848 0.356 . . . . 0.0 110.857 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' THR . . . . . 0.413 HG21 ' HG3' ' A' ' 71' ' ' GLU . 21.3 p -100.77 46.43 0.95 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.548 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.427 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -150.84 -145.13 4.06 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.24 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.42 ' O ' ' HZ ' ' A' ' 112' ' ' PHE . 1.4 pt20 -124.86 149.06 47.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.182 0.515 . . . . 0.0 111.429 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -58.86 -26.54 64.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.944 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -57.42 -7.25 0.56 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.41 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -89.75 -16.45 30.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.099 0.476 . . . . 0.0 110.566 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.575 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 3.7 mt -88.64 108.21 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.696 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -109.07 -31.39 7.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.168 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.558 ' CD2' HG22 ' A' ' 65' ' ' THR . 38.3 mt . . . . . 0 N--CA 1.464 0.231 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.64 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 121.163 0.506 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.453 ' CG ' ' HB1' ' A' ' 31' ' ' ALA . 4.9 m-85 -133.66 145.62 50.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.014 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.739 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -90.68 -33.77 8.25 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.817 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.16 146.55 27.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.884 0.373 . . . . 0.0 110.761 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.575 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 39.6 p-90 -134.76 167.12 21.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.187 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.456 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 13.0 t -164.98 168.85 17.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.426 0.632 . . . . 0.0 112.243 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.707 ' CE3' ' ND2' ' A' ' 23' ' ' ASN . 36.4 m95 -106.01 106.89 17.61 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.085 178.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.432 ' O ' ' N ' ' A' ' 28' ' ' ILE . 29.8 m -122.43 171.02 11.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.126 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.592 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 11.6 p -72.4 173.45 5.62 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.716 ' HB3' HD22 ' A' ' 158' ' ' LEU . 5.3 Cg_exo -65.01 -53.59 0.84 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 121.564 1.509 . . . . 0.0 110.374 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.22 -25.8 68.23 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.599 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -73.04 -49.03 31.06 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.611 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.651 HD11 ' O ' ' A' ' 41' ' ' GLN . 4.2 tp -56.07 -38.62 70.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.909 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.618 HG21 ' HD3' ' A' ' 155' ' ' LYS . 14.0 mm -62.66 -40.74 89.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.137 0.494 . . . . 0.0 110.636 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.85 -47.98 70.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.261 0.553 . . . . 0.0 110.556 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.535 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -76.32 -22.32 55.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.695 -179.181 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.637 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 10.0 t -75.46 179.44 5.25 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.113 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.778 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 21.0 m -86.28 158.36 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.196 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.577 ' HA ' ' HD3' ' A' ' 151' ' ' LYS . 8.9 mt-10 -60.64 -49.52 77.2 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.147 0.499 . . . . 0.0 110.799 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -54.09 -8.49 0.19 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.352 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -135.21 -6.02 2.33 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.577 ' HD3' ' HA ' ' A' ' 148' ' ' GLU . 1.2 mtpp -58.62 -62.26 6.05 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.717 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.487 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 18.1 Cg_endo -60.6 -27.29 84.58 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.308 2.005 . . . . 0.0 111.505 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.686 ' O ' HG23 ' A' ' 157' ' ' VAL . 22.1 t -67.51 -53.35 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.522 ' HE2' ' HA ' ' A' ' 41' ' ' GLN . 6.4 m-30 -63.18 -38.22 90.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.101 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.618 ' HD3' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -56.88 -45.39 82.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.071 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.509 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.5 tt0 -67.31 -33.42 75.24 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 153' ' ' VAL . 81.3 t -66.71 -41.75 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.613 178.198 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.716 HD22 ' HB3' ' A' ' 139' ' ' PRO . 54.6 mt -62.88 -44.84 95.02 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.404 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.98 -40.67 63.92 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.219 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.672 HG11 ' HA ' ' A' ' 76' ' ' VAL . 60.8 t -67.51 -43.41 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.242 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.601 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 21.6 m-30 -80.94 4.89 17.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.495 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.607 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.63 -52.69 72.22 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.798 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 17.9 Cg_endo -58.08 -11.91 11.36 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.067 1.845 . . . . 0.0 112.058 179.088 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.504 ' CE1' ' HB2' ' A' ' 74' ' ' ALA . 43.1 m80 -110.26 -19.02 13.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.502 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 96.9 mt . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.661 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 5.4 mtm . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.715 0.293 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.724 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 7.0 p-10 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.227 -179.366 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.426 ' HG3' ' CZ3' ' A' ' 79' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 121.261 0.553 . . . . 0.0 109.953 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.681 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 3.6 m-80 -129.83 172.18 11.94 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.039 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.698 ' CG1' HD11 ' A' ' 47' ' ' ILE . 21.1 m -138.89 167.31 20.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.495 0.664 . . . . 0.0 111.727 179.196 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.714 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -134.83 161.08 24.48 Favored Glycine 0 N--CA 1.438 -1.191 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.521 178.726 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.8 HG23 ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -129.21 119.92 50.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.09 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.474 ' O ' HD12 ' A' ' 109' ' ' LEU . 37.4 t -101.66 111.08 23.21 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.02 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.754 HD22 HG11 ' A' ' 67' ' ' VAL . 59.9 tp -105.9 124.34 49.41 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.925 -178.37 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.69 ' HB3' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -116.51 137.58 52.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.8 -179.954 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.482 ' OD1' ' CH2' ' A' ' 136' ' ' TRP . 6.7 m-20 -96.8 -173.8 2.82 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.307 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -54.81 -5.03 0.08 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.128 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 3.0 m-20 -101.76 -1.54 32.18 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 122.173 -0.329 . . . . 0.0 111.787 -178.819 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 11.4 mmtm 69.5 23.3 6.05 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -177.924 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.825 ' C ' HD12 ' A' ' 28' ' ' ILE . 84.2 mttt -95.59 -167.4 1.6 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.876 179.267 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.825 HD12 ' C ' ' A' ' 27' ' ' LYS . 2.1 mp -136.0 146.27 29.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.968 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.608 ' CE1' HD13 ' A' ' 119' ' ' ILE . 90.3 t80 -70.55 138.73 51.19 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.514 179.512 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.841 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -140.22 149.1 42.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.099 179.593 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.555 ' HB1' ' HB3' ' A' ' 131' ' ' PHE . . . -143.55 145.0 32.19 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.045 -179.701 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.658 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 28.4 p -98.97 145.74 26.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.09 0.471 . . . . 0.0 111.466 -179.512 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.641 ' O ' ' N ' ' A' ' 35' ' ' ASP . 25.3 mtp180 -69.34 129.82 40.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.783 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.649 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.5 OUTLIER -56.85 55.49 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.862 -179.98 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.641 ' N ' ' O ' ' A' ' 33' ' ' ARG . 0.9 OUTLIER -177.23 -34.82 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.157 0.504 . . . . 0.0 110.223 -179.688 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.491 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 7.1 mm -117.18 106.02 47.93 Favored Pre-proline 0 N--CA 1.451 -0.411 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.135 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -58.53 -60.51 0.35 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.396 2.731 . . . . 0.0 114.443 -178.134 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.92 1.48 3.37 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.285 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.658 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.4 94.35 9.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.631 0.253 . . . . 0.0 110.991 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.662 ' O ' ' HA ' ' A' ' 146' ' ' THR . 71.1 m95 -99.24 141.82 31.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.343 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -146.54 174.08 11.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.954 0.883 . . . . 0.0 112.378 -179.531 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.552 ' SD ' HG21 ' A' ' 28' ' ' ILE . 2.6 ttp -108.62 140.28 21.65 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 113.932 -1.486 . . . . 0.0 109.121 178.82 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.419 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 9.4 Cg_endo -52.09 146.56 29.9 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.097 1.865 . . . . 0.0 111.817 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.84 157.12 2.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.325 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 16' ' ' ASN . . . -158.39 -172.12 25.13 Favored Glycine 0 C--O 1.226 -0.383 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.662 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.681 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -107.97 139.95 15.27 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.242 -0.98 . . . . 0.0 113.614 -179.593 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.698 HD11 ' CG1' ' A' ' 17' ' ' VAL . 6.5 mt -71.52 146.5 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.694 0.283 . . . . 0.0 110.824 179.504 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.95 -175.17 0.68 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.848 0.356 . . . . 0.0 111.081 179.744 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -48.75 -51.45 28.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.304 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -142.52 62.79 0.51 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.351 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -117.87 150.92 38.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.676 0.274 . . . . 0.0 110.332 179.764 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.415 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 1.3 m-20 -68.87 141.16 92.03 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.346 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 33.5 Cg_exo -61.55 -45.34 18.19 Favored 'Trans proline' 0 CA--C 1.513 -0.563 0 C-N-CA 122.2 1.933 . . . . 0.0 111.513 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.786 ' HE ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -51.57 -48.22 63.22 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.042 179.39 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.613 ' HA ' HD12 ' A' ' 58' ' ' ILE . 94.0 m-20 -65.77 -43.99 87.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.638 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.88 -41.19 91.04 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.627 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.8 ' HB1' HG23 ' A' ' 19' ' ' ILE . . . -58.63 -54.11 50.74 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.903 178.746 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.715 HD11 ' NE ' ' A' ' 54' ' ' ARG . 10.6 mt -56.37 -51.73 60.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.056 179.023 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -61.31 -56.7 17.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.49 -179.247 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.429 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 74.9 mm-40 -50.47 -42.63 54.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.019 0.437 . . . . 0.0 110.015 179.366 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.698 ' HB2' HG13 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -52.08 -49.34 63.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.419 178.732 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.807 ' HG2' HG23 ' A' ' 68' ' ' THR . 4.2 tmm_? -64.13 -65.97 0.61 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.626 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -48.27 -22.53 0.69 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.495 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -100.32 -34.16 10.1 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -178.246 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 49.5 p -123.12 -8.81 8.22 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.31 -0.556 . . . . 0.0 112.365 -178.536 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 80.53 -18.03 9.47 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.385 -178.592 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.754 HG11 HD22 ' A' ' 21' ' ' LEU . 97.8 t -57.15 121.05 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.263 0.554 . . . . 0.0 111.413 179.257 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.807 HG23 ' HG2' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -129.14 -39.37 1.55 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.89 178.731 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.3 m -62.79 75.06 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.483 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -158.93 156.23 29.1 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.575 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.54 151.45 49.43 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.236 179.389 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.786 HG21 ' HE ' ' A' ' 54' ' ' ARG . 7.8 t -75.59 130.77 35.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.318 0.58 . . . . 0.0 112.166 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.579 HD11 ' HB2' ' A' ' 111' ' ' LYS . 0.9 OUTLIER -111.75 -19.2 7.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.555 178.805 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.542 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -169.81 178.38 4.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.626 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.6 OUTLIER -156.23 149.23 24.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.833 179.63 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.807 ' HA ' HG11 ' A' ' 160' ' ' VAL . 52.6 t -73.08 137.86 79.1 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-O 121.186 0.517 . . . . 0.0 111.574 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.607 ' HD2' HG13 ' A' ' 76' ' ' VAL . 20.4 Cg_endo -62.52 -70.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.397 2.732 . . . . 0.0 112.794 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.724 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -87.45 173.55 9.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.063 -178.723 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.507 ' HB3' ' HB1' ' A' ' 104' ' ' ALA . 48.9 m95 -93.97 100.09 12.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.964 179.738 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.606 HD11 HG22 ' A' ' 157' ' ' VAL . 52.1 mt . . . . . 0 C--N 1.327 -0.385 0 CA-C-O 120.922 0.391 . . . . 0.0 110.893 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.507 ' HB1' ' HB3' ' A' ' 79' ' ' TRP . . . . . . . . 0 CA--C 1.514 -0.412 0 CA-C-O 121.016 0.436 . . . . 0.0 109.833 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.626 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 35.2 mt-30 -128.96 122.42 30.11 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.362 -178.068 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.03 135.33 44.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.509 179.693 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.714 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 42.7 m95 -103.66 166.25 10.54 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.063 0.458 . . . . 0.0 111.636 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 53' ' ' PRO . 91.1 m-85 -141.53 155.33 45.81 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.836 -179.471 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.688 HD11 ' SD ' ' A' ' 22' ' ' MET . 8.4 tp -101.14 141.96 33.27 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.459 179.126 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.663 ' CE2' HG22 ' A' ' 72' ' ' VAL . 49.4 m-85 -144.83 144.34 31.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.49 0.662 . . . . 0.0 112.502 -178.598 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 9.5 tttt -103.65 125.98 50.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.731 177.874 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.659 ' CD1' HD21 ' A' ' 21' ' ' LEU . 51.0 t80 -78.85 97.37 5.95 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.032 0.444 . . . . 0.0 110.939 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 39.1 p -97.1 51.03 1.1 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.536 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -153.17 -146.77 4.45 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.422 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.409 ' O ' ' HZ ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -122.4 145.12 48.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.177 0.513 . . . . 0.0 111.069 179.786 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -59.12 -26.15 64.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.05 -179.137 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -58.37 -5.07 0.45 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.209 -179.707 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -90.88 -18.23 25.15 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.996 0.427 . . . . 0.0 110.977 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.608 HD13 ' CE1' ' A' ' 29' ' ' PHE . 5.5 mt -83.85 103.53 11.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.709 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -101.68 -12.53 18.32 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.243 -179.419 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.931 HD11 ' HB3' ' A' ' 134' ' ' TRP . 16.6 mt . . . . . 0 N--CA 1.473 0.693 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.057 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 . . . . . 0 N--CA 1.463 0.188 0 CA-C-O 121.13 0.49 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.904 ' HB2' HD13 ' A' ' 121' ' ' LEU . 6.5 m-85 -105.3 147.03 28.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.696 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.649 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -86.2 -34.95 11.47 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.953 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -154.37 154.79 33.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.626 0.251 . . . . 0.0 111.2 179.911 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.931 ' HB3' HD11 ' A' ' 121' ' ' LEU . 36.4 p-90 -133.31 164.48 27.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.059 0.457 . . . . 0.0 111.875 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.5 t -157.99 165.61 34.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.685 -179.419 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.484 ' CD1' ' HZ3' ' A' ' 134' ' ' TRP . 89.6 m95 -106.75 97.53 7.31 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.936 178.305 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.626 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 21.0 m -113.37 163.11 10.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.338 179.611 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.551 ' HB ' ' CD ' ' A' ' 139' ' ' PRO . 10.5 p -70.92 174.32 3.77 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.199 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.636 ' HG3' HD11 ' A' ' 28' ' ' ILE . 12.2 Cg_exo -63.25 -53.35 1.53 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.543 1.495 . . . . 0.0 111.279 179.698 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -27.11 68.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.074 0.464 . . . . 0.0 111.067 179.332 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.401 ' HG3' ' OG1' ' A' ' 138' ' ' THR . 21.7 mt-30 -72.23 -47.3 51.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.882 179.767 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.841 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.3 OUTLIER -55.34 -41.41 72.44 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.482 179.498 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.657 HG22 ' HG3' ' A' ' 151' ' ' LYS . 28.9 mm -61.12 -34.24 59.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.553 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.57 -52.08 17.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.861 179.115 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.3 mp -72.97 -21.78 60.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.228 -179.309 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.662 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 8.2 t -73.21 173.87 8.83 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.99 0.424 . . . . 0.0 111.675 -178.743 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.689 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 16.3 m -79.83 154.03 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.984 -179.743 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.448 ' C ' ' H ' ' A' ' 150' ' ' LYS . 4.0 mt-10 -58.41 -54.82 42.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.849 0.357 . . . . 0.0 110.73 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.689 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 51.7 p90 -56.93 2.47 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.589 ' HG2' ' CZ ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -137.53 -6.41 1.75 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.581 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.657 ' HG3' HG22 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -64.44 -56.35 23.53 Favored Pre-proline 0 N--CA 1.464 0.262 0 N-CA-C 111.326 0.121 . . . . 0.0 111.326 -179.979 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 29.4 Cg_endo -63.66 -28.5 69.19 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.278 1.985 . . . . 0.0 111.834 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.771 ' O ' HG23 ' A' ' 157' ' ' VAL . 25.9 t -68.66 -51.09 49.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.718 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.589 ' CZ ' ' HG2' ' A' ' 150' ' ' LYS . 16.5 m-30 -64.93 -40.74 95.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.678 178.449 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.577 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -53.9 -43.62 69.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.401 -179.675 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.418 ' O ' HG23 ' A' ' 160' ' ' VAL . 3.9 tt0 -69.38 -32.44 71.48 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.218 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 153' ' ' VAL . 46.9 t -65.0 -41.81 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.683 178.709 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.513 HD22 ' HB3' ' A' ' 139' ' ' PRO . 37.3 mt -62.54 -46.71 87.13 Favored 'General case' 0 CA--C 1.524 -0.038 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.366 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.43 -38.54 29.66 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.884 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.807 HG11 ' HA ' ' A' ' 76' ' ' VAL . 80.1 t -68.85 -44.21 81.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.354 177.727 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.68 ' CE2' HG12 ' A' ' 157' ' ' VAL . 22.4 m-30 -79.6 4.18 16.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.284 -179.287 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.609 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.38 -53.64 64.0 Favored Pre-proline 0 C--N 1.327 -0.378 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.71 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 16.9 Cg_endo -57.91 -12.77 13.0 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.44 2.093 . . . . 0.0 111.907 178.827 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.542 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 91.3 m-70 -109.4 -16.95 13.9 Favored 'General case' 0 N--CA 1.46 0.027 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.457 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 95.5 mt . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.165 -0.921 . . . . 0.0 110.803 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.41 ' N ' ' SD ' ' A' ' 6' ' ' MET . 2.2 mpp? . . . . . 0 N--CA 1.455 -0.175 0 CA-C-O 120.567 0.222 . . . . 0.0 110.442 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 16.1 t70 . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 110.35 -179.854 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.494 ' C ' HD12 ' A' ' 47' ' ' ILE . 2.5 ttt180 . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 121.042 0.449 . . . . 0.0 110.408 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.678 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 59.1 m-20 -133.08 176.85 8.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.163 179.072 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.682 HG13 HD11 ' A' ' 47' ' ' ILE . 27.2 m -142.2 164.58 17.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.252 0.549 . . . . 0.0 111.703 179.109 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.591 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -130.33 155.71 21.21 Favored Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.847 178.65 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.117 HG21 HD22 ' A' ' 61' ' ' LEU . 3.7 mp -122.06 119.42 58.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.154 0.502 . . . . 0.0 112.021 -178.979 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.523 ' O ' HD12 ' A' ' 109' ' ' LEU . 50.0 t -103.79 101.69 11.51 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.133 178.602 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.713 HD22 HG11 ' A' ' 67' ' ' VAL . 31.3 tp -102.68 121.52 42.6 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.898 -178.452 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.722 ' SD ' HD11 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -116.23 142.69 46.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.849 179.602 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.503 ' OD1' ' CZ3' ' A' ' 136' ' ' TRP . 7.8 m-20 -95.94 -177.72 4.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.465 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -56.14 -4.85 0.14 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.521 179.501 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.547 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.7 OUTLIER -103.13 -0.61 30.36 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.79 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.562 ' HE2' ' HE3' ' A' ' 22' ' ' MET . 1.8 mmtp 72.61 23.82 2.95 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -178.249 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.634 ' HB3' ' O ' ' A' ' 137' ' ' VAL . 25.9 mttt -94.77 175.24 6.73 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.217 179.285 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.713 HD11 ' HG3' ' A' ' 139' ' ' PRO . 1.8 mm -120.01 141.16 41.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.976 0.417 . . . . 0.0 111.064 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.665 ' HE2' HG21 ' A' ' 65' ' ' THR . 58.3 t80 -66.8 107.07 2.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.278 179.23 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.767 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -101.51 139.09 37.65 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.823 0.344 . . . . 0.0 110.929 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -138.14 132.0 31.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.281 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.68 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 53.4 p -99.0 146.29 26.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.839 0.352 . . . . 0.0 111.584 -179.341 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.5 mtp180 -69.34 128.13 35.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.432 179.601 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.748 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -45.18 -35.4 3.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.356 0.598 . . . . 0.0 110.984 -179.884 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -72.4 -36.15 68.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.765 179.797 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.6 mm -124.47 111.45 28.02 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.764 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -75.24 -20.75 16.11 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.432 2.088 . . . . 0.0 113.023 -179.273 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -92.63 -7.52 46.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.387 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.68 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.8 93.06 8.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.807 0.337 . . . . 0.0 111.047 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.626 ' O ' ' HA ' ' A' ' 146' ' ' THR . 81.6 m95 -88.0 144.03 26.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.015 179.142 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -153.76 174.38 14.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.54 0.686 . . . . 0.0 111.878 -179.2 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.58 ' HB3' ' CZ3' ' A' ' 107' ' ' TRP . 2.0 mtm -108.36 146.17 33.04 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.98 179.596 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -50.75 156.23 4.76 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.465 2.11 . . . . 0.0 111.995 179.783 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.683 ' HA ' HD12 ' A' ' 19' ' ' ILE . 4.2 pt20 -176.41 174.02 2.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.946 -179.391 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.467 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . 178.96 154.81 13.41 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.306 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.678 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -82.56 135.68 14.42 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.205 -179.382 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.682 HD11 HG13 ' A' ' 17' ' ' VAL . 2.8 mt -70.07 144.66 13.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.736 0.303 . . . . 0.0 111.141 179.801 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.77 -174.76 0.34 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.243 179.345 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -48.52 -77.06 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.04 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -113.27 57.35 0.45 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.689 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.451 ' O ' HG21 ' A' ' 47' ' ' ILE . 9.2 tp10 -115.77 148.35 39.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.795 0.331 . . . . 0.0 110.896 179.731 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 78.8 m-20 -72.16 142.58 85.03 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.536 179.677 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.497 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 56.7 Cg_exo -54.42 -45.43 41.02 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.714 2.276 . . . . 0.0 112.579 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.814 ' CZ ' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -52.14 -44.49 64.58 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.29 -179.616 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -65.71 -47.43 75.39 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.461 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.02 -43.19 99.36 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.412 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.627 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -58.13 -58.57 7.86 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.617 178.796 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.543 HD11 ' HG3' ' A' ' 54' ' ' ARG . 20.8 mt -56.17 -51.23 64.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.377 179.368 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -63.13 -64.89 0.78 Allowed 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.452 -179.511 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.467 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 56.2 mm-40 -42.29 -44.98 4.06 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.004 0.43 . . . . 0.0 110.43 179.932 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.117 HD22 HG21 ' A' ' 19' ' ' ILE . 14.4 tp -51.58 -46.76 63.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.975 178.562 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.886 ' HG3' HG23 ' A' ' 68' ' ' THR . 21.1 ttm180 -65.12 -65.76 0.63 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.25 179.429 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -49.39 -21.59 0.93 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.372 -179.266 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -97.87 -36.5 10.16 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.2 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.76 HG22 ' CD2' ' A' ' 121' ' ' LEU . 0.8 OUTLIER -128.95 -3.1 5.18 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.717 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 77.4 -12.19 15.02 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.415 -179.5 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.713 HG11 HD22 ' A' ' 21' ' ' LEU . 50.2 t -57.85 110.99 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-O 121.235 0.54 . . . . 0.0 111.503 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.886 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.6 OUTLIER -123.08 -40.33 2.41 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.668 178.629 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.7 m -62.17 73.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.396 179.485 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -160.66 158.22 28.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.023 0.439 . . . . 0.0 112.174 -179.631 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -129.66 149.42 51.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.655 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.814 HG11 ' CZ ' ' A' ' 54' ' ' ARG . 3.3 t -73.73 127.26 35.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.069 0.461 . . . . 0.0 110.962 179.227 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.544 HD11 ' N ' ' A' ' 111' ' ' LYS . 1.0 OUTLIER -106.61 -19.81 6.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.181 179.32 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.46 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.91 176.57 4.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.182 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.38 145.76 24.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.414 179.635 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.74 ' HA ' HG11 ' A' ' 160' ' ' VAL . 52.8 t -71.5 137.17 83.48 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.0 0.429 . . . . 0.0 110.859 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.49 ' HD2' HG13 ' A' ' 76' ' ' VAL . 17.7 Cg_endo -59.1 -66.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.198 2.599 . . . . 0.0 112.715 -179.575 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.502 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -96.65 -176.38 3.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.207 -178.965 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.539 ' O ' ' HG ' ' A' ' 80' ' ' LEU . 37.3 m95 -89.49 -154.43 0.31 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.815 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 79' ' ' TRP . 81.6 mt . . . . . 0 C--N 1.33 -0.255 0 CA-C-O 121.103 0.478 . . . . 0.0 110.725 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 -0.112 0 CA-C-O 120.959 0.409 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.583 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 24.1 mt-30 -129.0 123.37 32.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.167 -178.473 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.541 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 4.4 ttpt -103.83 140.93 36.98 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.659 179.429 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.591 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 24.8 m95 -105.19 167.46 9.71 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.399 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.497 ' CZ ' ' HB2' ' A' ' 53' ' ' PRO . 78.3 m-85 -143.39 156.1 44.59 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.09 -179.496 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.722 HD11 ' SD ' ' A' ' 22' ' ' MET . 8.0 tp -103.59 138.66 39.95 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.769 179.007 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.728 ' CE2' HG22 ' A' ' 72' ' ' VAL . 55.7 m-85 -142.92 144.45 32.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.397 0.618 . . . . 0.0 112.634 -178.896 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 22.4 tttt -104.11 123.59 47.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.522 177.734 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.629 ' HB2' HD11 ' A' ' 21' ' ' LEU . 55.3 t80 -79.31 99.62 7.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.875 0.369 . . . . 0.0 110.629 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 30.2 p -96.96 41.64 1.11 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.405 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -140.29 -148.33 5.14 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.54 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -121.21 148.4 44.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.955 0.407 . . . . 0.0 111.151 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.449 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 9.5 p-10 -58.6 -38.24 77.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.37 0.605 . . . . 0.0 111.181 -179.558 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -56.57 -3.8 0.12 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.286 -179.402 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -90.05 -21.01 22.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.121 0.486 . . . . 0.0 110.326 179.371 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.65 HD13 ' CE1' ' A' ' 29' ' ' PHE . 14.3 mt -85.89 105.17 14.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.124 179.646 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.424 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 18.0 p-10 -102.82 -26.18 13.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.087 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.76 ' CD2' HG22 ' A' ' 65' ' ' THR . 56.3 mt . . . . . 0 N--CA 1.464 0.236 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.025 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.485 ' O ' HD12 ' A' ' 34' ' ' LEU . 5.1 mp0 . . . . . 0 N--CA 1.462 0.159 0 CA-C-O 120.789 0.328 . . . . 0.0 111.326 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.712 ' CE2' HG23 ' A' ' 65' ' ' THR . 3.1 m-85 -104.75 143.05 33.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.069 0.461 . . . . 0.0 110.64 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.748 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -90.14 -35.63 7.5 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.705 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -150.28 148.21 28.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.96 0.41 . . . . 0.0 110.619 179.626 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.536 ' CD2' ' HE1' ' A' ' 29' ' ' PHE . 38.1 p-90 -137.14 167.98 20.49 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.607 179.465 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.466 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 42.9 t -160.27 174.64 13.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.318 0.58 . . . . 0.0 112.314 -178.983 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.503 ' CZ3' ' OD1' ' A' ' 23' ' ' ASN . 78.7 m95 -109.23 100.71 9.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.551 178.384 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.634 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 28.9 m -119.03 165.61 14.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.53 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 26.8 p -71.63 167.24 32.36 Favored Pre-proline 0 C--N 1.327 -0.411 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.11 179.351 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.713 ' HG3' HD11 ' A' ' 28' ' ' ILE . 21.6 Cg_exo -59.43 -54.59 2.41 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.818 1.678 . . . . 0.0 110.435 179.554 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.3 -28.86 70.0 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.391 178.237 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.49 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 40.0 mt-30 -71.55 -46.4 59.61 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.248 179.707 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.767 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -57.65 -39.05 76.14 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.72 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.968 HG21 ' HD3' ' A' ' 155' ' ' LYS . 27.5 mm -60.3 -36.24 67.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.639 179.268 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.84 -53.3 15.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.242 0.544 . . . . 0.0 110.881 179.559 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.72 -19.52 62.04 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.448 -179.14 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.675 HG22 ' O ' ' A' ' 143' ' ' ILE . 7.6 t -73.02 179.64 3.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.056 0.455 . . . . 0.0 111.523 -179.115 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.635 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 21.9 m -85.28 151.25 3.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.439 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.458 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 48.4 mt-10 -58.48 -53.86 53.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.801 0.334 . . . . 0.0 111.227 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.619 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 53.1 p90 -56.28 0.81 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -179.721 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.597 ' HB2' HG23 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -136.83 -7.99 1.86 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.482 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.562 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 0.0 OUTLIER -62.53 -52.79 62.86 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.895 -0.138 . . . . 0.0 111.072 179.562 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 28.6 Cg_endo -63.47 -28.58 70.89 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.121 1.88 . . . . 0.0 111.895 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.81 ' O ' HG23 ' A' ' 157' ' ' VAL . 23.3 t -68.42 -49.33 66.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.824 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.525 ' CE1' ' HG2' ' A' ' 150' ' ' LYS . 5.4 m-30 -66.58 -40.59 89.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.806 178.87 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.968 ' HD3' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -53.2 -44.82 68.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.518 179.449 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.431 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.5 OUTLIER -68.32 -33.34 74.13 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.133 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 153' ' ' VAL . 64.2 t -66.07 -41.31 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.695 178.688 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.566 HD22 ' HB3' ' A' ' 139' ' ' PRO . 64.8 mt -64.88 -45.01 87.77 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.55 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.35 -41.41 63.03 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.235 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.74 HG11 ' HA ' ' A' ' 76' ' ' VAL . 94.0 t -66.11 -42.33 91.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.033 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.56 ' CE2' HG12 ' A' ' 157' ' ' VAL . 19.7 m-30 -81.05 6.35 13.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.554 -179.192 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.594 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.46 -53.64 64.04 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.55 179.592 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 18.1 Cg_endo -59.56 -12.14 16.45 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.021 1.814 . . . . 0.0 111.86 178.712 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.46 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 96.5 m-70 -107.37 -18.55 13.84 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.292 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 78.3 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.794 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.445 ' C ' ' HB2' ' A' ' 78' ' ' TYR . 0.3 OUTLIER . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.527 0.203 . . . . 0.0 110.597 . . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.748 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 17.9 t70 . . . . . 0 N--CA 1.462 0.167 0 CA-C-O 120.713 0.292 . . . . 0.0 111.358 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.671 ' HB2' ' CZ3' ' A' ' 79' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.417 0 CA-C-O 121.33 0.586 . . . . 0.0 111.184 . . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.668 ' CB ' ' HA2' ' A' ' 46' ' ' GLY . 75.1 m-20 -131.61 176.57 8.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.235 -179.767 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.748 HG13 HD11 ' A' ' 47' ' ' ILE . 18.4 m -141.97 157.37 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 120.221 -0.592 . . . . 0.0 112.377 179.626 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.475 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -126.28 168.43 18.42 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.209 178.39 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 1.079 HG21 HD13 ' A' ' 61' ' ' LEU . 5.1 mp -128.73 116.62 41.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -178.745 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.599 ' O ' HD12 ' A' ' 109' ' ' LEU . 8.3 t -103.87 98.23 8.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.617 178.28 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.939 HD22 HG11 ' A' ' 67' ' ' VAL . 13.6 tp -99.25 127.2 45.22 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.792 -178.976 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.716 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -121.62 151.63 40.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.821 179.496 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.547 ' N ' ' OD1' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -94.61 173.84 7.41 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.859 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.443 ' HA ' ' HE3' ' A' ' 111' ' ' LYS . 20.6 p30 -57.91 -5.68 0.45 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.653 176.819 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.568 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 4.9 m-20 -102.55 0.38 33.4 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.081 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.568 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 24.3 mmtp 75.18 22.73 1.7 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.262 -178.464 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.716 ' O ' ' HA ' ' A' ' 22' ' ' MET . 5.6 mmtt -93.37 143.81 25.92 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.803 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.743 HG13 ' HA ' ' A' ' 139' ' ' PRO . 1.8 mm -97.43 136.18 29.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.206 0.527 . . . . 0.0 111.762 -178.819 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.681 ' HB2' HD23 ' A' ' 21' ' ' LEU . 4.4 t80 -65.78 100.71 0.57 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.51 178.49 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.655 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -96.11 141.01 30.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.793 0.33 . . . . 0.0 111.058 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -138.12 131.6 30.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.487 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.763 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 53.8 p -99.3 144.48 28.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.887 0.375 . . . . 0.0 111.593 -179.358 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.413 ' HB3' ' OD1' ' A' ' 35' ' ' ASP . 3.8 mtp180 -71.97 128.0 34.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.807 179.62 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.704 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -44.02 -38.38 3.5 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.251 0.548 . . . . 0.0 111.141 179.918 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.413 ' OD1' ' HB3' ' A' ' 33' ' ' ARG . 4.8 p-10 -71.77 -34.04 69.13 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.215 -179.925 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.8 mt -124.85 105.38 29.63 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.73 0.3 . . . . 0.0 111.006 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -69.73 -20.16 35.33 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.687 2.258 . . . . 0.0 112.748 -179.673 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -93.84 -7.59 42.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.651 -179.599 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.763 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.52 100.49 13.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.615 0.245 . . . . 0.0 111.032 -179.851 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.641 ' O ' ' HA ' ' A' ' 146' ' ' THR . 76.2 m95 -96.25 146.82 24.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.098 179.167 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.622 ' HG3' ' HG1' ' A' ' 146' ' ' THR . 0.2 OUTLIER -162.48 -128.75 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.668 -179.184 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.497 ' H ' ' HB3' ' A' ' 41' ' ' GLN . 2.1 ptt? 178.96 163.13 0.7 Allowed Pre-proline 0 N--CA 1.448 -0.571 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.843 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.946 ' HG2' HD12 ' A' ' 61' ' ' LEU . 82.0 Cg_exo -45.07 148.85 1.48 Allowed 'Trans proline' 0 CA--C 1.529 0.241 0 C-N-CA 122.454 2.103 . . . . 0.0 113.047 -179.229 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.546 ' HG3' ' O ' ' A' ' 17' ' ' VAL . 51.9 tt0 -173.79 145.79 1.19 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.465 -179.452 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.793 ' HA3' ' HG2' ' A' ' 60' ' ' GLU . . . -145.81 -168.71 13.4 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.293 179.739 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.668 ' HA2' ' CB ' ' A' ' 16' ' ' ASN . . . -117.47 17.2 12.43 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 119.997 -1.097 . . . . 0.0 115.382 -178.595 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.748 HD11 HG13 ' A' ' 17' ' ' VAL . 11.3 mt 62.01 136.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 117.796 0.798 . . . . 0.0 111.444 179.122 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.524 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 3.3 m-20 -69.68 -175.97 0.96 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.857 179.366 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -47.89 -81.08 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.428 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -108.12 55.48 0.51 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.814 179.567 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 4.0 tp10 -116.66 142.95 46.23 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.892 0.377 . . . . 0.0 111.159 -179.356 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.466 ' HB2' ' ND2' ' A' ' 55' ' ' ASN . 7.6 m-20 -64.8 168.89 6.12 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.102 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 4.2 Cg_exo -77.25 -53.75 0.07 OUTLIER 'Trans proline' 0 CA--C 1.515 -0.468 0 C-N-CA 122.742 2.295 . . . . 0.0 113.472 -178.747 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.619 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -49.17 -51.78 30.44 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.065 -179.255 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 56' ' ' ALA . 18.2 p30 -62.31 -37.91 87.38 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 119.816 -0.754 . . . . 0.0 110.501 -179.301 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.504 ' N ' ' OD1' ' A' ' 55' ' ' ASN . . . -64.39 -44.77 90.27 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.735 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.584 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -60.02 -61.54 2.53 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.904 178.271 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.619 ' CD1' ' O ' ' A' ' 54' ' ' ARG . 2.6 mp -53.41 -46.9 59.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.626 179.454 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 5.4 mmt180 -64.18 -62.52 1.57 Allowed 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.739 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.793 ' HG2' ' HA3' ' A' ' 45' ' ' GLY . 0.2 OUTLIER -42.56 -43.09 3.61 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.185 0.517 . . . . 0.0 110.171 179.667 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 1.079 HD13 HG21 ' A' ' 19' ' ' ILE . 1.9 tp -50.0 -47.92 52.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.998 178.851 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.892 ' HG2' HG23 ' A' ' 68' ' ' THR . 1.9 tmm_? -67.07 -65.94 0.62 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.079 178.885 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -49.26 -24.3 1.74 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.373 -179.106 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -93.95 -36.94 11.94 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.39 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.596 ' HB ' HG23 ' A' ' 119' ' ' ILE . 1.4 p -127.81 -31.24 2.44 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.402 -0.519 . . . . 0.0 112.395 -178.941 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.501 ' HA2' ' HD2' ' A' ' 62' ' ' ARG . . . 106.92 -13.75 41.27 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.654 -178.896 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.939 HG11 HD22 ' A' ' 21' ' ' LEU . 73.6 t -55.77 107.18 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-O 121.167 0.508 . . . . 0.0 111.022 179.523 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.892 HG23 ' HG2' ' A' ' 62' ' ' ARG . 0.6 OUTLIER -121.47 -39.41 2.66 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.577 178.716 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.7 m -61.55 74.22 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.863 178.859 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -162.56 157.19 21.79 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.113 0.482 . . . . 0.0 112.029 -179.309 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -126.72 148.76 49.85 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.055 179.154 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.712 HG22 ' CD1' ' A' ' 110' ' ' PHE . 24.8 t -76.06 126.28 36.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.12 0.485 . . . . 0.0 111.627 179.615 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.53 HD11 ' HB2' ' A' ' 111' ' ' LYS . 0.7 OUTLIER -107.5 -21.49 5.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.421 179.289 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.443 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -169.49 177.43 4.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.81 -179.192 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.53 152.16 21.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.527 179.689 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.836 ' HA ' HG11 ' A' ' 160' ' ' VAL . 43.1 t -71.9 135.87 82.82 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.974 0.416 . . . . 0.0 111.055 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.431 ' HD2' HG13 ' A' ' 76' ' ' VAL . 18.1 Cg_endo -60.13 -62.21 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.075 2.516 . . . . 0.0 112.612 -179.452 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.748 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -98.01 -177.3 3.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.154 -179.186 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.671 ' CZ3' ' HB2' ' A' ' 15' ' ' ARG . 28.8 m95 -94.27 -152.73 0.35 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.557 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 79' ' ' TRP . 24.2 mt . . . . . 0 C--N 1.328 -0.338 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.586 ' O ' ' HA ' ' A' ' 15' ' ' ARG . . . . . . . . 0 C--O 1.223 -0.331 0 CA-C-O 120.59 0.233 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.664 ' CG ' ' HB2' ' A' ' 16' ' ' ASN . 18.7 mt-30 -113.87 123.29 49.42 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.044 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.488 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 2.2 ttpt -106.03 133.44 50.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.3 177.807 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.504 ' CZ2' ' CE1' ' A' ' 154' ' ' TYR . 41.8 m95 -102.72 160.48 14.55 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.023 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.507 ' HB3' ' CE1' ' A' ' 110' ' ' PHE . 90.8 m-85 -133.91 154.12 51.29 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.705 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.686 HD22 ' CG ' ' A' ' 161' ' ' PHE . 11.5 tp -109.83 128.24 55.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.149 179.648 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.879 ' CE2' HG23 ' A' ' 19' ' ' ILE . 5.4 m-85 -133.9 147.75 51.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.279 0.561 . . . . 0.0 111.8 179.929 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 21.8 tttt -99.47 124.52 44.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.572 178.542 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.619 ' HB2' HD11 ' A' ' 21' ' ' LEU . 34.8 t80 -78.54 101.03 7.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.882 0.373 . . . . 0.0 110.952 179.599 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 15.9 p -98.99 40.77 1.18 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.74 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.27 -146.66 4.68 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.364 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -120.82 153.7 36.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.887 0.375 . . . . 0.0 111.216 179.786 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.488 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 4.4 p30 -59.7 -39.2 83.82 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.487 0.66 . . . . 0.0 111.164 -179.611 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -59.31 -1.74 0.24 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.86 -1.063 . . . . 0.0 112.161 -179.325 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -89.93 -17.91 27.09 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.864 0.364 . . . . 0.0 110.701 179.701 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.711 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 13.6 mt -80.81 102.66 6.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.588 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -102.0 94.3 5.71 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.899 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.641 HD11 ' HD1' ' A' ' 134' ' ' TRP . 44.9 mt . . . . . 0 C--N 1.33 -0.256 0 CA-C-O 121.028 0.442 . . . . 0.0 110.613 179.745 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.583 ' O ' HD12 ' A' ' 34' ' ' LEU . 2.4 mp0 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.889 0.376 . . . . 0.0 110.781 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.446 ' CE1' HG23 ' A' ' 65' ' ' THR . 0.8 OUTLIER -103.8 141.88 35.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.434 179.902 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.704 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -83.86 -34.82 17.51 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.005 -179.642 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.06 149.77 29.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.855 0.36 . . . . 0.0 110.46 179.787 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.711 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 32.7 p-90 -137.89 170.12 16.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.066 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.454 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 22.8 t -165.71 177.53 7.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.513 0.673 . . . . 0.0 111.918 -178.681 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.487 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 73.6 m95 -111.42 103.49 11.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.422 178.437 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.433 ' O ' ' N ' ' A' ' 28' ' ' ILE . 31.7 m -119.26 171.68 7.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.556 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 22.3 p -74.0 167.29 36.85 Favored Pre-proline 0 C--N 1.326 -0.431 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.955 179.143 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.743 ' HA ' HG13 ' A' ' 28' ' ' ILE . 21.7 Cg_exo -59.11 -55.85 1.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.772 1.648 . . . . 0.0 110.347 178.979 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.37 -25.41 68.28 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.855 178.494 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.408 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 9.1 mm-40 -72.84 -47.16 48.59 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.73 -179.74 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.655 HD13 ' HB2' ' A' ' 30' ' ' ALA . 20.3 tp -59.64 -37.73 79.47 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.817 HG21 ' HG2' ' A' ' 155' ' ' LYS . 12.7 mm -63.03 -36.15 74.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.555 178.94 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.27 -52.99 15.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.333 0.587 . . . . 0.0 110.367 179.607 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.458 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -72.2 -16.77 61.96 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.575 -179.239 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.641 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 12.7 t -76.45 176.0 8.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.019 0.438 . . . . 0.0 111.46 -179.652 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.548 ' HB ' ' CE1' ' A' ' 149' ' ' PHE . 17.6 m -74.9 150.88 6.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.674 179.432 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.43 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 50.6 mt-10 -58.32 -53.28 60.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.869 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.548 ' CE1' ' HB ' ' A' ' 147' ' ' VAL . 38.2 p90 -57.47 0.91 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -179.577 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.45 ' HB2' HG23 ' A' ' 147' ' ' VAL . 53.1 mttt -134.41 -9.17 2.54 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.99 -0.444 . . . . 0.0 111.967 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.686 ' HG3' HG22 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -60.58 -54.64 52.82 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.919 -0.128 . . . . 0.0 110.823 179.781 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 38.8 Cg_endo -67.5 -28.18 38.71 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.196 1.931 . . . . 0.0 111.61 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.61 ' O ' HG23 ' A' ' 157' ' ' VAL . 37.8 t -68.74 -50.96 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.369 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.504 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 5.8 m-30 -66.68 -38.49 86.91 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.669 178.449 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.817 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -56.09 -39.99 72.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.595 179.837 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.407 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.6 OUTLIER -69.07 -31.98 71.12 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.02 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.629 HG12 ' CE2' ' A' ' 161' ' ' PHE . 42.2 t -64.77 -42.11 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.69 178.699 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.497 HD22 ' HB3' ' A' ' 139' ' ' PRO . 64.9 mt -64.49 -44.22 91.66 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.661 179.625 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 38.5 t -52.63 -40.32 62.65 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.142 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.836 HG11 ' HA ' ' A' ' 76' ' ' VAL . 91.2 t -67.43 -42.48 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.518 -0.765 . . . . 0.0 108.984 177.849 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.686 ' CG ' HD22 ' A' ' 109' ' ' LEU . 21.1 m-30 -80.72 6.47 12.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.188 -179.527 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.598 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.46 -53.41 66.43 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.684 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 18.0 Cg_endo -57.67 -12.87 12.49 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.143 1.896 . . . . 0.0 111.869 178.811 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 164' ' ' HIS . . . . . 0.443 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 90.5 m-70 -108.68 -19.36 13.45 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.263 -179.925 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 97.7 mt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.606 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.476 ' C ' ' HB2' ' A' ' 78' ' ' TYR . 16.0 mtm . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.67 0.271 . . . . 0.0 110.416 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.641 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 4.1 p-10 . . . . . 0 C--N 1.331 -0.204 0 CA-C-O 120.748 0.309 . . . . 0.0 111.498 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.631 ' HG3' ' CZ3' ' A' ' 79' ' ' TRP . 1.2 ttp180 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.743 0.306 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.676 ' HB2' ' HG2' ' A' ' 105' ' ' GLN . 0.5 OUTLIER -133.0 -177.5 4.54 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.14 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.725 HG13 ' CG1' ' A' ' 47' ' ' ILE . 35.3 m -140.71 168.06 17.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.289 179.303 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.677 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -134.16 154.45 21.4 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.329 179.077 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.831 ' HB ' ' HB2' ' A' ' 43' ' ' PRO . 3.1 mp -126.66 117.32 47.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.005 0.431 . . . . 0.0 111.871 -179.379 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.652 ' O ' HD12 ' A' ' 109' ' ' LEU . 42.1 t -98.48 99.43 10.59 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.928 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.83 HD22 HG11 ' A' ' 67' ' ' VAL . 24.3 tp -98.31 115.18 27.88 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.522 -178.407 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.666 ' HE1' ' HE2' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -115.6 163.0 16.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.44 179.253 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.737 ' ND2' ' CE3' ' A' ' 136' ' ' TRP . 0.4 OUTLIER -98.5 168.11 10.39 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.169 179.958 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -55.71 -4.43 0.11 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.195 177.83 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.564 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -100.63 2.92 42.12 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.934 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.666 ' HE2' ' HE1' ' A' ' 22' ' ' MET . 5.6 mmtp 74.44 21.55 2.31 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.01 -178.352 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.582 ' HB2' ' OD1' ' A' ' 23' ' ' ASN . 1.9 mmtt -92.33 150.03 21.08 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.839 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.763 HD11 ' HG3' ' A' ' 139' ' ' PRO . 1.5 mm -102.92 137.2 31.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.997 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.608 ' CE1' HD13 ' A' ' 119' ' ' ILE . 88.4 t80 -76.55 138.35 40.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.534 177.932 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.619 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -143.5 153.05 42.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.943 0.402 . . . . 0.0 110.877 -179.708 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.604 ' HB1' ' CB ' ' A' ' 131' ' ' PHE . . . -145.8 132.39 19.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.523 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 4.1 m -97.38 153.26 18.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.127 0.489 . . . . 0.0 111.76 -179.016 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.651 ' O ' ' N ' ' A' ' 35' ' ' ASP . 6.7 mtp180 -68.83 131.64 45.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.966 -179.254 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.745 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -55.37 55.3 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.218 0.607 . . . . 0.0 112.191 179.979 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.651 ' N ' ' O ' ' A' ' 33' ' ' ARG . 1.3 t0 -178.31 -29.67 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.07 0.462 . . . . 0.0 109.977 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.477 HD12 ' NE ' ' A' ' 33' ' ' ARG . 24.0 mt -118.82 107.4 42.4 Favored Pre-proline 0 N--CA 1.451 -0.376 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.62 179.522 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.04 -18.26 21.46 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.514 2.143 . . . . 0.0 112.852 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -94.53 -13.04 26.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.666 -179.755 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.629 ' HB1' ' CG1' ' A' ' 147' ' ' VAL . . . -92.38 101.38 13.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.71 0.291 . . . . 0.0 110.816 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.649 ' O ' ' HA ' ' A' ' 146' ' ' THR . 68.1 m95 -102.81 147.6 26.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.135 179.527 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.445 ' HG2' ' C ' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -152.2 160.27 43.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.269 0.557 . . . . 0.0 111.751 -179.984 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.476 ' HB2' ' HE2' ' A' ' 42' ' ' MET . 6.4 mtm -98.64 154.02 37.66 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.055 179.227 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.831 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 52.9 Cg_exo -49.08 154.19 3.62 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.574 2.183 . . . . 0.0 112.152 -179.77 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.663 ' HA ' HD12 ' A' ' 19' ' ' ILE . 13.7 pt20 -177.4 178.15 1.1 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.882 -178.759 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' GLY . . . . . 0.499 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . 170.91 150.11 6.83 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.426 -0.893 . . . . 0.0 112.578 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.675 ' HA2' ' CB ' ' A' ' 16' ' ' ASN . . . -74.47 135.03 18.89 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.688 -179.475 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.725 ' CG1' HG13 ' A' ' 17' ' ' VAL . 11.7 mt -70.64 141.73 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.939 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -68.39 -171.02 0.23 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.843 0.354 . . . . 0.0 110.993 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.549 ' HG3' ' H ' ' A' ' 50' ' ' GLY . 2.3 pt-20 -49.06 -67.32 0.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.525 -179.476 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.549 ' H ' ' HG3' ' A' ' 49' ' ' GLU . . . -127.67 54.39 0.78 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.742 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -108.99 148.15 31.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.746 0.308 . . . . 0.0 110.504 -179.692 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.429 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 7.7 m-20 -68.84 140.67 91.71 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.253 179.843 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.551 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 35.3 Cg_exo -60.23 -47.14 15.54 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.325 2.017 . . . . 0.0 111.682 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.86 ' HE ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -53.04 -45.98 68.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.564 179.404 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.51 ' HA ' HD12 ' A' ' 58' ' ' ILE . 12.6 m-20 -67.31 -43.85 80.64 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.431 179.63 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.24 -42.05 94.43 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.646 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.773 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -57.78 -55.53 33.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.94 178.604 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.601 HD11 ' CZ ' ' A' ' 54' ' ' ARG . 14.4 mt -55.15 -54.08 28.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.257 179.284 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -61.28 -63.67 1.21 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.811 -179.538 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' GLU . . . . . 0.499 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 46.4 mm-40 -43.94 -47.29 8.46 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.164 0.507 . . . . 0.0 110.017 179.181 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.623 HD12 ' CB ' ' A' ' 43' ' ' PRO . 0.2 OUTLIER -50.12 -46.72 53.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.066 178.336 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.818 ' HG3' HG23 ' A' ' 68' ' ' THR . 24.6 ttm180 -63.15 -64.67 0.84 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.48 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -48.32 -20.16 0.37 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.532 0.568 . . . . 0.0 112.532 -179.194 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -98.4 -38.52 9.19 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -178.173 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.672 HG22 HD23 ' A' ' 121' ' ' LEU . 1.0 OUTLIER -125.29 -5.6 7.2 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.704 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 79.02 -11.69 27.56 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.349 -0.929 . . . . 0.0 111.904 -178.74 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.83 HG11 HD22 ' A' ' 21' ' ' LEU . 58.8 t -57.91 114.19 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 121.033 0.445 . . . . 0.0 111.185 179.509 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.818 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.9 OUTLIER -124.36 -41.33 2.18 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.187 178.285 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.413 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 14.9 m -61.37 73.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.302 179.307 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.16 152.34 18.75 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.359 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -126.2 150.63 48.21 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.232 179.291 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.86 HG21 ' HE ' ' A' ' 54' ' ' ARG . 21.3 t -74.79 127.93 36.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.146 0.498 . . . . 0.0 111.766 179.683 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.589 HD11 ' HB2' ' A' ' 111' ' ' LYS . 1.6 mt -105.73 -18.96 6.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.146 179.325 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -170.94 176.56 4.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.54 179.806 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -155.04 146.76 23.3 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.37 179.43 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.878 ' HA ' HG11 ' A' ' 160' ' ' VAL . 54.7 t -70.64 140.19 86.71 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 120.918 0.39 . . . . 0.0 111.068 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.644 ' HD2' HG13 ' A' ' 76' ' ' VAL . 29.9 Cg_endo -63.55 -59.44 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.138 2.558 . . . . 0.0 112.288 -179.787 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -102.31 -174.63 2.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.433 -179.202 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.631 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 34.1 m95 -89.26 -158.96 0.54 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.665 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.583 ' HB2' ' O ' ' A' ' 105' ' ' GLN . 65.8 mt . . . . . 0 N--CA 1.464 0.269 0 CA-C-O 121.248 0.547 . . . . 0.0 110.87 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.174 0 CA-C-O 120.912 0.387 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.676 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 28.7 mt-30 -132.03 126.7 34.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.488 -178.663 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 13.3 ttmt -102.7 134.88 45.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.283 179.46 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.677 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 17.2 m95 -101.82 163.64 12.15 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.483 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.621 ' HB2' ' HE1' ' A' ' 110' ' ' PHE . 96.4 m-85 -141.36 153.12 44.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.207 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.652 HD12 ' O ' ' A' ' 20' ' ' CYS . 15.7 tp -99.7 139.03 35.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.942 179.628 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.821 ' CE2' HG22 ' A' ' 72' ' ' VAL . 41.6 m-85 -140.97 145.36 35.88 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.355 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.615 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 14.1 tttt -102.93 123.74 47.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.848 178.545 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.685 ' HB2' HD11 ' A' ' 21' ' ' LEU . 54.8 t80 -78.3 98.11 5.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.958 0.408 . . . . 0.0 110.454 179.124 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 43.7 p -95.9 41.62 1.1 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.622 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.413 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -143.67 -146.86 4.61 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.143 -179.68 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 115' ' ' GLN . . . . . 0.417 ' O ' ' HZ ' ' A' ' 112' ' ' PHE . 3.7 mm100 -124.02 149.02 46.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.987 0.422 . . . . 0.0 111.219 -179.626 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -58.47 -30.65 67.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.536 -179.494 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -59.65 -4.79 0.72 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.099 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -90.69 -20.28 22.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.023 0.44 . . . . 0.0 110.482 179.712 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.608 HD13 ' CE1' ' A' ' 29' ' ' PHE . 11.8 mt -83.97 106.56 14.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.426 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 2.7 t30 -102.19 -25.29 13.75 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.954 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.672 HD23 HG22 ' A' ' 65' ' ' THR . 74.0 mt . . . . . 0 N--CA 1.467 0.415 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.363 179.719 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.595 ' O ' HD12 ' A' ' 34' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.461 0.113 0 CA-C-O 120.706 0.288 . . . . 0.0 111.002 . . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.604 ' CB ' ' HB1' ' A' ' 31' ' ' ALA . 3.1 m-85 -102.25 140.71 36.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.171 0.51 . . . . 0.0 110.359 179.606 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.745 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -85.74 -35.79 11.17 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.922 -179.404 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.23 145.92 27.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.971 0.415 . . . . 0.0 110.439 179.823 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.608 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 36.4 p-90 -132.0 163.75 27.71 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.919 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.438 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 32.0 t -160.93 175.69 12.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.337 0.589 . . . . 0.0 111.987 -179.476 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.737 ' CE3' ' ND2' ' A' ' 23' ' ' ASN . 31.2 m95 -110.42 101.07 9.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.509 178.461 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 28' ' ' ILE . 28.4 m -116.43 164.8 12.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.899 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.598 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 17.4 p -71.33 170.22 12.51 Favored Pre-proline 0 C--N 1.324 -0.52 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.447 179.776 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.809 ' HB3' HD22 ' A' ' 158' ' ' LEU . 15.7 Cg_exo -59.86 -58.92 0.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.805 1.67 . . . . 0.0 110.335 179.149 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.9 -29.07 69.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.995 178.716 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.486 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.7 OUTLIER -72.47 -46.59 54.15 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.275 179.796 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.619 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.5 OUTLIER -57.47 -40.51 78.71 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.341 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.724 HG21 ' HG2' ' A' ' 155' ' ' LYS . 36.3 mm -60.6 -37.21 74.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.913 179.375 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.21 -49.79 39.79 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.232 0.539 . . . . 0.0 111.02 179.498 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.23 -21.07 59.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.433 -179.086 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.649 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 10.7 t -74.19 174.83 8.19 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.24 -179.481 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.629 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 33.3 m -85.01 146.01 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.461 -179.254 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.542 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 41.7 mt-10 -49.97 -50.89 45.33 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.364 -179.783 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -52.84 -7.17 0.07 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 148' ' ' GLU . 5.1 mttm -137.18 -4.44 1.9 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.64 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.575 ' HG2' ' O ' ' A' ' 143' ' ' ILE . 11.3 mttt -61.17 -59.11 14.77 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 121.279 -0.169 . . . . 0.0 110.972 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.542 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 22.4 Cg_endo -60.96 -28.83 86.9 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.407 2.072 . . . . 0.0 111.653 179.588 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.732 ' O ' HG23 ' A' ' 157' ' ' VAL . 30.5 t -68.61 -55.03 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.277 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.531 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 7.4 m-30 -61.65 -39.73 92.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.864 178.494 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.724 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -56.32 -43.79 79.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.922 -179.946 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.462 ' O ' HG23 ' A' ' 160' ' ' VAL . 2.7 tt0 -67.63 -31.69 71.88 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.568 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 153' ' ' VAL . 47.1 t -65.83 -41.34 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.651 178.729 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.809 HD22 ' HB3' ' A' ' 139' ' ' PRO . 64.0 mt -62.31 -47.01 86.15 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.023 -179.891 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.8 m -51.9 -38.75 57.43 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.966 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.878 HG11 ' HA ' ' A' ' 76' ' ' VAL . 92.6 t -68.21 -44.22 84.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.273 177.892 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.652 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 21.2 m-30 -79.67 4.3 16.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.901 -179.381 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.566 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.38 -54.96 50.97 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.649 179.692 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 17.4 Cg_endo -57.92 -12.74 12.97 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.024 1.816 . . . . 0.0 111.666 178.807 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -108.25 -16.25 14.29 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.437 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 77.6 mt . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.712 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' MET . . . . . 0.572 ' O ' ' HB2' ' A' ' 78' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.121 0 CA-C-O 120.582 0.23 . . . . 0.0 110.501 . . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.475 ' HA ' ' CB ' ' A' ' 78' ' ' TYR . 3.3 t0 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.051 -179.454 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' ARG . . . . . 0.51 ' HG2' HD12 ' A' ' 47' ' ' ILE . 1.6 ttp180 . . . . . 0 CA--C 1.529 0.161 0 CA-C-O 120.896 0.379 . . . . 0.0 111.962 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ASN . . . . . 0.781 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 3.1 m-80 -133.35 176.91 8.1 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.117 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.669 HG13 ' CG1' ' A' ' 47' ' ' ILE . 12.5 m -140.91 169.24 15.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.784 0.326 . . . . 0.0 111.299 179.494 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.573 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -134.84 162.85 24.76 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.779 -0.725 . . . . 0.0 112.264 179.423 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ILE . . . . . 0.95 HG21 HD22 ' A' ' 61' ' ' LEU . 3.9 mp -128.62 120.59 52.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -178.963 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.603 ' O ' HD12 ' A' ' 109' ' ' LEU . 29.6 t -107.01 98.02 7.73 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.916 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.788 HD22 HG11 ' A' ' 67' ' ' VAL . 4.7 tp -104.69 126.13 51.46 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.946 -178.488 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' MET . . . . . 0.502 ' CE ' HD13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -124.51 162.8 23.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.786 179.009 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.777 ' ND2' ' CE3' ' A' ' 136' ' ' TRP . 0.3 OUTLIER -98.89 171.25 8.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.205 179.78 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -56.7 -5.12 0.2 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.512 177.865 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' ASP . . . . . 0.508 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -98.21 3.7 48.93 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 120.781 0.324 . . . . 0.0 111.687 -179.111 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 26' ' ' LYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 15.1 mmtp 73.22 19.45 3.55 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.182 -178.611 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.6 OUTLIER -96.81 142.19 29.11 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.923 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.678 HD12 ' N ' ' A' ' 28' ' ' ILE . 2.7 mp -102.22 145.83 11.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.804 0.811 . . . . 0.0 112.648 -177.991 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.576 ' CE1' HD13 ' A' ' 119' ' ' ILE . 86.2 t80 -74.65 138.7 43.06 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.779 179.665 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.831 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -140.54 147.19 39.12 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.712 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.45 ' HB1' ' CB ' ' A' ' 131' ' ' PHE . . . -137.87 137.97 38.63 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.909 0.385 . . . . 0.0 111.039 -179.542 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.747 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 91.5 p -100.15 144.8 28.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.39 -179.665 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.472 ' HD3' ' CB ' ' A' ' 39' ' ' ALA . 5.2 mtp180 -70.06 126.48 29.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.74 179.579 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.717 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.7 OUTLIER -43.36 -34.81 1.34 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.361 0.6 . . . . 0.0 110.596 179.756 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -72.83 -41.5 64.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.858 179.614 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.419 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 17.4 mt -120.78 104.54 41.92 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.054 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -66.79 -21.62 50.76 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.728 2.285 . . . . 0.0 112.661 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -92.19 -4.96 53.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.464 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.747 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.52 92.26 7.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.605 0.241 . . . . 0.0 111.338 -179.734 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.628 ' O ' ' HA ' ' A' ' 146' ' ' THR . 81.5 m95 -89.07 144.65 25.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.325 179.194 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.07 162.38 36.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.259 0.552 . . . . 0.0 111.314 -179.486 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' MET . . . . . 0.533 ' HB3' ' CZ3' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -97.95 149.46 35.74 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.595 179.79 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 43' ' ' PRO . . . . . 0.475 ' CG ' HD13 ' A' ' 61' ' ' LEU . 5.1 Cg_endo -48.41 156.67 1.63 Allowed 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.533 2.155 . . . . 0.0 112.022 179.684 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.601 ' HA ' HD12 ' A' ' 19' ' ' ILE . 19.1 pt20 -176.4 -179.95 1.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.601 -179.657 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 170.49 157.3 12.39 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.191 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.74 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -82.84 137.23 16.33 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.339 -179.435 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.669 ' CG1' HG13 ' A' ' 17' ' ' VAL . 43.5 mt -69.58 142.35 16.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.827 0.346 . . . . 0.0 110.965 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -68.98 -174.27 0.58 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.662 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -48.5 -81.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.14 179.727 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.74 54.75 0.53 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.399 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -115.5 147.1 41.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.918 0.39 . . . . 0.0 110.963 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.09 164.36 53.22 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.469 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 5.9 Cg_exo -74.85 -46.61 0.24 Allowed 'Trans proline' 0 CA--C 1.516 -0.405 0 C-N-CA 122.762 2.308 . . . . 0.0 111.584 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.757 ' NH2' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -51.68 -46.02 63.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.807 179.851 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 3.7 m120 -65.14 -48.04 74.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.309 179.688 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.12 -43.2 99.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.861 179.472 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.507 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -59.15 -58.31 9.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.897 178.537 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.492 HD11 ' HG3' ' A' ' 54' ' ' ARG . 26.0 mt -56.93 -49.64 78.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.425 179.38 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.427 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 6.1 ttp180 -64.18 -63.63 1.1 Allowed 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.354 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -42.18 -43.62 3.42 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.957 0.408 . . . . 0.0 110.277 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.95 HD22 HG21 ' A' ' 19' ' ' ILE . 13.6 tp -51.77 -50.11 61.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.053 178.557 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.87 ' HG3' HG23 ' A' ' 68' ' ' THR . 1.1 ttt180 -63.01 -64.96 0.76 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.987 179.456 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -48.82 -25.37 1.84 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.768 -179.553 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -92.72 -40.19 10.84 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -178.522 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' THR . . . . . 0.729 HG22 HD23 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -121.44 -34.45 3.44 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.59 -179.233 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 106.42 -11.7 43.26 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.409 -178.874 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.788 HG11 HD22 ' A' ' 21' ' ' LEU . 32.4 t -57.22 111.44 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-O 121.111 0.481 . . . . 0.0 111.58 179.534 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' THR . . . . . 0.87 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.8 OUTLIER -122.71 -39.15 2.56 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.79 178.505 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.0 m -61.97 74.76 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.077 179.104 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -162.14 155.81 21.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.026 0.441 . . . . 0.0 111.963 -179.435 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -126.72 147.94 49.92 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.363 179.447 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.757 HG11 ' NH2' ' A' ' 54' ' ' ARG . 6.6 t -75.58 126.81 36.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.222 0.534 . . . . 0.0 111.425 179.334 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.54 HD11 ' HB2' ' A' ' 111' ' ' LYS . 0.8 OUTLIER -106.97 -20.77 5.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.28 179.537 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -169.81 177.92 4.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.647 -179.702 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -155.08 150.16 26.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.502 179.817 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.855 ' HA ' HG11 ' A' ' 160' ' ' VAL . 44.0 t -71.71 136.18 83.19 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.894 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.4 ' HD2' HG13 ' A' ' 76' ' ' VAL . 16.6 Cg_endo -55.06 -69.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.041 2.494 . . . . 0.0 112.138 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' TYR . . . . . 0.572 ' HB2' ' O ' ' A' ' 6' ' ' MET . 0.1 OUTLIER -94.07 -172.45 2.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.666 -179.759 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 79' ' ' TRP . . . . . 0.48 ' NE1' ' HE2' ' A' ' 106' ' ' LYS . 29.2 m95 -90.06 -158.47 0.53 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 178.816 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.593 HD12 ' HD1' ' A' ' 107' ' ' TRP . 57.8 mt . . . . . 0 C--N 1.328 -0.327 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -179.772 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.371 0 CA-C-O 121.102 0.477 . . . . 0.0 109.948 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.781 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 43.1 mt-30 -128.14 128.32 44.62 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -177.518 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.48 ' HE2' ' NE1' ' A' ' 79' ' ' TRP . 19.8 ttmt -104.9 134.89 47.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.539 178.044 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' TRP . . . . . 0.593 ' HD1' HD12 ' A' ' 80' ' ' LEU . 32.6 m95 -102.91 162.8 12.63 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.073 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 108' ' ' PHE . . . . . 0.47 ' HB3' ' CE1' ' A' ' 110' ' ' PHE . 98.2 m-85 -138.44 153.0 48.85 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.866 -179.875 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 109' ' ' LEU . . . . . 0.603 HD12 ' O ' ' A' ' 20' ' ' CYS . 19.2 tp -108.78 122.45 47.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.876 179.528 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.732 ' CE1' HG22 ' A' ' 72' ' ' VAL . 8.8 m-85 -127.47 148.4 50.31 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.243 0.544 . . . . 0.0 111.689 179.912 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 111' ' ' LYS . . . . . 0.56 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 33.2 tttt -98.59 124.81 43.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.428 178.343 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 112' ' ' PHE . . . . . 0.661 ' HB2' HD11 ' A' ' 21' ' ' LEU . 46.6 t80 -78.43 102.01 7.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.85 0.357 . . . . 0.0 110.901 179.702 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.8 p -99.33 42.0 1.12 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.288 179.573 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.92 -149.13 5.14 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.727 -179.803 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.46 150.06 42.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.989 0.423 . . . . 0.0 111.243 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.458 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 4.1 p30 -58.05 -38.92 77.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.376 0.608 . . . . 0.0 111.272 -179.667 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.63 -3.07 0.16 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.981 -1.008 . . . . 0.0 112.381 -179.6 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -89.18 -18.63 26.74 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.051 0.453 . . . . 0.0 110.435 179.469 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.618 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 7.5 mt -86.81 107.24 16.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.962 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.547 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 7.9 p-10 -96.98 -22.67 16.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.222 -179.567 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.729 HD23 HG22 ' A' ' 65' ' ' THR . 47.6 mt . . . . . 0 N--CA 1.466 0.331 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.743 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.668 0.27 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 131' ' ' PHE . . . . . 0.45 ' CB ' ' HB1' ' A' ' 31' ' ' ALA . 1.5 m-85 -108.88 141.6 40.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.874 0.369 . . . . 0.0 110.348 179.683 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.717 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -91.31 -30.84 10.27 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.387 -179.703 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.51 150.52 32.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.731 0.3 . . . . 0.0 110.598 179.501 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 134' ' ' TRP . . . . . 0.618 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 40.3 p-90 -137.78 168.74 19.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.089 179.532 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.451 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 27.2 t -163.5 174.32 11.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.392 0.615 . . . . 0.0 112.54 -178.983 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 136' ' ' TRP . . . . . 0.777 ' CE3' ' ND2' ' A' ' 23' ' ' ASN . 36.8 m95 -110.12 107.08 16.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.849 177.96 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.425 ' O ' ' N ' ' A' ' 28' ' ' ILE . 26.4 m -121.71 172.64 8.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.678 -179.711 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.577 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 25.3 p -74.08 171.36 11.29 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.812 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.676 ' HB3' HD22 ' A' ' 158' ' ' LEU . 9.2 Cg_exo -63.19 -54.55 1.04 Allowed 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 121.331 1.354 . . . . 0.0 109.851 178.999 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.68 -29.02 70.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.965 178.717 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.495 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 2.9 mt-30 -71.27 -46.46 60.88 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.933 0.397 . . . . 0.0 110.259 179.408 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 142' ' ' LEU . . . . . 0.831 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -57.5 -39.86 77.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.651 179.59 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 143' ' ' ILE . . . . . 0.768 HG21 ' HG2' ' A' ' 155' ' ' LYS . 26.1 mm -62.31 -38.34 80.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.298 179.279 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.98 -51.44 32.51 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.349 0.595 . . . . 0.0 110.781 179.639 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.36 -21.24 61.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.713 -179.093 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 146' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 8.3 t -73.7 173.91 9.13 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.502 -179.108 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 147' ' ' VAL . . . . . 0.66 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 29.9 m -77.13 155.67 5.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.689 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.484 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 72.2 mt-10 -58.44 -55.74 31.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.151 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.66 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 29.5 p90 -56.01 -0.64 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -179.594 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.462 ' HD3' ' OH ' ' A' ' 154' ' ' TYR . 48.9 mttt -135.04 -7.85 2.33 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.83 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.524 ' HG2' ' HD3' ' A' ' 152' ' ' PRO . 0.1 OUTLIER -62.57 -56.72 27.25 Favored Pre-proline 0 C--N 1.328 -0.358 0 O-C-N 122.43 -0.169 . . . . 0.0 110.975 179.762 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.524 ' HD3' ' HG2' ' A' ' 151' ' ' LYS . 30.6 Cg_endo -64.56 -25.8 62.27 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.061 1.841 . . . . 0.0 111.149 179.197 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.764 ' O ' HG23 ' A' ' 157' ' ' VAL . 20.6 t -68.55 -50.9 51.87 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.456 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.462 ' OH ' ' HD3' ' A' ' 150' ' ' LYS . 9.0 m-30 -67.89 -36.67 80.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.975 178.664 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.768 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -58.53 -40.89 84.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.543 179.532 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.0 -35.7 74.58 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.91 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 157' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 153' ' ' VAL . 61.5 t -66.53 -39.85 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.695 178.821 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.676 HD22 ' HB3' ' A' ' 139' ' ' PRO . 27.7 mt -63.14 -42.4 99.46 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.556 179.741 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 67.3 m -54.38 -39.89 67.63 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.37 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 160' ' ' VAL . . . . . 0.855 HG11 ' HA ' ' A' ' 76' ' ' VAL . 95.1 t -67.71 -45.16 85.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.178 177.788 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 161' ' ' PHE . . . . . 0.612 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 22.0 m-30 -80.45 5.01 16.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.724 -178.748 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 162' ' ' ALA . . . . . 0.63 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.23 -52.02 77.45 Favored Pre-proline 0 C--N 1.328 -0.353 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.815 179.617 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 163' ' ' PRO . . . . . 0.63 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.2 Cg_endo -58.36 -11.75 11.69 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.328 2.019 . . . . 0.0 112.296 179.172 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -111.78 -18.21 12.78 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.4 -179.698 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 91.7 mt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.811 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 112.538 -0.225 . . . . 0.0 112.538 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.41 174.25 13.13 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.699 2.266 . . . . 0.0 112.515 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.88 -172.0 2.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.729 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.409 ' O ' ' OG ' ' A' ' 5' ' ' SER . . . -117.21 -27.12 2.75 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.455 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.784 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 68.6 p 56.32 -87.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.755 0.312 . . . . 0.0 111.784 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.553 ' HE1' ' OG1' ' A' ' 81' ' ' THR . 8.7 mtm 64.59 127.39 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.771 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.718 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 5.6 t70 -67.69 -9.84 47.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.465 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -136.72 118.86 11.53 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.213 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.439 ' HD3' ' NE1' ' A' ' 79' ' ' TRP . 11.7 Cg_endo -55.33 119.87 7.26 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.406 2.071 . . . . 0.0 112.356 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.445 ' HD2' ' CD2' ' A' ' 13' ' ' TYR . 9.1 Cg_exo -71.82 172.35 14.7 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.017 2.478 . . . . 0.0 112.743 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.14 133.51 39.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.925 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 99' ' ' ASP . . . 56.17 91.04 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.717 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.502 ' CE1' ' HG2' ' A' ' 101' ' ' LYS . 5.0 m-85 -161.17 136.37 7.64 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.442 ' HB3' ' CG ' ' A' ' 103' ' ' GLN . 24.0 ttt85 -70.53 85.56 0.62 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.847 0.355 . . . . 0.0 111.838 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.597 ' CG ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -51.78 106.44 0.14 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.096 0.474 . . . . 0.0 110.892 179.251 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.689 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 2.2 m-80 -132.88 175.01 9.73 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.414 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.597 HG13 ' CG1' ' A' ' 47' ' ' ILE . 4.2 m -142.62 164.96 16.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.252 0.549 . . . . 0.0 111.638 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.557 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -134.09 156.71 22.5 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.0 HG23 ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -128.98 122.24 56.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.321 0.581 . . . . 0.0 112.198 -179.156 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.2 t -101.17 110.7 22.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.296 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.802 HD21 ' HD1' ' A' ' 112' ' ' PHE . 61.7 tp -107.4 124.69 50.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.045 0.45 . . . . 0.0 111.727 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.665 ' SD ' HD11 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -117.77 142.91 46.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.876 -179.756 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.484 ' OD1' ' CH2' ' A' ' 136' ' ' TRP . 4.7 m-20 -96.85 -175.74 3.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.532 0.682 . . . . 0.0 111.34 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -56.06 -5.74 0.2 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.688 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.508 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 1.2 m-20 -103.47 -0.77 29.46 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 40.3 mmtt 71.7 24.82 3.38 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.608 ' HB3' ' O ' ' A' ' 137' ' ' VAL . 71.9 mttt -94.49 -177.55 4.27 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.923 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.847 HD11 ' HG3' ' A' ' 139' ' ' PRO . 1.8 mm -122.85 141.53 42.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.939 0.399 . . . . 0.0 111.39 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.734 ' HE2' HG21 ' A' ' 65' ' ' THR . 17.9 t80 -67.63 106.77 2.3 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.065 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.542 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . . . -103.77 138.47 40.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.021 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.52 ' HB1' ' CG ' ' A' ' 131' ' ' PHE . . . -138.06 138.73 39.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.277 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.542 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 47.9 p -100.6 148.13 25.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.021 0.438 . . . . 0.0 111.933 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.664 ' NE ' HD12 ' A' ' 36' ' ' ILE . 11.1 mtp85 -70.66 129.09 38.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.868 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.711 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.3 OUTLIER -55.49 56.44 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.381 0.425 . . . . 0.0 111.992 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.661 ' N ' ' O ' ' A' ' 33' ' ' ARG . 11.5 p-10 -177.35 -37.63 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.251 0.548 . . . . 0.0 109.815 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.664 HD12 ' NE ' ' A' ' 33' ' ' ARG . 18.8 mt -113.05 108.5 53.11 Favored Pre-proline 0 N--CA 1.454 -0.268 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.574 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.09 -18.26 21.34 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.485 2.123 . . . . 0.0 113.145 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -95.41 -9.49 32.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.748 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.59 ' HB1' ' CG1' ' A' ' 147' ' ' VAL . . . -92.53 91.71 7.72 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.897 0.379 . . . . 0.0 111.416 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.657 ' O ' ' HA ' ' A' ' 146' ' ' THR . 75.9 m95 -94.13 147.17 23.42 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.023 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.22 163.28 20.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.156 0.503 . . . . 0.0 111.452 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.41 ' HG3' ' CH2' ' A' ' 107' ' ' TRP . 1.0 OUTLIER -100.6 156.05 35.65 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.517 178.477 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.419 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 8.3 Cg_endo -49.97 152.73 7.06 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.441 2.094 . . . . 0.0 112.355 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -177.8 148.28 0.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.262 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.54 -160.66 10.09 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.654 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.689 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -120.2 142.44 16.03 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.602 -0.808 . . . . 0.0 113.243 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.597 ' CG1' HG13 ' A' ' 17' ' ' VAL . 30.2 mt -69.64 144.32 14.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.722 0.296 . . . . 0.0 111.168 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.17 -174.88 0.68 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.578 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -48.54 -59.85 3.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.13 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -132.64 59.79 0.68 Allowed Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.384 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' A' ' 52' ' ' ASP . 4.9 tp10 -118.26 155.64 30.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.825 0.345 . . . . 0.0 110.784 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.403 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -72.71 154.13 91.34 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.506 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.537 ' HA ' HG11 ' A' ' 17' ' ' VAL . 12.2 Cg_exo -70.86 -49.22 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.597 2.198 . . . . 0.0 111.427 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.668 ' HE ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -53.21 -45.36 68.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.326 179.58 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.528 ' HA ' HD12 ' A' ' 58' ' ' ILE . 2.9 m-20 -67.91 -44.11 77.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.193 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.46 93.04 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.0 ' HB1' HG23 ' A' ' 19' ' ' ILE . . . -58.01 -54.95 41.11 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.768 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.553 HD11 ' CD ' ' A' ' 54' ' ' ARG . 14.1 mt -56.6 -53.01 46.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.185 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 59' ' ' ARG . 16.2 mtt-85 -60.85 -59.41 5.43 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.638 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -46.87 -44.7 19.8 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 121.3 0.572 . . . . 0.0 109.768 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.908 HD12 ' HB ' ' A' ' 19' ' ' ILE . 7.2 tt -51.01 -46.51 61.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.482 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.737 ' HG3' HG23 ' A' ' 68' ' ' THR . 10.2 ttt180 -65.04 -64.52 0.84 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.869 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -48.28 -20.46 0.39 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -97.29 -36.26 10.47 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.761 HG22 ' CD2' ' A' ' 121' ' ' LEU . 17.3 p -129.09 -8.16 4.85 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.38 -13.4 40.46 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.36 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.698 HG11 HD22 ' A' ' 21' ' ' LEU . 54.9 t -59.25 114.1 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-O 121.233 0.54 . . . . 0.0 111.207 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.737 HG23 ' HG3' ' A' ' 62' ' ' ARG . 1.0 OUTLIER -121.98 -38.77 2.68 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.915 179.028 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.464 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 10.4 m -61.55 74.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.614 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.64 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -157.47 156.09 31.49 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.086 0.47 . . . . 0.0 111.835 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -129.58 150.91 50.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.44 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.957 HG22 ' CE2' ' A' ' 110' ' ' PHE . 8.0 t -74.46 126.38 35.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.146 0.498 . . . . 0.0 111.363 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.564 HD11 ' N ' ' A' ' 111' ' ' LYS . 1.0 OUTLIER -107.0 -20.38 6.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.054 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.452 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.75 175.78 4.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.009 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -155.11 146.65 23.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.523 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.721 ' HA ' HG11 ' A' ' 160' ' ' VAL . 69.9 t -71.08 135.58 84.95 Favored Pre-proline 0 N--CA 1.453 -0.31 0 CA-C-O 121.002 0.43 . . . . 0.0 110.349 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.522 ' HD2' HG13 ' A' ' 76' ' ' VAL . 29.5 Cg_endo -63.69 -54.39 0.99 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.951 2.434 . . . . 0.0 112.586 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.718 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.8 OUTLIER -100.48 -179.23 4.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.695 -179.128 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.638 ' O ' HD23 ' A' ' 80' ' ' LEU . 44.9 m95 -92.62 -155.94 0.45 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.069 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.784 ' HA ' ' HA ' ' A' ' 5' ' ' SER . 80.6 mt -162.9 105.31 1.04 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.818 0.342 . . . . 0.0 110.259 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.784 HG22 ' HB2' ' A' ' 104' ' ' ALA . 66.6 p -104.06 95.32 5.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.288 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.86 89.02 4.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.751 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -72.99 154.74 40.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.001 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.624 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 4.9 m-85 -103.78 158.0 32.77 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.902 0.382 . . . . 0.0 111.431 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.489 ' HB3' ' HD2' ' A' ' 86' ' ' PRO . 32.0 Cg_exo -57.94 177.59 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.737 2.291 . . . . 0.0 111.893 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 85' ' ' PRO . 23.5 Cg_endo -62.02 -28.38 80.41 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.312 2.008 . . . . 0.0 112.132 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.25 -58.05 3.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.627 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.624 ' HB ' ' HB3' ' A' ' 84' ' ' PHE . 57.3 t -68.34 -25.56 31.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.057 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.616 ' HD2' ' CB ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -54.94 -51.96 64.48 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.87 0.366 . . . . 0.0 110.763 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.447 ' HA ' HD13 ' A' ' 94' ' ' ILE . 34.2 mt-10 -62.63 -23.56 67.14 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.148 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.9 mttm -93.61 -16.09 24.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.267 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.602 HD12 ' CD1' ' A' ' 84' ' ' PHE . 1.9 tm? -120.29 -64.74 1.22 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.835 0.35 . . . . 0.0 111.137 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.616 ' CB ' ' HD2' ' A' ' 89' ' ' ARG . 14.7 t-20 -49.44 -61.16 2.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.37 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.447 HD13 ' HA ' ' A' ' 90' ' ' GLU . 2.4 mp -71.71 -8.04 10.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.234 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.411 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 16.6 tt0 -72.83 -6.76 47.07 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.518 0.199 . . . . 0.0 111.506 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.51 ' CD1' ' HB2' ' A' ' 100' ' ' TRP . 43.3 m95 -104.83 -19.35 13.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.662 0.268 . . . . 0.0 111.233 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 133.72 -83.95 0.29 Allowed Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.742 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -171.85 28.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.351 0.595 . . . . 0.0 111.612 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.466 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 68.0 m-20 -129.4 -44.69 1.24 Allowed 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.145 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.588 ' O ' ' HB3' ' A' ' 101' ' ' LYS . 11.7 m95 -67.14 -164.88 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.212 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.588 ' HB3' ' O ' ' A' ' 100' ' ' TRP . 0.0 OUTLIER 165.45 0.9 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.651 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 175.47 -144.29 7.13 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 119.838 -1.172 . . . . 0.0 112.778 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.583 ' O ' ' HA ' ' A' ' 81' ' ' THR . 2.0 mt-30 -146.43 110.03 4.85 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.681 -0.118 . . . . 0.0 110.681 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.784 ' HB2' HG22 ' A' ' 81' ' ' THR . . . -91.68 111.92 23.63 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.051 0.453 . . . . 0.0 110.246 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.679 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 3.7 mt-30 -125.42 129.71 50.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.406 -178.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.486 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 3.4 ttpt -104.35 135.55 45.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.375 178.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.557 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 53.9 m95 -103.04 161.87 13.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.318 0.58 . . . . 0.0 112.348 -178.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.531 ' HB2' ' HE1' ' A' ' 110' ' ' PHE . 96.3 m-85 -140.89 153.99 45.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.527 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.665 HD11 ' SD ' ' A' ' 22' ' ' MET . 10.5 tp -101.18 141.01 34.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.852 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.957 ' CE2' HG22 ' A' ' 72' ' ' VAL . 90.6 m-85 -143.16 145.57 32.94 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.64 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 56.4 tttt -103.4 124.83 49.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.94 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.802 ' HD1' HD21 ' A' ' 21' ' ' LEU . 41.1 t80 -78.87 96.04 5.57 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.743 0.306 . . . . 0.0 111.288 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 15.8 p -98.39 52.67 1.03 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.545 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -152.59 -146.35 4.34 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.526 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.16 147.41 46.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.131 0.491 . . . . 0.0 111.318 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -61.19 -27.72 68.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.163 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -56.7 -4.31 0.15 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.283 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -90.8 -16.97 27.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.889 0.376 . . . . 0.0 110.931 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.647 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 5.5 mt -84.13 98.41 5.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.171 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 47.8 p-10 -104.0 -8.51 19.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.015 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.761 ' CD2' HG22 ' A' ' 65' ' ' THR . 46.8 mt 42.91 26.82 0.08 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.609 0.243 . . . . 0.0 111.545 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.513 HD23 ' HB3' ' A' ' 129' ' ' PRO . 11.2 mt -106.23 -173.39 2.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.006 0.431 . . . . 0.0 111.642 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 173.49 127.29 0.97 Allowed Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.689 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.56 87.13 6.25 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.016 0.436 . . . . 0.0 111.067 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.403 ' O ' ' CB ' ' A' ' 126' ' ' SER . . . -129.47 1.19 6.03 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.934 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 125' ' ' GLY . 3.9 p 80.86 -13.93 0.88 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -91.51 -77.32 0.43 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.683 0.278 . . . . 0.0 111.146 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.536 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 0.1 OUTLIER -179.98 160.08 0.85 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.612 179.503 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.536 ' HD2' ' HB2' ' A' ' 128' ' ' LYS . 11.9 Cg_endo -65.87 -179.93 1.54 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.217 1.945 . . . . 0.0 111.872 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -95.06 -67.45 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.535 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.729 ' HB2' HD13 ' A' ' 121' ' ' LEU . 3.4 m-85 -105.37 146.45 29.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.086 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.711 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -92.62 -34.3 7.04 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.874 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -148.83 144.17 26.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.661 0.267 . . . . 0.0 110.98 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.647 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 47.2 p-90 -132.61 166.82 21.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.915 0.388 . . . . 0.0 111.546 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.6 t -160.73 178.7 9.2 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.894 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.484 ' CH2' ' OD1' ' A' ' 23' ' ' ASN . 86.2 m95 -114.41 100.99 8.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.723 178.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.608 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 19.9 m -118.67 164.89 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.052 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.537 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 23.2 p -72.3 166.32 42.66 Favored Pre-proline 0 C--N 1.328 -0.35 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.544 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.847 ' HG3' HD11 ' A' ' 28' ' ' ILE . 25.6 Cg_exo -58.2 -55.46 2.21 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.072 1.848 . . . . 0.0 110.668 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -63.58 -27.86 69.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.291 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.508 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.8 OUTLIER -72.73 -46.24 54.59 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.354 179.496 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.542 ' CD1' ' HB2' ' A' ' 30' ' ' ALA . 2.8 tp -58.32 -39.38 79.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.763 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 1.082 HG21 ' HD3' ' A' ' 155' ' ' LYS . 12.7 mm -62.57 -31.84 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.048 0.452 . . . . 0.0 110.417 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.62 -53.5 11.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.71 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.81 -19.14 61.39 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.803 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.657 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 14.2 t -73.87 175.32 7.41 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.424 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.59 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 34.3 m -85.05 144.28 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.649 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.473 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 2.7 mt-10 -48.13 -46.65 34.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.942 0.401 . . . . 0.0 111.351 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -52.7 -11.37 0.21 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 154' ' ' TYR . 31.9 mttm -132.57 -3.27 3.35 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -63.33 -55.46 35.72 Favored Pre-proline 0 C--N 1.326 -0.439 0 O-C-N 122.431 -0.168 . . . . 0.0 111.203 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 29.8 Cg_endo -64.96 -29.25 57.7 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.067 1.845 . . . . 0.0 111.719 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.61 ' O ' HG23 ' A' ' 157' ' ' VAL . 29.3 t -69.26 -51.54 42.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.495 ' HB2' ' CD1' ' A' ' 143' ' ' ILE . 7.4 m-30 -64.84 -37.19 86.78 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.84 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 1.082 ' HD3' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -56.22 -45.87 79.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.672 179.244 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.458 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.3 tt0 -67.68 -30.6 70.17 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 153' ' ' VAL . 90.8 t -68.57 -41.16 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.511 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.711 HD22 ' HB3' ' A' ' 139' ' ' PRO . 67.9 mt -64.56 -47.23 79.51 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.453 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.4 p -50.22 -42.48 51.72 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.721 HG11 ' HA ' ' A' ' 76' ' ' VAL . 98.7 t -65.43 -41.34 90.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.58 ' CD2' HD13 ' A' ' 109' ' ' LEU . 21.5 m-30 -81.82 5.75 17.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.933 -1.031 . . . . 0.0 112.933 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.621 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.88 -51.78 79.46 Favored Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.649 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.1 Cg_endo -60.05 -11.73 16.61 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.123 1.882 . . . . 0.0 111.996 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.452 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 95.7 m-70 -108.46 -19.19 13.54 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.366 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 96.8 mt . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.868 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 CA-C-O 120.276 -0.18 . . . . 0.0 112.945 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.2 156.28 35.71 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.495 2.13 . . . . 0.0 112.909 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.489 HD21 ' HB2' ' A' ' 152' ' ' PRO . 0.1 OUTLIER -139.79 106.47 5.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.212 179.162 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.14 -41.33 85.69 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.806 -0.711 . . . . 0.0 113.113 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.839 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 0.7 OUTLIER 70.08 -98.13 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 122.171 0.188 . . . . 0.0 111.16 -179.5 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.46 ' HE2' ' N ' ' A' ' 5' ' ' SER . 8.4 mtm 65.58 132.38 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.665 0.269 . . . . 0.0 111.032 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.772 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 3.9 p-10 -71.66 -22.67 61.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.642 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m -101.44 140.99 21.71 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.684 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.517 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 68.1 Cg_endo -74.89 128.17 11.35 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.133 1.889 . . . . 0.0 111.351 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.56 ' HB2' ' CE1' ' A' ' 13' ' ' TYR . 1.1 Cg_endo -82.88 167.07 14.69 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.966 2.444 . . . . 0.0 112.773 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -49.14 124.41 8.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.031 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 100' ' ' TRP . . . 51.58 98.11 0.01 OUTLIER Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.751 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.56 ' CE1' ' HB2' ' A' ' 10' ' ' PRO . 11.0 m-85 -153.84 136.11 14.89 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.696 0.284 . . . . 0.0 110.694 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.427 ' HB3' ' HG3' ' A' ' 103' ' ' GLN . 1.7 ttt180 -70.86 75.32 0.62 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.083 0.468 . . . . 0.0 111.689 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.837 ' HG2' HD12 ' A' ' 47' ' ' ILE . 4.3 ttp180 -47.87 113.7 0.77 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.453 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.643 ' OD1' ' HG2' ' A' ' 105' ' ' GLN . 0.2 OUTLIER -134.89 173.39 11.76 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.993 179.241 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.861 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 33.6 m -132.12 160.33 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 CA-C-O 120.986 0.422 . . . . 0.0 111.917 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.621 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -127.08 148.22 17.27 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.26 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.908 HG21 HD22 ' A' ' 61' ' ' LEU . 2.8 mp -122.5 117.11 51.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.642 ' O ' HD12 ' A' ' 109' ' ' LEU . 43.9 t -101.04 99.7 10.19 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.723 HD22 HG11 ' A' ' 67' ' ' VAL . 21.2 tp -101.26 117.03 34.17 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.005 -177.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.566 ' HE2' HD13 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -119.98 160.1 23.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.795 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.646 ' ND2' ' CE3' ' A' ' 136' ' ' TRP . 0.2 OUTLIER -97.3 174.24 6.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.19 0.519 . . . . 0.0 110.416 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -57.59 -5.63 0.39 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.245 177.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.572 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.5 OUTLIER -99.39 3.5 45.91 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.709 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 5.8 mmtp 73.75 18.77 3.35 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.349 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.558 ' O ' ' HA ' ' A' ' 22' ' ' MET . 2.9 mttt -96.27 142.05 28.88 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.686 HD12 ' N ' ' A' ' 28' ' ' ILE . 2.5 mp -100.79 144.48 12.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.574 0.702 . . . . 0.0 112.063 -178.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.689 ' CE1' HD13 ' A' ' 119' ' ' ILE . 92.1 t80 -75.39 140.2 42.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.007 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.971 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -137.76 151.6 48.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.615 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.54 ' HB1' ' CB ' ' A' ' 131' ' ' PHE . . . -139.83 135.91 33.47 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.319 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.71 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 96.6 p -98.08 140.66 32.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.913 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.46 ' HD2' ' HB3' ' A' ' 39' ' ' ALA . 1.7 mtt-85 -67.65 127.84 34.24 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.849 0.357 . . . . 0.0 110.767 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.711 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.6 OUTLIER -45.88 -34.88 4.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.295 0.569 . . . . 0.0 110.458 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -71.47 -38.3 71.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.139 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.408 ' N ' ' O ' ' A' ' 33' ' ' ARG . 31.3 mm -125.41 108.94 26.53 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.98 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.3 -18.51 23.24 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.578 2.185 . . . . 0.0 112.862 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -92.2 -12.24 33.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.664 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.909 ' HB1' ' CG1' ' A' ' 147' ' ' VAL . . . -91.48 104.98 17.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.759 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.549 ' O ' ' HA ' ' A' ' 146' ' ' THR . 75.6 m95 -96.82 152.49 18.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.632 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.53 ' HG3' ' C ' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -158.18 160.99 37.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.475 0.655 . . . . 0.0 111.927 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.633 ' HG3' HD11 ' A' ' 142' ' ' LEU . 13.4 mtm -98.87 155.04 37.07 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.092 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.874 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 51.4 Cg_exo -50.74 144.94 24.81 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.23 1.954 . . . . 0.0 112.087 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.861 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -170.57 141.62 1.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.079 -179.503 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.569 ' O ' ' HB2' ' A' ' 16' ' ' ASN . . . -148.71 -173.41 19.46 Favored Glycine 0 C--O 1.224 -0.471 0 N-CA-C 111.446 -0.661 . . . . 0.0 111.446 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.578 ' HA2' ' CB ' ' A' ' 16' ' ' ASN . . . -95.82 -154.32 30.46 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.508 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.837 HD12 ' HG2' ' A' ' 15' ' ' ARG . 1.7 mt -163.12 125.53 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 122.535 0.334 . . . . 0.0 110.736 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.27 172.41 12.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.995 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.455 ' HG3' ' H ' ' A' ' 50' ' ' GLY . 1.8 pt-20 -46.92 -76.66 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.61 -179.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.455 ' H ' ' HG3' ' A' ' 49' ' ' GLU . . . -85.17 34.49 3.24 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.963 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.708 ' OE1' ' HB2' ' A' ' 56' ' ' ALA . 4.8 tm-20 -113.19 123.94 51.37 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.545 ' HB2' ' OD1' ' A' ' 55' ' ' ASN . 1.8 m-20 -70.59 158.69 87.25 Favored Pre-proline 0 C--N 1.326 -0.439 0 C-N-CA 120.62 -0.432 . . . . 0.0 109.857 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.557 ' CA ' HG11 ' A' ' 17' ' ' VAL . 6.8 Cg_exo -74.19 -50.11 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.874 2.383 . . . . 0.0 113.463 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.835 ' CZ ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -49.52 -45.2 47.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.267 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.545 ' OD1' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -67.67 -44.79 76.98 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.053 0.454 . . . . 0.0 110.321 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.708 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . . . -58.72 -41.73 87.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.686 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.774 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -57.64 -56.77 17.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.2 0.524 . . . . 0.0 109.639 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.631 HG12 ' HE2' ' A' ' 110' ' ' PHE . 26.9 mt -54.38 -53.78 27.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.26 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.559 ' HA ' HH11 ' A' ' 59' ' ' ARG . 0.0 OUTLIER -62.11 -60.06 4.15 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.82 -179.246 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.439 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 16.6 mm-40 -46.21 -49.85 16.54 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.56 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.908 HD22 HG21 ' A' ' 19' ' ' ILE . 9.7 tp -49.74 -44.56 48.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.34 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.843 ' HD3' HG23 ' A' ' 68' ' ' THR . 21.9 tpt85 -63.85 -65.44 0.68 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.491 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.4 ' OE2' ' HB3' ' A' ' 59' ' ' ARG . 0.8 OUTLIER -49.22 -22.62 1.06 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -179.15 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -97.21 -32.71 11.79 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -177.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 119' ' ' ILE . 5.6 p -127.65 -6.28 5.74 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.483 ' HA2' ' HD2' ' A' ' 62' ' ' ARG . . . 79.36 -14.36 16.81 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.08 -1.057 . . . . 0.0 111.561 -178.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.723 HG11 HD22 ' A' ' 21' ' ' LEU . 78.7 t -58.55 117.25 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 121.11 0.481 . . . . 0.0 111.682 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.843 HG23 ' HD3' ' A' ' 62' ' ' ARG . 0.3 OUTLIER -128.26 -38.96 1.74 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.457 178.003 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.1 m -62.41 73.44 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.941 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.16 155.31 22.7 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.866 0.365 . . . . 0.0 111.957 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.436 ' HG3' HG21 ' A' ' 113' ' ' THR . 1.7 mt-10 -128.62 151.34 49.6 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.573 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.835 HG21 ' CZ ' ' A' ' 54' ' ' ARG . 12.2 t -75.07 126.71 36.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.405 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.657 HD11 ' HB2' ' A' ' 111' ' ' LYS . 1.4 mt -106.71 -19.32 6.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.31 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.505 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -171.05 175.73 4.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.606 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.9 OUTLIER -153.17 143.73 22.62 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.256 179.4 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.786 ' HA ' HG11 ' A' ' 160' ' ' VAL . 38.6 t -70.52 131.97 87.79 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 120.937 0.399 . . . . 0.0 111.087 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.488 ' HD2' HG11 ' A' ' 160' ' ' VAL . 34.4 Cg_endo -65.13 -50.74 1.9 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.057 2.505 . . . . 0.0 112.987 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.772 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 3.1 p90 -100.07 177.43 5.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.983 0.421 . . . . 0.0 111.931 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.632 ' CH2' ' HG3' ' A' ' 15' ' ' ARG . 58.7 m95 -94.2 -163.44 1.05 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.727 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.839 ' HA ' ' HA ' ' A' ' 5' ' ' SER . 15.9 mt -159.94 104.15 1.52 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.055 0.455 . . . . 0.0 110.626 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.842 HG22 ' HA ' ' A' ' 104' ' ' ALA . 5.4 p -109.8 101.73 10.57 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.765 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.432 ' O ' ' C ' ' A' ' 83' ' ' ASP . 4.5 t80 -78.88 37.07 0.29 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.092 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 82' ' ' TYR . 5.7 p-10 25.3 -110.03 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.112 0.565 . . . . 0.0 112.413 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.897 ' HB2' HD22 ' A' ' 93' ' ' ASN . 0.1 OUTLIER 174.63 -178.58 0.11 Allowed Pre-proline 0 C--N 1.332 -0.187 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -179.315 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.618 ' HB2' HG23 ' A' ' 88' ' ' VAL . 78.4 Cg_exo -55.21 177.3 0.11 Allowed 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.21 1.94 . . . . 0.0 112.082 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' A' ' 85' ' ' PRO . 52.4 Cg_endo -71.24 -54.39 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.676 2.251 . . . . 0.0 113.659 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.66 -35.04 34.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.856 0.36 . . . . 0.0 111.216 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.618 HG23 ' HB2' ' A' ' 85' ' ' PRO . 12.9 t -61.3 -14.03 9.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.046 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.583 ' O ' ' HB2' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -58.84 -76.73 0.04 OUTLIER 'General case' 0 CA--C 1.527 0.087 0 CA-C-O 121.001 0.429 . . . . 0.0 110.966 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.829 ' HA ' HD13 ' A' ' 94' ' ' ILE . 0.9 OUTLIER -65.17 -12.07 47.17 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.89 -33.77 15.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.6 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.595 ' HB3' HG12 ' A' ' 88' ' ' VAL . 2.6 tm? -121.88 -51.37 2.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.907 0.384 . . . . 0.0 112.031 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.897 HD22 ' HB2' ' A' ' 84' ' ' PHE . 6.8 m120 -52.02 -57.61 8.99 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.52 -178.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.829 HD13 ' HA ' ' A' ' 90' ' ' GLU . 4.1 mp -74.94 -7.74 10.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.322 0.582 . . . . 0.0 109.675 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.464 ' HB3' ' H ' ' A' ' 96' ' ' TRP . 0.2 OUTLIER -79.16 -100.81 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.892 179.832 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.625 ' CD1' ' CD1' ' A' ' 100' ' ' TRP . 80.9 m95 40.9 29.84 0.08 Allowed 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 122.593 0.357 . . . . 0.0 111.64 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.67 -55.75 4.72 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.466 -0.874 . . . . 0.0 112.518 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 40.0 t -175.38 145.0 0.73 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.955 0.407 . . . . 0.0 111.27 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.416 ' C ' ' HA3' ' A' ' 12' ' ' GLY . 0.2 OUTLIER 58.15 84.4 0.1 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.792 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.625 ' CD1' ' CD1' ' A' ' 96' ' ' TRP . 0.4 OUTLIER -171.04 175.31 4.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.842 0.353 . . . . 0.0 111.102 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.71 ' HD3' HG13 ' A' ' 94' ' ' ILE . 4.3 ttpt 167.51 6.83 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.348 -178.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.491 ' HA3' ' CE2' ' A' ' 13' ' ' TYR . . . 169.25 -157.06 28.74 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.969 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.807 ' O ' ' HA ' ' A' ' 81' ' ' THR . 7.7 tt0 -147.2 117.0 7.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.792 0.296 . . . . 0.0 110.697 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.842 ' HA ' HG22 ' A' ' 81' ' ' THR . . . -94.2 123.95 37.91 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.247 0.546 . . . . 0.0 110.642 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.643 ' HG2' ' OD1' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -125.43 119.4 28.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.432 -177.412 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.619 ' HE2' ' CE2' ' A' ' 79' ' ' TRP . 2.0 ttmm -104.17 134.4 47.48 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.621 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 16.0 m95 -101.68 164.67 11.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.279 0.561 . . . . 0.0 112.303 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.586 ' HB2' ' HE1' ' A' ' 110' ' ' PHE . 95.9 m-85 -140.05 153.18 46.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.09 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.642 HD12 ' O ' ' A' ' 20' ' ' CYS . 16.5 tp -101.24 141.04 34.69 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.844 0.354 . . . . 0.0 110.983 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.809 ' CE2' HG22 ' A' ' 72' ' ' VAL . 45.7 m-85 -142.43 145.77 34.13 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.594 0.712 . . . . 0.0 112.759 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.657 ' HB2' HD11 ' A' ' 73' ' ' ILE . 8.6 tttt -104.88 122.82 46.58 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.065 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.669 ' HD2' HD21 ' A' ' 21' ' ' LEU . 36.5 t80 -77.23 95.81 4.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.99 0.424 . . . . 0.0 110.709 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.436 HG21 ' HG3' ' A' ' 71' ' ' GLU . 28.5 p -95.77 55.27 1.61 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.917 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -159.64 -140.99 3.02 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.678 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.541 ' HG3' ' CG ' ' A' ' 117' ' ' GLN . 0.7 OUTLIER -125.81 147.61 49.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.785 0.326 . . . . 0.0 110.948 179.627 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.513 ' HB3' ' CH2' ' A' ' 134' ' ' TRP . 85.7 m-20 -62.1 -28.18 69.45 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.541 ' CG ' ' HG3' ' A' ' 115' ' ' GLN . 0.2 OUTLIER -57.65 -5.09 0.33 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.218 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -88.0 -17.66 30.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.017 0.436 . . . . 0.0 110.602 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.689 HD13 ' CE1' ' A' ' 29' ' ' PHE . 9.1 mt -81.09 105.26 10.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.393 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.463 ' C ' ' H ' ' A' ' 122' ' ' LEU . 23.9 t30 -104.27 -26.26 12.56 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.695 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.481 HD22 ' HD2' ' A' ' 131' ' ' PHE . 63.5 mt 73.11 -34.23 0.29 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.12 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.524 HD23 ' HB3' ' A' ' 129' ' ' PRO . 60.7 mt -74.57 161.46 29.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.967 0.413 . . . . 0.0 110.797 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.06 -6.41 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 CA-C-N 115.702 -0.681 . . . . 0.0 113.091 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -140.32 70.36 1.36 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.819 0.343 . . . . 0.0 110.215 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -76.73 42.29 1.77 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.777 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.01 -28.37 12.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.926 0.393 . . . . 0.0 110.408 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.91 -47.98 0.18 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.919 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 23.3 pttt -178.93 153.61 0.76 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.075 0.464 . . . . 0.0 111.083 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.524 ' HB3' HD23 ' A' ' 122' ' ' LEU . 11.7 Cg_endo -74.6 -174.27 1.8 Allowed 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.629 2.219 . . . . 0.0 113.049 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.512 ' O ' HD12 ' A' ' 34' ' ' LEU . 4.5 mp0 -88.89 -72.77 0.53 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.854 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.54 ' CB ' ' HB1' ' A' ' 31' ' ' ALA . 2.7 m-85 -104.8 142.74 34.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.144 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.711 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -83.72 -36.25 14.27 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.709 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -151.31 154.18 36.24 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.22 -0.49 . . . . 0.0 110.6 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.553 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 23.8 p-90 -135.25 166.79 22.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.825 0.345 . . . . 0.0 111.116 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.449 ' N ' ' HZ3' ' A' ' 40' ' ' TRP . 29.9 t -161.24 163.22 31.17 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.346 0.593 . . . . 0.0 111.657 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.646 ' CE3' ' ND2' ' A' ' 23' ' ' ASN . 77.2 m95 -110.46 108.32 18.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.054 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' A' ' 28' ' ' ILE . 34.0 m -123.31 173.72 8.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.861 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.561 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 15.2 p -72.97 172.47 7.84 Favored Pre-proline 0 C--N 1.323 -0.571 0 C-N-CA 120.449 -0.501 . . . . 0.0 109.885 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.709 ' HB3' HD22 ' A' ' 158' ' ' LEU . 13.4 Cg_exo -61.75 -55.25 1.18 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.427 1.418 . . . . 0.0 110.314 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.1 -30.81 71.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.066 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -69.86 -48.55 58.41 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.87 0.367 . . . . 0.0 110.153 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.971 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -54.43 -41.17 69.07 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.429 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.596 HG21 ' HD3' ' A' ' 155' ' ' LYS . 28.3 mm -60.13 -36.87 70.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.936 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.56 -52.28 22.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.41 0.624 . . . . 0.0 111.037 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.4 mp -70.85 -24.88 62.6 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.849 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 5.2 t -71.8 169.5 15.6 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.539 0.685 . . . . 0.0 111.825 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.909 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 33.8 m -74.3 154.69 6.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.846 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.504 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 0.4 OUTLIER -60.91 -54.59 43.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.071 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.446 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 39.9 p90 -57.07 0.63 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.422 ' HE3' HH22 ' A' ' 33' ' ' ARG . 13.6 mmtt -133.77 -7.7 2.79 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 122.032 -0.417 . . . . 0.0 111.873 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.496 ' HG3' HG23 ' A' ' 143' ' ' ILE . 0.4 OUTLIER -62.03 -59.24 13.69 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.276 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.504 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 19.2 Cg_endo -59.5 -28.54 87.73 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.347 2.031 . . . . 0.0 111.337 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.791 ' O ' HG23 ' A' ' 157' ' ' VAL . 24.4 t -68.81 -50.69 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.422 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 7.6 m-30 -66.0 -38.01 87.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.875 178.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.596 ' HD3' HG21 ' A' ' 143' ' ' ILE . 4.8 tptp -56.3 -43.36 78.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.393 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.492 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.3 tp10 -68.17 -34.4 76.24 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 153' ' ' VAL . 58.5 t -66.01 -41.0 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.615 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.709 HD22 ' HB3' ' A' ' 139' ' ' PRO . 38.3 mt -63.8 -45.33 90.15 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.621 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 28.4 t -53.96 -40.0 66.45 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.786 HG11 ' HA ' ' A' ' 76' ' ' VAL . 62.0 t -67.73 -41.44 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-O 121.491 0.662 . . . . 0.0 109.309 178.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.605 ' CE2' HG12 ' A' ' 157' ' ' VAL . 21.9 m-30 -80.74 4.72 18.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.354 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.62 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.44 -52.45 74.52 Favored Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.604 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.4 Cg_endo -58.48 -13.05 15.55 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.177 1.918 . . . . 0.0 111.603 178.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.505 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 94.5 m-70 -107.85 -19.33 13.56 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.125 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 98.0 mt . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.624 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 112.612 -0.195 . . . . 0.0 112.612 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.37 133.92 55.04 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.656 2.237 . . . . 0.0 111.845 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.735 HD21 ' HB3' ' A' ' 80' ' ' LEU . 0.4 OUTLIER 63.52 120.91 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.952 0.406 . . . . 0.0 110.48 -179.666 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.496 ' HA3' ' HE1' ' A' ' 6' ' ' MET . . . -80.7 -54.67 3.6 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.182 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.718 ' HB3' ' HA ' ' A' ' 80' ' ' LEU . 50.9 p 51.85 98.34 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.496 ' HE1' ' HA3' ' A' ' 4' ' ' GLY . 1.9 mmt -94.22 157.57 16.0 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -65.31 -52.95 50.64 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 89.2 p -98.71 148.97 35.28 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.928 178.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.473 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 56.8 Cg_endo -71.76 118.47 5.66 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.17 1.913 . . . . 0.0 112.505 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.583 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 1.1 Cg_endo -79.81 171.55 15.35 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 123.133 2.555 . . . . 0.0 113.185 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -52.28 129.2 27.5 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.518 ' CA ' ' HA ' ' A' ' 100' ' ' TRP . . . 53.24 25.83 27.0 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.56 178.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.583 ' CD1' ' HB2' ' A' ' 10' ' ' PRO . 10.5 m-85 -98.55 48.06 0.98 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.76 0.314 . . . . 0.0 110.761 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.683 ' HD2' ' HG2' ' A' ' 103' ' ' GLN . 0.0 OUTLIER 34.89 -154.53 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.4 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.496 ' HG3' HD12 ' A' ' 47' ' ' ILE . 0.3 OUTLIER 177.13 91.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.233 -179.262 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.986 ' HB2' ' HG2' ' A' ' 105' ' ' GLN . 0.7 OUTLIER -134.05 -178.83 5.21 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.553 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.657 HG21 ' N ' ' A' ' 57' ' ' ALA . 23.8 m -140.59 166.63 18.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.348 0.594 . . . . 0.0 111.768 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.572 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -131.33 161.38 23.6 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 178.597 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.023 HG21 HD22 ' A' ' 61' ' ' LEU . 3.6 mp -128.64 119.19 49.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.008 0.432 . . . . 0.0 112.04 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.455 ' O ' HD12 ' A' ' 109' ' ' LEU . 10.2 t -104.25 105.0 15.0 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.845 HD22 HG11 ' A' ' 67' ' ' VAL . 13.1 tp -108.28 122.28 46.64 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.789 -178.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.769 ' HE1' HD13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -119.37 163.31 17.38 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.818 179.455 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.673 ' ND2' ' CE3' ' A' ' 136' ' ' TRP . 0.3 OUTLIER -99.85 168.67 9.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.435 179.818 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.645 ' HA ' ' HE2' ' A' ' 111' ' ' LYS . 71.2 m-20 -56.33 -4.88 0.16 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.021 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.511 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 1.2 m-20 -100.06 2.61 43.45 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.795 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.586 ' NZ ' ' HA ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER 73.91 21.64 2.61 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.173 -178.376 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.651 ' HB2' ' OD1' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -93.86 145.62 24.48 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.045 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.778 HG13 ' HA ' ' A' ' 139' ' ' PRO . 1.5 mm -100.51 139.11 22.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.465 0.65 . . . . 0.0 111.994 -178.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.662 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 82.2 t80 -79.21 140.27 37.73 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.109 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 1.014 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -143.71 157.97 44.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.046 0.451 . . . . 0.0 111.033 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.566 ' HB1' ' CB ' ' A' ' 131' ' ' PHE . . . -146.51 138.93 25.08 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.996 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.635 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 60.7 p -99.8 147.99 24.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.297 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.653 ' O ' ' N ' ' A' ' 35' ' ' ASP . 18.2 mtp180 -69.75 129.01 38.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.403 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.824 HD13 ' HG2' ' A' ' 129' ' ' PRO . 0.3 OUTLIER -54.96 55.31 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.653 ' N ' ' O ' ' A' ' 33' ' ' ARG . 23.0 t70 -177.4 -28.42 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.87 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.479 HG13 ' CZ ' ' A' ' 33' ' ' ARG . 25.5 mm -119.21 110.65 37.56 Favored Pre-proline 0 N--CA 1.455 -0.181 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.606 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -75.67 -20.28 15.72 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.633 2.222 . . . . 0.0 112.905 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.36 -8.49 32.37 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.635 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.8 104.09 16.38 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 120.616 0.246 . . . . 0.0 110.881 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.714 ' O ' ' HA ' ' A' ' 146' ' ' THR . 65.9 m95 -105.89 144.6 32.39 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.909 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.591 ' HG3' ' C ' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -156.92 161.62 39.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.487 0.66 . . . . 0.0 111.622 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.555 ' HB3' ' CZ3' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -96.82 152.87 38.71 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.36 179.062 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.632 ' HG3' HD13 ' A' ' 61' ' ' LEU . 5.1 Cg_endo -48.61 158.74 1.02 Allowed 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.197 2.598 . . . . 0.0 111.976 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.604 ' HA ' HD12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -178.82 -179.67 0.63 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.453 0.168 . . . . 0.0 111.084 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.639 ' HA3' ' HG2' ' A' ' 60' ' ' GLU . . . 164.4 155.79 8.56 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.696 -0.764 . . . . 0.0 113.11 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.724 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -76.66 132.09 12.09 Favored Glycine 0 C--N 1.334 0.431 0 N-CA-C 114.702 0.641 . . . . 0.0 114.702 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.676 HG12 ' HA ' ' A' ' 53' ' ' PRO . 2.9 mt -68.93 145.83 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.406 -0.397 . . . . 0.0 110.464 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -67.51 -173.12 0.28 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.171 0.51 . . . . 0.0 111.144 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.465 ' HG2' ' H ' ' A' ' 50' ' ' GLY . 1.4 pm0 -50.16 -82.45 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.282 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.465 ' H ' ' HG2' ' A' ' 49' ' ' GLU . . . -109.76 54.6 0.54 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.083 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -115.16 154.61 28.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.096 0.474 . . . . 0.0 110.363 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.473 ' HB2' ' ND2' ' A' ' 55' ' ' ASN . 0.6 OUTLIER -70.44 156.39 91.97 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.805 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.676 ' HA ' HG12 ' A' ' 47' ' ' ILE . 2.7 Cg_exo -74.88 -53.22 0.1 Allowed 'Trans proline' 0 CA--C 1.507 -0.843 0 C-N-CA 122.702 2.268 . . . . 0.0 112.217 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.608 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -48.18 -52.98 18.48 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.925 179.309 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.535 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 1.2 m-20 -53.75 -46.49 70.91 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.002 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 60' ' ' GLU . . . -60.01 -42.34 94.07 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.657 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -59.07 -61.91 2.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.494 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.608 ' CD1' ' O ' ' A' ' 54' ' ' ARG . 3.3 mp -55.88 -46.51 80.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.497 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.535 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 0.7 OUTLIER -63.14 -63.1 1.29 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.44 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.639 ' HG2' ' HA3' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -42.8 -46.35 5.17 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 120.944 0.402 . . . . 0.0 110.045 179.38 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.023 HD22 HG21 ' A' ' 19' ' ' ILE . 12.0 tp -50.05 -47.75 53.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.153 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.867 ' HG3' HG23 ' A' ' 68' ' ' THR . 40.0 ttp180 -64.77 -62.25 1.68 Allowed 'General case' 0 CA--C 1.523 -0.091 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.415 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -51.61 -20.41 1.98 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.806 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -100.62 -36.85 9.01 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.668 ' O ' ' HA ' ' A' ' 119' ' ' ILE . 2.3 p -127.23 1.97 6.41 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 70.15 -11.82 1.94 Allowed Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.375 -178.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.845 HG11 HD22 ' A' ' 21' ' ' LEU . 75.2 t -58.14 109.72 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-O 121.198 0.523 . . . . 0.0 111.422 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.867 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.6 OUTLIER -121.75 -41.3 2.47 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.898 178.495 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.437 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 7.4 m -60.75 74.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.692 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.561 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.43 153.36 19.5 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.992 0.425 . . . . 0.0 112.097 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -124.4 148.23 47.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.237 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.773 HG22 ' CE1' ' A' ' 110' ' ' PHE . 20.3 t -76.04 126.59 36.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.956 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.769 HD13 ' HE1' ' A' ' 22' ' ' MET . 0.6 OUTLIER -109.25 -19.08 7.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.276 179.074 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.433 ' HB3' ' HB3' ' A' ' 109' ' ' LEU . . . -169.78 176.73 4.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.214 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.9 OUTLIER -162.74 149.24 12.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.885 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.746 ' HA ' HG11 ' A' ' 160' ' ' VAL . 41.5 t -71.64 140.59 84.33 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.293 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.618 ' HD2' HG13 ' A' ' 76' ' ' VAL . 32.6 Cg_endo -64.91 -72.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.931 2.421 . . . . 0.0 113.424 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.423 ' HE1' HD21 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -85.18 176.34 8.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.197 0.522 . . . . 0.0 111.74 -178.84 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.486 ' O ' ' HA ' ' A' ' 5' ' ' SER . 29.8 m95 -93.27 109.28 20.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.652 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.735 ' HB3' HD21 ' A' ' 3' ' ' LEU . 39.4 mt -64.44 110.83 2.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.808 0.337 . . . . 0.0 111.329 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.948 HG22 ' HA ' ' A' ' 104' ' ' ALA . 8.0 p -115.02 -169.84 1.63 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.318 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.465 ' CE1' ' HB2' ' A' ' 103' ' ' GLN . 4.9 p90 -172.81 78.67 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.655 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -70.67 157.18 38.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.696 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.552 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 1.6 m-85 -100.56 163.63 17.79 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-O 120.934 0.397 . . . . 0.0 111.206 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.612 ' HB2' ' HD2' ' A' ' 86' ' ' PRO . 98.4 Cg_endo -84.12 -178.86 3.67 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.475 2.783 . . . . 0.0 112.776 -179.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.612 ' HD2' ' HB2' ' A' ' 85' ' ' PRO . 10.9 Cg_endo -52.11 151.86 15.81 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 122.451 2.101 . . . . 0.0 112.255 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.607 ' O ' ' HB2' ' A' ' 91' ' ' LYS . 0.0 OUTLIER 72.88 -41.97 0.52 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.963 -179.579 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.411 HG11 ' HD2' ' A' ' 84' ' ' PHE . 18.0 t -79.14 -31.42 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-O 120.786 0.327 . . . . 0.0 110.865 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.614 ' O ' ' HB2' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -60.9 -67.2 0.42 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.896 179.601 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.781 ' HA ' HD13 ' A' ' 94' ' ' ILE . 1.0 OUTLIER -61.63 -13.08 19.18 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 179.776 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.607 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -91.18 -35.34 14.59 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.811 0.338 . . . . 0.0 111.64 -179.61 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.491 HD22 ' O ' ' A' ' 92' ' ' LEU . 1.4 tm? -119.38 -52.71 2.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.118 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.96 ' HB3' ' HA ' ' A' ' 101' ' ' LYS . 5.0 m120 -51.56 -34.4 36.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.961 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.781 HD13 ' HA ' ' A' ' 90' ' ' GLU . 1.5 mp -94.81 -12.83 8.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.03 0.443 . . . . 0.0 110.133 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -69.76 -2.69 12.69 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.093 179.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.608 ' HB2' ' CD1' ' A' ' 100' ' ' TRP . 44.4 m95 -84.2 16.06 3.19 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.632 0.253 . . . . 0.0 111.195 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.74 ' O ' ' HB2' ' A' ' 98' ' ' SER . . . 67.88 113.28 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.302 -0.952 . . . . 0.0 111.322 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.74 ' HB2' ' O ' ' A' ' 97' ' ' GLY . 2.9 m 87.08 -167.97 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 122.824 0.45 . . . . 0.0 110.331 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -44.44 -91.98 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.481 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.669 ' CZ3' ' HA ' ' A' ' 14' ' ' ARG . 6.5 m95 54.65 170.58 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 120.757 0.313 . . . . 0.0 110.995 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.96 ' HA ' ' HB3' ' A' ' 93' ' ' ASN . 0.7 OUTLIER 169.75 28.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.765 179.145 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.434 ' HA2' ' ND2' ' A' ' 93' ' ' ASN . . . 154.91 -161.63 30.42 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.907 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.686 ' O ' ' HA ' ' A' ' 81' ' ' THR . 1.0 OUTLIER -147.59 120.15 8.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 117.133 0.467 . . . . 0.0 111.805 -179.876 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.948 ' HA ' HG22 ' A' ' 81' ' ' THR . . . -107.78 111.16 23.19 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.004 0.43 . . . . 0.0 110.723 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.986 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 70.0 mt-30 -122.48 130.61 53.24 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.476 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 1.1 ttpp -105.5 131.02 53.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.915 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.572 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 20.5 m95 -102.23 163.07 12.44 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.543 ' CE2' ' HG3' ' A' ' 54' ' ' ARG . 92.6 m-85 -140.69 148.5 40.89 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.235 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.632 HD22 ' HB3' ' A' ' 161' ' ' PHE . 18.8 tp -102.4 128.68 48.89 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.922 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.905 ' CE2' HG23 ' A' ' 19' ' ' ILE . 7.7 m-85 -134.54 148.25 50.45 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 121.314 0.578 . . . . 0.0 112.156 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.645 ' HE2' ' HA ' ' A' ' 24' ' ' ASN . 2.1 tttt -98.75 126.12 44.28 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.933 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.753 ' HD2' HD21 ' A' ' 21' ' ' LEU . 33.8 t80 -78.12 96.43 5.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.14 0.495 . . . . 0.0 110.512 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 82.4 p -96.65 50.01 1.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.672 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.437 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -155.37 -144.13 3.84 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.553 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.419 ' N ' ' HE1' ' A' ' 112' ' ' PHE . 8.0 pt20 -123.85 151.42 43.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.115 0.483 . . . . 0.0 111.564 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -62.36 -25.01 67.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.299 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -59.92 -4.97 0.83 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.946 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -91.16 -17.8 25.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.98 0.419 . . . . 0.0 110.613 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.668 ' HA ' ' O ' ' A' ' 65' ' ' THR . 8.8 mt -81.05 104.2 9.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.937 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 1.0 OUTLIER -102.18 -26.52 13.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.055 179.849 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.641 HD23 HG22 ' A' ' 65' ' ' THR . 61.7 mt 74.23 -36.62 0.34 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.842 0.353 . . . . 0.0 111.667 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 1.045 HD23 ' HB3' ' A' ' 129' ' ' PRO . 90.8 mt -71.62 164.94 24.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.244 0.545 . . . . 0.0 111.185 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -130.08 4.37 6.01 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.371 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 61.35 56.1 2.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.143 0.497 . . . . 0.0 110.814 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -124.91 145.3 15.66 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.037 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.6 -4.05 14.03 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.983 -0.128 . . . . 0.0 111.119 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.593 ' O ' ' HG3' ' A' ' 128' ' ' LYS . 0.2 OUTLIER -88.06 -79.09 0.3 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.251 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.593 ' HG3' ' O ' ' A' ' 127' ' ' GLU . 29.1 mttm -177.0 163.09 1.54 Allowed Pre-proline 0 N--CA 1.451 -0.383 0 CA-C-O 121.545 0.688 . . . . 0.0 111.117 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 1.045 ' HB3' HD23 ' A' ' 122' ' ' LEU . 33.6 Cg_endo -74.97 -176.72 3.01 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 123.514 2.809 . . . . 0.0 113.282 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.14 -62.26 1.3 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.439 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.566 ' CB ' ' HB1' ' A' ' 31' ' ' ALA . 4.2 m-85 -114.7 140.72 48.63 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.312 0.577 . . . . 0.0 111.473 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.805 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -80.81 -35.85 23.88 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.754 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -153.75 153.78 32.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.963 0.411 . . . . 0.0 110.66 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.571 ' HD1' HD11 ' A' ' 121' ' ' LEU . 32.6 p-90 -135.18 166.04 24.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.093 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.432 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 13.2 t -161.45 166.95 26.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.097 0.475 . . . . 0.0 111.847 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.673 ' CE3' ' ND2' ' A' ' 23' ' ' ASN . 53.7 m95 -109.31 103.57 12.54 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.344 178.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.484 ' O ' ' N ' ' A' ' 28' ' ' ILE . 28.5 m -117.56 168.96 8.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.5 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.597 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 11.3 p -71.43 170.63 11.15 Favored Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.965 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.778 ' HA ' HG13 ' A' ' 28' ' ' ILE . 24.4 Cg_exo -57.7 -58.89 0.67 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 121.957 1.772 . . . . 0.0 109.841 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.8 -29.86 69.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.624 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -70.73 -48.4 54.71 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 120.934 0.397 . . . . 0.0 110.656 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 1.014 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -54.6 -41.97 70.55 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.745 ' CG2' ' HG3' ' A' ' 151' ' ' LYS . 24.3 mm -61.73 -33.92 59.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.255 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.78 -51.54 16.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.377 0.608 . . . . 0.0 110.321 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.42 -21.23 62.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.696 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.714 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 14.7 t -73.45 175.36 7.06 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.717 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.713 ' CG2' ' HD2' ' A' ' 150' ' ' LYS . 34.0 m -86.05 148.26 4.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.655 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.541 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 2.1 mt-10 -48.31 -50.32 30.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.467 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.3 -4.24 0.08 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.713 ' HD2' ' CG2' ' A' ' 147' ' ' VAL . 18.7 mttt -136.51 -7.14 1.96 Allowed 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.745 ' HG3' ' CG2' ' A' ' 143' ' ' ILE . 2.7 ttpp -62.99 -54.34 47.41 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.35 0.119 . . . . 0.0 110.816 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.541 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 38.0 Cg_endo -66.38 -29.44 45.71 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.435 2.09 . . . . 0.0 110.989 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.801 ' O ' HG23 ' A' ' 157' ' ' VAL . 9.3 t -68.1 -55.91 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.55 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 4.6 m-30 -63.09 -37.4 87.05 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.581 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.741 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -55.78 -45.34 78.17 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.441 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.548 ' O ' HG23 ' A' ' 160' ' ' VAL . 12.8 tm-20 -67.49 -34.58 77.43 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 153' ' ' VAL . 47.9 t -63.35 -42.1 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.546 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.593 HD22 ' HB3' ' A' ' 139' ' ' PRO . 36.0 mt -63.91 -43.92 94.5 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.883 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.9 m -56.85 -39.31 74.05 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.746 HG11 ' HA ' ' A' ' 76' ' ' VAL . 76.1 t -67.54 -42.4 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.664 ' CE2' HG12 ' A' ' 157' ' ' VAL . 18.8 m-30 -81.24 7.13 12.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.089 -0.959 . . . . 0.0 112.006 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.553 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.97 -54.9 51.9 Favored Pre-proline 0 C--N 1.332 -0.169 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.178 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 15.9 Cg_endo -57.58 -12.94 12.4 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 121.825 1.683 . . . . 0.0 111.768 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.429 ' CE1' ' HB2' ' A' ' 74' ' ' ALA . 42.3 m80 -107.46 -17.25 14.17 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.237 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 98.2 mt . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.586 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 CA-C-O 120.309 -0.162 . . . . 0.0 112.713 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.454 ' C ' ' HG ' ' A' ' 3' ' ' LEU . 53.1 Cg_exo -53.09 -178.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.512 2.141 . . . . 0.0 112.046 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.711 ' O ' HD12 ' A' ' 3' ' ' LEU . 1.3 pp 32.15 94.18 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.349 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.08 138.9 21.3 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.127 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.507 ' HB3' ' CD1' ' A' ' 78' ' ' TYR . 1.3 m -82.28 -74.5 0.34 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.066 0.46 . . . . 0.0 111.386 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 5.1 mpp? 63.46 129.25 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.72 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.651 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 1.5 p30 -66.79 -33.23 75.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.983 0.42 . . . . 0.0 110.353 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.443 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 0.4 OUTLIER -103.83 146.36 32.37 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.231 179.211 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.524 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 61.0 Cg_endo -71.78 105.2 1.75 Allowed 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.364 2.043 . . . . 0.0 111.854 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.612 ' HB2' ' CE2' ' A' ' 13' ' ' TYR . 10.3 Cg_endo -51.57 164.49 0.9 Allowed 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 123.46 2.773 . . . . 0.0 113.135 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -53.78 134.15 42.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.783 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.63 88.4 0.01 OUTLIER Glycine 0 C--N 1.331 0.27 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.0 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.612 ' CE2' ' HB2' ' A' ' 10' ' ' PRO . 12.3 m-85 -151.9 130.48 12.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.854 0.359 . . . . 0.0 110.97 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.675 ' HA ' ' CZ3' ' A' ' 100' ' ' TRP . 6.5 ttt180 -66.48 81.34 0.1 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.272 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.808 ' HG2' HD12 ' A' ' 47' ' ' ILE . 4.7 ttp180 -49.07 109.89 0.3 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.967 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.737 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 2.1 m-80 -131.66 176.39 8.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.395 -0.82 . . . . 0.0 108.96 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.663 HG13 ' CG1' ' A' ' 47' ' ' ILE . 6.2 m -144.1 166.15 13.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.794 0.33 . . . . 0.0 111.389 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.487 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -136.4 160.24 24.68 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.144 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.679 HG13 ' HB1' ' A' ' 57' ' ' ALA . 3.6 mp -129.23 119.36 48.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.043 0.449 . . . . 0.0 111.536 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.69 ' O ' HD12 ' A' ' 109' ' ' LEU . 3.0 t -98.29 92.73 5.85 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.182 -0.674 . . . . 0.0 109.182 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.688 HD22 HG11 ' A' ' 67' ' ' VAL . 39.2 tp -91.01 123.32 34.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.741 -178.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.765 ' CG ' HD11 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -117.46 152.57 34.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.126 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.75 ' ND2' ' CE3' ' A' ' 136' ' ' TRP . 0.2 OUTLIER -97.66 174.9 6.4 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.507 -179.321 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -56.76 -6.11 0.29 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.769 177.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.526 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -101.25 -1.7 33.03 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.631 0.253 . . . . 0.0 111.43 -179.151 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 6.1 mmpt? 75.6 21.72 1.69 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.106 -178.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.674 ' O ' ' HA ' ' A' ' 22' ' ' MET . 6.0 mttt -91.59 175.65 6.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.693 HD11 ' HG3' ' A' ' 139' ' ' PRO . 1.8 mm -118.77 138.12 50.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.131 0.491 . . . . 0.0 111.756 -178.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.536 ' CZ ' HG21 ' A' ' 65' ' ' THR . 9.9 t80 -63.72 101.62 0.37 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.181 178.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.669 ' HA ' ' O ' ' A' ' 41' ' ' GLN . . . -97.86 137.37 36.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.935 0.398 . . . . 0.0 111.315 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.449 ' HB1' ' CG ' ' A' ' 131' ' ' PHE . . . -137.64 139.86 40.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.331 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.604 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 60.1 p -104.47 150.59 24.43 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.619 ' O ' ' N ' ' A' ' 35' ' ' ASP . 4.9 mtp180 -74.55 129.93 38.64 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.309 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.715 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -56.89 52.71 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.883 0.473 . . . . 0.0 112.211 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.619 ' N ' ' O ' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -174.97 -37.03 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.054 0.454 . . . . 0.0 110.18 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.576 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 3.8 mm -112.09 106.23 56.24 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.739 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.53 -60.14 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.07 2.513 . . . . 0.0 113.895 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -67.9 2.87 1.76 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.604 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.85 93.24 8.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.749 0.309 . . . . 0.0 111.454 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.55 ' O ' ' HA ' ' A' ' 146' ' ' THR . 76.4 m95 -98.68 155.04 17.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.089 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.669 ' O ' ' HA ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -162.72 -139.35 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.976 -0.289 . . . . 0.0 111.002 -178.564 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.583 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 4.9 ptt? -176.91 163.36 1.56 Allowed Pre-proline 0 N--CA 1.446 -0.671 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.871 ' HG3' HD13 ' A' ' 61' ' ' LEU . 2.9 Cg_endo -38.22 130.24 1.0 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.276 2.651 . . . . 0.0 113.342 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.599 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 1.7 tm0? -174.23 141.65 0.75 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.118 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -161.49 -156.45 8.33 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.472 -0.871 . . . . 0.0 112.387 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.71 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -118.24 138.94 14.24 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.03 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.808 HD12 ' HG2' ' A' ' 15' ' ' ARG . 46.2 mt -69.49 145.03 13.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.864 0.364 . . . . 0.0 111.63 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -69.15 -174.34 0.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.817 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -48.58 -75.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.127 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -116.33 56.24 0.53 Allowed Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.276 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -115.16 147.68 39.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.808 0.337 . . . . 0.0 110.773 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -71.12 160.16 83.33 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.606 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.537 ' HA ' HG11 ' A' ' 17' ' ' VAL . 15.8 Cg_exo -69.38 -49.07 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.672 2.248 . . . . 0.0 111.653 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.843 ' NH2' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -52.21 -45.78 65.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.689 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.8 m120 -64.53 -45.3 87.79 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.857 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.535 ' HA ' ' HD3' ' A' ' 59' ' ' ARG . . . -62.51 -45.62 92.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.688 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.679 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -57.29 -55.15 38.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.317 0.579 . . . . 0.0 109.832 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.531 HD11 ' HG3' ' A' ' 54' ' ' ARG . 27.1 mt -56.43 -51.06 69.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.4 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.535 ' HD3' ' HA ' ' A' ' 56' ' ' ALA . 2.8 ptm180 -65.17 -54.18 33.56 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.557 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.4 OUTLIER -46.25 -44.62 16.51 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.295 0.569 . . . . 0.0 109.884 179.374 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.871 HD13 ' HG3' ' A' ' 43' ' ' PRO . 8.4 tp -51.48 -51.62 53.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.489 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.841 ' HG3' HG23 ' A' ' 68' ' ' THR . 15.1 ttm180 -64.87 -61.6 2.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.473 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -51.33 -23.47 3.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.111 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -97.13 -38.18 9.83 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.689 HG22 ' CD2' ' A' ' 121' ' ' LEU . 1.1 p -131.26 -3.33 3.89 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 78.75 -9.44 36.98 Favored Glycine 0 CA--C 1.517 0.205 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.135 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.776 ' HB ' HD11 ' A' ' 61' ' ' LEU . 69.6 t -58.49 111.76 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.209 0.528 . . . . 0.0 111.444 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.841 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.8 OUTLIER -121.63 -39.38 2.65 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.429 178.493 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.419 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 14.2 m -62.7 70.37 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.93 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.37 152.89 19.01 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.216 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 0.3 OUTLIER -129.06 157.81 40.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.297 179.443 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.843 HG11 ' NH2' ' A' ' 54' ' ' ARG . 16.5 t -78.62 131.08 35.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.261 0.553 . . . . 0.0 112.033 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.84 ' N ' HD13 ' A' ' 73' ' ' ILE . 0.8 OUTLIER -104.7 -22.5 4.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.176 178.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.435 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -171.83 178.26 3.08 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.703 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.27 145.02 30.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.011 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.827 ' HA ' HG11 ' A' ' 160' ' ' VAL . 53.5 t -70.98 136.94 84.9 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.858 0.361 . . . . 0.0 110.533 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.43 ' HD2' HG13 ' A' ' 76' ' ' VAL . 12.2 Cg_endo -53.11 -68.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.943 2.429 . . . . 0.0 111.831 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.651 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -96.65 -173.36 2.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.692 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.52 ' CD1' ' HD3' ' A' ' 106' ' ' LYS . 31.9 m95 -89.3 -157.18 0.44 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.637 ' HB2' ' O ' ' A' ' 105' ' ' GLN . 72.1 mt -162.7 101.49 1.03 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.7 HG22 ' HA ' ' A' ' 104' ' ' ALA . 5.4 p -104.24 -165.0 1.1 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.234 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 3' ' ' LEU . 0.2 OUTLIER -168.33 70.66 0.09 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.564 179.583 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.512 ' HB3' ' OH ' ' A' ' 13' ' ' TYR . 1.0 OUTLIER -66.28 175.58 2.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.813 -179.236 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.843 ' CE1' HD12 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -122.93 159.27 54.54 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.214 -179.073 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.42 ' HD2' HG21 ' A' ' 88' ' ' VAL . 63.3 Cg_exo -50.22 176.61 0.03 OUTLIER 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.577 2.184 . . . . 0.0 111.205 178.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 85' ' ' PRO . 54.4 Cg_endo -70.08 -44.83 1.65 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 121.977 1.784 . . . . 0.0 112.968 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.92 -29.11 63.96 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.516 ' O ' HG12 ' A' ' 88' ' ' VAL . 61.8 t -67.78 -6.98 5.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.56 ' O ' HD13 ' A' ' 94' ' ' ILE . 3.4 mmm180 -64.09 0.62 0.88 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.529 ' HA ' HD13 ' A' ' 94' ' ' ILE . 2.3 mt-10 -119.43 -16.75 8.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.903 0.382 . . . . 0.0 110.607 178.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.89 -26.69 16.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.036 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.843 HD12 ' CE1' ' A' ' 84' ' ' PHE . 1.8 tm? -117.2 -53.09 2.48 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.715 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.553 ' HB3' ' O ' ' A' ' 89' ' ' ARG . 14.6 t-20 -55.96 -51.26 68.32 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.858 0.361 . . . . 0.0 110.511 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.56 HD13 ' O ' ' A' ' 89' ' ' ARG . 1.7 mp -66.9 -14.27 17.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.436 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.491 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 8.2 tp-100 -70.2 -13.27 62.11 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.943 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -106.05 0.12 25.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.205 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 73.25 -75.64 0.96 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.119 -1.039 . . . . 0.0 110.974 -178.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.66 -165.27 0.11 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 178.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -94.74 107.83 19.84 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.93 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.675 ' CZ3' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -114.87 -20.29 10.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.51 179.813 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.532 ' HA ' ' HZ ' ' A' ' 84' ' ' PHE . 0.7 OUTLIER 16.38 54.35 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -178.851 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 100' ' ' TRP . . . 109.81 -174.3 17.65 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.488 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.647 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 12.7 tt0 -144.89 107.61 4.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.557 -0.322 . . . . 0.0 110.207 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.7 ' HA ' HG22 ' A' ' 81' ' ' THR . . . -90.42 116.95 28.75 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.204 0.526 . . . . 0.0 110.99 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.737 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -126.0 123.75 39.18 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.434 -178.809 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.52 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 9.3 ttpt -102.93 138.63 39.57 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 177.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.487 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 31.3 m95 -103.36 162.68 12.8 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -177.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.402 ' CZ ' ' HB2' ' A' ' 53' ' ' PRO . 90.4 m-85 -139.74 155.55 47.27 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.881 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.765 HD11 ' CG ' ' A' ' 22' ' ' MET . 39.4 tp -100.99 138.14 38.43 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.961 -0.295 . . . . 0.0 110.272 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.7 ' CZ ' HG22 ' A' ' 72' ' ' VAL . 23.8 m-85 -139.25 137.21 35.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.203 0.525 . . . . 0.0 112.155 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 10.2 ttmt -102.12 126.16 49.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.392 177.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.669 ' CE1' HG13 ' A' ' 67' ' ' VAL . 34.0 t80 -78.57 98.27 6.07 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.769 0.318 . . . . 0.0 110.999 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 8.0 p -97.86 50.4 1.03 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.419 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -152.64 -147.39 4.59 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.339 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -118.94 150.84 39.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.939 0.4 . . . . 0.0 110.885 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -59.77 -35.1 73.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.728 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -6.39 0.21 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.083 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.84 -14.52 34.19 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.743 0.306 . . . . 0.0 111.023 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.71 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 19.2 mt -78.98 100.37 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.029 0.442 . . . . 0.0 111.999 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 65' ' ' THR . 2.2 t30 -104.16 98.73 8.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.752 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.689 ' CD2' HG22 ' A' ' 65' ' ' THR . 35.8 mt -69.84 -10.6 59.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.953 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.531 HD22 ' HB3' ' A' ' 129' ' ' PRO . 3.3 mm? -98.3 -174.01 2.72 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.875 0.369 . . . . 0.0 111.039 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 128.0 -7.61 6.81 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.726 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -101.83 73.67 1.43 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.937 0.399 . . . . 0.0 110.818 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -65.17 153.54 50.61 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.587 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 64.35 15.33 9.4 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -149.03 -96.5 0.07 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 121.228 -0.189 . . . . 0.0 111.029 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.2 pttt -179.46 155.41 0.77 Allowed Pre-proline 0 C--O 1.232 0.157 0 CA-C-O 120.993 0.425 . . . . 0.0 111.069 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.531 ' HB3' HD22 ' A' ' 122' ' ' LEU . 9.6 Cg_endo -70.98 -174.34 1.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.639 2.226 . . . . 0.0 112.212 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.448 ' C ' HD12 ' A' ' 34' ' ' LEU . 15.7 mm-40 -97.05 -66.71 0.88 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.361 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.643 ' CE2' HG23 ' A' ' 65' ' ' THR . 4.8 m-85 -103.45 143.82 32.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.108 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.715 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -85.92 -36.16 10.52 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.388 -0.911 . . . . 0.0 111.985 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -151.37 141.42 22.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.965 0.412 . . . . 0.0 110.925 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.71 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 42.7 p-90 -128.94 166.68 18.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.073 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.433 ' N ' ' HZ3' ' A' ' 40' ' ' TRP . 27.3 t -161.02 179.11 8.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.769 -178.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.75 ' CE3' ' ND2' ' A' ' 23' ' ' ASN . 75.8 m95 -114.01 103.73 11.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.59 178.443 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.3 m -119.22 168.44 11.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.776 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.513 ' HB ' ' CD ' ' A' ' 139' ' ' PRO . 17.6 p -74.01 169.89 16.99 Favored Pre-proline 0 CA--C 1.516 -0.358 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.491 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.693 ' HG3' HD11 ' A' ' 28' ' ' ILE . 16.6 Cg_exo -61.57 -53.53 2.23 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.781 1.654 . . . . 0.0 110.512 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.59 -27.72 69.14 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.782 178.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.434 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.2 OUTLIER -73.37 -44.29 58.93 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.486 179.743 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.476 HD11 ' O ' ' A' ' 41' ' ' GLN . 5.4 tp -58.94 -38.35 78.81 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.801 HG21 ' HG2' ' A' ' 155' ' ' LYS . 12.2 mm -63.74 -37.09 78.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.53 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.53 -49.66 52.4 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.297 0.57 . . . . 0.0 110.201 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.411 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -73.92 -20.15 60.47 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.752 -179.286 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.624 HG23 ' HG2' ' A' ' 151' ' ' LYS . 12.7 t -76.2 173.11 11.77 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.514 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.5 m -80.43 147.24 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.248 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.613 ' HA ' ' HE2' ' A' ' 151' ' ' LYS . 5.3 mt-10 -52.21 -47.65 65.52 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.249 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -52.08 -10.91 0.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.47 ' HB3' ' CE1' ' A' ' 154' ' ' TYR . 21.1 mttt -135.72 -5.52 2.21 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.624 ' HG2' HG23 ' A' ' 146' ' ' THR . 7.2 mtmm -58.28 -61.32 7.77 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 121.278 -0.169 . . . . 0.0 111.154 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.541 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 35.3 Cg_endo -64.83 -26.36 59.85 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.608 2.205 . . . . 0.0 111.738 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.726 ' O ' HG23 ' A' ' 157' ' ' VAL . 26.3 t -68.25 -50.78 54.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.487 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 7.5 m-30 -66.46 -38.33 87.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.734 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.801 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -58.13 -42.1 85.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.073 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.26 -32.9 70.94 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 153' ' ' VAL . 84.0 t -67.13 -41.09 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.728 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.566 HD22 ' HB3' ' A' ' 139' ' ' PRO . 44.8 mt -64.15 -39.26 93.63 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.93 0.395 . . . . 0.0 110.22 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 16.9 m -55.81 -41.1 73.69 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.827 HG11 ' HA ' ' A' ' 76' ' ' VAL . 95.5 t -66.81 -44.84 88.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.175 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.574 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 21.7 m-30 -80.79 5.09 16.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.575 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.636 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.17 -51.86 78.7 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.745 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 18.1 Cg_endo -58.71 -12.18 13.81 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.231 1.954 . . . . 0.0 111.961 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.435 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 89.2 m-70 -110.32 -20.95 12.45 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.252 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 89.3 mt . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.938 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 CA-C-O 120.217 -0.213 . . . . 0.0 112.654 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.52 ' O ' ' HB3' ' A' ' 82' ' ' TYR . 50.3 Cg_exo -54.05 168.6 0.83 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.68 2.253 . . . . 0.0 112.744 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.594 HD11 HG22 ' A' ' 153' ' ' VAL . 4.5 mm? -120.27 95.34 4.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.394 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.87 -43.76 8.1 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.197 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.774 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 1.4 m 62.82 -96.64 0.06 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.413 ' H ' ' HB2' ' A' ' 5' ' ' SER . 12.6 mtm 64.22 135.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.526 0.203 . . . . 0.0 110.49 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 29.7 t0 -64.45 -42.65 95.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.945 0.403 . . . . 0.0 110.728 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.485 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 4.8 p -102.55 110.09 62.22 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.947 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.541 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 70.1 Cg_endo -76.21 103.7 1.79 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.441 2.094 . . . . 0.0 112.688 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.579 ' HG2' ' CD2' ' A' ' 13' ' ' TYR . 6.6 Cg_endo -50.85 161.29 1.45 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 123.547 2.831 . . . . 0.0 113.778 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.21 161.55 3.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.236 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.76 ' O ' ' HA ' ' A' ' 100' ' ' TRP . . . 81.6 -20.63 7.27 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.241 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.579 ' CD2' ' HG2' ' A' ' 10' ' ' PRO . 11.7 m-85 -87.27 130.76 34.47 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 122.431 -0.452 . . . . 0.0 110.505 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.696 ' HB3' ' HG2' ' A' ' 103' ' ' GLN . 3.7 tpt180 -69.86 95.52 0.92 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.804 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.58 ' HG3' ' CZ3' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -51.08 113.05 0.83 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.553 178.974 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.745 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 40.9 m-20 -131.05 170.64 14.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.165 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.547 HG13 ' CG1' ' A' ' 47' ' ' ILE . 13.2 m -141.06 162.61 22.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.462 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.642 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -134.31 159.17 23.72 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.613 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.092 HG21 HD22 ' A' ' 61' ' ' LEU . 3.8 mp -128.41 119.02 49.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.776 ' O ' HD12 ' A' ' 109' ' ' LEU . 41.9 t -97.85 89.42 4.59 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.85 HD22 HG11 ' A' ' 67' ' ' VAL . 27.1 tp -90.4 115.6 27.7 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.448 -178.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.655 ' SD ' HD11 ' A' ' 109' ' ' LEU . 1.7 ptt? -118.28 166.1 13.03 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.058 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.739 ' ND2' ' CE3' ' A' ' 136' ' ' TRP . 0.3 OUTLIER -101.36 167.85 9.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.298 179.492 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -55.89 -4.06 0.1 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.578 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.594 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 1.7 m-20 -100.67 2.63 41.73 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.594 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER 76.38 20.13 1.57 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.941 -178.374 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 22' ' ' MET . 2.1 mmtt -92.69 147.88 22.51 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.867 HD11 ' HG3' ' A' ' 139' ' ' PRO . 0.8 OUTLIER -101.0 138.82 23.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.164 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.567 ' HZ ' HG21 ' A' ' 65' ' ' THR . 12.1 t80 -78.46 134.37 37.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.831 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.637 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -140.2 151.81 45.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.05 0.452 . . . . 0.0 111.224 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.712 ' HB1' ' CB ' ' A' ' 131' ' ' PHE . . . -143.28 133.43 24.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.637 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 3.4 m -97.25 156.5 16.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.165 0.507 . . . . 0.0 112.002 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.577 ' O ' ' N ' ' A' ' 35' ' ' ASP . 32.8 mtp85 -74.47 129.92 38.65 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.742 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.746 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 1.2 mp -57.3 54.9 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.221 0.608 . . . . 0.0 112.289 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.577 ' N ' ' O ' ' A' ' 33' ' ' ARG . 9.9 p-10 -175.89 -33.72 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.062 0.458 . . . . 0.0 109.919 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 4.5 mt -117.51 103.05 51.53 Favored Pre-proline 0 N--CA 1.448 -0.549 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.475 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -61.27 -47.34 12.34 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.014 2.476 . . . . 0.0 113.344 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.83 -2.08 22.14 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.506 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -95.55 95.63 8.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.852 0.358 . . . . 0.0 111.428 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.623 ' O ' ' HA ' ' A' ' 146' ' ' THR . 66.6 m95 -100.59 150.94 22.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.893 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.85 165.03 37.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.319 0.581 . . . . 0.0 111.52 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.438 ' HB2' ' HE2' ' A' ' 42' ' ' MET . 27.0 mtm -100.56 150.51 37.04 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.111 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.528 ' CB ' HD13 ' A' ' 61' ' ' LEU . 4.8 Cg_endo -50.07 150.79 9.75 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.236 1.957 . . . . 0.0 111.89 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.576 ' HA ' HD12 ' A' ' 19' ' ' ILE . 18.2 pt20 -175.58 177.56 1.74 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.606 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.401 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . 175.09 158.84 20.09 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.136 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.745 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -87.54 134.88 12.76 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.164 -1.017 . . . . 0.0 113.39 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.547 ' CG1' HG13 ' A' ' 17' ' ' VAL . 50.1 mt -68.25 148.23 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.058 0.456 . . . . 0.0 111.908 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -69.98 -172.74 0.57 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.203 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.46 -77.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.141 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -112.51 56.22 0.48 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.58 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.484 ' O ' HG21 ' A' ' 47' ' ' ILE . 3.3 tp10 -114.25 149.31 36.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.75 0.31 . . . . 0.0 110.711 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -71.14 155.1 93.58 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.321 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.519 ' HA ' HG11 ' A' ' 17' ' ' VAL . 4.7 Cg_exo -74.92 -50.84 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.758 2.305 . . . . 0.0 112.277 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.675 ' CZ ' HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -51.31 -46.56 62.59 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.731 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.773 ' HA ' HD12 ' A' ' 58' ' ' ILE . 52.5 m-80 -68.09 -40.33 82.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.104 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.59 -43.14 99.4 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.671 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -57.02 -51.35 69.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.072 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.773 HD12 ' HA ' ' A' ' 55' ' ' ASN . 12.3 mt -56.38 -54.82 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.983 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.53 -63.62 1.21 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.289 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.401 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 0.4 OUTLIER -42.32 -46.56 4.62 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.039 0.447 . . . . 0.0 110.223 179.686 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.092 HD22 HG21 ' A' ' 19' ' ' ILE . 8.2 tp -52.34 -46.76 66.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.487 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.914 ' HG3' HG23 ' A' ' 68' ' ' THR . 23.0 ttm180 -64.22 -63.06 1.25 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.171 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -49.78 -20.09 0.78 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -95.95 -40.52 9.24 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.817 HG22 HD23 ' A' ' 121' ' ' LEU . 0.7 OUTLIER -126.34 -5.31 6.6 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.074 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 81.59 -11.71 44.44 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.214 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.85 HG11 HD22 ' A' ' 21' ' ' LEU . 71.7 t -57.81 114.73 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.155 0.503 . . . . 0.0 111.5 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.914 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.6 OUTLIER -123.38 -39.06 2.49 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.33 178.126 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.418 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 5.9 m -62.67 73.32 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.214 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -162.64 155.3 19.29 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.942 0.401 . . . . 0.0 111.75 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.96 153.99 48.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.452 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.68 HG22 ' CZ ' ' A' ' 110' ' ' PHE . 43.4 t -76.55 131.78 34.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.336 0.588 . . . . 0.0 112.378 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.695 ' N ' HD13 ' A' ' 73' ' ' ILE . 1.2 mm -103.91 -21.43 5.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.176 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.468 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -169.94 178.62 3.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.182 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -146.3 140.59 26.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.037 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.726 ' HA ' HG11 ' A' ' 160' ' ' VAL . 48.3 t -70.37 138.33 86.57 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.978 0.418 . . . . 0.0 110.535 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.532 ' HD2' HG13 ' A' ' 76' ' ' VAL . 19.1 Cg_endo -58.92 -68.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.993 2.462 . . . . 0.0 112.477 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -96.67 -173.38 2.72 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.829 -179.405 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.58 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 44.0 m95 -93.72 -159.03 0.66 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.536 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.774 ' HA ' ' HA ' ' A' ' 5' ' ' SER . 41.0 mt -160.12 102.73 1.45 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.366 0.603 . . . . 0.0 111.131 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.904 HG22 ' HB2' ' A' ' 104' ' ' ALA . 24.4 p -107.17 -178.36 3.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.368 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.528 ' CE1' ' HB2' ' A' ' 103' ' ' GLN . 1.6 p90 -170.11 71.71 0.06 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.192 178.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -67.18 139.97 57.46 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.674 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 2.4 m-85 -103.58 162.03 21.24 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.433 ' HB3' ' HD2' ' A' ' 86' ' ' PRO . 26.7 Cg_exo -62.97 175.77 2.24 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.138 2.559 . . . . 0.0 112.119 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 85' ' ' PRO . 18.5 Cg_endo -59.71 -22.81 69.19 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.502 2.135 . . . . 0.0 112.907 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -76.02 -47.78 23.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.915 0.388 . . . . 0.0 110.535 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.674 ' HB ' ' HB3' ' A' ' 84' ' ' PHE . 47.5 t -84.08 -17.83 10.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.038 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.662 ' HG3' ' HB3' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -66.0 -1.07 2.73 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.146 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.631 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 0.3 OUTLIER -96.75 -44.81 6.92 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 121.891 -0.506 . . . . 0.0 110.674 179.111 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.9 mmtm -83.61 -0.63 51.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.673 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.562 ' HG ' ' CE1' ' A' ' 84' ' ' PHE . 1.2 tm? -121.38 -65.85 1.1 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.669 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.662 ' HB3' ' HG3' ' A' ' 89' ' ' ARG . 42.7 t30 -61.45 -54.3 45.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.013 0.435 . . . . 0.0 111.18 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.631 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 1.7 mp -57.7 -14.17 2.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.235 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.502 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 49.0 mm-40 -74.25 -15.73 60.98 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.855 0.36 . . . . 0.0 110.669 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.556 ' HB2' ' CG ' ' A' ' 100' ' ' TRP . 6.2 m95 -103.43 -92.97 0.34 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.403 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.458 ' C ' ' HD1' ' A' ' 100' ' ' TRP . . . 171.13 -127.81 1.51 Allowed Glycine 0 C--N 1.339 0.703 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.629 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.466 ' O ' ' CD1' ' A' ' 100' ' ' TRP . 2.9 p -75.05 148.44 39.8 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 69.03 -39.92 0.44 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 178.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.76 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 78.9 m95 -44.72 172.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.613 ' HB3' ' O ' ' A' ' 100' ' ' TRP . 1.4 pttt 163.0 0.53 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.82 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 177.82 -159.37 25.12 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.912 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.696 ' HG2' ' HB3' ' A' ' 14' ' ' ARG . 35.1 mt-30 -147.08 111.03 5.04 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.892 0.346 . . . . 0.0 111.397 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.904 ' HB2' HG22 ' A' ' 81' ' ' THR . . . -92.26 125.42 36.92 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.871 0.367 . . . . 0.0 110.835 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.633 ' HB3' ' HB2' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -133.66 128.53 35.25 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.845 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.478 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 5.3 ttpp -102.32 132.39 48.32 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.642 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 19.5 m95 -104.93 160.86 14.68 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.481 ' HB2' ' HE1' ' A' ' 110' ' ' PHE . 91.4 m-85 -137.99 154.37 49.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.667 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.776 HD12 ' O ' ' A' ' 20' ' ' CYS . 32.5 tp -97.65 141.69 30.36 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.708 ' CD1' HG23 ' A' ' 19' ' ' ILE . 23.3 m-85 -139.15 138.21 36.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.292 0.567 . . . . 0.0 112.116 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.563 ' HB2' HD11 ' A' ' 73' ' ' ILE . 1.4 ttpt -103.59 128.31 50.88 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.437 177.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.563 ' HD1' HD21 ' A' ' 21' ' ' LEU . 36.9 t80 -78.1 102.82 7.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.818 0.342 . . . . 0.0 111.008 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 49.2 p -100.47 47.65 0.93 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.009 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.418 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -152.73 -146.08 4.28 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.485 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -117.89 146.77 43.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.885 0.374 . . . . 0.0 110.814 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -59.51 -32.36 70.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.705 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -59.29 -4.48 0.56 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.907 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.15 -15.63 31.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.619 0.247 . . . . 0.0 110.951 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.747 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 17.6 mt -76.11 99.67 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.912 0.386 . . . . 0.0 111.541 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 65' ' ' THR . 1.5 m120 -106.16 95.95 6.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.687 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.817 HD23 HG22 ' A' ' 65' ' ' THR . 11.2 mt -70.47 -5.44 28.67 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.838 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.45 ' CD2' ' HG3' ' A' ' 129' ' ' PRO . 1.9 mt -128.46 12.42 6.44 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.286 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.26 -120.19 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.19 -0.529 . . . . 0.0 113.226 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -95.17 138.39 32.95 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.911 0.386 . . . . 0.0 111.28 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -176.75 -116.43 0.47 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.173 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.76 -68.67 0.89 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.923 0.392 . . . . 0.0 110.336 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -147.51 -82.26 0.13 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.064 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 12.7 pttm -78.91 155.9 77.5 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.187 0.517 . . . . 0.0 110.931 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.45 ' HG3' ' CD2' ' A' ' 122' ' ' LEU . 61.1 Cg_endo -76.47 179.25 6.59 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 123.028 2.486 . . . . 0.0 112.594 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.98 -39.89 5.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.712 ' CB ' ' HB1' ' A' ' 31' ' ' ALA . 3.4 m-85 -120.02 138.63 53.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.217 0.532 . . . . 0.0 109.898 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.746 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -83.26 -36.45 14.68 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.026 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -149.03 144.43 26.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.948 0.404 . . . . 0.0 110.615 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.747 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 33.4 p-90 -129.63 163.73 25.42 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.455 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.417 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 34.9 t -163.38 176.59 9.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.914 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.739 ' CE3' ' ND2' ' A' ' 23' ' ' ASN . 28.5 m95 -111.76 103.42 11.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.317 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 28' ' ' ILE . 24.2 m -118.39 166.26 12.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.565 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 14.5 p -71.82 171.49 9.15 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.216 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.867 ' HG3' HD11 ' A' ' 28' ' ' ILE . 13.4 Cg_exo -63.14 -54.18 1.21 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 121.83 1.687 . . . . 0.0 109.87 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -64.29 -28.35 69.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.911 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.431 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.4 OUTLIER -73.14 -45.75 54.93 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.393 179.745 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.637 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -58.44 -39.45 79.88 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 139' ' ' PRO . 27.3 mm -61.99 -33.76 59.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.132 0.491 . . . . 0.0 110.032 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.03 -53.17 11.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.379 0.609 . . . . 0.0 110.818 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.1 mp -72.56 -19.38 61.51 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.72 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.623 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 11.7 t -74.19 177.72 5.59 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.4 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.752 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 20.9 m -84.46 151.03 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.767 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.458 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 10.6 mt-10 -55.26 -54.75 39.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.486 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.752 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 44.3 p90 -55.93 -2.1 0.05 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.422 ' HG3' ' CE2' ' A' ' 149' ' ' PHE . 29.6 mttm -133.42 -8.06 2.91 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.502 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 0.4 OUTLIER -61.35 -56.45 33.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 121.49 -0.084 . . . . 0.0 111.196 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 22.7 Cg_endo -62.48 -28.94 78.23 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.163 1.909 . . . . 0.0 111.591 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.804 ' O ' HG23 ' A' ' 157' ' ' VAL . 31.2 t -67.16 -51.63 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.472 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 6.9 m-30 -66.19 -39.37 89.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.965 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.544 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -56.29 -42.43 77.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.684 179.731 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.446 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.7 OUTLIER -69.07 -33.32 73.37 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.167 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 153' ' ' VAL . 48.8 t -67.5 -40.61 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.43 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.707 HD22 ' HB3' ' A' ' 139' ' ' PRO . 36.9 mt -63.44 -47.1 83.26 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.247 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.8 t -50.72 -42.86 57.68 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.536 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.726 HG11 ' HA ' ' A' ' 76' ' ' VAL . 79.5 t -65.74 -41.65 90.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.548 ' CE2' HG12 ' A' ' 157' ' ' VAL . 18.3 m-30 -80.84 5.19 16.76 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.597 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.616 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.63 -52.77 71.66 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.6 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.0 Cg_endo -58.18 -12.4 12.88 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.112 1.874 . . . . 0.0 111.876 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.468 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 95.0 m-70 -108.5 -20.23 13.18 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.333 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 95.4 mt . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.105 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 112.343 -0.303 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.607 ' C ' HD12 ' A' ' 3' ' ' LEU . 73.5 Cg_exo -50.31 134.19 37.63 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.556 2.171 . . . . 0.0 111.996 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.607 HD12 ' C ' ' A' ' 2' ' ' PRO . 0.3 OUTLIER 57.99 -172.18 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.253 -179.052 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.636 ' HA3' ' HE2' ' A' ' 6' ' ' MET . . . -134.1 -4.28 2.98 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.17 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.91 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 88.5 p 55.99 -92.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.636 ' HE2' ' HA3' ' A' ' 4' ' ' GLY . 2.8 mtm 70.09 128.54 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.674 0.273 . . . . 0.0 110.605 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.672 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 9.2 t0 -67.0 -31.74 72.5 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.004 0.43 . . . . 0.0 110.812 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 m -102.22 145.24 30.15 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.242 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.47 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 57.5 Cg_endo -71.02 106.3 1.86 Allowed 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.116 1.877 . . . . 0.0 111.556 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.83 ' CG ' HG21 ' A' ' 81' ' ' THR . 6.9 Cg_endo -48.58 166.07 0.15 Allowed 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 123.025 2.483 . . . . 0.0 112.392 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -50.7 121.36 5.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.71 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.581 ' HA3' ' HA ' ' A' ' 100' ' ' TRP . . . 50.95 103.51 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.676 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.604 ' CE2' ' HG3' ' A' ' 101' ' ' LYS . 9.5 m-85 -158.24 142.21 15.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.48 0.181 . . . . 0.0 110.84 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.516 ' HD2' ' CH2' ' A' ' 96' ' ' TRP . 17.5 ttt-85 -70.91 86.76 0.71 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.802 0.334 . . . . 0.0 111.604 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.547 ' HG2' HD13 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -50.49 109.44 0.31 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.275 0.56 . . . . 0.0 110.322 179.035 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.706 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 3.4 m120 -132.6 173.99 10.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.405 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.693 HG12 HD11 ' A' ' 47' ' ' ILE . 2.1 m -140.63 166.73 18.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.409 0.623 . . . . 0.0 111.831 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.672 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -133.33 155.08 21.52 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.252 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.691 HG13 ' HB1' ' A' ' 57' ' ' ALA . 3.4 mp -126.88 119.17 52.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.986 0.422 . . . . 0.0 111.956 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' A' ' 110' ' ' PHE . 45.4 t -101.79 102.41 13.03 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.963 HD22 HG11 ' A' ' 67' ' ' VAL . 15.5 tp -105.39 118.87 37.65 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.108 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.635 ' HE2' HD13 ' A' ' 73' ' ' ILE . 1.2 ptm -119.75 161.61 20.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.83 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.498 ' OD1' ' CE3' ' A' ' 136' ' ' TRP . 0.2 OUTLIER -95.77 169.96 9.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.962 0.411 . . . . 0.0 110.155 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -56.62 -5.0 0.18 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.054 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.552 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 4.7 m-20 -98.87 2.93 47.1 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.552 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER 75.76 19.45 1.98 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.942 -178.538 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 22' ' ' MET . 1.1 mmtt -94.46 140.8 29.35 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.672 HD13 ' N ' ' A' ' 139' ' ' PRO . 3.0 mp -102.4 145.57 11.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.681 0.753 . . . . 0.0 112.218 -178.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.576 ' CE1' HD13 ' A' ' 119' ' ' ILE . 83.8 t80 -76.89 137.31 39.06 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.914 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.984 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -140.45 148.64 41.47 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.145 -0.316 . . . . 0.0 110.145 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.543 ' HB1' ' CB ' ' A' ' 131' ' ' PHE . . . -138.58 136.82 36.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.841 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.751 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 91.5 p -97.15 143.33 28.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.946 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.774 ' HE ' HD12 ' A' ' 36' ' ' ILE . 21.9 mtp85 -68.95 127.48 33.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.738 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.73 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.7 OUTLIER -43.78 -35.31 1.84 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.304 0.573 . . . . 0.0 110.835 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -72.71 -40.09 66.44 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.007 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.774 HD12 ' HE ' ' A' ' 33' ' ' ARG . 8.7 mt -125.31 104.76 28.48 Favored Pre-proline 0 N--CA 1.455 -0.175 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.738 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.75 -20.2 52.64 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.738 2.292 . . . . 0.0 112.871 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.48 -6.59 54.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.706 0.288 . . . . 0.0 111.496 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.751 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.56 93.27 8.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.123 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.664 ' O ' ' HA ' ' A' ' 146' ' ' THR . 78.1 m95 -90.89 144.93 25.18 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.543 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.428 ' HA ' ' HE2' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -158.73 162.6 37.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.184 0.516 . . . . 0.0 111.232 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.508 ' HB2' ' HE2' ' A' ' 42' ' ' MET . 1.8 mtm -98.08 152.05 37.84 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.892 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.415 ' HG2' ' O ' ' A' ' 19' ' ' ILE . 1.5 Cg_endo -46.96 144.86 7.8 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.239 1.96 . . . . 0.0 111.873 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 17' ' ' VAL . 6.7 tt0 -172.68 146.4 1.65 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.578 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.416 ' HA3' ' HG3' ' A' ' 60' ' ' GLU . . . -157.32 -167.02 17.79 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.9 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.706 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -117.85 137.68 13.37 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.133 -1.032 . . . . 0.0 113.655 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.693 HD11 HG12 ' A' ' 17' ' ' VAL . 3.3 mt -70.52 148.78 10.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.356 -0.422 . . . . 0.0 111.735 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -68.61 -173.8 0.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.372 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -49.11 -78.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.178 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -111.93 57.13 0.44 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.601 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.485 ' O ' HG21 ' A' ' 47' ' ' ILE . 7.4 tp10 -117.4 153.86 32.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.946 0.403 . . . . 0.0 110.871 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.86 161.61 77.79 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.486 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.541 ' HA ' HG12 ' A' ' 47' ' ' ILE . 7.3 Cg_exo -74.21 -47.87 0.23 Allowed 'Trans proline' 0 CA--C 1.514 -0.517 0 C-N-CA 122.857 2.371 . . . . 0.0 111.226 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.777 HH11 HG13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -51.98 -44.03 63.86 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.213 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -68.09 -42.13 80.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.946 0.403 . . . . 0.0 110.402 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.434 ' HA ' ' HG2' ' A' ' 59' ' ' ARG . . . -60.49 -44.46 95.93 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.691 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -57.96 -53.7 55.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.388 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.777 HG13 HH11 ' A' ' 54' ' ' ARG . 57.4 mt -53.27 -52.82 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.526 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.455 ' HG3' ' N ' ' A' ' 60' ' ' GLU . 9.2 ptm180 -63.43 -56.57 15.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.824 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.455 ' N ' ' HG3' ' A' ' 59' ' ' ARG . 29.2 mm-40 -50.99 -48.45 61.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.063 0.459 . . . . 0.0 110.054 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.568 HD21 HG12 ' A' ' 67' ' ' VAL . 14.1 tp -51.01 -48.5 61.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.393 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.937 ' HG2' HG23 ' A' ' 68' ' ' THR . 1.0 OUTLIER -66.77 -63.29 1.1 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.328 0.585 . . . . 0.0 110.721 179.304 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.67 -22.36 2.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.088 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -99.74 -38.06 8.84 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.617 HG22 HD23 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -127.22 -13.6 5.56 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.858 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.501 ' HA2' ' HD2' ' A' ' 62' ' ' ARG . . . 85.4 -13.42 55.38 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.254 -0.974 . . . . 0.0 111.76 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.963 HG11 HD22 ' A' ' 21' ' ' LEU . 27.3 t -57.31 106.02 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 121.236 0.541 . . . . 0.0 111.135 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.937 HG23 ' HG2' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -121.18 -39.86 2.65 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.219 178.605 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.0 m -62.68 73.43 0.02 OUTLIER 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.064 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -164.0 159.1 20.33 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.674 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.45 152.18 49.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.873 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.509 HG22 ' CE1' ' A' ' 110' ' ' PHE . 19.9 t -75.14 127.7 36.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.056 0.455 . . . . 0.0 111.076 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.635 HD13 ' HE2' ' A' ' 22' ' ' MET . 2.3 mt -108.1 -19.12 6.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.902 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.473 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.09 176.24 4.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.204 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.595 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.1 pm0 -154.39 145.26 22.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.453 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.776 ' HA ' HG11 ' A' ' 160' ' ' VAL . 53.5 t -71.25 138.32 84.28 Favored Pre-proline 0 C--N 1.329 -0.286 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.927 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.622 ' HD2' HG13 ' A' ' 76' ' ' VAL . 21.3 Cg_endo -61.82 -55.34 1.13 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.814 2.342 . . . . 0.0 112.696 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.672 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 1.2 p90 -102.17 -178.64 3.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.491 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.56 ' CD1' ' HD3' ' A' ' 106' ' ' LYS . 39.3 m95 -93.54 -157.56 0.55 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.392 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.91 ' HA ' ' HA ' ' A' ' 5' ' ' SER . 55.7 mt -161.7 100.84 1.16 Allowed 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.83 HG21 ' CG ' ' A' ' 10' ' ' PRO . 0.8 OUTLIER -106.82 122.92 47.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.157 -177.666 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.416 ' OH ' HG11 ' A' ' 153' ' ' VAL . 20.9 m-85 -78.75 -166.49 0.89 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.942 178.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -176.39 145.23 0.57 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.676 0.274 . . . . 0.0 110.549 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.571 ' HB2' HD12 ' A' ' 92' ' ' LEU . 4.1 m-85 -96.64 166.72 13.51 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.762 0.315 . . . . 0.0 111.366 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.433 ' HD2' ' HB ' ' A' ' 88' ' ' VAL . 19.9 Cg_exo -65.6 177.07 2.99 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.631 2.221 . . . . 0.0 111.95 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.416 ' HD2' ' CB ' ' A' ' 85' ' ' PRO . 56.4 Cg_endo -70.04 -23.27 29.71 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.351 2.034 . . . . 0.0 112.312 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -84.64 -61.5 1.77 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.247 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.433 ' HB ' ' HD2' ' A' ' 85' ' ' PRO . 11.3 t -63.9 -12.53 11.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.766 0.317 . . . . 0.0 111.35 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.608 ' HD2' ' CB ' ' A' ' 93' ' ' ASN . 0.1 OUTLIER -59.66 -2.62 0.38 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.458 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.553 ' HA ' HD13 ' A' ' 94' ' ' ILE . 1.4 mm-40 -106.76 -21.74 12.94 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.652 0.263 . . . . 0.0 111.03 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.55 -15.14 17.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.876 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.741 HD13 ' N ' ' A' ' 93' ' ' ASN . 0.3 OUTLIER -116.0 -56.12 2.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.312 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.741 ' N ' HD13 ' A' ' 92' ' ' LEU . 0.9 OUTLIER -59.88 -54.18 49.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.355 0.598 . . . . 0.0 110.863 179.42 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.553 HD13 ' HA ' ' A' ' 90' ' ' GLU . 1.7 mp -68.43 -12.85 16.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.321 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.472 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 0.5 OUTLIER -69.8 -14.83 62.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.334 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.608 ' HB2' ' HB2' ' A' ' 100' ' ' TRP . 28.8 m95 -95.95 20.16 10.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.634 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.07 -71.75 2.91 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.114 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.421 ' O ' ' CG ' ' A' ' 99' ' ' ASP . 53.0 p -176.98 159.88 1.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.813 -0.227 . . . . 0.0 110.579 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.421 ' CG ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER 80.62 -39.18 0.16 Allowed 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.365 0.416 . . . . 0.0 111.729 179.639 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.608 ' HB2' ' HB2' ' A' ' 96' ' ' TRP . 14.8 m95 -58.4 -171.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.306 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.676 ' HA ' ' OD1' ' A' ' 93' ' ' ASN . 0.6 OUTLIER 166.59 12.57 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.771 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.444 ' HA3' ' CE1' ' A' ' 13' ' ' TYR . . . 161.37 -148.82 17.01 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.822 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.745 ' O ' ' HA ' ' A' ' 81' ' ' THR . 72.7 mt-30 -146.17 117.69 8.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 117.021 0.41 . . . . 0.0 111.516 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.523 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -91.49 126.95 36.74 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 120.874 0.369 . . . . 0.0 110.177 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.647 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 23.9 mt-30 -136.45 124.06 22.31 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.56 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 14.4 ttpp -104.76 140.36 38.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.165 178.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.672 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 19.4 m95 -110.11 160.23 16.65 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.701 ' HB2' HH21 ' A' ' 54' ' ' ARG . 19.0 m-85 -139.07 160.12 40.53 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.125 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.61 HD11 ' SD ' ' A' ' 22' ' ' MET . 11.7 tp -98.44 142.52 29.96 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.622 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.531 ' HZ ' ' NH1' ' A' ' 54' ' ' ARG . 5.7 m-85 -135.36 145.71 47.65 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.541 ' CA ' HD11 ' A' ' 73' ' ' ILE . 1.8 tttt -106.31 117.16 33.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.854 177.004 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.665 ' HB2' HD11 ' A' ' 21' ' ' LEU . 55.1 t80 -78.03 101.29 6.86 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.661 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 14.1 p -97.58 40.43 1.16 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.406 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.402 ' C ' ' CE2' ' A' ' 112' ' ' PHE . . . -140.64 -148.36 5.11 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.805 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -123.64 152.03 42.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.702 0.287 . . . . 0.0 111.129 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.444 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 11.6 p-10 -58.31 -39.16 78.63 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.418 0.627 . . . . 0.0 111.204 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -58.2 -3.72 0.28 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.335 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -89.29 -17.34 29.15 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.092 0.473 . . . . 0.0 110.432 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.587 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 9.4 mt -88.74 106.84 17.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.462 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 27.3 t30 -100.09 -20.31 16.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.167 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.617 HD23 HG22 ' A' ' 65' ' ' THR . 66.8 mt 75.95 -31.14 0.19 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.089 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.513 HD11 ' HD3' ' A' ' 129' ' ' PRO . 4.3 mm? -76.78 177.28 7.74 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.83 0.348 . . . . 0.0 111.156 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 117.99 125.68 3.57 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.736 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 46.89 96.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.838 0.351 . . . . 0.0 111.46 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -150.84 155.5 26.19 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.555 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 61.3 m -90.91 -21.44 21.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.55 0.214 . . . . 0.0 111.091 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.508 ' C ' ' HG3' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -149.63 -50.07 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.398 -179.552 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.769 ' HB3' ' HD2' ' A' ' 129' ' ' PRO . 25.0 mtpt -157.92 165.96 17.55 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-O 121.183 0.516 . . . . 0.0 111.246 -178.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.769 ' HD2' ' HB3' ' A' ' 128' ' ' LYS . 6.2 Cg_endo -53.02 -174.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.195 2.597 . . . . 0.0 112.758 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.06 -48.44 3.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.363 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.543 ' CB ' ' HB1' ' A' ' 31' ' ' ALA . 1.4 m-85 -109.74 140.71 43.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.987 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.73 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -89.98 -32.12 10.25 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.12 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.95 152.25 34.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.885 0.374 . . . . 0.0 110.363 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.587 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 37.3 p-90 -137.76 167.62 21.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.009 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.468 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 30.5 t -162.42 175.58 11.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.481 0.657 . . . . 0.0 112.168 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.498 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 35.6 m95 -111.25 105.65 14.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.105 178.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 25.2 m -120.93 170.1 11.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.6 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 18.4 p -73.01 172.0 9.01 Favored Pre-proline 0 CA--C 1.518 -0.284 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.971 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.672 ' N ' HD13 ' A' ' 28' ' ' ILE . 11.4 Cg_exo -62.81 -55.85 0.74 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.579 1.519 . . . . 0.0 110.286 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -64.23 -25.14 67.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.351 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.431 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 1.8 mm-40 -72.96 -47.63 43.7 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.483 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.984 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -57.79 -39.38 77.4 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.848 -179.812 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.636 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 6.2 mm -62.82 -37.74 79.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.316 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.51 -48.99 58.78 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.312 0.577 . . . . 0.0 110.488 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.3 mp -75.0 -20.19 59.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.137 -0.938 . . . . 0.0 113.115 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.664 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 14.1 t -74.92 178.58 5.46 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.787 -178.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.684 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 27.7 m -82.89 148.62 5.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.115 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.502 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 45.4 mt-10 -55.1 -53.06 60.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.441 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.684 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 51.1 p90 -56.66 -2.22 0.07 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.443 ' HG3' ' CE2' ' A' ' 149' ' ' PHE . 21.5 mttt -134.76 -7.6 2.43 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' A' ' 143' ' ' ILE . 7.6 mtmm -58.88 -60.02 11.86 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.56 0.219 . . . . 0.0 111.095 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.502 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 31.8 Cg_endo -62.89 -26.78 74.51 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.397 2.064 . . . . 0.0 111.631 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.644 ' O ' HG23 ' A' ' 157' ' ' VAL . 26.0 t -68.85 -50.99 49.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.428 ' HE2' ' HA ' ' A' ' 41' ' ' GLN . 12.6 m-30 -65.76 -37.3 85.97 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.532 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.621 ' HE2' ' HA ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -57.68 -40.69 80.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.986 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.549 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.3 OUTLIER -68.11 -32.55 72.93 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.83 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 153' ' ' VAL . 48.6 t -66.64 -42.07 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.007 178.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.584 HD12 ' HE2' ' A' ' 155' ' ' LYS . 34.7 mt -64.36 -47.56 78.83 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.58 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 2.9 p -50.01 -40.63 45.13 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.776 HG11 ' HA ' ' A' ' 76' ' ' VAL . 57.7 t -68.1 -41.37 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.35 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.601 ' CE2' HG12 ' A' ' 157' ' ' VAL . 21.0 m-30 -80.87 4.26 19.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.402 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.618 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.48 -51.5 81.35 Favored Pre-proline 0 C--N 1.331 -0.22 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.776 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.8 Cg_endo -58.63 -12.67 14.93 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.064 1.843 . . . . 0.0 111.818 178.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.473 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 89.4 m-70 -108.76 -18.51 13.69 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.253 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 85.8 mt . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.331 -0.842 . . . . 0.0 110.678 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 CA-C-O 120.192 -0.227 . . . . 0.0 112.648 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.16 166.63 1.54 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.603 2.202 . . . . 0.0 112.827 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.721 HD21 HG22 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -80.01 134.88 36.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.081 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.43 ' O ' ' OG ' ' A' ' 5' ' ' SER . . . -94.68 -15.63 45.56 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.415 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.597 ' HA ' ' O ' ' A' ' 79' ' ' TRP . 3.6 p 58.43 -87.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.422 ' H ' ' HG ' ' A' ' 5' ' ' SER . 9.2 mtm 67.53 137.84 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.853 0.359 . . . . 0.0 111.116 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.765 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 17.3 t0 -66.97 -39.85 87.31 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.416 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.8 m -98.11 138.82 20.95 Favored Pre-proline 0 C--N 1.325 -0.486 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.35 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.426 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 74.4 Cg_endo -75.46 107.5 2.49 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.156 1.904 . . . . 0.0 112.236 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.52 ' HG2' ' CD1' ' A' ' 13' ' ' TYR . 4.9 Cg_endo -48.27 165.21 0.16 Allowed 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 123.315 2.677 . . . . 0.0 112.794 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -51.1 129.7 24.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.412 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.31 85.99 0.02 OUTLIER Glycine 0 CA--C 1.517 0.192 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.797 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.52 ' CD1' ' HG2' ' A' ' 10' ' ' PRO . 9.8 m-85 -152.34 152.28 31.9 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.977 0.417 . . . . 0.0 111.588 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.842 ' HG3' ' H ' ' A' ' 15' ' ' ARG . 9.7 tpt180 -63.93 -154.58 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.697 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.842 ' H ' ' HG3' ' A' ' 14' ' ' ARG . 1.5 ttt180 176.64 96.38 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 122.881 0.472 . . . . 0.0 109.863 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.646 ' HA ' ' H ' ' A' ' 47' ' ' ILE . 1.5 m120 -129.84 173.19 10.9 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.713 HG13 HD11 ' A' ' 47' ' ' ILE . 30.2 m -134.33 165.53 31.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.736 0.779 . . . . 0.0 111.683 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.825 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -131.42 158.2 22.65 Favored Glycine 0 N--CA 1.433 -1.539 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.502 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.992 HG21 HD22 ' A' ' 61' ' ' LEU . 3.4 mp -123.27 117.95 53.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.496 0.665 . . . . 0.0 111.976 -178.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.538 ' O ' HD12 ' A' ' 109' ' ' LEU . 37.6 t -104.43 103.74 13.5 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.879 HD22 HG11 ' A' ' 67' ' ' VAL . 30.8 tp -104.47 122.96 46.62 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.893 -177.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.739 ' HB3' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -113.64 137.58 51.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.714 179.845 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.443 ' OD1' ' CZ3' ' A' ' 136' ' ' TRP . 5.6 m-20 -98.11 -172.25 2.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.475 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -52.38 -7.59 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.187 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.522 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 3.7 m-20 -99.73 -7.21 25.87 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.996 0.427 . . . . 0.0 111.045 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.766 ' HE2' ' HA ' ' A' ' 165' ' ' LEU . 0.0 OUTLIER 73.38 20.42 3.22 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 121.652 0.739 . . . . 0.0 109.291 -179.379 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.801 ' C ' HD12 ' A' ' 28' ' ' ILE . 7.1 mttp -91.72 -161.03 0.78 Allowed 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.767 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.801 HD12 ' C ' ' A' ' 27' ' ' LYS . 2.5 mp -135.61 145.73 31.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.42 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.579 ' CE1' HD13 ' A' ' 119' ' ' ILE . 81.0 t80 -65.77 110.99 3.02 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.326 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.635 ' HB2' HG22 ' A' ' 137' ' ' VAL . . . -100.21 137.56 38.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.842 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.75 132.94 37.45 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.809 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.842 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 48.6 p -98.81 141.39 31.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.221 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.498 ' NH1' HD12 ' A' ' 36' ' ' ILE . 11.1 mtp-105 -68.67 127.1 31.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.193 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.791 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.3 OUTLIER -45.9 -34.12 3.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.294 0.568 . . . . 0.0 110.73 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.39 -39.78 67.71 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.519 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.498 HD12 ' NH1' ' A' ' 33' ' ' ARG . 27.9 mt -123.63 106.64 32.13 Favored Pre-proline 0 N--CA 1.455 -0.214 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.084 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -68.37 -19.88 42.99 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.714 2.276 . . . . 0.0 112.628 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -91.39 -7.46 50.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.514 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.842 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -90.71 96.46 10.65 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.04 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.618 ' O ' ' HA ' ' A' ' 146' ' ' THR . 75.8 m95 -94.76 146.61 24.06 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.116 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.569 ' O ' ' HA ' ' A' ' 30' ' ' ALA . 0.5 OUTLIER -157.79 -124.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.56 -179.29 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.579 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 9.8 ptt? 179.98 163.29 0.86 Allowed Pre-proline 0 N--CA 1.452 -0.345 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.579 ' HD2' ' HB2' ' A' ' 42' ' ' MET . 10.2 Cg_endo -50.99 147.05 20.18 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.114 2.542 . . . . 0.0 112.577 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.609 ' HA ' HD12 ' A' ' 19' ' ' ILE . 10.6 pt20 -174.22 146.61 1.13 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.809 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.463 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . -160.52 154.38 25.4 Favored Glycine 0 C--O 1.228 -0.273 0 C-N-CA 120.146 -1.026 . . . . 0.0 112.789 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.64 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -78.31 136.95 19.02 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.611 -0.804 . . . . 0.0 114.034 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.713 HD11 HG13 ' A' ' 17' ' ' VAL . 3.7 mt -69.62 141.93 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.13 -0.535 . . . . 0.0 110.469 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -68.45 -172.95 0.38 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.738 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -48.22 -73.33 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.208 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -118.42 57.17 0.55 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.483 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 52' ' ' ASP . 2.1 tp10 -114.34 147.43 39.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.66 0.266 . . . . 0.0 110.456 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 26.9 m-20 -70.9 139.83 85.81 Favored Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.159 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.642 ' HB2' ' HZ ' ' A' ' 108' ' ' PHE . 38.6 Cg_exo -58.27 -47.7 18.72 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.354 2.036 . . . . 0.0 112.016 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.845 ' HE ' HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -52.93 -46.17 67.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.904 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.666 ' HA ' HD12 ' A' ' 58' ' ' ILE . 86.7 m-20 -68.0 -40.97 82.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.242 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.71 -44.49 96.83 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.765 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.657 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -56.41 -54.49 45.07 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.812 178.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.845 HD11 ' HE ' ' A' ' 54' ' ' ARG . 10.1 mt -55.25 -55.31 17.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.173 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -60.47 -61.66 2.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.945 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.463 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 4.4 mm-40 -46.89 -43.74 19.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.179 0.514 . . . . 0.0 109.777 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.992 HD22 HG21 ' A' ' 19' ' ' ILE . 9.0 tp -51.17 -48.27 61.96 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.923 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.746 ' HG3' HG23 ' A' ' 68' ' ' THR . 17.9 ttm180 -64.66 -62.91 1.29 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.164 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -49.7 -22.97 1.53 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.268 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -96.02 -37.73 10.52 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.667 HG22 HD23 ' A' ' 121' ' ' LEU . 1.3 p -124.34 -35.69 2.75 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.638 -0.425 . . . . 0.0 112.027 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 107.16 -13.53 40.47 Favored Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -178.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.879 HG11 HD22 ' A' ' 21' ' ' LEU . 78.1 t -56.24 109.75 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 120.889 0.376 . . . . 0.0 110.49 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.746 HG23 ' HG3' ' A' ' 62' ' ' ARG . 3.9 p -120.86 -41.06 2.58 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.315 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.406 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 15.6 m -60.89 72.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.234 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -160.79 157.95 27.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.196 0.522 . . . . 0.0 112.213 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.16 149.63 50.88 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.131 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.809 HG22 ' CE2' ' A' ' 110' ' ' PHE . 12.8 t -74.0 128.14 36.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.172 0.51 . . . . 0.0 111.923 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.541 HD13 ' CE ' ' A' ' 22' ' ' MET . 0.9 OUTLIER -108.83 -18.25 7.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.363 178.668 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.464 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -168.54 179.69 4.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.399 0.619 . . . . 0.0 112.325 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -160.09 147.22 16.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.568 179.764 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.898 ' HA ' HG11 ' A' ' 160' ' ' VAL . 42.7 t -71.2 140.12 85.19 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-O 120.959 0.409 . . . . 0.0 111.533 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.632 ' HD2' HG13 ' A' ' 76' ' ' VAL . 32.2 Cg_endo -64.89 -69.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.094 2.53 . . . . 0.0 112.931 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.765 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -87.4 172.41 9.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.689 -178.909 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.597 ' O ' ' HA ' ' A' ' 5' ' ' SER . 54.3 m95 -92.93 102.72 15.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.846 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.56 ' CD1' HG22 ' A' ' 157' ' ' VAL . 65.3 mt -63.02 109.67 1.55 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.916 0.388 . . . . 0.0 110.79 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.766 HG22 ' HA ' ' A' ' 104' ' ' ALA . 21.4 p -100.38 -160.32 0.79 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.886 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.403 ' HD1' HD23 ' A' ' 3' ' ' LEU . 1.2 t80 -175.12 60.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.536 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.08 148.96 46.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.666 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.71 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 39.0 m-85 -99.56 161.07 25.73 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.215 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.535 ' HB3' ' HD2' ' A' ' 86' ' ' PRO . 38.4 Cg_exo -56.76 -178.32 0.08 OUTLIER 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 123.06 2.507 . . . . 0.0 112.062 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.535 ' HD2' ' HB3' ' A' ' 85' ' ' PRO . 33.7 Cg_endo -64.5 -22.08 65.57 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.447 2.098 . . . . 0.0 112.681 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -77.11 -62.46 1.64 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.992 0.425 . . . . 0.0 110.464 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.71 ' HB ' ' HB3' ' A' ' 84' ' ' PHE . 37.5 t -64.6 -17.38 21.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.026 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.672 ' HG3' ' HB2' ' A' ' 93' ' ' ASN . 2.9 ttp180 -55.04 -62.63 1.54 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.093 0.473 . . . . 0.0 110.636 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.853 ' HA ' HD13 ' A' ' 94' ' ' ILE . 2.2 mm-40 -62.93 -13.29 32.69 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.792 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.09 -33.61 15.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.718 0.294 . . . . 0.0 111.784 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.547 ' C ' HD13 ' A' ' 92' ' ' LEU . 1.8 tm? -120.48 -54.48 2.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.264 0.554 . . . . 0.0 111.504 -178.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.853 ' HB3' ' HA ' ' A' ' 101' ' ' LYS . 1.7 m-20 -52.56 -57.5 9.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.943 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.853 HD13 ' HA ' ' A' ' 90' ' ' GLU . 4.3 mp -75.29 -6.42 8.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.709 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.14 -1.11 24.58 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.858 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.631 ' CZ3' ' HD3' ' A' ' 14' ' ' ARG . 77.8 m95 -92.71 30.15 1.62 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.715 0.293 . . . . 0.0 110.822 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.408 ' O ' ' CB ' ' A' ' 98' ' ' SER . . . 68.05 19.49 71.94 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.663 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.463 ' O ' ' HD1' ' A' ' 100' ' ' TRP . 5.3 m 82.5 160.62 0.14 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 122.372 0.269 . . . . 0.0 111.037 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.3 t70 77.23 25.93 0.74 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.631 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.682 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 30.3 m95 -139.36 -164.67 1.71 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.997 -178.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.853 ' HA ' ' HB3' ' A' ' 93' ' ' ASN . 12.2 ttpp 163.64 12.08 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.441 0.463 . . . . 0.0 111.998 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 161.92 -163.57 34.85 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 120.314 -0.946 . . . . 0.0 111.987 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.589 ' O ' ' HA ' ' A' ' 81' ' ' THR . 36.3 mt-30 -144.98 123.58 12.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.886 0.343 . . . . 0.0 111.48 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.766 ' HA ' HG22 ' A' ' 81' ' ' THR . . . -100.35 125.47 46.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.667 179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.541 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 36.7 mt-30 -132.32 126.19 32.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.296 0.569 . . . . 0.0 112.354 -178.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 3.3 ttmt -104.55 135.14 46.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.897 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.825 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 38.8 m95 -101.81 165.58 11.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.198 0.523 . . . . 0.0 112.082 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.642 ' HZ ' ' HB2' ' A' ' 53' ' ' PRO . 97.6 m-85 -141.01 152.69 45.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.892 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.668 HD11 ' SD ' ' A' ' 22' ' ' MET . 10.0 tp -101.2 140.04 36.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.744 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.809 ' CE2' HG22 ' A' ' 72' ' ' VAL . 50.6 m-85 -141.49 143.58 33.91 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 26.5 tttt -100.83 124.59 46.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.247 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.753 ' CE1' HG13 ' A' ' 67' ' ' VAL . 30.8 t80 -78.71 101.36 7.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.728 0.299 . . . . 0.0 110.64 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 18.3 p -98.26 40.54 1.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.501 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.406 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -144.43 -145.41 4.34 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.777 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -121.63 149.07 43.71 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.965 0.412 . . . . 0.0 111.449 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.424 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 11.3 p-10 -60.47 -36.32 77.98 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.501 0.667 . . . . 0.0 111.081 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -57.01 -2.87 0.09 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.405 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 116' ' ' ASP . 3.4 tt0 -89.66 -17.71 27.86 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.163 0.506 . . . . 0.0 110.149 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.579 HD13 ' CE1' ' A' ' 29' ' ' PHE . 9.6 mt -83.36 100.65 7.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.373 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -94.86 -0.46 54.03 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.68 HD11 ' HD1' ' A' ' 134' ' ' TRP . 53.5 mt 40.55 27.06 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.636 ' HG ' ' O ' ' A' ' 121' ' ' LEU . 0.4 OUTLIER -171.25 -173.99 1.37 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.945 0.402 . . . . 0.0 111.182 -179.413 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 112.84 128.99 5.05 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.573 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 12.7 t0 58.74 75.51 0.39 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.816 0.341 . . . . 0.0 111.021 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -178.84 89.4 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.356 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.17 -4.81 15.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.65 0.262 . . . . 0.0 111.202 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.586 ' O ' ' HG3' ' A' ' 128' ' ' LYS . 12.0 mt-10 -88.5 -75.13 0.44 Allowed 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.506 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.586 ' HG3' ' O ' ' A' ' 127' ' ' GLU . 12.7 mttt -175.34 164.16 2.15 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.694 0.759 . . . . 0.0 111.576 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.659 ' HG2' HD13 ' A' ' 34' ' ' LEU . 22.5 Cg_endo -72.78 -173.69 1.28 Allowed 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 123.681 2.921 . . . . 0.0 113.261 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.544 ' HG3' ' CE1' ' A' ' 131' ' ' PHE . 2.5 tp10 -114.51 -46.48 2.96 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.693 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.553 ' HE2' HG23 ' A' ' 65' ' ' THR . 1.6 m-85 -126.93 140.11 52.57 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.987 0.422 . . . . 0.0 110.378 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.791 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -84.44 -33.44 19.66 Favored Glycine 0 CA--C 1.507 -0.43 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.211 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.59 151.83 29.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.506 -0.347 . . . . 0.0 110.254 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.68 ' HD1' HD11 ' A' ' 121' ' ' LEU . 37.0 p-90 -138.48 169.56 17.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.591 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.516 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 45.9 t -162.06 177.47 9.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.287 0.565 . . . . 0.0 111.364 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.473 ' CE2' ' CZ3' ' A' ' 134' ' ' TRP . 79.7 m95 -109.47 95.65 5.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.95 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.703 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 25.4 m -116.4 162.82 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.772 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.6 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 12.7 p -72.27 174.13 4.65 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.915 0.388 . . . . 0.0 110.567 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.712 ' HB3' HD22 ' A' ' 158' ' ' LEU . 9.4 Cg_exo -63.46 -57.08 0.41 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.526 1.484 . . . . 0.0 110.291 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -60.66 -32.33 71.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.277 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.413 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.9 OUTLIER -70.66 -47.63 58.97 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.566 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.547 HD13 ' CB ' ' A' ' 30' ' ' ALA . 38.7 tp -57.04 -38.42 73.16 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.668 HG12 ' O ' ' A' ' 139' ' ' PRO . 19.9 mm -60.77 -35.66 65.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.286 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -50.12 35.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.213 0.53 . . . . 0.0 110.867 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.505 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -73.85 -21.13 60.22 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.132 -179.525 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.618 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 14.9 t -74.52 171.52 13.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.996 0.427 . . . . 0.0 111.383 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.498 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 27.7 m -73.67 157.27 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.248 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.485 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 15.4 pt-20 -62.19 -54.17 44.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.12 0.486 . . . . 0.0 110.749 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.498 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 41.5 p90 -57.77 -1.15 0.09 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.418 ' HE3' ' HE2' ' A' ' 149' ' ' PHE . 75.0 mttt -132.57 -8.07 3.24 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.162 0.437 . . . . 0.0 111.878 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.536 ' HG3' HG22 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -61.7 -55.98 37.03 Favored Pre-proline 0 N--CA 1.463 0.192 0 CA-C-O 120.422 0.153 . . . . 0.0 110.744 179.308 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.519 ' HD3' ' HD2' ' A' ' 151' ' ' LYS . 29.9 Cg_endo -64.21 -28.51 64.41 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.083 1.855 . . . . 0.0 111.239 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.789 ' O ' HG23 ' A' ' 157' ' ' VAL . 21.6 t -68.04 -52.92 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.503 ' HE1' ' CZ2' ' A' ' 107' ' ' TRP . 16.0 m-30 -63.42 -39.66 95.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.79 178.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.621 ' HD3' HG21 ' A' ' 143' ' ' ILE . 0.1 OUTLIER -53.79 -45.4 70.72 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.083 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.499 ' O ' HG23 ' A' ' 160' ' ' VAL . 3.0 tt0 -67.74 -33.88 75.74 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 153' ' ' VAL . 47.3 t -64.77 -42.36 94.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.392 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.712 HD22 ' HB3' ' A' ' 139' ' ' PRO . 52.1 mt -63.84 -44.14 94.07 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.362 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 40.0 t -52.09 -39.78 60.27 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.898 HG11 ' HA ' ' A' ' 76' ' ' VAL . 57.7 t -66.77 -41.15 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.105 177.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.72 ' CE2' HG12 ' A' ' 157' ' ' VAL . 23.1 m-30 -80.44 5.9 13.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.694 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.7 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . . . -62.88 -50.99 74.62 Favored Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.828 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.7 ' HD3' ' HB3' ' A' ' 162' ' ' ALA . 31.2 Cg_exo -57.67 -15.43 20.74 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 121.896 1.731 . . . . 0.0 111.209 178.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.464 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 83.6 m-70 -107.56 -25.76 11.21 Favored 'General case' 0 N--CA 1.458 -0.065 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.012 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.766 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 50.1 mt . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.543 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.425 ' HA2' ' CZ ' ' A' ' 82' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 112.404 -0.278 . . . . 0.0 112.404 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.37 136.14 68.11 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.575 2.183 . . . . 0.0 112.132 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.18 121.81 41.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.664 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.71 -19.06 45.6 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.562 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.608 ' HA ' ' O ' ' A' ' 79' ' ' TRP . 0.8 OUTLIER 64.95 -78.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.067 0.46 . . . . 0.0 111.401 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 5.7 mtm 68.51 130.63 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.681 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.716 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 9.7 t70 -66.19 -35.64 80.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.043 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.7 m -93.95 140.4 22.94 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.261 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.447 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 69.0 Cg_endo -74.64 106.4 2.25 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.378 2.052 . . . . 0.0 112.601 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.486 ' HB2' ' CE2' ' A' ' 13' ' ' TYR . 12.2 Cg_endo -54.42 -166.98 0.01 OUTLIER 'Trans proline' 0 CA--C 1.518 -0.313 0 C-N-CA 123.342 2.695 . . . . 0.0 112.659 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.5 ' O ' ' C ' ' A' ' 12' ' ' GLY . 0.1 OUTLIER -50.74 -165.78 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.163 179.617 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.5 ' C ' ' O ' ' A' ' 11' ' ' GLU . . . -24.53 -84.59 0.01 OUTLIER Glycine 0 C--N 1.335 0.488 0 CA-C-N 116.258 -0.428 . . . . 0.0 113.151 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.545 ' HA ' ' O ' ' A' ' 100' ' ' TRP . 11.0 m-85 59.25 137.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.616 0.246 . . . . 0.0 110.987 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.746 ' HA ' ' CZ3' ' A' ' 100' ' ' TRP . 8.8 ttt180 -66.71 74.66 0.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.34 0.591 . . . . 0.0 110.598 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.731 ' HG2' HD12 ' A' ' 47' ' ' ILE . 0.7 OUTLIER -48.16 101.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.22 -179.656 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.739 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 3.4 m-80 -132.91 172.9 11.99 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.67 HG13 ' CG1' ' A' ' 47' ' ' ILE . 11.1 m -137.26 170.86 17.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 120.963 0.411 . . . . 0.0 111.221 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.562 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -137.1 158.82 24.46 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.814 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.967 HG21 HD22 ' A' ' 61' ' ' LEU . 3.5 mp -131.99 122.76 49.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.589 ' O ' HD12 ' A' ' 109' ' ' LEU . 51.6 t -103.34 92.39 4.48 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.877 HD22 HG11 ' A' ' 67' ' ' VAL . 8.5 tp -98.3 122.06 40.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.647 -178.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.682 ' HE1' HD13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -122.94 160.55 25.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.757 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.619 ' ND2' ' CD2' ' A' ' 136' ' ' TRP . 24.2 m-20 -97.34 -178.12 4.06 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.526 0.679 . . . . 0.0 111.034 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -60.54 -7.41 2.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.747 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 1.3 m-20 -99.71 3.1 44.85 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER 72.51 22.05 3.46 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.073 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -96.41 140.74 30.62 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.724 HD12 ' N ' ' A' ' 28' ' ' ILE . 2.1 mp -97.2 144.03 11.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.658 0.742 . . . . 0.0 112.094 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.61 ' CZ ' HG21 ' A' ' 65' ' ' THR . 5.5 t80 -70.74 106.62 3.62 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.462 -1.245 . . . . 0.0 111.014 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.665 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -104.0 142.87 33.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.72 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.518 ' HB1' ' CG ' ' A' ' 131' ' ' PHE . . . -141.3 137.0 32.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.728 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 10.0 p -101.88 151.41 22.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.645 ' O ' ' N ' ' A' ' 35' ' ' ASP . 7.7 mtp180 -73.4 129.27 37.65 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.367 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.733 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -56.08 53.96 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.72 0.408 . . . . 0.0 112.083 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.645 ' N ' ' O ' ' A' ' 33' ' ' ARG . 4.7 t0 -175.78 -35.31 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.082 0.468 . . . . 0.0 110.098 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.545 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 6.7 mm -112.97 106.05 55.35 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.559 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.81 -62.08 0.18 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.122 2.548 . . . . 0.0 113.98 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -67.2 0.7 2.54 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.74 96.88 10.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.776 0.322 . . . . 0.0 111.059 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.634 ' O ' ' HA ' ' A' ' 146' ' ' THR . 69.7 m95 -100.93 148.51 24.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.783 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.456 ' NE2' ' CD ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -156.19 163.64 39.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.636 0.731 . . . . 0.0 112.466 -179.102 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.707 ' SD ' HG21 ' A' ' 28' ' ' ILE . 12.2 mtm -97.93 150.93 37.27 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.481 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.498 ' CB ' HD13 ' A' ' 61' ' ' LEU . 4.7 Cg_endo -50.18 146.35 18.15 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.186 1.924 . . . . 0.0 111.966 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.582 ' HA ' HD12 ' A' ' 19' ' ' ILE . 1.1 pt20 -173.07 150.96 2.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.642 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.435 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . -160.14 160.67 31.86 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.387 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.739 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -81.13 139.67 20.69 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.479 -179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.731 HD12 ' HG2' ' A' ' 15' ' ' ARG . 40.5 mt -69.82 138.94 21.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.639 -0.281 . . . . 0.0 111.385 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -69.04 -173.54 0.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.974 0.416 . . . . 0.0 110.914 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -46.09 -82.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.148 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -112.07 55.97 0.49 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.994 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -112.4 147.67 35.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.952 0.406 . . . . 0.0 110.852 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -68.73 164.33 46.88 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.132 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 3.6 Cg_exo -78.91 -51.41 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.689 2.259 . . . . 0.0 111.401 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.908 ' CZ ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -51.94 -46.04 64.56 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.331 179.41 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.788 ' HA ' HD12 ' A' ' 58' ' ' ILE . 75.7 m-20 -67.11 -41.8 85.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.108 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.402 ' HB1' ' OE2' ' A' ' 60' ' ' GLU . . . -61.07 -44.22 97.71 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.776 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -56.49 -52.27 65.36 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.747 178.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.788 HD12 ' HA ' ' A' ' 55' ' ' ASN . 9.7 mt -56.32 -55.8 16.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.261 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.73 -63.89 1.14 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.011 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.435 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 0.2 OUTLIER -43.52 -46.12 6.84 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-O 121.248 0.547 . . . . 0.0 110.039 179.583 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.967 HD22 HG21 ' A' ' 19' ' ' ILE . 10.0 tp -52.84 -47.11 67.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.156 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.898 ' HG3' HG23 ' A' ' 68' ' ' THR . 19.7 ttm180 -64.48 -64.97 0.74 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.33 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.12 -21.79 0.82 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.324 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -96.57 -35.17 11.17 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.766 HG22 HD23 ' A' ' 121' ' ' LEU . 0.6 OUTLIER -129.91 -4.69 4.55 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -178.594 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 80.35 -11.13 39.41 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.448 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.877 HG11 HD22 ' A' ' 21' ' ' LEU . 85.4 t -58.0 112.62 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-O 121.079 0.466 . . . . 0.0 111.625 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.898 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -123.86 -39.86 2.36 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.646 178.172 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.6 m -62.24 75.62 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.955 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.63 157.84 25.24 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.157 0.503 . . . . 0.0 112.305 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -131.29 150.17 52.26 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.442 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.908 HG21 ' CZ ' ' A' ' 54' ' ' ARG . 6.4 t -75.51 127.09 36.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.21 0.529 . . . . 0.0 111.414 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.682 HD13 ' HE1' ' A' ' 22' ' ' MET . 0.7 OUTLIER -109.13 -19.65 6.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.559 179.466 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.523 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -168.92 177.47 4.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.755 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -157.46 147.78 20.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.664 179.851 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.784 ' HA ' HG11 ' A' ' 160' ' ' VAL . 50.2 t -71.51 139.17 83.74 Favored Pre-proline 0 C--N 1.332 -0.152 0 CA-C-O 121.084 0.469 . . . . 0.0 110.827 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HD2' HG13 ' A' ' 76' ' ' VAL . 36.4 Cg_endo -66.21 -52.88 0.75 Allowed 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.805 2.337 . . . . 0.0 112.916 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.716 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -101.21 174.12 6.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.314 0.578 . . . . 0.0 112.13 -178.763 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.608 ' O ' ' HA ' ' A' ' 5' ' ' SER . 46.9 m95 -92.61 95.86 9.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.487 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.651 ' CD1' HG22 ' A' ' 157' ' ' VAL . 62.4 mt -57.5 110.56 0.89 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.776 0.322 . . . . 0.0 110.823 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.626 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 3.7 p -107.21 -158.46 0.65 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.229 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.425 ' CZ ' ' HA2' ' A' ' 1' ' ' GLY . 7.2 t80 -169.26 40.05 0.03 OUTLIER 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.732 0.301 . . . . 0.0 111.239 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -73.19 162.65 29.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.869 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.748 ' HD2' HD12 ' A' ' 92' ' ' LEU . 1.1 m-85 -99.66 160.82 26.38 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.413 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.536 ' HD2' ' HD1' ' A' ' 84' ' ' PHE . 31.4 Cg_exo -58.78 -174.98 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.657 2.238 . . . . 0.0 111.528 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' A' ' 85' ' ' PRO . 54.0 Cg_endo -70.43 -9.08 25.11 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.105 1.87 . . . . 0.0 113.361 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.407 ' HG3' ' H ' ' A' ' 88' ' ' VAL . 0.2 OUTLIER -99.25 -53.05 3.34 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.2 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.588 HG11 ' CE1' ' A' ' 84' ' ' PHE . 21.1 t -72.42 -8.52 11.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.737 0.303 . . . . 0.0 111.118 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.649 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.7 OUTLIER -68.2 -2.41 8.03 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.587 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.3 -22.61 10.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.746 0.308 . . . . 0.0 110.951 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.58 -23.26 19.1 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.262 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.748 HD12 ' HD2' ' A' ' 84' ' ' PHE . 1.3 tm? -120.1 -56.21 2.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.885 0.374 . . . . 0.0 111.186 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.701 ' OD1' ' HA ' ' A' ' 101' ' ' LYS . 1.4 t-20 -51.13 -58.33 6.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.61 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.649 HD13 ' O ' ' A' ' 89' ' ' ARG . 1.7 mp -67.18 -12.93 15.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.22 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 1.2 mm-40 -76.38 -5.85 49.05 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.734 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.684 ' HB3' ' HD1' ' A' ' 100' ' ' TRP . 70.5 m95 -87.95 16.78 5.51 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.073 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.487 ' O ' ' CB ' ' A' ' 98' ' ' SER . . . 79.66 0.85 85.73 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.562 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.487 ' CB ' ' O ' ' A' ' 97' ' ' GLY . 2.2 p 89.29 161.2 0.06 Allowed 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 122.75 0.42 . . . . 0.0 111.572 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 65.42 19.61 11.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.11 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.746 ' CZ3' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -116.32 -30.61 5.87 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.478 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.701 ' HA ' ' OD1' ' A' ' 93' ' ' ASN . 0.9 OUTLIER 17.21 54.92 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -178.716 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 100.43 -163.78 18.93 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.896 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.626 ' O ' ' HA ' ' A' ' 81' ' ' THR . 5.5 tt0 -145.01 101.33 3.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.47 -0.365 . . . . 0.0 110.373 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.598 ' HA ' HG22 ' A' ' 81' ' ' THR . . . -90.6 112.39 24.08 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.196 0.522 . . . . 0.0 110.397 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.694 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 40.7 mt-30 -126.12 133.07 51.74 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -105.72 130.66 53.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.34 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.562 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 14.3 m95 -99.34 161.47 13.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.055 0.455 . . . . 0.0 111.735 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.495 ' CE1' ' HG2' ' A' ' 54' ' ' ARG . 98.1 m-85 -139.9 152.13 46.16 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.292 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.672 ' HG ' HD12 ' A' ' 73' ' ' ILE . 17.3 tp -99.01 134.81 41.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.458 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.577 ' CZ ' HG22 ' A' ' 72' ' ' VAL . 27.2 m-85 -136.46 144.67 44.51 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 15.2 tttt -103.94 119.95 40.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.216 177.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.702 ' CE1' HG13 ' A' ' 67' ' ' VAL . 43.0 t80 -78.37 100.46 6.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.794 0.331 . . . . 0.0 110.667 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 18.6 p -97.13 45.16 1.04 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.85 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.68 -147.93 4.75 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.058 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -119.34 149.72 41.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 0.0 111.056 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.446 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 14.7 p-10 -60.38 -38.68 84.69 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.512 0.672 . . . . 0.0 111.243 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -55.98 -3.03 0.07 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.598 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.401 ' H ' ' C ' ' A' ' 116' ' ' ASP . 1.1 tt0 -89.71 -18.88 25.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.943 0.401 . . . . 0.0 110.556 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.699 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 20.1 mt -85.0 106.21 14.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.849 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 38.3 t30 -100.54 -25.41 14.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.327 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.766 HD23 HG22 ' A' ' 65' ' ' THR . 46.5 mt 78.91 -34.41 0.16 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.206 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.932 HD23 ' HB3' ' A' ' 129' ' ' PRO . 66.9 mt -62.92 167.64 4.57 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.996 0.426 . . . . 0.0 111.22 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -152.26 2.9 0.36 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.273 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.1 p30 49.74 39.8 18.67 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.992 0.425 . . . . 0.0 111.042 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -74.13 1.49 48.4 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.331 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 65.64 24.85 11.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.94 0.37 . . . . 0.0 110.733 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.92 -59.34 0.28 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.543 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? -178.39 155.42 0.94 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.976 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.932 ' HB3' HD23 ' A' ' 122' ' ' LEU . 13.9 Cg_endo -72.61 -175.22 1.74 Allowed 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.5 2.133 . . . . 0.0 112.179 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.522 ' O ' HD12 ' A' ' 34' ' ' LEU . 3.1 mm-40 -92.7 -71.21 0.66 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.358 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.655 ' CE2' HG23 ' A' ' 65' ' ' THR . 1.9 m-85 -104.41 142.42 34.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.673 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.733 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -85.03 -37.46 10.02 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.043 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -146.24 145.39 30.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.76 0.314 . . . . 0.0 110.483 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.699 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 36.2 p-90 -135.71 170.95 15.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.27 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.5 t -167.68 178.48 5.3 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.491 0.662 . . . . 0.0 112.719 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.619 ' CD2' ' ND2' ' A' ' 23' ' ' ASN . 81.2 m95 -113.12 102.99 10.91 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.588 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 28' ' ' ILE . 25.4 m -120.83 170.44 10.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.586 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 11.1 p -75.41 173.05 7.65 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.889 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.675 ' HB3' HD22 ' A' ' 158' ' ' LEU . 12.3 Cg_exo -62.61 -54.01 1.49 Allowed 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.731 1.621 . . . . 0.0 110.381 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -63.93 -30.69 71.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.356 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.76 -43.77 65.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.474 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.665 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -59.8 -39.27 84.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.313 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.754 HG21 ' HG2' ' A' ' 155' ' ' LYS . 34.1 mm -63.04 -37.21 78.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.19 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.94 -50.81 38.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.35 0.595 . . . . 0.0 110.528 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.3 mp -73.49 -19.82 60.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.179 -0.918 . . . . 0.0 112.709 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 12.4 t -75.81 172.06 13.33 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.111 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.471 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 26.9 m -82.77 145.17 8.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.378 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.554 ' HG3' ' HE3' ' A' ' 151' ' ' LYS . 6.7 mt-10 -47.46 -50.32 23.27 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.602 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -50.2 -12.27 0.08 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -135.37 -3.91 2.38 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.62 ' HG2' HG23 ' A' ' 146' ' ' THR . 8.1 mttt -58.69 -60.71 9.5 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.379 0.133 . . . . 0.0 111.178 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.497 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 32.3 Cg_endo -64.44 -27.57 62.53 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.641 2.227 . . . . 0.0 111.754 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.797 ' O ' HG23 ' A' ' 157' ' ' VAL . 40.3 t -67.88 -50.41 59.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.501 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 8.9 m-30 -66.59 -38.54 87.23 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.021 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.754 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -57.24 -41.18 79.09 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.812 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.406 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.4 tt0 -70.09 -31.48 69.08 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 153' ' ' VAL . 51.0 t -66.9 -42.2 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.797 178.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.675 HD22 ' HB3' ' A' ' 139' ' ' PRO . 74.0 mt -63.89 -40.23 96.04 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.238 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 64.2 m -56.41 -41.79 76.93 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.784 HG11 ' HA ' ' A' ' 76' ' ' VAL . 89.3 t -66.74 -43.72 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 115.525 -0.761 . . . . 0.0 108.983 177.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.504 ' CE2' HG12 ' A' ' 157' ' ' VAL . 21.9 m-30 -81.12 7.46 11.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.436 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.692 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . . . -59.22 -50.45 87.56 Favored Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.755 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.692 ' HD3' ' HB3' ' A' ' 162' ' ' ALA . 34.0 Cg_exo -59.41 -13.05 18.87 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.425 2.083 . . . . 0.0 111.58 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.523 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 86.7 m-70 -109.02 -20.75 12.92 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.294 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.509 HD23 ' HZ1' ' A' ' 26' ' ' LYS . 83.8 mt . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.942 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.953 0 N-CA-C 112.194 -0.362 . . . . 0.0 112.194 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.37 132.72 49.87 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.567 2.178 . . . . 0.0 111.75 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 1.067 HD21 HG22 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -92.39 141.48 28.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.072 0.463 . . . . 0.0 111.161 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.482 ' C ' ' HG ' ' A' ' 5' ' ' SER . . . -96.97 12.53 65.63 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.661 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.966 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 97.5 p 55.45 -89.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' A' ' 5' ' ' SER . 1.9 mpp? 67.39 122.37 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.847 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.697 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 12.4 p-10 -69.37 -32.46 71.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.015 0.436 . . . . 0.0 110.759 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.458 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 29.8 m -103.07 134.23 19.9 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.203 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.441 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 68.7 Cg_endo -74.79 104.41 1.88 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.26 1.974 . . . . 0.0 112.317 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.584 ' HG2' ' CD2' ' A' ' 13' ' ' TYR . 6.2 Cg_endo -49.62 163.6 0.45 Allowed 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 123.107 2.538 . . . . 0.0 112.665 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -51.01 130.41 25.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.651 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.84 87.89 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.504 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.657 ' CZ ' ' HG3' ' A' ' 101' ' ' LYS . 8.2 m-85 -154.21 153.72 32.26 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.611 ' HG2' HD21 ' A' ' 16' ' ' ASN . 0.2 OUTLIER -65.23 -158.18 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.543 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.655 ' HG2' HD12 ' A' ' 47' ' ' ILE . 23.2 ttt180 179.98 101.34 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.212 0.53 . . . . 0.0 109.751 -178.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.611 HD21 ' HG2' ' A' ' 14' ' ' ARG . 23.7 m-80 -130.9 171.68 12.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.981 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.701 HG13 HD11 ' A' ' 47' ' ' ILE . 22.4 m -134.26 163.34 37.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.14 0.495 . . . . 0.0 111.199 178.172 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.615 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -138.66 157.87 24.82 Favored Glycine 0 N--CA 1.442 -0.955 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.301 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.659 HG21 HD13 ' A' ' 61' ' ' LEU . 2.1 mp -128.56 118.22 46.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.588 ' O ' HD12 ' A' ' 109' ' ' LEU . 50.3 t -96.82 98.34 10.05 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 177.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.629 HD21 ' HD1' ' A' ' 112' ' ' PHE . 32.0 tp -99.29 116.18 30.87 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.106 -177.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.891 ' HE2' HD13 ' A' ' 73' ' ' ILE . 1.6 ptt? -119.66 161.77 20.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.027 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.52 ' N ' ' OD1' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -94.45 171.32 8.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.092 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -57.34 -5.53 0.32 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.703 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.575 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.6 OUTLIER -99.37 3.04 45.79 Favored 'General case' 0 CA--C 1.521 -0.136 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.877 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 11.0 mmtp 73.71 21.88 2.68 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.986 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.613 ' O ' ' HA ' ' A' ' 22' ' ' MET . 2.3 mmtt -92.66 143.17 26.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.729 HD11 ' HG3' ' A' ' 139' ' ' PRO . 1.4 mm -98.96 138.0 24.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.17 0.51 . . . . 0.0 112.283 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.608 ' CE1' HD13 ' A' ' 119' ' ' ILE . 78.1 t80 -75.05 136.67 41.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.398 177.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.715 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -140.33 151.48 45.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.679 0.275 . . . . 0.0 111.102 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -141.34 138.14 32.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.33 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.69 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 43.9 p -95.69 144.87 25.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.66 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.457 ' NE ' HD12 ' A' ' 36' ' ' ILE . 35.1 mtp180 -69.68 136.15 50.71 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.213 0.53 . . . . 0.0 111.318 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.93 ' H ' HD23 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -42.11 -48.9 4.82 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.583 -178.947 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -71.69 -33.25 68.64 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.95 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.457 HD12 ' NE ' ' A' ' 33' ' ' ARG . 2.8 mt -122.45 110.46 32.24 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.758 0.313 . . . . 0.0 111.531 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.6 -18.77 15.15 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.449 2.099 . . . . 0.0 112.382 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -91.73 -10.45 40.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.352 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.693 ' HB1' ' CG1' ' A' ' 147' ' ' VAL . . . -91.2 96.47 10.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.564 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.69 ' O ' ' HA ' ' A' ' 146' ' ' THR . 76.0 m95 -90.86 147.59 23.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.682 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -154.84 169.73 23.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.471 0.653 . . . . 0.0 111.667 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.505 ' HB2' ' HE2' ' A' ' 42' ' ' MET . 19.3 mtm -107.3 147.2 34.78 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.176 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.484 ' CG ' HD12 ' A' ' 61' ' ' LEU . 5.3 Cg_endo -48.8 136.88 27.91 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.459 2.106 . . . . 0.0 111.525 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.504 ' HA ' HD12 ' A' ' 19' ' ' ILE . 3.1 pp0? -173.08 155.01 2.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.996 0.427 . . . . 0.0 111.269 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.484 ' O ' ' HB3' ' A' ' 16' ' ' ASN . . . -156.04 -165.1 14.04 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.571 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.569 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -95.71 -148.72 24.64 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.209 -0.996 . . . . 0.0 113.243 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.701 HD11 HG13 ' A' ' 17' ' ' VAL . 3.0 mt -163.04 125.92 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.545 -0.328 . . . . 0.0 110.488 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.29 169.51 16.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.083 0.468 . . . . 0.0 111.122 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -46.25 -62.22 1.44 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.696 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -99.88 42.35 1.99 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.775 -0.726 . . . . 0.0 113.089 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -119.64 128.81 54.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.553 0.216 . . . . 0.0 110.571 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -69.13 164.61 46.59 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.592 ' HA ' HG11 ' A' ' 17' ' ' VAL . 3.4 Cg_exo -76.81 -48.05 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.65 2.233 . . . . 0.0 111.912 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.755 HH21 HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -55.84 -43.87 77.43 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.21 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 73.9 m-20 -66.92 -45.13 78.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.293 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.29 -43.79 98.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.605 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -57.37 -61.14 2.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.902 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.546 HG12 ' CE2' ' A' ' 110' ' ' PHE . 25.4 mt -54.61 -48.65 70.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.393 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 13.5 ttt180 -64.96 -62.24 1.67 Allowed 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 121.066 -0.254 . . . . 0.0 111.078 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -42.53 -48.68 5.35 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-O 120.908 0.385 . . . . 0.0 110.101 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.659 HD13 HG21 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -51.25 -47.84 62.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.267 178.761 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.9 ' HG3' HG23 ' A' ' 68' ' ' THR . 9.0 ttm180 -63.94 -65.28 0.7 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.124 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -48.62 -19.94 0.4 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -98.82 -35.37 10.14 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.795 HG22 HD23 ' A' ' 121' ' ' LEU . 0.7 OUTLIER -124.68 -6.93 7.4 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 120.326 -0.549 . . . . 0.0 112.319 -178.932 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 79.56 -12.35 28.09 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.488 -178.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.717 HG22 HG12 ' A' ' 119' ' ' ILE . 78.9 t -57.43 121.8 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 121.164 0.506 . . . . 0.0 111.306 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.9 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.6 OUTLIER -131.78 -38.22 1.14 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.808 178.637 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 113' ' ' THR . 5.8 m -61.24 71.75 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.894 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -159.81 153.34 22.52 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.097 0.475 . . . . 0.0 112.212 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -128.19 151.73 48.9 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.845 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.799 HG22 ' CE2' ' A' ' 110' ' ' PHE . 10.8 t -75.43 132.66 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 121.313 0.577 . . . . 0.0 111.575 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.891 HD13 ' HE2' ' A' ' 22' ' ' MET . 1.7 mt -109.85 -18.79 7.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.932 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.489 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.22 176.03 4.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.604 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -152.71 145.58 24.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.452 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.735 ' HA ' HG11 ' A' ' 160' ' ' VAL . 52.9 t -71.94 134.67 83.27 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.142 0.496 . . . . 0.0 111.208 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.522 ' HD2' HG13 ' A' ' 76' ' ' VAL . 33.0 Cg_endo -67.39 -56.87 0.2 Allowed 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.912 2.408 . . . . 0.0 113.01 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.697 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 1.3 p90 -97.29 178.28 5.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.813 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.582 ' O ' HD23 ' A' ' 80' ' ' LEU . 56.1 m95 -94.83 -158.58 0.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.47 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.966 ' HA ' ' HA ' ' A' ' 5' ' ' SER . 13.1 mt -159.87 103.24 1.5 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.127 0.489 . . . . 0.0 110.359 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.89 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 7.2 p -115.02 100.66 8.35 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.35 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.631 ' CD2' HD23 ' A' ' 3' ' ' LEU . 0.1 OUTLIER -83.03 91.93 7.28 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.135 178.606 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.422 ' HB3' ' H ' ' A' ' 84' ' ' PHE . 1.9 m-20 -69.53 -136.88 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.868 ' HB2' HD12 ' A' ' 92' ' ' LEU . 0.6 OUTLIER -176.96 156.03 1.26 Allowed Pre-proline 0 N--CA 1.466 0.369 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.623 ' HD2' ' HD1' ' A' ' 84' ' ' PHE . 41.6 Cg_exo -58.35 -176.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.429 2.086 . . . . 0.0 111.043 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 85' ' ' PRO . 39.2 Cg_endo -66.6 -11.23 30.91 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.341 2.027 . . . . 0.0 113.188 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -86.18 -62.8 1.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.631 0.253 . . . . 0.0 111.194 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.564 ' HB ' ' CG ' ' A' ' 84' ' ' PHE . 3.2 t -70.57 -20.73 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.291 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.573 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -48.42 -27.03 2.38 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.896 0.379 . . . . 0.0 110.408 179.54 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.811 ' HA ' HD13 ' A' ' 94' ' ' ILE . 7.1 mt-10 -68.24 -64.04 0.94 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.051 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.448 ' O ' ' HG2' ' A' ' 95' ' ' GLN . 13.5 mttt -66.2 -6.46 13.69 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.763 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.868 HD12 ' HB2' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -99.35 -63.69 1.1 Allowed 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.17 179.089 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.553 ' ND2' ' HB3' ' A' ' 101' ' ' LYS . 59.7 t-20 -81.41 -50.38 9.52 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.811 HD13 ' HA ' ' A' ' 90' ' ' GLU . 3.0 mp -68.52 -8.36 9.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.723 -178.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -80.7 -3.13 49.59 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.574 0.226 . . . . 0.0 111.056 178.526 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.524 ' CD1' ' O ' ' A' ' 92' ' ' LEU . 81.5 m95 -108.17 -55.38 2.38 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.826 0.346 . . . . 0.0 111.55 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 171.57 -81.39 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.36 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -170.01 25.98 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.343 0.592 . . . . 0.0 111.755 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -131.25 -54.22 1.03 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.941 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.586 ' CZ3' ' HA ' ' A' ' 14' ' ' ARG . 43.2 m95 -54.62 -175.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.079 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.657 ' HG3' ' CZ ' ' A' ' 13' ' ' TYR . 4.2 ptpt 164.6 9.26 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.403 ' HA2' HD21 ' A' ' 92' ' ' LEU . . . 175.23 -161.7 31.01 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.347 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.89 ' O ' ' HA ' ' A' ' 81' ' ' THR . 7.1 mt-30 -146.36 117.66 7.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.199 0.499 . . . . 0.0 111.427 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.696 ' HB2' HG22 ' A' ' 81' ' ' THR . . . -94.02 122.75 36.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.018 0.437 . . . . 0.0 111.791 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.865 ' HG2' ' HB2' ' A' ' 80' ' ' LEU . 1.0 OUTLIER -129.2 118.82 23.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.875 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 78' ' ' TYR . 16.3 ttpp -102.91 129.07 49.5 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.939 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.615 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 22.7 m95 -102.38 165.18 11.26 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -177.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.518 ' CZ ' ' HB2' ' A' ' 53' ' ' PRO . 96.5 m-85 -137.53 153.94 49.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.546 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.588 HD12 ' O ' ' A' ' 20' ' ' CYS . 16.8 tp -101.08 139.46 36.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.402 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.799 ' CE2' HG22 ' A' ' 72' ' ' VAL . 34.0 m-85 -141.88 145.97 35.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.555 0.693 . . . . 0.0 112.828 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.706 ' HB2' HD11 ' A' ' 73' ' ' ILE . 18.7 tttt -104.69 123.3 47.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.917 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.629 ' HD1' HD21 ' A' ' 21' ' ' LEU . 46.5 t80 -78.6 95.32 5.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.868 0.366 . . . . 0.0 110.663 179.115 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.419 ' N ' ' O ' ' A' ' 69' ' ' SER . 65.7 p -94.16 50.89 1.43 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.876 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -151.99 -143.43 3.7 Favored Glycine 0 N--CA 1.453 -0.217 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.055 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -124.97 150.0 47.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.368 . . . . 0.0 111.244 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.476 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 20.3 p-10 -57.07 -39.03 74.16 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.519 0.676 . . . . 0.0 111.143 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -58.21 -4.58 0.37 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.101 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -89.62 -17.02 29.24 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.079 0.466 . . . . 0.0 110.128 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.717 HG12 HG22 ' A' ' 67' ' ' VAL . 7.6 mt -78.77 99.88 3.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.33 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.98 91.08 3.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.529 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.795 HD23 HG22 ' A' ' 65' ' ' THR . 0.6 OUTLIER -69.93 -14.27 62.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.73 0.3 . . . . 0.0 110.631 179.74 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.494 ' CD2' ' HG3' ' A' ' 129' ' ' PRO . 2.9 mt -106.72 -165.69 1.1 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.886 -179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 121.14 128.09 3.5 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.472 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 57.56 -179.07 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.82 0.343 . . . . 0.0 110.906 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -65.51 -84.27 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.207 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . 0.438 ' C ' ' H ' ' A' ' 128' ' ' LYS . 0.1 OUTLIER 59.21 15.04 3.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.462 0.172 . . . . 0.0 111.289 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 70.09 -41.64 0.49 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.614 0.245 . . . . 0.0 111.475 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.438 ' H ' ' C ' ' A' ' 126' ' ' SER . 0.0 OUTLIER -178.0 157.84 1.15 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.935 0.398 . . . . 0.0 110.654 179.396 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.494 ' HG3' ' CD2' ' A' ' 122' ' ' LEU . 2.3 Cg_endo -65.95 -174.08 0.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.948 1.766 . . . . 0.0 111.587 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.663 ' C ' HD21 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -99.73 -34.84 10.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.298 0.57 . . . . 0.0 109.74 179.408 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.648 ' N ' HD21 ' A' ' 34' ' ' LEU . 4.9 m-85 -133.78 139.18 46.16 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.758 ' N ' HD22 ' A' ' 34' ' ' LEU . . . -77.58 -35.79 35.52 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.848 -178.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -156.13 152.01 27.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.872 0.368 . . . . 0.0 111.083 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.64 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 27.5 p-90 -133.15 163.99 28.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.197 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.489 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 13.4 t -158.95 167.33 29.66 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.157 0.503 . . . . 0.0 112.072 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.473 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 37.3 m95 -103.44 102.84 12.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.4 177.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 28' ' ' ILE . 26.4 m -118.21 164.91 14.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.593 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 26.8 p -71.64 168.98 17.52 Favored Pre-proline 0 C--N 1.325 -0.474 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.408 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.729 ' HG3' HD11 ' A' ' 28' ' ' ILE . 16.2 Cg_exo -58.91 -58.82 0.57 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 121.72 1.613 . . . . 0.0 110.826 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.28 -27.16 68.83 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.794 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.526 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 12.2 mt-30 -71.69 -47.47 53.85 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.205 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.715 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -56.24 -41.28 75.48 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.637 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.816 HG21 ' HG2' ' A' ' 155' ' ' LYS . 19.1 mm -61.44 -34.57 61.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.219 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.39 -50.92 23.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.262 0.553 . . . . 0.0 110.858 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.2 mp -73.49 -21.47 60.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.311 -0.858 . . . . 0.0 112.281 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.69 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 12.1 t -73.61 174.81 7.78 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.918 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.693 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 33.0 m -80.02 160.2 4.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.688 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.47 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 2.4 mt-10 -60.59 -51.9 67.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.07 0.462 . . . . 0.0 110.915 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.24 -7.65 0.15 Allowed 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -131.43 -6.38 3.75 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.612 ' HG3' HG22 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -61.74 -53.57 59.55 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 110.543 -0.169 . . . . 0.0 110.543 179.499 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 39.5 Cg_endo -67.97 -28.88 35.03 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.259 1.973 . . . . 0.0 111.347 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 1.067 HG22 HD21 ' A' ' 3' ' ' LEU . 17.3 t -68.47 -52.83 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.469 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 6.1 m-30 -65.75 -37.1 85.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.784 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.816 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -57.46 -41.61 80.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.591 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.481 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.6 OUTLIER -68.35 -34.32 75.88 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.465 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 153' ' ' VAL . 53.8 t -64.9 -41.17 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.347 178.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.606 HD22 ' HB3' ' A' ' 139' ' ' PRO . 56.7 mt -63.65 -48.91 75.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.666 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -49.2 -40.1 32.16 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.735 HG11 ' HA ' ' A' ' 76' ' ' VAL . 58.5 t -67.63 -42.91 87.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.328 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.63 ' CE2' HG12 ' A' ' 157' ' ' VAL . 21.9 m-30 -80.71 5.15 16.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.38 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.607 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.85 -53.36 67.22 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.628 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.7 Cg_endo -58.77 -13.2 17.09 Favored 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 122.17 1.914 . . . . 0.0 111.729 178.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.489 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 95.1 m-70 -107.06 -19.08 13.73 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.205 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 96.5 mt . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.807 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 112.566 -0.213 . . . . 0.0 112.566 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.54 -179.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.551 2.168 . . . . 0.0 111.673 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.561 HD21 HG22 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -91.17 165.42 13.49 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.028 0.442 . . . . 0.0 111.377 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -115.08 -29.31 2.6 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.615 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . 1.02 ' HB3' HD23 ' A' ' 80' ' ' LEU . 0.3 OUTLIER 63.16 138.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.2 0.524 . . . . 0.0 111.577 179.574 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 4.1 mtm -144.58 155.94 43.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.383 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.526 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 12.2 t70 -64.55 -47.59 78.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.916 0.389 . . . . 0.0 110.54 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.425 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 0.8 OUTLIER -100.18 148.96 35.58 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.107 179.087 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.533 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 57.7 Cg_endo -71.86 105.33 1.78 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.259 1.973 . . . . 0.0 112.06 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.691 ' CG ' HG21 ' A' ' 81' ' ' THR . 6.2 Cg_endo -49.43 166.53 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 123.122 2.548 . . . . 0.0 113.043 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -53.45 130.91 37.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.057 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.511 ' CA ' ' HA ' ' A' ' 100' ' ' TRP . . . 56.25 81.89 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.293 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.648 ' CE1' ' HB ' ' A' ' 81' ' ' THR . 35.4 m-85 -154.16 119.7 5.18 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.769 ' HB3' ' HG3' ' A' ' 103' ' ' GLN . 8.3 ttt180 -66.56 91.28 0.18 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.054 0.454 . . . . 0.0 111.526 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.865 ' HG2' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -48.0 112.94 0.64 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.214 179.324 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.637 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 3.1 m120 -131.59 173.74 10.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.46 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.615 HG13 HG13 ' A' ' 47' ' ' ILE . 6.6 m -139.55 165.32 22.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.174 0.511 . . . . 0.0 111.84 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.529 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -135.38 155.31 22.08 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 178.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.091 HG23 ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -129.67 124.51 59.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.069 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.533 ' CB ' ' HE2' ' A' ' 161' ' ' PHE . 0.5 OUTLIER -106.6 108.69 20.32 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.953 177.717 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.875 HD22 HG11 ' A' ' 67' ' ' VAL . 11.0 tp -104.19 124.3 48.87 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.582 -178.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.713 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -124.34 155.18 39.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.95 179.342 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.506 ' OD1' ' CE3' ' A' ' 136' ' ' TRP . 0.2 OUTLIER -92.85 176.04 6.58 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.05 0.452 . . . . 0.0 110.134 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.453 ' HA ' ' HE3' ' A' ' 111' ' ' LYS . 1.1 m-80 -57.24 -6.94 0.46 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.064 177.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.604 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 5.5 m-20 -100.46 -0.15 38.56 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.604 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 14.7 mmtm 76.97 19.86 1.33 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.291 -178.545 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.713 ' O ' ' HA ' ' A' ' 22' ' ' MET . 3.8 mmtt -93.57 141.58 28.31 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.69 HD12 ' N ' ' A' ' 28' ' ' ILE . 2.2 mp -101.5 143.51 14.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.669 0.747 . . . . 0.0 112.358 -178.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.657 ' CE2' HG21 ' A' ' 65' ' ' THR . 11.3 t80 -69.85 108.05 3.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.196 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.734 ' CB ' HD13 ' A' ' 142' ' ' LEU . . . -106.92 145.89 31.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.948 0.404 . . . . 0.0 110.924 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -139.5 137.52 35.57 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.236 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.808 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 25.0 p -99.19 141.75 31.55 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.998 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.581 ' NH1' ' HG2' ' A' ' 41' ' ' GLN . 1.7 mtt85 -69.59 128.34 36.14 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.728 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.5 OUTLIER -46.4 -35.73 5.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.318 0.58 . . . . 0.0 110.891 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.487 ' O ' HD13 ' A' ' 36' ' ' ILE . 4.0 m-20 -70.67 -33.97 71.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.665 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.487 HD13 ' O ' ' A' ' 35' ' ' ASP . 20.4 mm -131.05 104.75 15.16 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.914 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.55 -20.37 60.4 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.765 2.31 . . . . 0.0 112.676 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.01 -4.0 53.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.412 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.808 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.97 91.83 8.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.112 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.558 ' O ' ' HA ' ' A' ' 146' ' ' THR . 77.3 m95 -91.83 164.38 13.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.357 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.581 ' HG2' ' NH1' ' A' ' 33' ' ' ARG . 0.0 OUTLIER 174.24 175.13 0.16 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.81 0.814 . . . . 0.0 112.264 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.612 ' HG3' ' CZ3' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -108.19 156.7 37.95 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.29 177.904 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.439 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 10.1 Cg_endo -50.7 157.35 3.64 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.498 2.132 . . . . 0.0 112.665 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.99 150.62 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.6 179.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -160.9 -157.27 8.64 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.447 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.637 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -122.22 143.01 15.33 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.91 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.865 HD12 ' HG2' ' A' ' 15' ' ' ARG . 48.5 mt -70.01 146.71 12.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.916 0.389 . . . . 0.0 111.532 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -69.49 -175.08 0.77 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.72 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.51 -61.33 2.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.339 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.85 57.35 0.73 Allowed Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.689 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.426 ' O ' HG21 ' A' ' 47' ' ' ILE . 47.7 tp10 -117.17 155.7 28.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.693 0.283 . . . . 0.0 110.469 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -72.02 161.56 78.19 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 5.6 Cg_exo -78.3 -49.17 0.09 OUTLIER 'Trans proline' 0 CA--C 1.515 -0.441 0 C-N-CA 122.635 2.223 . . . . 0.0 111.73 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.814 ' HE ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -52.26 -46.92 65.99 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.47 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.454 ' HA ' HD12 ' A' ' 58' ' ' ILE . 20.2 m120 -67.71 -41.85 82.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.376 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.22 -42.26 98.29 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.091 ' HB1' HG23 ' A' ' 19' ' ' ILE . . . -57.47 -54.27 48.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.855 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.513 HD11 ' CZ ' ' A' ' 54' ' ' ARG . 21.3 mt -56.39 -53.0 45.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.854 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 59' ' ' ARG . 24.1 mtt180 -61.21 -57.71 11.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.652 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 15.1 mm-40 -46.5 -46.03 18.83 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.553 0.692 . . . . 0.0 109.709 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.955 HD21 ' HB ' ' A' ' 67' ' ' VAL . 10.1 tt -52.81 -46.69 67.81 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.959 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.827 ' HD3' HG23 ' A' ' 68' ' ' THR . 0.7 OUTLIER -62.77 -63.43 1.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.995 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -50.42 -22.54 1.92 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.357 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 8.6 mt-10 -96.74 -34.76 11.22 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -177.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.657 HG21 ' CE2' ' A' ' 29' ' ' PHE . 0.8 OUTLIER -130.29 -15.44 3.67 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.465 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.549 ' HA2' ' NE ' ' A' ' 62' ' ' ARG . . . 93.07 -16.32 60.79 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.656 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.955 ' HB ' HD21 ' A' ' 61' ' ' LEU . 74.8 t -58.15 113.86 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.262 0.553 . . . . 0.0 111.937 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.827 HG23 ' HD3' ' A' ' 62' ' ' ARG . 0.2 OUTLIER -125.87 -36.78 2.35 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.716 178.075 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.9 m -63.6 73.83 0.03 OUTLIER 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.698 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -159.28 157.06 29.85 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.898 0.38 . . . . 0.0 111.981 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.8 149.08 50.42 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.101 179.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.952 HG22 ' CE2' ' A' ' 110' ' ' PHE . 19.1 t -74.21 126.3 34.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.077 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.566 HD11 ' HB2' ' A' ' 111' ' ' LYS . 1.4 mt -105.52 -17.6 7.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.236 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.45 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -171.09 175.71 4.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.484 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.0 OUTLIER -154.06 138.65 16.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.109 179.492 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.632 ' HA ' HG11 ' A' ' 160' ' ' VAL . 52.3 t -71.33 135.27 84.43 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-O 121.178 0.513 . . . . 0.0 111.16 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.521 ' HD2' HG13 ' A' ' 76' ' ' VAL . 27.3 Cg_endo -66.16 -70.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.867 2.378 . . . . 0.0 112.027 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.53 ' O ' HG12 ' A' ' 76' ' ' VAL . 6.4 p90 -78.33 170.67 16.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.095 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.609 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 48.2 m95 -93.64 -155.14 0.43 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.467 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.02 HD23 ' HB3' ' A' ' 5' ' ' SER . 20.8 mt -161.35 106.32 1.33 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.691 HG21 ' CG ' ' A' ' 10' ' ' PRO . 20.0 p -100.79 100.62 11.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.705 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -77.63 58.94 1.88 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.833 0.349 . . . . 0.0 110.531 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.483 ' HB2' ' NE ' ' A' ' 89' ' ' ARG . 5.7 p30 -68.47 170.06 9.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.27 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.567 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 2.3 m-85 -104.77 172.22 4.29 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.664 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.567 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 52.1 Cg_exo -56.27 170.88 1.02 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.408 2.072 . . . . 0.0 112.296 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 85' ' ' PRO . 26.9 Cg_endo -61.7 -16.44 48.58 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.676 2.251 . . . . 0.0 112.71 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.22 -56.59 3.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.791 0.329 . . . . 0.0 110.547 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.465 ' HB ' ' HB3' ' A' ' 84' ' ' PHE . 14.0 t -69.06 -15.36 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.041 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.631 ' HG3' ' O ' ' A' ' 89' ' ' ARG . 12.0 tpp85 -68.44 -2.65 9.08 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.83 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.96 ' HA ' HG12 ' A' ' 94' ' ' ILE . 0.6 OUTLIER -111.43 -49.34 3.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.781 0.324 . . . . 0.0 111.66 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 56.0 mttt -65.46 -23.0 66.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.655 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.627 HD13 ' HE1' ' A' ' 96' ' ' TRP . 1.4 tm? -120.96 -59.67 1.72 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.726 ' ND2' ' HA2' ' A' ' 102' ' ' GLY . 7.7 m120 -57.24 -51.68 68.39 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -177.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.96 HG12 ' HA ' ' A' ' 90' ' ' GLU . 8.5 mm -65.89 -3.1 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.854 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.634 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.3 OUTLIER -99.96 -103.06 0.23 Allowed 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.627 ' HE1' HD13 ' A' ' 92' ' ' LEU . 65.8 m95 56.86 -60.01 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.128 0.49 . . . . 0.0 111.193 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 95' ' ' GLN . . . 168.28 -95.46 0.11 Allowed Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.3 -166.63 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.48 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 0.5 OUTLIER -67.16 79.09 0.14 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.557 0.217 . . . . 0.0 110.522 179.659 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.586 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 88.4 m95 -105.29 -167.92 1.4 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.627 ' HG2' ' HD2' ' A' ' 89' ' ' ARG . 0.0 OUTLIER 168.16 15.72 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.778 -179.416 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.726 ' HA2' ' ND2' ' A' ' 93' ' ' ASN . . . 154.55 -158.27 28.13 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.769 ' HG3' ' HB3' ' A' ' 14' ' ' ARG . 6.4 tt0 -144.93 113.34 6.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.894 0.347 . . . . 0.0 111.443 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.589 ' HB2' HG22 ' A' ' 81' ' ' THR . . . -93.13 122.12 35.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.133 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.571 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 5.2 mt-30 -128.99 127.33 41.43 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.535 ' HB2' ' CD2' ' A' ' 79' ' ' TRP . 2.0 ttpt -105.67 141.38 37.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.718 178.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.612 ' CZ3' ' HG3' ' A' ' 42' ' ' MET . 54.9 m95 -105.98 163.74 12.52 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.266 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.595 ' HB2' ' HE1' ' A' ' 110' ' ' PHE . 96.0 m-85 -141.07 152.47 44.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.895 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.695 HD11 ' SD ' ' A' ' 22' ' ' MET . 17.8 tp -101.87 143.29 31.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.13 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.999 ' CE1' HG22 ' A' ' 19' ' ' ILE . 54.8 m-85 -144.51 145.08 31.66 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.637 0.732 . . . . 0.0 112.965 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.566 ' HB2' HD11 ' A' ' 73' ' ' ILE . 4.4 tttt -104.23 126.06 51.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.737 178.253 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.636 ' CD1' HD21 ' A' ' 21' ' ' LEU . 34.9 t80 -78.99 100.74 7.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.741 0.305 . . . . 0.0 110.868 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 72.7 p -100.83 50.06 0.88 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.993 0.425 . . . . 0.0 110.952 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -154.1 -145.58 4.19 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.294 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -121.5 150.89 40.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.017 0.437 . . . . 0.0 110.973 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.505 ' HB3' ' HH2' ' A' ' 134' ' ' TRP . 44.7 m-20 -59.11 -34.72 72.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.032 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -58.96 -2.62 0.26 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.191 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.57 -15.23 33.31 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.805 0.336 . . . . 0.0 111.037 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.745 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 11.3 mt -78.54 100.3 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.828 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -102.42 92.34 4.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.099 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.718 HD11 ' HD1' ' A' ' 134' ' ' TRP . 38.0 mt -67.48 -57.62 6.2 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.159 0.504 . . . . 0.0 110.036 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.41 HD22 ' HB3' ' A' ' 129' ' ' PRO . 2.4 mm? -71.46 -176.02 1.43 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.356 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 111.94 -3.09 27.2 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.003 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.82 81.41 3.14 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.786 0.327 . . . . 0.0 111.044 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -77.0 59.25 3.53 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.337 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 98.5 p -120.31 -55.01 2.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.14 0.495 . . . . 0.0 110.771 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -146.91 -46.72 0.18 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.476 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.52 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 0.1 OUTLIER -178.05 156.89 1.09 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 121.27 0.557 . . . . 0.0 111.343 178.767 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.52 ' HD2' ' HB2' ' A' ' 128' ' ' LYS . 28.6 Cg_endo -69.72 -179.9 3.22 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 123.104 2.536 . . . . 0.0 112.808 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.571 ' O ' HD12 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -89.76 -70.67 0.65 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.673 179.713 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.531 ' CE1' HG23 ' A' ' 65' ' ' THR . 2.6 m-85 -106.67 142.6 36.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.497 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.728 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -80.77 -36.01 23.58 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.478 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.51 155.54 36.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.261 -0.47 . . . . 0.0 110.274 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.745 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 25.0 p-90 -140.45 167.53 21.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.159 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.546 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 26.6 t -163.01 176.13 10.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.286 0.565 . . . . 0.0 111.533 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.506 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 64.5 m95 -111.75 103.73 12.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.48 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.415 HG23 ' HB2' ' A' ' 142' ' ' LEU . 26.0 m -121.67 171.54 10.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.375 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.634 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 10.9 p -74.15 177.03 2.34 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 1.003 ' HB2' HD21 ' A' ' 158' ' ' LEU . 13.9 Cg_endo -74.27 -47.37 0.25 Allowed 'Trans proline' 0 N--CA 1.443 -1.481 0 C-N-CA 121.242 1.294 . . . . 0.0 109.964 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.4 -32.89 73.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.9 177.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.61 -47.97 57.46 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.021 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.734 HD13 ' CB ' ' A' ' 30' ' ' ALA . 23.9 tp -60.75 -37.61 82.38 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.715 ' O ' HG22 ' A' ' 146' ' ' THR . 31.1 mm -59.19 -40.09 80.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 121.373 0.606 . . . . 0.0 109.468 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.29 -51.67 34.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.127 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.468 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -72.76 -17.94 61.55 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.97 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.715 HG22 ' O ' ' A' ' 143' ' ' ILE . 14.2 t -74.64 -175.94 2.62 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.063 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.694 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 28.7 m -87.74 151.41 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.06 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.702 ' HG2' ' N ' ' A' ' 149' ' ' PHE . 0.6 OUTLIER -58.76 -53.41 58.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.938 0.399 . . . . 0.0 111.368 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.702 ' N ' ' HG2' ' A' ' 148' ' ' GLU . 48.0 p90 -56.18 -3.35 0.09 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.452 ' HE2' ' CE2' ' A' ' 149' ' ' PHE . 0.7 OUTLIER -133.14 -4.84 3.06 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.757 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.655 ' HG2' ' O ' ' A' ' 143' ' ' ILE . 9.1 mttt -62.37 -59.99 11.31 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.48 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 13.6 Cg_endo -56.57 -26.07 62.39 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.25 1.966 . . . . 0.0 111.635 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.561 HG22 HD21 ' A' ' 3' ' ' LEU . 12.1 t -68.69 -54.16 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.545 ' O ' ' HB ' ' A' ' 157' ' ' VAL . 4.9 m-30 -65.3 -37.05 85.96 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.807 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.428 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -57.31 -40.46 77.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.264 179.585 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.411 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.9 OUTLIER -66.68 -29.39 69.39 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.075 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.545 ' HB ' ' O ' ' A' ' 154' ' ' TYR . 88.9 t -64.67 -39.23 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.216 179.133 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 1.003 HD21 ' HB2' ' A' ' 139' ' ' PRO . 0.2 OUTLIER -61.33 -50.1 74.3 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.074 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.4 m -51.95 -43.05 63.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.932 0.396 . . . . 0.0 110.028 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.632 HG11 ' HA ' ' A' ' 76' ' ' VAL . 50.0 t -68.15 -42.2 84.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.346 0.593 . . . . 0.0 109.433 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.544 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 13.2 m-30 -81.28 5.14 18.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.739 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.616 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.44 -52.14 76.38 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.692 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 17.8 Cg_endo -59.72 -12.06 16.71 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.263 1.975 . . . . 0.0 112.045 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.528 ' O ' ' HE3' ' A' ' 26' ' ' LYS . 92.3 m-70 -109.17 -20.77 12.87 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.337 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 94.0 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.974 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.148 0 N-CA-C 112.172 -0.371 . . . . 0.0 112.172 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.442 ' HB2' ' HB2' ' A' ' 152' ' ' PRO . 53.3 Cg_exo -52.32 149.59 22.33 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.553 2.168 . . . . 0.0 112.077 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.717 ' CD1' HG22 ' A' ' 153' ' ' VAL . 0.0 OUTLIER 48.38 -175.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.093 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -124.35 -53.46 0.19 Allowed Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.991 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . 1.005 ' HB3' HD23 ' A' ' 80' ' ' LEU . 0.3 OUTLIER 65.23 129.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.791 0.329 . . . . 0.0 111.345 179.486 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.479 ' C ' ' HB2' ' A' ' 78' ' ' TYR . 0.7 OUTLIER -145.89 149.28 33.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.49 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.673 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 1.8 t0 -65.46 -6.47 10.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.319 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.456 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 0.7 OUTLIER -145.16 128.93 8.63 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.391 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.479 ' HG3' ' HD2' ' A' ' 15' ' ' ARG . 56.7 Cg_endo -69.74 104.53 1.33 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.674 2.249 . . . . 0.0 112.563 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.594 ' HG2' ' CE2' ' A' ' 13' ' ' TYR . 6.2 Cg_endo -49.94 165.49 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.282 2.655 . . . . 0.0 112.801 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.65 132.95 31.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.126 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.729 ' CA ' ' HA ' ' A' ' 100' ' ' TRP . . . 71.02 67.38 1.9 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.733 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.594 ' CE2' ' HG2' ' A' ' 10' ' ' PRO . 10.3 m-85 -153.33 119.5 5.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.526 0.203 . . . . 0.0 110.673 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.593 ' HA ' ' HZ3' ' A' ' 100' ' ' TRP . 7.4 tpt180 -66.36 94.7 0.28 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.51 0.671 . . . . 0.0 111.886 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.626 ' HG3' ' CZ3' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -52.74 112.83 0.91 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.218 178.493 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.991 ' HB2' ' HG2' ' A' ' 105' ' ' GLN . 3.0 m120 -135.48 172.86 12.4 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.978 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.706 HG13 ' CG1' ' A' ' 47' ' ' ILE . 5.3 m -136.98 168.7 21.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.592 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -140.45 154.6 24.23 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.388 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.011 HG23 ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -129.05 125.33 62.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.158 0.504 . . . . 0.0 111.98 -178.851 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.526 ' O ' HD12 ' A' ' 109' ' ' LEU . 43.4 t -104.57 102.85 12.46 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 178.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.887 HD22 HG11 ' A' ' 67' ' ' VAL . 24.7 tp -104.14 119.2 38.42 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.366 0.603 . . . . 0.0 111.659 -178.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.689 ' HE3' HD13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -119.86 158.92 25.63 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.786 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.714 ' ND2' ' CD2' ' A' ' 136' ' ' TRP . 77.6 m-20 -98.02 179.1 4.89 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.806 0.812 . . . . 0.0 111.819 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -58.44 -6.55 0.7 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.354 -1.293 . . . . 0.0 111.464 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.546 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.6 OUTLIER -101.21 3.39 40.92 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.726 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 3.1 mmpp? 72.08 22.53 3.67 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -178.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 22' ' ' MET . 10.3 mttt -95.02 149.97 20.67 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.725 HG13 ' HA ' ' A' ' 139' ' ' PRO . 1.9 mm -100.98 138.51 24.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.3 0.571 . . . . 0.0 111.519 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.627 ' CE1' HD13 ' A' ' 119' ' ' ILE . 72.6 t80 -73.63 133.62 43.49 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.358 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.828 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -133.53 152.68 51.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.82 0.343 . . . . 0.0 111.175 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.556 ' HB1' ' CB ' ' A' ' 131' ' ' PHE . . . -145.4 136.19 24.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.939 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.644 ' HA ' ' NH2' ' A' ' 33' ' ' ARG . 39.3 p -99.41 147.73 24.95 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.99 0.424 . . . . 0.0 111.829 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.644 ' NH2' ' HA ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -69.9 131.38 44.35 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.933 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.758 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.5 OUTLIER -57.13 51.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 179.694 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.619 ' N ' ' O ' ' A' ' 33' ' ' ARG . 0.6 OUTLIER -175.31 -26.69 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.666 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.517 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 5.3 mm -119.92 106.54 41.27 Favored Pre-proline 0 CA--C 1.53 0.189 0 CA-C-O 120.968 0.413 . . . . 0.0 110.649 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.22 -63.76 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.447 2.765 . . . . 0.0 114.019 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -64.91 0.47 1.19 Allowed 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.54 ' HB1' ' HE ' ' A' ' 33' ' ' ARG . . . -90.56 110.91 22.04 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 120.528 0.204 . . . . 0.0 110.838 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.705 ' O ' ' HA ' ' A' ' 146' ' ' THR . 74.4 m95 -118.78 150.57 39.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.746 0.308 . . . . 0.0 110.611 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.581 ' HG3' ' NH2' ' A' ' 33' ' ' ARG . 67.0 mt-30 -157.96 173.4 16.82 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.385 0.612 . . . . 0.0 111.687 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.438 ' SD ' HG21 ' A' ' 28' ' ' ILE . 3.3 mtm -106.63 152.77 40.84 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.958 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.527 ' O ' HG12 ' A' ' 19' ' ' ILE . 12.5 Cg_endo -55.68 144.22 76.5 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.124 1.883 . . . . 0.0 111.499 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.433 ' CB ' ' HA2' ' A' ' 18' ' ' GLY . 3.9 pt20 -175.94 157.14 1.86 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.819 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.43 ' HA3' ' OE1' ' A' ' 60' ' ' GLU . . . -161.89 -159.42 10.16 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.469 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.61 ' C ' HG13 ' A' ' 47' ' ' ILE . . . -99.4 -148.72 23.43 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.595 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.706 ' CG1' HG13 ' A' ' 17' ' ' VAL . 7.5 mt -158.68 141.03 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 122.803 0.441 . . . . 0.0 110.077 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -67.84 -173.45 0.35 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.336 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.54 -81.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.41 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -107.49 54.88 0.54 Allowed Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.06 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -112.07 136.78 51.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.773 0.32 . . . . 0.0 110.928 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.479 ' HB2' ' ND2' ' A' ' 55' ' ' ASN . 13.5 m-20 -66.52 147.46 98.96 Favored Pre-proline 0 N--CA 1.453 -0.285 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.34 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.572 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 23.1 Cg_exo -64.37 -48.51 4.5 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 123.077 2.518 . . . . 0.0 113.393 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.887 ' HE ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -45.72 -50.83 13.34 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.603 -179.428 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.479 ' ND2' ' HB2' ' A' ' 52' ' ' ASP . 22.2 p30 -65.7 -42.07 91.6 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.7 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.446 ' N ' ' OD1' ' A' ' 55' ' ' ASN . . . -60.29 -41.9 94.34 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.011 ' HB1' HG23 ' A' ' 19' ' ' ILE . . . -57.78 -53.37 58.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.247 178.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.783 HD11 ' NE ' ' A' ' 54' ' ' ARG . 33.0 mt -60.26 -52.32 62.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.932 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.68 -56.66 17.33 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.353 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.43 ' OE1' ' HA3' ' A' ' 45' ' ' GLY . 47.4 mm-40 -47.78 -47.31 30.86 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.902 HD21 ' HB ' ' A' ' 67' ' ' VAL . 10.2 tt -50.68 -50.46 54.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.873 178.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.82 ' HG3' HG23 ' A' ' 68' ' ' THR . 32.9 ttt180 -61.55 -63.24 1.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.492 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -49.85 -19.36 0.65 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.25 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -101.28 -35.38 9.28 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.584 HG21 ' CE2' ' A' ' 29' ' ' PHE . 1.3 p -126.08 -1.23 7.12 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.74 -13.12 4.3 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.027 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.902 ' HB ' HD21 ' A' ' 61' ' ' LEU . 71.1 t -58.52 111.57 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-O 121.106 0.479 . . . . 0.0 111.273 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.82 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.8 OUTLIER -121.6 -41.44 2.48 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.921 178.973 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 113' ' ' THR . 20.3 m -59.95 74.14 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.33 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.522 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.76 156.72 23.22 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.33 151.64 50.61 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.478 179.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.967 HG22 ' CE2' ' A' ' 110' ' ' PHE . 6.5 t -75.95 127.61 37.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.527 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.689 HD13 ' HE3' ' A' ' 22' ' ' MET . 1.2 mt -106.68 -19.72 6.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.799 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.504 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.54 176.68 4.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.955 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -154.76 146.16 23.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.422 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.886 ' HA ' HG11 ' A' ' 160' ' ' VAL . 54.3 t -70.71 136.82 85.57 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.624 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.522 ' HD2' HG11 ' A' ' 160' ' ' VAL . 17.5 Cg_endo -55.48 -62.44 0.27 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.901 2.401 . . . . 0.0 112.568 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.673 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -100.47 -175.87 3.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.371 -179.186 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.643 ' CD1' ' HD3' ' A' ' 106' ' ' LYS . 40.4 m95 -90.05 -160.09 0.66 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.007 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.005 HD23 ' HB3' ' A' ' 5' ' ' SER . 36.2 mt -162.18 106.92 1.2 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.843 HG22 ' HA ' ' A' ' 104' ' ' ALA . 9.7 p -103.47 -174.35 2.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.192 0.52 . . . . 0.0 111.704 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.54 ' CE2' HD22 ' A' ' 3' ' ' LEU . 0.2 OUTLIER -171.39 69.11 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.012 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -71.92 160.24 32.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.527 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.545 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 27.5 m-85 -97.61 171.52 5.86 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.113 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.546 ' HB3' ' HD2' ' A' ' 86' ' ' PRO . 43.7 Cg_exo -56.92 -178.03 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.759 2.306 . . . . 0.0 111.828 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 85' ' ' PRO . 35.3 Cg_endo -65.04 -24.49 59.8 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.368 2.046 . . . . 0.0 112.566 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.21 -62.68 1.47 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.285 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.515 ' HB ' ' HB3' ' A' ' 84' ' ' PHE . 22.0 t -66.26 -18.06 23.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.45 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.645 ' O ' ' HB2' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -57.35 -24.51 55.62 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.733 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.584 ' HA ' ' CD1' ' A' ' 94' ' ' ILE . 0.9 OUTLIER -104.44 -11.29 17.15 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.664 -179.453 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.639 ' O ' ' HB2' ' A' ' 95' ' ' GLN . 0.1 OUTLIER -86.86 -47.83 8.7 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.369 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.572 HD13 ' N ' ' A' ' 93' ' ' ASN . 1.1 tm? -102.66 -55.86 2.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.149 0.499 . . . . 0.0 111.16 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.745 ' O ' ' HB2' ' A' ' 100' ' ' TRP . 94.1 m-20 -52.35 -34.35 47.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.685 -177.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.642 HD12 ' O ' ' A' ' 89' ' ' ARG . 1.1 mp -93.3 -12.97 8.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.385 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.639 ' HB2' ' O ' ' A' ' 91' ' ' LYS . 2.4 tp60 -64.44 -4.56 4.06 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.131 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.797 ' HB2' ' CD1' ' A' ' 100' ' ' TRP . 63.5 m95 -84.9 10.18 12.39 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.625 0.232 . . . . 0.0 111.625 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 55.6 41.86 83.0 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.297 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.604 ' HB2' ' HE1' ' A' ' 100' ' ' TRP . 0.4 OUTLIER -175.13 27.96 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.327 0.584 . . . . 0.0 111.474 179.757 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.488 ' O ' ' HA ' ' A' ' 94' ' ' ILE . 2.7 t70 74.98 -69.71 0.17 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.255 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.797 ' CD1' ' HB2' ' A' ' 96' ' ' TRP . 58.6 m95 50.75 -150.81 0.24 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.471 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.698 ' HA ' ' HB3' ' A' ' 93' ' ' ASN . 11.9 ttmt 170.64 11.98 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.602 0.361 . . . . 0.0 111.968 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.534 ' HA2' ' OD1' ' A' ' 93' ' ' ASN . . . 148.66 -162.23 28.83 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.211 -179.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.538 ' HA ' ' N ' ' A' ' 14' ' ' ARG . 0.4 OUTLIER -142.18 126.07 17.16 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 117.455 0.628 . . . . 0.0 111.413 179.773 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.843 ' HA ' HG22 ' A' ' 81' ' ' THR . . . -97.22 127.77 43.49 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.869 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.991 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 45.8 mt-30 -130.33 124.66 32.81 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -178.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.643 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 16.3 ttpp -103.41 138.1 40.61 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.98 178.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.592 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 14.3 m95 -104.76 165.21 11.22 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.346 0.593 . . . . 0.0 112.428 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.695 ' HB2' ' HE1' ' A' ' 110' ' ' PHE . 96.1 m-85 -142.17 152.49 43.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.0 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.526 HD12 ' O ' ' A' ' 20' ' ' CYS . 18.1 tp -98.83 137.68 37.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.86 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.967 ' CE2' HG22 ' A' ' 72' ' ' VAL . 49.2 m-85 -139.03 145.46 39.64 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.575 ' HB2' HD11 ' A' ' 73' ' ' ILE . 14.6 tttm -104.0 124.04 48.3 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.771 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.864 ' HD2' HD21 ' A' ' 21' ' ' LEU . 36.7 t80 -78.23 96.46 5.23 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.889 0.376 . . . . 0.0 110.568 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.452 ' H ' ' HA ' ' A' ' 70' ' ' ALA . 71.0 p -95.33 57.44 1.98 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.362 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.404 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -163.06 -143.81 3.82 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.546 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.495 ' N ' ' HE1' ' A' ' 112' ' ' PHE . 7.4 mm100 -123.82 146.66 48.2 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.019 0.438 . . . . 0.0 111.463 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.424 ' HB3' ' CH2' ' A' ' 134' ' ' TRP . 90.3 m-20 -62.05 -23.57 66.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.834 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -3.92 0.45 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.971 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.0 tp10 -90.27 -18.05 26.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.065 0.46 . . . . 0.0 110.544 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.627 HD13 ' CE1' ' A' ' 29' ' ' PHE . 8.4 mt -82.33 104.41 10.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.834 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.496 ' C ' ' H ' ' A' ' 122' ' ' LEU . 3.2 p30 -102.61 -26.41 13.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.032 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.596 HD11 ' HD1' ' A' ' 134' ' ' TRP . 68.0 mt 68.69 -30.15 0.18 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.596 ' HA ' ' HB3' ' A' ' 129' ' ' PRO . 95.6 mt -78.49 6.34 8.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.66 0.267 . . . . 0.0 111.385 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -67.92 75.97 0.23 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.554 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.69 -106.45 0.16 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.833 -0.684 . . . . 0.0 111.09 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -169.55 -151.02 7.09 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.634 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 92.3 p -71.23 -5.38 31.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.616 0.246 . . . . 0.0 111.537 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.59 ' O ' ' HG2' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -85.61 -77.5 0.29 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.585 0.231 . . . . 0.0 111.254 -179.498 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.638 ' HD2' ' CD ' ' A' ' 129' ' ' PRO . 4.1 mmtt -176.87 163.66 1.57 Allowed Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 121.373 0.606 . . . . 0.0 110.58 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.638 ' CD ' ' HD2' ' A' ' 128' ' ' LYS . 29.3 Cg_endo -74.2 -172.67 1.21 Allowed 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 123.738 2.959 . . . . 0.0 112.644 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.83 -42.48 4.7 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.35 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.556 ' CB ' ' HB1' ' A' ' 31' ' ' ALA . 3.2 m-85 -130.76 140.84 50.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.092 0.472 . . . . 0.0 110.911 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.758 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -78.44 -35.77 32.12 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.785 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -155.75 152.46 28.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.369 -0.416 . . . . 0.0 110.74 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.596 ' HD1' HD11 ' A' ' 121' ' ' LEU . 29.0 p-90 -132.2 164.61 25.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.118 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.428 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 23.4 t -159.46 165.74 32.45 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.325 0.583 . . . . 0.0 112.048 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.714 ' CD2' ' ND2' ' A' ' 23' ' ' ASN . 91.6 m95 -108.39 102.09 11.23 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.481 178.329 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' ' 28' ' ' ILE . 28.9 m -117.47 171.29 6.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.837 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.585 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 27.8 p -71.99 167.1 34.54 Favored Pre-proline 0 CA--C 1.513 -0.465 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.889 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.725 ' HA ' HG13 ' A' ' 28' ' ' ILE . 21.7 Cg_exo -57.7 -58.83 0.69 Allowed 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.428 1.418 . . . . 0.0 109.889 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.11 -27.17 68.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.035 178.594 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.474 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 2.0 mm-40 -71.91 -48.36 46.04 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.1 0.476 . . . . 0.0 110.259 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.828 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -55.37 -40.74 71.69 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.22 179.711 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.787 HG21 ' HG2' ' A' ' 155' ' ' LYS . 27.3 mm -61.83 -31.84 52.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.329 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.73 -53.42 10.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.354 0.597 . . . . 0.0 110.33 179.1 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.08 -18.62 61.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.835 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.705 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 14.8 t -73.77 174.69 8.07 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.395 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.402 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 18.7 m -86.41 149.56 4.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.589 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.605 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 19.9 mt-10 -47.33 -52.3 16.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.95 0.405 . . . . 0.0 111.334 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -55.26 -3.71 0.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . 10.2 mmtm -136.08 -8.2 2.06 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -178.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.746 ' HG3' ' CG2' ' A' ' 143' ' ' ILE . 2.6 ttpp -64.53 -57.77 15.87 Favored Pre-proline 0 C--N 1.322 -0.589 0 C-N-CA 121.145 -0.222 . . . . 0.0 110.66 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.605 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 36.7 Cg_endo -66.06 -30.95 46.88 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.566 2.177 . . . . 0.0 111.469 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.801 ' O ' HG23 ' A' ' 157' ' ' VAL . 23.4 t -68.07 -51.71 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.587 ' CZ ' ' HB3' ' A' ' 150' ' ' LYS . 15.4 m-30 -65.36 -39.17 91.98 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.591 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.787 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -54.41 -45.26 72.9 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.934 -179.951 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.405 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.7 OUTLIER -66.94 -35.46 80.03 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.307 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 153' ' ' VAL . 46.4 t -65.16 -41.63 92.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.721 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.499 HD22 ' HB3' ' A' ' 139' ' ' PRO . 30.1 mt -63.41 -43.03 98.7 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.164 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.88 -38.45 70.18 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.886 HG11 ' HA ' ' A' ' 76' ' ' VAL . 85.0 t -68.79 -43.08 83.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.619 ' CE2' HG12 ' A' ' 157' ' ' VAL . 22.2 m-30 -80.77 5.19 16.57 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.964 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.593 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.32 -52.89 71.21 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.07 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.4 Cg_endo -57.75 -13.41 14.35 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 121.664 1.576 . . . . 0.0 111.741 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.504 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 86.9 m-70 -108.06 -21.91 12.61 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.09 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 85.9 mt . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.397 -0.811 . . . . 0.0 110.569 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.114 0 N-CA-C 112.427 -0.269 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.513 ' HB2' HD23 ' A' ' 3' ' ' LEU . 38.2 Cg_endo -66.78 -174.99 0.51 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.34 2.027 . . . . 0.0 112.39 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.653 HD13 HG22 ' A' ' 153' ' ' VAL . 0.4 OUTLIER 37.88 98.63 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.313 -179.654 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.54 -14.66 75.53 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.295 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.767 ' HB3' HD23 ' A' ' 80' ' ' LEU . 0.7 OUTLIER 64.18 -81.68 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.929 0.395 . . . . 0.0 111.617 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.2 mtm 65.47 138.86 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.395 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.728 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 4.2 p30 -66.63 -5.49 11.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.85 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.27 130.86 13.9 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.5 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 40.9 Cg_endo -66.83 107.96 1.38 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.333 2.022 . . . . 0.0 112.249 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.505 ' HG2' ' CE1' ' A' ' 13' ' ' TYR . 2.0 Cg_endo -43.49 168.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 123.357 2.705 . . . . 0.0 112.855 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -51.05 128.58 21.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.905 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.589 ' CA ' ' HA ' ' A' ' 100' ' ' TRP . . . 61.64 75.66 0.29 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.778 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.508 ' CE2' ' HA3' ' A' ' 102' ' ' GLY . 11.7 m-85 -151.13 109.62 3.8 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.408 ' HA ' ' CZ3' ' A' ' 100' ' ' TRP . 1.5 tpt180 -70.07 95.55 0.97 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.878 0.37 . . . . 0.0 111.069 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.618 ' HB2' ' HZ3' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -51.98 131.84 31.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.239 0.542 . . . . 0.0 111.862 -179.788 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.678 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 2.1 m-80 -131.18 174.95 9.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.742 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.768 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 16.0 m -143.82 157.81 16.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.95 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.59 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -127.96 167.24 20.3 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.22 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.057 HG21 HD22 ' A' ' 61' ' ' LEU . 5.3 mp -126.91 123.2 62.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.24 0.543 . . . . 0.0 112.461 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.654 ' O ' HD12 ' A' ' 109' ' ' LEU . 1.4 t -107.49 96.12 6.18 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.438 -0.801 . . . . 0.0 108.9 178.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.817 HD22 HG11 ' A' ' 67' ' ' VAL . 26.5 tp -99.61 122.97 43.42 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.917 -178.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.612 ' HG2' HD11 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -119.64 151.53 38.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.399 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.847 ' ND2' ' CE3' ' A' ' 136' ' ' TRP . 0.3 OUTLIER -96.24 175.44 6.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.313 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -58.31 -3.68 0.29 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.352 177.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.595 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.7 OUTLIER -99.1 -1.26 39.96 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 120.605 0.24 . . . . 0.0 111.376 -179.251 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.595 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 1.4 mmtm 75.12 20.98 2.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.961 -178.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.721 ' C ' HD12 ' A' ' 28' ' ' ILE . 4.8 mttt -93.41 -178.64 4.8 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.721 HD12 ' C ' ' A' ' 27' ' ' LYS . 2.8 mp -135.67 144.93 32.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.585 0.707 . . . . 0.0 111.886 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.578 ' CE1' HD13 ' A' ' 119' ' ' ILE . 33.2 t80 -66.17 108.33 2.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.985 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.654 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -102.99 140.19 37.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.163 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.07 134.16 32.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.747 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.58 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 55.6 p -100.12 149.21 23.75 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.075 0.464 . . . . 0.0 111.785 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.622 ' O ' ' N ' ' A' ' 35' ' ' ASP . 26.3 mtp85 -72.42 129.95 39.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.489 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.716 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -55.72 56.22 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.995 0.518 . . . . 0.0 112.346 179.799 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.622 ' N ' ' O ' ' A' ' 33' ' ' ARG . 3.0 p-10 -177.08 -33.03 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.157 0.503 . . . . 0.0 109.866 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.459 HD12 ' HE ' ' A' ' 33' ' ' ARG . 21.1 mt -116.66 105.72 49.46 Favored Pre-proline 0 N--CA 1.452 -0.366 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.482 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.52 -19.62 21.54 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.442 2.095 . . . . 0.0 112.88 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -92.38 -9.74 40.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.551 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.636 ' HB1' HG13 ' A' ' 147' ' ' VAL . . . -94.19 106.44 18.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.805 0.336 . . . . 0.0 111.278 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.594 ' O ' ' HA ' ' A' ' 146' ' ' THR . 68.9 m95 -105.71 144.61 32.22 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.75 178.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.589 ' HG3' ' HG1' ' A' ' 146' ' ' THR . 0.8 OUTLIER -153.73 -125.73 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.095 -179.742 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.632 ' SD ' HD21 ' A' ' 142' ' ' LEU . 0.0 OUTLIER 177.62 160.81 0.56 Allowed Pre-proline 0 N--CA 1.453 -0.32 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.743 ' HG3' HD13 ' A' ' 61' ' ' LEU . 1.6 Cg_endo -40.69 142.29 0.74 Allowed 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 123.546 2.831 . . . . 0.0 113.03 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.768 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -172.62 146.4 1.68 Allowed 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.884 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -160.62 -162.63 12.71 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.332 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.678 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -120.05 139.93 14.21 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.887 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.629 ' CG1' HG13 ' A' ' 17' ' ' VAL . 28.7 mt -69.37 142.03 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.838 0.352 . . . . 0.0 111.131 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -69.01 -174.12 0.57 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.93 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -49.66 -79.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.049 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -110.1 50.32 0.78 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.285 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -111.57 149.59 31.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.822 0.344 . . . . 0.0 110.576 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.41 162.38 70.57 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.159 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.565 ' HB3' HD11 ' A' ' 47' ' ' ILE . 1.2 Cg_endo -82.96 -51.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.974 2.45 . . . . 0.0 112.021 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.737 ' CZ ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -49.98 -47.33 52.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.623 179.594 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -69.25 -38.26 78.37 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.046 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.82 -45.02 95.63 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.679 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -58.05 -55.48 34.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.405 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.573 HD11 ' CD ' ' A' ' 54' ' ' ARG . 47.2 mt -57.55 -46.53 86.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.183 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.08 -66.08 0.59 Allowed 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.278 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.551 ' CG ' HD11 ' A' ' 19' ' ' ILE . 23.6 pt-20 -43.06 -40.45 3.12 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.114 0.483 . . . . 0.0 110.199 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.057 HD22 HG21 ' A' ' 19' ' ' ILE . 4.9 tp -52.23 -47.42 65.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.376 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.86 ' HG2' HG23 ' A' ' 68' ' ' THR . 1.6 tmm_? -63.51 -63.91 1.05 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.957 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -51.13 -21.17 1.8 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.17 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -97.53 -38.41 9.58 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.722 HG22 ' CD2' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -128.88 -15.15 4.37 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -178.853 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.51 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 91.54 -14.23 64.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.193 -1.004 . . . . 0.0 112.835 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.817 HG11 HD22 ' A' ' 21' ' ' LEU . 55.7 t -56.26 110.57 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.104 0.478 . . . . 0.0 111.321 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.86 HG23 ' HG2' ' A' ' 62' ' ' ARG . 0.9 OUTLIER -122.34 -39.8 2.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.466 178.203 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.407 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 9.4 m -62.37 74.39 0.02 OUTLIER 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.456 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -162.85 154.86 18.33 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.922 0.391 . . . . 0.0 111.795 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.22 146.63 50.35 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.209 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.737 HG21 ' CZ ' ' A' ' 54' ' ' ARG . 8.5 t -76.73 129.96 36.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.202 0.525 . . . . 0.0 112.224 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.702 HD11 ' HB2' ' A' ' 111' ' ' LYS . 0.7 OUTLIER -113.3 -18.12 7.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.947 179.43 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.464 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -169.04 178.63 4.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.147 0.499 . . . . 0.0 112.013 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.465 ' HB3' ' HD1' ' A' ' 108' ' ' PHE . 1.4 pm0 -157.66 152.71 25.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.882 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.841 ' HA ' HG11 ' A' ' 160' ' ' VAL . 33.7 t -72.93 136.61 79.78 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.265 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.615 ' HD2' HG21 ' A' ' 160' ' ' VAL . 20.7 Cg_endo -59.45 -76.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.943 2.428 . . . . 0.0 112.564 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.728 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -80.65 171.68 14.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.698 -179.179 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.618 ' HZ3' ' HB2' ' A' ' 15' ' ' ARG . 27.9 m95 -94.33 97.53 10.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.608 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.767 HD23 ' HB3' ' A' ' 5' ' ' SER . 51.1 mt -58.97 109.39 0.82 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.8 0.333 . . . . 0.0 110.89 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.762 HG22 ' HA ' ' A' ' 104' ' ' ALA . 5.1 p -100.01 -167.56 1.47 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.007 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.412 ' HD1' ' HB3' ' A' ' 3' ' ' LEU . 2.5 t80 -170.64 80.17 0.09 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.662 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -70.22 158.3 36.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.441 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.507 ' HB2' HD12 ' A' ' 92' ' ' LEU . 6.1 m-85 -102.87 166.42 11.94 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.948 0.404 . . . . 0.0 112.007 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.519 ' HB2' ' HD2' ' A' ' 86' ' ' PRO . 85.8 Cg_endo -92.1 177.26 1.73 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.332 2.688 . . . . 0.0 112.549 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.519 ' HD2' ' HB2' ' A' ' 85' ' ' PRO . 10.9 Cg_endo -53.07 159.65 5.2 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.392 2.061 . . . . 0.0 112.026 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 86' ' ' PRO . 2.6 tptt 70.86 -58.41 0.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.126 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.41 ' CG1' ' HD2' ' A' ' 84' ' ' PHE . 11.2 t -65.07 -37.38 80.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.988 0.423 . . . . 0.0 110.64 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.558 ' HD2' HD22 ' A' ' 93' ' ' ASN . 0.0 OUTLIER -48.78 -38.49 22.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.93 -179.712 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.714 ' HA ' HD13 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -70.41 -24.41 62.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.79 0.329 . . . . 0.0 110.791 179.509 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.529 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -98.5 -7.82 27.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.803 179.478 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.596 HD13 ' N ' ' A' ' 93' ' ' ASN . 0.8 OUTLIER -122.09 -59.29 1.67 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.329 -179.602 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.639 ' CG ' ' HA ' ' A' ' 101' ' ' LYS . 31.9 t-20 -61.86 -64.28 0.99 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.207 0.527 . . . . 0.0 111.924 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.714 HD13 ' HA ' ' A' ' 90' ' ' GLU . 3.9 mp -63.03 -9.89 5.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.376 -178.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.529 ' HG3' ' O ' ' A' ' 91' ' ' LYS . 6.2 mm100 -78.19 -1.82 34.61 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.247 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.667 ' HB3' ' CD1' ' A' ' 100' ' ' TRP . 86.6 m95 -91.47 -3.11 56.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.544 0.212 . . . . 0.0 111.566 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.62 -77.37 0.63 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.755 -0.736 . . . . 0.0 113.377 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.402 ' HB3' ' NE1' ' A' ' 100' ' ' TRP . 0.2 OUTLIER -66.11 -168.56 0.05 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.892 0.377 . . . . 0.0 111.433 -179.267 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.33 104.88 4.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.785 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.667 ' CD1' ' HB3' ' A' ' 96' ' ' TRP . 71.7 m95 -141.57 -164.59 1.81 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.838 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.639 ' HA ' ' CG ' ' A' ' 93' ' ' ASN . 0.7 OUTLIER 164.56 24.21 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 O-C-N 123.226 0.329 . . . . 0.0 111.589 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.508 ' HA3' ' CE2' ' A' ' 13' ' ' TYR . . . 154.3 -160.44 29.5 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.492 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 81' ' ' THR . 0.1 OUTLIER -149.27 122.26 8.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.827 0.314 . . . . 0.0 111.34 -179.631 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.762 ' HA ' HG22 ' A' ' 81' ' ' THR . . . -97.96 121.18 39.56 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.551 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 2.9 mt-30 -123.19 123.75 41.48 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.427 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 1.0 OUTLIER -104.25 132.66 50.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.435 178.364 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.59 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 51.6 m95 -101.74 166.53 10.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.241 0.543 . . . . 0.0 112.448 -178.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.575 ' CD1' ' HG2' ' A' ' 54' ' ' ARG . 98.0 m-85 -141.47 151.63 43.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.955 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.654 HD12 ' O ' ' A' ' 20' ' ' CYS . 29.5 tp -107.68 126.73 52.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.968 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.883 ' CE2' HG23 ' A' ' 19' ' ' ILE . 4.1 m-85 -132.8 145.54 51.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.315 0.578 . . . . 0.0 111.918 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.702 ' HB2' HD11 ' A' ' 73' ' ' ILE . 47.8 tttt -95.27 127.69 41.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.602 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.804 ' CD1' HD21 ' A' ' 21' ' ' LEU . 38.2 t80 -78.33 101.33 7.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.898 0.38 . . . . 0.0 110.853 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.6 p -100.53 53.07 0.87 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.702 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.407 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -158.04 -146.49 4.53 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.409 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -121.85 152.1 39.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.995 0.426 . . . . 0.0 111.26 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.449 ' HB3' ' HH2' ' A' ' 134' ' ' TRP . 61.4 m-20 -60.12 -35.1 74.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.874 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -58.18 -2.05 0.16 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.116 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 116' ' ' ASP . 0.7 OUTLIER -90.41 -15.8 30.26 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.942 0.401 . . . . 0.0 110.853 179.543 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.68 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 14.3 mt -81.05 100.6 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.223 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 65' ' ' THR . 6.5 p-10 -103.78 93.68 5.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.339 178.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.722 ' CD2' HG22 ' A' ' 65' ' ' THR . 39.0 mt -65.81 -48.92 70.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.076 0.465 . . . . 0.0 110.1 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.54 HD22 ' HG3' ' A' ' 129' ' ' PRO . 61.1 mt -77.25 164.89 25.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.807 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 140.8 -8.91 2.8 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.371 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.14 79.71 3.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.811 0.339 . . . . 0.0 110.237 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -83.07 33.32 2.91 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.703 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.4 t -106.78 -37.11 6.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.833 0.349 . . . . 0.0 110.653 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -146.99 -59.2 0.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.888 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 27.6 pttt -178.3 156.02 0.99 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 121.132 0.492 . . . . 0.0 111.336 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.54 ' HG3' HD22 ' A' ' 122' ' ' LEU . 14.6 Cg_endo -71.49 -176.88 2.14 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.709 2.273 . . . . 0.0 112.432 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.653 ' O ' HD12 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -97.22 -69.89 0.74 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.371 -179.534 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.675 ' CE2' HG23 ' A' ' 65' ' ' THR . 2.2 m-85 -102.23 139.71 37.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.136 0.493 . . . . 0.0 110.573 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.716 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -82.34 -36.89 16.01 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.013 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -151.57 149.33 29.05 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.86 0.362 . . . . 0.0 110.53 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.707 ' HD1' HD11 ' A' ' 121' ' ' LEU . 31.9 p-90 -136.53 166.41 23.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.063 0.458 . . . . 0.0 111.236 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.483 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 29.5 t -162.56 178.48 8.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.381 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.847 ' CE3' ' ND2' ' A' ' 23' ' ' ASN . 64.8 m95 -114.21 99.66 7.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.742 178.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 22.2 m -113.89 169.05 5.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.347 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.572 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 20.9 p -74.71 171.91 10.29 Favored Pre-proline 0 C--N 1.324 -0.536 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.881 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.669 ' HB3' HD22 ' A' ' 158' ' ' LEU . 13.1 Cg_exo -62.47 -54.36 1.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.488 1.459 . . . . 0.0 110.279 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.67 -29.1 70.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.995 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.443 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 33.3 mt-30 -71.69 -47.33 54.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.328 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.654 HD13 ' HB2' ' A' ' 30' ' ' ALA . 64.2 tp -57.95 -38.92 76.86 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.714 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 27.7 mm -61.27 -38.8 80.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.517 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.92 -50.48 49.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.223 0.535 . . . . 0.0 110.565 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.429 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -74.54 -19.16 60.45 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.718 -179.154 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.949 HG23 ' HG3' ' A' ' 151' ' ' LYS . 14.7 t -74.88 174.03 9.82 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.487 -179.429 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.636 HG13 ' HB1' ' A' ' 39' ' ' ALA . 24.1 m -78.08 154.73 5.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.46 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.759 ' HA ' ' HD3' ' A' ' 151' ' ' LYS . 13.5 mt-10 -60.89 -54.85 39.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.079 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.517 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 35.7 p90 -55.52 -1.48 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.429 ' HG3' ' CD2' ' A' ' 149' ' ' PHE . 58.1 mttt -135.27 -6.82 2.29 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.949 ' HG3' HG23 ' A' ' 146' ' ' THR . 14.0 mtpp -60.71 -62.19 6.47 Favored Pre-proline 0 CA--C 1.531 0.237 0 O-C-N 122.317 -0.239 . . . . 0.0 111.335 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.495 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 18.6 Cg_endo -59.92 -27.13 84.24 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.239 1.959 . . . . 0.0 111.334 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.653 HG22 HD13 ' A' ' 3' ' ' LEU . 26.3 t -68.8 -50.85 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.474 ' HE1' ' CZ2' ' A' ' 107' ' ' TRP . 14.3 m-30 -65.78 -39.56 91.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.672 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.655 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.5 OUTLIER -56.09 -40.65 73.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.332 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.439 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.6 OUTLIER -70.57 -31.41 68.43 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 153' ' ' VAL . 90.3 t -66.28 -41.31 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.593 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.669 HD22 ' HB3' ' A' ' 139' ' ' PRO . 58.7 mt -63.78 -41.97 97.86 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.468 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 14.5 m -54.54 -41.02 69.25 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.841 HG11 ' HA ' ' A' ' 76' ' ' VAL . 98.4 t -66.57 -44.07 90.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.553 178.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.625 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 22.4 m-30 -81.21 5.09 18.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.384 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.7 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . . . -59.4 -50.45 87.29 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.015 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.7 ' HD3' ' HB3' ' A' ' 162' ' ' ALA . 36.8 Cg_exo -59.22 -11.86 14.42 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.528 2.152 . . . . 0.0 112.051 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.464 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 73.8 m-70 -113.13 -17.52 12.37 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.437 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 97.9 mt . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.791 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.406 ' N ' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.603 -0.199 . . . . 0.0 112.603 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.406 ' HD3' ' N ' ' A' ' 1' ' ' GLY . 51.8 Cg_exo -53.93 155.99 13.51 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.535 2.157 . . . . 0.0 112.277 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.414 HD11 HG22 ' A' ' 153' ' ' VAL . 2.3 tp 60.18 108.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.315 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.07 -47.61 12.98 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.518 -0.848 . . . . 0.0 111.552 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.657 ' HA ' ' O ' ' A' ' 79' ' ' TRP . 0.7 OUTLIER 71.69 -75.43 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.089 0.471 . . . . 0.0 112.023 179.269 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.469 ' HB2' ' O ' ' A' ' 5' ' ' SER . 4.0 mpp? 67.79 131.37 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.039 -178.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.607 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 30.1 t70 -66.04 -35.65 81.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.822 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.98 152.15 40.28 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.508 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.499 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 59.1 Cg_endo -72.11 106.98 2.14 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.465 2.11 . . . . 0.0 112.199 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.617 ' HB2' ' CE1' ' A' ' 13' ' ' TYR . 11.6 Cg_endo -54.17 -174.07 0.02 OUTLIER 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 123.205 2.604 . . . . 0.0 112.707 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 13' ' ' TYR . 1.5 pt-20 -52.48 -157.66 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.859 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.584 ' O ' ' HA ' ' A' ' 100' ' ' TRP . . . -58.69 65.89 0.01 OUTLIER Glycine 0 C--N 1.33 0.23 0 CA-C-N 116.004 -0.543 . . . . 0.0 113.98 -178.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.617 ' CE1' ' HB2' ' A' ' 10' ' ' PRO . 16.5 m-85 -93.12 148.11 22.29 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.746 ' HA ' ' HZ3' ' A' ' 100' ' ' TRP . 1.0 OUTLIER -65.16 82.95 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.143 0.497 . . . . 0.0 111.021 179.497 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.556 ' HG2' HD12 ' A' ' 47' ' ' ILE . 1.1 ttp180 -50.89 102.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.181 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.78 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 0.9 OUTLIER -134.48 167.35 20.93 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.387 179.091 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.644 HG13 ' CG1' ' A' ' 47' ' ' ILE . 12.5 m -136.05 166.33 27.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.976 0.417 . . . . 0.0 111.289 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.536 ' HA3' ' CE3' ' A' ' 107' ' ' TRP . . . -134.02 154.77 21.51 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.546 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.952 HG21 HD22 ' A' ' 61' ' ' LEU . 3.7 mp -125.45 121.5 60.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.074 0.464 . . . . 0.0 111.862 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.553 ' O ' HD12 ' A' ' 109' ' ' LEU . 0.4 OUTLIER -101.1 92.24 4.91 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.742 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.778 HD22 HG11 ' A' ' 67' ' ' VAL . 22.7 tp -96.57 113.38 24.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.534 -178.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.515 ' SD ' HD11 ' A' ' 109' ' ' LEU . 1.3 ptt? -116.14 167.24 11.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.707 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.786 ' ND2' ' CE3' ' A' ' 136' ' ' TRP . 0.3 OUTLIER -102.09 168.99 9.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.384 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -56.79 -3.55 0.12 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.418 177.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.573 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 1.8 m-20 -99.55 3.03 45.28 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 3.7 mmtm 74.46 20.4 2.52 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.114 -178.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.44 ' HB2' ' OD1' ' A' ' 23' ' ' ASN . 1.2 mmtt -94.85 145.35 24.96 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.809 HD11 ' HG3' ' A' ' 139' ' ' PRO . 1.1 mm -99.32 140.95 17.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.995 0.426 . . . . 0.0 112.082 -177.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.495 ' CE1' HD13 ' A' ' 119' ' ' ILE . 73.1 t80 -78.15 135.23 37.62 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.463 178.228 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.621 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . . . -141.3 153.83 45.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.776 0.322 . . . . 0.0 110.79 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.636 ' HB1' ' HB3' ' A' ' 131' ' ' PHE . . . -142.55 145.13 33.29 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.64 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 17.6 p -94.31 148.18 22.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.543 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.4 mtp180 -69.35 133.6 48.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.084 0.469 . . . . 0.0 111.006 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.001 ' H ' HD23 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -38.47 -48.78 1.42 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.612 -178.881 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.426 ' O ' HD13 ' A' ' 36' ' ' ILE . 0.8 OUTLIER -75.17 -34.9 61.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.171 -179.569 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.426 HD13 ' O ' ' A' ' 35' ' ' ASP . 29.2 mm -123.31 104.41 34.73 Favored Pre-proline 0 C--O 1.233 0.184 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.01 -16.89 45.89 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.862 2.375 . . . . 0.0 112.377 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -89.89 -10.15 46.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.425 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.633 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.78 88.64 6.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.935 0.398 . . . . 0.0 110.338 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.621 ' O ' ' HA ' ' A' ' 146' ' ' THR . 75.8 m95 -85.57 146.53 26.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.365 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.494 ' HB3' ' OH ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -165.41 162.16 19.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.921 -179.871 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.751 ' SD ' HD21 ' A' ' 142' ' ' LEU . 0.0 OUTLIER -98.3 156.93 35.25 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.079 179.206 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.524 ' HG3' HD13 ' A' ' 61' ' ' LEU . 1.9 Cg_endo -44.34 155.07 0.26 Allowed 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.048 2.499 . . . . 0.0 113.08 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.587 ' HA ' HD12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -176.17 171.36 2.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.207 -179.576 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.484 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . 176.9 152.55 9.92 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.677 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.78 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -77.75 135.97 17.35 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.602 -0.809 . . . . 0.0 113.358 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.644 ' CG1' HG13 ' A' ' 17' ' ' VAL . 16.9 mt -69.46 145.6 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.734 0.302 . . . . 0.0 111.007 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.57 -175.66 0.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.028 0.442 . . . . 0.0 111.257 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.22 -47.5 65.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.856 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -143.34 52.79 0.62 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.286 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -112.9 150.22 32.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.772 0.32 . . . . 0.0 110.446 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.1 156.26 90.21 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.903 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 3.0 Cg_exo -73.93 -49.35 0.2 Allowed 'Trans proline' 0 CA--C 1.515 -0.442 0 C-N-CA 122.41 2.074 . . . . 0.0 111.113 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.923 ' CZ ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -53.13 -46.57 68.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.307 179.293 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.542 ' HA ' HD12 ' A' ' 58' ' ' ILE . 84.9 m-20 -67.7 -40.11 84.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.135 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.04 -44.7 96.13 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.808 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -56.07 -52.21 65.07 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.931 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.705 HD11 ' HE ' ' A' ' 54' ' ' ARG . 22.4 mt -56.43 -56.45 13.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.548 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -60.05 4.42 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.672 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.484 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -45.87 -47.53 16.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.155 0.503 . . . . 0.0 109.744 179.081 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.952 HD22 HG21 ' A' ' 19' ' ' ILE . 4.2 tp -50.25 -46.64 55.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.324 178.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.798 ' HG3' HG23 ' A' ' 68' ' ' THR . 18.7 ttm180 -64.98 -63.51 1.09 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.357 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -49.78 -22.66 1.5 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.436 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.693 ' O ' HD21 ' A' ' 122' ' ' LEU . 31.3 mt-10 -97.01 -36.58 10.47 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -177.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.542 HG22 ' CD2' ' A' ' 121' ' ' LEU . 0.6 OUTLIER -124.26 -13.77 7.13 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.979 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 86.04 -16.24 43.93 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.232 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.778 HG11 HD22 ' A' ' 21' ' ' LEU . 52.3 t -58.13 117.26 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-O 121.254 0.549 . . . . 0.0 111.42 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.798 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.9 OUTLIER -122.64 -38.13 2.68 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.652 178.568 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.8 m -62.31 73.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.581 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.595 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -160.74 157.69 27.35 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.019 0.438 . . . . 0.0 112.126 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -131.53 152.19 50.96 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.95 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.923 HG21 ' CZ ' ' A' ' 54' ' ' ARG . 4.2 t -75.24 127.15 36.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.148 0.499 . . . . 0.0 111.428 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.569 HD11 ' HB2' ' A' ' 111' ' ' LYS . 1.6 mt -107.95 -19.67 6.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.596 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.454 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -169.56 176.78 4.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.0 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.3 OUTLIER -154.89 146.44 23.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.752 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.821 ' HA ' HG11 ' A' ' 160' ' ' VAL . 50.7 t -72.58 140.58 81.82 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.106 0.479 . . . . 0.0 111.203 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.635 ' HD2' HG13 ' A' ' 76' ' ' VAL . 26.8 Cg_endo -62.08 -62.67 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.27 2.647 . . . . 0.0 113.138 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -96.53 177.05 5.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.049 -178.514 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.657 ' O ' ' HA ' ' A' ' 5' ' ' SER . 49.9 m95 -93.38 97.45 10.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.174 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.923 HD12 ' CD1' ' A' ' 107' ' ' TRP . 38.3 mt -57.27 110.57 0.87 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.885 0.374 . . . . 0.0 111.087 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.768 HG22 ' HA ' ' A' ' 104' ' ' ALA . 1.8 p -112.78 -165.3 0.98 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.804 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -170.58 72.8 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.767 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -70.99 164.77 24.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.459 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.626 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 3.9 m-85 -104.63 160.43 26.03 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.229 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.495 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 30.4 Cg_exo -60.82 178.44 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.662 2.241 . . . . 0.0 111.285 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.472 ' HD2' ' CB ' ' A' ' 85' ' ' PRO . 17.9 Cg_endo -60.08 -16.09 37.48 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.181 1.92 . . . . 0.0 112.98 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.47 -62.05 1.54 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.769 0.319 . . . . 0.0 111.341 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.626 ' HB ' ' HB3' ' A' ' 84' ' ' PHE . 31.0 t -66.07 -6.52 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.704 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.535 ' O ' ' HB2' ' A' ' 93' ' ' ASN . 0.5 OUTLIER -67.66 -0.33 3.88 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.685 ' HA ' HD13 ' A' ' 94' ' ' ILE . 0.4 OUTLIER -120.14 -22.48 6.62 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.715 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.561 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -91.12 -13.69 32.58 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.095 179.477 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.72 HD13 ' N ' ' A' ' 93' ' ' ASN . 1.2 tm? -121.45 -64.16 1.25 Allowed 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.39 0.614 . . . . 0.0 110.443 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.811 ' HB3' ' HA ' ' A' ' 101' ' ' LYS . 4.7 m120 -51.75 -23.2 4.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.615 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.685 HD13 ' HA ' ' A' ' 90' ' ' GLU . 2.0 mp -112.54 -6.93 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.36 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' A' ' 92' ' ' LEU . 1.3 pt20 -61.4 -11.4 10.15 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.574 ' HB2' ' CD1' ' A' ' 100' ' ' TRP . 11.9 m95 -93.37 35.69 1.09 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.499 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 54.5 84.58 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.883 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.3 p 58.17 162.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.82 0.343 . . . . 0.0 111.185 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 100' ' ' TRP . 2.0 t0 56.26 -160.25 0.21 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.66 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.746 ' HZ3' ' HA ' ' A' ' 14' ' ' ARG . 91.8 m95 65.81 173.25 0.23 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.297 179.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.811 ' HA ' ' HB3' ' A' ' 93' ' ' ASN . 0.0 OUTLIER 167.06 67.49 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 179.699 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.84 -165.45 12.58 Favored Glycine 0 C--N 1.339 0.716 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.652 177.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.585 ' O ' ' HA ' ' A' ' 81' ' ' THR . 36.8 mt-30 -141.29 117.63 10.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.708 0.29 . . . . 0.0 110.634 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.768 ' HA ' HG22 ' A' ' 81' ' ' THR . . . -101.75 112.94 25.7 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.717 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.732 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 10.6 mt-30 -122.21 126.47 48.32 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.49 ' HB2' ' CE3' ' A' ' 79' ' ' TRP . 2.4 ttmt -102.69 131.96 49.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.245 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.923 ' CD1' HD12 ' A' ' 80' ' ' LEU . 74.6 m95 -101.99 161.35 13.74 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -177.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.505 ' CE1' ' HG2' ' A' ' 54' ' ' ARG . 99.5 m-85 -142.64 150.53 40.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.784 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.63 HD12 ' H ' ' A' ' 110' ' ' PHE . 15.0 tp -98.56 139.72 33.87 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.255 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.63 ' H ' HD12 ' A' ' 109' ' ' LEU . 32.0 m-85 -138.81 142.72 38.71 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -178.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.595 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 1.1 tttt -102.28 120.18 40.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.679 178.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.612 ' HB2' HD11 ' A' ' 21' ' ' LEU . 65.4 t80 -78.23 98.72 5.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.796 0.332 . . . . 0.0 110.596 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.4 p -95.25 39.64 1.11 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.601 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.402 ' C ' ' CE2' ' A' ' 112' ' ' PHE . . . -135.64 -148.22 5.58 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.268 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.444 ' HB2' ' HG2' ' A' ' 117' ' ' GLN . 0.1 OUTLIER -125.45 150.32 47.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.857 0.36 . . . . 0.0 111.137 179.474 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -58.43 -39.7 80.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.483 0.658 . . . . 0.0 110.662 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.444 ' HG2' ' HB2' ' A' ' 115' ' ' GLN . 14.8 pt20 -58.61 -3.5 0.31 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.913 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -89.03 -22.14 23.11 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.238 0.542 . . . . 0.0 110.234 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.589 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 10.5 mt -83.05 100.11 6.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.19 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.428 ' O ' ' C ' ' A' ' 121' ' ' LEU . 1.6 p-10 -97.51 9.38 42.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.021 -179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.718 ' C ' HD22 ' A' ' 122' ' ' LEU . 71.7 mt 31.49 56.51 0.28 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.22 0.533 . . . . 0.0 111.56 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.829 HD23 ' HB3' ' A' ' 129' ' ' PRO . 0.5 OUTLIER 58.49 165.44 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.264 179.756 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -162.24 -131.34 1.21 Allowed Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 51.02 -162.24 0.07 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.882 0.373 . . . . 0.0 111.172 179.004 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.82 60.3 0.55 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.077 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.1 m -97.38 -63.22 1.15 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.766 0.317 . . . . 0.0 111.31 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 128' ' ' LYS . 5.0 tt0 -145.6 -74.61 0.22 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.138 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 129' ' ' PRO . 12.6 pttp -179.31 148.26 0.52 Allowed Pre-proline 0 C--N 1.332 -0.171 0 CA-C-O 121.137 0.494 . . . . 0.0 111.81 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.829 ' HB3' HD23 ' A' ' 122' ' ' LEU . 5.9 Cg_exo -69.55 -165.41 0.15 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 123.011 2.474 . . . . 0.0 112.829 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.692 ' C ' HD21 ' A' ' 34' ' ' LEU . 3.9 tp10 -109.25 -32.83 7.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.872 178.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.722 ' N ' HD21 ' A' ' 34' ' ' LEU . 2.1 m-85 -131.91 139.0 48.6 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 178.044 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.708 ' N ' HD22 ' A' ' 34' ' ' LEU . . . -85.92 -33.13 16.09 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.688 -178.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 31' ' ' ALA . 1.9 tt0 -150.78 153.87 36.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.338 0.113 . . . . 0.0 110.947 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.611 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 43.3 p-90 -135.36 168.28 19.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.057 0.456 . . . . 0.0 111.691 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.431 ' N ' ' HZ3' ' A' ' 40' ' ' TRP . 15.9 t -162.74 167.26 23.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.526 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.786 ' CE3' ' ND2' ' A' ' 23' ' ' ASN . 53.7 m95 -103.95 102.91 12.69 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.6 ' O ' ' N ' ' A' ' 28' ' ' ILE . 21.7 m -119.66 165.08 15.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.556 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 19.0 p -72.01 170.98 10.48 Favored Pre-proline 0 C--N 1.327 -0.413 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.027 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.809 ' HG3' HD11 ' A' ' 28' ' ' ILE . 13.7 Cg_exo -62.88 -54.58 1.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.031 1.821 . . . . 0.0 110.41 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -64.94 -26.75 68.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.584 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.483 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.8 OUTLIER -72.04 -46.56 56.56 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.502 179.582 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.751 HD21 ' SD ' ' A' ' 42' ' ' MET . 0.6 OUTLIER -57.35 -38.38 74.05 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.832 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.55 ' O ' HG22 ' A' ' 146' ' ' THR . 7.1 mm -60.88 -35.95 68.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.215 0.531 . . . . 0.0 110.219 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.68 -51.69 26.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.202 0.525 . . . . 0.0 110.769 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.75 -19.97 60.64 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.415 -0.812 . . . . 0.0 112.712 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.621 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 7.3 t -73.78 177.76 5.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.976 0.417 . . . . 0.0 111.487 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.597 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 16.2 m -82.24 149.5 4.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.334 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.508 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 42.6 mt-10 -60.29 -55.21 36.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.049 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.597 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 55.1 p90 -54.24 -4.34 0.05 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.49 ' HG2' ' CZ ' ' A' ' 154' ' ' TYR . 0.1 OUTLIER -132.73 -6.54 3.2 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.435 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.584 ' HG3' HG23 ' A' ' 146' ' ' THR . 11.6 mttt -59.79 -59.49 13.67 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.508 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 11.8 Cg_endo -55.73 -27.66 62.64 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.312 2.008 . . . . 0.0 111.651 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.754 ' O ' HG23 ' A' ' 157' ' ' VAL . 39.5 t -69.27 -53.9 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.494 ' OH ' ' HB3' ' A' ' 41' ' ' GLN . 9.1 m-30 -63.51 -36.86 85.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.855 178.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.563 ' HE2' ' HA ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -57.73 -43.5 85.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.085 179.782 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -69.11 -28.49 66.52 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 153' ' ' VAL . 48.6 t -68.48 -42.25 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.973 178.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.659 HD22 ' HB3' ' A' ' 139' ' ' PRO . 47.8 mt -63.68 -43.5 96.5 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.561 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.8 t -53.76 -41.3 67.01 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.821 HG11 ' HA ' ' A' ' 76' ' ' VAL . 88.2 t -66.75 -42.59 89.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.378 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.609 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 22.1 m-30 -80.15 4.08 18.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.552 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.606 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.58 -53.1 69.59 Favored Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 120.531 -0.467 . . . . 0.0 110.644 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 18.9 Cg_endo -58.89 -12.21 14.41 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.141 1.894 . . . . 0.0 111.921 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.454 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 92.9 m-70 -109.19 -17.98 13.73 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.28 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 95.6 mt . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.854 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.132 0 N-CA-C 112.393 -0.283 . . . . 0.0 112.393 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.49 146.44 33.37 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.523 2.149 . . . . 0.0 112.129 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.972 HD11 HG22 ' A' ' 153' ' ' VAL . 8.2 mt 62.21 -173.31 0.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.109 0.481 . . . . 0.0 110.873 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.43 -43.23 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.836 ' HB3' HD23 ' A' ' 80' ' ' LEU . 0.3 OUTLIER 52.0 105.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 179.281 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.6 mpp? -103.63 140.72 37.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.054 178.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.619 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 33.1 t70 -66.92 -8.66 31.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.368 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.01 114.08 6.98 Favored Pre-proline 0 CA--C 1.531 0.242 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.519 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 22.7 Cg_endo -61.45 118.61 5.49 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.378 2.052 . . . . 0.0 112.456 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.519 ' HD3' ' HA ' ' A' ' 9' ' ' PRO . 4.0 Cg_exo -81.8 167.42 16.57 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.197 2.598 . . . . 0.0 112.761 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.36 153.47 7.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.403 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' A' ' 100' ' ' TRP . . . 69.02 1.81 27.91 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 121.054 -0.593 . . . . 0.0 114.194 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 10' ' ' PRO . 21.7 m-85 -92.38 124.48 36.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.476 0.638 . . . . 0.0 110.708 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.465 ' N ' ' HA ' ' A' ' 103' ' ' GLN . 0.8 OUTLIER -68.98 82.84 0.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.919 0.39 . . . . 0.0 110.891 179.393 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.457 ' CG ' HD12 ' A' ' 47' ' ' ILE . 5.4 ttp180 -50.21 111.75 0.57 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.475 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.696 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 3.2 m120 -135.34 -178.76 5.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.127 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.582 HG13 HG13 ' A' ' 47' ' ' ILE . 14.9 m -142.65 167.57 14.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.39 0.614 . . . . 0.0 111.967 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.572 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -138.18 155.41 23.37 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.891 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.022 HG23 ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -131.31 129.23 62.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.063 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.49 ' O ' HD12 ' A' ' 109' ' ' LEU . 35.4 t -108.77 106.11 15.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.898 178.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.778 HD22 HG11 ' A' ' 67' ' ' VAL . 7.4 tp -105.98 123.59 48.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.845 -178.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.624 ' CE ' HD13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -124.22 165.98 16.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.113 179.444 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.527 ' N ' ' OD1' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -97.45 171.96 8.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.004 0.431 . . . . 0.0 110.406 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 m-20 -58.48 -5.35 0.52 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.585 177.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.534 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -99.8 2.6 44.18 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.782 0.325 . . . . 0.0 111.771 -179.137 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 17.1 mmtp 73.61 22.29 2.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.953 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 22' ' ' MET . 2.2 mmtt -93.0 143.87 25.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.876 HD11 ' HG3' ' A' ' 139' ' ' PRO . 0.9 OUTLIER -98.07 138.02 23.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.286 0.565 . . . . 0.0 112.457 -177.913 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.534 ' CZ ' HG21 ' A' ' 65' ' ' THR . 17.1 t80 -80.22 135.1 36.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.726 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.74 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -142.58 151.77 41.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.945 0.403 . . . . 0.0 111.281 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.651 ' HB1' ' CB ' ' A' ' 131' ' ' PHE . . . -143.14 136.77 28.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.309 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.656 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 3.5 p -97.19 152.65 18.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.847 0.356 . . . . 0.0 111.45 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.659 ' O ' ' N ' ' A' ' 35' ' ' ASP . 15.3 mtp180 -68.54 130.43 42.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.731 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.74 HD11 ' HB2' ' A' ' 129' ' ' PRO . 0.3 OUTLIER -53.32 52.42 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.145 0.578 . . . . 0.0 112.491 -179.722 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.659 ' N ' ' O ' ' A' ' 33' ' ' ARG . 0.5 OUTLIER -177.68 -36.06 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.895 0.379 . . . . 0.0 110.347 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.628 HD13 ' NE ' ' A' ' 33' ' ' ARG . 4.0 mp -112.61 103.01 55.34 Favored Pre-proline 0 N--CA 1.454 -0.25 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.58 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -62.99 -46.04 11.42 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.167 2.578 . . . . 0.0 113.45 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -72.32 -4.44 29.81 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.656 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -94.75 93.03 7.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.798 0.332 . . . . 0.0 111.083 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.656 ' O ' ' HA ' ' A' ' 146' ' ' THR . 63.7 m95 -100.15 145.93 27.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.438 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.96 158.1 21.88 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.403 0.621 . . . . 0.0 111.593 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.47 ' HG3' ' HZ3' ' A' ' 107' ' ' TRP . 3.4 ptp -94.28 158.46 35.82 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.198 178.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.439 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 9.4 Cg_endo -49.31 154.47 3.87 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.423 2.082 . . . . 0.0 112.223 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -178.56 140.9 0.2 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.142 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.423 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -157.63 164.82 33.27 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.757 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.621 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -88.25 142.19 17.28 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.894 -0.669 . . . . 0.0 113.54 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.582 HG13 HG13 ' A' ' 17' ' ' VAL . 3.9 mt -70.44 146.73 11.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 122.66 0.384 . . . . 0.0 111.283 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -67.54 -174.55 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.406 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.88 -60.78 2.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.163 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.97 61.97 0.65 Allowed Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.465 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.504 ' O ' HG21 ' A' ' 47' ' ' ILE . 3.9 tp10 -119.94 155.86 31.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.731 0.3 . . . . 0.0 110.818 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.426 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -71.99 158.84 86.94 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.352 179.63 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.458 ' HA ' HG11 ' A' ' 17' ' ' VAL . 2.9 Cg_exo -76.12 -50.37 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.605 2.203 . . . . 0.0 111.67 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.878 ' CZ ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -53.07 -44.95 67.9 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.508 179.798 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.46 ' HA ' HD12 ' A' ' 58' ' ' ILE . 12.7 m120 -67.81 -42.13 82.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.012 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.416 ' O ' ' HG2' ' A' ' 60' ' ' GLU . . . -62.2 -42.6 99.44 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.022 ' HB1' HG23 ' A' ' 19' ' ' ILE . . . -56.55 -53.72 54.32 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.808 178.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.622 HD11 ' NE ' ' A' ' 54' ' ' ARG . 17.7 mt -57.56 -53.51 43.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.065 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -60.06 -58.69 7.44 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.923 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 56' ' ' ALA . 26.0 mm-40 -47.34 -45.84 25.03 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.226 0.536 . . . . 0.0 109.634 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.84 HD12 ' HB ' ' A' ' 19' ' ' ILE . 7.5 tt -51.83 -49.69 62.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.257 178.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.779 ' HG3' HG23 ' A' ' 68' ' ' THR . 47.7 ttt180 -63.06 -62.83 1.44 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.167 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.44 ' O ' ' CD1' ' A' ' 122' ' ' LEU . 6.2 mm-40 -51.35 -19.16 1.2 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.32 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.517 ' O ' HD21 ' A' ' 122' ' ' LEU . 13.5 mm-40 -98.91 -32.54 11.26 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -178.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.573 HG22 ' CD2' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -131.78 -11.61 3.42 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.609 -178.684 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.14 -15.16 55.17 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.464 -0.874 . . . . 0.0 111.967 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.778 HG11 HD22 ' A' ' 21' ' ' LEU . 77.7 t -58.3 113.72 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 121.248 0.546 . . . . 0.0 111.358 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.779 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -121.47 -39.96 2.61 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.481 178.637 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.432 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 6.1 m -62.5 74.6 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.14 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -158.88 154.94 26.84 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.667 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.403 ' HG3' HG21 ' A' ' 113' ' ' THR . 0.9 OUTLIER -128.16 151.46 49.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.432 179.607 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.878 HG21 ' CZ ' ' A' ' 54' ' ' ARG . 2.8 t -74.9 127.8 36.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.725 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.694 HD12 ' HG ' ' A' ' 109' ' ' LEU . 1.0 OUTLIER -109.11 -17.87 7.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.332 178.922 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.552 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -169.04 173.73 6.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.569 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 2.6 pm0 -153.09 136.06 15.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.648 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.65 ' HA ' HG11 ' A' ' 160' ' ' VAL . 41.8 t -73.48 137.48 77.79 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.03 0.443 . . . . 0.0 111.081 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.594 ' HD2' HG13 ' A' ' 76' ' ' VAL . 41.6 Cg_endo -72.09 -73.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.723 2.282 . . . . 0.0 112.54 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.619 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 2.2 p90 -67.57 157.81 33.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.097 0.475 . . . . 0.0 111.543 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.611 ' O ' HG23 ' A' ' 81' ' ' THR . 49.7 m95 -94.75 109.4 21.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.187 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.836 HD23 ' HB3' ' A' ' 5' ' ' SER . 15.0 mt -61.94 115.66 4.24 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.893 HG22 ' HA ' ' A' ' 104' ' ' ALA . 11.4 p -117.92 126.25 52.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.124 0.488 . . . . 0.0 112.272 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.68 ' CZ ' HG21 ' A' ' 153' ' ' VAL . 0.5 OUTLIER -80.02 39.32 0.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.971 179.303 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -73.07 134.24 44.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.759 0.314 . . . . 0.0 111.054 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.467 ' CE1' ' HG ' ' A' ' 92' ' ' LEU . 7.2 m-85 -103.75 156.91 34.94 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.976 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.461 ' CB ' ' HD2' ' A' ' 86' ' ' PRO . 15.6 Cg_exo -68.99 176.94 5.54 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.827 2.352 . . . . 0.0 111.589 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.461 ' HD2' ' CB ' ' A' ' 85' ' ' PRO . 6.3 Cg_endo -48.59 160.17 0.68 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.335 2.023 . . . . 0.0 111.793 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.4 ' CB ' ' O ' ' A' ' 86' ' ' PRO . 0.3 OUTLIER 79.4 -53.94 0.42 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.678 -179.405 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.9 t -63.6 -31.48 53.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.95 0.405 . . . . 0.0 110.57 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 93' ' ' ASN . 4.8 mmt85 -59.68 -51.81 68.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.109 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.611 ' HA ' HD13 ' A' ' 94' ' ' ILE . 1.8 mp0 -56.38 -23.74 39.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.065 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 47.8 mttt -98.59 -20.66 16.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.152 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.467 ' HG ' ' CE1' ' A' ' 84' ' ' PHE . 2.0 tm? -119.83 -61.81 1.56 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.714 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 89' ' ' ARG . 52.1 t-20 -47.49 -59.69 3.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.872 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.611 HD13 ' HA ' ' A' ' 90' ' ' GLU . 3.3 mp -75.17 -6.9 9.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.071 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.68 -0.09 25.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.579 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -94.08 27.14 2.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.688 0.28 . . . . 0.0 111.478 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 52.69 24.26 17.75 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 121.026 -0.607 . . . . 0.0 113.263 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -174.72 -174.48 0.82 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.694 0.283 . . . . 0.0 110.904 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.48 -89.01 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.459 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.501 ' O ' ' HB3' ' A' ' 101' ' ' LYS . 0.0 OUTLIER 57.84 -176.31 0.07 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.88 0.371 . . . . 0.0 111.39 179.058 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 100' ' ' TRP . 0.1 OUTLIER 163.17 52.66 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.649 179.27 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.85 -170.69 13.77 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.505 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.625 ' O ' ' HA ' ' A' ' 81' ' ' THR . 18.4 mt-30 -146.98 120.41 9.03 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.893 ' HA ' HG22 ' A' ' 81' ' ' THR . . . -91.04 116.97 29.21 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.101 0.477 . . . . 0.0 109.884 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.696 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 6.3 mt-30 -124.51 123.08 39.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.534 -177.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.518 ' HD3' ' CE2' ' A' ' 79' ' ' TRP . 14.2 ttpp -101.69 135.28 43.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.482 178.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.496 ' CD1' HD12 ' A' ' 80' ' ' LEU . 73.6 m95 -101.78 163.44 12.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.263 0.554 . . . . 0.0 112.445 -178.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.525 ' CE1' ' HG2' ' A' ' 54' ' ' ARG . 98.1 m-85 -143.18 150.63 39.65 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.839 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.694 ' HG ' HD12 ' A' ' 73' ' ' ILE . 20.1 tp -99.26 138.77 35.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.311 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.806 ' CE2' HG22 ' A' ' 72' ' ' VAL . 62.0 m-85 -139.76 140.28 36.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.642 0.734 . . . . 0.0 112.888 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.591 ' N ' HD11 ' A' ' 73' ' ' ILE . 1.7 tttt -101.27 123.63 45.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.754 178.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.625 ' CE1' HG13 ' A' ' 67' ' ' VAL . 39.4 t80 -78.34 96.61 5.35 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.809 0.337 . . . . 0.0 111.166 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.403 HG21 ' HG3' ' A' ' 71' ' ' GLU . 17.3 p -97.7 49.68 1.03 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.039 0.447 . . . . 0.0 110.596 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.432 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -150.01 -148.57 4.8 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.296 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.45 ' HB2' ' HG2' ' A' ' 117' ' ' GLN . 28.7 mt-30 -121.84 151.46 40.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.823 0.344 . . . . 0.0 110.936 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -61.11 -28.8 69.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.8 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLN . . . . . 0.45 ' HG2' ' HB2' ' A' ' 115' ' ' GLN . 2.1 pt20 -59.0 -3.2 0.32 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.137 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -90.7 -17.68 26.34 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.903 0.382 . . . . 0.0 110.895 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.692 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 15.9 mt -81.76 95.89 3.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.615 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -96.72 3.8 52.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.951 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.573 ' CD2' HG22 ' A' ' 65' ' ' THR . 29.5 mt 38.29 63.35 0.86 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.975 0.417 . . . . 0.0 111.449 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.772 HD23 ' HB3' ' A' ' 129' ' ' PRO . 1.8 mm? 64.79 -172.34 0.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.334 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -171.33 -1.59 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.742 -0.663 . . . . 0.0 113.495 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -143.67 -164.72 1.93 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.796 0.331 . . . . 0.0 110.861 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 124.48 167.69 12.71 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.65 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.77 -10.8 59.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.701 0.286 . . . . 0.0 111.319 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -146.06 -67.88 0.28 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.833 0.349 . . . . 0.0 110.618 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.5 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 4.9 pttt -168.99 159.79 7.92 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.05 0.452 . . . . 0.0 111.224 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.772 ' HB3' HD23 ' A' ' 122' ' ' LEU . 51.7 Cg_exo -48.17 -167.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 123.459 2.773 . . . . 0.0 113.771 -178.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -96.12 -33.88 11.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.834 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.651 ' CB ' ' HB1' ' A' ' 31' ' ' ALA . 3.2 m-85 -127.62 140.91 51.8 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.114 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.679 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -96.25 -29.28 8.52 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.498 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.403 ' HG2' ' OG ' ' A' ' 32' ' ' SER . 0.2 OUTLIER -145.18 146.75 31.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.725 0.298 . . . . 0.0 110.339 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.692 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 40.8 p-90 -135.89 165.77 24.86 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.939 0.399 . . . . 0.0 111.548 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.452 ' N ' ' HZ3' ' A' ' 40' ' ' TRP . 36.6 t -164.61 177.5 8.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.335 0.588 . . . . 0.0 112.164 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.537 ' NE1' ' HZ3' ' A' ' 134' ' ' TRP . 35.2 m95 -113.24 104.58 12.48 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.338 178.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.528 ' O ' ' N ' ' A' ' 28' ' ' ILE . 16.3 m -120.05 168.71 12.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.279 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.527 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 23.3 p -73.09 168.86 20.86 Favored Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.24 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.876 ' HG3' HD11 ' A' ' 28' ' ' ILE . 16.5 Cg_exo -61.88 -53.27 2.23 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 121.866 1.71 . . . . 0.0 110.471 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.7 -27.79 68.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.654 178.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.499 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 37.2 mt-30 -72.42 -46.28 55.86 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.045 0.45 . . . . 0.0 110.154 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.74 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.5 OUTLIER -56.26 -40.76 74.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.826 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.488 ' O ' HG22 ' A' ' 146' ' ' THR . 14.9 mm -62.15 -34.0 61.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.234 0.54 . . . . 0.0 110.158 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.89 -51.51 25.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.21 0.528 . . . . 0.0 110.714 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.6 mp -73.86 -20.99 60.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.877 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.656 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 11.7 t -73.77 175.81 6.88 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.504 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.533 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 23.0 m -86.44 149.72 4.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.996 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 151' ' ' LYS . 3.0 tt0 -50.81 -50.85 55.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.643 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -51.13 -11.4 0.1 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -131.8 -3.06 3.68 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.543 ' HG3' ' CG2' ' A' ' 146' ' ' THR . 0.6 OUTLIER -60.66 -63.43 4.31 Favored Pre-proline 0 C--N 1.325 -0.458 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.143 179.799 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.431 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 17.3 Cg_endo -58.33 -30.27 90.62 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.429 2.086 . . . . 0.0 111.962 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.972 HG22 HD11 ' A' ' 3' ' ' LEU . 19.0 t -68.9 -51.41 44.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.485 ' CE1' ' CH2' ' A' ' 107' ' ' TRP . 7.7 m-30 -63.4 -36.41 83.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.919 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.46 ' HD3' HG13 ' A' ' 143' ' ' ILE . 0.5 OUTLIER -57.86 -46.31 85.01 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.112 179.608 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.463 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.7 OUTLIER -67.03 -31.94 72.82 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.57 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 153' ' ' VAL . 92.4 t -66.76 -41.48 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.415 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.724 HD22 ' HB3' ' A' ' 139' ' ' PRO . 62.8 mt -64.03 -44.51 92.32 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.4 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.7 t -53.49 -42.84 67.71 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.65 HG11 ' HA ' ' A' ' 76' ' ' VAL . 92.3 t -66.48 -42.18 89.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.172 178.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.555 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 21.9 m-30 -81.79 5.9 17.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.624 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.705 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . . . -59.09 -50.86 85.59 Favored Pre-proline 0 C--N 1.327 -0.382 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.004 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.705 ' HD3' ' HB3' ' A' ' 162' ' ' ALA . 30.6 Cg_exo -60.12 -10.84 13.74 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.346 2.031 . . . . 0.0 112.085 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.552 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 87.6 m-70 -111.23 -18.24 13.0 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.44 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 96.7 mt . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.868 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.19 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.06 137.44 76.46 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.57 2.18 . . . . 0.0 112.33 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.92 HD11 HG22 ' A' ' 153' ' ' VAL . 0.1 OUTLIER 61.75 -174.69 0.13 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.049 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.07 -47.7 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.02 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.728 ' HB3' HD23 ' A' ' 80' ' ' LEU . 0.9 OUTLIER 62.95 137.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.047 0.451 . . . . 0.0 111.813 179.409 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.573 ' C ' ' HB2' ' A' ' 78' ' ' TYR . 0.4 OUTLIER -143.81 138.24 28.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.283 179.714 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.589 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 2.8 p30 -63.12 -9.29 10.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.682 0.277 . . . . 0.0 111.004 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.0 p -146.49 140.44 15.29 Favored Pre-proline 0 CA--C 1.53 0.21 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.469 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 45.9 Cg_endo -67.46 107.91 1.5 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.298 1.999 . . . . 0.0 112.193 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.469 ' HG3' ' SD ' ' A' ' 6' ' ' MET . 4.6 Cg_endo -49.27 165.05 0.24 Allowed 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.233 2.622 . . . . 0.0 113.091 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -51.42 128.38 22.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.395 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 53.42 78.91 0.1 OUTLIER Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.741 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -151.98 155.96 39.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.578 0.228 . . . . 0.0 110.743 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.757 ' HA ' ' HZ3' ' A' ' 100' ' ' TRP . 0.1 OUTLIER -66.33 -159.74 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.093 -179.201 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.601 ' HG2' HD12 ' A' ' 47' ' ' ILE . 6.7 ttp180 179.52 102.26 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.35 0.595 . . . . 0.0 110.103 -178.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.672 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 2.2 m-80 -128.81 175.29 8.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.844 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.761 HG13 ' CG1' ' A' ' 47' ' ' ILE . 25.7 m -134.64 159.5 41.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.177 0.513 . . . . 0.0 110.872 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.615 ' HA3' ' CE3' ' A' ' 107' ' ' TRP . . . -131.64 155.3 21.32 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.006 HG21 HD22 ' A' ' 61' ' ' LEU . 1.6 mp -125.37 117.08 48.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.476 ' O ' HD12 ' A' ' 109' ' ' LEU . 6.1 t -101.39 99.23 9.55 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.822 HD22 HG11 ' A' ' 67' ' ' VAL . 41.5 tp -100.83 119.09 38.15 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.727 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.801 ' HE2' HD13 ' A' ' 73' ' ' ILE . 0.4 OUTLIER -119.75 159.77 23.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.926 179.656 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.5 ' N ' ' OD1' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -94.6 171.87 8.53 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.024 0.44 . . . . 0.0 110.232 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -58.23 -4.77 0.39 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.675 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.612 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.5 OUTLIER -101.02 2.58 40.68 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.03 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.612 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 2.1 mmtm 75.12 20.86 2.03 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.186 -178.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.632 ' O ' ' HA ' ' A' ' 22' ' ' MET . 3.8 mmtt -92.2 143.87 25.99 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.756 HD11 ' HG3' ' A' ' 139' ' ' PRO . 1.6 mm -97.26 136.93 26.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.092 0.472 . . . . 0.0 112.009 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.567 ' CE1' HD13 ' A' ' 119' ' ' ILE . 33.8 t80 -74.13 105.53 5.38 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.41 178.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.603 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -103.88 144.37 31.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.799 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.405 ' HB1' ' CG ' ' A' ' 131' ' ' PHE . . . -142.25 131.37 23.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.388 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.785 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 6.6 p -97.9 147.29 24.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.069 0.461 . . . . 0.0 111.747 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 33' ' ' ARG . 4.7 mtp180 -68.36 128.95 38.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.389 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.697 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -45.14 -35.86 3.41 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.277 0.56 . . . . 0.0 110.883 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.53 -38.01 68.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.038 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.9 mt -122.81 105.92 34.84 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.214 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.11 -21.17 36.89 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.825 2.35 . . . . 0.0 112.967 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -92.06 -6.97 50.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.709 0.29 . . . . 0.0 111.568 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.785 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.34 95.45 10.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.691 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.658 ' O ' ' HA ' ' A' ' 146' ' ' THR . 72.3 m95 -93.65 136.73 33.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.912 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.513 ' HG3' ' C ' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -161.59 158.41 26.22 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.105 0.479 . . . . 0.0 110.699 179.755 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.597 ' HG3' ' HZ3' ' A' ' 107' ' ' TRP . 0.1 OUTLIER -94.34 157.8 36.83 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.55 178.844 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.508 ' CG ' HD13 ' A' ' 61' ' ' LEU . 2.8 Cg_endo -44.08 151.79 0.46 Allowed 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 123.119 2.546 . . . . 0.0 112.891 -179.126 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -171.39 143.06 1.77 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.201 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.672 ' O ' ' HB3' ' A' ' 16' ' ' ASN . . . -140.48 -178.38 17.0 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.65 ' HA2' ' CB ' ' A' ' 16' ' ' ASN . . . -112.18 23.58 15.97 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.016 -1.088 . . . . 0.0 114.736 -178.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.761 ' CG1' HG13 ' A' ' 17' ' ' VAL . 29.9 mt 60.13 130.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 117.543 0.672 . . . . 0.0 111.064 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.3 -176.15 0.71 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.825 0.345 . . . . 0.0 110.88 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.69 -81.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.212 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.39 55.91 0.49 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.359 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -116.21 153.01 32.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.873 0.368 . . . . 0.0 111.002 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.61 173.54 3.93 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.488 ' HA ' HG11 ' A' ' 17' ' ' VAL . 8.9 Cg_endo -85.53 -54.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.378 2.052 . . . . 0.0 111.678 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.806 ' HE ' HD11 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -54.36 -43.34 71.23 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.315 179.012 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.713 ' HA ' HD12 ' A' ' 58' ' ' ILE . 7.2 m-20 -69.44 -40.81 76.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.308 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.415 ' O ' ' CG ' ' A' ' 60' ' ' GLU . . . -60.78 -45.73 93.24 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.445 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -54.29 -49.37 69.77 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.014 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.806 HD11 ' HE ' ' A' ' 54' ' ' ARG . 18.0 mt -58.97 -55.47 23.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.246 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.67 -63.67 1.22 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.187 -179.174 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.614 ' CD ' HD11 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -47.2 -37.43 10.26 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.407 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.006 HD22 HG21 ' A' ' 19' ' ' ILE . 9.8 tp -53.24 -48.43 68.21 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.868 178.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.901 ' HG3' HG23 ' A' ' 68' ' ' THR . 16.7 ttp180 -64.17 -64.23 0.94 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.489 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -48.98 -22.1 0.8 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.272 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -96.99 -37.45 10.17 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -178.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.562 HG22 ' CD2' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -127.66 -5.04 5.84 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.571 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 78.16 -13.88 13.4 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.252 -0.975 . . . . 0.0 111.872 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.822 HG11 HD22 ' A' ' 21' ' ' LEU . 75.3 t -58.62 112.71 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-O 121.194 0.521 . . . . 0.0 111.291 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.901 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.8 OUTLIER -121.59 -40.43 2.56 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.414 178.653 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.427 ' HB2' ' HA3' ' A' ' 114' ' ' GLY . 11.8 m -62.09 74.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.38 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.62 156.45 23.21 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.84 152.03 50.62 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.758 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.541 HG22 ' CE2' ' A' ' 110' ' ' PHE . 3.3 t -75.0 126.75 36.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.95 0.405 . . . . 0.0 111.186 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.801 HD13 ' HE2' ' A' ' 22' ' ' MET . 1.0 OUTLIER -107.47 -19.66 6.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.266 179.218 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.429 ' HB2' ' CE1' ' A' ' 164' ' ' HIS . . . -170.88 176.39 4.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.582 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -154.46 148.37 25.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.422 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.799 ' HA ' HG11 ' A' ' 160' ' ' VAL . 55.3 t -70.65 139.29 86.14 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.983 0.42 . . . . 0.0 110.894 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.57 ' HD2' HG13 ' A' ' 76' ' ' VAL . 18.7 Cg_endo -59.04 -62.9 0.15 Allowed 'Trans proline' 0 CA--C 1.519 -0.271 0 C-N-CA 123.233 2.622 . . . . 0.0 112.499 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.589 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -103.46 -172.47 2.12 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.426 -178.909 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.602 ' O ' ' HB3' ' A' ' 5' ' ' SER . 64.5 m95 -91.8 -158.29 0.57 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.974 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.781 ' HB3' HD21 ' A' ' 3' ' ' LEU . 26.6 mt -164.44 105.4 0.86 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.744 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 23.9 p -104.62 -172.92 2.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.206 0.527 . . . . 0.0 111.289 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.682 ' CE2' HD12 ' A' ' 3' ' ' LEU . 0.2 OUTLIER -169.6 70.98 0.07 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.834 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -70.39 163.4 26.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.137 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.701 ' HB2' HD11 ' A' ' 92' ' ' LEU . 6.4 m-85 -97.86 168.61 9.74 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.304 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.49 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 16.8 Cg_exo -67.29 177.09 4.07 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.566 2.177 . . . . 0.0 111.132 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.4 ' HD2' ' CB ' ' A' ' 85' ' ' PRO . 56.0 Cg_endo -70.25 8.18 0.94 Allowed 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.397 2.065 . . . . 0.0 113.27 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.459 ' HG3' ' H ' ' A' ' 88' ' ' VAL . 0.9 OUTLIER -109.38 -45.92 3.64 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.703 0.287 . . . . 0.0 111.152 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.602 ' O ' HD12 ' A' ' 92' ' ' LEU . 13.9 t -87.76 -20.82 7.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.601 179.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.509 ' O ' ' HB2' ' A' ' 93' ' ' ASN . 1.4 tmm_? -37.85 -70.67 0.09 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.556 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.587 ' HA ' HD13 ' A' ' 94' ' ' ILE . 0.5 OUTLIER -63.46 -12.34 30.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.544 179.828 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.653 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -88.33 -29.85 20.01 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.312 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.849 HD13 ' H ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -122.92 -36.19 2.91 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -179.199 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.849 ' H ' HD13 ' A' ' 92' ' ' LEU . 68.0 m-20 -73.37 -57.98 3.63 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -177.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.587 HD13 ' HA ' ' A' ' 90' ' ' GLU . 3.1 mp -74.28 -4.58 5.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.353 0.596 . . . . 0.0 110.083 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.653 ' HG3' ' O ' ' A' ' 91' ' ' LYS . 0.9 OUTLIER -78.54 -2.06 36.95 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.678 179.2 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.47 ' HB2' ' CB ' ' A' ' 100' ' ' TRP . 62.2 m95 -82.84 -76.97 0.25 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.635 0.255 . . . . 0.0 110.795 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 162.98 64.07 0.02 OUTLIER Glycine 0 CA--C 1.521 0.429 0 C-N-CA 120.346 -0.931 . . . . 0.0 113.67 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 69.2 m 65.1 145.64 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.935 0.397 . . . . 0.0 111.773 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.35 1.75 2.16 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.551 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.757 ' HZ3' ' HA ' ' A' ' 14' ' ' ARG . 92.1 m95 -103.44 163.76 12.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.038 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.788 ' HA ' ' HB3' ' A' ' 93' ' ' ASN . 15.1 ttmt 167.76 29.51 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.379 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 150.84 -160.01 28.42 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.722 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.744 ' O ' ' HA ' ' A' ' 81' ' ' THR . 2.7 mt-30 -147.2 113.25 5.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.103 0.451 . . . . 0.0 112.085 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.686 ' HB2' HG22 ' A' ' 81' ' ' THR . . . -96.13 119.42 34.59 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.61 179.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.463 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 15.7 mt-30 -126.31 123.97 39.24 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.571 ' HB2' ' CE3' ' A' ' 79' ' ' TRP . 0.7 OUTLIER -104.46 139.19 39.74 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.134 178.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.615 ' CE3' ' HA3' ' A' ' 18' ' ' GLY . 77.8 m95 -106.82 162.91 13.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.371 0.605 . . . . 0.0 112.576 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.616 ' CD1' ' HG2' ' A' ' 54' ' ' ARG . 96.5 m-85 -140.0 152.98 46.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.205 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.599 HD11 ' SD ' ' A' ' 22' ' ' MET . 11.8 tp -99.99 136.93 39.15 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.557 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.608 ' CE2' HG12 ' A' ' 58' ' ' ILE . 29.6 m-85 -140.03 144.54 36.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.504 0.669 . . . . 0.0 112.631 -178.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.569 ' HB2' HD11 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -104.39 123.17 46.96 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.977 178.397 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.624 ' CD1' HD21 ' A' ' 21' ' ' LEU . 56.6 t80 -79.13 99.42 6.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.912 0.387 . . . . 0.0 110.552 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 69' ' ' SER . 30.3 p -95.78 41.71 1.1 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.324 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 69' ' ' SER . . . -141.81 -148.33 5.01 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.651 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -122.7 149.84 43.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.951 0.405 . . . . 0.0 111.359 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.437 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 18.1 p-10 -58.99 -37.0 75.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.386 0.612 . . . . 0.0 111.231 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -57.43 -3.5 0.17 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.46 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -90.49 -20.54 22.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.146 0.498 . . . . 0.0 110.303 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.567 HD13 ' CE1' ' A' ' 29' ' ' PHE . 9.7 mt -88.35 107.07 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.215 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.474 ' C ' ' H ' ' A' ' 122' ' ' LEU . 58.1 t30 -102.23 -26.07 13.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.191 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.562 ' CD2' HG22 ' A' ' 65' ' ' THR . 56.9 mt 71.02 -37.48 0.39 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.178 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.705 ' HA ' ' HB3' ' A' ' 129' ' ' PRO . 18.8 mt -91.14 9.41 31.16 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.154 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.1 -124.69 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.126 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 40.8 t0 57.11 -106.82 0.35 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.735 -0.232 . . . . 0.0 110.912 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 116.84 44.74 0.57 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.731 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 51.6 p -120.24 -53.53 2.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.974 0.416 . . . . 0.0 111.126 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -147.38 -42.73 0.17 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.169 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.658 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 4.4 pttm -177.43 161.83 1.42 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.174 0.511 . . . . 0.0 111.494 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.705 ' HB3' ' HA ' ' A' ' 122' ' ' LEU . 11.0 Cg_endo -60.01 179.15 0.31 Allowed 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 123.157 2.571 . . . . 0.0 112.754 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.461 ' HB2' ' CE1' ' A' ' 131' ' ' PHE . 61.0 mm-40 -111.28 -34.7 6.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.539 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.502 ' CE1' HG23 ' A' ' 65' ' ' THR . 0.7 OUTLIER -134.02 143.87 48.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.104 -179.872 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.697 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -89.73 -33.69 8.96 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.054 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.35 142.9 28.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.836 0.35 . . . . 0.0 110.543 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.534 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 34.5 p-90 -135.29 170.33 16.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.137 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.45 ' N ' ' CE3' ' A' ' 134' ' ' TRP . 22.6 t -168.33 176.66 5.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.315 0.579 . . . . 0.0 111.758 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.507 ' CE2' ' CZ3' ' A' ' 134' ' ' TRP . 48.0 m95 -110.69 102.84 11.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.479 178.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 28' ' ' ILE . 29.6 m -118.19 167.6 11.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.548 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 18.3 p -72.51 169.53 16.63 Favored Pre-proline 0 C--N 1.326 -0.429 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.211 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.756 ' HG3' HD11 ' A' ' 28' ' ' ILE . 17.1 Cg_exo -60.2 -56.51 1.08 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.723 1.615 . . . . 0.0 110.379 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -62.76 -27.76 69.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.73 178.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.44 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 10.8 mt-30 -71.35 -48.81 47.92 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.544 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.603 HD13 ' HB2' ' A' ' 30' ' ' ALA . 5.2 tp -57.41 -38.48 74.39 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.654 ' O ' HG22 ' A' ' 146' ' ' THR . 16.4 mm -60.13 -36.71 69.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.538 179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.98 -53.04 14.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.247 0.546 . . . . 0.0 110.954 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.78 -19.0 62.07 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.174 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.658 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 13.1 t -73.57 177.33 5.42 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.112 0.482 . . . . 0.0 111.302 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.515 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 36.0 m -81.03 149.53 4.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.748 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.415 ' C ' ' H ' ' A' ' 150' ' ' LYS . 2.7 mt-10 -57.83 -53.47 57.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.813 0.34 . . . . 0.0 110.988 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.5 ' CD2' ' HG3' ' A' ' 150' ' ' LYS . 39.4 p90 -57.08 2.38 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.501 ' HD2' HG21 ' A' ' 147' ' ' VAL . 6.4 mtpp -139.12 -5.95 1.43 Allowed 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 0.2 OUTLIER -63.09 -52.39 63.0 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.849 -0.159 . . . . 0.0 110.686 179.681 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 151' ' ' LYS . 15.1 Cg_exo -65.28 -29.3 54.96 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.296 1.997 . . . . 0.0 111.393 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.92 HG22 HD11 ' A' ' 3' ' ' LEU . 37.2 t -67.92 -53.55 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.517 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 4.0 m-30 -63.31 -39.49 94.69 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.578 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.625 ' HE2' ' HA ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -56.22 -38.18 70.71 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.247 179.527 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.69 ' OE1' HD11 ' A' ' 80' ' ' LEU . 4.7 tm-20 -68.48 -36.53 79.09 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.62 HG12 ' CE2' ' A' ' 161' ' ' PHE . 40.0 t -64.51 -41.02 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.863 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.659 HD22 ' HB3' ' A' ' 139' ' ' PRO . 43.4 mt -65.4 -46.94 78.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.939 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -52.15 -40.34 61.27 Favored 'General case' 0 CA--C 1.522 -0.127 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.799 HG11 ' HA ' ' A' ' 76' ' ' VAL . 98.4 t -67.33 -42.43 87.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.62 ' CE2' HG12 ' A' ' 157' ' ' VAL . 17.3 m-30 -80.09 5.49 14.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.034 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.592 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.1 -53.72 63.06 Favored Pre-proline 0 C--N 1.331 -0.229 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.528 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 18.2 Cg_endo -58.41 -13.26 16.13 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 121.989 1.793 . . . . 0.0 111.56 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.429 ' CE1' ' HB2' ' A' ' 74' ' ' ALA . 40.5 m80 -107.25 -17.71 14.07 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.986 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 92.3 mt . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.026 -0.987 . . . . 0.0 110.368 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.191 0 N-CA-C 112.372 -0.291 . . . . 0.0 112.372 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.56 135.24 55.14 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.518 2.145 . . . . 0.0 112.142 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.887 ' CD2' HD22 ' A' ' 80' ' ' LEU . 0.3 OUTLIER 62.31 115.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.886 -179.891 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.56 -46.17 15.7 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.321 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.784 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 0.7 OUTLIER 72.67 -65.01 0.37 Allowed 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.953 0.406 . . . . 0.0 111.375 -179.894 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.407 ' HB2' ' O ' ' A' ' 5' ' ' SER . 3.6 mpp? 63.87 125.2 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.642 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.446 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 6.3 p-10 -65.12 -47.56 76.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.892 0.377 . . . . 0.0 110.211 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.42 153.27 41.43 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.128 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.482 ' HB3' ' CZ2' ' A' ' 79' ' ' TRP . 61.0 Cg_endo -74.46 106.35 2.22 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.513 2.142 . . . . 0.0 112.635 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 11' ' ' GLU . 14.2 Cg_endo -55.7 -171.49 0.03 OUTLIER 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.025 2.483 . . . . 0.0 112.625 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.469 ' CB ' ' HE2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -50.34 -165.4 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.913 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 11' ' ' GLU . . . -28.42 -86.93 0.01 OUTLIER Glycine 0 C--N 1.339 0.738 0 CA-C-N 115.943 -0.571 . . . . 0.0 113.172 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.65 ' HE1' ' HB3' ' A' ' 83' ' ' ASP . 9.9 m-85 60.39 153.58 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.875 0.369 . . . . 0.0 111.729 179.073 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.552 ' HB2' ' HZ3' ' A' ' 100' ' ' TRP . 0.0 OUTLIER -69.64 67.9 0.24 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.774 178.973 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -46.5 98.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.278 0.561 . . . . 0.0 110.786 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.837 ' HB2' ' HG2' ' A' ' 105' ' ' GLN . 2.8 m-80 -132.26 173.73 10.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.338 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.716 HG13 ' CG1' ' A' ' 47' ' ' ILE . 11.5 m -140.49 169.6 15.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.18 0.514 . . . . 0.0 111.281 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.615 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -136.25 153.95 21.76 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.253 178.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.832 HG23 ' CE1' ' A' ' 110' ' ' PHE . 2.4 mp -126.34 122.16 60.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.491 ' O ' HD12 ' A' ' 109' ' ' LEU . 40.9 t -104.88 107.62 18.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.083 177.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.793 HD21 ' CD2' ' A' ' 112' ' ' PHE . 17.3 tp -106.08 126.66 52.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.726 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.77 ' SD ' HD11 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -118.82 141.04 49.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.057 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.451 ' OD1' ' CH2' ' A' ' 136' ' ' TRP . 5.6 m-20 -95.22 -175.98 3.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.191 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -55.5 -6.25 0.17 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.472 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 4.5 m-20 -100.71 -0.13 37.9 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.465 ' NZ ' ' HE3' ' A' ' 22' ' ' MET . 30.0 mmtt 68.68 23.57 7.07 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 22' ' ' MET . 72.2 mttt -95.13 176.78 6.1 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.915 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.621 HD11 ' HG3' ' A' ' 139' ' ' PRO . 2.0 mm -116.94 142.14 32.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.344 0.592 . . . . 0.0 111.249 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.617 ' CZ ' HG21 ' A' ' 65' ' ' THR . 6.6 t80 -66.88 103.48 1.14 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.108 179.015 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' A' ' 41' ' ' GLN . . . -97.58 137.87 35.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.986 0.422 . . . . 0.0 111.253 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.426 ' HB1' ' CG ' ' A' ' 131' ' ' PHE . . . -139.25 132.69 30.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.477 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.662 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 77.0 p -101.32 146.9 26.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.919 0.39 . . . . 0.0 111.38 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 33' ' ' ARG . 5.5 mtp85 -69.55 128.98 38.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.37 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.715 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.6 OUTLIER -44.69 -37.04 3.43 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.37 0.605 . . . . 0.0 111.034 -179.863 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.86 -36.47 70.13 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.752 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.7 mm -122.99 110.57 31.23 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.12 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.23 -19.74 13.25 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.397 2.064 . . . . 0.0 112.644 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -91.06 -10.1 43.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.471 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.733 ' HB1' ' CG1' ' A' ' 147' ' ' VAL . . . -92.24 95.01 9.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.691 0.282 . . . . 0.0 111.075 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.661 ' O ' ' HA ' ' A' ' 146' ' ' THR . 78.7 m95 -87.99 158.41 18.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.126 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.664 ' O ' ' HA ' ' A' ' 30' ' ' ALA . 1.6 mt-30 -166.95 -138.25 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.629 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.531 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 8.5 ptt? -175.82 162.23 2.03 Favored Pre-proline 0 N--CA 1.453 -0.319 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.755 ' HG3' HD12 ' A' ' 61' ' ' LEU . 1.5 Cg_endo -40.9 134.19 2.51 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 123.257 2.638 . . . . 0.0 113.088 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -173.73 143.51 1.0 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.875 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.453 ' HA3' ' HG2' ' A' ' 60' ' ' GLU . . . -159.6 -158.64 9.26 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.783 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.715 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -117.31 141.8 16.85 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.742 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.716 ' CG1' HG13 ' A' ' 17' ' ' VAL . 13.9 mt -71.69 143.0 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 122.496 0.319 . . . . 0.0 110.88 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -69.23 -176.19 0.89 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.919 0.39 . . . . 0.0 110.587 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -49.13 -81.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.225 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -108.05 53.22 0.61 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.251 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -118.35 153.73 33.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.915 0.388 . . . . 0.0 111.048 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.53 163.29 64.6 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.426 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.467 ' HA ' HG12 ' A' ' 47' ' ' ILE . 5.8 Cg_exo -78.5 -52.58 0.06 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 122.952 2.435 . . . . 0.0 112.486 -179.389 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.653 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -48.89 -51.85 27.68 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.762 179.659 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -57.26 -42.68 82.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.175 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 60' ' ' GLU . . . -61.59 -43.52 98.7 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.603 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -57.57 -57.77 11.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.344 177.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.653 HD13 ' O ' ' A' ' 54' ' ' ARG . 1.9 mp -55.23 -48.99 75.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.577 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.7 mtt180 -65.01 -62.55 1.48 Allowed 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.304 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.453 ' HG2' ' HA3' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -42.3 -47.26 4.79 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.118 0.485 . . . . 0.0 110.119 179.581 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.755 HD12 ' HG3' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -50.8 -49.37 58.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.083 178.715 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.93 ' HG3' HG23 ' A' ' 68' ' ' THR . 13.9 ttp180 -63.73 -65.54 0.67 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.493 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -49.02 -20.4 0.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -98.1 -35.48 10.4 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -178.378 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.872 HG22 HD23 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -133.03 7.99 4.03 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -178.38 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.87 -9.73 2.68 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.974 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.734 HG13 ' CE2' ' A' ' 112' ' ' PHE . 77.1 t -56.76 108.66 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-O 121.153 0.501 . . . . 0.0 111.393 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.93 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.6 OUTLIER -124.58 -39.71 2.28 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.593 178.26 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.0 m -63.77 70.91 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.991 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -156.96 156.91 33.8 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.037 0.446 . . . . 0.0 111.932 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.427 ' HG3' HG21 ' A' ' 113' ' ' THR . 0.9 OUTLIER -129.39 149.1 51.31 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.435 179.108 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.967 HG22 ' CE2' ' A' ' 110' ' ' PHE . 12.3 t -74.71 125.0 33.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 111' ' ' LYS . 0.9 OUTLIER -105.5 -21.62 5.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.12 179.302 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -170.42 177.02 4.21 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.554 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 2.0 pm0 -155.36 152.05 28.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.757 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.725 ' HA ' HG11 ' A' ' 160' ' ' VAL . 54.1 t -70.48 132.57 87.49 Favored Pre-proline 0 C--N 1.327 -0.387 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.814 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -57.97 -55.12 2.51 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.125 2.55 . . . . 0.0 112.681 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.556 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.6 OUTLIER -101.88 -174.36 2.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.65 -179.518 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.505 ' HB2' ' O ' ' A' ' 5' ' ' SER . 33.9 m95 -94.65 -154.67 0.43 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.887 HD22 ' CD2' ' A' ' 3' ' ' LEU . 95.5 mt -163.47 105.26 0.97 Allowed 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.763 HG22 ' HA ' ' A' ' 104' ' ' ALA . 4.5 p -125.09 100.26 6.48 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.283 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -78.42 52.46 1.15 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.65 ' HB3' ' HE1' ' A' ' 13' ' ' TYR . 3.3 p30 -71.32 -156.42 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.935 -178.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.701 ' CE1' ' HG2' ' A' ' 89' ' ' ARG . 49.6 p90 -101.39 145.39 30.36 Favored Pre-proline 0 N--CA 1.452 -0.369 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.648 -179.088 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.608 ' CB ' ' HD2' ' A' ' 86' ' ' PRO . 47.0 Cg_exo -53.22 -170.54 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.52 2.147 . . . . 0.0 110.787 178.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.608 ' HD2' ' CB ' ' A' ' 85' ' ' PRO . 18.7 Cg_endo -59.54 -76.6 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 121.712 1.608 . . . . 0.0 113.837 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -76.51 43.85 0.33 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.574 HG21 ' HD2' ' A' ' 85' ' ' PRO . 58.5 t -121.47 -0.18 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.701 ' HG2' ' CE1' ' A' ' 84' ' ' PHE . 5.2 mmm180 -40.63 -66.08 0.35 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.127 0.489 . . . . 0.0 111.373 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.759 ' HA ' HD13 ' A' ' 94' ' ' ILE . 7.9 tt0 -65.18 -15.15 62.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.918 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.673 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -86.95 -35.9 18.63 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.488 -179.512 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.645 ' HB3' ' HB3' ' A' ' 84' ' ' PHE . 2.1 tm? -123.11 -46.03 2.09 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.505 ' HB3' ' O ' ' A' ' 89' ' ' ARG . 35.5 t-20 -53.01 -61.76 2.09 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.96 0.409 . . . . 0.0 111.919 -178.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.759 HD13 ' HA ' ' A' ' 90' ' ' GLU . 2.6 mp -63.7 -8.51 4.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.172 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.673 ' HG3' ' O ' ' A' ' 91' ' ' LYS . 3.6 mm-40 -76.48 -6.14 50.49 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.619 0.247 . . . . 0.0 111.46 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.498 ' HE1' ' CD1' ' A' ' 92' ' ' LEU . 93.1 m95 -97.84 24.81 6.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.904 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.47 ' O ' ' CB ' ' A' ' 98' ' ' SER . . . 93.5 18.67 37.68 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.314 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 97' ' ' GLY . 0.9 OUTLIER 88.48 125.12 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.86 0.362 . . . . 0.0 110.842 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.3 t0 57.02 112.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.41 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.895 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -162.32 -82.88 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.374 179.799 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.895 ' HB2' ' O ' ' A' ' 100' ' ' TRP . 6.7 mptt 128.77 -45.34 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.983 0.913 . . . . 0.0 111.521 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 159.72 -128.5 2.01 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.23 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.678 ' O ' ' HA ' ' A' ' 81' ' ' THR . 9.6 mt-30 -145.87 106.88 4.14 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 122.992 -0.122 . . . . 0.0 110.733 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.763 ' HA ' HG22 ' A' ' 81' ' ' THR . . . -97.86 118.69 34.97 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.095 0.474 . . . . 0.0 111.276 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.837 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 71.1 mt-30 -132.51 122.65 25.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.291 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.455 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 14.8 ttpp -105.2 138.26 41.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.482 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.615 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 28.4 m95 -103.96 162.75 12.87 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.585 ' HB2' ' HE1' ' A' ' 110' ' ' PHE . 51.3 m-85 -140.34 154.07 46.63 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.479 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.77 HD11 ' SD ' ' A' ' 22' ' ' MET . 12.0 tp -103.22 140.97 36.67 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.323 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.967 ' CE2' HG22 ' A' ' 72' ' ' VAL . 63.1 m-85 -143.69 150.0 38.03 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 16.5 tttt -106.69 124.21 49.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.533 178.3 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.793 ' CD2' HD21 ' A' ' 21' ' ' LEU . 16.0 t80 -78.92 100.88 7.43 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.012 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.427 HG21 ' HG3' ' A' ' 71' ' ' GLU . 60.1 p -95.9 39.98 1.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.115 0.483 . . . . 0.0 110.845 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -145.64 -144.12 4.06 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.078 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.776 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 50.6 mt-30 -123.11 160.8 25.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.898 0.38 . . . . 0.0 111.207 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.409 ' HB2' ' CZ2' ' A' ' 134' ' ' TRP . 9.2 p-10 -60.14 -27.67 67.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.665 0.745 . . . . 0.0 111.309 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -52.82 -5.78 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.321 -1.309 . . . . 0.0 113.741 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.776 ' HG2' ' O ' ' A' ' 115' ' ' GLN . 0.1 OUTLIER -90.96 -24.48 20.12 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.085 178.785 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.608 ' HA ' ' O ' ' A' ' 65' ' ' THR . 7.0 mt -84.53 101.39 8.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.619 -0.718 . . . . 0.0 112.442 -178.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.455 ' C ' ' H ' ' A' ' 122' ' ' LEU . 12.4 t30 -107.04 -32.0 8.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.403 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.872 HD23 HG22 ' A' ' 65' ' ' THR . 9.9 mt 74.04 -40.3 0.45 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.035 0.445 . . . . 0.0 110.519 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.787 ' HA ' ' HB3' ' A' ' 129' ' ' PRO . 34.6 mt -78.27 175.33 10.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.911 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 155.2 123.04 0.82 Allowed Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.051 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -96.22 129.77 43.45 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.756 0.312 . . . . 0.0 110.988 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 157.89 -21.51 0.38 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.504 -0.855 . . . . 0.0 113.103 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 55.0 p -115.58 -81.01 0.61 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.955 0.377 . . . . 0.0 111.283 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.82 -42.08 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.191 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.748 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 0.5 OUTLIER -177.47 163.61 1.4 Allowed Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 121.276 0.56 . . . . 0.0 111.589 179.576 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.787 ' HB3' ' HA ' ' A' ' 122' ' ' LEU . 17.3 Cg_endo -57.95 -176.91 0.08 OUTLIER 'Trans proline' 0 CA--C 1.528 0.18 0 C-N-CA 123.184 2.589 . . . . 0.0 112.313 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -110.59 -42.65 4.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.596 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.626 ' CE2' HG23 ' A' ' 65' ' ' THR . 1.6 m-85 -130.68 143.3 50.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.05 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.715 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -87.46 -35.96 9.09 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.639 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -148.34 144.76 27.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.944 0.402 . . . . 0.0 110.741 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.687 ' HD1' HD11 ' A' ' 121' ' ' LEU . 39.0 p-90 -135.88 169.34 17.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.94 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.428 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 33.6 t -162.75 176.3 10.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.315 0.578 . . . . 0.0 112.03 -178.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.451 ' CH2' ' OD1' ' A' ' 23' ' ' ASN . 83.4 m95 -110.71 103.03 11.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.314 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.44 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 30.1 m -120.55 167.83 13.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.911 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.542 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 24.3 p -72.2 167.26 33.7 Favored Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.066 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.621 ' HG3' HD11 ' A' ' 28' ' ' ILE . 20.2 Cg_exo -59.62 -55.65 1.64 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.731 1.621 . . . . 0.0 110.296 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -62.7 -26.93 68.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.265 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.45 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 11.7 mm100 -72.51 -46.84 52.76 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.625 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.635 HD11 ' O ' ' A' ' 41' ' ' GLN . 1.5 tp -58.21 -38.52 76.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.858 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.825 HG21 ' HG2' ' A' ' 155' ' ' LYS . 28.9 mm -62.31 -38.89 82.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.252 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.27 -50.16 55.63 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.307 0.575 . . . . 0.0 110.729 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.58 -20.22 60.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.967 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.661 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 13.2 t -74.89 176.37 7.18 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.141 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.733 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 35.3 m -81.63 142.79 13.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.818 0.342 . . . . 0.0 111.53 -179.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.523 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 55.2 mt-10 -50.27 -51.15 47.29 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.278 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.15 -10.91 0.09 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -135.25 -4.02 2.4 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.644 ' HG2' ' O ' ' A' ' 143' ' ' ILE . 9.7 mttt -59.47 -57.98 22.9 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 120.36 0.124 . . . . 0.0 111.164 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 20.8 Cg_endo -60.78 -27.55 84.99 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.427 2.085 . . . . 0.0 111.658 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.733 ' O ' HG23 ' A' ' 157' ' ' VAL . 39.0 t -68.97 -52.89 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.547 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 5.0 m-30 -64.31 -40.65 96.34 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.505 178.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.825 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -55.85 -41.34 74.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.258 179.521 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -68.31 -33.46 74.35 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 153' ' ' VAL . 44.6 t -66.42 -40.77 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.944 178.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.617 HD22 ' HB3' ' A' ' 139' ' ' PRO . 52.2 mt -63.46 -45.83 89.01 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.644 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.15 -40.14 45.52 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.725 HG11 ' HA ' ' A' ' 76' ' ' VAL . 88.8 t -66.99 -42.69 88.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.944 177.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.689 ' CE2' HG12 ' A' ' 157' ' ' VAL . 14.1 m-30 -81.03 5.58 16.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.685 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.631 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.42 -51.89 78.55 Favored Pre-proline 0 C--N 1.331 -0.237 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.428 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 18.1 Cg_endo -59.08 -12.39 15.54 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.021 1.814 . . . . 0.0 111.716 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -107.69 -20.14 13.32 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.464 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 96.8 mt . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.761 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -56.08 171.81 0.73 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.598 2.199 . . . . 0.0 112.029 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.997 HD11 HG22 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -103.81 105.92 16.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.93 0.395 . . . . 0.0 111.158 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -88.78 172.5 40.66 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.883 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.644 ' HB3' HD23 ' A' ' 80' ' ' LEU . 71.3 p -151.81 -79.24 0.11 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.979 0.419 . . . . 0.0 111.853 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.472 ' HB2' ' O ' ' A' ' 5' ' ' SER . 3.9 mpp? 68.23 133.56 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.534 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.735 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 63.8 t0 -65.45 -32.55 74.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.952 0.406 . . . . 0.0 110.489 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.15 125.85 36.71 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.902 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.49 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 73.5 Cg_endo -75.02 105.66 2.13 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.196 1.931 . . . . 0.0 112.126 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.516 ' HG2' ' CG ' ' A' ' 13' ' ' TYR . 1.9 Cg_endo -46.02 177.34 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 123.132 2.555 . . . . 0.0 112.28 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.6 ' HB3' ' HB3' ' A' ' 99' ' ' ASP . 6.1 mm-40 -40.29 115.55 0.57 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.283 0.564 . . . . 0.0 111.994 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.534 ' HA3' ' HA ' ' A' ' 100' ' ' TRP . . . 61.19 -80.21 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.372 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.516 ' CG ' ' HG2' ' A' ' 10' ' ' PRO . 8.6 m-85 38.52 56.84 1.81 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.627 ' HA ' ' CH2' ' A' ' 100' ' ' TRP . 0.0 OUTLIER 32.61 -152.93 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.792 179.346 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.536 ' HG2' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER 176.64 96.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.031 0.443 . . . . 0.0 110.144 -179.498 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.62 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 8.8 m120 -133.19 172.67 12.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.132 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.663 HG13 ' CG1' ' A' ' 47' ' ' ILE . 16.6 m -135.84 164.98 30.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.224 0.535 . . . . 0.0 111.443 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.719 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -138.67 155.88 23.89 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.97 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.814 HG13 ' HB1' ' A' ' 57' ' ' ALA . 2.5 mp -131.11 123.91 54.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.51 ' O ' HD12 ' A' ' 109' ' ' LEU . 8.6 t -102.33 101.22 11.45 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.871 HD22 HG11 ' A' ' 67' ' ' VAL . 20.7 tp -99.58 117.52 34.15 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.359 -178.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.491 ' SD ' HD11 ' A' ' 109' ' ' LEU . 1.4 ptt? -118.08 166.74 12.19 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.729 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.716 ' ND2' ' CE3' ' A' ' 136' ' ' TRP . 0.3 OUTLIER -101.21 169.67 8.76 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.28 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -56.37 -4.5 0.14 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.52 178.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.5 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 2.7 m-20 -99.06 2.96 46.61 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 3.3 mmtp 74.18 20.47 2.69 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.014 -178.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.462 ' HB2' ' OD1' ' A' ' 23' ' ' ASN . 1.1 mmtt -94.17 145.55 24.62 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.817 HD11 ' HG3' ' A' ' 139' ' ' PRO . 1.1 mm -97.93 139.94 19.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.294 0.568 . . . . 0.0 112.473 -177.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.408 ' HE1' ' CD2' ' A' ' 134' ' ' TRP . 18.6 t80 -75.99 122.54 24.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.809 178.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.62 ' HA ' ' O ' ' A' ' 41' ' ' GLN . . . -122.68 146.68 47.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.967 0.413 . . . . 0.0 111.124 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.446 ' O ' ' HG3' ' A' ' 41' ' ' GLN . . . -137.65 136.5 37.52 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.407 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.574 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 97.0 p -100.73 144.52 29.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.909 0.385 . . . . 0.0 111.049 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.2 mtp-105 -69.83 126.71 30.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.487 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.697 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.3 OUTLIER -45.43 -33.37 2.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.296 0.57 . . . . 0.0 110.781 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.01 -38.23 64.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.008 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.473 HG22 ' H ' ' A' ' 39' ' ' ALA . 56.1 mt -124.67 104.56 30.65 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.09 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.24 -18.1 50.4 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.727 2.285 . . . . 0.0 112.774 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -94.22 -11.0 31.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.554 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.8 ' HB1' ' CG1' ' A' ' 147' ' ' VAL . . . -91.42 96.77 10.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.778 0.323 . . . . 0.0 111.196 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.552 ' O ' ' HA ' ' A' ' 146' ' ' THR . 77.1 m95 -89.53 161.89 15.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.341 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.62 ' O ' ' HA ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -169.26 -139.47 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.932 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.487 ' H ' ' HB2' ' A' ' 41' ' ' GLN . 10.2 ptt? -175.07 161.93 2.34 Favored Pre-proline 0 C--N 1.327 -0.386 0 O-C-N 122.196 -0.315 . . . . 0.0 110.368 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 42' ' ' MET . 1.9 Cg_endo -40.8 131.91 2.72 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.015 2.477 . . . . 0.0 112.946 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.465 ' HA ' HD12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -178.44 144.66 0.3 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.652 179.755 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.675 ' HA3' ' HG2' ' A' ' 60' ' ' GLU . . . -161.26 -163.12 13.63 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.059 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.62 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -109.3 145.94 16.73 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.723 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.663 ' CG1' HG13 ' A' ' 17' ' ' VAL . 19.8 mt -72.49 143.64 13.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 122.354 0.262 . . . . 0.0 110.973 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -69.54 -174.85 0.75 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.836 0.35 . . . . 0.0 110.458 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -48.48 -71.13 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.147 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -120.9 54.23 0.67 Allowed Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.384 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -113.47 150.66 32.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.803 0.335 . . . . 0.0 110.875 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -69.66 158.89 85.89 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.053 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.555 ' HA ' HG11 ' A' ' 17' ' ' VAL . 4.0 Cg_exo -76.4 -50.37 0.11 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.595 2.197 . . . . 0.0 111.426 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.819 ' HE ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -52.49 -46.81 66.77 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.297 179.325 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -66.9 -41.81 86.53 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.056 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.562 ' O ' ' HB2' ' A' ' 60' ' ' GLU . . . -61.13 -44.43 97.35 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.814 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -55.43 -53.98 49.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.094 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.675 HD11 ' NE ' ' A' ' 54' ' ' ARG . 34.6 mt -55.02 -53.73 31.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.098 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 -62.29 -60.76 3.11 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.976 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.675 ' HG2' ' HA3' ' A' ' 45' ' ' GLY . 0.6 OUTLIER -44.1 -48.25 8.99 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.105 0.479 . . . . 0.0 110.121 179.269 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.688 HD13 HG21 ' A' ' 19' ' ' ILE . 0.8 OUTLIER -52.73 -46.23 67.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.565 179.046 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.805 ' HG3' HG23 ' A' ' 68' ' ' THR . 42.9 ttp180 -64.87 -62.75 1.37 Allowed 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 121.343 0.592 . . . . 0.0 111.015 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -50.09 -21.69 1.37 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.359 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -96.11 -36.6 10.93 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.575 HG23 ' CE2' ' A' ' 131' ' ' PHE . 3.6 p -127.27 -4.62 6.12 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.819 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 80.3 -12.07 34.23 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.362 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.871 HG11 HD22 ' A' ' 21' ' ' LEU . 64.3 t -58.2 118.98 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 121.33 0.586 . . . . 0.0 111.587 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.805 HG23 ' HG3' ' A' ' 62' ' ' ARG . 1.1 p -127.2 -40.01 1.86 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.402 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.8 m -62.54 76.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.512 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -162.92 156.7 20.24 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -129.82 150.17 51.24 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.858 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.819 HG21 ' HE ' ' A' ' 54' ' ' ARG . 21.3 t -74.0 129.41 36.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.265 0.555 . . . . 0.0 111.753 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.641 HD11 ' HB2' ' A' ' 111' ' ' LYS . 1.3 mt -110.56 -18.36 7.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.452 179.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.493 ' HB2' ' CG ' ' A' ' 164' ' ' HIS . . . -171.3 175.93 4.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.405 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -154.6 150.01 27.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.603 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.731 ' HA ' HG11 ' A' ' 160' ' ' VAL . 11.2 t -72.03 136.85 82.08 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.846 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.697 ' HD2' HG21 ' A' ' 160' ' ' VAL . 35.1 Cg_endo -67.56 -60.25 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.9 2.4 . . . . 0.0 113.306 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.735 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -94.27 172.98 7.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.08 -178.478 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.59 ' HB3' ' HB1' ' A' ' 104' ' ' ALA . 57.1 m95 -91.71 100.69 13.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.281 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.644 HD23 ' HB3' ' A' ' 5' ' ' SER . 88.8 mt -60.02 112.97 2.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.054 0.454 . . . . 0.0 110.783 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.876 HG22 ' HA ' ' A' ' 104' ' ' ALA . 4.3 p -114.22 -172.19 2.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.899 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -171.89 67.4 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.212 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -67.04 169.54 8.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.206 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.653 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 28.9 m-85 -97.08 174.98 2.85 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.692 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.559 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 52.2 Cg_exo -55.35 -178.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 121.946 1.764 . . . . 0.0 111.529 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.491 ' HD2' ' HB3' ' A' ' 85' ' ' PRO . 46.8 Cg_endo -69.82 -1.62 8.84 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.218 1.946 . . . . 0.0 112.929 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.9 -61.84 1.56 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.804 0.335 . . . . 0.0 110.701 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.653 ' HB ' ' HB3' ' A' ' 84' ' ' PHE . 59.3 t -58.75 -41.5 82.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.067 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.673 ' O ' ' HB2' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -78.35 -1.23 32.32 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.246 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.993 ' HA ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -110.4 -14.93 14.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.922 0.392 . . . . 0.0 111.209 179.376 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.8 -22.29 12.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.548 179.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.676 HD13 ' HE1' ' A' ' 96' ' ' TRP . 1.3 tm? -120.83 -48.19 2.27 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.508 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.673 ' HB2' ' O ' ' A' ' 89' ' ' ARG . 2.1 m-80 -67.73 -30.35 69.81 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.561 -179.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.993 HD13 ' HA ' ' A' ' 90' ' ' GLU . 1.1 mp -68.9 -9.73 12.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.879 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.586 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -101.54 -103.04 0.26 Allowed 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.636 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.676 ' HE1' HD13 ' A' ' 92' ' ' LEU . 66.6 m95 57.2 -65.24 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.948 0.499 . . . . 0.0 111.697 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 95' ' ' GLN . . . -171.5 -125.08 0.8 Allowed Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.095 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.37 101.58 0.76 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.992 0.425 . . . . 0.0 110.95 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.6 ' HB3' ' HB3' ' A' ' 11' ' ' GLU . 0.2 OUTLIER 65.89 -81.66 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.315 -179.463 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.627 ' CH2' ' HA ' ' A' ' 14' ' ' ARG . 27.9 m95 55.16 169.98 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.907 178.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.852 ' HG3' HD12 ' A' ' 94' ' ' ILE . 0.0 OUTLIER 166.69 29.96 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.576 -179.723 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.627 ' HA2' ' OD1' ' A' ' 93' ' ' ASN . . . 149.48 -153.32 25.08 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.037 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.517 ' O ' ' HA ' ' A' ' 81' ' ' THR . 32.4 mt-30 -144.6 117.54 8.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.724 0.262 . . . . 0.0 110.805 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.876 ' HA ' HG22 ' A' ' 81' ' ' THR . . . -105.14 116.44 31.95 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.165 0.507 . . . . 0.0 111.262 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.454 ' CG ' ' HB2' ' A' ' 16' ' ' ASN . 8.0 mt-30 -126.15 125.18 42.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.943 -178.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.49 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 3.5 ttmm -104.95 136.83 43.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.554 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.719 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 23.8 m95 -103.14 170.39 7.99 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 53' ' ' PRO . 96.2 m-85 -141.8 154.14 45.01 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.913 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.524 HD12 ' H ' ' A' ' 110' ' ' PHE . 15.6 tp -101.76 138.56 38.58 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.67 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.747 ' CZ ' HG22 ' A' ' 72' ' ' VAL . 31.0 m-85 -141.68 144.07 33.9 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.641 ' HB2' HD11 ' A' ' 73' ' ' ILE . 3.2 tttm -102.21 124.91 48.62 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.962 178.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.597 ' HD1' HD21 ' A' ' 21' ' ' LEU . 49.9 t80 -78.38 99.88 6.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.811 0.339 . . . . 0.0 110.56 178.896 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 35.1 p -99.37 51.29 0.94 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.027 0.442 . . . . 0.0 110.501 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -153.81 -146.93 4.51 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.504 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.439 ' O ' ' HZ ' ' A' ' 112' ' ' PHE . 2.7 mm-40 -120.93 146.61 46.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.028 0.442 . . . . 0.0 110.714 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.4 ' HB3' ' CH2' ' A' ' 134' ' ' TRP . 18.1 m-20 -57.15 -33.08 67.05 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.873 -178.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -58.23 -5.64 0.51 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.862 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -90.73 -15.19 30.68 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.64 0.257 . . . . 0.0 111.026 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.653 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 19.2 mt -77.9 100.24 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.901 0.381 . . . . 0.0 111.883 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -105.8 97.34 7.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.498 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.756 HD13 ' HB2' ' A' ' 131' ' ' PHE . 27.2 mt -69.78 -11.11 60.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.11 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.592 HD23 ' HB3' ' A' ' 129' ' ' PRO . 22.2 mt -86.29 172.18 10.66 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.979 0.419 . . . . 0.0 111.327 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -154.91 -125.81 0.98 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.075 -0.584 . . . . 0.0 112.161 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.02 123.51 38.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.763 0.316 . . . . 0.0 110.76 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -65.11 75.57 0.08 OUTLIER Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.44 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -119.18 -35.06 3.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.658 0.266 . . . . 0.0 111.089 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -146.37 -59.55 0.3 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.182 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -179.96 156.01 0.74 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.02 0.438 . . . . 0.0 110.792 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.592 ' HB3' HD23 ' A' ' 122' ' ' LEU . 11.7 Cg_endo -71.96 -174.66 1.4 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.43 2.087 . . . . 0.0 112.287 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -92.5 -70.99 0.67 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.014 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.756 ' HB2' HD13 ' A' ' 121' ' ' LEU . 2.0 m-85 -104.18 144.15 31.97 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.401 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.697 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -88.72 -35.54 8.37 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.558 -0.83 . . . . 0.0 111.713 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.6 148.4 28.59 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.854 0.359 . . . . 0.0 110.719 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.653 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 37.6 p-90 -135.4 165.31 25.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.264 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.426 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 22.6 t -160.13 176.95 11.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.392 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.716 ' CE3' ' ND2' ' A' ' 23' ' ' ASN . 41.9 m95 -113.75 105.02 12.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.224 178.099 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 28' ' ' ILE . 24.4 m -119.39 170.3 9.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.269 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.549 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 24.4 p -72.86 169.32 17.94 Favored Pre-proline 0 C--N 1.324 -0.529 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.504 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.817 ' HG3' HD11 ' A' ' 28' ' ' ILE . 17.3 Cg_exo -60.52 -51.83 4.66 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.082 1.855 . . . . 0.0 110.401 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -67.41 -28.81 68.23 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.847 178.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.455 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 2.3 mt-30 -71.35 -47.05 58.78 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.614 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.538 ' CD1' ' HB2' ' A' ' 30' ' ' ALA . 3.5 tp -55.67 -39.24 70.68 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.536 ' O ' HG22 ' A' ' 146' ' ' THR . 24.2 mm -62.82 -38.37 81.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.233 0.54 . . . . 0.0 110.514 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.73 -49.86 55.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.187 0.517 . . . . 0.0 110.627 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.437 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -74.63 -21.65 59.33 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.02 -179.196 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.687 HG23 ' HG3' ' A' ' 151' ' ' LYS . 6.2 t -73.49 -178.92 3.24 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.68 -178.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.8 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 30.7 m -86.39 151.1 3.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.822 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.58 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 0.1 OUTLIER -58.93 -53.69 55.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.683 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.56 ' H ' ' HG3' ' A' ' 148' ' ' GLU . 39.3 p90 -55.38 -3.44 0.06 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 28.4 mttm -133.15 -7.4 3.02 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.687 ' HG3' HG23 ' A' ' 146' ' ' THR . 8.1 mttt -60.37 -61.7 7.42 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.629 0.252 . . . . 0.0 111.192 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.709 ' HB2' ' HG ' ' A' ' 3' ' ' LEU . 10.7 Cg_endo -53.92 -31.28 62.29 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.742 2.295 . . . . 0.0 112.011 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.997 HG22 HD11 ' A' ' 3' ' ' LEU . 38.9 t -67.18 -52.05 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.485 ' HE2' ' HA ' ' A' ' 41' ' ' GLN . 4.0 m-30 -63.77 -37.93 89.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.651 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.506 ' HD3' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -55.93 -46.74 78.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.822 179.504 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.548 ' HG2' HD21 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -67.26 -28.92 68.44 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.416 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 153' ' ' VAL . 47.4 t -68.89 -42.24 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.717 178.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.494 HD22 ' HB3' ' A' ' 139' ' ' PRO . 49.4 mt -63.91 -46.43 84.86 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.551 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 40.5 t -50.33 -42.19 52.53 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.731 HG11 ' HA ' ' A' ' 76' ' ' VAL . 94.6 t -65.92 -42.03 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.282 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.61 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 16.8 m-30 -81.07 4.9 18.23 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.534 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.702 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . . . -58.86 -50.18 89.37 Favored Pre-proline 0 C--N 1.329 -0.294 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.653 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.702 ' HD3' ' HB3' ' A' ' 162' ' ' ALA . 24.2 Cg_exo -61.55 -11.93 22.3 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.389 2.059 . . . . 0.0 111.602 178.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.493 ' CG ' ' HB2' ' A' ' 74' ' ' ALA . 54.6 m80 -109.69 -17.8 13.61 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.341 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 86.3 mt . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.725 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.415 ' HA2' ' HG3' ' A' ' 85' ' ' PRO . . . . . . . . 0 N--CA 1.488 2.146 0 N-CA-C 112.57 -0.212 . . . . 0.0 112.57 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.98 -179.18 4.39 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.466 2.11 . . . . 0.0 112.107 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.542 HD23 ' H ' ' A' ' 3' ' ' LEU . 0.2 OUTLIER -94.7 148.6 22.11 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.465 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.477 ' O ' ' OG ' ' A' ' 5' ' ' SER . . . -104.67 -17.13 15.55 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.424 -0.894 . . . . 0.0 113.752 -178.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.932 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 15.4 p 60.23 -104.66 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 12.4 mtm 68.12 130.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.762 0.315 . . . . 0.0 110.653 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.721 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 11.3 p-10 -69.07 -23.63 64.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.607 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.37 122.75 42.83 Favored Pre-proline 0 C--N 1.325 -0.471 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.686 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 71.6 Cg_endo -75.56 115.0 4.09 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.116 1.878 . . . . 0.0 112.076 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.46 ' HD2' ' CD2' ' A' ' 13' ' ' TYR . 4.3 Cg_exo -79.81 175.42 10.53 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.227 2.618 . . . . 0.0 112.76 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -55.92 152.8 9.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.118 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 100' ' ' TRP . . . 51.08 69.28 1.17 Allowed Glycine 0 C--N 1.329 0.179 0 C-N-CA 121.171 -0.537 . . . . 0.0 113.579 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.564 ' CE1' ' O ' ' A' ' 101' ' ' LYS . 30.2 m-85 -152.94 114.0 4.16 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.534 ' HG2' ' CZ3' ' A' ' 96' ' ' TRP . 0.7 OUTLIER -67.2 89.1 0.19 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.262 0.553 . . . . 0.0 111.705 -179.14 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.598 ' HG2' HD12 ' A' ' 47' ' ' ILE . 3.9 ttp180 -53.29 113.97 1.32 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.579 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.712 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 66.0 m-20 -133.47 176.54 8.45 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.218 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.801 HG13 ' CG1' ' A' ' 47' ' ' ILE . 13.1 m -139.25 166.29 21.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.365 0.602 . . . . 0.0 112.079 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.59 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -133.83 162.2 24.41 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.365 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.869 HG21 HD22 ' A' ' 61' ' ' LEU . 3.4 mp -129.49 117.47 42.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.551 ' O ' HD12 ' A' ' 109' ' ' LEU . 0.5 OUTLIER -103.86 99.76 9.54 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.992 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.832 HD11 ' HB2' ' A' ' 112' ' ' PHE . 12.4 tp -102.26 126.87 49.38 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.847 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.59 ' HE3' HD13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -124.49 153.84 41.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.239 -179.724 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.675 ' ND2' ' CD2' ' A' ' 136' ' ' TRP . 47.2 m-20 -99.39 -178.61 3.96 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.684 0.754 . . . . 0.0 111.094 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -58.73 -6.17 0.7 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.041 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.523 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 2.7 m-20 -99.55 0.19 41.8 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -178.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 2.0 mmtm 72.7 21.92 3.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.921 -178.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.552 ' C ' HD12 ' A' ' 28' ' ' ILE . 15.3 mttt -95.77 169.19 10.18 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.735 HD12 ' N ' ' A' ' 28' ' ' ILE . 1.5 mp -117.67 143.24 28.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.475 0.655 . . . . 0.0 111.566 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.519 ' CE2' ' HD3' ' A' ' 43' ' ' PRO . 6.5 t80 -64.48 99.65 0.32 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.724 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.756 ' HA ' ' O ' ' A' ' 41' ' ' GLN . . . -96.46 138.73 33.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.193 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.23 135.98 39.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.578 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.733 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 70.0 p -102.15 141.95 34.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.852 0.358 . . . . 0.0 111.473 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.9 128.11 34.88 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.515 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.707 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.3 OUTLIER -44.24 -37.82 3.45 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.181 0.515 . . . . 0.0 111.04 -179.859 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -71.59 -35.24 70.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.508 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.403 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 16.3 mt -126.4 106.72 24.06 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 120.728 0.299 . . . . 0.0 111.068 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.7 -43.84 12.03 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.86 2.374 . . . . 0.0 113.276 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -75.29 -3.55 33.99 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.769 ' HB1' ' CG1' ' A' ' 147' ' ' VAL . . . -92.34 96.13 10.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.751 0.31 . . . . 0.0 110.671 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.603 ' CD1' ' HB3' ' A' ' 145' ' ' LEU . 74.1 m95 -94.46 163.0 13.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.57 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.756 ' O ' ' HA ' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -174.31 -135.3 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.341 -178.945 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.626 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 6.4 ptt? -177.03 165.32 1.45 Allowed Pre-proline 0 N--CA 1.453 -0.307 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.904 ' HG3' HD13 ' A' ' 61' ' ' LEU . 4.1 Cg_endo -45.05 144.47 3.84 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.736 2.291 . . . . 0.0 113.246 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.462 ' HA ' HD12 ' A' ' 19' ' ' ILE . 21.1 pt20 -174.26 141.94 0.76 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.323 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.538 ' HA3' ' HG3' ' A' ' 60' ' ' GLU . . . -142.65 -173.21 14.29 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.991 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.701 ' HA2' ' CB ' ' A' ' 16' ' ' ASN . . . -116.68 22.07 11.04 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 119.984 -1.103 . . . . 0.0 114.445 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.801 ' CG1' HG13 ' A' ' 17' ' ' VAL . 43.1 mt 61.28 131.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 117.234 0.517 . . . . 0.0 111.346 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -68.02 -176.18 0.67 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.724 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -47.67 -69.74 0.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.315 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -119.13 57.1 0.56 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.504 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -117.95 150.72 38.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.888 0.375 . . . . 0.0 110.945 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.84 173.09 4.53 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.748 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.639 ' HA ' HG11 ' A' ' 17' ' ' VAL . 2.0 Cg_endo -80.74 -52.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.541 2.16 . . . . 0.0 111.58 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.739 ' HE ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -54.01 -44.22 70.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.515 179.153 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -68.52 -45.09 73.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.372 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.428 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -60.51 -42.47 96.45 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.717 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -56.66 -60.16 3.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.319 0.58 . . . . 0.0 109.723 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.543 HD11 ' CD ' ' A' ' 54' ' ' ARG . 47.2 mt -53.92 -51.33 46.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.207 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -61.02 -62.68 1.68 Allowed 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.85 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.538 ' HG3' ' HA3' ' A' ' 45' ' ' GLY . 8.8 mm-40 -43.71 -44.03 6.3 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.261 0.553 . . . . 0.0 109.908 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.96 HD11 ' HB ' ' A' ' 67' ' ' VAL . 0.6 OUTLIER -51.87 -47.96 64.28 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.968 178.59 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.721 ' HG3' HG23 ' A' ' 68' ' ' THR . 38.5 ttt180 -63.23 -65.58 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.214 0.531 . . . . 0.0 111.095 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -47.75 -25.27 1.18 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.317 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -93.38 -35.58 12.95 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.605 ' HB ' HG23 ' A' ' 119' ' ' ILE . 1.4 p -127.68 -37.14 1.99 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.752 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 111.48 -10.56 28.34 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.184 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.96 ' HB ' HD11 ' A' ' 61' ' ' LEU . 68.6 t -56.86 111.97 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.197 0.523 . . . . 0.0 111.633 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.721 HG23 ' HG3' ' A' ' 62' ' ' ARG . 6.9 p -123.66 -39.15 2.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.651 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.4 m -62.48 74.43 0.02 OUTLIER 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.018 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -160.88 157.11 26.04 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -128.01 144.85 51.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.095 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.808 HG22 ' CE1' ' A' ' 110' ' ' PHE . 21.6 t -73.98 125.79 33.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.129 0.49 . . . . 0.0 111.319 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.619 HD11 ' HB2' ' A' ' 111' ' ' LYS . 1.0 OUTLIER -107.36 -20.06 6.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.683 179.728 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.468 ' CB ' ' CE1' ' A' ' 164' ' ' HIS . . . -169.73 177.46 4.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.818 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.478 ' HB3' ' HD1' ' A' ' 108' ' ' PHE . 3.7 pm0 -157.73 150.59 23.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.563 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.854 ' HA ' HG11 ' A' ' 160' ' ' VAL . 53.4 t -71.91 134.44 83.48 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.135 0.493 . . . . 0.0 111.354 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.46 ' HD2' HG13 ' A' ' 76' ' ' VAL . 29.7 Cg_endo -63.77 -54.06 1.09 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.099 2.533 . . . . 0.0 112.657 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.721 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 2.4 p90 -99.11 178.79 4.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.235 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.549 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 43.5 m95 -94.56 -158.0 0.6 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.623 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.932 ' HA ' ' HA ' ' A' ' 5' ' ' SER . 70.6 mt -160.31 101.69 1.39 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.023 0.439 . . . . 0.0 110.197 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.753 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 77.8 p -89.69 115.38 27.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.016 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.813 ' CZ ' HG21 ' A' ' 153' ' ' VAL . 12.9 m-85 -78.33 61.43 2.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.624 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.63 127.11 31.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.71 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.702 ' CD1' HD12 ' A' ' 92' ' ' LEU . 57.1 m-85 -102.36 159.51 29.15 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.759 0.314 . . . . 0.0 110.961 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.488 ' HB3' ' HD2' ' A' ' 86' ' ' PRO . 33.9 Cg_exo -56.54 178.39 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.452 2.102 . . . . 0.0 111.761 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 85' ' ' PRO . 33.0 Cg_endo -63.91 -30.71 67.59 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.374 2.049 . . . . 0.0 112.352 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -70.93 -50.88 29.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.649 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.682 ' HB ' ' HB3' ' A' ' 84' ' ' PHE . 30.6 t -73.9 -21.74 18.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.913 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.725 ' HG3' ' HB3' ' A' ' 93' ' ' ASN . 2.1 tpp180 -57.59 -47.68 81.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.909 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.793 ' HA ' HD13 ' A' ' 94' ' ' ILE . 3.6 mt-10 -71.31 -17.91 62.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.717 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.27 -22.37 17.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.856 0.36 . . . . 0.0 110.743 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.702 HD12 ' CD1' ' A' ' 84' ' ' PHE . 1.5 tm? -120.93 -62.36 1.45 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.664 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.725 ' HB3' ' HG3' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -47.45 -61.51 1.88 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.31 0.576 . . . . 0.0 112.171 -179.613 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.793 HD13 ' HA ' ' A' ' 90' ' ' GLU . 3.9 mp -68.98 -5.11 4.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.79 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.28 -4.38 58.37 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.562 ' HB2' ' CD1' ' A' ' 100' ' ' TRP . 65.9 m95 -95.76 -0.06 51.8 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' A' ' 98' ' ' SER . . . 66.21 119.6 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.158 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.527 ' HB2' ' O ' ' A' ' 97' ' ' GLY . 0.1 OUTLIER 89.97 -166.3 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 122.877 0.471 . . . . 0.0 110.704 -179.567 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.21 -85.74 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.769 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.669 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 29.8 m95 56.75 178.57 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.799 -0.182 . . . . 0.0 110.868 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.71 ' HA ' ' OD1' ' A' ' 93' ' ' ASN . 1.6 ttpp 161.78 64.15 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 122.643 0.377 . . . . 0.0 111.098 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.03 -172.12 20.42 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.524 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.753 ' O ' ' HA ' ' A' ' 81' ' ' THR . 0.0 OUTLIER -144.04 118.86 9.9 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 120.536 0.208 . . . . 0.0 110.935 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.463 ' HB2' HG22 ' A' ' 81' ' ' THR . . . -86.88 115.93 24.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.278 0.561 . . . . 0.0 109.595 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.712 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 13.1 mt-30 -121.98 123.32 41.39 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.662 -177.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 78' ' ' TYR . 5.1 ttpt -104.62 135.47 45.95 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 177.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.59 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 19.5 m95 -101.2 162.74 12.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.205 0.526 . . . . 0.0 112.3 -178.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.614 ' CD1' ' HG2' ' A' ' 54' ' ' ARG . 97.6 m-85 -137.38 149.37 46.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.643 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.551 HD12 ' O ' ' A' ' 20' ' ' CYS . 19.0 tp -102.62 125.63 49.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.31 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.808 ' CE1' HG22 ' A' ' 72' ' ' VAL . 11.9 m-85 -128.87 144.84 51.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.296 0.569 . . . . 0.0 111.507 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.619 ' HB2' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -96.35 118.56 33.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.397 179.137 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.832 ' HB2' HD11 ' A' ' 21' ' ' LEU . 50.6 t80 -79.06 94.61 5.35 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.319 179.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 19.5 p -94.67 45.46 1.12 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.378 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.34 -146.2 4.6 Favored Glycine 0 C--N 1.331 0.298 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.263 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -121.02 146.89 46.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.963 0.411 . . . . 0.0 111.401 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.504 ' HB2' ' CZ2' ' A' ' 134' ' ' TRP . 11.2 p-10 -58.3 -39.88 80.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.19 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -57.52 -4.4 0.25 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.278 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -88.85 -16.35 32.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.014 0.435 . . . . 0.0 110.562 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.627 HG12 HG22 ' A' ' 67' ' ' VAL . 11.0 mt -82.35 102.83 8.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.951 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -101.2 98.86 9.22 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.285 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.82 HD13 ' HB2' ' A' ' 131' ' ' PHE . 50.8 mt -68.74 -1.65 7.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.637 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.847 ' HA ' ' HB3' ' A' ' 129' ' ' PRO . 12.1 mt -73.05 -149.35 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 121.285 -0.166 . . . . 0.0 110.761 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLY . . . . . 0.475 ' H ' ' HB3' ' A' ' 122' ' ' LEU . . . 156.83 136.89 2.2 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -88.07 86.82 7.17 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.127 0.489 . . . . 0.0 110.631 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 161.69 134.56 1.66 Allowed Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.645 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.8 p 69.96 0.1 2.94 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.721 0.296 . . . . 0.0 111.677 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 71.32 -47.33 0.66 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.392 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 129' ' ' PRO . 30.4 pttt -78.05 145.54 69.71 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.017 0.437 . . . . 0.0 111.107 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.847 ' HB3' ' HA ' ' A' ' 122' ' ' LEU . 13.4 Cg_endo -82.99 -171.43 1.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.085 2.523 . . . . 0.0 112.826 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.625 ' O ' HD12 ' A' ' 34' ' ' LEU . 1.9 mp0 -87.29 -74.03 0.45 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.759 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.82 ' HB2' HD13 ' A' ' 121' ' ' LEU . 0.5 OUTLIER -102.16 142.26 33.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.492 178.894 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.707 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -82.53 -35.39 19.98 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.145 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.93 147.88 27.1 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.751 0.31 . . . . 0.0 110.735 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.6 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 39.1 p-90 -137.4 173.47 11.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.045 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.449 ' N ' ' HZ3' ' A' ' 40' ' ' TRP . 22.0 t -168.57 -179.46 3.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.462 0.649 . . . . 0.0 112.003 -178.254 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.675 ' CD2' ' ND2' ' A' ' 23' ' ' ASN . 88.8 m95 -113.25 100.72 8.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.907 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.467 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 32.6 m -118.3 169.78 8.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.283 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.579 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 12.3 p -74.04 172.32 8.84 Favored Pre-proline 0 C--N 1.329 -0.317 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.161 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.601 ' HB3' HD22 ' A' ' 158' ' ' LEU . 16.4 Cg_exo -61.87 -56.96 0.6 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.845 1.697 . . . . 0.0 110.337 179.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.38 -27.93 69.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.563 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.409 ' HG3' ' OG1' ' A' ' 138' ' ' THR . 1.0 OUTLIER -70.98 -49.31 46.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.503 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.717 HD13 ' HB2' ' A' ' 30' ' ' ALA . 12.8 tp -57.74 -37.39 73.52 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.61 ' O ' HG22 ' A' ' 146' ' ' THR . 13.2 mm -62.47 -39.3 83.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.14 0.495 . . . . 0.0 110.698 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.32 -48.91 63.64 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.325 0.583 . . . . 0.0 110.437 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.603 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -75.53 -18.78 59.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.742 -179.149 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.686 ' OG1' ' HG3' ' A' ' 41' ' ' GLN . 15.2 t -76.31 178.02 6.82 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.364 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.769 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 19.2 m -87.34 147.49 5.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.987 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.496 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 52.4 mt-10 -50.87 -49.79 58.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.927 0.394 . . . . 0.0 111.599 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.458 ' O ' ' HE1' ' A' ' 82' ' ' TYR . 1.2 m-85 -52.14 -7.13 0.05 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.547 ' HD3' ' CG2' ' A' ' 147' ' ' VAL . 7.7 mptt -137.09 -2.38 2.07 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.559 ' HG2' ' O ' ' A' ' 143' ' ' ILE . 14.7 mttt -63.79 -62.9 4.56 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 111.533 0.197 . . . . 0.0 111.533 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 19.3 Cg_endo -60.41 -29.04 87.92 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.266 1.978 . . . . 0.0 111.422 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.813 HG21 ' CZ ' ' A' ' 82' ' ' TYR . 21.2 t -68.23 -51.37 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.553 ' OH ' ' HG2' ' A' ' 41' ' ' GLN . 7.6 m-30 -63.95 -36.96 85.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.729 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.501 ' HD3' HG21 ' A' ' 143' ' ' ILE . 0.2 OUTLIER -57.93 -42.83 85.69 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.597 179.289 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.424 ' HG3' ' OH ' ' A' ' 78' ' ' TYR . 1.2 tp10 -68.35 -35.23 77.45 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 153' ' ' VAL . 59.2 t -66.21 -41.86 89.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.551 178.339 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.601 HD22 ' HB3' ' A' ' 139' ' ' PRO . 40.8 mt -64.87 -41.73 95.43 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.901 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.75 -38.74 70.21 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.854 HG11 ' HA ' ' A' ' 76' ' ' VAL . 98.7 t -69.06 -44.55 81.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.194 177.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.588 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 22.1 m-30 -80.05 4.98 15.43 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.392 -179.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.628 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.97 -52.44 74.81 Favored Pre-proline 0 C--N 1.329 -0.316 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.757 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 17.4 Cg_endo -57.77 -12.37 11.63 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.226 1.951 . . . . 0.0 112.088 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.468 ' CE1' ' CB ' ' A' ' 74' ' ' ALA . 32.5 m80 -110.46 -19.98 12.75 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.342 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 93.4 mt . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.163 -0.923 . . . . 0.0 110.733 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.132 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -52.05 149.65 20.67 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.544 2.163 . . . . 0.0 112.259 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.785 HD11 HG22 ' A' ' 153' ' ' VAL . 2.5 mt -145.22 -167.73 2.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.113 0.483 . . . . 0.0 110.848 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.541 ' O ' ' HA ' ' A' ' 80' ' ' LEU . . . -159.53 144.2 9.93 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.63 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.61 ' HB3' ' CD1' ' A' ' 78' ' ' TYR . 0.7 OUTLIER -120.47 -76.16 0.58 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.117 0.458 . . . . 0.0 111.804 -179.652 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.413 ' HE2' ' N ' ' A' ' 5' ' ' SER . 3.8 mtm 65.68 132.05 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.606 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.508 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 10.8 p-10 -64.19 -44.94 90.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.549 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.7 p -97.43 155.09 37.71 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.42 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.47 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 57.5 Cg_endo -71.1 106.38 1.89 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.274 1.983 . . . . 0.0 111.683 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.567 ' HG2' ' CD2' ' A' ' 13' ' ' TYR . 8.1 Cg_endo -48.8 165.74 0.17 Allowed 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 123.157 2.571 . . . . 0.0 113.112 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -51.75 127.61 21.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.257 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.478 ' O ' ' CG ' ' A' ' 101' ' ' LYS . . . 41.89 95.1 0.01 OUTLIER Glycine 0 C--O 1.226 -0.381 0 CA-C-N 115.673 -0.694 . . . . 0.0 113.855 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.567 ' CD2' ' HG2' ' A' ' 10' ' ' PRO . 9.2 m-85 -153.95 147.34 24.93 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.82 0.343 . . . . 0.0 110.466 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.645 ' HB3' ' HG2' ' A' ' 103' ' ' GLN . 28.1 ttt180 -71.17 83.58 0.73 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.243 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.612 ' HG3' ' CZ3' ' A' ' 79' ' ' TRP . 2.0 ttp180 -50.71 111.35 0.53 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.684 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 2.2 m-80 -132.72 174.6 10.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.901 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.676 HG13 ' CG1' ' A' ' 47' ' ' ILE . 14.4 m -141.8 167.22 16.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.969 0.414 . . . . 0.0 110.796 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.64 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -136.05 159.38 24.29 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.562 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.012 HG22 ' CE1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -130.7 120.91 49.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.29 0.567 . . . . 0.0 112.321 -178.586 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.686 ' O ' HD12 ' A' ' 109' ' ' LEU . 53.0 t -104.3 100.09 9.81 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.073 178.457 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.868 HD22 HG11 ' A' ' 67' ' ' VAL . 12.0 tp -99.84 119.81 38.77 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.178 -178.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.597 ' SD ' HD11 ' A' ' 109' ' ' LEU . 0.6 OUTLIER -121.4 157.89 29.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.808 179.801 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.694 ' ND2' ' CE3' ' A' ' 136' ' ' TRP . 0.2 OUTLIER -97.16 172.48 7.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.45 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -57.06 -4.14 0.17 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.479 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.605 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.7 OUTLIER -100.25 0.72 40.86 Favored 'General case' 0 C--N 1.34 0.17 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -178.88 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 3.8 mmtm 76.45 19.17 1.68 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.222 -178.47 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 22' ' ' MET . 2.8 mttt -95.73 143.97 26.52 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.659 HD12 ' N ' ' A' ' 28' ' ' ILE . 3.1 mp -102.75 145.48 12.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.54 0.686 . . . . 0.0 112.23 -178.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.575 ' CE1' HD13 ' A' ' 119' ' ' ILE . 90.8 t80 -74.98 138.68 42.43 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.643 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.907 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -137.51 148.65 46.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.972 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -141.11 134.48 29.71 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.911 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.676 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 2.1 m -95.09 151.14 19.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.924 0.392 . . . . 0.0 111.122 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.0 mtp-105 -69.61 132.29 45.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.425 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.018 ' H ' HD23 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -39.18 -46.52 1.49 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.961 -178.924 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.24 -34.76 68.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.181 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.509 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 19.5 mt -119.05 114.44 35.15 Favored Pre-proline 0 CA--C 1.529 0.17 0 C-N-CA 120.954 -0.299 . . . . 0.0 111.297 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -78.27 -20.42 11.22 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.171 1.914 . . . . 0.0 112.279 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -91.57 -10.08 41.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.922 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.676 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -90.51 92.86 9.05 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.483 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.659 ' O ' ' HA ' ' A' ' 146' ' ' THR . 76.8 m95 -88.32 148.88 24.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.657 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.3 158.02 31.61 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.346 0.593 . . . . 0.0 111.567 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.543 ' HG3' HD11 ' A' ' 142' ' ' LEU . 28.3 mtm -90.41 148.51 39.09 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.991 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.464 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 11.3 Cg_endo -53.88 151.5 26.32 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.729 1.619 . . . . 0.0 111.319 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.416 ' HA ' ' CD1' ' A' ' 19' ' ' ILE . 4.1 pt20 -174.74 154.23 1.91 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.419 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.432 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . -159.9 159.94 31.11 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.298 -0.953 . . . . 0.0 112.151 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.684 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -86.79 137.34 14.74 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.693 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.676 ' CG1' HG13 ' A' ' 17' ' ' VAL . 45.2 mt -68.36 146.51 12.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.616 0.246 . . . . 0.0 111.289 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -68.66 -174.64 0.58 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.017 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.05 -61.36 2.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.472 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.59 58.62 0.7 Allowed Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.764 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.436 ' O ' HG21 ' A' ' 47' ' ' ILE . 2.3 tp10 -117.44 154.06 32.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.68 0.276 . . . . 0.0 110.623 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.72 159.78 84.07 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.53 ' HA ' HG11 ' A' ' 17' ' ' VAL . 6.1 Cg_exo -78.54 -49.85 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.528 2.152 . . . . 0.0 111.686 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.746 ' HE ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -51.49 -46.64 63.23 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.305 179.563 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -67.38 -44.61 78.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.351 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.68 -39.9 90.12 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.924 ' HB1' HG23 ' A' ' 19' ' ' ILE . . . -58.6 -56.12 26.27 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.442 0.639 . . . . 0.0 109.565 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.573 HD11 ' NE ' ' A' ' 54' ' ' ARG . 23.6 mt -55.86 -52.71 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.854 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -62.1 -58.19 8.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.826 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.432 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 70.6 mm-40 -46.21 -45.63 17.03 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.382 0.61 . . . . 0.0 109.848 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.89 HD21 ' HB ' ' A' ' 67' ' ' VAL . 9.9 tt -52.45 -45.91 66.23 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.865 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.706 ' HD2' ' HA2' ' A' ' 66' ' ' GLY . 19.9 tpt85 -62.81 -65.6 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.377 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -50.11 -23.91 2.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.076 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.52 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 6.3 mt-10 -91.87 -35.29 14.14 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -177.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.525 HG21 ' CE2' ' A' ' 29' ' ' PHE . 1.7 p -123.76 -43.79 2.11 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 120.505 -0.478 . . . . 0.0 112.141 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.706 ' HA2' ' HD2' ' A' ' 62' ' ' ARG . . . 119.89 -17.58 10.0 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.275 -178.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.89 ' HB ' HD21 ' A' ' 61' ' ' LEU . 76.5 t -58.73 115.22 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-O 121.443 0.64 . . . . 0.0 111.842 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.646 HG23 ' HD3' ' A' ' 62' ' ' ARG . 0.5 OUTLIER -124.55 -37.04 2.55 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.5 178.223 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.4 m -62.35 73.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.102 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.572 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -159.63 156.08 27.3 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -128.65 148.57 50.81 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.328 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.837 HG22 ' CE2' ' A' ' 110' ' ' PHE . 26.2 t -75.25 127.92 36.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.108 0.48 . . . . 0.0 111.341 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.662 HD11 ' HB2' ' A' ' 111' ' ' LYS . 1.7 mt -107.84 -18.58 7.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.482 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.437 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.91 175.48 4.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.219 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.4 pt-20 -151.52 149.68 29.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.469 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.833 ' HA ' HG11 ' A' ' 160' ' ' VAL . 39.7 t -72.92 134.94 80.77 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.99 0.424 . . . . 0.0 111.144 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.48 ' HD2' HG11 ' A' ' 160' ' ' VAL . 17.8 Cg_endo -57.0 -68.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.201 2.601 . . . . 0.0 112.707 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.61 ' CD1' ' HB3' ' A' ' 5' ' ' SER . 0.1 OUTLIER -95.5 -174.86 3.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.76 -178.833 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.612 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 47.2 m95 -90.9 -158.05 0.53 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.037 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 5' ' ' SER . 50.7 mt -162.31 103.14 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.947 0.404 . . . . 0.0 110.552 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.613 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 66.5 p -90.11 -175.23 4.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.696 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.54 ' CD2' HD21 ' A' ' 3' ' ' LEU . 0.7 OUTLIER -169.78 64.7 0.05 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.185 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.492 ' HA ' HD21 ' A' ' 93' ' ' ASN . 9.9 p-10 -74.11 172.62 11.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.853 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.493 ' H ' ' HG2' ' A' ' 89' ' ' ARG . 4.8 m-85 -95.63 175.29 2.85 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.825 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.589 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 49.6 Cg_exo -55.17 166.52 2.25 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.29 1.993 . . . . 0.0 112.05 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.51 -7.19 6.62 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.605 2.204 . . . . 0.0 113.522 -179.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.83 -36.37 5.71 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.614 0.245 . . . . 0.0 111.501 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.586 ' HB ' ' HD2' ' A' ' 85' ' ' PRO . 12.4 t -87.15 -27.59 5.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.391 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.85 ' O ' ' HB2' ' A' ' 93' ' ' ASN . 2.6 tmm_? -59.62 -19.58 50.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.865 0.364 . . . . 0.0 111.251 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.614 ' HA ' HD13 ' A' ' 94' ' ' ILE . 4.3 tt0 -97.58 -21.3 17.15 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.47 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -96.14 -17.58 20.75 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.266 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.613 HD13 ' HE1' ' A' ' 96' ' ' TRP . 1.5 tm? -119.57 -57.17 2.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.778 0.323 . . . . 0.0 111.119 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.85 ' HB2' ' O ' ' A' ' 89' ' ' ARG . 4.1 m120 -60.38 -46.72 88.96 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.614 HD13 ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp -63.89 -8.71 4.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.445 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.7 OUTLIER -98.41 -103.06 0.21 Allowed 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.108 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.613 ' HE1' HD13 ' A' ' 92' ' ' LEU . 59.8 m95 59.8 -65.0 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.16 0.584 . . . . 0.0 111.577 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 95' ' ' GLN . . . -173.57 -54.91 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.991 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 43.5 t -174.92 139.08 0.48 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.25 0.547 . . . . 0.0 111.436 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 52.41 19.0 1.03 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.29 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.633 ' CZ2' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -96.68 175.6 6.31 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.86 0.362 . . . . 0.0 111.329 -179.519 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.536 ' HA ' ' HB3' ' A' ' 93' ' ' ASN . 1.0 OUTLIER 167.89 31.12 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.633 179.534 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.504 ' HA3' ' HE1' ' A' ' 13' ' ' TYR . . . 143.07 -157.38 26.86 Favored Glycine 0 C--N 1.332 0.36 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.645 ' HG2' ' HB3' ' A' ' 14' ' ' ARG . 17.0 mt-30 -146.47 108.19 4.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.129 0.465 . . . . 0.0 111.373 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.605 ' HB2' HG22 ' A' ' 81' ' ' THR . . . -94.1 118.31 31.34 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.299 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.677 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.8 OUTLIER -130.53 130.46 44.17 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -178.575 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.514 ' HE2' ' CE2' ' A' ' 79' ' ' TRP . 1.9 ttmt -104.04 135.87 44.75 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.64 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 18.7 m95 -105.68 164.01 12.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -177.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.53 ' CD2' ' HG2' ' A' ' 54' ' ' ARG . 96.3 m-85 -139.44 153.59 47.61 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.528 -179.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.686 HD12 ' O ' ' A' ' 20' ' ' CYS . 13.8 tp -100.91 142.61 32.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.429 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 1.012 ' CE1' HG22 ' A' ' 19' ' ' ILE . 10.1 m-85 -144.54 146.13 32.2 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.662 ' HB2' HD11 ' A' ' 73' ' ' ILE . 22.8 tttt -101.56 124.57 47.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.474 178.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.701 ' CE1' HG13 ' A' ' 67' ' ' VAL . 49.4 t80 -77.91 97.37 5.28 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.549 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 59.3 p -96.72 53.91 1.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.035 0.445 . . . . 0.0 110.588 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -157.96 -147.24 4.75 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.492 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -122.31 149.15 44.13 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.996 0.427 . . . . 0.0 110.826 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.466 ' HB3' ' CH2' ' A' ' 134' ' ' TRP . 76.6 m-20 -58.61 -32.26 68.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.291 -179.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -59.31 -5.45 0.75 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.464 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.65 -16.11 33.22 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.944 0.402 . . . . 0.0 111.005 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.734 HG12 HG22 ' A' ' 67' ' ' VAL . 6.1 mt -79.04 101.84 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.901 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.467 ' C ' ' H ' ' A' ' 122' ' ' LEU . 3.8 t30 -101.21 92.85 5.16 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.767 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.728 ' C ' HD22 ' A' ' 122' ' ' LEU . 87.5 mt -72.42 41.49 0.09 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.896 0.379 . . . . 0.0 110.626 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.942 HD23 ' HB3' ' A' ' 129' ' ' PRO . 0.4 OUTLIER 57.64 153.57 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.4 0.619 . . . . 0.0 111.805 179.665 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -162.43 -1.25 0.06 OUTLIER Glycine 0 CA--C 1.518 0.26 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.576 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.401 ' O ' ' O ' ' A' ' 125' ' ' GLY . 0.9 OUTLIER -100.86 -161.4 0.86 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 122.64 0.376 . . . . 0.0 110.412 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 124' ' ' ASP . . . -56.56 -115.08 0.01 OUTLIER Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.951 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 59.15 15.57 4.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.606 0.241 . . . . 0.0 111.203 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 128' ' ' LYS . 0.0 OUTLIER 70.94 -48.44 0.67 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.327 -179.772 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.554 ' HE3' ' HG ' ' A' ' 34' ' ' LEU . 8.7 ptmt -179.83 148.13 0.48 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.119 0.485 . . . . 0.0 111.573 178.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.942 ' HB3' HD23 ' A' ' 122' ' ' LEU . 6.3 Cg_exo -65.22 -161.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 123.055 2.503 . . . . 0.0 112.533 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.695 ' C ' HD21 ' A' ' 34' ' ' LEU . 6.5 mm-40 -110.86 -36.47 5.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.679 178.498 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.647 ' N ' HD21 ' A' ' 34' ' ' LEU . 8.4 m-85 -132.24 142.84 49.55 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.721 ' N ' HD22 ' A' ' 34' ' ' LEU . . . -86.9 -32.16 15.61 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.397 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 31' ' ' ALA . 1.9 tt0 -154.52 154.47 33.17 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.725 0.297 . . . . 0.0 111.337 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.64 ' CE2' HD12 ' A' ' 119' ' ' ILE . 22.1 p-90 -134.6 164.94 26.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.217 0.532 . . . . 0.0 112.162 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.425 ' N ' ' HZ3' ' A' ' 40' ' ' TRP . 12.2 t -159.24 162.93 36.24 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.277 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.694 ' CE3' ' ND2' ' A' ' 23' ' ' ASN . 51.7 m95 -107.1 105.67 15.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.018 178.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 28' ' ' ILE . 30.1 m -121.34 170.96 10.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.882 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.598 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 17.2 p -72.38 173.32 5.79 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.68 ' HB3' HD22 ' A' ' 158' ' ' LEU . 7.0 Cg_exo -64.68 -52.8 1.19 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 121.623 1.548 . . . . 0.0 109.896 178.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -64.44 -31.65 72.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.654 178.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.463 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.9 OUTLIER -70.11 -45.92 65.89 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.051 179.645 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.907 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -56.92 -39.91 75.34 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.682 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.643 HG21 ' CE ' ' A' ' 155' ' ' LYS . 33.4 mm -62.47 -33.89 61.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.087 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.46 -53.45 13.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.239 0.542 . . . . 0.0 110.54 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.4 mp -71.62 -21.19 61.87 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.649 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.659 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 7.4 t -74.99 169.38 18.11 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.586 -178.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.572 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 25.4 m -72.86 162.49 4.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.615 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.731 ' HG2' ' N ' ' A' ' 149' ' ' PHE . 0.3 OUTLIER -67.87 -50.98 53.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.19 0.519 . . . . 0.0 110.88 179.762 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.731 ' N ' ' HG2' ' A' ' 148' ' ' GLU . 40.2 p90 -58.52 -2.58 0.22 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.938 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.526 ' HG3' ' CD2' ' A' ' 149' ' ' PHE . 23.6 mttt -132.15 -7.49 3.43 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.56 ' HG3' HG23 ' A' ' 143' ' ' ILE . 0.3 OUTLIER -63.23 -56.13 30.33 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 121.307 -0.157 . . . . 0.0 110.63 179.286 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 20.0 Cg_endo -61.87 -28.21 81.08 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.214 1.942 . . . . 0.0 111.636 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.815 ' O ' HG23 ' A' ' 157' ' ' VAL . 15.0 t -68.83 -48.5 70.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.528 ' CE1' ' CH2' ' A' ' 107' ' ' TRP . 7.5 m-30 -68.83 -37.65 79.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.765 178.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.643 ' CE ' HG21 ' A' ' 143' ' ' ILE . 2.0 tptp -55.34 -44.83 76.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.521 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.417 ' O ' HG23 ' A' ' 160' ' ' VAL . 4.7 tt0 -67.57 -34.25 76.66 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 153' ' ' VAL . 47.7 t -67.79 -41.0 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.847 178.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.68 HD22 ' HB3' ' A' ' 139' ' ' PRO . 38.7 mt -62.77 -44.91 94.95 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.385 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 62.5 m -51.54 -40.29 59.39 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.833 HG11 ' HA ' ' A' ' 76' ' ' VAL . 81.9 t -67.28 -42.23 87.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.142 178.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.687 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 22.3 m-30 -80.12 2.8 22.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.496 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.597 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.98 -52.81 72.18 Favored Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.053 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.6 Cg_endo -58.11 -12.09 11.9 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.153 1.902 . . . . 0.0 112.136 179.099 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.437 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 87.1 m-70 -110.72 -16.12 13.68 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.492 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.687 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 93.7 mt . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.912 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.443 ' C ' ' H ' ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.415 ' HD3' ' HA3' ' A' ' 1' ' ' GLY . 27.5 Cg_exo -63.18 4.56 0.4 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.879 2.386 . . . . 0.0 113.551 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.58 HD11 HG22 ' A' ' 153' ' ' VAL . 2.8 mm? -94.32 76.11 3.94 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.301 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.459 ' O ' ' HE1' ' A' ' 6' ' ' MET . . . -95.62 64.28 1.29 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.085 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.548 ' HB3' HD23 ' A' ' 80' ' ' LEU . 99.7 p -59.52 155.48 15.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.979 0.418 . . . . 0.0 111.774 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.503 ' HE2' ' N ' ' A' ' 6' ' ' MET . 0.0 OUTLIER -145.23 132.4 20.46 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.383 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.78 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 9.0 t0 -61.36 -36.07 79.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.944 0.402 . . . . 0.0 110.062 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.544 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 61.9 p -100.62 121.38 53.11 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.572 178.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.503 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 46.3 Cg_endo -69.1 102.54 0.93 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.175 1.916 . . . . 0.0 113.624 -178.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.803 ' O ' ' O ' ' A' ' 11' ' ' GLU . 5.9 Cg_endo -50.78 169.47 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 123.236 2.624 . . . . 0.0 112.122 178.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLU . . . . . 0.803 ' O ' ' O ' ' A' ' 10' ' ' PRO . 68.9 mm-40 6.06 -146.95 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 O-C-N 124.144 0.903 . . . . 0.0 112.971 178.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 99' ' ' ASP . . . -57.39 -81.26 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.765 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.596 ' H ' ' HA ' ' A' ' 100' ' ' TRP . 9.6 m-85 61.85 130.89 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.881 0.372 . . . . 0.0 110.618 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.5 ' HB3' ' HG2' ' A' ' 103' ' ' GLN . 2.1 ttt180 -72.19 86.23 1.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.435 -179.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.449 ' HG3' ' CZ3' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -49.05 108.89 0.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.115 0.483 . . . . 0.0 110.173 179.008 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.71 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 3.4 m120 -132.3 173.1 11.62 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.899 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.66 ' CG1' HD11 ' A' ' 47' ' ' ILE . 21.2 m -143.71 162.41 15.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.318 0.58 . . . . 0.0 112.425 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.649 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -133.95 158.98 23.58 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 177.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.016 HG23 ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -134.14 126.34 49.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.987 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.533 ' O ' HD12 ' A' ' 109' ' ' LEU . 35.8 t -102.82 100.64 10.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.237 178.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.9 HD22 HG11 ' A' ' 67' ' ' VAL . 11.4 tp -99.73 118.91 37.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.435 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.584 ' CE ' HD13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -120.48 166.54 13.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.633 179.622 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.707 ' ND2' ' CE3' ' A' ' 136' ' ' TRP . 0.3 OUTLIER -101.04 171.9 7.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.573 -179.695 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -56.82 -5.32 0.22 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.525 178.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.534 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 1.4 m-20 -98.53 1.95 47.07 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.66 0.267 . . . . 0.0 111.687 -178.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.1 OUTLIER 76.07 18.31 2.0 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.102 -178.508 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.2 OUTLIER -94.68 142.17 27.76 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.836 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.684 HD13 ' N ' ' A' ' 139' ' ' PRO . 3.7 mp -99.33 146.47 8.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.761 0.791 . . . . 0.0 112.612 -178.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.568 ' CE1' HD13 ' A' ' 119' ' ' ILE . 87.2 t80 -78.15 136.97 37.94 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.239 -1.346 . . . . 0.0 110.035 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.621 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -137.88 146.77 43.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.893 0.378 . . . . 0.0 110.336 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.453 ' HB1' ' CG ' ' A' ' 131' ' ' PHE . . . -138.69 132.33 30.67 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.138 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.596 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 28.5 m -99.15 148.36 24.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.233 -179.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 36' ' ' ILE . 4.8 mtp180 -69.13 127.9 34.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.649 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.739 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 1.7 mp -43.69 -37.51 2.67 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.175 0.512 . . . . 0.0 111.035 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.08 -36.77 72.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.851 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.4 ' N ' ' O ' ' A' ' 33' ' ' ARG . 23.1 mt -121.63 112.9 32.19 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.076 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.96 -18.76 11.29 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.258 1.972 . . . . 0.0 112.843 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -92.88 -11.26 33.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.511 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.778 ' HB1' ' CG1' ' A' ' 147' ' ' VAL . . . -92.05 99.55 12.36 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 120.817 0.341 . . . . 0.0 110.715 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.637 ' O ' ' HA ' ' A' ' 146' ' ' THR . 72.4 m95 -94.39 157.33 16.07 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.98 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.651 ' O ' HD11 ' A' ' 142' ' ' LEU . 22.9 mt-30 -159.89 -131.69 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 121.111 -0.235 . . . . 0.0 110.399 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.526 ' H ' ' HB3' ' A' ' 41' ' ' GLN . 3.0 ptt? -179.14 161.67 1.0 Allowed Pre-proline 0 N--CA 1.453 -0.31 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.523 ' HD2' ' HB2' ' A' ' 42' ' ' MET . 9.8 Cg_endo -49.86 140.91 29.8 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.119 1.879 . . . . 0.0 112.242 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.583 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER 179.77 144.17 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.73 -179.173 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.495 ' HA3' ' HG2' ' A' ' 60' ' ' GLU . . . -160.47 -156.62 8.27 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.14 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.71 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -117.84 138.55 14.07 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.132 -1.032 . . . . 0.0 113.539 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.66 HD11 ' CG1' ' A' ' 17' ' ' VAL . 4.2 mt -69.54 148.44 11.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.488 -0.356 . . . . 0.0 111.006 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -68.92 -174.25 0.57 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.849 0.357 . . . . 0.0 110.686 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -47.96 -62.26 1.55 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.464 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.82 60.67 0.68 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.559 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.476 ' O ' HG21 ' A' ' 47' ' ' ILE . 3.7 tp10 -117.04 153.28 32.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.765 0.317 . . . . 0.0 110.669 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 7.9 m-20 -70.13 147.08 95.43 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 16.7 Cg_exo -67.09 -46.51 3.04 Favored 'Trans proline' 0 CA--C 1.513 -0.529 0 C-N-CA 122.138 1.892 . . . . 0.0 111.395 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.79 ' NE ' HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -52.21 -49.02 64.75 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.097 179.153 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.532 ' HA ' HD12 ' A' ' 58' ' ' ILE . 2.4 m120 -63.77 -44.31 93.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.512 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 60' ' ' GLU . . . -60.58 -42.28 96.38 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 1.016 ' HB1' HG23 ' A' ' 19' ' ' ILE . . . -56.07 -52.93 62.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.978 178.776 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.79 HD11 ' NE ' ' A' ' 54' ' ' ARG . 17.3 mt -57.49 -54.37 31.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.881 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -61.39 -58.68 7.24 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.729 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.495 ' HG2' ' HA3' ' A' ' 45' ' ' GLY . 0.7 OUTLIER -45.38 -45.41 12.6 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.536 0.684 . . . . 0.0 109.511 179.318 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.789 HD12 ' HB ' ' A' ' 19' ' ' ILE . 7.6 tt -52.55 -51.14 61.15 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.731 178.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.847 ' HG3' HG23 ' A' ' 68' ' ' THR . 7.3 ttm105 -62.44 -62.46 1.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.195 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -51.38 -20.48 1.77 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.43 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -100.57 -35.58 9.47 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.558 HG22 ' CD2' ' A' ' 121' ' ' LEU . 0.8 OUTLIER -124.1 -11.3 7.56 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.027 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 84.54 -14.5 46.25 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.868 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.9 HG11 HD22 ' A' ' 21' ' ' LEU . 39.8 t -57.99 115.2 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.434 0.635 . . . . 0.0 111.316 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.847 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -123.54 -39.94 2.39 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.813 178.93 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.427 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 7.2 m -63.0 74.98 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.643 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -160.27 155.91 25.57 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.413 ' HG3' HG21 ' A' ' 113' ' ' THR . 2.9 mt-10 -128.48 151.39 49.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.399 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.702 HG21 ' HE ' ' A' ' 54' ' ' ARG . 20.2 t -75.64 130.72 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-O 121.292 0.567 . . . . 0.0 112.066 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.589 HD12 ' HG ' ' A' ' 109' ' ' LEU . 1.0 OUTLIER -111.04 -19.11 7.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.37 179.045 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.504 ' HB2' ' CE1' ' A' ' 164' ' ' HIS . . . -170.94 176.54 4.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.812 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.4 OUTLIER -157.05 145.21 19.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.123 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.672 ' HA ' HG11 ' A' ' 160' ' ' VAL . 25.6 t -72.1 138.03 81.9 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-O 121.006 0.431 . . . . 0.0 110.838 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.598 ' HD2' HG13 ' A' ' 76' ' ' VAL . 73.7 Cg_endo -76.87 -45.09 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.9 2.4 . . . . 0.0 113.49 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.78 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 1.1 p90 -99.41 161.84 13.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.147 0.499 . . . . 0.0 112.242 -178.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.449 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 73.2 m95 -95.14 109.95 21.96 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.851 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.548 HD23 ' HB3' ' A' ' 5' ' ' SER . 17.3 mt -68.02 125.67 27.06 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.128 -0.229 . . . . 0.0 110.527 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . 1.086 HG22 ' HA ' ' A' ' 104' ' ' ALA . 21.1 p -139.81 92.13 2.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.86 0.362 . . . . 0.0 111.806 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.468 ' O ' ' C ' ' A' ' 83' ' ' ASP . 0.2 OUTLIER -79.86 38.08 0.38 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.487 179.179 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.468 ' C ' ' O ' ' A' ' 82' ' ' TYR . 3.6 p30 27.66 -132.59 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.387 0.275 . . . . 0.0 111.501 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.625 ' CD1' HD21 ' A' ' 92' ' ' LEU . 0.5 OUTLIER -141.79 178.66 1.44 Allowed Pre-proline 0 C--O 1.231 0.098 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.163 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.657 ' HB2' HG23 ' A' ' 88' ' ' VAL . 74.9 Cg_exo -52.59 156.08 9.24 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 121.816 1.677 . . . . 0.0 111.452 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.36 -10.43 26.01 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.659 2.239 . . . . 0.0 113.413 -178.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.0 -20.37 11.56 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.795 HG12 HD12 ' A' ' 92' ' ' LEU . 10.6 t -91.49 -28.49 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.744 ' HD2' ' HB2' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -30.83 -77.51 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.134 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.561 ' O ' HG21 ' A' ' 94' ' ' ILE . 41.6 mt-10 -62.05 -10.34 9.76 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.997 0.427 . . . . 0.0 111.369 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 88' ' ' VAL . 0.8 OUTLIER -84.73 -36.21 21.95 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.948 0.404 . . . . 0.0 109.992 179.426 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 1.093 HD13 ' H ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -121.36 -74.23 0.62 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.559 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 1.093 ' H ' HD13 ' A' ' 92' ' ' LEU . 6.8 m120 -24.1 -62.19 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.221 1.008 . . . . 0.0 112.879 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.561 HG21 ' O ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -55.39 -48.28 77.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 114.361 -1.29 . . . . 0.0 113.127 -178.463 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.472 ' HB3' ' H ' ' A' ' 96' ' ' TRP . 0.6 OUTLIER -62.82 -102.1 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -177.213 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.719 ' HE1' HD22 ' A' ' 92' ' ' LEU . 77.7 m95 49.12 26.0 1.31 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 98' ' ' SER . . . 67.26 39.1 92.13 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.155 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 97' ' ' GLY . 1.4 m 84.97 154.83 0.09 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.771 0.32 . . . . 0.0 111.042 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.511 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 1.3 m-20 51.52 89.98 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.718 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.596 ' HA ' ' H ' ' A' ' 13' ' ' TYR . 0.9 OUTLIER 174.06 173.7 0.17 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.67 -179.561 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.585 ' HA ' ' HB3' ' A' ' 93' ' ' ASN . 0.0 OUTLIER 169.46 19.86 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.961 -179.682 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.679 ' HA2' ' ND2' ' A' ' 93' ' ' ASN . . . 154.95 -144.17 10.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 119.919 -1.134 . . . . 0.0 112.827 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.5 ' HG2' ' HB3' ' A' ' 14' ' ' ARG . 15.3 mt-30 -143.77 116.71 8.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.446 0.165 . . . . 0.0 110.616 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 1.086 ' HA ' HG22 ' A' ' 81' ' ' THR . . . -98.81 120.92 40.06 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.175 0.512 . . . . 0.0 110.646 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.706 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 53.6 mt-30 -128.8 123.51 33.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.986 -178.55 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.446 ' HB2' ' CE3' ' A' ' 79' ' ' TRP . 0.8 OUTLIER -103.25 134.85 45.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.816 178.604 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.543 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 73.0 m95 -102.29 159.01 15.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.306 0.574 . . . . 0.0 112.268 -178.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.458 ' CZ ' ' HB2' ' A' ' 53' ' ' PRO . 93.9 m-85 -139.26 151.15 46.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.485 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.589 ' HG ' HD12 ' A' ' 73' ' ' ILE . 24.0 tp -100.33 139.36 36.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.7 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.746 ' CE1' HG22 ' A' ' 19' ' ' ILE . 40.5 m-85 -140.95 144.92 35.41 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.579 ' HB2' HD11 ' A' ' 73' ' ' ILE . 29.9 tttt -103.37 124.28 48.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.804 177.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.468 ' HB2' HD11 ' A' ' 21' ' ' LEU . 44.4 t80 -78.47 101.85 7.53 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.848 0.356 . . . . 0.0 110.857 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' THR . . . . . 0.413 HG21 ' HG3' ' A' ' 71' ' ' GLU . 21.3 p -100.77 46.43 0.95 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.548 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.427 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -150.84 -145.13 4.06 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.24 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.42 ' O ' ' HZ ' ' A' ' 112' ' ' PHE . 1.4 pt20 -124.86 149.06 47.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.182 0.515 . . . . 0.0 111.429 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -58.86 -26.54 64.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.944 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -57.42 -7.25 0.56 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.41 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -89.75 -16.45 30.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.099 0.476 . . . . 0.0 110.566 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.575 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 3.7 mt -88.64 108.21 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.696 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.416 ' C ' ' H ' ' A' ' 122' ' ' LEU . 14.1 p-10 -109.07 -31.39 7.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.168 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.558 ' CD2' HG22 ' A' ' 65' ' ' THR . 38.3 mt 75.04 -39.74 0.42 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.64 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.74 ' HA ' ' HB3' ' A' ' 129' ' ' PRO . 78.2 mt -67.2 171.12 6.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.574 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.33 111.24 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.976 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -144.61 -9.74 0.63 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.333 -0.434 . . . . 0.0 111.417 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 135.76 40.95 0.14 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.213 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 67.96 7.81 6.04 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.577 0.227 . . . . 0.0 111.328 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -97.54 -72.29 0.65 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.913 0.387 . . . . 0.0 110.856 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.621 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 7.7 ptpp? -178.97 160.3 1.01 Allowed Pre-proline 0 C--N 1.332 -0.159 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.247 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.74 ' HB3' ' HA ' ' A' ' 122' ' ' LEU . 15.2 Cg_endo -62.65 -177.84 0.34 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 123.053 2.502 . . . . 0.0 112.602 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -109.88 -35.05 6.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.072 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.453 ' CG ' ' HB1' ' A' ' 31' ' ' ALA . 4.9 m-85 -133.66 145.62 50.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.014 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.739 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -90.68 -33.77 8.25 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.817 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.16 146.55 27.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.884 0.373 . . . . 0.0 110.761 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.575 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 39.6 p-90 -134.76 167.12 21.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.187 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.456 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 13.0 t -164.98 168.85 17.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.426 0.632 . . . . 0.0 112.243 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.707 ' CE3' ' ND2' ' A' ' 23' ' ' ASN . 36.4 m95 -106.01 106.89 17.61 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.085 178.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.432 ' O ' ' N ' ' A' ' 28' ' ' ILE . 29.8 m -122.43 171.02 11.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.126 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.592 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 11.6 p -72.4 173.45 5.62 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.716 ' HB3' HD22 ' A' ' 158' ' ' LEU . 5.3 Cg_exo -65.01 -53.59 0.84 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 121.564 1.509 . . . . 0.0 110.374 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.22 -25.8 68.23 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.599 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -73.04 -49.03 31.06 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.611 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.651 HD11 ' O ' ' A' ' 41' ' ' GLN . 4.2 tp -56.07 -38.62 70.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.909 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.618 HG21 ' HD3' ' A' ' 155' ' ' LYS . 14.0 mm -62.66 -40.74 89.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.137 0.494 . . . . 0.0 110.636 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.85 -47.98 70.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.261 0.553 . . . . 0.0 110.556 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.535 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -76.32 -22.32 55.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.695 -179.181 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.637 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 10.0 t -75.46 179.44 5.25 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.113 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.778 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 21.0 m -86.28 158.36 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.196 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.577 ' HA ' ' HD3' ' A' ' 151' ' ' LYS . 8.9 mt-10 -60.64 -49.52 77.2 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.147 0.499 . . . . 0.0 110.799 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -54.09 -8.49 0.19 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.352 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -135.21 -6.02 2.33 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.577 ' HD3' ' HA ' ' A' ' 148' ' ' GLU . 1.2 mtpp -58.62 -62.26 6.05 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.717 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.503 ' HB2' ' CD2' ' A' ' 3' ' ' LEU . 18.1 Cg_endo -60.6 -27.29 84.58 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.308 2.005 . . . . 0.0 111.505 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.686 ' O ' HG23 ' A' ' 157' ' ' VAL . 22.1 t -67.51 -53.35 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.522 ' HE2' ' HA ' ' A' ' 41' ' ' GLN . 6.4 m-30 -63.18 -38.22 90.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.101 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.618 ' HD3' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -56.88 -45.39 82.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.071 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.509 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.5 tt0 -67.31 -33.42 75.24 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 153' ' ' VAL . 81.3 t -66.71 -41.75 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.613 178.198 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.716 HD22 ' HB3' ' A' ' 139' ' ' PRO . 54.6 mt -62.88 -44.84 95.02 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.404 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.98 -40.67 63.92 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.219 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.672 HG11 ' HA ' ' A' ' 76' ' ' VAL . 60.8 t -67.51 -43.41 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.242 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.601 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 21.6 m-30 -80.94 4.89 17.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.495 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.607 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.63 -52.69 72.22 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.798 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 17.9 Cg_endo -58.08 -11.91 11.36 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.067 1.845 . . . . 0.0 112.058 179.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.504 ' CE1' ' HB2' ' A' ' 74' ' ' ALA . 43.1 m80 -110.26 -19.02 13.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.502 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 96.9 mt . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.661 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 CA-C-O 120.126 -0.263 . . . . 0.0 112.581 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.36 173.71 9.27 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.574 2.182 . . . . 0.0 112.239 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.434 HD23 ' N ' ' A' ' 3' ' ' LEU . 0.2 OUTLIER -103.95 123.68 47.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.014 -179.968 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.07 -22.75 37.25 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.696 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.604 ' HA ' ' O ' ' A' ' 79' ' ' TRP . 1.1 m 65.76 -82.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.971 0.415 . . . . 0.0 111.042 -179.735 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 5.4 mtm 67.03 137.61 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.757 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.724 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 7.0 p-10 -67.64 -40.18 84.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.227 -179.366 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.9 142.4 24.54 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 121.154 -0.218 . . . . 0.0 110.707 179.592 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.78 106.92 2.35 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.467 2.111 . . . . 0.0 112.058 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.534 ' HB2' ' CE1' ' A' ' 13' ' ' TYR . 3.2 Cg_endo -47.86 165.23 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.096 2.531 . . . . 0.0 113.01 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -52.22 129.64 28.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.19 179.57 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 53.16 84.96 0.02 OUTLIER Glycine 0 CA--C 1.517 0.214 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.778 179.812 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.534 ' CE1' ' HB2' ' A' ' 10' ' ' PRO . 9.5 m-85 -149.93 152.0 34.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.824 0.345 . . . . 0.0 111.42 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.565 ' HG2' HD21 ' A' ' 16' ' ' ASN . 0.7 OUTLIER -64.01 -152.77 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.923 -179.427 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.538 ' H ' ' HG3' ' A' ' 14' ' ' ARG . 0.0 OUTLIER 177.94 95.61 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.261 0.553 . . . . 0.0 109.953 -178.772 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.681 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 3.6 m-80 -129.83 172.18 11.94 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.039 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.698 ' CG1' HD11 ' A' ' 47' ' ' ILE . 21.1 m -138.89 167.31 20.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.495 0.664 . . . . 0.0 111.727 179.196 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.714 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -134.83 161.08 24.48 Favored Glycine 0 N--CA 1.438 -1.191 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.521 178.726 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.8 HG23 ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -129.21 119.92 50.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.09 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.474 ' O ' HD12 ' A' ' 109' ' ' LEU . 37.4 t -101.66 111.08 23.21 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.02 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.754 HD22 HG11 ' A' ' 67' ' ' VAL . 59.9 tp -105.9 124.34 49.41 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.925 -178.37 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.69 ' HB3' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -116.51 137.58 52.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.8 -179.954 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.482 ' OD1' ' CH2' ' A' ' 136' ' ' TRP . 6.7 m-20 -96.8 -173.8 2.82 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.307 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -54.81 -5.03 0.08 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.128 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 3.0 m-20 -101.76 -1.54 32.18 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 122.173 -0.329 . . . . 0.0 111.787 -178.819 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 11.4 mmtm 69.5 23.3 6.05 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -177.924 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.825 ' C ' HD12 ' A' ' 28' ' ' ILE . 84.2 mttt -95.59 -167.4 1.6 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.876 179.267 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.825 HD12 ' C ' ' A' ' 27' ' ' LYS . 2.1 mp -136.0 146.27 29.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.968 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.608 ' CE1' HD13 ' A' ' 119' ' ' ILE . 90.3 t80 -70.55 138.73 51.19 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.514 179.512 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.841 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -140.22 149.1 42.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.099 179.593 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.555 ' HB1' ' HB3' ' A' ' 131' ' ' PHE . . . -143.55 145.0 32.19 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.045 -179.701 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.658 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 28.4 p -98.97 145.74 26.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.09 0.471 . . . . 0.0 111.466 -179.512 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.641 ' O ' ' N ' ' A' ' 35' ' ' ASP . 25.3 mtp180 -69.34 129.82 40.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.783 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.649 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.5 OUTLIER -56.85 55.49 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.862 -179.98 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.641 ' N ' ' O ' ' A' ' 33' ' ' ARG . 0.9 OUTLIER -177.23 -34.82 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.157 0.504 . . . . 0.0 110.223 -179.688 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.491 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 7.1 mm -117.18 106.02 47.93 Favored Pre-proline 0 N--CA 1.451 -0.411 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.135 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -58.53 -60.51 0.35 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.396 2.731 . . . . 0.0 114.443 -178.134 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.92 1.48 3.37 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.285 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.658 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.4 94.35 9.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.631 0.253 . . . . 0.0 110.991 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.662 ' O ' ' HA ' ' A' ' 146' ' ' THR . 71.1 m95 -99.24 141.82 31.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.343 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -146.54 174.08 11.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.954 0.883 . . . . 0.0 112.378 -179.531 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.552 ' SD ' HG21 ' A' ' 28' ' ' ILE . 2.6 ttp -108.62 140.28 21.65 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 113.932 -1.486 . . . . 0.0 109.121 178.82 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.419 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 9.4 Cg_endo -52.09 146.56 29.9 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.097 1.865 . . . . 0.0 111.817 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.84 157.12 2.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.325 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 16' ' ' ASN . . . -158.39 -172.12 25.13 Favored Glycine 0 C--O 1.226 -0.383 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.662 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.681 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -107.97 139.95 15.27 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.242 -0.98 . . . . 0.0 113.614 -179.593 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.698 HD11 ' CG1' ' A' ' 17' ' ' VAL . 6.5 mt -71.52 146.5 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.694 0.283 . . . . 0.0 110.824 179.504 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.95 -175.17 0.68 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.848 0.356 . . . . 0.0 111.081 179.744 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -48.75 -51.45 28.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.304 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -142.52 62.79 0.51 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.351 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -117.87 150.92 38.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.676 0.274 . . . . 0.0 110.332 179.764 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.415 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 1.3 m-20 -68.87 141.16 92.03 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.346 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 33.5 Cg_exo -61.55 -45.34 18.19 Favored 'Trans proline' 0 CA--C 1.513 -0.563 0 C-N-CA 122.2 1.933 . . . . 0.0 111.513 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.786 ' HE ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -51.57 -48.22 63.22 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.042 179.39 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.613 ' HA ' HD12 ' A' ' 58' ' ' ILE . 94.0 m-20 -65.77 -43.99 87.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.638 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.88 -41.19 91.04 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.627 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.8 ' HB1' HG23 ' A' ' 19' ' ' ILE . . . -58.63 -54.11 50.74 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.903 178.746 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.715 HD11 ' NE ' ' A' ' 54' ' ' ARG . 10.6 mt -56.37 -51.73 60.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.056 179.023 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -61.31 -56.7 17.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.49 -179.247 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.429 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 74.9 mm-40 -50.47 -42.63 54.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.019 0.437 . . . . 0.0 110.015 179.366 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.698 ' HB2' HG13 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -52.08 -49.34 63.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.419 178.732 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.807 ' HG2' HG23 ' A' ' 68' ' ' THR . 4.2 tmm_? -64.13 -65.97 0.61 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.626 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -48.27 -22.53 0.69 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.495 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -100.32 -34.16 10.1 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -178.246 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 49.5 p -123.12 -8.81 8.22 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.31 -0.556 . . . . 0.0 112.365 -178.536 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 80.53 -18.03 9.47 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.385 -178.592 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.754 HG11 HD22 ' A' ' 21' ' ' LEU . 97.8 t -57.15 121.05 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.263 0.554 . . . . 0.0 111.413 179.257 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.807 HG23 ' HG2' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -129.14 -39.37 1.55 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.89 178.731 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.3 m -62.79 75.06 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.483 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -158.93 156.23 29.1 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.575 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.54 151.45 49.43 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.236 179.389 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.786 HG21 ' HE ' ' A' ' 54' ' ' ARG . 7.8 t -75.59 130.77 35.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.318 0.58 . . . . 0.0 112.166 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.579 HD11 ' HB2' ' A' ' 111' ' ' LYS . 0.9 OUTLIER -111.75 -19.2 7.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.555 178.805 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.542 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -169.81 178.38 4.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.626 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.6 OUTLIER -156.23 149.23 24.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.833 179.63 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.807 ' HA ' HG11 ' A' ' 160' ' ' VAL . 52.6 t -73.08 137.86 79.1 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-O 121.186 0.517 . . . . 0.0 111.574 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.607 ' HD2' HG13 ' A' ' 76' ' ' VAL . 20.4 Cg_endo -62.52 -70.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.397 2.732 . . . . 0.0 112.794 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.724 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -87.45 173.55 9.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.063 -178.723 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.604 ' O ' ' HA ' ' A' ' 5' ' ' SER . 48.9 m95 -93.97 100.09 12.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.964 179.738 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.606 HD11 HG22 ' A' ' 157' ' ' VAL . 52.1 mt -58.45 112.91 1.74 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.922 0.391 . . . . 0.0 110.893 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.683 HG22 ' HA ' ' A' ' 104' ' ' ALA . 15.7 p -105.88 -165.23 1.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.944 -179.589 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -169.64 47.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.495 179.703 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -72.39 146.61 46.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.518 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.548 ' CB ' ' HB ' ' A' ' 88' ' ' VAL . 38.4 m-85 -98.92 173.07 4.11 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.263 -179.464 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.516 ' CD ' ' HB3' ' A' ' 84' ' ' PHE . 33.6 Cg_exo -61.77 -173.85 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.618 2.212 . . . . 0.0 111.369 179.439 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.556 ' HA ' ' HG3' ' A' ' 89' ' ' ARG . 71.3 Cg_endo -75.56 17.16 0.68 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.346 2.031 . . . . 0.0 113.53 -179.714 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.59 -59.76 1.96 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.889 0.376 . . . . 0.0 110.821 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.548 ' HB ' ' CB ' ' A' ' 84' ' ' PHE . 44.9 t -56.09 -20.9 10.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.352 179.659 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.556 ' HG3' ' HA ' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -47.58 -42.54 24.0 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.084 0.469 . . . . 0.0 111.272 -179.668 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.56 ' HA ' HD13 ' A' ' 94' ' ' ILE . 3.7 tt0 -65.17 -17.45 64.49 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.007 -179.819 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -102.78 -22.18 13.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.965 179.479 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.622 HD13 ' N ' ' A' ' 93' ' ' ASN . 1.2 tm? -121.5 -58.23 1.78 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.326 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.622 ' N ' HD13 ' A' ' 92' ' ' LEU . 25.9 t-20 -50.99 -63.93 0.97 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.949 0.404 . . . . 0.0 111.512 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.56 HD13 ' HA ' ' A' ' 90' ' ' GLU . 3.9 mp -71.7 -4.82 5.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.275 -179.288 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 34.3 tt0 -72.03 -6.66 43.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.355 178.913 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.508 ' HB2' ' CG ' ' A' ' 100' ' ' TRP . 71.6 m95 -100.3 -6.35 26.03 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.753 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.55 39.52 97.96 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.082 179.444 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.59 -163.53 0.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.713 0.292 . . . . 0.0 110.895 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.76 82.66 4.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.267 179.252 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.635 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 48.6 m95 -124.56 -164.99 1.32 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.657 -179.544 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.635 ' HB2' ' O ' ' A' ' 100' ' ' TRP . 19.7 ttpt 166.41 -13.36 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.256 0.347 . . . . 0.0 111.712 -179.701 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -175.6 -162.98 27.68 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.192 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.525 ' O ' ' HA ' ' A' ' 81' ' ' THR . 31.4 mt-30 -143.2 124.94 15.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.777 0.322 . . . . 0.0 110.6 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.683 ' HA ' HG22 ' A' ' 81' ' ' THR . . . -97.58 121.99 40.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.833 179.29 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.626 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 35.2 mt-30 -128.96 122.42 30.11 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.362 -178.068 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.03 135.33 44.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.509 179.693 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.714 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 42.7 m95 -103.66 166.25 10.54 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.063 0.458 . . . . 0.0 111.636 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 53' ' ' PRO . 91.1 m-85 -141.53 155.33 45.81 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.836 -179.471 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.688 HD11 ' SD ' ' A' ' 22' ' ' MET . 8.4 tp -101.14 141.96 33.27 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.459 179.126 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.663 ' CE2' HG22 ' A' ' 72' ' ' VAL . 49.4 m-85 -144.83 144.34 31.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.49 0.662 . . . . 0.0 112.502 -178.598 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 9.5 tttt -103.65 125.98 50.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.731 177.874 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.659 ' CD1' HD21 ' A' ' 21' ' ' LEU . 51.0 t80 -78.85 97.37 5.95 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.032 0.444 . . . . 0.0 110.939 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 39.1 p -97.1 51.03 1.1 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.536 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -153.17 -146.77 4.45 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.422 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.409 ' O ' ' HZ ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -122.4 145.12 48.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.177 0.513 . . . . 0.0 111.069 179.786 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -59.12 -26.15 64.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.05 -179.137 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -58.37 -5.07 0.45 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.209 -179.707 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -90.88 -18.23 25.15 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.996 0.427 . . . . 0.0 110.977 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.608 HD13 ' CE1' ' A' ' 29' ' ' PHE . 5.5 mt -83.85 103.53 11.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.709 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.429 ' O ' ' N ' ' A' ' 122' ' ' LEU . 0.8 OUTLIER -101.68 -12.53 18.32 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.243 -179.419 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.931 HD11 ' HB3' ' A' ' 134' ' ' TRP . 16.6 mt 37.07 28.57 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.057 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.881 ' HA ' ' HB3' ' A' ' 129' ' ' PRO . 10.7 mt -105.0 4.46 31.69 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.827 -179.511 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.56 130.36 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.497 -0.859 . . . . 0.0 111.96 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.35 69.55 7.0 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.343 0.592 . . . . 0.0 110.424 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -161.66 172.86 37.94 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.107 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.2 8.99 33.04 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.614 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -91.47 -75.04 0.49 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.841 0.353 . . . . 0.0 111.246 -179.756 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.599 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 1.7 pttm -178.68 163.73 1.1 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.735 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.881 ' HB3' ' HA ' ' A' ' 122' ' ' LEU . 27.7 Cg_endo -66.41 166.35 21.9 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.904 2.403 . . . . 0.0 112.815 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -97.72 -61.04 1.45 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.253 179.815 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.904 ' HB2' HD13 ' A' ' 121' ' ' LEU . 6.5 m-85 -105.3 147.03 28.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.696 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.649 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -86.2 -34.95 11.47 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.953 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -154.37 154.79 33.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.626 0.251 . . . . 0.0 111.2 179.911 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.931 ' HB3' HD11 ' A' ' 121' ' ' LEU . 36.4 p-90 -133.31 164.48 27.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.059 0.457 . . . . 0.0 111.875 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.5 t -157.99 165.61 34.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.685 -179.419 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.484 ' CD1' ' HZ3' ' A' ' 134' ' ' TRP . 89.6 m95 -106.75 97.53 7.31 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.936 178.305 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.626 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 21.0 m -113.37 163.11 10.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.338 179.611 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.551 ' HB ' ' CD ' ' A' ' 139' ' ' PRO . 10.5 p -70.92 174.32 3.77 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.199 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.636 ' HG3' HD11 ' A' ' 28' ' ' ILE . 12.2 Cg_exo -63.25 -53.35 1.53 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.543 1.495 . . . . 0.0 111.279 179.698 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -27.11 68.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.074 0.464 . . . . 0.0 111.067 179.332 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.401 ' HG3' ' OG1' ' A' ' 138' ' ' THR . 21.7 mt-30 -72.23 -47.3 51.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.882 179.767 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.841 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.3 OUTLIER -55.34 -41.41 72.44 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.482 179.498 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.657 HG22 ' HG3' ' A' ' 151' ' ' LYS . 28.9 mm -61.12 -34.24 59.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.553 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.57 -52.08 17.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.861 179.115 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.3 mp -72.97 -21.78 60.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.228 -179.309 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.662 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 8.2 t -73.21 173.87 8.83 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.99 0.424 . . . . 0.0 111.675 -178.743 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.689 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 16.3 m -79.83 154.03 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.984 -179.743 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.448 ' C ' ' H ' ' A' ' 150' ' ' LYS . 4.0 mt-10 -58.41 -54.82 42.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.849 0.357 . . . . 0.0 110.73 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.689 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 51.7 p90 -56.93 2.47 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.589 ' HG2' ' CZ ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -137.53 -6.41 1.75 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.581 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.657 ' HG3' HG22 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -64.44 -56.35 23.53 Favored Pre-proline 0 N--CA 1.464 0.262 0 N-CA-C 111.326 0.121 . . . . 0.0 111.326 -179.979 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 29.4 Cg_endo -63.66 -28.5 69.19 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.278 1.985 . . . . 0.0 111.834 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.771 ' O ' HG23 ' A' ' 157' ' ' VAL . 25.9 t -68.66 -51.09 49.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.718 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.589 ' CZ ' ' HG2' ' A' ' 150' ' ' LYS . 16.5 m-30 -64.93 -40.74 95.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.678 178.449 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.577 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -53.9 -43.62 69.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.401 -179.675 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.418 ' O ' HG23 ' A' ' 160' ' ' VAL . 3.9 tt0 -69.38 -32.44 71.48 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.218 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 153' ' ' VAL . 46.9 t -65.0 -41.81 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.683 178.709 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.513 HD22 ' HB3' ' A' ' 139' ' ' PRO . 37.3 mt -62.54 -46.71 87.13 Favored 'General case' 0 CA--C 1.524 -0.038 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.366 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.43 -38.54 29.66 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.884 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.807 HG11 ' HA ' ' A' ' 76' ' ' VAL . 80.1 t -68.85 -44.21 81.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.354 177.727 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.68 ' CE2' HG12 ' A' ' 157' ' ' VAL . 22.4 m-30 -79.6 4.18 16.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.284 -179.287 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.609 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.38 -53.64 64.0 Favored Pre-proline 0 C--N 1.327 -0.378 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.71 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 16.9 Cg_endo -57.91 -12.77 13.0 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.44 2.093 . . . . 0.0 111.907 178.827 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.542 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 91.3 m-70 -109.4 -16.95 13.9 Favored 'General case' 0 N--CA 1.46 0.027 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.457 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 95.5 mt . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.165 -0.921 . . . . 0.0 110.803 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 112.615 -0.194 . . . . 0.0 112.615 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.62 ' HG2' ' HB3' ' A' ' 152' ' ' PRO . 74.1 Cg_exo -50.38 177.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.668 2.245 . . . . 0.0 112.545 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.538 ' HG ' ' C ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER 44.64 -172.05 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.278 0.561 . . . . 0.0 111.656 -179.489 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -126.4 128.32 6.32 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.535 179.411 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.822 ' HB3' HD23 ' A' ' 80' ' ' LEU . 93.8 p -121.27 104.08 9.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.943 0.402 . . . . 0.0 111.217 -179.409 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.41 ' SD ' ' N ' ' A' ' 6' ' ' MET . 2.2 mpp? -96.92 149.66 21.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.442 179.789 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 16.1 t70 -63.83 -54.71 30.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 110.35 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.456 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 0.9 OUTLIER -98.24 145.35 29.69 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.83 178.655 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.459 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 41.9 Cg_endo -67.28 105.15 0.98 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.255 1.97 . . . . 0.0 111.989 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 9' ' ' PRO . 9.2 Cg_endo -52.21 165.34 0.96 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 123.086 2.524 . . . . 0.0 112.193 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -50.82 122.25 7.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.244 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' ' 100' ' ' TRP . . . 52.55 80.13 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.538 179.36 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.458 ' CG ' ' HG2' ' A' ' 10' ' ' PRO . 8.9 m-85 -149.51 62.34 1.02 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.822 0.344 . . . . 0.0 110.499 179.317 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.66 ' HA ' ' CZ3' ' A' ' 100' ' ' TRP . 2.0 ttt-85 31.05 -152.43 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.82 179.571 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.494 ' C ' HD12 ' A' ' 47' ' ' ILE . 2.5 ttt180 176.32 95.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.042 0.449 . . . . 0.0 110.408 -179.422 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.678 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 59.1 m-20 -133.08 176.85 8.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.163 179.072 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.682 HG13 HD11 ' A' ' 47' ' ' ILE . 27.2 m -142.2 164.58 17.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.252 0.549 . . . . 0.0 111.703 179.109 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.591 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -130.33 155.71 21.21 Favored Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.847 178.65 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.117 HG21 HD22 ' A' ' 61' ' ' LEU . 3.7 mp -122.06 119.42 58.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.154 0.502 . . . . 0.0 112.021 -178.979 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.523 ' O ' HD12 ' A' ' 109' ' ' LEU . 50.0 t -103.79 101.69 11.51 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.133 178.602 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.713 HD22 HG11 ' A' ' 67' ' ' VAL . 31.3 tp -102.68 121.52 42.6 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.898 -178.452 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.722 ' SD ' HD11 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -116.23 142.69 46.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.849 179.602 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.503 ' OD1' ' CZ3' ' A' ' 136' ' ' TRP . 7.8 m-20 -95.94 -177.72 4.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.465 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -56.14 -4.85 0.14 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.521 179.501 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.547 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.7 OUTLIER -103.13 -0.61 30.36 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.79 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.562 ' HE2' ' HE3' ' A' ' 22' ' ' MET . 1.8 mmtp 72.61 23.82 2.95 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -178.249 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.634 ' HB3' ' O ' ' A' ' 137' ' ' VAL . 25.9 mttt -94.77 175.24 6.73 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.217 179.285 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.713 HD11 ' HG3' ' A' ' 139' ' ' PRO . 1.8 mm -120.01 141.16 41.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.976 0.417 . . . . 0.0 111.064 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.665 ' HE2' HG21 ' A' ' 65' ' ' THR . 58.3 t80 -66.8 107.07 2.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.278 179.23 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.767 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -101.51 139.09 37.65 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.823 0.344 . . . . 0.0 110.929 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -138.14 132.0 31.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.281 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.68 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 53.4 p -99.0 146.29 26.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.839 0.352 . . . . 0.0 111.584 -179.341 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 17.5 mtp180 -69.34 128.13 35.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.432 179.601 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.748 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -45.18 -35.4 3.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.356 0.598 . . . . 0.0 110.984 -179.884 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -72.4 -36.15 68.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.765 179.797 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.6 mm -124.47 111.45 28.02 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.764 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -75.24 -20.75 16.11 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.432 2.088 . . . . 0.0 113.023 -179.273 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -92.63 -7.52 46.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.387 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.68 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.8 93.06 8.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.807 0.337 . . . . 0.0 111.047 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.626 ' O ' ' HA ' ' A' ' 146' ' ' THR . 81.6 m95 -88.0 144.03 26.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.015 179.142 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -153.76 174.38 14.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.54 0.686 . . . . 0.0 111.878 -179.2 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.58 ' HB3' ' CZ3' ' A' ' 107' ' ' TRP . 2.0 mtm -108.36 146.17 33.04 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.98 179.596 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -50.75 156.23 4.76 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.465 2.11 . . . . 0.0 111.995 179.783 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.683 ' HA ' HD12 ' A' ' 19' ' ' ILE . 4.2 pt20 -176.41 174.02 2.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.946 -179.391 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.467 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . 178.96 154.81 13.41 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.306 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.678 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -82.56 135.68 14.42 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.205 -179.382 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.682 HD11 HG13 ' A' ' 17' ' ' VAL . 2.8 mt -70.07 144.66 13.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.736 0.303 . . . . 0.0 111.141 179.801 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.77 -174.76 0.34 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.243 179.345 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -48.52 -77.06 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.04 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -113.27 57.35 0.45 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.689 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.451 ' O ' HG21 ' A' ' 47' ' ' ILE . 9.2 tp10 -115.77 148.35 39.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.795 0.331 . . . . 0.0 110.896 179.731 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 78.8 m-20 -72.16 142.58 85.03 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.536 179.677 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.497 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 56.7 Cg_exo -54.42 -45.43 41.02 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.714 2.276 . . . . 0.0 112.579 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.814 ' CZ ' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -52.14 -44.49 64.58 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.29 -179.616 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -65.71 -47.43 75.39 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.461 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.02 -43.19 99.36 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.412 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.627 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -58.13 -58.57 7.86 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.617 178.796 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.543 HD11 ' HG3' ' A' ' 54' ' ' ARG . 20.8 mt -56.17 -51.23 64.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.377 179.368 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -63.13 -64.89 0.78 Allowed 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.452 -179.511 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.467 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 56.2 mm-40 -42.29 -44.98 4.06 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.004 0.43 . . . . 0.0 110.43 179.932 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.117 HD22 HG21 ' A' ' 19' ' ' ILE . 14.4 tp -51.58 -46.76 63.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.975 178.562 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.886 ' HG3' HG23 ' A' ' 68' ' ' THR . 21.1 ttm180 -65.12 -65.76 0.63 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.25 179.429 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -49.39 -21.59 0.93 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.372 -179.266 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -97.87 -36.5 10.16 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.2 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.76 HG22 ' CD2' ' A' ' 121' ' ' LEU . 0.8 OUTLIER -128.95 -3.1 5.18 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.717 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 77.4 -12.19 15.02 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.415 -179.5 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.713 HG11 HD22 ' A' ' 21' ' ' LEU . 50.2 t -57.85 110.99 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-O 121.235 0.54 . . . . 0.0 111.503 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.886 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.6 OUTLIER -123.08 -40.33 2.41 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.668 178.629 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.7 m -62.17 73.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.396 179.485 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -160.66 158.22 28.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.023 0.439 . . . . 0.0 112.174 -179.631 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -129.66 149.42 51.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.655 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.814 HG11 ' CZ ' ' A' ' 54' ' ' ARG . 3.3 t -73.73 127.26 35.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.069 0.461 . . . . 0.0 110.962 179.227 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.544 HD11 ' N ' ' A' ' 111' ' ' LYS . 1.0 OUTLIER -106.61 -19.81 6.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.181 179.32 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.46 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.91 176.57 4.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.182 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.38 145.76 24.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.414 179.635 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.74 ' HA ' HG11 ' A' ' 160' ' ' VAL . 52.8 t -71.5 137.17 83.48 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.0 0.429 . . . . 0.0 110.859 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.49 ' HD2' HG13 ' A' ' 76' ' ' VAL . 17.7 Cg_endo -59.1 -66.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.198 2.599 . . . . 0.0 112.715 -179.575 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.528 ' CD1' ' HB2' ' A' ' 5' ' ' SER . 0.1 OUTLIER -96.65 -176.38 3.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.207 -178.965 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.539 ' O ' ' HG ' ' A' ' 80' ' ' LEU . 37.3 m95 -89.49 -154.43 0.31 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.815 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.822 HD23 ' HB3' ' A' ' 5' ' ' SER . 81.6 mt -162.16 105.51 1.16 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.103 0.478 . . . . 0.0 110.725 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.898 HG22 ' HA ' ' A' ' 104' ' ' ALA . 16.9 p -114.37 174.16 6.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.023 -179.836 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.505 ' O ' ' O ' ' A' ' 83' ' ' ASP . 39.7 p90 -172.63 37.95 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.213 179.297 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 82' ' ' TYR . 2.9 p30 38.09 -171.69 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 179.296 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.656 ' CZ ' HD11 ' A' ' 92' ' ' LEU . 3.1 m-85 -112.36 176.41 1.5 Allowed Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.211 179.708 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.606 ' HB3' ' HD2' ' A' ' 86' ' ' PRO . 88.5 Cg_exo -50.22 -176.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.62 2.213 . . . . 0.0 112.255 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.606 ' HD2' ' HB3' ' A' ' 85' ' ' PRO . 31.0 Cg_endo -66.09 -62.03 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.111 1.874 . . . . 0.0 113.03 -179.193 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.68 -28.54 40.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.751 0.31 . . . . 0.0 111.259 -179.616 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.563 ' HB ' ' HD2' ' A' ' 85' ' ' PRO . 41.7 t -66.82 -17.14 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.213 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.681 ' HD2' ' ND2' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -67.95 0.48 3.45 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.805 -179.742 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.82 ' HA ' HG12 ' A' ' 94' ' ' ILE . 7.2 mt-10 -121.72 -66.25 1.06 Allowed 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.991 0.424 . . . . 0.0 111.659 179.629 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.26 -41.09 65.16 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -179.051 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.656 HD11 ' CZ ' ' A' ' 84' ' ' PHE . 0.6 OUTLIER -104.33 -56.2 2.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.952 0.406 . . . . 0.0 111.851 -178.769 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.681 ' ND2' ' HD2' ' A' ' 89' ' ' ARG . 9.7 t30 -55.43 -49.49 72.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.157 -178.335 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.82 HG12 ' HA ' ' A' ' 90' ' ' GLU . 32.8 mm -75.8 -8.35 11.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.038 0.447 . . . . 0.0 110.464 179.29 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.453 ' HB3' ' H ' ' A' ' 96' ' ' TRP . 0.0 OUTLIER -80.81 -100.57 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.675 -179.71 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.585 ' CE3' ' CZ3' ' A' ' 100' ' ' TRP . 89.1 m95 41.36 31.03 0.15 Allowed 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.658 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.463 ' O ' ' CB ' ' A' ' 98' ' ' SER . . . 64.63 54.98 25.44 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.929 179.592 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 97' ' ' GLY . 6.5 t 87.2 162.33 0.08 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.513 0.325 . . . . 0.0 111.127 179.65 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 100' ' ' TRP . 6.9 p-10 39.51 -140.93 0.05 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.565 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.66 ' CZ3' ' HA ' ' A' ' 14' ' ' ARG . 35.9 m95 67.9 174.84 0.27 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 110.608 -0.145 . . . . 0.0 110.608 -179.419 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.67 ' HA ' ' ND2' ' A' ' 93' ' ' ASN . 16.9 ptpt 165.31 31.46 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.568 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 151.83 -158.94 28.05 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.235 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.492 ' HA ' ' CB ' ' A' ' 14' ' ' ARG . 24.8 mt-30 -147.13 126.84 13.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.962 0.381 . . . . 0.0 111.94 -179.77 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.898 ' HA ' HG22 ' A' ' 81' ' ' THR . . . -108.12 123.31 48.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.874 179.224 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.583 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 24.1 mt-30 -129.0 123.37 32.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.167 -178.473 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.541 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 4.4 ttpt -103.83 140.93 36.98 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.659 179.429 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.591 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 24.8 m95 -105.19 167.46 9.71 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.399 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.497 ' CZ ' ' HB2' ' A' ' 53' ' ' PRO . 78.3 m-85 -143.39 156.1 44.59 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.09 -179.496 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.722 HD11 ' SD ' ' A' ' 22' ' ' MET . 8.0 tp -103.59 138.66 39.95 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.769 179.007 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.728 ' CE2' HG22 ' A' ' 72' ' ' VAL . 55.7 m-85 -142.92 144.45 32.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.397 0.618 . . . . 0.0 112.634 -178.896 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 22.4 tttt -104.11 123.59 47.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.522 177.734 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.629 ' HB2' HD11 ' A' ' 21' ' ' LEU . 55.3 t80 -79.31 99.62 7.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.875 0.369 . . . . 0.0 110.629 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 30.2 p -96.96 41.64 1.11 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.405 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -140.29 -148.33 5.14 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.54 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -121.21 148.4 44.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.955 0.407 . . . . 0.0 111.151 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.449 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 9.5 p-10 -58.6 -38.24 77.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.37 0.605 . . . . 0.0 111.181 -179.558 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -56.57 -3.8 0.12 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.286 -179.402 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -90.05 -21.01 22.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.121 0.486 . . . . 0.0 110.326 179.371 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.65 HD13 ' CE1' ' A' ' 29' ' ' PHE . 14.3 mt -85.89 105.17 14.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.124 179.646 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.424 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 18.0 p-10 -102.82 -26.18 13.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.087 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.76 ' CD2' HG22 ' A' ' 65' ' ' THR . 56.3 mt 76.62 -36.05 0.25 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.025 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.59 HD23 ' HB3' ' A' ' 129' ' ' PRO . 96.3 mt -66.95 -169.44 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.999 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 118.01 -5.87 15.68 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.252 -179.454 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.418 ' HB3' ' O ' ' A' ' 128' ' ' LYS . 0.6 OUTLIER -102.68 63.13 0.84 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.466 -0.367 . . . . 0.0 110.457 179.767 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -77.71 45.33 2.42 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.672 -179.828 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.6 t -120.65 -40.66 2.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.907 0.384 . . . . 0.0 110.745 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -146.61 -45.3 0.19 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.107 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.418 ' O ' ' HB3' ' A' ' 124' ' ' ASP . 48.4 pttt -178.4 155.49 0.95 Allowed Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.95 0.405 . . . . 0.0 111.053 179.044 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.59 ' HB3' HD23 ' A' ' 122' ' ' LEU . 18.1 Cg_endo -71.41 -175.78 1.69 Allowed 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.709 2.272 . . . . 0.0 112.401 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.485 ' O ' HD12 ' A' ' 34' ' ' LEU . 5.1 mp0 -95.51 -69.46 0.75 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.326 -179.612 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.712 ' CE2' HG23 ' A' ' 65' ' ' THR . 3.1 m-85 -104.75 143.05 33.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.069 0.461 . . . . 0.0 110.64 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.748 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -90.14 -35.63 7.5 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.705 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -150.28 148.21 28.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.96 0.41 . . . . 0.0 110.619 179.626 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.536 ' CD2' ' HE1' ' A' ' 29' ' ' PHE . 38.1 p-90 -137.14 167.98 20.49 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.607 179.465 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.466 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 42.9 t -160.27 174.64 13.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.318 0.58 . . . . 0.0 112.314 -178.983 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.503 ' CZ3' ' OD1' ' A' ' 23' ' ' ASN . 78.7 m95 -109.23 100.71 9.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.551 178.384 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.634 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 28.9 m -119.03 165.61 14.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.53 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 26.8 p -71.63 167.24 32.36 Favored Pre-proline 0 C--N 1.327 -0.411 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.11 179.351 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.713 ' HG3' HD11 ' A' ' 28' ' ' ILE . 21.6 Cg_exo -59.43 -54.59 2.41 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.818 1.678 . . . . 0.0 110.435 179.554 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.3 -28.86 70.0 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.391 178.237 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.49 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 40.0 mt-30 -71.55 -46.4 59.61 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.248 179.707 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.767 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -57.65 -39.05 76.14 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.72 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.968 HG21 ' HD3' ' A' ' 155' ' ' LYS . 27.5 mm -60.3 -36.24 67.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.639 179.268 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.84 -53.3 15.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.242 0.544 . . . . 0.0 110.881 179.559 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.72 -19.52 62.04 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.448 -179.14 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.675 HG22 ' O ' ' A' ' 143' ' ' ILE . 7.6 t -73.02 179.64 3.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.056 0.455 . . . . 0.0 111.523 -179.115 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.635 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 21.9 m -85.28 151.25 3.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.439 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.458 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 48.4 mt-10 -58.48 -53.86 53.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.801 0.334 . . . . 0.0 111.227 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.619 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 53.1 p90 -56.28 0.81 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -179.721 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.597 ' HB2' HG23 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -136.83 -7.99 1.86 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.482 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.562 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 0.0 OUTLIER -62.53 -52.79 62.86 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.895 -0.138 . . . . 0.0 111.072 179.562 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.62 ' HB3' ' HG2' ' A' ' 2' ' ' PRO . 28.6 Cg_endo -63.47 -28.58 70.89 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.121 1.88 . . . . 0.0 111.895 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.81 ' O ' HG23 ' A' ' 157' ' ' VAL . 23.3 t -68.42 -49.33 66.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.824 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.525 ' CE1' ' HG2' ' A' ' 150' ' ' LYS . 5.4 m-30 -66.58 -40.59 89.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.806 178.87 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.968 ' HD3' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -53.2 -44.82 68.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.518 179.449 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.431 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.5 OUTLIER -68.32 -33.34 74.13 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.133 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 153' ' ' VAL . 64.2 t -66.07 -41.31 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.695 178.688 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.566 HD22 ' HB3' ' A' ' 139' ' ' PRO . 64.8 mt -64.88 -45.01 87.77 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.55 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.35 -41.41 63.03 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.235 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.74 HG11 ' HA ' ' A' ' 76' ' ' VAL . 94.0 t -66.11 -42.33 91.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.033 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.56 ' CE2' HG12 ' A' ' 157' ' ' VAL . 19.7 m-30 -81.05 6.35 13.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.554 -179.192 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.594 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.46 -53.64 64.04 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.55 179.592 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 18.1 Cg_endo -59.56 -12.14 16.45 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.021 1.814 . . . . 0.0 111.86 178.712 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.46 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 96.5 m-70 -107.37 -18.55 13.84 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.292 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 78.3 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.794 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.54 -0.224 . . . . 0.0 112.54 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.77 -177.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.652 2.234 . . . . 0.0 112.209 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.691 HD21 ' HB2' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -98.98 132.44 44.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.909 179.9 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.08 132.48 11.01 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.973 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.895 ' HB3' HD23 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -120.37 139.97 52.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.881 0.372 . . . . 0.0 111.321 -179.829 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.484 ' HE1' ' OG1' ' A' ' 81' ' ' THR . 0.3 OUTLIER -143.78 147.31 33.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.597 -179.949 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.748 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 17.9 t70 -65.02 -10.29 28.52 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.713 0.292 . . . . 0.0 111.358 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' SER . . . . . 0.437 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -143.18 117.39 6.21 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.608 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.622 ' HB3' ' CB ' ' A' ' 104' ' ' ALA . 57.6 Cg_endo -68.71 105.37 1.29 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.533 2.155 . . . . 0.0 112.853 -179.391 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.618 ' HG2' ' CD2' ' A' ' 13' ' ' TYR . 8.6 Cg_endo -52.04 161.3 2.51 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.941 2.427 . . . . 0.0 112.577 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -55.49 129.67 39.75 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.546 179.501 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.924 ' HA2' ' HA ' ' A' ' 100' ' ' TRP . . . 108.76 -25.04 20.38 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.415 -0.898 . . . . 0.0 114.272 178.141 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.618 ' CD2' ' HG2' ' A' ' 10' ' ' PRO . 87.3 m-85 -87.44 121.19 29.55 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.909 0.355 . . . . 0.0 110.47 -179.604 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.695 ' HA ' ' HZ3' ' A' ' 100' ' ' TRP . 0.0 OUTLIER -71.48 85.34 0.84 Allowed 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.018 0.437 . . . . 0.0 110.825 179.91 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.671 ' HB2' ' CZ3' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -49.01 123.72 7.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.184 -179.932 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.668 ' CB ' ' HA2' ' A' ' 46' ' ' GLY . 75.1 m-20 -131.61 176.57 8.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.235 -179.767 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.748 HG13 HD11 ' A' ' 47' ' ' ILE . 18.4 m -141.97 157.37 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 120.221 -0.592 . . . . 0.0 112.377 179.626 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.475 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -126.28 168.43 18.42 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.209 178.39 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 1.079 HG21 HD13 ' A' ' 61' ' ' LEU . 5.1 mp -128.73 116.62 41.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -178.745 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.599 ' O ' HD12 ' A' ' 109' ' ' LEU . 8.3 t -103.87 98.23 8.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.617 178.28 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.939 HD22 HG11 ' A' ' 67' ' ' VAL . 13.6 tp -99.25 127.2 45.22 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.792 -178.976 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.716 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -121.62 151.63 40.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.821 179.496 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.547 ' N ' ' OD1' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -94.61 173.84 7.41 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.859 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.443 ' HA ' ' HE3' ' A' ' 111' ' ' LYS . 20.6 p30 -57.91 -5.68 0.45 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.653 176.819 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.568 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 4.9 m-20 -102.55 0.38 33.4 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.081 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.568 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 24.3 mmtp 75.18 22.73 1.7 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.262 -178.464 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.716 ' O ' ' HA ' ' A' ' 22' ' ' MET . 5.6 mmtt -93.37 143.81 25.92 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.803 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.743 HG13 ' HA ' ' A' ' 139' ' ' PRO . 1.8 mm -97.43 136.18 29.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.206 0.527 . . . . 0.0 111.762 -178.819 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.681 ' HB2' HD23 ' A' ' 21' ' ' LEU . 4.4 t80 -65.78 100.71 0.57 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.51 178.49 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.655 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -96.11 141.01 30.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.793 0.33 . . . . 0.0 111.058 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -138.12 131.6 30.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.487 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.763 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 53.8 p -99.3 144.48 28.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.887 0.375 . . . . 0.0 111.593 -179.358 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.413 ' HB3' ' OD1' ' A' ' 35' ' ' ASP . 3.8 mtp180 -71.97 128.0 34.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.807 179.62 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.704 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -44.02 -38.38 3.5 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.251 0.548 . . . . 0.0 111.141 179.918 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.413 ' OD1' ' HB3' ' A' ' 33' ' ' ARG . 4.8 p-10 -71.77 -34.04 69.13 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.215 -179.925 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.8 mt -124.85 105.38 29.63 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.73 0.3 . . . . 0.0 111.006 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -69.73 -20.16 35.33 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.687 2.258 . . . . 0.0 112.748 -179.673 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -93.84 -7.59 42.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.651 -179.599 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.763 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.52 100.49 13.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.615 0.245 . . . . 0.0 111.032 -179.851 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.641 ' O ' ' HA ' ' A' ' 146' ' ' THR . 76.2 m95 -96.25 146.82 24.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.098 179.167 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.622 ' HG3' ' HG1' ' A' ' 146' ' ' THR . 0.2 OUTLIER -162.48 -128.75 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.668 -179.184 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.497 ' H ' ' HB3' ' A' ' 41' ' ' GLN . 2.1 ptt? 178.96 163.13 0.7 Allowed Pre-proline 0 N--CA 1.448 -0.571 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.843 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.946 ' HG2' HD12 ' A' ' 61' ' ' LEU . 82.0 Cg_exo -45.07 148.85 1.48 Allowed 'Trans proline' 0 CA--C 1.529 0.241 0 C-N-CA 122.454 2.103 . . . . 0.0 113.047 -179.229 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.546 ' HG3' ' O ' ' A' ' 17' ' ' VAL . 51.9 tt0 -173.79 145.79 1.19 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.465 -179.452 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.793 ' HA3' ' HG2' ' A' ' 60' ' ' GLU . . . -145.81 -168.71 13.4 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.293 179.739 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.668 ' HA2' ' CB ' ' A' ' 16' ' ' ASN . . . -117.47 17.2 12.43 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 119.997 -1.097 . . . . 0.0 115.382 -178.595 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.748 HD11 HG13 ' A' ' 17' ' ' VAL . 11.3 mt 62.01 136.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 117.796 0.798 . . . . 0.0 111.444 179.122 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.524 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 3.3 m-20 -69.68 -175.97 0.96 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.857 179.366 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -47.89 -81.08 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.428 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -108.12 55.48 0.51 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.814 179.567 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 4.0 tp10 -116.66 142.95 46.23 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.892 0.377 . . . . 0.0 111.159 -179.356 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.466 ' HB2' ' ND2' ' A' ' 55' ' ' ASN . 7.6 m-20 -64.8 168.89 6.12 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.102 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 4.2 Cg_exo -77.25 -53.75 0.07 OUTLIER 'Trans proline' 0 CA--C 1.515 -0.468 0 C-N-CA 122.742 2.295 . . . . 0.0 113.472 -178.747 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.619 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -49.17 -51.78 30.44 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.065 -179.255 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 56' ' ' ALA . 18.2 p30 -62.31 -37.91 87.38 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 119.816 -0.754 . . . . 0.0 110.501 -179.301 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.504 ' N ' ' OD1' ' A' ' 55' ' ' ASN . . . -64.39 -44.77 90.27 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.735 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.584 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -60.02 -61.54 2.53 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.904 178.271 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.619 ' CD1' ' O ' ' A' ' 54' ' ' ARG . 2.6 mp -53.41 -46.9 59.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.626 179.454 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 5.4 mmt180 -64.18 -62.52 1.57 Allowed 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.739 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.793 ' HG2' ' HA3' ' A' ' 45' ' ' GLY . 0.2 OUTLIER -42.56 -43.09 3.61 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.185 0.517 . . . . 0.0 110.171 179.667 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 1.079 HD13 HG21 ' A' ' 19' ' ' ILE . 1.9 tp -50.0 -47.92 52.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.998 178.851 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.892 ' HG2' HG23 ' A' ' 68' ' ' THR . 1.9 tmm_? -67.07 -65.94 0.62 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.079 178.885 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -49.26 -24.3 1.74 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.373 -179.106 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -93.95 -36.94 11.94 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.39 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.596 ' HB ' HG23 ' A' ' 119' ' ' ILE . 1.4 p -127.81 -31.24 2.44 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.402 -0.519 . . . . 0.0 112.395 -178.941 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.501 ' HA2' ' HD2' ' A' ' 62' ' ' ARG . . . 106.92 -13.75 41.27 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.654 -178.896 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.939 HG11 HD22 ' A' ' 21' ' ' LEU . 73.6 t -55.77 107.18 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-O 121.167 0.508 . . . . 0.0 111.022 179.523 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.892 HG23 ' HG2' ' A' ' 62' ' ' ARG . 0.6 OUTLIER -121.47 -39.41 2.66 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.577 178.716 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.7 m -61.55 74.22 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.863 178.859 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -162.56 157.19 21.79 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.113 0.482 . . . . 0.0 112.029 -179.309 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -126.72 148.76 49.85 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.055 179.154 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.712 HG22 ' CD1' ' A' ' 110' ' ' PHE . 24.8 t -76.06 126.28 36.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.12 0.485 . . . . 0.0 111.627 179.615 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.53 HD11 ' HB2' ' A' ' 111' ' ' LYS . 0.7 OUTLIER -107.5 -21.49 5.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.421 179.289 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.443 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -169.49 177.43 4.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.81 -179.192 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.53 152.16 21.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.527 179.689 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.836 ' HA ' HG11 ' A' ' 160' ' ' VAL . 43.1 t -71.9 135.87 82.82 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.974 0.416 . . . . 0.0 111.055 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.431 ' HD2' HG13 ' A' ' 76' ' ' VAL . 18.1 Cg_endo -60.13 -62.21 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.075 2.516 . . . . 0.0 112.612 -179.452 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.748 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -98.01 -177.3 3.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.154 -179.186 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.671 ' CZ3' ' HB2' ' A' ' 15' ' ' ARG . 28.8 m95 -94.27 -152.73 0.35 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.557 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.895 HD23 ' HB3' ' A' ' 5' ' ' SER . 24.2 mt -164.39 101.97 0.83 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.754 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.747 HG22 ' HB2' ' A' ' 104' ' ' ALA . 77.7 p -92.89 92.88 8.1 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.898 0.38 . . . . 0.0 111.878 -178.958 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -78.48 87.55 4.47 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.865 178.832 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -72.01 161.65 30.61 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.594 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.799 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 46.7 m-85 -102.7 143.77 27.27 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.234 -179.319 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.52 ' HB3' ' HD2' ' A' ' 86' ' ' PRO . 37.6 Cg_exo -58.26 -178.6 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.62 2.213 . . . . 0.0 111.821 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 85' ' ' PRO . 35.0 Cg_endo -65.49 -11.65 31.36 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.139 1.893 . . . . 0.0 112.488 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.61 -43.48 10.15 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.843 0.354 . . . . 0.0 110.856 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.799 ' HB ' ' HB3' ' A' ' 84' ' ' PHE . 17.1 t -90.76 -24.85 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.325 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.617 ' O ' HD13 ' A' ' 94' ' ' ILE . 7.1 tpp85 -68.94 -4.44 16.64 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.969 0.414 . . . . 0.0 110.491 178.984 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.756 ' HA ' HD13 ' A' ' 94' ' ' ILE . 2.0 mt-10 -114.08 -15.31 12.28 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.719 0.295 . . . . 0.0 111.464 179.643 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.77 -27.7 14.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.867 0.365 . . . . 0.0 110.969 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.655 HD22 ' O ' ' A' ' 92' ' ' LEU . 0.9 OUTLIER -120.13 -52.89 2.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.979 -179.662 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.579 ' HA ' ' CD1' ' A' ' 96' ' ' TRP . 7.2 m120 -62.26 -23.14 66.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.865 -179.017 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.756 HD13 ' HA ' ' A' ' 90' ' ' GLU . 0.7 OUTLIER -74.14 -14.73 16.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.298 179.308 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.518 ' HB3' ' H ' ' A' ' 96' ' ' TRP . 0.4 OUTLIER -81.82 -102.3 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.208 179.469 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.846 ' HB3' ' CD1' ' A' ' 100' ' ' TRP . 93.4 m95 33.53 97.41 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 178.511 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -41.1 -70.08 0.45 Allowed Glycine 0 CA--C 1.522 0.498 0 CA-C-N 115.709 -0.678 . . . . 0.0 113.132 179.524 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.24 -164.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.865 0.364 . . . . 0.0 110.753 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.567 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 0.6 OUTLIER -87.04 88.13 7.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.061 179.698 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.924 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 52.7 m95 -107.14 -165.63 1.08 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.108 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.669 ' HB2' ' O ' ' A' ' 100' ' ' TRP . 0.1 OUTLIER 159.23 62.96 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.516 0.726 . . . . 0.0 109.74 -179.268 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.8 -169.86 14.88 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.459 -0.876 . . . . 0.0 112.708 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.676 ' O ' ' HA ' ' A' ' 81' ' ' THR . 40.9 mt-30 -148.32 127.09 12.58 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.758 0.313 . . . . 0.0 111.466 -179.56 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.747 ' HB2' HG22 ' A' ' 81' ' ' THR . . . -92.49 116.27 28.84 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.941 179.859 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.664 ' CG ' ' HB2' ' A' ' 16' ' ' ASN . 18.7 mt-30 -113.87 123.29 49.42 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.044 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.488 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 2.2 ttpt -106.03 133.44 50.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.3 177.807 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.504 ' CZ2' ' CE1' ' A' ' 154' ' ' TYR . 41.8 m95 -102.72 160.48 14.55 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.023 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.507 ' HB3' ' CE1' ' A' ' 110' ' ' PHE . 90.8 m-85 -133.91 154.12 51.29 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.705 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.686 HD22 ' CG ' ' A' ' 161' ' ' PHE . 11.5 tp -109.83 128.24 55.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.149 179.648 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.879 ' CE2' HG23 ' A' ' 19' ' ' ILE . 5.4 m-85 -133.9 147.75 51.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.279 0.561 . . . . 0.0 111.8 179.929 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 21.8 tttt -99.47 124.52 44.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.572 178.542 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.619 ' HB2' HD11 ' A' ' 21' ' ' LEU . 34.8 t80 -78.54 101.03 7.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.882 0.373 . . . . 0.0 110.952 179.599 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 15.9 p -98.99 40.77 1.18 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.74 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.27 -146.66 4.68 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.364 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -120.82 153.7 36.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.887 0.375 . . . . 0.0 111.216 179.786 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.488 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 4.4 p30 -59.7 -39.2 83.82 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.487 0.66 . . . . 0.0 111.164 -179.611 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -59.31 -1.74 0.24 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.86 -1.063 . . . . 0.0 112.161 -179.325 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -89.93 -17.91 27.09 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.864 0.364 . . . . 0.0 110.701 179.701 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.711 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 13.6 mt -80.81 102.66 6.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.588 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -102.0 94.3 5.71 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.899 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.641 HD11 ' HD1' ' A' ' 134' ' ' TRP . 44.9 mt -67.72 -41.26 83.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.028 0.442 . . . . 0.0 110.613 179.745 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.68 HD22 ' HG3' ' A' ' 129' ' ' PRO . 6.0 mt -97.34 143.96 27.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.189 -179.522 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -154.01 -129.21 1.3 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.195 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.02 102.83 14.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.704 0.287 . . . . 0.0 110.888 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -164.29 119.32 0.87 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.547 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.61 -10.44 59.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.606 0.241 . . . . 0.0 111.219 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' A' ' 128' ' ' LYS . 6.5 tt0 -90.74 -72.99 0.55 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.694 0.283 . . . . 0.0 110.752 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 127' ' ' GLU . 0.1 OUTLIER 179.79 153.56 0.62 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.688 178.988 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.68 ' HG3' HD22 ' A' ' 122' ' ' LEU . 10.5 Cg_endo -73.4 -173.41 1.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.552 2.168 . . . . 0.0 112.393 179.645 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.583 ' O ' HD12 ' A' ' 34' ' ' LEU . 2.4 mp0 -89.79 -74.28 0.49 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.781 179.852 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.446 ' CE1' HG23 ' A' ' 65' ' ' THR . 0.8 OUTLIER -103.8 141.88 35.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.434 179.902 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.704 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -83.86 -34.82 17.51 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.005 -179.642 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.06 149.77 29.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.855 0.36 . . . . 0.0 110.46 179.787 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.711 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 32.7 p-90 -137.89 170.12 16.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.066 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.454 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 22.8 t -165.71 177.53 7.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.513 0.673 . . . . 0.0 111.918 -178.681 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.487 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 73.6 m95 -111.42 103.49 11.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.422 178.437 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.433 ' O ' ' N ' ' A' ' 28' ' ' ILE . 31.7 m -119.26 171.68 7.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.556 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 22.3 p -74.0 167.29 36.85 Favored Pre-proline 0 C--N 1.326 -0.431 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.955 179.143 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.743 ' HA ' HG13 ' A' ' 28' ' ' ILE . 21.7 Cg_exo -59.11 -55.85 1.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.772 1.648 . . . . 0.0 110.347 178.979 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.37 -25.41 68.28 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.855 178.494 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.408 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 9.1 mm-40 -72.84 -47.16 48.59 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.73 -179.74 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.655 HD13 ' HB2' ' A' ' 30' ' ' ALA . 20.3 tp -59.64 -37.73 79.47 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.817 HG21 ' HG2' ' A' ' 155' ' ' LYS . 12.7 mm -63.03 -36.15 74.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.555 178.94 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.27 -52.99 15.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.333 0.587 . . . . 0.0 110.367 179.607 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.458 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -72.2 -16.77 61.96 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.575 -179.239 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.641 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 12.7 t -76.45 176.0 8.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.019 0.438 . . . . 0.0 111.46 -179.652 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.548 ' HB ' ' CE1' ' A' ' 149' ' ' PHE . 17.6 m -74.9 150.88 6.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.674 179.432 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.43 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 50.6 mt-10 -58.32 -53.28 60.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.869 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.548 ' CE1' ' HB ' ' A' ' 147' ' ' VAL . 38.2 p90 -57.47 0.91 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -179.577 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.45 ' HB2' HG23 ' A' ' 147' ' ' VAL . 53.1 mttt -134.41 -9.17 2.54 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.99 -0.444 . . . . 0.0 111.967 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.686 ' HG3' HG22 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -60.58 -54.64 52.82 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.919 -0.128 . . . . 0.0 110.823 179.781 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.691 ' HB2' HD21 ' A' ' 3' ' ' LEU . 38.8 Cg_endo -67.5 -28.18 38.71 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.196 1.931 . . . . 0.0 111.61 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.61 ' O ' HG23 ' A' ' 157' ' ' VAL . 37.8 t -68.74 -50.96 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.369 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.504 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 5.8 m-30 -66.68 -38.49 86.91 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.669 178.449 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.817 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -56.09 -39.99 72.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.595 179.837 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.407 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.6 OUTLIER -69.07 -31.98 71.12 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.02 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.629 HG12 ' CE2' ' A' ' 161' ' ' PHE . 42.2 t -64.77 -42.11 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.69 178.699 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.497 HD22 ' HB3' ' A' ' 139' ' ' PRO . 64.9 mt -64.49 -44.22 91.66 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.661 179.625 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 38.5 t -52.63 -40.32 62.65 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.142 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.836 HG11 ' HA ' ' A' ' 76' ' ' VAL . 91.2 t -67.43 -42.48 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.518 -0.765 . . . . 0.0 108.984 177.849 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.686 ' CG ' HD22 ' A' ' 109' ' ' LEU . 21.1 m-30 -80.72 6.47 12.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.188 -179.527 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.598 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.46 -53.41 66.43 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.684 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 18.0 Cg_endo -57.67 -12.87 12.49 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.143 1.896 . . . . 0.0 111.869 178.811 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 164' ' ' HIS . . . . . 0.443 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 90.5 m-70 -108.68 -19.36 13.45 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.263 -179.925 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 97.7 mt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.606 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.564 -0.214 . . . . 0.0 112.564 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -72.95 -167.28 0.34 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.477 2.118 . . . . 0.0 111.927 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.594 HD11 HG22 ' A' ' 153' ' ' VAL . 4.4 mm? 60.55 110.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.81 0.338 . . . . 0.0 110.601 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.479 ' O ' ' HG3' ' A' ' 6' ' ' MET . . . -96.29 -39.53 4.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.826 -179.754 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.867 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 11.5 p 57.89 -103.54 0.18 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.438 0.295 . . . . 0.0 111.741 -179.366 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.479 ' HG3' ' O ' ' A' ' 4' ' ' GLY . 16.0 mtm 64.45 128.28 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.67 0.271 . . . . 0.0 110.416 -179.141 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.641 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 4.1 p-10 -67.05 -6.4 17.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.748 0.309 . . . . 0.0 111.498 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 79.3 p -142.26 107.43 5.68 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.586 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.547 ' HB3' ' CB ' ' A' ' 104' ' ' ALA . 57.3 Cg_endo -70.45 107.78 2.07 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.423 2.082 . . . . 0.0 112.823 -179.242 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.497 ' HD2' ' HA ' ' A' ' 9' ' ' PRO . 2.7 Cg_endo -47.4 167.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.177 2.585 . . . . 0.0 112.668 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -49.3 137.1 14.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.077 179.758 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.529 ' HA3' ' O ' ' A' ' 99' ' ' ASP . . . 62.5 64.31 3.97 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.839 179.658 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.458 ' CD2' ' HG2' ' A' ' 10' ' ' PRO . 11.5 m-85 -149.65 55.2 0.96 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.062 0.458 . . . . 0.0 110.857 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.621 ' CB ' ' HA ' ' A' ' 103' ' ' GLN . 0.2 OUTLIER 32.23 -157.54 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.578 179.185 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.631 ' HG3' ' CZ3' ' A' ' 79' ' ' TRP . 1.2 ttp180 176.57 93.09 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.743 0.306 . . . . 0.0 111.142 -178.552 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.676 ' HB2' ' HG2' ' A' ' 105' ' ' GLN . 3.2 m120 -133.0 -177.5 4.54 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.14 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.725 HG13 ' CG1' ' A' ' 47' ' ' ILE . 35.3 m -140.71 168.06 17.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.289 179.303 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.677 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -134.16 154.45 21.4 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.329 179.077 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.831 ' HB ' ' HB2' ' A' ' 43' ' ' PRO . 3.1 mp -126.66 117.32 47.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.005 0.431 . . . . 0.0 111.871 -179.379 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.652 ' O ' HD12 ' A' ' 109' ' ' LEU . 42.1 t -98.48 99.43 10.59 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.928 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.83 HD22 HG11 ' A' ' 67' ' ' VAL . 24.3 tp -98.31 115.18 27.88 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.522 -178.407 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.666 ' HE1' ' HE2' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -115.6 163.0 16.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.44 179.253 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.737 ' ND2' ' CE3' ' A' ' 136' ' ' TRP . 0.4 OUTLIER -98.5 168.11 10.39 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.169 179.958 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -55.71 -4.43 0.11 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.195 177.83 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.564 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -100.63 2.92 42.12 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.934 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.666 ' HE2' ' HE1' ' A' ' 22' ' ' MET . 5.6 mmtp 74.44 21.55 2.31 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.01 -178.352 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.582 ' HB2' ' OD1' ' A' ' 23' ' ' ASN . 1.9 mmtt -92.33 150.03 21.08 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.839 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.763 HD11 ' HG3' ' A' ' 139' ' ' PRO . 1.5 mm -102.92 137.2 31.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.997 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.608 ' CE1' HD13 ' A' ' 119' ' ' ILE . 88.4 t80 -76.55 138.35 40.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.534 177.932 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.619 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -143.5 153.05 42.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.943 0.402 . . . . 0.0 110.877 -179.708 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.604 ' HB1' ' CB ' ' A' ' 131' ' ' PHE . . . -145.8 132.39 19.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.523 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 4.1 m -97.38 153.26 18.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.127 0.489 . . . . 0.0 111.76 -179.016 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.651 ' O ' ' N ' ' A' ' 35' ' ' ASP . 6.7 mtp180 -68.83 131.64 45.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.966 -179.254 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.745 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -55.37 55.3 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.218 0.607 . . . . 0.0 112.191 179.979 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.651 ' N ' ' O ' ' A' ' 33' ' ' ARG . 1.3 t0 -178.31 -29.67 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.07 0.462 . . . . 0.0 109.977 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.477 HD12 ' NE ' ' A' ' 33' ' ' ARG . 24.0 mt -118.82 107.4 42.4 Favored Pre-proline 0 N--CA 1.451 -0.376 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.62 179.522 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.04 -18.26 21.46 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.514 2.143 . . . . 0.0 112.852 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -94.53 -13.04 26.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.666 -179.755 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.629 ' HB1' ' CG1' ' A' ' 147' ' ' VAL . . . -92.38 101.38 13.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.71 0.291 . . . . 0.0 110.816 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.649 ' O ' ' HA ' ' A' ' 146' ' ' THR . 68.1 m95 -102.81 147.6 26.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.135 179.527 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.445 ' HG2' ' C ' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -152.2 160.27 43.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.269 0.557 . . . . 0.0 111.751 -179.984 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.476 ' HB2' ' HE2' ' A' ' 42' ' ' MET . 6.4 mtm -98.64 154.02 37.66 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.055 179.227 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.831 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 52.9 Cg_exo -49.08 154.19 3.62 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.574 2.183 . . . . 0.0 112.152 -179.77 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.663 ' HA ' HD12 ' A' ' 19' ' ' ILE . 13.7 pt20 -177.4 178.15 1.1 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.882 -178.759 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.499 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . 170.91 150.11 6.83 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.426 -0.893 . . . . 0.0 112.578 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.675 ' HA2' ' CB ' ' A' ' 16' ' ' ASN . . . -74.47 135.03 18.89 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.688 -179.475 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.725 ' CG1' HG13 ' A' ' 17' ' ' VAL . 11.7 mt -70.64 141.73 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.939 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -68.39 -171.02 0.23 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.843 0.354 . . . . 0.0 110.993 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.549 ' HG3' ' H ' ' A' ' 50' ' ' GLY . 2.3 pt-20 -49.06 -67.32 0.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.525 -179.476 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.549 ' H ' ' HG3' ' A' ' 49' ' ' GLU . . . -127.67 54.39 0.78 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.742 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -108.99 148.15 31.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.746 0.308 . . . . 0.0 110.504 -179.692 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.429 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 7.7 m-20 -68.84 140.67 91.71 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.253 179.843 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.551 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 35.3 Cg_exo -60.23 -47.14 15.54 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.325 2.017 . . . . 0.0 111.682 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.86 ' HE ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -53.04 -45.98 68.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.564 179.404 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.51 ' HA ' HD12 ' A' ' 58' ' ' ILE . 12.6 m-20 -67.31 -43.85 80.64 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.431 179.63 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.24 -42.05 94.43 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.646 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.773 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -57.78 -55.53 33.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.94 178.604 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.601 HD11 ' CZ ' ' A' ' 54' ' ' ARG . 14.4 mt -55.15 -54.08 28.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.257 179.284 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -61.28 -63.67 1.21 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.811 -179.538 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.499 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 46.4 mm-40 -43.94 -47.29 8.46 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.164 0.507 . . . . 0.0 110.017 179.181 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.623 HD12 ' CB ' ' A' ' 43' ' ' PRO . 0.2 OUTLIER -50.12 -46.72 53.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.066 178.336 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.818 ' HG3' HG23 ' A' ' 68' ' ' THR . 24.6 ttm180 -63.15 -64.67 0.84 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.48 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -48.32 -20.16 0.37 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.532 0.568 . . . . 0.0 112.532 -179.194 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -98.4 -38.52 9.19 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -178.173 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.672 HG22 HD23 ' A' ' 121' ' ' LEU . 1.0 OUTLIER -125.29 -5.6 7.2 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.704 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 79.02 -11.69 27.56 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.349 -0.929 . . . . 0.0 111.904 -178.74 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.83 HG11 HD22 ' A' ' 21' ' ' LEU . 58.8 t -57.91 114.19 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 121.033 0.445 . . . . 0.0 111.185 179.509 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.818 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.9 OUTLIER -124.36 -41.33 2.18 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.187 178.285 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.413 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 14.9 m -61.37 73.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.302 179.307 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.16 152.34 18.75 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.359 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -126.2 150.63 48.21 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.232 179.291 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.86 HG21 ' HE ' ' A' ' 54' ' ' ARG . 21.3 t -74.79 127.93 36.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.146 0.498 . . . . 0.0 111.766 179.683 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.589 HD11 ' HB2' ' A' ' 111' ' ' LYS . 1.6 mt -105.73 -18.96 6.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.146 179.325 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -170.94 176.56 4.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.54 179.806 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -155.04 146.76 23.3 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.37 179.43 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.878 ' HA ' HG11 ' A' ' 160' ' ' VAL . 54.7 t -70.64 140.19 86.71 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 120.918 0.39 . . . . 0.0 111.068 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.644 ' HD2' HG13 ' A' ' 76' ' ' VAL . 29.9 Cg_endo -63.55 -59.44 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.138 2.558 . . . . 0.0 112.288 -179.787 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -102.31 -174.63 2.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.433 -179.202 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.631 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 34.1 m95 -89.26 -158.96 0.54 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.665 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.867 ' HA ' ' HA ' ' A' ' 5' ' ' SER . 65.8 mt -161.37 101.42 1.21 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.248 0.547 . . . . 0.0 110.87 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.834 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 70.8 p -96.59 -173.75 2.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.28 -179.681 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -171.0 58.23 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.742 179.627 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.9 p30 -70.58 173.28 7.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.598 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.626 ' CD2' HD12 ' A' ' 92' ' ' LEU . 4.2 m-85 -101.05 166.49 12.32 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.165 -179.815 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.517 ' CB ' ' HD2' ' A' ' 86' ' ' PRO . 26.2 Cg_exo -61.69 -177.23 0.22 Allowed 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.68 2.253 . . . . 0.0 111.23 179.514 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 85' ' ' PRO . 36.0 Cg_endo -66.23 -3.23 8.31 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.191 1.927 . . . . 0.0 112.982 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.63 -67.1 0.91 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.993 0.425 . . . . 0.0 111.021 -179.806 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.611 ' HB ' ' HB3' ' A' ' 84' ' ' PHE . 13.0 t -61.32 -14.68 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.961 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.602 HH11 ' HB3' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -50.15 -76.49 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.933 0.397 . . . . 0.0 111.275 179.552 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.897 ' HA ' HD13 ' A' ' 94' ' ' ILE . 3.7 mm-40 -55.27 -17.13 4.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.678 -179.59 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -81.84 -49.46 10.34 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.046 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.626 HD12 ' CD2' ' A' ' 84' ' ' PHE . 1.5 tm? -111.03 -46.46 3.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.809 0.337 . . . . 0.0 111.366 -179.015 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.617 ' HB3' ' HA ' ' A' ' 101' ' ' LYS . 10.8 m120 -54.88 -38.82 68.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.653 -179.414 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.897 HD13 ' HA ' ' A' ' 90' ' ' GLU . 1.7 mp -92.88 -10.25 9.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.004 0.431 . . . . 0.0 110.231 179.18 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.513 ' HB2' ' O ' ' A' ' 91' ' ' LYS . 0.9 OUTLIER -67.68 -4.65 12.73 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.939 179.887 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 96' ' ' TRP . . . . . 0.772 ' HB2' ' HB2' ' A' ' 100' ' ' TRP . 60.7 m95 -84.58 32.87 0.51 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.668 0.27 . . . . 0.0 111.077 179.765 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.605 ' O ' ' HB2' ' A' ' 98' ' ' SER . . . 73.87 23.06 77.32 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.661 -179.917 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.605 ' HB2' ' O ' ' A' ' 97' ' ' GLY . 15.5 m 78.3 170.57 0.2 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.383 0.273 . . . . 0.0 110.901 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.593 ' HB2' ' O ' ' A' ' 98' ' ' SER . 1.1 m-20 75.79 -45.79 0.54 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.523 -179.69 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.772 ' HB2' ' HB2' ' A' ' 96' ' ' TRP . 29.3 m95 -72.4 -166.19 0.24 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.496 -179.694 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.617 ' HA ' ' HB3' ' A' ' 93' ' ' ASN . 0.0 OUTLIER 167.65 9.33 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.758 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 165.73 -156.4 28.31 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.934 -179.812 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.834 ' O ' ' HA ' ' A' ' 81' ' ' THR . 62.2 tt0 -148.68 113.83 5.51 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.748 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.685 ' HB2' HG22 ' A' ' 81' ' ' THR . . . -98.48 121.21 40.14 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.126 179.522 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.676 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 28.7 mt-30 -132.03 126.7 34.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.488 -178.663 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 13.3 ttmt -102.7 134.88 45.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.283 179.46 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.677 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 17.2 m95 -101.82 163.64 12.15 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.483 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.621 ' HB2' ' HE1' ' A' ' 110' ' ' PHE . 96.4 m-85 -141.36 153.12 44.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.207 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.652 HD12 ' O ' ' A' ' 20' ' ' CYS . 15.7 tp -99.7 139.03 35.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.942 179.628 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.821 ' CE2' HG22 ' A' ' 72' ' ' VAL . 41.6 m-85 -140.97 145.36 35.88 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.355 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.615 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 14.1 tttt -102.93 123.74 47.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.848 178.545 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.685 ' HB2' HD11 ' A' ' 21' ' ' LEU . 54.8 t80 -78.3 98.11 5.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.958 0.408 . . . . 0.0 110.454 179.124 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 43.7 p -95.9 41.62 1.1 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.622 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.413 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -143.67 -146.86 4.61 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.143 -179.68 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 115' ' ' GLN . . . . . 0.417 ' O ' ' HZ ' ' A' ' 112' ' ' PHE . 3.7 mm100 -124.02 149.02 46.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.987 0.422 . . . . 0.0 111.219 -179.626 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -58.47 -30.65 67.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.536 -179.494 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -59.65 -4.79 0.72 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.099 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -90.69 -20.28 22.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.023 0.44 . . . . 0.0 110.482 179.712 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.608 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 11.8 mt -83.97 106.56 14.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.426 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 5.4 t-20 -102.19 -25.29 13.75 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.954 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.672 HD23 HG22 ' A' ' 65' ' ' THR . 74.0 mt 74.62 -38.01 0.37 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.363 179.719 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.63 HD23 ' HB3' ' A' ' 129' ' ' PRO . 8.7 mt -76.96 168.42 20.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.92 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -111.28 -129.02 5.39 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.131 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -98.78 22.54 9.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.788 0.328 . . . . 0.0 111.082 179.827 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 57.29 81.02 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.547 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.85 -46.9 2.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.906 0.384 . . . . 0.0 110.878 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -147.36 -47.17 0.17 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.698 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.5 pttt -178.03 155.15 1.0 Allowed Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.053 179.031 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.63 ' HB3' HD23 ' A' ' 122' ' ' LEU . 27.8 Cg_endo -74.69 -178.41 4.05 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.899 2.399 . . . . 0.0 112.774 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.595 ' O ' HD12 ' A' ' 34' ' ' LEU . 0.6 OUTLIER -96.53 -65.17 0.98 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.002 -179.575 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.604 ' CB ' ' HB1' ' A' ' 31' ' ' ALA . 3.1 m-85 -102.25 140.71 36.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.171 0.51 . . . . 0.0 110.359 179.606 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.745 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -85.74 -35.79 11.17 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.922 -179.404 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.23 145.92 27.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.971 0.415 . . . . 0.0 110.439 179.823 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.608 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 36.4 p-90 -132.0 163.75 27.71 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.919 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.438 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 32.0 t -160.93 175.69 12.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.337 0.589 . . . . 0.0 111.987 -179.476 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.737 ' CE3' ' ND2' ' A' ' 23' ' ' ASN . 31.2 m95 -110.42 101.07 9.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.509 178.461 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 28' ' ' ILE . 28.4 m -116.43 164.8 12.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.899 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.598 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 17.4 p -71.33 170.22 12.51 Favored Pre-proline 0 C--N 1.324 -0.52 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.447 179.776 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.809 ' HB3' HD22 ' A' ' 158' ' ' LEU . 15.7 Cg_exo -59.86 -58.92 0.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.805 1.67 . . . . 0.0 110.335 179.149 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.9 -29.07 69.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.995 178.716 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.486 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.7 OUTLIER -72.47 -46.59 54.15 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.275 179.796 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.619 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.5 OUTLIER -57.47 -40.51 78.71 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.341 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.724 HG21 ' HG2' ' A' ' 155' ' ' LYS . 36.3 mm -60.6 -37.21 74.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.913 179.375 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.21 -49.79 39.79 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.232 0.539 . . . . 0.0 111.02 179.498 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.23 -21.07 59.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.433 -179.086 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.649 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 10.7 t -74.19 174.83 8.19 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.24 -179.481 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.629 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 33.3 m -85.01 146.01 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.461 -179.254 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.542 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 41.7 mt-10 -49.97 -50.89 45.33 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.364 -179.783 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -52.84 -7.17 0.07 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 148' ' ' GLU . 5.1 mttm -137.18 -4.44 1.9 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.64 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.575 ' HG2' ' O ' ' A' ' 143' ' ' ILE . 11.3 mttt -61.17 -59.11 14.77 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 121.279 -0.169 . . . . 0.0 110.972 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.542 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 22.4 Cg_endo -60.96 -28.83 86.9 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.407 2.072 . . . . 0.0 111.653 179.588 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.732 ' O ' HG23 ' A' ' 157' ' ' VAL . 30.5 t -68.61 -55.03 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.277 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.531 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 7.4 m-30 -61.65 -39.73 92.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.864 178.494 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.724 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -56.32 -43.79 79.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.922 -179.946 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.462 ' O ' HG23 ' A' ' 160' ' ' VAL . 2.7 tt0 -67.63 -31.69 71.88 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.568 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 153' ' ' VAL . 47.1 t -65.83 -41.34 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.651 178.729 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.809 HD22 ' HB3' ' A' ' 139' ' ' PRO . 64.0 mt -62.31 -47.01 86.15 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.023 -179.891 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.8 m -51.9 -38.75 57.43 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.878 HG11 ' HA ' ' A' ' 76' ' ' VAL . 92.6 t -68.21 -44.22 84.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.273 177.892 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.652 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 21.2 m-30 -79.67 4.3 16.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.901 -179.381 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.566 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.38 -54.96 50.97 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.649 179.692 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 17.4 Cg_endo -57.92 -12.74 12.97 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.024 1.816 . . . . 0.0 111.666 178.807 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 38.3 m80 -108.25 -16.25 14.29 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.437 -179.897 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 77.6 mt . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.712 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 112.348 -0.301 . . . . 0.0 112.348 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.06 165.96 1.12 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.389 2.059 . . . . 0.0 111.931 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.746 HD11 HG22 ' A' ' 153' ' ' VAL . 27.6 mt 61.46 -172.31 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.022 0.439 . . . . 0.0 111.192 179.941 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -154.28 49.11 0.5 Allowed Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.819 179.443 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.902 ' HB3' HD23 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -52.79 148.74 7.03 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.153 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 6' ' ' MET . . . . . 0.572 ' O ' ' HB2' ' A' ' 78' ' ' TYR . 0.0 OUTLIER -144.83 155.7 43.63 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.501 179.601 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.475 ' HA ' ' CB ' ' A' ' 78' ' ' TYR . 3.3 t0 -61.45 -55.45 31.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.051 -179.454 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.5 m -97.28 154.35 38.11 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.48 179.463 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.488 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 55.8 Cg_endo -70.26 106.6 1.78 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.279 1.986 . . . . 0.0 112.102 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.582 ' HG2' ' CD2' ' A' ' 13' ' ' TYR . 9.7 Cg_endo -52.74 163.33 1.98 Allowed 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 123.256 2.638 . . . . 0.0 113.177 -179.687 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -54.06 134.46 43.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.322 -0.853 . . . . 0.0 111.451 179.574 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 101' ' ' LYS . . . 51.2 88.13 0.01 OUTLIER Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.909 179.401 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.582 ' CD2' ' HG2' ' A' ' 10' ' ' PRO . 12.5 m-85 -154.63 125.52 7.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.674 0.273 . . . . 0.0 110.628 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ARG . . . . . 0.564 ' HA ' ' CZ3' ' A' ' 100' ' ' TRP . 17.2 ttt-85 -63.09 89.77 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.025 0.441 . . . . 0.0 110.499 179.743 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' ARG . . . . . 0.51 ' CG ' HD12 ' A' ' 47' ' ' ILE . 1.6 ttp180 -55.47 106.91 0.27 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.962 -179.776 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ASN . . . . . 0.781 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 3.1 m-80 -133.35 176.91 8.1 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.117 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.669 HG13 ' CG1' ' A' ' 47' ' ' ILE . 12.5 m -140.91 169.24 15.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.784 0.326 . . . . 0.0 111.299 179.494 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.573 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -134.84 162.85 24.76 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.779 -0.725 . . . . 0.0 112.264 179.423 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.95 HG21 HD22 ' A' ' 61' ' ' LEU . 3.9 mp -128.62 120.59 52.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -178.963 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.603 ' O ' HD12 ' A' ' 109' ' ' LEU . 29.6 t -107.01 98.02 7.73 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.916 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.788 HD22 HG11 ' A' ' 67' ' ' VAL . 4.7 tp -104.69 126.13 51.46 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.946 -178.488 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' MET . . . . . 0.502 ' CE ' HD13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -124.51 162.8 23.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.786 179.009 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.777 ' ND2' ' CE3' ' A' ' 136' ' ' TRP . 0.3 OUTLIER -98.89 171.25 8.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.205 179.78 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -56.7 -5.12 0.2 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.512 177.865 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' ASP . . . . . 0.508 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -98.21 3.7 48.93 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 120.781 0.324 . . . . 0.0 111.687 -179.111 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 15.1 mmtp 73.22 19.45 3.55 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.182 -178.611 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.6 OUTLIER -96.81 142.19 29.11 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.923 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.678 HD12 ' N ' ' A' ' 28' ' ' ILE . 2.7 mp -102.22 145.83 11.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.804 0.811 . . . . 0.0 112.648 -177.991 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.576 ' CE1' HD13 ' A' ' 119' ' ' ILE . 86.2 t80 -74.65 138.7 43.06 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.779 179.665 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.831 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -140.54 147.19 39.12 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.712 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.45 ' HB1' ' CB ' ' A' ' 131' ' ' PHE . . . -137.87 137.97 38.63 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.909 0.385 . . . . 0.0 111.039 -179.542 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.747 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 91.5 p -100.15 144.8 28.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.39 -179.665 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.472 ' HD3' ' CB ' ' A' ' 39' ' ' ALA . 5.2 mtp180 -70.06 126.48 29.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.74 179.579 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.717 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.7 OUTLIER -43.36 -34.81 1.34 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.361 0.6 . . . . 0.0 110.596 179.756 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -72.83 -41.5 64.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.858 179.614 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.419 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 17.4 mt -120.78 104.54 41.92 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.054 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -66.79 -21.62 50.76 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.728 2.285 . . . . 0.0 112.661 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -92.19 -4.96 53.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.464 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.747 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.52 92.26 7.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.605 0.241 . . . . 0.0 111.338 -179.734 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.628 ' O ' ' HA ' ' A' ' 146' ' ' THR . 81.5 m95 -89.07 144.65 25.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.325 179.194 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.07 162.38 36.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.259 0.552 . . . . 0.0 111.314 -179.486 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.533 ' HB3' ' CZ3' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -97.95 149.46 35.74 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.595 179.79 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 43' ' ' PRO . . . . . 0.475 ' CG ' HD13 ' A' ' 61' ' ' LEU . 5.1 Cg_endo -48.41 156.67 1.63 Allowed 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.533 2.155 . . . . 0.0 112.022 179.684 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.601 ' HA ' HD12 ' A' ' 19' ' ' ILE . 19.1 pt20 -176.4 -179.95 1.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.601 -179.657 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 170.49 157.3 12.39 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.191 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.74 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -82.84 137.23 16.33 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.339 -179.435 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.669 ' CG1' HG13 ' A' ' 17' ' ' VAL . 43.5 mt -69.58 142.35 16.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.827 0.346 . . . . 0.0 110.965 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -68.98 -174.27 0.58 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.662 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -48.5 -81.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.14 179.727 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.74 54.75 0.53 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.399 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -115.5 147.1 41.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.918 0.39 . . . . 0.0 110.963 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.09 164.36 53.22 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.469 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 5.9 Cg_exo -74.85 -46.61 0.24 Allowed 'Trans proline' 0 CA--C 1.516 -0.405 0 C-N-CA 122.762 2.308 . . . . 0.0 111.584 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.757 ' NH2' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -51.68 -46.02 63.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.807 179.851 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 3.7 m120 -65.14 -48.04 74.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.309 179.688 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.12 -43.2 99.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.861 179.472 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.507 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -59.15 -58.31 9.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.897 178.537 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.492 HD11 ' HG3' ' A' ' 54' ' ' ARG . 26.0 mt -56.93 -49.64 78.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.425 179.38 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.427 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 6.1 ttp180 -64.18 -63.63 1.1 Allowed 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.354 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -42.18 -43.62 3.42 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.957 0.408 . . . . 0.0 110.277 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.95 HD22 HG21 ' A' ' 19' ' ' ILE . 13.6 tp -51.77 -50.11 61.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.053 178.557 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.87 ' HG3' HG23 ' A' ' 68' ' ' THR . 1.1 ttt180 -63.01 -64.96 0.76 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.987 179.456 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -48.82 -25.37 1.84 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.768 -179.553 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -92.72 -40.19 10.84 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -178.522 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' THR . . . . . 0.729 HG22 HD23 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -121.44 -34.45 3.44 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.59 -179.233 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 106.42 -11.7 43.26 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.409 -178.874 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.788 HG11 HD22 ' A' ' 21' ' ' LEU . 32.4 t -57.22 111.44 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-O 121.111 0.481 . . . . 0.0 111.58 179.534 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' THR . . . . . 0.87 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.8 OUTLIER -122.71 -39.15 2.56 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.79 178.505 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.0 m -61.97 74.76 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.077 179.104 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -162.14 155.81 21.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.026 0.441 . . . . 0.0 111.963 -179.435 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -126.72 147.94 49.92 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.363 179.447 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.757 HG11 ' NH2' ' A' ' 54' ' ' ARG . 6.6 t -75.58 126.81 36.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.222 0.534 . . . . 0.0 111.425 179.334 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.54 HD11 ' HB2' ' A' ' 111' ' ' LYS . 0.8 OUTLIER -106.97 -20.77 5.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.28 179.537 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -169.81 177.92 4.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.647 -179.702 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -155.08 150.16 26.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.502 179.817 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.855 ' HA ' HG11 ' A' ' 160' ' ' VAL . 44.0 t -71.71 136.18 83.19 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.894 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.4 ' HD2' HG13 ' A' ' 76' ' ' VAL . 16.6 Cg_endo -55.06 -69.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.041 2.494 . . . . 0.0 112.138 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.572 ' HB2' ' O ' ' A' ' 6' ' ' MET . 0.1 OUTLIER -94.07 -172.45 2.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.666 -179.759 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 79' ' ' TRP . . . . . 0.48 ' NE1' ' HE2' ' A' ' 106' ' ' LYS . 29.2 m95 -90.06 -158.47 0.53 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 178.816 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.902 HD23 ' HB3' ' A' ' 5' ' ' SER . 57.8 mt -162.21 111.5 1.47 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -179.772 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' THR . . . . . 0.912 HG22 ' HA ' ' A' ' 104' ' ' ALA . 29.8 p -109.05 -166.43 1.11 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.557 -179.239 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -168.08 43.32 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.434 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.471 ' HB2' ' CE1' ' A' ' 13' ' ' TYR . 33.1 t70 -71.59 152.82 42.59 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.189 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' PHE . . . . . 0.636 ' CD2' HG11 ' A' ' 88' ' ' VAL . 3.3 m-85 -104.77 165.32 13.47 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 120.957 0.408 . . . . 0.0 111.878 -178.806 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.614 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 33.2 Cg_exo -61.57 174.17 2.34 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.971 2.447 . . . . 0.0 111.623 179.542 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 85' ' ' PRO . 10.9 Cg_endo -52.95 -37.83 78.64 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.657 2.238 . . . . 0.0 112.749 -179.774 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.18 -61.27 2.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.879 0.371 . . . . 0.0 110.586 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.636 HG11 ' CD2' ' A' ' 84' ' ' PHE . 52.5 t -68.13 -27.2 36.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.833 179.628 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' ARG . . . . . 0.725 ' HG3' ' CB ' ' A' ' 93' ' ' ASN . 3.1 tpp85 -50.59 -39.93 51.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.179 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.621 ' HA ' HD13 ' A' ' 94' ' ' ILE . 20.1 mt-10 -72.0 -20.31 61.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.237 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -98.89 -13.08 20.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.969 179.778 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.67 HD13 ' N ' ' A' ' 93' ' ' ASN . 1.1 tm? -121.21 -61.81 1.5 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.737 0.304 . . . . 0.0 111.584 -179.572 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.725 ' CB ' ' HG3' ' A' ' 89' ' ' ARG . 37.4 t-20 -55.91 -56.84 15.89 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.186 0.517 . . . . 0.0 111.303 -179.595 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' ILE . . . . . 0.621 HD13 ' HA ' ' A' ' 90' ' ' GLU . 2.9 mp -72.31 -10.07 13.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.514 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' GLN . . . . . 0.494 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 51.7 tt0 -66.33 -17.57 64.84 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.969 179.203 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -105.11 20.81 18.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.1 179.479 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 68.62 -75.95 0.29 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.344 -0.931 . . . . 0.0 111.707 -179.043 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 25.3 p -68.38 -170.18 0.18 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.158 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.418 ' C ' ' H ' ' A' ' 101' ' ' LYS . 0.6 OUTLIER -64.98 -85.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.003 -179.959 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.72 ' CE3' ' HA ' ' A' ' 100' ' ' TRP . 0.0 OUTLIER 73.82 -31.07 0.21 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.512 0.325 . . . . 0.0 111.761 -179.779 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 100' ' ' TRP . 0.6 OUTLIER 14.06 55.8 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -179.292 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 100' ' ' TRP . . . 101.01 -163.29 18.27 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.646 -0.787 . . . . 0.0 113.711 177.919 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.67 ' O ' ' HA ' ' A' ' 81' ' ' THR . 6.7 mt-30 -144.41 118.25 9.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.679 -0.261 . . . . 0.0 110.575 -179.742 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.912 ' HA ' HG22 ' A' ' 81' ' ' THR . . . -90.33 117.86 29.39 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.102 0.477 . . . . 0.0 109.948 179.52 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.781 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 43.1 mt-30 -128.14 128.32 44.62 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -177.518 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.48 ' HE2' ' NE1' ' A' ' 79' ' ' TRP . 19.8 ttmt -104.9 134.89 47.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.539 178.044 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' TRP . . . . . 0.593 ' HD1' HD12 ' A' ' 80' ' ' LEU . 32.6 m95 -102.91 162.8 12.63 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.073 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 108' ' ' PHE . . . . . 0.47 ' HB3' ' CE1' ' A' ' 110' ' ' PHE . 98.2 m-85 -138.44 153.0 48.85 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.866 -179.875 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 109' ' ' LEU . . . . . 0.603 HD12 ' O ' ' A' ' 20' ' ' CYS . 19.2 tp -108.78 122.45 47.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.876 179.528 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.732 ' CE1' HG22 ' A' ' 72' ' ' VAL . 8.8 m-85 -127.47 148.4 50.31 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.243 0.544 . . . . 0.0 111.689 179.912 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.56 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 33.2 tttt -98.59 124.81 43.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.428 178.343 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.661 ' HB2' HD11 ' A' ' 21' ' ' LEU . 46.6 t80 -78.43 102.01 7.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.85 0.357 . . . . 0.0 110.901 179.702 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.8 p -99.33 42.0 1.12 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.288 179.573 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.92 -149.13 5.14 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.727 -179.803 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.46 150.06 42.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.989 0.423 . . . . 0.0 111.243 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.458 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 4.1 p30 -58.05 -38.92 77.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.376 0.608 . . . . 0.0 111.272 -179.667 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.63 -3.07 0.16 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.981 -1.008 . . . . 0.0 112.381 -179.6 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -89.18 -18.63 26.74 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.051 0.453 . . . . 0.0 110.435 179.469 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.618 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 7.5 mt -86.81 107.24 16.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.962 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.547 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 7.9 p-10 -96.98 -22.67 16.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.222 -179.567 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.729 HD23 HG22 ' A' ' 65' ' ' THR . 47.6 mt 76.76 -34.75 0.22 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.743 179.618 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.473 ' CD2' ' HG3' ' A' ' 129' ' ' PRO . 78.3 mt -63.54 162.84 12.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.191 0.52 . . . . 0.0 111.585 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -169.47 3.51 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.187 0 CA-C-N 115.512 -0.767 . . . . 0.0 113.197 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.0 90.74 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.918 0.389 . . . . 0.0 111.027 -179.847 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -103.98 -133.35 7.83 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.463 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.9 t -94.85 -23.76 17.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.68 0.276 . . . . 0.0 111.252 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.426 ' O ' ' CG ' ' A' ' 128' ' ' LYS . 1.0 OUTLIER -146.91 -42.43 0.18 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.264 -179.867 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.808 ' HB3' ' HD2' ' A' ' 129' ' ' PRO . 55.8 mttt -162.4 167.01 13.02 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-O 121.189 0.519 . . . . 0.0 111.309 -178.679 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.808 ' HD2' ' HB3' ' A' ' 128' ' ' LYS . 6.3 Cg_endo -48.63 -172.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.616 2.877 . . . . 0.0 112.739 -179.827 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -101.33 -53.91 2.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.854 -179.76 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' PHE . . . . . 0.45 ' CB ' ' HB1' ' A' ' 31' ' ' ALA . 1.5 m-85 -108.88 141.6 40.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.874 0.369 . . . . 0.0 110.348 179.683 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.717 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -91.31 -30.84 10.27 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.387 -179.703 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.51 150.52 32.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.731 0.3 . . . . 0.0 110.598 179.501 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 134' ' ' TRP . . . . . 0.618 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 40.3 p-90 -137.78 168.74 19.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.089 179.532 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.451 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 27.2 t -163.5 174.32 11.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.392 0.615 . . . . 0.0 112.54 -178.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 136' ' ' TRP . . . . . 0.777 ' CE3' ' ND2' ' A' ' 23' ' ' ASN . 36.8 m95 -110.12 107.08 16.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.849 177.96 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.425 ' O ' ' N ' ' A' ' 28' ' ' ILE . 26.4 m -121.71 172.64 8.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.678 -179.711 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.577 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 25.3 p -74.08 171.36 11.29 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.812 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.676 ' HB3' HD22 ' A' ' 158' ' ' LEU . 9.2 Cg_exo -63.19 -54.55 1.04 Allowed 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 121.331 1.354 . . . . 0.0 109.851 178.999 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.68 -29.02 70.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.965 178.717 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.495 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 2.9 mt-30 -71.27 -46.46 60.88 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.933 0.397 . . . . 0.0 110.259 179.408 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 142' ' ' LEU . . . . . 0.831 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -57.5 -39.86 77.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.651 179.59 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.768 HG21 ' HG2' ' A' ' 155' ' ' LYS . 26.1 mm -62.31 -38.34 80.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.298 179.279 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.98 -51.44 32.51 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.349 0.595 . . . . 0.0 110.781 179.639 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.36 -21.24 61.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.713 -179.093 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 146' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 8.3 t -73.7 173.91 9.13 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.502 -179.108 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 147' ' ' VAL . . . . . 0.66 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 29.9 m -77.13 155.67 5.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.689 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.484 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 72.2 mt-10 -58.44 -55.74 31.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.151 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.66 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 29.5 p90 -56.01 -0.64 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -179.594 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.462 ' HD3' ' OH ' ' A' ' 154' ' ' TYR . 48.9 mttt -135.04 -7.85 2.33 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.83 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.524 ' HG2' ' HD3' ' A' ' 152' ' ' PRO . 0.1 OUTLIER -62.57 -56.72 27.25 Favored Pre-proline 0 C--N 1.328 -0.358 0 O-C-N 122.43 -0.169 . . . . 0.0 110.975 179.762 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.524 ' HD3' ' HG2' ' A' ' 151' ' ' LYS . 30.6 Cg_endo -64.56 -25.8 62.27 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.061 1.841 . . . . 0.0 111.149 179.197 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.764 ' O ' HG23 ' A' ' 157' ' ' VAL . 20.6 t -68.55 -50.9 51.87 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.456 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.462 ' OH ' ' HD3' ' A' ' 150' ' ' LYS . 9.0 m-30 -67.89 -36.67 80.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.975 178.664 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.768 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -58.53 -40.89 84.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.543 179.532 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.0 -35.7 74.58 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.91 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 157' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 153' ' ' VAL . 61.5 t -66.53 -39.85 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.695 178.821 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.676 HD22 ' HB3' ' A' ' 139' ' ' PRO . 27.7 mt -63.14 -42.4 99.46 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.556 179.741 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 67.3 m -54.38 -39.89 67.63 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.37 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 160' ' ' VAL . . . . . 0.855 HG11 ' HA ' ' A' ' 76' ' ' VAL . 95.1 t -67.71 -45.16 85.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.178 177.788 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 161' ' ' PHE . . . . . 0.612 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 22.0 m-30 -80.45 5.01 16.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.724 -178.748 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 162' ' ' ALA . . . . . 0.63 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.23 -52.02 77.45 Favored Pre-proline 0 C--N 1.328 -0.353 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.815 179.617 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 163' ' ' PRO . . . . . 0.63 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.2 Cg_endo -58.36 -11.75 11.69 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.328 2.019 . . . . 0.0 112.296 179.172 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -111.78 -18.21 12.78 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.4 -179.698 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 91.7 mt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.811 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 8.7 mtm . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.863 0.363 . . . . 0.0 110.771 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.718 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 5.6 t70 . . . . . 0 C--N 1.331 -0.219 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.465 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.597 ' CG ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.089 0 CA-C-O 121.096 0.474 . . . . 0.0 110.892 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.689 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 2.2 m-80 -132.88 175.01 9.73 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.414 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.597 HG13 ' CG1' ' A' ' 47' ' ' ILE . 4.2 m -142.62 164.96 16.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.252 0.549 . . . . 0.0 111.638 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.557 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -134.09 156.71 22.5 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.0 HG23 ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -128.98 122.24 56.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.321 0.581 . . . . 0.0 112.198 -179.156 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.2 t -101.17 110.7 22.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.296 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.802 HD21 ' HD1' ' A' ' 112' ' ' PHE . 61.7 tp -107.4 124.69 50.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.045 0.45 . . . . 0.0 111.727 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.665 ' SD ' HD11 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -117.77 142.91 46.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.876 -179.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.484 ' OD1' ' CH2' ' A' ' 136' ' ' TRP . 4.7 m-20 -96.85 -175.74 3.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.532 0.682 . . . . 0.0 111.34 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -56.06 -5.74 0.2 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.688 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.508 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 1.2 m-20 -103.47 -0.77 29.46 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 40.3 mmtt 71.7 24.82 3.38 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.608 ' HB3' ' O ' ' A' ' 137' ' ' VAL . 71.9 mttt -94.49 -177.55 4.27 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.923 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.847 HD11 ' HG3' ' A' ' 139' ' ' PRO . 1.8 mm -122.85 141.53 42.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.939 0.399 . . . . 0.0 111.39 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.734 ' HE2' HG21 ' A' ' 65' ' ' THR . 17.9 t80 -67.63 106.77 2.3 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.065 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.542 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . . . -103.77 138.47 40.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.021 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.52 ' HB1' ' CG ' ' A' ' 131' ' ' PHE . . . -138.06 138.73 39.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.277 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.542 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 47.9 p -100.6 148.13 25.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.021 0.438 . . . . 0.0 111.933 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.664 ' NE ' HD12 ' A' ' 36' ' ' ILE . 11.1 mtp85 -70.66 129.09 38.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.868 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.711 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.3 OUTLIER -55.49 56.44 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.381 0.425 . . . . 0.0 111.992 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.661 ' N ' ' O ' ' A' ' 33' ' ' ARG . 11.5 p-10 -177.35 -37.63 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.251 0.548 . . . . 0.0 109.815 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.664 HD12 ' NE ' ' A' ' 33' ' ' ARG . 18.8 mt -113.05 108.5 53.11 Favored Pre-proline 0 N--CA 1.454 -0.268 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.574 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.09 -18.26 21.34 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.485 2.123 . . . . 0.0 113.145 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -95.41 -9.49 32.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.748 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.59 ' HB1' ' CG1' ' A' ' 147' ' ' VAL . . . -92.53 91.71 7.72 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.897 0.379 . . . . 0.0 111.416 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.657 ' O ' ' HA ' ' A' ' 146' ' ' THR . 75.9 m95 -94.13 147.17 23.42 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.023 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.22 163.28 20.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.156 0.503 . . . . 0.0 111.452 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.41 ' HG3' ' CH2' ' A' ' 107' ' ' TRP . 1.0 OUTLIER -100.6 156.05 35.65 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.517 178.477 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.419 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 8.3 Cg_endo -49.97 152.73 7.06 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.441 2.094 . . . . 0.0 112.355 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -177.8 148.28 0.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.262 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.54 -160.66 10.09 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.654 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.689 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -120.2 142.44 16.03 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.602 -0.808 . . . . 0.0 113.243 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.597 ' CG1' HG13 ' A' ' 17' ' ' VAL . 30.2 mt -69.64 144.32 14.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.722 0.296 . . . . 0.0 111.168 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.17 -174.88 0.68 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.578 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -48.54 -59.85 3.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.13 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -132.64 59.79 0.68 Allowed Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.384 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' A' ' 52' ' ' ASP . 4.9 tp10 -118.26 155.64 30.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.825 0.345 . . . . 0.0 110.784 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.403 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -72.71 154.13 91.34 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.506 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.537 ' HA ' HG11 ' A' ' 17' ' ' VAL . 12.2 Cg_exo -70.86 -49.22 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.597 2.198 . . . . 0.0 111.427 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.668 ' HE ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -53.21 -45.36 68.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.326 179.58 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.528 ' HA ' HD12 ' A' ' 58' ' ' ILE . 2.9 m-20 -67.91 -44.11 77.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.193 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.46 93.04 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.0 ' HB1' HG23 ' A' ' 19' ' ' ILE . . . -58.01 -54.95 41.11 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.768 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.553 HD11 ' CZ ' ' A' ' 54' ' ' ARG . 14.1 mt -56.6 -53.01 46.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.185 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 59' ' ' ARG . 16.2 mtt-85 -60.85 -59.41 5.43 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.638 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -46.87 -44.7 19.8 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 121.3 0.572 . . . . 0.0 109.768 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.908 HD12 ' HB ' ' A' ' 19' ' ' ILE . 7.2 tt -51.01 -46.51 61.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.482 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.737 ' HG3' HG23 ' A' ' 68' ' ' THR . 10.2 ttt180 -65.04 -64.52 0.84 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.869 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -48.28 -20.46 0.39 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -97.29 -36.26 10.47 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.761 HG22 ' CD2' ' A' ' 121' ' ' LEU . 17.3 p -129.09 -8.16 4.85 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.38 -13.4 40.46 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.36 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.698 HG11 HD22 ' A' ' 21' ' ' LEU . 54.9 t -59.25 114.1 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-O 121.233 0.54 . . . . 0.0 111.207 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.737 HG23 ' HG3' ' A' ' 62' ' ' ARG . 1.0 OUTLIER -121.98 -38.77 2.68 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.915 179.028 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.464 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 10.4 m -61.55 74.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.614 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.64 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -157.47 156.09 31.49 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.086 0.47 . . . . 0.0 111.835 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -129.58 150.91 50.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.44 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.957 HG22 ' CE2' ' A' ' 110' ' ' PHE . 8.0 t -74.46 126.38 35.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.146 0.498 . . . . 0.0 111.363 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.564 HD11 ' N ' ' A' ' 111' ' ' LYS . 1.0 OUTLIER -107.0 -20.38 6.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.054 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.452 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.75 175.78 4.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.009 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -155.11 146.65 23.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.523 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.721 ' HA ' HG11 ' A' ' 160' ' ' VAL . 69.9 t -71.08 135.58 84.95 Favored Pre-proline 0 N--CA 1.453 -0.31 0 CA-C-O 121.002 0.43 . . . . 0.0 110.349 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.522 ' HD2' HG13 ' A' ' 76' ' ' VAL . 29.5 Cg_endo -63.69 -54.39 0.99 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.951 2.434 . . . . 0.0 112.586 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.718 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.8 OUTLIER -100.48 -179.23 4.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.695 -179.128 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.638 ' O ' HD23 ' A' ' 80' ' ' LEU . 44.9 m95 -92.62 -155.94 0.45 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.069 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.638 HD23 ' O ' ' A' ' 79' ' ' TRP . 80.6 mt . . . . . 0 N--CA 1.465 0.294 0 CA-C-O 120.818 0.342 . . . . 0.0 110.259 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.375 0 CA-C-O 121.051 0.453 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.679 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 3.7 mt-30 -125.42 129.71 50.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.406 -178.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.486 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 3.4 ttpt -104.35 135.55 45.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.375 178.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.557 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 53.9 m95 -103.04 161.87 13.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.318 0.58 . . . . 0.0 112.348 -178.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.531 ' HB2' ' HE1' ' A' ' 110' ' ' PHE . 96.3 m-85 -140.89 153.99 45.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.527 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.665 HD11 ' SD ' ' A' ' 22' ' ' MET . 10.5 tp -101.18 141.01 34.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.852 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.957 ' CE2' HG22 ' A' ' 72' ' ' VAL . 90.6 m-85 -143.16 145.57 32.94 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.64 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 56.4 tttt -103.4 124.83 49.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.94 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.802 ' HD1' HD21 ' A' ' 21' ' ' LEU . 41.1 t80 -78.87 96.04 5.57 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.743 0.306 . . . . 0.0 111.288 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 15.8 p -98.39 52.67 1.03 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.545 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -152.59 -146.35 4.34 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.526 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.16 147.41 46.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.131 0.491 . . . . 0.0 111.318 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -61.19 -27.72 68.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.163 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -56.7 -4.31 0.15 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.283 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -90.8 -16.97 27.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.889 0.376 . . . . 0.0 110.931 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.647 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 5.5 mt -84.13 98.41 5.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.171 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 47.8 p-10 -104.0 -8.51 19.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.015 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.761 ' CD2' HG22 ' A' ' 65' ' ' THR . 46.8 mt . . . . . 0 N--CA 1.466 0.368 0 CA-C-O 120.609 0.243 . . . . 0.0 111.545 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.766 0.317 . . . . 0.0 111.535 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.729 ' HB2' HD13 ' A' ' 121' ' ' LEU . 3.4 m-85 -105.37 146.45 29.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.086 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.711 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -92.62 -34.3 7.04 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.874 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -148.83 144.17 26.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.661 0.267 . . . . 0.0 110.98 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.647 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 47.2 p-90 -132.61 166.82 21.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.915 0.388 . . . . 0.0 111.546 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.6 t -160.73 178.7 9.2 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.894 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.484 ' CH2' ' OD1' ' A' ' 23' ' ' ASN . 86.2 m95 -114.41 100.99 8.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.723 178.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.608 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 19.9 m -118.67 164.89 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.052 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.537 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 23.2 p -72.3 166.32 42.66 Favored Pre-proline 0 C--N 1.328 -0.35 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.544 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.847 ' HG3' HD11 ' A' ' 28' ' ' ILE . 25.6 Cg_exo -58.2 -55.46 2.21 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.072 1.848 . . . . 0.0 110.668 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -63.58 -27.86 69.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.291 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.508 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.8 OUTLIER -72.73 -46.24 54.59 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.354 179.496 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.542 ' CD1' ' HB2' ' A' ' 30' ' ' ALA . 2.8 tp -58.32 -39.38 79.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.763 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 1.082 HG21 ' HD3' ' A' ' 155' ' ' LYS . 12.7 mm -62.57 -31.84 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.048 0.452 . . . . 0.0 110.417 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.62 -53.5 11.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.71 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.81 -19.14 61.39 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.803 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.657 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 14.2 t -73.87 175.32 7.41 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.424 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.59 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 34.3 m -85.05 144.28 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.649 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.473 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 2.7 mt-10 -48.13 -46.65 34.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.942 0.401 . . . . 0.0 111.351 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -52.7 -11.37 0.21 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 154' ' ' TYR . 31.9 mttm -132.57 -3.27 3.35 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -63.33 -55.46 35.72 Favored Pre-proline 0 C--N 1.326 -0.439 0 O-C-N 122.431 -0.168 . . . . 0.0 111.203 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 29.8 Cg_endo -64.96 -29.25 57.7 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.067 1.845 . . . . 0.0 111.719 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.61 ' O ' HG23 ' A' ' 157' ' ' VAL . 29.3 t -69.26 -51.54 42.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.495 ' HB2' ' CD1' ' A' ' 143' ' ' ILE . 7.4 m-30 -64.84 -37.19 86.78 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.84 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 1.082 ' HD3' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -56.22 -45.87 79.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.672 179.244 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.458 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.3 tt0 -67.68 -30.6 70.17 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 153' ' ' VAL . 90.8 t -68.57 -41.16 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.511 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.711 HD22 ' HB3' ' A' ' 139' ' ' PRO . 67.9 mt -64.56 -47.23 79.51 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.453 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.4 p -50.22 -42.48 51.72 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.721 HG11 ' HA ' ' A' ' 76' ' ' VAL . 98.7 t -65.43 -41.34 90.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.58 ' CD2' HD13 ' A' ' 109' ' ' LEU . 21.5 m-30 -81.82 5.75 17.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.933 -1.031 . . . . 0.0 112.933 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.621 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.88 -51.78 79.46 Favored Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.649 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.1 Cg_endo -60.05 -11.73 16.61 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.123 1.882 . . . . 0.0 111.996 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.452 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 95.7 m-70 -108.46 -19.19 13.54 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.366 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 96.8 mt . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.868 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.4 ' O ' ' HB2' ' A' ' 79' ' ' TRP . 8.4 mtm . . . . . 0 CA--C 1.524 -0.05 0 CA-C-O 120.665 0.269 . . . . 0.0 111.032 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.772 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 3.9 p-10 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.642 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.837 ' HG2' HD12 ' A' ' 47' ' ' ILE . 4.3 ttp180 . . . . . 0 CA--C 1.532 0.27 0 CA-C-O 121.02 0.438 . . . . 0.0 111.453 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.643 ' OD1' ' HG2' ' A' ' 105' ' ' GLN . 0.2 OUTLIER -134.89 173.39 11.76 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.993 179.241 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.861 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 33.6 m -132.12 160.33 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 CA-C-O 120.986 0.422 . . . . 0.0 111.917 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.621 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -127.08 148.22 17.27 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.26 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.908 HG21 HD22 ' A' ' 61' ' ' LEU . 2.8 mp -122.5 117.11 51.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.642 ' O ' HD12 ' A' ' 109' ' ' LEU . 43.9 t -101.04 99.7 10.19 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.723 HD22 HG11 ' A' ' 67' ' ' VAL . 21.2 tp -101.26 117.03 34.17 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.005 -177.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.566 ' HE2' HD13 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -119.98 160.1 23.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.795 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.633 ' ND2' ' HB2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -97.3 174.24 6.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.19 0.519 . . . . 0.0 110.416 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -57.59 -5.63 0.39 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.245 177.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.572 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.5 OUTLIER -99.39 3.5 45.91 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.709 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 5.8 mmtp 73.75 18.77 3.35 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.349 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.633 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 2.9 mttt -96.27 142.05 28.88 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.686 HD12 ' N ' ' A' ' 28' ' ' ILE . 2.5 mp -100.79 144.48 12.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.574 0.702 . . . . 0.0 112.063 -178.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.689 ' CE1' HD13 ' A' ' 119' ' ' ILE . 92.1 t80 -75.39 140.2 42.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.007 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.971 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -137.76 151.6 48.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.615 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.54 ' HB1' ' CB ' ' A' ' 131' ' ' PHE . . . -139.83 135.91 33.47 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.319 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.71 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 96.6 p -98.08 140.66 32.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.913 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.46 ' HD2' ' HB3' ' A' ' 39' ' ' ALA . 1.7 mtt-85 -67.65 127.84 34.24 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.849 0.357 . . . . 0.0 110.767 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.711 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.6 OUTLIER -45.88 -34.88 4.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.295 0.569 . . . . 0.0 110.458 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -71.47 -38.3 71.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.139 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.408 ' N ' ' O ' ' A' ' 33' ' ' ARG . 31.3 mm -125.41 108.94 26.53 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.98 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.3 -18.51 23.24 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.578 2.185 . . . . 0.0 112.862 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -92.2 -12.24 33.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.664 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.909 ' HB1' ' CG1' ' A' ' 147' ' ' VAL . . . -91.48 104.98 17.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.759 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.549 ' O ' ' HA ' ' A' ' 146' ' ' THR . 75.6 m95 -96.82 152.49 18.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.632 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.53 ' HG3' ' C ' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -158.18 160.99 37.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.475 0.655 . . . . 0.0 111.927 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.633 ' HG3' HD11 ' A' ' 142' ' ' LEU . 13.4 mtm -98.87 155.04 37.07 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.092 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.874 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 51.4 Cg_exo -50.74 144.94 24.81 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.23 1.954 . . . . 0.0 112.087 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.861 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -170.57 141.62 1.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.079 -179.503 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.569 ' O ' ' HB2' ' A' ' 16' ' ' ASN . . . -148.71 -173.41 19.46 Favored Glycine 0 C--O 1.224 -0.471 0 N-CA-C 111.446 -0.661 . . . . 0.0 111.446 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.578 ' HA2' ' CB ' ' A' ' 16' ' ' ASN . . . -95.82 -154.32 30.46 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.508 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.837 HD12 ' HG2' ' A' ' 15' ' ' ARG . 1.7 mt -163.12 125.53 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 122.535 0.334 . . . . 0.0 110.736 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.27 172.41 12.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.995 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.455 ' HG3' ' H ' ' A' ' 50' ' ' GLY . 1.8 pt-20 -46.92 -76.66 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.61 -179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.455 ' H ' ' HG3' ' A' ' 49' ' ' GLU . . . -85.17 34.49 3.24 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.963 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.708 ' OE1' ' HB2' ' A' ' 56' ' ' ALA . 4.8 tm-20 -113.19 123.94 51.37 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.545 ' HB2' ' OD1' ' A' ' 55' ' ' ASN . 1.8 m-20 -70.59 158.69 87.25 Favored Pre-proline 0 C--N 1.326 -0.439 0 C-N-CA 120.62 -0.432 . . . . 0.0 109.857 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.557 ' CA ' HG11 ' A' ' 17' ' ' VAL . 6.8 Cg_exo -74.19 -50.11 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.874 2.383 . . . . 0.0 113.463 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.835 ' CZ ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -49.52 -45.2 47.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.267 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.545 ' OD1' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -67.67 -44.79 76.98 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.053 0.454 . . . . 0.0 110.321 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.708 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . . . -58.72 -41.73 87.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.686 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.774 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -57.64 -56.77 17.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.2 0.524 . . . . 0.0 109.639 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.631 HG12 ' HE2' ' A' ' 110' ' ' PHE . 26.9 mt -54.38 -53.78 27.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.26 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.559 ' HA ' HH11 ' A' ' 59' ' ' ARG . 0.0 OUTLIER -62.11 -60.06 4.15 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.82 -179.246 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.439 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 16.6 mm-40 -46.21 -49.85 16.54 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.908 HD22 HG21 ' A' ' 19' ' ' ILE . 9.7 tp -49.74 -44.56 48.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.34 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.843 ' HD3' HG23 ' A' ' 68' ' ' THR . 21.9 tpt85 -63.85 -65.44 0.68 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.491 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.4 ' OE2' ' HB3' ' A' ' 59' ' ' ARG . 0.8 OUTLIER -49.22 -22.62 1.06 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -179.15 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -97.21 -32.71 11.79 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -177.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 119' ' ' ILE . 5.6 p -127.65 -6.28 5.74 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.483 ' HA2' ' HD2' ' A' ' 62' ' ' ARG . . . 79.36 -14.36 16.81 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.08 -1.057 . . . . 0.0 111.561 -178.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.723 HG11 HD22 ' A' ' 21' ' ' LEU . 78.7 t -58.55 117.25 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 121.11 0.481 . . . . 0.0 111.682 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.843 HG23 ' HD3' ' A' ' 62' ' ' ARG . 0.3 OUTLIER -128.26 -38.96 1.74 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.457 178.003 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.1 m -62.41 73.44 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.941 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.16 155.31 22.7 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.866 0.365 . . . . 0.0 111.957 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.436 ' HG3' HG21 ' A' ' 113' ' ' THR . 1.7 mt-10 -128.62 151.34 49.6 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.573 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.835 HG21 ' CZ ' ' A' ' 54' ' ' ARG . 12.2 t -75.07 126.71 36.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.405 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.657 HD11 ' HB2' ' A' ' 111' ' ' LYS . 1.4 mt -106.71 -19.32 6.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.31 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.505 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -171.05 175.73 4.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.606 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.9 OUTLIER -153.17 143.73 22.62 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.256 179.4 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.786 ' HA ' HG11 ' A' ' 160' ' ' VAL . 38.6 t -70.52 131.97 87.79 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 120.937 0.399 . . . . 0.0 111.087 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.488 ' HD2' HG11 ' A' ' 160' ' ' VAL . 34.4 Cg_endo -65.13 -50.74 1.9 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.057 2.505 . . . . 0.0 112.987 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.772 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 3.1 p90 -100.07 177.43 5.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.983 0.421 . . . . 0.0 111.931 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.632 ' CH2' ' HG3' ' A' ' 15' ' ' ARG . 58.7 m95 -94.2 -163.44 1.05 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.727 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.596 HD23 ' O ' ' A' ' 79' ' ' TRP . 15.9 mt . . . . . 0 N--CA 1.463 0.196 0 CA-C-O 121.055 0.455 . . . . 0.0 110.626 -179.264 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.454 ' O ' ' ND2' ' A' ' 16' ' ' ASN . . . . . . . . 0 CA--C 1.515 -0.402 0 CA-C-O 121.247 0.546 . . . . 0.0 110.642 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.643 ' HG2' ' OD1' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -125.43 119.4 28.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.432 -177.412 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.619 ' HE2' ' CE2' ' A' ' 79' ' ' TRP . 2.0 ttmm -104.17 134.4 47.48 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.621 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 16.0 m95 -101.68 164.67 11.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.279 0.561 . . . . 0.0 112.303 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.586 ' HB2' ' HE1' ' A' ' 110' ' ' PHE . 95.9 m-85 -140.05 153.18 46.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.09 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.642 HD12 ' O ' ' A' ' 20' ' ' CYS . 16.5 tp -101.24 141.04 34.69 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.844 0.354 . . . . 0.0 110.983 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.809 ' CE2' HG22 ' A' ' 72' ' ' VAL . 45.7 m-85 -142.43 145.77 34.13 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.594 0.712 . . . . 0.0 112.759 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.657 ' HB2' HD11 ' A' ' 73' ' ' ILE . 8.6 tttt -104.88 122.82 46.58 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.065 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.669 ' HD2' HD21 ' A' ' 21' ' ' LEU . 36.5 t80 -77.23 95.81 4.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.99 0.424 . . . . 0.0 110.709 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.436 HG21 ' HG3' ' A' ' 71' ' ' GLU . 28.5 p -95.77 55.27 1.61 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.917 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -159.64 -140.99 3.02 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.678 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.541 ' HG3' ' CG ' ' A' ' 117' ' ' GLN . 0.7 OUTLIER -125.81 147.61 49.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.785 0.326 . . . . 0.0 110.948 179.627 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.513 ' HB3' ' CH2' ' A' ' 134' ' ' TRP . 85.7 m-20 -62.1 -28.18 69.45 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.541 ' CG ' ' HG3' ' A' ' 115' ' ' GLN . 0.2 OUTLIER -57.65 -5.09 0.33 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.218 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -88.0 -17.66 30.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.017 0.436 . . . . 0.0 110.602 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.689 HD13 ' CE1' ' A' ' 29' ' ' PHE . 9.1 mt -81.09 105.26 10.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.393 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.423 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 23.9 t30 -104.27 -26.26 12.56 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.695 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.481 HD22 ' HD2' ' A' ' 131' ' ' PHE . 63.5 mt . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.12 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.512 ' O ' HD12 ' A' ' 34' ' ' LEU . 4.5 mp0 . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.954 0.407 . . . . 0.0 110.854 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.54 ' CB ' ' HB1' ' A' ' 31' ' ' ALA . 2.7 m-85 -104.8 142.74 34.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.144 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.711 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -83.72 -36.25 14.27 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.709 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -151.31 154.18 36.24 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.22 -0.49 . . . . 0.0 110.6 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.553 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 23.8 p-90 -135.25 166.79 22.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.825 0.345 . . . . 0.0 111.116 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.449 ' N ' ' HZ3' ' A' ' 40' ' ' TRP . 29.9 t -161.24 163.22 31.17 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.346 0.593 . . . . 0.0 111.657 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.56 ' CZ3' ' HB2' ' A' ' 29' ' ' PHE . 77.2 m95 -110.46 108.32 18.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.054 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' A' ' 28' ' ' ILE . 34.0 m -123.31 173.72 8.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.861 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.561 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 15.2 p -72.97 172.47 7.84 Favored Pre-proline 0 C--N 1.323 -0.571 0 C-N-CA 120.449 -0.501 . . . . 0.0 109.885 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.709 ' HB3' HD22 ' A' ' 158' ' ' LEU . 13.4 Cg_exo -61.75 -55.25 1.18 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.427 1.418 . . . . 0.0 110.314 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.1 -30.81 71.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.066 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -69.86 -48.55 58.41 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.87 0.367 . . . . 0.0 110.153 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.971 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -54.43 -41.17 69.07 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.429 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.596 HG21 ' HD3' ' A' ' 155' ' ' LYS . 28.3 mm -60.13 -36.87 70.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.936 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.56 -52.28 22.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.41 0.624 . . . . 0.0 111.037 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.4 mp -70.85 -24.88 62.6 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.849 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 5.2 t -71.8 169.5 15.6 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.539 0.685 . . . . 0.0 111.825 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.909 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 33.8 m -74.3 154.69 6.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.846 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.504 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 0.4 OUTLIER -60.91 -54.59 43.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.071 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.446 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 39.9 p90 -57.07 0.63 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.422 ' HE3' HH22 ' A' ' 33' ' ' ARG . 13.6 mmtt -133.77 -7.7 2.79 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 122.032 -0.417 . . . . 0.0 111.873 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.496 ' HG3' HG23 ' A' ' 143' ' ' ILE . 0.4 OUTLIER -62.03 -59.24 13.69 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.276 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.504 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 19.2 Cg_endo -59.5 -28.54 87.73 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.347 2.031 . . . . 0.0 111.337 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.791 ' O ' HG23 ' A' ' 157' ' ' VAL . 24.4 t -68.81 -50.69 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.422 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 7.6 m-30 -66.0 -38.01 87.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.875 178.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.596 ' HD3' HG21 ' A' ' 143' ' ' ILE . 4.8 tptp -56.3 -43.36 78.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.393 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.492 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.3 tp10 -68.17 -34.4 76.24 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 153' ' ' VAL . 58.5 t -66.01 -41.0 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.615 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.709 HD22 ' HB3' ' A' ' 139' ' ' PRO . 38.3 mt -63.8 -45.33 90.15 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.621 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 28.4 t -53.96 -40.0 66.45 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.786 HG11 ' HA ' ' A' ' 76' ' ' VAL . 62.0 t -67.73 -41.44 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-O 121.491 0.662 . . . . 0.0 109.309 178.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.605 ' CE2' HG12 ' A' ' 157' ' ' VAL . 21.9 m-30 -80.74 4.72 18.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.354 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.62 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.44 -52.45 74.52 Favored Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.604 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.4 Cg_endo -58.48 -13.05 15.55 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.177 1.918 . . . . 0.0 111.603 178.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.505 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 94.5 m-70 -107.85 -19.33 13.56 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.125 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 98.0 mt . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.624 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.9 mmt . . . . . 0 C--O 1.232 0.175 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.0 t70 . . . . . 0 C--N 1.323 -0.544 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.501 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.496 ' HG3' HD12 ' A' ' 47' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.454 -0.235 0 N-CA-C 110.233 -0.284 . . . . 0.0 110.233 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.986 ' HB2' ' HG2' ' A' ' 105' ' ' GLN . 0.7 OUTLIER -134.05 -178.83 5.21 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.553 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.657 HG21 ' N ' ' A' ' 57' ' ' ALA . 23.8 m -140.59 166.63 18.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.348 0.594 . . . . 0.0 111.768 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.572 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -131.33 161.38 23.6 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 178.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.023 HG21 HD22 ' A' ' 61' ' ' LEU . 3.6 mp -128.64 119.19 49.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.008 0.432 . . . . 0.0 112.04 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.455 ' O ' HD12 ' A' ' 109' ' ' LEU . 10.2 t -104.25 105.0 15.0 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.845 HD22 HG11 ' A' ' 67' ' ' VAL . 13.1 tp -108.28 122.28 46.64 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.789 -178.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.769 ' HE1' HD13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -119.37 163.31 17.38 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.818 179.455 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.803 ' ND2' ' HB2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -99.85 168.67 9.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.435 179.818 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.645 ' HA ' ' HE2' ' A' ' 111' ' ' LYS . 71.2 m-20 -56.33 -4.88 0.16 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.021 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.511 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 1.2 m-20 -100.06 2.61 43.45 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.795 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.586 ' NZ ' ' HA ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER 73.91 21.64 2.61 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.173 -178.376 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.803 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -93.86 145.62 24.48 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.045 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.778 HG13 ' HA ' ' A' ' 139' ' ' PRO . 1.5 mm -100.51 139.11 22.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.465 0.65 . . . . 0.0 111.994 -178.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.662 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 82.2 t80 -79.21 140.27 37.73 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.109 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 1.014 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -143.71 157.97 44.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.046 0.451 . . . . 0.0 111.033 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.566 ' HB1' ' CB ' ' A' ' 131' ' ' PHE . . . -146.51 138.93 25.08 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.996 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.635 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 60.7 p -99.8 147.99 24.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.297 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.653 ' O ' ' N ' ' A' ' 35' ' ' ASP . 18.2 mtp180 -69.75 129.01 38.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.403 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.805 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.3 OUTLIER -54.96 55.31 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.653 ' N ' ' O ' ' A' ' 33' ' ' ARG . 23.0 t70 -177.4 -28.42 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.87 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.479 HG13 ' CZ ' ' A' ' 33' ' ' ARG . 25.5 mm -119.21 110.65 37.56 Favored Pre-proline 0 N--CA 1.455 -0.181 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.606 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -75.67 -20.28 15.72 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.633 2.222 . . . . 0.0 112.905 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.36 -8.49 32.37 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.635 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.8 104.09 16.38 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 120.616 0.246 . . . . 0.0 110.881 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.714 ' O ' ' HA ' ' A' ' 146' ' ' THR . 65.9 m95 -105.89 144.6 32.39 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.909 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.591 ' HG3' ' C ' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -156.92 161.62 39.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.487 0.66 . . . . 0.0 111.622 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.555 ' HB3' ' CZ3' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -96.82 152.87 38.71 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.36 179.062 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.632 ' HG3' HD13 ' A' ' 61' ' ' LEU . 5.1 Cg_endo -48.61 158.74 1.02 Allowed 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.197 2.598 . . . . 0.0 111.976 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.604 ' HA ' HD12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -178.82 -179.67 0.63 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.453 0.168 . . . . 0.0 111.084 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.639 ' HA3' ' HG2' ' A' ' 60' ' ' GLU . . . 164.4 155.79 8.56 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.696 -0.764 . . . . 0.0 113.11 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.724 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -76.66 132.09 12.09 Favored Glycine 0 C--N 1.334 0.431 0 N-CA-C 114.702 0.641 . . . . 0.0 114.702 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.676 HG12 ' HA ' ' A' ' 53' ' ' PRO . 2.9 mt -68.93 145.83 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.406 -0.397 . . . . 0.0 110.464 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -67.51 -173.12 0.28 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.171 0.51 . . . . 0.0 111.144 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.465 ' HG2' ' H ' ' A' ' 50' ' ' GLY . 1.4 pm0 -50.16 -82.45 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.282 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.465 ' H ' ' HG2' ' A' ' 49' ' ' GLU . . . -109.76 54.6 0.54 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.083 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -115.16 154.61 28.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.096 0.474 . . . . 0.0 110.363 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.473 ' HB2' ' ND2' ' A' ' 55' ' ' ASN . 0.6 OUTLIER -70.44 156.39 91.97 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.805 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.676 ' HA ' HG12 ' A' ' 47' ' ' ILE . 2.7 Cg_exo -74.88 -53.22 0.1 Allowed 'Trans proline' 0 CA--C 1.507 -0.843 0 C-N-CA 122.702 2.268 . . . . 0.0 112.217 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.608 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -48.18 -52.98 18.48 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.925 179.309 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.535 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 1.2 m-20 -53.75 -46.49 70.91 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.002 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 60' ' ' GLU . . . -60.01 -42.34 94.07 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.657 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -59.07 -61.91 2.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.494 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.608 ' CD1' ' O ' ' A' ' 54' ' ' ARG . 3.3 mp -55.88 -46.51 80.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.497 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.535 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 0.7 OUTLIER -63.14 -63.1 1.29 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.44 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.639 ' HG2' ' HA3' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -42.8 -46.35 5.17 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 120.944 0.402 . . . . 0.0 110.045 179.38 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.023 HD22 HG21 ' A' ' 19' ' ' ILE . 12.0 tp -50.05 -47.75 53.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.153 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.867 ' HG3' HG23 ' A' ' 68' ' ' THR . 40.0 ttp180 -64.77 -62.25 1.68 Allowed 'General case' 0 CA--C 1.523 -0.091 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.415 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -51.61 -20.41 1.98 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.806 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -100.62 -36.85 9.01 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.668 ' O ' ' HA ' ' A' ' 119' ' ' ILE . 2.3 p -127.23 1.97 6.41 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 70.15 -11.82 1.94 Allowed Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.375 -178.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.845 HG11 HD22 ' A' ' 21' ' ' LEU . 75.2 t -58.14 109.72 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-O 121.198 0.523 . . . . 0.0 111.422 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.867 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.6 OUTLIER -121.75 -41.3 2.47 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.898 178.495 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.437 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 7.4 m -60.75 74.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.692 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.561 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.43 153.36 19.5 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.992 0.425 . . . . 0.0 112.097 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -124.4 148.23 47.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.237 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.773 HG22 ' CE1' ' A' ' 110' ' ' PHE . 20.3 t -76.04 126.59 36.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.956 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.769 HD13 ' HE1' ' A' ' 22' ' ' MET . 0.6 OUTLIER -109.25 -19.08 7.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.276 179.074 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.433 ' HB3' ' HB3' ' A' ' 109' ' ' LEU . . . -169.78 176.73 4.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.214 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.9 OUTLIER -162.74 149.24 12.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.885 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.746 ' HA ' HG11 ' A' ' 160' ' ' VAL . 41.5 t -71.64 140.59 84.33 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.293 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.618 ' HD2' HG13 ' A' ' 76' ' ' VAL . 32.6 Cg_endo -64.91 -72.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.931 2.421 . . . . 0.0 113.424 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.423 ' HE1' HD21 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -85.18 176.34 8.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.197 0.522 . . . . 0.0 111.74 -178.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.485 ' HH2' HD13 ' A' ' 47' ' ' ILE . 29.8 m95 -93.27 109.28 20.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.652 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.453 HD11 ' OE1' ' A' ' 156' ' ' GLU . 39.4 mt . . . . . 0 C--N 1.326 -0.456 0 CA-C-O 120.808 0.337 . . . . 0.0 111.329 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.254 0 CA-C-O 121.004 0.43 . . . . 0.0 110.723 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.986 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 70.0 mt-30 -122.48 130.61 53.24 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.476 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 1.1 ttpp -105.5 131.02 53.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.915 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.572 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 20.5 m95 -102.23 163.07 12.44 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.543 ' CE2' ' HG3' ' A' ' 54' ' ' ARG . 92.6 m-85 -140.69 148.5 40.89 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.235 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.632 HD22 ' HB3' ' A' ' 161' ' ' PHE . 18.8 tp -102.4 128.68 48.89 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.922 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.905 ' CE2' HG23 ' A' ' 19' ' ' ILE . 7.7 m-85 -134.54 148.25 50.45 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 121.314 0.578 . . . . 0.0 112.156 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.645 ' HE2' ' HA ' ' A' ' 24' ' ' ASN . 2.1 tttt -98.75 126.12 44.28 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.933 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.753 ' HD2' HD21 ' A' ' 21' ' ' LEU . 33.8 t80 -78.12 96.43 5.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.14 0.495 . . . . 0.0 110.512 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 82.4 p -96.65 50.01 1.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.672 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.437 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -155.37 -144.13 3.84 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.553 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.419 ' N ' ' HE1' ' A' ' 112' ' ' PHE . 8.0 pt20 -123.85 151.42 43.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.115 0.483 . . . . 0.0 111.564 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -62.36 -25.01 67.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.299 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -59.92 -4.97 0.83 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.946 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -91.16 -17.8 25.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.98 0.419 . . . . 0.0 110.613 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.668 ' HA ' ' O ' ' A' ' 65' ' ' THR . 8.8 mt -81.05 104.2 9.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.937 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 2.3 t30 -102.18 -26.52 13.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.055 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.641 HD23 HG22 ' A' ' 65' ' ' THR . 61.7 mt . . . . . 0 N--CA 1.466 0.369 0 CA-C-O 120.842 0.353 . . . . 0.0 111.667 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.53 0.197 0 CA-C-O 120.584 0.231 . . . . 0.0 111.439 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.566 ' CB ' ' HB1' ' A' ' 31' ' ' ALA . 4.2 m-85 -114.7 140.72 48.63 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.312 0.577 . . . . 0.0 111.473 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.805 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -80.81 -35.85 23.88 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.754 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -153.75 153.78 32.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.963 0.411 . . . . 0.0 110.66 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.571 ' HD1' HD11 ' A' ' 121' ' ' LEU . 32.6 p-90 -135.18 166.04 24.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.093 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.432 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 13.2 t -161.45 166.95 26.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.097 0.475 . . . . 0.0 111.847 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.662 ' CZ3' ' HB2' ' A' ' 29' ' ' PHE . 53.7 m95 -109.31 103.57 12.54 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.344 178.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.484 ' O ' ' N ' ' A' ' 28' ' ' ILE . 28.5 m -117.56 168.96 8.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.5 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.597 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 11.3 p -71.43 170.63 11.15 Favored Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.965 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.778 ' HA ' HG13 ' A' ' 28' ' ' ILE . 24.4 Cg_exo -57.7 -58.89 0.67 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 121.957 1.772 . . . . 0.0 109.841 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.8 -29.86 69.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.624 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -70.73 -48.4 54.71 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 120.934 0.397 . . . . 0.0 110.656 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 1.014 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -54.6 -41.97 70.55 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.745 ' CG2' ' HG3' ' A' ' 151' ' ' LYS . 24.3 mm -61.73 -33.92 59.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.255 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.78 -51.54 16.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.377 0.608 . . . . 0.0 110.321 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.42 -21.23 62.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.696 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.714 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 14.7 t -73.45 175.36 7.06 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.717 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.713 ' CG2' ' HD2' ' A' ' 150' ' ' LYS . 34.0 m -86.05 148.26 4.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.655 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.541 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 2.1 mt-10 -48.31 -50.32 30.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.467 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.3 -4.24 0.08 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.713 ' HD2' ' CG2' ' A' ' 147' ' ' VAL . 18.7 mttt -136.51 -7.14 1.96 Allowed 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.745 ' HG3' ' CG2' ' A' ' 143' ' ' ILE . 2.7 ttpp -62.99 -54.34 47.41 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.35 0.119 . . . . 0.0 110.816 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.541 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 38.0 Cg_endo -66.38 -29.44 45.71 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.435 2.09 . . . . 0.0 110.989 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.801 ' O ' HG23 ' A' ' 157' ' ' VAL . 9.3 t -68.1 -55.91 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.55 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 4.6 m-30 -63.09 -37.4 87.05 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.581 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.741 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -55.78 -45.34 78.17 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.441 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.548 ' O ' HG23 ' A' ' 160' ' ' VAL . 12.8 tm-20 -67.49 -34.58 77.43 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 153' ' ' VAL . 47.9 t -63.35 -42.1 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.546 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.593 HD22 ' HB3' ' A' ' 139' ' ' PRO . 36.0 mt -63.91 -43.92 94.5 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.883 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.9 m -56.85 -39.31 74.05 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.746 HG11 ' HA ' ' A' ' 76' ' ' VAL . 76.1 t -67.54 -42.4 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.664 ' CE2' HG12 ' A' ' 157' ' ' VAL . 18.8 m-30 -81.24 7.13 12.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.089 -0.959 . . . . 0.0 112.006 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.553 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.97 -54.9 51.9 Favored Pre-proline 0 C--N 1.332 -0.169 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.178 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 15.9 Cg_endo -57.58 -12.94 12.4 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 121.825 1.683 . . . . 0.0 111.768 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.431 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 78.4 m-70 -107.46 -17.25 14.17 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.237 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 98.2 mt . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.586 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 5.1 mpp? . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.827 0.346 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.651 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 1.5 p30 . . . . . 0 C--N 1.329 -0.296 0 CA-C-O 120.983 0.42 . . . . 0.0 110.353 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.808 ' HG2' HD12 ' A' ' 47' ' ' ILE . 4.7 ttp180 . . . . . 0 N--CA 1.462 0.152 0 CA-C-O 121.103 0.478 . . . . 0.0 111.967 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.737 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 2.1 m-80 -131.66 176.39 8.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.395 -0.82 . . . . 0.0 108.96 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.663 HG13 ' CG1' ' A' ' 47' ' ' ILE . 6.2 m -144.1 166.15 13.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.794 0.33 . . . . 0.0 111.389 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.487 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -136.4 160.24 24.68 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.144 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.679 HG13 ' HB1' ' A' ' 57' ' ' ALA . 3.6 mp -129.23 119.36 48.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.043 0.449 . . . . 0.0 111.536 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.69 ' O ' HD12 ' A' ' 109' ' ' LEU . 3.0 t -98.29 92.73 5.85 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.182 -0.674 . . . . 0.0 109.182 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.688 HD22 HG11 ' A' ' 67' ' ' VAL . 39.2 tp -91.01 123.32 34.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.741 -178.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.765 ' CG ' HD11 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -117.46 152.57 34.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.126 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.61 ' OD1' ' CE3' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -97.66 174.9 6.4 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.507 -179.321 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -56.76 -6.11 0.29 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.769 177.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.526 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -101.25 -1.7 33.03 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.631 0.253 . . . . 0.0 111.43 -179.151 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 6.1 mmpt? 75.6 21.72 1.69 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.106 -178.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.674 ' O ' ' HA ' ' A' ' 22' ' ' MET . 6.0 mttt -91.59 175.65 6.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.693 HD11 ' HG3' ' A' ' 139' ' ' PRO . 1.8 mm -118.77 138.12 50.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.131 0.491 . . . . 0.0 111.756 -178.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.536 ' CZ ' HG21 ' A' ' 65' ' ' THR . 9.9 t80 -63.72 101.62 0.37 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.181 178.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.669 ' HA ' ' O ' ' A' ' 41' ' ' GLN . . . -97.86 137.37 36.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.935 0.398 . . . . 0.0 111.315 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.449 ' HB1' ' CG ' ' A' ' 131' ' ' PHE . . . -137.64 139.86 40.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.331 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.604 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 60.1 p -104.47 150.59 24.43 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.619 ' O ' ' N ' ' A' ' 35' ' ' ASP . 4.9 mtp180 -74.55 129.93 38.64 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.309 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.715 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -56.89 52.71 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.883 0.473 . . . . 0.0 112.211 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.619 ' N ' ' O ' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -174.97 -37.03 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.054 0.454 . . . . 0.0 110.18 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.576 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 3.8 mm -112.09 106.23 56.24 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.739 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.53 -60.14 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.07 2.513 . . . . 0.0 113.895 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -67.9 2.87 1.76 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.604 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.85 93.24 8.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.749 0.309 . . . . 0.0 111.454 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.55 ' O ' ' HA ' ' A' ' 146' ' ' THR . 76.4 m95 -98.68 155.04 17.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.089 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.669 ' O ' ' HA ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -162.72 -139.35 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.976 -0.289 . . . . 0.0 111.002 -178.564 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.583 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 4.9 ptt? -176.91 163.36 1.56 Allowed Pre-proline 0 N--CA 1.446 -0.671 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.871 ' HG3' HD13 ' A' ' 61' ' ' LEU . 2.9 Cg_endo -38.22 130.24 1.0 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.276 2.651 . . . . 0.0 113.342 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.599 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 1.7 tm0? -174.23 141.65 0.75 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.118 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -161.49 -156.45 8.33 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.472 -0.871 . . . . 0.0 112.387 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.71 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -118.24 138.94 14.24 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.03 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.808 HD12 ' HG2' ' A' ' 15' ' ' ARG . 46.2 mt -69.49 145.03 13.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.864 0.364 . . . . 0.0 111.63 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -69.15 -174.34 0.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.817 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -48.58 -75.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.127 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -116.33 56.24 0.53 Allowed Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.276 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -115.16 147.68 39.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.808 0.337 . . . . 0.0 110.773 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -71.12 160.16 83.33 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.606 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.537 ' HA ' HG11 ' A' ' 17' ' ' VAL . 15.8 Cg_exo -69.38 -49.07 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.672 2.248 . . . . 0.0 111.653 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.843 ' NH2' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -52.21 -45.78 65.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.689 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -64.53 -45.3 87.79 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.857 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.535 ' HA ' ' HD3' ' A' ' 59' ' ' ARG . . . -62.51 -45.62 92.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.688 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.679 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -57.29 -55.15 38.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.317 0.579 . . . . 0.0 109.832 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.531 HD11 ' HG3' ' A' ' 54' ' ' ARG . 27.1 mt -56.43 -51.06 69.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.4 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.535 ' HD3' ' HA ' ' A' ' 56' ' ' ALA . 2.8 ptm180 -65.17 -54.18 33.56 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.557 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.4 OUTLIER -46.25 -44.62 16.51 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.295 0.569 . . . . 0.0 109.884 179.374 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.871 HD13 ' HG3' ' A' ' 43' ' ' PRO . 8.4 tp -51.48 -51.62 53.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.489 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.841 ' HG3' HG23 ' A' ' 68' ' ' THR . 15.1 ttm180 -64.87 -61.6 2.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.473 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -51.33 -23.47 3.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.111 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -97.13 -38.18 9.83 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.689 HG22 ' CD2' ' A' ' 121' ' ' LEU . 1.1 p -131.26 -3.33 3.89 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 78.75 -9.44 36.98 Favored Glycine 0 CA--C 1.517 0.205 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.135 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.776 ' HB ' HD11 ' A' ' 61' ' ' LEU . 69.6 t -58.49 111.76 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.209 0.528 . . . . 0.0 111.444 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.841 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.8 OUTLIER -121.63 -39.38 2.65 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.429 178.493 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.419 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 14.2 m -62.7 70.37 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.93 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.37 152.89 19.01 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.216 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 0.3 OUTLIER -129.06 157.81 40.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.297 179.443 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.843 HG11 ' NH2' ' A' ' 54' ' ' ARG . 16.5 t -78.62 131.08 35.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.261 0.553 . . . . 0.0 112.033 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.84 HD13 ' N ' ' A' ' 73' ' ' ILE . 0.8 OUTLIER -104.7 -22.5 4.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.176 178.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.435 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -171.83 178.26 3.08 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.703 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.27 145.02 30.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.011 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.827 ' HA ' HG11 ' A' ' 160' ' ' VAL . 53.5 t -70.98 136.94 84.9 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.858 0.361 . . . . 0.0 110.533 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.43 ' HD2' HG13 ' A' ' 76' ' ' VAL . 12.2 Cg_endo -53.11 -68.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.943 2.429 . . . . 0.0 111.831 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.651 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -96.65 -173.36 2.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.692 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.52 ' CD1' ' HD3' ' A' ' 106' ' ' LYS . 31.9 m95 -89.3 -157.18 0.44 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.637 ' HB2' ' O ' ' A' ' 105' ' ' GLN . 72.1 mt . . . . . 0 C--N 1.326 -0.425 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 179.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.526 0 CA-C-O 121.204 0.526 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.737 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 3.2 mt-30 -126.0 123.75 39.18 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.434 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.52 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 9.3 ttpt -102.93 138.63 39.57 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 177.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.487 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 31.3 m95 -103.36 162.68 12.8 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -177.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.402 ' CZ ' ' HB2' ' A' ' 53' ' ' PRO . 90.4 m-85 -139.74 155.55 47.27 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.881 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.765 HD11 ' CG ' ' A' ' 22' ' ' MET . 39.4 tp -100.99 138.14 38.43 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.961 -0.295 . . . . 0.0 110.272 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.7 ' CZ ' HG22 ' A' ' 72' ' ' VAL . 23.8 m-85 -139.25 137.21 35.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.203 0.525 . . . . 0.0 112.155 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 10.2 ttmt -102.12 126.16 49.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.392 177.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.669 ' CE1' HG13 ' A' ' 67' ' ' VAL . 34.0 t80 -78.57 98.27 6.07 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.769 0.318 . . . . 0.0 110.999 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 8.0 p -97.86 50.4 1.03 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.419 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -152.64 -147.39 4.59 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.339 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -118.94 150.84 39.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.939 0.4 . . . . 0.0 110.885 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -59.77 -35.1 73.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.728 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -6.39 0.21 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.083 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.84 -14.52 34.19 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.743 0.306 . . . . 0.0 111.023 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.71 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 19.2 mt -78.98 100.37 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.029 0.442 . . . . 0.0 111.999 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 65' ' ' THR . 2.2 t30 -104.16 98.73 8.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.752 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.689 ' CD2' HG22 ' A' ' 65' ' ' THR . 35.8 mt . . . . . 0 C--N 1.331 -0.235 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.953 179.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.448 ' C ' HD12 ' A' ' 34' ' ' LEU . 15.7 mm-40 . . . . . 0 CA--C 1.521 -0.14 0 CA-C-O 121.044 0.449 . . . . 0.0 110.361 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.643 ' CE2' HG23 ' A' ' 65' ' ' THR . 4.8 m-85 -103.45 143.82 32.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.108 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.715 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -85.92 -36.16 10.52 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.388 -0.911 . . . . 0.0 111.985 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -151.37 141.42 22.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.965 0.412 . . . . 0.0 110.925 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.71 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 42.7 p-90 -128.94 166.68 18.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.073 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.433 ' N ' ' HZ3' ' A' ' 40' ' ' TRP . 27.3 t -161.02 179.11 8.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.769 -178.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.61 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 75.8 m95 -114.01 103.73 11.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.59 178.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.3 m -119.22 168.44 11.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.776 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.513 ' HB ' ' CD ' ' A' ' 139' ' ' PRO . 17.6 p -74.01 169.89 16.99 Favored Pre-proline 0 CA--C 1.516 -0.358 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.491 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.693 ' HG3' HD11 ' A' ' 28' ' ' ILE . 16.6 Cg_exo -61.57 -53.53 2.23 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.781 1.654 . . . . 0.0 110.512 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.59 -27.72 69.14 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.782 178.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.434 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.2 OUTLIER -73.37 -44.29 58.93 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.486 179.743 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.476 HD11 ' O ' ' A' ' 41' ' ' GLN . 5.4 tp -58.94 -38.35 78.81 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.801 HG21 ' HG2' ' A' ' 155' ' ' LYS . 12.2 mm -63.74 -37.09 78.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.53 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.53 -49.66 52.4 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.297 0.57 . . . . 0.0 110.201 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.411 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -73.92 -20.15 60.47 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.752 -179.286 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.624 HG23 ' HG2' ' A' ' 151' ' ' LYS . 12.7 t -76.2 173.11 11.77 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.514 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.5 m -80.43 147.24 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.248 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.613 ' HA ' ' HE2' ' A' ' 151' ' ' LYS . 5.3 mt-10 -52.21 -47.65 65.52 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.249 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -52.08 -10.91 0.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.47 ' HB3' ' CE1' ' A' ' 154' ' ' TYR . 21.1 mttt -135.72 -5.52 2.21 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.624 ' HG2' HG23 ' A' ' 146' ' ' THR . 7.2 mtmm -58.28 -61.32 7.77 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 121.278 -0.169 . . . . 0.0 111.154 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.541 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 35.3 Cg_endo -64.83 -26.36 59.85 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.608 2.205 . . . . 0.0 111.738 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.726 ' O ' HG23 ' A' ' 157' ' ' VAL . 26.3 t -68.25 -50.78 54.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.487 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 7.5 m-30 -66.46 -38.33 87.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.734 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.801 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -58.13 -42.1 85.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.073 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.26 -32.9 70.94 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 153' ' ' VAL . 84.0 t -67.13 -41.09 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.728 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.566 HD22 ' HB3' ' A' ' 139' ' ' PRO . 44.8 mt -64.15 -39.26 93.63 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.93 0.395 . . . . 0.0 110.22 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 16.9 m -55.81 -41.1 73.69 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.827 HG11 ' HA ' ' A' ' 76' ' ' VAL . 95.5 t -66.81 -44.84 88.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.175 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.574 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 21.7 m-30 -80.79 5.09 16.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.575 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.636 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.17 -51.86 78.7 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.745 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 18.1 Cg_endo -58.71 -12.18 13.81 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.231 1.954 . . . . 0.0 111.961 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.435 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 89.2 m-70 -110.32 -20.95 12.45 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.252 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 89.3 mt . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.938 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 12.6 mtm . . . . . 0 CA--C 1.53 0.189 0 CA-C-O 120.526 0.203 . . . . 0.0 110.49 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 29.7 t0 . . . . . 0 C--N 1.332 -0.184 0 CA-C-O 120.945 0.403 . . . . 0.0 110.728 -179.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.58 ' HG3' ' CZ3' ' A' ' 79' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.167 0 CA-C-O 120.8 0.333 . . . . 0.0 110.553 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.745 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 8.6 m120 -131.05 170.64 14.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.165 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.547 HG13 ' CG1' ' A' ' 47' ' ' ILE . 13.2 m -141.06 162.61 22.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.462 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.642 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -134.31 159.17 23.72 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.613 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.092 HG21 HD22 ' A' ' 61' ' ' LEU . 3.8 mp -128.41 119.02 49.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.776 ' O ' HD12 ' A' ' 109' ' ' LEU . 41.9 t -97.85 89.42 4.59 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.85 HD22 HG11 ' A' ' 67' ' ' VAL . 27.1 tp -90.4 115.6 27.7 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.448 -178.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.655 ' SD ' HD11 ' A' ' 109' ' ' LEU . 1.7 ptt? -118.28 166.1 13.03 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.058 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.61 ' ND2' ' HB2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -101.36 167.85 9.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.298 179.492 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -55.89 -4.06 0.1 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.578 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.594 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 1.7 m-20 -100.67 2.63 41.73 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.594 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER 76.38 20.13 1.57 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.941 -178.374 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.61 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 2.1 mmtt -92.69 147.88 22.51 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.867 HD11 ' HG3' ' A' ' 139' ' ' PRO . 0.8 OUTLIER -101.0 138.82 23.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.164 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.567 ' HZ ' HG21 ' A' ' 65' ' ' THR . 12.1 t80 -78.46 134.37 37.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.831 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.637 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -140.2 151.81 45.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.05 0.452 . . . . 0.0 111.224 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.712 ' HB1' ' CB ' ' A' ' 131' ' ' PHE . . . -143.28 133.43 24.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.637 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 3.4 m -97.25 156.5 16.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.165 0.507 . . . . 0.0 112.002 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.577 ' O ' ' N ' ' A' ' 35' ' ' ASP . 32.8 mtp85 -74.47 129.92 38.65 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.742 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.746 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 1.2 mp -57.3 54.9 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.221 0.608 . . . . 0.0 112.289 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.577 ' N ' ' O ' ' A' ' 33' ' ' ARG . 9.9 p-10 -175.89 -33.72 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.062 0.458 . . . . 0.0 109.919 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 4.5 mt -117.51 103.05 51.53 Favored Pre-proline 0 N--CA 1.448 -0.549 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.475 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -61.27 -47.34 12.34 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.014 2.476 . . . . 0.0 113.344 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.83 -2.08 22.14 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.506 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -95.55 95.63 8.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.852 0.358 . . . . 0.0 111.428 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.623 ' O ' ' HA ' ' A' ' 146' ' ' THR . 66.6 m95 -100.59 150.94 22.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.893 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.85 165.03 37.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.319 0.581 . . . . 0.0 111.52 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.438 ' HB2' ' HE2' ' A' ' 42' ' ' MET . 27.0 mtm -100.56 150.51 37.04 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.111 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.528 ' CB ' HD13 ' A' ' 61' ' ' LEU . 4.8 Cg_endo -50.07 150.79 9.75 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.236 1.957 . . . . 0.0 111.89 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.576 ' HA ' HD12 ' A' ' 19' ' ' ILE . 18.2 pt20 -175.58 177.56 1.74 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.606 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.401 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . 175.09 158.84 20.09 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.136 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.745 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -87.54 134.88 12.76 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.164 -1.017 . . . . 0.0 113.39 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.547 ' CG1' HG13 ' A' ' 17' ' ' VAL . 50.1 mt -68.25 148.23 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.058 0.456 . . . . 0.0 111.908 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -69.98 -172.74 0.57 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.203 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.46 -77.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.141 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -112.51 56.22 0.48 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.58 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.484 ' O ' HG21 ' A' ' 47' ' ' ILE . 3.3 tp10 -114.25 149.31 36.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.75 0.31 . . . . 0.0 110.711 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -71.14 155.1 93.58 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.321 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.519 ' HA ' HG11 ' A' ' 17' ' ' VAL . 4.7 Cg_exo -74.92 -50.84 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.758 2.305 . . . . 0.0 112.277 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.675 ' CZ ' HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -51.31 -46.56 62.59 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.731 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.773 ' HA ' HD12 ' A' ' 58' ' ' ILE . 52.5 m-80 -68.09 -40.33 82.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.104 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.59 -43.14 99.4 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.671 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -57.02 -51.35 69.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.072 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.773 HD12 ' HA ' ' A' ' 55' ' ' ASN . 12.3 mt -56.38 -54.82 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.983 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.53 -63.62 1.21 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.289 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.401 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 0.4 OUTLIER -42.32 -46.56 4.62 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.039 0.447 . . . . 0.0 110.223 179.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.092 HD22 HG21 ' A' ' 19' ' ' ILE . 8.2 tp -52.34 -46.76 66.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.487 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.914 ' HG3' HG23 ' A' ' 68' ' ' THR . 23.0 ttm180 -64.22 -63.06 1.25 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.171 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -49.78 -20.09 0.78 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -95.95 -40.52 9.24 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.817 HG22 HD23 ' A' ' 121' ' ' LEU . 0.7 OUTLIER -126.34 -5.31 6.6 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.074 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 81.59 -11.71 44.44 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.214 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.85 HG11 HD22 ' A' ' 21' ' ' LEU . 71.7 t -57.81 114.73 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.155 0.503 . . . . 0.0 111.5 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.914 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.6 OUTLIER -123.38 -39.06 2.49 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.33 178.126 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.418 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 5.9 m -62.67 73.32 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.214 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -162.64 155.3 19.29 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.942 0.401 . . . . 0.0 111.75 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.96 153.99 48.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.452 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.68 HG22 ' CZ ' ' A' ' 110' ' ' PHE . 43.4 t -76.55 131.78 34.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.336 0.588 . . . . 0.0 112.378 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.695 HD13 ' N ' ' A' ' 73' ' ' ILE . 1.2 mm -103.91 -21.43 5.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.176 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.468 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -169.94 178.62 3.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.182 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -146.3 140.59 26.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.037 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.726 ' HA ' HG11 ' A' ' 160' ' ' VAL . 48.3 t -70.37 138.33 86.57 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.978 0.418 . . . . 0.0 110.535 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.532 ' HD2' HG13 ' A' ' 76' ' ' VAL . 19.1 Cg_endo -58.92 -68.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.993 2.462 . . . . 0.0 112.477 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -96.67 -173.38 2.72 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.829 -179.405 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.58 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 44.0 m95 -93.72 -159.03 0.66 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.536 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.562 ' HB2' ' HG2' ' A' ' 105' ' ' GLN . 41.0 mt . . . . . 0 C--N 1.331 -0.222 0 CA-C-O 121.366 0.603 . . . . 0.0 111.131 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.403 ' HB3' HH21 ' A' ' 15' ' ' ARG . . . . . . . . 0 N--CA 1.465 0.276 0 CA-C-O 120.871 0.367 . . . . 0.0 110.835 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.633 ' HB3' ' HB2' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -133.66 128.53 35.25 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.478 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 5.3 ttpp -102.32 132.39 48.32 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.642 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 19.5 m95 -104.93 160.86 14.68 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.481 ' HB2' ' HE1' ' A' ' 110' ' ' PHE . 91.4 m-85 -137.99 154.37 49.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.667 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.776 HD12 ' O ' ' A' ' 20' ' ' CYS . 32.5 tp -97.65 141.69 30.36 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.708 ' CD1' HG23 ' A' ' 19' ' ' ILE . 23.3 m-85 -139.15 138.21 36.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.292 0.567 . . . . 0.0 112.116 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.563 ' HB2' HD11 ' A' ' 73' ' ' ILE . 1.4 ttpt -103.59 128.31 50.88 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.437 177.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.563 ' HD1' HD21 ' A' ' 21' ' ' LEU . 36.9 t80 -78.1 102.82 7.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.818 0.342 . . . . 0.0 111.008 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 49.2 p -100.47 47.65 0.93 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.009 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.418 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -152.73 -146.08 4.28 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.485 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -117.89 146.77 43.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.885 0.374 . . . . 0.0 110.814 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -59.51 -32.36 70.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.705 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -59.29 -4.48 0.56 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.907 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.15 -15.63 31.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.619 0.247 . . . . 0.0 110.951 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.747 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 17.6 mt -76.11 99.67 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.912 0.386 . . . . 0.0 111.541 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 65' ' ' THR . 1.5 m120 -106.16 95.95 6.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.687 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.817 HD23 HG22 ' A' ' 65' ' ' THR . 11.2 mt . . . . . 0 CA--C 1.532 0.277 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.838 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.461 0.095 0 CA-C-O 120.714 0.292 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.712 ' CB ' ' HB1' ' A' ' 31' ' ' ALA . 3.4 m-85 -120.02 138.63 53.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.217 0.532 . . . . 0.0 109.898 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.746 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -83.26 -36.45 14.68 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.026 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -149.03 144.43 26.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.948 0.404 . . . . 0.0 110.615 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.747 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 33.4 p-90 -129.63 163.73 25.42 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.455 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.417 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 34.9 t -163.38 176.59 9.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.914 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.589 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 28.5 m95 -111.76 103.42 11.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.317 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 28' ' ' ILE . 24.2 m -118.39 166.26 12.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.565 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 14.5 p -71.82 171.49 9.15 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.216 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.867 ' HG3' HD11 ' A' ' 28' ' ' ILE . 13.4 Cg_exo -63.14 -54.18 1.21 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 121.83 1.687 . . . . 0.0 109.87 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -64.29 -28.35 69.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.911 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.431 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.4 OUTLIER -73.14 -45.75 54.93 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.393 179.745 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.637 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -58.44 -39.45 79.88 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 139' ' ' PRO . 27.3 mm -61.99 -33.76 59.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.132 0.491 . . . . 0.0 110.032 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.03 -53.17 11.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.379 0.609 . . . . 0.0 110.818 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.1 mp -72.56 -19.38 61.51 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.72 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.623 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 11.7 t -74.19 177.72 5.59 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.4 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.752 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 20.9 m -84.46 151.03 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.767 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.458 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 10.6 mt-10 -55.26 -54.75 39.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.486 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.752 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 44.3 p90 -55.93 -2.1 0.05 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.422 ' HG3' ' CE2' ' A' ' 149' ' ' PHE . 29.6 mttm -133.42 -8.06 2.91 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.502 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 0.4 OUTLIER -61.35 -56.45 33.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 121.49 -0.084 . . . . 0.0 111.196 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 22.7 Cg_endo -62.48 -28.94 78.23 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.163 1.909 . . . . 0.0 111.591 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.804 ' O ' HG23 ' A' ' 157' ' ' VAL . 31.2 t -67.16 -51.63 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.472 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 6.9 m-30 -66.19 -39.37 89.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.965 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.544 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -56.29 -42.43 77.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.684 179.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.446 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.7 OUTLIER -69.07 -33.32 73.37 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.167 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 153' ' ' VAL . 48.8 t -67.5 -40.61 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.43 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.707 HD22 ' HB3' ' A' ' 139' ' ' PRO . 36.9 mt -63.44 -47.1 83.26 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.247 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.8 t -50.72 -42.86 57.68 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.536 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.726 HG11 ' HA ' ' A' ' 76' ' ' VAL . 79.5 t -65.74 -41.65 90.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.548 ' CE2' HG12 ' A' ' 157' ' ' VAL . 18.3 m-30 -80.84 5.19 16.76 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.597 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.616 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.63 -52.77 71.66 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.6 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.0 Cg_endo -58.18 -12.4 12.88 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.112 1.874 . . . . 0.0 111.876 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.468 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 95.0 m-70 -108.5 -20.23 13.18 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.333 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 95.4 mt . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.105 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.8 mtm . . . . . 0 CA--C 1.528 0.133 0 CA-C-O 120.674 0.273 . . . . 0.0 110.605 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.672 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 9.2 t0 . . . . . 0 C--N 1.333 -0.139 0 CA-C-O 121.004 0.43 . . . . 0.0 110.812 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.547 ' HG2' HD13 ' A' ' 47' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 121.275 0.56 . . . . 0.0 110.322 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.706 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 3.4 m120 -132.6 173.99 10.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.405 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.693 HG12 HD11 ' A' ' 47' ' ' ILE . 2.1 m -140.63 166.73 18.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.409 0.623 . . . . 0.0 111.831 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.672 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -133.33 155.08 21.52 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.252 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.691 HG13 ' HB1' ' A' ' 57' ' ' ALA . 3.4 mp -126.88 119.17 52.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.986 0.422 . . . . 0.0 111.956 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' A' ' 110' ' ' PHE . 45.4 t -101.79 102.41 13.03 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.963 HD22 HG11 ' A' ' 67' ' ' VAL . 15.5 tp -105.39 118.87 37.65 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.108 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.635 ' HE2' HD13 ' A' ' 73' ' ' ILE . 1.2 ptm -119.75 161.61 20.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.83 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.498 ' OD1' ' CE3' ' A' ' 136' ' ' TRP . 0.2 OUTLIER -95.77 169.96 9.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.962 0.411 . . . . 0.0 110.155 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -56.62 -5.0 0.18 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.054 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.552 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 4.7 m-20 -98.87 2.93 47.1 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.552 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER 75.76 19.45 1.98 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.942 -178.538 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 22' ' ' MET . 1.1 mmtt -94.46 140.8 29.35 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.672 HD13 ' N ' ' A' ' 139' ' ' PRO . 3.0 mp -102.4 145.57 11.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.681 0.753 . . . . 0.0 112.218 -178.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.576 ' CE1' HD13 ' A' ' 119' ' ' ILE . 83.8 t80 -76.89 137.31 39.06 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.914 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.984 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -140.45 148.64 41.47 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.145 -0.316 . . . . 0.0 110.145 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.543 ' HB1' ' CB ' ' A' ' 131' ' ' PHE . . . -138.58 136.82 36.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.841 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.751 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 91.5 p -97.15 143.33 28.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.946 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.774 ' HE ' HD12 ' A' ' 36' ' ' ILE . 21.9 mtp85 -68.95 127.48 33.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.738 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.73 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.7 OUTLIER -43.78 -35.31 1.84 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.304 0.573 . . . . 0.0 110.835 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -72.71 -40.09 66.44 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.007 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.774 HD12 ' HE ' ' A' ' 33' ' ' ARG . 8.7 mt -125.31 104.76 28.48 Favored Pre-proline 0 N--CA 1.455 -0.175 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.738 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.75 -20.2 52.64 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.738 2.292 . . . . 0.0 112.871 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.48 -6.59 54.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.706 0.288 . . . . 0.0 111.496 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.751 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.56 93.27 8.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.123 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.664 ' O ' ' HA ' ' A' ' 146' ' ' THR . 78.1 m95 -90.89 144.93 25.18 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.543 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.428 ' HA ' ' HE2' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -158.73 162.6 37.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.184 0.516 . . . . 0.0 111.232 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.508 ' HB2' ' HE2' ' A' ' 42' ' ' MET . 1.8 mtm -98.08 152.05 37.84 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.892 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.415 ' HG2' ' O ' ' A' ' 19' ' ' ILE . 1.5 Cg_endo -46.96 144.86 7.8 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.239 1.96 . . . . 0.0 111.873 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 17' ' ' VAL . 12.5 tt0 -172.68 146.4 1.65 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.578 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.416 ' HA3' ' HG3' ' A' ' 60' ' ' GLU . . . -157.32 -167.02 17.79 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.9 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.706 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -117.85 137.68 13.37 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.133 -1.032 . . . . 0.0 113.655 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.693 HD11 HG12 ' A' ' 17' ' ' VAL . 3.3 mt -70.52 148.78 10.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.356 -0.422 . . . . 0.0 111.735 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -68.61 -173.8 0.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.372 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -49.11 -78.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.178 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -111.93 57.13 0.44 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.601 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.485 ' O ' HG21 ' A' ' 47' ' ' ILE . 7.4 tp10 -117.4 153.86 32.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.946 0.403 . . . . 0.0 110.871 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.86 161.61 77.79 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.486 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.541 ' HA ' HG12 ' A' ' 47' ' ' ILE . 7.3 Cg_exo -74.21 -47.87 0.23 Allowed 'Trans proline' 0 CA--C 1.514 -0.517 0 C-N-CA 122.857 2.371 . . . . 0.0 111.226 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.777 HH11 HG13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -51.98 -44.03 63.86 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.213 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -68.09 -42.13 80.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.946 0.403 . . . . 0.0 110.402 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.434 ' HA ' ' HG2' ' A' ' 59' ' ' ARG . . . -60.49 -44.46 95.93 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.691 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -57.96 -53.7 55.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.388 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.777 HG13 HH11 ' A' ' 54' ' ' ARG . 57.4 mt -53.27 -52.82 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.526 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.455 ' HG3' ' N ' ' A' ' 60' ' ' GLU . 9.2 ptm180 -63.43 -56.57 15.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.824 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.455 ' N ' ' HG3' ' A' ' 59' ' ' ARG . 29.2 mm-40 -50.99 -48.45 61.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.063 0.459 . . . . 0.0 110.054 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.568 HD21 HG12 ' A' ' 67' ' ' VAL . 14.1 tp -51.01 -48.5 61.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.393 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.937 ' HG2' HG23 ' A' ' 68' ' ' THR . 1.0 OUTLIER -66.77 -63.29 1.1 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.328 0.585 . . . . 0.0 110.721 179.304 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.67 -22.36 2.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.088 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -99.74 -38.06 8.84 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.617 HG22 HD23 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -127.22 -13.6 5.56 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.858 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.501 ' HA2' ' HD2' ' A' ' 62' ' ' ARG . . . 85.4 -13.42 55.38 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.254 -0.974 . . . . 0.0 111.76 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.963 HG11 HD22 ' A' ' 21' ' ' LEU . 27.3 t -57.31 106.02 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 121.236 0.541 . . . . 0.0 111.135 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.937 HG23 ' HG2' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -121.18 -39.86 2.65 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.219 178.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.0 m -62.68 73.43 0.02 OUTLIER 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.064 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -164.0 159.1 20.33 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.674 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.45 152.18 49.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.873 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.509 HG22 ' CE1' ' A' ' 110' ' ' PHE . 19.9 t -75.14 127.7 36.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.056 0.455 . . . . 0.0 111.076 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.635 HD13 ' HE2' ' A' ' 22' ' ' MET . 2.3 mt -108.1 -19.12 6.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.902 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.473 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.09 176.24 4.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.204 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.595 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.1 pm0 -154.39 145.26 22.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.453 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.776 ' HA ' HG11 ' A' ' 160' ' ' VAL . 53.5 t -71.25 138.32 84.28 Favored Pre-proline 0 C--N 1.329 -0.286 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.927 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.622 ' HD2' HG13 ' A' ' 76' ' ' VAL . 21.3 Cg_endo -61.82 -55.34 1.13 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.814 2.342 . . . . 0.0 112.696 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.672 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 1.2 p90 -102.17 -178.64 3.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.491 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.56 ' CD1' ' HD3' ' A' ' 106' ' ' LYS . 39.3 m95 -93.54 -157.56 0.55 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.392 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.539 HD23 ' O ' ' A' ' 79' ' ' TRP . 55.7 mt . . . . . 0 CA--C 1.516 -0.349 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.176 0 CA-C-O 120.874 0.369 . . . . 0.0 110.177 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.647 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 23.9 mt-30 -136.45 124.06 22.31 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.56 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 14.4 ttpp -104.76 140.36 38.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.165 178.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.672 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 19.4 m95 -110.11 160.23 16.65 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.701 ' HB2' HH21 ' A' ' 54' ' ' ARG . 19.0 m-85 -139.07 160.12 40.53 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.125 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.61 HD11 ' SD ' ' A' ' 22' ' ' MET . 11.7 tp -98.44 142.52 29.96 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.622 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.531 ' HZ ' ' NH1' ' A' ' 54' ' ' ARG . 5.7 m-85 -135.36 145.71 47.65 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.541 ' CA ' HD11 ' A' ' 73' ' ' ILE . 1.8 tttt -106.31 117.16 33.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.854 177.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.665 ' HB2' HD11 ' A' ' 21' ' ' LEU . 55.1 t80 -78.03 101.29 6.86 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.661 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 14.1 p -97.58 40.43 1.16 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.406 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.402 ' C ' ' CE2' ' A' ' 112' ' ' PHE . . . -140.64 -148.36 5.11 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.805 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -123.64 152.03 42.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.702 0.287 . . . . 0.0 111.129 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.444 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 11.6 p-10 -58.31 -39.16 78.63 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.418 0.627 . . . . 0.0 111.204 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -58.2 -3.72 0.28 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.335 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -89.29 -17.34 29.15 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.092 0.473 . . . . 0.0 110.432 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.587 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 9.4 mt -88.74 106.84 17.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.462 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 27.3 t30 -100.09 -20.31 16.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.167 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.617 HD23 HG22 ' A' ' 65' ' ' THR . 66.8 mt . . . . . 0 N--CA 1.463 0.217 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.089 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.872 0.368 . . . . 0.0 110.363 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.543 ' CB ' ' HB1' ' A' ' 31' ' ' ALA . 1.4 m-85 -109.74 140.71 43.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.987 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.73 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -89.98 -32.12 10.25 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.12 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.95 152.25 34.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.885 0.374 . . . . 0.0 110.363 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.587 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 37.3 p-90 -137.76 167.62 21.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.009 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.468 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 30.5 t -162.42 175.58 11.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.481 0.657 . . . . 0.0 112.168 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.498 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 35.6 m95 -111.25 105.65 14.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.105 178.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 25.2 m -120.93 170.1 11.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.6 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 18.4 p -73.01 172.0 9.01 Favored Pre-proline 0 CA--C 1.518 -0.284 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.971 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.672 ' N ' HD13 ' A' ' 28' ' ' ILE . 11.4 Cg_exo -62.81 -55.85 0.74 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.579 1.519 . . . . 0.0 110.286 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -64.23 -25.14 67.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.351 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.431 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 1.8 mm-40 -72.96 -47.63 43.7 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.483 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.984 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -57.79 -39.38 77.4 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.848 -179.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.636 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 6.2 mm -62.82 -37.74 79.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.316 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.51 -48.99 58.78 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.312 0.577 . . . . 0.0 110.488 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.3 mp -75.0 -20.19 59.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.137 -0.938 . . . . 0.0 113.115 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.664 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 14.1 t -74.92 178.58 5.46 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.787 -178.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.684 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 27.7 m -82.89 148.62 5.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.115 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.502 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 45.4 mt-10 -55.1 -53.06 60.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.441 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.684 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 51.1 p90 -56.66 -2.22 0.07 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.443 ' HG3' ' CE2' ' A' ' 149' ' ' PHE . 21.5 mttt -134.76 -7.6 2.43 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' A' ' 143' ' ' ILE . 7.6 mtmm -58.88 -60.02 11.86 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.56 0.219 . . . . 0.0 111.095 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.502 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 31.8 Cg_endo -62.89 -26.78 74.51 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.397 2.064 . . . . 0.0 111.631 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.644 ' O ' HG23 ' A' ' 157' ' ' VAL . 26.0 t -68.85 -50.99 49.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.428 ' HE2' ' HA ' ' A' ' 41' ' ' GLN . 12.6 m-30 -65.76 -37.3 85.97 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.532 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.621 ' HE2' ' HA ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -57.68 -40.69 80.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.986 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.549 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.3 OUTLIER -68.11 -32.55 72.93 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.83 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 153' ' ' VAL . 48.6 t -66.64 -42.07 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.007 178.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.584 HD12 ' HE2' ' A' ' 155' ' ' LYS . 34.7 mt -64.36 -47.56 78.83 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.58 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 2.9 p -50.01 -40.63 45.13 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.776 HG11 ' HA ' ' A' ' 76' ' ' VAL . 57.7 t -68.1 -41.37 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.35 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.601 ' CE2' HG12 ' A' ' 157' ' ' VAL . 21.0 m-30 -80.87 4.26 19.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.402 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.618 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.48 -51.5 81.35 Favored Pre-proline 0 C--N 1.331 -0.22 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.776 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.8 Cg_endo -58.63 -12.67 14.93 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.064 1.843 . . . . 0.0 111.818 178.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.473 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 89.4 m-70 -108.76 -18.51 13.69 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.253 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 85.8 mt . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.331 -0.842 . . . . 0.0 110.678 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 9.2 mtm . . . . . 0 N--CA 1.463 0.195 0 CA-C-O 120.853 0.359 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.765 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 17.3 t0 . . . . . 0 N--CA 1.464 0.237 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.416 -179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.6 ' HA ' ' O ' ' A' ' 104' ' ' ALA . 1.5 ttt180 . . . . . 0 N--CA 1.451 -0.393 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.646 ' HA ' ' H ' ' A' ' 47' ' ' ILE . 1.5 m120 -129.84 173.19 10.9 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.713 HG13 HD11 ' A' ' 47' ' ' ILE . 30.2 m -134.33 165.53 31.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.736 0.779 . . . . 0.0 111.683 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.825 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -131.42 158.2 22.65 Favored Glycine 0 N--CA 1.433 -1.539 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.502 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.992 HG21 HD22 ' A' ' 61' ' ' LEU . 3.4 mp -123.27 117.95 53.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.496 0.665 . . . . 0.0 111.976 -178.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.538 ' O ' HD12 ' A' ' 109' ' ' LEU . 37.6 t -104.43 103.74 13.5 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.879 HD22 HG11 ' A' ' 67' ' ' VAL . 30.8 tp -104.47 122.96 46.62 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.893 -177.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.739 ' HB3' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -113.64 137.58 51.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.714 179.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.443 ' OD1' ' CZ3' ' A' ' 136' ' ' TRP . 5.6 m-20 -98.11 -172.25 2.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.475 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -52.38 -7.59 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.187 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.522 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 3.7 m-20 -99.73 -7.21 25.87 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.996 0.427 . . . . 0.0 111.045 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.766 ' HE2' ' HA ' ' A' ' 165' ' ' LEU . 0.0 OUTLIER 73.38 20.42 3.22 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 121.652 0.739 . . . . 0.0 109.291 -179.379 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.801 ' C ' HD12 ' A' ' 28' ' ' ILE . 7.1 mttp -91.72 -161.03 0.78 Allowed 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.767 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.801 HD12 ' C ' ' A' ' 27' ' ' LYS . 2.5 mp -135.61 145.73 31.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.42 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.579 ' CE1' HD13 ' A' ' 119' ' ' ILE . 81.0 t80 -65.77 110.99 3.02 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.326 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.635 ' HB2' HG22 ' A' ' 137' ' ' VAL . . . -100.21 137.56 38.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.842 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.75 132.94 37.45 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.809 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.842 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 48.6 p -98.81 141.39 31.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.221 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.498 ' NH1' HD12 ' A' ' 36' ' ' ILE . 11.1 mtp-105 -68.67 127.1 31.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.193 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.791 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.3 OUTLIER -45.9 -34.12 3.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.294 0.568 . . . . 0.0 110.73 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.39 -39.78 67.71 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.519 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.498 HD12 ' NH1' ' A' ' 33' ' ' ARG . 27.9 mt -123.63 106.64 32.13 Favored Pre-proline 0 N--CA 1.455 -0.214 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.084 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -68.37 -19.88 42.99 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.714 2.276 . . . . 0.0 112.628 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -91.39 -7.46 50.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.514 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.842 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -90.71 96.46 10.65 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.04 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.618 ' O ' ' HA ' ' A' ' 146' ' ' THR . 75.8 m95 -94.76 146.61 24.06 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.116 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.569 ' O ' ' HA ' ' A' ' 30' ' ' ALA . 0.5 OUTLIER -157.79 -124.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.56 -179.29 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.579 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 9.8 ptt? 179.98 163.29 0.86 Allowed Pre-proline 0 N--CA 1.452 -0.345 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.579 ' HD2' ' HB2' ' A' ' 42' ' ' MET . 10.2 Cg_endo -50.99 147.05 20.18 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.114 2.542 . . . . 0.0 112.577 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.609 ' HA ' HD12 ' A' ' 19' ' ' ILE . 10.6 pt20 -174.22 146.61 1.13 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.809 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.463 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . -160.52 154.38 25.4 Favored Glycine 0 C--O 1.228 -0.273 0 C-N-CA 120.146 -1.026 . . . . 0.0 112.789 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.64 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -78.31 136.95 19.02 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.611 -0.804 . . . . 0.0 114.034 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.713 HD11 HG13 ' A' ' 17' ' ' VAL . 3.7 mt -69.62 141.93 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.13 -0.535 . . . . 0.0 110.469 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -68.45 -172.95 0.38 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.738 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -48.22 -73.33 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.208 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -118.42 57.17 0.55 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.483 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 52' ' ' ASP . 2.1 tp10 -114.34 147.43 39.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.66 0.266 . . . . 0.0 110.456 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 26.9 m-20 -70.9 139.83 85.81 Favored Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.159 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.642 ' HB2' ' HZ ' ' A' ' 108' ' ' PHE . 38.6 Cg_exo -58.27 -47.7 18.72 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.354 2.036 . . . . 0.0 112.016 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.845 ' HE ' HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -52.93 -46.17 67.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.904 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.666 ' HA ' HD12 ' A' ' 58' ' ' ILE . 86.7 m-20 -68.0 -40.97 82.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.242 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.71 -44.49 96.83 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.765 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.657 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -56.41 -54.49 45.07 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.812 178.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.845 HD11 ' HE ' ' A' ' 54' ' ' ARG . 10.1 mt -55.25 -55.31 17.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.173 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -60.47 -61.66 2.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.945 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.463 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 4.4 mm-40 -46.89 -43.74 19.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.179 0.514 . . . . 0.0 109.777 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.992 HD22 HG21 ' A' ' 19' ' ' ILE . 9.0 tp -51.17 -48.27 61.96 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.923 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.746 ' HG3' HG23 ' A' ' 68' ' ' THR . 17.9 ttm180 -64.66 -62.91 1.29 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.164 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -49.7 -22.97 1.53 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.268 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -96.02 -37.73 10.52 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.667 HG22 HD23 ' A' ' 121' ' ' LEU . 1.3 p -124.34 -35.69 2.75 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.638 -0.425 . . . . 0.0 112.027 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 107.16 -13.53 40.47 Favored Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -178.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.879 HG11 HD22 ' A' ' 21' ' ' LEU . 78.1 t -56.24 109.75 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 120.889 0.376 . . . . 0.0 110.49 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.746 HG23 ' HG3' ' A' ' 62' ' ' ARG . 3.9 p -120.86 -41.06 2.58 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.315 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.406 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 15.6 m -60.89 72.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.234 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -160.79 157.95 27.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.196 0.522 . . . . 0.0 112.213 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.16 149.63 50.88 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.131 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.809 HG22 ' CE2' ' A' ' 110' ' ' PHE . 12.8 t -74.0 128.14 36.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.172 0.51 . . . . 0.0 111.923 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.541 HD13 ' CE ' ' A' ' 22' ' ' MET . 0.9 OUTLIER -108.83 -18.25 7.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.363 178.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.464 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -168.54 179.69 4.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.399 0.619 . . . . 0.0 112.325 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -160.09 147.22 16.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.568 179.764 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.898 ' HA ' HG11 ' A' ' 160' ' ' VAL . 42.7 t -71.2 140.12 85.19 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-O 120.959 0.409 . . . . 0.0 111.533 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.632 ' HD2' HG13 ' A' ' 76' ' ' VAL . 32.2 Cg_endo -64.89 -69.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.094 2.53 . . . . 0.0 112.931 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.765 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -87.4 172.41 9.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.689 -178.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.569 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 54.3 m95 -92.93 102.72 15.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.846 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.56 ' CD1' HG22 ' A' ' 157' ' ' VAL . 65.3 mt . . . . . 0 C--N 1.328 -0.357 0 CA-C-O 120.916 0.388 . . . . 0.0 110.79 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.6 ' O ' ' HA ' ' A' ' 15' ' ' ARG . . . . . . . . 0 C--O 1.225 -0.216 0 CA-C-O 120.799 0.333 . . . . 0.0 110.667 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.541 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 36.7 mt-30 -132.32 126.19 32.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.296 0.569 . . . . 0.0 112.354 -178.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 3.3 ttmt -104.55 135.14 46.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.897 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.825 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 38.8 m95 -101.81 165.58 11.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.198 0.523 . . . . 0.0 112.082 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.642 ' HZ ' ' HB2' ' A' ' 53' ' ' PRO . 97.6 m-85 -141.01 152.69 45.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.892 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.668 HD11 ' SD ' ' A' ' 22' ' ' MET . 10.0 tp -101.2 140.04 36.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.744 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.809 ' CE2' HG22 ' A' ' 72' ' ' VAL . 50.6 m-85 -141.49 143.58 33.91 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 26.5 tttt -100.83 124.59 46.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.247 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.753 ' CE1' HG13 ' A' ' 67' ' ' VAL . 30.8 t80 -78.71 101.36 7.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.728 0.299 . . . . 0.0 110.64 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 18.3 p -98.26 40.54 1.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.501 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.406 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -144.43 -145.41 4.34 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.777 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -121.63 149.07 43.71 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.965 0.412 . . . . 0.0 111.449 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.424 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 11.3 p-10 -60.47 -36.32 77.98 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.501 0.667 . . . . 0.0 111.081 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -57.01 -2.87 0.09 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.405 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 116' ' ' ASP . 3.4 tt0 -89.66 -17.71 27.86 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.163 0.506 . . . . 0.0 110.149 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.579 HD13 ' CE1' ' A' ' 29' ' ' PHE . 9.6 mt -83.36 100.65 7.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.373 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -94.86 -0.46 54.03 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.68 HD11 ' HD1' ' A' ' 134' ' ' TRP . 53.5 mt . . . . . 0 N--CA 1.468 0.436 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.544 ' HG3' ' CE1' ' A' ' 131' ' ' PHE . 2.5 tp10 . . . . . 0 N--CA 1.463 0.209 0 CA-C-O 120.731 0.3 . . . . 0.0 110.693 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.553 ' HE2' HG23 ' A' ' 65' ' ' THR . 1.6 m-85 -126.93 140.11 52.57 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.987 0.422 . . . . 0.0 110.378 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.791 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -84.44 -33.44 19.66 Favored Glycine 0 CA--C 1.507 -0.43 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.211 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.59 151.83 29.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.506 -0.347 . . . . 0.0 110.254 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.68 ' HD1' HD11 ' A' ' 121' ' ' LEU . 37.0 p-90 -138.48 169.56 17.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.591 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.516 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 45.9 t -162.06 177.47 9.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.287 0.565 . . . . 0.0 111.364 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.473 ' CE2' ' CZ3' ' A' ' 134' ' ' TRP . 79.7 m95 -109.47 95.65 5.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.95 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.703 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 25.4 m -116.4 162.82 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.772 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.6 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 12.7 p -72.27 174.13 4.65 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.915 0.388 . . . . 0.0 110.567 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.712 ' HB3' HD22 ' A' ' 158' ' ' LEU . 9.4 Cg_exo -63.46 -57.08 0.41 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.526 1.484 . . . . 0.0 110.291 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -60.66 -32.33 71.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.277 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.413 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.9 OUTLIER -70.66 -47.63 58.97 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.566 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.547 HD13 ' CB ' ' A' ' 30' ' ' ALA . 38.7 tp -57.04 -38.42 73.16 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.668 HG12 ' O ' ' A' ' 139' ' ' PRO . 19.9 mm -60.77 -35.66 65.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.286 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -50.12 35.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.213 0.53 . . . . 0.0 110.867 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.505 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -73.85 -21.13 60.22 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.132 -179.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.618 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 14.9 t -74.52 171.52 13.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.996 0.427 . . . . 0.0 111.383 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.498 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 27.7 m -73.67 157.27 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.248 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.485 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 15.4 pt-20 -62.19 -54.17 44.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.12 0.486 . . . . 0.0 110.749 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.498 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 41.5 p90 -57.77 -1.15 0.09 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.418 ' HE3' ' HE2' ' A' ' 149' ' ' PHE . 75.0 mttt -132.57 -8.07 3.24 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.162 0.437 . . . . 0.0 111.878 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.536 ' HG3' HG22 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -61.7 -55.98 37.03 Favored Pre-proline 0 N--CA 1.463 0.192 0 CA-C-O 120.422 0.153 . . . . 0.0 110.744 179.308 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.519 ' HD3' ' HD2' ' A' ' 151' ' ' LYS . 29.9 Cg_endo -64.21 -28.51 64.41 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.083 1.855 . . . . 0.0 111.239 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.789 ' O ' HG23 ' A' ' 157' ' ' VAL . 21.6 t -68.04 -52.92 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.503 ' HE1' ' CZ2' ' A' ' 107' ' ' TRP . 16.0 m-30 -63.42 -39.66 95.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.79 178.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.621 ' HD3' HG21 ' A' ' 143' ' ' ILE . 0.1 OUTLIER -53.79 -45.4 70.72 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.083 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.499 ' O ' HG23 ' A' ' 160' ' ' VAL . 3.0 tt0 -67.74 -33.88 75.74 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 153' ' ' VAL . 47.3 t -64.77 -42.36 94.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.392 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.712 HD22 ' HB3' ' A' ' 139' ' ' PRO . 52.1 mt -63.84 -44.14 94.07 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.362 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 40.0 t -52.09 -39.78 60.27 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.898 HG11 ' HA ' ' A' ' 76' ' ' VAL . 57.7 t -66.77 -41.15 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.105 177.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.72 ' CE2' HG12 ' A' ' 157' ' ' VAL . 23.1 m-30 -80.44 5.9 13.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.694 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.7 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . . . -62.88 -50.99 74.62 Favored Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.828 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.7 ' HD3' ' HB3' ' A' ' 162' ' ' ALA . 31.2 Cg_exo -57.67 -15.43 20.74 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 121.896 1.731 . . . . 0.0 111.209 178.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.464 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 83.6 m-70 -107.56 -25.76 11.21 Favored 'General case' 0 N--CA 1.458 -0.065 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.012 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.766 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 50.1 mt . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.543 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 5.7 mtm . . . . . 0 N--CA 1.461 0.076 0 CA-C-O 120.85 0.357 . . . . 0.0 110.681 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.716 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 9.7 t70 . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.043 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.731 ' HG2' HD12 ' A' ' 47' ' ' ILE . 0.7 OUTLIER . . . . . 0 CA--C 1.528 0.1 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.739 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 3.4 m-80 -132.91 172.9 11.99 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.67 HG13 ' CG1' ' A' ' 47' ' ' ILE . 11.1 m -137.26 170.86 17.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 120.963 0.411 . . . . 0.0 111.221 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.562 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -137.1 158.82 24.46 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.814 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.967 HG21 HD22 ' A' ' 61' ' ' LEU . 3.5 mp -131.99 122.76 49.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.589 ' O ' HD12 ' A' ' 109' ' ' LEU . 51.6 t -103.34 92.39 4.48 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.877 HD22 HG11 ' A' ' 67' ' ' VAL . 8.5 tp -98.3 122.06 40.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.647 -178.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.693 ' HE1' HD13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -122.94 160.55 25.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.757 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.496 ' ND2' ' HB3' ' A' ' 112' ' ' PHE . 1.6 m120 -97.34 -178.12 4.06 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.526 0.679 . . . . 0.0 111.034 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -60.54 -7.41 2.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.747 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 1.3 m-20 -99.71 3.1 44.85 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER 72.51 22.05 3.46 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.073 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -96.41 140.74 30.62 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.724 ' N ' HD12 ' A' ' 28' ' ' ILE . 2.1 mp -97.2 144.03 11.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.658 0.742 . . . . 0.0 112.094 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.61 ' CZ ' HG21 ' A' ' 65' ' ' THR . 5.5 t80 -70.74 106.62 3.62 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.462 -1.245 . . . . 0.0 111.014 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.665 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -104.0 142.87 33.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.72 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.518 ' HB1' ' CG ' ' A' ' 131' ' ' PHE . . . -141.3 137.0 32.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.728 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 10.0 p -101.88 151.41 22.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.645 ' O ' ' N ' ' A' ' 35' ' ' ASP . 7.7 mtp180 -73.4 129.27 37.65 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.367 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.733 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -56.08 53.96 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.72 0.408 . . . . 0.0 112.083 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.645 ' N ' ' O ' ' A' ' 33' ' ' ARG . 4.7 t0 -175.78 -35.31 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.082 0.468 . . . . 0.0 110.098 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.545 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 6.7 mm -112.97 106.05 55.35 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.559 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.81 -62.08 0.18 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.122 2.548 . . . . 0.0 113.98 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -67.2 0.7 2.54 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.74 96.88 10.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.776 0.322 . . . . 0.0 111.059 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.634 ' O ' ' HA ' ' A' ' 146' ' ' THR . 69.7 m95 -100.93 148.51 24.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.783 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.456 ' NE2' ' CD ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -156.19 163.64 39.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.636 0.731 . . . . 0.0 112.466 -179.102 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.707 ' SD ' HG21 ' A' ' 28' ' ' ILE . 12.2 mtm -97.93 150.93 37.27 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.481 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.498 ' CB ' HD13 ' A' ' 61' ' ' LEU . 4.7 Cg_endo -50.18 146.35 18.15 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.186 1.924 . . . . 0.0 111.966 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.582 ' HA ' HD12 ' A' ' 19' ' ' ILE . 1.1 pt20 -173.07 150.96 2.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.642 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.435 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . -160.14 160.67 31.86 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.387 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.739 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -81.13 139.67 20.69 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.479 -179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.731 HD12 ' HG2' ' A' ' 15' ' ' ARG . 40.5 mt -69.82 138.94 21.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.639 -0.281 . . . . 0.0 111.385 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -69.04 -173.54 0.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.974 0.416 . . . . 0.0 110.914 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -46.09 -82.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.148 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -112.07 55.97 0.49 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.994 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -112.4 147.67 35.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.952 0.406 . . . . 0.0 110.852 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -68.73 164.33 46.88 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.132 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 3.6 Cg_exo -78.91 -51.41 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.689 2.259 . . . . 0.0 111.401 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.908 ' CZ ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -51.94 -46.04 64.56 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.331 179.41 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.788 ' HA ' HD12 ' A' ' 58' ' ' ILE . 75.7 m-20 -67.11 -41.8 85.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.108 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.402 ' HB1' ' OE2' ' A' ' 60' ' ' GLU . . . -61.07 -44.22 97.71 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.776 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -56.49 -52.27 65.36 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.747 178.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.788 HD12 ' HA ' ' A' ' 55' ' ' ASN . 9.7 mt -56.32 -55.8 16.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.261 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.73 -63.89 1.14 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.011 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.435 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 0.2 OUTLIER -43.52 -46.12 6.84 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-O 121.248 0.547 . . . . 0.0 110.039 179.583 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.967 HD22 HG21 ' A' ' 19' ' ' ILE . 10.0 tp -52.84 -47.11 67.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.156 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.898 ' HG3' HG23 ' A' ' 68' ' ' THR . 19.7 ttm180 -64.48 -64.97 0.74 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.33 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.12 -21.79 0.82 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.324 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -96.57 -35.17 11.17 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.766 HG22 HD23 ' A' ' 121' ' ' LEU . 0.6 OUTLIER -129.91 -4.69 4.55 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -178.594 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 80.35 -11.13 39.41 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.448 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.877 HG11 HD22 ' A' ' 21' ' ' LEU . 85.4 t -58.0 112.62 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-O 121.079 0.466 . . . . 0.0 111.625 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.898 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -123.86 -39.86 2.36 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.646 178.172 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.6 m -62.24 75.62 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.955 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.63 157.84 25.24 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.157 0.503 . . . . 0.0 112.305 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -131.29 150.17 52.26 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.442 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.908 HG21 ' CZ ' ' A' ' 54' ' ' ARG . 6.4 t -75.51 127.09 36.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.21 0.529 . . . . 0.0 111.414 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.693 HD13 ' HE1' ' A' ' 22' ' ' MET . 0.7 OUTLIER -109.13 -19.65 6.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.559 179.466 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.523 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -168.92 177.47 4.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.755 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -157.46 147.78 20.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.664 179.851 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.784 ' HA ' HG11 ' A' ' 160' ' ' VAL . 50.2 t -71.51 139.17 83.74 Favored Pre-proline 0 C--N 1.332 -0.152 0 CA-C-O 121.084 0.469 . . . . 0.0 110.827 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HD2' HG13 ' A' ' 76' ' ' VAL . 36.4 Cg_endo -66.21 -52.88 0.75 Allowed 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.805 2.337 . . . . 0.0 112.916 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.716 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -101.21 174.12 6.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.314 0.578 . . . . 0.0 112.13 -178.763 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . . . . . . . . . 46.9 m95 -92.61 95.86 9.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.487 -179.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.651 ' CD1' HG22 ' A' ' 157' ' ' VAL . 62.4 mt . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 120.776 0.322 . . . . 0.0 110.823 179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.267 0 CA-C-O 121.196 0.522 . . . . 0.0 110.397 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.694 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 40.7 mt-30 -126.12 133.07 51.74 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -105.72 130.66 53.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.34 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.562 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 14.3 m95 -99.34 161.47 13.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.055 0.455 . . . . 0.0 111.735 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.495 ' CE1' ' HG2' ' A' ' 54' ' ' ARG . 98.1 m-85 -139.9 152.13 46.16 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.292 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.672 ' HG ' HD12 ' A' ' 73' ' ' ILE . 17.3 tp -99.01 134.81 41.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.458 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.577 ' CZ ' HG22 ' A' ' 72' ' ' VAL . 27.2 m-85 -136.46 144.67 44.51 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 15.2 tttt -103.94 119.95 40.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.216 177.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.702 ' CE1' HG13 ' A' ' 67' ' ' VAL . 43.0 t80 -78.37 100.46 6.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.794 0.331 . . . . 0.0 110.667 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 18.6 p -97.13 45.16 1.04 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.85 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.68 -147.93 4.75 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.058 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -119.34 149.72 41.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 0.0 111.056 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.446 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 14.7 p-10 -60.38 -38.68 84.69 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.512 0.672 . . . . 0.0 111.243 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -55.98 -3.03 0.07 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.598 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.401 ' H ' ' C ' ' A' ' 116' ' ' ASP . 1.1 tt0 -89.71 -18.88 25.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.943 0.401 . . . . 0.0 110.556 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.699 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 20.1 mt -85.0 106.21 14.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.849 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 38.3 t30 -100.54 -25.41 14.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.327 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.766 HD23 HG22 ' A' ' 65' ' ' THR . 46.5 mt . . . . . 0 N--CA 1.465 0.322 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.206 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.522 ' O ' HD12 ' A' ' 34' ' ' LEU . 3.1 mm-40 . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.991 0.424 . . . . 0.0 111.358 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.655 ' CE2' HG23 ' A' ' 65' ' ' THR . 1.9 m-85 -104.41 142.42 34.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.673 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.733 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -85.03 -37.46 10.02 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.043 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -146.24 145.39 30.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.76 0.314 . . . . 0.0 110.483 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.699 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 36.2 p-90 -135.71 170.95 15.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.27 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.5 t -167.68 178.48 5.3 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.491 0.662 . . . . 0.0 112.719 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.468 ' CD2' ' OD1' ' A' ' 23' ' ' ASN . 81.2 m95 -113.12 102.99 10.91 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.588 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 28' ' ' ILE . 25.4 m -120.83 170.44 10.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.586 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 11.1 p -75.41 173.05 7.65 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.889 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.675 ' HB3' HD22 ' A' ' 158' ' ' LEU . 12.3 Cg_exo -62.61 -54.01 1.49 Allowed 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.731 1.621 . . . . 0.0 110.381 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -63.93 -30.69 71.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.356 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.76 -43.77 65.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.474 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.665 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -59.8 -39.27 84.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.313 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.754 HG21 ' HG2' ' A' ' 155' ' ' LYS . 34.1 mm -63.04 -37.21 78.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.19 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.94 -50.81 38.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.35 0.595 . . . . 0.0 110.528 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.3 mp -73.49 -19.82 60.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.179 -0.918 . . . . 0.0 112.709 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 12.4 t -75.81 172.06 13.33 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.111 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.471 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 26.9 m -82.77 145.17 8.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.378 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.554 ' HG3' ' HE3' ' A' ' 151' ' ' LYS . 6.7 mt-10 -47.46 -50.32 23.27 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.602 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -50.2 -12.27 0.08 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -135.37 -3.91 2.38 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.62 ' HG2' HG23 ' A' ' 146' ' ' THR . 8.1 mttt -58.69 -60.71 9.5 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.379 0.133 . . . . 0.0 111.178 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.497 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 32.3 Cg_endo -64.44 -27.57 62.53 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.641 2.227 . . . . 0.0 111.754 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.797 ' O ' HG23 ' A' ' 157' ' ' VAL . 40.3 t -67.88 -50.41 59.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.501 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 8.9 m-30 -66.59 -38.54 87.23 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.021 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.754 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -57.24 -41.18 79.09 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.812 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.406 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.4 tt0 -70.09 -31.48 69.08 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 153' ' ' VAL . 51.0 t -66.9 -42.2 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.797 178.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.675 HD22 ' HB3' ' A' ' 139' ' ' PRO . 74.0 mt -63.89 -40.23 96.04 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.238 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 64.2 m -56.41 -41.79 76.93 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.784 HG11 ' HA ' ' A' ' 76' ' ' VAL . 89.3 t -66.74 -43.72 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 115.525 -0.761 . . . . 0.0 108.983 177.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.504 ' CE2' HG12 ' A' ' 157' ' ' VAL . 21.9 m-30 -81.12 7.46 11.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.436 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.692 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . . . -59.22 -50.45 87.56 Favored Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.755 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.692 ' HD3' ' HB3' ' A' ' 162' ' ' ALA . 34.0 Cg_exo -59.41 -13.05 18.87 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.425 2.083 . . . . 0.0 111.58 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.523 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 86.7 m-70 -109.02 -20.75 12.92 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.294 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.509 HD23 ' HZ1' ' A' ' 26' ' ' LYS . 83.8 mt . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.942 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.434 ' O ' ' HB2' ' A' ' 79' ' ' TRP . 1.9 mpp? . . . . . 0 CA--C 1.523 -0.076 0 CA-C-O 120.641 0.258 . . . . 0.0 110.847 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.697 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 12.4 p-10 . . . . . 0 C--N 1.331 -0.197 0 CA-C-O 121.015 0.436 . . . . 0.0 110.759 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.655 ' HG2' HD12 ' A' ' 47' ' ' ILE . 23.2 ttt180 . . . . . 0 N--CA 1.45 -0.457 0 CA-C-O 121.212 0.53 . . . . 0.0 109.751 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.569 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 23.7 m-80 -130.9 171.68 12.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.981 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.701 HG13 HD11 ' A' ' 47' ' ' ILE . 22.4 m -134.26 163.34 37.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.14 0.495 . . . . 0.0 111.199 178.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.615 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -138.66 157.87 24.82 Favored Glycine 0 N--CA 1.442 -0.955 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.301 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.659 HG21 HD13 ' A' ' 61' ' ' LEU . 2.1 mp -128.56 118.22 46.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.588 ' O ' HD12 ' A' ' 109' ' ' LEU . 50.3 t -96.82 98.34 10.05 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 177.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.629 HD21 ' HD1' ' A' ' 112' ' ' PHE . 32.0 tp -99.29 116.18 30.87 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.106 -177.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.891 ' HE2' HD13 ' A' ' 73' ' ' ILE . 1.6 ptt? -119.66 161.77 20.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.027 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.52 ' N ' ' OD1' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -94.45 171.32 8.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.092 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -57.34 -5.53 0.32 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.703 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.575 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.6 OUTLIER -99.37 3.04 45.79 Favored 'General case' 0 CA--C 1.521 -0.136 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 11.0 mmtp 73.71 21.88 2.68 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.986 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.613 ' O ' ' HA ' ' A' ' 22' ' ' MET . 2.3 mmtt -92.66 143.17 26.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.729 HD11 ' HG3' ' A' ' 139' ' ' PRO . 1.4 mm -98.96 138.0 24.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.17 0.51 . . . . 0.0 112.283 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.608 ' CE1' HD13 ' A' ' 119' ' ' ILE . 78.1 t80 -75.05 136.67 41.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.398 177.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.715 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -140.33 151.48 45.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.679 0.275 . . . . 0.0 111.102 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -141.34 138.14 32.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.33 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.69 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 43.9 p -95.69 144.87 25.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.66 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.457 ' NE ' HD12 ' A' ' 36' ' ' ILE . 35.1 mtp180 -69.68 136.15 50.71 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.213 0.53 . . . . 0.0 111.318 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.93 HD23 ' H ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -42.11 -48.9 4.82 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.583 -178.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -71.69 -33.25 68.64 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.95 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.457 HD12 ' NE ' ' A' ' 33' ' ' ARG . 2.8 mt -122.45 110.46 32.24 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.758 0.313 . . . . 0.0 111.531 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.6 -18.77 15.15 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.449 2.099 . . . . 0.0 112.382 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -91.73 -10.45 40.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.352 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.693 ' HB1' ' CG1' ' A' ' 147' ' ' VAL . . . -91.2 96.47 10.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.564 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.69 ' O ' ' HA ' ' A' ' 146' ' ' THR . 76.0 m95 -90.86 147.59 23.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.682 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -154.84 169.73 23.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.471 0.653 . . . . 0.0 111.667 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.505 ' HB2' ' HE2' ' A' ' 42' ' ' MET . 19.3 mtm -107.3 147.2 34.78 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.176 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.484 ' CG ' HD12 ' A' ' 61' ' ' LEU . 5.3 Cg_endo -48.8 136.88 27.91 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.459 2.106 . . . . 0.0 111.525 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.504 ' HA ' HD12 ' A' ' 19' ' ' ILE . 3.1 pp0? -173.08 155.01 2.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.996 0.427 . . . . 0.0 111.269 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.484 ' O ' ' HB3' ' A' ' 16' ' ' ASN . . . -156.04 -165.1 14.04 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.571 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.569 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -95.71 -148.72 24.64 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.209 -0.996 . . . . 0.0 113.243 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.701 HD11 HG13 ' A' ' 17' ' ' VAL . 3.0 mt -163.04 125.92 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.545 -0.328 . . . . 0.0 110.488 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.29 169.51 16.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.083 0.468 . . . . 0.0 111.122 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -46.25 -62.22 1.44 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.696 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -99.88 42.35 1.99 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.775 -0.726 . . . . 0.0 113.089 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -119.64 128.81 54.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.553 0.216 . . . . 0.0 110.571 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -69.13 164.61 46.59 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.592 ' HA ' HG11 ' A' ' 17' ' ' VAL . 3.4 Cg_exo -76.81 -48.05 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.65 2.233 . . . . 0.0 111.912 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.755 HH21 HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -55.84 -43.87 77.43 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.21 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 73.9 m-20 -66.92 -45.13 78.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.293 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.29 -43.79 98.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.605 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -57.37 -61.14 2.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.902 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.546 HG12 ' CE2' ' A' ' 110' ' ' PHE . 25.4 mt -54.61 -48.65 70.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.393 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 13.5 ttt180 -64.96 -62.24 1.67 Allowed 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 121.066 -0.254 . . . . 0.0 111.078 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -42.53 -48.68 5.35 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-O 120.908 0.385 . . . . 0.0 110.101 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.659 HD13 HG21 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -51.25 -47.84 62.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.267 178.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.9 ' HG3' HG23 ' A' ' 68' ' ' THR . 9.0 ttm180 -63.94 -65.28 0.7 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.124 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -48.62 -19.94 0.4 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -98.82 -35.37 10.14 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.795 HG22 HD23 ' A' ' 121' ' ' LEU . 0.7 OUTLIER -124.68 -6.93 7.4 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 120.326 -0.549 . . . . 0.0 112.319 -178.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 79.56 -12.35 28.09 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.488 -178.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.717 HG22 HG12 ' A' ' 119' ' ' ILE . 78.9 t -57.43 121.8 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 121.164 0.506 . . . . 0.0 111.306 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.9 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.6 OUTLIER -131.78 -38.22 1.14 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.808 178.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 113' ' ' THR . 5.8 m -61.24 71.75 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.894 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -159.81 153.34 22.52 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.097 0.475 . . . . 0.0 112.212 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -128.19 151.73 48.9 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.845 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.799 HG22 ' CE2' ' A' ' 110' ' ' PHE . 10.8 t -75.43 132.66 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 121.313 0.577 . . . . 0.0 111.575 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.891 HD13 ' HE2' ' A' ' 22' ' ' MET . 1.7 mt -109.85 -18.79 7.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.932 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.489 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.22 176.03 4.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.604 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -152.71 145.58 24.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.452 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.735 ' HA ' HG11 ' A' ' 160' ' ' VAL . 52.9 t -71.94 134.67 83.27 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.142 0.496 . . . . 0.0 111.208 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.522 ' HD2' HG13 ' A' ' 76' ' ' VAL . 33.0 Cg_endo -67.39 -56.87 0.2 Allowed 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.912 2.408 . . . . 0.0 113.01 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.697 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 1.3 p90 -97.29 178.28 5.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.813 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.582 ' O ' HD23 ' A' ' 80' ' ' LEU . 56.1 m95 -94.83 -158.58 0.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.47 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.865 ' HB2' ' HG2' ' A' ' 105' ' ' GLN . 13.1 mt . . . . . 0 N--CA 1.463 0.22 0 CA-C-O 121.127 0.489 . . . . 0.0 110.359 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.432 ' HA ' ' O ' ' A' ' 80' ' ' LEU . . . . . . . . 0 CA--C 1.522 -0.126 0 CA-C-O 121.018 0.437 . . . . 0.0 111.791 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.865 ' HG2' ' HB2' ' A' ' 80' ' ' LEU . 0.9 OUTLIER -129.2 118.82 23.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.875 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 78' ' ' TYR . 16.3 ttpp -102.91 129.07 49.5 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.939 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.615 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 22.7 m95 -102.38 165.18 11.26 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -177.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.518 ' CZ ' ' HB2' ' A' ' 53' ' ' PRO . 96.5 m-85 -137.53 153.94 49.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.546 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.588 HD12 ' O ' ' A' ' 20' ' ' CYS . 16.8 tp -101.08 139.46 36.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.402 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.799 ' CE2' HG22 ' A' ' 72' ' ' VAL . 34.0 m-85 -141.88 145.97 35.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.555 0.693 . . . . 0.0 112.828 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.706 ' HB2' HD11 ' A' ' 73' ' ' ILE . 18.7 tttt -104.69 123.3 47.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.917 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.629 ' HD1' HD21 ' A' ' 21' ' ' LEU . 46.5 t80 -78.6 95.32 5.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.868 0.366 . . . . 0.0 110.663 179.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.419 ' N ' ' O ' ' A' ' 69' ' ' SER . 65.7 p -94.16 50.89 1.43 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.876 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -151.99 -143.43 3.7 Favored Glycine 0 N--CA 1.453 -0.217 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.055 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -124.97 150.0 47.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.368 . . . . 0.0 111.244 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.476 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 20.3 p-10 -57.07 -39.03 74.16 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.519 0.676 . . . . 0.0 111.143 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -58.21 -4.58 0.37 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.101 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -89.62 -17.02 29.24 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.079 0.466 . . . . 0.0 110.128 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.717 HG12 HG22 ' A' ' 67' ' ' VAL . 7.6 mt -78.77 99.88 3.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.33 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.98 91.08 3.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.529 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.795 HD23 HG22 ' A' ' 65' ' ' THR . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 120.73 0.3 . . . . 0.0 110.631 179.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.663 ' C ' HD21 ' A' ' 34' ' ' LEU . 0.8 OUTLIER . . . . . 0 CA--C 1.52 -0.204 0 CA-C-O 121.298 0.57 . . . . 0.0 109.74 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.648 ' N ' HD21 ' A' ' 34' ' ' LEU . 4.9 m-85 -133.78 139.18 46.16 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.758 ' N ' HD22 ' A' ' 34' ' ' LEU . . . -77.58 -35.79 35.52 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.848 -178.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -156.13 152.01 27.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.872 0.368 . . . . 0.0 111.083 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.64 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 27.5 p-90 -133.15 163.99 28.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.197 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.489 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 13.4 t -158.95 167.33 29.66 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.157 0.503 . . . . 0.0 112.072 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.473 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 37.3 m95 -103.44 102.84 12.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.4 177.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 28' ' ' ILE . 26.4 m -118.21 164.91 14.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.593 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 26.8 p -71.64 168.98 17.52 Favored Pre-proline 0 C--N 1.325 -0.474 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.408 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.729 ' HG3' HD11 ' A' ' 28' ' ' ILE . 16.2 Cg_exo -58.91 -58.82 0.57 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 121.72 1.613 . . . . 0.0 110.826 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.28 -27.16 68.83 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.794 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.526 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 29.1 mt-30 -71.69 -47.47 53.85 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.205 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.715 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -56.24 -41.28 75.48 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.816 HG21 ' HG2' ' A' ' 155' ' ' LYS . 19.1 mm -61.44 -34.57 61.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.219 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.39 -50.92 23.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.262 0.553 . . . . 0.0 110.858 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.2 mp -73.49 -21.47 60.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.311 -0.858 . . . . 0.0 112.281 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.69 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 12.1 t -73.61 174.81 7.78 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.918 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.693 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 33.0 m -80.02 160.2 4.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.688 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.47 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 2.4 mt-10 -60.59 -51.9 67.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.07 0.462 . . . . 0.0 110.915 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.24 -7.65 0.15 Allowed 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -131.43 -6.38 3.75 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.612 ' HG3' HG22 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -61.74 -53.57 59.55 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 110.543 -0.169 . . . . 0.0 110.543 179.499 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 39.5 Cg_endo -67.97 -28.88 35.03 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.259 1.973 . . . . 0.0 111.347 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.689 ' O ' HG23 ' A' ' 157' ' ' VAL . 17.3 t -68.47 -52.83 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.469 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 6.1 m-30 -65.75 -37.1 85.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.784 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.816 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -57.46 -41.61 80.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.591 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.481 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.6 OUTLIER -68.35 -34.32 75.88 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.465 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 153' ' ' VAL . 53.8 t -64.9 -41.17 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.347 178.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.606 HD22 ' HB3' ' A' ' 139' ' ' PRO . 56.7 mt -63.65 -48.91 75.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.666 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -49.2 -40.1 32.16 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.735 HG11 ' HA ' ' A' ' 76' ' ' VAL . 58.5 t -67.63 -42.91 87.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.328 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.63 ' CE2' HG12 ' A' ' 157' ' ' VAL . 21.9 m-30 -80.71 5.15 16.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.38 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.607 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.85 -53.36 67.22 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.628 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.7 Cg_endo -58.77 -13.2 17.09 Favored 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 122.17 1.914 . . . . 0.0 111.729 178.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.489 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 95.1 m-70 -107.06 -19.08 13.73 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.205 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 96.5 mt . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.807 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 4.1 mtm . . . . . 0 N--CA 1.456 -0.142 0 CA-C-O 120.59 0.233 . . . . 0.0 110.383 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.526 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 12.2 t70 . . . . . 0 C--N 1.33 -0.263 0 CA-C-O 120.916 0.389 . . . . 0.0 110.54 -179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.865 ' HG2' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 121.064 0.459 . . . . 0.0 111.214 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.637 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 2.0 m-80 -131.59 173.74 10.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.46 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.615 HG13 HG13 ' A' ' 47' ' ' ILE . 6.6 m -139.55 165.32 22.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.174 0.511 . . . . 0.0 111.84 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.529 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -135.38 155.31 22.08 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 178.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.091 HG23 ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -129.67 124.51 59.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.069 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.533 ' CB ' ' HE2' ' A' ' 161' ' ' PHE . 0.5 OUTLIER -106.6 108.69 20.32 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.953 177.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.875 HD22 HG11 ' A' ' 67' ' ' VAL . 11.0 tp -104.19 124.3 48.87 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.582 -178.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.713 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -124.34 155.18 39.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.95 179.342 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.506 ' OD1' ' CE3' ' A' ' 136' ' ' TRP . 0.2 OUTLIER -92.85 176.04 6.58 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.05 0.452 . . . . 0.0 110.134 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.453 ' HA ' ' HE3' ' A' ' 111' ' ' LYS . 1.1 m-80 -57.24 -6.94 0.46 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.064 177.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.604 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 5.5 m-20 -100.46 -0.15 38.56 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.604 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 14.7 mmtm 76.97 19.86 1.33 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.291 -178.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.713 ' O ' ' HA ' ' A' ' 22' ' ' MET . 3.8 mmtt -93.57 141.58 28.31 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.69 HD12 ' N ' ' A' ' 28' ' ' ILE . 2.2 mp -101.5 143.51 14.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.669 0.747 . . . . 0.0 112.358 -178.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.657 ' CE2' HG21 ' A' ' 65' ' ' THR . 11.3 t80 -69.85 108.05 3.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.196 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.734 ' CB ' HD13 ' A' ' 142' ' ' LEU . . . -106.92 145.89 31.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.948 0.404 . . . . 0.0 110.924 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -139.5 137.52 35.57 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.236 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.808 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 25.0 p -99.19 141.75 31.55 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.998 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.581 ' NH1' ' HG2' ' A' ' 41' ' ' GLN . 1.7 mtt85 -69.59 128.34 36.14 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.728 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.5 OUTLIER -46.4 -35.73 5.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.318 0.58 . . . . 0.0 110.891 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.487 ' O ' HD13 ' A' ' 36' ' ' ILE . 4.0 m-20 -70.67 -33.97 71.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.665 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.487 HD13 ' O ' ' A' ' 35' ' ' ASP . 20.4 mm -131.05 104.75 15.16 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.914 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.55 -20.37 60.4 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.765 2.31 . . . . 0.0 112.676 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.01 -4.0 53.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.412 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.808 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.97 91.83 8.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.112 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.558 ' O ' ' HA ' ' A' ' 146' ' ' THR . 77.3 m95 -91.83 164.38 13.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.357 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.581 ' HG2' ' NH1' ' A' ' 33' ' ' ARG . 0.0 OUTLIER 174.24 175.13 0.16 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.81 0.814 . . . . 0.0 112.264 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.612 ' HG3' ' CZ3' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -108.19 156.7 37.95 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.29 177.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.439 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 10.1 Cg_endo -50.7 157.35 3.64 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.498 2.132 . . . . 0.0 112.665 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 177.99 150.62 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.6 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -160.9 -157.27 8.64 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.447 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.637 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -122.22 143.01 15.33 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.91 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.865 HD12 ' HG2' ' A' ' 15' ' ' ARG . 48.5 mt -70.01 146.71 12.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.916 0.389 . . . . 0.0 111.532 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -69.49 -175.08 0.77 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.72 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.51 -61.33 2.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.339 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.85 57.35 0.73 Allowed Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.689 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.426 ' O ' HG21 ' A' ' 47' ' ' ILE . 47.7 tp10 -117.17 155.7 28.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.693 0.283 . . . . 0.0 110.469 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -72.02 161.56 78.19 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 5.6 Cg_exo -78.3 -49.17 0.09 OUTLIER 'Trans proline' 0 CA--C 1.515 -0.441 0 C-N-CA 122.635 2.223 . . . . 0.0 111.73 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.814 ' HE ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -52.26 -46.92 65.99 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.47 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.454 ' HA ' HD12 ' A' ' 58' ' ' ILE . 70.3 m-20 -67.71 -41.85 82.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.376 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.22 -42.26 98.29 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.091 ' HB1' HG23 ' A' ' 19' ' ' ILE . . . -57.47 -54.27 48.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.855 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.513 HD11 ' CZ ' ' A' ' 54' ' ' ARG . 21.3 mt -56.39 -53.0 45.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.854 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 59' ' ' ARG . 24.1 mtt180 -61.21 -57.71 11.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.652 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 15.1 mm-40 -46.5 -46.03 18.83 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.553 0.692 . . . . 0.0 109.709 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.955 HD21 ' HB ' ' A' ' 67' ' ' VAL . 10.1 tt -52.81 -46.69 67.81 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.959 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.827 ' HD3' HG23 ' A' ' 68' ' ' THR . 0.7 OUTLIER -62.77 -63.43 1.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.995 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -50.42 -22.54 1.92 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.357 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 8.6 mt-10 -96.74 -34.76 11.22 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -177.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.657 HG21 ' CE2' ' A' ' 29' ' ' PHE . 0.8 OUTLIER -130.29 -15.44 3.67 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.465 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.549 ' HA2' ' NE ' ' A' ' 62' ' ' ARG . . . 93.07 -16.32 60.79 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.656 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.955 ' HB ' HD21 ' A' ' 61' ' ' LEU . 74.8 t -58.15 113.86 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.262 0.553 . . . . 0.0 111.937 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.827 HG23 ' HD3' ' A' ' 62' ' ' ARG . 0.2 OUTLIER -125.87 -36.78 2.35 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.716 178.075 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.9 m -63.6 73.83 0.03 OUTLIER 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.698 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -159.28 157.06 29.85 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.898 0.38 . . . . 0.0 111.981 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.8 149.08 50.42 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.101 179.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.952 HG22 ' CE2' ' A' ' 110' ' ' PHE . 19.1 t -74.21 126.3 34.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.077 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.566 HD11 ' HB2' ' A' ' 111' ' ' LYS . 1.4 mt -105.52 -17.6 7.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.236 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.45 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -171.09 175.71 4.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.484 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.0 OUTLIER -154.06 138.65 16.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.109 179.492 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.632 ' HA ' HG11 ' A' ' 160' ' ' VAL . 52.3 t -71.33 135.27 84.43 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-O 121.178 0.513 . . . . 0.0 111.16 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.521 ' HD2' HG13 ' A' ' 76' ' ' VAL . 27.3 Cg_endo -66.16 -70.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.867 2.378 . . . . 0.0 112.027 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.53 ' O ' HG12 ' A' ' 76' ' ' VAL . 6.4 p90 -78.33 170.67 16.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.095 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.609 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 48.2 m95 -93.64 -155.14 0.43 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.467 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.532 HD12 ' HD1' ' A' ' 107' ' ' TRP . 20.8 mt . . . . . 0 C--N 1.326 -0.426 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.119 0 N-CA-C 110.133 -0.321 . . . . 0.0 110.133 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.571 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 5.2 mt-30 -128.99 127.33 41.43 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.535 ' HB2' ' CD2' ' A' ' 79' ' ' TRP . 2.0 ttpt -105.67 141.38 37.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.718 178.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.612 ' CZ3' ' HG3' ' A' ' 42' ' ' MET . 54.9 m95 -105.98 163.74 12.52 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.595 ' HB2' ' HE1' ' A' ' 110' ' ' PHE . 96.0 m-85 -141.07 152.47 44.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.895 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.695 HD11 ' SD ' ' A' ' 22' ' ' MET . 17.8 tp -101.87 143.29 31.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.13 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.999 ' CE1' HG22 ' A' ' 19' ' ' ILE . 54.8 m-85 -144.51 145.08 31.66 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.637 0.732 . . . . 0.0 112.965 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.566 ' HB2' HD11 ' A' ' 73' ' ' ILE . 4.4 tttt -104.23 126.06 51.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.737 178.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.636 ' CD1' HD21 ' A' ' 21' ' ' LEU . 34.9 t80 -78.99 100.74 7.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.741 0.305 . . . . 0.0 110.868 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 72.7 p -100.83 50.06 0.88 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.993 0.425 . . . . 0.0 110.952 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -154.1 -145.58 4.19 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.294 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -121.5 150.89 40.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.017 0.437 . . . . 0.0 110.973 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.505 ' HB3' ' HH2' ' A' ' 134' ' ' TRP . 44.7 m-20 -59.11 -34.72 72.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.032 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -58.96 -2.62 0.26 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.191 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.57 -15.23 33.31 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.805 0.336 . . . . 0.0 111.037 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.745 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 11.3 mt -78.54 100.3 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.828 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -102.42 92.34 4.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.099 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.718 HD11 ' HD1' ' A' ' 134' ' ' TRP . 38.0 mt . . . . . 0 C--N 1.331 -0.215 0 CA-C-O 121.159 0.504 . . . . 0.0 110.036 179.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.571 ' O ' HD12 ' A' ' 34' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.057 0 CA-C-O 120.995 0.426 . . . . 0.0 110.673 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.531 ' CE1' HG23 ' A' ' 65' ' ' THR . 2.6 m-85 -106.67 142.6 36.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.497 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.728 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -80.77 -36.01 23.58 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.478 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.51 155.54 36.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.261 -0.47 . . . . 0.0 110.274 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.745 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 25.0 p-90 -140.45 167.53 21.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.159 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.546 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 26.6 t -163.01 176.13 10.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.286 0.565 . . . . 0.0 111.533 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.506 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 64.5 m95 -111.75 103.73 12.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.48 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.415 HG23 ' HB2' ' A' ' 142' ' ' LEU . 26.0 m -121.67 171.54 10.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.375 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.634 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 10.9 p -74.15 177.03 2.34 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 1.003 ' HB2' HD21 ' A' ' 158' ' ' LEU . 13.9 Cg_endo -74.27 -47.37 0.25 Allowed 'Trans proline' 0 N--CA 1.443 -1.481 0 C-N-CA 121.242 1.294 . . . . 0.0 109.964 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.4 -32.89 73.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.9 177.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.61 -47.97 57.46 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.021 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.734 HD13 ' CB ' ' A' ' 30' ' ' ALA . 23.9 tp -60.75 -37.61 82.38 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.715 ' O ' HG22 ' A' ' 146' ' ' THR . 31.1 mm -59.19 -40.09 80.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 121.373 0.606 . . . . 0.0 109.468 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.29 -51.67 34.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.127 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.468 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -72.76 -17.94 61.55 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.715 HG22 ' O ' ' A' ' 143' ' ' ILE . 14.2 t -74.64 -175.94 2.62 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.063 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.694 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 28.7 m -87.74 151.41 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.06 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.702 ' HG2' ' N ' ' A' ' 149' ' ' PHE . 0.6 OUTLIER -58.76 -53.41 58.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.938 0.399 . . . . 0.0 111.368 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.702 ' N ' ' HG2' ' A' ' 148' ' ' GLU . 48.0 p90 -56.18 -3.35 0.09 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.452 ' HE2' ' CE2' ' A' ' 149' ' ' PHE . 0.7 OUTLIER -133.14 -4.84 3.06 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.655 ' HG2' ' O ' ' A' ' 143' ' ' ILE . 9.1 mttt -62.37 -59.99 11.31 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.48 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 13.6 Cg_endo -56.57 -26.07 62.39 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.25 1.966 . . . . 0.0 111.635 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . . . . . . . . . 12.1 t -68.69 -54.16 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.545 ' O ' ' HB ' ' A' ' 157' ' ' VAL . 4.9 m-30 -65.3 -37.05 85.96 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.807 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.428 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -57.31 -40.46 77.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.264 179.585 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.411 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.9 OUTLIER -66.68 -29.39 69.39 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.075 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.545 ' HB ' ' O ' ' A' ' 154' ' ' TYR . 88.9 t -64.67 -39.23 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.216 179.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 1.003 HD21 ' HB2' ' A' ' 139' ' ' PRO . 0.2 OUTLIER -61.33 -50.1 74.3 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.074 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.4 m -51.95 -43.05 63.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.932 0.396 . . . . 0.0 110.028 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.632 HG11 ' HA ' ' A' ' 76' ' ' VAL . 50.0 t -68.15 -42.2 84.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.346 0.593 . . . . 0.0 109.433 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.544 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 13.2 m-30 -81.28 5.14 18.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.739 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.616 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.44 -52.14 76.38 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.692 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 17.8 Cg_endo -59.72 -12.06 16.71 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.263 1.975 . . . . 0.0 112.045 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.528 ' O ' ' HE3' ' A' ' 26' ' ' LYS . 92.3 m-70 -109.17 -20.77 12.87 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.337 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 94.0 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.974 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.479 ' C ' ' HB2' ' A' ' 78' ' ' TYR . 0.7 OUTLIER . . . . . 0 CA--C 1.522 -0.111 0 CA-C-O 120.711 0.291 . . . . 0.0 110.49 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.673 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 1.8 t0 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.319 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.626 ' HG3' ' CZ3' ' A' ' 79' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.333 0 CA-C-O 121.274 0.559 . . . . 0.0 110.218 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.991 ' HB2' ' HG2' ' A' ' 105' ' ' GLN . 3.0 m120 -135.48 172.86 12.4 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.978 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.706 HG13 ' CG1' ' A' ' 47' ' ' ILE . 5.3 m -136.98 168.7 21.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.592 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -140.45 154.6 24.23 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.388 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.011 HG23 ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -129.05 125.33 62.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.158 0.504 . . . . 0.0 111.98 -178.851 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.526 ' O ' HD12 ' A' ' 109' ' ' LEU . 43.4 t -104.57 102.85 12.46 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 178.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.887 HD22 HG11 ' A' ' 67' ' ' VAL . 24.7 tp -104.14 119.2 38.42 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.366 0.603 . . . . 0.0 111.659 -178.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.689 ' HE3' HD13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -119.86 158.92 25.63 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.786 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.654 ' ND2' ' HB3' ' A' ' 112' ' ' PHE . 6.9 m120 -98.02 179.1 4.89 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.806 0.812 . . . . 0.0 111.819 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -58.44 -6.55 0.7 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.354 -1.293 . . . . 0.0 111.464 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.546 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.6 OUTLIER -101.21 3.39 40.92 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.726 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 3.1 mmpp? 72.08 22.53 3.67 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -178.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 22' ' ' MET . 10.3 mttt -95.02 149.97 20.67 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.725 HG13 ' HA ' ' A' ' 139' ' ' PRO . 1.9 mm -100.98 138.51 24.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.3 0.571 . . . . 0.0 111.519 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.627 ' CE1' HD13 ' A' ' 119' ' ' ILE . 72.6 t80 -73.63 133.62 43.49 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.358 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.828 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -133.53 152.68 51.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.82 0.343 . . . . 0.0 111.175 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.556 ' HB1' ' CB ' ' A' ' 131' ' ' PHE . . . -145.4 136.19 24.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.939 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.644 ' HA ' ' NH2' ' A' ' 33' ' ' ARG . 39.3 p -99.41 147.73 24.95 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.99 0.424 . . . . 0.0 111.829 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.644 ' NH2' ' HA ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -69.9 131.38 44.35 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.933 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.758 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.5 OUTLIER -57.13 51.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 179.694 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.619 ' N ' ' O ' ' A' ' 33' ' ' ARG . 0.6 OUTLIER -175.31 -26.69 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.666 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.517 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 5.3 mm -119.92 106.54 41.27 Favored Pre-proline 0 CA--C 1.53 0.189 0 CA-C-O 120.968 0.413 . . . . 0.0 110.649 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.22 -63.76 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.447 2.765 . . . . 0.0 114.019 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -64.91 0.47 1.19 Allowed 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.54 ' HB1' ' HE ' ' A' ' 33' ' ' ARG . . . -90.56 110.91 22.04 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 120.528 0.204 . . . . 0.0 110.838 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.705 ' O ' ' HA ' ' A' ' 146' ' ' THR . 74.4 m95 -118.78 150.57 39.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.746 0.308 . . . . 0.0 110.611 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.581 ' HG3' ' NH2' ' A' ' 33' ' ' ARG . 67.0 mt-30 -157.96 173.4 16.82 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.385 0.612 . . . . 0.0 111.687 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.438 ' SD ' HG21 ' A' ' 28' ' ' ILE . 3.3 mtm -106.63 152.77 40.84 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.958 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.527 ' O ' HG12 ' A' ' 19' ' ' ILE . 12.5 Cg_endo -55.68 144.22 76.5 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.124 1.883 . . . . 0.0 111.499 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.433 ' CB ' ' HA2' ' A' ' 18' ' ' GLY . 3.9 pt20 -175.94 157.14 1.86 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.819 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.43 ' HA3' ' OE1' ' A' ' 60' ' ' GLU . . . -161.89 -159.42 10.16 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.469 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.61 ' C ' HG13 ' A' ' 47' ' ' ILE . . . -99.4 -148.72 23.43 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.595 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.706 ' CG1' HG13 ' A' ' 17' ' ' VAL . 7.5 mt -158.68 141.03 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 122.803 0.441 . . . . 0.0 110.077 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -67.84 -173.45 0.35 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.336 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.54 -81.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.41 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -107.49 54.88 0.54 Allowed Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.06 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -112.07 136.78 51.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.773 0.32 . . . . 0.0 110.928 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.479 ' HB2' ' ND2' ' A' ' 55' ' ' ASN . 13.5 m-20 -66.52 147.46 98.96 Favored Pre-proline 0 N--CA 1.453 -0.285 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.34 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.572 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 23.1 Cg_exo -64.37 -48.51 4.5 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 123.077 2.518 . . . . 0.0 113.393 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.887 ' HE ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -45.72 -50.83 13.34 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.603 -179.428 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.479 ' ND2' ' HB2' ' A' ' 52' ' ' ASP . 22.2 p30 -65.7 -42.07 91.6 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.7 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.446 ' N ' ' OD1' ' A' ' 55' ' ' ASN . . . -60.29 -41.9 94.34 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.011 ' HB1' HG23 ' A' ' 19' ' ' ILE . . . -57.78 -53.37 58.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.247 178.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.783 HD11 ' NE ' ' A' ' 54' ' ' ARG . 33.0 mt -60.26 -52.32 62.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.932 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.68 -56.66 17.33 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.353 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.43 ' OE1' ' HA3' ' A' ' 45' ' ' GLY . 47.4 mm-40 -47.78 -47.31 30.86 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.902 HD21 ' HB ' ' A' ' 67' ' ' VAL . 10.2 tt -50.68 -50.46 54.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.873 178.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.82 ' HG3' HG23 ' A' ' 68' ' ' THR . 32.9 ttt180 -61.55 -63.24 1.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.492 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -49.85 -19.36 0.65 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.25 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -101.28 -35.38 9.28 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.584 HG21 ' CE2' ' A' ' 29' ' ' PHE . 1.3 p -126.08 -1.23 7.12 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.74 -13.12 4.3 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.027 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.902 ' HB ' HD21 ' A' ' 61' ' ' LEU . 71.1 t -58.52 111.57 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-O 121.106 0.479 . . . . 0.0 111.273 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.82 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.8 OUTLIER -121.6 -41.44 2.48 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.921 178.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 113' ' ' THR . 20.3 m -59.95 74.14 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.33 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.522 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.76 156.72 23.22 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.33 151.64 50.61 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.478 179.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.967 HG22 ' CE2' ' A' ' 110' ' ' PHE . 6.5 t -75.95 127.61 37.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.527 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.689 HD13 ' HE3' ' A' ' 22' ' ' MET . 1.2 mt -106.68 -19.72 6.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.799 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.504 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.54 176.68 4.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.955 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -154.76 146.16 23.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.422 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.886 ' HA ' HG11 ' A' ' 160' ' ' VAL . 54.3 t -70.71 136.82 85.57 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.624 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.522 ' HD2' HG11 ' A' ' 160' ' ' VAL . 17.5 Cg_endo -55.48 -62.44 0.27 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.901 2.401 . . . . 0.0 112.568 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.673 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -100.47 -175.87 3.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.371 -179.186 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.643 ' CD1' ' HD3' ' A' ' 106' ' ' LYS . 40.4 m95 -90.05 -160.09 0.66 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.007 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.506 HD11 HG22 ' A' ' 157' ' ' VAL . 36.2 mt . . . . . 0 N--CA 1.465 0.282 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 -0.087 0 CA-C-O 120.862 0.363 . . . . 0.0 110.869 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.991 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 45.8 mt-30 -130.33 124.66 32.81 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -178.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.643 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 16.3 ttpp -103.41 138.1 40.61 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.98 178.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.592 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 14.3 m95 -104.76 165.21 11.22 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.346 0.593 . . . . 0.0 112.428 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.695 ' HB2' ' HE1' ' A' ' 110' ' ' PHE . 96.1 m-85 -142.17 152.49 43.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.0 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.526 HD12 ' O ' ' A' ' 20' ' ' CYS . 18.1 tp -98.83 137.68 37.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.86 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.967 ' CE2' HG22 ' A' ' 72' ' ' VAL . 49.2 m-85 -139.03 145.46 39.64 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.575 ' HB2' HD11 ' A' ' 73' ' ' ILE . 14.6 tttm -104.0 124.04 48.3 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.771 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.864 ' HD2' HD21 ' A' ' 21' ' ' LEU . 36.7 t80 -78.23 96.46 5.23 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.889 0.376 . . . . 0.0 110.568 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.452 ' H ' ' HA ' ' A' ' 70' ' ' ALA . 71.0 p -95.33 57.44 1.98 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.362 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.404 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -163.06 -143.81 3.82 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.546 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.495 ' N ' ' HE1' ' A' ' 112' ' ' PHE . 7.4 mm100 -123.82 146.66 48.2 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.019 0.438 . . . . 0.0 111.463 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.424 ' HB3' ' CH2' ' A' ' 134' ' ' TRP . 90.3 m-20 -62.05 -23.57 66.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.834 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -3.92 0.45 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.971 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.0 tp10 -90.27 -18.05 26.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.065 0.46 . . . . 0.0 110.544 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.627 HD13 ' CE1' ' A' ' 29' ' ' PHE . 8.4 mt -82.33 104.41 10.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.834 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.6 p-10 -102.61 -26.41 13.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.032 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.596 HD11 ' HD1' ' A' ' 134' ' ' TRP . 68.0 mt . . . . . 0 N--CA 1.469 0.479 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 179.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.464 0.244 0 CA-C-O 120.685 0.278 . . . . 0.0 111.35 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.556 ' CB ' ' HB1' ' A' ' 31' ' ' ALA . 3.2 m-85 -130.76 140.84 50.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.092 0.472 . . . . 0.0 110.911 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.758 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -78.44 -35.77 32.12 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.785 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -155.75 152.46 28.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.369 -0.416 . . . . 0.0 110.74 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.596 ' HD1' HD11 ' A' ' 121' ' ' LEU . 29.0 p-90 -132.2 164.61 25.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.118 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.428 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 23.4 t -159.46 165.74 32.45 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.325 0.583 . . . . 0.0 112.048 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.564 ' CD2' ' OD1' ' A' ' 23' ' ' ASN . 91.6 m95 -108.39 102.09 11.23 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.481 178.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' ' 28' ' ' ILE . 28.9 m -117.47 171.29 6.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.837 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.585 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 27.8 p -71.99 167.1 34.54 Favored Pre-proline 0 CA--C 1.513 -0.465 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.889 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.725 ' HA ' HG13 ' A' ' 28' ' ' ILE . 21.7 Cg_exo -57.7 -58.83 0.69 Allowed 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.428 1.418 . . . . 0.0 109.889 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.11 -27.17 68.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.035 178.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.474 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 2.0 mm-40 -71.91 -48.36 46.04 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.1 0.476 . . . . 0.0 110.259 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.828 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -55.37 -40.74 71.69 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.22 179.711 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.787 HG21 ' HG2' ' A' ' 155' ' ' LYS . 27.3 mm -61.83 -31.84 52.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.329 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.73 -53.42 10.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.354 0.597 . . . . 0.0 110.33 179.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.08 -18.62 61.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.835 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.705 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 14.8 t -73.77 174.69 8.07 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.395 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.402 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 18.7 m -86.41 149.56 4.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.589 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.605 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 19.9 mt-10 -47.33 -52.3 16.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.95 0.405 . . . . 0.0 111.334 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -55.26 -3.71 0.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . 10.2 mmtm -136.08 -8.2 2.06 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -178.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.746 ' HG3' ' CG2' ' A' ' 143' ' ' ILE . 2.6 ttpp -64.53 -57.77 15.87 Favored Pre-proline 0 C--N 1.322 -0.589 0 C-N-CA 121.145 -0.222 . . . . 0.0 110.66 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.605 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 36.7 Cg_endo -66.06 -30.95 46.88 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.566 2.177 . . . . 0.0 111.469 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.801 ' O ' HG23 ' A' ' 157' ' ' VAL . 23.4 t -68.07 -51.71 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.587 ' CZ ' ' HB3' ' A' ' 150' ' ' LYS . 15.4 m-30 -65.36 -39.17 91.98 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.591 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.787 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -54.41 -45.26 72.9 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.934 -179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.405 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.7 OUTLIER -66.94 -35.46 80.03 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.307 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 153' ' ' VAL . 46.4 t -65.16 -41.63 92.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.721 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.499 HD22 ' HB3' ' A' ' 139' ' ' PRO . 30.1 mt -63.41 -43.03 98.7 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.164 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.88 -38.45 70.18 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.886 HG11 ' HA ' ' A' ' 76' ' ' VAL . 85.0 t -68.79 -43.08 83.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.619 ' CE2' HG12 ' A' ' 157' ' ' VAL . 22.2 m-30 -80.77 5.19 16.57 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.964 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.593 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.32 -52.89 71.21 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.07 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.4 Cg_endo -57.75 -13.41 14.35 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 121.664 1.576 . . . . 0.0 111.741 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.504 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 86.9 m-70 -108.06 -21.91 12.61 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.09 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 85.9 mt . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.397 -0.811 . . . . 0.0 110.569 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.2 mtm . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.804 0.335 . . . . 0.0 110.395 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.728 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 4.2 p30 . . . . . 0 C--N 1.331 -0.236 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.85 -179.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.618 ' HB2' ' HZ3' ' A' ' 79' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.122 0 CA-C-O 121.239 0.542 . . . . 0.0 111.862 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.678 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 2.1 m-80 -131.18 174.95 9.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.742 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.768 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 16.0 m -143.82 157.81 16.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.95 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.59 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -127.96 167.24 20.3 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.22 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.057 HG21 HD22 ' A' ' 61' ' ' LEU . 5.3 mp -126.91 123.2 62.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.24 0.543 . . . . 0.0 112.461 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.654 ' O ' HD12 ' A' ' 109' ' ' LEU . 1.4 t -107.49 96.12 6.18 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.438 -0.801 . . . . 0.0 108.9 178.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.817 HD22 HG11 ' A' ' 67' ' ' VAL . 26.5 tp -99.61 122.97 43.42 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.917 -178.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.612 ' HG2' HD11 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -119.64 151.53 38.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.399 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.711 ' OD1' ' CE3' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -96.24 175.44 6.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.313 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -58.31 -3.68 0.29 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.352 177.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.595 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.7 OUTLIER -99.1 -1.26 39.96 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 120.605 0.24 . . . . 0.0 111.376 -179.251 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.595 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 1.4 mmtm 75.12 20.98 2.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.961 -178.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.721 ' C ' HD12 ' A' ' 28' ' ' ILE . 4.8 mttt -93.41 -178.64 4.8 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.721 HD12 ' C ' ' A' ' 27' ' ' LYS . 2.8 mp -135.67 144.93 32.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.585 0.707 . . . . 0.0 111.886 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.578 ' CE1' HD13 ' A' ' 119' ' ' ILE . 33.2 t80 -66.17 108.33 2.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.985 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.654 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -102.99 140.19 37.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.163 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.07 134.16 32.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.747 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.58 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 55.6 p -100.12 149.21 23.75 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.075 0.464 . . . . 0.0 111.785 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.622 ' O ' ' N ' ' A' ' 35' ' ' ASP . 26.3 mtp85 -72.42 129.95 39.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.489 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.716 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -55.72 56.22 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.995 0.518 . . . . 0.0 112.346 179.799 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.622 ' N ' ' O ' ' A' ' 33' ' ' ARG . 3.0 p-10 -177.08 -33.03 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.157 0.503 . . . . 0.0 109.866 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.459 HD12 ' HE ' ' A' ' 33' ' ' ARG . 21.1 mt -116.66 105.72 49.46 Favored Pre-proline 0 N--CA 1.452 -0.366 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.482 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.52 -19.62 21.54 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.442 2.095 . . . . 0.0 112.88 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -92.38 -9.74 40.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.551 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.636 ' HB1' HG13 ' A' ' 147' ' ' VAL . . . -94.19 106.44 18.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.805 0.336 . . . . 0.0 111.278 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.594 ' O ' ' HA ' ' A' ' 146' ' ' THR . 68.9 m95 -105.71 144.61 32.22 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.75 178.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.589 ' HG3' ' HG1' ' A' ' 146' ' ' THR . 0.8 OUTLIER -153.73 -125.73 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.095 -179.742 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.632 ' SD ' HD21 ' A' ' 142' ' ' LEU . 0.0 OUTLIER 177.62 160.81 0.56 Allowed Pre-proline 0 N--CA 1.453 -0.32 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.743 ' HG3' HD13 ' A' ' 61' ' ' LEU . 1.6 Cg_endo -40.69 142.29 0.74 Allowed 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 123.546 2.831 . . . . 0.0 113.03 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.768 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -172.62 146.4 1.68 Allowed 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.884 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -160.62 -162.63 12.71 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.332 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.678 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -120.05 139.93 14.21 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.887 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.629 ' CG1' HG13 ' A' ' 17' ' ' VAL . 28.7 mt -69.37 142.03 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.838 0.352 . . . . 0.0 111.131 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -69.01 -174.12 0.57 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.93 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -49.66 -79.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.049 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -110.1 50.32 0.78 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.285 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -111.57 149.59 31.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.822 0.344 . . . . 0.0 110.576 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.41 162.38 70.57 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.159 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.565 ' HB3' HD11 ' A' ' 47' ' ' ILE . 1.2 Cg_endo -82.96 -51.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.974 2.45 . . . . 0.0 112.021 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.737 ' CZ ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -49.98 -47.33 52.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.623 179.594 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -69.25 -38.26 78.37 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.046 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.82 -45.02 95.63 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.679 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -58.05 -55.48 34.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.405 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.573 HD11 ' CD ' ' A' ' 54' ' ' ARG . 47.2 mt -57.55 -46.53 86.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.183 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.08 -66.08 0.59 Allowed 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.278 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.551 ' CG ' HD11 ' A' ' 19' ' ' ILE . 23.6 pt-20 -43.06 -40.45 3.12 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.114 0.483 . . . . 0.0 110.199 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.057 HD22 HG21 ' A' ' 19' ' ' ILE . 4.9 tp -52.23 -47.42 65.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.376 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.86 ' HG2' HG23 ' A' ' 68' ' ' THR . 1.6 tmm_? -63.51 -63.91 1.05 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.957 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -51.13 -21.17 1.8 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.17 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -97.53 -38.41 9.58 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.722 HG22 ' CD2' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -128.88 -15.15 4.37 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -178.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.51 ' HA2' ' HD2' ' A' ' 62' ' ' ARG . . . 91.54 -14.23 64.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.193 -1.004 . . . . 0.0 112.835 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.817 HG11 HD22 ' A' ' 21' ' ' LEU . 55.7 t -56.26 110.57 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.104 0.478 . . . . 0.0 111.321 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.86 HG23 ' HG2' ' A' ' 62' ' ' ARG . 0.9 OUTLIER -122.34 -39.8 2.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.466 178.203 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.407 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 9.4 m -62.37 74.39 0.02 OUTLIER 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.456 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -162.85 154.86 18.33 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.922 0.391 . . . . 0.0 111.795 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.22 146.63 50.35 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.209 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.737 HG21 ' CZ ' ' A' ' 54' ' ' ARG . 8.5 t -76.73 129.96 36.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.202 0.525 . . . . 0.0 112.224 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.702 HD11 ' HB2' ' A' ' 111' ' ' LYS . 0.7 OUTLIER -113.3 -18.12 7.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.947 179.43 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.464 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -169.04 178.63 4.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.147 0.499 . . . . 0.0 112.013 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.465 ' HB3' ' HD1' ' A' ' 108' ' ' PHE . 1.4 pm0 -157.66 152.71 25.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.882 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.841 ' HA ' HG11 ' A' ' 160' ' ' VAL . 33.7 t -72.93 136.61 79.78 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.265 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.615 ' HD2' HG21 ' A' ' 160' ' ' VAL . 20.7 Cg_endo -59.45 -76.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.943 2.428 . . . . 0.0 112.564 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.728 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -80.65 171.68 14.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.698 -179.179 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.618 ' HZ3' ' HB2' ' A' ' 15' ' ' ARG . 27.9 m95 -94.33 97.53 10.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.608 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.512 ' CD1' HG22 ' A' ' 157' ' ' VAL . 51.1 mt . . . . . 0 C--N 1.33 -0.278 0 CA-C-O 120.8 0.333 . . . . 0.0 110.89 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.506 ' O ' ' HA ' ' A' ' 15' ' ' ARG . . . . . . . . 0 C--O 1.224 -0.274 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.551 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 2.9 mt-30 -123.19 123.75 41.48 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.427 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 1.0 OUTLIER -104.25 132.66 50.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.435 178.364 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.59 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 51.6 m95 -101.74 166.53 10.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.241 0.543 . . . . 0.0 112.448 -178.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.575 ' CD1' ' HG2' ' A' ' 54' ' ' ARG . 98.0 m-85 -141.47 151.63 43.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.955 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.654 HD12 ' O ' ' A' ' 20' ' ' CYS . 29.5 tp -107.68 126.73 52.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.968 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.883 ' CE2' HG23 ' A' ' 19' ' ' ILE . 4.1 m-85 -132.8 145.54 51.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.315 0.578 . . . . 0.0 111.918 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.702 ' HB2' HD11 ' A' ' 73' ' ' ILE . 47.8 tttt -95.27 127.69 41.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.602 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.804 ' CD1' HD21 ' A' ' 21' ' ' LEU . 38.2 t80 -78.33 101.33 7.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.898 0.38 . . . . 0.0 110.853 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.6 p -100.53 53.07 0.87 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.702 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.407 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -158.04 -146.49 4.53 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.409 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -121.85 152.1 39.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.995 0.426 . . . . 0.0 111.26 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.449 ' HB3' ' HH2' ' A' ' 134' ' ' TRP . 61.4 m-20 -60.12 -35.1 74.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.874 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -58.18 -2.05 0.16 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.116 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 116' ' ' ASP . 0.7 OUTLIER -90.41 -15.8 30.26 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.942 0.401 . . . . 0.0 110.853 179.543 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.68 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 14.3 mt -81.05 100.6 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.223 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 65' ' ' THR . 6.5 p-10 -103.78 93.68 5.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.339 178.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.722 ' CD2' HG22 ' A' ' 65' ' ' THR . 39.0 mt . . . . . 0 C--N 1.331 -0.226 0 CA-C-O 121.076 0.465 . . . . 0.0 110.1 179.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.653 ' O ' HD12 ' A' ' 34' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.461 0.084 0 CA-C-O 120.796 0.331 . . . . 0.0 111.371 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.675 ' CE2' HG23 ' A' ' 65' ' ' THR . 2.2 m-85 -102.23 139.71 37.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.136 0.493 . . . . 0.0 110.573 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.716 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -82.34 -36.89 16.01 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.013 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -151.57 149.33 29.05 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.86 0.362 . . . . 0.0 110.53 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.707 ' HD1' HD11 ' A' ' 121' ' ' LEU . 31.9 p-90 -136.53 166.41 23.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.063 0.458 . . . . 0.0 111.236 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.483 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 29.5 t -162.56 178.48 8.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.381 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.711 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 64.8 m95 -114.21 99.66 7.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.742 178.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 22.2 m -113.89 169.05 5.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.347 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.572 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 20.9 p -74.71 171.91 10.29 Favored Pre-proline 0 C--N 1.324 -0.536 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.881 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.669 ' HB3' HD22 ' A' ' 158' ' ' LEU . 13.1 Cg_exo -62.47 -54.36 1.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.488 1.459 . . . . 0.0 110.279 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.67 -29.1 70.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.995 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.443 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 33.3 mt-30 -71.69 -47.33 54.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.328 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.654 HD13 ' HB2' ' A' ' 30' ' ' ALA . 64.2 tp -57.95 -38.92 76.86 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.714 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 27.7 mm -61.27 -38.8 80.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.517 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.92 -50.48 49.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.223 0.535 . . . . 0.0 110.565 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.429 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -74.54 -19.16 60.45 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.718 -179.154 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.949 HG23 ' HG3' ' A' ' 151' ' ' LYS . 14.7 t -74.88 174.03 9.82 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.487 -179.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.636 HG13 ' HB1' ' A' ' 39' ' ' ALA . 24.1 m -78.08 154.73 5.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.46 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.759 ' HA ' ' HD3' ' A' ' 151' ' ' LYS . 13.5 mt-10 -60.89 -54.85 39.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.079 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.517 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 35.7 p90 -55.52 -1.48 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.429 ' HG3' ' CD2' ' A' ' 149' ' ' PHE . 58.1 mttt -135.27 -6.82 2.29 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.949 ' HG3' HG23 ' A' ' 146' ' ' THR . 14.0 mtpp -60.71 -62.19 6.47 Favored Pre-proline 0 CA--C 1.531 0.237 0 O-C-N 122.317 -0.239 . . . . 0.0 111.335 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.495 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 18.6 Cg_endo -59.92 -27.13 84.24 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.239 1.959 . . . . 0.0 111.334 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.645 ' O ' HG23 ' A' ' 157' ' ' VAL . 26.3 t -68.8 -50.85 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.474 ' HE1' ' CZ2' ' A' ' 107' ' ' TRP . 14.3 m-30 -65.78 -39.56 91.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.672 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.655 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.5 OUTLIER -56.09 -40.65 73.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.332 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.439 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.6 OUTLIER -70.57 -31.41 68.43 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 153' ' ' VAL . 90.3 t -66.28 -41.31 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.593 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.669 HD22 ' HB3' ' A' ' 139' ' ' PRO . 58.7 mt -63.78 -41.97 97.86 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.468 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 14.5 m -54.54 -41.02 69.25 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.841 HG11 ' HA ' ' A' ' 76' ' ' VAL . 98.4 t -66.57 -44.07 90.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.553 178.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.625 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 22.4 m-30 -81.21 5.09 18.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.384 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.7 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . . . -59.4 -50.45 87.29 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.015 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.7 ' HD3' ' HB3' ' A' ' 162' ' ' ALA . 36.8 Cg_exo -59.22 -11.86 14.42 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.528 2.152 . . . . 0.0 112.051 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.464 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 73.8 m-70 -113.13 -17.52 12.37 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.437 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 97.9 mt . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.791 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 4.0 mpp? . . . . . 0 N--CA 1.461 0.098 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.607 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 30.1 t70 . . . . . 0 C--N 1.327 -0.378 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.822 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.556 ' HG2' HD12 ' A' ' 47' ' ' ILE . 1.1 ttp180 . . . . . 0 N--CA 1.461 0.108 0 CA-C-O 120.964 0.412 . . . . 0.0 111.181 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.78 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 0.9 OUTLIER -134.48 167.35 20.93 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.387 179.091 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.644 HG13 ' CG1' ' A' ' 47' ' ' ILE . 12.5 m -136.05 166.33 27.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.976 0.417 . . . . 0.0 111.289 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.536 ' HA3' ' CE3' ' A' ' 107' ' ' TRP . . . -134.02 154.77 21.51 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.546 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.952 HG21 HD22 ' A' ' 61' ' ' LEU . 3.7 mp -125.45 121.5 60.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.074 0.464 . . . . 0.0 111.862 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.553 ' O ' HD12 ' A' ' 109' ' ' LEU . 0.4 OUTLIER -101.1 92.24 4.91 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.742 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.778 HD22 HG11 ' A' ' 67' ' ' VAL . 22.7 tp -96.57 113.38 24.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.534 -178.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.515 ' SD ' HD11 ' A' ' 109' ' ' LEU . 1.3 ptt? -116.14 167.24 11.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.707 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.636 ' OD1' ' CE3' ' A' ' 136' ' ' TRP . 0.0 OUTLIER -102.09 168.99 9.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.384 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -56.79 -3.55 0.12 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.418 177.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.573 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 1.8 m-20 -99.55 3.03 45.28 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 3.7 mmtm 74.46 20.4 2.52 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.114 -178.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.582 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 1.2 mmtt -94.85 145.35 24.96 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.809 HD11 ' HG3' ' A' ' 139' ' ' PRO . 1.1 mm -99.32 140.95 17.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.995 0.426 . . . . 0.0 112.082 -177.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.495 ' CE1' HD13 ' A' ' 119' ' ' ILE . 73.1 t80 -78.15 135.23 37.62 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.463 178.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.621 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . . . -141.3 153.83 45.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.776 0.322 . . . . 0.0 110.79 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.636 ' HB1' ' HB3' ' A' ' 131' ' ' PHE . . . -142.55 145.13 33.29 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.64 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 17.6 p -94.31 148.18 22.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.543 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.4 mtp180 -69.35 133.6 48.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.084 0.469 . . . . 0.0 111.006 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.001 HD23 ' H ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -38.47 -48.78 1.42 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.612 -178.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.426 ' O ' HD13 ' A' ' 36' ' ' ILE . 0.8 OUTLIER -75.17 -34.9 61.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.171 -179.569 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.426 HD13 ' O ' ' A' ' 35' ' ' ASP . 29.2 mm -123.31 104.41 34.73 Favored Pre-proline 0 C--O 1.233 0.184 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.01 -16.89 45.89 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.862 2.375 . . . . 0.0 112.377 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -89.89 -10.15 46.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.425 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.633 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.78 88.64 6.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.935 0.398 . . . . 0.0 110.338 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.621 ' O ' ' HA ' ' A' ' 146' ' ' THR . 75.8 m95 -85.57 146.53 26.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.365 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.494 ' HB3' ' OH ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -165.41 162.16 19.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.921 -179.871 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.751 ' SD ' HD21 ' A' ' 142' ' ' LEU . 0.0 OUTLIER -98.3 156.93 35.25 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.079 179.206 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.524 ' HG3' HD13 ' A' ' 61' ' ' LEU . 1.9 Cg_endo -44.34 155.07 0.26 Allowed 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.048 2.499 . . . . 0.0 113.08 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.587 ' HA ' HD12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -176.17 171.36 2.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.207 -179.576 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.484 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . 176.9 152.55 9.92 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.677 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.78 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -77.75 135.97 17.35 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.602 -0.809 . . . . 0.0 113.358 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.644 ' CG1' HG13 ' A' ' 17' ' ' VAL . 16.9 mt -69.46 145.6 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.734 0.302 . . . . 0.0 111.007 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.57 -175.66 0.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.028 0.442 . . . . 0.0 111.257 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.22 -47.5 65.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.856 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -143.34 52.79 0.62 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.286 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -112.9 150.22 32.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.772 0.32 . . . . 0.0 110.446 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.1 156.26 90.21 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.903 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 3.0 Cg_exo -73.93 -49.35 0.2 Allowed 'Trans proline' 0 CA--C 1.515 -0.442 0 C-N-CA 122.41 2.074 . . . . 0.0 111.113 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.923 ' CZ ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -53.13 -46.57 68.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.307 179.293 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.542 ' HA ' HD12 ' A' ' 58' ' ' ILE . 84.9 m-20 -67.7 -40.11 84.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.135 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.04 -44.7 96.13 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.808 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -56.07 -52.21 65.07 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.931 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.705 HD11 ' HE ' ' A' ' 54' ' ' ARG . 22.4 mt -56.43 -56.45 13.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.548 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -60.05 4.42 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.672 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.484 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -45.87 -47.53 16.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.155 0.503 . . . . 0.0 109.744 179.081 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.952 HD22 HG21 ' A' ' 19' ' ' ILE . 4.2 tp -50.25 -46.64 55.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.324 178.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.798 ' HG3' HG23 ' A' ' 68' ' ' THR . 18.7 ttm180 -64.98 -63.51 1.09 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.357 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -49.78 -22.66 1.5 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.436 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.428 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 31.3 mt-10 -97.01 -36.58 10.47 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -177.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.542 HG22 ' CD2' ' A' ' 121' ' ' LEU . 0.6 OUTLIER -124.26 -13.77 7.13 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 86.04 -16.24 43.93 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.232 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.778 HG11 HD22 ' A' ' 21' ' ' LEU . 52.3 t -58.13 117.26 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-O 121.254 0.549 . . . . 0.0 111.42 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.798 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.9 OUTLIER -122.64 -38.13 2.68 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.652 178.568 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.8 m -62.31 73.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.581 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.595 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -160.74 157.69 27.35 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.019 0.438 . . . . 0.0 112.126 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -131.53 152.19 50.96 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.95 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.923 HG21 ' CZ ' ' A' ' 54' ' ' ARG . 4.2 t -75.24 127.15 36.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.148 0.499 . . . . 0.0 111.428 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.569 HD11 ' HB2' ' A' ' 111' ' ' LYS . 1.6 mt -107.95 -19.67 6.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.596 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.454 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -169.56 176.78 4.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.0 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.3 OUTLIER -154.89 146.44 23.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.752 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.821 ' HA ' HG11 ' A' ' 160' ' ' VAL . 50.7 t -72.58 140.58 81.82 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.106 0.479 . . . . 0.0 111.203 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.635 ' HD2' HG13 ' A' ' 76' ' ' VAL . 26.8 Cg_endo -62.08 -62.67 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.27 2.647 . . . . 0.0 113.138 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -96.53 177.05 5.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.049 -178.514 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.49 ' CE3' ' HB2' ' A' ' 106' ' ' LYS . 49.9 m95 -93.38 97.45 10.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.174 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.923 HD12 ' CD1' ' A' ' 107' ' ' TRP . 38.3 mt . . . . . 0 C--N 1.326 -0.419 0 CA-C-O 120.885 0.374 . . . . 0.0 111.087 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.396 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.732 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 10.6 mt-30 -122.21 126.47 48.32 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.49 ' HB2' ' CE3' ' A' ' 79' ' ' TRP . 2.4 ttmt -102.69 131.96 49.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.245 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.923 ' CD1' HD12 ' A' ' 80' ' ' LEU . 74.6 m95 -101.99 161.35 13.74 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -177.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.505 ' CE1' ' HG2' ' A' ' 54' ' ' ARG . 99.5 m-85 -142.64 150.53 40.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.784 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.63 HD12 ' H ' ' A' ' 110' ' ' PHE . 15.0 tp -98.56 139.72 33.87 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.255 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.63 ' H ' HD12 ' A' ' 109' ' ' LEU . 32.0 m-85 -138.81 142.72 38.71 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -178.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.595 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 1.1 tttt -102.28 120.18 40.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.679 178.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.612 ' HB2' HD11 ' A' ' 21' ' ' LEU . 65.4 t80 -78.23 98.72 5.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.796 0.332 . . . . 0.0 110.596 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.4 p -95.25 39.64 1.11 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.601 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.402 ' C ' ' CE2' ' A' ' 112' ' ' PHE . . . -135.64 -148.22 5.58 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.268 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.444 ' HB2' ' HG2' ' A' ' 117' ' ' GLN . 0.1 OUTLIER -125.45 150.32 47.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.857 0.36 . . . . 0.0 111.137 179.474 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -58.43 -39.7 80.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.483 0.658 . . . . 0.0 110.662 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.444 ' HG2' ' HB2' ' A' ' 115' ' ' GLN . 14.8 pt20 -58.61 -3.5 0.31 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.913 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -89.03 -22.14 23.11 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.238 0.542 . . . . 0.0 110.234 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.589 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 10.5 mt -83.05 100.11 6.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.19 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.428 ' O ' ' C ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -97.51 9.38 42.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.021 -179.546 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.542 ' CD2' HG22 ' A' ' 65' ' ' THR . 71.7 mt . . . . . 0 N--CA 1.467 0.399 0 CA-C-O 121.22 0.533 . . . . 0.0 111.56 -179.264 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.692 ' C ' HD21 ' A' ' 34' ' ' LEU . 3.9 tp10 . . . . . 0 N--CA 1.454 -0.247 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.722 ' N ' HD21 ' A' ' 34' ' ' LEU . 2.1 m-85 -131.91 139.0 48.6 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 178.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.708 ' N ' HD22 ' A' ' 34' ' ' LEU . . . -85.92 -33.13 16.09 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.688 -178.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 31' ' ' ALA . 1.9 tt0 -150.78 153.87 36.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.338 0.113 . . . . 0.0 110.947 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.611 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 43.3 p-90 -135.36 168.28 19.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.057 0.456 . . . . 0.0 111.691 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.431 ' N ' ' HZ3' ' A' ' 40' ' ' TRP . 15.9 t -162.74 167.26 23.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.526 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.636 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 53.7 m95 -103.95 102.91 12.69 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.6 ' O ' ' N ' ' A' ' 28' ' ' ILE . 21.7 m -119.66 165.08 15.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.556 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 19.0 p -72.01 170.98 10.48 Favored Pre-proline 0 C--N 1.327 -0.413 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.027 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.809 ' HG3' HD11 ' A' ' 28' ' ' ILE . 13.7 Cg_exo -62.88 -54.58 1.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.031 1.821 . . . . 0.0 110.41 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -64.94 -26.75 68.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.584 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.483 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.8 OUTLIER -72.04 -46.56 56.56 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.502 179.582 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.751 HD21 ' SD ' ' A' ' 42' ' ' MET . 0.6 OUTLIER -57.35 -38.38 74.05 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.832 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.55 ' O ' HG22 ' A' ' 146' ' ' THR . 7.1 mm -60.88 -35.95 68.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.215 0.531 . . . . 0.0 110.219 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.68 -51.69 26.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.202 0.525 . . . . 0.0 110.769 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.75 -19.97 60.64 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.415 -0.812 . . . . 0.0 112.712 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.621 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 7.3 t -73.78 177.76 5.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.976 0.417 . . . . 0.0 111.487 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.597 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 16.2 m -82.24 149.5 4.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.334 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.508 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 42.6 mt-10 -60.29 -55.21 36.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.049 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.597 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 55.1 p90 -54.24 -4.34 0.05 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.49 ' HG2' ' CZ ' ' A' ' 154' ' ' TYR . 0.1 OUTLIER -132.73 -6.54 3.2 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.435 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.584 ' HG3' HG23 ' A' ' 146' ' ' THR . 11.6 mttt -59.79 -59.49 13.67 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.508 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 11.8 Cg_endo -55.73 -27.66 62.64 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.312 2.008 . . . . 0.0 111.651 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.754 ' O ' HG23 ' A' ' 157' ' ' VAL . 39.5 t -69.27 -53.9 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.494 ' OH ' ' HB3' ' A' ' 41' ' ' GLN . 9.1 m-30 -63.51 -36.86 85.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.855 178.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.563 ' HE2' ' HA ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -57.73 -43.5 85.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.085 179.782 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -69.11 -28.49 66.52 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 153' ' ' VAL . 48.6 t -68.48 -42.25 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.973 178.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.659 HD22 ' HB3' ' A' ' 139' ' ' PRO . 47.8 mt -63.68 -43.5 96.5 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.561 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.8 t -53.76 -41.3 67.01 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.821 HG11 ' HA ' ' A' ' 76' ' ' VAL . 88.2 t -66.75 -42.59 89.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.378 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.609 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 22.1 m-30 -80.15 4.08 18.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.552 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.606 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.58 -53.1 69.59 Favored Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 120.531 -0.467 . . . . 0.0 110.644 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 18.9 Cg_endo -58.89 -12.21 14.41 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.141 1.894 . . . . 0.0 111.921 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.454 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 92.9 m-70 -109.19 -17.98 13.73 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.28 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 95.6 mt . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.854 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.6 mpp? . . . . . 0 N--CA 1.454 -0.265 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.619 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 33.1 t70 . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.368 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.457 ' CG ' HD12 ' A' ' 47' ' ' ILE . 5.4 ttp180 . . . . . 0 N--CA 1.464 0.245 0 CA-C-O 120.973 0.416 . . . . 0.0 111.475 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.696 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 3.2 m120 -135.34 -178.76 5.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.127 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.582 HG13 HG13 ' A' ' 47' ' ' ILE . 14.9 m -142.65 167.57 14.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.39 0.614 . . . . 0.0 111.967 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.572 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -138.18 155.41 23.37 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.891 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.022 HG23 ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -131.31 129.23 62.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.063 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.49 ' O ' HD12 ' A' ' 109' ' ' LEU . 35.4 t -108.77 106.11 15.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.898 178.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.778 HD22 HG11 ' A' ' 67' ' ' VAL . 7.4 tp -105.98 123.59 48.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.845 -178.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.624 ' CE ' HD13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -124.22 165.98 16.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.113 179.444 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.527 ' N ' ' OD1' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -97.45 171.96 8.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.004 0.431 . . . . 0.0 110.406 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -58.48 -5.35 0.52 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.585 177.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.534 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -99.8 2.6 44.18 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.782 0.325 . . . . 0.0 111.771 -179.137 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 17.1 mmtp 73.61 22.29 2.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.953 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 22' ' ' MET . 2.2 mmtt -93.0 143.87 25.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.876 HD11 ' HG3' ' A' ' 139' ' ' PRO . 0.9 OUTLIER -98.07 138.02 23.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.286 0.565 . . . . 0.0 112.457 -177.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.534 ' CZ ' HG21 ' A' ' 65' ' ' THR . 17.1 t80 -80.22 135.1 36.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.726 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.74 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -142.58 151.77 41.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.945 0.403 . . . . 0.0 111.281 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.651 ' HB1' ' CB ' ' A' ' 131' ' ' PHE . . . -143.14 136.77 28.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.309 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.656 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 3.5 p -97.19 152.65 18.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.847 0.356 . . . . 0.0 111.45 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.659 ' O ' ' N ' ' A' ' 35' ' ' ASP . 15.3 mtp180 -68.54 130.43 42.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.731 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.679 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.3 OUTLIER -53.32 52.42 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.145 0.578 . . . . 0.0 112.491 -179.722 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.659 ' N ' ' O ' ' A' ' 33' ' ' ARG . 0.5 OUTLIER -177.68 -36.06 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.895 0.379 . . . . 0.0 110.347 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.628 HD13 ' NE ' ' A' ' 33' ' ' ARG . 4.0 mp -112.61 103.01 55.34 Favored Pre-proline 0 N--CA 1.454 -0.25 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.58 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -62.99 -46.04 11.42 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.167 2.578 . . . . 0.0 113.45 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -72.32 -4.44 29.81 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.656 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -94.75 93.03 7.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.798 0.332 . . . . 0.0 111.083 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.656 ' O ' ' HA ' ' A' ' 146' ' ' THR . 63.7 m95 -100.15 145.93 27.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.438 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.96 158.1 21.88 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.403 0.621 . . . . 0.0 111.593 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.47 ' HG3' ' HZ3' ' A' ' 107' ' ' TRP . 3.4 ptp -94.28 158.46 35.82 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.198 178.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.439 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 9.4 Cg_endo -49.31 154.47 3.87 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.423 2.082 . . . . 0.0 112.223 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -178.56 140.9 0.2 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.142 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.423 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -157.63 164.82 33.27 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.757 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.621 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -88.25 142.19 17.28 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.894 -0.669 . . . . 0.0 113.54 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.582 HG13 HG13 ' A' ' 17' ' ' VAL . 3.9 mt -70.44 146.73 11.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 122.66 0.384 . . . . 0.0 111.283 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -67.54 -174.55 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.406 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.88 -60.78 2.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.163 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.97 61.97 0.65 Allowed Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.465 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.504 ' O ' HG21 ' A' ' 47' ' ' ILE . 3.9 tp10 -119.94 155.86 31.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.731 0.3 . . . . 0.0 110.818 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.426 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -71.99 158.84 86.94 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.352 179.63 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.458 ' HA ' HG11 ' A' ' 17' ' ' VAL . 2.9 Cg_exo -76.12 -50.37 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.605 2.203 . . . . 0.0 111.67 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.878 ' CZ ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -53.07 -44.95 67.9 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.508 179.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.46 ' HA ' HD12 ' A' ' 58' ' ' ILE . 18.5 m-80 -67.81 -42.13 82.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.012 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.416 ' O ' ' HG2' ' A' ' 60' ' ' GLU . . . -62.2 -42.6 99.44 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.022 ' HB1' HG23 ' A' ' 19' ' ' ILE . . . -56.55 -53.72 54.32 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.808 178.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.622 HD11 ' NE ' ' A' ' 54' ' ' ARG . 17.7 mt -57.56 -53.51 43.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.065 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -60.06 -58.69 7.44 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.923 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 56' ' ' ALA . 26.0 mm-40 -47.34 -45.84 25.03 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.226 0.536 . . . . 0.0 109.634 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.84 HD12 ' HB ' ' A' ' 19' ' ' ILE . 7.5 tt -51.83 -49.69 62.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.257 178.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.779 ' HG3' HG23 ' A' ' 68' ' ' THR . 47.7 ttt180 -63.06 -62.83 1.44 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.167 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -51.35 -19.16 1.2 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.32 -179.321 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -98.91 -32.54 11.26 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -178.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.573 HG22 ' CD2' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -131.78 -11.61 3.42 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.609 -178.684 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.14 -15.16 55.17 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.464 -0.874 . . . . 0.0 111.967 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.778 HG11 HD22 ' A' ' 21' ' ' LEU . 77.7 t -58.3 113.72 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 121.248 0.546 . . . . 0.0 111.358 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.779 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -121.47 -39.96 2.61 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.481 178.637 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.432 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 6.1 m -62.5 74.6 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.14 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -158.88 154.94 26.84 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.667 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.403 ' HG3' HG21 ' A' ' 113' ' ' THR . 0.9 OUTLIER -128.16 151.46 49.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.432 179.607 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.878 HG21 ' CZ ' ' A' ' 54' ' ' ARG . 2.8 t -74.9 127.8 36.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.725 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.694 HD12 ' HG ' ' A' ' 109' ' ' LEU . 1.0 OUTLIER -109.11 -17.87 7.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.332 178.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.552 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -169.04 173.73 6.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.569 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 2.6 pm0 -153.09 136.06 15.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.648 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.65 ' HA ' HG11 ' A' ' 160' ' ' VAL . 41.8 t -73.48 137.48 77.79 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.03 0.443 . . . . 0.0 111.081 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.594 ' HD2' HG13 ' A' ' 76' ' ' VAL . 41.6 Cg_endo -72.09 -73.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.723 2.282 . . . . 0.0 112.54 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.619 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 2.2 p90 -67.57 157.81 33.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.097 0.475 . . . . 0.0 111.543 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.518 ' CE2' ' HD3' ' A' ' 106' ' ' LYS . 49.7 m95 -94.75 109.4 21.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.187 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.496 HD12 ' CD1' ' A' ' 107' ' ' TRP . 15.0 mt . . . . . 0 C--N 1.329 -0.284 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.404 0 CA-C-O 121.101 0.477 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.696 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 6.3 mt-30 -124.51 123.08 39.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.534 -177.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.518 ' HD3' ' CE2' ' A' ' 79' ' ' TRP . 14.2 ttpp -101.69 135.28 43.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.482 178.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.496 ' CD1' HD12 ' A' ' 80' ' ' LEU . 73.6 m95 -101.78 163.44 12.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.263 0.554 . . . . 0.0 112.445 -178.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.525 ' CE1' ' HG2' ' A' ' 54' ' ' ARG . 98.1 m-85 -143.18 150.63 39.65 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.839 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.694 ' HG ' HD12 ' A' ' 73' ' ' ILE . 20.1 tp -99.26 138.77 35.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.311 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.806 ' CE2' HG22 ' A' ' 72' ' ' VAL . 62.0 m-85 -139.76 140.28 36.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.642 0.734 . . . . 0.0 112.888 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.591 ' N ' HD11 ' A' ' 73' ' ' ILE . 1.7 tttt -101.27 123.63 45.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.754 178.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.625 ' CE1' HG13 ' A' ' 67' ' ' VAL . 39.4 t80 -78.34 96.61 5.35 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.809 0.337 . . . . 0.0 111.166 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.403 HG21 ' HG3' ' A' ' 71' ' ' GLU . 17.3 p -97.7 49.68 1.03 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.039 0.447 . . . . 0.0 110.596 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.432 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -150.01 -148.57 4.8 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.296 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.45 ' HB2' ' HG2' ' A' ' 117' ' ' GLN . 28.7 mt-30 -121.84 151.46 40.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.823 0.344 . . . . 0.0 110.936 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -61.11 -28.8 69.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.8 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . 0.45 ' HG2' ' HB2' ' A' ' 115' ' ' GLN . 2.1 pt20 -59.0 -3.2 0.32 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.137 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -90.7 -17.68 26.34 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.903 0.382 . . . . 0.0 110.895 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.692 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 15.9 mt -81.76 95.89 3.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.615 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -96.72 3.8 52.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.951 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.573 ' CD2' HG22 ' A' ' 65' ' ' THR . 29.5 mt . . . . . 0 N--CA 1.466 0.363 0 CA-C-O 120.975 0.417 . . . . 0.0 111.449 -179.436 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 . . . . . 0 N--CA 1.455 -0.19 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.651 ' CB ' ' HB1' ' A' ' 31' ' ' ALA . 3.2 m-85 -127.62 140.91 51.8 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.114 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.679 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -96.25 -29.28 8.52 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.498 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.403 ' HG2' ' OG ' ' A' ' 32' ' ' SER . 0.2 OUTLIER -145.18 146.75 31.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.725 0.298 . . . . 0.0 110.339 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.692 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 40.8 p-90 -135.89 165.77 24.86 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.939 0.399 . . . . 0.0 111.548 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.452 ' N ' ' HZ3' ' A' ' 40' ' ' TRP . 36.6 t -164.61 177.5 8.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.335 0.588 . . . . 0.0 112.164 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.537 ' NE1' ' HZ3' ' A' ' 134' ' ' TRP . 35.2 m95 -113.24 104.58 12.48 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.338 178.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.528 ' O ' ' N ' ' A' ' 28' ' ' ILE . 16.3 m -120.05 168.71 12.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.279 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.527 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 23.3 p -73.09 168.86 20.86 Favored Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.24 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.876 ' HG3' HD11 ' A' ' 28' ' ' ILE . 16.5 Cg_exo -61.88 -53.27 2.23 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 121.866 1.71 . . . . 0.0 110.471 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.7 -27.79 68.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.654 178.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.499 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 37.2 mt-30 -72.42 -46.28 55.86 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.045 0.45 . . . . 0.0 110.154 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.74 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.5 OUTLIER -56.26 -40.76 74.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.826 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.488 ' O ' HG22 ' A' ' 146' ' ' THR . 14.9 mm -62.15 -34.0 61.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.234 0.54 . . . . 0.0 110.158 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.89 -51.51 25.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.21 0.528 . . . . 0.0 110.714 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.6 mp -73.86 -20.99 60.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.877 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.656 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 11.7 t -73.77 175.81 6.88 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.504 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.533 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 23.0 m -86.44 149.72 4.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.996 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 151' ' ' LYS . 3.0 tt0 -50.81 -50.85 55.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.643 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -51.13 -11.4 0.1 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -131.8 -3.06 3.68 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.543 ' HG3' ' CG2' ' A' ' 146' ' ' THR . 0.6 OUTLIER -60.66 -63.43 4.31 Favored Pre-proline 0 C--N 1.325 -0.458 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.143 179.799 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.431 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 17.3 Cg_endo -58.33 -30.27 90.62 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.429 2.086 . . . . 0.0 111.962 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.711 ' O ' HG23 ' A' ' 157' ' ' VAL . 19.0 t -68.9 -51.41 44.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.485 ' CE1' ' CH2' ' A' ' 107' ' ' TRP . 7.7 m-30 -63.4 -36.41 83.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.919 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.46 ' HD3' HG13 ' A' ' 143' ' ' ILE . 0.5 OUTLIER -57.86 -46.31 85.01 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.112 179.608 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.463 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.7 OUTLIER -67.03 -31.94 72.82 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.57 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 153' ' ' VAL . 92.4 t -66.76 -41.48 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.415 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.724 HD22 ' HB3' ' A' ' 139' ' ' PRO . 62.8 mt -64.03 -44.51 92.32 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.4 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.7 t -53.49 -42.84 67.71 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.65 HG11 ' HA ' ' A' ' 76' ' ' VAL . 92.3 t -66.48 -42.18 89.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.172 178.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.555 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 21.9 m-30 -81.79 5.9 17.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.624 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.705 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . . . -59.09 -50.86 85.59 Favored Pre-proline 0 C--N 1.327 -0.382 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.004 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.705 ' HD3' ' HB3' ' A' ' 162' ' ' ALA . 30.6 Cg_exo -60.12 -10.84 13.74 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.346 2.031 . . . . 0.0 112.085 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.552 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 87.6 m-70 -111.23 -18.24 13.0 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.44 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 96.7 mt . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.868 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.573 ' C ' ' HB2' ' A' ' 78' ' ' TYR . 0.4 OUTLIER . . . . . 0 CA--C 1.523 -0.074 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.589 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 2.8 p30 . . . . . 0 C--N 1.329 -0.322 0 CA-C-O 120.682 0.277 . . . . 0.0 111.004 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.601 ' HG2' HD12 ' A' ' 47' ' ' ILE . 6.7 ttp180 . . . . . 0 N--CA 1.451 -0.396 0 CA-C-O 121.35 0.595 . . . . 0.0 110.103 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.672 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 2.2 m-80 -128.81 175.29 8.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.844 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.761 HG13 ' CG1' ' A' ' 47' ' ' ILE . 25.7 m -134.64 159.5 41.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.177 0.513 . . . . 0.0 110.872 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.615 ' HA3' ' CE3' ' A' ' 107' ' ' TRP . . . -131.64 155.3 21.32 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.006 HG21 HD22 ' A' ' 61' ' ' LEU . 1.6 mp -125.37 117.08 48.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.476 ' O ' HD12 ' A' ' 109' ' ' LEU . 6.1 t -101.39 99.23 9.55 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.822 HD22 HG11 ' A' ' 67' ' ' VAL . 41.5 tp -100.83 119.09 38.15 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.727 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.801 ' HE2' HD13 ' A' ' 73' ' ' ILE . 0.4 OUTLIER -119.75 159.77 23.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.926 179.656 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.5 ' N ' ' OD1' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -94.6 171.87 8.53 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.024 0.44 . . . . 0.0 110.232 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -58.23 -4.77 0.39 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.675 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.612 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.5 OUTLIER -101.02 2.58 40.68 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.03 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.612 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 2.1 mmtm 75.12 20.86 2.03 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.186 -178.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.632 ' O ' ' HA ' ' A' ' 22' ' ' MET . 3.8 mmtt -92.2 143.87 25.99 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.756 HD11 ' HG3' ' A' ' 139' ' ' PRO . 1.6 mm -97.26 136.93 26.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.092 0.472 . . . . 0.0 112.009 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.567 ' CE1' HD13 ' A' ' 119' ' ' ILE . 33.8 t80 -74.13 105.53 5.38 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.41 178.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.603 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -103.88 144.37 31.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.799 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.405 ' HB1' ' CG ' ' A' ' 131' ' ' PHE . . . -142.25 131.37 23.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.388 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.785 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 6.6 p -97.9 147.29 24.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.069 0.461 . . . . 0.0 111.747 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 33' ' ' ARG . 4.7 mtp180 -68.36 128.95 38.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.389 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.697 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -45.14 -35.86 3.41 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.277 0.56 . . . . 0.0 110.883 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.53 -38.01 68.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.038 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.9 mt -122.81 105.92 34.84 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.214 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.11 -21.17 36.89 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.825 2.35 . . . . 0.0 112.967 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -92.06 -6.97 50.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.709 0.29 . . . . 0.0 111.568 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.785 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.34 95.45 10.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.691 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.658 ' O ' ' HA ' ' A' ' 146' ' ' THR . 72.3 m95 -93.65 136.73 33.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.912 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.513 ' HG3' ' C ' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -161.59 158.41 26.22 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.105 0.479 . . . . 0.0 110.699 179.755 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.597 ' HG3' ' HZ3' ' A' ' 107' ' ' TRP . 0.1 OUTLIER -94.34 157.8 36.83 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.55 178.844 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.508 ' CG ' HD13 ' A' ' 61' ' ' LEU . 2.8 Cg_endo -44.08 151.79 0.46 Allowed 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 123.119 2.546 . . . . 0.0 112.891 -179.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -171.39 143.06 1.77 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.201 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.672 ' O ' ' HB3' ' A' ' 16' ' ' ASN . . . -140.48 -178.38 17.0 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.65 ' HA2' ' CB ' ' A' ' 16' ' ' ASN . . . -112.18 23.58 15.97 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.016 -1.088 . . . . 0.0 114.736 -178.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.761 ' CG1' HG13 ' A' ' 17' ' ' VAL . 29.9 mt 60.13 130.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 117.543 0.672 . . . . 0.0 111.064 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.3 -176.15 0.71 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.825 0.345 . . . . 0.0 110.88 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.69 -81.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.212 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.39 55.91 0.49 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.359 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -116.21 153.01 32.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.873 0.368 . . . . 0.0 111.002 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.61 173.54 3.93 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.488 ' HA ' HG11 ' A' ' 17' ' ' VAL . 8.9 Cg_endo -85.53 -54.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.378 2.052 . . . . 0.0 111.678 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.806 ' HE ' HD11 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -54.36 -43.34 71.23 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.315 179.012 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.713 ' HA ' HD12 ' A' ' 58' ' ' ILE . 7.2 m-20 -69.44 -40.81 76.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.308 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.415 ' O ' ' CG ' ' A' ' 60' ' ' GLU . . . -60.78 -45.73 93.24 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.445 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -54.29 -49.37 69.77 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.014 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.806 HD11 ' HE ' ' A' ' 54' ' ' ARG . 18.0 mt -58.97 -55.47 23.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.246 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.67 -63.67 1.22 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.187 -179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.614 ' CD ' HD11 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -47.2 -37.43 10.26 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.407 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.006 HD22 HG21 ' A' ' 19' ' ' ILE . 9.8 tp -53.24 -48.43 68.21 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.868 178.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.901 ' HG3' HG23 ' A' ' 68' ' ' THR . 16.7 ttp180 -64.17 -64.23 0.94 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.489 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -48.98 -22.1 0.8 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.272 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -96.99 -37.45 10.17 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -178.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.562 HG22 ' CD2' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -127.66 -5.04 5.84 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.571 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 78.16 -13.88 13.4 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.252 -0.975 . . . . 0.0 111.872 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.822 HG11 HD22 ' A' ' 21' ' ' LEU . 75.3 t -58.62 112.71 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-O 121.194 0.521 . . . . 0.0 111.291 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.901 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.8 OUTLIER -121.59 -40.43 2.56 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.414 178.653 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.427 ' HB2' ' HA3' ' A' ' 114' ' ' GLY . 11.8 m -62.09 74.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.38 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.62 156.45 23.21 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.84 152.03 50.62 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.758 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.541 HG22 ' CE2' ' A' ' 110' ' ' PHE . 3.3 t -75.0 126.75 36.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.95 0.405 . . . . 0.0 111.186 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.801 HD13 ' HE2' ' A' ' 22' ' ' MET . 1.0 OUTLIER -107.47 -19.66 6.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.266 179.218 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.463 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.88 176.39 4.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.582 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -154.46 148.37 25.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.422 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.799 ' HA ' HG11 ' A' ' 160' ' ' VAL . 55.3 t -70.65 139.29 86.14 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.983 0.42 . . . . 0.0 110.894 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.57 ' HD2' HG13 ' A' ' 76' ' ' VAL . 18.7 Cg_endo -59.04 -62.9 0.15 Allowed 'Trans proline' 0 CA--C 1.519 -0.271 0 C-N-CA 123.233 2.622 . . . . 0.0 112.499 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.589 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -103.46 -172.47 2.12 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.426 -178.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.596 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 64.5 m95 -91.8 -158.29 0.57 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.974 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.69 HD11 ' OE1' ' A' ' 156' ' ' GLU . 26.6 mt . . . . . 0 C--N 1.328 -0.358 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 -0.094 0 CA-C-O 120.7 0.286 . . . . 0.0 110.61 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.463 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 15.7 mt-30 -126.31 123.97 39.24 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.571 ' HB2' ' CE3' ' A' ' 79' ' ' TRP . 0.7 OUTLIER -104.46 139.19 39.74 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.134 178.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.615 ' CE3' ' HA3' ' A' ' 18' ' ' GLY . 77.8 m95 -106.82 162.91 13.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.371 0.605 . . . . 0.0 112.576 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.616 ' CD1' ' HG2' ' A' ' 54' ' ' ARG . 96.5 m-85 -140.0 152.98 46.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.205 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.599 HD11 ' SD ' ' A' ' 22' ' ' MET . 11.8 tp -99.99 136.93 39.15 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.557 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.608 ' CE2' HG12 ' A' ' 58' ' ' ILE . 29.6 m-85 -140.03 144.54 36.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.504 0.669 . . . . 0.0 112.631 -178.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.569 ' HB2' HD11 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -104.39 123.17 46.96 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.977 178.397 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.624 ' CD1' HD21 ' A' ' 21' ' ' LEU . 56.6 t80 -79.13 99.42 6.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.912 0.387 . . . . 0.0 110.552 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 69' ' ' SER . 30.3 p -95.78 41.71 1.1 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.324 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 69' ' ' SER . . . -141.81 -148.33 5.01 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.651 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -122.7 149.84 43.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.951 0.405 . . . . 0.0 111.359 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.437 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 18.1 p-10 -58.99 -37.0 75.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.386 0.612 . . . . 0.0 111.231 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -57.43 -3.5 0.17 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.46 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -90.49 -20.54 22.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.146 0.498 . . . . 0.0 110.303 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.567 HD13 ' CE1' ' A' ' 29' ' ' PHE . 9.7 mt -88.35 107.07 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.215 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.414 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 58.1 t30 -102.23 -26.07 13.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.191 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.562 ' CD2' HG22 ' A' ' 65' ' ' THR . 56.9 mt . . . . . 0 N--CA 1.464 0.233 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.178 -179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.461 ' HB2' ' CE1' ' A' ' 131' ' ' PHE . 61.0 mm-40 . . . . . 0 C--O 1.231 0.124 0 CA-C-O 120.986 0.422 . . . . 0.0 110.539 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.502 ' CE1' HG23 ' A' ' 65' ' ' THR . 0.7 OUTLIER -134.02 143.87 48.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.104 -179.872 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.697 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -89.73 -33.69 8.96 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.054 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.35 142.9 28.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.836 0.35 . . . . 0.0 110.543 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.534 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 34.5 p-90 -135.29 170.33 16.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.137 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.45 ' N ' ' CE3' ' A' ' 134' ' ' TRP . 22.6 t -168.33 176.66 5.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.315 0.579 . . . . 0.0 111.758 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.507 ' CE2' ' CZ3' ' A' ' 134' ' ' TRP . 48.0 m95 -110.69 102.84 11.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.479 178.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 28' ' ' ILE . 29.6 m -118.19 167.6 11.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.548 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 18.3 p -72.51 169.53 16.63 Favored Pre-proline 0 C--N 1.326 -0.429 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.211 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.756 ' HG3' HD11 ' A' ' 28' ' ' ILE . 17.1 Cg_exo -60.2 -56.51 1.08 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.723 1.615 . . . . 0.0 110.379 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -62.76 -27.76 69.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.73 178.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.44 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 10.8 mt-30 -71.35 -48.81 47.92 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.544 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.603 HD13 ' HB2' ' A' ' 30' ' ' ALA . 5.2 tp -57.41 -38.48 74.39 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.654 ' O ' HG22 ' A' ' 146' ' ' THR . 16.4 mm -60.13 -36.71 69.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.538 179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.98 -53.04 14.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.247 0.546 . . . . 0.0 110.954 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.78 -19.0 62.07 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.174 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.658 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 13.1 t -73.57 177.33 5.42 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.112 0.482 . . . . 0.0 111.302 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.515 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 36.0 m -81.03 149.53 4.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.748 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.415 ' C ' ' H ' ' A' ' 150' ' ' LYS . 2.7 mt-10 -57.83 -53.47 57.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.813 0.34 . . . . 0.0 110.988 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.5 ' CD2' ' HG3' ' A' ' 150' ' ' LYS . 39.4 p90 -57.08 2.38 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.501 ' HD2' HG21 ' A' ' 147' ' ' VAL . 6.4 mtpp -139.12 -5.95 1.43 Allowed 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 0.2 OUTLIER -63.09 -52.39 63.0 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.849 -0.159 . . . . 0.0 110.686 179.681 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 151' ' ' LYS . 15.1 Cg_exo -65.28 -29.3 54.96 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.296 1.997 . . . . 0.0 111.393 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.562 ' O ' HG23 ' A' ' 157' ' ' VAL . 37.2 t -67.92 -53.55 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.517 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 4.0 m-30 -63.31 -39.49 94.69 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.578 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.625 ' HE2' ' HA ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -56.22 -38.18 70.71 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.247 179.527 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.69 ' OE1' HD11 ' A' ' 80' ' ' LEU . 4.7 tm-20 -68.48 -36.53 79.09 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.62 HG12 ' CE2' ' A' ' 161' ' ' PHE . 40.0 t -64.51 -41.02 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.863 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.659 HD22 ' HB3' ' A' ' 139' ' ' PRO . 43.4 mt -65.4 -46.94 78.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.939 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -52.15 -40.34 61.27 Favored 'General case' 0 CA--C 1.522 -0.127 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.799 HG11 ' HA ' ' A' ' 76' ' ' VAL . 98.4 t -67.33 -42.43 87.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.62 ' CE2' HG12 ' A' ' 157' ' ' VAL . 17.3 m-30 -80.09 5.49 14.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.034 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.592 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.1 -53.72 63.06 Favored Pre-proline 0 C--N 1.331 -0.229 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.528 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 18.2 Cg_endo -58.41 -13.26 16.13 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 121.989 1.793 . . . . 0.0 111.56 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.463 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 93.8 m-70 -107.25 -17.71 14.07 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.986 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 92.3 mt . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.026 -0.987 . . . . 0.0 110.368 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.6 mpp? . . . . . 0 N--CA 1.458 -0.051 0 CA-C-O 120.678 0.275 . . . . 0.0 110.642 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.446 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 6.3 p-10 . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 120.892 0.377 . . . . 0.0 110.211 179.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 . . . . . 0 C--O 1.231 0.088 0 CA-C-O 121.278 0.561 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.837 ' HB2' ' HG2' ' A' ' 105' ' ' GLN . 2.8 m-80 -132.26 173.73 10.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.338 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.716 HG13 ' CG1' ' A' ' 47' ' ' ILE . 11.5 m -140.49 169.6 15.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.18 0.514 . . . . 0.0 111.281 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.615 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -136.25 153.95 21.76 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.253 178.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.832 HG23 ' CE1' ' A' ' 110' ' ' PHE . 2.4 mp -126.34 122.16 60.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.491 ' O ' HD12 ' A' ' 109' ' ' LEU . 40.9 t -104.88 107.62 18.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.083 177.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.793 HD21 ' CD2' ' A' ' 112' ' ' PHE . 17.3 tp -106.08 126.66 52.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.726 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.77 ' SD ' HD11 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -118.82 141.04 49.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.057 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.451 ' OD1' ' CH2' ' A' ' 136' ' ' TRP . 5.6 m-20 -95.22 -175.98 3.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.191 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -55.5 -6.25 0.17 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.472 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 4.5 m-20 -100.71 -0.13 37.9 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.465 ' NZ ' ' HE3' ' A' ' 22' ' ' MET . 30.0 mmtt 68.68 23.57 7.07 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 22' ' ' MET . 72.2 mttt -95.13 176.78 6.1 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.915 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.621 HD11 ' HG3' ' A' ' 139' ' ' PRO . 2.0 mm -116.94 142.14 32.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.344 0.592 . . . . 0.0 111.249 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.617 ' CZ ' HG21 ' A' ' 65' ' ' THR . 6.6 t80 -66.88 103.48 1.14 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.108 179.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' A' ' 41' ' ' GLN . . . -97.58 137.87 35.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.986 0.422 . . . . 0.0 111.253 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.426 ' HB1' ' CG ' ' A' ' 131' ' ' PHE . . . -139.25 132.69 30.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.477 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.662 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 77.0 p -101.32 146.9 26.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.919 0.39 . . . . 0.0 111.38 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 33' ' ' ARG . 5.5 mtp85 -69.55 128.98 38.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.37 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.715 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.6 OUTLIER -44.69 -37.04 3.43 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.37 0.605 . . . . 0.0 111.034 -179.863 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.86 -36.47 70.13 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.752 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.7 mm -122.99 110.57 31.23 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.12 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.23 -19.74 13.25 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.397 2.064 . . . . 0.0 112.644 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -91.06 -10.1 43.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.471 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.733 ' HB1' ' CG1' ' A' ' 147' ' ' VAL . . . -92.24 95.01 9.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.691 0.282 . . . . 0.0 111.075 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.661 ' O ' ' HA ' ' A' ' 146' ' ' THR . 78.7 m95 -87.99 158.41 18.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.126 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.664 ' O ' ' HA ' ' A' ' 30' ' ' ALA . 1.6 mt-30 -166.95 -138.25 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.629 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.531 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 8.5 ptt? -175.82 162.23 2.03 Favored Pre-proline 0 N--CA 1.453 -0.319 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.755 ' HG3' HD12 ' A' ' 61' ' ' LEU . 1.5 Cg_endo -40.9 134.19 2.51 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 123.257 2.638 . . . . 0.0 113.088 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -173.73 143.51 1.0 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.875 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.453 ' HA3' ' HG2' ' A' ' 60' ' ' GLU . . . -159.6 -158.64 9.26 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.783 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.715 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -117.31 141.8 16.85 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.742 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.716 ' CG1' HG13 ' A' ' 17' ' ' VAL . 13.9 mt -71.69 143.0 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 122.496 0.319 . . . . 0.0 110.88 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -69.23 -176.19 0.89 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.919 0.39 . . . . 0.0 110.587 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -49.13 -81.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.225 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -108.05 53.22 0.61 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.251 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -118.35 153.73 33.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.915 0.388 . . . . 0.0 111.048 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.53 163.29 64.6 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.426 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.467 ' HA ' HG12 ' A' ' 47' ' ' ILE . 5.8 Cg_exo -78.5 -52.58 0.06 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 122.952 2.435 . . . . 0.0 112.486 -179.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.653 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -48.89 -51.85 27.68 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.762 179.659 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -57.26 -42.68 82.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.175 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 60' ' ' GLU . . . -61.59 -43.52 98.7 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.603 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -57.57 -57.77 11.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.344 177.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.653 HD13 ' O ' ' A' ' 54' ' ' ARG . 1.9 mp -55.23 -48.99 75.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.577 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.7 mtt180 -65.01 -62.55 1.48 Allowed 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.304 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.453 ' HG2' ' HA3' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -42.3 -47.26 4.79 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.118 0.485 . . . . 0.0 110.119 179.581 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.755 HD12 ' HG3' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -50.8 -49.37 58.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.083 178.715 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.93 ' HG3' HG23 ' A' ' 68' ' ' THR . 13.9 ttp180 -63.73 -65.54 0.67 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.493 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -49.02 -20.4 0.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -98.1 -35.48 10.4 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -178.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.872 HG22 HD23 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -133.03 7.99 4.03 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -178.38 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.87 -9.73 2.68 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.974 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.734 HG13 ' CE2' ' A' ' 112' ' ' PHE . 77.1 t -56.76 108.66 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-O 121.153 0.501 . . . . 0.0 111.393 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.93 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.6 OUTLIER -124.58 -39.71 2.28 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.593 178.26 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.0 m -63.77 70.91 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.991 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -156.96 156.91 33.8 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.037 0.446 . . . . 0.0 111.932 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.427 ' HG3' HG21 ' A' ' 113' ' ' THR . 0.9 OUTLIER -129.39 149.1 51.31 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.435 179.108 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.967 HG22 ' CE2' ' A' ' 110' ' ' PHE . 12.3 t -74.71 125.0 33.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 111' ' ' LYS . 0.9 OUTLIER -105.5 -21.62 5.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.12 179.302 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -170.42 177.02 4.21 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.554 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 2.0 pm0 -155.36 152.05 28.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.757 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.725 ' HA ' HG11 ' A' ' 160' ' ' VAL . 54.1 t -70.48 132.57 87.49 Favored Pre-proline 0 C--N 1.327 -0.387 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.814 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -57.97 -55.12 2.51 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.125 2.55 . . . . 0.0 112.681 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.556 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.6 OUTLIER -101.88 -174.36 2.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.65 -179.518 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.472 ' O ' ' HG ' ' A' ' 80' ' ' LEU . 33.9 m95 -94.65 -154.67 0.43 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.612 ' HB2' ' O ' ' A' ' 105' ' ' GLN . 95.5 mt . . . . . 0 CA--C 1.515 -0.392 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.198 0 CA-C-O 121.095 0.474 . . . . 0.0 111.276 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.837 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 71.1 mt-30 -132.51 122.65 25.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.291 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.455 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 14.8 ttpp -105.2 138.26 41.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.482 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.615 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 28.4 m95 -103.96 162.75 12.87 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.585 ' HB2' ' HE1' ' A' ' 110' ' ' PHE . 51.3 m-85 -140.34 154.07 46.63 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.479 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.77 HD11 ' SD ' ' A' ' 22' ' ' MET . 12.0 tp -103.22 140.97 36.67 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.323 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.967 ' CE2' HG22 ' A' ' 72' ' ' VAL . 63.1 m-85 -143.69 150.0 38.03 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 16.5 tttt -106.69 124.21 49.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.533 178.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.793 ' CD2' HD21 ' A' ' 21' ' ' LEU . 16.0 t80 -78.92 100.88 7.43 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.012 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.427 HG21 ' HG3' ' A' ' 71' ' ' GLU . 60.1 p -95.9 39.98 1.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.115 0.483 . . . . 0.0 110.845 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -145.64 -144.12 4.06 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.078 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.776 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 50.6 mt-30 -123.11 160.8 25.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.898 0.38 . . . . 0.0 111.207 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.409 ' HB2' ' CZ2' ' A' ' 134' ' ' TRP . 9.2 p-10 -60.14 -27.67 67.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.665 0.745 . . . . 0.0 111.309 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -52.82 -5.78 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.321 -1.309 . . . . 0.0 113.741 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.776 ' HG2' ' O ' ' A' ' 115' ' ' GLN . 0.1 OUTLIER -90.96 -24.48 20.12 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.085 178.785 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.608 ' HA ' ' O ' ' A' ' 65' ' ' THR . 7.0 mt -84.53 101.39 8.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.619 -0.718 . . . . 0.0 112.442 -178.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -107.04 -32.0 8.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.403 179.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.872 HD23 HG22 ' A' ' 65' ' ' THR . 9.9 mt . . . . . 0 C--N 1.331 -0.206 0 CA-C-O 121.035 0.445 . . . . 0.0 110.519 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 . . . . . 0 N--CA 1.463 0.182 0 CA-C-O 121.015 0.436 . . . . 0.0 110.596 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.626 ' CE2' HG23 ' A' ' 65' ' ' THR . 1.6 m-85 -130.68 143.3 50.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.05 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.715 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -87.46 -35.96 9.09 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.639 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -148.34 144.76 27.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.944 0.402 . . . . 0.0 110.741 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.687 ' HD1' HD11 ' A' ' 121' ' ' LEU . 39.0 p-90 -135.88 169.34 17.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.94 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.428 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 33.6 t -162.75 176.3 10.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.315 0.578 . . . . 0.0 112.03 -178.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.451 ' CH2' ' OD1' ' A' ' 23' ' ' ASN . 83.4 m95 -110.71 103.03 11.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.314 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.44 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 30.1 m -120.55 167.83 13.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.911 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.542 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 24.3 p -72.2 167.26 33.7 Favored Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.066 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.621 ' HG3' HD11 ' A' ' 28' ' ' ILE . 20.2 Cg_exo -59.62 -55.65 1.64 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.731 1.621 . . . . 0.0 110.296 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -62.7 -26.93 68.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.265 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.45 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 11.7 mm100 -72.51 -46.84 52.76 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.625 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.635 HD11 ' O ' ' A' ' 41' ' ' GLN . 1.5 tp -58.21 -38.52 76.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.858 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.825 HG21 ' HG2' ' A' ' 155' ' ' LYS . 28.9 mm -62.31 -38.89 82.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.252 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.27 -50.16 55.63 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.307 0.575 . . . . 0.0 110.729 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.58 -20.22 60.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.967 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.661 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 13.2 t -74.89 176.37 7.18 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.141 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.733 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 35.3 m -81.63 142.79 13.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.818 0.342 . . . . 0.0 111.53 -179.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.523 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 55.2 mt-10 -50.27 -51.15 47.29 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.278 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.15 -10.91 0.09 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -135.25 -4.02 2.4 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.644 ' HG2' ' O ' ' A' ' 143' ' ' ILE . 9.7 mttt -59.47 -57.98 22.9 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 120.36 0.124 . . . . 0.0 111.164 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 20.8 Cg_endo -60.78 -27.55 84.99 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.427 2.085 . . . . 0.0 111.658 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.733 ' O ' HG23 ' A' ' 157' ' ' VAL . 39.0 t -68.97 -52.89 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.547 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 5.0 m-30 -64.31 -40.65 96.34 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.505 178.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.825 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -55.85 -41.34 74.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.258 179.521 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -68.31 -33.46 74.35 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 153' ' ' VAL . 44.6 t -66.42 -40.77 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.944 178.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.617 HD22 ' HB3' ' A' ' 139' ' ' PRO . 52.2 mt -63.46 -45.83 89.01 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.644 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.15 -40.14 45.52 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.725 HG11 ' HA ' ' A' ' 76' ' ' VAL . 88.8 t -66.99 -42.69 88.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.944 177.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.689 ' CE2' HG12 ' A' ' 157' ' ' VAL . 14.1 m-30 -81.03 5.58 16.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.685 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.631 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.42 -51.89 78.55 Favored Pre-proline 0 C--N 1.331 -0.237 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.428 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 18.1 Cg_endo -59.08 -12.39 15.54 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.021 1.814 . . . . 0.0 111.716 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -107.69 -20.14 13.32 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.464 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 96.8 mt . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.761 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.462 0.141 0 CA-C-O 120.745 0.307 . . . . 0.0 110.534 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.735 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 63.8 t0 . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 120.952 0.406 . . . . 0.0 110.489 -179.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.536 ' HG2' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.166 0 CA-C-O 121.031 0.443 . . . . 0.0 110.144 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.62 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 4.2 m-80 -133.19 172.67 12.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.132 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.663 HG13 ' CG1' ' A' ' 47' ' ' ILE . 16.6 m -135.84 164.98 30.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.224 0.535 . . . . 0.0 111.443 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.719 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -138.67 155.88 23.89 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.97 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.814 HG13 ' HB1' ' A' ' 57' ' ' ALA . 2.5 mp -131.11 123.91 54.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.51 ' O ' HD12 ' A' ' 109' ' ' LEU . 8.6 t -102.33 101.22 11.45 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.871 HD22 HG11 ' A' ' 67' ' ' VAL . 20.7 tp -99.58 117.52 34.15 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.359 -178.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.491 ' SD ' HD11 ' A' ' 109' ' ' LEU . 1.4 ptt? -118.08 166.74 12.19 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.729 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.599 ' ND2' ' HB2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -101.21 169.67 8.76 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.28 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -56.37 -4.5 0.14 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.52 178.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.5 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 2.7 m-20 -99.06 2.96 46.61 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 3.3 mmtp 74.18 20.47 2.69 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.014 -178.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.599 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 1.1 mmtt -94.17 145.55 24.62 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.817 HD11 ' HG3' ' A' ' 139' ' ' PRO . 1.1 mm -97.93 139.94 19.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.294 0.568 . . . . 0.0 112.473 -177.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.408 ' HE1' ' CD2' ' A' ' 134' ' ' TRP . 18.6 t80 -75.99 122.54 24.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.809 178.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.62 ' HA ' ' O ' ' A' ' 41' ' ' GLN . . . -122.68 146.68 47.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.967 0.413 . . . . 0.0 111.124 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.446 ' O ' ' HG3' ' A' ' 41' ' ' GLN . . . -137.65 136.5 37.52 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.407 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.574 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 97.0 p -100.73 144.52 29.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.909 0.385 . . . . 0.0 111.049 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.2 mtp-105 -69.83 126.71 30.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.487 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.697 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.3 OUTLIER -45.43 -33.37 2.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.296 0.57 . . . . 0.0 110.781 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.01 -38.23 64.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.008 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.473 HG22 ' H ' ' A' ' 39' ' ' ALA . 56.1 mt -124.67 104.56 30.65 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.09 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.24 -18.1 50.4 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.727 2.285 . . . . 0.0 112.774 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -94.22 -11.0 31.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.554 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.8 ' HB1' ' CG1' ' A' ' 147' ' ' VAL . . . -91.42 96.77 10.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.778 0.323 . . . . 0.0 111.196 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.552 ' O ' ' HA ' ' A' ' 146' ' ' THR . 77.1 m95 -89.53 161.89 15.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.341 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.62 ' O ' ' HA ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -169.26 -139.47 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.932 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.487 ' H ' ' HB2' ' A' ' 41' ' ' GLN . 10.2 ptt? -175.07 161.93 2.34 Favored Pre-proline 0 C--N 1.327 -0.386 0 O-C-N 122.196 -0.315 . . . . 0.0 110.368 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 42' ' ' MET . 1.9 Cg_endo -40.8 131.91 2.72 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.015 2.477 . . . . 0.0 112.946 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.465 ' HA ' HD12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -178.44 144.66 0.3 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.652 179.755 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.675 ' HA3' ' HG2' ' A' ' 60' ' ' GLU . . . -161.26 -163.12 13.63 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.059 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.62 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -109.3 145.94 16.73 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.723 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.663 ' CG1' HG13 ' A' ' 17' ' ' VAL . 19.8 mt -72.49 143.64 13.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 122.354 0.262 . . . . 0.0 110.973 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -69.54 -174.85 0.75 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.836 0.35 . . . . 0.0 110.458 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -48.48 -71.13 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.147 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -120.9 54.23 0.67 Allowed Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.384 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -113.47 150.66 32.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.803 0.335 . . . . 0.0 110.875 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -69.66 158.89 85.89 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.053 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.555 ' HA ' HG11 ' A' ' 17' ' ' VAL . 4.0 Cg_exo -76.4 -50.37 0.11 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.595 2.197 . . . . 0.0 111.426 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.819 ' HE ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -52.49 -46.81 66.77 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.297 179.325 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -66.9 -41.81 86.53 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.056 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.562 ' O ' ' HB2' ' A' ' 60' ' ' GLU . . . -61.13 -44.43 97.35 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.814 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -55.43 -53.98 49.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.094 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.675 HD11 ' NE ' ' A' ' 54' ' ' ARG . 34.6 mt -55.02 -53.73 31.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.098 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 -62.29 -60.76 3.11 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.976 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.675 ' HG2' ' HA3' ' A' ' 45' ' ' GLY . 0.6 OUTLIER -44.1 -48.25 8.99 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.105 0.479 . . . . 0.0 110.121 179.269 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.688 HD13 HG21 ' A' ' 19' ' ' ILE . 0.8 OUTLIER -52.73 -46.23 67.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.565 179.046 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.805 ' HG3' HG23 ' A' ' 68' ' ' THR . 42.9 ttp180 -64.87 -62.75 1.37 Allowed 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 121.343 0.592 . . . . 0.0 111.015 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -50.09 -21.69 1.37 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.359 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -96.11 -36.6 10.93 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.575 HG23 ' CE2' ' A' ' 131' ' ' PHE . 3.6 p -127.27 -4.62 6.12 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 80.3 -12.07 34.23 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.362 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.871 HG11 HD22 ' A' ' 21' ' ' LEU . 64.3 t -58.2 118.98 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 121.33 0.586 . . . . 0.0 111.587 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.805 HG23 ' HG3' ' A' ' 62' ' ' ARG . 1.1 p -127.2 -40.01 1.86 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.402 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.8 m -62.54 76.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.512 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -162.92 156.7 20.24 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -129.82 150.17 51.24 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.858 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.819 HG21 ' HE ' ' A' ' 54' ' ' ARG . 21.3 t -74.0 129.41 36.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.265 0.555 . . . . 0.0 111.753 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.641 HD11 ' HB2' ' A' ' 111' ' ' LYS . 1.3 mt -110.56 -18.36 7.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.452 179.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.493 ' HB2' ' CG ' ' A' ' 164' ' ' HIS . . . -171.3 175.93 4.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.405 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -154.6 150.01 27.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.603 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.731 ' HA ' HG11 ' A' ' 160' ' ' VAL . 11.2 t -72.03 136.85 82.08 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.846 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.697 ' HD2' HG21 ' A' ' 160' ' ' VAL . 35.1 Cg_endo -67.56 -60.25 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.9 2.4 . . . . 0.0 113.306 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.735 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -94.27 172.98 7.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.08 -178.478 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.59 ' HB3' ' HB1' ' A' ' 104' ' ' ALA . 57.1 m95 -91.71 100.69 13.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.281 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.548 HD21 ' HG2' ' A' ' 156' ' ' GLU . 88.8 mt . . . . . 0 C--N 1.328 -0.336 0 CA-C-O 121.054 0.454 . . . . 0.0 110.783 -179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.59 ' HB1' ' HB3' ' A' ' 79' ' ' TRP . . . . . . . . 0 CA--C 1.521 -0.149 0 CA-C-O 121.165 0.507 . . . . 0.0 111.262 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.454 ' CG ' ' HB2' ' A' ' 16' ' ' ASN . 35.6 mt-30 -126.15 125.18 42.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.943 -178.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.49 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 3.5 ttmm -104.95 136.83 43.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.554 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.719 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 23.8 m95 -103.14 170.39 7.99 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 53' ' ' PRO . 96.2 m-85 -141.8 154.14 45.01 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.913 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.524 HD12 ' H ' ' A' ' 110' ' ' PHE . 15.6 tp -101.76 138.56 38.58 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.67 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.747 ' CZ ' HG22 ' A' ' 72' ' ' VAL . 31.0 m-85 -141.68 144.07 33.9 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.641 ' HB2' HD11 ' A' ' 73' ' ' ILE . 3.2 tttm -102.21 124.91 48.62 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.962 178.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.597 ' HD1' HD21 ' A' ' 21' ' ' LEU . 49.9 t80 -78.38 99.88 6.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.811 0.339 . . . . 0.0 110.56 178.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 35.1 p -99.37 51.29 0.94 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.027 0.442 . . . . 0.0 110.501 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -153.81 -146.93 4.51 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.504 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.439 ' O ' ' HZ ' ' A' ' 112' ' ' PHE . 2.7 mm-40 -120.93 146.61 46.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.028 0.442 . . . . 0.0 110.714 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.4 ' HB3' ' CH2' ' A' ' 134' ' ' TRP . 18.1 m-20 -57.15 -33.08 67.05 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.873 -178.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -58.23 -5.64 0.51 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.862 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -90.73 -15.19 30.68 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.64 0.257 . . . . 0.0 111.026 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.653 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 19.2 mt -77.9 100.24 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.901 0.381 . . . . 0.0 111.883 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -105.8 97.34 7.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.498 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.756 HD13 ' HB2' ' A' ' 131' ' ' PHE . 27.2 mt . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.11 -179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 . . . . . 0 C--O 1.233 0.201 0 CA-C-O 120.907 0.384 . . . . 0.0 111.014 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.756 ' HB2' HD13 ' A' ' 121' ' ' LEU . 2.0 m-85 -104.18 144.15 31.97 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.401 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.697 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -88.72 -35.54 8.37 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.558 -0.83 . . . . 0.0 111.713 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.6 148.4 28.59 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.854 0.359 . . . . 0.0 110.719 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.653 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 37.6 p-90 -135.4 165.31 25.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.264 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.426 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 22.6 t -160.13 176.95 11.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.392 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.57 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 41.9 m95 -113.75 105.02 12.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.224 178.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 28' ' ' ILE . 24.4 m -119.39 170.3 9.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.269 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.549 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 24.4 p -72.86 169.32 17.94 Favored Pre-proline 0 C--N 1.324 -0.529 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.504 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.817 ' HG3' HD11 ' A' ' 28' ' ' ILE . 17.3 Cg_exo -60.52 -51.83 4.66 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.082 1.855 . . . . 0.0 110.401 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -67.41 -28.81 68.23 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.847 178.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.455 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 2.3 mt-30 -71.35 -47.05 58.78 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.614 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.538 ' CD1' ' HB2' ' A' ' 30' ' ' ALA . 3.5 tp -55.67 -39.24 70.68 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.536 ' O ' HG22 ' A' ' 146' ' ' THR . 24.2 mm -62.82 -38.37 81.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.233 0.54 . . . . 0.0 110.514 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.73 -49.86 55.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.187 0.517 . . . . 0.0 110.627 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.437 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -74.63 -21.65 59.33 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.02 -179.196 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.687 HG23 ' HG3' ' A' ' 151' ' ' LYS . 6.2 t -73.49 -178.92 3.24 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.68 -178.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.8 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 30.7 m -86.39 151.1 3.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.822 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.58 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 0.1 OUTLIER -58.93 -53.69 55.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.683 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.56 ' H ' ' HG3' ' A' ' 148' ' ' GLU . 39.3 p90 -55.38 -3.44 0.06 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 28.4 mttm -133.15 -7.4 3.02 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.687 ' HG3' HG23 ' A' ' 146' ' ' THR . 8.1 mttt -60.37 -61.7 7.42 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.629 0.252 . . . . 0.0 111.192 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.58 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 10.7 Cg_endo -53.92 -31.28 62.29 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.742 2.295 . . . . 0.0 112.011 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.851 ' O ' HG23 ' A' ' 157' ' ' VAL . 38.9 t -67.18 -52.05 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.485 ' HE2' ' HA ' ' A' ' 41' ' ' GLN . 4.0 m-30 -63.77 -37.93 89.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.651 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.506 ' HD3' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -55.93 -46.74 78.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.822 179.504 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.548 ' HG2' HD21 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -67.26 -28.92 68.44 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.416 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 153' ' ' VAL . 47.4 t -68.89 -42.24 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.717 178.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.494 HD22 ' HB3' ' A' ' 139' ' ' PRO . 49.4 mt -63.91 -46.43 84.86 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.551 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 40.5 t -50.33 -42.19 52.53 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.731 HG11 ' HA ' ' A' ' 76' ' ' VAL . 94.6 t -65.92 -42.03 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.282 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.61 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 16.8 m-30 -81.07 4.9 18.23 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.534 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.702 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . . . -58.86 -50.18 89.37 Favored Pre-proline 0 C--N 1.329 -0.294 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.653 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.702 ' HD3' ' HB3' ' A' ' 162' ' ' ALA . 24.2 Cg_exo -61.55 -11.93 22.3 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.389 2.059 . . . . 0.0 111.602 178.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.493 ' CG ' ' HB2' ' A' ' 74' ' ' ALA . 84.1 m-70 -109.69 -17.8 13.61 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.341 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 86.3 mt . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.725 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 12.4 mtm . . . . . 0 N--CA 1.46 0.058 0 CA-C-O 120.762 0.315 . . . . 0.0 110.653 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.721 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 11.3 p-10 . . . . . 0 C--N 1.33 -0.243 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.607 -179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.598 ' HG2' HD12 ' A' ' 47' ' ' ILE . 3.9 ttp180 . . . . . 0 CA--C 1.532 0.252 0 CA-C-O 120.905 0.383 . . . . 0.0 111.579 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.712 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 66.0 m-20 -133.47 176.54 8.45 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.218 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.801 HG13 ' CG1' ' A' ' 47' ' ' ILE . 13.1 m -139.25 166.29 21.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.365 0.602 . . . . 0.0 112.079 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.59 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -133.83 162.2 24.41 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.365 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.869 HG21 HD22 ' A' ' 61' ' ' LEU . 3.4 mp -129.49 117.47 42.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.551 ' O ' HD12 ' A' ' 109' ' ' LEU . 0.5 OUTLIER -103.86 99.76 9.54 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.832 HD11 ' HB2' ' A' ' 112' ' ' PHE . 12.4 tp -102.26 126.87 49.38 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.847 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.59 ' HE3' HD13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -124.49 153.84 41.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.239 -179.724 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.574 ' ND2' ' HB3' ' A' ' 112' ' ' PHE . 2.2 m120 -99.39 -178.61 3.96 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.684 0.754 . . . . 0.0 111.094 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -58.73 -6.17 0.7 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.041 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.523 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 2.7 m-20 -99.55 0.19 41.8 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -178.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 2.0 mmtm 72.7 21.92 3.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.921 -178.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.552 ' C ' HD12 ' A' ' 28' ' ' ILE . 15.3 mttt -95.77 169.19 10.18 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.735 HD12 ' N ' ' A' ' 28' ' ' ILE . 1.5 mp -117.67 143.24 28.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.475 0.655 . . . . 0.0 111.566 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.519 ' CE2' ' HD3' ' A' ' 43' ' ' PRO . 6.5 t80 -64.48 99.65 0.32 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.724 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.756 ' HA ' ' O ' ' A' ' 41' ' ' GLN . . . -96.46 138.73 33.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.193 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.23 135.98 39.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.578 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.733 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 70.0 p -102.15 141.95 34.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.852 0.358 . . . . 0.0 111.473 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.9 128.11 34.88 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.515 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.707 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.3 OUTLIER -44.24 -37.82 3.45 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.181 0.515 . . . . 0.0 111.04 -179.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -71.59 -35.24 70.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.508 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.403 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 16.3 mt -126.4 106.72 24.06 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 120.728 0.299 . . . . 0.0 111.068 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.7 -43.84 12.03 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.86 2.374 . . . . 0.0 113.276 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -75.29 -3.55 33.99 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.769 ' HB1' ' CG1' ' A' ' 147' ' ' VAL . . . -92.34 96.13 10.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.751 0.31 . . . . 0.0 110.671 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.603 ' CD1' ' HB3' ' A' ' 145' ' ' LEU . 74.1 m95 -94.46 163.0 13.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.57 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.756 ' O ' ' HA ' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -174.31 -135.3 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.341 -178.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.626 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 6.4 ptt? -177.03 165.32 1.45 Allowed Pre-proline 0 N--CA 1.453 -0.307 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.904 ' HG3' HD13 ' A' ' 61' ' ' LEU . 4.1 Cg_endo -45.05 144.47 3.84 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.736 2.291 . . . . 0.0 113.246 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.462 ' HA ' HD12 ' A' ' 19' ' ' ILE . 21.1 pt20 -174.26 141.94 0.76 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.323 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.538 ' HA3' ' HG3' ' A' ' 60' ' ' GLU . . . -142.65 -173.21 14.29 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.991 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.701 ' HA2' ' CB ' ' A' ' 16' ' ' ASN . . . -116.68 22.07 11.04 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 119.984 -1.103 . . . . 0.0 114.445 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.801 ' CG1' HG13 ' A' ' 17' ' ' VAL . 43.1 mt 61.28 131.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 117.234 0.517 . . . . 0.0 111.346 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -68.02 -176.18 0.67 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.724 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -47.67 -69.74 0.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.315 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -119.13 57.1 0.56 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.504 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -117.95 150.72 38.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.888 0.375 . . . . 0.0 110.945 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.84 173.09 4.53 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.748 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.639 ' HA ' HG11 ' A' ' 17' ' ' VAL . 2.0 Cg_endo -80.74 -52.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.541 2.16 . . . . 0.0 111.58 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.739 ' HE ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -54.01 -44.22 70.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.515 179.153 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -68.52 -45.09 73.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.372 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.428 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -60.51 -42.47 96.45 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.717 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -56.66 -60.16 3.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.319 0.58 . . . . 0.0 109.723 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.543 HD11 ' CD ' ' A' ' 54' ' ' ARG . 47.2 mt -53.92 -51.33 46.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.207 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -61.02 -62.68 1.68 Allowed 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.85 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.538 ' HG3' ' HA3' ' A' ' 45' ' ' GLY . 8.8 mm-40 -43.71 -44.03 6.3 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.261 0.553 . . . . 0.0 109.908 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.96 HD11 ' HB ' ' A' ' 67' ' ' VAL . 0.6 OUTLIER -51.87 -47.96 64.28 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.968 178.59 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.721 ' HG3' HG23 ' A' ' 68' ' ' THR . 38.5 ttt180 -63.23 -65.58 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.214 0.531 . . . . 0.0 111.095 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -47.75 -25.27 1.18 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.317 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -93.38 -35.58 12.95 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.605 ' HB ' HG23 ' A' ' 119' ' ' ILE . 1.4 p -127.68 -37.14 1.99 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.752 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 111.48 -10.56 28.34 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.184 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.96 ' HB ' HD11 ' A' ' 61' ' ' LEU . 68.6 t -56.86 111.97 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.197 0.523 . . . . 0.0 111.633 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.721 HG23 ' HG3' ' A' ' 62' ' ' ARG . 6.9 p -123.66 -39.15 2.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.651 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.4 m -62.48 74.43 0.02 OUTLIER 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.018 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -160.88 157.11 26.04 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -128.01 144.85 51.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.095 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.808 HG22 ' CE1' ' A' ' 110' ' ' PHE . 21.6 t -73.98 125.79 33.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.129 0.49 . . . . 0.0 111.319 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.619 HD11 ' HB2' ' A' ' 111' ' ' LYS . 1.0 OUTLIER -107.36 -20.06 6.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.683 179.728 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.505 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -169.73 177.46 4.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.818 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.478 ' HB3' ' HD1' ' A' ' 108' ' ' PHE . 3.7 pm0 -157.73 150.59 23.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.563 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.854 ' HA ' HG11 ' A' ' 160' ' ' VAL . 53.4 t -71.91 134.44 83.48 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.135 0.493 . . . . 0.0 111.354 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.46 ' HD2' HG13 ' A' ' 76' ' ' VAL . 29.7 Cg_endo -63.77 -54.06 1.09 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.099 2.533 . . . . 0.0 112.657 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.721 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 2.4 p90 -99.11 178.79 4.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.235 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.549 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 43.5 m95 -94.56 -158.0 0.6 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.623 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.528 HD23 ' O ' ' A' ' 79' ' ' TRP . 70.6 mt . . . . . 0 N--CA 1.464 0.256 0 CA-C-O 121.023 0.439 . . . . 0.0 110.197 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 15' ' ' ARG . . . . . . . . 0 CA--C 1.516 -0.348 0 CA-C-O 121.278 0.561 . . . . 0.0 109.595 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.712 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 13.1 mt-30 -121.98 123.32 41.39 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.662 -177.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 78' ' ' TYR . 5.1 ttpt -104.62 135.47 45.95 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 177.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.59 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 19.5 m95 -101.2 162.74 12.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.205 0.526 . . . . 0.0 112.3 -178.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.614 ' CD1' ' HG2' ' A' ' 54' ' ' ARG . 97.6 m-85 -137.38 149.37 46.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.643 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.551 HD12 ' O ' ' A' ' 20' ' ' CYS . 19.0 tp -102.62 125.63 49.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.31 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.808 ' CE1' HG22 ' A' ' 72' ' ' VAL . 11.9 m-85 -128.87 144.84 51.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.296 0.569 . . . . 0.0 111.507 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.619 ' HB2' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -96.35 118.56 33.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.397 179.137 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.832 ' HB2' HD11 ' A' ' 21' ' ' LEU . 50.6 t80 -79.06 94.61 5.35 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.319 179.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 19.5 p -94.67 45.46 1.12 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.378 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.34 -146.2 4.6 Favored Glycine 0 C--N 1.331 0.298 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.263 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -121.02 146.89 46.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.963 0.411 . . . . 0.0 111.401 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.504 ' HB2' ' CZ2' ' A' ' 134' ' ' TRP . 11.2 p-10 -58.3 -39.88 80.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.19 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -57.52 -4.4 0.25 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.278 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -88.85 -16.35 32.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.014 0.435 . . . . 0.0 110.562 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.627 HG12 HG22 ' A' ' 67' ' ' VAL . 11.0 mt -82.35 102.83 8.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.951 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -101.2 98.86 9.22 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.285 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.82 HD13 ' HB2' ' A' ' 131' ' ' PHE . 50.8 mt . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.637 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.625 ' O ' HD12 ' A' ' 34' ' ' LEU . 1.9 mp0 . . . . . 0 C--O 1.23 0.076 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.82 ' HB2' HD13 ' A' ' 121' ' ' LEU . 0.5 OUTLIER -102.16 142.26 33.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.492 178.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.707 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -82.53 -35.39 19.98 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.145 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.93 147.88 27.1 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.751 0.31 . . . . 0.0 110.735 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.6 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 39.1 p-90 -137.4 173.47 11.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.045 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.449 ' N ' ' HZ3' ' A' ' 40' ' ' TRP . 22.0 t -168.57 -179.46 3.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.462 0.649 . . . . 0.0 112.003 -178.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.527 ' CD2' ' OD1' ' A' ' 23' ' ' ASN . 88.8 m95 -113.25 100.72 8.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.907 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.467 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 32.6 m -118.3 169.78 8.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.283 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.579 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 12.3 p -74.04 172.32 8.84 Favored Pre-proline 0 C--N 1.329 -0.317 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.161 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.601 ' HB3' HD22 ' A' ' 158' ' ' LEU . 16.4 Cg_exo -61.87 -56.96 0.6 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.845 1.697 . . . . 0.0 110.337 179.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.38 -27.93 69.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.563 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.409 ' HG3' ' OG1' ' A' ' 138' ' ' THR . 1.0 OUTLIER -70.98 -49.31 46.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.503 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.717 HD13 ' HB2' ' A' ' 30' ' ' ALA . 12.8 tp -57.74 -37.39 73.52 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.61 ' O ' HG22 ' A' ' 146' ' ' THR . 13.2 mm -62.47 -39.3 83.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.14 0.495 . . . . 0.0 110.698 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.32 -48.91 63.64 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.325 0.583 . . . . 0.0 110.437 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.603 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -75.53 -18.78 59.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.742 -179.149 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.686 ' OG1' ' HG3' ' A' ' 41' ' ' GLN . 15.2 t -76.31 178.02 6.82 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.364 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.769 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 19.2 m -87.34 147.49 5.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.987 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.496 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 52.4 mt-10 -50.87 -49.79 58.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.927 0.394 . . . . 0.0 111.599 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.426 ' C ' ' HD2' ' A' ' 150' ' ' LYS . 1.2 m-85 -52.14 -7.13 0.05 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.547 ' HD3' ' CG2' ' A' ' 147' ' ' VAL . 7.7 mptt -137.09 -2.38 2.07 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.559 ' HG2' ' O ' ' A' ' 143' ' ' ILE . 14.7 mttt -63.79 -62.9 4.56 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 111.533 0.197 . . . . 0.0 111.533 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 19.3 Cg_endo -60.41 -29.04 87.92 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.266 1.978 . . . . 0.0 111.422 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.719 ' O ' HG23 ' A' ' 157' ' ' VAL . 21.2 t -68.23 -51.37 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.553 ' OH ' ' HG2' ' A' ' 41' ' ' GLN . 7.6 m-30 -63.95 -36.96 85.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.729 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.501 ' HD3' HG21 ' A' ' 143' ' ' ILE . 0.2 OUTLIER -57.93 -42.83 85.69 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.597 179.289 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.424 ' HG3' ' OH ' ' A' ' 78' ' ' TYR . 1.2 tp10 -68.35 -35.23 77.45 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 153' ' ' VAL . 59.2 t -66.21 -41.86 89.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.551 178.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.601 HD22 ' HB3' ' A' ' 139' ' ' PRO . 40.8 mt -64.87 -41.73 95.43 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.901 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.75 -38.74 70.21 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.854 HG11 ' HA ' ' A' ' 76' ' ' VAL . 98.7 t -69.06 -44.55 81.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.194 177.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.588 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 22.1 m-30 -80.05 4.98 15.43 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.392 -179.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.628 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.97 -52.44 74.81 Favored Pre-proline 0 C--N 1.329 -0.316 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.757 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 17.4 Cg_endo -57.77 -12.37 11.63 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.226 1.951 . . . . 0.0 112.088 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.505 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 85.0 m-70 -110.46 -19.98 12.75 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.342 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 93.4 mt . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.163 -0.923 . . . . 0.0 110.733 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.405 ' O ' ' HB2' ' A' ' 78' ' ' TYR . 3.8 mtm . . . . . 0 C--O 1.233 0.194 0 CA-C-O 120.759 0.314 . . . . 0.0 110.606 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.508 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 10.8 p-10 . . . . . 0 C--N 1.331 -0.211 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.549 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.612 ' HG3' ' CZ3' ' A' ' 79' ' ' TRP . 2.0 ttp180 . . . . . 0 C--O 1.234 0.265 0 CA-C-O 121.042 0.449 . . . . 0.0 110.859 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.684 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 2.2 m-80 -132.72 174.6 10.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.901 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.676 HG13 ' CG1' ' A' ' 47' ' ' ILE . 14.4 m -141.8 167.22 16.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.969 0.414 . . . . 0.0 110.796 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.64 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -136.05 159.38 24.29 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.562 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.012 HG22 ' CE1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -130.7 120.91 49.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.29 0.567 . . . . 0.0 112.321 -178.586 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.686 ' O ' HD12 ' A' ' 109' ' ' LEU . 53.0 t -104.3 100.09 9.81 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.073 178.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.868 HD22 HG11 ' A' ' 67' ' ' VAL . 12.0 tp -99.84 119.81 38.77 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.178 -178.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.597 ' SD ' HD11 ' A' ' 109' ' ' LEU . 0.6 OUTLIER -121.4 157.89 29.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.808 179.801 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.552 ' ND2' ' HB2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -97.16 172.48 7.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.45 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -57.06 -4.14 0.17 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.479 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.605 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.7 OUTLIER -100.25 0.72 40.86 Favored 'General case' 0 C--N 1.34 0.17 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -178.88 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 3.8 mmtm 76.45 19.17 1.68 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.222 -178.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 22' ' ' MET . 2.8 mttt -95.73 143.97 26.52 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.659 ' N ' HD12 ' A' ' 28' ' ' ILE . 3.1 mp -102.75 145.48 12.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.54 0.686 . . . . 0.0 112.23 -178.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.575 ' CE1' HD13 ' A' ' 119' ' ' ILE . 90.8 t80 -74.98 138.68 42.43 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.643 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.907 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -137.51 148.65 46.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.972 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -141.11 134.48 29.71 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.911 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.676 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 2.1 m -95.09 151.14 19.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.924 0.392 . . . . 0.0 111.122 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.0 mtp-105 -69.61 132.29 45.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.425 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.018 HD23 ' H ' ' A' ' 34' ' ' LEU . 0.1 OUTLIER -39.18 -46.52 1.49 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.961 -178.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.24 -34.76 68.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.181 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.509 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 19.5 mt -119.05 114.44 35.15 Favored Pre-proline 0 CA--C 1.529 0.17 0 C-N-CA 120.954 -0.299 . . . . 0.0 111.297 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -78.27 -20.42 11.22 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.171 1.914 . . . . 0.0 112.279 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -91.57 -10.08 41.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.922 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.676 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -90.51 92.86 9.05 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.483 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.659 ' O ' ' HA ' ' A' ' 146' ' ' THR . 76.8 m95 -88.32 148.88 24.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.657 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.3 158.02 31.61 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.346 0.593 . . . . 0.0 111.567 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.543 ' HG3' HD11 ' A' ' 142' ' ' LEU . 28.3 mtm -90.41 148.51 39.09 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.991 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.464 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 11.3 Cg_endo -53.88 151.5 26.32 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.729 1.619 . . . . 0.0 111.319 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.416 ' HA ' ' CD1' ' A' ' 19' ' ' ILE . 4.1 pt20 -174.74 154.23 1.91 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.419 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.432 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . -159.9 159.94 31.11 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.298 -0.953 . . . . 0.0 112.151 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.684 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -86.79 137.34 14.74 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.693 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.676 ' CG1' HG13 ' A' ' 17' ' ' VAL . 45.2 mt -68.36 146.51 12.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.616 0.246 . . . . 0.0 111.289 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -68.66 -174.64 0.58 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.017 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.05 -61.36 2.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.472 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.59 58.62 0.7 Allowed Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.764 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.436 ' O ' HG21 ' A' ' 47' ' ' ILE . 2.3 tp10 -117.44 154.06 32.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.68 0.276 . . . . 0.0 110.623 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.72 159.78 84.07 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.53 ' HA ' HG11 ' A' ' 17' ' ' VAL . 6.1 Cg_exo -78.54 -49.85 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.528 2.152 . . . . 0.0 111.686 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.746 ' HE ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -51.49 -46.64 63.23 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.305 179.563 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -67.38 -44.61 78.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.351 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.68 -39.9 90.12 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.924 ' HB1' HG23 ' A' ' 19' ' ' ILE . . . -58.6 -56.12 26.27 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.442 0.639 . . . . 0.0 109.565 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.573 HD11 ' NE ' ' A' ' 54' ' ' ARG . 23.6 mt -55.86 -52.71 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.854 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -62.1 -58.19 8.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.826 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.432 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 70.6 mm-40 -46.21 -45.63 17.03 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.382 0.61 . . . . 0.0 109.848 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.89 HD21 ' HB ' ' A' ' 67' ' ' VAL . 9.9 tt -52.45 -45.91 66.23 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.865 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.706 ' HD2' ' HA2' ' A' ' 66' ' ' GLY . 19.9 tpt85 -62.81 -65.6 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.377 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -50.11 -23.91 2.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.076 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . 0.52 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 6.3 mt-10 -91.87 -35.29 14.14 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -177.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.525 HG21 ' CE2' ' A' ' 29' ' ' PHE . 1.7 p -123.76 -43.79 2.11 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 120.505 -0.478 . . . . 0.0 112.141 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.706 ' HA2' ' HD2' ' A' ' 62' ' ' ARG . . . 119.89 -17.58 10.0 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.275 -178.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.89 ' HB ' HD21 ' A' ' 61' ' ' LEU . 76.5 t -58.73 115.22 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-O 121.443 0.64 . . . . 0.0 111.842 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.646 HG23 ' HD3' ' A' ' 62' ' ' ARG . 0.5 OUTLIER -124.55 -37.04 2.55 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.5 178.223 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.4 m -62.35 73.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.102 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.572 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -159.63 156.08 27.3 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -128.65 148.57 50.81 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.328 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.837 HG22 ' CE2' ' A' ' 110' ' ' PHE . 26.2 t -75.25 127.92 36.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.108 0.48 . . . . 0.0 111.341 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.662 HD11 ' HB2' ' A' ' 111' ' ' LYS . 1.7 mt -107.84 -18.58 7.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.482 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.437 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.91 175.48 4.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.219 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.4 pt-20 -151.52 149.68 29.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.469 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.833 ' HA ' HG11 ' A' ' 160' ' ' VAL . 39.7 t -72.92 134.94 80.77 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.99 0.424 . . . . 0.0 111.144 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.48 ' HD2' HG11 ' A' ' 160' ' ' VAL . 17.8 Cg_endo -57.0 -68.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.201 2.601 . . . . 0.0 112.707 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.524 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -95.5 -174.86 3.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.76 -178.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.612 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 47.2 m95 -90.9 -158.05 0.53 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.037 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 79' ' ' TRP . 50.7 mt . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 120.947 0.404 . . . . 0.0 110.552 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.22 0 CA-C-O 120.676 0.274 . . . . 0.0 110.299 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.677 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.8 OUTLIER -130.53 130.46 44.17 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -178.575 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.514 ' HE2' ' CE2' ' A' ' 79' ' ' TRP . 1.9 ttmt -104.04 135.87 44.75 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.64 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 18.7 m95 -105.68 164.01 12.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -177.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.53 ' CD2' ' HG2' ' A' ' 54' ' ' ARG . 96.3 m-85 -139.44 153.59 47.61 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.528 -179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.686 HD12 ' O ' ' A' ' 20' ' ' CYS . 13.8 tp -100.91 142.61 32.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.429 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 1.012 ' CE1' HG22 ' A' ' 19' ' ' ILE . 10.1 m-85 -144.54 146.13 32.2 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.662 ' HB2' HD11 ' A' ' 73' ' ' ILE . 22.8 tttt -101.56 124.57 47.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.474 178.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.701 ' CE1' HG13 ' A' ' 67' ' ' VAL . 49.4 t80 -77.91 97.37 5.28 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.549 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 59.3 p -96.72 53.91 1.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.035 0.445 . . . . 0.0 110.588 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -157.96 -147.24 4.75 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.492 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -122.31 149.15 44.13 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.996 0.427 . . . . 0.0 110.826 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.466 ' HB3' ' CH2' ' A' ' 134' ' ' TRP . 76.6 m-20 -58.61 -32.26 68.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.291 -179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -59.31 -5.45 0.75 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.464 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.65 -16.11 33.22 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.944 0.402 . . . . 0.0 111.005 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.734 HG12 HG22 ' A' ' 67' ' ' VAL . 6.1 mt -79.04 101.84 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.901 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -101.21 92.85 5.16 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.767 179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.575 HD11 ' CD1' ' A' ' 134' ' ' TRP . 87.5 mt . . . . . 0 C--N 1.333 -0.144 0 CA-C-O 120.896 0.379 . . . . 0.0 110.626 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.695 ' C ' HD21 ' A' ' 34' ' ' LEU . 6.5 mm-40 . . . . . 0 N--CA 1.454 -0.231 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.647 ' N ' HD21 ' A' ' 34' ' ' LEU . 8.4 m-85 -132.24 142.84 49.55 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.721 ' N ' HD22 ' A' ' 34' ' ' LEU . . . -86.9 -32.16 15.61 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.397 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 31' ' ' ALA . 1.9 tt0 -154.52 154.47 33.17 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.725 0.297 . . . . 0.0 111.337 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.64 ' CE2' HD12 ' A' ' 119' ' ' ILE . 22.1 p-90 -134.6 164.94 26.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.217 0.532 . . . . 0.0 112.162 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.425 ' N ' ' HZ3' ' A' ' 40' ' ' TRP . 12.2 t -159.24 162.93 36.24 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.277 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.544 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 51.7 m95 -107.1 105.67 15.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.018 178.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 28' ' ' ILE . 30.1 m -121.34 170.96 10.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.882 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.598 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 17.2 p -72.38 173.32 5.79 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.68 ' HB3' HD22 ' A' ' 158' ' ' LEU . 7.0 Cg_exo -64.68 -52.8 1.19 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 121.623 1.548 . . . . 0.0 109.896 178.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -64.44 -31.65 72.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.654 178.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.463 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.9 OUTLIER -70.11 -45.92 65.89 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.051 179.645 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.907 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -56.92 -39.91 75.34 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.682 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.643 HG21 ' CE ' ' A' ' 155' ' ' LYS . 33.4 mm -62.47 -33.89 61.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.087 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.46 -53.45 13.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.239 0.542 . . . . 0.0 110.54 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.4 mp -71.62 -21.19 61.87 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.649 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.659 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 7.4 t -74.99 169.38 18.11 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.586 -178.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.572 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 25.4 m -72.86 162.49 4.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.615 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.731 ' HG2' ' N ' ' A' ' 149' ' ' PHE . 0.3 OUTLIER -67.87 -50.98 53.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.19 0.519 . . . . 0.0 110.88 179.762 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.731 ' N ' ' HG2' ' A' ' 148' ' ' GLU . 40.2 p90 -58.52 -2.58 0.22 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.938 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.526 ' HG3' ' CD2' ' A' ' 149' ' ' PHE . 23.6 mttt -132.15 -7.49 3.43 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.56 ' HG3' HG23 ' A' ' 143' ' ' ILE . 0.3 OUTLIER -63.23 -56.13 30.33 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 121.307 -0.157 . . . . 0.0 110.63 179.286 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 20.0 Cg_endo -61.87 -28.21 81.08 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.214 1.942 . . . . 0.0 111.636 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.815 ' O ' HG23 ' A' ' 157' ' ' VAL . 15.0 t -68.83 -48.5 70.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.528 ' CE1' ' CH2' ' A' ' 107' ' ' TRP . 7.5 m-30 -68.83 -37.65 79.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.765 178.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.643 ' CE ' HG21 ' A' ' 143' ' ' ILE . 2.0 tptp -55.34 -44.83 76.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.521 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.417 ' O ' HG23 ' A' ' 160' ' ' VAL . 4.7 tt0 -67.57 -34.25 76.66 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 153' ' ' VAL . 47.7 t -67.79 -41.0 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.847 178.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.68 HD22 ' HB3' ' A' ' 139' ' ' PRO . 38.7 mt -62.77 -44.91 94.95 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.385 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 62.5 m -51.54 -40.29 59.39 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.833 HG11 ' HA ' ' A' ' 76' ' ' VAL . 81.9 t -67.28 -42.23 87.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.142 178.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.687 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 22.3 m-30 -80.12 2.8 22.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.496 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.597 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.98 -52.81 72.18 Favored Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.053 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.6 Cg_endo -58.11 -12.09 11.9 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.153 1.902 . . . . 0.0 112.136 179.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.437 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 87.1 m-70 -110.72 -16.12 13.68 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.492 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.687 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 93.7 mt . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.912 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.46 ' HB2' ' HE3' ' A' ' 6' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.089 0 N-CA-C 110.383 -0.229 . . . . 0.0 110.383 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.78 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 9.0 t0 . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 120.944 0.402 . . . . 0.0 110.062 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.449 ' HG3' ' CZ3' ' A' ' 79' ' ' TRP . 0.0 OUTLIER . . . . . 0 CA--C 1.522 -0.128 0 CA-C-O 121.115 0.483 . . . . 0.0 110.173 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.71 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 3.4 m120 -132.3 173.1 11.62 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.899 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.66 ' CG1' HD11 ' A' ' 47' ' ' ILE . 21.2 m -143.71 162.41 15.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.318 0.58 . . . . 0.0 112.425 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.649 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -133.95 158.98 23.58 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 177.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.016 HG23 ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -134.14 126.34 49.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.533 ' O ' HD12 ' A' ' 109' ' ' LEU . 35.8 t -102.82 100.64 10.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.237 178.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.9 HD22 HG11 ' A' ' 67' ' ' VAL . 11.4 tp -99.73 118.91 37.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.435 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.584 ' CE ' HD13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -120.48 166.54 13.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.633 179.622 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.559 ' OD1' ' CE3' ' A' ' 136' ' ' TRP . 0.0 OUTLIER -101.04 171.9 7.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.573 -179.695 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -56.82 -5.32 0.22 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.525 178.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.534 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 1.4 m-20 -98.53 1.95 47.07 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.66 0.267 . . . . 0.0 111.687 -178.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.1 OUTLIER 76.07 18.31 2.0 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.102 -178.508 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.514 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 0.2 OUTLIER -94.68 142.17 27.76 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.836 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.684 HD13 ' N ' ' A' ' 139' ' ' PRO . 3.7 mp -99.33 146.47 8.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.761 0.791 . . . . 0.0 112.612 -178.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.568 ' CE1' HD13 ' A' ' 119' ' ' ILE . 87.2 t80 -78.15 136.97 37.94 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.239 -1.346 . . . . 0.0 110.035 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.621 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -137.88 146.77 43.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.893 0.378 . . . . 0.0 110.336 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.453 ' HB1' ' CG ' ' A' ' 131' ' ' PHE . . . -138.69 132.33 30.67 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.138 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.596 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 28.5 m -99.15 148.36 24.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.233 -179.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 36' ' ' ILE . 4.8 mtp180 -69.13 127.9 34.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.649 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.739 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 1.7 mp -43.69 -37.51 2.67 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.175 0.512 . . . . 0.0 111.035 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.08 -36.77 72.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.851 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.4 ' N ' ' O ' ' A' ' 33' ' ' ARG . 23.1 mt -121.63 112.9 32.19 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.076 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.96 -18.76 11.29 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.258 1.972 . . . . 0.0 112.843 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -92.88 -11.26 33.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.511 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.778 ' HB1' ' CG1' ' A' ' 147' ' ' VAL . . . -92.05 99.55 12.36 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 120.817 0.341 . . . . 0.0 110.715 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.637 ' O ' ' HA ' ' A' ' 146' ' ' THR . 72.4 m95 -94.39 157.33 16.07 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.98 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.651 ' O ' HD11 ' A' ' 142' ' ' LEU . 22.9 mt-30 -159.89 -131.69 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 121.111 -0.235 . . . . 0.0 110.399 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.526 ' H ' ' HB3' ' A' ' 41' ' ' GLN . 3.0 ptt? -179.14 161.67 1.0 Allowed Pre-proline 0 N--CA 1.453 -0.31 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.523 ' HD2' ' HB2' ' A' ' 42' ' ' MET . 9.8 Cg_endo -49.86 140.91 29.8 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.119 1.879 . . . . 0.0 112.242 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.583 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER 179.77 144.17 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.73 -179.173 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.495 ' HA3' ' HG2' ' A' ' 60' ' ' GLU . . . -160.47 -156.62 8.27 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.14 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.71 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -117.84 138.55 14.07 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.132 -1.032 . . . . 0.0 113.539 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.66 HD11 ' CG1' ' A' ' 17' ' ' VAL . 4.2 mt -69.54 148.44 11.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.488 -0.356 . . . . 0.0 111.006 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -68.92 -174.25 0.57 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.849 0.357 . . . . 0.0 110.686 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -47.96 -62.26 1.55 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.464 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.82 60.67 0.68 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.559 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.476 ' O ' HG21 ' A' ' 47' ' ' ILE . 3.7 tp10 -117.04 153.28 32.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.765 0.317 . . . . 0.0 110.669 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 7.9 m-20 -70.13 147.08 95.43 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 16.7 Cg_exo -67.09 -46.51 3.04 Favored 'Trans proline' 0 CA--C 1.513 -0.529 0 C-N-CA 122.138 1.892 . . . . 0.0 111.395 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.79 ' NE ' HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -52.21 -49.02 64.75 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.097 179.153 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.532 ' HA ' HD12 ' A' ' 58' ' ' ILE . 2.4 m120 -63.77 -44.31 93.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.512 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 60' ' ' GLU . . . -60.58 -42.28 96.38 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 1.016 ' HB1' HG23 ' A' ' 19' ' ' ILE . . . -56.07 -52.93 62.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.978 178.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.79 HD11 ' NE ' ' A' ' 54' ' ' ARG . 17.3 mt -57.49 -54.37 31.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.881 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -61.39 -58.68 7.24 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.729 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.495 ' HG2' ' HA3' ' A' ' 45' ' ' GLY . 0.7 OUTLIER -45.38 -45.41 12.6 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.536 0.684 . . . . 0.0 109.511 179.318 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.789 HD12 ' HB ' ' A' ' 19' ' ' ILE . 7.6 tt -52.55 -51.14 61.15 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.731 178.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.847 ' HG3' HG23 ' A' ' 68' ' ' THR . 7.3 ttm105 -62.44 -62.46 1.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.195 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -51.38 -20.48 1.77 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.43 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -100.57 -35.58 9.47 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.558 HG22 ' CD2' ' A' ' 121' ' ' LEU . 0.8 OUTLIER -124.1 -11.3 7.56 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.027 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 84.54 -14.5 46.25 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.868 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.9 HG11 HD22 ' A' ' 21' ' ' LEU . 39.8 t -57.99 115.2 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.434 0.635 . . . . 0.0 111.316 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.847 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -123.54 -39.94 2.39 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.813 178.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.427 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 7.2 m -63.0 74.98 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.643 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -160.27 155.91 25.57 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . 0.413 ' HG3' HG21 ' A' ' 113' ' ' THR . 2.9 mt-10 -128.48 151.39 49.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.399 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.702 HG21 ' HE ' ' A' ' 54' ' ' ARG . 20.2 t -75.64 130.72 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-O 121.292 0.567 . . . . 0.0 112.066 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.589 HD12 ' HG ' ' A' ' 109' ' ' LEU . 1.0 OUTLIER -111.04 -19.11 7.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.37 179.045 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.473 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.94 176.54 4.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.812 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.4 OUTLIER -157.05 145.21 19.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.123 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.672 ' HA ' HG11 ' A' ' 160' ' ' VAL . 25.6 t -72.1 138.03 81.9 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-O 121.006 0.431 . . . . 0.0 110.838 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.598 ' HD2' HG13 ' A' ' 76' ' ' VAL . 73.7 Cg_endo -76.87 -45.09 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.9 2.4 . . . . 0.0 113.49 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.78 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 1.1 p90 -99.41 161.84 13.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.147 0.499 . . . . 0.0 112.242 -178.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.449 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 73.2 m95 -95.14 109.95 21.96 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.851 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.501 HD12 ' CD1' ' A' ' 107' ' ' TRP . 17.3 mt . . . . . 0 C--N 1.328 -0.343 0 C-N-CA 121.128 -0.229 . . . . 0.0 110.527 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.444 0 CA-C-O 121.175 0.512 . . . . 0.0 110.646 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.706 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 53.6 mt-30 -128.8 123.51 33.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.986 -178.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.446 ' HB2' ' CE3' ' A' ' 79' ' ' TRP . 0.8 OUTLIER -103.25 134.85 45.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.816 178.604 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.543 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 73.0 m95 -102.29 159.01 15.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.306 0.574 . . . . 0.0 112.268 -178.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.458 ' CZ ' ' HB2' ' A' ' 53' ' ' PRO . 93.9 m-85 -139.26 151.15 46.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.485 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.589 ' HG ' HD12 ' A' ' 73' ' ' ILE . 24.0 tp -100.33 139.36 36.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.7 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.746 ' CE1' HG22 ' A' ' 19' ' ' ILE . 40.5 m-85 -140.95 144.92 35.41 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.579 ' HB2' HD11 ' A' ' 73' ' ' ILE . 29.9 tttt -103.37 124.28 48.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.804 177.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.468 ' HB2' HD11 ' A' ' 21' ' ' LEU . 44.4 t80 -78.47 101.85 7.53 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.848 0.356 . . . . 0.0 110.857 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . 0.413 HG21 ' HG3' ' A' ' 71' ' ' GLU . 21.3 p -100.77 46.43 0.95 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.548 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.427 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -150.84 -145.13 4.06 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.24 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.42 ' O ' ' HZ ' ' A' ' 112' ' ' PHE . 1.4 pt20 -124.86 149.06 47.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.182 0.515 . . . . 0.0 111.429 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -58.86 -26.54 64.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.944 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -57.42 -7.25 0.56 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.41 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -89.75 -16.45 30.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.099 0.476 . . . . 0.0 110.566 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.575 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 3.7 mt -88.64 108.21 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.696 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -109.07 -31.39 7.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.168 179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.558 ' CD2' HG22 ' A' ' 65' ' ' THR . 38.3 mt . . . . . 0 N--CA 1.464 0.231 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.64 -179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 . . . . . 0 N--CA 1.457 -0.112 0 CA-C-O 121.163 0.506 . . . . 0.0 110.072 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.453 ' CG ' ' HB1' ' A' ' 31' ' ' ALA . 4.9 m-85 -133.66 145.62 50.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.014 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.739 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -90.68 -33.77 8.25 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.817 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.16 146.55 27.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.884 0.373 . . . . 0.0 110.761 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.575 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 39.6 p-90 -134.76 167.12 21.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.187 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.456 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 13.0 t -164.98 168.85 17.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.426 0.632 . . . . 0.0 112.243 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.559 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 36.4 m95 -106.01 106.89 17.61 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.085 178.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.432 ' O ' ' N ' ' A' ' 28' ' ' ILE . 29.8 m -122.43 171.02 11.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.126 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.592 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 11.6 p -72.4 173.45 5.62 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.716 ' HB3' HD22 ' A' ' 158' ' ' LEU . 5.3 Cg_exo -65.01 -53.59 0.84 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 121.564 1.509 . . . . 0.0 110.374 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.22 -25.8 68.23 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.599 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -73.04 -49.03 31.06 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.611 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.651 HD11 ' O ' ' A' ' 41' ' ' GLN . 4.2 tp -56.07 -38.62 70.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.909 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.618 HG21 ' HD3' ' A' ' 155' ' ' LYS . 14.0 mm -62.66 -40.74 89.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.137 0.494 . . . . 0.0 110.636 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.85 -47.98 70.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.261 0.553 . . . . 0.0 110.556 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.535 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -76.32 -22.32 55.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.695 -179.181 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.637 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 10.0 t -75.46 179.44 5.25 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.113 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.778 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 21.0 m -86.28 158.36 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.196 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.577 ' HA ' ' HD3' ' A' ' 151' ' ' LYS . 8.9 mt-10 -60.64 -49.52 77.2 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.147 0.499 . . . . 0.0 110.799 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -54.09 -8.49 0.19 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.352 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -135.21 -6.02 2.33 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.577 ' HD3' ' HA ' ' A' ' 148' ' ' GLU . 1.2 mtpp -58.62 -62.26 6.05 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.717 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.487 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 18.1 Cg_endo -60.6 -27.29 84.58 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.308 2.005 . . . . 0.0 111.505 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.686 ' O ' HG23 ' A' ' 157' ' ' VAL . 22.1 t -67.51 -53.35 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.522 ' HE2' ' HA ' ' A' ' 41' ' ' GLN . 6.4 m-30 -63.18 -38.22 90.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.101 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.618 ' HD3' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -56.88 -45.39 82.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.071 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.509 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.5 tt0 -67.31 -33.42 75.24 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 153' ' ' VAL . 81.3 t -66.71 -41.75 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.613 178.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.716 HD22 ' HB3' ' A' ' 139' ' ' PRO . 54.6 mt -62.88 -44.84 95.02 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.404 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.98 -40.67 63.92 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.672 HG11 ' HA ' ' A' ' 76' ' ' VAL . 60.8 t -67.51 -43.41 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.242 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.601 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 21.6 m-30 -80.94 4.89 17.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.495 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.607 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.63 -52.69 72.22 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.798 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 17.9 Cg_endo -58.08 -11.91 11.36 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.067 1.845 . . . . 0.0 112.058 179.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.473 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 83.3 m-70 -110.26 -19.02 13.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.502 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 96.9 mt . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.661 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 5.4 mtm . . . . . 0 N--CA 1.457 -0.105 0 CA-C-O 120.715 0.293 . . . . 0.0 110.757 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.724 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 7.0 p-10 . . . . . 0 C--N 1.328 -0.351 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.227 -179.366 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.426 ' HG3' ' CZ3' ' A' ' 79' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 121.261 0.553 . . . . 0.0 109.953 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.681 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 3.6 m-80 -129.83 172.18 11.94 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.039 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.698 ' CG1' HD11 ' A' ' 47' ' ' ILE . 21.1 m -138.89 167.31 20.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.495 0.664 . . . . 0.0 111.727 179.196 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.714 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -134.83 161.08 24.48 Favored Glycine 0 N--CA 1.438 -1.191 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.521 178.726 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.8 HG23 ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -129.21 119.92 50.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.09 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.474 ' O ' HD12 ' A' ' 109' ' ' LEU . 37.4 t -101.66 111.08 23.21 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.02 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.754 HD22 HG11 ' A' ' 67' ' ' VAL . 59.9 tp -105.9 124.34 49.41 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.925 -178.37 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.69 ' HB3' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -116.51 137.58 52.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.8 -179.954 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.482 ' OD1' ' CH2' ' A' ' 136' ' ' TRP . 6.7 m-20 -96.8 -173.8 2.82 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.307 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -54.81 -5.03 0.08 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.128 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 3.0 m-20 -101.76 -1.54 32.18 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 122.173 -0.329 . . . . 0.0 111.787 -178.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 11.4 mmtm 69.5 23.3 6.05 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -177.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.825 ' C ' HD12 ' A' ' 28' ' ' ILE . 84.2 mttt -95.59 -167.4 1.6 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.876 179.267 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.825 HD12 ' C ' ' A' ' 27' ' ' LYS . 2.1 mp -136.0 146.27 29.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.968 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.608 ' CE1' HD13 ' A' ' 119' ' ' ILE . 90.3 t80 -70.55 138.73 51.19 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.514 179.512 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.841 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -140.22 149.1 42.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.099 179.593 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.555 ' HB1' ' HB3' ' A' ' 131' ' ' PHE . . . -143.55 145.0 32.19 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.045 -179.701 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.658 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 28.4 p -98.97 145.74 26.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.09 0.471 . . . . 0.0 111.466 -179.512 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.641 ' O ' ' N ' ' A' ' 35' ' ' ASP . 25.3 mtp180 -69.34 129.82 40.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.783 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.649 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.5 OUTLIER -56.85 55.49 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.862 -179.98 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.641 ' N ' ' O ' ' A' ' 33' ' ' ARG . 0.9 OUTLIER -177.23 -34.82 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.157 0.504 . . . . 0.0 110.223 -179.688 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.491 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 7.1 mm -117.18 106.02 47.93 Favored Pre-proline 0 N--CA 1.451 -0.411 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.135 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -58.53 -60.51 0.35 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.396 2.731 . . . . 0.0 114.443 -178.134 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.92 1.48 3.37 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.285 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.658 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.4 94.35 9.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.631 0.253 . . . . 0.0 110.991 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.662 ' O ' ' HA ' ' A' ' 146' ' ' THR . 71.1 m95 -99.24 141.82 31.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.343 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.534 ' NE2' ' HD2' ' A' ' 33' ' ' ARG . 12.5 mt-30 -146.54 174.08 11.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.954 0.883 . . . . 0.0 112.378 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.552 ' SD ' HG21 ' A' ' 28' ' ' ILE . 2.6 ttp -108.62 140.28 21.65 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 113.932 -1.486 . . . . 0.0 109.121 178.82 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.419 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 9.4 Cg_endo -52.09 146.56 29.9 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.097 1.865 . . . . 0.0 111.817 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.84 157.12 2.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.325 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 16' ' ' ASN . . . -158.39 -172.12 25.13 Favored Glycine 0 C--O 1.226 -0.383 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.662 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.681 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -107.97 139.95 15.27 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.242 -0.98 . . . . 0.0 113.614 -179.593 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.698 HD11 ' CG1' ' A' ' 17' ' ' VAL . 6.5 mt -71.52 146.5 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.694 0.283 . . . . 0.0 110.824 179.504 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.95 -175.17 0.68 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.848 0.356 . . . . 0.0 111.081 179.744 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -48.75 -51.45 28.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.304 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -142.52 62.79 0.51 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.351 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -117.87 150.92 38.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.676 0.274 . . . . 0.0 110.332 179.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.415 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 1.3 m-20 -68.87 141.16 92.03 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.346 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 33.5 Cg_exo -61.55 -45.34 18.19 Favored 'Trans proline' 0 CA--C 1.513 -0.563 0 C-N-CA 122.2 1.933 . . . . 0.0 111.513 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.786 ' HE ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -51.57 -48.22 63.22 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.042 179.39 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.613 ' HA ' HD12 ' A' ' 58' ' ' ILE . 94.0 m-20 -65.77 -43.99 87.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.638 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.88 -41.19 91.04 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.8 ' HB1' HG23 ' A' ' 19' ' ' ILE . . . -58.63 -54.11 50.74 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.903 178.746 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.715 HD11 ' NE ' ' A' ' 54' ' ' ARG . 10.6 mt -56.37 -51.73 60.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.056 179.023 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -61.31 -56.7 17.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.49 -179.247 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.429 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 74.9 mm-40 -50.47 -42.63 54.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.019 0.437 . . . . 0.0 110.015 179.366 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.698 ' HB2' HG13 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -52.08 -49.34 63.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.419 178.732 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.807 ' HG2' HG23 ' A' ' 68' ' ' THR . 4.2 tmm_? -64.13 -65.97 0.61 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.626 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -48.27 -22.53 0.69 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.495 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -100.32 -34.16 10.1 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -178.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 49.5 p -123.12 -8.81 8.22 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.31 -0.556 . . . . 0.0 112.365 -178.536 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 80.53 -18.03 9.47 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.385 -178.592 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.754 HG11 HD22 ' A' ' 21' ' ' LEU . 97.8 t -57.15 121.05 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.263 0.554 . . . . 0.0 111.413 179.257 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.807 HG23 ' HG2' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -129.14 -39.37 1.55 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.89 178.731 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.3 m -62.79 75.06 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.483 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -158.93 156.23 29.1 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.575 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.54 151.45 49.43 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.236 179.389 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.786 HG21 ' HE ' ' A' ' 54' ' ' ARG . 7.8 t -75.59 130.77 35.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.318 0.58 . . . . 0.0 112.166 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.579 HD11 ' HB2' ' A' ' 111' ' ' LYS . 0.9 OUTLIER -111.75 -19.2 7.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.555 178.805 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.542 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -169.81 178.38 4.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.626 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.6 OUTLIER -156.23 149.23 24.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.833 179.63 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.807 ' HA ' HG11 ' A' ' 160' ' ' VAL . 52.6 t -73.08 137.86 79.1 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-O 121.186 0.517 . . . . 0.0 111.574 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.607 ' HD2' HG13 ' A' ' 76' ' ' VAL . 20.4 Cg_endo -62.52 -70.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.397 2.732 . . . . 0.0 112.794 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.724 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -87.45 173.55 9.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.063 -178.723 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.507 ' HB3' ' HB1' ' A' ' 104' ' ' ALA . 48.9 m95 -93.97 100.09 12.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.964 179.738 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.606 HD11 HG22 ' A' ' 157' ' ' VAL . 52.1 mt . . . . . 0 C--N 1.327 -0.385 0 CA-C-O 120.922 0.391 . . . . 0.0 110.893 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.507 ' HB1' ' HB3' ' A' ' 79' ' ' TRP . . . . . . . . 0 CA--C 1.514 -0.412 0 CA-C-O 121.016 0.436 . . . . 0.0 109.833 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.626 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 9.4 mt-30 -128.96 122.42 30.11 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.362 -178.068 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.03 135.33 44.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.509 179.693 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.714 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 42.7 m95 -103.66 166.25 10.54 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.063 0.458 . . . . 0.0 111.636 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 53' ' ' PRO . 91.1 m-85 -141.53 155.33 45.81 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.836 -179.471 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.688 HD11 ' SD ' ' A' ' 22' ' ' MET . 8.4 tp -101.14 141.96 33.27 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.459 179.126 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.663 ' CE2' HG22 ' A' ' 72' ' ' VAL . 49.4 m-85 -144.83 144.34 31.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.49 0.662 . . . . 0.0 112.502 -178.598 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 9.5 tttt -103.65 125.98 50.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.731 177.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.659 ' CD1' HD21 ' A' ' 21' ' ' LEU . 51.0 t80 -78.85 97.37 5.95 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.032 0.444 . . . . 0.0 110.939 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 39.1 p -97.1 51.03 1.1 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.536 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -153.17 -146.77 4.45 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.422 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.409 ' O ' ' HZ ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -122.4 145.12 48.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.177 0.513 . . . . 0.0 111.069 179.786 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -59.12 -26.15 64.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.05 -179.137 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -58.37 -5.07 0.45 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.209 -179.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -90.88 -18.23 25.15 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.996 0.427 . . . . 0.0 110.977 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.608 HD13 ' CE1' ' A' ' 29' ' ' PHE . 5.5 mt -83.85 103.53 11.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.709 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -101.68 -12.53 18.32 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.243 -179.419 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.931 HD11 ' HB3' ' A' ' 134' ' ' TRP . 16.6 mt . . . . . 0 N--CA 1.473 0.693 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.057 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 . . . . . 0 N--CA 1.463 0.188 0 CA-C-O 121.13 0.49 . . . . 0.0 110.253 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.904 ' HB2' HD13 ' A' ' 121' ' ' LEU . 6.5 m-85 -105.3 147.03 28.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.696 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.649 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -86.2 -34.95 11.47 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.953 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -154.37 154.79 33.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.626 0.251 . . . . 0.0 111.2 179.911 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.931 ' HB3' HD11 ' A' ' 121' ' ' LEU . 36.4 p-90 -133.31 164.48 27.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.059 0.457 . . . . 0.0 111.875 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.5 t -157.99 165.61 34.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.685 -179.419 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.484 ' CD1' ' HZ3' ' A' ' 134' ' ' TRP . 89.6 m95 -106.75 97.53 7.31 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.936 178.305 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.626 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 21.0 m -113.37 163.11 10.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.338 179.611 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.551 ' HB ' ' CD ' ' A' ' 139' ' ' PRO . 10.5 p -70.92 174.32 3.77 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.199 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.636 ' HG3' HD11 ' A' ' 28' ' ' ILE . 12.2 Cg_exo -63.25 -53.35 1.53 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.543 1.495 . . . . 0.0 111.279 179.698 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -27.11 68.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.074 0.464 . . . . 0.0 111.067 179.332 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.401 ' HG3' ' OG1' ' A' ' 138' ' ' THR . 21.7 mt-30 -72.23 -47.3 51.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.882 179.767 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.841 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.3 OUTLIER -55.34 -41.41 72.44 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.482 179.498 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.657 HG22 ' HG3' ' A' ' 151' ' ' LYS . 28.9 mm -61.12 -34.24 59.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.553 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.57 -52.08 17.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.861 179.115 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.3 mp -72.97 -21.78 60.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.228 -179.309 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.662 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 8.2 t -73.21 173.87 8.83 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.99 0.424 . . . . 0.0 111.675 -178.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.689 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 16.3 m -79.83 154.03 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.984 -179.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.448 ' C ' ' H ' ' A' ' 150' ' ' LYS . 4.0 mt-10 -58.41 -54.82 42.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.849 0.357 . . . . 0.0 110.73 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.689 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 51.7 p90 -56.93 2.47 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.589 ' HG2' ' CZ ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -137.53 -6.41 1.75 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.581 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.657 ' HG3' HG22 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -64.44 -56.35 23.53 Favored Pre-proline 0 N--CA 1.464 0.262 0 N-CA-C 111.326 0.121 . . . . 0.0 111.326 -179.979 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 29.4 Cg_endo -63.66 -28.5 69.19 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.278 1.985 . . . . 0.0 111.834 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.771 ' O ' HG23 ' A' ' 157' ' ' VAL . 25.9 t -68.66 -51.09 49.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.718 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.589 ' CZ ' ' HG2' ' A' ' 150' ' ' LYS . 16.5 m-30 -64.93 -40.74 95.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.678 178.449 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.577 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -53.9 -43.62 69.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.401 -179.675 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.418 ' O ' HG23 ' A' ' 160' ' ' VAL . 3.9 tt0 -69.38 -32.44 71.48 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.218 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 153' ' ' VAL . 46.9 t -65.0 -41.81 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.683 178.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.513 HD22 ' HB3' ' A' ' 139' ' ' PRO . 37.3 mt -62.54 -46.71 87.13 Favored 'General case' 0 CA--C 1.524 -0.038 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.366 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.43 -38.54 29.66 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.807 HG11 ' HA ' ' A' ' 76' ' ' VAL . 80.1 t -68.85 -44.21 81.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.354 177.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.68 ' CE2' HG12 ' A' ' 157' ' ' VAL . 22.4 m-30 -79.6 4.18 16.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.284 -179.287 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.609 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.38 -53.64 64.0 Favored Pre-proline 0 C--N 1.327 -0.378 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.71 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 16.9 Cg_endo -57.91 -12.77 13.0 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.44 2.093 . . . . 0.0 111.907 178.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.542 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 91.3 m-70 -109.4 -16.95 13.9 Favored 'General case' 0 N--CA 1.46 0.027 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.457 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 95.5 mt . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.165 -0.921 . . . . 0.0 110.803 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.41 ' N ' ' SD ' ' A' ' 6' ' ' MET . 2.2 mpp? . . . . . 0 N--CA 1.455 -0.175 0 CA-C-O 120.567 0.222 . . . . 0.0 110.442 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 16.1 t70 . . . . . 0 C--N 1.328 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 110.35 -179.854 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.494 ' C ' HD12 ' A' ' 47' ' ' ILE . 2.5 ttt180 . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 121.042 0.449 . . . . 0.0 110.408 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.678 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 59.1 m-20 -133.08 176.85 8.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.163 179.072 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.682 HG13 HD11 ' A' ' 47' ' ' ILE . 27.2 m -142.2 164.58 17.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.252 0.549 . . . . 0.0 111.703 179.109 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.591 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -130.33 155.71 21.21 Favored Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.847 178.65 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.117 HG21 HD22 ' A' ' 61' ' ' LEU . 3.7 mp -122.06 119.42 58.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.154 0.502 . . . . 0.0 112.021 -178.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.523 ' O ' HD12 ' A' ' 109' ' ' LEU . 50.0 t -103.79 101.69 11.51 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.133 178.602 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.713 HD22 HG11 ' A' ' 67' ' ' VAL . 31.3 tp -102.68 121.52 42.6 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.898 -178.452 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.722 ' SD ' HD11 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -116.23 142.69 46.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.849 179.602 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.503 ' OD1' ' CZ3' ' A' ' 136' ' ' TRP . 7.8 m-20 -95.94 -177.72 4.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.465 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -56.14 -4.85 0.14 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.521 179.501 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.547 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.7 OUTLIER -103.13 -0.61 30.36 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.79 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.562 ' HE2' ' HE3' ' A' ' 22' ' ' MET . 1.8 mmtp 72.61 23.82 2.95 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -178.249 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.634 ' HB3' ' O ' ' A' ' 137' ' ' VAL . 25.9 mttt -94.77 175.24 6.73 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.217 179.285 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.713 HD11 ' HG3' ' A' ' 139' ' ' PRO . 1.8 mm -120.01 141.16 41.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.976 0.417 . . . . 0.0 111.064 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.665 ' HE2' HG21 ' A' ' 65' ' ' THR . 58.3 t80 -66.8 107.07 2.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.278 179.23 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.767 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -101.51 139.09 37.65 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.823 0.344 . . . . 0.0 110.929 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -138.14 132.0 31.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.281 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.68 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 53.4 p -99.0 146.29 26.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.839 0.352 . . . . 0.0 111.584 -179.341 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.428 ' HD2' ' NE2' ' A' ' 41' ' ' GLN . 17.5 mtp180 -69.34 128.13 35.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.432 179.601 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.748 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -45.18 -35.4 3.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.356 0.598 . . . . 0.0 110.984 -179.884 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -72.4 -36.15 68.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.765 179.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.6 mm -124.47 111.45 28.02 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.764 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -75.24 -20.75 16.11 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.432 2.088 . . . . 0.0 113.023 -179.273 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -92.63 -7.52 46.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.387 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.68 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.8 93.06 8.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.807 0.337 . . . . 0.0 111.047 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.626 ' O ' ' HA ' ' A' ' 146' ' ' THR . 81.6 m95 -88.0 144.03 26.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.015 179.142 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.428 ' NE2' ' HD2' ' A' ' 33' ' ' ARG . 11.5 mt-30 -153.76 174.38 14.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.54 0.686 . . . . 0.0 111.878 -179.2 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.58 ' HB3' ' CZ3' ' A' ' 107' ' ' TRP . 2.0 mtm -108.36 146.17 33.04 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.98 179.596 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -50.75 156.23 4.76 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.465 2.11 . . . . 0.0 111.995 179.783 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.683 ' HA ' HD12 ' A' ' 19' ' ' ILE . 4.2 pt20 -176.41 174.02 2.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.946 -179.391 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.467 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . 178.96 154.81 13.41 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.306 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.678 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -82.56 135.68 14.42 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.205 -179.382 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.682 HD11 HG13 ' A' ' 17' ' ' VAL . 2.8 mt -70.07 144.66 13.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.736 0.303 . . . . 0.0 111.141 179.801 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.77 -174.76 0.34 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.243 179.345 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -48.52 -77.06 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.04 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -113.27 57.35 0.45 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.689 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.451 ' O ' HG21 ' A' ' 47' ' ' ILE . 9.2 tp10 -115.77 148.35 39.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.795 0.331 . . . . 0.0 110.896 179.731 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 78.8 m-20 -72.16 142.58 85.03 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.536 179.677 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.497 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 56.7 Cg_exo -54.42 -45.43 41.02 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.714 2.276 . . . . 0.0 112.579 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.814 ' CZ ' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -52.14 -44.49 64.58 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.29 -179.616 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -65.71 -47.43 75.39 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.461 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.02 -43.19 99.36 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.412 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.627 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -58.13 -58.57 7.86 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.617 178.796 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.543 HD11 ' HG3' ' A' ' 54' ' ' ARG . 20.8 mt -56.17 -51.23 64.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.377 179.368 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -63.13 -64.89 0.78 Allowed 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.452 -179.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.467 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 56.2 mm-40 -42.29 -44.98 4.06 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.004 0.43 . . . . 0.0 110.43 179.932 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.117 HD22 HG21 ' A' ' 19' ' ' ILE . 14.4 tp -51.58 -46.76 63.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.975 178.562 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.886 ' HG3' HG23 ' A' ' 68' ' ' THR . 21.1 ttm180 -65.12 -65.76 0.63 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.25 179.429 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -49.39 -21.59 0.93 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.372 -179.266 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -97.87 -36.5 10.16 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.2 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.76 HG22 ' CD2' ' A' ' 121' ' ' LEU . 0.8 OUTLIER -128.95 -3.1 5.18 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.717 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 77.4 -12.19 15.02 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.415 -179.5 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.713 HG11 HD22 ' A' ' 21' ' ' LEU . 50.2 t -57.85 110.99 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-O 121.235 0.54 . . . . 0.0 111.503 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.886 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.6 OUTLIER -123.08 -40.33 2.41 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.668 178.629 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.7 m -62.17 73.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.396 179.485 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -160.66 158.22 28.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.023 0.439 . . . . 0.0 112.174 -179.631 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -129.66 149.42 51.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.655 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.814 HG11 ' CZ ' ' A' ' 54' ' ' ARG . 3.3 t -73.73 127.26 35.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.069 0.461 . . . . 0.0 110.962 179.227 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.544 HD11 ' N ' ' A' ' 111' ' ' LYS . 1.0 OUTLIER -106.61 -19.81 6.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.181 179.32 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.46 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.91 176.57 4.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.182 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.38 145.76 24.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.414 179.635 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.74 ' HA ' HG11 ' A' ' 160' ' ' VAL . 52.8 t -71.5 137.17 83.48 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.0 0.429 . . . . 0.0 110.859 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.49 ' HD2' HG13 ' A' ' 76' ' ' VAL . 17.7 Cg_endo -59.1 -66.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.198 2.599 . . . . 0.0 112.715 -179.575 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.502 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.1 OUTLIER -96.65 -176.38 3.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.207 -178.965 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.539 ' O ' ' HG ' ' A' ' 80' ' ' LEU . 37.3 m95 -89.49 -154.43 0.31 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.815 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 79' ' ' TRP . 81.6 mt . . . . . 0 C--N 1.33 -0.255 0 CA-C-O 121.103 0.478 . . . . 0.0 110.725 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 -0.112 0 CA-C-O 120.959 0.409 . . . . 0.0 110.874 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.583 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 24.1 mt-30 -129.0 123.37 32.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.167 -178.473 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.541 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 4.4 ttpt -103.83 140.93 36.98 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.659 179.429 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.591 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 24.8 m95 -105.19 167.46 9.71 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.399 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.497 ' CZ ' ' HB2' ' A' ' 53' ' ' PRO . 78.3 m-85 -143.39 156.1 44.59 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.09 -179.496 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.722 HD11 ' SD ' ' A' ' 22' ' ' MET . 8.0 tp -103.59 138.66 39.95 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.769 179.007 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.728 ' CE2' HG22 ' A' ' 72' ' ' VAL . 55.7 m-85 -142.92 144.45 32.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.397 0.618 . . . . 0.0 112.634 -178.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 22.4 tttt -104.11 123.59 47.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.522 177.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.629 ' HB2' HD11 ' A' ' 21' ' ' LEU . 55.3 t80 -79.31 99.62 7.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.875 0.369 . . . . 0.0 110.629 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 30.2 p -96.96 41.64 1.11 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.405 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -140.29 -148.33 5.14 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.54 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -121.21 148.4 44.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.955 0.407 . . . . 0.0 111.151 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.449 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 9.5 p-10 -58.6 -38.24 77.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.37 0.605 . . . . 0.0 111.181 -179.558 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -56.57 -3.8 0.12 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.286 -179.402 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -90.05 -21.01 22.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.121 0.486 . . . . 0.0 110.326 179.371 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.65 HD13 ' CE1' ' A' ' 29' ' ' PHE . 14.3 mt -85.89 105.17 14.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.124 179.646 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.424 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 18.0 p-10 -102.82 -26.18 13.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.087 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.76 ' CD2' HG22 ' A' ' 65' ' ' THR . 56.3 mt . . . . . 0 N--CA 1.464 0.236 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.025 -179.929 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.485 ' O ' HD12 ' A' ' 34' ' ' LEU . 5.1 mp0 . . . . . 0 N--CA 1.462 0.159 0 CA-C-O 120.789 0.328 . . . . 0.0 111.326 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.712 ' CE2' HG23 ' A' ' 65' ' ' THR . 3.1 m-85 -104.75 143.05 33.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.069 0.461 . . . . 0.0 110.64 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.748 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -90.14 -35.63 7.5 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.705 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -150.28 148.21 28.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.96 0.41 . . . . 0.0 110.619 179.626 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.536 ' CD2' ' HE1' ' A' ' 29' ' ' PHE . 38.1 p-90 -137.14 167.98 20.49 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.607 179.465 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.466 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 42.9 t -160.27 174.64 13.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.318 0.58 . . . . 0.0 112.314 -178.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.503 ' CZ3' ' OD1' ' A' ' 23' ' ' ASN . 78.7 m95 -109.23 100.71 9.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.551 178.384 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.634 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 28.9 m -119.03 165.61 14.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.53 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 26.8 p -71.63 167.24 32.36 Favored Pre-proline 0 C--N 1.327 -0.411 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.11 179.351 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.713 ' HG3' HD11 ' A' ' 28' ' ' ILE . 21.6 Cg_exo -59.43 -54.59 2.41 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.818 1.678 . . . . 0.0 110.435 179.554 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.3 -28.86 70.0 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.391 178.237 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.49 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 40.0 mt-30 -71.55 -46.4 59.61 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.248 179.707 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.767 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -57.65 -39.05 76.14 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.72 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.968 HG21 ' HD3' ' A' ' 155' ' ' LYS . 27.5 mm -60.3 -36.24 67.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.639 179.268 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.84 -53.3 15.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.242 0.544 . . . . 0.0 110.881 179.559 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.72 -19.52 62.04 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.448 -179.14 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.675 HG22 ' O ' ' A' ' 143' ' ' ILE . 7.6 t -73.02 179.64 3.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.056 0.455 . . . . 0.0 111.523 -179.115 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.635 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 21.9 m -85.28 151.25 3.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.439 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.458 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 48.4 mt-10 -58.48 -53.86 53.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.801 0.334 . . . . 0.0 111.227 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.619 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 53.1 p90 -56.28 0.81 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -179.721 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.597 ' HB2' HG23 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -136.83 -7.99 1.86 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.482 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.562 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 0.0 OUTLIER -62.53 -52.79 62.86 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.895 -0.138 . . . . 0.0 111.072 179.562 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 28.6 Cg_endo -63.47 -28.58 70.89 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.121 1.88 . . . . 0.0 111.895 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.81 ' O ' HG23 ' A' ' 157' ' ' VAL . 23.3 t -68.42 -49.33 66.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.824 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.525 ' CE1' ' HG2' ' A' ' 150' ' ' LYS . 5.4 m-30 -66.58 -40.59 89.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.806 178.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.968 ' HD3' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -53.2 -44.82 68.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.518 179.449 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.431 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.5 OUTLIER -68.32 -33.34 74.13 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.133 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 153' ' ' VAL . 64.2 t -66.07 -41.31 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.695 178.688 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.566 HD22 ' HB3' ' A' ' 139' ' ' PRO . 64.8 mt -64.88 -45.01 87.77 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.55 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.35 -41.41 63.03 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.235 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.74 HG11 ' HA ' ' A' ' 76' ' ' VAL . 94.0 t -66.11 -42.33 91.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.033 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.56 ' CE2' HG12 ' A' ' 157' ' ' VAL . 19.7 m-30 -81.05 6.35 13.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.554 -179.192 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.594 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.46 -53.64 64.04 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.55 179.592 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 18.1 Cg_endo -59.56 -12.14 16.45 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.021 1.814 . . . . 0.0 111.86 178.712 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.46 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 96.5 m-70 -107.37 -18.55 13.84 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.292 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 78.3 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.794 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.445 ' C ' ' HB2' ' A' ' 78' ' ' TYR . 0.3 OUTLIER . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.527 0.203 . . . . 0.0 110.597 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.748 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 17.9 t70 . . . . . 0 N--CA 1.462 0.167 0 CA-C-O 120.713 0.292 . . . . 0.0 111.358 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.671 ' HB2' ' CZ3' ' A' ' 79' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.417 0 CA-C-O 121.33 0.586 . . . . 0.0 111.184 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.668 ' CB ' ' HA2' ' A' ' 46' ' ' GLY . 75.1 m-20 -131.61 176.57 8.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.235 -179.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.748 HG13 HD11 ' A' ' 47' ' ' ILE . 18.4 m -141.97 157.37 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 120.221 -0.592 . . . . 0.0 112.377 179.626 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.475 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -126.28 168.43 18.42 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.209 178.39 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 1.079 HG21 HD13 ' A' ' 61' ' ' LEU . 5.1 mp -128.73 116.62 41.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -178.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.599 ' O ' HD12 ' A' ' 109' ' ' LEU . 8.3 t -103.87 98.23 8.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.617 178.28 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.939 HD22 HG11 ' A' ' 67' ' ' VAL . 13.6 tp -99.25 127.2 45.22 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.792 -178.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.716 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -121.62 151.63 40.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.821 179.496 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.547 ' N ' ' OD1' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -94.61 173.84 7.41 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.859 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.443 ' HA ' ' HE3' ' A' ' 111' ' ' LYS . 20.6 p30 -57.91 -5.68 0.45 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.653 176.819 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.568 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 4.9 m-20 -102.55 0.38 33.4 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.081 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.568 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 24.3 mmtp 75.18 22.73 1.7 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.262 -178.464 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.716 ' O ' ' HA ' ' A' ' 22' ' ' MET . 5.6 mmtt -93.37 143.81 25.92 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.803 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.743 HG13 ' HA ' ' A' ' 139' ' ' PRO . 1.8 mm -97.43 136.18 29.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.206 0.527 . . . . 0.0 111.762 -178.819 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.681 ' HB2' HD23 ' A' ' 21' ' ' LEU . 4.4 t80 -65.78 100.71 0.57 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.51 178.49 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.655 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -96.11 141.01 30.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.793 0.33 . . . . 0.0 111.058 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -138.12 131.6 30.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.487 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.763 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 53.8 p -99.3 144.48 28.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.887 0.375 . . . . 0.0 111.593 -179.358 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.413 ' HB3' ' OD1' ' A' ' 35' ' ' ASP . 3.8 mtp180 -71.97 128.0 34.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.807 179.62 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.704 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -44.02 -38.38 3.5 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.251 0.548 . . . . 0.0 111.141 179.918 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.413 ' OD1' ' HB3' ' A' ' 33' ' ' ARG . 4.8 p-10 -71.77 -34.04 69.13 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.215 -179.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.8 mt -124.85 105.38 29.63 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.73 0.3 . . . . 0.0 111.006 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -69.73 -20.16 35.33 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.687 2.258 . . . . 0.0 112.748 -179.673 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -93.84 -7.59 42.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.651 -179.599 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.763 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.52 100.49 13.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.615 0.245 . . . . 0.0 111.032 -179.851 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.641 ' O ' ' HA ' ' A' ' 146' ' ' THR . 76.2 m95 -96.25 146.82 24.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.098 179.167 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.622 ' HG3' ' HG1' ' A' ' 146' ' ' THR . 0.2 OUTLIER -162.48 -128.75 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.668 -179.184 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.497 ' H ' ' HB3' ' A' ' 41' ' ' GLN . 2.1 ptt? 178.96 163.13 0.7 Allowed Pre-proline 0 N--CA 1.448 -0.571 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.843 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.946 ' HG2' HD12 ' A' ' 61' ' ' LEU . 82.0 Cg_exo -45.07 148.85 1.48 Allowed 'Trans proline' 0 CA--C 1.529 0.241 0 C-N-CA 122.454 2.103 . . . . 0.0 113.047 -179.229 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.546 ' HG3' ' O ' ' A' ' 17' ' ' VAL . 51.9 tt0 -173.79 145.79 1.19 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.465 -179.452 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.793 ' HA3' ' HG2' ' A' ' 60' ' ' GLU . . . -145.81 -168.71 13.4 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.293 179.739 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.668 ' HA2' ' CB ' ' A' ' 16' ' ' ASN . . . -117.47 17.2 12.43 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 119.997 -1.097 . . . . 0.0 115.382 -178.595 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.748 HD11 HG13 ' A' ' 17' ' ' VAL . 11.3 mt 62.01 136.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 117.796 0.798 . . . . 0.0 111.444 179.122 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.524 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 3.3 m-20 -69.68 -175.97 0.96 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.857 179.366 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -47.89 -81.08 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.428 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -108.12 55.48 0.51 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.814 179.567 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 4.0 tp10 -116.66 142.95 46.23 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.892 0.377 . . . . 0.0 111.159 -179.356 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.466 ' HB2' ' ND2' ' A' ' 55' ' ' ASN . 7.6 m-20 -64.8 168.89 6.12 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.102 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 4.2 Cg_exo -77.25 -53.75 0.07 OUTLIER 'Trans proline' 0 CA--C 1.515 -0.468 0 C-N-CA 122.742 2.295 . . . . 0.0 113.472 -178.747 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.619 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -49.17 -51.78 30.44 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.065 -179.255 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 56' ' ' ALA . 18.2 p30 -62.31 -37.91 87.38 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 119.816 -0.754 . . . . 0.0 110.501 -179.301 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.504 ' N ' ' OD1' ' A' ' 55' ' ' ASN . . . -64.39 -44.77 90.27 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.735 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.584 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -60.02 -61.54 2.53 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.904 178.271 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.619 ' CD1' ' O ' ' A' ' 54' ' ' ARG . 2.6 mp -53.41 -46.9 59.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.626 179.454 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 5.4 mmt180 -64.18 -62.52 1.57 Allowed 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.739 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.793 ' HG2' ' HA3' ' A' ' 45' ' ' GLY . 0.2 OUTLIER -42.56 -43.09 3.61 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.185 0.517 . . . . 0.0 110.171 179.667 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 1.079 HD13 HG21 ' A' ' 19' ' ' ILE . 1.9 tp -50.0 -47.92 52.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.998 178.851 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.892 ' HG2' HG23 ' A' ' 68' ' ' THR . 1.9 tmm_? -67.07 -65.94 0.62 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.079 178.885 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -49.26 -24.3 1.74 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.373 -179.106 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -93.95 -36.94 11.94 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.39 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.596 ' HB ' HG23 ' A' ' 119' ' ' ILE . 1.4 p -127.81 -31.24 2.44 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.402 -0.519 . . . . 0.0 112.395 -178.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.501 ' HA2' ' HD2' ' A' ' 62' ' ' ARG . . . 106.92 -13.75 41.27 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.654 -178.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.939 HG11 HD22 ' A' ' 21' ' ' LEU . 73.6 t -55.77 107.18 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-O 121.167 0.508 . . . . 0.0 111.022 179.523 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.892 HG23 ' HG2' ' A' ' 62' ' ' ARG . 0.6 OUTLIER -121.47 -39.41 2.66 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.577 178.716 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.7 m -61.55 74.22 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.863 178.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -162.56 157.19 21.79 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.113 0.482 . . . . 0.0 112.029 -179.309 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -126.72 148.76 49.85 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.055 179.154 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.712 HG22 ' CD1' ' A' ' 110' ' ' PHE . 24.8 t -76.06 126.28 36.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.12 0.485 . . . . 0.0 111.627 179.615 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.53 HD11 ' HB2' ' A' ' 111' ' ' LYS . 0.7 OUTLIER -107.5 -21.49 5.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.421 179.289 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.443 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -169.49 177.43 4.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.81 -179.192 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.53 152.16 21.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.527 179.689 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.836 ' HA ' HG11 ' A' ' 160' ' ' VAL . 43.1 t -71.9 135.87 82.82 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.974 0.416 . . . . 0.0 111.055 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.431 ' HD2' HG13 ' A' ' 76' ' ' VAL . 18.1 Cg_endo -60.13 -62.21 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.075 2.516 . . . . 0.0 112.612 -179.452 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.748 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -98.01 -177.3 3.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.154 -179.186 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.671 ' CZ3' ' HB2' ' A' ' 15' ' ' ARG . 28.8 m95 -94.27 -152.73 0.35 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.557 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 79' ' ' TRP . 24.2 mt . . . . . 0 C--N 1.328 -0.338 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.754 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.586 ' O ' ' HA ' ' A' ' 15' ' ' ARG . . . . . . . . 0 C--O 1.223 -0.331 0 CA-C-O 120.59 0.233 . . . . 0.0 110.941 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.664 ' CG ' ' HB2' ' A' ' 16' ' ' ASN . 18.7 mt-30 -113.87 123.29 49.42 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.044 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.488 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 2.2 ttpt -106.03 133.44 50.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.3 177.807 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.504 ' CZ2' ' CE1' ' A' ' 154' ' ' TYR . 41.8 m95 -102.72 160.48 14.55 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.023 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.507 ' HB3' ' CE1' ' A' ' 110' ' ' PHE . 90.8 m-85 -133.91 154.12 51.29 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.705 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.686 HD22 ' CG ' ' A' ' 161' ' ' PHE . 11.5 tp -109.83 128.24 55.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.149 179.648 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.879 ' CE2' HG23 ' A' ' 19' ' ' ILE . 5.4 m-85 -133.9 147.75 51.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.279 0.561 . . . . 0.0 111.8 179.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 21.8 tttt -99.47 124.52 44.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.572 178.542 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.619 ' HB2' HD11 ' A' ' 21' ' ' LEU . 34.8 t80 -78.54 101.03 7.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.882 0.373 . . . . 0.0 110.952 179.599 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 15.9 p -98.99 40.77 1.18 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.74 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.27 -146.66 4.68 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.364 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -120.82 153.7 36.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.887 0.375 . . . . 0.0 111.216 179.786 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.488 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 4.4 p30 -59.7 -39.2 83.82 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.487 0.66 . . . . 0.0 111.164 -179.611 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -59.31 -1.74 0.24 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.86 -1.063 . . . . 0.0 112.161 -179.325 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -89.93 -17.91 27.09 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.864 0.364 . . . . 0.0 110.701 179.701 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.711 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 13.6 mt -80.81 102.66 6.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.588 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -102.0 94.3 5.71 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.899 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.641 HD11 ' HD1' ' A' ' 134' ' ' TRP . 44.9 mt . . . . . 0 C--N 1.33 -0.256 0 CA-C-O 121.028 0.442 . . . . 0.0 110.613 179.745 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.583 ' O ' HD12 ' A' ' 34' ' ' LEU . 2.4 mp0 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.889 0.376 . . . . 0.0 110.781 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.446 ' CE1' HG23 ' A' ' 65' ' ' THR . 0.8 OUTLIER -103.8 141.88 35.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.434 179.902 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.704 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -83.86 -34.82 17.51 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.005 -179.642 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.06 149.77 29.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.855 0.36 . . . . 0.0 110.46 179.787 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.711 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 32.7 p-90 -137.89 170.12 16.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.066 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.454 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 22.8 t -165.71 177.53 7.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.513 0.673 . . . . 0.0 111.918 -178.681 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.487 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 73.6 m95 -111.42 103.49 11.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.422 178.437 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.433 ' O ' ' N ' ' A' ' 28' ' ' ILE . 31.7 m -119.26 171.68 7.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.556 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 22.3 p -74.0 167.29 36.85 Favored Pre-proline 0 C--N 1.326 -0.431 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.955 179.143 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.743 ' HA ' HG13 ' A' ' 28' ' ' ILE . 21.7 Cg_exo -59.11 -55.85 1.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.772 1.648 . . . . 0.0 110.347 178.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.37 -25.41 68.28 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.855 178.494 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.408 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 9.1 mm-40 -72.84 -47.16 48.59 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.73 -179.74 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.655 HD13 ' HB2' ' A' ' 30' ' ' ALA . 20.3 tp -59.64 -37.73 79.47 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.817 HG21 ' HG2' ' A' ' 155' ' ' LYS . 12.7 mm -63.03 -36.15 74.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.555 178.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.27 -52.99 15.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.333 0.587 . . . . 0.0 110.367 179.607 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.458 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -72.2 -16.77 61.96 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.575 -179.239 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.641 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 12.7 t -76.45 176.0 8.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.019 0.438 . . . . 0.0 111.46 -179.652 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.548 ' HB ' ' CE1' ' A' ' 149' ' ' PHE . 17.6 m -74.9 150.88 6.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.674 179.432 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.43 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 50.6 mt-10 -58.32 -53.28 60.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.869 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.548 ' CE1' ' HB ' ' A' ' 147' ' ' VAL . 38.2 p90 -57.47 0.91 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -179.577 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.45 ' HB2' HG23 ' A' ' 147' ' ' VAL . 53.1 mttt -134.41 -9.17 2.54 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.99 -0.444 . . . . 0.0 111.967 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.686 ' HG3' HG22 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -60.58 -54.64 52.82 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.919 -0.128 . . . . 0.0 110.823 179.781 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.51 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 38.8 Cg_endo -67.5 -28.18 38.71 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.196 1.931 . . . . 0.0 111.61 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.61 ' O ' HG23 ' A' ' 157' ' ' VAL . 37.8 t -68.74 -50.96 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.369 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.504 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 5.8 m-30 -66.68 -38.49 86.91 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.669 178.449 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.817 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -56.09 -39.99 72.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.595 179.837 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.407 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.6 OUTLIER -69.07 -31.98 71.12 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.02 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.629 HG12 ' CE2' ' A' ' 161' ' ' PHE . 42.2 t -64.77 -42.11 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.69 178.699 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.497 HD22 ' HB3' ' A' ' 139' ' ' PRO . 64.9 mt -64.49 -44.22 91.66 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.661 179.625 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 38.5 t -52.63 -40.32 62.65 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.142 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.836 HG11 ' HA ' ' A' ' 76' ' ' VAL . 91.2 t -67.43 -42.48 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.518 -0.765 . . . . 0.0 108.984 177.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.686 ' CG ' HD22 ' A' ' 109' ' ' LEU . 21.1 m-30 -80.72 6.47 12.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.188 -179.527 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.598 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.46 -53.41 66.43 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.684 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 18.0 Cg_endo -57.67 -12.87 12.49 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.143 1.896 . . . . 0.0 111.869 178.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.443 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 90.5 m-70 -108.68 -19.36 13.45 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.263 -179.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 97.7 mt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.606 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.476 ' C ' ' HB2' ' A' ' 78' ' ' TYR . 16.0 mtm . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.67 0.271 . . . . 0.0 110.416 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.641 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 4.1 p-10 . . . . . 0 C--N 1.331 -0.204 0 CA-C-O 120.748 0.309 . . . . 0.0 111.498 -179.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.631 ' HG3' ' CZ3' ' A' ' 79' ' ' TRP . 1.2 ttp180 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.743 0.306 . . . . 0.0 111.142 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.676 ' HB2' ' HG2' ' A' ' 105' ' ' GLN . 0.5 OUTLIER -133.0 -177.5 4.54 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.14 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.725 HG13 ' CG1' ' A' ' 47' ' ' ILE . 35.3 m -140.71 168.06 17.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.289 179.303 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.677 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -134.16 154.45 21.4 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.329 179.077 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.831 ' HB ' ' HB2' ' A' ' 43' ' ' PRO . 3.1 mp -126.66 117.32 47.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.005 0.431 . . . . 0.0 111.871 -179.379 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.652 ' O ' HD12 ' A' ' 109' ' ' LEU . 42.1 t -98.48 99.43 10.59 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.83 HD22 HG11 ' A' ' 67' ' ' VAL . 24.3 tp -98.31 115.18 27.88 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.522 -178.407 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.666 ' HE1' ' HE2' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -115.6 163.0 16.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.44 179.253 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.72 ' ND2' ' HB2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -98.5 168.11 10.39 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.169 179.958 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -55.71 -4.43 0.11 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.195 177.83 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.564 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -100.63 2.92 42.12 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.934 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.666 ' HE2' ' HE1' ' A' ' 22' ' ' MET . 5.6 mmtp 74.44 21.55 2.31 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.01 -178.352 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.72 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 1.9 mmtt -92.33 150.03 21.08 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.763 HD11 ' HG3' ' A' ' 139' ' ' PRO . 1.5 mm -102.92 137.2 31.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.608 ' CE1' HD13 ' A' ' 119' ' ' ILE . 88.4 t80 -76.55 138.35 40.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.534 177.932 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.619 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -143.5 153.05 42.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.943 0.402 . . . . 0.0 110.877 -179.708 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.604 ' HB1' ' CB ' ' A' ' 131' ' ' PHE . . . -145.8 132.39 19.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.523 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 4.1 m -97.38 153.26 18.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.127 0.489 . . . . 0.0 111.76 -179.016 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.651 ' O ' ' N ' ' A' ' 35' ' ' ASP . 6.7 mtp180 -68.83 131.64 45.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.966 -179.254 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.745 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -55.37 55.3 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.218 0.607 . . . . 0.0 112.191 179.979 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.651 ' N ' ' O ' ' A' ' 33' ' ' ARG . 1.3 t0 -178.31 -29.67 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.07 0.462 . . . . 0.0 109.977 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.477 HD12 ' NE ' ' A' ' 33' ' ' ARG . 24.0 mt -118.82 107.4 42.4 Favored Pre-proline 0 N--CA 1.451 -0.376 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.62 179.522 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.04 -18.26 21.46 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.514 2.143 . . . . 0.0 112.852 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -94.53 -13.04 26.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.666 -179.755 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.629 ' HB1' ' CG1' ' A' ' 147' ' ' VAL . . . -92.38 101.38 13.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.71 0.291 . . . . 0.0 110.816 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.649 ' O ' ' HA ' ' A' ' 146' ' ' THR . 68.1 m95 -102.81 147.6 26.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.135 179.527 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.445 ' HG2' ' C ' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -152.2 160.27 43.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.269 0.557 . . . . 0.0 111.751 -179.984 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.476 ' HB2' ' HE2' ' A' ' 42' ' ' MET . 6.4 mtm -98.64 154.02 37.66 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.055 179.227 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.831 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 52.9 Cg_exo -49.08 154.19 3.62 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.574 2.183 . . . . 0.0 112.152 -179.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.663 ' HA ' HD12 ' A' ' 19' ' ' ILE . 13.7 pt20 -177.4 178.15 1.1 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.882 -178.759 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . 0.499 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . 170.91 150.11 6.83 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.426 -0.893 . . . . 0.0 112.578 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.675 ' HA2' ' CB ' ' A' ' 16' ' ' ASN . . . -74.47 135.03 18.89 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.688 -179.475 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.725 ' CG1' HG13 ' A' ' 17' ' ' VAL . 11.7 mt -70.64 141.73 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -68.39 -171.02 0.23 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.843 0.354 . . . . 0.0 110.993 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.549 ' HG3' ' H ' ' A' ' 50' ' ' GLY . 2.3 pt-20 -49.06 -67.32 0.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.525 -179.476 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.549 ' H ' ' HG3' ' A' ' 49' ' ' GLU . . . -127.67 54.39 0.78 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.742 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -108.99 148.15 31.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.746 0.308 . . . . 0.0 110.504 -179.692 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.429 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 7.7 m-20 -68.84 140.67 91.71 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.253 179.843 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.551 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 35.3 Cg_exo -60.23 -47.14 15.54 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.325 2.017 . . . . 0.0 111.682 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.86 ' HE ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -53.04 -45.98 68.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.564 179.404 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.51 ' HA ' HD12 ' A' ' 58' ' ' ILE . 12.6 m-20 -67.31 -43.85 80.64 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.431 179.63 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.24 -42.05 94.43 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.646 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.773 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -57.78 -55.53 33.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.94 178.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.601 HD11 ' CZ ' ' A' ' 54' ' ' ARG . 14.4 mt -55.15 -54.08 28.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.257 179.284 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -61.28 -63.67 1.21 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.811 -179.538 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . 0.499 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 46.4 mm-40 -43.94 -47.29 8.46 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.164 0.507 . . . . 0.0 110.017 179.181 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.623 HD12 ' CB ' ' A' ' 43' ' ' PRO . 0.2 OUTLIER -50.12 -46.72 53.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.066 178.336 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.818 ' HG3' HG23 ' A' ' 68' ' ' THR . 24.6 ttm180 -63.15 -64.67 0.84 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.48 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -48.32 -20.16 0.37 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.532 0.568 . . . . 0.0 112.532 -179.194 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -98.4 -38.52 9.19 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -178.173 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.672 HG22 HD23 ' A' ' 121' ' ' LEU . 1.0 OUTLIER -125.29 -5.6 7.2 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.704 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 79.02 -11.69 27.56 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.349 -0.929 . . . . 0.0 111.904 -178.74 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.83 HG11 HD22 ' A' ' 21' ' ' LEU . 58.8 t -57.91 114.19 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 121.033 0.445 . . . . 0.0 111.185 179.509 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.818 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.9 OUTLIER -124.36 -41.33 2.18 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.187 178.285 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.413 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 14.9 m -61.37 73.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.302 179.307 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.16 152.34 18.75 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.359 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -126.2 150.63 48.21 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.232 179.291 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.86 HG21 ' HE ' ' A' ' 54' ' ' ARG . 21.3 t -74.79 127.93 36.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.146 0.498 . . . . 0.0 111.766 179.683 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.589 HD11 ' HB2' ' A' ' 111' ' ' LYS . 1.6 mt -105.73 -18.96 6.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.146 179.325 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.498 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.94 176.56 4.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.54 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -155.04 146.76 23.3 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.37 179.43 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.878 ' HA ' HG11 ' A' ' 160' ' ' VAL . 54.7 t -70.64 140.19 86.71 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 120.918 0.39 . . . . 0.0 111.068 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.644 ' HD2' HG13 ' A' ' 76' ' ' VAL . 29.9 Cg_endo -63.55 -59.44 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.138 2.558 . . . . 0.0 112.288 -179.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -102.31 -174.63 2.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.433 -179.202 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.631 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 34.1 m95 -89.26 -158.96 0.54 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.665 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.583 ' HB2' ' O ' ' A' ' 105' ' ' GLN . 65.8 mt . . . . . 0 N--CA 1.464 0.269 0 CA-C-O 121.248 0.547 . . . . 0.0 110.87 -179.956 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.174 0 CA-C-O 120.912 0.387 . . . . 0.0 111.126 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.676 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 28.7 mt-30 -132.03 126.7 34.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.488 -178.663 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 13.3 ttmt -102.7 134.88 45.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.283 179.46 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.677 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 17.2 m95 -101.82 163.64 12.15 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.483 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.621 ' HB2' ' HE1' ' A' ' 110' ' ' PHE . 96.4 m-85 -141.36 153.12 44.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.207 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.652 HD12 ' O ' ' A' ' 20' ' ' CYS . 15.7 tp -99.7 139.03 35.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.942 179.628 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.821 ' CE2' HG22 ' A' ' 72' ' ' VAL . 41.6 m-85 -140.97 145.36 35.88 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.355 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.615 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 14.1 tttt -102.93 123.74 47.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.848 178.545 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.685 ' HB2' HD11 ' A' ' 21' ' ' LEU . 54.8 t80 -78.3 98.11 5.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.958 0.408 . . . . 0.0 110.454 179.124 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 43.7 p -95.9 41.62 1.1 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.622 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.413 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -143.67 -146.86 4.61 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.143 -179.68 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . 0.417 ' O ' ' HZ ' ' A' ' 112' ' ' PHE . 3.7 mm100 -124.02 149.02 46.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.987 0.422 . . . . 0.0 111.219 -179.626 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -58.47 -30.65 67.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.536 -179.494 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -59.65 -4.79 0.72 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.099 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -90.69 -20.28 22.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.023 0.44 . . . . 0.0 110.482 179.712 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.608 HD13 ' CE1' ' A' ' 29' ' ' PHE . 11.8 mt -83.97 106.56 14.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.426 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 2.7 t30 -102.19 -25.29 13.75 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.954 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.672 HD23 HG22 ' A' ' 65' ' ' THR . 74.0 mt . . . . . 0 N--CA 1.467 0.415 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.363 179.719 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.595 ' O ' HD12 ' A' ' 34' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.461 0.113 0 CA-C-O 120.706 0.288 . . . . 0.0 111.002 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.604 ' CB ' ' HB1' ' A' ' 31' ' ' ALA . 3.1 m-85 -102.25 140.71 36.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.171 0.51 . . . . 0.0 110.359 179.606 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.745 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -85.74 -35.79 11.17 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.922 -179.404 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.23 145.92 27.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.971 0.415 . . . . 0.0 110.439 179.823 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.608 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 36.4 p-90 -132.0 163.75 27.71 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.919 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.438 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 32.0 t -160.93 175.69 12.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.337 0.589 . . . . 0.0 111.987 -179.476 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.587 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 31.2 m95 -110.42 101.07 9.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.509 178.461 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 28' ' ' ILE . 28.4 m -116.43 164.8 12.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.598 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 17.4 p -71.33 170.22 12.51 Favored Pre-proline 0 C--N 1.324 -0.52 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.447 179.776 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.809 ' HB3' HD22 ' A' ' 158' ' ' LEU . 15.7 Cg_exo -59.86 -58.92 0.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.805 1.67 . . . . 0.0 110.335 179.149 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.9 -29.07 69.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.995 178.716 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.486 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.7 OUTLIER -72.47 -46.59 54.15 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.275 179.796 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.619 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.5 OUTLIER -57.47 -40.51 78.71 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.341 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.724 HG21 ' HG2' ' A' ' 155' ' ' LYS . 36.3 mm -60.6 -37.21 74.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.913 179.375 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.21 -49.79 39.79 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.232 0.539 . . . . 0.0 111.02 179.498 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.23 -21.07 59.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.433 -179.086 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.649 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 10.7 t -74.19 174.83 8.19 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.24 -179.481 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.629 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 33.3 m -85.01 146.01 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.461 -179.254 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.542 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 41.7 mt-10 -49.97 -50.89 45.33 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.364 -179.783 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -52.84 -7.17 0.07 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 148' ' ' GLU . 5.1 mttm -137.18 -4.44 1.9 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.575 ' HG2' ' O ' ' A' ' 143' ' ' ILE . 11.3 mttt -61.17 -59.11 14.77 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 121.279 -0.169 . . . . 0.0 110.972 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.542 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 22.4 Cg_endo -60.96 -28.83 86.9 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.407 2.072 . . . . 0.0 111.653 179.588 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.732 ' O ' HG23 ' A' ' 157' ' ' VAL . 30.5 t -68.61 -55.03 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.277 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.531 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 7.4 m-30 -61.65 -39.73 92.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.864 178.494 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.724 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -56.32 -43.79 79.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.922 -179.946 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.462 ' O ' HG23 ' A' ' 160' ' ' VAL . 2.7 tt0 -67.63 -31.69 71.88 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.568 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 153' ' ' VAL . 47.1 t -65.83 -41.34 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.651 178.729 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.809 HD22 ' HB3' ' A' ' 139' ' ' PRO . 64.0 mt -62.31 -47.01 86.15 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.023 -179.891 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.8 m -51.9 -38.75 57.43 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.878 HG11 ' HA ' ' A' ' 76' ' ' VAL . 92.6 t -68.21 -44.22 84.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.273 177.892 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.652 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 21.2 m-30 -79.67 4.3 16.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.901 -179.381 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.566 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.38 -54.96 50.97 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.649 179.692 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 17.4 Cg_endo -57.92 -12.74 12.97 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.024 1.816 . . . . 0.0 111.666 178.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.498 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 89.6 m-70 -108.25 -16.25 14.29 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.437 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 77.6 mt . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.712 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' MET . . . . . 0.572 ' O ' ' HB2' ' A' ' 78' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.461 0.121 0 CA-C-O 120.582 0.23 . . . . 0.0 110.501 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.475 ' HA ' ' CB ' ' A' ' 78' ' ' TYR . 3.3 t0 . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.051 -179.454 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' ARG . . . . . 0.51 ' CG ' HD12 ' A' ' 47' ' ' ILE . 1.6 ttp180 . . . . . 0 CA--C 1.529 0.161 0 CA-C-O 120.896 0.379 . . . . 0.0 111.962 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ASN . . . . . 0.781 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 3.1 m-80 -133.35 176.91 8.1 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.117 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.669 HG13 ' CG1' ' A' ' 47' ' ' ILE . 12.5 m -140.91 169.24 15.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.784 0.326 . . . . 0.0 111.299 179.494 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.573 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -134.84 162.85 24.76 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.779 -0.725 . . . . 0.0 112.264 179.423 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ILE . . . . . 0.95 HG21 HD22 ' A' ' 61' ' ' LEU . 3.9 mp -128.62 120.59 52.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -178.963 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.603 ' O ' HD12 ' A' ' 109' ' ' LEU . 29.6 t -107.01 98.02 7.73 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.788 HD22 HG11 ' A' ' 67' ' ' VAL . 4.7 tp -104.69 126.13 51.46 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.946 -178.488 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' MET . . . . . 0.502 ' CE ' HD13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -124.51 162.8 23.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.786 179.009 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.635 ' OD1' ' CE3' ' A' ' 136' ' ' TRP . 0.0 OUTLIER -98.89 171.25 8.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.205 179.78 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -56.7 -5.12 0.2 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.512 177.865 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' ASP . . . . . 0.508 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -98.21 3.7 48.93 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 120.781 0.324 . . . . 0.0 111.687 -179.111 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 15.1 mmtp 73.22 19.45 3.55 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.182 -178.611 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.512 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -96.81 142.19 29.11 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.923 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.678 ' N ' HD12 ' A' ' 28' ' ' ILE . 2.7 mp -102.22 145.83 11.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.804 0.811 . . . . 0.0 112.648 -177.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.576 ' CE1' HD13 ' A' ' 119' ' ' ILE . 86.2 t80 -74.65 138.7 43.06 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.779 179.665 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.831 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -140.54 147.19 39.12 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.712 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.45 ' HB1' ' CB ' ' A' ' 131' ' ' PHE . . . -137.87 137.97 38.63 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.909 0.385 . . . . 0.0 111.039 -179.542 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.747 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 91.5 p -100.15 144.8 28.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.39 -179.665 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.472 ' HD3' ' CB ' ' A' ' 39' ' ' ALA . 5.2 mtp180 -70.06 126.48 29.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.74 179.579 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.717 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.7 OUTLIER -43.36 -34.81 1.34 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.361 0.6 . . . . 0.0 110.596 179.756 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -72.83 -41.5 64.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.858 179.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.419 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 17.4 mt -120.78 104.54 41.92 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.054 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -66.79 -21.62 50.76 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.728 2.285 . . . . 0.0 112.661 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -92.19 -4.96 53.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.464 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.747 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.52 92.26 7.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.605 0.241 . . . . 0.0 111.338 -179.734 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.628 ' O ' ' HA ' ' A' ' 146' ' ' THR . 81.5 m95 -89.07 144.65 25.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.325 179.194 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.07 162.38 36.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.259 0.552 . . . . 0.0 111.314 -179.486 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . 0.533 ' HB3' ' CZ3' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -97.95 149.46 35.74 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.595 179.79 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' PRO . . . . . 0.475 ' CG ' HD13 ' A' ' 61' ' ' LEU . 5.1 Cg_endo -48.41 156.67 1.63 Allowed 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.533 2.155 . . . . 0.0 112.022 179.684 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.601 ' HA ' HD12 ' A' ' 19' ' ' ILE . 11.7 pt20 -176.4 -179.95 1.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.601 -179.657 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 170.49 157.3 12.39 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.191 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.74 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -82.84 137.23 16.33 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.339 -179.435 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.669 ' CG1' HG13 ' A' ' 17' ' ' VAL . 43.5 mt -69.58 142.35 16.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.827 0.346 . . . . 0.0 110.965 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -68.98 -174.27 0.58 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.662 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -48.5 -81.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.14 179.727 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.74 54.75 0.53 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.399 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -115.5 147.1 41.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.918 0.39 . . . . 0.0 110.963 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.09 164.36 53.22 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.469 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 5.9 Cg_exo -74.85 -46.61 0.24 Allowed 'Trans proline' 0 CA--C 1.516 -0.405 0 C-N-CA 122.762 2.308 . . . . 0.0 111.584 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.757 ' NH2' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -51.68 -46.02 63.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.807 179.851 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 3.7 m120 -65.14 -48.04 74.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.309 179.688 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.12 -43.2 99.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.861 179.472 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.507 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -59.15 -58.31 9.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.897 178.537 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.492 HD11 ' HG3' ' A' ' 54' ' ' ARG . 26.0 mt -56.93 -49.64 78.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.425 179.38 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.427 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 6.1 ttp180 -64.18 -63.63 1.1 Allowed 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.354 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -42.18 -43.62 3.42 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.957 0.408 . . . . 0.0 110.277 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.95 HD22 HG21 ' A' ' 19' ' ' ILE . 13.6 tp -51.77 -50.11 61.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.053 178.557 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.87 ' HG3' HG23 ' A' ' 68' ' ' THR . 1.1 ttt180 -63.01 -64.96 0.76 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.987 179.456 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -48.82 -25.37 1.84 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.768 -179.553 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -92.72 -40.19 10.84 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -178.522 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' THR . . . . . 0.729 HG22 HD23 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -121.44 -34.45 3.44 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.59 -179.233 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 106.42 -11.7 43.26 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.409 -178.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.788 HG11 HD22 ' A' ' 21' ' ' LEU . 32.4 t -57.22 111.44 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-O 121.111 0.481 . . . . 0.0 111.58 179.534 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' THR . . . . . 0.87 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.8 OUTLIER -122.71 -39.15 2.56 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.79 178.505 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.0 m -61.97 74.76 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.077 179.104 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -162.14 155.81 21.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.026 0.441 . . . . 0.0 111.963 -179.435 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -126.72 147.94 49.92 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.363 179.447 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.757 HG11 ' NH2' ' A' ' 54' ' ' ARG . 6.6 t -75.58 126.81 36.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.222 0.534 . . . . 0.0 111.425 179.334 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.54 HD11 ' HB2' ' A' ' 111' ' ' LYS . 0.8 OUTLIER -106.97 -20.77 5.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.28 179.537 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.409 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -169.81 177.92 4.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.647 -179.702 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -155.08 150.16 26.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.502 179.817 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.855 ' HA ' HG11 ' A' ' 160' ' ' VAL . 44.0 t -71.71 136.18 83.19 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.894 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.4 ' HD2' HG13 ' A' ' 76' ' ' VAL . 16.6 Cg_endo -55.06 -69.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.041 2.494 . . . . 0.0 112.138 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . 0.572 ' HB2' ' O ' ' A' ' 6' ' ' MET . 0.1 OUTLIER -94.07 -172.45 2.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.666 -179.759 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' TRP . . . . . 0.48 ' NE1' ' HE2' ' A' ' 106' ' ' LYS . 29.2 m95 -90.06 -158.47 0.53 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 178.816 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.593 HD12 ' HD1' ' A' ' 107' ' ' TRP . 57.8 mt . . . . . 0 C--N 1.328 -0.327 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -179.772 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.515 -0.371 0 CA-C-O 121.102 0.477 . . . . 0.0 109.948 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.781 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 43.1 mt-30 -128.14 128.32 44.62 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -177.518 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.48 ' HE2' ' NE1' ' A' ' 79' ' ' TRP . 19.8 ttmt -104.9 134.89 47.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.539 178.044 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' TRP . . . . . 0.593 ' HD1' HD12 ' A' ' 80' ' ' LEU . 32.6 m95 -102.91 162.8 12.63 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.073 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' PHE . . . . . 0.47 ' HB3' ' CE1' ' A' ' 110' ' ' PHE . 98.2 m-85 -138.44 153.0 48.85 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.866 -179.875 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' LEU . . . . . 0.603 HD12 ' O ' ' A' ' 20' ' ' CYS . 19.2 tp -108.78 122.45 47.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.876 179.528 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.732 ' CE1' HG22 ' A' ' 72' ' ' VAL . 8.8 m-85 -127.47 148.4 50.31 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.243 0.544 . . . . 0.0 111.689 179.912 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' LYS . . . . . 0.56 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 33.2 tttt -98.59 124.81 43.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.428 178.343 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' PHE . . . . . 0.661 ' HB2' HD11 ' A' ' 21' ' ' LEU . 46.6 t80 -78.43 102.01 7.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.85 0.357 . . . . 0.0 110.901 179.702 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.8 p -99.33 42.0 1.12 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.288 179.573 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.92 -149.13 5.14 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.727 -179.803 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.46 150.06 42.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.989 0.423 . . . . 0.0 111.243 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.458 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 4.1 p30 -58.05 -38.92 77.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.376 0.608 . . . . 0.0 111.272 -179.667 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.63 -3.07 0.16 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.981 -1.008 . . . . 0.0 112.381 -179.6 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -89.18 -18.63 26.74 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.051 0.453 . . . . 0.0 110.435 179.469 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.618 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 7.5 mt -86.81 107.24 16.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.962 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.547 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 7.9 p-10 -96.98 -22.67 16.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.222 -179.567 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.729 HD23 HG22 ' A' ' 65' ' ' THR . 47.6 mt . . . . . 0 N--CA 1.466 0.331 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.743 179.618 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.668 0.27 . . . . 0.0 110.854 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' PHE . . . . . 0.45 ' CB ' ' HB1' ' A' ' 31' ' ' ALA . 1.5 m-85 -108.88 141.6 40.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.874 0.369 . . . . 0.0 110.348 179.683 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.717 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -91.31 -30.84 10.27 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.387 -179.703 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.51 150.52 32.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.731 0.3 . . . . 0.0 110.598 179.501 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' TRP . . . . . 0.618 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 40.3 p-90 -137.78 168.74 19.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.089 179.532 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.451 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 27.2 t -163.5 174.32 11.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.392 0.615 . . . . 0.0 112.54 -178.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' TRP . . . . . 0.635 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 36.8 m95 -110.12 107.08 16.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.849 177.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.425 ' O ' ' N ' ' A' ' 28' ' ' ILE . 26.4 m -121.71 172.64 8.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.678 -179.711 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.577 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 25.3 p -74.08 171.36 11.29 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.812 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.676 ' HB3' HD22 ' A' ' 158' ' ' LEU . 9.2 Cg_exo -63.19 -54.55 1.04 Allowed 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 121.331 1.354 . . . . 0.0 109.851 178.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.68 -29.02 70.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.965 178.717 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.495 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 2.9 mt-30 -71.27 -46.46 60.88 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.933 0.397 . . . . 0.0 110.259 179.408 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 142' ' ' LEU . . . . . 0.831 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -57.5 -39.86 77.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.651 179.59 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 143' ' ' ILE . . . . . 0.768 HG21 ' HG2' ' A' ' 155' ' ' LYS . 26.1 mm -62.31 -38.34 80.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.298 179.279 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.98 -51.44 32.51 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.349 0.595 . . . . 0.0 110.781 179.639 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.36 -21.24 61.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.713 -179.093 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 8.3 t -73.7 173.91 9.13 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.502 -179.108 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 147' ' ' VAL . . . . . 0.66 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 29.9 m -77.13 155.67 5.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.689 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.484 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 72.2 mt-10 -58.44 -55.74 31.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.151 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.66 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 29.5 p90 -56.01 -0.64 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -179.594 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.462 ' HD3' ' OH ' ' A' ' 154' ' ' TYR . 48.9 mttt -135.04 -7.85 2.33 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.83 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.524 ' HG2' ' HD3' ' A' ' 152' ' ' PRO . 0.1 OUTLIER -62.57 -56.72 27.25 Favored Pre-proline 0 C--N 1.328 -0.358 0 O-C-N 122.43 -0.169 . . . . 0.0 110.975 179.762 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.524 ' HD3' ' HG2' ' A' ' 151' ' ' LYS . 30.6 Cg_endo -64.56 -25.8 62.27 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.061 1.841 . . . . 0.0 111.149 179.197 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.764 ' O ' HG23 ' A' ' 157' ' ' VAL . 20.6 t -68.55 -50.9 51.87 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.456 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.462 ' OH ' ' HD3' ' A' ' 150' ' ' LYS . 9.0 m-30 -67.89 -36.67 80.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.975 178.664 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.768 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -58.53 -40.89 84.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.543 179.532 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.0 -35.7 74.58 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.91 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 157' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 153' ' ' VAL . 61.5 t -66.53 -39.85 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.695 178.821 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.676 HD22 ' HB3' ' A' ' 139' ' ' PRO . 27.7 mt -63.14 -42.4 99.46 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.556 179.741 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 67.3 m -54.38 -39.89 67.63 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.37 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . 0.855 HG11 ' HA ' ' A' ' 76' ' ' VAL . 95.1 t -67.71 -45.16 85.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.178 177.788 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 161' ' ' PHE . . . . . 0.612 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 22.0 m-30 -80.45 5.01 16.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.724 -178.748 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . 0.63 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.23 -52.02 77.45 Favored Pre-proline 0 C--N 1.328 -0.353 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.815 179.617 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . 0.63 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.2 Cg_endo -58.36 -11.75 11.69 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.328 2.019 . . . . 0.0 112.296 179.172 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 164' ' ' HIS . . . . . 0.409 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 81.8 m-70 -111.78 -18.21 12.78 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.4 -179.698 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 91.7 mt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.811 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 112.538 -0.225 . . . . 0.0 112.538 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.41 174.25 13.13 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.699 2.266 . . . . 0.0 112.515 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -127.88 -172.0 2.58 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.729 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.409 ' O ' ' OG ' ' A' ' 5' ' ' SER . . . -117.21 -27.12 2.75 Favored Glycine 0 CA--C 1.519 0.321 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.455 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.784 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 68.6 p 56.32 -87.51 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.755 0.312 . . . . 0.0 111.784 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.553 ' HE1' ' OG1' ' A' ' 81' ' ' THR . 8.7 mtm 64.59 127.39 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.771 -179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.718 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 5.6 t70 -67.69 -9.84 47.07 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.465 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -136.72 118.86 11.53 Favored Pre-proline 0 C--N 1.331 -0.217 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.213 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.439 ' HD3' ' NE1' ' A' ' 79' ' ' TRP . 11.7 Cg_endo -55.33 119.87 7.26 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.406 2.071 . . . . 0.0 112.356 -179.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.445 ' HD2' ' CD2' ' A' ' 13' ' ' TYR . 9.1 Cg_exo -71.82 172.35 14.7 Favored 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.017 2.478 . . . . 0.0 112.743 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.14 133.51 39.05 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.925 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.466 ' HA3' ' O ' ' A' ' 99' ' ' ASP . . . 56.17 91.04 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 115.885 -0.598 . . . . 0.0 113.717 178.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.502 ' CE1' ' HG2' ' A' ' 101' ' ' LYS . 5.0 m-85 -161.17 136.37 7.64 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 178.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.442 ' HB3' ' CG ' ' A' ' 103' ' ' GLN . 24.0 ttt85 -70.53 85.56 0.62 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-O 120.847 0.355 . . . . 0.0 111.838 -179.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.597 ' CG ' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -51.78 106.44 0.14 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.096 0.474 . . . . 0.0 110.892 179.251 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.689 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 2.2 m-80 -132.88 175.01 9.73 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.414 178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.597 HG13 ' CG1' ' A' ' 47' ' ' ILE . 4.2 m -142.62 164.96 16.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.252 0.549 . . . . 0.0 111.638 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.557 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -134.09 156.71 22.5 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 178.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.0 HG23 ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -128.98 122.24 56.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.321 0.581 . . . . 0.0 112.198 -179.156 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 43.2 t -101.17 110.7 22.75 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.165 -0.925 . . . . 0.0 109.296 178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.802 HD21 ' HD1' ' A' ' 112' ' ' PHE . 61.7 tp -107.4 124.69 50.21 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.045 0.45 . . . . 0.0 111.727 -178.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.665 ' SD ' HD11 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -117.77 142.91 46.74 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.876 -179.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.484 ' OD1' ' CH2' ' A' ' 136' ' ' TRP . 4.7 m-20 -96.85 -175.74 3.37 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.532 0.682 . . . . 0.0 111.34 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -56.06 -5.74 0.2 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.897 -1.047 . . . . 0.0 112.688 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.508 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 1.2 m-20 -103.47 -0.77 29.46 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 111.758 0.281 . . . . 0.0 111.758 -179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 40.3 mmtt 71.7 24.82 3.38 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.608 ' HB3' ' O ' ' A' ' 137' ' ' VAL . 71.9 mttt -94.49 -177.55 4.27 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.923 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.847 HD11 ' HG3' ' A' ' 139' ' ' PRO . 1.8 mm -122.85 141.53 42.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.939 0.399 . . . . 0.0 111.39 -179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.734 ' HE2' HG21 ' A' ' 65' ' ' THR . 17.9 t80 -67.63 106.77 2.3 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.065 178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.542 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . . . -103.77 138.47 40.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.021 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.52 ' HB1' ' CG ' ' A' ' 131' ' ' PHE . . . -138.06 138.73 39.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.277 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.542 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 47.9 p -100.6 148.13 25.17 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.021 0.438 . . . . 0.0 111.933 -179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.664 ' NE ' HD12 ' A' ' 36' ' ' ILE . 11.1 mtp85 -70.66 129.09 38.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.868 179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.711 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.3 OUTLIER -55.49 56.44 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 O-C-N 123.381 0.425 . . . . 0.0 111.992 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.661 ' N ' ' O ' ' A' ' 33' ' ' ARG . 11.5 p-10 -177.35 -37.63 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.251 0.548 . . . . 0.0 109.815 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.664 HD12 ' NE ' ' A' ' 33' ' ' ARG . 18.8 mt -113.05 108.5 53.11 Favored Pre-proline 0 N--CA 1.454 -0.268 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.574 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -74.09 -18.26 21.34 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.485 2.123 . . . . 0.0 113.145 -179.268 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 -95.41 -9.49 32.58 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.748 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.59 ' HB1' ' CG1' ' A' ' 147' ' ' VAL . . . -92.53 91.71 7.72 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.897 0.379 . . . . 0.0 111.416 -179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.657 ' O ' ' HA ' ' A' ' 146' ' ' THR . 75.9 m95 -94.13 147.17 23.42 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.023 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.22 163.28 20.22 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.156 0.503 . . . . 0.0 111.452 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.41 ' HG3' ' CH2' ' A' ' 107' ' ' TRP . 1.0 OUTLIER -100.6 156.05 35.65 Favored Pre-proline 0 C--N 1.326 -0.445 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.517 178.477 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.419 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 8.3 Cg_endo -49.97 152.73 7.06 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 122.441 2.094 . . . . 0.0 112.355 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -177.8 148.28 0.53 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.262 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -155.54 -160.66 10.09 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.374 -0.917 . . . . 0.0 112.654 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.689 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -120.2 142.44 16.03 Favored Glycine 0 N--CA 1.448 -0.558 0 C-N-CA 120.602 -0.808 . . . . 0.0 113.243 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.597 ' CG1' HG13 ' A' ' 17' ' ' VAL . 30.2 mt -69.64 144.32 14.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 120.722 0.296 . . . . 0.0 111.168 179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -69.17 -174.88 0.68 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.578 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -48.54 -59.85 3.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.13 179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -132.64 59.79 0.68 Allowed Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.384 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.403 ' HG3' ' N ' ' A' ' 52' ' ' ASP . 4.9 tp10 -118.26 155.64 30.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.825 0.345 . . . . 0.0 110.784 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.403 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 0.2 OUTLIER -72.71 154.13 91.34 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.506 179.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.537 ' HA ' HG11 ' A' ' 17' ' ' VAL . 12.2 Cg_exo -70.86 -49.22 0.42 Allowed 'Trans proline' 0 C--N 1.345 0.346 0 C-N-CA 122.597 2.198 . . . . 0.0 111.427 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.668 ' HE ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -53.21 -45.36 68.62 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.326 179.58 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.528 ' HA ' HD12 ' A' ' 58' ' ' ILE . 2.9 m-20 -67.91 -44.11 77.68 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.193 179.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.86 -40.46 93.04 Favored 'General case' 0 CA--C 1.515 -0.372 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.0 ' HB1' HG23 ' A' ' 19' ' ' ILE . . . -58.01 -54.95 41.11 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.768 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.553 HD11 ' CD ' ' A' ' 54' ' ' ARG . 14.1 mt -56.6 -53.01 46.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.185 179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 59' ' ' ARG . 16.2 mtt-85 -60.85 -59.41 5.43 Favored 'General case' 0 C--O 1.231 0.128 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.638 -179.286 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -46.87 -44.7 19.8 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 121.3 0.572 . . . . 0.0 109.768 179.675 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.908 HD12 ' HB ' ' A' ' 19' ' ' ILE . 7.2 tt -51.01 -46.51 61.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.482 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.737 ' HG3' HG23 ' A' ' 68' ' ' THR . 10.2 ttt180 -65.04 -64.52 0.84 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.869 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.8 mm-40 -48.28 -20.46 0.39 Allowed 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 6.0 mm-40 -97.29 -36.26 10.47 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.761 HG22 ' CD2' ' A' ' 121' ' ' LEU . 17.3 p -129.09 -8.16 4.85 Favored 'General case' 0 N--CA 1.466 0.348 0 N-CA-C 112.761 0.652 . . . . 0.0 112.761 -178.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.38 -13.4 40.46 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.42 -0.895 . . . . 0.0 112.36 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.698 HG11 HD22 ' A' ' 21' ' ' LEU . 54.9 t -59.25 114.1 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 CA-C-O 121.233 0.54 . . . . 0.0 111.207 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.737 HG23 ' HG3' ' A' ' 62' ' ' ARG . 1.0 OUTLIER -121.98 -38.77 2.68 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.367 -0.833 . . . . 0.0 109.915 179.028 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.464 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 10.4 m -61.55 74.18 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.614 179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.64 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -157.47 156.09 31.49 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 121.086 0.47 . . . . 0.0 111.835 -179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -129.58 150.91 50.71 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.44 179.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.957 HG22 ' CE2' ' A' ' 110' ' ' PHE . 8.0 t -74.46 126.38 35.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.146 0.498 . . . . 0.0 111.363 179.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.564 HD11 ' N ' ' A' ' 111' ' ' LYS . 1.0 OUTLIER -107.0 -20.38 6.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.054 179.201 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.452 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.75 175.78 4.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.582 -0.735 . . . . 0.0 111.009 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -155.11 146.65 23.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.523 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.721 ' HA ' HG11 ' A' ' 160' ' ' VAL . 69.9 t -71.08 135.58 84.95 Favored Pre-proline 0 N--CA 1.453 -0.31 0 CA-C-O 121.002 0.43 . . . . 0.0 110.349 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.522 ' HD2' HG13 ' A' ' 76' ' ' VAL . 29.5 Cg_endo -63.69 -54.39 0.99 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.951 2.434 . . . . 0.0 112.586 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.718 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.8 OUTLIER -100.48 -179.23 4.04 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.695 -179.128 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.638 ' O ' HD23 ' A' ' 80' ' ' LEU . 44.9 m95 -92.62 -155.94 0.45 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.069 179.242 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.784 ' HA ' ' HA ' ' A' ' 5' ' ' SER . 80.6 mt -162.9 105.31 1.04 Allowed 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.818 0.342 . . . . 0.0 110.259 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.784 HG22 ' HB2' ' A' ' 104' ' ' ALA . 66.6 p -104.06 95.32 5.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.288 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -78.86 89.02 4.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.751 179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -72.99 154.74 40.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.001 179.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.624 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 4.9 m-85 -103.78 158.0 32.77 Favored Pre-proline 0 C--N 1.326 -0.432 0 CA-C-O 120.902 0.382 . . . . 0.0 111.431 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.489 ' HB3' ' HD2' ' A' ' 86' ' ' PRO . 32.0 Cg_exo -57.94 177.59 0.25 Allowed 'Trans proline' 0 C--N 1.346 0.404 0 C-N-CA 122.737 2.291 . . . . 0.0 111.893 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.489 ' HD2' ' HB3' ' A' ' 85' ' ' PRO . 23.5 Cg_endo -62.02 -28.38 80.41 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.312 2.008 . . . . 0.0 112.132 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.25 -58.05 3.58 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.627 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.624 ' HB ' ' HB3' ' A' ' 84' ' ' PHE . 57.3 t -68.34 -25.56 31.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.057 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.616 ' HD2' ' CB ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -54.94 -51.96 64.48 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.87 0.366 . . . . 0.0 110.763 -179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.447 ' HA ' HD13 ' A' ' 94' ' ' ILE . 34.2 mt-10 -62.63 -23.56 67.14 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.148 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.9 mttm -93.61 -16.09 24.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.267 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.602 HD12 ' CD1' ' A' ' 84' ' ' PHE . 1.9 tm? -120.29 -64.74 1.22 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.835 0.35 . . . . 0.0 111.137 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.616 ' CB ' ' HD2' ' A' ' 89' ' ' ARG . 14.7 t-20 -49.44 -61.16 2.25 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.37 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.447 ' N ' HD12 ' A' ' 94' ' ' ILE . 2.4 mp -71.71 -8.04 10.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.234 -179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.411 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 16.6 tt0 -72.83 -6.76 47.07 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.518 0.199 . . . . 0.0 111.506 179.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.51 ' CD1' ' HB2' ' A' ' 100' ' ' TRP . 43.3 m95 -104.83 -19.35 13.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.662 0.268 . . . . 0.0 111.233 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 133.72 -83.95 0.29 Allowed Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.495 -0.86 . . . . 0.0 112.742 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -171.85 28.52 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.351 0.595 . . . . 0.0 111.612 -179.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.466 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 68.0 m-20 -129.4 -44.69 1.24 Allowed 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.293 -0.867 . . . . 0.0 111.145 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.588 ' O ' ' HB3' ' A' ' 101' ' ' LYS . 11.7 m95 -67.14 -164.88 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.212 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.588 ' HB3' ' O ' ' A' ' 100' ' ' TRP . 0.0 OUTLIER 165.45 0.9 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -179.651 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 175.47 -144.29 7.13 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 119.838 -1.172 . . . . 0.0 112.778 -179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.583 ' O ' ' HA ' ' A' ' 81' ' ' THR . 2.0 mt-30 -146.43 110.03 4.85 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.681 -0.118 . . . . 0.0 110.681 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.784 ' HB2' HG22 ' A' ' 81' ' ' THR . . . -91.68 111.92 23.63 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.051 0.453 . . . . 0.0 110.246 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.679 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 3.7 mt-30 -125.42 129.71 50.4 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.406 -178.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.486 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 3.4 ttpt -104.35 135.55 45.59 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.824 -0.626 . . . . 0.0 109.375 178.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.557 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 53.9 m95 -103.04 161.87 13.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.318 0.58 . . . . 0.0 112.348 -178.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.531 ' HB2' ' HE1' ' A' ' 110' ' ' PHE . 96.3 m-85 -140.89 153.99 45.94 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.527 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.665 HD11 ' SD ' ' A' ' 22' ' ' MET . 10.5 tp -101.18 141.01 34.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.852 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.957 ' CE2' HG22 ' A' ' 72' ' ' VAL . 90.6 m-85 -143.16 145.57 32.94 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -179.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.64 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 56.4 tttt -103.4 124.83 49.43 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.94 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.802 ' HD1' HD21 ' A' ' 21' ' ' LEU . 41.1 t80 -78.87 96.04 5.57 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 120.743 0.306 . . . . 0.0 111.288 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 15.8 p -98.39 52.67 1.03 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.545 179.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.464 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -152.59 -146.35 4.34 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.526 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.16 147.41 46.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.131 0.491 . . . . 0.0 111.318 179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 63.0 m-20 -61.19 -27.72 68.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.163 -179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.4 mm-40 -56.7 -4.31 0.15 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.283 -179.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -90.8 -16.97 27.41 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.889 0.376 . . . . 0.0 110.931 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.647 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 5.5 mt -84.13 98.41 5.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.171 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 47.8 p-10 -104.0 -8.51 19.53 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.086 -0.506 . . . . 0.0 112.015 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.761 ' CD2' HG22 ' A' ' 65' ' ' THR . 46.8 mt 42.91 26.82 0.08 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.609 0.243 . . . . 0.0 111.545 -178.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.513 HD23 ' HB3' ' A' ' 129' ' ' PRO . 11.2 mt -106.23 -173.39 2.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.006 0.431 . . . . 0.0 111.642 -179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 173.49 127.29 0.97 Allowed Glycine 0 N--CA 1.446 -0.654 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.689 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.56 87.13 6.25 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.016 0.436 . . . . 0.0 111.067 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.403 ' O ' ' CB ' ' A' ' 126' ' ' SER . . . -129.47 1.19 6.03 Favored Glycine 0 CA--C 1.52 0.39 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.934 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 125' ' ' GLY . 3.9 p 80.86 -13.93 0.88 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.218 0.451 . . . . 0.0 112.218 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.4 mt-10 -91.51 -77.32 0.43 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.683 0.278 . . . . 0.0 111.146 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.536 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 0.1 OUTLIER -179.98 160.08 0.85 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.612 179.503 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.536 ' HD2' ' HB2' ' A' ' 128' ' ' LYS . 11.9 Cg_endo -65.87 -179.93 1.54 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 122.217 1.945 . . . . 0.0 111.872 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 50.2 tp10 -95.06 -67.45 0.85 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.535 -179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.729 ' HB2' HD13 ' A' ' 121' ' ' LEU . 3.4 m-85 -105.37 146.45 29.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.086 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.711 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -92.62 -34.3 7.04 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.874 179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -148.83 144.17 26.78 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.661 0.267 . . . . 0.0 110.98 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.647 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 47.2 p-90 -132.61 166.82 21.24 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.915 0.388 . . . . 0.0 111.546 179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.6 t -160.73 178.7 9.2 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.894 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.484 ' CH2' ' OD1' ' A' ' 23' ' ' ASN . 86.2 m95 -114.41 100.99 8.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.723 178.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.608 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 19.9 m -118.67 164.89 14.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.052 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.537 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 23.2 p -72.3 166.32 42.66 Favored Pre-proline 0 C--N 1.328 -0.35 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.544 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.847 ' HG3' HD11 ' A' ' 28' ' ' ILE . 25.6 Cg_exo -58.2 -55.46 2.21 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.072 1.848 . . . . 0.0 110.668 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -63.58 -27.86 69.54 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.291 178.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.508 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.8 OUTLIER -72.73 -46.24 54.59 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.354 179.496 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.542 ' CD1' ' HB2' ' A' ' 30' ' ' ALA . 2.8 tp -58.32 -39.38 79.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.763 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 1.082 HG21 ' HD3' ' A' ' 155' ' ' LYS . 12.7 mm -62.57 -31.84 53.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.048 0.452 . . . . 0.0 110.417 179.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -72.62 -53.5 11.68 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.71 179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.81 -19.14 61.39 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.803 -179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.657 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 14.2 t -73.87 175.32 7.41 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.424 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.59 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 34.3 m -85.05 144.28 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.649 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.473 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 2.7 mt-10 -48.13 -46.65 34.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.942 0.401 . . . . 0.0 111.351 -179.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -52.7 -11.37 0.21 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.471 ' HB3' ' CE1' ' A' ' 154' ' ' TYR . 31.9 mttm -132.57 -3.27 3.35 Favored 'General case' 0 C--N 1.332 -0.156 0 N-CA-C 112.834 0.679 . . . . 0.0 112.834 -178.493 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.509 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -63.33 -55.46 35.72 Favored Pre-proline 0 C--N 1.326 -0.439 0 O-C-N 122.431 -0.168 . . . . 0.0 111.203 179.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 29.8 Cg_endo -64.96 -29.25 57.7 Favored 'Trans proline' 0 C--N 1.349 0.579 0 C-N-CA 122.067 1.845 . . . . 0.0 111.719 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.61 ' O ' HG23 ' A' ' 157' ' ' VAL . 29.3 t -69.26 -51.54 42.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.495 ' HB2' ' CD1' ' A' ' 143' ' ' ILE . 7.4 m-30 -64.84 -37.19 86.78 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.421 -0.809 . . . . 0.0 109.84 179.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 1.082 ' HD3' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -56.22 -45.87 79.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.672 179.244 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.458 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.3 tt0 -67.68 -30.6 70.17 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.61 HG23 ' O ' ' A' ' 153' ' ' VAL . 90.8 t -68.57 -41.16 82.8 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 CA-C-N 115.483 -0.78 . . . . 0.0 109.511 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.711 HD22 ' HB3' ' A' ' 139' ' ' PRO . 67.9 mt -64.56 -47.23 79.51 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.453 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 17.4 p -50.22 -42.48 51.72 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.721 HG11 ' HA ' ' A' ' 76' ' ' VAL . 98.7 t -65.43 -41.34 90.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.58 ' CD2' HD13 ' A' ' 109' ' ' LEU . 21.5 m-30 -81.82 5.75 17.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 114.933 -1.031 . . . . 0.0 112.933 -178.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.621 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.88 -51.78 79.46 Favored Pre-proline 0 C--N 1.328 -0.329 0 C-N-CA 120.501 -0.48 . . . . 0.0 110.649 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.621 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.1 Cg_endo -60.05 -11.73 16.61 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.123 1.882 . . . . 0.0 111.996 178.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.452 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 95.7 m-70 -108.46 -19.19 13.54 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.366 -179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 96.8 mt . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.868 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.198 0 CA-C-O 120.276 -0.18 . . . . 0.0 112.945 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -59.2 156.28 35.71 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.495 2.13 . . . . 0.0 112.909 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.489 HD21 ' HB2' ' A' ' 152' ' ' PRO . 0.1 OUTLIER -139.79 106.47 5.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.212 179.162 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -56.14 -41.33 85.69 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 120.806 -0.711 . . . . 0.0 113.113 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.839 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 0.7 OUTLIER 70.08 -98.13 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 122.171 0.188 . . . . 0.0 111.16 -179.5 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.46 ' HE2' ' N ' ' A' ' 5' ' ' SER . 8.4 mtm 65.58 132.38 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.665 0.269 . . . . 0.0 111.032 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.772 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 3.9 p-10 -71.66 -22.67 61.64 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.485 -0.325 . . . . 0.0 111.642 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.2 m -101.44 140.99 21.71 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.482 -0.327 . . . . 0.0 110.684 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.517 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 68.1 Cg_endo -74.89 128.17 11.35 Favored 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.133 1.889 . . . . 0.0 111.351 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.56 ' HB2' ' CE1' ' A' ' 13' ' ' TYR . 1.1 Cg_endo -82.88 167.07 14.69 Favored 'Trans proline' 0 N--CA 1.456 -0.689 0 C-N-CA 122.966 2.444 . . . . 0.0 112.773 -179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -49.14 124.41 8.89 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.031 179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 100' ' ' TRP . . . 51.58 98.11 0.01 OUTLIER Glycine 0 CA--C 1.523 0.567 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.751 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.56 ' CE1' ' HB2' ' A' ' 10' ' ' PRO . 11.0 m-85 -153.84 136.11 14.89 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.696 0.284 . . . . 0.0 110.694 179.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.44 ' HD3' ' NE2' ' A' ' 103' ' ' GLN . 1.7 ttt180 -70.86 75.32 0.62 Allowed 'General case' 0 N--CA 1.463 0.21 0 CA-C-O 121.083 0.468 . . . . 0.0 111.689 -179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.837 ' HG2' HD12 ' A' ' 47' ' ' ILE . 4.3 ttp180 -47.87 113.7 0.77 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.453 179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.643 ' OD1' ' HG2' ' A' ' 105' ' ' GLN . 0.2 OUTLIER -134.89 173.39 11.76 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.993 179.241 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.861 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 33.6 m -132.12 160.33 42.54 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.553 0 CA-C-O 120.986 0.422 . . . . 0.0 111.917 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.621 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -127.08 148.22 17.27 Favored Glycine 0 N--CA 1.443 -0.877 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.26 178.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.908 HG21 HD22 ' A' ' 61' ' ' LEU . 2.8 mp -122.5 117.11 51.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.642 ' O ' HD12 ' A' ' 109' ' ' LEU . 43.9 t -101.04 99.7 10.19 Favored 'General case' 0 CA--C 1.516 -0.344 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 177.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.723 HD22 HG11 ' A' ' 67' ' ' VAL . 21.2 tp -101.26 117.03 34.17 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.005 -177.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.566 ' HE2' HD13 ' A' ' 73' ' ' ILE . 0.7 OUTLIER -119.98 160.1 23.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.795 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.633 ' ND2' ' HB2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -97.3 174.24 6.81 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.19 0.519 . . . . 0.0 110.416 179.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.5 m-20 -57.59 -5.63 0.39 Allowed 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.245 177.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.572 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.5 OUTLIER -99.39 3.5 45.91 Favored 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 -178.709 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.572 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 5.8 mmtp 73.75 18.77 3.35 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.349 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.633 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 2.9 mttt -96.27 142.05 28.88 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.686 HD12 ' N ' ' A' ' 28' ' ' ILE . 2.5 mp -100.79 144.48 12.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.574 0.702 . . . . 0.0 112.063 -178.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.689 ' CE1' HD13 ' A' ' 119' ' ' ILE . 92.1 t80 -75.39 140.2 42.84 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.007 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.971 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -137.76 151.6 48.33 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.615 179.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.54 ' HB1' ' CB ' ' A' ' 131' ' ' PHE . . . -139.83 135.91 33.47 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.319 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.71 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 96.6 p -98.08 140.66 32.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.913 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.46 ' HD2' ' HB3' ' A' ' 39' ' ' ALA . 1.7 mtt-85 -67.65 127.84 34.24 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 120.849 0.357 . . . . 0.0 110.767 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.711 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.6 OUTLIER -45.88 -34.88 4.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.295 0.569 . . . . 0.0 110.458 -179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -71.47 -38.3 71.25 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.139 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.408 ' N ' ' O ' ' A' ' 33' ' ' ARG . 31.3 mm -125.41 108.94 26.53 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.98 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.3 -18.51 23.24 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.578 2.185 . . . . 0.0 112.862 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -92.2 -12.24 33.29 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.664 -179.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.909 ' HB1' ' CG1' ' A' ' 147' ' ' VAL . . . -91.48 104.98 17.42 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.759 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.549 ' O ' ' HA ' ' A' ' 146' ' ' THR . 75.6 m95 -96.82 152.49 18.63 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.632 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.53 ' HG3' ' C ' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -158.18 160.99 37.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.475 0.655 . . . . 0.0 111.927 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.633 ' HG3' HD11 ' A' ' 142' ' ' LEU . 13.4 mtm -98.87 155.04 37.07 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.092 179.053 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.874 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 51.4 Cg_exo -50.74 144.94 24.81 Favored 'Trans proline' 0 CA--C 1.529 0.248 0 C-N-CA 122.23 1.954 . . . . 0.0 112.087 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.861 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -170.57 141.62 1.93 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.079 -179.503 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.569 ' O ' ' HB2' ' A' ' 16' ' ' ASN . . . -148.71 -173.41 19.46 Favored Glycine 0 C--O 1.224 -0.471 0 N-CA-C 111.446 -0.661 . . . . 0.0 111.446 179.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.578 ' HA2' ' CB ' ' A' ' 16' ' ' ASN . . . -95.82 -154.32 30.46 Favored Glycine 0 C--N 1.331 0.263 0 C-N-CA 120.371 -0.919 . . . . 0.0 113.508 -179.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.837 HD12 ' HG2' ' A' ' 15' ' ' ARG . 1.7 mt -163.12 125.53 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 C-N-CA 122.535 0.334 . . . . 0.0 110.736 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -75.27 172.41 12.48 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.995 179.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.455 ' HG3' ' H ' ' A' ' 50' ' ' GLY . 1.8 pt-20 -46.92 -76.66 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.61 -179.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.455 ' H ' ' HG3' ' A' ' 49' ' ' GLU . . . -85.17 34.49 3.24 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.963 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.708 ' OE1' ' HB2' ' A' ' 56' ' ' ALA . 4.8 tm-20 -113.19 123.94 51.37 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.545 ' HB2' ' OD1' ' A' ' 55' ' ' ASN . 1.8 m-20 -70.59 158.69 87.25 Favored Pre-proline 0 C--N 1.326 -0.439 0 C-N-CA 120.62 -0.432 . . . . 0.0 109.857 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.557 ' CA ' HG11 ' A' ' 17' ' ' VAL . 6.8 Cg_exo -74.19 -50.11 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.874 2.383 . . . . 0.0 113.463 -178.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.835 ' CZ ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -49.52 -45.2 47.02 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.267 -179.718 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.545 ' OD1' ' HB2' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -67.67 -44.79 76.98 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.053 0.454 . . . . 0.0 110.321 179.898 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.708 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . . . -58.72 -41.73 87.06 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.686 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.774 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -57.64 -56.77 17.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.2 0.524 . . . . 0.0 109.639 178.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.631 HG12 ' HE2' ' A' ' 110' ' ' PHE . 26.9 mt -54.38 -53.78 27.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.26 179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.559 ' HA ' HH11 ' A' ' 59' ' ' ARG . 0.0 OUTLIER -62.11 -60.06 4.15 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.82 -179.246 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.439 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 16.6 mm-40 -46.21 -49.85 16.54 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 178.56 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.908 HD22 HG21 ' A' ' 19' ' ' ILE . 9.7 tp -49.74 -44.56 48.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.34 178.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.843 ' HD3' HG23 ' A' ' 68' ' ' THR . 21.9 tpt85 -63.85 -65.44 0.68 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.735 -0.666 . . . . 0.0 111.491 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.4 ' OE2' ' HB3' ' A' ' 59' ' ' ARG . 0.8 OUTLIER -49.22 -22.62 1.06 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -179.15 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -97.21 -32.71 11.79 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -177.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.492 ' O ' ' HA ' ' A' ' 119' ' ' ILE . 5.6 p -127.65 -6.28 5.74 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -178.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.483 ' HA2' ' HD2' ' A' ' 62' ' ' ARG . . . 79.36 -14.36 16.81 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.08 -1.057 . . . . 0.0 111.561 -178.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.723 HG11 HD22 ' A' ' 21' ' ' LEU . 78.7 t -58.55 117.25 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-O 121.11 0.481 . . . . 0.0 111.682 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.843 HG23 ' HD3' ' A' ' 62' ' ' ARG . 0.3 OUTLIER -128.26 -38.96 1.74 Allowed 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.457 178.003 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.1 m -62.41 73.44 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.941 178.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.16 155.31 22.7 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 120.866 0.365 . . . . 0.0 111.957 -179.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.436 ' HG3' HG21 ' A' ' 113' ' ' THR . 1.7 mt-10 -128.62 151.34 49.6 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.573 179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.835 HG21 ' CZ ' ' A' ' 54' ' ' ARG . 12.2 t -75.07 126.71 36.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.405 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.657 HD11 ' HB2' ' A' ' 111' ' ' LYS . 1.4 mt -106.71 -19.32 6.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.31 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.505 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -171.05 175.73 4.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.606 -179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.9 OUTLIER -153.17 143.73 22.62 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.256 179.4 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.786 ' HA ' HG11 ' A' ' 160' ' ' VAL . 38.6 t -70.52 131.97 87.79 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 120.937 0.399 . . . . 0.0 111.087 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.488 ' HD2' HG11 ' A' ' 160' ' ' VAL . 34.4 Cg_endo -65.13 -50.74 1.9 Allowed 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 123.057 2.505 . . . . 0.0 112.987 -179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.772 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 3.1 p90 -100.07 177.43 5.09 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.983 0.421 . . . . 0.0 111.931 -178.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.632 ' CH2' ' HG3' ' A' ' 15' ' ' ARG . 58.7 m95 -94.2 -163.44 1.05 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.727 179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.839 ' HA ' ' HA ' ' A' ' 5' ' ' SER . 15.9 mt -159.94 104.15 1.52 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.055 0.455 . . . . 0.0 110.626 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.842 HG22 ' HA ' ' A' ' 104' ' ' ALA . 5.4 p -109.8 101.73 10.57 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.765 -179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.432 ' O ' ' C ' ' A' ' 83' ' ' ASP . 4.5 t80 -78.88 37.07 0.29 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.092 179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.432 ' C ' ' O ' ' A' ' 82' ' ' TYR . 5.7 p-10 25.3 -110.03 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.112 0.565 . . . . 0.0 112.413 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.645 ' CB ' HD21 ' A' ' 93' ' ' ASN . 0.1 OUTLIER 174.63 -178.58 0.11 Allowed Pre-proline 0 C--N 1.332 -0.187 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -179.315 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.618 ' HB2' HG23 ' A' ' 88' ' ' VAL . 78.4 Cg_exo -55.21 177.3 0.11 Allowed 'Trans proline' 0 CA--C 1.53 0.324 0 C-N-CA 122.21 1.94 . . . . 0.0 112.082 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' A' ' 85' ' ' PRO . 52.4 Cg_endo -71.24 -54.39 0.16 Allowed 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.676 2.251 . . . . 0.0 113.659 -178.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.66 -35.04 34.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.856 0.36 . . . . 0.0 111.216 -179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.618 HG23 ' HB2' ' A' ' 85' ' ' PRO . 12.9 t -61.3 -14.03 9.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.046 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.658 ' HA ' ' ND2' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -58.84 -76.73 0.04 OUTLIER 'General case' 0 CA--C 1.527 0.087 0 CA-C-O 121.001 0.429 . . . . 0.0 110.966 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.829 ' HA ' HD13 ' A' ' 94' ' ' ILE . 0.9 OUTLIER -65.17 -12.07 47.17 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 179.976 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -90.89 -33.77 15.5 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.6 -179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.595 ' HB3' HG12 ' A' ' 88' ' ' VAL . 2.6 tm? -121.88 -51.37 2.03 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.907 0.384 . . . . 0.0 112.031 -179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.658 ' ND2' ' HA ' ' A' ' 89' ' ' ARG . 2.6 m-80 -52.02 -57.61 8.99 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.656 -0.702 . . . . 0.0 112.52 -178.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.829 HD13 ' HA ' ' A' ' 90' ' ' GLU . 4.1 mp -74.94 -7.74 10.54 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.322 0.582 . . . . 0.0 109.675 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.464 ' HB3' ' H ' ' A' ' 96' ' ' TRP . 0.2 OUTLIER -79.16 -100.81 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.573 -0.74 . . . . 0.0 111.892 179.832 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.625 ' CD1' ' CD1' ' A' ' 100' ' ' TRP . 80.9 m95 40.9 29.84 0.08 Allowed 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 122.593 0.357 . . . . 0.0 111.64 -179.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 80.67 -55.75 4.72 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.466 -0.874 . . . . 0.0 112.518 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 40.0 t -175.38 145.0 0.73 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.955 0.407 . . . . 0.0 111.27 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.416 ' C ' ' HA3' ' A' ' 12' ' ' GLY . 0.2 OUTLIER 58.15 84.4 0.1 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.792 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.625 ' CD1' ' CD1' ' A' ' 96' ' ' TRP . 0.4 OUTLIER -171.04 175.31 4.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.842 0.353 . . . . 0.0 111.102 -179.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.71 ' HD3' HG13 ' A' ' 94' ' ' ILE . 4.3 ttpt 167.51 6.83 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.348 -178.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.491 ' HA3' ' CE2' ' A' ' 13' ' ' TYR . . . 169.25 -157.06 28.74 Favored Glycine 0 C--N 1.335 0.478 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.969 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.807 ' O ' ' HA ' ' A' ' 81' ' ' THR . 48.3 tt0 -147.2 117.0 7.15 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.792 0.296 . . . . 0.0 110.697 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.842 ' HA ' HG22 ' A' ' 81' ' ' THR . . . -94.2 123.95 37.91 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-O 121.247 0.546 . . . . 0.0 110.642 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.643 ' HG2' ' OD1' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -125.43 119.4 28.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.195 -0.911 . . . . 0.0 112.432 -177.412 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.619 ' HE2' ' CE2' ' A' ' 79' ' ' TRP . 2.0 ttmm -104.17 134.4 47.48 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 177.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.621 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 16.0 m95 -101.68 164.67 11.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.279 0.561 . . . . 0.0 112.303 -178.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.586 ' HB2' ' HE1' ' A' ' 110' ' ' PHE . 95.9 m-85 -140.05 153.18 46.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.169 -0.923 . . . . 0.0 110.09 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.642 HD12 ' O ' ' A' ' 20' ' ' CYS . 16.5 tp -101.24 141.04 34.69 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 120.844 0.354 . . . . 0.0 110.983 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.809 ' CE2' HG22 ' A' ' 72' ' ' VAL . 45.7 m-85 -142.43 145.77 34.13 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-O 121.594 0.712 . . . . 0.0 112.759 -178.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.657 ' HB2' HD11 ' A' ' 73' ' ' ILE . 8.6 tttt -104.88 122.82 46.58 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.065 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.669 ' HD2' HD21 ' A' ' 21' ' ' LEU . 36.5 t80 -77.23 95.81 4.4 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.99 0.424 . . . . 0.0 110.709 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.436 HG21 ' HG3' ' A' ' 71' ' ' GLU . 28.5 p -95.77 55.27 1.61 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.917 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -159.64 -140.99 3.02 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.678 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.541 ' HG3' ' CG ' ' A' ' 117' ' ' GLN . 0.7 OUTLIER -125.81 147.61 49.37 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.785 0.326 . . . . 0.0 110.948 179.627 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.513 ' HB3' ' CH2' ' A' ' 134' ' ' TRP . 85.7 m-20 -62.1 -28.18 69.45 Favored 'General case' 0 N--CA 1.465 0.313 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.541 ' CG ' ' HG3' ' A' ' 115' ' ' GLN . 0.2 OUTLIER -57.65 -5.09 0.33 Allowed 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -179.218 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 25.2 tp10 -88.0 -17.66 30.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.017 0.436 . . . . 0.0 110.602 179.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.689 HD13 ' CE1' ' A' ' 29' ' ' PHE . 9.1 mt -81.09 105.26 10.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.393 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.463 ' C ' ' H ' ' A' ' 122' ' ' LEU . 23.9 t30 -104.27 -26.26 12.56 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.695 179.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.481 HD22 ' HD2' ' A' ' 131' ' ' PHE . 63.5 mt 73.11 -34.23 0.29 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.12 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.524 HD23 ' HB3' ' A' ' 129' ' ' PRO . 60.7 mt -74.57 161.46 29.71 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 120.967 0.413 . . . . 0.0 110.797 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 167.06 -6.41 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 CA-C-N 115.702 -0.681 . . . . 0.0 113.091 -179.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -140.32 70.36 1.36 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 120.819 0.343 . . . . 0.0 110.215 179.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -76.73 42.29 1.77 Allowed Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.777 -179.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -101.01 -28.37 12.77 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.926 0.393 . . . . 0.0 110.408 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.91 -47.98 0.18 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.919 -179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 23.3 pttt -178.93 153.61 0.76 Allowed Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.075 0.464 . . . . 0.0 111.083 179.359 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.524 ' HB3' HD23 ' A' ' 122' ' ' LEU . 11.7 Cg_endo -74.6 -174.27 1.8 Allowed 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 122.629 2.219 . . . . 0.0 113.049 179.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.512 ' O ' HD12 ' A' ' 34' ' ' LEU . 4.5 mp0 -88.89 -72.77 0.53 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.854 -179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.54 ' CB ' ' HB1' ' A' ' 31' ' ' ALA . 2.7 m-85 -104.8 142.74 34.18 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.144 -179.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.711 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -83.72 -36.25 14.27 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.709 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -151.31 154.18 36.24 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.22 -0.49 . . . . 0.0 110.6 179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.553 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 23.8 p-90 -135.25 166.79 22.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.825 0.345 . . . . 0.0 111.116 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.449 ' N ' ' HZ3' ' A' ' 40' ' ' TRP . 29.9 t -161.24 163.22 31.17 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 121.346 0.593 . . . . 0.0 111.657 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.56 ' CZ3' ' HB2' ' A' ' 29' ' ' PHE . 77.2 m95 -110.46 108.32 18.29 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.054 178.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.445 ' O ' ' N ' ' A' ' 28' ' ' ILE . 34.0 m -123.31 173.72 8.68 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.866 0 CA-C-N 115.516 -0.766 . . . . 0.0 109.861 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.561 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 15.2 p -72.97 172.47 7.84 Favored Pre-proline 0 C--N 1.323 -0.571 0 C-N-CA 120.449 -0.501 . . . . 0.0 109.885 178.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.709 ' HB3' HD22 ' A' ' 158' ' ' LEU . 13.4 Cg_exo -61.75 -55.25 1.18 Allowed 'Trans proline' 0 N--CA 1.453 -0.884 0 C-N-CA 121.427 1.418 . . . . 0.0 110.314 179.26 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -63.1 -30.81 71.89 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.066 178.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 24.7 mt-30 -69.86 -48.55 58.41 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.87 0.367 . . . . 0.0 110.153 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.971 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -54.43 -41.17 69.07 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.429 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.596 HG21 ' HD3' ' A' ' 155' ' ' LYS . 28.3 mm -60.13 -36.87 70.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.936 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -70.56 -52.28 22.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.41 0.624 . . . . 0.0 111.037 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.4 mp -70.85 -24.88 62.6 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.849 -179.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.549 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 5.2 t -71.8 169.5 15.6 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-O 121.539 0.685 . . . . 0.0 111.825 -178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.909 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 33.8 m -74.3 154.69 6.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.872 -1.058 . . . . 0.0 110.846 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.504 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 0.4 OUTLIER -60.91 -54.59 43.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.071 -179.77 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.446 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 39.9 p90 -57.07 0.63 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 113.721 1.008 . . . . 0.0 113.721 -179.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.422 ' HE3' HH22 ' A' ' 33' ' ' ARG . 13.6 mmtt -133.77 -7.7 2.79 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 122.032 -0.417 . . . . 0.0 111.873 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.496 ' HG3' HG23 ' A' ' 143' ' ' ILE . 0.4 OUTLIER -62.03 -59.24 13.69 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.776 -0.193 . . . . 0.0 111.276 179.929 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.504 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 19.2 Cg_endo -59.5 -28.54 87.73 Favored 'Trans proline' 0 C--N 1.348 0.552 0 C-N-CA 122.347 2.031 . . . . 0.0 111.337 179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.791 ' O ' HG23 ' A' ' 157' ' ' VAL . 24.4 t -68.81 -50.69 52.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 178.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.422 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 7.6 m-30 -66.0 -38.01 87.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.875 178.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.596 ' HD3' HG21 ' A' ' 143' ' ' ILE . 4.8 tptp -56.3 -43.36 78.84 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.393 179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.492 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.3 tp10 -68.17 -34.4 76.24 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.791 HG23 ' O ' ' A' ' 153' ' ' VAL . 58.5 t -66.01 -41.0 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.863 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.615 178.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.709 HD22 ' HB3' ' A' ' 139' ' ' PRO . 38.3 mt -63.8 -45.33 90.15 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.621 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 28.4 t -53.96 -40.0 66.45 Favored 'General case' 0 CA--C 1.522 -0.128 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 179.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.786 HG11 ' HA ' ' A' ' 76' ' ' VAL . 62.0 t -67.73 -41.44 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 CA-C-O 121.491 0.662 . . . . 0.0 109.309 178.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.605 ' CE2' HG12 ' A' ' 157' ' ' VAL . 21.9 m-30 -80.74 4.72 18.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.075 -0.966 . . . . 0.0 112.354 -179.552 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.62 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.44 -52.45 74.52 Favored Pre-proline 0 C--N 1.33 -0.263 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.604 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.62 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.4 Cg_endo -58.48 -13.05 15.55 Favored 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.177 1.918 . . . . 0.0 111.603 178.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.505 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 94.5 m-70 -107.85 -19.33 13.56 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.125 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.571 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 98.0 mt . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.276 -0.869 . . . . 0.0 110.624 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 112.612 -0.195 . . . . 0.0 112.612 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -53.37 133.92 55.04 Favored 'Trans proline' 0 C--N 1.344 0.326 0 C-N-CA 122.656 2.237 . . . . 0.0 111.845 179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.735 HD21 ' HB3' ' A' ' 80' ' ' LEU . 0.4 OUTLIER 63.52 120.91 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.952 0.406 . . . . 0.0 110.48 -179.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.496 ' HA3' ' HE1' ' A' ' 6' ' ' MET . . . -80.7 -54.67 3.6 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.556 -0.831 . . . . 0.0 112.182 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.718 ' HB3' ' HA ' ' A' ' 80' ' ' LEU . 50.9 p 51.85 98.34 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 112.499 0.555 . . . . 0.0 112.499 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.496 ' HE1' ' HA3' ' A' ' 4' ' ' GLY . 1.9 mmt -94.22 157.57 16.0 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 178.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -65.31 -52.95 50.64 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.886 -0.412 . . . . 0.0 109.886 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 89.2 p -98.71 148.97 35.28 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.928 178.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.473 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 56.8 Cg_endo -71.76 118.47 5.66 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.17 1.913 . . . . 0.0 112.505 -179.562 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.583 ' HB2' ' CD1' ' A' ' 13' ' ' TYR . 1.1 Cg_endo -79.81 171.55 15.35 Favored 'Trans proline' 0 CA--C 1.534 0.481 0 C-N-CA 123.133 2.555 . . . . 0.0 113.185 -179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -52.28 129.2 27.5 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.518 ' CA ' ' HA ' ' A' ' 100' ' ' TRP . . . 53.24 25.83 27.0 Favored Glycine 0 N--CA 1.451 -0.348 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.56 178.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.583 ' CD1' ' HB2' ' A' ' 10' ' ' PRO . 10.5 m-85 -98.55 48.06 0.98 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.76 0.314 . . . . 0.0 110.761 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.683 ' HD2' ' HG2' ' A' ' 103' ' ' GLN . 0.0 OUTLIER 34.89 -154.53 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 179.4 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.496 ' HG3' HD12 ' A' ' 47' ' ' ILE . 0.3 OUTLIER 177.13 91.1 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.233 -179.262 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.986 ' HB2' ' HG2' ' A' ' 105' ' ' GLN . 0.7 OUTLIER -134.05 -178.83 5.21 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.553 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.657 HG21 ' N ' ' A' ' 57' ' ' ALA . 23.8 m -140.59 166.63 18.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-O 121.348 0.594 . . . . 0.0 111.768 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.572 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -131.33 161.38 23.6 Favored Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.742 -0.943 . . . . 0.0 110.742 178.597 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.023 HG21 HD22 ' A' ' 61' ' ' LEU . 3.6 mp -128.64 119.19 49.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.008 0.432 . . . . 0.0 112.04 -179.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.455 ' O ' HD12 ' A' ' 109' ' ' LEU . 10.2 t -104.25 105.0 15.0 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 177.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.845 HD22 HG11 ' A' ' 67' ' ' VAL . 13.1 tp -108.28 122.28 46.64 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.872 -0.603 . . . . 0.0 111.789 -178.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.769 ' HE1' HD13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -119.37 163.31 17.38 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.818 179.455 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.803 ' ND2' ' HB2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -99.85 168.67 9.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.435 179.818 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.645 ' HA ' ' HE2' ' A' ' 111' ' ' LYS . 71.2 m-20 -56.33 -4.88 0.16 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.921 -0.581 . . . . 0.0 111.021 177.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.511 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 1.2 m-20 -100.06 2.61 43.45 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.795 -179.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.586 ' NZ ' ' HA ' ' A' ' 165' ' ' LEU . 0.1 OUTLIER 73.91 21.64 2.61 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.173 -178.376 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.803 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -93.86 145.62 24.48 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.045 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.778 HG13 ' HA ' ' A' ' 139' ' ' PRO . 1.5 mm -100.51 139.11 22.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.465 0.65 . . . . 0.0 111.994 -178.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.662 ' HB2' ' CZ3' ' A' ' 136' ' ' TRP . 82.2 t80 -79.21 140.27 37.73 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 114.683 -1.144 . . . . 0.0 110.109 178.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 1.014 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -143.71 157.97 44.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.046 0.451 . . . . 0.0 111.033 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.566 ' HB1' ' CB ' ' A' ' 131' ' ' PHE . . . -146.51 138.93 25.08 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.996 -179.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.635 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 60.7 p -99.8 147.99 24.89 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.297 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.653 ' O ' ' N ' ' A' ' 35' ' ' ASP . 18.2 mtp180 -69.75 129.01 38.41 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.403 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.824 HD13 ' HG2' ' A' ' 129' ' ' PRO . 0.3 OUTLIER -54.96 55.31 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.576 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.653 ' N ' ' O ' ' A' ' 33' ' ' ARG . 23.0 t70 -177.4 -28.42 0.01 OUTLIER 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.917 -0.583 . . . . 0.0 109.87 179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.479 HG13 ' CZ ' ' A' ' 33' ' ' ARG . 25.5 mm -119.21 110.65 37.56 Favored Pre-proline 0 N--CA 1.455 -0.181 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.606 179.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -75.67 -20.28 15.72 Favored 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.633 2.222 . . . . 0.0 112.905 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -96.36 -8.49 32.37 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 112.001 0.371 . . . . 0.0 112.001 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.635 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.8 104.09 16.38 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 120.616 0.246 . . . . 0.0 110.881 179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.714 ' O ' ' HA ' ' A' ' 146' ' ' THR . 65.9 m95 -105.89 144.6 32.39 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.909 179.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.591 ' HG3' ' C ' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -156.92 161.62 39.65 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.487 0.66 . . . . 0.0 111.622 179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.555 ' HB3' ' CZ3' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -96.82 152.87 38.71 Favored Pre-proline 0 C--N 1.321 -0.674 0 CA-C-N 114.926 -1.033 . . . . 0.0 110.36 179.062 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.632 ' HG3' HD13 ' A' ' 61' ' ' LEU . 5.1 Cg_endo -48.61 158.74 1.02 Allowed 'Trans proline' 0 CA--C 1.534 0.515 0 C-N-CA 123.197 2.598 . . . . 0.0 111.976 179.028 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.604 ' HA ' HD12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -178.82 -179.67 0.63 Allowed 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.453 0.168 . . . . 0.0 111.084 -179.837 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.639 ' HA3' ' HG2' ' A' ' 60' ' ' GLU . . . 164.4 155.79 8.56 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 120.696 -0.764 . . . . 0.0 113.11 178.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.724 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -76.66 132.09 12.09 Favored Glycine 0 C--N 1.334 0.431 0 N-CA-C 114.702 0.641 . . . . 0.0 114.702 -178.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.676 HG12 ' HA ' ' A' ' 53' ' ' PRO . 2.9 mt -68.93 145.83 13.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.406 -0.397 . . . . 0.0 110.464 178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -67.51 -173.12 0.28 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 121.171 0.51 . . . . 0.0 111.144 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.465 ' HG2' ' H ' ' A' ' 50' ' ' GLY . 1.4 pm0 -50.16 -82.45 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.282 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.465 ' H ' ' HG2' ' A' ' 49' ' ' GLU . . . -109.76 54.6 0.54 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.083 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -115.16 154.61 28.66 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.096 0.474 . . . . 0.0 110.363 -179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.473 ' HB2' ' ND2' ' A' ' 55' ' ' ASN . 0.6 OUTLIER -70.44 156.39 91.97 Favored Pre-proline 0 C--N 1.326 -0.413 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.805 -179.927 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.676 ' HA ' HG12 ' A' ' 47' ' ' ILE . 2.7 Cg_exo -74.88 -53.22 0.1 Allowed 'Trans proline' 0 CA--C 1.507 -0.843 0 C-N-CA 122.702 2.268 . . . . 0.0 112.217 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.608 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 0.3 OUTLIER -48.18 -52.98 18.48 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.925 179.309 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.535 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 1.2 m-20 -53.75 -46.49 70.91 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.596 -0.442 . . . . 0.0 110.002 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 60' ' ' GLU . . . -60.01 -42.34 94.07 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.657 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -59.07 -61.91 2.29 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.345 -0.843 . . . . 0.0 110.494 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.608 ' CD1' ' O ' ' A' ' 54' ' ' ARG . 3.3 mp -55.88 -46.51 80.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.497 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.535 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 0.7 OUTLIER -63.14 -63.1 1.29 Allowed 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 120.356 -0.538 . . . . 0.0 110.44 179.605 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.639 ' HG2' ' HA3' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -42.8 -46.35 5.17 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-O 120.944 0.402 . . . . 0.0 110.045 179.38 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.023 HD22 HG21 ' A' ' 19' ' ' ILE . 12.0 tp -50.05 -47.75 53.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.153 178.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.867 ' HG3' HG23 ' A' ' 68' ' ' THR . 40.0 ttp180 -64.77 -62.25 1.68 Allowed 'General case' 0 CA--C 1.523 -0.091 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.415 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -51.61 -20.41 1.98 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.806 -179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -100.62 -36.85 9.01 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 113.24 0.83 . . . . 0.0 113.24 -178.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.668 ' O ' ' HA ' ' A' ' 119' ' ' ILE . 2.3 p -127.23 1.97 6.41 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 113.003 0.742 . . . . 0.0 113.003 -178.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 70.15 -11.82 1.94 Allowed Glycine 0 CA--C 1.522 0.512 0 C-N-CA 120.209 -0.996 . . . . 0.0 112.375 -178.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.845 HG11 HD22 ' A' ' 21' ' ' LEU . 75.2 t -58.14 109.72 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.411 0 CA-C-O 121.198 0.523 . . . . 0.0 111.422 179.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.867 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.6 OUTLIER -121.75 -41.3 2.47 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.732 -0.667 . . . . 0.0 109.898 178.495 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.437 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 7.4 m -60.75 74.16 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.692 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.561 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.43 153.36 19.5 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 120.992 0.425 . . . . 0.0 112.097 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -124.4 148.23 47.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.237 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.773 HG22 ' CE1' ' A' ' 110' ' ' PHE . 20.3 t -76.04 126.59 36.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.956 179.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.769 HD13 ' HE1' ' A' ' 22' ' ' MET . 0.6 OUTLIER -109.25 -19.08 7.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.276 179.074 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.433 ' HB3' ' HB3' ' A' ' 109' ' ' LEU . . . -169.78 176.73 4.73 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.214 -178.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.9 OUTLIER -162.74 149.24 12.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.885 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.746 ' HA ' HG11 ' A' ' 160' ' ' VAL . 41.5 t -71.64 140.59 84.33 Favored Pre-proline 0 CA--C 1.534 0.351 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.293 -179.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.618 ' HD2' HG13 ' A' ' 76' ' ' VAL . 32.6 Cg_endo -64.91 -72.33 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.533 0 C-N-CA 122.931 2.421 . . . . 0.0 113.424 -179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.423 ' HE1' HD21 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -85.18 176.34 8.42 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.197 0.522 . . . . 0.0 111.74 -178.84 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.486 ' O ' ' HA ' ' A' ' 5' ' ' SER . 29.8 m95 -93.27 109.28 20.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.652 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.735 ' HB3' HD21 ' A' ' 3' ' ' LEU . 39.4 mt -64.44 110.83 2.42 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.808 0.337 . . . . 0.0 111.329 -179.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.948 HG22 ' HA ' ' A' ' 104' ' ' ALA . 8.0 p -115.02 -169.84 1.63 Allowed 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.318 179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.465 ' CE1' ' HB2' ' A' ' 103' ' ' GLN . 4.9 p90 -172.81 78.67 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.655 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.5 p-10 -70.67 157.18 38.44 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.513 -0.312 . . . . 0.0 110.696 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.552 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 1.6 m-85 -100.56 163.63 17.79 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-O 120.934 0.397 . . . . 0.0 111.206 -179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.612 ' HB2' ' HD2' ' A' ' 86' ' ' PRO . 98.4 Cg_endo -84.12 -178.86 3.67 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.475 2.783 . . . . 0.0 112.776 -179.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.612 ' HD2' ' HB2' ' A' ' 85' ' ' PRO . 10.9 Cg_endo -52.11 151.86 15.81 Favored 'Trans proline' 0 C--N 1.357 0.997 0 C-N-CA 122.451 2.101 . . . . 0.0 112.255 -179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.607 ' O ' ' HB2' ' A' ' 91' ' ' LYS . 0.0 OUTLIER 72.88 -41.97 0.52 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.963 -179.579 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.411 HG11 ' HD2' ' A' ' 84' ' ' PHE . 18.0 t -79.14 -31.42 14.62 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 CA-C-O 120.786 0.327 . . . . 0.0 110.865 179.831 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.614 ' O ' ' HB2' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -60.9 -67.2 0.42 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 116.24 -0.436 . . . . 0.0 109.896 179.601 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.781 ' HA ' HD13 ' A' ' 94' ' ' ILE . 1.0 OUTLIER -61.63 -13.08 19.18 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 179.776 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.607 ' HB2' ' O ' ' A' ' 87' ' ' LYS . 0.0 OUTLIER -91.18 -35.34 14.59 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 120.811 0.338 . . . . 0.0 111.64 -179.61 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.491 HD22 ' O ' ' A' ' 92' ' ' LEU . 1.4 tm? -119.38 -52.71 2.26 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.118 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.96 ' HB3' ' HA ' ' A' ' 101' ' ' LYS . 5.0 m120 -51.56 -34.4 36.62 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.961 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.781 HD13 ' HA ' ' A' ' 90' ' ' GLU . 1.5 mp -94.81 -12.83 8.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.03 0.443 . . . . 0.0 110.133 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.76 -2.69 12.69 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.114 -0.494 . . . . 0.0 112.093 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.608 ' HB2' ' CD1' ' A' ' 100' ' ' TRP . 44.4 m95 -84.2 16.06 3.19 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.632 0.253 . . . . 0.0 111.195 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.74 ' O ' ' HB2' ' A' ' 98' ' ' SER . . . 67.88 113.28 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.302 -0.952 . . . . 0.0 111.322 -179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.74 ' HB2' ' O ' ' A' ' 97' ' ' GLY . 2.9 m 87.08 -167.97 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 122.824 0.45 . . . . 0.0 110.331 -179.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -44.44 -91.98 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.481 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.669 ' CZ3' ' HA ' ' A' ' 14' ' ' ARG . 6.5 m95 54.65 170.58 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.147 0 CA-C-O 120.757 0.313 . . . . 0.0 110.995 -179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.96 ' HA ' ' HB3' ' A' ' 93' ' ' ASN . 0.7 OUTLIER 169.75 28.19 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.765 179.145 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.434 ' HA2' ' ND2' ' A' ' 93' ' ' ASN . . . 154.91 -161.63 30.42 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.766 -0.731 . . . . 0.0 111.907 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.686 ' O ' ' HA ' ' A' ' 81' ' ' THR . 1.3 mt-30 -147.59 120.15 8.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 117.133 0.467 . . . . 0.0 111.805 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.948 ' HA ' HG22 ' A' ' 81' ' ' THR . . . -107.78 111.16 23.19 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.004 0.43 . . . . 0.0 110.723 178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.986 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 70.0 mt-30 -122.48 130.61 53.24 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.732 0.641 . . . . 0.0 112.732 -178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.476 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 1.1 ttpp -105.5 131.02 53.43 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.915 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.572 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 20.5 m95 -102.23 163.07 12.44 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.543 ' CE2' ' HG3' ' A' ' 54' ' ' ARG . 92.6 m-85 -140.69 148.5 40.89 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.235 179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.632 HD22 ' HB3' ' A' ' 161' ' ' PHE . 18.8 tp -102.4 128.68 48.89 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.922 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.905 ' CE2' HG23 ' A' ' 19' ' ' ILE . 7.7 m-85 -134.54 148.25 50.45 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-O 121.314 0.578 . . . . 0.0 112.156 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.645 ' HE2' ' HA ' ' A' ' 24' ' ' ASN . 2.1 tttt -98.75 126.12 44.28 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.933 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.753 ' HD2' HD21 ' A' ' 21' ' ' LEU . 33.8 t80 -78.12 96.43 5.15 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.14 0.495 . . . . 0.0 110.512 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 82.4 p -96.65 50.01 1.11 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.672 -179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.437 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -155.37 -144.13 3.84 Favored Glycine 0 C--N 1.331 0.261 0 C-N-CA 120.912 -0.661 . . . . 0.0 112.553 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.419 ' N ' ' HE1' ' A' ' 112' ' ' PHE . 8.0 pt20 -123.85 151.42 43.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.115 0.483 . . . . 0.0 111.564 179.741 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -62.36 -25.01 67.67 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.61 -0.723 . . . . 0.0 112.299 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -59.92 -4.97 0.83 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.946 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -91.16 -17.8 25.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.98 0.419 . . . . 0.0 110.613 179.53 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.668 ' HA ' ' O ' ' A' ' 65' ' ' THR . 8.8 mt -81.05 104.2 9.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.937 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.465 HD22 ' HB2' ' A' ' 122' ' ' LEU . 2.3 t30 -102.18 -26.52 13.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.055 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.641 HD23 HG22 ' A' ' 65' ' ' THR . 61.7 mt 74.23 -36.62 0.34 Allowed 'General case' 0 N--CA 1.466 0.369 0 CA-C-O 120.842 0.353 . . . . 0.0 111.667 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 1.045 HD23 ' HB3' ' A' ' 129' ' ' PRO . 90.8 mt -71.62 164.94 24.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.244 0.545 . . . . 0.0 111.185 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -130.08 4.37 6.01 Favored Glycine 0 N--CA 1.448 -0.539 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.371 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 61.35 56.1 2.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.143 0.497 . . . . 0.0 110.814 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -124.91 145.3 15.66 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.037 179.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.6 -4.05 14.03 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 122.983 -0.128 . . . . 0.0 111.119 179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.593 ' O ' ' HG3' ' A' ' 128' ' ' LYS . 0.2 OUTLIER -88.06 -79.09 0.3 Allowed 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 121.053 -0.259 . . . . 0.0 111.251 -179.998 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.593 ' HG3' ' O ' ' A' ' 127' ' ' GLU . 29.1 mttm -177.0 163.09 1.54 Allowed Pre-proline 0 N--CA 1.451 -0.383 0 CA-C-O 121.545 0.688 . . . . 0.0 111.117 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 1.045 ' HB3' HD23 ' A' ' 122' ' ' LEU . 33.6 Cg_endo -74.97 -176.72 3.01 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 123.514 2.809 . . . . 0.0 113.282 179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.14 -62.26 1.3 Allowed 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.782 -0.644 . . . . 0.0 111.439 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.566 ' CB ' ' HB1' ' A' ' 31' ' ' ALA . 4.2 m-85 -114.7 140.72 48.63 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.312 0.577 . . . . 0.0 111.473 -179.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.805 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -80.81 -35.85 23.88 Favored Glycine 0 N--CA 1.449 -0.466 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.754 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -153.75 153.78 32.84 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.963 0.411 . . . . 0.0 110.66 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.571 ' HD1' HD11 ' A' ' 121' ' ' LEU . 32.6 p-90 -135.18 166.04 24.0 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.093 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.432 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 13.2 t -161.45 166.95 26.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.097 0.475 . . . . 0.0 111.847 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.662 ' CZ3' ' HB2' ' A' ' 29' ' ' PHE . 53.7 m95 -109.31 103.57 12.54 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.344 178.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.484 ' O ' ' N ' ' A' ' 28' ' ' ILE . 28.5 m -117.56 168.96 8.6 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.762 -0.653 . . . . 0.0 109.5 -179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.597 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 11.3 p -71.43 170.63 11.15 Favored Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 119.56 -0.856 . . . . 0.0 109.965 179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.778 ' HA ' HG13 ' A' ' 28' ' ' ILE . 24.4 Cg_exo -57.7 -58.89 0.67 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 121.957 1.772 . . . . 0.0 109.841 178.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -60.8 -29.86 69.71 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.685 -0.689 . . . . 0.0 111.624 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -70.73 -48.4 54.71 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-O 120.934 0.397 . . . . 0.0 110.656 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 1.014 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -54.6 -41.97 70.55 Favored 'General case' 0 CA--C 1.51 -0.583 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.745 ' CG2' ' HG3' ' A' ' 151' ' ' LYS . 24.3 mm -61.73 -33.92 59.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.255 179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.78 -51.54 16.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.377 0.608 . . . . 0.0 110.321 179.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -71.42 -21.23 62.01 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.281 -0.872 . . . . 0.0 112.696 -179.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.714 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 14.7 t -73.45 175.36 7.06 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.717 -179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.713 ' CG2' ' HD2' ' A' ' 150' ' ' LYS . 34.0 m -86.05 148.26 4.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.655 179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.541 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 2.1 mt-10 -48.31 -50.32 30.58 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.467 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -55.3 -4.24 0.08 Allowed 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.716 0.636 . . . . 0.0 112.716 -179.589 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.713 ' HD2' ' CG2' ' A' ' 147' ' ' VAL . 18.7 mttt -136.51 -7.14 1.96 Allowed 'General case' 0 N--CA 1.463 0.225 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -178.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.745 ' HG3' ' CG2' ' A' ' 143' ' ' ILE . 2.7 ttpp -62.99 -54.34 47.41 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.35 0.119 . . . . 0.0 110.816 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.541 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 38.0 Cg_endo -66.38 -29.44 45.71 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.435 2.09 . . . . 0.0 110.989 178.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.801 ' O ' HG23 ' A' ' 157' ' ' VAL . 9.3 t -68.1 -55.91 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 108.37 -0.974 . . . . 0.0 108.37 177.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.55 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 4.6 m-30 -63.09 -37.4 87.05 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.332 -0.849 . . . . 0.0 109.581 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.741 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -55.78 -45.34 78.17 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.441 179.554 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.548 ' O ' HG23 ' A' ' 160' ' ' VAL . 12.8 tm-20 -67.49 -34.58 77.43 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 153' ' ' VAL . 47.9 t -63.35 -42.1 95.11 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 CA-C-N 115.723 -0.671 . . . . 0.0 109.546 179.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.593 HD22 ' HB3' ' A' ' 139' ' ' PRO . 36.0 mt -63.91 -43.92 94.5 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.883 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.9 m -56.85 -39.31 74.05 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.746 HG11 ' HA ' ' A' ' 76' ' ' VAL . 76.1 t -67.54 -42.4 86.85 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 177.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.664 ' CE2' HG12 ' A' ' 157' ' ' VAL . 18.8 m-30 -81.24 7.13 12.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.089 -0.959 . . . . 0.0 112.006 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.553 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.97 -54.9 51.9 Favored Pre-proline 0 C--N 1.332 -0.169 0 C-N-CA 120.803 -0.359 . . . . 0.0 111.178 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 15.9 Cg_endo -57.58 -12.94 12.4 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 121.825 1.683 . . . . 0.0 111.768 179.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.431 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 78.4 m-70 -107.46 -17.25 14.17 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.237 179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 98.2 mt . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.272 -0.87 . . . . 0.0 110.586 179.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.169 0 CA-C-O 120.309 -0.162 . . . . 0.0 112.713 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.454 ' C ' ' HG ' ' A' ' 3' ' ' LEU . 53.1 Cg_exo -53.09 -178.52 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.512 2.141 . . . . 0.0 112.046 179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.711 ' O ' HD12 ' A' ' 3' ' ' LEU . 1.3 pp 32.15 94.18 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 115.978 -0.556 . . . . 0.0 112.349 179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -79.08 138.9 21.3 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.558 -0.83 . . . . 0.0 112.127 179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.507 ' HB3' ' CD1' ' A' ' 78' ' ' TYR . 1.3 m -82.28 -74.5 0.34 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.066 0.46 . . . . 0.0 111.386 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 5.1 mpp? 63.46 129.25 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.72 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.651 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 1.5 p30 -66.79 -33.23 75.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.983 0.42 . . . . 0.0 110.353 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.443 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 0.4 OUTLIER -103.83 146.36 32.37 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.231 179.211 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.524 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 61.0 Cg_endo -71.78 105.2 1.75 Allowed 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.364 2.043 . . . . 0.0 111.854 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.612 ' HB2' ' CE2' ' A' ' 13' ' ' TYR . 10.3 Cg_endo -51.57 164.49 0.9 Allowed 'Trans proline' 0 C--O 1.231 0.134 0 C-N-CA 123.46 2.773 . . . . 0.0 113.135 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 14.0 mt-10 -53.78 134.15 42.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.783 179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 49.63 88.4 0.01 OUTLIER Glycine 0 C--N 1.331 0.27 0 C-N-CA 121.074 -0.584 . . . . 0.0 113.0 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.612 ' CE2' ' HB2' ' A' ' 10' ' ' PRO . 12.3 m-85 -151.9 130.48 12.25 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.854 0.359 . . . . 0.0 110.97 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.675 ' HA ' ' CZ3' ' A' ' 100' ' ' TRP . 6.5 ttt180 -66.48 81.34 0.1 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.272 179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.808 ' HG2' HD12 ' A' ' 47' ' ' ILE . 4.7 ttp180 -49.07 109.89 0.3 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.967 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.737 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 2.1 m-80 -131.66 176.39 8.36 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.395 -0.82 . . . . 0.0 108.96 178.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.663 HG13 ' CG1' ' A' ' 47' ' ' ILE . 6.2 m -144.1 166.15 13.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.794 0.33 . . . . 0.0 111.389 178.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.487 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -136.4 160.24 24.68 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.808 -0.711 . . . . 0.0 112.144 179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.679 HG13 ' HB1' ' A' ' 57' ' ' ALA . 3.6 mp -129.23 119.36 48.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.043 0.449 . . . . 0.0 111.536 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.69 ' O ' HD12 ' A' ' 109' ' ' LEU . 3.0 t -98.29 92.73 5.85 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.182 -0.674 . . . . 0.0 109.182 178.871 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.688 HD22 HG11 ' A' ' 67' ' ' VAL . 39.2 tp -91.01 123.32 34.39 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.741 -178.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.765 ' CG ' HD11 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -117.46 152.57 34.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.126 179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.61 ' OD1' ' CE3' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -97.66 174.9 6.4 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.507 -179.321 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -56.76 -6.11 0.29 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.769 177.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.526 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -101.25 -1.7 33.03 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.631 0.253 . . . . 0.0 111.43 -179.151 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 6.1 mmpt? 75.6 21.72 1.69 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.106 -178.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.674 ' O ' ' HA ' ' A' ' 22' ' ' MET . 6.0 mttt -91.59 175.65 6.83 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.693 HD11 ' HG3' ' A' ' 139' ' ' PRO . 1.8 mm -118.77 138.12 50.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.131 0.491 . . . . 0.0 111.756 -178.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.536 ' CZ ' HG21 ' A' ' 65' ' ' THR . 9.9 t80 -63.72 101.62 0.37 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.181 178.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.669 ' HA ' ' O ' ' A' ' 41' ' ' GLN . . . -97.86 137.37 36.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.935 0.398 . . . . 0.0 111.315 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.449 ' HB1' ' CG ' ' A' ' 131' ' ' PHE . . . -137.64 139.86 40.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.331 179.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.604 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 60.1 p -104.47 150.59 24.43 Favored 'General case' 0 C--N 1.332 -0.162 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -178.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.619 ' O ' ' N ' ' A' ' 35' ' ' ASP . 4.9 mtp180 -74.55 129.93 38.64 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.309 179.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.715 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -56.89 52.71 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 122.883 0.473 . . . . 0.0 112.211 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.619 ' N ' ' O ' ' A' ' 33' ' ' ARG . 0.1 OUTLIER -174.97 -37.03 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.054 0.454 . . . . 0.0 110.18 -179.722 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.576 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 3.8 mm -112.09 106.23 56.24 Favored Pre-proline 0 CA--C 1.532 0.252 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.739 -179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -59.53 -60.14 0.34 Allowed 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.07 2.513 . . . . 0.0 113.895 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -67.9 2.87 1.76 Allowed 'General case' 0 N--CA 1.464 0.268 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -178.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.604 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.85 93.24 8.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.749 0.309 . . . . 0.0 111.454 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.55 ' O ' ' HA ' ' A' ' 146' ' ' THR . 76.4 m95 -98.68 155.04 17.52 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.089 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.669 ' O ' ' HA ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -162.72 -139.35 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.976 -0.289 . . . . 0.0 111.002 -178.564 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.583 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 4.9 ptt? -176.91 163.36 1.56 Allowed Pre-proline 0 N--CA 1.446 -0.671 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -179.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.871 ' HG3' HD13 ' A' ' 61' ' ' LEU . 2.9 Cg_endo -38.22 130.24 1.0 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.276 2.651 . . . . 0.0 113.342 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.599 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 1.7 tm0? -174.23 141.65 0.75 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.118 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -161.49 -156.45 8.33 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.472 -0.871 . . . . 0.0 112.387 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.71 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -118.24 138.94 14.24 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.261 -0.971 . . . . 0.0 113.03 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.808 HD12 ' HG2' ' A' ' 15' ' ' ARG . 46.2 mt -69.49 145.03 13.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 120.864 0.364 . . . . 0.0 111.63 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -69.15 -174.34 0.62 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.817 179.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 -48.58 -75.19 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.127 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -116.33 56.24 0.53 Allowed Glycine 0 C--N 1.332 0.309 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.276 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -115.16 147.68 39.98 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.808 0.337 . . . . 0.0 110.773 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -71.12 160.16 83.33 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.606 179.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.537 ' HA ' HG11 ' A' ' 17' ' ' VAL . 15.8 Cg_exo -69.38 -49.07 0.65 Allowed 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.672 2.248 . . . . 0.0 111.653 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.843 ' NH2' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -52.21 -45.78 65.37 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.689 179.708 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -64.53 -45.3 87.79 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.857 179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.535 ' HA ' ' HD3' ' A' ' 59' ' ' ARG . . . -62.51 -45.62 92.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.688 179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.679 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -57.29 -55.15 38.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.317 0.579 . . . . 0.0 109.832 178.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.531 HD11 ' HG3' ' A' ' 54' ' ' ARG . 27.1 mt -56.43 -51.06 69.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.4 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.535 ' HD3' ' HA ' ' A' ' 56' ' ' ALA . 2.8 ptm180 -65.17 -54.18 33.56 Favored 'General case' 0 N--CA 1.464 0.227 0 C-N-CA 120.608 -0.437 . . . . 0.0 111.557 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 56' ' ' ALA . 0.4 OUTLIER -46.25 -44.62 16.51 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.295 0.569 . . . . 0.0 109.884 179.374 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.871 HD13 ' HG3' ' A' ' 43' ' ' PRO . 8.4 tp -51.48 -51.62 53.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.489 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.841 ' HG3' HG23 ' A' ' 68' ' ' THR . 15.1 ttm180 -64.87 -61.6 2.07 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.473 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -51.33 -23.47 3.69 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.077 -0.51 . . . . 0.0 112.111 -179.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -97.13 -38.18 9.83 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 113.246 0.832 . . . . 0.0 113.246 -178.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.689 HG22 ' CD2' ' A' ' 121' ' ' LEU . 1.1 p -131.26 -3.33 3.89 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 78.75 -9.44 36.98 Favored Glycine 0 CA--C 1.517 0.205 0 C-N-CA 120.534 -0.841 . . . . 0.0 113.135 179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.776 ' HB ' HD11 ' A' ' 61' ' ' LEU . 69.6 t -58.49 111.76 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.317 0 CA-C-O 121.209 0.528 . . . . 0.0 111.444 179.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.841 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.8 OUTLIER -121.63 -39.38 2.65 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.429 178.493 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.419 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 14.2 m -62.7 70.37 0.02 OUTLIER 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.93 178.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.544 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.37 152.89 19.01 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.216 -179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.4 ' O ' ' HA ' ' A' ' 110' ' ' PHE . 0.3 OUTLIER -129.06 157.81 40.69 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.297 179.443 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.843 HG11 ' NH2' ' A' ' 54' ' ' ARG . 16.5 t -78.62 131.08 35.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.261 0.553 . . . . 0.0 112.033 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.84 ' N ' HD13 ' A' ' 73' ' ' ILE . 0.8 OUTLIER -104.7 -22.5 4.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.176 178.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.435 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -171.83 178.26 3.08 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.703 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.27 145.02 30.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.121 -0.945 . . . . 0.0 110.011 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.827 ' HA ' HG11 ' A' ' 160' ' ' VAL . 53.5 t -70.98 136.94 84.9 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.858 0.361 . . . . 0.0 110.533 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.43 ' HD2' HG13 ' A' ' 76' ' ' VAL . 12.2 Cg_endo -53.11 -68.08 0.08 OUTLIER 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.943 2.429 . . . . 0.0 111.831 179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.651 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -96.65 -173.36 2.72 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.692 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.52 ' CD1' ' HD3' ' A' ' 106' ' ' LYS . 31.9 m95 -89.3 -157.18 0.44 Allowed 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 179.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.637 ' HB2' ' O ' ' A' ' 105' ' ' GLN . 72.1 mt -162.7 101.49 1.03 Allowed 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.298 -0.631 . . . . 0.0 109.298 179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.7 HG22 ' HA ' ' A' ' 104' ' ' ALA . 5.4 p -104.24 -165.0 1.1 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.234 -178.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 3' ' ' LEU . 0.2 OUTLIER -168.33 70.66 0.09 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.564 179.583 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.512 ' HB3' ' OH ' ' A' ' 13' ' ' TYR . 1.0 OUTLIER -66.28 175.58 2.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.813 -179.236 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.843 ' CE1' HD12 ' A' ' 92' ' ' LEU . 0.3 OUTLIER -122.93 159.27 54.54 Favored Pre-proline 0 C--N 1.322 -0.615 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.214 -179.073 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.42 ' HD2' HG21 ' A' ' 88' ' ' VAL . 63.3 Cg_exo -50.22 176.61 0.03 OUTLIER 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.577 2.184 . . . . 0.0 111.205 178.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.41 ' HD2' ' HB3' ' A' ' 85' ' ' PRO . 54.4 Cg_endo -70.08 -44.83 1.65 Allowed 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 121.977 1.784 . . . . 0.0 112.968 -179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -71.92 -29.11 63.96 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.79 0.293 . . . . 0.0 111.79 -179.497 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.516 HG12 ' O ' ' A' ' 88' ' ' VAL . 61.8 t -67.78 -6.98 5.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.56 ' O ' HD13 ' A' ' 94' ' ' ILE . 3.4 mmm180 -64.09 0.62 0.88 Allowed 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -179.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.529 ' HA ' HD13 ' A' ' 94' ' ' ILE . 2.3 mt-10 -119.43 -16.75 8.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.903 0.382 . . . . 0.0 110.607 178.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.89 -26.69 16.06 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.036 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.843 HD12 ' CE1' ' A' ' 84' ' ' PHE . 1.8 tm? -117.2 -53.09 2.48 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.715 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.553 ' HB3' ' O ' ' A' ' 89' ' ' ARG . 14.6 t-20 -55.96 -51.26 68.32 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 120.858 0.361 . . . . 0.0 110.511 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.56 HD13 ' O ' ' A' ' 89' ' ' ARG . 1.7 mp -66.9 -14.27 17.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.436 179.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.491 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 8.2 tp-100 -70.2 -13.27 62.11 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.943 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -106.05 0.12 25.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.205 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 73.25 -75.64 0.96 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.119 -1.039 . . . . 0.0 110.974 -178.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.66 -165.27 0.11 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 178.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -94.74 107.83 19.84 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.93 179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.675 ' CZ3' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -114.87 -20.29 10.63 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.638 -0.256 . . . . 0.0 111.51 179.813 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.532 ' HA ' ' HZ ' ' A' ' 84' ' ' PHE . 0.7 OUTLIER 16.38 54.35 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.368 0 N-CA-C 113.937 1.088 . . . . 0.0 113.937 -178.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 100' ' ' TRP . . . 109.81 -174.3 17.65 Favored Glycine 0 C--N 1.334 0.419 0 C-N-CA 120.353 -0.927 . . . . 0.0 113.488 177.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.647 ' HG3' ' O ' ' A' ' 14' ' ' ARG . 12.7 tt0 -144.89 107.61 4.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.557 -0.322 . . . . 0.0 110.207 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.7 ' HA ' HG22 ' A' ' 81' ' ' THR . . . -90.42 116.95 28.75 Favored 'General case' 0 CA--C 1.511 -0.526 0 CA-C-O 121.204 0.526 . . . . 0.0 110.99 -179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.737 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 3.2 mt-30 -126.0 123.75 39.18 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.444 -0.798 . . . . 0.0 112.434 -178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.52 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 9.3 ttpt -102.93 138.63 39.57 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.346 -0.612 . . . . 0.0 109.346 177.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.487 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 31.3 m95 -103.36 162.68 12.8 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.918 0.711 . . . . 0.0 112.918 -177.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.402 ' CZ ' ' HB2' ' A' ' 53' ' ' PRO . 90.4 m-85 -139.74 155.55 47.27 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.881 179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.765 HD11 ' CG ' ' A' ' 22' ' ' MET . 39.4 tp -100.99 138.14 38.43 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 120.961 -0.295 . . . . 0.0 110.272 179.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.7 ' CZ ' HG22 ' A' ' 72' ' ' VAL . 23.8 m-85 -139.25 137.21 35.72 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.203 0.525 . . . . 0.0 112.155 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.544 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 10.2 ttmt -102.12 126.16 49.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.52 -0.764 . . . . 0.0 109.392 177.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.669 ' CE1' HG13 ' A' ' 67' ' ' VAL . 34.0 t80 -78.57 98.27 6.07 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.769 0.318 . . . . 0.0 110.999 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 8.0 p -97.86 50.4 1.03 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.419 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -152.64 -147.39 4.59 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.339 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 14.4 mt-30 -118.94 150.84 39.22 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.939 0.4 . . . . 0.0 110.885 179.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -59.77 -35.1 73.93 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.728 -179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -6.39 0.21 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.514 -0.767 . . . . 0.0 112.083 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.84 -14.52 34.19 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 120.743 0.306 . . . . 0.0 111.023 179.521 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.71 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 19.2 mt -78.98 100.37 3.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.029 0.442 . . . . 0.0 111.999 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.45 ' N ' ' O ' ' A' ' 65' ' ' THR . 2.2 t30 -104.16 98.73 8.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.752 179.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.689 ' CD2' HG22 ' A' ' 65' ' ' THR . 35.8 mt -69.84 -10.6 59.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.542 -0.299 . . . . 0.0 110.953 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.531 HD22 ' HB3' ' A' ' 129' ' ' PRO . 3.3 mm? -98.3 -174.01 2.72 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.875 0.369 . . . . 0.0 111.039 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 128.0 -7.61 6.81 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.726 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -101.83 73.67 1.43 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.937 0.399 . . . . 0.0 110.818 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -65.17 153.54 50.61 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.587 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 64.35 15.33 9.4 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 111.612 0.227 . . . . 0.0 111.612 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -149.03 -96.5 0.07 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 121.228 -0.189 . . . . 0.0 111.029 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 13.2 pttt -179.46 155.41 0.77 Allowed Pre-proline 0 C--O 1.232 0.157 0 CA-C-O 120.993 0.425 . . . . 0.0 111.069 179.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.531 ' HB3' HD22 ' A' ' 122' ' ' LEU . 9.6 Cg_endo -70.98 -174.34 1.12 Allowed 'Trans proline' 0 N--CA 1.457 -0.619 0 C-N-CA 122.639 2.226 . . . . 0.0 112.212 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.448 ' C ' HD12 ' A' ' 34' ' ' LEU . 15.7 mm-40 -97.05 -66.71 0.88 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.361 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.643 ' CE2' HG23 ' A' ' 65' ' ' THR . 4.8 m-85 -103.45 143.82 32.2 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.108 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.715 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -85.92 -36.16 10.52 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.388 -0.911 . . . . 0.0 111.985 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -151.37 141.42 22.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.965 0.412 . . . . 0.0 110.925 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.71 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 42.7 p-90 -128.94 166.68 18.67 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.073 179.33 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.433 ' N ' ' HZ3' ' A' ' 40' ' ' TRP . 27.3 t -161.02 179.11 8.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.769 -178.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.61 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 75.8 m95 -114.01 103.73 11.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.59 178.443 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 18.3 m -119.22 168.44 11.47 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.776 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.513 ' HB ' ' CD ' ' A' ' 139' ' ' PRO . 17.6 p -74.01 169.89 16.99 Favored Pre-proline 0 CA--C 1.516 -0.358 0 C-N-CA 120.102 -0.639 . . . . 0.0 109.491 178.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.693 ' HG3' HD11 ' A' ' 28' ' ' ILE . 16.6 Cg_exo -61.57 -53.53 2.23 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.781 1.654 . . . . 0.0 110.512 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.59 -27.72 69.14 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.782 178.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.434 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.2 OUTLIER -73.37 -44.29 58.93 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.486 179.743 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.476 HD11 ' O ' ' A' ' 41' ' ' GLN . 5.4 tp -58.94 -38.35 78.81 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.546 -0.539 . . . . 0.0 109.546 179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.801 HG21 ' HG2' ' A' ' 155' ' ' LYS . 12.2 mm -63.74 -37.09 78.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.53 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -69.53 -49.66 52.4 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.297 0.57 . . . . 0.0 110.201 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.411 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -73.92 -20.15 60.47 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.232 -0.895 . . . . 0.0 112.752 -179.286 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.624 HG23 ' HG2' ' A' ' 151' ' ' LYS . 12.7 t -76.2 173.11 11.77 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.514 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . . . . . . . . . 35.5 m -80.43 147.24 6.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.248 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.613 ' HA ' ' HE2' ' A' ' 151' ' ' LYS . 5.3 mt-10 -52.21 -47.65 65.52 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.249 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -52.08 -10.91 0.14 Allowed 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.47 ' HB3' ' CE1' ' A' ' 154' ' ' TYR . 21.1 mttt -135.72 -5.52 2.21 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 112.516 0.562 . . . . 0.0 112.516 -178.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.624 ' HG2' HG23 ' A' ' 146' ' ' THR . 7.2 mtmm -58.28 -61.32 7.77 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 121.278 -0.169 . . . . 0.0 111.154 179.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.541 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 35.3 Cg_endo -64.83 -26.36 59.85 Favored 'Trans proline' 0 C--N 1.348 0.527 0 C-N-CA 122.608 2.205 . . . . 0.0 111.738 179.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.726 ' O ' HG23 ' A' ' 157' ' ' VAL . 26.3 t -68.25 -50.78 54.55 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 178.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.487 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 7.5 m-30 -66.46 -38.33 87.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.734 178.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.801 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -58.13 -42.1 85.12 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.082 -0.963 . . . . 0.0 111.073 -179.894 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -70.26 -32.9 70.94 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 153' ' ' VAL . 84.0 t -67.13 -41.09 86.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 CA-C-N 115.197 -0.91 . . . . 0.0 109.728 178.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.566 HD22 ' HB3' ' A' ' 139' ' ' PRO . 44.8 mt -64.15 -39.26 93.63 Favored 'General case' 0 CA--C 1.52 -0.209 0 CA-C-O 120.93 0.395 . . . . 0.0 110.22 179.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 16.9 m -55.81 -41.1 73.69 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 109.11 -0.7 . . . . 0.0 109.11 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.827 HG11 ' HA ' ' A' ' 76' ' ' VAL . 95.5 t -66.81 -44.84 88.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 115.278 -0.874 . . . . 0.0 109.175 177.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.574 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 21.7 m-30 -80.79 5.09 16.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.886 -1.052 . . . . 0.0 112.575 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.636 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.17 -51.86 78.7 Favored Pre-proline 0 C--N 1.328 -0.328 0 C-N-CA 120.56 -0.456 . . . . 0.0 110.745 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.636 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 18.1 Cg_endo -58.71 -12.18 13.81 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.231 1.954 . . . . 0.0 111.961 178.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.435 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 89.2 m-70 -110.32 -20.95 12.45 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.252 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 89.3 mt . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.251 -0.88 . . . . 0.0 110.938 -179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.211 0 CA-C-O 120.217 -0.213 . . . . 0.0 112.654 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.52 ' O ' ' HB3' ' A' ' 82' ' ' TYR . 50.3 Cg_exo -54.05 168.6 0.83 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.68 2.253 . . . . 0.0 112.744 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.594 HD11 HG22 ' A' ' 153' ' ' VAL . 4.5 mm? -120.27 95.34 4.7 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.394 -179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -81.87 -43.76 8.1 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.197 -179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.774 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 1.4 m 62.82 -96.64 0.06 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 111.987 0.365 . . . . 0.0 111.987 -179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.413 ' H ' ' HB2' ' A' ' 5' ' ' SER . 12.6 mtm 64.22 135.09 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.526 0.203 . . . . 0.0 110.49 -179.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.561 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 29.7 t0 -64.45 -42.65 95.83 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.945 0.403 . . . . 0.0 110.728 -179.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.485 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 4.8 p -102.55 110.09 62.22 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 116.176 -0.465 . . . . 0.0 109.947 179.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.541 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 70.1 Cg_endo -76.21 103.7 1.79 Allowed 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.441 2.094 . . . . 0.0 112.688 -179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.579 ' HG2' ' CD2' ' A' ' 13' ' ' TYR . 6.6 Cg_endo -50.85 161.29 1.45 Allowed 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 123.547 2.831 . . . . 0.0 113.778 -179.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.21 161.55 3.15 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.236 179.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.76 ' O ' ' HA ' ' A' ' 100' ' ' TRP . . . 81.6 -20.63 7.27 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.73 -0.748 . . . . 0.0 113.241 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.579 ' CD2' ' HG2' ' A' ' 10' ' ' PRO . 11.7 m-85 -87.27 130.76 34.47 Favored 'General case' 0 C--N 1.321 -0.642 0 O-C-N 122.431 -0.452 . . . . 0.0 110.505 -179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.696 ' HB3' ' HG2' ' A' ' 103' ' ' GLN . 3.7 tpt180 -69.86 95.52 0.92 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.804 -178.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.58 ' HG3' ' CZ3' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -51.08 113.05 0.83 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.553 178.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.745 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 8.6 m120 -131.05 170.64 14.24 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.165 179.199 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.547 HG13 ' CG1' ' A' ' 47' ' ' ILE . 13.2 m -141.06 162.61 22.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.462 178.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.642 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -134.31 159.17 23.72 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.356 -0.926 . . . . 0.0 111.613 179.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.092 HG21 HD22 ' A' ' 61' ' ' LEU . 3.8 mp -128.41 119.02 49.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.776 ' O ' HD12 ' A' ' 109' ' ' LEU . 41.9 t -97.85 89.42 4.59 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 177.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.85 HD22 HG11 ' A' ' 67' ' ' VAL . 27.1 tp -90.4 115.6 27.7 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.497 -0.774 . . . . 0.0 111.448 -178.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.655 ' SD ' HD11 ' A' ' 109' ' ' LEU . 1.7 ptt? -118.28 166.1 13.03 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.058 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.61 ' ND2' ' HB2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -101.36 167.85 9.91 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.298 179.492 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -55.89 -4.06 0.1 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.578 178.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.594 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 1.7 m-20 -100.67 2.63 41.73 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -178.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.594 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER 76.38 20.13 1.57 Allowed 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.941 -178.374 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.61 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 2.1 mmtt -92.69 147.88 22.51 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.867 HD11 ' HG3' ' A' ' 139' ' ' PRO . 0.8 OUTLIER -101.0 138.82 23.94 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 N-CA-C 112.929 0.714 . . . . 0.0 112.929 -177.164 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.567 ' HZ ' HG21 ' A' ' 65' ' ' THR . 12.1 t80 -78.46 134.37 37.35 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.831 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.637 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -140.2 151.81 45.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.05 0.452 . . . . 0.0 111.224 -179.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.712 ' HB1' ' CB ' ' A' ' 131' ' ' PHE . . . -143.28 133.43 24.4 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.507 -0.769 . . . . 0.0 109.637 179.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 3.4 m -97.25 156.5 16.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.165 0.507 . . . . 0.0 112.002 -178.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.577 ' O ' ' N ' ' A' ' 35' ' ' ASP . 32.8 mtp85 -74.47 129.92 38.65 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.742 -179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.746 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 1.2 mp -57.3 54.9 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.221 0.608 . . . . 0.0 112.289 179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.577 ' N ' ' O ' ' A' ' 33' ' ' ARG . 9.9 p-10 -175.89 -33.72 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.062 0.458 . . . . 0.0 109.919 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.505 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 4.5 mt -117.51 103.05 51.53 Favored Pre-proline 0 N--CA 1.448 -0.549 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.475 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_exo -61.27 -47.34 12.34 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 123.014 2.476 . . . . 0.0 113.344 -178.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.83 -2.08 22.14 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 112.165 0.432 . . . . 0.0 112.165 -178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.506 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -95.55 95.63 8.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.852 0.358 . . . . 0.0 111.428 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.623 ' O ' ' HA ' ' A' ' 146' ' ' THR . 66.6 m95 -100.59 150.94 22.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.893 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.85 165.03 37.71 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.319 0.581 . . . . 0.0 111.52 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.438 ' HE2' ' HB2' ' A' ' 42' ' ' MET . 27.0 mtm -100.56 150.51 37.04 Favored Pre-proline 0 C--N 1.323 -0.568 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.111 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.528 ' CB ' HD13 ' A' ' 61' ' ' LEU . 4.8 Cg_endo -50.07 150.79 9.75 Favored 'Trans proline' 0 N--CA 1.461 -0.391 0 C-N-CA 122.236 1.957 . . . . 0.0 111.89 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.576 ' HA ' HD12 ' A' ' 19' ' ' ILE . 18.2 pt20 -175.58 177.56 1.74 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.606 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.401 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . 175.09 158.84 20.09 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.136 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.745 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -87.54 134.88 12.76 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.164 -1.017 . . . . 0.0 113.39 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.547 ' CG1' HG13 ' A' ' 17' ' ' VAL . 50.1 mt -68.25 148.23 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.058 0.456 . . . . 0.0 111.908 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 -69.98 -172.74 0.57 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.203 178.419 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -50.46 -77.08 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.141 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -112.51 56.22 0.48 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.58 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.484 ' O ' HG21 ' A' ' 47' ' ' ILE . 3.3 tp10 -114.25 149.31 36.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.75 0.31 . . . . 0.0 110.711 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -71.14 155.1 93.58 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.321 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.519 ' HA ' HG11 ' A' ' 17' ' ' VAL . 4.7 Cg_exo -74.92 -50.84 0.13 Allowed 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.758 2.305 . . . . 0.0 112.277 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.675 ' CZ ' HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -51.31 -46.56 62.59 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.364 -0.834 . . . . 0.0 110.731 179.877 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.773 ' HA ' HD12 ' A' ' 58' ' ' ILE . 52.5 m-80 -68.09 -40.33 82.67 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.104 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.59 -43.14 99.4 Favored 'General case' 0 CA--C 1.516 -0.345 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.671 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -57.02 -51.35 69.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.072 178.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.773 HD12 ' HA ' ' A' ' 55' ' ' ASN . 12.3 mt -56.38 -54.82 23.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.983 179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.53 -63.62 1.21 Allowed 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.289 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.401 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 0.4 OUTLIER -42.32 -46.56 4.62 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 121.039 0.447 . . . . 0.0 110.223 179.686 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.092 HD22 HG21 ' A' ' 19' ' ' ILE . 8.2 tp -52.34 -46.76 66.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.487 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.914 ' HG3' HG23 ' A' ' 68' ' ' THR . 23.0 ttm180 -64.22 -63.06 1.25 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.171 179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -49.78 -20.09 0.78 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -95.95 -40.52 9.24 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 113.234 0.827 . . . . 0.0 113.234 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.817 HG22 HD23 ' A' ' 121' ' ' LEU . 0.7 OUTLIER -126.34 -5.31 6.6 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.074 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 81.59 -11.71 44.44 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.214 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.85 HG11 HD22 ' A' ' 21' ' ' LEU . 71.7 t -57.81 114.73 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 121.155 0.503 . . . . 0.0 111.5 179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.914 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.6 OUTLIER -123.38 -39.06 2.49 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.33 178.126 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.418 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 5.9 m -62.67 73.32 0.02 OUTLIER 'General case' 0 C--N 1.334 -0.106 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.214 179.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.518 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -162.64 155.3 19.29 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.942 0.401 . . . . 0.0 111.75 -179.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.96 153.99 48.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.452 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.68 HG22 ' CZ ' ' A' ' 110' ' ' PHE . 43.4 t -76.55 131.78 34.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.336 0.588 . . . . 0.0 112.378 -179.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.695 ' N ' HD13 ' A' ' 73' ' ' ILE . 1.2 mm -103.91 -21.43 5.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-N 115.048 -0.978 . . . . 0.0 110.176 179.296 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.468 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -169.94 178.62 3.9 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.182 -179.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -146.3 140.59 26.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.037 179.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.726 ' HA ' HG11 ' A' ' 160' ' ' VAL . 48.3 t -70.37 138.33 86.57 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.978 0.418 . . . . 0.0 110.535 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.532 ' HD2' HG13 ' A' ' 76' ' ' VAL . 19.1 Cg_endo -58.92 -68.57 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.993 2.462 . . . . 0.0 112.477 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.561 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -96.67 -173.38 2.72 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.294 -0.866 . . . . 0.0 110.829 -179.405 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.58 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 44.0 m95 -93.72 -159.03 0.66 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.536 179.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.774 ' HA ' ' HA ' ' A' ' 5' ' ' SER . 41.0 mt -160.12 102.73 1.45 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.366 0.603 . . . . 0.0 111.131 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.904 HG22 ' HB2' ' A' ' 104' ' ' ALA . 24.4 p -107.17 -178.36 3.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.368 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.528 ' CE1' ' HB2' ' A' ' 103' ' ' GLN . 1.6 p90 -170.11 71.71 0.06 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.192 178.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -67.18 139.97 57.46 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 179.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.674 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 2.4 m-85 -103.58 162.03 21.24 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -178.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.433 ' HB3' ' HD2' ' A' ' 86' ' ' PRO . 26.7 Cg_exo -62.97 175.77 2.24 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.138 2.559 . . . . 0.0 112.119 179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.433 ' HD2' ' HB3' ' A' ' 85' ' ' PRO . 18.5 Cg_endo -59.71 -22.81 69.19 Favored 'Trans proline' 0 C--N 1.349 0.582 0 C-N-CA 122.502 2.135 . . . . 0.0 112.907 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 26.9 tptt -76.02 -47.78 23.49 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.915 0.388 . . . . 0.0 110.535 179.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.674 ' HB ' ' HB3' ' A' ' 84' ' ' PHE . 47.5 t -84.08 -17.83 10.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.038 179.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.662 ' HG3' ' HB3' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -66.0 -1.07 2.73 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -179.146 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.631 ' O ' ' HB ' ' A' ' 94' ' ' ILE . 0.3 OUTLIER -96.75 -44.81 6.92 Favored 'General case' 0 C--N 1.332 -0.187 0 O-C-N 121.891 -0.506 . . . . 0.0 110.674 179.111 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 12.9 mmtm -83.61 -0.63 51.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.673 179.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.562 ' HG ' ' CE1' ' A' ' 84' ' ' PHE . 1.2 tm? -121.38 -65.85 1.1 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.669 -179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.662 ' HB3' ' HG3' ' A' ' 89' ' ' ARG . 5.3 t-20 -61.45 -54.3 45.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.013 0.435 . . . . 0.0 111.18 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.631 ' HB ' ' O ' ' A' ' 90' ' ' GLU . 1.7 mp -57.7 -14.17 2.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.235 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.502 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 49.0 mm-40 -74.25 -15.73 60.98 Favored 'General case' 0 C--O 1.231 0.085 0 CA-C-O 120.855 0.36 . . . . 0.0 110.669 178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.556 ' HB2' ' CG ' ' A' ' 100' ' ' TRP . 6.2 m95 -103.43 -92.97 0.34 Allowed 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.403 179.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.458 ' C ' ' HD1' ' A' ' 100' ' ' TRP . . . 171.13 -127.81 1.51 Allowed Glycine 0 C--N 1.339 0.703 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.629 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.466 ' O ' ' CD1' ' A' ' 100' ' ' TRP . 2.9 p -75.05 148.44 39.8 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.032 0.382 . . . . 0.0 112.032 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 69.03 -39.92 0.44 Allowed 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 178.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.76 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 78.9 m95 -44.72 172.7 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.613 ' HB3' ' O ' ' A' ' 100' ' ' TRP . 1.4 pttt 163.0 0.53 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.82 -179.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 177.82 -159.37 25.12 Favored Glycine 0 C--N 1.334 0.425 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.912 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.696 ' HG2' ' HB3' ' A' ' 14' ' ' ARG . 35.1 mt-30 -147.08 111.03 5.04 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.892 0.346 . . . . 0.0 111.397 179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.904 ' HB2' HG22 ' A' ' 81' ' ' THR . . . -92.26 125.42 36.92 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 120.871 0.367 . . . . 0.0 110.835 179.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.633 ' HB3' ' HB2' ' A' ' 16' ' ' ASN . 0.0 OUTLIER -133.66 128.53 35.25 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -178.845 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.478 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 5.3 ttpp -102.32 132.39 48.32 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 177.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.642 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 19.5 m95 -104.93 160.86 14.68 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -177.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.481 ' HB2' ' HE1' ' A' ' 110' ' ' PHE . 91.4 m-85 -137.99 154.37 49.35 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 114.717 -1.129 . . . . 0.0 109.667 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.776 HD12 ' O ' ' A' ' 20' ' ' CYS . 32.5 tp -97.65 141.69 30.36 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 179.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.708 ' CD1' HG23 ' A' ' 19' ' ' ILE . 23.3 m-85 -139.15 138.21 36.79 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.292 0.567 . . . . 0.0 112.116 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.563 ' HB2' HD11 ' A' ' 73' ' ' ILE . 1.4 ttpt -103.59 128.31 50.88 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.437 177.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.563 ' HD1' HD21 ' A' ' 21' ' ' LEU . 36.9 t80 -78.1 102.82 7.68 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.818 0.342 . . . . 0.0 111.008 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 49.2 p -100.47 47.65 0.93 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.009 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.418 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -152.73 -146.08 4.28 Favored Glycine 0 N--CA 1.453 -0.185 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.485 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -117.89 146.77 43.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.885 0.374 . . . . 0.0 110.814 179.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -59.51 -32.36 70.22 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.705 -179.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 44.9 mt-30 -59.29 -4.48 0.56 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.907 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -90.15 -15.63 31.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.619 0.247 . . . . 0.0 110.951 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.747 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 17.6 mt -76.11 99.67 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 120.912 0.386 . . . . 0.0 111.541 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.402 ' N ' ' O ' ' A' ' 65' ' ' THR . 1.5 m120 -106.16 95.95 6.13 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.687 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.817 HD23 HG22 ' A' ' 65' ' ' THR . 11.2 mt -70.47 -5.44 28.67 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 121.098 -0.241 . . . . 0.0 110.838 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.45 ' CD2' ' HG3' ' A' ' 129' ' ' PRO . 1.9 mt -128.46 12.42 6.44 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.286 -179.653 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -57.26 -120.19 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 121.19 -0.529 . . . . 0.0 113.226 -179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -95.17 138.39 32.95 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.911 0.386 . . . . 0.0 111.28 -179.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -176.75 -116.43 0.47 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.987 -0.625 . . . . 0.0 112.173 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -119.76 -68.67 0.89 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.923 0.392 . . . . 0.0 110.336 179.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -147.51 -82.26 0.13 Allowed 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.064 179.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 12.7 pttm -78.91 155.9 77.5 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.187 0.517 . . . . 0.0 110.931 178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.45 ' HG3' ' CD2' ' A' ' 122' ' ' LEU . 61.1 Cg_endo -76.47 179.25 6.59 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 123.028 2.486 . . . . 0.0 112.594 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -106.98 -39.89 5.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.891 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.712 ' CB ' ' HB1' ' A' ' 31' ' ' ALA . 3.4 m-85 -120.02 138.63 53.39 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.217 0.532 . . . . 0.0 109.898 179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.746 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -83.26 -36.45 14.68 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.026 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -149.03 144.43 26.71 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.948 0.404 . . . . 0.0 110.615 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.747 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 33.4 p-90 -129.63 163.73 25.42 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.455 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.417 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 34.9 t -163.38 176.59 9.68 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.914 -179.183 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.589 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 28.5 m95 -111.76 103.42 11.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.317 178.138 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.557 ' O ' ' N ' ' A' ' 28' ' ' ILE . 24.2 m -118.39 166.26 12.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.565 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 14.5 p -71.82 171.49 9.15 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.331 -0.548 . . . . 0.0 110.216 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.867 ' HG3' HD11 ' A' ' 28' ' ' ILE . 13.4 Cg_exo -63.14 -54.18 1.21 Allowed 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 121.83 1.687 . . . . 0.0 109.87 179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -64.29 -28.35 69.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.911 178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.431 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.4 OUTLIER -73.14 -45.75 54.93 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.393 179.745 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.637 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -58.44 -39.45 79.88 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.57 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 139' ' ' PRO . 27.3 mm -61.99 -33.76 59.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.132 0.491 . . . . 0.0 110.032 179.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.03 -53.17 11.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.379 0.609 . . . . 0.0 110.818 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.1 mp -72.56 -19.38 61.51 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.72 -179.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.623 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 11.7 t -74.19 177.72 5.59 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.4 -179.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.752 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 20.9 m -84.46 151.03 3.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.767 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.458 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 10.6 mt-10 -55.26 -54.75 39.52 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.486 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.752 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 44.3 p90 -55.93 -2.1 0.05 Allowed 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -179.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.422 ' HG3' ' CE2' ' A' ' 149' ' ' PHE . 29.6 mttm -133.42 -8.06 2.91 Favored 'General case' 0 N--CA 1.466 0.354 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.502 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 0.4 OUTLIER -61.35 -56.45 33.7 Favored Pre-proline 0 C--N 1.329 -0.322 0 C-N-CA 121.49 -0.084 . . . . 0.0 111.196 -179.765 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.502 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 22.7 Cg_endo -62.48 -28.94 78.23 Favored 'Trans proline' 0 C--N 1.347 0.478 0 C-N-CA 122.163 1.909 . . . . 0.0 111.591 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.804 ' O ' HG23 ' A' ' 157' ' ' VAL . 31.2 t -67.16 -51.63 51.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.43 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.472 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 6.9 m-30 -66.19 -39.37 89.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.965 178.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.544 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -56.29 -42.43 77.54 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.684 179.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.446 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.7 OUTLIER -69.07 -33.32 73.37 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.167 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.804 HG23 ' O ' ' A' ' 153' ' ' VAL . 48.8 t -67.5 -40.61 84.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.43 178.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.707 HD22 ' HB3' ' A' ' 139' ' ' PRO . 36.9 mt -63.44 -47.1 83.26 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.247 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.8 t -50.72 -42.86 57.68 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.536 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.726 HG11 ' HA ' ' A' ' 76' ' ' VAL . 79.5 t -65.74 -41.65 90.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 178.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.548 ' CE2' HG12 ' A' ' 157' ' ' VAL . 18.3 m-30 -80.84 5.19 16.76 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.597 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.616 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.63 -52.77 71.66 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.549 -0.46 . . . . 0.0 110.6 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.0 Cg_endo -58.18 -12.4 12.88 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.112 1.874 . . . . 0.0 111.876 178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.468 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 95.0 m-70 -108.5 -20.23 13.18 Favored 'General case' 0 C--N 1.333 -0.134 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.333 -179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 95.4 mt . . . . . 0 C--O 1.25 1.095 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.105 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 112.343 -0.303 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.607 ' C ' HD12 ' A' ' 3' ' ' LEU . 73.5 Cg_exo -50.31 134.19 37.63 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.556 2.171 . . . . 0.0 111.996 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.607 HD12 ' C ' ' A' ' 2' ' ' PRO . 0.3 OUTLIER 57.99 -172.18 0.1 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.253 -179.052 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.636 ' HA3' ' HE2' ' A' ' 6' ' ' MET . . . -134.1 -4.28 2.98 Favored Glycine 0 CA--C 1.519 0.338 0 C-N-CA 120.489 -0.862 . . . . 0.0 113.17 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.91 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 88.5 p 55.99 -92.07 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.636 ' HE2' ' HA3' ' A' ' 4' ' ' GLY . 2.8 mtm 70.09 128.54 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.674 0.273 . . . . 0.0 110.605 -179.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.672 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 9.2 t0 -67.0 -31.74 72.5 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.004 0.43 . . . . 0.0 110.812 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 1.7 m -102.22 145.24 30.15 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.242 179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.47 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 57.5 Cg_endo -71.02 106.3 1.86 Allowed 'Trans proline' 0 N--CA 1.463 -0.307 0 C-N-CA 122.116 1.877 . . . . 0.0 111.556 179.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.83 ' CG ' HG21 ' A' ' 81' ' ' THR . 6.9 Cg_endo -48.58 166.07 0.15 Allowed 'Trans proline' 0 N--CA 1.463 -0.266 0 C-N-CA 123.025 2.483 . . . . 0.0 112.392 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 29.2 mm-40 -50.7 121.36 5.75 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.969 -0.559 . . . . 0.0 111.71 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.581 ' HA3' ' HA ' ' A' ' 100' ' ' TRP . . . 50.95 103.51 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 CA-C-N 115.764 -0.653 . . . . 0.0 113.676 179.003 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.604 ' CE2' ' HG3' ' A' ' 101' ' ' LYS . 9.5 m-85 -158.24 142.21 15.64 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.48 0.181 . . . . 0.0 110.84 179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.516 ' HD2' ' CH2' ' A' ' 96' ' ' TRP . 17.5 ttt-85 -70.91 86.76 0.71 Allowed 'General case' 0 C--N 1.333 -0.124 0 CA-C-O 120.802 0.334 . . . . 0.0 111.604 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.547 ' HG2' HD13 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -50.49 109.44 0.31 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.275 0.56 . . . . 0.0 110.322 179.035 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.706 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 3.4 m120 -132.6 173.99 10.75 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.405 179.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.693 HG12 HD11 ' A' ' 47' ' ' ILE . 2.1 m -140.63 166.73 18.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 121.409 0.623 . . . . 0.0 111.831 179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.672 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -133.33 155.08 21.52 Favored Glycine 0 N--CA 1.442 -0.929 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.252 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.691 HG13 ' HB1' ' A' ' 57' ' ' ALA . 3.4 mp -126.88 119.17 52.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 120.986 0.422 . . . . 0.0 111.956 -179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.492 ' O ' ' N ' ' A' ' 110' ' ' PHE . 45.4 t -101.79 102.41 13.03 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.963 HD22 HG11 ' A' ' 67' ' ' VAL . 15.5 tp -105.39 118.87 37.65 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.282 -0.417 . . . . 0.0 112.108 -178.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.635 ' HE2' HD13 ' A' ' 73' ' ' ILE . 1.2 ptm -119.75 161.61 20.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.83 179.376 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.498 ' OD1' ' CE3' ' A' ' 136' ' ' TRP . 0.2 OUTLIER -95.77 169.96 9.65 Favored 'General case' 0 N--CA 1.454 -0.269 0 CA-C-O 120.962 0.411 . . . . 0.0 110.155 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -56.62 -5.0 0.18 Allowed 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.736 -0.665 . . . . 0.0 111.054 177.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.552 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 4.7 m-20 -98.87 2.93 47.1 Favored 'General case' 0 CA--C 1.522 -0.12 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.552 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.4 OUTLIER 75.76 19.45 1.98 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.942 -178.538 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.566 ' O ' ' HA ' ' A' ' 22' ' ' MET . 1.1 mmtt -94.46 140.8 29.35 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.672 HD13 ' N ' ' A' ' 139' ' ' PRO . 3.0 mp -102.4 145.57 11.79 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.681 0.753 . . . . 0.0 112.218 -178.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.576 ' CE1' HD13 ' A' ' 119' ' ' ILE . 83.8 t80 -76.89 137.31 39.06 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.463 -1.244 . . . . 0.0 110.914 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.984 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -140.45 148.64 41.47 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 110.145 -0.316 . . . . 0.0 110.145 179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.543 ' HB1' ' CB ' ' A' ' 131' ' ' PHE . . . -138.58 136.82 36.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.841 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.751 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 91.5 p -97.15 143.33 28.07 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.946 -179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.774 ' HE ' HD12 ' A' ' 36' ' ' ILE . 21.9 mtp85 -68.95 127.48 33.27 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.738 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.73 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.7 OUTLIER -43.78 -35.31 1.84 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.304 0.573 . . . . 0.0 110.835 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -72.71 -40.09 66.44 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.007 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.774 HD12 ' HE ' ' A' ' 33' ' ' ARG . 8.7 mt -125.31 104.76 28.48 Favored Pre-proline 0 N--CA 1.455 -0.175 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.738 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -66.75 -20.2 52.64 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.738 2.292 . . . . 0.0 112.871 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.48 -6.59 54.65 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.706 0.288 . . . . 0.0 111.496 -179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.751 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.56 93.27 8.45 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.123 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.664 ' O ' ' HA ' ' A' ' 146' ' ' THR . 78.1 m95 -90.89 144.93 25.18 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.543 179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.428 ' HA ' ' HE2' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -158.73 162.6 37.15 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.184 0.516 . . . . 0.0 111.232 -179.853 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.508 ' HE2' ' HB2' ' A' ' 42' ' ' MET . 1.8 mtm -98.08 152.05 37.84 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.892 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.415 ' HG2' ' O ' ' A' ' 19' ' ' ILE . 1.5 Cg_endo -46.96 144.86 7.8 Favored 'Trans proline' 0 N--CA 1.461 -0.42 0 C-N-CA 122.239 1.96 . . . . 0.0 111.873 179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.424 ' HG3' ' O ' ' A' ' 17' ' ' VAL . 12.5 tt0 -172.68 146.4 1.65 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.578 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.416 ' HA3' ' HG3' ' A' ' 60' ' ' GLU . . . -157.32 -167.02 17.79 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.9 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.706 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -117.85 137.68 13.37 Favored Glycine 0 C--N 1.331 0.273 0 C-N-CA 120.133 -1.032 . . . . 0.0 113.655 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.693 HD11 HG12 ' A' ' 17' ' ' VAL . 3.3 mt -70.52 148.78 10.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.356 -0.422 . . . . 0.0 111.735 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -68.61 -173.8 0.49 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.372 178.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -49.11 -78.62 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.178 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -111.93 57.13 0.44 Allowed Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.601 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.485 ' O ' HG21 ' A' ' 47' ' ' ILE . 7.4 tp10 -117.4 153.86 32.34 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.946 0.403 . . . . 0.0 110.871 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.86 161.61 77.79 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.486 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.541 ' HA ' HG12 ' A' ' 47' ' ' ILE . 7.3 Cg_exo -74.21 -47.87 0.23 Allowed 'Trans proline' 0 CA--C 1.514 -0.517 0 C-N-CA 122.857 2.371 . . . . 0.0 111.226 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.777 HH11 HG13 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -51.98 -44.03 63.86 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.802 -1.09 . . . . 0.0 111.213 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 91.4 m-20 -68.09 -42.13 80.8 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 120.946 0.403 . . . . 0.0 110.402 178.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.434 ' HA ' ' HG2' ' A' ' 59' ' ' ARG . . . -60.49 -44.46 95.93 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.691 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -57.96 -53.7 55.21 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.388 178.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.777 HG13 HH11 ' A' ' 54' ' ' ARG . 57.4 mt -53.27 -52.82 27.61 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.265 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.526 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.455 ' HG3' ' N ' ' A' ' 60' ' ' GLU . 9.2 ptm180 -63.43 -56.57 15.13 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.824 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.455 ' N ' ' HG3' ' A' ' 59' ' ' ARG . 29.2 mm-40 -50.99 -48.45 61.32 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.063 0.459 . . . . 0.0 110.054 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.568 HD21 HG12 ' A' ' 67' ' ' VAL . 14.1 tp -51.01 -48.5 61.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.393 179.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.937 ' HG2' HG23 ' A' ' 68' ' ' THR . 1.0 OUTLIER -66.77 -63.29 1.1 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 121.328 0.585 . . . . 0.0 110.721 179.304 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -50.67 -22.36 2.02 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.724 -0.671 . . . . 0.0 112.088 -179.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -99.74 -38.06 8.84 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.617 HG22 HD23 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -127.22 -13.6 5.56 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -178.858 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.501 ' HA2' ' HD2' ' A' ' 62' ' ' ARG . . . 85.4 -13.42 55.38 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.254 -0.974 . . . . 0.0 111.76 -179.019 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.963 HG11 HD22 ' A' ' 21' ' ' LEU . 27.3 t -57.31 106.02 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 121.236 0.541 . . . . 0.0 111.135 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.937 HG23 ' HG2' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -121.18 -39.86 2.65 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.219 178.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.0 m -62.68 73.43 0.02 OUTLIER 'General case' 0 C--O 1.233 0.188 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.064 178.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -164.0 159.1 20.33 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.674 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -129.45 152.18 49.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.873 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.509 HG22 ' CE1' ' A' ' 110' ' ' PHE . 19.9 t -75.14 127.7 36.81 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.056 0.455 . . . . 0.0 111.076 179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.635 HD13 ' HE2' ' A' ' 22' ' ' MET . 2.3 mt -108.1 -19.12 6.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.902 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.473 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.09 176.24 4.72 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.204 -179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.595 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.1 pm0 -154.39 145.26 22.56 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.745 -0.662 . . . . 0.0 110.453 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.776 ' HA ' HG11 ' A' ' 160' ' ' VAL . 53.5 t -71.25 138.32 84.28 Favored Pre-proline 0 C--N 1.329 -0.286 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.927 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.622 ' HD2' HG13 ' A' ' 76' ' ' VAL . 21.3 Cg_endo -61.82 -55.34 1.13 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.814 2.342 . . . . 0.0 112.696 -179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.672 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 1.2 p90 -102.17 -178.64 3.76 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.491 -179.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.56 ' CD1' ' HD3' ' A' ' 106' ' ' LYS . 39.3 m95 -93.54 -157.56 0.55 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.474 -0.785 . . . . 0.0 110.392 179.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.91 ' HA ' ' HA ' ' A' ' 5' ' ' SER . 55.7 mt -161.7 100.84 1.16 Allowed 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 179.614 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.83 HG21 ' CG ' ' A' ' 10' ' ' PRO . 0.8 OUTLIER -106.82 122.92 47.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.157 -177.666 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.416 ' OH ' HG11 ' A' ' 153' ' ' VAL . 20.9 m-85 -78.75 -166.49 0.89 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.942 178.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -176.39 145.23 0.57 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.676 0.274 . . . . 0.0 110.549 179.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.571 ' HB2' HD12 ' A' ' 92' ' ' LEU . 4.1 m-85 -96.64 166.72 13.51 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-O 120.762 0.315 . . . . 0.0 111.366 -179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.433 ' HD2' ' HB ' ' A' ' 88' ' ' VAL . 19.9 Cg_exo -65.6 177.07 2.99 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.631 2.221 . . . . 0.0 111.95 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.416 ' HD2' ' CB ' ' A' ' 85' ' ' PRO . 56.4 Cg_endo -70.04 -23.27 29.71 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.351 2.034 . . . . 0.0 112.312 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 5.0 mttm -84.64 -61.5 1.77 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.247 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.433 ' HB ' ' HD2' ' A' ' 85' ' ' PRO . 11.3 t -63.9 -12.53 11.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 CA-C-O 120.766 0.317 . . . . 0.0 111.35 179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.608 ' HD2' ' CB ' ' A' ' 93' ' ' ASN . 0.1 OUTLIER -59.66 -2.62 0.38 Allowed 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.458 179.58 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.553 ' HA ' HD13 ' A' ' 94' ' ' ILE . 1.4 mm-40 -106.76 -21.74 12.94 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.652 0.263 . . . . 0.0 111.03 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.55 -15.14 17.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.876 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.741 HD13 ' N ' ' A' ' 93' ' ' ASN . 0.3 OUTLIER -116.0 -56.12 2.35 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.312 -179.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.741 ' N ' HD13 ' A' ' 92' ' ' LEU . 0.9 OUTLIER -59.88 -54.18 49.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.355 0.598 . . . . 0.0 110.863 179.42 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.553 HD13 ' HA ' ' A' ' 90' ' ' GLU . 1.7 mp -68.43 -12.85 16.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.321 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.472 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 0.5 OUTLIER -69.8 -14.83 62.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.334 179.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.608 ' HB2' ' HB2' ' A' ' 100' ' ' TRP . 28.8 m95 -95.95 20.16 10.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.634 -179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.07 -71.75 2.91 Favored Glycine 0 CA--C 1.518 0.278 0 C-N-CA 120.67 -0.776 . . . . 0.0 113.114 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.421 ' O ' ' CG ' ' A' ' 99' ' ' ASP . 53.0 p -176.98 159.88 1.74 Allowed 'General case' 0 C--N 1.329 -0.296 0 O-C-N 122.813 -0.227 . . . . 0.0 110.579 -179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.421 ' CG ' ' O ' ' A' ' 98' ' ' SER . 0.0 OUTLIER 80.62 -39.18 0.16 Allowed 'General case' 0 N--CA 1.468 0.468 0 O-C-N 123.365 0.416 . . . . 0.0 111.729 179.639 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.608 ' HB2' ' HB2' ' A' ' 96' ' ' TRP . 14.8 m95 -58.4 -171.13 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.306 -179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.676 ' HA ' ' OD1' ' A' ' 93' ' ' ASN . 0.6 OUTLIER 166.59 12.57 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 N-CA-C 112.517 0.562 . . . . 0.0 112.517 -179.771 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.444 ' HA3' ' CE1' ' A' ' 13' ' ' TYR . . . 161.37 -148.82 17.01 Favored Glycine 0 CA--C 1.52 0.366 0 C-N-CA 120.754 -0.736 . . . . 0.0 111.822 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.745 ' O ' ' HA ' ' A' ' 81' ' ' THR . 72.7 mt-30 -146.17 117.69 8.01 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 117.021 0.41 . . . . 0.0 111.516 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.523 ' CB ' HG22 ' A' ' 81' ' ' THR . . . -91.49 126.95 36.74 Favored 'General case' 0 CA--C 1.52 -0.176 0 CA-C-O 120.874 0.369 . . . . 0.0 110.177 179.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.647 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 23.9 mt-30 -136.45 124.06 22.31 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.794 0.664 . . . . 0.0 112.794 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.56 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 14.4 ttpp -104.76 140.36 38.2 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.165 178.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.672 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 19.4 m95 -110.11 160.23 16.65 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.701 ' HB2' HH21 ' A' ' 54' ' ' ARG . 19.0 m-85 -139.07 160.12 40.53 Favored 'General case' 0 N--CA 1.463 0.187 0 CA-C-N 115.337 -0.847 . . . . 0.0 110.125 178.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.61 HD11 ' SD ' ' A' ' 22' ' ' MET . 11.7 tp -98.44 142.52 29.96 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.675 -0.239 . . . . 0.0 110.622 178.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.531 ' HZ ' ' NH1' ' A' ' 54' ' ' ARG . 5.7 m-85 -135.36 145.71 47.65 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 -178.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.541 ' CA ' HD11 ' A' ' 73' ' ' ILE . 1.8 tttt -106.31 117.16 33.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 114.877 -1.056 . . . . 0.0 108.854 177.004 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.665 ' HB2' HD11 ' A' ' 21' ' ' LEU . 55.1 t80 -78.03 101.29 6.86 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.661 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 14.1 p -97.58 40.43 1.16 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.406 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.402 ' C ' ' CE2' ' A' ' 112' ' ' PHE . . . -140.64 -148.36 5.11 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.805 -179.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -123.64 152.03 42.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.702 0.287 . . . . 0.0 111.129 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.444 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 11.6 p-10 -58.31 -39.16 78.63 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.418 0.627 . . . . 0.0 111.204 -179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -58.2 -3.72 0.28 Allowed 'General case' 0 C--N 1.317 -0.812 0 CA-C-N 114.868 -1.06 . . . . 0.0 112.335 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -89.29 -17.34 29.15 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.092 0.473 . . . . 0.0 110.432 179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.587 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 9.4 mt -88.74 106.84 17.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.462 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.47 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 27.3 t30 -100.09 -20.31 16.08 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.167 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.617 HD23 HG22 ' A' ' 65' ' ' THR . 66.8 mt 75.95 -31.14 0.19 Allowed 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.089 -179.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.513 HD11 ' HD3' ' A' ' 129' ' ' PRO . 4.3 mm? -76.78 177.28 7.74 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.83 0.348 . . . . 0.0 111.156 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 117.99 125.68 3.57 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.736 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 46.89 96.01 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.838 0.351 . . . . 0.0 111.46 179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -150.84 155.5 26.19 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.555 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 61.3 m -90.91 -21.44 21.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.55 0.214 . . . . 0.0 111.091 -179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.508 ' C ' ' HG3' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -149.63 -50.07 0.14 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.398 -179.552 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.769 ' HB3' ' HD2' ' A' ' 129' ' ' PRO . 25.0 mtpt -157.92 165.96 17.55 Favored Pre-proline 0 C--N 1.332 -0.186 0 CA-C-O 121.183 0.516 . . . . 0.0 111.246 -178.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.769 ' HD2' ' HB3' ' A' ' 128' ' ' LYS . 6.2 Cg_endo -53.02 -174.0 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 123.195 2.597 . . . . 0.0 112.758 -179.094 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -106.06 -48.44 3.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.363 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.543 ' CB ' ' HB1' ' A' ' 31' ' ' ALA . 1.4 m-85 -109.74 140.71 43.31 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.987 179.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.73 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -89.98 -32.12 10.25 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.511 -0.852 . . . . 0.0 112.12 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.95 152.25 34.67 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.885 0.374 . . . . 0.0 110.363 179.521 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.587 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 37.3 p-90 -137.76 167.62 21.34 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.009 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.468 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 30.5 t -162.42 175.58 11.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.481 0.657 . . . . 0.0 112.168 -178.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.498 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 35.6 m95 -111.25 105.65 14.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.105 178.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 25.2 m -120.93 170.1 11.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 110.152 -0.314 . . . . 0.0 110.152 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.6 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 18.4 p -73.01 172.0 9.01 Favored Pre-proline 0 CA--C 1.518 -0.284 0 C-N-CA 120.478 -0.489 . . . . 0.0 109.971 178.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.672 ' N ' HD13 ' A' ' 28' ' ' ILE . 11.4 Cg_exo -62.81 -55.85 0.74 Allowed 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 121.579 1.519 . . . . 0.0 110.286 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -64.23 -25.14 67.93 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.034 -0.985 . . . . 0.0 110.351 178.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.431 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 1.8 mm-40 -72.96 -47.63 43.7 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.483 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.984 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -57.79 -39.38 77.4 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 109.848 -179.812 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.636 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 6.2 mm -62.82 -37.74 79.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.316 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.51 -48.99 58.78 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.312 0.577 . . . . 0.0 110.488 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.3 mp -75.0 -20.19 59.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.137 -0.938 . . . . 0.0 113.115 -179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.664 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 14.1 t -74.92 178.58 5.46 Favored 'General case' 0 C--N 1.328 -0.326 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.787 -178.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.684 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 27.7 m -82.89 148.62 5.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.115 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.502 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 45.4 mt-10 -55.1 -53.06 60.68 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.441 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.684 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 51.1 p90 -56.66 -2.22 0.07 Allowed 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.443 ' HG3' ' CE2' ' A' ' 149' ' ' PHE . 21.5 mttt -134.76 -7.6 2.43 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' A' ' 143' ' ' ILE . 7.6 mtmm -58.88 -60.02 11.86 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.56 0.219 . . . . 0.0 111.095 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.502 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 31.8 Cg_endo -62.89 -26.78 74.51 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 122.397 2.064 . . . . 0.0 111.631 179.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.644 ' O ' HG23 ' A' ' 157' ' ' VAL . 26.0 t -68.85 -50.99 49.5 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.371 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.428 ' HE2' ' HA ' ' A' ' 41' ' ' GLN . 12.6 m-30 -65.76 -37.3 85.97 Favored 'General case' 0 N--CA 1.449 -0.484 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.532 178.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.621 ' HE2' ' HA ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -57.68 -40.69 80.0 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.986 179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.549 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.3 OUTLIER -68.11 -32.55 72.93 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 178.83 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 153' ' ' VAL . 48.6 t -66.64 -42.07 89.18 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.743 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.007 178.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.584 HD12 ' HE2' ' A' ' 155' ' ' LYS . 34.7 mt -64.36 -47.56 78.83 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.58 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 2.9 p -50.01 -40.63 45.13 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 179.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.776 HG11 ' HA ' ' A' ' 76' ' ' VAL . 57.7 t -68.1 -41.37 84.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 CA-C-N 115.441 -0.799 . . . . 0.0 109.35 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.601 ' CE2' HG12 ' A' ' 157' ' ' VAL . 21.0 m-30 -80.87 4.26 19.87 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.402 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.618 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.48 -51.5 81.35 Favored Pre-proline 0 C--N 1.331 -0.22 0 C-N-CA 120.676 -0.41 . . . . 0.0 110.776 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.8 Cg_endo -58.63 -12.67 14.93 Favored 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.064 1.843 . . . . 0.0 111.818 178.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.473 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 89.4 m-70 -108.76 -18.51 13.69 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.253 -179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 85.8 mt . . . . . 0 C--O 1.248 0.983 0 CA-C-O 118.331 -0.842 . . . . 0.0 110.678 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 CA-C-O 120.192 -0.227 . . . . 0.0 112.648 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.16 166.63 1.54 Allowed 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.603 2.202 . . . . 0.0 112.827 -179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.721 HD21 HG22 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -80.01 134.88 36.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.081 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.43 ' O ' ' OG ' ' A' ' 5' ' ' SER . . . -94.68 -15.63 45.56 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.415 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.597 ' HA ' ' O ' ' A' ' 79' ' ' TRP . 3.6 p 58.43 -87.45 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 112.133 0.42 . . . . 0.0 112.133 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.422 ' H ' ' HG ' ' A' ' 5' ' ' SER . 9.2 mtm 67.53 137.84 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.853 0.359 . . . . 0.0 111.116 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.765 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 17.3 t0 -66.97 -39.85 87.31 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.416 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 38.8 m -98.11 138.82 20.95 Favored Pre-proline 0 C--N 1.325 -0.486 0 C-N-CA 121.067 -0.253 . . . . 0.0 110.35 179.257 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.426 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 74.4 Cg_endo -75.46 107.5 2.49 Favored 'Trans proline' 0 C--O 1.234 0.299 0 C-N-CA 122.156 1.904 . . . . 0.0 112.236 -179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.52 ' HG2' ' CD1' ' A' ' 13' ' ' TYR . 4.9 Cg_endo -48.27 165.21 0.16 Allowed 'Trans proline' 0 N--CA 1.463 -0.303 0 C-N-CA 123.315 2.677 . . . . 0.0 112.794 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -51.1 129.7 24.6 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.412 179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 54.31 85.99 0.02 OUTLIER Glycine 0 CA--C 1.517 0.192 0 C-N-CA 120.833 -0.699 . . . . 0.0 112.797 179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.52 ' CD1' ' HG2' ' A' ' 10' ' ' PRO . 9.8 m-85 -152.34 152.28 31.9 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-O 120.977 0.417 . . . . 0.0 111.588 -179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.842 ' HG3' ' H ' ' A' ' 15' ' ' ARG . 9.7 tpt180 -63.93 -154.58 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.697 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.842 ' H ' ' HG3' ' A' ' 14' ' ' ARG . 1.5 ttt180 176.64 96.38 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 122.881 0.472 . . . . 0.0 109.863 -179.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.646 ' HA ' ' H ' ' A' ' 47' ' ' ILE . 1.5 m120 -129.84 173.19 10.9 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.713 HG13 HD11 ' A' ' 47' ' ' ILE . 30.2 m -134.33 165.53 31.29 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-O 121.736 0.779 . . . . 0.0 111.683 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.825 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -131.42 158.2 22.65 Favored Glycine 0 N--CA 1.433 -1.539 0 CA-C-N 114.56 -1.2 . . . . 0.0 110.502 178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.992 HG21 HD22 ' A' ' 61' ' ' LEU . 3.4 mp -123.27 117.95 53.1 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-O 121.496 0.665 . . . . 0.0 111.976 -178.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.538 ' O ' HD12 ' A' ' 109' ' ' LEU . 37.6 t -104.43 103.74 13.5 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.204 -1.036 . . . . 0.0 108.204 178.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.879 HD22 HG11 ' A' ' 67' ' ' VAL . 30.8 tp -104.47 122.96 46.62 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.893 -177.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.739 ' HB3' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -113.64 137.58 51.4 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.714 179.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.443 ' OD1' ' CZ3' ' A' ' 136' ' ' TRP . 5.6 m-20 -98.11 -172.25 2.32 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.475 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -52.38 -7.59 0.07 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.187 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.522 ' HB3' ' HG3' ' A' ' 27' ' ' LYS . 3.7 m-20 -99.73 -7.21 25.87 Favored 'General case' 0 CA--C 1.516 -0.349 0 CA-C-O 120.996 0.427 . . . . 0.0 111.045 -179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.766 ' HE2' ' HA ' ' A' ' 165' ' ' LEU . 0.0 OUTLIER 73.38 20.42 3.22 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 121.652 0.739 . . . . 0.0 109.291 -179.379 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.801 ' C ' HD12 ' A' ' 28' ' ' ILE . 7.1 mttp -91.72 -161.03 0.78 Allowed 'General case' 0 C--O 1.221 -0.395 0 CA-C-N 115.031 -0.986 . . . . 0.0 108.767 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.801 HD12 ' C ' ' A' ' 27' ' ' LYS . 2.5 mp -135.61 145.73 31.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 C-N-CA 119.888 -0.725 . . . . 0.0 111.42 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.579 ' CE1' HD13 ' A' ' 119' ' ' ILE . 81.0 t80 -65.77 110.99 3.02 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.963 -1.017 . . . . 0.0 110.326 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.635 ' HB2' HG22 ' A' ' 137' ' ' VAL . . . -100.21 137.56 38.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.842 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -135.75 132.94 37.45 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.809 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.842 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 48.6 p -98.81 141.39 31.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.221 -179.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.498 ' NH1' HD12 ' A' ' 36' ' ' ILE . 11.1 mtp-105 -68.67 127.1 31.83 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.193 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.791 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.3 OUTLIER -45.9 -34.12 3.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.294 0.568 . . . . 0.0 110.73 -179.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -72.39 -39.78 67.71 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.519 179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.498 HD12 ' NH1' ' A' ' 33' ' ' ARG . 27.9 mt -123.63 106.64 32.13 Favored Pre-proline 0 N--CA 1.455 -0.214 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.084 179.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_exo -68.37 -19.88 42.99 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.714 2.276 . . . . 0.0 112.628 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.4 p30 -91.39 -7.46 50.71 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.514 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.842 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -90.71 96.46 10.65 Favored 'General case' 0 C--O 1.224 -0.278 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.04 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.618 ' O ' ' HA ' ' A' ' 146' ' ' THR . 75.8 m95 -94.76 146.61 24.06 Favored 'General case' 0 C--O 1.222 -0.385 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.116 179.84 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.569 ' O ' ' HA ' ' A' ' 30' ' ' ALA . 0.5 OUTLIER -157.79 -124.81 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.844 -0.342 . . . . 0.0 111.56 -179.29 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.579 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 9.8 ptt? 179.98 163.29 0.86 Allowed Pre-proline 0 N--CA 1.452 -0.345 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.579 ' HD2' ' HB2' ' A' ' 42' ' ' MET . 10.2 Cg_endo -50.99 147.05 20.18 Favored 'Trans proline' 0 N--CA 1.463 -0.309 0 C-N-CA 123.114 2.542 . . . . 0.0 112.577 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.609 ' HA ' HD12 ' A' ' 19' ' ' ILE . 10.6 pt20 -174.22 146.61 1.13 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.809 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.463 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . -160.52 154.38 25.4 Favored Glycine 0 C--O 1.228 -0.273 0 C-N-CA 120.146 -1.026 . . . . 0.0 112.789 -179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.64 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -78.31 136.95 19.02 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.611 -0.804 . . . . 0.0 114.034 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.713 HD11 HG13 ' A' ' 17' ' ' VAL . 3.7 mt -69.62 141.93 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 CA-C-N 115.13 -0.535 . . . . 0.0 110.469 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -68.45 -172.95 0.38 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.738 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 -48.22 -73.33 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.861 -0.609 . . . . 0.0 111.208 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -118.42 57.17 0.55 Allowed Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.954 -0.641 . . . . 0.0 112.483 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.401 ' HG3' ' N ' ' A' ' 52' ' ' ASP . 2.1 tp10 -114.34 147.43 39.13 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.66 0.266 . . . . 0.0 110.456 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.43 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 26.9 m-20 -70.9 139.83 85.81 Favored Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 120.902 -0.319 . . . . 0.0 110.159 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.642 ' HB2' ' HZ ' ' A' ' 108' ' ' PHE . 38.6 Cg_exo -58.27 -47.7 18.72 Favored 'Trans proline' 0 C--O 1.233 0.228 0 C-N-CA 122.354 2.036 . . . . 0.0 112.016 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.845 ' HE ' HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -52.93 -46.17 67.97 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.904 179.723 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.666 ' HA ' HD12 ' A' ' 58' ' ' ILE . 86.7 m-20 -68.0 -40.97 82.93 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.741 -0.663 . . . . 0.0 110.242 179.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.71 -44.49 96.83 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.031 -0.532 . . . . 0.0 109.765 179.395 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.657 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -56.41 -54.49 45.07 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-N 116.016 -0.538 . . . . 0.0 109.812 178.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.845 HD11 ' HE ' ' A' ' 54' ' ' ARG . 10.1 mt -55.25 -55.31 17.3 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.173 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.0 mmm180 -60.47 -61.66 2.43 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.945 -179.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.463 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 4.4 mm-40 -46.89 -43.74 19.08 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.179 0.514 . . . . 0.0 109.777 179.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.992 HD22 HG21 ' A' ' 19' ' ' ILE . 9.0 tp -51.17 -48.27 61.96 Favored 'General case' 0 C--O 1.233 0.184 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.923 178.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.746 ' HG3' HG23 ' A' ' 68' ' ' THR . 17.9 ttm180 -64.66 -62.91 1.29 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.164 179.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -49.7 -22.97 1.53 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.92 -0.582 . . . . 0.0 112.268 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -96.02 -37.73 10.52 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.667 HG22 HD23 ' A' ' 121' ' ' LEU . 1.3 p -124.34 -35.69 2.75 Favored 'General case' 0 N--CA 1.465 0.279 0 C-N-CA 120.638 -0.425 . . . . 0.0 112.027 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 107.16 -13.53 40.47 Favored Glycine 0 N--CA 1.449 -0.468 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -178.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.879 HG11 HD22 ' A' ' 21' ' ' LEU . 78.1 t -56.24 109.75 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.52 -0.211 0 CA-C-O 120.889 0.376 . . . . 0.0 110.49 179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.746 HG23 ' HG3' ' A' ' 62' ' ' ARG . 3.9 p -120.86 -41.06 2.58 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.315 178.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.406 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 15.6 m -60.89 72.27 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.234 179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -160.79 157.95 27.68 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.196 0.522 . . . . 0.0 112.213 -179.5 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -129.16 149.63 50.88 Favored 'General case' 0 C--O 1.226 -0.159 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.131 179.176 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.809 HG22 ' CE2' ' A' ' 110' ' ' PHE . 12.8 t -74.0 128.14 36.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.172 0.51 . . . . 0.0 111.923 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.541 HD13 ' CE ' ' A' ' 22' ' ' MET . 0.9 OUTLIER -108.83 -18.25 7.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.363 178.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.464 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -168.54 179.69 4.23 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.399 0.619 . . . . 0.0 112.325 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.1 OUTLIER -160.09 147.22 16.24 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.113 -0.949 . . . . 0.0 110.568 179.764 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.898 ' HA ' HG11 ' A' ' 160' ' ' VAL . 42.7 t -71.2 140.12 85.19 Favored Pre-proline 0 CA--C 1.533 0.298 0 CA-C-O 120.959 0.409 . . . . 0.0 111.533 -179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.632 ' HD2' HG13 ' A' ' 76' ' ' VAL . 32.2 Cg_endo -64.89 -69.4 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 123.094 2.53 . . . . 0.0 112.931 -179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.765 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -87.4 172.41 9.84 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.689 -178.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.597 ' O ' ' HA ' ' A' ' 5' ' ' SER . 54.3 m95 -92.93 102.72 15.08 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.308 -0.86 . . . . 0.0 110.846 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.56 ' CD1' HG22 ' A' ' 157' ' ' VAL . 65.3 mt -63.02 109.67 1.55 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.916 0.388 . . . . 0.0 110.79 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.766 HG22 ' HA ' ' A' ' 104' ' ' ALA . 21.4 p -100.38 -160.32 0.79 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.886 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.403 ' HD1' HD23 ' A' ' 3' ' ' LEU . 1.2 t80 -175.12 60.14 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.536 179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -71.08 148.96 46.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.666 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.71 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 39.0 m-85 -99.56 161.07 25.73 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.215 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.535 ' HB3' ' HD2' ' A' ' 86' ' ' PRO . 38.4 Cg_exo -56.76 -178.32 0.08 OUTLIER 'Trans proline' 0 CA--C 1.532 0.377 0 C-N-CA 123.06 2.507 . . . . 0.0 112.062 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.535 ' HD2' ' HB3' ' A' ' 85' ' ' PRO . 33.7 Cg_endo -64.5 -22.08 65.57 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.447 2.098 . . . . 0.0 112.681 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 4.2 tttp -77.11 -62.46 1.64 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.992 0.425 . . . . 0.0 110.464 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.71 ' HB ' ' HB3' ' A' ' 84' ' ' PHE . 37.5 t -64.6 -17.38 21.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.026 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.672 ' HG3' ' HB2' ' A' ' 93' ' ' ASN . 2.9 ttp180 -55.04 -62.63 1.54 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.093 0.473 . . . . 0.0 110.636 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.853 ' HA ' HD13 ' A' ' 94' ' ' ILE . 2.2 mm-40 -62.93 -13.29 32.69 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.792 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.09 -33.61 15.41 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.718 0.294 . . . . 0.0 111.784 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.547 ' C ' HD13 ' A' ' 92' ' ' LEU . 1.8 tm? -120.48 -54.48 2.07 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.264 0.554 . . . . 0.0 111.504 -178.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.853 ' HB3' ' HA ' ' A' ' 101' ' ' LYS . 1.7 m-20 -52.56 -57.5 9.78 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.035 -0.984 . . . . 0.0 112.943 -178.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.853 HD13 ' HA ' ' A' ' 90' ' ' GLU . 4.3 mp -75.29 -6.42 8.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 C-N-CA 120.423 -0.511 . . . . 0.0 109.709 179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -76.14 -1.11 24.58 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.858 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.631 ' CZ3' ' HD3' ' A' ' 14' ' ' ARG . 77.8 m95 -92.71 30.15 1.62 Allowed 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.715 0.293 . . . . 0.0 110.822 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.408 ' O ' ' CB ' ' A' ' 98' ' ' SER . . . 68.05 19.49 71.94 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.663 -179.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.463 ' O ' ' HD1' ' A' ' 100' ' ' TRP . 5.3 m 82.5 160.62 0.14 Allowed 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 122.372 0.269 . . . . 0.0 111.037 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 11.3 t70 77.23 25.93 0.74 Allowed 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.631 179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.682 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 30.3 m95 -139.36 -164.67 1.71 Allowed 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.997 -178.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.853 ' HA ' ' HB3' ' A' ' 93' ' ' ASN . 12.2 ttpp 163.64 12.08 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.441 0.463 . . . . 0.0 111.998 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 161.92 -163.57 34.85 Favored Glycine 0 C--N 1.335 0.502 0 C-N-CA 120.314 -0.946 . . . . 0.0 111.987 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.589 ' O ' ' HA ' ' A' ' 81' ' ' THR . 36.3 mt-30 -144.98 123.58 12.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.886 0.343 . . . . 0.0 111.48 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.766 ' HA ' HG22 ' A' ' 81' ' ' THR . . . -100.35 125.47 46.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.667 179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.541 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 36.7 mt-30 -132.32 126.19 32.71 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.296 0.569 . . . . 0.0 112.354 -178.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.497 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 3.3 ttmt -104.55 135.14 46.52 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.897 -179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.825 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 38.8 m95 -101.81 165.58 11.13 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.198 0.523 . . . . 0.0 112.082 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.642 ' HZ ' ' HB2' ' A' ' 53' ' ' PRO . 97.6 m-85 -141.01 152.69 45.1 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.892 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.668 HD11 ' SD ' ' A' ' 22' ' ' MET . 10.0 tp -101.2 140.04 36.05 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.744 179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.809 ' CE2' HG22 ' A' ' 72' ' ' VAL . 50.6 m-85 -141.49 143.58 33.91 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -179.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 26.5 tttt -100.83 124.59 46.72 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 114.986 -1.006 . . . . 0.0 109.247 177.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.753 ' CE1' HG13 ' A' ' 67' ' ' VAL . 30.8 t80 -78.71 101.36 7.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.728 0.299 . . . . 0.0 110.64 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 18.3 p -98.26 40.54 1.17 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.501 179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.406 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -144.43 -145.41 4.34 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.777 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 10.0 mt-30 -121.63 149.07 43.71 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.965 0.412 . . . . 0.0 111.449 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.424 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 11.3 p-10 -60.47 -36.32 77.98 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.501 0.667 . . . . 0.0 111.081 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -57.01 -2.87 0.09 Allowed 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.73 -1.123 . . . . 0.0 112.405 -179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 116' ' ' ASP . 3.4 tt0 -89.66 -17.71 27.86 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 121.163 0.506 . . . . 0.0 110.149 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.579 HD13 ' CE1' ' A' ' 29' ' ' PHE . 9.6 mt -83.36 100.65 7.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.373 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 51.3 t30 -94.86 -0.46 54.03 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.063 0.394 . . . . 0.0 112.063 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.68 HD11 ' HD1' ' A' ' 134' ' ' TRP . 53.5 mt 40.55 27.06 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.636 ' HG ' ' O ' ' A' ' 121' ' ' LEU . 0.4 OUTLIER -171.25 -173.99 1.37 Allowed 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.945 0.402 . . . . 0.0 111.182 -179.413 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 112.84 128.99 5.05 Favored Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.676 -0.693 . . . . 0.0 112.573 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 12.7 t0 58.74 75.51 0.39 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.816 0.341 . . . . 0.0 111.021 179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -178.84 89.4 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.564 -0.827 . . . . 0.0 112.356 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.17 -4.81 15.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.65 0.262 . . . . 0.0 111.202 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.586 ' O ' ' HG3' ' A' ' 128' ' ' LYS . 12.0 mt-10 -88.5 -75.13 0.44 Allowed 'General case' 0 CA--C 1.519 -0.228 0 CA-C-N 116.614 -0.266 . . . . 0.0 110.506 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.586 ' HG3' ' O ' ' A' ' 127' ' ' GLU . 12.7 mttt -175.34 164.16 2.15 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.694 0.759 . . . . 0.0 111.576 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.659 ' HG2' HD13 ' A' ' 34' ' ' LEU . 22.5 Cg_endo -72.78 -173.69 1.28 Allowed 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 123.681 2.921 . . . . 0.0 113.261 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.544 ' HG3' ' CE1' ' A' ' 131' ' ' PHE . 2.5 tp10 -114.51 -46.48 2.96 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.693 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.553 ' HE2' HG23 ' A' ' 65' ' ' THR . 1.6 m-85 -126.93 140.11 52.57 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.987 0.422 . . . . 0.0 110.378 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.791 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -84.44 -33.44 19.66 Favored Glycine 0 CA--C 1.507 -0.43 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.211 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -154.59 151.83 29.31 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.506 -0.347 . . . . 0.0 110.254 -179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.68 ' HD1' HD11 ' A' ' 121' ' ' LEU . 37.0 p-90 -138.48 169.56 17.58 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.591 179.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.516 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 45.9 t -162.06 177.47 9.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.287 0.565 . . . . 0.0 111.364 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.473 ' CE2' ' CZ3' ' A' ' 134' ' ' TRP . 79.7 m95 -109.47 95.65 5.76 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.95 178.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.703 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 25.4 m -116.4 162.82 14.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.772 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.6 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 12.7 p -72.27 174.13 4.65 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 120.915 0.388 . . . . 0.0 110.567 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.712 ' HB3' HD22 ' A' ' 158' ' ' LEU . 9.4 Cg_exo -63.46 -57.08 0.41 Allowed 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 121.526 1.484 . . . . 0.0 110.291 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -60.66 -32.33 71.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.595 -0.73 . . . . 0.0 111.277 178.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.413 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.9 OUTLIER -70.66 -47.63 58.97 Favored 'General case' 0 CA--C 1.516 -0.333 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.566 179.627 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.547 HD13 ' CB ' ' A' ' 30' ' ' ALA . 38.7 tp -57.04 -38.42 73.16 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.668 HG12 ' O ' ' A' ' 139' ' ' PRO . 19.9 mm -60.77 -35.66 65.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.311 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.286 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.33 -50.12 35.55 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.213 0.53 . . . . 0.0 110.867 179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.505 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -73.85 -21.13 60.22 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 115.181 -0.918 . . . . 0.0 112.132 -179.525 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.618 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 14.9 t -74.52 171.52 13.64 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.996 0.427 . . . . 0.0 111.383 -179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.498 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 27.7 m -73.67 157.27 6.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.248 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.485 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 15.4 pt-20 -62.19 -54.17 44.77 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.12 0.486 . . . . 0.0 110.749 179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.498 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 41.5 p90 -57.77 -1.15 0.09 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.451 0.908 . . . . 0.0 113.451 -179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.418 ' HE3' ' HE2' ' A' ' 149' ' ' PHE . 75.0 mttt -132.57 -8.07 3.24 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.162 0.437 . . . . 0.0 111.878 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.536 ' HG3' HG22 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -61.7 -55.98 37.03 Favored Pre-proline 0 N--CA 1.463 0.192 0 CA-C-O 120.422 0.153 . . . . 0.0 110.744 179.308 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.519 ' HD3' ' HD2' ' A' ' 151' ' ' LYS . 29.9 Cg_endo -64.21 -28.51 64.41 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.083 1.855 . . . . 0.0 111.239 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.789 ' O ' HG23 ' A' ' 157' ' ' VAL . 21.6 t -68.04 -52.92 33.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.503 ' HE1' ' CZ2' ' A' ' 107' ' ' TRP . 16.0 m-30 -63.42 -39.66 95.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.79 178.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.621 ' HD3' HG21 ' A' ' 143' ' ' ILE . 0.1 OUTLIER -53.79 -45.4 70.72 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.083 -179.817 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.499 ' O ' HG23 ' A' ' 160' ' ' VAL . 3.0 tt0 -67.74 -33.88 75.74 Favored 'General case' 0 CA--C 1.508 -0.672 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.789 HG23 ' O ' ' A' ' 153' ' ' VAL . 47.3 t -64.77 -42.36 94.73 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.392 178.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.712 HD22 ' HB3' ' A' ' 139' ' ' PRO . 52.1 mt -63.84 -44.14 94.07 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.362 179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 40.0 t -52.09 -39.78 60.27 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.898 HG11 ' HA ' ' A' ' 76' ' ' VAL . 57.7 t -66.77 -41.15 87.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 CA-C-N 115.454 -0.794 . . . . 0.0 109.105 177.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.72 ' CE2' HG12 ' A' ' 157' ' ' VAL . 23.1 m-30 -80.44 5.9 13.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.694 -179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.7 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . . . -62.88 -50.99 74.62 Favored Pre-proline 0 C--N 1.329 -0.309 0 C-N-CA 120.963 -0.295 . . . . 0.0 110.828 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.7 ' HD3' ' HB3' ' A' ' 162' ' ' ALA . 31.2 Cg_exo -57.67 -15.43 20.74 Favored 'Trans proline' 0 C--N 1.344 0.321 0 C-N-CA 121.896 1.731 . . . . 0.0 111.209 178.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.464 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 83.6 m-70 -107.56 -25.76 11.21 Favored 'General case' 0 N--CA 1.458 -0.065 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.012 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.766 ' HA ' ' HE2' ' A' ' 26' ' ' LYS . 50.1 mt . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.246 -0.883 . . . . 0.0 110.543 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.425 ' HA2' ' CZ ' ' A' ' 82' ' ' TYR . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 112.404 -0.278 . . . . 0.0 112.404 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -54.37 136.14 68.11 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.575 2.183 . . . . 0.0 112.132 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -118.18 121.81 41.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.664 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -90.71 -19.06 45.6 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.562 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.608 ' HA ' ' O ' ' A' ' 79' ' ' TRP . 0.8 OUTLIER 64.95 -78.24 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.067 0.46 . . . . 0.0 111.401 -179.866 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 5.7 mtm 68.51 130.63 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.681 -179.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.716 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 9.7 t70 -66.19 -35.64 80.99 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.043 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 59.7 m -93.95 140.4 22.94 Favored Pre-proline 0 C--N 1.327 -0.404 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.261 179.351 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.447 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 69.0 Cg_endo -74.64 106.4 2.25 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.378 2.052 . . . . 0.0 112.601 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.486 ' HB2' ' CE2' ' A' ' 13' ' ' TYR . 12.2 Cg_endo -54.42 -166.98 0.01 OUTLIER 'Trans proline' 0 CA--C 1.518 -0.313 0 C-N-CA 123.342 2.695 . . . . 0.0 112.659 179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.5 ' O ' ' C ' ' A' ' 12' ' ' GLY . 0.1 OUTLIER -50.74 -165.78 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.163 179.617 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.5 ' C ' ' O ' ' A' ' 11' ' ' GLU . . . -24.53 -84.59 0.01 OUTLIER Glycine 0 C--N 1.335 0.488 0 CA-C-N 116.258 -0.428 . . . . 0.0 113.151 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.545 ' HA ' ' O ' ' A' ' 100' ' ' TRP . 11.0 m-85 59.25 137.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.616 0.246 . . . . 0.0 110.987 179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.746 ' HA ' ' CZ3' ' A' ' 100' ' ' TRP . 8.8 ttt180 -66.71 74.66 0.1 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.34 0.591 . . . . 0.0 110.598 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.731 ' HG2' HD12 ' A' ' 47' ' ' ILE . 0.7 OUTLIER -48.16 101.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.22 -179.656 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.739 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 3.4 m-80 -132.91 172.9 11.99 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.67 HG13 ' CG1' ' A' ' 47' ' ' ILE . 11.1 m -137.26 170.86 17.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 120.963 0.411 . . . . 0.0 111.221 179.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.562 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -137.1 158.82 24.46 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.814 179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.967 HG21 HD22 ' A' ' 61' ' ' LEU . 3.5 mp -131.99 122.76 49.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.589 ' O ' HD12 ' A' ' 109' ' ' LEU . 51.6 t -103.34 92.39 4.48 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 178.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.877 HD22 HG11 ' A' ' 67' ' ' VAL . 8.5 tp -98.3 122.06 40.99 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.647 -178.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.682 ' HE1' HD13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -122.94 160.55 25.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.757 179.889 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.496 ' ND2' ' HB3' ' A' ' 112' ' ' PHE . 1.6 m120 -97.34 -178.12 4.06 Favored 'General case' 0 CA--C 1.518 -0.282 0 CA-C-O 121.526 0.679 . . . . 0.0 111.034 179.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -60.54 -7.41 2.13 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.652 -1.158 . . . . 0.0 111.747 178.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 1.3 m-20 -99.71 3.1 44.85 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.0 OUTLIER 72.51 22.05 3.46 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -178.073 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 22' ' ' MET . 0.1 OUTLIER -96.41 140.74 30.62 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 179.271 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.724 HD12 ' N ' ' A' ' 28' ' ' ILE . 2.1 mp -97.2 144.03 11.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.658 0.742 . . . . 0.0 112.094 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.61 ' CZ ' HG21 ' A' ' 65' ' ' THR . 5.5 t80 -70.74 106.62 3.62 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.462 -1.245 . . . . 0.0 111.014 -179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.665 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -104.0 142.87 33.69 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.72 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.518 ' HB1' ' CG ' ' A' ' 131' ' ' PHE . . . -141.3 137.0 32.14 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.728 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 10.0 p -101.88 151.41 22.12 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -179.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.645 ' O ' ' N ' ' A' ' 35' ' ' ASP . 7.7 mtp180 -73.4 129.27 37.65 Favored 'General case' 0 C--N 1.334 -0.077 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.367 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.733 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -56.08 53.96 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 122.72 0.408 . . . . 0.0 112.083 179.626 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.645 ' N ' ' O ' ' A' ' 33' ' ' ARG . 4.7 t0 -175.78 -35.31 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.082 0.468 . . . . 0.0 110.098 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.545 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 6.7 mm -112.97 106.05 55.35 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.559 -179.748 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.81 -62.08 0.18 Allowed 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.122 2.548 . . . . 0.0 113.98 -178.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 24.3 m-20 -67.2 0.7 2.54 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.583 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.74 96.88 10.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.776 0.322 . . . . 0.0 111.059 179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.634 ' O ' ' HA ' ' A' ' 146' ' ' THR . 69.7 m95 -100.93 148.51 24.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.783 179.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.456 ' NE2' ' CD ' ' A' ' 33' ' ' ARG . 0.0 OUTLIER -156.19 163.64 39.35 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.636 0.731 . . . . 0.0 112.466 -179.102 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.707 ' SD ' HG21 ' A' ' 28' ' ' ILE . 12.2 mtm -97.93 150.93 37.27 Favored Pre-proline 0 C--N 1.326 -0.414 0 CA-C-N 114.839 -1.073 . . . . 0.0 109.481 179.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.498 ' CB ' HD13 ' A' ' 61' ' ' LEU . 4.7 Cg_endo -50.18 146.35 18.15 Favored 'Trans proline' 0 N--CA 1.461 -0.44 0 C-N-CA 122.186 1.924 . . . . 0.0 111.966 -179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.582 ' HA ' HD12 ' A' ' 19' ' ' ILE . 1.1 pt20 -173.07 150.96 2.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.642 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.435 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . -160.14 160.67 31.86 Favored Glycine 0 C--N 1.331 0.296 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.387 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.739 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -81.13 139.67 20.69 Favored Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.519 -0.848 . . . . 0.0 113.479 -179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.731 HD12 ' HG2' ' A' ' 15' ' ' ARG . 40.5 mt -69.82 138.94 21.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.639 -0.281 . . . . 0.0 111.385 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -69.04 -173.54 0.51 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.974 0.416 . . . . 0.0 110.914 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -46.09 -82.86 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.148 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -112.07 55.97 0.49 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.801 -0.714 . . . . 0.0 111.994 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -112.4 147.67 35.95 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.952 0.406 . . . . 0.0 110.852 -179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -68.73 164.33 46.88 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.132 179.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 3.6 Cg_exo -78.91 -51.41 0.06 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 122.689 2.259 . . . . 0.0 111.401 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.908 ' CZ ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -51.94 -46.04 64.56 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.331 179.41 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.788 ' HA ' HD12 ' A' ' 58' ' ' ILE . 75.7 m-20 -67.11 -41.8 85.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.108 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.402 ' HB1' ' OE2' ' A' ' 60' ' ' GLU . . . -61.07 -44.22 97.71 Favored 'General case' 0 CA--C 1.516 -0.355 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.776 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -56.49 -52.27 65.36 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.747 178.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.788 HD12 ' HA ' ' A' ' 55' ' ' ASN . 9.7 mt -56.32 -55.8 16.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.261 179.18 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -60.73 -63.89 1.14 Allowed 'General case' 0 C--O 1.232 0.133 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.011 -179.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.435 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 0.2 OUTLIER -43.52 -46.12 6.84 Favored 'General case' 0 N--CA 1.461 0.125 0 CA-C-O 121.248 0.547 . . . . 0.0 110.039 179.583 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.967 HD22 HG21 ' A' ' 19' ' ' ILE . 10.0 tp -52.84 -47.11 67.98 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.156 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.898 ' HG3' HG23 ' A' ' 68' ' ' THR . 19.7 ttm180 -64.48 -64.97 0.74 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.33 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.12 -21.79 0.82 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.324 -179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -96.57 -35.17 11.17 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 113.214 0.82 . . . . 0.0 113.214 -178.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.766 HG22 HD23 ' A' ' 121' ' ' LEU . 0.6 OUTLIER -129.91 -4.69 4.55 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.975 0.732 . . . . 0.0 112.975 -178.594 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 80.35 -11.13 39.41 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.448 -179.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.877 HG11 HD22 ' A' ' 21' ' ' LEU . 85.4 t -58.0 112.62 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-O 121.079 0.466 . . . . 0.0 111.625 179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.898 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -123.86 -39.86 2.36 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.646 178.172 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.6 m -62.24 75.62 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.955 178.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.594 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.63 157.84 25.24 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.157 0.503 . . . . 0.0 112.305 -179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -131.29 150.17 52.26 Favored 'General case' 0 C--N 1.334 -0.097 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.442 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.908 HG21 ' CZ ' ' A' ' 54' ' ' ARG . 6.4 t -75.51 127.09 36.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.21 0.529 . . . . 0.0 111.414 179.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.682 HD13 ' HE1' ' A' ' 22' ' ' MET . 0.7 OUTLIER -109.13 -19.65 6.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.525 -0.762 . . . . 0.0 110.559 179.466 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.523 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -168.92 177.47 4.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.755 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.0 OUTLIER -157.46 147.78 20.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.664 179.851 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.784 ' HA ' HG11 ' A' ' 160' ' ' VAL . 50.2 t -71.51 139.17 83.74 Favored Pre-proline 0 C--N 1.332 -0.152 0 CA-C-O 121.084 0.469 . . . . 0.0 110.827 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.652 ' HD2' HG13 ' A' ' 76' ' ' VAL . 36.4 Cg_endo -66.21 -52.88 0.75 Allowed 'Trans proline' 0 N--CA 1.463 -0.269 0 C-N-CA 122.805 2.337 . . . . 0.0 112.916 -179.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.716 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -101.21 174.12 6.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.314 0.578 . . . . 0.0 112.13 -178.763 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.608 ' O ' ' HA ' ' A' ' 5' ' ' SER . 46.9 m95 -92.61 95.86 9.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.25 -0.886 . . . . 0.0 111.487 -179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.651 ' CD1' HG22 ' A' ' 157' ' ' VAL . 62.4 mt -57.5 110.56 0.89 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.776 0.322 . . . . 0.0 110.823 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.626 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 3.7 p -107.21 -158.46 0.65 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.229 -179.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.425 ' CZ ' ' HA2' ' A' ' 1' ' ' GLY . 7.2 t80 -169.26 40.05 0.03 OUTLIER 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.732 0.301 . . . . 0.0 111.239 -179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -73.19 162.65 29.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.869 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.748 ' HD2' HD12 ' A' ' 92' ' ' LEU . 1.1 m-85 -99.66 160.82 26.38 Favored Pre-proline 0 CA--C 1.534 0.363 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.413 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.536 ' HD2' ' HD1' ' A' ' 84' ' ' PHE . 31.4 Cg_exo -58.78 -174.98 0.08 OUTLIER 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.657 2.238 . . . . 0.0 111.528 179.287 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.527 ' HD2' ' CB ' ' A' ' 85' ' ' PRO . 54.0 Cg_endo -70.43 -9.08 25.11 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.105 1.87 . . . . 0.0 113.361 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.407 ' HG3' ' H ' ' A' ' 88' ' ' VAL . 0.2 OUTLIER -99.25 -53.05 3.34 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.2 179.936 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.588 HG11 ' CE1' ' A' ' 84' ' ' PHE . 21.1 t -72.42 -8.52 11.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.737 0.303 . . . . 0.0 111.118 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.649 ' O ' HD13 ' A' ' 94' ' ' ILE . 0.7 OUTLIER -68.2 -2.41 8.03 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.587 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.3 -22.61 10.35 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.746 0.308 . . . . 0.0 110.951 179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.58 -23.26 19.1 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.262 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.748 HD12 ' HD2' ' A' ' 84' ' ' PHE . 1.3 tm? -120.1 -56.21 2.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.885 0.374 . . . . 0.0 111.186 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.701 ' OD1' ' HA ' ' A' ' 101' ' ' LYS . 1.4 t-20 -51.13 -58.33 6.4 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.61 -179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.649 HD13 ' O ' ' A' ' 89' ' ' ARG . 1.7 mp -67.18 -12.93 15.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.22 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.479 ' HB2' ' O ' ' A' ' 92' ' ' LEU . 1.2 mm-40 -76.38 -5.85 49.05 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.734 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.684 ' HB3' ' HD1' ' A' ' 100' ' ' TRP . 70.5 m95 -87.95 16.78 5.51 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 121.01 -0.276 . . . . 0.0 111.073 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.487 ' O ' ' CB ' ' A' ' 98' ' ' SER . . . 79.66 0.85 85.73 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.244 -0.979 . . . . 0.0 112.562 -179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.487 ' CB ' ' O ' ' A' ' 97' ' ' GLY . 2.2 p 89.29 161.2 0.06 Allowed 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 122.75 0.42 . . . . 0.0 111.572 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 65.42 19.61 11.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.744 -0.662 . . . . 0.0 112.11 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.746 ' CZ3' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -116.32 -30.61 5.87 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.931 -0.308 . . . . 0.0 111.478 -179.983 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.701 ' HA ' ' OD1' ' A' ' 93' ' ' ASN . 0.9 OUTLIER 17.21 54.92 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -178.716 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 100.43 -163.78 18.93 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.784 -0.722 . . . . 0.0 113.896 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.626 ' O ' ' HA ' ' A' ' 81' ' ' THR . 5.5 tt0 -145.01 101.33 3.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.47 -0.365 . . . . 0.0 110.373 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.598 ' HA ' HG22 ' A' ' 81' ' ' THR . . . -90.6 112.39 24.08 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-O 121.196 0.522 . . . . 0.0 110.397 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.694 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 40.7 mt-30 -126.12 133.07 51.74 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 113.265 0.839 . . . . 0.0 113.265 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 1.8 ttmm -105.72 130.66 53.68 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.34 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.562 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 14.3 m95 -99.34 161.47 13.6 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.055 0.455 . . . . 0.0 111.735 -178.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.495 ' CE1' ' HG2' ' A' ' 54' ' ' ARG . 98.1 m-85 -139.9 152.13 46.16 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.292 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.672 ' HG ' HD12 ' A' ' 73' ' ' ILE . 17.3 tp -99.01 134.81 41.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.458 179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.577 ' CZ ' HG22 ' A' ' 72' ' ' VAL . 27.2 m-85 -136.46 144.67 44.51 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 112.884 0.698 . . . . 0.0 112.884 -178.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.594 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 15.2 tttt -103.94 119.95 40.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.063 -0.971 . . . . 0.0 109.216 177.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.702 ' CE1' HG13 ' A' ' 67' ' ' VAL . 43.0 t80 -78.37 100.46 6.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.794 0.331 . . . . 0.0 110.667 179.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 18.6 p -97.13 45.16 1.04 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.85 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -144.68 -147.93 4.75 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.058 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 45.2 mt-30 -119.34 149.72 41.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.889 0.376 . . . . 0.0 111.056 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.446 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 14.7 p-10 -60.38 -38.68 84.69 Favored 'General case' 0 CA--C 1.519 -0.238 0 CA-C-O 121.512 0.672 . . . . 0.0 111.243 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 13.8 pt20 -55.98 -3.03 0.07 Allowed 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.598 -179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.401 ' H ' ' C ' ' A' ' 116' ' ' ASP . 1.1 tt0 -89.71 -18.88 25.56 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.943 0.401 . . . . 0.0 110.556 179.43 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.699 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 20.1 mt -85.0 106.21 14.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.849 179.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 38.3 t30 -100.54 -25.41 14.19 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.327 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.766 HD23 HG22 ' A' ' 65' ' ' THR . 46.5 mt 78.91 -34.41 0.16 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.206 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.932 HD23 ' HB3' ' A' ' 129' ' ' PRO . 66.9 mt -62.92 167.64 4.57 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.996 0.426 . . . . 0.0 111.22 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -152.26 2.9 0.36 Allowed Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.819 -0.705 . . . . 0.0 113.273 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.1 p30 49.74 39.8 18.67 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.992 0.425 . . . . 0.0 111.042 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -74.13 1.49 48.4 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.331 -179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 65.64 24.85 11.62 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.94 0.37 . . . . 0.0 110.733 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -146.92 -59.34 0.28 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.543 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 5.8 ptpp? -178.39 155.42 0.94 Allowed Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.976 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.932 ' HB3' HD23 ' A' ' 122' ' ' LEU . 13.9 Cg_endo -72.61 -175.22 1.74 Allowed 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.5 2.133 . . . . 0.0 112.179 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.522 ' O ' HD12 ' A' ' 34' ' ' LEU . 3.1 mm-40 -92.7 -71.21 0.66 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.358 -179.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.655 ' CE2' HG23 ' A' ' 65' ' ' THR . 1.9 m-85 -104.41 142.42 34.61 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.673 -179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.733 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -85.03 -37.46 10.02 Favored Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.043 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -146.24 145.39 30.38 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.76 0.314 . . . . 0.0 110.483 179.761 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.699 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 36.2 p-90 -135.71 170.95 15.16 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.27 179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 36.5 t -167.68 178.48 5.3 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.491 0.662 . . . . 0.0 112.719 -178.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.468 ' CD2' ' OD1' ' A' ' 23' ' ' ASN . 81.2 m95 -113.12 102.99 10.91 Favored 'General case' 0 C--N 1.333 -0.151 0 CA-C-N 114.861 -1.063 . . . . 0.0 109.588 178.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.431 ' O ' ' N ' ' A' ' 28' ' ' ILE . 25.4 m -120.83 170.44 10.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.586 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 11.1 p -75.41 173.05 7.65 Favored Pre-proline 0 C--N 1.327 -0.375 0 C-N-CA 120.515 -0.474 . . . . 0.0 109.889 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.675 ' HB3' HD22 ' A' ' 158' ' ' LEU . 12.3 Cg_exo -62.61 -54.01 1.49 Allowed 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.731 1.621 . . . . 0.0 110.381 179.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -63.93 -30.69 71.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.328 -0.851 . . . . 0.0 111.356 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -71.76 -43.77 65.2 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.615 -0.266 . . . . 0.0 110.474 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.665 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -59.8 -39.27 84.42 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 179.313 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.754 HG21 ' HG2' ' A' ' 155' ' ' LYS . 34.1 mm -63.04 -37.21 78.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.19 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -69.94 -50.81 38.26 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.35 0.595 . . . . 0.0 110.528 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.3 mp -73.49 -19.82 60.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.179 -0.918 . . . . 0.0 112.709 -179.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.634 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 12.4 t -75.81 172.06 13.33 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.111 -179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.471 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 26.9 m -82.77 145.17 8.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.378 -179.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.554 ' HG3' ' HE3' ' A' ' 151' ' ' LYS . 6.7 mt-10 -47.46 -50.32 23.27 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.602 -179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -50.2 -12.27 0.08 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -135.37 -3.91 2.38 Favored 'General case' 0 CA--C 1.531 0.212 0 N-CA-C 112.77 0.655 . . . . 0.0 112.77 -178.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.62 ' HG2' HG23 ' A' ' 146' ' ' THR . 8.1 mttt -58.69 -60.71 9.5 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 120.379 0.133 . . . . 0.0 111.178 179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.497 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 32.3 Cg_endo -64.44 -27.57 62.53 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.641 2.227 . . . . 0.0 111.754 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.797 ' O ' HG23 ' A' ' 157' ' ' VAL . 40.3 t -67.88 -50.41 59.91 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.501 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 8.9 m-30 -66.59 -38.54 87.23 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.021 178.565 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.754 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -57.24 -41.18 79.09 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.812 -179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.406 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.4 tt0 -70.09 -31.48 69.08 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.797 HG23 ' O ' ' A' ' 153' ' ' VAL . 51.0 t -66.9 -42.2 88.63 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 CA-C-N 115.265 -0.88 . . . . 0.0 109.797 178.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.675 HD22 ' HB3' ' A' ' 139' ' ' PRO . 74.0 mt -63.89 -40.23 96.04 Favored 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.238 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 64.2 m -56.41 -41.79 76.93 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 179.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.784 HG11 ' HA ' ' A' ' 76' ' ' VAL . 89.3 t -66.74 -43.72 89.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 CA-C-N 115.525 -0.761 . . . . 0.0 108.983 177.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.504 ' CE2' HG12 ' A' ' 157' ' ' VAL . 21.9 m-30 -81.12 7.46 11.0 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.436 -179.283 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.692 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . . . -59.22 -50.45 87.56 Favored Pre-proline 0 C--N 1.329 -0.283 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.755 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.692 ' HD3' ' HB3' ' A' ' 162' ' ' ALA . 34.0 Cg_exo -59.41 -13.05 18.87 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.425 2.083 . . . . 0.0 111.58 178.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.523 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 86.7 m-70 -109.02 -20.75 12.92 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.294 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.509 HD23 ' HZ1' ' A' ' 26' ' ' LYS . 83.8 mt . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.942 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.953 0 N-CA-C 112.194 -0.362 . . . . 0.0 112.194 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -53.37 132.72 49.87 Favored 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.567 2.178 . . . . 0.0 111.75 179.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 1.067 HD21 HG22 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -92.39 141.48 28.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.072 0.463 . . . . 0.0 111.161 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.482 ' C ' ' HG ' ' A' ' 5' ' ' SER . . . -96.97 12.53 65.63 Favored Glycine 0 CA--C 1.52 0.354 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.661 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.966 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 97.5 p 55.45 -89.44 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.461 ' HB2' ' O ' ' A' ' 5' ' ' SER . 1.9 mpp? 67.39 122.37 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.847 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.697 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 12.4 p-10 -69.37 -32.46 71.52 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.015 0.436 . . . . 0.0 110.759 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.458 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 29.8 m -103.07 134.23 19.9 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.203 179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.441 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 68.7 Cg_endo -74.79 104.41 1.88 Allowed 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.26 1.974 . . . . 0.0 112.317 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.584 ' HG2' ' CD2' ' A' ' 13' ' ' TYR . 6.2 Cg_endo -49.62 163.6 0.45 Allowed 'Trans proline' 0 N--CA 1.464 -0.261 0 C-N-CA 123.107 2.538 . . . . 0.0 112.665 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -51.01 130.41 25.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.651 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 51.84 87.89 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.504 179.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.657 ' CZ ' ' HG3' ' A' ' 101' ' ' LYS . 8.2 m-85 -154.21 153.72 32.26 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.611 ' HG2' HD21 ' A' ' 16' ' ' ASN . 0.2 OUTLIER -65.23 -158.18 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.527 0 C-N-CA 120.864 -0.334 . . . . 0.0 110.543 -179.491 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.655 ' HG2' HD12 ' A' ' 47' ' ' ILE . 23.2 ttt180 179.98 101.34 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.212 0.53 . . . . 0.0 109.751 -178.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.611 HD21 ' HG2' ' A' ' 14' ' ' ARG . 23.7 m-80 -130.9 171.68 12.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.981 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.701 HG13 HD11 ' A' ' 47' ' ' ILE . 22.4 m -134.26 163.34 37.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.14 0.495 . . . . 0.0 111.199 178.172 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.615 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -138.66 157.87 24.82 Favored Glycine 0 N--CA 1.442 -0.955 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.301 179.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.659 HG21 HD13 ' A' ' 61' ' ' LEU . 2.1 mp -128.56 118.22 46.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 112.474 0.546 . . . . 0.0 112.474 -179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.588 ' O ' HD12 ' A' ' 109' ' ' LEU . 50.3 t -96.82 98.34 10.05 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 177.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.629 HD21 ' HD1' ' A' ' 112' ' ' PHE . 32.0 tp -99.29 116.18 30.87 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.106 -177.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.891 ' HE2' HD13 ' A' ' 73' ' ' ILE . 1.6 ptt? -119.66 161.77 20.12 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.846 -0.615 . . . . 0.0 111.027 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.52 ' OD1' ' N ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -94.45 171.32 8.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.092 179.944 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -57.34 -5.53 0.32 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.703 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.575 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.6 OUTLIER -99.37 3.04 45.79 Favored 'General case' 0 CA--C 1.521 -0.136 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.575 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 11.0 mmtp 73.71 21.88 2.68 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.025 -0.534 . . . . 0.0 109.986 -178.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.613 ' O ' ' HA ' ' A' ' 22' ' ' MET . 2.3 mmtt -92.66 143.17 26.58 Favored 'General case' 0 N--CA 1.449 -0.495 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.729 HD11 ' HG3' ' A' ' 139' ' ' PRO . 1.4 mm -98.96 138.0 24.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.737 0 CA-C-O 121.17 0.51 . . . . 0.0 112.283 -178.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.608 ' CE1' HD13 ' A' ' 119' ' ' ILE . 78.1 t80 -75.05 136.67 41.19 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.398 177.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.715 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -140.33 151.48 45.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.679 0.275 . . . . 0.0 111.102 -179.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.518 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -141.34 138.14 32.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.33 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.69 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 43.9 p -95.69 144.87 25.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.66 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.457 ' NE ' HD12 ' A' ' 36' ' ' ILE . 35.1 mtp180 -69.68 136.15 50.71 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 121.213 0.53 . . . . 0.0 111.318 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.93 ' H ' HD23 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -42.11 -48.9 4.82 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.583 -178.947 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -71.69 -33.25 68.64 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.95 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.457 HD12 ' NE ' ' A' ' 33' ' ' ARG . 2.8 mt -122.45 110.46 32.24 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 120.758 0.313 . . . . 0.0 111.531 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -76.6 -18.77 15.15 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.449 2.099 . . . . 0.0 112.382 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -91.73 -10.45 40.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.352 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.693 ' HB1' ' CG1' ' A' ' 147' ' ' VAL . . . -91.2 96.47 10.59 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.564 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.69 ' O ' ' HA ' ' A' ' 146' ' ' THR . 76.0 m95 -90.86 147.59 23.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.682 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -154.84 169.73 23.32 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.471 0.653 . . . . 0.0 111.667 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.505 ' HE2' ' HB2' ' A' ' 42' ' ' MET . 19.3 mtm -107.3 147.2 34.78 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.176 179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.484 ' CG ' HD12 ' A' ' 61' ' ' LEU . 5.3 Cg_endo -48.8 136.88 27.91 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.459 2.106 . . . . 0.0 111.525 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.504 ' HA ' HD12 ' A' ' 19' ' ' ILE . 3.1 pp0? -173.08 155.01 2.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.996 0.427 . . . . 0.0 111.269 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.484 ' O ' ' HB3' ' A' ' 16' ' ' ASN . . . -156.04 -165.1 14.04 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.896 -0.669 . . . . 0.0 111.571 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.569 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -95.71 -148.72 24.64 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.209 -0.996 . . . . 0.0 113.243 -179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.701 HD11 HG13 ' A' ' 17' ' ' VAL . 3.0 mt -163.04 125.92 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.545 -0.328 . . . . 0.0 110.488 -179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.29 169.51 16.95 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.083 0.468 . . . . 0.0 111.122 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -46.25 -62.22 1.44 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.696 -179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -99.88 42.35 1.99 Allowed Glycine 0 C--N 1.333 0.368 0 C-N-CA 120.775 -0.726 . . . . 0.0 113.089 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -119.64 128.81 54.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.553 0.216 . . . . 0.0 110.571 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -69.13 164.61 46.59 Favored Pre-proline 0 C--N 1.329 -0.293 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.592 ' HA ' HG11 ' A' ' 17' ' ' VAL . 3.4 Cg_exo -76.81 -48.05 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.4 0 C-N-CA 122.65 2.233 . . . . 0.0 111.912 -179.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.755 HH21 HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -55.84 -43.87 77.43 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.21 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.41 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 73.9 m-20 -66.92 -45.13 78.83 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.293 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.29 -43.79 98.02 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 178.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.605 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -57.37 -61.14 2.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.902 178.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.546 HG12 ' CE2' ' A' ' 110' ' ' PHE . 25.4 mt -54.61 -48.65 70.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.297 -0.865 . . . . 0.0 111.393 179.505 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.41 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 13.5 ttt180 -64.96 -62.24 1.67 Allowed 'General case' 0 CA--C 1.52 -0.189 0 C-N-CA 121.066 -0.254 . . . . 0.0 111.078 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -42.53 -48.68 5.35 Favored 'General case' 0 CA--C 1.522 -0.134 0 CA-C-O 120.908 0.385 . . . . 0.0 110.101 179.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.659 HD13 HG21 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -51.25 -47.84 62.31 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.267 178.761 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.9 ' HG3' HG23 ' A' ' 68' ' ' THR . 9.0 ttm180 -63.94 -65.28 0.7 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.124 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -48.62 -19.94 0.4 Allowed 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 -179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -98.82 -35.37 10.14 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.516 0.932 . . . . 0.0 113.516 -178.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.795 HG22 HD23 ' A' ' 121' ' ' LEU . 0.7 OUTLIER -124.68 -6.93 7.4 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 120.326 -0.549 . . . . 0.0 112.319 -178.932 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 79.56 -12.35 28.09 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.441 -0.885 . . . . 0.0 111.488 -178.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.717 HG22 HG12 ' A' ' 119' ' ' ILE . 78.9 t -57.43 121.8 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 CA-C-O 121.164 0.506 . . . . 0.0 111.306 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.9 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.6 OUTLIER -131.78 -38.22 1.14 Allowed 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.808 178.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 113' ' ' THR . 5.8 m -61.24 71.75 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.894 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -159.81 153.34 22.52 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.097 0.475 . . . . 0.0 112.212 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -128.19 151.73 48.9 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.845 179.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.799 HG22 ' CE2' ' A' ' 110' ' ' PHE . 10.8 t -75.43 132.66 32.86 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.401 0 CA-C-O 121.313 0.577 . . . . 0.0 111.575 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.891 HD13 ' HE2' ' A' ' 22' ' ' MET . 1.7 mt -109.85 -18.79 7.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 CA-C-N 115.463 -0.79 . . . . 0.0 109.932 178.83 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.489 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.22 176.03 4.71 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.668 -0.696 . . . . 0.0 111.604 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -152.71 145.58 24.43 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.452 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.735 ' HA ' HG11 ' A' ' 160' ' ' VAL . 52.9 t -71.94 134.67 83.27 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.142 0.496 . . . . 0.0 111.208 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.522 ' HD2' HG13 ' A' ' 76' ' ' VAL . 33.0 Cg_endo -67.39 -56.87 0.2 Allowed 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.912 2.408 . . . . 0.0 113.01 -179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.697 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 1.3 p90 -97.29 178.28 5.28 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.813 -178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.582 ' O ' HD23 ' A' ' 80' ' ' LEU . 56.1 m95 -94.83 -158.58 0.65 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.47 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.966 ' HA ' ' HA ' ' A' ' 5' ' ' SER . 13.1 mt -159.87 103.24 1.5 Allowed 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 121.127 0.489 . . . . 0.0 110.359 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.89 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 7.2 p -115.02 100.66 8.35 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.35 -178.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.631 ' CD2' HD23 ' A' ' 3' ' ' LEU . 0.1 OUTLIER -83.03 91.93 7.28 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.277 -0.569 . . . . 0.0 111.135 178.606 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.422 ' HB3' ' H ' ' A' ' 84' ' ' PHE . 1.9 m-20 -69.53 -136.88 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 109.873 -0.417 . . . . 0.0 109.873 179.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.868 ' HB2' HD12 ' A' ' 92' ' ' LEU . 0.6 OUTLIER -176.96 156.03 1.26 Allowed Pre-proline 0 N--CA 1.466 0.369 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.623 ' HD2' ' HD1' ' A' ' 84' ' ' PHE . 41.6 Cg_exo -58.35 -176.61 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.541 0 C-N-CA 122.429 2.086 . . . . 0.0 111.043 178.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.533 ' HD2' ' HB3' ' A' ' 85' ' ' PRO . 39.2 Cg_endo -66.6 -11.23 30.91 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.341 2.027 . . . . 0.0 113.188 -179.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 8.0 tttt -86.18 -62.8 1.43 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.631 0.253 . . . . 0.0 111.194 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.564 ' HB ' ' CG ' ' A' ' 84' ' ' PHE . 3.2 t -70.57 -20.73 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.588 -0.278 . . . . 0.0 111.291 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.573 ' HB2' ' O ' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -48.42 -27.03 2.38 Favored 'General case' 0 N--CA 1.462 0.165 0 CA-C-O 120.896 0.379 . . . . 0.0 110.408 179.54 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.811 ' HA ' HD13 ' A' ' 94' ' ' ILE . 7.1 mt-10 -68.24 -64.04 0.94 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.051 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.448 ' O ' ' HG2' ' A' ' 95' ' ' GLN . 13.5 mttt -66.2 -6.46 13.69 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 120.909 -0.316 . . . . 0.0 110.763 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.868 HD12 ' HB2' ' A' ' 84' ' ' PHE . 0.1 OUTLIER -99.35 -63.69 1.1 Allowed 'General case' 0 CA--C 1.529 0.142 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.17 179.089 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.553 ' ND2' ' HB3' ' A' ' 101' ' ' LYS . 59.7 t-20 -81.41 -50.38 9.52 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.811 HD13 ' HA ' ' A' ' 90' ' ' GLU . 3.0 mp -68.52 -8.36 9.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.723 -178.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.473 ' HG2' ' O ' ' A' ' 92' ' ' LEU . 0.0 OUTLIER -80.7 -3.13 49.59 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 120.574 0.226 . . . . 0.0 111.056 178.526 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.524 ' CD1' ' O ' ' A' ' 92' ' ' LEU . 81.5 m95 -108.17 -55.38 2.38 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.826 0.346 . . . . 0.0 111.55 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 171.57 -81.39 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.36 -179.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -170.01 25.98 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 121.343 0.592 . . . . 0.0 111.755 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 82.1 m-20 -131.25 -54.22 1.03 Allowed 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.941 179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.586 ' CZ3' ' HA ' ' A' ' 14' ' ' ARG . 43.2 m95 -54.62 -175.5 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.993 -1.003 . . . . 0.0 111.079 179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.657 ' HG3' ' CZ ' ' A' ' 13' ' ' TYR . 4.2 ptpt 164.6 9.26 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.403 ' HA2' HD21 ' A' ' 92' ' ' LEU . . . 175.23 -161.7 31.01 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.347 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.89 ' O ' ' HA ' ' A' ' 81' ' ' THR . 7.1 mt-30 -146.36 117.66 7.89 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.199 0.499 . . . . 0.0 111.427 -179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.696 ' HB2' HG22 ' A' ' 81' ' ' THR . . . -94.02 122.75 36.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.018 0.437 . . . . 0.0 111.791 -179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.865 ' HG2' ' HB2' ' A' ' 80' ' ' LEU . 0.9 OUTLIER -129.2 118.82 23.01 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.875 -179.79 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.432 ' HG3' ' O ' ' A' ' 78' ' ' TYR . 16.3 ttpp -102.91 129.07 49.5 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.393 -0.821 . . . . 0.0 108.939 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.615 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 22.7 m95 -102.38 165.18 11.26 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -177.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.518 ' CZ ' ' HB2' ' A' ' 53' ' ' PRO . 96.5 m-85 -137.53 153.94 49.92 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 114.946 -1.025 . . . . 0.0 110.546 -179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.588 HD12 ' O ' ' A' ' 20' ' ' CYS . 16.8 tp -101.08 139.46 36.72 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.402 179.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.799 ' CE2' HG22 ' A' ' 72' ' ' VAL . 34.0 m-85 -141.88 145.97 35.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.555 0.693 . . . . 0.0 112.828 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.706 ' HB2' HD11 ' A' ' 73' ' ' ILE . 18.7 tttt -104.69 123.3 47.37 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.917 178.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.629 ' HD1' HD21 ' A' ' 21' ' ' LEU . 46.5 t80 -78.6 95.32 5.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.868 0.366 . . . . 0.0 110.663 179.115 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.419 ' N ' ' O ' ' A' ' 69' ' ' SER . 65.7 p -94.16 50.89 1.43 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.876 -179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -151.99 -143.43 3.7 Favored Glycine 0 N--CA 1.453 -0.217 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.055 179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -124.97 150.0 47.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.874 0.368 . . . . 0.0 111.244 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.476 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 20.3 p-10 -57.07 -39.03 74.16 Favored 'General case' 0 CA--C 1.517 -0.29 0 CA-C-O 121.519 0.676 . . . . 0.0 111.143 -179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -58.21 -4.58 0.37 Allowed 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.101 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -89.62 -17.02 29.24 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 121.079 0.466 . . . . 0.0 110.128 179.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.717 HG12 HG22 ' A' ' 67' ' ' VAL . 7.6 mt -78.77 99.88 3.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.33 179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -107.98 91.08 3.5 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.529 179.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.795 HD23 HG22 ' A' ' 65' ' ' THR . 0.6 OUTLIER -69.93 -14.27 62.64 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.73 0.3 . . . . 0.0 110.631 179.74 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.494 ' CD2' ' HG3' ' A' ' 129' ' ' PRO . 2.9 mt -106.72 -165.69 1.1 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.886 -179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 121.14 128.09 3.5 Favored Glycine 0 C--N 1.332 0.323 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.472 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 57.56 -179.07 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.82 0.343 . . . . 0.0 110.906 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -65.51 -84.27 0.09 OUTLIER Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.207 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . 0.438 ' C ' ' H ' ' A' ' 128' ' ' LYS . 0.1 OUTLIER 59.21 15.04 3.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.462 0.172 . . . . 0.0 111.289 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 70.09 -41.64 0.49 Allowed 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.614 0.245 . . . . 0.0 111.475 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.438 ' H ' ' C ' ' A' ' 126' ' ' SER . 0.0 OUTLIER -178.0 157.84 1.15 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-O 120.935 0.398 . . . . 0.0 110.654 179.396 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.494 ' HG3' ' CD2' ' A' ' 122' ' ' LEU . 2.3 Cg_endo -65.95 -174.08 0.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 121.948 1.766 . . . . 0.0 111.587 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.663 ' C ' HD21 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -99.73 -34.84 10.02 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.298 0.57 . . . . 0.0 109.74 179.408 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.648 ' N ' HD21 ' A' ' 34' ' ' LEU . 4.9 m-85 -133.78 139.18 46.16 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.758 ' N ' HD22 ' A' ' 34' ' ' LEU . . . -77.58 -35.79 35.52 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.326 -0.94 . . . . 0.0 111.848 -178.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -156.13 152.01 27.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.872 0.368 . . . . 0.0 111.083 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.64 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 27.5 p-90 -133.15 163.99 28.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.197 179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.489 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 13.4 t -158.95 167.33 29.66 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.157 0.503 . . . . 0.0 112.072 -178.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.473 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 37.3 m95 -103.44 102.84 12.76 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.573 -0.739 . . . . 0.0 109.4 177.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 28' ' ' ILE . 26.4 m -118.21 164.91 14.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.593 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 26.8 p -71.64 168.98 17.52 Favored Pre-proline 0 C--N 1.325 -0.474 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.408 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.729 ' HG3' HD11 ' A' ' 28' ' ' ILE . 16.2 Cg_exo -58.91 -58.82 0.57 Allowed 'Trans proline' 0 N--CA 1.46 -0.494 0 C-N-CA 121.72 1.613 . . . . 0.0 110.826 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.28 -27.16 68.83 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.794 178.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.526 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 29.1 mt-30 -71.69 -47.47 53.85 Favored 'General case' 0 CA--C 1.517 -0.301 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.205 179.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.715 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -56.24 -41.28 75.48 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 179.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.816 HG21 ' HG2' ' A' ' 155' ' ' LYS . 19.1 mm -61.44 -34.57 61.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.219 179.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.39 -50.92 23.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.262 0.553 . . . . 0.0 110.858 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.2 mp -73.49 -21.47 60.41 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.311 -0.858 . . . . 0.0 112.281 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.69 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 12.1 t -73.61 174.81 7.78 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.674 -0.41 . . . . 0.0 110.918 -179.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.693 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 33.0 m -80.02 160.2 4.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.688 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.47 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 2.4 mt-10 -60.59 -51.9 67.46 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.07 0.462 . . . . 0.0 110.915 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -54.24 -7.65 0.15 Allowed 'General case' 0 N--CA 1.466 0.37 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -131.43 -6.38 3.75 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.612 ' HG3' HG22 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -61.74 -53.57 59.55 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 110.543 -0.169 . . . . 0.0 110.543 179.499 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.545 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 39.5 Cg_endo -67.97 -28.88 35.03 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 122.259 1.973 . . . . 0.0 111.347 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 1.067 HG22 HD21 ' A' ' 3' ' ' LEU . 17.3 t -68.47 -52.83 32.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.544 -0.91 . . . . 0.0 108.544 178.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.469 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 6.1 m-30 -65.75 -37.1 85.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.784 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.816 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -57.46 -41.61 80.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.377 -0.829 . . . . 0.0 110.591 179.72 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.481 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.6 OUTLIER -68.35 -34.32 75.88 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 179.465 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 153' ' ' VAL . 53.8 t -64.9 -41.17 91.43 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 CA-C-N 115.005 -0.998 . . . . 0.0 109.347 178.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.606 HD22 ' HB3' ' A' ' 139' ' ' PRO . 56.7 mt -63.65 -48.91 75.3 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.666 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -49.2 -40.1 32.16 Favored 'General case' 0 CA--C 1.519 -0.235 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.735 HG11 ' HA ' ' A' ' 76' ' ' VAL . 58.5 t -67.63 -42.91 87.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.683 -0.689 . . . . 0.0 109.328 178.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.63 ' CE2' HG12 ' A' ' 157' ' ' VAL . 21.9 m-30 -80.71 5.15 16.56 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.38 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.607 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.85 -53.36 67.22 Favored Pre-proline 0 C--N 1.327 -0.385 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.628 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.7 Cg_endo -58.77 -13.2 17.09 Favored 'Trans proline' 0 CA--C 1.53 0.289 0 C-N-CA 122.17 1.914 . . . . 0.0 111.729 178.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.489 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 95.1 m-70 -107.06 -19.08 13.73 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.205 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.602 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 96.5 mt . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.807 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 112.566 -0.213 . . . . 0.0 112.566 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.54 -179.99 0.04 OUTLIER 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.551 2.168 . . . . 0.0 111.673 179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.561 HD21 HG22 ' A' ' 153' ' ' VAL . 0.3 OUTLIER -91.17 165.42 13.49 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 121.028 0.442 . . . . 0.0 111.377 -179.94 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -115.08 -29.31 2.6 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.615 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 1.02 ' HB3' HD23 ' A' ' 80' ' ' LEU . 0.3 OUTLIER 63.16 138.71 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.2 0.524 . . . . 0.0 111.577 179.574 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 4.1 mtm -144.58 155.94 43.9 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.383 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.526 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 12.2 t70 -64.55 -47.59 78.21 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.916 0.389 . . . . 0.0 110.54 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.425 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 0.8 OUTLIER -100.18 148.96 35.58 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.107 179.087 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.533 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 57.7 Cg_endo -71.86 105.33 1.78 Allowed 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.259 1.973 . . . . 0.0 112.06 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.691 ' CG ' HG21 ' A' ' 81' ' ' THR . 6.2 Cg_endo -49.43 166.53 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 123.122 2.548 . . . . 0.0 113.043 -179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -53.45 130.91 37.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.057 179.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.511 ' CA ' ' HA ' ' A' ' 100' ' ' TRP . . . 56.25 81.89 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.801 -0.714 . . . . 0.0 113.293 179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.648 ' CE1' ' HB ' ' A' ' 81' ' ' THR . 35.4 m-85 -154.16 119.7 5.18 Favored 'General case' 0 C--N 1.326 -0.413 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.769 ' HB3' ' HG3' ' A' ' 103' ' ' GLN . 8.3 ttt180 -66.56 91.28 0.18 Allowed 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.054 0.454 . . . . 0.0 111.526 -178.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.865 ' HG2' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER -48.0 112.94 0.64 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.214 179.324 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.637 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 2.0 m-80 -131.59 173.74 10.81 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.46 179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.615 HG13 HG13 ' A' ' 47' ' ' ILE . 6.6 m -139.55 165.32 22.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.174 0.511 . . . . 0.0 111.84 179.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.529 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -135.38 155.31 22.08 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 110.821 -0.912 . . . . 0.0 110.821 178.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.091 HG23 ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -129.67 124.51 59.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -179.069 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.533 ' CB ' ' HE2' ' A' ' 161' ' ' PHE . 0.5 OUTLIER -106.6 108.69 20.32 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.358 -0.837 . . . . 0.0 108.953 177.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.875 HD22 HG11 ' A' ' 67' ' ' VAL . 11.0 tp -104.19 124.3 48.87 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.582 -178.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.713 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -124.34 155.18 39.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.95 179.342 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.506 ' OD1' ' CE3' ' A' ' 136' ' ' TRP . 0.2 OUTLIER -92.85 176.04 6.58 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.05 0.452 . . . . 0.0 110.134 179.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.453 ' HA ' ' HE3' ' A' ' 111' ' ' LYS . 1.1 m-80 -57.24 -6.94 0.46 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.064 177.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.604 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 5.5 m-20 -100.46 -0.15 38.56 Favored 'General case' 0 C--N 1.338 0.079 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.604 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 14.7 mmtm 76.97 19.86 1.33 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.291 -178.545 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.713 ' O ' ' HA ' ' A' ' 22' ' ' MET . 3.8 mmtt -93.57 141.58 28.31 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.69 HD12 ' N ' ' A' ' 28' ' ' ILE . 2.2 mp -101.5 143.51 14.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.669 0.747 . . . . 0.0 112.358 -178.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.657 ' CE2' HG21 ' A' ' 65' ' ' THR . 11.3 t80 -69.85 108.05 3.8 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.196 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.734 ' CB ' HD13 ' A' ' 142' ' ' LEU . . . -106.92 145.89 31.67 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.948 0.404 . . . . 0.0 110.924 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.462 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -139.5 137.52 35.57 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.236 179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.808 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 25.0 p -99.19 141.75 31.55 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 121.077 -0.249 . . . . 0.0 110.998 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.581 ' NH1' ' HG2' ' A' ' 41' ' ' GLN . 1.7 mtt85 -69.59 128.34 36.14 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 179.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.728 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.5 OUTLIER -46.4 -35.73 5.79 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.318 0.58 . . . . 0.0 110.891 -179.577 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.487 ' O ' HD13 ' A' ' 36' ' ' ILE . 4.0 m-20 -70.67 -33.97 71.5 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.665 179.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.487 HD13 ' O ' ' A' ' 35' ' ' ASP . 20.4 mm -131.05 104.75 15.16 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.914 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_exo -65.55 -20.37 60.4 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.765 2.31 . . . . 0.0 112.676 -179.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.01 -4.0 53.4 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.412 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.808 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.97 91.83 8.04 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.112 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.558 ' O ' ' HA ' ' A' ' 146' ' ' THR . 77.3 m95 -91.83 164.38 13.7 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.357 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.581 ' HG2' ' NH1' ' A' ' 33' ' ' ARG . 0.0 OUTLIER 174.24 175.13 0.16 Allowed 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.81 0.814 . . . . 0.0 112.264 -179.74 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.612 ' HG3' ' CZ3' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -108.19 156.7 37.95 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.29 177.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.439 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 10.1 Cg_endo -50.7 157.35 3.64 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.498 2.132 . . . . 0.0 112.665 -179.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 177.99 150.62 0.22 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.6 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -160.9 -157.27 8.64 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.318 -0.944 . . . . 0.0 112.447 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.637 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -122.22 143.01 15.33 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.91 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.865 HD12 ' HG2' ' A' ' 15' ' ' ARG . 48.5 mt -70.01 146.71 12.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.916 0.389 . . . . 0.0 111.532 -179.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -69.49 -175.08 0.77 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.72 179.551 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -48.51 -61.33 2.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.339 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.85 57.35 0.73 Allowed Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.689 -179.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.426 ' O ' HG21 ' A' ' 47' ' ' ILE . 47.7 tp10 -117.17 155.7 28.92 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.693 0.283 . . . . 0.0 110.469 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -72.02 161.56 78.19 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 109.986 -0.376 . . . . 0.0 109.986 179.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.508 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 5.6 Cg_exo -78.3 -49.17 0.09 OUTLIER 'Trans proline' 0 CA--C 1.515 -0.441 0 C-N-CA 122.635 2.223 . . . . 0.0 111.73 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.814 ' HE ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -52.26 -46.92 65.99 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.47 179.794 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.454 ' HA ' HD12 ' A' ' 58' ' ' ILE . 70.3 m-20 -67.71 -41.85 82.9 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.376 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.22 -42.26 98.29 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.091 ' HB1' HG23 ' A' ' 19' ' ' ILE . . . -57.47 -54.27 48.77 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.855 178.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.513 HD11 ' CZ ' ' A' ' 54' ' ' ARG . 21.3 mt -56.39 -53.0 45.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.854 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 59' ' ' ARG . 24.1 mtt180 -61.21 -57.71 11.3 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.652 -178.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.414 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 15.1 mm-40 -46.5 -46.03 18.83 Favored 'General case' 0 CA--C 1.521 -0.162 0 CA-C-O 121.553 0.692 . . . . 0.0 109.709 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.955 HD21 ' HB ' ' A' ' 67' ' ' VAL . 10.1 tt -52.81 -46.69 67.81 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.721 -1.127 . . . . 0.0 110.959 178.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.827 ' HD3' HG23 ' A' ' 68' ' ' THR . 0.7 OUTLIER -62.77 -63.43 1.22 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.995 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -50.42 -22.54 1.92 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.357 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 60' ' ' GLU . 8.6 mt-10 -96.74 -34.76 11.22 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 -177.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.657 HG21 ' CE2' ' A' ' 29' ' ' PHE . 0.8 OUTLIER -130.29 -15.44 3.67 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.465 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.549 ' HA2' ' NE ' ' A' ' 62' ' ' ARG . . . 93.07 -16.32 60.79 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.281 -0.961 . . . . 0.0 112.656 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.955 ' HB ' HD21 ' A' ' 61' ' ' LEU . 74.8 t -58.15 113.86 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.262 0.553 . . . . 0.0 111.937 -179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.827 HG23 ' HD3' ' A' ' 62' ' ' ARG . 0.2 OUTLIER -125.87 -36.78 2.35 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.404 -0.817 . . . . 0.0 109.716 178.075 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.9 m -63.6 73.83 0.03 OUTLIER 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.698 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -159.28 157.06 29.85 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 120.898 0.38 . . . . 0.0 111.981 -179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -127.8 149.08 50.42 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.101 179.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.952 HG22 ' CE2' ' A' ' 110' ' ' PHE . 19.1 t -74.21 126.3 34.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.077 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.566 HD11 ' HB2' ' A' ' 111' ' ' LYS . 1.4 mt -105.52 -17.6 7.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.236 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.45 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -171.09 175.71 4.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.484 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.0 OUTLIER -154.06 138.65 16.9 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.109 179.492 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.632 ' HA ' HG11 ' A' ' 160' ' ' VAL . 52.3 t -71.33 135.27 84.43 Favored Pre-proline 0 N--CA 1.453 -0.284 0 CA-C-O 121.178 0.513 . . . . 0.0 111.16 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.521 ' HD2' HG13 ' A' ' 76' ' ' VAL . 27.3 Cg_endo -66.16 -70.08 0.03 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.867 2.378 . . . . 0.0 112.027 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.53 ' O ' HG12 ' A' ' 76' ' ' VAL . 6.4 p90 -78.33 170.67 16.24 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.095 -179.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.609 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 48.2 m95 -93.64 -155.14 0.43 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.467 179.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.02 HD23 ' HB3' ' A' ' 5' ' ' SER . 20.8 mt -161.35 106.32 1.33 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.691 HG21 ' CG ' ' A' ' 10' ' ' PRO . 20.0 p -100.79 100.62 11.31 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.032 -0.531 . . . . 0.0 111.705 -178.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 6.0 t80 -77.63 58.94 1.88 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.833 0.349 . . . . 0.0 110.531 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.483 ' HB2' ' NE ' ' A' ' 89' ' ' ARG . 5.7 p30 -68.47 170.06 9.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.27 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.567 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 2.3 m-85 -104.77 172.22 4.29 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.664 -179.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.567 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 52.1 Cg_exo -56.27 170.88 1.02 Allowed 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.408 2.072 . . . . 0.0 112.296 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 85' ' ' PRO . 26.9 Cg_endo -61.7 -16.44 48.58 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.676 2.251 . . . . 0.0 112.71 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -92.22 -56.59 3.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.791 0.329 . . . . 0.0 110.547 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.465 ' HB ' ' HB3' ' A' ' 84' ' ' PHE . 14.0 t -69.06 -15.36 19.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.041 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.85 ' HA ' HD22 ' A' ' 93' ' ' ASN . 12.0 tpp85 -68.44 -2.65 9.08 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 116.489 -0.323 . . . . 0.0 111.83 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.96 ' HA ' HG12 ' A' ' 94' ' ' ILE . 0.6 OUTLIER -111.43 -49.34 3.01 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.781 0.324 . . . . 0.0 111.66 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 56.0 mttt -65.46 -23.0 66.81 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.655 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.627 HD13 ' HE1' ' A' ' 96' ' ' TRP . 1.4 tm? -120.96 -59.67 1.72 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.85 HD22 ' HA ' ' A' ' 89' ' ' ARG . 27.3 m-80 -57.24 -51.68 68.39 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -177.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.96 HG12 ' HA ' ' A' ' 90' ' ' GLU . 8.5 mm -65.89 -3.1 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 C-N-CA 120.487 -0.485 . . . . 0.0 110.854 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.634 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.3 OUTLIER -99.96 -103.06 0.23 Allowed 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -179.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.627 ' HE1' HD13 ' A' ' 92' ' ' LEU . 65.8 m95 56.86 -60.01 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.128 0.49 . . . . 0.0 111.193 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.634 ' N ' ' O ' ' A' ' 95' ' ' GLN . . . 168.28 -95.46 0.11 Allowed Glycine 0 N--CA 1.449 -0.465 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -66.3 -166.63 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 178.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.48 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 0.5 OUTLIER -67.16 79.09 0.14 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.557 0.217 . . . . 0.0 110.522 179.659 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.586 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 88.4 m95 -105.29 -167.92 1.4 Allowed 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -179.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.627 ' HG2' ' HD2' ' A' ' 89' ' ' ARG . 0.0 OUTLIER 168.16 15.72 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.778 -179.416 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.583 ' HA2' ' OD1' ' A' ' 93' ' ' ASN . . . 154.55 -158.27 28.13 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.769 ' HG3' ' HB3' ' A' ' 14' ' ' ARG . 6.4 tt0 -144.93 113.34 6.61 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.894 0.347 . . . . 0.0 111.443 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.589 ' HB2' HG22 ' A' ' 81' ' ' THR . . . -93.13 122.12 35.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.133 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.571 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 5.2 mt-30 -128.99 127.33 41.43 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 -178.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.535 ' HB2' ' CD2' ' A' ' 79' ' ' TRP . 2.0 ttpt -105.67 141.38 37.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.718 178.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.612 ' CZ3' ' HG3' ' A' ' 42' ' ' MET . 54.9 m95 -105.98 163.74 12.52 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.266 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.595 ' HB2' ' HE1' ' A' ' 110' ' ' PHE . 96.0 m-85 -141.07 152.47 44.83 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.895 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.695 HD11 ' SD ' ' A' ' 22' ' ' MET . 17.8 tp -101.87 143.29 31.94 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.551 -0.295 . . . . 0.0 111.13 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.999 ' CE1' HG22 ' A' ' 19' ' ' ILE . 54.8 m-85 -144.51 145.08 31.66 Favored 'General case' 0 CA--C 1.518 -0.28 0 CA-C-O 121.637 0.732 . . . . 0.0 112.965 -179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.566 ' HB2' HD11 ' A' ' 73' ' ' ILE . 4.4 tttt -104.23 126.06 51.02 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.56 -1.2 . . . . 0.0 109.737 178.253 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.636 ' CD1' HD21 ' A' ' 21' ' ' LEU . 34.9 t80 -78.99 100.74 7.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.741 0.305 . . . . 0.0 110.868 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 72.7 p -100.83 50.06 0.88 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.993 0.425 . . . . 0.0 110.952 -179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -154.1 -145.58 4.19 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.294 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -121.5 150.89 40.93 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.017 0.437 . . . . 0.0 110.973 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.505 ' HB3' ' HH2' ' A' ' 134' ' ' TRP . 44.7 m-20 -59.11 -34.72 72.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.032 -179.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -58.96 -2.62 0.26 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.191 -179.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.57 -15.23 33.31 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-O 120.805 0.336 . . . . 0.0 111.037 179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.745 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 11.3 mt -78.54 100.3 3.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.828 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -102.42 92.34 4.65 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.099 179.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.718 HD11 ' HD1' ' A' ' 134' ' ' TRP . 38.0 mt -67.48 -57.62 6.2 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.159 0.504 . . . . 0.0 110.036 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.41 HD22 ' HB3' ' A' ' 129' ' ' PRO . 2.4 mm? -71.46 -176.02 1.43 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.441 -0.8 . . . . 0.0 111.356 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 111.94 -3.09 27.2 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 121.021 -0.609 . . . . 0.0 113.003 179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.82 81.41 3.14 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 120.786 0.327 . . . . 0.0 111.044 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -77.0 59.25 3.53 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.337 179.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 98.5 p -120.31 -55.01 2.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.14 0.495 . . . . 0.0 110.771 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -146.91 -46.72 0.18 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.476 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.52 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 0.1 OUTLIER -178.05 156.89 1.09 Allowed Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 121.27 0.557 . . . . 0.0 111.343 178.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.52 ' HD2' ' HB2' ' A' ' 128' ' ' LYS . 28.6 Cg_endo -69.72 -179.9 3.22 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 123.104 2.536 . . . . 0.0 112.808 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.571 ' O ' HD12 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -89.76 -70.67 0.65 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.673 179.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.531 ' CE1' HG23 ' A' ' 65' ' ' THR . 2.6 m-85 -106.67 142.6 36.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.497 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.728 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -80.77 -36.01 23.58 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.698 -0.763 . . . . 0.0 111.478 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.51 155.54 36.41 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.261 -0.47 . . . . 0.0 110.274 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.745 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 25.0 p-90 -140.45 167.53 21.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.159 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.546 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 26.6 t -163.01 176.13 10.43 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.286 0.565 . . . . 0.0 111.533 -178.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.506 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 64.5 m95 -111.75 103.73 12.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.48 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.415 HG23 ' HB2' ' A' ' 142' ' ' LEU . 26.0 m -121.67 171.54 10.24 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.375 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.634 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 10.9 p -74.15 177.03 2.34 Favored Pre-proline 0 C--N 1.319 -0.736 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 178.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 1.003 ' HB2' HD21 ' A' ' 158' ' ' LEU . 13.9 Cg_endo -74.27 -47.37 0.25 Allowed 'Trans proline' 0 N--CA 1.443 -1.481 0 C-N-CA 121.242 1.294 . . . . 0.0 109.964 178.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.4 -32.89 73.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.9 177.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -70.61 -47.97 57.46 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.021 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.734 HD13 ' CB ' ' A' ' 30' ' ' ALA . 23.9 tp -60.75 -37.61 82.38 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.715 ' O ' HG22 ' A' ' 146' ' ' THR . 31.1 mm -59.19 -40.09 80.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 CA-C-O 121.373 0.606 . . . . 0.0 109.468 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.29 -51.67 34.99 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.127 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.468 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -72.76 -17.94 61.55 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.97 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.715 HG22 ' O ' ' A' ' 143' ' ' ILE . 14.2 t -74.64 -175.94 2.62 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.063 -179.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.694 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 28.7 m -87.74 151.41 3.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.06 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.702 ' HG2' ' N ' ' A' ' 149' ' ' PHE . 0.6 OUTLIER -58.76 -53.41 58.68 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.938 0.399 . . . . 0.0 111.368 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.702 ' N ' ' HG2' ' A' ' 148' ' ' GLU . 48.0 p90 -56.18 -3.35 0.09 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.452 ' HE2' ' CE2' ' A' ' 149' ' ' PHE . 0.7 OUTLIER -133.14 -4.84 3.06 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.655 ' HG2' ' O ' ' A' ' 143' ' ' ILE . 9.1 mttt -62.37 -59.99 11.31 Favored Pre-proline 0 C--N 1.328 -0.349 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.48 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 13.6 Cg_endo -56.57 -26.07 62.39 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.25 1.966 . . . . 0.0 111.635 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.561 HG22 HD21 ' A' ' 3' ' ' LEU . 12.1 t -68.69 -54.16 22.65 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.361 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.545 ' O ' ' HB ' ' A' ' 157' ' ' VAL . 4.9 m-30 -65.3 -37.05 85.96 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.807 178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.428 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -57.31 -40.46 77.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.264 179.585 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.411 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.9 OUTLIER -66.68 -29.39 69.39 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.075 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.545 ' HB ' ' O ' ' A' ' 154' ' ' TYR . 88.9 t -64.67 -39.23 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.216 179.133 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 1.003 HD21 ' HB2' ' A' ' 139' ' ' PRO . 0.2 OUTLIER -61.33 -50.1 74.3 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.074 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 15.4 m -51.95 -43.05 63.33 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.932 0.396 . . . . 0.0 110.028 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.632 HG11 ' HA ' ' A' ' 76' ' ' VAL . 50.0 t -68.15 -42.2 84.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-O 121.346 0.593 . . . . 0.0 109.433 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.544 ' CE2' ' CG1' ' A' ' 157' ' ' VAL . 13.2 m-30 -81.28 5.14 18.12 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.739 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.616 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.44 -52.14 76.38 Favored Pre-proline 0 C--N 1.328 -0.365 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.692 179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.616 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 17.8 Cg_endo -59.72 -12.06 16.71 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.263 1.975 . . . . 0.0 112.045 178.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.528 ' O ' ' HE3' ' A' ' 26' ' ' LYS . 92.3 m-70 -109.17 -20.77 12.87 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.337 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 94.0 mt . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.974 -179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.148 0 N-CA-C 112.172 -0.371 . . . . 0.0 112.172 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.442 ' HB2' ' HB2' ' A' ' 152' ' ' PRO . 53.3 Cg_exo -52.32 149.59 22.33 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.553 2.168 . . . . 0.0 112.077 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.717 ' CD1' HG22 ' A' ' 153' ' ' VAL . 0.0 OUTLIER 48.38 -175.5 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.093 -179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -124.35 -53.46 0.19 Allowed Glycine 0 C--N 1.33 0.237 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.991 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 1.005 ' HB3' HD23 ' A' ' 80' ' ' LEU . 0.3 OUTLIER 65.23 129.52 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.791 0.329 . . . . 0.0 111.345 179.486 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.479 ' C ' ' HB2' ' A' ' 78' ' ' TYR . 0.7 OUTLIER -145.89 149.28 33.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.49 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.673 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 1.8 t0 -65.46 -6.47 10.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.319 -179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.456 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 0.7 OUTLIER -145.16 128.93 8.63 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.391 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.479 ' HG3' ' HD2' ' A' ' 15' ' ' ARG . 56.7 Cg_endo -69.74 104.53 1.33 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.674 2.249 . . . . 0.0 112.563 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.594 ' HG2' ' CE2' ' A' ' 13' ' ' TYR . 6.2 Cg_endo -49.94 165.49 0.32 Allowed 'Trans proline' 0 C--N 1.345 0.36 0 C-N-CA 123.282 2.655 . . . . 0.0 112.801 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.65 132.95 31.16 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.126 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.729 ' CA ' ' HA ' ' A' ' 100' ' ' TRP . . . 71.02 67.38 1.9 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.518 -0.849 . . . . 0.0 112.733 179.479 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.594 ' CE2' ' HG2' ' A' ' 10' ' ' PRO . 10.3 m-85 -153.33 119.5 5.46 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.526 0.203 . . . . 0.0 110.673 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.593 ' HA ' ' HZ3' ' A' ' 100' ' ' TRP . 7.4 tpt180 -66.36 94.7 0.28 Allowed 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.51 0.671 . . . . 0.0 111.886 -179.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.626 ' HG3' ' CZ3' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -52.74 112.83 0.91 Allowed 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 114.86 -1.064 . . . . 0.0 110.218 178.493 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.991 ' HB2' ' HG2' ' A' ' 105' ' ' GLN . 3.0 m120 -135.48 172.86 12.4 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.978 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.706 HG13 ' CG1' ' A' ' 47' ' ' ILE . 5.3 m -136.98 168.7 21.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 -179.701 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.592 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -140.45 154.6 24.23 Favored Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 114.603 -1.181 . . . . 0.0 111.388 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.011 HG23 ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -129.05 125.33 62.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.158 0.504 . . . . 0.0 111.98 -178.851 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.526 ' O ' HD12 ' A' ' 109' ' ' LEU . 43.4 t -104.57 102.85 12.46 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 107.961 -1.125 . . . . 0.0 107.961 178.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.887 HD22 HG11 ' A' ' 67' ' ' VAL . 24.7 tp -104.14 119.2 38.42 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.366 0.603 . . . . 0.0 111.659 -178.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.689 ' HE3' HD13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -119.86 158.92 25.63 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.42 -0.809 . . . . 0.0 110.786 -179.803 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.654 ' ND2' ' HB3' ' A' ' 112' ' ' PHE . 6.9 m120 -98.02 179.1 4.89 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-O 121.806 0.812 . . . . 0.0 111.819 -179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -58.44 -6.55 0.7 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.354 -1.293 . . . . 0.0 111.464 178.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.546 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.6 OUTLIER -101.21 3.39 40.92 Favored 'General case' 0 CA--C 1.519 -0.242 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -178.726 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.546 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 3.1 mmpp? 72.08 22.53 3.67 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 -178.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 22' ' ' MET . 10.3 mttt -95.02 149.97 20.67 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.725 HG13 ' HA ' ' A' ' 139' ' ' PRO . 1.9 mm -100.98 138.51 24.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.3 0.571 . . . . 0.0 111.519 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.627 ' CE1' HD13 ' A' ' 119' ' ' ILE . 72.6 t80 -73.63 133.62 43.49 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.358 178.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.828 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -133.53 152.68 51.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.82 0.343 . . . . 0.0 111.175 -179.328 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.556 ' HB1' ' CB ' ' A' ' 131' ' ' PHE . . . -145.4 136.19 24.5 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.939 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.644 ' HA ' ' NH2' ' A' ' 33' ' ' ARG . 39.3 p -99.41 147.73 24.95 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.99 0.424 . . . . 0.0 111.829 -178.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.644 ' NH2' ' HA ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -69.9 131.38 44.35 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.933 179.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.758 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.5 OUTLIER -57.13 51.98 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 179.694 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.619 ' N ' ' O ' ' A' ' 33' ' ' ARG . 0.6 OUTLIER -175.31 -26.69 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.666 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.517 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 5.3 mm -119.92 106.54 41.27 Favored Pre-proline 0 CA--C 1.53 0.189 0 CA-C-O 120.968 0.413 . . . . 0.0 110.649 179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_exo -60.22 -63.76 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 123.447 2.765 . . . . 0.0 114.019 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 71.7 m-20 -64.91 0.47 1.19 Allowed 'General case' 0 N--CA 1.463 0.212 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -178.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.54 ' HB1' ' HE ' ' A' ' 33' ' ' ARG . . . -90.56 110.91 22.04 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 120.528 0.204 . . . . 0.0 110.838 179.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.705 ' O ' ' HA ' ' A' ' 146' ' ' THR . 74.4 m95 -118.78 150.57 39.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.746 0.308 . . . . 0.0 110.611 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.581 ' HG3' ' NH2' ' A' ' 33' ' ' ARG . 67.0 mt-30 -157.96 173.4 16.82 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.385 0.612 . . . . 0.0 111.687 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.438 ' SD ' HG21 ' A' ' 28' ' ' ILE . 3.3 mtm -106.63 152.77 40.84 Favored Pre-proline 0 C--N 1.319 -0.718 0 CA-C-N 114.596 -1.184 . . . . 0.0 109.958 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.527 ' O ' HG12 ' A' ' 19' ' ' ILE . 12.5 Cg_endo -55.68 144.22 76.5 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.124 1.883 . . . . 0.0 111.499 179.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.433 ' CB ' ' HA2' ' A' ' 18' ' ' GLY . 3.9 pt20 -175.94 157.14 1.86 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.563 -0.29 . . . . 0.0 110.819 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.43 ' HA3' ' OE1' ' A' ' 60' ' ' GLU . . . -161.89 -159.42 10.16 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.469 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.61 ' C ' HG13 ' A' ' 47' ' ' ILE . . . -99.4 -148.72 23.43 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.595 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.706 ' CG1' HG13 ' A' ' 17' ' ' VAL . 7.5 mt -158.68 141.03 5.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 C-N-CA 122.803 0.441 . . . . 0.0 110.077 -179.313 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -67.84 -173.45 0.35 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.336 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.54 -81.35 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.41 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -107.49 54.88 0.54 Allowed Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.06 -179.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -112.07 136.78 51.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.773 0.32 . . . . 0.0 110.928 -179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.479 ' HB2' ' ND2' ' A' ' 55' ' ' ASN . 13.5 m-20 -66.52 147.46 98.96 Favored Pre-proline 0 N--CA 1.453 -0.285 0 C-N-CA 120.658 -0.417 . . . . 0.0 110.34 179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.572 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 23.1 Cg_exo -64.37 -48.51 4.5 Favored 'Trans proline' 0 N--CA 1.465 -0.171 0 C-N-CA 123.077 2.518 . . . . 0.0 113.393 -179.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.887 ' HE ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -45.72 -50.83 13.34 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.603 -179.428 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.479 ' ND2' ' HB2' ' A' ' 52' ' ' ASP . 22.2 p30 -65.7 -42.07 91.6 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 120.79 -0.364 . . . . 0.0 110.7 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.446 ' N ' ' OD1' ' A' ' 55' ' ' ASN . . . -60.29 -41.9 94.34 Favored 'General case' 0 CA--C 1.509 -0.597 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.011 ' HB1' HG23 ' A' ' 19' ' ' ILE . . . -57.78 -53.37 58.94 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.134 -0.939 . . . . 0.0 110.247 178.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.783 HD11 ' NE ' ' A' ' 54' ' ' ARG . 33.0 mt -60.26 -52.32 62.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.932 179.477 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -61.68 -56.66 17.33 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 115.716 -0.675 . . . . 0.0 111.353 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.43 ' OE1' ' HA3' ' A' ' 45' ' ' GLY . 47.4 mm-40 -47.78 -47.31 30.86 Favored 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.902 HD21 ' HB ' ' A' ' 67' ' ' VAL . 10.2 tt -50.68 -50.46 54.87 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.984 -1.007 . . . . 0.0 110.873 178.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.82 ' HG3' HG23 ' A' ' 68' ' ' THR . 32.9 ttt180 -61.55 -63.24 1.34 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.268 -0.878 . . . . 0.0 111.492 -179.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -49.85 -19.36 0.65 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.25 -178.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 51.7 mt-10 -101.28 -35.38 9.28 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.296 0.85 . . . . 0.0 113.296 -178.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.584 HG21 ' CE2' ' A' ' 29' ' ' PHE . 1.3 p -126.08 -1.23 7.12 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 -178.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 73.74 -13.12 4.3 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 120.191 -1.004 . . . . 0.0 112.027 -178.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.902 ' HB ' HD21 ' A' ' 61' ' ' LEU . 71.1 t -58.52 111.57 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 CA-C-O 121.106 0.479 . . . . 0.0 111.273 179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.82 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.8 OUTLIER -121.6 -41.44 2.48 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.921 178.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.409 ' O ' ' N ' ' A' ' 113' ' ' THR . 20.3 m -59.95 74.14 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.33 -179.864 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.522 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.76 156.72 23.22 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -130.33 151.64 50.61 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.478 179.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.967 HG22 ' CE2' ' A' ' 110' ' ' PHE . 6.5 t -75.95 127.61 37.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.527 179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.689 HD13 ' HE3' ' A' ' 22' ' ' MET . 1.2 mt -106.68 -19.72 6.45 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.799 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.504 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.54 176.68 4.25 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.955 -179.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -154.76 146.16 23.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.142 -0.936 . . . . 0.0 110.422 179.631 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.886 ' HA ' HG11 ' A' ' 160' ' ' VAL . 54.3 t -70.71 136.82 85.57 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.624 -179.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.522 ' HD2' HG11 ' A' ' 160' ' ' VAL . 17.5 Cg_endo -55.48 -62.44 0.27 Allowed 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 122.901 2.401 . . . . 0.0 112.568 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.673 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -100.47 -175.87 3.04 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.371 -179.186 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.643 ' CD1' ' HD3' ' A' ' 106' ' ' LYS . 40.4 m95 -90.05 -160.09 0.66 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.007 179.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.005 HD23 ' HB3' ' A' ' 5' ' ' SER . 36.2 mt -162.18 106.92 1.2 Allowed 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.843 HG22 ' HA ' ' A' ' 104' ' ' ALA . 9.7 p -103.47 -174.35 2.53 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.192 0.52 . . . . 0.0 111.704 -179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.54 ' CE2' HD22 ' A' ' 3' ' ' LEU . 0.2 OUTLIER -171.39 69.11 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.012 180.0 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -71.92 160.24 32.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.527 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.545 ' HB3' ' HD2' ' A' ' 85' ' ' PRO . 27.5 m-85 -97.61 171.52 5.86 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.113 -179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.546 ' HB3' ' HD2' ' A' ' 86' ' ' PRO . 43.7 Cg_exo -56.92 -178.03 0.08 OUTLIER 'Trans proline' 0 C--N 1.348 0.532 0 C-N-CA 122.759 2.306 . . . . 0.0 111.828 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.546 ' HD2' ' HB3' ' A' ' 85' ' ' PRO . 35.3 Cg_endo -65.04 -24.49 59.8 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.368 2.046 . . . . 0.0 112.566 -179.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -75.21 -62.68 1.47 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.285 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.515 ' HB ' ' HB3' ' A' ' 84' ' ' PHE . 22.0 t -66.26 -18.06 23.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.45 179.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.645 ' O ' ' HB2' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -57.35 -24.51 55.62 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.579 -0.282 . . . . 0.0 110.733 179.947 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.584 ' HA ' ' CD1' ' A' ' 94' ' ' ILE . 0.9 OUTLIER -104.44 -11.29 17.15 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.664 -179.453 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.639 ' O ' ' HB2' ' A' ' 95' ' ' GLN . 0.1 OUTLIER -86.86 -47.83 8.7 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -179.369 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.572 HD13 ' N ' ' A' ' 93' ' ' ASN . 1.1 tm? -102.66 -55.86 2.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.149 0.499 . . . . 0.0 111.16 -179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.745 ' O ' ' HB2' ' A' ' 100' ' ' TRP . 94.1 m-20 -52.35 -34.35 47.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.445 -0.798 . . . . 0.0 112.685 -177.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.642 HD12 ' O ' ' A' ' 89' ' ' ARG . 1.1 mp -93.3 -12.97 8.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.639 ' HB2' ' O ' ' A' ' 91' ' ' LYS . 2.4 tp60 -64.44 -4.56 4.06 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.131 179.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.797 ' HB2' ' CD1' ' A' ' 100' ' ' TRP . 63.5 m95 -84.9 10.18 12.39 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.625 0.232 . . . . 0.0 111.625 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 55.6 41.86 83.0 Favored Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.669 -0.777 . . . . 0.0 113.297 179.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.604 ' HB2' ' HE1' ' A' ' 100' ' ' TRP . 0.4 OUTLIER -175.13 27.96 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.327 0.584 . . . . 0.0 111.474 179.757 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.488 ' O ' ' HA ' ' A' ' 94' ' ' ILE . 2.7 t70 74.98 -69.71 0.17 Allowed 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.255 179.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.797 ' CD1' ' HB2' ' A' ' 96' ' ' TRP . 58.6 m95 50.75 -150.81 0.24 Allowed 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.471 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.698 ' HA ' ' HB3' ' A' ' 93' ' ' ASN . 11.9 ttmt 170.64 11.98 0.0 OUTLIER 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 122.602 0.361 . . . . 0.0 111.968 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.534 ' HA2' ' OD1' ' A' ' 93' ' ' ASN . . . 148.66 -162.23 28.83 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.427 -0.892 . . . . 0.0 111.211 -179.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.538 ' HA ' ' N ' ' A' ' 14' ' ' ARG . 0.4 OUTLIER -142.18 126.07 17.16 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 117.455 0.628 . . . . 0.0 111.413 179.773 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.843 ' HA ' HG22 ' A' ' 81' ' ' THR . . . -97.22 127.77 43.49 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.869 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.991 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 45.8 mt-30 -130.33 124.66 32.81 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -178.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.643 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 16.3 ttpp -103.41 138.1 40.61 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.98 178.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.592 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 14.3 m95 -104.76 165.21 11.22 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.346 0.593 . . . . 0.0 112.428 -178.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.695 ' HB2' ' HE1' ' A' ' 110' ' ' PHE . 96.1 m-85 -142.17 152.49 43.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.0 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.526 HD12 ' O ' ' A' ' 20' ' ' CYS . 18.1 tp -98.83 137.68 37.05 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.86 179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.967 ' CE2' HG22 ' A' ' 72' ' ' VAL . 49.2 m-85 -139.03 145.46 39.64 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -178.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.575 ' HB2' HD11 ' A' ' 73' ' ' ILE . 14.6 tttm -104.0 124.04 48.3 Favored 'General case' 0 CA--C 1.518 -0.259 0 CA-C-N 114.812 -1.086 . . . . 0.0 109.771 178.213 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.864 ' HD2' HD21 ' A' ' 21' ' ' LEU . 36.7 t80 -78.23 96.46 5.23 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.889 0.376 . . . . 0.0 110.568 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.452 ' H ' ' HA ' ' A' ' 70' ' ' ALA . 71.0 p -95.33 57.44 1.98 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.362 -179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.404 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -163.06 -143.81 3.82 Favored Glycine 0 C--N 1.333 0.374 0 C-N-CA 121.02 -0.61 . . . . 0.0 112.546 -179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.495 ' N ' ' HE1' ' A' ' 112' ' ' PHE . 7.4 mm100 -123.82 146.66 48.2 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.019 0.438 . . . . 0.0 111.463 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.424 ' HB3' ' CH2' ' A' ' 134' ' ' TRP . 90.3 m-20 -62.05 -23.57 66.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.785 -0.643 . . . . 0.0 111.834 -179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.17 -3.92 0.45 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.971 -179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 27.0 tp10 -90.27 -18.05 26.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.065 0.46 . . . . 0.0 110.544 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.627 HD13 ' CE1' ' A' ' 29' ' ' PHE . 8.4 mt -82.33 104.41 10.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.834 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.496 ' C ' ' H ' ' A' ' 122' ' ' LEU . 2.6 p-10 -102.61 -26.41 13.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.967 -0.56 . . . . 0.0 111.032 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.596 HD11 ' HD1' ' A' ' 134' ' ' TRP . 68.0 mt 68.69 -30.15 0.18 Allowed 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 179.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.596 ' HA ' ' HB3' ' A' ' 129' ' ' PRO . 95.6 mt -78.49 6.34 8.78 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.66 0.267 . . . . 0.0 111.385 -179.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -67.92 75.97 0.23 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.554 179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.69 -106.45 0.16 Allowed 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.833 -0.684 . . . . 0.0 111.09 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -169.55 -151.02 7.09 Favored Glycine 0 C--N 1.332 0.313 0 C-N-CA 120.55 -0.833 . . . . 0.0 112.634 -179.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 92.3 p -71.23 -5.38 31.61 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.616 0.246 . . . . 0.0 111.537 179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.59 ' O ' ' HG2' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -85.61 -77.5 0.29 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.585 0.231 . . . . 0.0 111.254 -179.498 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.638 ' HD2' ' CD ' ' A' ' 129' ' ' PRO . 4.1 mmtt -176.87 163.66 1.57 Allowed Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 121.373 0.606 . . . . 0.0 110.58 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.638 ' CD ' ' HD2' ' A' ' 128' ' ' LYS . 29.3 Cg_endo -74.2 -172.67 1.21 Allowed 'Trans proline' 0 N--CA 1.463 -0.291 0 C-N-CA 123.738 2.959 . . . . 0.0 112.644 179.23 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -107.83 -42.48 4.7 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.35 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.556 ' CB ' ' HB1' ' A' ' 31' ' ' ALA . 3.2 m-85 -130.76 140.84 50.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.092 0.472 . . . . 0.0 110.911 -179.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.758 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -78.44 -35.77 32.12 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.652 -0.704 . . . . 0.0 111.785 -179.675 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -155.75 152.46 28.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.369 -0.416 . . . . 0.0 110.74 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.596 ' HD1' HD11 ' A' ' 121' ' ' LEU . 29.0 p-90 -132.2 164.61 25.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.118 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.428 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 23.4 t -159.46 165.74 32.45 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 121.325 0.583 . . . . 0.0 112.048 -179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.564 ' CD2' ' OD1' ' A' ' 23' ' ' ASN . 91.6 m95 -108.39 102.09 11.23 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.481 178.329 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.419 ' O ' ' N ' ' A' ' 28' ' ' ILE . 28.9 m -117.47 171.29 6.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.837 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.585 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 27.8 p -71.99 167.1 34.54 Favored Pre-proline 0 CA--C 1.513 -0.465 0 C-N-CA 120.241 -0.584 . . . . 0.0 109.889 179.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.725 ' HA ' HG13 ' A' ' 28' ' ' ILE . 21.7 Cg_exo -57.7 -58.83 0.69 Allowed 'Trans proline' 0 N--CA 1.454 -0.829 0 C-N-CA 121.428 1.418 . . . . 0.0 109.889 178.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.11 -27.17 68.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.035 178.594 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.474 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 2.0 mm-40 -71.91 -48.36 46.04 Favored 'General case' 0 CA--C 1.513 -0.461 0 CA-C-O 121.1 0.476 . . . . 0.0 110.259 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.828 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -55.37 -40.74 71.69 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.22 179.711 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.787 HG21 ' HG2' ' A' ' 155' ' ' LYS . 27.3 mm -61.83 -31.84 52.24 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.329 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.73 -53.42 10.37 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.354 0.597 . . . . 0.0 110.33 179.1 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -72.08 -18.62 61.91 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.835 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.705 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 14.8 t -73.77 174.69 8.07 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.517 -0.473 . . . . 0.0 111.395 -179.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.402 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 18.7 m -86.41 149.56 4.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.589 179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.605 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 19.9 mt-10 -47.33 -52.3 16.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.95 0.405 . . . . 0.0 111.334 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -55.26 -3.71 0.06 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.587 ' HB3' ' CZ ' ' A' ' 154' ' ' TYR . 10.2 mmtm -136.08 -8.2 2.06 Favored 'General case' 0 N--CA 1.463 0.192 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -178.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.746 ' HG3' ' CG2' ' A' ' 143' ' ' ILE . 2.6 ttpp -64.53 -57.77 15.87 Favored Pre-proline 0 C--N 1.322 -0.589 0 C-N-CA 121.145 -0.222 . . . . 0.0 110.66 179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.605 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 36.7 Cg_endo -66.06 -30.95 46.88 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.566 2.177 . . . . 0.0 111.469 179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.801 ' O ' HG23 ' A' ' 157' ' ' VAL . 23.4 t -68.07 -51.71 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.587 ' CZ ' ' HB3' ' A' ' 150' ' ' LYS . 15.4 m-30 -65.36 -39.17 91.98 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.591 178.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.787 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -54.41 -45.26 72.9 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.934 -179.951 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.405 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.7 OUTLIER -66.94 -35.46 80.03 Favored 'General case' 0 N--CA 1.446 -0.674 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 179.307 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.801 HG23 ' O ' ' A' ' 153' ' ' VAL . 46.4 t -65.16 -41.63 92.23 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.85 0 CA-C-N 115.254 -0.885 . . . . 0.0 109.721 178.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.499 HD22 ' HB3' ' A' ' 139' ' ' PRO . 30.1 mt -63.41 -43.03 98.7 Favored 'General case' 0 CA--C 1.518 -0.263 0 CA-C-N 115.859 -0.61 . . . . 0.0 111.164 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -55.88 -38.45 70.18 Favored 'General case' 0 CA--C 1.518 -0.284 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.306 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.886 HG11 ' HA ' ' A' ' 76' ' ' VAL . 85.0 t -68.79 -43.08 83.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.619 ' CE2' HG12 ' A' ' 157' ' ' VAL . 22.2 m-30 -80.77 5.19 16.57 Favored 'General case' 0 N--CA 1.453 -0.295 0 CA-C-N 115.277 -0.874 . . . . 0.0 111.964 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.593 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.32 -52.89 71.21 Favored Pre-proline 0 C--N 1.329 -0.29 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.07 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.593 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.4 Cg_endo -57.75 -13.41 14.35 Favored 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 121.664 1.576 . . . . 0.0 111.741 179.144 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.504 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 86.9 m-70 -108.06 -21.91 12.61 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.09 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 85.9 mt . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.397 -0.811 . . . . 0.0 110.569 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.114 0 N-CA-C 112.427 -0.269 . . . . 0.0 112.427 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.513 ' HB2' HD23 ' A' ' 3' ' ' LEU . 38.2 Cg_endo -66.78 -174.99 0.51 Allowed 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.34 2.027 . . . . 0.0 112.39 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.653 HD13 HG22 ' A' ' 153' ' ' VAL . 0.4 OUTLIER 37.88 98.63 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.313 -179.654 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -82.54 -14.66 75.53 Favored Glycine 0 CA--C 1.52 0.349 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.295 179.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.767 ' HB3' HD23 ' A' ' 80' ' ' LEU . 0.7 OUTLIER 64.18 -81.68 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.929 0.395 . . . . 0.0 111.617 179.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.2 mtm 65.47 138.86 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.395 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.728 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 4.2 p30 -66.63 -5.49 11.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.343 -0.389 . . . . 0.0 111.85 -179.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.27 130.86 13.9 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 110.235 -0.283 . . . . 0.0 110.235 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.5 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 40.9 Cg_endo -66.83 107.96 1.38 Allowed 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.333 2.022 . . . . 0.0 112.249 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.505 ' HG2' ' CE1' ' A' ' 13' ' ' TYR . 2.0 Cg_endo -43.49 168.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 123.357 2.705 . . . . 0.0 112.855 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -51.05 128.58 21.95 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.905 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.589 ' CA ' ' HA ' ' A' ' 100' ' ' TRP . . . 61.64 75.66 0.29 Allowed Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.419 -0.896 . . . . 0.0 112.778 179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.508 ' CE2' ' HA3' ' A' ' 102' ' ' GLY . 11.7 m-85 -151.13 109.62 3.8 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.408 ' HA ' ' CZ3' ' A' ' 100' ' ' TRP . 1.5 tpt180 -70.07 95.55 0.97 Allowed 'General case' 0 C--O 1.232 0.165 0 CA-C-O 120.878 0.37 . . . . 0.0 111.069 -179.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.618 ' HB2' ' HZ3' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -51.98 131.84 31.85 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.239 0.542 . . . . 0.0 111.862 -179.788 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.678 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 2.1 m-80 -131.18 174.95 9.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.339 -0.846 . . . . 0.0 108.742 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.768 ' O ' ' HG2' ' A' ' 44' ' ' GLN . 16.0 m -143.82 157.81 16.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.95 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.59 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -127.96 167.24 20.3 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.22 178.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.057 HG21 HD22 ' A' ' 61' ' ' LEU . 5.3 mp -126.91 123.2 62.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.24 0.543 . . . . 0.0 112.461 -179.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.654 ' O ' HD12 ' A' ' 109' ' ' LEU . 1.4 t -107.49 96.12 6.18 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.438 -0.801 . . . . 0.0 108.9 178.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.817 HD22 HG11 ' A' ' 67' ' ' VAL . 26.5 tp -99.61 122.97 43.42 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.917 -178.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.612 ' HG2' HD11 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -119.64 151.53 38.54 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.399 -179.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.711 ' OD1' ' CE3' ' A' ' 136' ' ' TRP . 0.1 OUTLIER -96.24 175.44 6.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.313 179.837 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -58.31 -3.68 0.29 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.352 177.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.595 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.7 OUTLIER -99.1 -1.26 39.96 Favored 'General case' 0 CA--C 1.521 -0.145 0 CA-C-O 120.605 0.24 . . . . 0.0 111.376 -179.251 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.595 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 1.4 mmtm 75.12 20.98 2.01 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.066 -0.516 . . . . 0.0 109.961 -178.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.721 ' C ' HD12 ' A' ' 28' ' ' ILE . 4.8 mttt -93.41 -178.64 4.8 Favored 'General case' 0 N--CA 1.452 -0.357 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 178.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.721 HD12 ' C ' ' A' ' 27' ' ' LYS . 2.8 mp -135.67 144.93 32.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 121.585 0.707 . . . . 0.0 111.886 -179.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.578 ' CE1' HD13 ' A' ' 119' ' ' ILE . 33.2 t80 -66.17 108.33 2.24 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.985 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.654 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -102.99 140.19 37.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.163 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -139.07 134.16 32.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.747 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.58 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 55.6 p -100.12 149.21 23.75 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.075 0.464 . . . . 0.0 111.785 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.622 ' O ' ' N ' ' A' ' 35' ' ' ASP . 26.3 mtp85 -72.42 129.95 39.57 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.489 179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.716 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -55.72 56.22 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 122.995 0.518 . . . . 0.0 112.346 179.799 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.622 ' N ' ' O ' ' A' ' 33' ' ' ARG . 3.0 p-10 -177.08 -33.03 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 121.157 0.503 . . . . 0.0 109.866 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.459 HD12 ' HE ' ' A' ' 33' ' ' ARG . 21.1 mt -116.66 105.72 49.46 Favored Pre-proline 0 N--CA 1.452 -0.366 0 CA-C-N 115.461 -0.79 . . . . 0.0 110.482 179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.52 -19.62 21.54 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.442 2.095 . . . . 0.0 112.88 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -92.38 -9.74 40.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.551 -179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.636 ' HB1' HG13 ' A' ' 147' ' ' VAL . . . -94.19 106.44 18.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.805 0.336 . . . . 0.0 111.278 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.594 ' O ' ' HA ' ' A' ' 146' ' ' THR . 68.9 m95 -105.71 144.61 32.22 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.75 178.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.589 ' HG3' ' HG1' ' A' ' 146' ' ' THR . 0.8 OUTLIER -153.73 -125.73 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.514 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.095 -179.742 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.632 ' SD ' HD21 ' A' ' 142' ' ' LEU . 0.0 OUTLIER 177.62 160.81 0.56 Allowed Pre-proline 0 N--CA 1.453 -0.32 0 N-CA-C 109.897 -0.408 . . . . 0.0 109.897 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.743 ' HG3' HD13 ' A' ' 61' ' ' LEU . 1.6 Cg_endo -40.69 142.29 0.74 Allowed 'Trans proline' 0 CA--C 1.53 0.285 0 C-N-CA 123.546 2.831 . . . . 0.0 113.03 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.768 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER -172.62 146.4 1.68 Allowed 'General case' 0 C--O 1.231 0.106 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.884 -179.899 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -160.62 -162.63 12.71 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.332 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.678 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -120.05 139.93 14.21 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.581 -0.818 . . . . 0.0 112.887 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.629 ' CG1' HG13 ' A' ' 17' ' ' VAL . 28.7 mt -69.37 142.03 16.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.838 0.352 . . . . 0.0 111.131 -179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -69.01 -174.12 0.57 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.93 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.5 tt0 -49.66 -79.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.022 -0.536 . . . . 0.0 111.049 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -110.1 50.32 0.78 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.737 -0.745 . . . . 0.0 112.285 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -111.57 149.59 31.21 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.822 0.344 . . . . 0.0 110.576 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -70.41 162.38 70.57 Favored Pre-proline 0 C--N 1.325 -0.497 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.159 179.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.565 ' HB3' HD11 ' A' ' 47' ' ' ILE . 1.2 Cg_endo -82.96 -51.58 0.04 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.362 0 C-N-CA 122.974 2.45 . . . . 0.0 112.021 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.737 ' CZ ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -49.98 -47.33 52.84 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.623 179.594 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -69.25 -38.26 78.37 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.046 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.82 -45.02 95.63 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.415 -0.587 . . . . 0.0 109.415 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.679 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -58.05 -55.48 34.35 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.405 178.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.573 HD11 ' CD ' ' A' ' 54' ' ' ARG . 47.2 mt -57.55 -46.53 86.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.183 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -63.08 -66.08 0.59 Allowed 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.88 -0.328 . . . . 0.0 111.278 -179.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.551 ' CG ' HD11 ' A' ' 19' ' ' ILE . 23.6 pt-20 -43.06 -40.45 3.12 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 121.114 0.483 . . . . 0.0 110.199 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.057 HD22 HG21 ' A' ' 19' ' ' ILE . 4.9 tp -52.23 -47.42 65.7 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.376 178.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.86 ' HG2' HG23 ' A' ' 68' ' ' THR . 1.6 tmm_? -63.51 -63.91 1.05 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.957 179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -51.13 -21.17 1.8 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.985 -0.552 . . . . 0.0 112.17 -179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 55.8 mt-10 -97.53 -38.41 9.58 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.722 HG22 ' CD2' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -128.88 -15.15 4.37 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -178.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.51 ' HA2' ' HD2' ' A' ' 62' ' ' ARG . . . 91.54 -14.23 64.5 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.193 -1.004 . . . . 0.0 112.835 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.817 HG11 HD22 ' A' ' 21' ' ' LEU . 55.7 t -56.26 110.57 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.104 0.478 . . . . 0.0 111.321 179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.86 HG23 ' HG2' ' A' ' 62' ' ' ARG . 0.9 OUTLIER -122.34 -39.8 2.54 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.466 178.203 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.407 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 9.4 m -62.37 74.39 0.02 OUTLIER 'General case' 0 C--O 1.233 0.197 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.456 179.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -162.85 154.86 18.33 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.922 0.391 . . . . 0.0 111.795 -179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.22 146.63 50.35 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.209 179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.737 HG21 ' CZ ' ' A' ' 54' ' ' ARG . 8.5 t -76.73 129.96 36.75 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.202 0.525 . . . . 0.0 112.224 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.702 HD11 ' HB2' ' A' ' 111' ' ' LYS . 0.7 OUTLIER -113.3 -18.12 7.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.947 179.43 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.464 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -169.04 178.63 4.38 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.147 0.499 . . . . 0.0 112.013 -179.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.465 ' HB3' ' HD1' ' A' ' 108' ' ' PHE . 1.4 pm0 -157.66 152.71 25.66 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.882 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.841 ' HA ' HG11 ' A' ' 160' ' ' VAL . 33.7 t -72.93 136.61 79.78 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.265 -179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.615 ' HD2' HG21 ' A' ' 160' ' ' VAL . 20.7 Cg_endo -59.45 -76.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.943 2.428 . . . . 0.0 112.564 -179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.728 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -80.65 171.68 14.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.698 -179.179 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.618 ' HZ3' ' HB2' ' A' ' 15' ' ' ARG . 27.9 m95 -94.33 97.53 10.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.608 179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.767 HD23 ' HB3' ' A' ' 5' ' ' SER . 51.1 mt -58.97 109.39 0.82 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.8 0.333 . . . . 0.0 110.89 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.762 HG22 ' HA ' ' A' ' 104' ' ' ALA . 5.1 p -100.01 -167.56 1.47 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.007 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.412 ' HD1' ' HB3' ' A' ' 3' ' ' LEU . 2.5 t80 -170.64 80.17 0.09 Allowed 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.662 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -70.22 158.3 36.09 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.441 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.507 ' HB2' HD12 ' A' ' 92' ' ' LEU . 6.1 m-85 -102.87 166.42 11.94 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 120.948 0.404 . . . . 0.0 112.007 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.519 ' HB2' ' HD2' ' A' ' 86' ' ' PRO . 85.8 Cg_endo -92.1 177.26 1.73 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.332 2.688 . . . . 0.0 112.549 -179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.519 ' HD2' ' HB2' ' A' ' 85' ' ' PRO . 10.9 Cg_endo -53.07 159.65 5.2 Favored 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.392 2.061 . . . . 0.0 112.026 179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.409 ' HB3' ' O ' ' A' ' 86' ' ' PRO . 2.6 tptt 70.86 -58.41 0.57 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.126 -179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.41 ' CG1' ' HD2' ' A' ' 84' ' ' PHE . 11.2 t -65.07 -37.38 80.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-O 120.988 0.423 . . . . 0.0 110.64 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.558 ' HD2' HD22 ' A' ' 93' ' ' ASN . 0.0 OUTLIER -48.78 -38.49 22.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.93 -179.712 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.714 ' HA ' HD13 ' A' ' 94' ' ' ILE . 0.0 OUTLIER -70.41 -24.41 62.92 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.79 0.329 . . . . 0.0 110.791 179.509 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.529 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -98.5 -7.82 27.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.803 179.478 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.596 HD13 ' N ' ' A' ' 93' ' ' ASN . 0.8 OUTLIER -122.09 -59.29 1.67 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.329 -179.602 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.639 ' CG ' ' HA ' ' A' ' 101' ' ' LYS . 31.9 t-20 -61.86 -64.28 0.99 Allowed 'General case' 0 N--CA 1.467 0.382 0 CA-C-O 121.207 0.527 . . . . 0.0 111.924 -179.683 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.714 HD13 ' HA ' ' A' ' 90' ' ' GLU . 3.9 mp -63.03 -9.89 5.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.376 -178.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.529 ' HG3' ' O ' ' A' ' 91' ' ' LYS . 6.2 mm100 -78.19 -1.82 34.61 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.247 179.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.667 ' HB3' ' CD1' ' A' ' 100' ' ' TRP . 86.6 m95 -91.47 -3.11 56.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.544 0.212 . . . . 0.0 111.566 -179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 71.62 -77.37 0.63 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.755 -0.736 . . . . 0.0 113.377 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.402 ' HB3' ' NE1' ' A' ' 100' ' ' TRP . 0.2 OUTLIER -66.11 -168.56 0.05 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.892 0.377 . . . . 0.0 111.433 -179.267 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -73.33 104.88 4.5 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.785 -179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.667 ' CD1' ' HB3' ' A' ' 96' ' ' TRP . 71.7 m95 -141.57 -164.59 1.81 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.838 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.639 ' HA ' ' CG ' ' A' ' 93' ' ' ASN . 0.7 OUTLIER 164.56 24.21 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 O-C-N 123.226 0.329 . . . . 0.0 111.589 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.508 ' HA3' ' CE2' ' A' ' 13' ' ' TYR . . . 154.3 -160.44 29.5 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.653 -0.784 . . . . 0.0 111.492 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 81' ' ' THR . 2.0 tt0 -149.27 122.26 8.81 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.827 0.314 . . . . 0.0 111.34 -179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.762 ' HA ' HG22 ' A' ' 81' ' ' THR . . . -97.96 121.18 39.56 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.551 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 2.9 mt-30 -123.19 123.75 41.48 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -178.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.427 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 1.0 OUTLIER -104.25 132.66 50.27 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.435 178.364 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.59 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 51.6 m95 -101.74 166.53 10.63 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.241 0.543 . . . . 0.0 112.448 -178.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.575 ' CD1' ' HG2' ' A' ' 54' ' ' ARG . 98.0 m-85 -141.47 151.63 43.52 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.955 -179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.654 HD12 ' O ' ' A' ' 20' ' ' CYS . 29.5 tp -107.68 126.73 52.95 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.968 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.883 ' CE2' HG23 ' A' ' 19' ' ' ILE . 4.1 m-85 -132.8 145.54 51.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.315 0.578 . . . . 0.0 111.918 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.702 ' HB2' HD11 ' A' ' 73' ' ' ILE . 47.8 tttt -95.27 127.69 41.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.602 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.804 ' CD1' HD21 ' A' ' 21' ' ' LEU . 38.2 t80 -78.33 101.33 7.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.898 0.38 . . . . 0.0 110.853 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 41.6 p -100.53 53.07 0.87 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.702 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.407 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -158.04 -146.49 4.53 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.409 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -121.85 152.1 39.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.995 0.426 . . . . 0.0 111.26 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.449 ' HB3' ' HH2' ' A' ' 134' ' ' TRP . 61.4 m-20 -60.12 -35.1 74.51 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.874 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -58.18 -2.05 0.16 Allowed 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.894 -0.594 . . . . 0.0 112.116 -179.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.413 ' H ' ' C ' ' A' ' 116' ' ' ASP . 0.7 OUTLIER -90.41 -15.8 30.26 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-O 120.942 0.401 . . . . 0.0 110.853 179.543 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.68 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 14.3 mt -81.05 100.6 5.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.223 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 65' ' ' THR . 6.5 p-10 -103.78 93.68 5.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.339 178.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.722 ' CD2' HG22 ' A' ' 65' ' ' THR . 39.0 mt -65.81 -48.92 70.1 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.076 0.465 . . . . 0.0 110.1 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.54 HD22 ' HG3' ' A' ' 129' ' ' PRO . 61.1 mt -77.25 164.89 25.17 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.807 179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 140.8 -8.91 2.8 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-N 115.817 -0.629 . . . . 0.0 112.371 -179.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -96.14 79.71 3.21 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.811 0.339 . . . . 0.0 110.237 179.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -83.07 33.32 2.91 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.703 -179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 25.4 t -106.78 -37.11 6.49 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.833 0.349 . . . . 0.0 110.653 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -146.99 -59.2 0.28 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.888 -179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 27.6 pttt -178.3 156.02 0.99 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-O 121.132 0.492 . . . . 0.0 111.336 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.54 ' HG3' HD22 ' A' ' 122' ' ' LEU . 14.6 Cg_endo -71.49 -176.88 2.14 Favored 'Trans proline' 0 N--CA 1.46 -0.48 0 C-N-CA 122.709 2.273 . . . . 0.0 112.432 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.653 ' O ' HD12 ' A' ' 34' ' ' LEU . 0.5 OUTLIER -97.22 -69.89 0.74 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.371 -179.534 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.675 ' CE2' HG23 ' A' ' 65' ' ' THR . 2.2 m-85 -102.23 139.71 37.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.136 0.493 . . . . 0.0 110.573 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.716 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -82.34 -36.89 16.01 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.013 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -151.57 149.33 29.05 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.86 0.362 . . . . 0.0 110.53 179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.707 ' HD1' HD11 ' A' ' 121' ' ' LEU . 31.9 p-90 -136.53 166.41 23.58 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.063 0.458 . . . . 0.0 111.236 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.483 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 29.5 t -162.56 178.48 8.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.381 -179.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.711 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 64.8 m95 -114.21 99.66 7.78 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.742 178.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 22.2 m -113.89 169.05 5.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.347 179.411 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.572 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 20.9 p -74.71 171.91 10.29 Favored Pre-proline 0 C--N 1.324 -0.536 0 C-N-CA 120.502 -0.479 . . . . 0.0 109.881 179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.669 ' HB3' HD22 ' A' ' 158' ' ' LEU . 13.1 Cg_exo -62.47 -54.36 1.37 Allowed 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 121.488 1.459 . . . . 0.0 110.279 179.143 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.67 -29.1 70.37 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.995 178.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.443 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 33.3 mt-30 -71.69 -47.33 54.79 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.328 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.654 HD13 ' HB2' ' A' ' 30' ' ' ALA . 64.2 tp -57.95 -38.92 76.86 Favored 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 109.565 -0.531 . . . . 0.0 109.565 179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.714 ' O ' ' HG2' ' A' ' 151' ' ' LYS . 27.7 mm -61.27 -38.8 80.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.517 179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.92 -50.48 49.13 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.223 0.535 . . . . 0.0 110.565 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.429 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -74.54 -19.16 60.45 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.267 -0.879 . . . . 0.0 112.718 -179.154 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.949 HG23 ' HG3' ' A' ' 151' ' ' LYS . 14.7 t -74.88 174.03 9.82 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.487 -179.429 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.636 HG13 ' HB1' ' A' ' 39' ' ' ALA . 24.1 m -78.08 154.73 5.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.46 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.759 ' HA ' ' HD3' ' A' ' 151' ' ' LYS . 13.5 mt-10 -60.89 -54.85 39.98 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.079 179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.517 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 35.7 p90 -55.52 -1.48 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 113.135 0.791 . . . . 0.0 113.135 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.429 ' HG3' ' CD2' ' A' ' 149' ' ' PHE . 58.1 mttt -135.27 -6.82 2.29 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.949 ' HG3' HG23 ' A' ' 146' ' ' THR . 14.0 mtpp -60.71 -62.19 6.47 Favored Pre-proline 0 CA--C 1.531 0.237 0 O-C-N 122.317 -0.239 . . . . 0.0 111.335 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.495 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 18.6 Cg_endo -59.92 -27.13 84.24 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.239 1.959 . . . . 0.0 111.334 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.653 HG22 HD13 ' A' ' 3' ' ' LEU . 26.3 t -68.8 -50.85 50.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.474 ' HE1' ' CZ2' ' A' ' 107' ' ' TRP . 14.3 m-30 -65.78 -39.56 91.1 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.782 -0.644 . . . . 0.0 109.672 178.158 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.655 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.5 OUTLIER -56.09 -40.65 73.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.023 -0.989 . . . . 0.0 111.332 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.439 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.6 OUTLIER -70.57 -31.41 68.43 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 109.056 -0.72 . . . . 0.0 109.056 178.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 153' ' ' VAL . 90.3 t -66.28 -41.31 88.84 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.697 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.593 178.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.669 HD22 ' HB3' ' A' ' 139' ' ' PRO . 58.7 mt -63.78 -41.97 97.86 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.468 179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 14.5 m -54.54 -41.02 69.25 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.841 HG11 ' HA ' ' A' ' 76' ' ' VAL . 98.4 t -66.57 -44.07 90.27 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.553 178.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.625 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 22.4 m-30 -81.21 5.09 18.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.879 -1.055 . . . . 0.0 112.384 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.7 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . . . -59.4 -50.45 87.29 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.015 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.7 ' HD3' ' HB3' ' A' ' 162' ' ' ALA . 36.8 Cg_exo -59.22 -11.86 14.42 Favored 'Trans proline' 0 C--N 1.344 0.335 0 C-N-CA 122.528 2.152 . . . . 0.0 112.051 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.464 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 73.8 m-70 -113.13 -17.52 12.37 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.437 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.625 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 97.9 mt . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.15 -0.929 . . . . 0.0 110.791 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.406 ' N ' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.603 -0.199 . . . . 0.0 112.603 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.406 ' HD3' ' N ' ' A' ' 1' ' ' GLY . 51.8 Cg_exo -53.93 155.99 13.51 Favored 'Trans proline' 0 C--N 1.344 0.309 0 C-N-CA 122.535 2.157 . . . . 0.0 112.277 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.414 HD11 HG22 ' A' ' 153' ' ' VAL . 2.3 tp 60.18 108.35 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.315 179.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.07 -47.61 12.98 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.518 -0.848 . . . . 0.0 111.552 179.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.657 ' HA ' ' O ' ' A' ' 79' ' ' TRP . 0.7 OUTLIER 71.69 -75.43 0.08 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.089 0.471 . . . . 0.0 112.023 179.269 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.469 ' HB2' ' O ' ' A' ' 5' ' ' SER . 4.0 mpp? 67.79 131.37 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.039 -178.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.607 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 30.1 t70 -66.04 -35.65 81.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.822 -179.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.98 152.15 40.28 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.508 179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.499 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 59.1 Cg_endo -72.11 106.98 2.14 Favored 'Trans proline' 0 C--N 1.344 0.294 0 C-N-CA 122.465 2.11 . . . . 0.0 112.199 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.617 ' HB2' ' CE1' ' A' ' 13' ' ' TYR . 11.6 Cg_endo -54.17 -174.07 0.02 OUTLIER 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 123.205 2.604 . . . . 0.0 112.707 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 13' ' ' TYR . 1.5 pt-20 -52.48 -157.66 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.859 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.584 ' O ' ' HA ' ' A' ' 100' ' ' TRP . . . -58.69 65.89 0.01 OUTLIER Glycine 0 C--N 1.33 0.23 0 CA-C-N 116.004 -0.543 . . . . 0.0 113.98 -178.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.617 ' CE1' ' HB2' ' A' ' 10' ' ' PRO . 16.5 m-85 -93.12 148.11 22.29 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.746 ' HA ' ' HZ3' ' A' ' 100' ' ' TRP . 1.0 OUTLIER -65.16 82.95 0.05 OUTLIER 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 121.143 0.497 . . . . 0.0 111.021 179.497 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.556 ' HG2' HD12 ' A' ' 47' ' ' ILE . 1.1 ttp180 -50.89 102.49 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.444 -0.798 . . . . 0.0 111.181 179.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.78 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 0.9 OUTLIER -134.48 167.35 20.93 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.762 -0.654 . . . . 0.0 109.387 179.091 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.644 HG13 ' CG1' ' A' ' 47' ' ' ILE . 12.5 m -136.05 166.33 27.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.976 0.417 . . . . 0.0 111.289 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.536 ' HA3' ' CE3' ' A' ' 107' ' ' TRP . . . -134.02 154.77 21.51 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.546 179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.952 HG21 HD22 ' A' ' 61' ' ' LEU . 3.7 mp -125.45 121.5 60.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 121.074 0.464 . . . . 0.0 111.862 -179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.553 ' O ' HD12 ' A' ' 109' ' ' LEU . 0.4 OUTLIER -101.1 92.24 4.91 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.742 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.778 HD22 HG11 ' A' ' 67' ' ' VAL . 22.7 tp -96.57 113.38 24.94 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.534 -178.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.515 ' SD ' HD11 ' A' ' 109' ' ' LEU . 1.3 ptt? -116.14 167.24 11.17 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.707 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.636 ' OD1' ' CE3' ' A' ' 136' ' ' TRP . 0.0 OUTLIER -102.09 168.99 9.02 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.384 179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.0 m-20 -56.79 -3.55 0.12 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.418 177.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.573 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 1.8 m-20 -99.55 3.03 45.28 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -179.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 3.7 mmtm 74.46 20.4 2.52 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.114 -178.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.582 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 1.2 mmtt -94.85 145.35 24.96 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.809 HD11 ' HG3' ' A' ' 139' ' ' PRO . 1.1 mm -99.32 140.95 17.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.995 0.426 . . . . 0.0 112.082 -177.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.495 ' CE1' HD13 ' A' ' 119' ' ' ILE . 73.1 t80 -78.15 135.23 37.62 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.463 178.228 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.621 ' HB2' ' CD1' ' A' ' 142' ' ' LEU . . . -141.3 153.83 45.38 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.776 0.322 . . . . 0.0 110.79 -179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.636 ' HB1' ' HB3' ' A' ' 131' ' ' PHE . . . -142.55 145.13 33.29 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.64 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.633 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 17.6 p -94.31 148.18 22.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.543 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.4 mtp180 -69.35 133.6 48.03 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.084 0.469 . . . . 0.0 111.006 -179.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.001 ' H ' HD23 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -38.47 -48.78 1.42 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.221 -0.899 . . . . 0.0 110.612 -178.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.426 ' O ' HD13 ' A' ' 36' ' ' ILE . 0.8 OUTLIER -75.17 -34.9 61.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 114.974 -1.012 . . . . 0.0 112.171 -179.569 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.426 HD13 ' O ' ' A' ' 35' ' ' ASP . 29.2 mm -123.31 104.41 34.73 Favored Pre-proline 0 C--O 1.233 0.184 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 -178.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_exo -68.01 -16.89 45.89 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.862 2.375 . . . . 0.0 112.377 179.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -89.89 -10.15 46.3 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.425 -179.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.633 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.78 88.64 6.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.935 0.398 . . . . 0.0 110.338 179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.621 ' O ' ' HA ' ' A' ' 146' ' ' THR . 75.8 m95 -85.57 146.53 26.85 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.365 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.494 ' HB3' ' OH ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -165.41 162.16 19.3 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.921 -179.871 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.751 ' SD ' HD21 ' A' ' 142' ' ' LEU . 0.0 OUTLIER -98.3 156.93 35.25 Favored Pre-proline 0 C--N 1.324 -0.517 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.079 179.206 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.524 ' HG3' HD13 ' A' ' 61' ' ' LEU . 1.9 Cg_endo -44.34 155.07 0.26 Allowed 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.048 2.499 . . . . 0.0 113.08 -179.302 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.587 ' HA ' HD12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -176.17 171.36 2.52 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.207 -179.576 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.484 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . 176.9 152.55 9.92 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.677 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.78 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -77.75 135.97 17.35 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.602 -0.809 . . . . 0.0 113.358 -179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.644 ' CG1' HG13 ' A' ' 17' ' ' VAL . 16.9 mt -69.46 145.6 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.734 0.302 . . . . 0.0 111.007 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -69.57 -175.66 0.88 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.028 0.442 . . . . 0.0 111.257 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -52.22 -47.5 65.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.856 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -143.34 52.79 0.62 Allowed Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.286 -179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -112.9 150.22 32.08 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.772 0.32 . . . . 0.0 110.446 179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.1 156.26 90.21 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.903 179.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 3.0 Cg_exo -73.93 -49.35 0.2 Allowed 'Trans proline' 0 CA--C 1.515 -0.442 0 C-N-CA 122.41 2.074 . . . . 0.0 111.113 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.923 ' CZ ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -53.13 -46.57 68.85 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.307 179.293 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.542 ' HA ' HD12 ' A' ' 58' ' ' ILE . 84.9 m-20 -67.7 -40.11 84.33 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.135 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.04 -44.7 96.13 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 179.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.808 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -56.07 -52.21 65.07 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.931 178.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.705 HD11 ' HE ' ' A' ' 54' ' ' ARG . 22.4 mt -56.43 -56.45 13.59 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.478 -0.783 . . . . 0.0 111.548 179.414 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.35 -60.05 4.42 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.672 -179.533 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.484 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -45.87 -47.53 16.06 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.155 0.503 . . . . 0.0 109.744 179.081 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.952 HD22 HG21 ' A' ' 19' ' ' ILE . 4.2 tp -50.25 -46.64 55.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.324 178.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.798 ' HG3' HG23 ' A' ' 68' ' ' THR . 18.7 ttm180 -64.98 -63.51 1.09 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.357 179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -49.78 -22.66 1.5 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.978 -0.555 . . . . 0.0 112.436 -179.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.693 ' O ' HD21 ' A' ' 122' ' ' LEU . 31.3 mt-10 -97.01 -36.58 10.47 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 113.31 0.855 . . . . 0.0 113.31 -177.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.542 HG22 ' CD2' ' A' ' 121' ' ' LEU . 0.6 OUTLIER -124.26 -13.77 7.13 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.979 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 86.04 -16.24 43.93 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.232 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.778 HG11 HD22 ' A' ' 21' ' ' LEU . 52.3 t -58.13 117.26 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 CA-C-O 121.254 0.549 . . . . 0.0 111.42 179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.798 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.9 OUTLIER -122.64 -38.13 2.68 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.652 178.568 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 19.8 m -62.31 73.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.581 179.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.595 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -160.74 157.69 27.35 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.019 0.438 . . . . 0.0 112.126 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -131.53 152.19 50.96 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.95 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.923 HG21 ' CZ ' ' A' ' 54' ' ' ARG . 4.2 t -75.24 127.15 36.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.148 0.499 . . . . 0.0 111.428 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.569 HD11 ' HB2' ' A' ' 111' ' ' LYS . 1.6 mt -107.95 -19.67 6.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.596 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.454 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -169.56 176.78 4.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.13 -0.487 . . . . 0.0 112.0 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.3 OUTLIER -154.89 146.44 23.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.752 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.821 ' HA ' HG11 ' A' ' 160' ' ' VAL . 50.7 t -72.58 140.58 81.82 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.106 0.479 . . . . 0.0 111.203 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.635 ' HD2' HG13 ' A' ' 76' ' ' VAL . 26.8 Cg_endo -62.08 -62.67 0.11 Allowed 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 123.27 2.647 . . . . 0.0 113.138 -179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.607 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -96.53 177.05 5.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.049 -178.514 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.657 ' O ' ' HA ' ' A' ' 5' ' ' SER . 49.9 m95 -93.38 97.45 10.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.174 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.923 HD12 ' CD1' ' A' ' 107' ' ' TRP . 38.3 mt -57.27 110.57 0.87 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.885 0.374 . . . . 0.0 111.087 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.768 HG22 ' HA ' ' A' ' 104' ' ' ALA . 1.8 p -112.78 -165.3 0.98 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.96 -0.563 . . . . 0.0 110.804 -179.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -170.58 72.8 0.06 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.767 179.62 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -70.99 164.77 24.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.459 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.626 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 3.9 m-85 -104.63 160.43 26.03 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.229 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.495 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 30.4 Cg_exo -60.82 178.44 0.49 Allowed 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 122.662 2.241 . . . . 0.0 111.285 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.472 ' HD2' ' CB ' ' A' ' 85' ' ' PRO . 17.9 Cg_endo -60.08 -16.09 37.48 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.181 1.92 . . . . 0.0 112.98 -179.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.47 -62.05 1.54 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.769 0.319 . . . . 0.0 111.341 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.626 ' HB ' ' HB3' ' A' ' 84' ' ' PHE . 31.0 t -66.07 -6.52 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.704 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.535 ' O ' ' HB2' ' A' ' 93' ' ' ASN . 0.5 OUTLIER -67.66 -0.33 3.88 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.685 ' HA ' HD13 ' A' ' 94' ' ' ILE . 0.4 OUTLIER -120.14 -22.48 6.62 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.715 179.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.561 ' O ' ' HB3' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -91.12 -13.69 32.58 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.095 179.477 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.72 HD13 ' N ' ' A' ' 93' ' ' ASN . 1.2 tm? -121.45 -64.16 1.25 Allowed 'General case' 0 C--N 1.333 -0.12 0 CA-C-O 121.39 0.614 . . . . 0.0 110.443 179.201 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.811 ' HB3' ' HA ' ' A' ' 101' ' ' LYS . 4.7 m120 -51.75 -23.2 4.28 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.615 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.685 HD13 ' HA ' ' A' ' 90' ' ' GLU . 2.0 mp -112.54 -6.93 11.84 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.413 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.36 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.567 ' HG2' ' O ' ' A' ' 92' ' ' LEU . 1.3 pt20 -61.4 -11.4 10.15 Favored 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.574 ' HB2' ' CD1' ' A' ' 100' ' ' TRP . 11.9 m95 -93.37 35.69 1.09 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.499 -179.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 54.5 84.58 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.883 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 10.3 p 58.17 162.67 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.82 0.343 . . . . 0.0 111.185 179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.455 ' O ' ' HB2' ' A' ' 100' ' ' TRP . 2.0 t0 56.26 -160.25 0.21 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.66 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.746 ' HZ3' ' HA ' ' A' ' 14' ' ' ARG . 91.8 m95 65.81 173.25 0.23 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.297 179.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.811 ' HA ' ' HB3' ' A' ' 93' ' ' ASN . 0.0 OUTLIER 167.06 67.49 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 179.699 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 108.84 -165.45 12.58 Favored Glycine 0 C--N 1.339 0.716 0 C-N-CA 120.277 -0.963 . . . . 0.0 113.652 177.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.585 ' O ' ' HA ' ' A' ' 81' ' ' THR . 36.8 mt-30 -141.29 117.63 10.76 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.708 0.29 . . . . 0.0 110.634 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.768 ' HA ' HG22 ' A' ' 81' ' ' THR . . . -101.75 112.94 25.7 Favored 'General case' 0 CA--C 1.515 -0.396 0 CA-C-N 116.133 -0.485 . . . . 0.0 109.717 179.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.732 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 10.6 mt-30 -122.21 126.47 48.32 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.99 0.737 . . . . 0.0 112.99 -177.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.49 ' HB2' ' CE3' ' A' ' 79' ' ' TRP . 2.4 ttmt -102.69 131.96 49.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.245 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.923 ' CD1' HD12 ' A' ' 80' ' ' LEU . 74.6 m95 -101.99 161.35 13.74 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.844 0.683 . . . . 0.0 112.844 -177.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.505 ' CE1' ' HG2' ' A' ' 54' ' ' ARG . 99.5 m-85 -142.64 150.53 40.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.148 -0.933 . . . . 0.0 110.784 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.63 HD12 ' H ' ' A' ' 110' ' ' PHE . 15.0 tp -98.56 139.72 33.87 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.255 179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.63 ' H ' HD12 ' A' ' 109' ' ' LEU . 32.0 m-85 -138.81 142.72 38.71 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -178.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.595 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 1.1 tttt -102.28 120.18 40.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.679 178.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.612 ' HB2' HD11 ' A' ' 21' ' ' LEU . 65.4 t80 -78.23 98.72 5.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.796 0.332 . . . . 0.0 110.596 179.341 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 7.4 p -95.25 39.64 1.11 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.601 179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.402 ' C ' ' CE2' ' A' ' 112' ' ' PHE . . . -135.64 -148.22 5.58 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.268 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.444 ' HB2' ' HG2' ' A' ' 117' ' ' GLN . 0.1 OUTLIER -125.45 150.32 47.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.857 0.36 . . . . 0.0 111.137 179.474 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -58.43 -39.7 80.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.483 0.658 . . . . 0.0 110.662 -179.663 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.444 ' HG2' ' HB2' ' A' ' 115' ' ' GLN . 14.8 pt20 -58.61 -3.5 0.31 Allowed 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 114.959 -1.019 . . . . 0.0 111.913 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -89.03 -22.14 23.11 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 121.238 0.542 . . . . 0.0 110.234 179.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.589 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 10.5 mt -83.05 100.11 6.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.351 -0.841 . . . . 0.0 111.19 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.428 ' O ' ' C ' ' A' ' 121' ' ' LEU . 0.0 OUTLIER -97.51 9.38 42.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.218 -0.446 . . . . 0.0 112.021 -179.546 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.718 ' C ' HD22 ' A' ' 122' ' ' LEU . 71.7 mt 31.49 56.51 0.28 Allowed 'General case' 0 N--CA 1.467 0.399 0 CA-C-O 121.22 0.533 . . . . 0.0 111.56 -179.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.829 HD23 ' HB3' ' A' ' 129' ' ' PRO . 0.5 OUTLIER 58.49 165.44 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.822 -0.626 . . . . 0.0 111.264 179.756 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -162.24 -131.34 1.21 Allowed Glycine 0 N--CA 1.445 -0.733 0 N-CA-C 111.294 -0.722 . . . . 0.0 111.294 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 51.02 -162.24 0.07 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.882 0.373 . . . . 0.0 111.172 179.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -141.82 60.3 0.55 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.973 -0.632 . . . . 0.0 112.077 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.1 m -97.38 -63.22 1.15 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.766 0.317 . . . . 0.0 111.31 -179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.403 ' O ' ' HB3' ' A' ' 128' ' ' LYS . 5.0 tt0 -145.6 -74.61 0.22 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.138 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 129' ' ' PRO . 12.6 pttp -179.31 148.26 0.52 Allowed Pre-proline 0 C--N 1.332 -0.171 0 CA-C-O 121.137 0.494 . . . . 0.0 111.81 179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.829 ' HB3' HD23 ' A' ' 122' ' ' LEU . 5.9 Cg_exo -69.55 -165.41 0.15 Allowed 'Trans proline' 0 N--CA 1.461 -0.403 0 C-N-CA 123.011 2.474 . . . . 0.0 112.829 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.692 ' C ' HD21 ' A' ' 34' ' ' LEU . 3.9 tp10 -109.25 -32.83 7.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.163 -0.926 . . . . 0.0 109.872 178.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.722 ' N ' HD21 ' A' ' 34' ' ' LEU . 2.1 m-85 -131.91 139.0 48.6 Favored 'General case' 0 N--CA 1.462 0.156 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 178.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.708 ' N ' HD22 ' A' ' 34' ' ' LEU . . . -85.92 -33.13 16.09 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.688 -178.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 31' ' ' ALA . 1.9 tt0 -150.78 153.87 36.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.338 0.113 . . . . 0.0 110.947 -179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.611 ' HA ' ' HA ' ' A' ' 31' ' ' ALA . 43.3 p-90 -135.36 168.28 19.5 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.057 0.456 . . . . 0.0 111.691 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.431 ' N ' ' HZ3' ' A' ' 40' ' ' TRP . 15.9 t -162.74 167.26 23.26 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.526 -179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.636 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 53.7 m95 -103.95 102.91 12.69 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.064 -0.717 . . . . 0.0 109.064 177.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.6 ' O ' ' N ' ' A' ' 28' ' ' ILE . 21.7 m -119.66 165.08 15.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.556 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 19.0 p -72.01 170.98 10.48 Favored Pre-proline 0 C--N 1.327 -0.413 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.027 179.255 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.809 ' HG3' HD11 ' A' ' 28' ' ' ILE . 13.7 Cg_exo -62.88 -54.58 1.11 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 122.031 1.821 . . . . 0.0 110.41 179.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -64.94 -26.75 68.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.584 178.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.483 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.8 OUTLIER -72.04 -46.56 56.56 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.502 179.582 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.751 HD21 ' SD ' ' A' ' 42' ' ' MET . 0.6 OUTLIER -57.35 -38.38 74.05 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.832 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.55 ' O ' HG22 ' A' ' 146' ' ' THR . 7.1 mm -60.88 -35.95 68.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.215 0.531 . . . . 0.0 110.219 179.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.68 -51.69 26.02 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.202 0.525 . . . . 0.0 110.769 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -73.75 -19.97 60.64 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.415 -0.812 . . . . 0.0 112.712 -179.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.621 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 7.3 t -73.78 177.76 5.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.976 0.417 . . . . 0.0 111.487 -179.163 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.597 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 16.2 m -82.24 149.5 4.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.182 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.334 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.508 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 42.6 mt-10 -60.29 -55.21 36.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.328 -0.397 . . . . 0.0 111.049 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.597 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 55.1 p90 -54.24 -4.34 0.05 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.718 0.636 . . . . 0.0 112.718 -179.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.49 ' HG2' ' CZ ' ' A' ' 154' ' ' TYR . 0.1 OUTLIER -132.73 -6.54 3.2 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 112.087 0.403 . . . . 0.0 112.087 -179.435 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.584 ' HG3' HG23 ' A' ' 146' ' ' THR . 11.6 mttt -59.79 -59.49 13.67 Favored Pre-proline 0 C--N 1.328 -0.362 0 N-CA-C 111.584 0.216 . . . . 0.0 111.584 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.508 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 11.8 Cg_endo -55.73 -27.66 62.64 Favored 'Trans proline' 0 C--N 1.348 0.528 0 C-N-CA 122.312 2.008 . . . . 0.0 111.651 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.754 ' O ' HG23 ' A' ' 157' ' ' VAL . 39.5 t -69.27 -53.9 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 178.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.494 ' OH ' ' HB3' ' A' ' 41' ' ' GLN . 9.1 m-30 -63.51 -36.86 85.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.855 178.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.563 ' HE2' ' HA ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -57.73 -43.5 85.37 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.381 -0.827 . . . . 0.0 111.085 179.782 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -69.11 -28.49 66.52 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 153' ' ' VAL . 48.6 t -68.48 -42.25 83.7 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 CA-C-N 115.23 -0.896 . . . . 0.0 109.973 178.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.659 HD22 ' HB3' ' A' ' 139' ' ' PRO . 47.8 mt -63.68 -43.5 96.5 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.561 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.8 t -53.76 -41.3 67.01 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.821 HG11 ' HA ' ' A' ' 76' ' ' VAL . 88.2 t -66.75 -42.59 89.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.378 178.046 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.609 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 22.1 m-30 -80.15 4.08 18.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.07 -0.968 . . . . 0.0 112.552 -179.18 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.606 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.58 -53.1 69.59 Favored Pre-proline 0 C--N 1.328 -0.336 0 C-N-CA 120.531 -0.467 . . . . 0.0 110.644 179.623 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 18.9 Cg_endo -58.89 -12.21 14.41 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.141 1.894 . . . . 0.0 111.921 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.454 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 92.9 m-70 -109.19 -17.98 13.73 Favored 'General case' 0 N--CA 1.461 0.114 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.28 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.609 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 95.6 mt . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.224 -0.893 . . . . 0.0 110.854 -179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.132 0 N-CA-C 112.393 -0.283 . . . . 0.0 112.393 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -52.49 146.44 33.37 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 122.523 2.149 . . . . 0.0 112.129 179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.972 HD11 HG22 ' A' ' 153' ' ' VAL . 8.2 mt 62.21 -173.31 0.15 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.109 0.481 . . . . 0.0 110.873 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -156.43 -43.23 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.228 -0.749 . . . . 0.0 111.228 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.836 ' HB3' HD23 ' A' ' 80' ' ' LEU . 0.3 OUTLIER 52.0 105.47 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 179.281 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.6 mpp? -103.63 140.72 37.18 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.054 178.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.619 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 33.1 t70 -66.92 -8.66 31.06 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.602 -0.272 . . . . 0.0 111.368 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -141.01 114.08 6.98 Favored Pre-proline 0 CA--C 1.531 0.242 0 N-CA-C 110.22 -0.289 . . . . 0.0 110.22 179.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.519 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 22.7 Cg_endo -61.45 118.61 5.49 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.378 2.052 . . . . 0.0 112.456 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.519 ' HD3' ' HA ' ' A' ' 9' ' ' PRO . 4.0 Cg_exo -81.8 167.42 16.57 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 123.197 2.598 . . . . 0.0 112.761 -179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.36 153.47 7.23 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.403 179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.42 ' CA ' ' HA ' ' A' ' 100' ' ' TRP . . . 69.02 1.81 27.91 Favored Glycine 0 CA--C 1.52 0.351 0 C-N-CA 121.054 -0.593 . . . . 0.0 114.194 178.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.469 ' HB2' ' O ' ' A' ' 10' ' ' PRO . 21.7 m-85 -92.38 124.48 36.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 117.476 0.638 . . . . 0.0 110.708 179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.465 ' N ' ' HA ' ' A' ' 103' ' ' GLN . 0.8 OUTLIER -68.98 82.84 0.31 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.919 0.39 . . . . 0.0 110.891 179.393 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.457 ' CG ' HD12 ' A' ' 47' ' ' ILE . 5.4 ttp180 -50.21 111.75 0.57 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.475 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.696 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 3.2 m120 -135.34 -178.76 5.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.127 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.582 HG13 HG13 ' A' ' 47' ' ' ILE . 14.9 m -142.65 167.57 14.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.39 0.614 . . . . 0.0 111.967 179.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.572 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -138.18 155.41 23.37 Favored Glycine 0 N--CA 1.448 -0.54 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.891 178.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.022 HG23 ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -131.31 129.23 62.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -179.063 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.49 ' O ' HD12 ' A' ' 109' ' ' LEU . 35.4 t -108.77 106.11 15.98 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.478 -0.783 . . . . 0.0 108.898 178.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.778 HD22 HG11 ' A' ' 67' ' ' VAL . 7.4 tp -105.98 123.59 48.22 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.845 -178.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.624 ' CE ' HD13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -124.22 165.98 16.67 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.113 179.444 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -97.45 171.96 8.06 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.004 0.431 . . . . 0.0 110.406 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -58.48 -5.35 0.52 Allowed 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.585 177.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.534 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -99.8 2.6 44.18 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.782 0.325 . . . . 0.0 111.771 -179.137 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 17.1 mmtp 73.61 22.29 2.65 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.953 -178.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 22' ' ' MET . 2.2 mmtt -93.0 143.87 25.81 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.876 HD11 ' HG3' ' A' ' 139' ' ' PRO . 0.9 OUTLIER -98.07 138.02 23.96 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.286 0.565 . . . . 0.0 112.457 -177.913 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.534 ' CZ ' HG21 ' A' ' 65' ' ' THR . 17.1 t80 -80.22 135.1 36.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.726 178.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.74 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -142.58 151.77 41.88 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.945 0.403 . . . . 0.0 111.281 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.651 ' HB1' ' CB ' ' A' ' 131' ' ' PHE . . . -143.14 136.77 28.55 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.309 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.656 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 3.5 p -97.19 152.65 18.62 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.847 0.356 . . . . 0.0 111.45 -179.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.659 ' O ' ' N ' ' A' ' 35' ' ' ASP . 15.3 mtp180 -68.54 130.43 42.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.731 -179.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.74 HD11 ' HB2' ' A' ' 129' ' ' PRO . 0.3 OUTLIER -53.32 52.42 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 123.145 0.578 . . . . 0.0 112.491 -179.722 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.659 ' N ' ' O ' ' A' ' 33' ' ' ARG . 0.5 OUTLIER -177.68 -36.06 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.895 0.379 . . . . 0.0 110.347 179.751 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.628 HD13 ' NE ' ' A' ' 33' ' ' ARG . 4.0 mp -112.61 103.01 55.34 Favored Pre-proline 0 N--CA 1.454 -0.25 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.58 179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -62.99 -46.04 11.42 Favored 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 123.167 2.578 . . . . 0.0 113.45 -178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -72.32 -4.44 29.81 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.656 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -94.75 93.03 7.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.798 0.332 . . . . 0.0 111.083 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.656 ' O ' ' HA ' ' A' ' 146' ' ' THR . 63.7 m95 -100.15 145.93 27.42 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.438 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.96 158.1 21.88 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.403 0.621 . . . . 0.0 111.593 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.47 ' HG3' ' HZ3' ' A' ' 107' ' ' TRP . 3.4 ptp -94.28 158.46 35.82 Favored Pre-proline 0 C--N 1.32 -0.676 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.198 178.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.439 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 9.4 Cg_endo -49.31 154.47 3.87 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.423 2.082 . . . . 0.0 112.223 -179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -178.56 140.9 0.2 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.142 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.423 ' O ' HG22 ' A' ' 17' ' ' VAL . . . -157.63 164.82 33.27 Favored Glycine 0 C--N 1.33 0.228 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.757 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.621 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -88.25 142.19 17.28 Favored Glycine 0 N--CA 1.447 -0.569 0 C-N-CA 120.894 -0.669 . . . . 0.0 113.54 -179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.582 HG13 HG13 ' A' ' 17' ' ' VAL . 3.9 mt -70.44 146.73 11.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 122.66 0.384 . . . . 0.0 111.283 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -67.54 -174.55 0.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.406 179.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.88 -60.78 2.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.163 179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.97 61.97 0.65 Allowed Glycine 0 C--N 1.33 0.214 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.465 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.504 ' O ' HG21 ' A' ' 47' ' ' ILE . 3.9 tp10 -119.94 155.86 31.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.731 0.3 . . . . 0.0 110.818 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.426 ' N ' ' HG3' ' A' ' 51' ' ' GLU . 0.4 OUTLIER -71.99 158.84 86.94 Favored Pre-proline 0 C--N 1.327 -0.384 0 CA-C-N 116.508 -0.315 . . . . 0.0 110.352 179.63 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.458 ' HA ' HG11 ' A' ' 17' ' ' VAL . 2.9 Cg_exo -76.12 -50.37 0.11 Allowed 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.605 2.203 . . . . 0.0 111.67 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.878 ' CZ ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -53.07 -44.95 67.9 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.508 179.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.46 ' HA ' HD12 ' A' ' 58' ' ' ILE . 18.5 m-80 -67.81 -42.13 82.03 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.012 179.347 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.416 ' O ' ' HG2' ' A' ' 60' ' ' GLU . . . -62.2 -42.6 99.44 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.022 ' HB1' HG23 ' A' ' 19' ' ' ILE . . . -56.55 -53.72 54.32 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.808 178.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.622 HD11 ' NE ' ' A' ' 54' ' ' ARG . 17.7 mt -57.56 -53.51 43.39 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.119 0 CA-C-N 115.472 -0.785 . . . . 0.0 111.065 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 9.8 tpt180 -60.06 -58.69 7.44 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 120.958 -0.297 . . . . 0.0 110.923 -179.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.416 ' HG2' ' O ' ' A' ' 56' ' ' ALA . 26.0 mm-40 -47.34 -45.84 25.03 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.226 0.536 . . . . 0.0 109.634 179.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.84 HD12 ' HB ' ' A' ' 19' ' ' ILE . 7.5 tt -51.83 -49.69 62.31 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.257 178.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.779 ' HG3' HG23 ' A' ' 68' ' ' THR . 47.7 ttt180 -63.06 -62.83 1.44 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.167 179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.44 ' O ' ' CD1' ' A' ' 122' ' ' LEU . 6.2 mm-40 -51.35 -19.16 1.2 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.828 -0.624 . . . . 0.0 112.32 -179.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.517 ' O ' HD21 ' A' ' 122' ' ' LEU . 13.5 mm-40 -98.91 -32.54 11.26 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -178.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.573 HG22 ' CD2' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -131.78 -11.61 3.42 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 120.203 -0.599 . . . . 0.0 112.609 -178.684 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 87.14 -15.16 55.17 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.464 -0.874 . . . . 0.0 111.967 -179.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.778 HG11 HD22 ' A' ' 21' ' ' LEU . 77.7 t -58.3 113.72 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-O 121.248 0.546 . . . . 0.0 111.358 179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.779 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -121.47 -39.96 2.61 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.481 178.637 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.432 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 6.1 m -62.5 74.6 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.14 179.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -158.88 154.94 26.84 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.667 -179.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.403 ' HG3' HG21 ' A' ' 113' ' ' THR . 0.9 OUTLIER -128.16 151.46 49.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.432 179.607 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.878 HG21 ' CZ ' ' A' ' 54' ' ' ARG . 2.8 t -74.9 127.8 36.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.725 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.694 HD12 ' HG ' ' A' ' 109' ' ' LEU . 1.0 OUTLIER -109.11 -17.87 7.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.332 178.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.552 ' HB2' ' CD2' ' A' ' 164' ' ' HIS . . . -169.04 173.73 6.71 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.569 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.418 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 2.6 pm0 -153.09 136.06 15.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.648 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.65 ' HA ' HG11 ' A' ' 160' ' ' VAL . 41.8 t -73.48 137.48 77.79 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.03 0.443 . . . . 0.0 111.081 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.594 ' HD2' HG13 ' A' ' 76' ' ' VAL . 41.6 Cg_endo -72.09 -73.54 0.02 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.723 2.282 . . . . 0.0 112.54 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.619 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 2.2 p90 -67.57 157.81 33.51 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.097 0.475 . . . . 0.0 111.543 -179.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.611 ' O ' HG23 ' A' ' 81' ' ' THR . 49.7 m95 -94.75 109.4 21.36 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.187 179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.836 HD23 ' HB3' ' A' ' 5' ' ' SER . 15.0 mt -61.94 115.66 4.24 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.862 -0.422 . . . . 0.0 109.862 179.133 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.893 HG22 ' HA ' ' A' ' 104' ' ' ALA . 11.4 p -117.92 126.25 52.01 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.124 0.488 . . . . 0.0 112.272 -178.741 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.68 ' CZ ' HG21 ' A' ' 153' ' ' VAL . 0.5 OUTLIER -80.02 39.32 0.43 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.971 179.303 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 16.4 p-10 -73.07 134.24 44.48 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.759 0.314 . . . . 0.0 111.054 -179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.467 ' CE1' ' HG ' ' A' ' 92' ' ' LEU . 7.2 m-85 -103.75 156.91 34.94 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.976 179.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.461 ' CB ' ' HD2' ' A' ' 86' ' ' PRO . 15.6 Cg_exo -68.99 176.94 5.54 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.827 2.352 . . . . 0.0 111.589 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.461 ' HD2' ' CB ' ' A' ' 85' ' ' PRO . 6.3 Cg_endo -48.59 160.17 0.68 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 122.335 2.023 . . . . 0.0 111.793 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.4 ' CB ' ' O ' ' A' ' 86' ' ' PRO . 0.3 OUTLIER 79.4 -53.94 0.42 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.545 -0.298 . . . . 0.0 110.678 -179.405 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . . . . . . . . . 38.9 t -63.6 -31.48 53.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.95 0.405 . . . . 0.0 110.57 179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.517 ' O ' ' N ' ' A' ' 93' ' ' ASN . 4.8 mmt85 -59.68 -51.81 68.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.109 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.611 ' HA ' HD13 ' A' ' 94' ' ' ILE . 1.8 mp0 -56.38 -23.74 39.84 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.462 -0.336 . . . . 0.0 111.065 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 47.8 mttt -98.59 -20.66 16.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.152 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.467 ' HG ' ' CE1' ' A' ' 84' ' ' PHE . 2.0 tm? -119.83 -61.81 1.56 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.714 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.517 ' N ' ' O ' ' A' ' 89' ' ' ARG . 52.1 t-20 -47.49 -59.69 3.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.872 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.611 HD13 ' HA ' ' A' ' 90' ' ' GLU . 3.3 mp -75.17 -6.9 9.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.071 -179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.68 -0.09 25.4 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.579 179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 87.1 m95 -94.08 27.14 2.94 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.688 0.28 . . . . 0.0 111.478 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 52.69 24.26 17.75 Favored Glycine 0 CA--C 1.519 0.286 0 C-N-CA 121.026 -0.607 . . . . 0.0 113.263 179.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -174.72 -174.48 0.82 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.694 0.283 . . . . 0.0 110.904 179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.48 -89.01 0.0 OUTLIER 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.459 179.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.501 ' O ' ' HB3' ' A' ' 101' ' ' LYS . 0.0 OUTLIER 57.84 -176.31 0.07 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.88 0.371 . . . . 0.0 111.39 179.058 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.501 ' HB3' ' O ' ' A' ' 100' ' ' TRP . 0.1 OUTLIER 163.17 52.66 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.649 179.27 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 111.85 -170.69 13.77 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.505 178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.625 ' O ' ' HA ' ' A' ' 81' ' ' THR . 18.4 mt-30 -146.98 120.41 9.03 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.352 -0.24 . . . . 0.0 110.352 179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.893 ' HA ' HG22 ' A' ' 81' ' ' THR . . . -91.04 116.97 29.21 Favored 'General case' 0 CA--C 1.514 -0.404 0 CA-C-O 121.101 0.477 . . . . 0.0 109.884 179.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.696 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 6.3 mt-30 -124.51 123.08 39.34 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.534 -177.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.518 ' HD3' ' CE2' ' A' ' 79' ' ' TRP . 14.2 ttpp -101.69 135.28 43.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.482 178.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.496 ' CD1' HD12 ' A' ' 80' ' ' LEU . 73.6 m95 -101.78 163.44 12.26 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.263 0.554 . . . . 0.0 112.445 -178.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.525 ' CE1' ' HG2' ' A' ' 54' ' ' ARG . 98.1 m-85 -143.18 150.63 39.65 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.839 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.694 ' HG ' HD12 ' A' ' 73' ' ' ILE . 20.1 tp -99.26 138.77 35.88 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.311 179.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.806 ' CE2' HG22 ' A' ' 72' ' ' VAL . 62.0 m-85 -139.76 140.28 36.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.642 0.734 . . . . 0.0 112.888 -178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.591 ' N ' HD11 ' A' ' 73' ' ' ILE . 1.7 tttt -101.27 123.63 45.69 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 114.777 -1.101 . . . . 0.0 109.754 178.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.625 ' CE1' HG13 ' A' ' 67' ' ' VAL . 39.4 t80 -78.34 96.61 5.35 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-O 120.809 0.337 . . . . 0.0 111.166 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.403 HG21 ' HG3' ' A' ' 71' ' ' GLU . 17.3 p -97.7 49.68 1.03 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.039 0.447 . . . . 0.0 110.596 179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.432 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -150.01 -148.57 4.8 Favored Glycine 0 N--CA 1.452 -0.254 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.296 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.45 ' HB2' ' HG2' ' A' ' 117' ' ' GLN . 28.7 mt-30 -121.84 151.46 40.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.823 0.344 . . . . 0.0 110.936 179.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -61.11 -28.8 69.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.8 -179.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . 0.45 ' HG2' ' HB2' ' A' ' 115' ' ' GLN . 2.1 pt20 -59.0 -3.2 0.32 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.919 -0.582 . . . . 0.0 112.137 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -90.7 -17.68 26.34 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.903 0.382 . . . . 0.0 110.895 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.692 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 15.9 mt -81.76 95.89 3.14 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.615 -179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -96.72 3.8 52.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.951 -179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.573 ' CD2' HG22 ' A' ' 65' ' ' THR . 29.5 mt 38.29 63.35 0.86 Allowed 'General case' 0 N--CA 1.466 0.363 0 CA-C-O 120.975 0.417 . . . . 0.0 111.449 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.772 HD23 ' HB3' ' A' ' 129' ' ' PRO . 1.8 mm? 64.79 -172.34 0.18 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.334 179.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -171.33 -1.59 0.03 OUTLIER Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.742 -0.663 . . . . 0.0 113.495 179.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -143.67 -164.72 1.93 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.796 0.331 . . . . 0.0 110.861 -179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 124.48 167.69 12.71 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.65 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.77 -10.8 59.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.701 0.286 . . . . 0.0 111.319 179.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -146.06 -67.88 0.28 Allowed 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.833 0.349 . . . . 0.0 110.618 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.5 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 4.9 pttt -168.99 159.79 7.92 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.05 0.452 . . . . 0.0 111.224 -179.069 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.772 ' HB3' HD23 ' A' ' 122' ' ' LEU . 51.7 Cg_exo -48.17 -167.7 0.0 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.281 0 C-N-CA 123.459 2.773 . . . . 0.0 113.771 -178.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -96.12 -33.88 11.91 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.834 179.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.651 ' CB ' ' HB1' ' A' ' 31' ' ' ALA . 3.2 m-85 -127.62 140.91 51.8 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.114 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.679 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -96.25 -29.28 8.52 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.498 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.403 ' HG2' ' OG ' ' A' ' 32' ' ' SER . 0.2 OUTLIER -145.18 146.75 31.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.725 0.298 . . . . 0.0 110.339 179.86 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.692 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 40.8 p-90 -135.89 165.77 24.86 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.939 0.399 . . . . 0.0 111.548 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.452 ' N ' ' HZ3' ' A' ' 40' ' ' TRP . 36.6 t -164.61 177.5 8.03 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.335 0.588 . . . . 0.0 112.164 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.537 ' NE1' ' HZ3' ' A' ' 134' ' ' TRP . 35.2 m95 -113.24 104.58 12.48 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.243 -0.89 . . . . 0.0 109.338 178.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.528 ' O ' ' N ' ' A' ' 28' ' ' ILE . 16.3 m -120.05 168.71 12.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.279 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.527 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 23.3 p -73.09 168.86 20.86 Favored Pre-proline 0 C--N 1.328 -0.369 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.24 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.876 ' HG3' HD11 ' A' ' 28' ' ' ILE . 16.5 Cg_exo -61.88 -53.27 2.23 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 121.866 1.71 . . . . 0.0 110.471 179.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -65.7 -27.79 68.59 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.654 178.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.499 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 37.2 mt-30 -72.42 -46.28 55.86 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.045 0.45 . . . . 0.0 110.154 179.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.74 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.5 OUTLIER -56.26 -40.76 74.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.826 179.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.488 ' O ' HG22 ' A' ' 146' ' ' THR . 14.9 mm -62.15 -34.0 61.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.234 0.54 . . . . 0.0 110.158 179.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.89 -51.51 25.77 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.21 0.528 . . . . 0.0 110.714 179.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.6 mp -73.86 -20.99 60.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.3 -0.864 . . . . 0.0 112.877 -179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.656 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 11.7 t -73.77 175.81 6.88 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 120.504 -0.478 . . . . 0.0 111.504 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.533 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 23.0 m -86.44 149.72 4.08 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.996 -179.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 151' ' ' LYS . 3.0 tt0 -50.81 -50.85 55.43 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.643 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -51.13 -11.4 0.1 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 113.021 0.748 . . . . 0.0 113.021 -179.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 2.7 mptt -131.8 -3.06 3.68 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -178.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.543 ' HG3' ' CG2' ' A' ' 146' ' ' THR . 0.6 OUTLIER -60.66 -63.43 4.31 Favored Pre-proline 0 C--N 1.325 -0.458 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.143 179.799 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.431 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 17.3 Cg_endo -58.33 -30.27 90.62 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 122.429 2.086 . . . . 0.0 111.962 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.972 HG22 HD11 ' A' ' 3' ' ' LEU . 19.0 t -68.9 -51.41 44.97 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.391 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 178.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.485 ' CE1' ' CH2' ' A' ' 107' ' ' TRP . 7.7 m-30 -63.4 -36.41 83.64 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.919 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.46 ' HD3' HG13 ' A' ' 143' ' ' ILE . 0.5 OUTLIER -57.86 -46.31 85.01 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.112 179.608 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.463 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.7 OUTLIER -67.03 -31.94 72.82 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 179.57 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.711 HG23 ' O ' ' A' ' 153' ' ' VAL . 92.4 t -66.76 -41.48 88.0 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.415 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.724 HD22 ' HB3' ' A' ' 139' ' ' PRO . 62.8 mt -64.03 -44.51 92.32 Favored 'General case' 0 CA--C 1.52 -0.19 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.4 179.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 1.7 t -53.49 -42.84 67.71 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.65 HG11 ' HA ' ' A' ' 76' ' ' VAL . 92.3 t -66.48 -42.18 89.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.172 178.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.555 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 21.9 m-30 -81.79 5.9 17.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.187 -0.915 . . . . 0.0 112.624 -179.272 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.705 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . . . -59.09 -50.86 85.59 Favored Pre-proline 0 C--N 1.327 -0.382 0 C-N-CA 120.656 -0.418 . . . . 0.0 111.004 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.705 ' HD3' ' HB3' ' A' ' 162' ' ' ALA . 30.6 Cg_exo -60.12 -10.84 13.74 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.346 2.031 . . . . 0.0 112.085 179.062 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.552 ' CD2' ' HB2' ' A' ' 74' ' ' ALA . 87.6 m-70 -111.23 -18.24 13.0 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.44 -179.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 96.7 mt . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.221 -0.895 . . . . 0.0 110.868 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.19 0 N-CA-C 112.498 -0.241 . . . . 0.0 112.498 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -55.06 137.44 76.46 Favored 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.57 2.18 . . . . 0.0 112.33 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.92 HD11 HG22 ' A' ' 153' ' ' VAL . 0.1 OUTLIER 61.75 -174.69 0.13 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.049 179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -157.07 -47.7 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.02 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.728 ' HB3' HD23 ' A' ' 80' ' ' LEU . 0.9 OUTLIER 62.95 137.87 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.047 0.451 . . . . 0.0 111.813 179.409 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.573 ' C ' ' HB2' ' A' ' 78' ' ' TYR . 0.4 OUTLIER -143.81 138.24 28.57 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.283 179.714 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.589 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 2.8 p30 -63.12 -9.29 10.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.682 0.277 . . . . 0.0 111.004 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 12.0 p -146.49 140.44 15.29 Favored Pre-proline 0 CA--C 1.53 0.21 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.469 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 45.9 Cg_endo -67.46 107.91 1.5 Allowed 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.298 1.999 . . . . 0.0 112.193 -179.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.469 ' HG3' ' SD ' ' A' ' 6' ' ' MET . 4.6 Cg_endo -49.27 165.05 0.24 Allowed 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 123.233 2.622 . . . . 0.0 113.091 -179.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -51.42 128.38 22.51 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.395 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 53.42 78.91 0.1 OUTLIER Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.741 179.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -151.98 155.96 39.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.578 0.228 . . . . 0.0 110.743 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.757 ' HA ' ' HZ3' ' A' ' 100' ' ' TRP . 0.1 OUTLIER -66.33 -159.74 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 C-N-CA 120.842 -0.343 . . . . 0.0 111.093 -179.201 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.601 ' HG2' HD12 ' A' ' 47' ' ' ILE . 6.7 ttp180 179.52 102.26 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 121.35 0.595 . . . . 0.0 110.103 -178.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.672 ' HB3' ' O ' ' A' ' 45' ' ' GLY . 2.2 m-80 -128.81 175.29 8.74 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.844 -179.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.761 HG13 ' CG1' ' A' ' 47' ' ' ILE . 25.7 m -134.64 159.5 41.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.177 0.513 . . . . 0.0 110.872 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.615 ' HA3' ' CE3' ' A' ' 107' ' ' TRP . . . -131.64 155.3 21.32 Favored Glycine 0 N--CA 1.442 -0.938 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 178.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.006 HG21 HD22 ' A' ' 61' ' ' LEU . 1.6 mp -125.37 117.08 48.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -178.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.476 ' O ' HD12 ' A' ' 109' ' ' LEU . 6.1 t -101.39 99.23 9.55 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.822 HD22 HG11 ' A' ' 67' ' ' VAL . 41.5 tp -100.83 119.09 38.15 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.727 -178.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.801 ' HE2' HD13 ' A' ' 73' ' ' ILE . 0.4 OUTLIER -119.75 159.77 23.88 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.926 179.656 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 23' ' ' ASN . 0.1 OUTLIER -94.6 171.87 8.53 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.024 0.44 . . . . 0.0 110.232 179.906 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -58.23 -4.77 0.39 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.675 176.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.612 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.5 OUTLIER -101.02 2.58 40.68 Favored 'General case' 0 CA--C 1.52 -0.204 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 -179.03 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.612 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 2.1 mmtm 75.12 20.86 2.03 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.186 -178.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.632 ' O ' ' HA ' ' A' ' 22' ' ' MET . 3.8 mmtt -92.2 143.87 25.99 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.228 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.756 HD11 ' HG3' ' A' ' 139' ' ' PRO . 1.6 mm -97.26 136.93 26.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.092 0.472 . . . . 0.0 112.009 -178.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.567 ' CE1' HD13 ' A' ' 119' ' ' ILE . 33.8 t80 -74.13 105.53 5.38 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.41 178.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.603 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -103.88 144.37 31.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.799 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.405 ' HB1' ' CG ' ' A' ' 131' ' ' PHE . . . -142.25 131.37 23.28 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.388 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.785 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 6.6 p -97.9 147.29 24.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.069 0.461 . . . . 0.0 111.747 -179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 33' ' ' ARG . 4.7 mtp180 -68.36 128.95 38.43 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.389 179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.697 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -45.14 -35.86 3.41 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 121.277 0.56 . . . . 0.0 110.883 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.53 -38.01 68.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.038 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.9 mt -122.81 105.92 34.84 Favored Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.214 -179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.11 -21.17 36.89 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.825 2.35 . . . . 0.0 112.967 -179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -92.06 -6.97 50.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.709 0.29 . . . . 0.0 111.568 -179.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.785 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.34 95.45 10.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.561 -0.29 . . . . 0.0 110.691 179.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.658 ' O ' ' HA ' ' A' ' 146' ' ' THR . 72.3 m95 -93.65 136.73 33.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.912 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.513 ' HG3' ' C ' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -161.59 158.41 26.22 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.105 0.479 . . . . 0.0 110.699 179.755 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.597 ' HG3' ' HZ3' ' A' ' 107' ' ' TRP . 0.1 OUTLIER -94.34 157.8 36.83 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 115.804 -0.634 . . . . 0.0 109.55 178.844 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.508 ' CG ' HD13 ' A' ' 61' ' ' LEU . 2.8 Cg_endo -44.08 151.79 0.46 Allowed 'Trans proline' 0 CA--C 1.531 0.335 0 C-N-CA 123.119 2.546 . . . . 0.0 112.891 -179.126 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -171.39 143.06 1.77 Allowed 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.201 -179.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.672 ' O ' ' HB3' ' A' ' 16' ' ' ASN . . . -140.48 -178.38 17.0 Favored Glycine 0 C--N 1.334 0.444 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.65 ' HA2' ' CB ' ' A' ' 16' ' ' ASN . . . -112.18 23.58 15.97 Favored Glycine 0 C--N 1.334 0.449 0 C-N-CA 120.016 -1.088 . . . . 0.0 114.736 -178.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.761 ' CG1' HG13 ' A' ' 17' ' ' VAL . 29.9 mt 60.13 130.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 117.543 0.672 . . . . 0.0 111.064 179.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -68.3 -176.15 0.71 Allowed 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.825 0.345 . . . . 0.0 110.88 179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -47.69 -81.17 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.212 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.39 55.91 0.49 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.359 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -116.21 153.01 32.63 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.873 0.368 . . . . 0.0 111.002 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.61 173.54 3.93 Favored Pre-proline 0 C--N 1.328 -0.339 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.014 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.488 ' HA ' HG11 ' A' ' 17' ' ' VAL . 8.9 Cg_endo -85.53 -54.17 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 122.378 2.052 . . . . 0.0 111.678 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.806 ' HE ' HD11 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -54.36 -43.34 71.23 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.315 179.012 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.713 ' HA ' HD12 ' A' ' 58' ' ' ILE . 7.2 m-20 -69.44 -40.81 76.97 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.308 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.415 ' O ' ' CG ' ' A' ' 60' ' ' GLU . . . -60.78 -45.73 93.24 Favored 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 179.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.445 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -54.29 -49.37 69.77 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.014 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.806 HD11 ' HE ' ' A' ' 54' ' ' ARG . 18.0 mt -58.97 -55.47 23.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.186 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.246 179.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.67 -63.67 1.22 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.187 -179.174 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.614 ' CD ' HD11 ' A' ' 19' ' ' ILE . 0.3 OUTLIER -47.2 -37.43 10.26 Favored 'General case' 0 C--N 1.332 -0.155 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 179.407 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.006 HD22 HG21 ' A' ' 19' ' ' ILE . 9.8 tp -53.24 -48.43 68.21 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.868 178.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.901 ' HG3' HG23 ' A' ' 68' ' ' THR . 16.7 ttp180 -64.17 -64.23 0.94 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.489 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -48.98 -22.1 0.8 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.156 -0.474 . . . . 0.0 112.272 -179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -96.99 -37.45 10.17 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -178.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.562 HG22 ' CD2' ' A' ' 121' ' ' LEU . 0.7 OUTLIER -127.66 -5.04 5.84 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 112.959 0.726 . . . . 0.0 112.959 -178.571 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 78.16 -13.88 13.4 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.252 -0.975 . . . . 0.0 111.872 -178.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.822 HG11 HD22 ' A' ' 21' ' ' LEU . 75.3 t -58.62 112.71 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 CA-C-O 121.194 0.521 . . . . 0.0 111.291 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.901 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.8 OUTLIER -121.59 -40.43 2.56 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.414 178.653 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.427 ' HB2' ' HA3' ' A' ' 114' ' ' GLY . 11.8 m -62.09 74.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.389 -0.823 . . . . 0.0 111.38 179.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.62 156.45 23.21 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -130.84 152.03 50.62 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.758 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.541 HG22 ' CE2' ' A' ' 110' ' ' PHE . 3.3 t -75.0 126.75 36.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 120.95 0.405 . . . . 0.0 111.186 179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.801 HD13 ' HE2' ' A' ' 22' ' ' MET . 1.0 OUTLIER -107.47 -19.66 6.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.266 179.218 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.463 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.88 176.39 4.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.582 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -154.46 148.37 25.61 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.422 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.799 ' HA ' HG11 ' A' ' 160' ' ' VAL . 55.3 t -70.65 139.29 86.14 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 120.983 0.42 . . . . 0.0 110.894 -179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.57 ' HD2' HG13 ' A' ' 76' ' ' VAL . 18.7 Cg_endo -59.04 -62.9 0.15 Allowed 'Trans proline' 0 CA--C 1.519 -0.271 0 C-N-CA 123.233 2.622 . . . . 0.0 112.499 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.589 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -103.46 -172.47 2.12 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.38 -0.827 . . . . 0.0 111.426 -178.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.602 ' O ' ' HB3' ' A' ' 5' ' ' SER . 64.5 m95 -91.8 -158.29 0.57 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.974 179.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.781 ' HB3' HD21 ' A' ' 3' ' ' LEU . 26.6 mt -164.44 105.4 0.86 Allowed 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.744 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 23.9 p -104.62 -172.92 2.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.206 0.527 . . . . 0.0 111.289 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.682 ' CE2' HD12 ' A' ' 3' ' ' LEU . 0.2 OUTLIER -169.6 70.98 0.07 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.834 179.805 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -70.39 163.4 26.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.137 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.701 ' HB2' HD11 ' A' ' 92' ' ' LEU . 6.4 m-85 -97.86 168.61 9.74 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.304 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.49 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 16.8 Cg_exo -67.29 177.09 4.07 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.566 2.177 . . . . 0.0 111.132 179.366 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.4 ' HD2' ' CB ' ' A' ' 85' ' ' PRO . 56.0 Cg_endo -70.25 8.18 0.94 Allowed 'Trans proline' 0 CA--C 1.532 0.385 0 C-N-CA 122.397 2.065 . . . . 0.0 113.27 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.459 ' HG3' ' H ' ' A' ' 88' ' ' VAL . 0.9 OUTLIER -109.38 -45.92 3.64 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-O 120.703 0.287 . . . . 0.0 111.152 179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.602 ' O ' HD12 ' A' ' 92' ' ' LEU . 13.9 t -87.76 -20.82 7.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.601 179.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.509 ' O ' ' HB2' ' A' ' 93' ' ' ASN . 1.4 tmm_? -37.85 -70.67 0.09 Allowed 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.556 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.587 ' HA ' HD13 ' A' ' 94' ' ' ILE . 0.5 OUTLIER -63.46 -12.34 30.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.312 -0.403 . . . . 0.0 111.544 179.828 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.653 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -88.33 -29.85 20.01 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 112.074 0.398 . . . . 0.0 112.074 -179.312 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.849 HD13 ' H ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -122.92 -36.19 2.91 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.248 0.833 . . . . 0.0 113.248 -179.199 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.849 ' H ' HD13 ' A' ' 92' ' ' LEU . 68.0 m-20 -73.37 -57.98 3.63 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 112.778 0.659 . . . . 0.0 112.778 -177.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.587 HD13 ' HA ' ' A' ' 90' ' ' GLU . 3.1 mp -74.28 -4.58 5.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.353 0.596 . . . . 0.0 110.083 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.653 ' HG3' ' O ' ' A' ' 91' ' ' LYS . 0.9 OUTLIER -78.54 -2.06 36.95 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.678 179.2 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.47 ' HB2' ' CB ' ' A' ' 100' ' ' TRP . 62.2 m95 -82.84 -76.97 0.25 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.635 0.255 . . . . 0.0 110.795 -179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 162.98 64.07 0.02 OUTLIER Glycine 0 CA--C 1.521 0.429 0 C-N-CA 120.346 -0.931 . . . . 0.0 113.67 179.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 69.2 m 65.1 145.64 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 120.935 0.397 . . . . 0.0 111.773 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 66.35 1.75 2.16 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 115.886 -0.597 . . . . 0.0 111.551 -179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.757 ' HZ3' ' HA ' ' A' ' 14' ' ' ARG . 92.1 m95 -103.44 163.76 12.08 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.708 -0.224 . . . . 0.0 111.038 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.788 ' HA ' ' HB3' ' A' ' 93' ' ' ASN . 15.1 ttmt 167.76 29.51 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.379 -179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 150.84 -160.01 28.42 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.731 -0.747 . . . . 0.0 111.722 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.744 ' O ' ' HA ' ' A' ' 81' ' ' THR . 2.7 mt-30 -147.2 113.25 5.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.103 0.451 . . . . 0.0 112.085 -179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.686 ' HB2' HG22 ' A' ' 81' ' ' THR . . . -96.13 119.42 34.59 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.61 179.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.463 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 15.7 mt-30 -126.31 123.97 39.24 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 112.3 0.481 . . . . 0.0 112.3 -178.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.571 ' HB2' ' CE3' ' A' ' 79' ' ' TRP . 0.7 OUTLIER -104.46 139.19 39.74 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.134 178.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.615 ' CE3' ' HA3' ' A' ' 18' ' ' GLY . 77.8 m95 -106.82 162.91 13.38 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.371 0.605 . . . . 0.0 112.576 -178.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.616 ' CD1' ' HG2' ' A' ' 54' ' ' ARG . 96.5 m-85 -140.0 152.98 46.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.205 -179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.599 HD11 ' SD ' ' A' ' 22' ' ' MET . 11.8 tp -99.99 136.93 39.15 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.557 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.608 ' CE2' HG12 ' A' ' 58' ' ' ILE . 29.6 m-85 -140.03 144.54 36.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.504 0.669 . . . . 0.0 112.631 -178.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.569 ' HB2' HD11 ' A' ' 73' ' ' ILE . 0.9 OUTLIER -104.39 123.17 46.96 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.86 -1.064 . . . . 0.0 109.977 178.397 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.624 ' CD1' HD21 ' A' ' 21' ' ' LEU . 56.6 t80 -79.13 99.42 6.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.912 0.387 . . . . 0.0 110.552 178.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.405 ' N ' ' O ' ' A' ' 69' ' ' SER . 30.3 p -95.78 41.71 1.1 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.324 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.427 ' HA3' ' HB2' ' A' ' 69' ' ' SER . . . -141.81 -148.33 5.01 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.651 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -122.7 149.84 43.52 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.951 0.405 . . . . 0.0 111.359 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.437 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 18.1 p-10 -58.99 -37.0 75.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.386 0.612 . . . . 0.0 111.231 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.2 mm-40 -57.43 -3.5 0.17 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.914 -1.039 . . . . 0.0 112.46 -179.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -90.49 -20.54 22.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.146 0.498 . . . . 0.0 110.303 179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.567 HD13 ' CE1' ' A' ' 29' ' ' PHE . 9.7 mt -88.35 107.07 17.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.215 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.474 ' C ' ' H ' ' A' ' 122' ' ' LEU . 58.1 t30 -102.23 -26.07 13.46 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.191 -179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.562 ' CD2' HG22 ' A' ' 65' ' ' THR . 56.9 mt 71.02 -37.48 0.39 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.427 -0.352 . . . . 0.0 111.178 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.705 ' HA ' ' HB3' ' A' ' 129' ' ' PRO . 18.8 mt -91.14 9.41 31.16 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.219 -0.446 . . . . 0.0 112.154 -179.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -66.1 -124.69 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.126 179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 40.8 t0 57.11 -106.82 0.35 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.735 -0.232 . . . . 0.0 110.912 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 116.84 44.74 0.57 Allowed Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.731 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 51.6 p -120.24 -53.53 2.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.974 0.416 . . . . 0.0 111.126 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -147.38 -42.73 0.17 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.169 -179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.658 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 4.4 pttm -177.43 161.83 1.42 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.174 0.511 . . . . 0.0 111.494 179.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.705 ' HB3' ' HA ' ' A' ' 122' ' ' LEU . 11.0 Cg_endo -60.01 179.15 0.31 Allowed 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 123.157 2.571 . . . . 0.0 112.754 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.461 ' HB2' ' CE1' ' A' ' 131' ' ' PHE . 61.0 mm-40 -111.28 -34.7 6.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.539 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.502 ' CE1' HG23 ' A' ' 65' ' ' THR . 0.7 OUTLIER -134.02 143.87 48.36 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.104 -179.872 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.697 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -89.73 -33.69 8.96 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.441 -0.885 . . . . 0.0 112.054 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -146.35 142.9 28.7 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.836 0.35 . . . . 0.0 110.543 179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.534 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 34.5 p-90 -135.29 170.33 16.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.137 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.45 ' N ' ' CE3' ' A' ' 134' ' ' TRP . 22.6 t -168.33 176.66 5.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.315 0.579 . . . . 0.0 111.758 -179.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.507 ' CE2' ' CZ3' ' A' ' 134' ' ' TRP . 48.0 m95 -110.69 102.84 11.37 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.212 -0.903 . . . . 0.0 109.479 178.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.447 ' O ' ' N ' ' A' ' 28' ' ' ILE . 29.6 m -118.19 167.6 11.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.548 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 18.3 p -72.51 169.53 16.63 Favored Pre-proline 0 C--N 1.326 -0.429 0 C-N-CA 120.262 -0.575 . . . . 0.0 110.211 179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.756 ' HG3' HD11 ' A' ' 28' ' ' ILE . 17.1 Cg_exo -60.2 -56.51 1.08 Allowed 'Trans proline' 0 N--CA 1.456 -0.709 0 C-N-CA 121.723 1.615 . . . . 0.0 110.379 179.018 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -62.76 -27.76 69.51 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.73 178.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.44 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 10.8 mt-30 -71.35 -48.81 47.92 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.544 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.603 HD13 ' HB2' ' A' ' 30' ' ' ALA . 5.2 tp -57.41 -38.48 74.39 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.654 ' O ' HG22 ' A' ' 146' ' ' THR . 16.4 mm -60.13 -36.71 69.6 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.538 179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.98 -53.04 14.25 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.247 0.546 . . . . 0.0 110.954 179.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.78 -19.0 62.07 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.315 -0.857 . . . . 0.0 112.174 -179.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.658 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 13.1 t -73.57 177.33 5.42 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-O 121.112 0.482 . . . . 0.0 111.302 -179.345 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.515 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 36.0 m -81.03 149.53 4.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.748 179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.415 ' C ' ' H ' ' A' ' 150' ' ' LYS . 2.7 mt-10 -57.83 -53.47 57.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.813 0.34 . . . . 0.0 110.988 179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.5 ' CD2' ' HG3' ' A' ' 150' ' ' LYS . 39.4 p90 -57.08 2.38 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.446 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.501 ' HD2' HG21 ' A' ' 147' ' ' VAL . 6.4 mtpp -139.12 -5.95 1.43 Allowed 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' A' ' 155' ' ' LYS . 0.2 OUTLIER -63.09 -52.39 63.0 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.849 -0.159 . . . . 0.0 110.686 179.681 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.408 ' CD ' ' N ' ' A' ' 151' ' ' LYS . 15.1 Cg_exo -65.28 -29.3 54.96 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.296 1.997 . . . . 0.0 111.393 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.92 HG22 HD11 ' A' ' 3' ' ' LEU . 37.2 t -67.92 -53.55 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 178.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.517 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 4.0 m-30 -63.31 -39.49 94.69 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.578 178.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.625 ' HE2' ' HA ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -56.22 -38.18 70.71 Favored 'General case' 0 N--CA 1.453 -0.282 0 CA-C-N 115.292 -0.867 . . . . 0.0 110.247 179.527 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.69 ' OE1' HD11 ' A' ' 80' ' ' LEU . 4.7 tm-20 -68.48 -36.53 79.09 Favored 'General case' 0 CA--C 1.507 -0.679 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.62 HG12 ' CE2' ' A' ' 161' ' ' PHE . 40.0 t -64.51 -41.02 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.863 179.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.659 HD22 ' HB3' ' A' ' 139' ' ' PRO . 43.4 mt -65.4 -46.94 78.04 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.939 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -52.15 -40.34 61.27 Favored 'General case' 0 CA--C 1.522 -0.127 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.799 HG11 ' HA ' ' A' ' 76' ' ' VAL . 98.4 t -67.33 -42.43 87.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 178.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.62 ' CE2' HG12 ' A' ' 157' ' ' VAL . 17.3 m-30 -80.09 5.49 14.13 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.044 -0.98 . . . . 0.0 112.034 -179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.592 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.1 -53.72 63.06 Favored Pre-proline 0 C--N 1.331 -0.229 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.528 179.378 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 18.2 Cg_endo -58.41 -13.26 16.13 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 121.989 1.793 . . . . 0.0 111.56 178.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.463 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 93.8 m-70 -107.25 -17.71 14.07 Favored 'General case' 0 CA--C 1.527 0.096 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.986 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.606 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 92.3 mt . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.026 -0.987 . . . . 0.0 110.368 179.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.191 0 N-CA-C 112.372 -0.291 . . . . 0.0 112.372 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -52.56 135.24 55.14 Favored 'Trans proline' 0 C--N 1.345 0.342 0 C-N-CA 122.518 2.145 . . . . 0.0 112.142 179.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.887 ' CD2' HD22 ' A' ' 80' ' ' LEU . 0.3 OUTLIER 62.31 115.01 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.886 -179.891 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -75.56 -46.17 15.7 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.321 179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.784 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 0.7 OUTLIER 72.67 -65.01 0.37 Allowed 'General case' 0 CA--C 1.516 -0.355 0 CA-C-O 120.953 0.406 . . . . 0.0 111.375 -179.894 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.407 ' HB2' ' O ' ' A' ' 5' ' ' SER . 3.6 mpp? 63.87 125.2 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.642 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.446 ' HA ' ' HB3' ' A' ' 78' ' ' TYR . 6.3 p-10 -65.12 -47.56 76.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.892 0.377 . . . . 0.0 110.211 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -93.42 153.27 41.43 Favored Pre-proline 0 C--N 1.326 -0.44 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.128 179.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.482 ' HB3' ' CZ2' ' A' ' 79' ' ' TRP . 61.0 Cg_endo -74.46 106.35 2.22 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.513 2.142 . . . . 0.0 112.635 -179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.453 ' O ' ' O ' ' A' ' 11' ' ' GLU . 14.2 Cg_endo -55.7 -171.49 0.03 OUTLIER 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 123.025 2.483 . . . . 0.0 112.625 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.469 ' CB ' ' HE2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -50.34 -165.4 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.913 -179.907 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 11' ' ' GLU . . . -28.42 -86.93 0.01 OUTLIER Glycine 0 C--N 1.339 0.738 0 CA-C-N 115.943 -0.571 . . . . 0.0 113.172 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.65 ' HE1' ' HB3' ' A' ' 83' ' ' ASP . 9.9 m-85 60.39 153.58 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.875 0.369 . . . . 0.0 111.729 179.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.552 ' HB2' ' HZ3' ' A' ' 100' ' ' TRP . 0.0 OUTLIER -69.64 67.9 0.24 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.774 178.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . . . . . . . . . 1.7 ttp180 -46.5 98.13 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.278 0.561 . . . . 0.0 110.786 -179.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.837 ' HB2' ' HG2' ' A' ' 105' ' ' GLN . 2.8 m-80 -132.26 173.73 10.96 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.239 -0.891 . . . . 0.0 109.338 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.716 HG13 ' CG1' ' A' ' 47' ' ' ILE . 11.5 m -140.49 169.6 15.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.18 0.514 . . . . 0.0 111.281 179.179 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.615 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -136.25 153.95 21.76 Favored Glycine 0 N--CA 1.44 -1.036 0 CA-C-N 115.518 -0.764 . . . . 0.0 111.253 178.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.832 HG23 ' CE1' ' A' ' 110' ' ' PHE . 2.4 mp -126.34 122.16 60.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 -178.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.491 ' O ' HD12 ' A' ' 109' ' ' LEU . 40.9 t -104.88 107.62 18.69 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.083 177.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.793 HD21 ' CD2' ' A' ' 112' ' ' PHE . 17.3 tp -106.08 126.66 52.48 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.726 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.77 ' SD ' HD11 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -118.82 141.04 49.01 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.731 -0.668 . . . . 0.0 111.057 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.451 ' OD1' ' CH2' ' A' ' 136' ' ' TRP . 5.6 m-20 -95.22 -175.98 3.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.191 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -55.5 -6.25 0.17 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.205 -0.907 . . . . 0.0 112.472 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.454 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 4.5 m-20 -100.71 -0.13 37.9 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 111.801 0.297 . . . . 0.0 111.801 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.465 ' NZ ' ' HE3' ' A' ' 22' ' ' MET . 30.0 mmtt 68.68 23.57 7.07 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 -177.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.61 ' O ' ' HA ' ' A' ' 22' ' ' MET . 72.2 mttt -95.13 176.78 6.1 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.174 -0.921 . . . . 0.0 108.915 179.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.621 HD11 ' HG3' ' A' ' 139' ' ' PRO . 2.0 mm -116.94 142.14 32.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-O 121.344 0.592 . . . . 0.0 111.249 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.617 ' CZ ' HG21 ' A' ' 65' ' ' THR . 6.6 t80 -66.88 103.48 1.14 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.108 179.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.664 ' HA ' ' O ' ' A' ' 41' ' ' GLN . . . -97.58 137.87 35.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.986 0.422 . . . . 0.0 111.253 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.426 ' HB1' ' CG ' ' A' ' 131' ' ' PHE . . . -139.25 132.69 30.19 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.477 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.662 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 77.0 p -101.32 146.9 26.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.919 0.39 . . . . 0.0 111.38 -179.358 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.425 HH11 ' HD2' ' A' ' 33' ' ' ARG . 5.5 mtp85 -69.55 128.98 38.41 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.37 179.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.715 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.6 OUTLIER -44.69 -37.04 3.43 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.37 0.605 . . . . 0.0 111.034 -179.863 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.86 -36.47 70.13 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.752 179.708 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 23.7 mm -122.99 110.57 31.23 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.12 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -77.23 -19.74 13.25 Favored 'Trans proline' 0 C--N 1.347 0.484 0 C-N-CA 122.397 2.064 . . . . 0.0 112.644 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -91.06 -10.1 43.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.471 -179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.733 ' HB1' ' CG1' ' A' ' 147' ' ' VAL . . . -92.24 95.01 9.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.691 0.282 . . . . 0.0 111.075 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.661 ' O ' ' HA ' ' A' ' 146' ' ' THR . 78.7 m95 -87.99 158.41 18.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.126 179.101 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.664 ' O ' ' HA ' ' A' ' 30' ' ' ALA . 1.6 mt-30 -166.95 -138.25 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.629 -178.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.531 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 8.5 ptt? -175.82 162.23 2.03 Favored Pre-proline 0 N--CA 1.453 -0.319 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.755 ' HG3' HD12 ' A' ' 61' ' ' LEU . 1.5 Cg_endo -40.9 134.19 2.51 Favored 'Trans proline' 0 N--CA 1.462 -0.332 0 C-N-CA 123.257 2.638 . . . . 0.0 113.088 -179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.421 ' HG2' ' O ' ' A' ' 42' ' ' MET . 0.0 OUTLIER -173.73 143.51 1.0 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.875 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.453 ' HA3' ' HG2' ' A' ' 60' ' ' GLU . . . -159.6 -158.64 9.26 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.783 -179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.715 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -117.31 141.8 16.85 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.37 -0.919 . . . . 0.0 113.742 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.716 ' CG1' HG13 ' A' ' 17' ' ' VAL . 13.9 mt -71.69 143.0 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 122.496 0.319 . . . . 0.0 110.88 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -69.23 -176.19 0.89 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.919 0.39 . . . . 0.0 110.587 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -49.13 -81.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.225 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -108.05 53.22 0.61 Allowed Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.251 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -118.35 153.73 33.53 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.915 0.388 . . . . 0.0 111.048 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -70.53 163.29 64.6 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.426 179.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.467 ' HA ' HG12 ' A' ' 47' ' ' ILE . 5.8 Cg_exo -78.5 -52.58 0.06 OUTLIER 'Trans proline' 0 CA--C 1.51 -0.678 0 C-N-CA 122.952 2.435 . . . . 0.0 112.486 -179.389 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.653 ' O ' HD13 ' A' ' 58' ' ' ILE . 0.2 OUTLIER -48.89 -51.85 27.68 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.762 179.659 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.1 m-80 -57.26 -42.68 82.02 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.175 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 60' ' ' GLU . . . -61.59 -43.52 98.7 Favored 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 177.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.603 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -57.57 -57.77 11.23 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.344 177.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.653 HD13 ' O ' ' A' ' 54' ' ' ARG . 1.9 mp -55.23 -48.99 75.81 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.577 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 25.7 mtt180 -65.01 -62.55 1.48 Allowed 'General case' 0 C--N 1.333 -0.118 0 C-N-CA 120.962 -0.295 . . . . 0.0 111.304 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.453 ' HG2' ' HA3' ' A' ' 45' ' ' GLY . 0.1 OUTLIER -42.3 -47.26 4.79 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 121.118 0.485 . . . . 0.0 110.119 179.581 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.755 HD12 ' HG3' ' A' ' 43' ' ' PRO . 0.1 OUTLIER -50.8 -49.37 58.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.083 178.715 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.93 ' HG3' HG23 ' A' ' 68' ' ' THR . 13.9 ttp180 -63.73 -65.54 0.67 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.781 -0.645 . . . . 0.0 111.493 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -49.02 -20.4 0.53 Allowed 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.022 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -98.1 -35.48 10.4 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 113.125 0.787 . . . . 0.0 113.125 -178.378 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.872 HG22 HD23 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -133.03 7.99 4.03 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -178.38 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 69.87 -9.73 2.68 Favored Glycine 0 CA--C 1.524 0.64 0 C-N-CA 120.15 -1.024 . . . . 0.0 112.974 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.734 HG13 ' CE2' ' A' ' 112' ' ' PHE . 77.1 t -56.76 108.66 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.22 0 CA-C-O 121.153 0.501 . . . . 0.0 111.393 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.93 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.6 OUTLIER -124.58 -39.71 2.28 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.593 178.26 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.0 m -63.77 70.91 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.991 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.551 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -156.96 156.91 33.8 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.037 0.446 . . . . 0.0 111.932 -179.213 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.427 ' HG3' HG21 ' A' ' 113' ' ' THR . 0.9 OUTLIER -129.39 149.1 51.31 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.435 179.108 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.967 HG22 ' CE2' ' A' ' 110' ' ' PHE . 12.3 t -74.71 125.0 33.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.511 HD11 ' HB2' ' A' ' 111' ' ' LYS . 0.9 OUTLIER -105.5 -21.62 5.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.12 179.302 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -170.42 177.02 4.21 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.661 -0.699 . . . . 0.0 111.554 -179.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.406 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 2.0 pm0 -155.36 152.05 28.65 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.757 179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.725 ' HA ' HG11 ' A' ' 160' ' ' VAL . 54.1 t -70.48 132.57 87.49 Favored Pre-proline 0 C--N 1.327 -0.387 0 C-N-CA 120.598 -0.441 . . . . 0.0 110.814 -179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -57.97 -55.12 2.51 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 123.125 2.55 . . . . 0.0 112.681 -179.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.556 ' O ' HG12 ' A' ' 76' ' ' VAL . 0.6 OUTLIER -101.88 -174.36 2.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.65 -179.518 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.505 ' HB2' ' O ' ' A' ' 5' ' ' SER . 33.9 m95 -94.65 -154.67 0.43 Allowed 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.887 HD22 ' CD2' ' A' ' 3' ' ' LEU . 95.5 mt -163.47 105.26 0.97 Allowed 'General case' 0 CA--C 1.515 -0.392 0 N-CA-C 109.497 -0.557 . . . . 0.0 109.497 179.611 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.763 HG22 ' HA ' ' A' ' 104' ' ' ALA . 4.5 p -125.09 100.26 6.48 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.283 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -78.42 52.46 1.15 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.65 ' HB3' ' HE1' ' A' ' 13' ' ' TYR . 3.3 p30 -71.32 -156.42 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 114.607 -1.179 . . . . 0.0 111.935 -178.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.701 ' CE1' ' HG2' ' A' ' 89' ' ' ARG . 49.6 p90 -101.39 145.39 30.36 Favored Pre-proline 0 N--CA 1.452 -0.369 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.648 -179.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.608 ' CB ' ' HD2' ' A' ' 86' ' ' PRO . 47.0 Cg_exo -53.22 -170.54 0.01 OUTLIER 'Trans proline' 0 CA--C 1.536 0.598 0 C-N-CA 122.52 2.147 . . . . 0.0 110.787 178.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.608 ' HD2' ' CB ' ' A' ' 85' ' ' PRO . 18.7 Cg_endo -59.54 -76.6 0.02 OUTLIER 'Trans proline' 0 CA--C 1.533 0.443 0 C-N-CA 121.712 1.608 . . . . 0.0 113.837 -178.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 10.1 mptt -76.51 43.85 0.33 Allowed 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 112.661 0.615 . . . . 0.0 112.661 -178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.574 HG21 ' HD2' ' A' ' 85' ' ' PRO . 58.5 t -121.47 -0.18 7.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.701 ' HG2' ' CE1' ' A' ' 84' ' ' PHE . 5.2 mmm180 -40.63 -66.08 0.35 Allowed 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.127 0.489 . . . . 0.0 111.373 179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.759 ' HA ' HD13 ' A' ' 94' ' ' ILE . 7.9 tt0 -65.18 -15.15 62.13 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.918 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.673 ' O ' ' HG3' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -86.95 -35.9 18.63 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 121.041 -0.264 . . . . 0.0 111.488 -179.512 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.645 ' HB3' ' HB3' ' A' ' 84' ' ' PHE . 2.1 tm? -123.11 -46.03 2.09 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 112.583 0.586 . . . . 0.0 112.583 -178.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.505 ' HB2' ' CE2' ' A' ' 84' ' ' PHE . 35.5 t-20 -53.01 -61.76 2.09 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 120.96 0.409 . . . . 0.0 111.919 -178.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.759 HD13 ' HA ' ' A' ' 90' ' ' GLU . 2.6 mp -63.7 -8.51 4.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.172 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.673 ' HG3' ' O ' ' A' ' 91' ' ' LYS . 3.6 mm-40 -76.48 -6.14 50.49 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.619 0.247 . . . . 0.0 111.46 179.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.498 ' HE1' ' CD1' ' A' ' 92' ' ' LEU . 93.1 m95 -97.84 24.81 6.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.518 -0.31 . . . . 0.0 110.904 179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.47 ' O ' ' CB ' ' A' ' 98' ' ' SER . . . 93.5 18.67 37.68 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.62 -0.8 . . . . 0.0 112.314 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 97' ' ' GLY . 0.9 OUTLIER 88.48 125.12 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.336 0 CA-C-O 120.86 0.362 . . . . 0.0 110.842 179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.3 t0 57.02 112.79 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.41 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.895 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 0.0 OUTLIER -162.32 -82.88 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.374 179.799 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.895 ' HB2' ' O ' ' A' ' 100' ' ' TRP . 6.7 mptt 128.77 -45.34 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.983 0.913 . . . . 0.0 111.521 178.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 159.72 -128.5 2.01 Favored Glycine 0 C--N 1.336 0.53 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.23 -178.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.678 ' O ' ' HA ' ' A' ' 81' ' ' THR . 9.6 mt-30 -145.87 106.88 4.14 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 122.992 -0.122 . . . . 0.0 110.733 179.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.763 ' HA ' HG22 ' A' ' 81' ' ' THR . . . -97.86 118.69 34.97 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-O 121.095 0.474 . . . . 0.0 111.276 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.837 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 71.1 mt-30 -132.51 122.65 25.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.615 -0.721 . . . . 0.0 112.291 -178.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.455 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 14.8 ttpp -105.2 138.26 41.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.482 179.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.615 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 28.4 m95 -103.96 162.75 12.87 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 112.493 0.553 . . . . 0.0 112.493 -178.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.585 ' HB2' ' HE1' ' A' ' 110' ' ' PHE . 51.3 m-85 -140.34 154.07 46.63 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.479 179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.77 HD11 ' SD ' ' A' ' 22' ' ' MET . 12.0 tp -103.22 140.97 36.67 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.506 -0.316 . . . . 0.0 111.323 179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.967 ' CE2' HG22 ' A' ' 72' ' ' VAL . 63.1 m-85 -143.69 150.0 38.03 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.551 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 16.5 tttt -106.69 124.21 49.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.533 178.3 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.793 ' CD2' HD21 ' A' ' 21' ' ' LEU . 16.0 t80 -78.92 100.88 7.43 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.688 -0.405 . . . . 0.0 110.012 178.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.427 HG21 ' HG3' ' A' ' 71' ' ' GLU . 60.1 p -95.9 39.98 1.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.115 0.483 . . . . 0.0 110.845 -179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -145.64 -144.12 4.06 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.675 -0.693 . . . . 0.0 112.078 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.776 ' O ' ' HG2' ' A' ' 118' ' ' GLU . 50.6 mt-30 -123.11 160.8 25.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.898 0.38 . . . . 0.0 111.207 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.409 ' HB2' ' CZ2' ' A' ' 134' ' ' TRP . 9.2 p-10 -60.14 -27.67 67.25 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.665 0.745 . . . . 0.0 111.309 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 15.4 mm-40 -52.82 -5.78 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 114.321 -1.309 . . . . 0.0 113.741 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.776 ' HG2' ' O ' ' A' ' 115' ' ' GLN . 0.1 OUTLIER -90.96 -24.48 20.12 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.085 178.785 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.608 ' HA ' ' O ' ' A' ' 65' ' ' THR . 7.0 mt -84.53 101.39 8.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 115.619 -0.718 . . . . 0.0 112.442 -178.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.455 ' C ' ' H ' ' A' ' 122' ' ' LEU . 12.4 t30 -107.04 -32.0 8.04 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.403 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.872 HD23 HG22 ' A' ' 65' ' ' THR . 9.9 mt 74.04 -40.3 0.45 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.035 0.445 . . . . 0.0 110.519 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.787 ' HA ' ' HB3' ' A' ' 129' ' ' PRO . 34.6 mt -78.27 175.33 10.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.639 -0.71 . . . . 0.0 111.911 -179.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 155.2 123.04 0.82 Allowed Glycine 0 N--CA 1.449 -0.446 0 CA-C-N 115.459 -0.791 . . . . 0.0 112.051 179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -96.22 129.77 43.45 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.756 0.312 . . . . 0.0 110.988 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 157.89 -21.51 0.38 Allowed Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.504 -0.855 . . . . 0.0 113.103 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 55.0 p -115.58 -81.01 0.61 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.955 0.377 . . . . 0.0 111.283 -179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.82 -42.08 0.14 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.191 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.748 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 0.5 OUTLIER -177.47 163.61 1.4 Allowed Pre-proline 0 C--N 1.331 -0.23 0 CA-C-O 121.276 0.56 . . . . 0.0 111.589 179.576 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.787 ' HB3' ' HA ' ' A' ' 122' ' ' LEU . 17.3 Cg_endo -57.95 -176.91 0.08 OUTLIER 'Trans proline' 0 CA--C 1.528 0.18 0 C-N-CA 123.184 2.589 . . . . 0.0 112.313 179.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 26.0 mm-40 -110.59 -42.65 4.02 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.596 179.789 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.626 ' CE2' HG23 ' A' ' 65' ' ' THR . 1.6 m-85 -130.68 143.3 50.65 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.05 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.715 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -87.46 -35.96 9.09 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.639 -179.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -148.34 144.76 27.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.944 0.402 . . . . 0.0 110.741 179.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.687 ' HD1' HD11 ' A' ' 121' ' ' LEU . 39.0 p-90 -135.88 169.34 17.74 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.94 179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.428 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 33.6 t -162.75 176.3 10.43 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 121.315 0.578 . . . . 0.0 112.03 -178.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.451 ' CH2' ' OD1' ' A' ' 23' ' ' ASN . 83.4 m95 -110.71 103.03 11.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.314 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.44 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 30.1 m -120.55 167.83 13.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.911 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.542 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 24.3 p -72.2 167.26 33.7 Favored Pre-proline 0 C--N 1.325 -0.476 0 C-N-CA 120.194 -0.602 . . . . 0.0 110.066 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.621 ' HG3' HD11 ' A' ' 28' ' ' ILE . 20.2 Cg_exo -59.62 -55.65 1.64 Allowed 'Trans proline' 0 N--CA 1.455 -0.755 0 C-N-CA 121.731 1.621 . . . . 0.0 110.296 179.516 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -62.7 -26.93 68.92 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.265 178.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.45 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 11.7 mm100 -72.51 -46.84 52.76 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.625 179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.635 HD11 ' O ' ' A' ' 41' ' ' GLN . 1.5 tp -58.21 -38.52 76.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.858 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.825 HG21 ' HG2' ' A' ' 155' ' ' LYS . 28.9 mm -62.31 -38.89 82.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.252 179.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.27 -50.16 55.63 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.307 0.575 . . . . 0.0 110.729 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -74.58 -20.22 60.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.294 -0.866 . . . . 0.0 112.967 -179.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.661 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 13.2 t -74.89 176.37 7.18 Favored 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.141 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.733 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 35.3 m -81.63 142.79 13.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.818 0.342 . . . . 0.0 111.53 -179.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.523 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 55.2 mt-10 -50.27 -51.15 47.29 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.278 179.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -51.15 -10.91 0.09 Allowed 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.6 mttm -135.25 -4.02 2.4 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 112.754 0.65 . . . . 0.0 112.754 -178.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.644 ' HG2' ' O ' ' A' ' 143' ' ' ILE . 9.7 mttt -59.47 -57.98 22.9 Favored Pre-proline 0 C--N 1.325 -0.479 0 CA-C-O 120.36 0.124 . . . . 0.0 111.164 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 20.8 Cg_endo -60.78 -27.55 84.99 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.427 2.085 . . . . 0.0 111.658 179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.733 ' O ' HG23 ' A' ' 157' ' ' VAL . 39.0 t -68.97 -52.89 29.62 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 178.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.547 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 5.0 m-30 -64.31 -40.65 96.34 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.505 178.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.825 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -55.85 -41.34 74.17 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.258 179.521 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -68.31 -33.46 74.35 Favored 'General case' 0 N--CA 1.446 -0.654 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 179.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.733 HG23 ' O ' ' A' ' 153' ' ' VAL . 44.6 t -66.42 -40.77 87.44 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.84 0 CA-C-N 115.304 -0.862 . . . . 0.0 109.944 178.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.617 HD22 ' HB3' ' A' ' 139' ' ' PRO . 52.2 mt -63.46 -45.83 89.01 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.644 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -50.15 -40.14 45.52 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.725 HG11 ' HA ' ' A' ' 76' ' ' VAL . 88.8 t -66.99 -42.69 88.99 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.333 -0.849 . . . . 0.0 108.944 177.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.689 ' CE2' HG12 ' A' ' 157' ' ' VAL . 14.1 m-30 -81.03 5.58 16.04 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 114.811 -1.086 . . . . 0.0 112.685 -179.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.631 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.42 -51.89 78.55 Favored Pre-proline 0 C--N 1.331 -0.237 0 C-N-CA 120.548 -0.461 . . . . 0.0 110.428 179.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.631 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 18.1 Cg_endo -59.08 -12.39 15.54 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 122.021 1.814 . . . . 0.0 111.716 178.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . . . . . . . . . 94.9 m-70 -107.69 -20.14 13.32 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.464 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.532 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 96.8 mt . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.761 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 112.525 -0.23 . . . . 0.0 112.525 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_exo -56.08 171.81 0.73 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.598 2.199 . . . . 0.0 112.029 179.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.997 HD11 HG22 ' A' ' 153' ' ' VAL . 0.2 OUTLIER -103.81 105.92 16.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.93 0.395 . . . . 0.0 111.158 -179.863 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -88.78 172.5 40.66 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.551 -0.833 . . . . 0.0 111.883 179.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.644 ' HB3' HD23 ' A' ' 80' ' ' LEU . 71.3 p -151.81 -79.24 0.11 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.979 0.419 . . . . 0.0 111.853 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.472 ' HB2' ' O ' ' A' ' 5' ' ' SER . 3.9 mpp? 68.23 133.56 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.534 -179.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.735 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 63.8 t0 -65.45 -32.55 74.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.952 0.406 . . . . 0.0 110.489 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -101.15 125.85 36.71 Favored Pre-proline 0 C--N 1.325 -0.472 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.902 179.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.49 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 73.5 Cg_endo -75.02 105.66 2.13 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.196 1.931 . . . . 0.0 112.126 -179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.516 ' HG2' ' CG ' ' A' ' 13' ' ' TYR . 1.9 Cg_endo -46.02 177.34 0.01 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 123.132 2.555 . . . . 0.0 112.28 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.6 ' HB3' ' HB3' ' A' ' 99' ' ' ASP . 6.1 mm-40 -40.29 115.55 0.57 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.283 0.564 . . . . 0.0 111.994 -179.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.534 ' HA3' ' HA ' ' A' ' 100' ' ' TRP . . . 61.19 -80.21 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 CA-C-N 115.169 -0.923 . . . . 0.0 112.372 179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.516 ' CG ' ' HG2' ' A' ' 10' ' ' PRO . 8.6 m-85 38.52 56.84 1.81 Allowed 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.627 ' HA ' ' CH2' ' A' ' 100' ' ' TRP . 0.0 OUTLIER 32.61 -152.93 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.41 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.792 179.346 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.536 ' HG2' HD12 ' A' ' 47' ' ' ILE . 0.0 OUTLIER 176.64 96.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.031 0.443 . . . . 0.0 110.144 -179.498 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.62 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 4.2 m-80 -133.19 172.67 12.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.132 179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.663 HG13 ' CG1' ' A' ' 47' ' ' ILE . 16.6 m -135.84 164.98 30.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.224 0.535 . . . . 0.0 111.443 178.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.719 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -138.67 155.88 23.89 Favored Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.97 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.814 HG13 ' HB1' ' A' ' 57' ' ' ALA . 2.5 mp -131.11 123.91 54.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 -178.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.51 ' O ' HD12 ' A' ' 109' ' ' LEU . 8.6 t -102.33 101.22 11.45 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 177.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.871 HD22 HG11 ' A' ' 67' ' ' VAL . 20.7 tp -99.58 117.52 34.15 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.359 -178.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.491 ' SD ' HD11 ' A' ' 109' ' ' LEU . 1.4 ptt? -118.08 166.74 12.19 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.729 179.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.599 ' ND2' ' HB2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -101.21 169.67 8.76 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.28 -179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -56.37 -4.5 0.14 Allowed 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.52 178.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.5 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 2.7 m-20 -99.06 2.96 46.61 Favored 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -178.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.5 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 3.3 mmtp 74.18 20.47 2.69 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.014 -178.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.599 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 1.1 mmtt -94.17 145.55 24.62 Favored 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.817 HD11 ' HG3' ' A' ' 139' ' ' PRO . 1.1 mm -97.93 139.94 19.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.294 0.568 . . . . 0.0 112.473 -177.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.408 ' HE1' ' CD2' ' A' ' 134' ' ' TRP . 18.6 t80 -75.99 122.54 24.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.279 -0.873 . . . . 0.0 109.809 178.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.62 ' HA ' ' O ' ' A' ' 41' ' ' GLN . . . -122.68 146.68 47.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.967 0.413 . . . . 0.0 111.124 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.446 ' O ' ' HG3' ' A' ' 41' ' ' GLN . . . -137.65 136.5 37.52 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.407 179.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.574 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 97.0 p -100.73 144.52 29.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.909 0.385 . . . . 0.0 111.049 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 11.2 mtp-105 -69.83 126.71 30.52 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.487 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.697 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.3 OUTLIER -45.43 -33.37 2.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.296 0.57 . . . . 0.0 110.781 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -74.01 -38.23 64.14 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.252 -0.886 . . . . 0.0 111.008 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.473 HG22 ' H ' ' A' ' 39' ' ' ALA . 56.1 mt -124.67 104.56 30.65 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.09 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -67.24 -18.1 50.4 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.727 2.285 . . . . 0.0 112.774 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -94.22 -11.0 31.2 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.554 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.8 ' HB1' ' CG1' ' A' ' 147' ' ' VAL . . . -91.42 96.77 10.69 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.778 0.323 . . . . 0.0 111.196 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.552 ' O ' ' HA ' ' A' ' 146' ' ' THR . 77.1 m95 -89.53 161.89 15.97 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.341 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.62 ' O ' ' HA ' ' A' ' 30' ' ' ALA . 0.0 OUTLIER -169.26 -139.47 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.122 -0.49 . . . . 0.0 109.932 179.979 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.487 ' H ' ' HB2' ' A' ' 41' ' ' GLN . 10.2 ptt? -175.07 161.93 2.34 Favored Pre-proline 0 C--N 1.327 -0.386 0 O-C-N 122.196 -0.315 . . . . 0.0 110.368 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 42' ' ' MET . 1.9 Cg_endo -40.8 131.91 2.72 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 123.015 2.477 . . . . 0.0 112.946 -179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.465 ' HA ' HD12 ' A' ' 19' ' ' ILE . 0.0 OUTLIER -178.44 144.66 0.3 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.652 179.755 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.675 ' HA3' ' HG2' ' A' ' 60' ' ' GLU . . . -161.26 -163.12 13.63 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.059 179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.62 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -109.3 145.94 16.73 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.38 -0.914 . . . . 0.0 113.723 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.663 ' CG1' HG13 ' A' ' 17' ' ' VAL . 19.8 mt -72.49 143.64 13.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 C-N-CA 122.354 0.262 . . . . 0.0 110.973 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -69.54 -174.85 0.75 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.836 0.35 . . . . 0.0 110.458 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -48.48 -71.13 0.07 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.147 179.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -120.9 54.23 0.67 Allowed Glycine 0 C--N 1.33 0.225 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.384 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.2 tp10 -113.47 150.66 32.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.803 0.335 . . . . 0.0 110.875 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 48.8 m-20 -69.66 158.89 85.89 Favored Pre-proline 0 C--N 1.326 -0.451 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.053 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.555 ' HA ' HG11 ' A' ' 17' ' ' VAL . 4.0 Cg_exo -76.4 -50.37 0.11 Allowed 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 122.595 2.197 . . . . 0.0 111.426 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.819 ' HE ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -52.49 -46.81 66.77 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 114.944 -1.025 . . . . 0.0 110.297 179.325 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -66.9 -41.81 86.53 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.056 179.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.562 ' O ' ' HB2' ' A' ' 60' ' ' GLU . . . -61.13 -44.43 97.35 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.814 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -55.43 -53.98 49.48 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.094 178.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.675 HD11 ' NE ' ' A' ' 54' ' ' ARG . 34.6 mt -55.02 -53.73 31.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.098 179.49 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 -62.29 -60.76 3.11 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.919 -0.312 . . . . 0.0 110.976 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.675 ' HG2' ' HA3' ' A' ' 45' ' ' GLY . 0.6 OUTLIER -44.1 -48.25 8.99 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.105 0.479 . . . . 0.0 110.121 179.269 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.688 HD13 HG21 ' A' ' 19' ' ' ILE . 0.8 OUTLIER -52.73 -46.23 67.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.565 179.046 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.805 ' HG3' HG23 ' A' ' 68' ' ' THR . 42.9 ttp180 -64.87 -62.75 1.37 Allowed 'General case' 0 C--O 1.225 -0.193 0 CA-C-O 121.343 0.592 . . . . 0.0 111.015 179.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -50.09 -21.69 1.37 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.827 -0.624 . . . . 0.0 112.359 -179.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -96.11 -36.6 10.93 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 113.29 0.848 . . . . 0.0 113.29 -178.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.575 HG23 ' CE2' ' A' ' 131' ' ' PHE . 3.6 p -127.27 -4.62 6.12 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.584 0.587 . . . . 0.0 112.584 -178.819 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 80.3 -12.07 34.23 Favored Glycine 0 CA--C 1.52 0.391 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.362 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.871 HG11 HD22 ' A' ' 21' ' ' LEU . 64.3 t -58.2 118.98 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.254 0 CA-C-O 121.33 0.586 . . . . 0.0 111.587 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.805 HG23 ' HG3' ' A' ' 62' ' ' ARG . 1.1 p -127.2 -40.01 1.86 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.402 178.396 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.8 m -62.54 76.35 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.512 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.578 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -162.92 156.7 20.24 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -179.817 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -129.82 150.17 51.24 Favored 'General case' 0 C--N 1.334 -0.099 0 CA-C-N 115.63 -0.713 . . . . 0.0 110.858 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.819 HG21 ' HE ' ' A' ' 54' ' ' ARG . 21.3 t -74.0 129.41 36.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.265 0.555 . . . . 0.0 111.753 179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.641 HD11 ' HB2' ' A' ' 111' ' ' LYS . 1.3 mt -110.56 -18.36 7.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.452 179.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.493 ' HB2' ' CG ' ' A' ' 164' ' ' HIS . . . -171.3 175.93 4.05 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.405 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -154.6 150.01 27.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.603 179.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.731 ' HA ' HG11 ' A' ' 160' ' ' VAL . 11.2 t -72.03 136.85 82.08 Favored Pre-proline 0 CA--C 1.532 0.282 0 CA-C-N 116.398 -0.365 . . . . 0.0 110.846 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.697 ' HD2' HG21 ' A' ' 160' ' ' VAL . 35.1 Cg_endo -67.56 -60.25 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.408 0 C-N-CA 122.9 2.4 . . . . 0.0 113.306 -179.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.735 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -94.27 172.98 7.87 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.08 -178.478 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.59 ' HB3' ' HB1' ' A' ' 104' ' ' ALA . 57.1 m95 -91.71 100.69 13.36 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.281 179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.644 HD23 ' HB3' ' A' ' 5' ' ' SER . 88.8 mt -60.02 112.97 2.08 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.054 0.454 . . . . 0.0 110.783 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.876 HG22 ' HA ' ' A' ' 104' ' ' ALA . 4.3 p -114.22 -172.19 2.05 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.899 -179.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -171.89 67.4 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.212 179.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 5.9 p30 -67.04 169.54 8.22 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.206 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.653 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 28.9 m-85 -97.08 174.98 2.85 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.692 -179.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.559 ' HD2' ' HB3' ' A' ' 84' ' ' PHE . 52.2 Cg_exo -55.35 -178.99 0.06 OUTLIER 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 121.946 1.764 . . . . 0.0 111.529 179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.491 ' HD2' ' HB3' ' A' ' 85' ' ' PRO . 46.8 Cg_endo -69.82 -1.62 8.84 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 122.218 1.946 . . . . 0.0 112.929 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -108.9 -61.84 1.56 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.804 0.335 . . . . 0.0 110.701 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.653 ' HB ' ' HB3' ' A' ' 84' ' ' PHE . 59.3 t -58.75 -41.5 82.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.067 179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.673 ' O ' ' HB2' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -78.35 -1.23 32.32 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.747 -0.381 . . . . 0.0 111.246 -179.815 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.993 ' HA ' HD13 ' A' ' 94' ' ' ILE . 0.2 OUTLIER -110.4 -14.93 14.04 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.922 0.392 . . . . 0.0 111.209 179.376 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.8 -22.29 12.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.548 179.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.676 HD13 ' HE1' ' A' ' 96' ' ' TRP . 1.3 tm? -120.83 -48.19 2.27 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.508 -179.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.673 ' HB2' ' O ' ' A' ' 89' ' ' ARG . 2.1 m-80 -67.73 -30.35 69.81 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.561 -179.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.993 HD13 ' HA ' ' A' ' 90' ' ' GLU . 1.1 mp -68.9 -9.73 12.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.879 179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.586 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -101.54 -103.04 0.26 Allowed 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -179.636 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.676 ' HE1' HD13 ' A' ' 92' ' ' LEU . 66.6 m95 57.2 -65.24 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.18 0 C-N-CA 122.948 0.499 . . . . 0.0 111.697 -179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.586 ' N ' ' O ' ' A' ' 95' ' ' GLN . . . -171.5 -125.08 0.8 Allowed Glycine 0 N--CA 1.45 -0.428 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.095 179.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.37 101.58 0.76 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.992 0.425 . . . . 0.0 110.95 179.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.6 ' HB3' ' HB3' ' A' ' 11' ' ' GLU . 0.2 OUTLIER 65.89 -81.66 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.315 -179.463 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.627 ' CH2' ' HA ' ' A' ' 14' ' ' ARG . 27.9 m95 55.16 169.98 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.279 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.907 178.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.852 ' HG3' HD12 ' A' ' 94' ' ' ILE . 0.0 OUTLIER 166.69 29.96 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.576 -179.723 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.627 ' HA2' ' OD1' ' A' ' 93' ' ' ASN . . . 149.48 -153.32 25.08 Favored Glycine 0 C--N 1.334 0.447 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.037 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.517 ' O ' ' HA ' ' A' ' 81' ' ' THR . 40.7 mt-30 -144.6 117.54 8.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.724 0.262 . . . . 0.0 110.805 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.876 ' HA ' HG22 ' A' ' 81' ' ' THR . . . -105.14 116.44 31.95 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.165 0.507 . . . . 0.0 111.262 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.454 ' CG ' ' HB2' ' A' ' 16' ' ' ASN . 35.6 mt-30 -126.15 125.18 42.06 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.943 -178.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.49 ' HD3' ' O ' ' A' ' 76' ' ' VAL . 3.5 ttmm -104.95 136.83 43.69 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.554 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.719 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 23.8 m95 -103.14 170.39 7.99 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.471 0.545 . . . . 0.0 112.471 -178.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.408 ' CZ ' ' HB2' ' A' ' 53' ' ' PRO . 96.2 m-85 -141.8 154.14 45.01 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.913 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.524 HD12 ' H ' ' A' ' 110' ' ' PHE . 15.6 tp -101.76 138.56 38.58 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.67 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.747 ' CZ ' HG22 ' A' ' 72' ' ' VAL . 31.0 m-85 -141.68 144.07 33.9 Favored 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.641 ' HB2' HD11 ' A' ' 73' ' ' ILE . 3.2 tttm -102.21 124.91 48.62 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 114.825 -1.079 . . . . 0.0 109.962 178.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.597 ' HD1' HD21 ' A' ' 21' ' ' LEU . 49.9 t80 -78.38 99.88 6.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.811 0.339 . . . . 0.0 110.56 178.896 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 35.1 p -99.37 51.29 0.94 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.027 0.442 . . . . 0.0 110.501 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -153.81 -146.93 4.51 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.504 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.439 ' O ' ' HZ ' ' A' ' 112' ' ' PHE . 2.7 mm-40 -120.93 146.61 46.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.028 0.442 . . . . 0.0 110.714 179.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.4 ' HB3' ' CH2' ' A' ' 134' ' ' TRP . 18.1 m-20 -57.15 -33.08 67.05 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.817 -0.628 . . . . 0.0 111.873 -178.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 2.2 pt20 -58.23 -5.64 0.51 Allowed 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.862 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -90.73 -15.19 30.68 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.64 0.257 . . . . 0.0 111.026 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.653 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 19.2 mt -77.9 100.24 3.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.901 0.381 . . . . 0.0 111.883 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 35.4 t30 -105.8 97.34 7.18 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.498 179.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.756 HD13 ' HB2' ' A' ' 131' ' ' PHE . 27.2 mt -69.78 -11.11 60.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.659 -0.246 . . . . 0.0 111.11 -179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.592 HD23 ' HB3' ' A' ' 129' ' ' PRO . 22.2 mt -86.29 172.18 10.66 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.979 0.419 . . . . 0.0 111.327 -179.748 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -154.91 -125.81 0.98 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 121.075 -0.584 . . . . 0.0 112.161 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.02 123.51 38.55 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.763 0.316 . . . . 0.0 110.76 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -65.11 75.57 0.08 OUTLIER Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.44 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -119.18 -35.06 3.69 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.658 0.266 . . . . 0.0 111.089 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -146.37 -59.55 0.3 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.182 -179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 9.6 ptpp? -179.96 156.01 0.74 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.02 0.438 . . . . 0.0 110.792 179.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.592 ' HB3' HD23 ' A' ' 122' ' ' LEU . 11.7 Cg_endo -71.96 -174.66 1.4 Allowed 'Trans proline' 0 N--CA 1.459 -0.548 0 C-N-CA 122.43 2.087 . . . . 0.0 112.287 179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -92.5 -70.99 0.67 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.014 -179.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.756 ' HB2' HD13 ' A' ' 121' ' ' LEU . 2.0 m-85 -104.18 144.15 31.97 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.401 179.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.697 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -88.72 -35.54 8.37 Favored Glycine 0 N--CA 1.445 -0.753 0 C-N-CA 120.558 -0.83 . . . . 0.0 111.713 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -150.6 148.4 28.59 Favored 'General case' 0 CA--C 1.519 -0.225 0 CA-C-O 120.854 0.359 . . . . 0.0 110.719 179.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.653 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 37.6 p-90 -135.4 165.31 25.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.264 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.426 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 22.6 t -160.13 176.95 11.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.392 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.57 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 41.9 m95 -113.75 105.02 12.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.224 178.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.552 ' O ' ' N ' ' A' ' 28' ' ' ILE . 24.4 m -119.39 170.3 9.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.269 -179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.549 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 24.4 p -72.86 169.32 17.94 Favored Pre-proline 0 C--N 1.324 -0.529 0 C-N-CA 120.374 -0.53 . . . . 0.0 110.504 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.817 ' HG3' HD11 ' A' ' 28' ' ' ILE . 17.3 Cg_exo -60.52 -51.83 4.66 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 C-N-CA 122.082 1.855 . . . . 0.0 110.401 179.58 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -67.41 -28.81 68.23 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.847 178.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.455 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 2.3 mt-30 -71.35 -47.05 58.78 Favored 'General case' 0 N--CA 1.462 0.127 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.614 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.538 ' CD1' ' HB2' ' A' ' 30' ' ' ALA . 3.5 tp -55.67 -39.24 70.68 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.536 ' O ' HG22 ' A' ' 146' ' ' THR . 24.2 mm -62.82 -38.37 81.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.233 0.54 . . . . 0.0 110.514 179.186 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.73 -49.86 55.41 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.187 0.517 . . . . 0.0 110.627 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.437 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -74.63 -21.65 59.33 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.367 -0.833 . . . . 0.0 113.02 -179.196 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.687 HG23 ' HG3' ' A' ' 151' ' ' LYS . 6.2 t -73.49 -178.92 3.24 Favored 'General case' 0 C--N 1.331 -0.222 0 C-N-CA 120.718 -0.393 . . . . 0.0 111.68 -178.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.8 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 30.7 m -86.39 151.1 3.68 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.822 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.58 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 0.1 OUTLIER -58.93 -53.69 55.61 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.683 179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.56 ' H ' ' HG3' ' A' ' 148' ' ' GLU . 39.3 p90 -55.38 -3.44 0.06 Allowed 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.066 0.765 . . . . 0.0 113.066 -179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 28.4 mttm -133.15 -7.4 3.02 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.129 0.418 . . . . 0.0 112.129 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.687 ' HG3' HG23 ' A' ' 146' ' ' THR . 8.1 mttt -60.37 -61.7 7.42 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 120.629 0.252 . . . . 0.0 111.192 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.709 ' HB2' ' HG ' ' A' ' 3' ' ' LEU . 10.7 Cg_endo -53.92 -31.28 62.29 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.742 2.295 . . . . 0.0 112.011 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.997 HG22 HD11 ' A' ' 3' ' ' LEU . 38.9 t -67.18 -52.05 47.15 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 178.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.485 ' HE2' ' HA ' ' A' ' 41' ' ' GLN . 4.0 m-30 -63.77 -37.93 89.19 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.651 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.506 ' HD3' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -55.93 -46.74 78.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.822 179.504 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.548 ' HG2' HD21 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -67.26 -28.92 68.44 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 179.416 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.851 HG23 ' O ' ' A' ' 153' ' ' VAL . 47.4 t -68.89 -42.24 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 CA-C-N 115.366 -0.833 . . . . 0.0 109.717 178.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.494 HD22 ' HB3' ' A' ' 139' ' ' PRO . 49.4 mt -63.91 -46.43 84.86 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.551 179.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 40.5 t -50.33 -42.19 52.53 Favored 'General case' 0 CA--C 1.517 -0.324 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 179.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.731 HG11 ' HA ' ' A' ' 76' ' ' VAL . 94.6 t -65.92 -42.03 91.1 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.603 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.282 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.61 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 16.8 m-30 -81.07 4.9 18.23 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 114.919 -1.037 . . . . 0.0 112.534 -178.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.702 ' HB3' ' HD3' ' A' ' 163' ' ' PRO . . . -58.86 -50.18 89.37 Favored Pre-proline 0 C--N 1.329 -0.294 0 C-N-CA 120.577 -0.449 . . . . 0.0 110.653 179.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.702 ' HD3' ' HB3' ' A' ' 162' ' ' ALA . 24.2 Cg_exo -61.55 -11.93 22.3 Favored 'Trans proline' 0 C--N 1.344 0.316 0 C-N-CA 122.389 2.059 . . . . 0.0 111.602 178.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.493 ' CG ' ' HB2' ' A' ' 74' ' ' ALA . 84.1 m-70 -109.69 -17.8 13.61 Favored 'General case' 0 C--O 1.231 0.11 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.341 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 86.3 mt . . . . . 0 C--O 1.249 1.077 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.725 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.415 ' HA2' ' HG3' ' A' ' 85' ' ' PRO . . . . . . . . 0 N--CA 1.488 2.146 0 N-CA-C 112.57 -0.212 . . . . 0.0 112.57 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -73.98 -179.18 4.39 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.466 2.11 . . . . 0.0 112.107 179.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.542 HD23 ' H ' ' A' ' 3' ' ' LEU . 0.2 OUTLIER -94.7 148.6 22.11 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 179.465 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.477 ' O ' ' OG ' ' A' ' 5' ' ' SER . . . -104.67 -17.13 15.55 Favored Glycine 0 CA--C 1.519 0.294 0 C-N-CA 120.424 -0.894 . . . . 0.0 113.752 -178.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.932 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 15.4 p 60.23 -104.66 0.19 Allowed 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 111.919 0.341 . . . . 0.0 111.919 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 12.4 mtm 68.12 130.81 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.762 0.315 . . . . 0.0 110.653 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.721 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 11.3 p-10 -69.07 -23.63 64.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.607 -179.526 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.37 122.75 42.83 Favored Pre-proline 0 C--N 1.325 -0.471 0 C-N-CA 120.996 -0.282 . . . . 0.0 110.686 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.439 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . 71.6 Cg_endo -75.56 115.0 4.09 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.116 1.878 . . . . 0.0 112.076 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.46 ' HD2' ' CD2' ' A' ' 13' ' ' TYR . 4.3 Cg_exo -79.81 175.42 10.53 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 123.227 2.618 . . . . 0.0 112.76 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -55.92 152.8 9.53 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.118 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.561 ' HA2' ' HA ' ' A' ' 100' ' ' TRP . . . 51.08 69.28 1.17 Allowed Glycine 0 C--N 1.329 0.179 0 C-N-CA 121.171 -0.537 . . . . 0.0 113.579 179.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.564 ' CE1' ' O ' ' A' ' 101' ' ' LYS . 30.2 m-85 -152.94 114.0 4.16 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 110.07 -0.344 . . . . 0.0 110.07 179.347 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.534 ' HG2' ' CZ3' ' A' ' 96' ' ' TRP . 0.7 OUTLIER -67.2 89.1 0.19 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.262 0.553 . . . . 0.0 111.705 -179.14 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.598 ' HG2' HD12 ' A' ' 47' ' ' ILE . 3.9 ttp180 -53.29 113.97 1.32 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.579 179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.712 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 66.0 m-20 -133.47 176.54 8.45 Favored 'General case' 0 C--O 1.223 -0.312 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.218 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.801 HG13 ' CG1' ' A' ' 47' ' ' ILE . 13.1 m -139.25 166.29 21.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.365 0.602 . . . . 0.0 112.079 178.865 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.59 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -133.83 162.2 24.41 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.365 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.869 HG21 HD22 ' A' ' 61' ' ' LEU . 3.4 mp -129.49 117.47 42.67 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -178.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.551 ' O ' HD12 ' A' ' 109' ' ' LEU . 0.5 OUTLIER -103.86 99.76 9.54 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 177.992 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.832 HD11 ' HB2' ' A' ' 112' ' ' PHE . 12.4 tp -102.26 126.87 49.38 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.847 -178.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.59 ' HE3' HD13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -124.49 153.84 41.43 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.049 -0.523 . . . . 0.0 112.239 -179.724 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.574 ' ND2' ' HB3' ' A' ' 112' ' ' PHE . 2.2 m120 -99.39 -178.61 3.96 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.684 0.754 . . . . 0.0 111.094 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -58.73 -6.17 0.7 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.581 -1.19 . . . . 0.0 112.041 178.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.523 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 2.7 m-20 -99.55 0.19 41.8 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 111.868 0.321 . . . . 0.0 111.868 -178.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 2.0 mmtm 72.7 21.92 3.34 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.921 -178.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.552 ' C ' HD12 ' A' ' 28' ' ' ILE . 15.3 mttt -95.77 169.19 10.18 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 178.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.735 HD12 ' N ' ' A' ' 28' ' ' ILE . 1.5 mp -117.67 143.24 28.75 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.475 0.655 . . . . 0.0 111.566 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.519 ' CE2' ' HD3' ' A' ' 43' ' ' PRO . 6.5 t80 -64.48 99.65 0.32 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.724 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.756 ' HA ' ' O ' ' A' ' 41' ' ' GLN . . . -96.46 138.73 33.62 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.193 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -136.23 135.98 39.52 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.578 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.733 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 70.0 p -102.15 141.95 34.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.852 0.358 . . . . 0.0 111.473 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -70.9 128.11 34.88 Favored 'General case' 0 N--CA 1.457 -0.115 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.515 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.707 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.3 OUTLIER -44.24 -37.82 3.45 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-O 121.181 0.515 . . . . 0.0 111.04 -179.859 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -71.59 -35.24 70.47 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.508 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.403 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 16.3 mt -126.4 106.72 24.06 Favored Pre-proline 0 C--N 1.331 -0.233 0 CA-C-O 120.728 0.299 . . . . 0.0 111.068 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.7 -43.84 12.03 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.86 2.374 . . . . 0.0 113.276 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 79.4 m-20 -75.29 -3.55 33.99 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 111.88 0.326 . . . . 0.0 111.88 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.769 ' HB1' ' CG1' ' A' ' 147' ' ' VAL . . . -92.34 96.13 10.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.751 0.31 . . . . 0.0 110.671 179.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.603 ' CD1' ' HB3' ' A' ' 145' ' ' LEU . 74.1 m95 -94.46 163.0 13.58 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.015 -0.538 . . . . 0.0 110.57 179.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.756 ' O ' ' HA ' ' A' ' 30' ' ' ALA . 0.1 OUTLIER -174.31 -135.3 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 121.032 -0.267 . . . . 0.0 111.341 -178.945 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.626 ' HB2' ' HD2' ' A' ' 43' ' ' PRO . 6.4 ptt? -177.03 165.32 1.45 Allowed Pre-proline 0 N--CA 1.453 -0.307 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.904 ' HG3' HD13 ' A' ' 61' ' ' LEU . 4.1 Cg_endo -45.05 144.47 3.84 Favored 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.736 2.291 . . . . 0.0 113.246 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.462 ' HA ' HD12 ' A' ' 19' ' ' ILE . 21.1 pt20 -174.26 141.94 0.76 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.323 179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.538 ' HA3' ' HG3' ' A' ' 60' ' ' GLU . . . -142.65 -173.21 14.29 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.627 -0.797 . . . . 0.0 111.991 179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.701 ' HA2' ' CB ' ' A' ' 16' ' ' ASN . . . -116.68 22.07 11.04 Favored Glycine 0 C--N 1.335 0.526 0 C-N-CA 119.984 -1.103 . . . . 0.0 114.445 -179.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.801 ' CG1' HG13 ' A' ' 17' ' ' VAL . 43.1 mt 61.28 131.5 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 117.234 0.517 . . . . 0.0 111.346 179.159 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -68.02 -176.18 0.67 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.724 179.767 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -47.67 -69.74 0.12 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.315 179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -119.13 57.1 0.56 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.504 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.0 tp10 -117.95 150.72 38.77 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.888 0.375 . . . . 0.0 110.945 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -69.84 173.09 4.53 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.748 179.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.639 ' HA ' HG11 ' A' ' 17' ' ' VAL . 2.0 Cg_endo -80.74 -52.78 0.04 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.541 2.16 . . . . 0.0 111.58 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.739 ' HE ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -54.01 -44.22 70.73 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.515 179.153 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -68.52 -45.09 73.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.372 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.428 ' HB1' ' HA ' ' A' ' 47' ' ' ILE . . . -60.51 -42.47 96.45 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.717 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -56.66 -60.16 3.96 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.319 0.58 . . . . 0.0 109.723 178.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.543 HD11 ' CD ' ' A' ' 54' ' ' ARG . 47.2 mt -53.92 -51.33 46.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.483 -0.781 . . . . 0.0 111.207 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -61.02 -62.68 1.68 Allowed 'General case' 0 CA--C 1.52 -0.187 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.85 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.538 ' HG3' ' HA3' ' A' ' 45' ' ' GLY . 8.8 mm-40 -43.71 -44.03 6.3 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-O 121.261 0.553 . . . . 0.0 109.908 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.96 HD11 ' HB ' ' A' ' 67' ' ' VAL . 0.6 OUTLIER -51.87 -47.96 64.28 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.968 178.59 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.721 ' HG3' HG23 ' A' ' 68' ' ' THR . 38.5 ttt180 -63.23 -65.58 0.66 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.214 0.531 . . . . 0.0 111.095 179.624 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -47.75 -25.27 1.18 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.792 -0.64 . . . . 0.0 112.317 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -93.38 -35.58 12.95 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -178.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.605 ' HB ' HG23 ' A' ' 119' ' ' ILE . 1.4 p -127.68 -37.14 1.99 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.92 -0.312 . . . . 0.0 111.752 -178.839 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.476 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 111.48 -10.56 28.34 Favored Glycine 0 N--CA 1.449 -0.434 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.184 -179.613 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.96 ' HB ' HD11 ' A' ' 61' ' ' LEU . 68.6 t -56.86 111.97 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.197 0.523 . . . . 0.0 111.633 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.721 HG23 ' HG3' ' A' ' 62' ' ' ARG . 6.9 p -123.66 -39.15 2.44 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.355 -0.839 . . . . 0.0 109.651 178.457 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 33.4 m -62.48 74.43 0.02 OUTLIER 'General case' 0 C--O 1.232 0.141 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.018 178.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.57 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -160.88 157.11 26.04 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 112.22 0.452 . . . . 0.0 112.22 -179.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -128.01 144.85 51.11 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.095 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.808 HG22 ' CE1' ' A' ' 110' ' ' PHE . 21.6 t -73.98 125.79 33.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.129 0.49 . . . . 0.0 111.319 179.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.619 HD11 ' HB2' ' A' ' 111' ' ' LYS . 1.0 OUTLIER -107.36 -20.06 6.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.683 179.728 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.505 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -169.73 177.46 4.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.818 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.478 ' HB3' ' HD1' ' A' ' 108' ' ' PHE . 3.7 pm0 -157.73 150.59 23.0 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.563 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.854 ' HA ' HG11 ' A' ' 160' ' ' VAL . 53.4 t -71.91 134.44 83.48 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.135 0.493 . . . . 0.0 111.354 -179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.46 ' HD2' HG13 ' A' ' 76' ' ' VAL . 29.7 Cg_endo -63.77 -54.06 1.09 Allowed 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.099 2.533 . . . . 0.0 112.657 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.721 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 2.4 p90 -99.11 178.79 4.81 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.235 -179.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.549 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 43.5 m95 -94.56 -158.0 0.6 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.623 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.932 ' HA ' ' HA ' ' A' ' 5' ' ' SER . 70.6 mt -160.31 101.69 1.39 Allowed 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.023 0.439 . . . . 0.0 110.197 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.753 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 77.8 p -89.69 115.38 27.02 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.984 -0.553 . . . . 0.0 112.016 -178.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.813 ' CZ ' HG21 ' A' ' 153' ' ' VAL . 12.9 m-85 -78.33 61.43 2.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.547 -0.751 . . . . 0.0 111.624 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.63 127.11 31.57 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.71 179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.702 ' CD1' HD12 ' A' ' 92' ' ' LEU . 57.1 m-85 -102.36 159.51 29.15 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 120.759 0.314 . . . . 0.0 110.961 179.288 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.488 ' HB3' ' HD2' ' A' ' 86' ' ' PRO . 33.9 Cg_exo -56.54 178.39 0.13 Allowed 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.452 2.102 . . . . 0.0 111.761 179.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 85' ' ' PRO . 33.0 Cg_endo -63.91 -30.71 67.59 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.374 2.049 . . . . 0.0 112.352 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -70.93 -50.88 29.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.649 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.682 ' HB ' ' HB3' ' A' ' 84' ' ' PHE . 30.6 t -73.9 -21.74 18.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.913 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.725 ' HG3' ' HB3' ' A' ' 93' ' ' ASN . 2.1 tpp180 -57.59 -47.68 81.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.909 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.793 ' HA ' HD13 ' A' ' 94' ' ' ILE . 3.6 mt-10 -71.31 -17.91 62.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.717 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.27 -22.37 17.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.856 0.36 . . . . 0.0 110.743 179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.702 HD12 ' CD1' ' A' ' 84' ' ' PHE . 1.5 tm? -120.93 -62.36 1.45 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.664 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.725 ' HB3' ' HG3' ' A' ' 89' ' ' ARG . 0.2 OUTLIER -47.45 -61.51 1.88 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.31 0.576 . . . . 0.0 112.171 -179.613 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.793 HD13 ' HA ' ' A' ' 90' ' ' GLU . 3.9 mp -68.98 -5.11 4.26 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.79 -179.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.28 -4.38 58.37 Favored 'General case' 0 C--N 1.332 -0.169 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.562 ' HB2' ' CD1' ' A' ' 100' ' ' TRP . 65.9 m95 -95.76 -0.06 51.8 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 -179.557 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' A' ' 98' ' ' SER . . . 66.21 119.6 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.256 -0.973 . . . . 0.0 112.158 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.527 ' HB2' ' O ' ' A' ' 97' ' ' GLY . 0.1 OUTLIER 89.97 -166.3 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 122.877 0.471 . . . . 0.0 110.704 -179.567 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -50.21 -85.74 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.769 -179.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.669 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 29.8 m95 56.75 178.57 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.799 -0.182 . . . . 0.0 110.868 -179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.71 ' HA ' ' OD1' ' A' ' 93' ' ' ASN . 1.6 ttpp 161.78 64.15 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 122.643 0.377 . . . . 0.0 111.098 179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 104.03 -172.12 20.42 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.524 179.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.753 ' O ' ' HA ' ' A' ' 81' ' ' THR . 1.0 OUTLIER -144.04 118.86 9.9 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 120.536 0.208 . . . . 0.0 110.935 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.463 ' HB2' HG22 ' A' ' 81' ' ' THR . . . -86.88 115.93 24.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.278 0.561 . . . . 0.0 109.595 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.712 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 13.1 mt-30 -121.98 123.32 41.39 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.662 -177.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 78' ' ' TYR . 5.1 ttpt -104.62 135.47 45.95 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 177.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.59 ' CE2' ' HA3' ' A' ' 18' ' ' GLY . 19.5 m95 -101.2 162.74 12.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.205 0.526 . . . . 0.0 112.3 -178.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.614 ' CD1' ' HG2' ' A' ' 54' ' ' ARG . 97.6 m-85 -137.38 149.37 46.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.395 -0.82 . . . . 0.0 110.643 -179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.551 HD12 ' O ' ' A' ' 20' ' ' CYS . 19.0 tp -102.62 125.63 49.41 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.31 179.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.808 ' CE1' HG22 ' A' ' 72' ' ' VAL . 11.9 m-85 -128.87 144.84 51.29 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.296 0.569 . . . . 0.0 111.507 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.619 ' HB2' HD11 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -96.35 118.56 33.15 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.175 -0.921 . . . . 0.0 109.397 179.137 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.832 ' HB2' HD11 ' A' ' 21' ' ' LEU . 50.6 t80 -79.06 94.61 5.35 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.702 -0.399 . . . . 0.0 110.319 179.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 19.5 p -94.67 45.46 1.12 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.378 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.34 -146.2 4.6 Favored Glycine 0 C--N 1.331 0.298 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.263 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -121.02 146.89 46.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.963 0.411 . . . . 0.0 111.401 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.504 ' HB2' ' CZ2' ' A' ' 134' ' ' TRP . 11.2 p-10 -58.3 -39.88 80.51 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.19 -179.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -57.52 -4.4 0.25 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.066 -0.97 . . . . 0.0 112.278 -179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -88.85 -16.35 32.22 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.014 0.435 . . . . 0.0 110.562 179.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.627 HG12 HG22 ' A' ' 67' ' ' VAL . 11.0 mt -82.35 102.83 8.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.951 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 10.4 t-20 -101.2 98.86 9.22 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.285 179.041 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.82 HD13 ' HB2' ' A' ' 131' ' ' PHE . 50.8 mt -68.74 -1.65 7.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.529 -0.305 . . . . 0.0 111.637 -179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.847 ' HA ' ' HB3' ' A' ' 129' ' ' PRO . 12.1 mt -73.05 -149.35 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 121.285 -0.166 . . . . 0.0 110.761 -179.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . 0.475 ' H ' ' HB3' ' A' ' 122' ' ' LEU . . . 156.83 136.89 2.2 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 111.296 -0.722 . . . . 0.0 111.296 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -88.07 86.82 7.17 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.127 0.489 . . . . 0.0 110.631 -179.572 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 161.69 134.56 1.66 Allowed Glycine 0 N--CA 1.45 -0.405 0 CA-C-N 115.455 -0.793 . . . . 0.0 111.645 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.8 p 69.96 0.1 2.94 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.721 0.296 . . . . 0.0 111.677 -179.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 71.32 -47.33 0.66 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.392 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 129' ' ' PRO . 30.4 pttt -78.05 145.54 69.71 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-O 121.017 0.437 . . . . 0.0 111.107 179.527 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.847 ' HB3' ' HA ' ' A' ' 122' ' ' LEU . 13.4 Cg_endo -82.99 -171.43 1.13 Allowed 'Trans proline' 0 N--CA 1.456 -0.728 0 C-N-CA 123.085 2.523 . . . . 0.0 112.826 179.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.625 ' O ' HD12 ' A' ' 34' ' ' LEU . 1.9 mp0 -87.29 -74.03 0.45 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.759 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.82 ' HB2' HD13 ' A' ' 121' ' ' LEU . 0.5 OUTLIER -102.16 142.26 33.7 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.76 -0.655 . . . . 0.0 109.492 178.894 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.707 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -82.53 -35.39 19.98 Favored Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.145 -179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.93 147.88 27.1 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.751 0.31 . . . . 0.0 110.735 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.6 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 39.1 p-90 -137.4 173.47 11.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.045 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.449 ' N ' ' HZ3' ' A' ' 40' ' ' TRP . 22.0 t -168.57 -179.46 3.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.462 0.649 . . . . 0.0 112.003 -178.254 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.527 ' CD2' ' OD1' ' A' ' 23' ' ' ASN . 88.8 m95 -113.25 100.72 8.78 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 114.891 -1.049 . . . . 0.0 109.907 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.467 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 32.6 m -118.3 169.78 8.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.283 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.579 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 12.3 p -74.04 172.32 8.84 Favored Pre-proline 0 C--N 1.329 -0.317 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.161 179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.601 ' HB3' HD22 ' A' ' 158' ' ' LEU . 16.4 Cg_exo -61.87 -56.96 0.6 Allowed 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.845 1.697 . . . . 0.0 110.337 179.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.38 -27.93 69.41 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.563 178.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.409 ' HG3' ' OG1' ' A' ' 138' ' ' THR . 1.0 OUTLIER -70.98 -49.31 46.73 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.503 179.588 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.717 HD13 ' HB2' ' A' ' 30' ' ' ALA . 12.8 tp -57.74 -37.39 73.52 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 109.784 -0.45 . . . . 0.0 109.784 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.61 ' O ' HG22 ' A' ' 146' ' ' THR . 13.2 mm -62.47 -39.3 83.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 121.14 0.495 . . . . 0.0 110.698 179.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -68.32 -48.91 63.64 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.325 0.583 . . . . 0.0 110.437 179.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.603 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -75.53 -18.78 59.69 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.153 -0.93 . . . . 0.0 112.742 -179.149 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.686 ' OG1' ' HG3' ' A' ' 41' ' ' GLN . 15.2 t -76.31 178.02 6.82 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.364 -179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.769 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 19.2 m -87.34 147.49 5.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.987 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.496 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 52.4 mt-10 -50.87 -49.79 58.4 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.927 0.394 . . . . 0.0 111.599 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.458 ' O ' ' HE1' ' A' ' 82' ' ' TYR . 1.2 m-85 -52.14 -7.13 0.05 Allowed 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 112.913 0.709 . . . . 0.0 112.913 -179.353 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.547 ' HD3' ' CG2' ' A' ' 147' ' ' VAL . 7.7 mptt -137.09 -2.38 2.07 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -178.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.559 ' HG2' ' O ' ' A' ' 143' ' ' ILE . 14.7 mttt -63.79 -62.9 4.56 Favored Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 111.533 0.197 . . . . 0.0 111.533 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.496 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 19.3 Cg_endo -60.41 -29.04 87.92 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.266 1.978 . . . . 0.0 111.422 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.813 HG21 ' CZ ' ' A' ' 82' ' ' TYR . 21.2 t -68.23 -51.37 48.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.553 ' OH ' ' HG2' ' A' ' 41' ' ' GLN . 7.6 m-30 -63.95 -36.96 85.69 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.69 -0.686 . . . . 0.0 109.729 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.501 ' HD3' HG21 ' A' ' 143' ' ' ILE . 0.2 OUTLIER -57.93 -42.83 85.69 Favored 'General case' 0 CA--C 1.516 -0.362 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.597 179.289 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.424 ' HG3' ' OH ' ' A' ' 78' ' ' TYR . 1.2 tp10 -68.35 -35.23 77.45 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 179.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 153' ' ' VAL . 59.2 t -66.21 -41.86 89.99 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.944 0 CA-C-N 115.292 -0.867 . . . . 0.0 109.551 178.339 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.601 HD22 ' HB3' ' A' ' 139' ' ' PRO . 40.8 mt -64.87 -41.73 95.43 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.901 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -55.75 -38.74 70.21 Favored 'General case' 0 CA--C 1.518 -0.25 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.854 HG11 ' HA ' ' A' ' 76' ' ' VAL . 98.7 t -69.06 -44.55 81.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.384 -0.826 . . . . 0.0 109.194 177.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.588 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 22.1 m-30 -80.05 4.98 15.43 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.392 -179.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.628 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.97 -52.44 74.81 Favored Pre-proline 0 C--N 1.329 -0.316 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.757 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 17.4 Cg_endo -57.77 -12.37 11.63 Favored 'Trans proline' 0 C--N 1.346 0.399 0 C-N-CA 122.226 1.951 . . . . 0.0 112.088 178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.505 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 85.0 m-70 -110.46 -19.98 12.75 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.342 -179.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 93.4 mt . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.163 -0.923 . . . . 0.0 110.733 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.132 0 N-CA-C 112.484 -0.246 . . . . 0.0 112.484 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_exo -52.05 149.65 20.67 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.544 2.163 . . . . 0.0 112.259 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.785 HD11 HG22 ' A' ' 153' ' ' VAL . 2.5 mt -145.22 -167.73 2.76 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.113 0.483 . . . . 0.0 110.848 -179.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.541 ' O ' ' HA ' ' A' ' 80' ' ' LEU . . . -159.53 144.2 9.93 Favored Glycine 0 N--CA 1.45 -0.403 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.63 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.61 ' HB3' ' CD1' ' A' ' 78' ' ' TYR . 0.7 OUTLIER -120.47 -76.16 0.58 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 117.117 0.458 . . . . 0.0 111.804 -179.652 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.413 ' HE2' ' N ' ' A' ' 5' ' ' SER . 3.8 mtm 65.68 132.05 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.606 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.508 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 10.8 p-10 -64.19 -44.94 90.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.549 -178.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 19.7 p -97.43 155.09 37.71 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.42 179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.47 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 57.5 Cg_endo -71.1 106.38 1.89 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.274 1.983 . . . . 0.0 111.683 179.543 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.567 ' HG2' ' CD2' ' A' ' 13' ' ' TYR . 8.1 Cg_endo -48.8 165.74 0.17 Allowed 'Trans proline' 0 N--CA 1.464 -0.214 0 C-N-CA 123.157 2.571 . . . . 0.0 113.112 -179.623 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -51.75 127.61 21.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.257 -179.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.478 ' O ' ' CG ' ' A' ' 101' ' ' LYS . . . 41.89 95.1 0.01 OUTLIER Glycine 0 C--O 1.226 -0.381 0 CA-C-N 115.673 -0.694 . . . . 0.0 113.855 178.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.567 ' CD2' ' HG2' ' A' ' 10' ' ' PRO . 9.2 m-85 -153.95 147.34 24.93 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.82 0.343 . . . . 0.0 110.466 179.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.645 ' HB3' ' HG2' ' A' ' 103' ' ' GLN . 28.1 ttt180 -71.17 83.58 0.73 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.243 -179.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.612 ' HG3' ' CZ3' ' A' ' 79' ' ' TRP . 2.0 ttp180 -50.71 111.35 0.53 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.859 179.358 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.684 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 2.2 m-80 -132.72 174.6 10.13 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.901 179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.676 HG13 ' CG1' ' A' ' 47' ' ' ILE . 14.4 m -141.8 167.22 16.28 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-O 120.969 0.414 . . . . 0.0 110.796 178.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.64 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -136.05 159.38 24.29 Favored Glycine 0 N--CA 1.444 -0.803 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.562 179.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.012 HG22 ' CE1' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -130.7 120.91 49.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 121.29 0.567 . . . . 0.0 112.321 -178.586 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.686 ' O ' HD12 ' A' ' 109' ' ' LEU . 53.0 t -104.3 100.09 9.81 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.073 178.457 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.868 HD22 HG11 ' A' ' 67' ' ' VAL . 12.0 tp -99.84 119.81 38.77 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.178 -178.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.597 ' SD ' HD11 ' A' ' 109' ' ' LEU . 0.6 OUTLIER -121.4 157.89 29.52 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.808 179.801 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.552 ' ND2' ' HB2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -97.16 172.48 7.79 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.45 -179.834 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -57.06 -4.14 0.17 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.479 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.605 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.7 OUTLIER -100.25 0.72 40.86 Favored 'General case' 0 C--N 1.34 0.17 0 N-CA-C 112.073 0.397 . . . . 0.0 112.073 -178.88 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.605 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 3.8 mmtm 76.45 19.17 1.68 Allowed 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.222 -178.47 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.555 ' O ' ' HA ' ' A' ' 22' ' ' MET . 2.8 mttt -95.73 143.97 26.52 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.659 HD12 ' N ' ' A' ' 28' ' ' ILE . 3.1 mp -102.75 145.48 12.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.54 0.686 . . . . 0.0 112.23 -178.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.575 ' CE1' HD13 ' A' ' 119' ' ' ILE . 90.8 t80 -74.98 138.68 42.43 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 114.661 -1.154 . . . . 0.0 110.643 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.907 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -137.51 148.65 46.17 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.323 -0.399 . . . . 0.0 109.972 179.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.469 ' HA ' ' HA ' ' A' ' 134' ' ' TRP . . . -141.11 134.48 29.71 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.911 179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.676 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 2.1 m -95.09 151.14 19.45 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.924 0.392 . . . . 0.0 111.122 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 15.0 mtp-105 -69.61 132.29 45.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.425 -179.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.018 ' H ' HD23 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -39.18 -46.52 1.49 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.961 -178.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -72.24 -34.76 68.52 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.991 -1.004 . . . . 0.0 112.181 -178.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.509 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 19.5 mt -119.05 114.44 35.15 Favored Pre-proline 0 CA--C 1.529 0.17 0 C-N-CA 120.954 -0.299 . . . . 0.0 111.297 -179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 74.7 Cg_endo -78.27 -20.42 11.22 Favored 'Trans proline' 0 C--N 1.348 0.543 0 C-N-CA 122.171 1.914 . . . . 0.0 112.279 179.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -91.57 -10.08 41.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.922 179.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.676 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -90.51 92.86 9.05 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.483 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.659 ' O ' ' HA ' ' A' ' 146' ' ' THR . 76.8 m95 -88.32 148.88 24.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.657 179.578 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.3 158.02 31.61 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.346 0.593 . . . . 0.0 111.567 -179.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.543 ' HG3' HD11 ' A' ' 142' ' ' LEU . 28.3 mtm -90.41 148.51 39.09 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 115.308 -0.86 . . . . 0.0 108.991 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.464 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 11.3 Cg_endo -53.88 151.5 26.32 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 121.729 1.619 . . . . 0.0 111.319 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.416 ' HA ' ' CD1' ' A' ' 19' ' ' ILE . 4.1 pt20 -174.74 154.23 1.91 Allowed 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.419 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.432 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . -159.9 159.94 31.11 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.298 -0.953 . . . . 0.0 112.151 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.684 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -86.79 137.34 14.74 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.377 -0.916 . . . . 0.0 112.693 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.676 ' CG1' HG13 ' A' ' 17' ' ' VAL . 45.2 mt -68.36 146.51 12.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.616 0.246 . . . . 0.0 111.289 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -68.66 -174.64 0.58 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.017 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -49.05 -61.36 2.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.472 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.59 58.62 0.7 Allowed Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.764 -179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.436 ' O ' HG21 ' A' ' 47' ' ' ILE . 2.3 tp10 -117.44 154.06 32.03 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.68 0.276 . . . . 0.0 110.623 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.72 159.78 84.07 Favored Pre-proline 0 C--N 1.327 -0.393 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.564 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.53 ' HA ' HG11 ' A' ' 17' ' ' VAL . 6.1 Cg_exo -78.54 -49.85 0.08 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.411 0 C-N-CA 122.528 2.152 . . . . 0.0 111.686 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.746 ' HE ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -51.49 -46.64 63.23 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.305 179.563 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 23.5 m-80 -67.38 -44.61 78.49 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.351 179.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.68 -39.9 90.12 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.924 ' HB1' HG23 ' A' ' 19' ' ' ILE . . . -58.6 -56.12 26.27 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.442 0.639 . . . . 0.0 109.565 178.614 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.573 HD11 ' NE ' ' A' ' 54' ' ' ARG . 23.6 mt -55.86 -52.71 46.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.854 179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -62.1 -58.19 8.74 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.826 -178.822 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.432 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 70.6 mm-40 -46.21 -45.63 17.03 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.382 0.61 . . . . 0.0 109.848 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.89 HD21 ' HB ' ' A' ' 67' ' ' VAL . 9.9 tt -52.45 -45.91 66.23 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.865 178.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.706 ' HD2' ' HA2' ' A' ' 66' ' ' GLY . 19.9 tpt85 -62.81 -65.6 0.66 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.377 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -50.11 -23.91 2.42 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.076 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.52 ' HB3' ' CE2' ' A' ' 131' ' ' PHE . 6.3 mt-10 -91.87 -35.29 14.14 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.256 0.835 . . . . 0.0 113.256 -177.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.525 HG21 ' CE2' ' A' ' 29' ' ' PHE . 1.7 p -123.76 -43.79 2.11 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 120.505 -0.478 . . . . 0.0 112.141 -179.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.706 ' HA2' ' HD2' ' A' ' 62' ' ' ARG . . . 119.89 -17.58 10.0 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.642 -0.79 . . . . 0.0 111.275 -178.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.89 ' HB ' HD21 ' A' ' 61' ' ' LEU . 76.5 t -58.73 115.22 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 CA-C-O 121.443 0.64 . . . . 0.0 111.842 179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.646 HG23 ' HD3' ' A' ' 62' ' ' ARG . 0.5 OUTLIER -124.55 -37.04 2.55 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.303 -0.862 . . . . 0.0 109.5 178.223 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.4 m -62.35 73.89 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.102 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.572 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -159.63 156.08 27.3 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.201 0.445 . . . . 0.0 112.201 -179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -128.65 148.57 50.81 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-N 115.643 -0.708 . . . . 0.0 110.328 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.837 HG22 ' CE2' ' A' ' 110' ' ' PHE . 26.2 t -75.25 127.92 36.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.108 0.48 . . . . 0.0 111.341 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.662 HD11 ' HB2' ' A' ' 111' ' ' LYS . 1.7 mt -107.84 -18.58 7.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.482 179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.437 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.91 175.48 4.42 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.635 -0.712 . . . . 0.0 111.219 -179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 1.4 pt-20 -151.52 149.68 29.5 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.469 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.833 ' HA ' HG11 ' A' ' 160' ' ' VAL . 39.7 t -72.92 134.94 80.77 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 120.99 0.424 . . . . 0.0 111.144 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.48 ' HD2' HG11 ' A' ' 160' ' ' VAL . 17.8 Cg_endo -57.0 -68.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.201 2.601 . . . . 0.0 112.707 -179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.61 ' CD1' ' HB3' ' A' ' 5' ' ' SER . 0.1 OUTLIER -95.5 -174.86 3.3 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.265 -0.88 . . . . 0.0 111.76 -178.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.612 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 47.2 m95 -90.9 -158.05 0.53 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.037 179.204 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.569 ' HA ' ' HA ' ' A' ' 5' ' ' SER . 50.7 mt -162.31 103.14 1.1 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.947 0.404 . . . . 0.0 110.552 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.613 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 66.5 p -90.11 -175.23 4.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.696 179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.54 ' CD2' HD21 ' A' ' 3' ' ' LEU . 0.7 OUTLIER -169.78 64.7 0.05 Allowed 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.185 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.492 ' HA ' HD21 ' A' ' 93' ' ' ASN . 9.9 p-10 -74.11 172.62 11.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.853 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.493 ' H ' ' HG2' ' A' ' 89' ' ' ARG . 4.8 m-85 -95.63 175.29 2.85 Favored Pre-proline 0 CA--C 1.531 0.232 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.825 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.589 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 49.6 Cg_exo -55.17 166.52 2.25 Favored 'Trans proline' 0 C--N 1.349 0.566 0 C-N-CA 122.29 1.993 . . . . 0.0 112.05 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -60.51 -7.19 6.62 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.605 2.204 . . . . 0.0 113.522 -179.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.83 -36.37 5.71 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.614 0.245 . . . . 0.0 111.501 -179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.586 ' HB ' ' HD2' ' A' ' 85' ' ' PRO . 12.4 t -87.15 -27.59 5.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.391 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.85 ' O ' ' HB2' ' A' ' 93' ' ' ASN . 2.6 tmm_? -59.62 -19.58 50.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.865 0.364 . . . . 0.0 111.251 179.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.614 ' HA ' HD13 ' A' ' 94' ' ' ILE . 4.3 tt0 -97.58 -21.3 17.15 Favored 'General case' 0 C--N 1.323 -0.561 0 C-N-CA 120.724 -0.39 . . . . 0.0 111.47 -179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -96.14 -17.58 20.75 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 121.088 -0.245 . . . . 0.0 111.266 -179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.613 HD13 ' HE1' ' A' ' 96' ' ' TRP . 1.5 tm? -119.57 -57.17 2.0 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.778 0.323 . . . . 0.0 111.119 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.85 ' HB2' ' O ' ' A' ' 89' ' ' ARG . 4.1 m120 -60.38 -46.72 88.96 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -179.006 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.614 HD13 ' HA ' ' A' ' 90' ' ' GLU . 1.4 mp -63.89 -8.71 4.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.445 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.545 ' O ' ' N ' ' A' ' 97' ' ' GLY . 0.7 OUTLIER -98.41 -103.06 0.21 Allowed 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.108 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.613 ' HE1' HD13 ' A' ' 92' ' ' LEU . 59.8 m95 59.8 -65.0 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 123.16 0.584 . . . . 0.0 111.577 -179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 95' ' ' GLN . . . -173.57 -54.91 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.991 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 43.5 t -174.92 139.08 0.48 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.25 0.547 . . . . 0.0 111.436 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 52.41 19.0 1.03 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.305 -0.861 . . . . 0.0 112.29 179.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.633 ' CZ2' ' HA ' ' A' ' 14' ' ' ARG . 0.0 OUTLIER -96.68 175.6 6.31 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.86 0.362 . . . . 0.0 111.329 -179.519 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.536 ' HA ' ' HB3' ' A' ' 93' ' ' ASN . 1.0 OUTLIER 167.89 31.12 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.394 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.633 179.534 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.504 ' HA3' ' HE1' ' A' ' 13' ' ' TYR . . . 143.07 -157.38 26.86 Favored Glycine 0 C--N 1.332 0.36 0 N-CA-C 111.392 -0.683 . . . . 0.0 111.392 179.487 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.645 ' HG2' ' HB3' ' A' ' 14' ' ' ARG . 17.0 mt-30 -146.47 108.19 4.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 117.129 0.465 . . . . 0.0 111.373 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.605 ' HB2' HG22 ' A' ' 81' ' ' THR . . . -94.1 118.31 31.34 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.352 -0.386 . . . . 0.0 110.299 179.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.677 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 0.8 OUTLIER -130.53 130.46 44.17 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 113.276 0.843 . . . . 0.0 113.276 -178.575 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.514 ' HE2' ' CE2' ' A' ' 79' ' ' TRP . 1.9 ttmt -104.04 135.87 44.75 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 177.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.64 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 18.7 m95 -105.68 164.01 12.24 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -177.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.53 ' CD2' ' HG2' ' A' ' 54' ' ' ARG . 96.3 m-85 -139.44 153.59 47.61 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.528 -179.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.686 HD12 ' O ' ' A' ' 20' ' ' CYS . 13.8 tp -100.91 142.61 32.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.576 -0.283 . . . . 0.0 111.429 179.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 1.012 ' CE1' HG22 ' A' ' 19' ' ' ILE . 10.1 m-85 -144.54 146.13 32.2 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.662 ' HB2' HD11 ' A' ' 73' ' ' ILE . 22.8 tttt -101.56 124.57 47.44 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.63 -1.168 . . . . 0.0 109.474 178.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.701 ' CE1' HG13 ' A' ' 67' ' ' VAL . 49.4 t80 -77.91 97.37 5.28 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.549 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 59.3 p -96.72 53.91 1.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.035 0.445 . . . . 0.0 110.588 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -157.96 -147.24 4.75 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.492 -179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 16.7 mt-30 -122.31 149.15 44.13 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.996 0.427 . . . . 0.0 110.826 179.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.466 ' HB3' ' CH2' ' A' ' 134' ' ' TRP . 76.6 m-20 -58.61 -32.26 68.83 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.291 -179.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 8.7 pt20 -59.31 -5.45 0.75 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.464 179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.65 -16.11 33.22 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.944 0.402 . . . . 0.0 111.005 179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.734 HG12 HG22 ' A' ' 67' ' ' VAL . 6.1 mt -79.04 101.84 4.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.901 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.467 ' C ' ' H ' ' A' ' 122' ' ' LEU . 3.8 t30 -101.21 92.85 5.16 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.767 179.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.728 ' C ' HD22 ' A' ' 122' ' ' LEU . 87.5 mt -72.42 41.49 0.09 Allowed 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.896 0.379 . . . . 0.0 110.626 179.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.942 HD23 ' HB3' ' A' ' 129' ' ' PRO . 0.4 OUTLIER 57.64 153.57 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.4 0.619 . . . . 0.0 111.805 179.665 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -162.43 -1.25 0.06 OUTLIER Glycine 0 CA--C 1.518 0.26 0 CA-C-N 115.215 -0.902 . . . . 0.0 112.576 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.401 ' O ' ' O ' ' A' ' 125' ' ' GLY . 0.9 OUTLIER -100.86 -161.4 0.86 Allowed 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 122.64 0.376 . . . . 0.0 110.412 179.915 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . 0.401 ' O ' ' O ' ' A' ' 124' ' ' ASP . . . -56.56 -115.08 0.01 OUTLIER Glycine 0 CA--C 1.521 0.413 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.951 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 59.15 15.57 4.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.606 0.241 . . . . 0.0 111.203 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.401 ' O ' ' HB3' ' A' ' 128' ' ' LYS . 0.0 OUTLIER 70.94 -48.44 0.67 Allowed 'General case' 0 C--O 1.232 0.16 0 CA-C-N 116.518 -0.31 . . . . 0.0 111.327 -179.772 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.554 ' HE3' ' HG ' ' A' ' 34' ' ' LEU . 8.7 ptmt -179.83 148.13 0.48 Allowed Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.119 0.485 . . . . 0.0 111.573 178.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.942 ' HB3' HD23 ' A' ' 122' ' ' LEU . 6.3 Cg_exo -65.22 -161.29 0.04 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.301 0 C-N-CA 123.055 2.503 . . . . 0.0 112.533 179.051 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.695 ' C ' HD21 ' A' ' 34' ' ' LEU . 6.5 mm-40 -110.86 -36.47 5.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.679 178.498 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.647 ' N ' HD21 ' A' ' 34' ' ' LEU . 8.4 m-85 -132.24 142.84 49.55 Favored 'General case' 0 CA--C 1.518 -0.285 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 177.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.721 ' N ' HD22 ' A' ' 34' ' ' LEU . . . -86.9 -32.16 15.61 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.397 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 31' ' ' ALA . 1.9 tt0 -154.52 154.47 33.17 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.725 0.297 . . . . 0.0 111.337 -179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.64 ' CE2' HD12 ' A' ' 119' ' ' ILE . 22.1 p-90 -134.6 164.94 26.36 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.217 0.532 . . . . 0.0 112.162 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.425 ' N ' ' HZ3' ' A' ' 40' ' ' TRP . 12.2 t -159.24 162.93 36.24 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.277 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.544 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 51.7 m95 -107.1 105.67 15.8 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.018 178.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 28' ' ' ILE . 30.1 m -121.34 170.96 10.76 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.882 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.598 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 17.2 p -72.38 173.32 5.79 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 178.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.68 ' HB3' HD22 ' A' ' 158' ' ' LEU . 7.0 Cg_exo -64.68 -52.8 1.19 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 121.623 1.548 . . . . 0.0 109.896 178.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -64.44 -31.65 72.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.654 178.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.463 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.9 OUTLIER -70.11 -45.92 65.89 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.051 179.645 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.907 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -56.92 -39.91 75.34 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 179.682 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.643 HG21 ' CE ' ' A' ' 155' ' ' LYS . 33.4 mm -62.47 -33.89 61.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.087 179.241 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.46 -53.45 13.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.239 0.542 . . . . 0.0 110.54 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.4 mp -71.62 -21.19 61.87 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.649 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.659 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 7.4 t -74.99 169.38 18.11 Favored 'General case' 0 CA--C 1.517 -0.322 0 C-N-CA 120.163 -0.615 . . . . 0.0 111.586 -178.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.572 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 25.4 m -72.86 162.49 4.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.615 179.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.731 ' HG2' ' N ' ' A' ' 149' ' ' PHE . 0.3 OUTLIER -67.87 -50.98 53.41 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.19 0.519 . . . . 0.0 110.88 179.762 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.731 ' N ' ' HG2' ' A' ' 148' ' ' GLU . 40.2 p90 -58.52 -2.58 0.22 Allowed 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.619 -0.719 . . . . 0.0 112.938 -179.577 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.526 ' HG3' ' CD2' ' A' ' 149' ' ' PHE . 23.6 mttt -132.15 -7.49 3.43 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.335 0.495 . . . . 0.0 112.335 -179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.56 ' HG3' HG23 ' A' ' 143' ' ' ILE . 0.3 OUTLIER -63.23 -56.13 30.33 Favored Pre-proline 0 C--N 1.33 -0.257 0 C-N-CA 121.307 -0.157 . . . . 0.0 110.63 179.286 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 20.0 Cg_endo -61.87 -28.21 81.08 Favored 'Trans proline' 0 C--N 1.35 0.634 0 C-N-CA 122.214 1.942 . . . . 0.0 111.636 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.815 ' O ' HG23 ' A' ' 157' ' ' VAL . 15.0 t -68.83 -48.5 70.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.528 ' CE1' ' CH2' ' A' ' 107' ' ' TRP . 7.5 m-30 -68.83 -37.65 79.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.765 178.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.643 ' CE ' HG21 ' A' ' 143' ' ' ILE . 2.0 tptp -55.34 -44.83 76.27 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.521 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.417 ' O ' HG23 ' A' ' 160' ' ' VAL . 4.7 tt0 -67.57 -34.25 76.66 Favored 'General case' 0 CA--C 1.512 -0.486 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.815 HG23 ' O ' ' A' ' 153' ' ' VAL . 47.7 t -67.79 -41.0 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.836 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.847 178.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.68 HD22 ' HB3' ' A' ' 139' ' ' PRO . 38.7 mt -62.77 -44.91 94.95 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.385 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 62.5 m -51.54 -40.29 59.39 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.833 HG11 ' HA ' ' A' ' 76' ' ' VAL . 81.9 t -67.28 -42.23 87.48 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.382 -0.827 . . . . 0.0 109.142 178.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.687 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 22.3 m-30 -80.12 2.8 22.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.496 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.597 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.98 -52.81 72.18 Favored Pre-proline 0 C--N 1.327 -0.384 0 C-N-CA 120.62 -0.432 . . . . 0.0 111.053 179.688 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.6 Cg_endo -58.11 -12.09 11.9 Favored 'Trans proline' 0 C--N 1.345 0.359 0 C-N-CA 122.153 1.902 . . . . 0.0 112.136 179.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.437 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 87.1 m-70 -110.72 -16.12 13.68 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.492 -179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.687 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 93.7 mt . . . . . 0 C--O 1.248 0.989 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.912 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.443 ' C ' ' H ' ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.489 2.185 0 N-CA-C 112.462 -0.255 . . . . 0.0 112.462 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.415 ' HD3' ' HA3' ' A' ' 1' ' ' GLY . 27.5 Cg_exo -63.18 4.56 0.4 Allowed 'Trans proline' 0 C--N 1.348 0.509 0 C-N-CA 122.879 2.386 . . . . 0.0 113.551 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.58 HD11 HG22 ' A' ' 153' ' ' VAL . 2.8 mm? -94.32 76.11 3.94 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.301 -179.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.459 ' O ' ' HE1' ' A' ' 6' ' ' MET . . . -95.62 64.28 1.29 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.085 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.548 ' HB3' HD23 ' A' ' 80' ' ' LEU . 99.7 p -59.52 155.48 15.13 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.979 0.418 . . . . 0.0 111.774 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.503 ' HE2' ' N ' ' A' ' 6' ' ' MET . 0.0 OUTLIER -145.23 132.4 20.46 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.383 179.926 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.78 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 9.0 t0 -61.36 -36.07 79.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.944 0.402 . . . . 0.0 110.062 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.544 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 61.9 p -100.62 121.38 53.11 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-N 115.98 -0.554 . . . . 0.0 109.572 178.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.503 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 46.3 Cg_endo -69.1 102.54 0.93 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.175 1.916 . . . . 0.0 113.624 -178.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.803 ' O ' ' O ' ' A' ' 11' ' ' GLU . 5.9 Cg_endo -50.78 169.47 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.302 0 C-N-CA 123.236 2.624 . . . . 0.0 112.122 178.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . 0.803 ' O ' ' O ' ' A' ' 10' ' ' PRO . 68.9 mm-40 6.06 -146.95 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.797 0 O-C-N 124.144 0.903 . . . . 0.0 112.971 178.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 99' ' ' ASP . . . -57.39 -81.26 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.559 -0.829 . . . . 0.0 111.765 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.596 ' H ' ' HA ' ' A' ' 100' ' ' TRP . 9.6 m-85 61.85 130.89 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.881 0.372 . . . . 0.0 110.618 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.5 ' HB3' ' HG2' ' A' ' 103' ' ' GLN . 2.1 ttt180 -72.19 86.23 1.07 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.435 -179.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.449 ' HG3' ' CZ3' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -49.05 108.89 0.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.115 0.483 . . . . 0.0 110.173 179.008 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.71 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 3.4 m120 -132.3 173.1 11.62 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.35 -0.841 . . . . 0.0 109.899 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.66 ' CG1' HD11 ' A' ' 47' ' ' ILE . 21.2 m -143.71 162.41 15.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-O 121.318 0.58 . . . . 0.0 112.425 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.649 ' C ' HD13 ' A' ' 19' ' ' ILE . . . -133.95 158.98 23.58 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 177.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.016 HG23 ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -134.14 126.34 49.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -178.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.533 ' O ' HD12 ' A' ' 109' ' ' LEU . 35.8 t -102.82 100.64 10.66 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.237 178.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.9 HD22 HG11 ' A' ' 67' ' ' VAL . 11.4 tp -99.73 118.91 37.24 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.435 -178.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.584 ' CE ' HD13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -120.48 166.54 13.46 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.633 179.622 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.559 ' OD1' ' CE3' ' A' ' 136' ' ' TRP . 0.0 OUTLIER -101.04 171.9 7.35 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.573 -179.695 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -56.82 -5.32 0.22 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.525 178.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.534 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 1.4 m-20 -98.53 1.95 47.07 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-O 120.66 0.267 . . . . 0.0 111.687 -178.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 0.1 OUTLIER 76.07 18.31 2.0 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.102 -178.508 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.514 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 0.2 OUTLIER -94.68 142.17 27.76 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 178.836 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.684 HD13 ' N ' ' A' ' 139' ' ' PRO . 3.7 mp -99.33 146.47 8.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 121.761 0.791 . . . . 0.0 112.612 -178.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.568 ' CE1' HD13 ' A' ' 119' ' ' ILE . 87.2 t80 -78.15 136.97 37.94 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 114.239 -1.346 . . . . 0.0 110.035 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.621 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -137.88 146.77 43.77 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.893 0.378 . . . . 0.0 110.336 179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.453 ' HB1' ' CG ' ' A' ' 131' ' ' PHE . . . -138.69 132.33 30.67 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.138 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.596 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 28.5 m -99.15 148.36 24.15 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.233 -179.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.4 ' O ' ' N ' ' A' ' 36' ' ' ILE . 4.8 mtp180 -69.13 127.9 34.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.649 179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.739 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 1.7 mp -43.69 -37.51 2.67 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-O 121.175 0.512 . . . . 0.0 111.035 -179.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -71.08 -36.77 72.35 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.287 -0.87 . . . . 0.0 110.851 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.4 ' N ' ' O ' ' A' ' 33' ' ' ARG . 23.1 mt -121.63 112.9 32.19 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.076 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -78.96 -18.76 11.29 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.258 1.972 . . . . 0.0 112.843 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -92.88 -11.26 33.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.511 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.778 ' HB1' ' CG1' ' A' ' 147' ' ' VAL . . . -92.05 99.55 12.36 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 120.817 0.341 . . . . 0.0 110.715 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.637 ' O ' ' HA ' ' A' ' 146' ' ' THR . 72.4 m95 -94.39 157.33 16.07 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.958 -0.565 . . . . 0.0 109.98 179.609 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.651 ' O ' HD11 ' A' ' 142' ' ' LEU . 22.9 mt-30 -159.89 -131.69 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 121.111 -0.235 . . . . 0.0 110.399 -179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.526 ' H ' ' HB3' ' A' ' 41' ' ' GLN . 3.0 ptt? -179.14 161.67 1.0 Allowed Pre-proline 0 N--CA 1.453 -0.31 0 N-CA-C 108.682 -0.858 . . . . 0.0 108.682 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.523 ' HD2' ' HB2' ' A' ' 42' ' ' MET . 9.8 Cg_endo -49.86 140.91 29.8 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.119 1.879 . . . . 0.0 112.242 -179.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.583 ' HG2' ' O ' ' A' ' 17' ' ' VAL . 0.0 OUTLIER 179.77 144.17 0.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.73 -179.173 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.495 ' HA3' ' HG2' ' A' ' 60' ' ' GLU . . . -160.47 -156.62 8.27 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.14 179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.71 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -117.84 138.55 14.07 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.132 -1.032 . . . . 0.0 113.539 -179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.66 HD11 ' CG1' ' A' ' 17' ' ' VAL . 4.2 mt -69.54 148.44 11.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 115.488 -0.356 . . . . 0.0 111.006 179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -68.92 -174.25 0.57 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.849 0.357 . . . . 0.0 110.686 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -47.96 -62.26 1.55 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.958 -0.565 . . . . 0.0 111.464 179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -130.82 60.67 0.68 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.559 -179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.476 ' O ' HG21 ' A' ' 47' ' ' ILE . 3.7 tp10 -117.04 153.28 32.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.765 0.317 . . . . 0.0 110.669 179.81 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 7.9 m-20 -70.13 147.08 95.43 Favored Pre-proline 0 C--N 1.328 -0.353 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.458 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 16.7 Cg_exo -67.09 -46.51 3.04 Favored 'Trans proline' 0 CA--C 1.513 -0.529 0 C-N-CA 122.138 1.892 . . . . 0.0 111.395 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.79 ' NE ' HD11 ' A' ' 58' ' ' ILE . 0.0 OUTLIER -52.21 -49.02 64.75 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.097 179.153 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.532 ' HA ' HD12 ' A' ' 58' ' ' ILE . 2.4 m120 -63.77 -44.31 93.81 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.512 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 60' ' ' GLU . . . -60.58 -42.28 96.38 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 1.016 ' HB1' HG23 ' A' ' 19' ' ' ILE . . . -56.07 -52.93 62.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.978 178.776 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.79 HD11 ' NE ' ' A' ' 54' ' ' ARG . 17.3 mt -57.49 -54.37 31.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.881 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -61.39 -58.68 7.24 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.729 -179.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.495 ' HG2' ' HA3' ' A' ' 45' ' ' GLY . 0.7 OUTLIER -45.38 -45.41 12.6 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-O 121.536 0.684 . . . . 0.0 109.511 179.318 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.789 HD12 ' HB ' ' A' ' 19' ' ' ILE . 7.6 tt -52.55 -51.14 61.15 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.874 -1.057 . . . . 0.0 110.731 178.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.847 ' HG3' HG23 ' A' ' 68' ' ' THR . 7.3 ttm105 -62.44 -62.46 1.73 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.195 179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -51.38 -20.48 1.77 Allowed 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.734 -0.666 . . . . 0.0 112.43 -179.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -100.57 -35.58 9.47 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.558 HG22 ' CD2' ' A' ' 121' ' ' LEU . 0.8 OUTLIER -124.1 -11.3 7.56 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -179.027 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 84.54 -14.5 46.25 Favored Glycine 0 CA--C 1.52 0.367 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.868 -179.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.9 HG11 HD22 ' A' ' 21' ' ' LEU . 39.8 t -57.99 115.2 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.434 0.635 . . . . 0.0 111.316 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.847 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -123.54 -39.94 2.39 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.987 -1.006 . . . . 0.0 109.813 178.93 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.427 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 7.2 m -63.0 74.98 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.826 -0.624 . . . . 0.0 111.643 179.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -160.27 155.91 25.57 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.413 ' HG3' HG21 ' A' ' 113' ' ' THR . 2.9 mt-10 -128.48 151.39 49.46 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.399 179.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.702 HG21 ' HE ' ' A' ' 54' ' ' ARG . 20.2 t -75.64 130.72 35.95 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.458 0 CA-C-O 121.292 0.567 . . . . 0.0 112.066 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.589 HD12 ' HG ' ' A' ' 109' ' ' LEU . 1.0 OUTLIER -111.04 -19.11 7.14 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.37 179.045 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.473 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.94 176.54 4.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.812 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.4 OUTLIER -157.05 145.21 19.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.123 -179.99 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.672 ' HA ' HG11 ' A' ' 160' ' ' VAL . 25.6 t -72.1 138.03 81.9 Favored Pre-proline 0 C--N 1.332 -0.194 0 CA-C-O 121.006 0.431 . . . . 0.0 110.838 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.598 ' HD2' HG13 ' A' ' 76' ' ' VAL . 73.7 Cg_endo -76.87 -45.09 0.18 Allowed 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.9 2.4 . . . . 0.0 113.49 -179.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.78 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 1.1 p90 -99.41 161.84 13.38 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.147 0.499 . . . . 0.0 112.242 -178.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.449 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 73.2 m95 -95.14 109.95 21.96 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.851 179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.548 HD23 ' HB3' ' A' ' 5' ' ' SER . 17.3 mt -68.02 125.67 27.06 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 121.128 -0.229 . . . . 0.0 110.527 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 1.086 HG22 ' HA ' ' A' ' 104' ' ' ALA . 21.1 p -139.81 92.13 2.53 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.86 0.362 . . . . 0.0 111.806 -179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.468 ' O ' ' C ' ' A' ' 83' ' ' ASP . 0.2 OUTLIER -79.86 38.08 0.38 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.487 179.179 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.468 ' C ' ' O ' ' A' ' 82' ' ' TYR . 3.6 p30 27.66 -132.59 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 122.387 0.275 . . . . 0.0 111.501 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.625 ' CD1' HD21 ' A' ' 92' ' ' LEU . 0.5 OUTLIER -141.79 178.66 1.44 Allowed Pre-proline 0 C--O 1.231 0.098 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.163 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.657 ' HB2' HG23 ' A' ' 88' ' ' VAL . 74.9 Cg_exo -52.59 156.08 9.24 Favored 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 121.816 1.677 . . . . 0.0 111.452 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.36 -10.43 26.01 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.659 2.239 . . . . 0.0 113.413 -178.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.0 -20.37 11.56 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 111.555 0.205 . . . . 0.0 111.555 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.795 HG12 HD12 ' A' ' 92' ' ' LEU . 10.6 t -91.49 -28.49 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 111.815 0.302 . . . . 0.0 111.815 -179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.744 ' HD2' ' HB2' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -30.83 -77.51 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.134 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.561 ' O ' HG21 ' A' ' 94' ' ' ILE . 41.6 mt-10 -62.05 -10.34 9.76 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.997 0.427 . . . . 0.0 111.369 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 88' ' ' VAL . 0.8 OUTLIER -84.73 -36.21 21.95 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.948 0.404 . . . . 0.0 109.992 179.426 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 1.093 HD13 ' H ' ' A' ' 93' ' ' ASN . 0.0 OUTLIER -121.36 -74.23 0.62 Allowed 'General case' 0 CA--C 1.548 0.867 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -179.559 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 1.093 ' H ' HD13 ' A' ' 92' ' ' LEU . 6.8 m120 -24.1 -62.19 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.221 1.008 . . . . 0.0 112.879 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.561 HG21 ' O ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -55.39 -48.28 77.12 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 CA-C-N 114.361 -1.29 . . . . 0.0 113.127 -178.463 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.472 ' HB3' ' H ' ' A' ' 96' ' ' TRP . 0.6 OUTLIER -62.82 -102.1 0.0 OUTLIER 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 113.537 0.94 . . . . 0.0 113.537 -177.213 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.719 ' HE1' HD22 ' A' ' 92' ' ' LEU . 77.7 m95 49.12 26.0 1.31 Allowed 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 111.742 0.275 . . . . 0.0 111.742 -178.962 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 98' ' ' SER . . . 67.26 39.1 92.13 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.155 179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 97' ' ' GLY . 1.4 m 84.97 154.83 0.09 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 120.771 0.32 . . . . 0.0 111.042 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.511 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 1.3 m-20 51.52 89.98 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.718 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.596 ' HA ' ' H ' ' A' ' 13' ' ' TYR . 0.9 OUTLIER 174.06 173.7 0.17 Allowed 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.651 -0.25 . . . . 0.0 110.67 -179.561 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.585 ' HA ' ' HB3' ' A' ' 93' ' ' ASN . 0.0 OUTLIER 169.46 19.86 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.581 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.961 -179.682 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.679 ' HA2' ' ND2' ' A' ' 93' ' ' ASN . . . 154.95 -144.17 10.78 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 119.919 -1.134 . . . . 0.0 112.827 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.5 ' HG2' ' HB3' ' A' ' 14' ' ' ARG . 15.3 mt-30 -143.77 116.71 8.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.446 0.165 . . . . 0.0 110.616 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 1.086 ' HA ' HG22 ' A' ' 81' ' ' THR . . . -98.81 120.92 40.06 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 121.175 0.512 . . . . 0.0 110.646 179.505 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.706 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 53.6 mt-30 -128.8 123.51 33.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.986 -178.55 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.446 ' HB2' ' CE3' ' A' ' 79' ' ' TRP . 0.8 OUTLIER -103.25 134.85 45.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.816 178.604 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.543 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 73.0 m95 -102.29 159.01 15.78 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.306 0.574 . . . . 0.0 112.268 -178.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.458 ' CZ ' ' HB2' ' A' ' 53' ' ' PRO . 93.9 m-85 -139.26 151.15 46.25 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.485 -179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.589 ' HG ' HD12 ' A' ' 73' ' ' ILE . 24.0 tp -100.33 139.36 36.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.7 179.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.746 ' CE1' HG22 ' A' ' 19' ' ' ILE . 40.5 m-85 -140.95 144.92 35.41 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 113.242 0.83 . . . . 0.0 113.242 -178.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.579 ' HB2' HD11 ' A' ' 73' ' ' ILE . 29.9 tttt -103.37 124.28 48.4 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 114.69 -1.141 . . . . 0.0 109.804 177.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.468 ' HB2' HD11 ' A' ' 21' ' ' LEU . 44.4 t80 -78.47 101.85 7.53 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.848 0.356 . . . . 0.0 110.857 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . 0.413 HG21 ' HG3' ' A' ' 71' ' ' GLU . 21.3 p -100.77 46.43 0.95 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.548 179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.427 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -150.84 -145.13 4.06 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.528 -0.844 . . . . 0.0 113.24 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.42 ' O ' ' HZ ' ' A' ' 112' ' ' PHE . 1.4 pt20 -124.86 149.06 47.89 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.182 0.515 . . . . 0.0 111.429 -179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -58.86 -26.54 64.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.944 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -57.42 -7.25 0.56 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.41 -179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 17.1 tp10 -89.75 -16.45 30.27 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.099 0.476 . . . . 0.0 110.566 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.575 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 3.7 mt -88.64 108.21 18.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.696 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.416 ' C ' ' H ' ' A' ' 122' ' ' LEU . 14.1 p-10 -109.07 -31.39 7.64 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.168 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.558 ' CD2' HG22 ' A' ' 65' ' ' THR . 38.3 mt 75.04 -39.74 0.42 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.64 -179.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.74 ' HA ' ' HB3' ' A' ' 129' ' ' PRO . 78.2 mt -67.2 171.12 6.07 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.574 -179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 73.33 111.24 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.421 -0.809 . . . . 0.0 112.976 179.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -144.61 -9.74 0.63 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.333 -0.434 . . . . 0.0 111.417 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 135.76 40.95 0.14 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.213 -179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 67.96 7.81 6.04 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.577 0.227 . . . . 0.0 111.328 -179.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -97.54 -72.29 0.65 Allowed 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.913 0.387 . . . . 0.0 110.856 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.621 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 7.7 ptpp? -178.97 160.3 1.01 Allowed Pre-proline 0 C--N 1.332 -0.159 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.247 179.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.74 ' HB3' ' HA ' ' A' ' 122' ' ' LEU . 15.2 Cg_endo -62.65 -177.84 0.34 Allowed 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 123.053 2.502 . . . . 0.0 112.602 179.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -109.88 -35.05 6.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.072 179.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.453 ' CG ' ' HB1' ' A' ' 31' ' ' ALA . 4.9 m-85 -133.66 145.62 50.12 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.014 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.739 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -90.68 -33.77 8.25 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.515 -0.85 . . . . 0.0 111.817 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -149.16 146.55 27.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.884 0.373 . . . . 0.0 110.761 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.575 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 39.6 p-90 -134.76 167.12 21.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.187 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.456 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 13.0 t -164.98 168.85 17.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.426 0.632 . . . . 0.0 112.243 -179.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.559 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 36.4 m95 -106.01 106.89 17.61 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.997 -1.001 . . . . 0.0 109.085 178.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.432 ' O ' ' N ' ' A' ' 28' ' ' ILE . 29.8 m -122.43 171.02 11.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.126 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.592 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 11.6 p -72.4 173.45 5.62 Favored Pre-proline 0 C--N 1.327 -0.374 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 178.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.716 ' HB3' HD22 ' A' ' 158' ' ' LEU . 5.3 Cg_exo -65.01 -53.59 0.84 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 121.564 1.509 . . . . 0.0 110.374 179.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.22 -25.8 68.23 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.599 178.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 5.0 mt-30 -73.04 -49.03 31.06 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.611 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.651 HD11 ' O ' ' A' ' 41' ' ' GLN . 4.2 tp -56.07 -38.62 70.91 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.147 -0.479 . . . . 0.0 109.909 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.618 HG21 ' HD3' ' A' ' 155' ' ' LYS . 14.0 mm -62.66 -40.74 89.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.137 0.494 . . . . 0.0 110.636 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -66.85 -47.98 70.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.261 0.553 . . . . 0.0 110.556 179.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.535 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 0.6 OUTLIER -76.32 -22.32 55.11 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.373 -0.83 . . . . 0.0 112.695 -179.181 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.637 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 10.0 t -75.46 179.44 5.25 Favored 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 120.59 -0.444 . . . . 0.0 111.113 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.778 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 21.0 m -86.28 158.36 3.27 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.301 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.196 -178.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.577 ' HA ' ' HD3' ' A' ' 151' ' ' LYS . 8.9 mt-10 -60.64 -49.52 77.2 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.147 0.499 . . . . 0.0 110.799 179.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -54.09 -8.49 0.19 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.352 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -135.21 -6.02 2.33 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 112.647 0.61 . . . . 0.0 112.647 -178.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.577 ' HD3' ' HA ' ' A' ' 148' ' ' GLU . 1.2 mtpp -58.62 -62.26 6.05 Favored Pre-proline 0 C--N 1.329 -0.3 0 C-N-CA 121.042 -0.263 . . . . 0.0 110.717 179.909 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.503 ' HB2' ' CD2' ' A' ' 3' ' ' LEU . 18.1 Cg_endo -60.6 -27.29 84.58 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.308 2.005 . . . . 0.0 111.505 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.686 ' O ' HG23 ' A' ' 157' ' ' VAL . 22.1 t -67.51 -53.35 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.522 ' HE2' ' HA ' ' A' ' 41' ' ' GLN . 6.4 m-30 -63.18 -38.22 90.31 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.101 178.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.618 ' HD3' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -56.88 -45.39 82.57 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.451 -0.795 . . . . 0.0 111.071 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.509 ' O ' HG23 ' A' ' 160' ' ' VAL . 1.5 tt0 -67.31 -33.42 75.24 Favored 'General case' 0 CA--C 1.513 -0.471 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 179.376 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 153' ' ' VAL . 81.3 t -66.71 -41.75 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.824 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.613 178.198 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.716 HD22 ' HB3' ' A' ' 139' ' ' PRO . 54.6 mt -62.88 -44.84 95.02 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.404 179.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -52.98 -40.67 63.92 Favored 'General case' 0 CA--C 1.518 -0.278 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 179.219 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.672 HG11 ' HA ' ' A' ' 76' ' ' VAL . 60.8 t -67.51 -43.41 87.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.242 178.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.601 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 21.6 m-30 -80.94 4.89 17.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 114.939 -1.028 . . . . 0.0 112.495 -179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.607 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.63 -52.69 72.22 Favored Pre-proline 0 C--N 1.329 -0.304 0 C-N-CA 120.749 -0.38 . . . . 0.0 110.798 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 17.9 Cg_endo -58.08 -11.91 11.36 Favored 'Trans proline' 0 C--N 1.345 0.379 0 C-N-CA 122.067 1.845 . . . . 0.0 112.058 179.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.473 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 83.3 m-70 -110.26 -19.02 13.14 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.502 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.601 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 96.9 mt . . . . . 0 C--O 1.248 0.974 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.661 179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.285 0 CA-C-O 120.126 -0.263 . . . . 0.0 112.581 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -68.36 173.71 9.27 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.574 2.182 . . . . 0.0 112.239 179.965 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.434 ' N ' HD23 ' A' ' 3' ' ' LEU . 0.2 OUTLIER -103.95 123.68 47.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.014 -179.968 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.07 -22.75 37.25 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.696 -179.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.604 ' HA ' ' O ' ' A' ' 79' ' ' TRP . 1.1 m 65.76 -82.27 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.971 0.415 . . . . 0.0 111.042 -179.735 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 5.4 mtm 67.03 137.61 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.757 -179.897 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.724 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 7.0 p-10 -67.64 -40.18 84.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.227 -179.366 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.9 142.4 24.54 Favored Pre-proline 0 C--N 1.328 -0.364 0 C-N-CA 121.154 -0.218 . . . . 0.0 110.707 179.592 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -74.78 106.92 2.35 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.467 2.111 . . . . 0.0 112.058 179.839 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.534 ' HB2' ' CE1' ' A' ' 13' ' ' TYR . 3.2 Cg_endo -47.86 165.23 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 123.096 2.531 . . . . 0.0 113.01 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 69.8 mm-40 -52.22 129.64 28.46 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.19 179.57 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 53.16 84.96 0.02 OUTLIER Glycine 0 CA--C 1.517 0.214 0 C-N-CA 120.896 -0.669 . . . . 0.0 112.778 179.812 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.534 ' CE1' ' HB2' ' A' ' 10' ' ' PRO . 9.5 m-85 -149.93 152.0 34.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.824 0.345 . . . . 0.0 111.42 179.935 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.565 ' HG2' HD21 ' A' ' 16' ' ' ASN . 0.7 OUTLIER -64.01 -152.77 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.923 -179.427 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.538 ' H ' ' HG3' ' A' ' 14' ' ' ARG . 0.0 OUTLIER 177.94 95.61 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.261 0.553 . . . . 0.0 109.953 -178.772 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.681 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 3.6 m-80 -129.83 172.18 11.94 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 108.812 -0.81 . . . . 0.0 108.812 179.039 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.698 ' CG1' HD11 ' A' ' 47' ' ' ILE . 21.1 m -138.89 167.31 20.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 121.495 0.664 . . . . 0.0 111.727 179.196 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.714 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -134.83 161.08 24.48 Favored Glycine 0 N--CA 1.438 -1.191 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.521 178.726 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.8 HG23 ' HB1' ' A' ' 57' ' ' ALA . 0.0 OUTLIER -129.21 119.92 50.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 112.01 0.374 . . . . 0.0 112.01 -179.09 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.474 ' O ' HD12 ' A' ' 109' ' ' LEU . 37.4 t -101.66 111.08 23.21 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.02 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.754 HD22 HG11 ' A' ' 67' ' ' VAL . 59.9 tp -105.9 124.34 49.41 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.925 -178.37 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.69 ' HB3' ' O ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -116.51 137.58 52.06 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.8 -179.954 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.482 ' OD1' ' CH2' ' A' ' 136' ' ' TRP . 6.7 m-20 -96.8 -173.8 2.82 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.307 -179.9 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -54.81 -5.03 0.08 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.128 -179.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 3.0 m-20 -101.76 -1.54 32.18 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 122.173 -0.329 . . . . 0.0 111.787 -178.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 11.4 mmtm 69.5 23.3 6.05 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 -177.924 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.825 ' C ' HD12 ' A' ' 28' ' ' ILE . 84.2 mttt -95.59 -167.4 1.6 Allowed 'General case' 0 N--CA 1.449 -0.48 0 CA-C-N 115.368 -0.833 . . . . 0.0 108.876 179.267 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.825 HD12 ' C ' ' A' ' 27' ' ' LYS . 2.1 mp -136.0 146.27 29.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 C-N-CA 120.332 -0.547 . . . . 0.0 110.968 179.716 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.608 ' CE1' HD13 ' A' ' 119' ' ' ILE . 90.3 t80 -70.55 138.73 51.19 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.514 179.512 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.841 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -140.22 149.1 42.48 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.099 179.593 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.555 ' HB1' ' HB3' ' A' ' 131' ' ' PHE . . . -143.55 145.0 32.19 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.045 -179.701 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.658 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 28.4 p -98.97 145.74 26.73 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.09 0.471 . . . . 0.0 111.466 -179.512 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.641 ' O ' ' N ' ' A' ' 35' ' ' ASP . 25.3 mtp180 -69.34 129.82 40.86 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.783 179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.649 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.5 OUTLIER -56.85 55.49 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.862 -179.98 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.641 ' N ' ' O ' ' A' ' 33' ' ' ARG . 0.9 OUTLIER -177.23 -34.82 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.157 0.504 . . . . 0.0 110.223 -179.688 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.491 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 7.1 mm -117.18 106.02 47.93 Favored Pre-proline 0 N--CA 1.451 -0.411 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.135 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_exo -58.53 -60.51 0.35 Allowed 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.396 2.731 . . . . 0.0 114.443 -178.134 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -68.92 1.48 3.37 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.585 0.587 . . . . 0.0 112.585 -178.285 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.658 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.4 94.35 9.45 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.631 0.253 . . . . 0.0 110.991 179.756 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.662 ' O ' ' HA ' ' A' ' 146' ' ' THR . 71.1 m95 -99.24 141.82 31.52 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.343 179.596 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.534 ' NE2' ' HD2' ' A' ' 33' ' ' ARG . 12.5 mt-30 -146.54 174.08 11.74 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.954 0.883 . . . . 0.0 112.378 -179.531 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.552 ' SD ' HG21 ' A' ' 28' ' ' ILE . 2.6 ttp -108.62 140.28 21.65 Favored Pre-proline 0 C--N 1.321 -0.644 0 CA-C-N 113.932 -1.486 . . . . 0.0 109.121 178.82 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.419 ' HB2' ' CG1' ' A' ' 19' ' ' ILE . 9.4 Cg_endo -52.09 146.56 29.9 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.097 1.865 . . . . 0.0 111.817 179.948 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -174.84 157.12 2.38 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.325 179.944 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.454 ' O ' ' HB3' ' A' ' 16' ' ' ASN . . . -158.39 -172.12 25.13 Favored Glycine 0 C--O 1.226 -0.383 0 C-N-CA 120.928 -0.653 . . . . 0.0 111.662 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.681 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -107.97 139.95 15.27 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.242 -0.98 . . . . 0.0 113.614 -179.593 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.698 HD11 ' CG1' ' A' ' 17' ' ' VAL . 6.5 mt -71.52 146.5 11.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.694 0.283 . . . . 0.0 110.824 179.504 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -68.95 -175.17 0.68 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.848 0.356 . . . . 0.0 111.081 179.744 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -48.75 -51.45 28.89 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.304 179.886 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -142.52 62.79 0.51 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.351 -179.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -117.87 150.92 38.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.676 0.274 . . . . 0.0 110.332 179.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.415 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 1.3 m-20 -68.87 141.16 92.03 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.346 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 33.5 Cg_exo -61.55 -45.34 18.19 Favored 'Trans proline' 0 CA--C 1.513 -0.563 0 C-N-CA 122.2 1.933 . . . . 0.0 111.513 -179.843 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.786 ' HE ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -51.57 -48.22 63.22 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.057 -0.974 . . . . 0.0 110.042 179.39 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.613 ' HA ' HD12 ' A' ' 58' ' ' ILE . 94.0 m-20 -65.77 -43.99 87.18 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.638 179.705 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.88 -41.19 91.04 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.8 ' HB1' HG23 ' A' ' 19' ' ' ILE . . . -58.63 -54.11 50.74 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.903 178.746 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.715 HD11 ' NE ' ' A' ' 54' ' ' ARG . 10.6 mt -56.37 -51.73 60.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.056 179.023 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 11.4 mmt180 -61.31 -56.7 17.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.49 -179.247 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.429 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 74.9 mm-40 -50.47 -42.63 54.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.019 0.437 . . . . 0.0 110.015 179.366 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.698 ' HB2' HG13 ' A' ' 19' ' ' ILE . 0.4 OUTLIER -52.08 -49.34 63.73 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.419 178.732 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.807 ' HG2' HG23 ' A' ' 68' ' ' THR . 4.2 tmm_? -64.13 -65.97 0.61 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.239 -0.891 . . . . 0.0 111.626 -179.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -48.27 -22.53 0.69 Allowed 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -178.495 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -100.32 -34.16 10.1 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 -178.246 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . . . . . . . . . 49.5 p -123.12 -8.81 8.22 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 120.31 -0.556 . . . . 0.0 112.365 -178.536 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 80.53 -18.03 9.47 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.385 -178.592 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.754 HG11 HD22 ' A' ' 21' ' ' LEU . 97.8 t -57.15 121.05 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 CA-C-O 121.263 0.554 . . . . 0.0 111.413 179.257 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.807 HG23 ' HG2' ' A' ' 62' ' ' ARG . 0.7 OUTLIER -129.14 -39.37 1.55 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.89 178.731 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.3 m -62.79 75.06 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.483 179.683 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.585 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -158.93 156.23 29.1 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -179.575 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.54 151.45 49.43 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.236 179.389 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.786 HG21 ' HE ' ' A' ' 54' ' ' ARG . 7.8 t -75.59 130.77 35.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.318 0.58 . . . . 0.0 112.166 179.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.579 HD11 ' HB2' ' A' ' 111' ' ' LYS . 0.9 OUTLIER -111.75 -19.2 7.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.555 178.805 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.542 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -169.81 178.38 4.07 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.626 179.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.417 ' HA ' ' HA ' ' A' ' 108' ' ' PHE . 0.6 OUTLIER -156.23 149.23 24.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.833 179.63 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.807 ' HA ' HG11 ' A' ' 160' ' ' VAL . 52.6 t -73.08 137.86 79.1 Favored Pre-proline 0 C--N 1.332 -0.175 0 CA-C-O 121.186 0.517 . . . . 0.0 111.574 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.607 ' HD2' HG13 ' A' ' 76' ' ' VAL . 20.4 Cg_endo -62.52 -70.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 123.397 2.732 . . . . 0.0 112.794 -179.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.724 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.1 OUTLIER -87.45 173.55 9.05 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.063 -178.723 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.604 ' O ' ' HA ' ' A' ' 5' ' ' SER . 48.9 m95 -93.97 100.09 12.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.964 179.738 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.606 HD11 HG22 ' A' ' 157' ' ' VAL . 52.1 mt -58.45 112.91 1.74 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.922 0.391 . . . . 0.0 110.893 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.683 HG22 ' HA ' ' A' ' 104' ' ' ALA . 15.7 p -105.88 -165.23 1.08 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.944 -179.589 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -169.64 47.64 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.495 179.703 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -72.39 146.61 46.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.518 179.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.548 ' CB ' ' HB ' ' A' ' 88' ' ' VAL . 38.4 m-85 -98.92 173.07 4.11 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.263 -179.464 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.516 ' CD ' ' HB3' ' A' ' 84' ' ' PHE . 33.6 Cg_exo -61.77 -173.85 0.13 Allowed 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.618 2.212 . . . . 0.0 111.369 179.439 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.556 ' HA ' ' HG3' ' A' ' 89' ' ' ARG . 71.3 Cg_endo -75.56 17.16 0.68 Allowed 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.346 2.031 . . . . 0.0 113.53 -179.714 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.59 -59.76 1.96 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-O 120.889 0.376 . . . . 0.0 110.821 179.926 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.548 ' HB ' ' CB ' ' A' ' 84' ' ' PHE . 44.9 t -56.09 -20.9 10.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.352 179.659 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.556 ' HG3' ' HA ' ' A' ' 86' ' ' PRO . 0.0 OUTLIER -47.58 -42.54 24.0 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 121.084 0.469 . . . . 0.0 111.272 -179.668 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.56 ' HA ' HD13 ' A' ' 94' ' ' ILE . 3.7 tt0 -65.17 -17.45 64.49 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.007 -179.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 13.5 mmtt -102.78 -22.18 13.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.965 179.479 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.622 HD13 ' N ' ' A' ' 93' ' ' ASN . 1.2 tm? -121.5 -58.23 1.78 Allowed 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.326 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.622 ' N ' HD13 ' A' ' 92' ' ' LEU . 25.9 t-20 -50.99 -63.93 0.97 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.949 0.404 . . . . 0.0 111.512 -179.946 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.56 HD13 ' HA ' ' A' ' 90' ' ' GLU . 3.9 mp -71.7 -4.82 5.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.275 -179.288 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.463 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 34.3 tt0 -72.03 -6.66 43.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.355 178.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.508 ' HB2' ' CG ' ' A' ' 100' ' ' TRP . 71.6 m95 -100.3 -6.35 26.03 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 -178.753 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 62.55 39.52 97.96 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.546 -0.835 . . . . 0.0 113.082 179.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -175.59 -163.53 0.12 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.713 0.292 . . . . 0.0 110.895 179.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.76 82.66 4.14 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.267 179.252 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.635 ' O ' ' HB2' ' A' ' 101' ' ' LYS . 48.6 m95 -124.56 -164.99 1.32 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.657 -179.544 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.635 ' HB2' ' O ' ' A' ' 100' ' ' TRP . 19.7 ttpt 166.41 -13.36 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 O-C-N 123.256 0.347 . . . . 0.0 111.712 -179.701 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -175.6 -162.98 27.68 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.413 -0.899 . . . . 0.0 112.192 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.525 ' O ' ' HA ' ' A' ' 81' ' ' THR . 31.4 mt-30 -143.2 124.94 15.0 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.777 0.322 . . . . 0.0 110.6 179.927 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.683 ' HA ' HG22 ' A' ' 81' ' ' THR . . . -97.58 121.99 40.14 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.097 -0.502 . . . . 0.0 109.833 179.29 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.626 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 9.4 mt-30 -128.96 122.42 30.11 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.362 -178.068 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -103.03 135.33 44.92 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.509 179.693 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.714 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 42.7 m95 -103.66 166.25 10.54 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.063 0.458 . . . . 0.0 111.636 -179.528 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 53' ' ' PRO . 91.1 m-85 -141.53 155.33 45.81 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.836 -179.471 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.688 HD11 ' SD ' ' A' ' 22' ' ' MET . 8.4 tp -101.14 141.96 33.27 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.459 179.126 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.663 ' CE2' HG22 ' A' ' 72' ' ' VAL . 49.4 m-85 -144.83 144.34 31.09 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.49 0.662 . . . . 0.0 112.502 -178.598 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.585 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 9.5 tttt -103.65 125.98 50.5 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.71 -1.132 . . . . 0.0 109.731 177.874 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.659 ' CD1' HD21 ' A' ' 21' ' ' LEU . 51.0 t80 -78.85 97.37 5.95 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-O 121.032 0.444 . . . . 0.0 110.939 179.722 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 39.1 p -97.1 51.03 1.1 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.536 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -153.17 -146.77 4.45 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.422 -179.848 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.409 ' O ' ' HZ ' ' A' ' 112' ' ' PHE . 0.0 OUTLIER -122.4 145.12 48.57 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.177 0.513 . . . . 0.0 111.069 179.786 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -59.12 -26.15 64.46 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.05 -179.137 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -58.37 -5.07 0.45 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.209 -179.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -90.88 -18.23 25.15 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.996 0.427 . . . . 0.0 110.977 179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.608 HD13 ' CE1' ' A' ' 29' ' ' PHE . 5.5 mt -83.85 103.53 11.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.709 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.516 ' ND2' HD12 ' A' ' 122' ' ' LEU . 0.5 OUTLIER -101.68 -12.53 18.32 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 115.945 -0.57 . . . . 0.0 112.243 -179.419 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.931 HD11 ' HB3' ' A' ' 134' ' ' TRP . 16.6 mt 37.07 28.57 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.693 0 N-CA-C 112.047 0.388 . . . . 0.0 112.047 -179.057 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.881 ' HA ' ' HB3' ' A' ' 129' ' ' PRO . 10.7 mt -105.0 4.46 31.69 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 120.551 -0.46 . . . . 0.0 111.827 -179.511 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 63.56 130.36 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.497 -0.859 . . . . 0.0 111.96 179.726 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.35 69.55 7.0 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.343 0.592 . . . . 0.0 110.424 -179.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -161.66 172.86 37.94 Favored Glycine 0 N--CA 1.45 -0.391 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.107 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -91.2 8.99 33.04 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.614 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -91.47 -75.04 0.49 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.841 0.353 . . . . 0.0 111.246 -179.756 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.599 ' HB2' ' HD2' ' A' ' 129' ' ' PRO . 1.7 pttm -178.68 163.73 1.1 Allowed Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.735 179.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.881 ' HB3' ' HA ' ' A' ' 122' ' ' LEU . 27.7 Cg_endo -66.41 166.35 21.9 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 122.904 2.403 . . . . 0.0 112.815 -179.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -97.72 -61.04 1.45 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.253 179.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.904 ' HB2' HD13 ' A' ' 121' ' ' LEU . 6.5 m-85 -105.3 147.03 28.55 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.696 179.742 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.649 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -86.2 -34.95 11.47 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.953 -179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.42 ' O ' ' HA ' ' A' ' 31' ' ' ALA . 0.9 OUTLIER -154.37 154.79 33.89 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.626 0.251 . . . . 0.0 111.2 179.911 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.931 ' HB3' HD11 ' A' ' 121' ' ' LEU . 36.4 p-90 -133.31 164.48 27.01 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.059 0.457 . . . . 0.0 111.875 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.5 t -157.99 165.61 34.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.685 -179.419 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.484 ' CD1' ' HZ3' ' A' ' 134' ' ' TRP . 89.6 m95 -106.75 97.53 7.31 Favored 'General case' 0 CA--C 1.516 -0.351 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.936 178.305 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.626 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 21.0 m -113.37 163.11 10.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.338 179.611 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.551 ' HB ' ' CD ' ' A' ' 139' ' ' PRO . 10.5 p -70.92 174.32 3.77 Favored Pre-proline 0 C--N 1.325 -0.474 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 179.199 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.636 ' HG3' HD11 ' A' ' 28' ' ' ILE . 12.2 Cg_exo -63.25 -53.35 1.53 Allowed 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 121.543 1.495 . . . . 0.0 111.279 179.698 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -27.11 68.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.074 0.464 . . . . 0.0 111.067 179.332 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.401 ' HG3' ' OG1' ' A' ' 138' ' ' THR . 21.7 mt-30 -72.23 -47.3 51.4 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.882 179.767 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.841 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.3 OUTLIER -55.34 -41.41 72.44 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.482 179.498 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.657 HG22 ' HG3' ' A' ' 151' ' ' LYS . 28.9 mm -61.12 -34.24 59.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.553 179.485 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.57 -52.08 17.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.861 179.115 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 1.3 mp -72.97 -21.78 60.8 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.331 -0.849 . . . . 0.0 112.228 -179.309 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.662 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 8.2 t -73.21 173.87 8.83 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.99 0.424 . . . . 0.0 111.675 -178.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.689 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 16.3 m -79.83 154.03 4.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.984 -179.743 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.448 ' C ' ' H ' ' A' ' 150' ' ' LYS . 4.0 mt-10 -58.41 -54.82 42.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.849 0.357 . . . . 0.0 110.73 -179.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.689 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 51.7 p90 -56.93 2.47 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -179.904 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.589 ' HG2' ' CZ ' ' A' ' 154' ' ' TYR . 0.0 OUTLIER -137.53 -6.41 1.75 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.182 0.438 . . . . 0.0 112.182 -179.581 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.657 ' HG3' HG22 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -64.44 -56.35 23.53 Favored Pre-proline 0 N--CA 1.464 0.262 0 N-CA-C 111.326 0.121 . . . . 0.0 111.326 -179.979 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 151' ' ' LYS . 29.4 Cg_endo -63.66 -28.5 69.19 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.278 1.985 . . . . 0.0 111.834 -179.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.771 ' O ' HG23 ' A' ' 157' ' ' VAL . 25.9 t -68.66 -51.09 49.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 178.718 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.589 ' CZ ' ' HG2' ' A' ' 150' ' ' LYS . 16.5 m-30 -64.93 -40.74 95.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.652 -0.703 . . . . 0.0 109.678 178.449 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.577 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -53.9 -43.62 69.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.908 -1.042 . . . . 0.0 111.401 -179.675 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.418 ' O ' HG23 ' A' ' 160' ' ' VAL . 3.9 tt0 -69.38 -32.44 71.48 Favored 'General case' 0 CA--C 1.511 -0.53 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 179.218 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.771 HG23 ' O ' ' A' ' 153' ' ' VAL . 46.9 t -65.0 -41.81 93.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 115.275 -0.875 . . . . 0.0 109.683 178.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.513 HD22 ' HB3' ' A' ' 139' ' ' PRO . 37.3 mt -62.54 -46.71 87.13 Favored 'General case' 0 CA--C 1.524 -0.038 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.366 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -49.43 -38.54 29.66 Favored 'General case' 0 C--O 1.231 0.123 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 178.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.807 HG11 ' HA ' ' A' ' 76' ' ' VAL . 80.1 t -68.85 -44.21 81.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.354 177.727 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.68 ' CE2' HG12 ' A' ' 157' ' ' VAL . 22.4 m-30 -79.6 4.18 16.72 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.018 -0.992 . . . . 0.0 112.284 -179.287 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.609 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.38 -53.64 64.0 Favored Pre-proline 0 C--N 1.327 -0.378 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.71 179.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.609 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 16.9 Cg_endo -57.91 -12.77 13.0 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.44 2.093 . . . . 0.0 111.907 178.827 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.542 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 91.3 m-70 -109.4 -16.95 13.9 Favored 'General case' 0 N--CA 1.46 0.027 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.457 -179.864 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.657 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 95.5 mt . . . . . 0 C--O 1.25 1.081 0 CA-C-O 118.165 -0.921 . . . . 0.0 110.803 -179.691 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 112.615 -0.194 . . . . 0.0 112.615 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.62 ' HG2' ' HB3' ' A' ' 152' ' ' PRO . 74.1 Cg_exo -50.38 177.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.344 0.33 0 C-N-CA 122.668 2.245 . . . . 0.0 112.545 -179.944 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.538 ' HG ' ' C ' ' A' ' 2' ' ' PRO . 0.0 OUTLIER 44.64 -172.05 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 CA-C-O 121.278 0.561 . . . . 0.0 111.656 -179.489 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -126.4 128.32 6.32 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.535 179.411 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.822 ' HB3' HD23 ' A' ' 80' ' ' LEU . 93.8 p -121.27 104.08 9.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.943 0.402 . . . . 0.0 111.217 -179.409 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.41 ' N ' ' SD ' ' A' ' 6' ' ' MET . 2.2 mpp? -96.92 149.66 21.63 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.442 179.789 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 16.1 t70 -63.83 -54.71 30.75 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.818 0.342 . . . . 0.0 110.35 -179.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.456 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 0.9 OUTLIER -98.24 145.35 29.69 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.83 178.655 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.459 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 41.9 Cg_endo -67.28 105.15 0.98 Allowed 'Trans proline' 0 C--N 1.342 0.222 0 C-N-CA 122.255 1.97 . . . . 0.0 111.989 179.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 9' ' ' PRO . 9.2 Cg_endo -52.21 165.34 0.96 Allowed 'Trans proline' 0 N--CA 1.465 -0.172 0 C-N-CA 123.086 2.524 . . . . 0.0 112.193 179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 56.3 mm-40 -50.82 122.25 7.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.244 179.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' ' 100' ' ' TRP . . . 52.55 80.13 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.538 179.36 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.458 ' CG ' ' HG2' ' A' ' 10' ' ' PRO . 8.9 m-85 -149.51 62.34 1.02 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.822 0.344 . . . . 0.0 110.499 179.317 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.66 ' HA ' ' CZ3' ' A' ' 100' ' ' TRP . 2.0 ttt-85 31.05 -152.43 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.82 179.571 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.494 ' C ' HD12 ' A' ' 47' ' ' ILE . 2.5 ttt180 176.32 95.89 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.042 0.449 . . . . 0.0 110.408 -179.422 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.678 ' HA ' ' HA2' ' A' ' 46' ' ' GLY . 59.1 m-20 -133.08 176.85 8.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.163 179.072 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.682 HG13 HD11 ' A' ' 47' ' ' ILE . 27.2 m -142.2 164.58 17.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 121.252 0.549 . . . . 0.0 111.703 179.109 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.591 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -130.33 155.71 21.21 Favored Glycine 0 N--CA 1.442 -0.951 0 CA-C-N 115.187 -0.915 . . . . 0.0 110.847 178.65 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.117 HG21 HD22 ' A' ' 61' ' ' LEU . 3.7 mp -122.06 119.42 58.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.154 0.502 . . . . 0.0 112.021 -178.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.523 ' O ' HD12 ' A' ' 109' ' ' LEU . 50.0 t -103.79 101.69 11.51 Favored 'General case' 0 CA--C 1.513 -0.458 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.133 178.602 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.713 HD22 HG11 ' A' ' 67' ' ' VAL . 31.3 tp -102.68 121.52 42.6 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.898 -178.452 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.722 ' SD ' HD11 ' A' ' 109' ' ' LEU . 0.0 OUTLIER -116.23 142.69 46.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.849 179.602 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.503 ' OD1' ' CZ3' ' A' ' 136' ' ' TRP . 7.8 m-20 -95.94 -177.72 4.11 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.465 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.5 m-80 -56.14 -4.85 0.14 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.953 -1.021 . . . . 0.0 112.521 179.501 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.547 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.7 OUTLIER -103.13 -0.61 30.36 Favored 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 111.889 0.329 . . . . 0.0 111.889 -178.79 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.562 ' HE2' ' HE3' ' A' ' 22' ' ' MET . 1.8 mmtp 72.61 23.82 2.95 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -178.249 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.634 ' HB3' ' O ' ' A' ' 137' ' ' VAL . 25.9 mttt -94.77 175.24 6.73 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.217 179.285 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.713 HD11 ' HG3' ' A' ' 139' ' ' PRO . 1.8 mm -120.01 141.16 41.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.976 0.417 . . . . 0.0 111.064 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.665 ' HE2' HG21 ' A' ' 65' ' ' THR . 58.3 t80 -66.8 107.07 2.05 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.278 179.23 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.767 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -101.51 139.09 37.65 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 120.823 0.344 . . . . 0.0 110.929 179.746 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -138.14 132.0 31.28 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.281 179.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.68 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 53.4 p -99.0 146.29 26.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.839 0.352 . . . . 0.0 111.584 -179.341 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.428 ' HD2' ' NE2' ' A' ' 41' ' ' GLN . 17.5 mtp180 -69.34 128.13 35.47 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.432 179.601 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.748 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -45.18 -35.4 3.22 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.356 0.598 . . . . 0.0 110.984 -179.884 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -72.4 -36.15 68.58 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.765 179.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 17.6 mm -124.47 111.45 28.02 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.764 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -75.24 -20.75 16.11 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.432 2.088 . . . . 0.0 113.023 -179.273 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -92.63 -7.52 46.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.565 -0.288 . . . . 0.0 111.387 -179.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.68 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.8 93.06 8.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.807 0.337 . . . . 0.0 111.047 179.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.626 ' O ' ' HA ' ' A' ' 146' ' ' THR . 81.6 m95 -88.0 144.03 26.76 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.015 179.142 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.428 ' NE2' ' HD2' ' A' ' 33' ' ' ARG . 11.5 mt-30 -153.76 174.38 14.61 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.54 0.686 . . . . 0.0 111.878 -179.2 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.58 ' HB3' ' CZ3' ' A' ' 107' ' ' TRP . 2.0 mtm -108.36 146.17 33.04 Favored Pre-proline 0 C--N 1.323 -0.561 0 CA-C-N 114.838 -1.074 . . . . 0.0 109.98 179.596 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_endo -50.75 156.23 4.76 Favored 'Trans proline' 0 C--N 1.343 0.25 0 C-N-CA 122.465 2.11 . . . . 0.0 111.995 179.783 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.683 ' HA ' HD12 ' A' ' 19' ' ' ILE . 4.2 pt20 -176.41 174.02 2.0 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.946 -179.391 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.467 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . 178.96 154.81 13.41 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.306 179.792 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.678 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -82.56 135.68 14.42 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.205 -179.382 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.682 HD11 HG13 ' A' ' 17' ' ' VAL . 2.8 mt -70.07 144.66 13.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 120.736 0.303 . . . . 0.0 111.141 179.801 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -66.77 -174.76 0.34 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.243 179.345 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -48.52 -77.06 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.04 179.692 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -113.27 57.35 0.45 Allowed Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.689 179.95 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.451 ' O ' HG21 ' A' ' 47' ' ' ILE . 9.2 tp10 -115.77 148.35 39.93 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.795 0.331 . . . . 0.0 110.896 179.731 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.402 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 78.8 m-20 -72.16 142.58 85.03 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.536 179.677 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.497 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 56.7 Cg_exo -54.42 -45.43 41.02 Favored 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.714 2.276 . . . . 0.0 112.579 -179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.814 ' CZ ' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -52.14 -44.49 64.58 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.29 -179.616 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -65.71 -47.43 75.39 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.461 179.969 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -62.02 -43.19 99.36 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.412 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.627 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -58.13 -58.57 7.86 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.617 178.796 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.543 HD11 ' HG3' ' A' ' 54' ' ' ARG . 20.8 mt -56.17 -51.23 64.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.377 179.368 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -63.13 -64.89 0.78 Allowed 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.452 -179.511 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.467 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 56.2 mm-40 -42.29 -44.98 4.06 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.004 0.43 . . . . 0.0 110.43 179.932 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.117 HD22 HG21 ' A' ' 19' ' ' ILE . 14.4 tp -51.58 -46.76 63.59 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.975 178.562 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.886 ' HG3' HG23 ' A' ' 68' ' ' THR . 21.1 ttm180 -65.12 -65.76 0.63 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.25 179.429 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -49.39 -21.59 0.93 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.914 -0.584 . . . . 0.0 112.372 -179.266 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -97.87 -36.5 10.16 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -178.2 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.76 HG22 ' CD2' ' A' ' 121' ' ' LEU . 0.8 OUTLIER -128.95 -3.1 5.18 Favored 'General case' 0 N--CA 1.466 0.339 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -178.717 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.48 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 77.4 -12.19 15.02 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.614 -0.803 . . . . 0.0 112.415 -179.5 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.713 HG11 HD22 ' A' ' 21' ' ' LEU . 50.2 t -57.85 110.99 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.293 0 CA-C-O 121.235 0.54 . . . . 0.0 111.503 179.711 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.886 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.6 OUTLIER -123.08 -40.33 2.41 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.469 -0.787 . . . . 0.0 109.668 178.629 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.7 m -62.17 73.59 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.396 179.485 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -160.66 158.22 28.48 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.023 0.439 . . . . 0.0 112.174 -179.631 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -129.66 149.42 51.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.655 179.787 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.814 HG11 ' CZ ' ' A' ' 54' ' ' ARG . 3.3 t -73.73 127.26 35.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.069 0.461 . . . . 0.0 110.962 179.227 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.544 HD11 ' N ' ' A' ' 111' ' ' LYS . 1.0 OUTLIER -106.61 -19.81 6.39 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.181 179.32 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.46 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.91 176.57 4.06 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.182 179.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -152.38 145.76 24.8 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.414 179.635 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.74 ' HA ' HG11 ' A' ' 160' ' ' VAL . 52.8 t -71.5 137.17 83.48 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.0 0.429 . . . . 0.0 110.859 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.49 ' HD2' HG13 ' A' ' 76' ' ' VAL . 17.7 Cg_endo -59.1 -66.54 0.07 OUTLIER 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 123.198 2.599 . . . . 0.0 112.715 -179.575 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.528 ' CD1' ' HB2' ' A' ' 5' ' ' SER . 0.1 OUTLIER -96.65 -176.38 3.58 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.383 -0.826 . . . . 0.0 111.207 -178.965 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.539 ' O ' ' HG ' ' A' ' 80' ' ' LEU . 37.3 m95 -89.49 -154.43 0.31 Allowed 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.815 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.822 HD23 ' HB3' ' A' ' 5' ' ' SER . 81.6 mt -162.16 105.51 1.16 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.103 0.478 . . . . 0.0 110.725 -179.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.898 HG22 ' HA ' ' A' ' 104' ' ' ALA . 16.9 p -114.37 174.16 6.09 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.023 -179.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.505 ' O ' ' O ' ' A' ' 83' ' ' ASP . 39.7 p90 -172.63 37.95 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.213 179.297 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.505 ' O ' ' O ' ' A' ' 82' ' ' TYR . 2.9 p30 38.09 -171.69 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 179.296 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.656 ' CZ ' HD11 ' A' ' 92' ' ' LEU . 3.1 m-85 -112.36 176.41 1.5 Allowed Pre-proline 0 CA--C 1.532 0.262 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.211 179.708 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.606 ' HB3' ' HD2' ' A' ' 86' ' ' PRO . 88.5 Cg_exo -50.22 -176.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.351 0.664 0 C-N-CA 122.62 2.213 . . . . 0.0 112.255 179.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.606 ' HD2' ' HB3' ' A' ' 85' ' ' PRO . 31.0 Cg_endo -66.09 -62.03 0.08 OUTLIER 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.111 1.874 . . . . 0.0 113.03 -179.193 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.68 -28.54 40.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.751 0.31 . . . . 0.0 111.259 -179.616 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.563 ' HB ' ' HD2' ' A' ' 85' ' ' PRO . 41.7 t -66.82 -17.14 22.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.213 179.812 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.681 ' HD2' ' ND2' ' A' ' 93' ' ' ASN . 0.2 OUTLIER -67.95 0.48 3.45 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.534 -0.303 . . . . 0.0 111.805 -179.742 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.82 ' HA ' HG12 ' A' ' 94' ' ' ILE . 7.2 mt-10 -121.72 -66.25 1.06 Allowed 'General case' 0 CA--C 1.529 0.143 0 CA-C-O 120.991 0.424 . . . . 0.0 111.659 179.629 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -53.26 -41.09 65.16 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -179.051 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.656 HD11 ' CZ ' ' A' ' 84' ' ' PHE . 0.6 OUTLIER -104.33 -56.2 2.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.952 0.406 . . . . 0.0 111.851 -178.769 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.681 ' ND2' ' HD2' ' A' ' 89' ' ' ARG . 9.7 t30 -55.43 -49.49 72.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.054 -0.521 . . . . 0.0 112.157 -178.335 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.82 HG12 ' HA ' ' A' ' 90' ' ' GLU . 32.8 mm -75.8 -8.35 11.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.038 0.447 . . . . 0.0 110.464 179.29 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.453 ' HB3' ' H ' ' A' ' 96' ' ' TRP . 1.1 tt0 -80.81 -100.57 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.675 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.585 ' CE3' ' CZ3' ' A' ' 100' ' ' TRP . 89.1 m95 41.36 31.03 0.15 Allowed 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.658 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.463 ' O ' ' CB ' ' A' ' 98' ' ' SER . . . 64.63 54.98 25.44 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.929 179.592 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 97' ' ' GLY . 6.5 t 87.2 162.33 0.08 Allowed 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 122.513 0.325 . . . . 0.0 111.127 179.65 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 100' ' ' TRP . 6.9 p-10 39.51 -140.93 0.05 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.565 179.858 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.66 ' CZ3' ' HA ' ' A' ' 14' ' ' ARG . 35.9 m95 67.9 174.84 0.27 Allowed 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 110.608 -0.145 . . . . 0.0 110.608 -179.419 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.67 ' HA ' ' ND2' ' A' ' 93' ' ' ASN . 16.9 ptpt 165.31 31.46 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 111.852 0.315 . . . . 0.0 111.852 -179.568 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 151.83 -158.94 28.05 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.103 -1.046 . . . . 0.0 112.235 -179.887 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.492 ' HA ' ' CB ' ' A' ' 14' ' ' ARG . 77.8 mt-30 -147.13 126.84 13.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.962 0.381 . . . . 0.0 111.94 -179.77 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.898 ' HA ' HG22 ' A' ' 81' ' ' THR . . . -108.12 123.31 48.52 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.874 179.224 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.583 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 24.1 mt-30 -129.0 123.37 32.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.703 -0.68 . . . . 0.0 112.167 -178.473 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.541 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 4.4 ttpt -103.83 140.93 36.98 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.659 179.429 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.591 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 24.8 m95 -105.19 167.46 9.71 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 -178.399 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.497 ' CZ ' ' HB2' ' A' ' 53' ' ' PRO . 78.3 m-85 -143.39 156.1 44.59 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.09 -179.496 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.722 HD11 ' SD ' ' A' ' 22' ' ' MET . 8.0 tp -103.59 138.66 39.95 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.769 179.007 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.728 ' CE2' HG22 ' A' ' 72' ' ' VAL . 55.7 m-85 -142.92 144.45 32.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.397 0.618 . . . . 0.0 112.634 -178.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.553 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 22.4 tttt -104.11 123.59 47.53 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.522 177.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.629 ' HB2' HD11 ' A' ' 21' ' ' LEU . 55.3 t80 -79.31 99.62 7.19 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.875 0.369 . . . . 0.0 110.629 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 30.2 p -96.96 41.64 1.11 Allowed 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.405 179.869 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -140.29 -148.33 5.14 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.54 -179.773 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 21.0 mm-40 -121.21 148.4 44.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.955 0.407 . . . . 0.0 111.151 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.449 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 9.5 p-10 -58.6 -38.24 77.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.37 0.605 . . . . 0.0 111.181 -179.558 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -56.57 -3.8 0.12 Allowed 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.014 -0.994 . . . . 0.0 112.286 -179.402 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -90.05 -21.01 22.55 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 121.121 0.486 . . . . 0.0 110.326 179.371 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.65 HD13 ' CE1' ' A' ' 29' ' ' PHE . 14.3 mt -85.89 105.17 14.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.124 179.646 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.424 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 18.0 p-10 -102.82 -26.18 13.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.087 -179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.76 ' CD2' HG22 ' A' ' 65' ' ' THR . 56.3 mt 76.62 -36.05 0.25 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.025 -179.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.59 HD23 ' HB3' ' A' ' 129' ' ' PRO . 96.3 mt -66.95 -169.44 0.09 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.999 -179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . 118.01 -5.87 15.68 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.252 -179.454 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.418 ' HB3' ' O ' ' A' ' 128' ' ' LYS . 0.6 OUTLIER -102.68 63.13 0.84 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.466 -0.367 . . . . 0.0 110.457 179.767 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -77.71 45.33 2.42 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.672 -179.828 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.6 t -120.65 -40.66 2.64 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.907 0.384 . . . . 0.0 110.745 179.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -146.61 -45.3 0.19 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.101 -0.499 . . . . 0.0 111.107 -179.947 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.418 ' O ' ' HB3' ' A' ' 124' ' ' ASP . 48.4 pttt -178.4 155.49 0.95 Allowed Pre-proline 0 C--N 1.331 -0.212 0 CA-C-O 120.95 0.405 . . . . 0.0 111.053 179.044 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.59 ' HB3' HD23 ' A' ' 122' ' ' LEU . 18.1 Cg_endo -71.41 -175.78 1.69 Allowed 'Trans proline' 0 N--CA 1.461 -0.437 0 C-N-CA 122.709 2.272 . . . . 0.0 112.401 179.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.485 ' O ' HD12 ' A' ' 34' ' ' LEU . 5.1 mp0 -95.51 -69.46 0.75 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.326 -179.612 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.712 ' CE2' HG23 ' A' ' 65' ' ' THR . 3.1 m-85 -104.75 143.05 33.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.069 0.461 . . . . 0.0 110.64 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.748 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -90.14 -35.63 7.5 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.782 -0.723 . . . . 0.0 111.705 -179.896 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -150.28 148.21 28.58 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.96 0.41 . . . . 0.0 110.619 179.626 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.536 ' CD2' ' HE1' ' A' ' 29' ' ' PHE . 38.1 p-90 -137.14 167.98 20.49 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.607 179.465 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.466 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 42.9 t -160.27 174.64 13.9 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.318 0.58 . . . . 0.0 112.314 -178.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.503 ' CZ3' ' OD1' ' A' ' 23' ' ' ASN . 78.7 m95 -109.23 100.71 9.81 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.048 -0.978 . . . . 0.0 109.551 178.384 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.634 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 28.9 m -119.03 165.61 14.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 -179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.53 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 26.8 p -71.63 167.24 32.36 Favored Pre-proline 0 C--N 1.327 -0.411 0 C-N-CA 120.094 -0.642 . . . . 0.0 110.11 179.351 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.713 ' HG3' HD11 ' A' ' 28' ' ' ILE . 21.6 Cg_exo -59.43 -54.59 2.41 Favored 'Trans proline' 0 N--CA 1.455 -0.754 0 C-N-CA 121.818 1.678 . . . . 0.0 110.435 179.554 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -64.3 -28.86 70.0 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.391 178.237 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.49 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 40.0 mt-30 -71.55 -46.4 59.61 Favored 'General case' 0 CA--C 1.519 -0.22 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.248 179.707 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.767 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -57.65 -39.05 76.14 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.72 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.968 HG21 ' HD3' ' A' ' 155' ' ' LYS . 27.5 mm -60.3 -36.24 67.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.639 179.268 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.84 -53.3 15.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.242 0.544 . . . . 0.0 110.881 179.559 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -71.72 -19.52 62.04 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.448 -179.14 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.675 HG22 ' O ' ' A' ' 143' ' ' ILE . 7.6 t -73.02 179.64 3.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.056 0.455 . . . . 0.0 111.523 -179.115 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.635 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 21.9 m -85.28 151.25 3.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.439 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.458 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 48.4 mt-10 -58.48 -53.86 53.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.801 0.334 . . . . 0.0 111.227 -179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.619 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 53.1 p90 -56.28 0.81 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -179.721 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.597 ' HB2' HG23 ' A' ' 147' ' ' VAL . 0.0 OUTLIER -136.83 -7.99 1.86 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -179.482 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.562 ' N ' ' HD2' ' A' ' 152' ' ' PRO . 0.0 OUTLIER -62.53 -52.79 62.86 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.895 -0.138 . . . . 0.0 111.072 179.562 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.62 ' HB3' ' HG2' ' A' ' 2' ' ' PRO . 28.6 Cg_endo -63.47 -28.58 70.89 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.121 1.88 . . . . 0.0 111.895 -179.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.81 ' O ' HG23 ' A' ' 157' ' ' VAL . 23.3 t -68.42 -49.33 66.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.824 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.525 ' CE1' ' HG2' ' A' ' 150' ' ' LYS . 5.4 m-30 -66.58 -40.59 89.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.806 178.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.968 ' HD3' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -53.2 -44.82 68.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.518 179.449 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.431 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.5 OUTLIER -68.32 -33.34 74.13 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.133 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.81 HG23 ' O ' ' A' ' 153' ' ' VAL . 64.2 t -66.07 -41.31 89.33 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.925 0 CA-C-N 115.213 -0.903 . . . . 0.0 109.695 178.688 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.566 HD22 ' HB3' ' A' ' 139' ' ' PRO . 64.8 mt -64.88 -45.01 87.77 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.55 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.35 -41.41 63.03 Favored 'General case' 0 CA--C 1.519 -0.244 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 179.235 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.74 HG11 ' HA ' ' A' ' 76' ' ' VAL . 94.0 t -66.11 -42.33 91.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.033 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.56 ' CE2' HG12 ' A' ' 157' ' ' VAL . 19.7 m-30 -81.05 6.35 13.84 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 114.732 -1.122 . . . . 0.0 112.554 -179.192 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.594 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.46 -53.64 64.04 Favored Pre-proline 0 C--N 1.329 -0.313 0 C-N-CA 120.589 -0.445 . . . . 0.0 110.55 179.592 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 18.1 Cg_endo -59.56 -12.14 16.45 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.021 1.814 . . . . 0.0 111.86 178.712 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.46 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 96.5 m-70 -107.37 -18.55 13.84 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.292 -179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 78.3 mt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.183 -0.913 . . . . 0.0 110.794 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.54 -0.224 . . . . 0.0 112.54 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.77 -177.55 0.04 OUTLIER 'Trans proline' 0 C--N 1.342 0.236 0 C-N-CA 122.652 2.234 . . . . 0.0 112.209 179.99 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.691 HD21 ' HB2' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -98.98 132.44 44.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.909 179.9 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -97.08 132.48 11.01 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.665 -0.778 . . . . 0.0 111.973 179.477 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.895 ' HB3' HD23 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -120.37 139.97 52.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.881 0.372 . . . . 0.0 111.321 -179.829 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.484 ' HE1' ' OG1' ' A' ' 81' ' ' THR . 0.3 OUTLIER -143.78 147.31 33.97 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.597 -179.949 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.748 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 17.9 t70 -65.02 -10.29 28.52 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.713 0.292 . . . . 0.0 111.358 179.972 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . 0.437 ' O ' ' HD3' ' A' ' 10' ' ' PRO . 0.1 OUTLIER -143.18 117.39 6.21 Favored Pre-proline 0 C--N 1.33 -0.277 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 179.608 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.622 ' HB3' ' CB ' ' A' ' 104' ' ' ALA . 57.6 Cg_endo -68.71 105.37 1.29 Allowed 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.533 2.155 . . . . 0.0 112.853 -179.391 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.618 ' HG2' ' CD2' ' A' ' 13' ' ' TYR . 8.6 Cg_endo -52.04 161.3 2.51 Favored 'Trans proline' 0 N--CA 1.462 -0.367 0 C-N-CA 122.941 2.427 . . . . 0.0 112.577 179.912 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -55.49 129.67 39.75 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.546 179.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.924 ' HA2' ' HA ' ' A' ' 100' ' ' TRP . . . 108.76 -25.04 20.38 Favored Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.415 -0.898 . . . . 0.0 114.272 178.141 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.618 ' CD2' ' HG2' ' A' ' 10' ' ' PRO . 87.3 m-85 -87.44 121.19 29.55 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.909 0.355 . . . . 0.0 110.47 -179.604 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.695 ' HA ' ' HZ3' ' A' ' 100' ' ' TRP . 0.0 OUTLIER -71.48 85.34 0.84 Allowed 'General case' 0 CA--C 1.515 -0.367 0 CA-C-O 121.018 0.437 . . . . 0.0 110.825 179.91 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.671 ' HB2' ' CZ3' ' A' ' 79' ' ' TRP . 0.0 OUTLIER -49.01 123.72 7.6 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.184 -179.932 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.668 ' CB ' ' HA2' ' A' ' 46' ' ' GLY . 75.1 m-20 -131.61 176.57 8.21 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.212 -0.904 . . . . 0.0 109.235 -179.767 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.748 HG13 HD11 ' A' ' 47' ' ' ILE . 18.4 m -141.97 157.37 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 C-N-CA 120.221 -0.592 . . . . 0.0 112.377 179.626 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.475 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -126.28 168.43 18.42 Favored Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.209 178.39 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 1.079 HG21 HD13 ' A' ' 61' ' ' LEU . 5.1 mp -128.73 116.62 41.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 112.697 0.628 . . . . 0.0 112.697 -178.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.599 ' O ' HD12 ' A' ' 109' ' ' LEU . 8.3 t -103.87 98.23 8.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.617 178.28 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.939 HD22 HG11 ' A' ' 67' ' ' VAL . 13.6 tp -99.25 127.2 45.22 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.792 -178.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.716 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -121.62 151.63 40.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.821 179.496 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.547 ' OD1' ' N ' ' A' ' 23' ' ' ASN . 0.0 OUTLIER -94.61 173.84 7.41 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.859 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.443 ' HA ' ' HE3' ' A' ' 111' ' ' LYS . 20.6 p30 -57.91 -5.68 0.45 Allowed 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.653 176.819 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.568 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 4.9 m-20 -102.55 0.38 33.4 Favored 'General case' 0 CA--C 1.52 -0.197 0 N-CA-C 111.887 0.328 . . . . 0.0 111.887 -179.081 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.568 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 24.3 mmtp 75.18 22.73 1.7 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.262 -178.464 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.716 ' O ' ' HA ' ' A' ' 22' ' ' MET . 5.6 mmtt -93.37 143.81 25.92 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 178.803 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.743 HG13 ' HA ' ' A' ' 139' ' ' PRO . 1.8 mm -97.43 136.18 29.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.206 0.527 . . . . 0.0 111.762 -178.819 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.681 ' HB2' HD23 ' A' ' 21' ' ' LEU . 4.4 t80 -65.78 100.71 0.57 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.51 178.49 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.655 ' HB2' HD13 ' A' ' 142' ' ' LEU . . . -96.11 141.01 30.01 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.793 0.33 . . . . 0.0 111.058 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -138.12 131.6 30.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.947 -0.57 . . . . 0.0 110.487 179.809 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.763 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 53.8 p -99.3 144.48 28.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.887 0.375 . . . . 0.0 111.593 -179.358 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.413 ' HB3' ' OD1' ' A' ' 35' ' ' ASP . 3.8 mtp180 -71.97 128.0 34.35 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.807 179.62 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.704 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -44.02 -38.38 3.5 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-O 121.251 0.548 . . . . 0.0 111.141 179.918 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.413 ' OD1' ' HB3' ' A' ' 33' ' ' ARG . 4.8 p-10 -71.77 -34.04 69.13 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.215 -179.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 18.8 mt -124.85 105.38 29.63 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 120.73 0.3 . . . . 0.0 111.006 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_exo -69.73 -20.16 35.33 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.687 2.258 . . . . 0.0 112.748 -179.673 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -93.84 -7.59 42.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.651 -179.599 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.763 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -91.52 100.49 13.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.615 0.245 . . . . 0.0 111.032 -179.851 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.641 ' O ' ' HA ' ' A' ' 146' ' ' THR . 76.2 m95 -96.25 146.82 24.38 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.098 179.167 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.622 ' HG3' ' HG1' ' A' ' 146' ' ' THR . 0.2 OUTLIER -162.48 -128.75 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.979 -0.288 . . . . 0.0 110.668 -179.184 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.497 ' H ' ' HB3' ' A' ' 41' ' ' GLN . 2.1 ptt? 178.96 163.13 0.7 Allowed Pre-proline 0 N--CA 1.448 -0.571 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 -179.843 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.946 ' HG2' HD12 ' A' ' 61' ' ' LEU . 82.0 Cg_exo -45.07 148.85 1.48 Allowed 'Trans proline' 0 CA--C 1.529 0.241 0 C-N-CA 122.454 2.103 . . . . 0.0 113.047 -179.229 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.546 ' HG3' ' O ' ' A' ' 17' ' ' VAL . 51.9 tt0 -173.79 145.79 1.19 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.465 -179.452 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.793 ' HA3' ' HG2' ' A' ' 60' ' ' GLU . . . -145.81 -168.71 13.4 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.293 179.739 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.668 ' HA2' ' CB ' ' A' ' 16' ' ' ASN . . . -117.47 17.2 12.43 Favored Glycine 0 C--N 1.337 0.595 0 C-N-CA 119.997 -1.097 . . . . 0.0 115.382 -178.595 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.748 HD11 HG13 ' A' ' 17' ' ' VAL . 11.3 mt 62.01 136.44 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 117.796 0.798 . . . . 0.0 111.444 179.122 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.524 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 3.3 m-20 -69.68 -175.97 0.96 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.857 179.366 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -47.89 -81.08 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.428 -179.947 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -108.12 55.48 0.51 Allowed Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.941 -0.647 . . . . 0.0 111.814 179.567 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.524 ' HB2' ' HB2' ' A' ' 48' ' ' ASP . 4.0 tp10 -116.66 142.95 46.23 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.892 0.377 . . . . 0.0 111.159 -179.356 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.466 ' HB2' ' ND2' ' A' ' 55' ' ' ASN . 7.6 m-20 -64.8 168.89 6.12 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.102 179.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 4.2 Cg_exo -77.25 -53.75 0.07 OUTLIER 'Trans proline' 0 CA--C 1.515 -0.468 0 C-N-CA 122.742 2.295 . . . . 0.0 113.472 -178.747 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.619 ' O ' ' CD1' ' A' ' 58' ' ' ILE . 0.0 OUTLIER -49.17 -51.78 30.44 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.065 -179.255 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 56' ' ' ALA . 18.2 p30 -62.31 -37.91 87.38 Favored 'General case' 0 C--N 1.323 -0.587 0 C-N-CA 119.816 -0.754 . . . . 0.0 110.501 -179.301 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.504 ' N ' ' OD1' ' A' ' 55' ' ' ASN . . . -64.39 -44.77 90.27 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 177.735 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.584 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -60.02 -61.54 2.53 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.904 178.271 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.619 ' CD1' ' O ' ' A' ' 54' ' ' ARG . 2.6 mp -53.41 -46.9 59.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.626 179.454 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 5.4 mmt180 -64.18 -62.52 1.57 Allowed 'General case' 0 CA--C 1.519 -0.244 0 C-N-CA 120.631 -0.428 . . . . 0.0 110.739 179.822 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.793 ' HG2' ' HA3' ' A' ' 45' ' ' GLY . 0.2 OUTLIER -42.56 -43.09 3.61 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.185 0.517 . . . . 0.0 110.171 179.667 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 1.079 HD13 HG21 ' A' ' 19' ' ' ILE . 1.9 tp -50.0 -47.92 52.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.998 178.851 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.892 ' HG2' HG23 ' A' ' 68' ' ' THR . 1.9 tmm_? -67.07 -65.94 0.62 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.079 178.885 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -49.26 -24.3 1.74 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.373 -179.106 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -93.95 -36.94 11.94 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.39 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.596 ' HB ' HG23 ' A' ' 119' ' ' ILE . 1.4 p -127.81 -31.24 2.44 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 120.402 -0.519 . . . . 0.0 112.395 -178.941 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.501 ' HA2' ' HD2' ' A' ' 62' ' ' ARG . . . 106.92 -13.75 41.27 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.654 -178.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.939 HG11 HD22 ' A' ' 21' ' ' LEU . 73.6 t -55.77 107.18 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-O 121.167 0.508 . . . . 0.0 111.022 179.523 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.892 HG23 ' HG2' ' A' ' 62' ' ' ARG . 0.6 OUTLIER -121.47 -39.41 2.66 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.577 178.716 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 18.7 m -61.55 74.22 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.863 178.859 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -162.56 157.19 21.79 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.113 0.482 . . . . 0.0 112.029 -179.309 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -126.72 148.76 49.85 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.055 179.154 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.712 HG22 ' CD1' ' A' ' 110' ' ' PHE . 24.8 t -76.06 126.28 36.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.12 0.485 . . . . 0.0 111.627 179.615 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.53 HD11 ' HB2' ' A' ' 111' ' ' LYS . 0.7 OUTLIER -107.5 -21.49 5.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.421 179.289 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.443 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -169.49 177.43 4.62 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.81 -179.192 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -159.53 152.16 21.45 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.527 179.689 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.836 ' HA ' HG11 ' A' ' 160' ' ' VAL . 43.1 t -71.9 135.87 82.82 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 120.974 0.416 . . . . 0.0 111.055 -179.701 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.431 ' HD2' HG13 ' A' ' 76' ' ' VAL . 18.1 Cg_endo -60.13 -62.21 0.17 Allowed 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.075 2.516 . . . . 0.0 112.612 -179.452 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.748 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.3 OUTLIER -98.01 -177.3 3.7 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.593 -0.73 . . . . 0.0 111.154 -179.186 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.671 ' CZ3' ' HB2' ' A' ' 15' ' ' ARG . 28.8 m95 -94.27 -152.73 0.35 Allowed 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 178.557 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.895 HD23 ' HB3' ' A' ' 5' ' ' SER . 24.2 mt -164.39 101.97 0.83 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 179.754 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.747 HG22 ' HB2' ' A' ' 104' ' ' ALA . 77.7 p -92.89 92.88 8.1 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.898 0.38 . . . . 0.0 111.878 -178.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 7.7 t80 -78.48 87.55 4.47 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 116.07 -0.514 . . . . 0.0 109.865 178.832 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -72.01 161.65 30.61 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 179.594 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.799 ' HB3' ' HB ' ' A' ' 88' ' ' VAL . 46.7 m-85 -102.7 143.77 27.27 Favored Pre-proline 0 C--N 1.318 -0.801 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.234 -179.319 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.52 ' HB3' ' HD2' ' A' ' 86' ' ' PRO . 37.6 Cg_exo -58.26 -178.6 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.381 0 C-N-CA 122.62 2.213 . . . . 0.0 111.821 -179.855 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.52 ' HD2' ' HB3' ' A' ' 85' ' ' PRO . 35.0 Cg_endo -65.49 -11.65 31.36 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.139 1.893 . . . . 0.0 112.488 -179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.61 -43.48 10.15 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.843 0.354 . . . . 0.0 110.856 179.827 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.799 ' HB ' ' HB3' ' A' ' 84' ' ' PHE . 17.1 t -90.76 -24.85 5.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.325 -179.896 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.617 ' O ' HD13 ' A' ' 94' ' ' ILE . 7.1 tpp85 -68.94 -4.44 16.64 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 120.969 0.414 . . . . 0.0 110.491 178.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.756 ' HA ' HD13 ' A' ' 94' ' ' ILE . 2.0 mt-10 -114.08 -15.31 12.28 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-O 120.719 0.295 . . . . 0.0 111.464 179.643 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.77 -27.7 14.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.867 0.365 . . . . 0.0 110.969 -179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.655 HD22 ' O ' ' A' ' 92' ' ' LEU . 0.9 OUTLIER -120.13 -52.89 2.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.979 -179.662 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.579 ' HA ' ' CD1' ' A' ' 96' ' ' TRP . 7.2 m120 -62.26 -23.14 66.53 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.865 -179.017 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.756 HD13 ' HA ' ' A' ' 90' ' ' GLU . 0.7 OUTLIER -74.14 -14.73 16.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.298 179.308 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.518 ' HB3' ' H ' ' A' ' 96' ' ' TRP . 0.4 OUTLIER -81.82 -102.3 0.03 OUTLIER 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.208 179.469 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.846 ' HB3' ' CD1' ' A' ' 100' ' ' TRP . 93.4 m95 33.53 97.41 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 112.867 0.691 . . . . 0.0 112.867 178.511 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -41.1 -70.08 0.45 Allowed Glycine 0 CA--C 1.522 0.498 0 CA-C-N 115.709 -0.678 . . . . 0.0 113.132 179.524 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -65.24 -164.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.865 0.364 . . . . 0.0 110.753 179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.567 ' O ' ' HA2' ' A' ' 12' ' ' GLY . 0.6 OUTLIER -87.04 88.13 7.63 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.061 179.698 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.924 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 52.7 m95 -107.14 -165.63 1.08 Allowed 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.108 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.669 ' HB2' ' O ' ' A' ' 100' ' ' TRP . 0.1 OUTLIER 159.23 62.96 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.516 0.726 . . . . 0.0 109.74 -179.268 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 107.8 -169.86 14.88 Favored Glycine 0 C--N 1.333 0.385 0 C-N-CA 120.459 -0.876 . . . . 0.0 112.708 179.655 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.676 ' O ' ' HA ' ' A' ' 81' ' ' THR . 40.9 mt-30 -148.32 127.09 12.58 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.758 0.313 . . . . 0.0 111.466 -179.56 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.747 ' HB2' HG22 ' A' ' 81' ' ' THR . . . -92.49 116.27 28.84 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.941 179.859 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.664 ' CG ' ' HB2' ' A' ' 16' ' ' ASN . 18.7 mt-30 -113.87 123.29 49.42 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -179.044 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.488 ' HD3' ' CD1' ' A' ' 79' ' ' TRP . 2.2 ttpt -106.03 133.44 50.75 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.3 177.807 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.504 ' CZ2' ' CE1' ' A' ' 154' ' ' TYR . 41.8 m95 -102.72 160.48 14.55 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.023 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.507 ' HB3' ' CE1' ' A' ' 110' ' ' PHE . 90.8 m-85 -133.91 154.12 51.29 Favored 'General case' 0 CA--C 1.53 0.182 0 CA-C-N 115.338 -0.846 . . . . 0.0 110.705 179.976 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.686 HD22 ' CG ' ' A' ' 161' ' ' PHE . 11.5 tp -109.83 128.24 55.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.149 179.648 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.879 ' CE2' HG23 ' A' ' 19' ' ' ILE . 5.4 m-85 -133.9 147.75 51.15 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.279 0.561 . . . . 0.0 111.8 179.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.554 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 21.8 tttt -99.47 124.52 44.7 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.572 178.542 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.619 ' HB2' HD11 ' A' ' 21' ' ' LEU . 34.8 t80 -78.54 101.03 7.17 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.882 0.373 . . . . 0.0 110.952 179.599 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 15.9 p -98.99 40.77 1.18 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.74 -179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -142.27 -146.66 4.68 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.938 -0.649 . . . . 0.0 112.364 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 2.3 pt20 -120.82 153.7 36.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.887 0.375 . . . . 0.0 111.216 179.786 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.488 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 4.4 p30 -59.7 -39.2 83.82 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-O 121.487 0.66 . . . . 0.0 111.164 -179.611 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 6.4 mm-40 -59.31 -1.74 0.24 Allowed 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.86 -1.063 . . . . 0.0 112.161 -179.325 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -89.93 -17.91 27.09 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.864 0.364 . . . . 0.0 110.701 179.701 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.711 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 13.6 mt -80.81 102.66 6.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.588 -179.821 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -102.0 94.3 5.71 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.899 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.641 HD11 ' HD1' ' A' ' 134' ' ' TRP . 44.9 mt -67.72 -41.26 83.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.028 0.442 . . . . 0.0 110.613 179.745 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.68 HD22 ' HG3' ' A' ' 129' ' ' PRO . 6.0 mt -97.34 143.96 27.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.189 -179.522 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -154.01 -129.21 1.3 Allowed Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.195 179.858 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -97.02 102.83 14.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.704 0.287 . . . . 0.0 110.888 179.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -164.29 119.32 0.87 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.547 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.61 -10.44 59.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.606 0.241 . . . . 0.0 111.219 179.808 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.404 ' O ' ' HB3' ' A' ' 128' ' ' LYS . 6.5 tt0 -90.74 -72.99 0.55 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.694 0.283 . . . . 0.0 110.752 179.948 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 127' ' ' GLU . 0.1 OUTLIER 179.79 153.56 0.62 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.688 178.988 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.68 ' HG3' HD22 ' A' ' 122' ' ' LEU . 10.5 Cg_endo -73.4 -173.41 1.3 Allowed 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 122.552 2.168 . . . . 0.0 112.393 179.645 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.583 ' O ' HD12 ' A' ' 34' ' ' LEU . 2.4 mp0 -89.79 -74.28 0.49 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.781 179.852 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.446 ' CE1' HG23 ' A' ' 65' ' ' THR . 0.8 OUTLIER -103.8 141.88 35.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.434 179.902 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.704 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -83.86 -34.82 17.51 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.005 -179.642 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.06 149.77 29.92 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.855 0.36 . . . . 0.0 110.46 179.787 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.711 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 32.7 p-90 -137.89 170.12 16.6 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.066 179.738 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.454 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 22.8 t -165.71 177.53 7.22 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.513 0.673 . . . . 0.0 111.918 -178.681 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.487 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 73.6 m95 -111.42 103.49 11.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.422 178.437 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.433 ' O ' ' N ' ' A' ' 28' ' ' ILE . 31.7 m -119.26 171.68 7.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 109.941 -0.392 . . . . 0.0 109.941 -179.881 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.556 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 22.3 p -74.0 167.29 36.85 Favored Pre-proline 0 C--N 1.326 -0.431 0 C-N-CA 120.157 -0.617 . . . . 0.0 109.955 179.143 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.743 ' HA ' HG13 ' A' ' 28' ' ' ILE . 21.7 Cg_exo -59.11 -55.85 1.69 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 121.772 1.648 . . . . 0.0 110.347 178.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.37 -25.41 68.28 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.855 178.494 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.408 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 9.1 mm-40 -72.84 -47.16 48.59 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.73 -179.74 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.655 HD13 ' HB2' ' A' ' 30' ' ' ALA . 20.3 tp -59.64 -37.73 79.47 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 179.865 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.817 HG21 ' HG2' ' A' ' 155' ' ' LYS . 12.7 mm -63.03 -36.15 74.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.555 178.94 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.27 -52.99 15.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.333 0.587 . . . . 0.0 110.367 179.607 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.458 ' HB3' ' CD1' ' A' ' 40' ' ' TRP . 0.5 OUTLIER -72.2 -16.77 61.96 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.575 -179.239 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.641 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 12.7 t -76.45 176.0 8.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.019 0.438 . . . . 0.0 111.46 -179.652 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.548 ' HB ' ' CE1' ' A' ' 149' ' ' PHE . 17.6 m -74.9 150.88 6.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.674 179.432 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.43 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 50.6 mt-10 -58.32 -53.28 60.11 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.869 179.848 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.548 ' CE1' ' HB ' ' A' ' 147' ' ' VAL . 38.2 p90 -57.47 0.91 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -179.577 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.45 ' HB2' HG23 ' A' ' 147' ' ' VAL . 53.1 mttt -134.41 -9.17 2.54 Favored 'General case' 0 N--CA 1.466 0.365 0 O-C-N 121.99 -0.444 . . . . 0.0 111.967 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.686 ' HG3' HG22 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -60.58 -54.64 52.82 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.919 -0.128 . . . . 0.0 110.823 179.781 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.691 ' HB2' HD21 ' A' ' 3' ' ' LEU . 38.8 Cg_endo -67.5 -28.18 38.71 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.196 1.931 . . . . 0.0 111.61 179.834 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.61 ' O ' HG23 ' A' ' 157' ' ' VAL . 37.8 t -68.74 -50.96 50.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.389 0 N-CA-C 108.441 -0.948 . . . . 0.0 108.441 178.369 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.504 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 5.8 m-30 -66.68 -38.49 86.91 Favored 'General case' 0 N--CA 1.451 -0.39 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.669 178.449 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.817 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -56.09 -39.99 72.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.595 179.837 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.407 ' O ' HG23 ' A' ' 160' ' ' VAL . 0.6 OUTLIER -69.07 -31.98 71.12 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 179.02 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.629 HG12 ' CE2' ' A' ' 161' ' ' PHE . 42.2 t -64.77 -42.11 94.03 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.796 0 CA-C-N 115.458 -0.792 . . . . 0.0 109.69 178.699 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.497 HD22 ' HB3' ' A' ' 139' ' ' PRO . 64.9 mt -64.49 -44.22 91.66 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.661 179.625 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 38.5 t -52.63 -40.32 62.65 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 179.142 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.836 HG11 ' HA ' ' A' ' 76' ' ' VAL . 91.2 t -67.43 -42.48 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 115.518 -0.765 . . . . 0.0 108.984 177.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.686 ' CG ' HD22 ' A' ' 109' ' ' LEU . 21.1 m-30 -80.72 6.47 12.78 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 114.899 -1.046 . . . . 0.0 112.188 -179.527 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.598 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -58.46 -53.41 66.43 Favored Pre-proline 0 C--N 1.33 -0.266 0 C-N-CA 120.716 -0.394 . . . . 0.0 110.684 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 18.0 Cg_endo -57.67 -12.87 12.49 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.143 1.896 . . . . 0.0 111.869 178.811 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.443 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 90.5 m-70 -108.68 -19.36 13.45 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.263 -179.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 97.7 mt . . . . . 0 C--O 1.248 1.022 0 CA-C-O 118.294 -0.86 . . . . 0.0 110.606 179.825 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.564 -0.214 . . . . 0.0 112.564 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -72.95 -167.28 0.34 Allowed 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.477 2.118 . . . . 0.0 111.927 179.652 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.594 HD11 HG22 ' A' ' 153' ' ' VAL . 4.4 mm? 60.55 110.02 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.81 0.338 . . . . 0.0 110.601 179.816 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.479 ' O ' ' HG3' ' A' ' 6' ' ' MET . . . -96.29 -39.53 4.22 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.826 -179.754 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.867 ' HA ' ' HA ' ' A' ' 80' ' ' LEU . 11.5 p 57.89 -103.54 0.18 Allowed 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.438 0.295 . . . . 0.0 111.741 -179.366 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.479 ' HG3' ' O ' ' A' ' 4' ' ' GLY . 16.0 mtm 64.45 128.28 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.67 0.271 . . . . 0.0 110.416 -179.141 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.641 ' HA ' ' HA ' ' A' ' 78' ' ' TYR . 4.1 p-10 -67.05 -6.4 17.05 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.748 0.309 . . . . 0.0 111.498 -179.821 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 79.3 p -142.26 107.43 5.68 Favored Pre-proline 0 C--N 1.33 -0.254 0 N-CA-C 110.025 -0.361 . . . . 0.0 110.025 179.586 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.547 ' HB3' ' CB ' ' A' ' 104' ' ' ALA . 57.3 Cg_endo -70.45 107.78 2.07 Favored 'Trans proline' 0 C--N 1.345 0.388 0 C-N-CA 122.423 2.082 . . . . 0.0 112.823 -179.242 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.497 ' HD2' ' HA ' ' A' ' 9' ' ' PRO . 2.7 Cg_endo -47.4 167.81 0.08 OUTLIER 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 123.177 2.585 . . . . 0.0 112.668 179.919 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -49.3 137.1 14.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.077 179.758 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.529 ' HA3' ' O ' ' A' ' 99' ' ' ASP . . . 62.5 64.31 3.97 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.54 -0.838 . . . . 0.0 112.839 179.658 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.458 ' CD2' ' HG2' ' A' ' 10' ' ' PRO . 11.5 m-85 -149.65 55.2 0.96 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.062 0.458 . . . . 0.0 110.857 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.945 ' HG2' HD21 ' A' ' 16' ' ' ASN . 0.2 OUTLIER 32.23 -157.54 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.538 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.578 179.185 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.631 ' HG3' ' CZ3' ' A' ' 79' ' ' TRP . 1.2 ttp180 176.57 93.09 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.743 0.306 . . . . 0.0 111.142 -178.552 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.945 HD21 ' HG2' ' A' ' 14' ' ' ARG . 0.5 OUTLIER -133.0 -177.5 4.54 Favored 'General case' 0 CA--C 1.51 -0.582 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.14 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.725 HG13 ' CG1' ' A' ' 47' ' ' ILE . 35.3 m -140.71 168.06 17.06 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.289 179.303 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.677 ' HA3' ' CD2' ' A' ' 107' ' ' TRP . . . -134.16 154.45 21.4 Favored Glycine 0 N--CA 1.441 -0.981 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.329 179.077 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.831 ' HB ' ' HB2' ' A' ' 43' ' ' PRO . 3.1 mp -126.66 117.32 47.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.005 0.431 . . . . 0.0 111.871 -179.379 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.652 ' O ' HD12 ' A' ' 109' ' ' LEU . 42.1 t -98.48 99.43 10.59 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 177.928 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.83 HD22 HG11 ' A' ' 67' ' ' VAL . 24.3 tp -98.31 115.18 27.88 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.522 -178.407 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.666 ' HE1' ' HE2' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -115.6 163.0 16.42 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.44 179.253 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.72 ' ND2' ' HB2' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -98.5 168.11 10.39 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.725 -0.671 . . . . 0.0 110.169 179.958 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 22.9 p30 -55.71 -4.43 0.11 Allowed 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.195 177.83 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.564 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -100.63 2.92 42.12 Favored 'General case' 0 CA--C 1.521 -0.163 0 N-CA-C 112.113 0.412 . . . . 0.0 112.113 -178.934 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.666 ' HE2' ' HE1' ' A' ' 22' ' ' MET . 5.6 mmtp 74.44 21.55 2.31 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.01 -178.352 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.72 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 1.9 mmtt -92.33 150.03 21.08 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.763 HD11 ' HG3' ' A' ' 139' ' ' PRO . 1.5 mm -102.92 137.2 31.97 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -177.997 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.608 ' CE1' HD13 ' A' ' 119' ' ' ILE . 88.4 t80 -76.55 138.35 40.14 Favored 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.648 -0.706 . . . . 0.0 109.534 177.932 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.619 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -143.5 153.05 42.21 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.943 0.402 . . . . 0.0 110.877 -179.708 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.604 ' HB1' ' CB ' ' A' ' 131' ' ' PHE . . . -145.8 132.39 19.85 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.523 -179.837 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 4.1 m -97.38 153.26 18.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.127 0.489 . . . . 0.0 111.76 -179.016 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.651 ' O ' ' N ' ' A' ' 35' ' ' ASP . 6.7 mtp180 -68.83 131.64 45.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.547 -0.752 . . . . 0.0 111.966 -179.254 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.745 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.4 OUTLIER -55.37 55.3 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.218 0.607 . . . . 0.0 112.191 179.979 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.651 ' N ' ' O ' ' A' ' 33' ' ' ARG . 1.3 t0 -178.31 -29.67 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.07 0.462 . . . . 0.0 109.977 179.981 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.477 HD12 ' NE ' ' A' ' 33' ' ' ARG . 24.0 mt -118.82 107.4 42.4 Favored Pre-proline 0 N--CA 1.451 -0.376 0 CA-C-N 115.837 -0.619 . . . . 0.0 110.62 179.522 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -74.04 -18.26 21.46 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.514 2.143 . . . . 0.0 112.852 -179.553 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -94.53 -13.04 26.47 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.666 -179.755 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.629 ' HB1' ' CG1' ' A' ' 147' ' ' VAL . . . -92.38 101.38 13.85 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.71 0.291 . . . . 0.0 110.816 179.565 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.649 ' O ' ' HA ' ' A' ' 146' ' ' THR . 68.1 m95 -102.81 147.6 26.68 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.135 179.527 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.445 ' HG2' ' C ' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -152.2 160.27 43.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.269 0.557 . . . . 0.0 111.751 -179.984 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.476 ' HE2' ' HB2' ' A' ' 42' ' ' MET . 6.4 mtm -98.64 154.02 37.66 Favored Pre-proline 0 C--N 1.325 -0.459 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.055 179.227 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.831 ' HB2' ' HB ' ' A' ' 19' ' ' ILE . 52.9 Cg_exo -49.08 154.19 3.62 Favored 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.574 2.183 . . . . 0.0 112.152 -179.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.663 ' HA ' HD12 ' A' ' 19' ' ' ILE . 13.7 pt20 -177.4 178.15 1.1 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.489 -0.323 . . . . 0.0 110.882 -178.759 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.499 ' HA3' ' CG ' ' A' ' 60' ' ' GLU . . . 170.91 150.11 6.83 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.426 -0.893 . . . . 0.0 112.578 179.855 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.675 ' HA2' ' CB ' ' A' ' 16' ' ' ASN . . . -74.47 135.03 18.89 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.458 -0.877 . . . . 0.0 113.688 -179.475 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.725 ' CG1' HG13 ' A' ' 17' ' ' VAL . 11.7 mt -70.64 141.73 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.549 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -68.39 -171.02 0.23 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.843 0.354 . . . . 0.0 110.993 -179.79 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.549 ' HG3' ' H ' ' A' ' 50' ' ' GLY . 2.3 pt-20 -49.06 -67.32 0.28 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.525 -179.476 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.549 ' H ' ' HG3' ' A' ' 49' ' ' GLU . . . -127.67 54.39 0.78 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.052 -0.594 . . . . 0.0 111.742 179.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -108.99 148.15 31.19 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.746 0.308 . . . . 0.0 110.504 -179.692 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.429 ' HA ' ' HD3' ' A' ' 53' ' ' PRO . 7.7 m-20 -68.84 140.67 91.71 Favored Pre-proline 0 C--N 1.325 -0.495 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.253 179.843 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.551 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 35.3 Cg_exo -60.23 -47.14 15.54 Favored 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.325 2.017 . . . . 0.0 111.682 -179.963 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.86 ' HE ' HG21 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -53.04 -45.98 68.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.118 -0.947 . . . . 0.0 110.564 179.404 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.51 ' HA ' HD12 ' A' ' 58' ' ' ILE . 12.6 m-20 -67.31 -43.85 80.64 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.431 179.63 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -60.24 -42.05 94.43 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.646 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.773 ' HB1' HG13 ' A' ' 19' ' ' ILE . . . -57.78 -55.53 33.65 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.94 178.604 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.601 HD11 ' CZ ' ' A' ' 54' ' ' ARG . 14.4 mt -55.15 -54.08 28.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.257 179.284 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -61.28 -63.67 1.21 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.811 -179.538 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.499 ' CG ' ' HA3' ' A' ' 45' ' ' GLY . 46.4 mm-40 -43.94 -47.29 8.46 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.164 0.507 . . . . 0.0 110.017 179.181 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.623 HD12 ' CB ' ' A' ' 43' ' ' PRO . 0.2 OUTLIER -50.12 -46.72 53.99 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.066 178.336 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.818 ' HG3' HG23 ' A' ' 68' ' ' THR . 24.6 ttm180 -63.15 -64.67 0.84 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.48 -179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -48.32 -20.16 0.37 Allowed 'General case' 0 C--N 1.324 -0.513 0 N-CA-C 112.532 0.568 . . . . 0.0 112.532 -179.194 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -98.4 -38.52 9.19 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -178.173 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.672 HG22 HD23 ' A' ' 121' ' ' LEU . 1.0 OUTLIER -125.29 -5.6 7.2 Favored 'General case' 0 N--CA 1.466 0.362 0 N-CA-C 112.603 0.594 . . . . 0.0 112.603 -178.704 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 79.02 -11.69 27.56 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.349 -0.929 . . . . 0.0 111.904 -178.74 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.83 HG11 HD22 ' A' ' 21' ' ' LEU . 58.8 t -57.91 114.19 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 CA-C-O 121.033 0.445 . . . . 0.0 111.185 179.509 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.818 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.9 OUTLIER -124.36 -41.33 2.18 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.187 178.285 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.413 ' CB ' ' HA3' ' A' ' 114' ' ' GLY . 14.9 m -61.37 73.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.468 -0.787 . . . . 0.0 111.302 179.307 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.615 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -161.16 152.34 18.75 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 112.344 0.498 . . . . 0.0 112.344 -179.359 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -126.2 150.63 48.21 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.232 179.291 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.86 HG21 ' HE ' ' A' ' 54' ' ' ARG . 21.3 t -74.79 127.93 36.64 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.146 0.498 . . . . 0.0 111.766 179.683 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.589 HD11 ' HB2' ' A' ' 111' ' ' LYS . 1.6 mt -105.73 -18.96 6.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.421 -0.809 . . . . 0.0 110.146 179.325 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.498 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -170.94 176.56 4.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.54 179.806 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -155.04 146.76 23.3 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.37 179.43 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.878 ' HA ' HG11 ' A' ' 160' ' ' VAL . 54.7 t -70.64 140.19 86.71 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-O 120.918 0.39 . . . . 0.0 111.068 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.644 ' HD2' HG13 ' A' ' 76' ' ' VAL . 29.9 Cg_endo -63.55 -59.44 0.21 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.138 2.558 . . . . 0.0 112.288 -179.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.641 ' HA ' ' HA ' ' A' ' 7' ' ' ASP . 0.2 OUTLIER -102.31 -174.63 2.62 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.433 -179.202 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.631 ' CZ3' ' HG3' ' A' ' 15' ' ' ARG . 34.1 m95 -89.26 -158.96 0.54 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.665 179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.867 ' HA ' ' HA ' ' A' ' 5' ' ' SER . 65.8 mt -161.37 101.42 1.21 Allowed 'General case' 0 N--CA 1.464 0.269 0 CA-C-O 121.248 0.547 . . . . 0.0 110.87 -179.956 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.834 ' HA ' ' O ' ' A' ' 103' ' ' GLN . 70.8 p -96.59 -173.75 2.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.418 -0.81 . . . . 0.0 111.28 -179.681 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -171.0 58.23 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.742 179.627 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 12.9 p30 -70.58 173.28 7.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.598 179.896 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.626 ' CD2' HD12 ' A' ' 92' ' ' LEU . 4.2 m-85 -101.05 166.49 12.32 Favored Pre-proline 0 C--N 1.326 -0.425 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.165 -179.815 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.517 ' CB ' ' HD2' ' A' ' 86' ' ' PRO . 26.2 Cg_exo -61.69 -177.23 0.22 Allowed 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.68 2.253 . . . . 0.0 111.23 179.514 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 85' ' ' PRO . 36.0 Cg_endo -66.23 -3.23 8.31 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.191 1.927 . . . . 0.0 112.982 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.63 -67.1 0.91 Allowed 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.993 0.425 . . . . 0.0 111.021 -179.806 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.611 ' HB ' ' HB3' ' A' ' 84' ' ' PHE . 13.0 t -61.32 -14.68 11.13 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.961 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.602 HH11 ' HB3' ' A' ' 89' ' ' ARG . 0.0 OUTLIER -50.15 -76.49 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-O 120.933 0.397 . . . . 0.0 111.275 179.552 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.897 ' HA ' HD13 ' A' ' 94' ' ' ILE . 3.7 mm-40 -55.27 -17.13 4.08 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.678 -179.59 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.513 ' O ' ' HB2' ' A' ' 95' ' ' GLN . 0.0 OUTLIER -81.84 -49.46 10.34 Favored 'General case' 0 C--N 1.332 -0.196 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.046 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.626 HD12 ' CD2' ' A' ' 84' ' ' PHE . 1.5 tm? -111.03 -46.46 3.32 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.809 0.337 . . . . 0.0 111.366 -179.015 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.617 ' HB3' ' HA ' ' A' ' 101' ' ' LYS . 10.8 m120 -54.88 -38.82 68.0 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.653 -179.414 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.897 HD13 ' HA ' ' A' ' 90' ' ' GLU . 1.7 mp -92.88 -10.25 9.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.004 0.431 . . . . 0.0 110.231 179.18 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.513 ' HB2' ' O ' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -67.68 -4.65 12.73 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.939 179.887 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . 0.772 ' HB2' ' HB2' ' A' ' 100' ' ' TRP . 60.7 m95 -84.58 32.87 0.51 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.668 0.27 . . . . 0.0 111.077 179.765 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.605 ' O ' ' HB2' ' A' ' 98' ' ' SER . . . 73.87 23.06 77.32 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.661 -179.917 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.605 ' HB2' ' O ' ' A' ' 97' ' ' GLY . 15.5 m 78.3 170.57 0.2 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.383 0.273 . . . . 0.0 110.901 179.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.593 ' HB2' ' O ' ' A' ' 98' ' ' SER . 1.1 m-20 75.79 -45.79 0.54 Allowed 'General case' 0 N--CA 1.467 0.405 0 CA-C-N 116.405 -0.361 . . . . 0.0 111.523 -179.69 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.772 ' HB2' ' HB2' ' A' ' 96' ' ' TRP . 29.3 m95 -72.4 -166.19 0.24 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.496 -179.694 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.617 ' HA ' ' HB3' ' A' ' 93' ' ' ASN . 0.0 OUTLIER 167.65 9.33 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -179.758 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . 165.73 -156.4 28.31 Favored Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.934 -179.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.834 ' O ' ' HA ' ' A' ' 81' ' ' THR . 62.2 tt0 -148.68 113.83 5.51 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.387 0.514 . . . . 0.0 112.387 -179.748 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.685 ' HB2' HG22 ' A' ' 81' ' ' THR . . . -98.48 121.21 40.14 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.126 179.522 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.676 ' HG2' ' HB2' ' A' ' 16' ' ' ASN . 28.7 mt-30 -132.03 126.7 34.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.861 -0.609 . . . . 0.0 112.488 -178.663 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 17' ' ' VAL . 13.3 ttmt -102.7 134.88 45.34 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.283 179.46 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.677 ' CD2' ' HA3' ' A' ' 18' ' ' GLY . 17.2 m95 -101.82 163.64 12.15 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -178.483 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.621 ' HB2' ' HE1' ' A' ' 110' ' ' PHE . 96.4 m-85 -141.36 153.12 44.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.207 -179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.652 HD12 ' O ' ' A' ' 20' ' ' CYS . 15.7 tp -99.7 139.03 35.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.52 -0.309 . . . . 0.0 110.942 179.628 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.821 ' CE2' HG22 ' A' ' 72' ' ' VAL . 41.6 m-85 -140.97 145.36 35.88 Favored 'General case' 0 CA--C 1.52 -0.194 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -179.355 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.615 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 14.1 tttt -102.93 123.74 47.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.84 -1.073 . . . . 0.0 109.848 178.545 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.685 ' HB2' HD11 ' A' ' 21' ' ' LEU . 54.8 t80 -78.3 98.11 5.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.958 0.408 . . . . 0.0 110.454 179.124 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 43.7 p -95.9 41.62 1.1 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.622 -179.912 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.413 ' HA3' ' CB ' ' A' ' 69' ' ' SER . . . -143.67 -146.86 4.61 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.699 -0.762 . . . . 0.0 113.143 -179.68 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . 0.417 ' O ' ' HZ ' ' A' ' 112' ' ' PHE . 3.7 mm100 -124.02 149.02 46.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.987 0.422 . . . . 0.0 111.219 -179.626 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.0 m-20 -58.47 -30.65 67.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.536 -179.494 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -59.65 -4.79 0.72 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.884 -0.598 . . . . 0.0 112.099 -179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -90.69 -20.28 22.65 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.023 0.44 . . . . 0.0 110.482 179.712 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.608 HD13 ' CE1' ' A' ' 29' ' ' PHE . 11.8 mt -83.97 106.56 14.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.426 -179.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.687 HD21 HD12 ' A' ' 122' ' ' LEU . 2.7 t30 -102.19 -25.29 13.75 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.954 -179.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.672 HD23 HG22 ' A' ' 65' ' ' THR . 74.0 mt 74.62 -38.01 0.37 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.363 179.719 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.687 HD12 HD21 ' A' ' 120' ' ' ASN . 8.7 mt -76.96 168.42 20.12 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.92 -179.579 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -111.28 -129.02 5.39 Favored Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.131 179.915 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -98.78 22.54 9.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.788 0.328 . . . . 0.0 111.082 179.827 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . 57.29 81.02 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.547 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -118.85 -46.9 2.53 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.906 0.384 . . . . 0.0 110.878 -179.745 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -147.36 -47.17 0.17 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.698 179.997 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 16.5 pttt -178.03 155.15 1.0 Allowed Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.053 179.031 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.63 ' HB3' HD23 ' A' ' 122' ' ' LEU . 27.8 Cg_endo -74.69 -178.41 4.05 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 122.899 2.399 . . . . 0.0 112.774 -179.847 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.595 ' O ' HD12 ' A' ' 34' ' ' LEU . 0.6 OUTLIER -96.53 -65.17 0.98 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.002 -179.575 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.604 ' CB ' ' HB1' ' A' ' 31' ' ' ALA . 3.1 m-85 -102.25 140.71 36.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.171 0.51 . . . . 0.0 110.359 179.606 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.745 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -85.74 -35.79 11.17 Favored Glycine 0 N--CA 1.45 -0.377 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.922 -179.404 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -149.23 145.92 27.35 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.971 0.415 . . . . 0.0 110.439 179.823 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.608 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 36.4 p-90 -132.0 163.75 27.71 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.919 179.786 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.438 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 32.0 t -160.93 175.69 12.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.337 0.589 . . . . 0.0 111.987 -179.476 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.587 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 31.2 m95 -110.42 101.07 9.81 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.08 -0.964 . . . . 0.0 109.509 178.461 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.518 ' O ' ' N ' ' A' ' 28' ' ' ILE . 28.4 m -116.43 164.8 12.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 179.899 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.598 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 17.4 p -71.33 170.22 12.51 Favored Pre-proline 0 C--N 1.324 -0.52 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.447 179.776 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.809 ' HB3' HD22 ' A' ' 158' ' ' LEU . 15.7 Cg_exo -59.86 -58.92 0.46 Allowed 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.805 1.67 . . . . 0.0 110.335 179.149 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.9 -29.07 69.36 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.571 -0.74 . . . . 0.0 110.995 178.716 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.486 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 0.7 OUTLIER -72.47 -46.59 54.15 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.409 -0.36 . . . . 0.0 110.275 179.796 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.619 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.5 OUTLIER -57.47 -40.51 78.71 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.341 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.724 HG21 ' HG2' ' A' ' 155' ' ' LYS . 36.3 mm -60.6 -37.21 74.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.913 179.375 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -71.21 -49.79 39.79 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.232 0.539 . . . . 0.0 111.02 179.498 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.23 -21.07 59.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.484 -0.78 . . . . 0.0 112.433 -179.086 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.649 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 10.7 t -74.19 174.83 8.19 Favored 'General case' 0 N--CA 1.464 0.236 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.24 -179.481 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.629 ' CG1' ' HB1' ' A' ' 39' ' ' ALA . 33.3 m -85.01 146.01 7.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.461 -179.254 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.542 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 41.7 mt-10 -49.97 -50.89 45.33 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.364 -179.783 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -52.84 -7.17 0.07 Allowed 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -179.816 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.402 ' H ' ' C ' ' A' ' 148' ' ' GLU . 5.1 mttm -137.18 -4.44 1.9 Allowed 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -178.64 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.575 ' HG2' ' O ' ' A' ' 143' ' ' ILE . 11.3 mttt -61.17 -59.11 14.77 Favored Pre-proline 0 C--N 1.327 -0.394 0 C-N-CA 121.279 -0.169 . . . . 0.0 110.972 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.542 ' HD2' ' O ' ' A' ' 148' ' ' GLU . 22.4 Cg_endo -60.96 -28.83 86.9 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.407 2.072 . . . . 0.0 111.653 179.588 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.732 ' O ' HG23 ' A' ' 157' ' ' VAL . 30.5 t -68.61 -55.03 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 178.277 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.531 ' CE1' ' CZ2' ' A' ' 107' ' ' TRP . 7.4 m-30 -61.65 -39.73 92.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.864 178.494 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.724 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -56.32 -43.79 79.32 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.922 -179.946 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.462 ' O ' HG23 ' A' ' 160' ' ' VAL . 2.7 tt0 -67.63 -31.69 71.88 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.568 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.732 HG23 ' O ' ' A' ' 153' ' ' VAL . 47.1 t -65.83 -41.34 89.95 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.979 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.651 178.729 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.809 HD22 ' HB3' ' A' ' 139' ' ' PRO . 64.0 mt -62.31 -47.01 86.15 Favored 'General case' 0 CA--C 1.521 -0.159 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.023 -179.891 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 4.8 m -51.9 -38.75 57.43 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 178.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.878 HG11 ' HA ' ' A' ' 76' ' ' VAL . 92.6 t -68.21 -44.22 84.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.273 177.892 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.652 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 21.2 m-30 -79.67 4.3 16.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.019 -0.991 . . . . 0.0 111.901 -179.381 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.566 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.38 -54.96 50.97 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 121.002 -0.279 . . . . 0.0 110.649 179.692 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 17.4 Cg_endo -57.92 -12.74 12.97 Favored 'Trans proline' 0 C--N 1.343 0.287 0 C-N-CA 122.024 1.816 . . . . 0.0 111.666 178.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.498 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 89.6 m-70 -108.25 -16.25 14.29 Favored 'General case' 0 CA--C 1.528 0.104 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.437 -179.897 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.652 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 77.6 mt . . . . . 0 C--O 1.249 1.055 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.712 -179.988 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.261 0 N-CA-C 112.348 -0.301 . . . . 0.0 112.348 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -53.06 165.96 1.12 Allowed 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.389 2.059 . . . . 0.0 111.931 179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.746 HD11 HG22 ' A' ' 153' ' ' VAL . 27.6 mt 61.46 -172.31 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.022 0.439 . . . . 0.0 111.192 179.941 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -154.28 49.11 0.5 Allowed Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.819 179.443 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.902 ' HB3' HD23 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -52.79 148.74 7.03 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -179.153 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . 0.572 ' O ' ' HB2' ' A' ' 78' ' ' TYR . 0.0 OUTLIER -144.83 155.7 43.63 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.501 179.601 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.475 ' HA ' ' CB ' ' A' ' 78' ' ' TYR . 3.3 t0 -61.45 -55.45 31.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.051 -179.454 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' SER . . . . . . . . . . . . . 58.5 m -97.28 154.35 38.11 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.694 -0.23 . . . . 0.0 110.48 179.463 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.488 ' HA ' ' HD2' ' A' ' 10' ' ' PRO . 55.8 Cg_endo -70.26 106.6 1.78 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.279 1.986 . . . . 0.0 112.102 179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.582 ' HG2' ' CD2' ' A' ' 13' ' ' TYR . 9.7 Cg_endo -52.74 163.33 1.98 Allowed 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 123.256 2.638 . . . . 0.0 113.177 -179.687 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -54.06 134.46 43.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.322 -0.853 . . . . 0.0 111.451 179.574 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 101' ' ' LYS . . . 51.2 88.13 0.01 OUTLIER Glycine 0 CA--C 1.518 0.228 0 C-N-CA 120.965 -0.636 . . . . 0.0 112.909 179.401 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.582 ' CD2' ' HG2' ' A' ' 10' ' ' PRO . 12.5 m-85 -154.63 125.52 7.14 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.674 0.273 . . . . 0.0 110.628 179.969 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ARG . . . . . 0.564 ' HA ' ' CZ3' ' A' ' 100' ' ' TRP . 17.2 ttt-85 -63.09 89.77 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 121.025 0.441 . . . . 0.0 110.499 179.743 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' ARG . . . . . 0.51 ' HG2' HD12 ' A' ' 47' ' ' ILE . 1.6 ttp180 -55.47 106.91 0.27 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.962 -179.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . 0.781 ' O ' ' HA ' ' A' ' 105' ' ' GLN . 3.1 m-80 -133.35 176.91 8.1 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.234 -0.654 . . . . 0.0 109.234 178.117 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.669 HG13 ' CG1' ' A' ' 47' ' ' ILE . 12.5 m -140.91 169.24 15.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 120.784 0.326 . . . . 0.0 111.299 179.494 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.573 ' HA3' ' CE2' ' A' ' 107' ' ' TRP . . . -134.84 162.85 24.76 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.779 -0.725 . . . . 0.0 112.264 179.423 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.95 HG21 HD22 ' A' ' 61' ' ' LEU . 3.9 mp -128.62 120.59 52.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 N-CA-C 112.246 0.462 . . . . 0.0 112.246 -178.963 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.603 ' O ' HD12 ' A' ' 109' ' ' LEU . 29.6 t -107.01 98.02 7.73 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 177.916 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.788 HD22 HG11 ' A' ' 67' ' ' VAL . 4.7 tp -104.69 126.13 51.46 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.946 -178.488 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' MET . . . . . 0.502 ' CE ' HD13 ' A' ' 73' ' ' ILE . 0.0 OUTLIER -124.51 162.8 23.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.786 179.009 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.635 ' OD1' ' CE3' ' A' ' 136' ' ' TRP . 0.0 OUTLIER -98.89 171.25 8.18 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.205 179.78 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.0 p-10 -56.7 -5.12 0.2 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.512 177.865 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' ASP . . . . . 0.508 ' O ' ' HB2' ' A' ' 26' ' ' LYS . 0.9 OUTLIER -98.21 3.7 48.93 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 120.781 0.324 . . . . 0.0 111.687 -179.111 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.508 ' HB2' ' O ' ' A' ' 25' ' ' ASP . 15.1 mmtp 73.22 19.45 3.55 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.182 -178.611 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.512 ' HB2' ' ND2' ' A' ' 23' ' ' ASN . 0.6 OUTLIER -96.81 142.19 29.11 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 178.923 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.678 HD12 ' N ' ' A' ' 28' ' ' ILE . 2.7 mp -102.22 145.83 11.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.804 0.811 . . . . 0.0 112.648 -177.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.576 ' CE1' HD13 ' A' ' 119' ' ' ILE . 86.2 t80 -74.65 138.7 43.06 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.779 179.665 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.831 ' HB2' HD12 ' A' ' 142' ' ' LEU . . . -140.54 147.19 39.12 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 179.712 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.45 ' HB1' ' CB ' ' A' ' 131' ' ' PHE . . . -137.87 137.97 38.63 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.909 0.385 . . . . 0.0 111.039 -179.542 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.747 ' HA ' ' O ' ' A' ' 39' ' ' ALA . 91.5 p -100.15 144.8 28.76 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.39 -179.665 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.472 ' HD3' ' CB ' ' A' ' 39' ' ' ALA . 5.2 mtp180 -70.06 126.48 29.81 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.74 179.579 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.717 ' HG ' ' CA ' ' A' ' 132' ' ' GLY . 0.7 OUTLIER -43.36 -34.81 1.34 Allowed 'General case' 0 N--CA 1.464 0.241 0 CA-C-O 121.361 0.6 . . . . 0.0 110.596 179.756 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -72.83 -41.5 64.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.858 179.614 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.419 ' HB ' ' HB3' ' A' ' 39' ' ' ALA . 17.4 mt -120.78 104.54 41.92 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.054 179.998 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_exo -66.79 -21.62 50.76 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.728 2.285 . . . . 0.0 112.661 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -92.19 -4.96 53.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.464 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.747 ' O ' ' HA ' ' A' ' 32' ' ' SER . . . -92.52 92.26 7.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.605 0.241 . . . . 0.0 111.338 -179.734 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.628 ' O ' ' HA ' ' A' ' 146' ' ' THR . 81.5 m95 -89.07 144.65 25.99 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.325 179.194 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.07 162.38 36.59 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.259 0.552 . . . . 0.0 111.314 -179.486 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.533 ' HB3' ' CZ3' ' A' ' 107' ' ' TRP . 0.0 OUTLIER -97.95 149.46 35.74 Favored Pre-proline 0 C--N 1.322 -0.612 0 CA-C-N 115.32 -0.855 . . . . 0.0 110.595 179.79 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' PRO . . . . . 0.475 ' CG ' HD13 ' A' ' 61' ' ' LEU . 5.1 Cg_endo -48.41 156.67 1.63 Allowed 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.533 2.155 . . . . 0.0 112.022 179.684 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.601 ' HA ' HD12 ' A' ' 19' ' ' ILE . 11.7 pt20 -176.4 -179.95 1.12 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.601 -179.657 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 170.49 157.3 12.39 Favored Glycine 0 C--N 1.33 0.206 0 C-N-CA 120.638 -0.791 . . . . 0.0 112.191 -179.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.74 ' HA2' ' HA ' ' A' ' 16' ' ' ASN . . . -82.84 137.23 16.33 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.404 -0.903 . . . . 0.0 113.339 -179.435 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.669 ' CG1' HG13 ' A' ' 17' ' ' VAL . 43.5 mt -69.58 142.35 16.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.827 0.346 . . . . 0.0 110.965 179.759 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -68.98 -174.27 0.58 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 179.662 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -48.5 -81.0 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.14 179.727 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -109.74 54.75 0.53 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.399 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 13.5 tp10 -115.5 147.1 41.04 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.918 0.39 . . . . 0.0 110.963 -179.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.09 164.36 53.22 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.469 179.631 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 108' ' ' PHE . 5.9 Cg_exo -74.85 -46.61 0.24 Allowed 'Trans proline' 0 CA--C 1.516 -0.405 0 C-N-CA 122.762 2.308 . . . . 0.0 111.584 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.757 ' NH2' HG11 ' A' ' 72' ' ' VAL . 0.0 OUTLIER -51.68 -46.02 63.66 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.807 179.851 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.427 ' O ' ' HB2' ' A' ' 59' ' ' ARG . 3.7 m120 -65.14 -48.04 74.96 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.309 179.688 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -61.12 -43.2 99.25 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.861 179.472 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.507 ' N ' HG21 ' A' ' 17' ' ' VAL . . . -59.15 -58.31 9.22 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.897 178.537 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.492 HD11 ' HG3' ' A' ' 54' ' ' ARG . 26.0 mt -56.93 -49.64 78.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.377 -0.829 . . . . 0.0 111.425 179.38 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.427 ' HB2' ' O ' ' A' ' 55' ' ' ASN . 6.1 ttp180 -64.18 -63.63 1.1 Allowed 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 121.011 -0.276 . . . . 0.0 111.354 -179.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 30.7 mm-40 -42.18 -43.62 3.42 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.957 0.408 . . . . 0.0 110.277 179.828 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.95 HD22 HG21 ' A' ' 19' ' ' ILE . 13.6 tp -51.77 -50.11 61.34 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.053 178.557 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.87 ' HG3' HG23 ' A' ' 68' ' ' THR . 1.1 ttt180 -63.01 -64.96 0.76 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.987 179.456 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -48.82 -25.37 1.84 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.809 -0.632 . . . . 0.0 111.768 -179.553 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -92.72 -40.19 10.84 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -178.522 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' THR . . . . . 0.729 HG22 HD23 ' A' ' 121' ' ' LEU . 0.8 OUTLIER -121.44 -34.45 3.44 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.59 -179.233 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 62' ' ' ARG . . . 106.42 -11.7 43.26 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.409 -178.874 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.788 HG11 HD22 ' A' ' 21' ' ' LEU . 32.4 t -57.22 111.44 0.43 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.238 0 CA-C-O 121.111 0.481 . . . . 0.0 111.58 179.534 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . 0.87 HG23 ' HG3' ' A' ' 62' ' ' ARG . 0.8 OUTLIER -122.71 -39.15 2.56 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.79 178.505 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.0 m -61.97 74.76 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.077 179.104 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.56 ' HA ' ' O ' ' A' ' 111' ' ' LYS . . . -162.14 155.81 21.09 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.026 0.441 . . . . 0.0 111.963 -179.435 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -126.72 147.94 49.92 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.363 179.447 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.757 HG11 ' NH2' ' A' ' 54' ' ' ARG . 6.6 t -75.58 126.81 36.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.222 0.534 . . . . 0.0 111.425 179.334 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.54 HD11 ' HB2' ' A' ' 111' ' ' LYS . 0.8 OUTLIER -106.97 -20.77 5.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.28 179.537 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.409 ' CB ' ' CD2' ' A' ' 164' ' ' HIS . . . -169.81 177.92 4.25 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.647 -179.702 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.7 pm0 -155.08 150.16 26.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.46 -0.791 . . . . 0.0 110.502 179.817 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.855 ' HA ' HG11 ' A' ' 160' ' ' VAL . 44.0 t -71.71 136.18 83.19 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.894 -179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.4 ' HD2' HG13 ' A' ' 76' ' ' VAL . 16.6 Cg_endo -55.06 -69.87 0.05 OUTLIER 'Trans proline' 0 C--N 1.347 0.498 0 C-N-CA 123.041 2.494 . . . . 0.0 112.138 -179.913 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.572 ' HB2' ' O ' ' A' ' 6' ' ' MET . 0.1 OUTLIER -94.07 -172.45 2.83 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.666 -179.759 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' TRP . . . . . 0.48 ' NE1' ' HE2' ' A' ' 106' ' ' LYS . 29.2 m95 -90.06 -158.47 0.53 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 178.816 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.902 HD23 ' HB3' ' A' ' 5' ' ' SER . 57.8 mt -162.21 111.5 1.47 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.916 -0.401 . . . . 0.0 109.916 -179.772 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . 0.912 HG22 ' HA ' ' A' ' 104' ' ' ALA . 29.8 p -109.05 -166.43 1.11 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.557 -179.239 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -168.08 43.32 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.888 -0.597 . . . . 0.0 110.434 -179.849 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.471 ' HB2' ' CE1' ' A' ' 13' ' ' TYR . 33.1 t70 -71.59 152.82 42.59 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.189 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' PHE . . . . . 0.636 ' CD2' HG11 ' A' ' 88' ' ' VAL . 3.3 m-85 -104.77 165.32 13.47 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-O 120.957 0.408 . . . . 0.0 111.878 -178.806 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.614 ' O ' ' HB2' ' A' ' 89' ' ' ARG . 33.2 Cg_exo -61.57 174.17 2.34 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.971 2.447 . . . . 0.0 111.623 179.542 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.432 ' HD2' ' HB3' ' A' ' 85' ' ' PRO . 10.9 Cg_endo -52.95 -37.83 78.64 Favored 'Trans proline' 0 C--N 1.347 0.476 0 C-N-CA 122.657 2.238 . . . . 0.0 112.749 -179.774 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.18 -61.27 2.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.879 0.371 . . . . 0.0 110.586 179.957 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.636 HG11 ' CD2' ' A' ' 84' ' ' PHE . 52.5 t -68.13 -27.2 36.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.833 179.628 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' ARG . . . . . 0.725 ' HG3' ' CB ' ' A' ' 93' ' ' ASN . 3.1 tpp85 -50.59 -39.93 51.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.179 -179.671 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.621 ' HA ' HD13 ' A' ' 94' ' ' ILE . 20.1 mt-10 -72.0 -20.31 61.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.237 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -98.89 -13.08 20.19 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.486 -0.324 . . . . 0.0 110.969 179.778 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.67 HD13 ' N ' ' A' ' 93' ' ' ASN . 1.1 tm? -121.21 -61.81 1.5 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.737 0.304 . . . . 0.0 111.584 -179.572 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.725 ' CB ' ' HG3' ' A' ' 89' ' ' ARG . 37.4 t-20 -55.91 -56.84 15.89 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 121.186 0.517 . . . . 0.0 111.303 -179.595 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' ILE . . . . . 0.621 HD13 ' HA ' ' A' ' 90' ' ' GLU . 2.9 mp -72.31 -10.07 13.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.514 -179.75 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' GLN . . . . . 0.494 ' HB3' ' O ' ' A' ' 92' ' ' LEU . 51.7 tt0 -66.33 -17.57 64.84 Favored 'General case' 0 C--N 1.334 -0.09 0 CA-C-N 116.462 -0.336 . . . . 0.0 110.969 179.203 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -105.11 20.81 18.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.1 179.479 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 68.62 -75.95 0.29 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.344 -0.931 . . . . 0.0 111.707 -179.043 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 25.3 p -68.38 -170.18 0.18 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 179.158 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.418 ' C ' ' H ' ' A' ' 101' ' ' LYS . 0.6 OUTLIER -64.98 -85.7 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 121.002 -0.279 . . . . 0.0 111.003 -179.959 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.72 ' HA ' ' CE3' ' A' ' 100' ' ' TRP . 0.0 OUTLIER 73.82 -31.07 0.21 Allowed 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 122.512 0.325 . . . . 0.0 111.761 -179.779 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.471 ' C ' ' O ' ' A' ' 100' ' ' TRP . 0.6 OUTLIER 14.06 55.8 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 113.794 1.035 . . . . 0.0 113.794 -179.292 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 100' ' ' TRP . . . 101.01 -163.29 18.27 Favored Glycine 0 C--N 1.332 0.32 0 C-N-CA 120.646 -0.787 . . . . 0.0 113.711 177.919 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.67 ' O ' ' HA ' ' A' ' 81' ' ' THR . 6.7 mt-30 -144.41 118.25 9.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.679 -0.261 . . . . 0.0 110.575 -179.742 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.912 ' HA ' HG22 ' A' ' 81' ' ' THR . . . -90.33 117.86 29.39 Favored 'General case' 0 CA--C 1.515 -0.371 0 CA-C-O 121.102 0.477 . . . . 0.0 109.948 179.52 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.781 ' HA ' ' O ' ' A' ' 16' ' ' ASN . 43.1 mt-30 -128.14 128.32 44.62 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 113.431 0.9 . . . . 0.0 113.431 -177.518 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.48 ' HE2' ' NE1' ' A' ' 79' ' ' TRP . 19.8 ttmt -104.9 134.89 47.26 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.539 178.044 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' TRP . . . . . 0.593 ' HD1' HD12 ' A' ' 80' ' ' LEU . 32.6 m95 -102.91 162.8 12.63 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.741 0.645 . . . . 0.0 112.741 -178.073 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' PHE . . . . . 0.47 ' HB3' ' CE1' ' A' ' 110' ' ' PHE . 98.2 m-85 -138.44 153.0 48.85 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.866 -179.875 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' LEU . . . . . 0.603 HD12 ' O ' ' A' ' 20' ' ' CYS . 19.2 tp -108.78 122.45 47.18 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.876 179.528 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.732 ' CE1' HG22 ' A' ' 72' ' ' VAL . 8.8 m-85 -127.47 148.4 50.31 Favored 'General case' 0 C--N 1.334 -0.102 0 CA-C-O 121.243 0.544 . . . . 0.0 111.689 179.912 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.56 ' O ' ' HA ' ' A' ' 70' ' ' ALA . 33.2 tttt -98.59 124.81 43.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.428 178.343 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.661 ' HB2' HD11 ' A' ' 21' ' ' LEU . 46.6 t80 -78.43 102.01 7.58 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.85 0.357 . . . . 0.0 110.901 179.702 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' THR . . . . . . . . . . . . . 20.8 p -99.33 42.0 1.12 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.288 179.573 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -141.92 -149.13 5.14 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.727 -179.803 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.46 150.06 42.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.989 0.423 . . . . 0.0 111.243 179.909 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.458 ' HB2' ' CH2' ' A' ' 134' ' ' TRP . 4.1 p30 -58.05 -38.92 77.21 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.376 0.608 . . . . 0.0 111.272 -179.667 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -57.63 -3.07 0.16 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.981 -1.008 . . . . 0.0 112.381 -179.6 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -89.18 -18.63 26.74 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 121.051 0.453 . . . . 0.0 110.435 179.469 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.618 HD12 ' CZ2' ' A' ' 134' ' ' TRP . 7.5 mt -86.81 107.24 16.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.962 179.754 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.547 ' O ' ' HB2' ' A' ' 121' ' ' LEU . 7.9 p-10 -96.98 -22.67 16.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.222 -179.567 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.729 HD23 HG22 ' A' ' 65' ' ' THR . 47.6 mt 76.76 -34.75 0.22 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.743 179.618 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.473 ' CD2' ' HG3' ' A' ' 129' ' ' PRO . 78.3 mt -63.54 162.84 12.1 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.191 0.52 . . . . 0.0 111.585 -179.616 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' GLY . . . . . . . . . . . . . . . -169.47 3.51 0.04 OUTLIER Glycine 0 N--CA 1.453 -0.187 0 CA-C-N 115.512 -0.767 . . . . 0.0 113.197 179.911 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER 59.0 90.74 0.05 OUTLIER 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.918 0.389 . . . . 0.0 111.027 -179.847 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' GLY . . . . . . . . . . . . . . . -103.98 -133.35 7.83 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.463 -179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 4.9 t -94.85 -23.76 17.33 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.68 0.276 . . . . 0.0 111.252 -179.936 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.426 ' O ' ' CG ' ' A' ' 128' ' ' LYS . 1.0 OUTLIER -146.91 -42.43 0.18 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.264 -179.867 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.808 ' HB3' ' HD2' ' A' ' 129' ' ' PRO . 55.8 mttt -162.4 167.01 13.02 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-O 121.189 0.519 . . . . 0.0 111.309 -178.679 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.808 ' HD2' ' HB3' ' A' ' 128' ' ' LYS . 6.3 Cg_endo -48.63 -172.44 0.0 OUTLIER 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 123.616 2.877 . . . . 0.0 112.739 -179.827 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -101.33 -53.91 2.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.854 -179.76 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' PHE . . . . . 0.45 ' CB ' ' HB1' ' A' ' 31' ' ' ALA . 1.5 m-85 -108.88 141.6 40.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.874 0.369 . . . . 0.0 110.348 179.683 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.717 ' CA ' ' HG ' ' A' ' 34' ' ' LEU . . . -91.31 -30.84 10.27 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.387 -179.703 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.51 150.52 32.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.731 0.3 . . . . 0.0 110.598 179.501 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' TRP . . . . . 0.618 ' CZ2' HD12 ' A' ' 119' ' ' ILE . 40.3 p-90 -137.78 168.74 19.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.089 179.532 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.451 ' N ' ' HE3' ' A' ' 134' ' ' TRP . 27.2 t -163.5 174.32 11.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.392 0.615 . . . . 0.0 112.54 -178.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' TRP . . . . . 0.635 ' CE3' ' OD1' ' A' ' 23' ' ' ASN . 36.8 m95 -110.12 107.08 16.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 114.95 -1.023 . . . . 0.0 108.849 177.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.425 ' O ' ' N ' ' A' ' 28' ' ' ILE . 26.4 m -121.71 172.64 8.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 116.621 -0.263 . . . . 0.0 110.678 -179.711 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.577 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 25.3 p -74.08 171.36 11.29 Favored Pre-proline 0 C--N 1.326 -0.456 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 178.812 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.676 ' HB3' HD22 ' A' ' 158' ' ' LEU . 9.2 Cg_exo -63.19 -54.55 1.04 Allowed 'Trans proline' 0 N--CA 1.453 -0.901 0 C-N-CA 121.331 1.354 . . . . 0.0 109.851 178.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.68 -29.02 70.3 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.965 178.717 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.495 ' HB2' ' OG1' ' A' ' 138' ' ' THR . 2.9 mt-30 -71.27 -46.46 60.88 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-O 120.933 0.397 . . . . 0.0 110.259 179.408 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 142' ' ' LEU . . . . . 0.831 HD12 ' HB2' ' A' ' 30' ' ' ALA . 0.4 OUTLIER -57.5 -39.86 77.42 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.048 -0.523 . . . . 0.0 109.651 179.59 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.768 HG21 ' HG2' ' A' ' 155' ' ' LYS . 26.1 mm -62.31 -38.34 80.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.298 179.279 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -69.98 -51.44 32.51 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.349 0.595 . . . . 0.0 110.781 179.639 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -72.36 -21.24 61.33 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.202 -0.908 . . . . 0.0 112.713 -179.093 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . 0.628 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 8.3 t -73.7 173.91 9.13 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.617 -0.433 . . . . 0.0 111.502 -179.108 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 147' ' ' VAL . . . . . 0.66 HG21 ' CZ ' ' A' ' 149' ' ' PHE . 29.9 m -77.13 155.67 5.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.689 179.883 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.484 ' O ' ' HD2' ' A' ' 152' ' ' PRO . 72.2 mt-10 -58.44 -55.74 31.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.151 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.66 ' CZ ' HG21 ' A' ' 147' ' ' VAL . 29.5 p90 -56.01 -0.64 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 -179.594 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.462 ' HD3' ' OH ' ' A' ' 154' ' ' TYR . 48.9 mttt -135.04 -7.85 2.33 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.407 0.521 . . . . 0.0 112.407 -179.83 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.524 ' HG2' ' HD3' ' A' ' 152' ' ' PRO . 0.1 OUTLIER -62.57 -56.72 27.25 Favored Pre-proline 0 C--N 1.328 -0.358 0 O-C-N 122.43 -0.169 . . . . 0.0 110.975 179.762 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.524 ' HD3' ' HG2' ' A' ' 151' ' ' LYS . 30.6 Cg_endo -64.56 -25.8 62.27 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.061 1.841 . . . . 0.0 111.149 179.197 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.764 ' O ' HG23 ' A' ' 157' ' ' VAL . 20.6 t -68.55 -50.9 51.87 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.342 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.456 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.462 ' OH ' ' HD3' ' A' ' 150' ' ' LYS . 9.0 m-30 -67.89 -36.67 80.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.975 178.664 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.768 ' HG2' HG21 ' A' ' 143' ' ' ILE . 0.0 OUTLIER -58.53 -40.89 84.22 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.543 179.532 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -70.0 -35.7 74.58 Favored 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 178.91 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 157' ' ' VAL . . . . . 0.764 HG23 ' O ' ' A' ' 153' ' ' VAL . 61.5 t -66.53 -39.85 84.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.781 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.695 178.821 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.676 HD22 ' HB3' ' A' ' 139' ' ' PRO . 27.7 mt -63.14 -42.4 99.46 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.556 179.741 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 159' ' ' SER . . . . . . . . . . . . . 67.3 m -54.38 -39.89 67.63 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.37 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . 0.855 HG11 ' HA ' ' A' ' 76' ' ' VAL . 95.1 t -67.71 -45.16 85.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.178 177.788 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 161' ' ' PHE . . . . . 0.612 ' O ' ' HG ' ' A' ' 165' ' ' LEU . 22.0 m-30 -80.45 5.01 16.32 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.724 -178.748 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . 0.63 ' N ' ' HD2' ' A' ' 163' ' ' PRO . . . -59.23 -52.02 77.45 Favored Pre-proline 0 C--N 1.328 -0.353 0 C-N-CA 120.625 -0.43 . . . . 0.0 110.815 179.617 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . 0.63 ' HD2' ' N ' ' A' ' 162' ' ' ALA . 19.2 Cg_endo -58.36 -11.75 11.69 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.328 2.019 . . . . 0.0 112.296 179.172 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 164' ' ' HIS . . . . . 0.409 ' CD2' ' CB ' ' A' ' 74' ' ' ALA . 81.8 m-70 -111.78 -18.21 12.78 Favored 'General case' 0 N--CA 1.462 0.153 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.4 -179.698 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 161' ' ' PHE . 91.7 mt . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.811 179.907 . . . . . . . . 1 1 . 1 stop_ save_